PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Seib, KL; Pigozzi, E; Muzzi, A; Gawthorne, JA; Delany, I; Jennings, MP; Rappuoli, R				Seib, Kate L.; Pigozzi, Eva; Muzzi, Alessandro; Gawthorne, Jayde A.; Delany, Isabel; Jennings, Michael P.; Rappuoli, Rino			A novel epigenetic regulator associated with the hypervirulent Neisseria meningitidis clonal complex 41/44	FASEB JOURNAL			English	Article						DNA methyltransferase; meningococcal infection; phase variation; phasevarion; virulence	RESTRICTION-MODIFICATION SYSTEM; PHASE VARIATION; HAEMOPHILUS-INFLUENZAE; TRANSCRIPTOME ANALYSIS; OXIDATIVE STRESS; CONTINGENCY LOCI; IDENTIFICATION; DISEASE; VACCINE; SEROGROUP	Neisseria meningitidis is a major cause of septicemia and meningitis. The hypervirulent clonal complex 41/44 (cc41/44) has emerged as the predominant cause of serogroup B meningococcal disease, having been responsible for recent outbreaks and epidemics worldwide. However, the meningococcal factors that enable transition from asymptomatic carriage to rapidly progressing disease are poorly understood. Here we describe a novel phase-variable DNA methyltransferase, ModD, which was identified in the genome sequence of a New Zealand epidemic isolate. Investigation of the distribution of modD in the wider meningococcal population, by PCR and sequence analysis of genetically diverse N. meningitidis strains, revealed the presence of modD in 20/27 strains in cc41/44, but in only 2/47 strains from other clonal complexes, indicating a significant association of modD with cc41/44 (Fisher's exact P value = 3 x 10(-10)). The modD gene contains 5'-ACCGA-3' repeats that mediate phase variation, leading to reversible on/off switching of modD expression. Microarray analysis of modD-on/off variants revealed that ModD regulates expression of multiple genes involved in colonization, infection, and protection against host defenses, with increased catalase expression in the modD-on variant conferring increased resistance to oxidative stress. The modulation of gene expression via the ModD phase-variable regulon (phasevarion), and its significant association with the cc41/44, suggest a role in the fitness and/or pathogenesis of strains belonging to the cc41/44.-Seib, K. L., Pigozzi, E., Muzzi, A., Gawthorne, J. A., Delany, I., Jennings, M. P., Rappuoli, R. A novel epigenetic regulator associated with the hypervirulent Neisseria meningitidis clonal complex 41/44. FASEB J. 25, 3622-3633 (2011). www.fasebj.org	[Seib, Kate L.] Novartis Vaccines, Microbial Mol Biol, I-53100 Siena, Italy; [Gawthorne, Jayde A.; Jennings, Michael P.] Griffith Univ, Inst Glyc, Gold Coast, Qld, Australia	Novartis; Griffith University	Seib, KL (corresponding author), Novartis Vaccines, Microbial Mol Biol, Via Fiorentina 1, I-53100 Siena, Italy.	kate.seib@novartis.com	Jennings, Michael P/G-4822-2013; Seib, Kate L/B-4670-2015	Jennings, Michael P/0000-0002-1027-4684; Seib, Kate L/0000-0002-7094-3528	Novartis Vaccines; Australian National Health and Medical Research Council [565526]	Novartis Vaccines; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Maria Scarselli, Yogitha Srikhanta, Duccio Medini, Sonia Budroni, Davide Serruto, Mariagrazia Pizza, Maurizio Comanducci, and Richard Moxon for useful discussions. The authors thank Stefania Bambini and Maurizio Comanducci (Novartis Vaccines) for providing meningococcal strains, Yogitha Srikhanta (Institute for Glycomics, Griffith University) for providing gonococcal FA1090 ModB1-on and Delta modB1 strains, Laura Fantappie' for help with microarray analysis, and the Australian Equine Genetics Research Centre for help with GeneScan fragment analysis. This work was supported by Novartis Vaccines (general support and a Novartis fellowship from the Ph.D. program in Cellular Biology of the University of Padova to E.P.) and the Australian National Health and Medical Research Council (C.J. Martin Fellowship to K. L. S.; program grant 565526 to M.P.J.).	Adamczyk-Poplawska M, 2009, FEMS MICROBIOL LETT, V300, P25, DOI 10.1111/j.1574-6968.2009.01760.x; Bambini S, 2009, VACCINE, V27, P2794, DOI 10.1016/j.vaccine.2009.02.098; Bart A, 2001, INFECT IMMUN, V69, P1816, DOI 10.1128/IAI.69.3.1816-1820.2001; Bayliss CD, 2001, J CLIN INVEST, V107, P657, DOI 10.1172/JCI12557; Bayliss CD, 2009, FEMS MICROBIOL REV, V33, P504, DOI 10.1111/j.1574-6976.2009.00162.x; BICKLE TA, 1993, MICROBIOL REV, V57, P434, DOI 10.1128/MMBR.57.2.434-450.1993; Bille E, 2005, J EXP MED, V201, P1905, DOI 10.1084/jem.20050112; Buckee CO, 2008, P NATL ACAD SCI USA, V105, P15082, DOI 10.1073/pnas.0712019105; Budroni S, 2011, P NATL ACAD SCI USA, V108, P4494, DOI 10.1073/pnas.1019751108; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; Caugant DA, 2008, INFECT GENET EVOL, V8, P558, DOI 10.1016/j.meegid.2008.04.002; de Vries N, 2002, J BACTERIOL, V184, P6615, DOI 10.1128/JB.184.23.6615-6624.2002; Delany I, 2006, J BACTERIOL, V188, P2483, DOI 10.1128/JB.188.7.2483-2492.2006; Dietrich G, 2003, J BACTERIOL, V185, P155, DOI 10.1128/JB.185.1.155-164.2003; Echenique-Rivera H, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002027; Elias J, 2010, EMERG INFECT DIS, V16, P464, DOI 10.3201/eid1603.091102; Exley RM, 2009, INFECT IMMUN, V77, P45, DOI 10.1128/IAI.00968-08; Fantappie L, 2011, MOL MICROBIOL, V80, P507, DOI 10.1111/j.1365-2958.2011.07592.x; Fox KL, 2007, NUCLEIC ACIDS RES, V35, P5242, DOI 10.1093/nar/gkm571; Frigimelica E, 2008, J INFECT DIS, V197, P1124, DOI 10.1086/533456; Grifantini R, 2003, P NATL ACAD SCI USA, V100, P9542, DOI 10.1073/pnas.1033001100; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; Guckenberger M, 2002, J BACTERIOL, V184, P2546, DOI 10.1128/JB.184.9.2546-2551.2002; Harrison LH, 2010, J INFECT DIS, V201, P1208, DOI 10.1086/651505; Harrison OB, 2009, J INFECT DIS, V200, P94, DOI 10.1086/599377; Heusipp G, 2007, INT J MED MICROBIOL, V297, P1, DOI 10.1016/j.ijmm.2006.10.002; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Ieva R, 2008, MOL MICROBIOL, V70, P1152, DOI 10.1111/j.1365-2958.2008.06468.x; Jolley KA, 2000, J CLIN MICROBIOL, V38, P4492, DOI 10.1128/JCM.38.12.4492-4498.2000; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; Levy C, 2010, PEDIATR INFECT DIS J, V29, P618, DOI 10.1097/INF.0b013e3181d3ce32; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Makarova KS, 2001, GENOME BIOL, V2; Martin P, 2003, MOL MICROBIOL, V50, P245, DOI 10.1046/j.1365-2958.2003.03678.x; Oster P, 2005, VACCINE, V23, P2191, DOI 10.1016/j.vaccine.2005.01.063; Peiser L, 2006, INFECT IMMUN, V74, P5191, DOI 10.1128/IAI.00124-06; Racloz VN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-175; Redaschi N, 1996, J MOL BIOL, V257, P790, DOI 10.1006/jmbi.1996.0202; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHOLTEN RJPM, 1993, CLIN INFECT DIS, V16, P237, DOI 10.1093/clind/16.2.237; SCHOLTEN RJPM, 1994, J INFECT DIS, V169, P673, DOI 10.1093/infdis/169.3.673; Seib KL, 2011, INFECT IMMUN, V79, P970, DOI 10.1128/IAI.00891-10; Seib KL, 2010, VACCINE, V28, P2416, DOI 10.1016/j.vaccine.2009.12.082; Seib KL, 2004, J INFECT DIS, V190, P136, DOI 10.1086/421299; Seib KL, 2002, FEMS IMMUNOL MED MIC, V32, P159; Skoglund A, 2007, J BACTERIOL, V189, P8914, DOI 10.1128/JB.00108-07; Snyder LAS, 2005, PLASMID, V54, P191, DOI 10.1016/j.plasmid.2005.04.005; Srikhanta YN, 2005, P NATL ACAD SCI USA, V102, P5547, DOI 10.1073/pnas.0501169102; Srikhanta YN, 2010, NAT REV MICROBIOL, V8, P196, DOI 10.1038/nrmicro2283; Srikhanta YN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000400; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Sun YH, 2000, NAT MED, V6, P1269, DOI 10.1038/81380; van der Ende A, 2000, INFECT IMMUN, V68, P6685, DOI 10.1128/IAI.68.12.6685-6690.2000; Wion D, 2006, NAT REV MICROBIOL, V4, P183, DOI 10.1038/nrmicro1350; Wu HJ, 2006, MOL MICROBIOL, V60, P401, DOI 10.1111/j.1365-2958.2006.05079.x; Yazdankhah SP, 2004, J CLIN MICROBIOL, V42, P5146, DOI 10.1128/JCM.42.11.5146-5153.2004	56	33	34	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3622	3633		10.1096/fj.11-183590	http://dx.doi.org/10.1096/fj.11-183590			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21680891				2022-12-25	WOS:000295356400032
J	Bouchecareilh, M; Higa, A; Fribourg, S; Moenner, M; Chevet, E				Bouchecareilh, Marion; Higa, Arisa; Fribourg, Sebastien; Moenner, Michel; Chevet, Eric			Peptides derived from the bifunctional kinase/RNase enzyme IRE1 alpha modulate IRE1 alpha activity and protect cells from endoplasmic reticulum stress	FASEB JOURNAL			English	Article						RIDD; UPR; alphascreen	UNFOLDED PROTEIN; CAENORHABDITIS-ELEGANS; TRANSMEMBRANE PROTEIN; MESSENGER-RNAS; ACTIVATION; ATF6; TRANSCRIPTION; SURVIVAL; DELIVERY; DOMAIN	Activation of the bifunctional kinase/RNase enzyme IRE1 alpha is part of an adaptive response triggered on accumulation of misfolded proteins in the endoplasmic reticulum (ER). To facilitate recovery of ER homeostasis, IRE1 alpha molecules oligomerize, allowing for their transautophosphorylation and endoribonuclease activation. These, in turn, induce the activation of specific transcriptional and post-transcriptional programs. To identify novel and selective modulators of IRE1 alpha activity, we investigated IRE1 alpha oligomerization properties using IRE1 alpha-derived peptides identified through an activity-based in vitro assay. We then used these peptides to probe IRE1 alpha activity in vitro and in vivo using both cultured human hepatocellular carcinoma-derived HuH7 cells and Caenorhabditis elegans experimental systems. We identified a peptide derived from the kinase domain of human IRE1 alpha, which promoted IRE1 alpha oligomerization in vitro, enhanced its Xbp1 mRNA cleavage activity in vitro (1.7 x) in cell culture (1.8 x) and in vivo (1.3 x), and attenuated both ER stress-mediated JNK activation and regulated IRE1-dependent mRNA decay (RIDD). This was accompanied by a 2.5-fold increase in survival on tunicamycin-induced ER stress and reduced apoptosis by 1.4-fold in cells expressing this peptide. Hence, targeted and selective activation of the catalytic properties of IRE1 alpha may consequently define new strategies to protect cells from deleterious effects of ER stress signaling.-Bouchecareilh, M., Higa, A., Fribourg, S., Moenner, M., Chevet, E. Peptides derived from the bifunctional kinase/RNase enzyme IRE1 alpha modulate IRE1 alpha activity and protect cells from endoplasmic reticulum stress. FASEB J. 25, 3115-3129 (2011). www.fasebj.org	[Bouchecareilh, Marion; Higa, Arisa; Chevet, Eric] Univ Bordeaux 2, INSERM, U1053, F-33076 Bordeaux, France; [Bouchecareilh, Marion; Fribourg, Sebastien; Chevet, Eric] Univ Bordeaux Segalen, Bordeaux, France; [Bouchecareilh, Marion; Moenner, Michel] INSERM, Talence, France; [Bouchecareilh, Marion; Moenner, Michel] Univ Bordeaux, Talence, France; [Fribourg, Sebastien] Inst Europeen Chim & Biol, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Chevet, E (corresponding author), Univ Bordeaux 2, INSERM, U1053, 146 Rue Leo Saignat, F-33076 Bordeaux, France.	eric.chevet@u-bordeaux2.fr	chevet, eric/E-4992-2016; Fribourg, Sebastien/M-7418-2014	chevet, eric/0000-0001-5855-4522; Fribourg, Sebastien/0000-0003-4112-7510	Marie Curie International Reintegration; Fondation pour la Recherche Medicale; Institut Federatif de Recherche [66]; Association pour la Recherche sur le Cancer; Avenir (Institut National de la Sante et de la Recherche Medicale)-Institut National du Cancer; Conseil Regional d'Aquitaine	Marie Curie International Reintegration(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Institut Federatif de Recherche; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Avenir (Institut National de la Sante et de la Recherche Medicale)-Institut National du Cancer(Institut National de la Sante et de la Recherche Medicale (Inserm)Institut National du Cancer (INCA) France); Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine)	The authors are grateful to Nathalie Dugot-Senant for technical help with confocal microscopy as well as J. Rosenbaum, V. Moreau, P. Cameron, E. Marza, N. Dejeans, S. Taouji, and M. Dominguez for critical reading of the manuscript. This work was funded by a Marie Curie International Reintegration grant; grants from the Fondation pour la Recherche Medicale, the Institut Federatif de Recherche 66, from and the Association pour la Recherche sur le Cancer; and an Avenir (Institut National de la Sante et de la Recherche Medicale)-Institut National du Cancer program grant to E. C. M. B. was supported by a Ph.D. fellowship from the Conseil Regional d'Aquitaine and a fellowship from the Fondation pour la Recherche Medicale.	Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Bouchecareilh M, 2010, J BIOMOL SCREEN, V15, P406, DOI 10.1177/1087057110363823; Caruso ME, 2008, MOL CELL BIOL, V28, P4261, DOI 10.1128/MCB.02252-07; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Delom F, 2007, BIOCHEM BIOPH RES CO, V352, P587, DOI 10.1016/j.bbrc.2006.11.046; Drogat B, 2007, CANCER RES, V67, P6700, DOI 10.1158/0008-5472.CAN-06-3235; FINNEY M, 1990, CELL, V63, P895, DOI 10.1016/0092-8674(90)90493-X; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014; Jenna S, 2005, MOL BIOL CELL, V16, P1629, DOI 10.1091/mbc.E04-08-0760; Kanemoto S, 2005, BIOCHEM BIOPH RES CO, V331, P1146, DOI 10.1016/j.bbrc.2005.04.039; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Lee KPK, 2011, METHOD ENZYMOL, V490, P271, DOI 10.1016/B978-0-12-385114-7.00016-7; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Moenner M, 2007, CANCER RES, V67, P10631, DOI 10.1158/0008-5472.CAN-07-1705; Nadanaka S, 2007, MOL CELL BIOL, V27, P1027, DOI 10.1128/MCB.00408-06; Nguyen DT, 2004, MOL BIOL CELL, V15, P4248, DOI 10.1091/mbc.E03-11-0851; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Volkmann K, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199737; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001	34	56	58	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3115	3129		10.1096/fj.11-182931	http://dx.doi.org/10.1096/fj.11-182931			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21680894				2022-12-25	WOS:000294435200025
J	Joshi, A; Garg, H; Ablan, SD; Freed, EO				Joshi, Anjali; Garg, Himanshu; Ablan, Sherimay D.; Freed, Eric O.			Evidence of a Role for Soluble N-Ethylmaleimide-sensitive Factor Attachment Protein Receptor (SNARE) Machinery in HIV-1 Assembly and Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; INFECTIOUS-ANEMIA VIRUS; GAG-MEMBRANE-BINDING; PLASMA-MEMBRANE; INTRACELLULAR TRAFFICKING; CELL-SURFACE; PARTICLE-PRODUCTION; PRIMARY MACROPHAGES; FUSION PROTEIN; MATRIX DOMAIN	Retrovirus assembly is a complex process that requires the orchestrated participation of viral components and host-cell factors. The concerted movement of different viral proteins to specific sites in the plasma membrane allows for virus particle assembly and ultimately budding and maturation of infectious virions. The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins constitute the minimal machinery that catalyzes the fusion of intracellular vesicles with the plasma membrane, thus regulating protein trafficking. Using siRNA and dominant negative approaches we demonstrate here that generalized disruption of the host SNARE machinery results in a significant reduction in human immunodeficiency virus type 1 (HIV-1) and equine infectious anemia virus particle production. Further analysis of the mechanism involved revealed a defect at the level of HIV-1 Gag localization to the plasma membrane. Our findings demonstrate for the first time a role of SNARE proteins in HIV-1 assembly and release, likely by affecting cellular trafficking pathways required for Gag transport and association with the plasma membrane.	[Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis, El Paso, TX 79905 USA; [Joshi, Anjali; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Paul L Foster Sch Med, Dept Pediat, El Paso, TX 79905 USA; [Ablan, Sherimay D.; Freed, Eric O.] NCI, Virus Cell Interact Sect, HIV Drug Resistance Program, NIH, Frederick, MD 21702 USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Joshi, A (corresponding author), 5001 El Paso Dr,MSB-1, El Paso, TX 79905 USA.	anjali.joshi@ttuhsc.edu			Center for Cancer Research, NCI, National Institutes of Health; Intramural AIDS Targeted Antiviral Program; NATIONAL CANCER INSTITUTE [ZIABC010775] Funding Source: NIH RePORTER	Center for Cancer Research, NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural AIDS Targeted Antiviral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Intramural Research Program of the Center for Cancer Research, NCI, National Institutes of Health. This work was also supported by the Intramural AIDS Targeted Antiviral Program.	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Adamson CS, 2007, ADV PHARMACOL, V55, P347, DOI 10.1016/S1054-3589(07)55010-6; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Bieniasz PD, 2006, VIROLOGY, V344, P55, DOI 10.1016/j.virol.2005.09.044; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Chang YF, 2007, J MOL BIOL, V370, P585, DOI 10.1016/j.jmb.2007.05.020; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Demirov DG, 2002, J VIROL, V76, P105, DOI 10.1128/JVI.76.1.105-117.2002; Dong XH, 2005, CELL, V120, P663, DOI 10.1016/j.cell.2004.12.023; Dubinsky WP, 1999, P NATL ACAD SCI USA, V96, P9421, DOI 10.1073/pnas.96.16.9421; EARL PL, 1991, J VIROL, V65, P2047, DOI 10.1128/JVI.65.4.2047-2055.1991; Ehrlich LS, 2010, J VIROL, V84, P6438, DOI 10.1128/JVI.01588-09; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GELDERBLOM HR, 1991, AIDS, V5, P617, DOI 10.1097/00002030-199106000-00001; GOFF SP, 2001, RETROVIRUSES THEIR R; Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Harrist AV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005020; Hong Wanjin, 2005, Biochim Biophys Acta, V1744, P493; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; JOSHI A, 2007, FUTURE HIV THER, V1, P427; Joshi A, 2008, MOL CELL, V30, P227, DOI 10.1016/j.molcel.2008.03.015; Joshi A, 2006, J VIROL, V80, P7939, DOI 10.1128/JVI.00355-06; Joshi A, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-72; Joshi A, 2009, J VIROL, V83, P5375, DOI 10.1128/JVI.00109-09; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; Kawanishi M, 2000, J BIOL CHEM, V275, P8240, DOI 10.1074/jbc.275.11.8240; KLIMKAIT T, 1990, J VIROL, V64, P621, DOI 10.1128/JVI.64.2.621-629.1990; LANDAU NR, 1992, J VIROL, V66, P5110, DOI 10.1128/JVI.66.8.5110-5113.1992; Llewellyn GN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001167; Low SH, 2003, DEV CELL, V4, P753, DOI 10.1016/S1534-5807(03)00122-9; MALHOTRA V, 1988, CELL, V54, P221, DOI 10.1016/0092-8674(88)90554-5; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martin-Serrano J, 2003, J VIROL, V77, P12373, DOI 10.1128/JVI.77.22.12373-12377.2003; Martin-Serrano J, 2001, NAT MED, V7, P1313, DOI 10.1038/nm1201-1313; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; Mcnew JA, 2008, CHEM REV, V108, P1669, DOI 10.1021/cr0782325; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Molle D, 2009, J BIOL CHEM, V284, P19727, DOI 10.1074/jbc.M109.019844; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; NAGIEC EE, 1995, J BIOL CHEM, V270, P29182, DOI 10.1074/jbc.270.49.29182; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Okayama M, 2007, FEBS LETT, V581, P4583, DOI 10.1016/j.febslet.2007.08.046; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 2004, J VIROL, V78, P1552, DOI 10.1128/JVI.78.3.1552-1563.2004; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Ono A, 2007, VIROLOGY, V360, P27, DOI 10.1016/j.virol.2006.10.011; Patnaik A, 2002, J VIROL, V76, P2641, DOI 10.1128/JVI.76.6.2641-2647.2002; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Piguet V, 1999, IMMUNOL REV, V168, P51, DOI 10.1111/j.1600-065X.1999.tb01282.x; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Rudner L, 2005, J VIROL, V79, P4055, DOI 10.1128/JVI.79.7.4055-4065.2005; Ryo A, 2008, P NATL ACAD SCI USA, V105, P294, DOI 10.1073/pnas.0704831105; Ryzhova EV, 2006, J VIROL, V80, P2694, DOI 10.1128/JVI.80.6.2694-2704.2006; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Shehu-Xhilaga M, 2004, J VIROL, V78, P724, DOI 10.1128/JVI.78.2.724-732.2004; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; SUMIDA M, 1994, J BIOL CHEM, V269, P20636; Swanstrom R., 1997, P263; Tang Y, 1999, J VIROL, V73, P10508, DOI 10.1128/JVI.73.12.10508-10513.1999; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; Vogt V. M., 1997, P27; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Waheed AA, 2010, VIRUSES-BASEL, V2, P1146, DOI 10.3390/v2051146; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; YEE JK, 1994, METHOD CELL BIOL, V43, P99; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032; Zimmerman C, 2002, NATURE, V415, P88, DOI 10.1038/415088a	86	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29861	29871		10.1074/jbc.M111.241521	http://dx.doi.org/10.1074/jbc.M111.241521			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21680744	Green Published, hybrid			2022-12-25	WOS:000294046600045
J	Hong, EH; Yun, HS; Kim, J; Um, HD; Lee, KH; Kang, CM; Lee, SJ; Chun, JS; Hwang, SG				Hong, Eun-Hee; Yun, Hong Shik; Kim, Jongdoo; Um, Hong-Duck; Lee, Kee-Ho; Kang, Chang-Mo; Lee, Su-Jae; Chun, Jang-Soo; Hwang, Sang-Gu			Nicotinamide Phosphoribosyltransferase Is Essential for Interleukin-1 beta-mediated Dedifferentiation of Articular Chondrocytes via SIRT1 and Extracellular Signal-regulated Kinase (ERK) Complex Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; DIFFERENTIATED PHENOTYPE; LIFE-SPAN; CARTILAGE; APOPTOSIS; INFLAMMATION; RESTRICTION; EXTENSION; VISFATIN	Although much is known about interleukin (IL)-1 beta and its role as a key mediator of cartilage destruction in osteoarthritis, only limited information is available on IL-1 beta signaling in chondrocyte dedifferentiation. Here, we have characterized the molecular mechanisms leading to the dedifferentiation of primary cultured articular chondrocytes by IL-1 beta treatment. IL-1 beta or lipopolysaccharide, but not phorbol 12-myristate 13-acetate, retinoic acid, or epidermal growth factor, induced nicotinamide phosphoribosyltransferase (NAMPT) expression, showing the association of inflammatory cytokines with NAMPT regulation. SIRT1, in turn, was activated NAMPT-dependently, without any alteration in the expression level. Activation or inhibition of SIRT1 oppositevely regulates IL-1 beta-mediated chondrocyte dedifferentiation, suggesting this protein as a key regulator of chondrocytes phenotype. SIRT1 activation promotes induction of ERK and p38 kinase activities, but not JNK, in response to IL-1 beta. Subsequently, ERK and p38 kinase activated by SIRT1 also induce SIRT1 activation, forming a positive feedback loop to sustain downstream signaling of these kinases. Moreover, we found that the SIRT1-ERK complex, but not SIRT1-p38, is engaged in IL-1 beta-induced chondrocyte dedifferentiation via a Sox-9-mediated mechanism. JNK is activated by IL-1 beta and modulates dedifferentiation of chondrocytes, but this pathway is independent on NAMPT-SIRT1 signaling. Based on these findings, we propose that IL-1 beta induces dedifferentiation of articular chondrocytes by up-regulation of SIRT1 activity enhanced by both NAMPT and ERK signaling.	[Hong, Eun-Hee; Yun, Hong Shik; Kim, Jongdoo; Um, Hong-Duck; Lee, Kee-Ho; Hwang, Sang-Gu] Korea Inst Radiol & Med Sci, Div Radiat Canc Res, Seoul 139706, South Korea; [Kang, Chang-Mo] Korea Inst Radiol & Med Sci, Div Radiat Effect, Seoul 139706, South Korea; [Hong, Eun-Hee; Yun, Hong Shik; Lee, Su-Jae] Hanyang Univ, Coll Nat Sci, Dept Chem, Seoul 133791, South Korea; [Chun, Jang-Soo] Gwangju Inst Sci & Technol, Dept Life Sci, Kwangju 500712, South Korea	Korea Institute of Radiological & Medical Sciences; Korea Institute of Radiological & Medical Sciences; Hanyang University; Gwangju Institute of Science & Technology (GIST)	Hwang, SG (corresponding author), Korea Inst Radiol & Med Sci, Div Radiat Canc Res, 215-4 Gongneung Dong, Seoul 139706, South Korea.	sgh63@kcch.re.kr	Um, Hong-Duk/AAH-3733-2021		National Research Foundation of Korea; Korea Research Foundation [KRF-2008-313-C00260]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Research Foundation(National Research Foundation of Korea)	This work was supported by the Nuclear Research and Development Program of the National Research Foundation of Korea and in part by Korea Research Foundation Grant KRF-2008-313-C00260.	Anderson RM, 2003, NATURE, V423, P181, DOI 10.1038/nature01578; Bobacz K, 2007, ARTHRITIS RHEUM-US, V56, P1880, DOI 10.1002/art.22637; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Goldring MB, 2008, ANN RHEUM DIS, V67, P75, DOI 10.1136/ard.2008.098764; Heraud F, 2000, ANN RHEUM DIS, V59, P959, DOI 10.1136/ard.59.12.959; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Hwang SG, 2005, FEBS LETT, V579, P4837, DOI 10.1016/j.febslet.2005.07.067; Hwang SG, 2005, J BIOL CHEM, V280, P29780, DOI 10.1074/jbc.M411793200; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Ijiri K, 2005, J BIOL CHEM, V280, P38544, DOI 10.1074/jbc.M504202200; Jacques C, 2006, VITAM HORM, V74, P371, DOI 10.1016/S0083-6729(06)74016-X; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Klooster AR, 2005, ARTHRITIS RES THER, V7, pR127, DOI 10.1186/ar1464; Kralisch S, 2005, AM J PHYSIOL-ENDOC M, V289, pE586, DOI 10.1152/ajpendo.00090.2005; Levy O, 2005, J ENDOTOXIN RES, V11, P113, DOI 10.1179/096805105X37376; Martinon F, 2004, CELL, V117, P561, DOI 10.1016/j.cell.2004.05.004; Murakami S, 2000, J BIOL CHEM, V275, P3687, DOI 10.1074/jbc.275.5.3687; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Peng H, 2008, J CELL PHYSIOL, V215, P562, DOI 10.1002/jcp.21338; Presle N, 2006, OSTEOARTHR CARTILAGE, V14, P690, DOI 10.1016/j.joca.2006.01.009; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Ryu JH, 2002, DEVELOPMENT, V129, P5541, DOI 10.1242/dev.00110; Sandell LJ, 2001, ARTHRITIS RES, V3, P107, DOI 10.1186/ar148; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yasuhara R, 2005, BIOCHEM J, V389, P315, DOI 10.1042/BJ20041996; Yoon YM, 2002, J BIOL CHEM, V277, P8412, DOI 10.1074/jbc.M110608200; Zhang T, 2010, BBA-PROTEINS PROTEOM, V1804, P1666, DOI 10.1016/j.bbapap.2009.10.022	34	48	51	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28619	28631		10.1074/jbc.M111.219832	http://dx.doi.org/10.1074/jbc.M111.219832			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21697093	hybrid, Green Published			2022-12-25	WOS:000293557800076
J	Martinez, A; Aliouat, E; Standaert-Vitse, A; Werkmeister, E; Pottier, M; Pincon, C; Dei-Cas, E; Aliouat-Denis, CM				Martinez, Anna; Aliouat, El Moukhtar; Standaert-Vitse, Annie; Werkmeister, Elisabeth; Pottier, Muriel; Pincon, Claire; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie			Ploidy of Cell-Sorted Trophic and Cystic Forms of Pneumocystis carinii	PLOS ONE			English	Article							SERIAL-THIN SECTIONS; NUCLEAR-DNA CONTENT; F-SP HOMINIS; 3-DIMENSIONAL RECONSTRUCTION; IMMUNOCOMPETENT CARRIERS; JIROVECII TRANSMISSION; LIFE-CYCLE; FISSION; ORGANISMS; PNEUMONIA	Once regarded as an AIDS-defining illness, Pneumocystis pneumonia (PcP) is nowadays prevailing in immunocompromised HIV-negative individuals such as patients receiving immunosuppressive therapies or affected by primary immunodeficiency. Moreover, Pneumocystis clinical spectrum is broadening to non-severely-immunocompromised subjects who could be colonized by the fungus while remaining asymptomatic for PcP, thus being able to transmit the infection by airborne route to susceptible hosts. Although the taxonomical position of the Pneumocystis genus has been clarified, several aspects of its life cycle remain elusive such as its mode of proliferation within the alveolus or its ploidy level. As no long-term culture model exists to grow Pneumocystis organisms in vitro, an option was to use a model of immunosuppressed rat infected with Pneumocystis carinii and sort life cycle stage fractions using a high-through-put cytometer. Subsequently, ploidy levels of the P. carinii trophic and cystic form fractions were measured by flow cytometry. In the cystic form, eight contents of DNA were measured thus strengthening the fact that each mature cyst contains eight haploid spores. Following release, each spore evolves into a trophic form. The majority of the trophic form fraction was haploid in our study. Some less abundant trophic forms displayed two contents of DNA indicating that they could undergo (i) mating/fusion leading to a diploid status or (ii) asexual mitotic division or (iii) both. Even less abundant trophic forms with four contents of DNA were suggestive of mitotic divisions occurring following mating in diploid trophic forms. Of interest, was the presence of trophic forms with three contents of DNA, an unusual finding that could be related to asymmetrical mitotic divisions occurring in other fungal species to create genetic diversity at lower energetic expenses than mating. Overall, ploidy data of P. carinii life cycle stages shed new light on the complexity of its modes of proliferation.	[Martinez, Anna; Aliouat, El Moukhtar; Standaert-Vitse, Annie; Pottier, Muriel; Pincon, Claire; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie] Univ Lille Nord France, Lille, France; [Martinez, Anna; Aliouat, El Moukhtar; Standaert-Vitse, Annie; Pottier, Muriel; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie] CIIL, CNRS, INSERM, U1019,UMR 8204, Lille, France; [Martinez, Anna; Aliouat, El Moukhtar; Standaert-Vitse, Annie; Werkmeister, Elisabeth; Pottier, Muriel; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie] Inst Pasteur, Lille, France; [Martinez, Anna; Aliouat, El Moukhtar; Standaert-Vitse, Annie; Pottier, Muriel; Pincon, Claire; Dei-Cas, Eduardo; Aliouat-Denis, Cecile-Marie] Univ Lille 2, Lille, France; [Werkmeister, Elisabeth] Inst Pasteur, Ctr Immunol & Biol Parasitaire, CNRS, MICPaL Facil,IFR142,UMR 8161, F-59019 Lille, France; [Pincon, Claire] Dept Biostat, EA2694, Lille, France; [Dei-Cas, Eduardo] CHU Lille, Reg & Univ Hosp Ctr, CBP, F-59037 Lille, France	Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Franche-Comte; CHU Besancon; Universite de Lille - ISITE; CHU Lille	Martinez, A (corresponding author), Univ Lille Nord France, Lille, France.	cecile.aliouat@univ-lille2.fr	Aliouat, El Moukhtar/D-2859-2018; Martinez, Anna/AAI-6447-2021; Standaert, Annie/AAD-8209-2020; Pinçon, Claire/AAD-8448-2020; Standaert, Annie/R-5826-2018; WERKMEISTER, Elisabeth/GLQ-7361-2022; Aliouat-Denis, Cecile-Marie/P-1934-2016; Pincon, Claire/N-1607-2016	Aliouat, El Moukhtar/0000-0003-2905-7126; Standaert, Annie/0000-0002-7752-3964; Standaert, Annie/0000-0002-7752-3964; Aliouat-Denis, Cecile-Marie/0000-0001-8388-4662; Pincon, Claire/0000-0002-5509-6199; Martinez, Anna/0000-0001-7245-9687	ANR-ERA-NET 'Pneumocystis' PathoGenoMics [ANR-06-PATHO-009-01]; Lille-Nord-de-France University; Pasteur Institute of Lille; Pasteur Institute of Lille ('Microscopie-Imagerie-Cytometrie du campus Pasteur Lille' (MICPaL) [IFR142]; ANR-ERA-NET	ANR-ERA-NET 'Pneumocystis' PathoGenoMics(French National Research Agency (ANR)); Lille-Nord-de-France University; Pasteur Institute of Lille; Pasteur Institute of Lille ('Microscopie-Imagerie-Cytometrie du campus Pasteur Lille' (MICPaL); ANR-ERA-NET(French National Research Agency (ANR))	This work was supported by ANR-ERA-NET 'Pneumocystis' PathoGenoMics (ANR-06-PATHO-009-01). We also thank the Lille-Nord-de-France University, the Pasteur Institute of Lille and the microscopy and flow cytometry platform of the Pasteur Institute of Lille ('Microscopie-Imagerie-Cytometrie du campus Pasteur Lille' (MICPaL), IFR142) for their support. The funders (ANR-ERA-NET, Lille Nord de France University and Pasteur Institute of Lille) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliouat E, 1999, J EUKARYOT MICROBIOL, V46, p116S; ALIOUAT EM, 1995, PARASITOL RES, V81, P82, DOI 10.1007/BF00932421; Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Aliouat-Denis CM, 2009, MEM I OSWALDO CRUZ, V104, P419, DOI 10.1590/S0074-02762009000300004; Aviles P, 2000, ANTIMICROB AGENTS CH, V44, P1284, DOI 10.1128/AAC.44.5.1284-1290.2000; Bennett RJ, 2003, EMBO J, V22, P2505, DOI 10.1093/emboj/cdg235; Calderon EJ, 2010, EXPERT REV ANTI-INFE, V8, P683, DOI [10.1586/eri.10.42, 10.1586/eri.10.11, 10.1586/ERI.10.42]; Catherinot E, 2010, INFECT DIS CLIN N AM, V24, P107, DOI 10.1016/j.idc.2009.10.010; Chabe M, 2004, EUR J CLIN MICROBIOL, V23, P89, DOI 10.1007/s10096-003-1092-2; Chabe M, 2011, FEMS YEAST RES, V11, P2, DOI 10.1111/j.1567-1364.2010.00698.x; Cornillot E, 2002, GENE, V293, P87, DOI 10.1016/S0378-1119(02)00604-2; Cushion MT, 2010, ANNU REV MICROBIOL, V64, P431, DOI 10.1146/annurev.micro.112408.134335; Cushion MT, 2004, TRENDS MICROBIOL, V12, P243, DOI 10.1016/j.tim.2004.03.005; Cushion MT, 1998, FEMS IMMUNOL MED MIC, V22, P51, DOI 10.1111/j.1574-695X.1998.tb01186.x; Cushion MT, 1997, INFECT IMMUN, V65, P4365, DOI 10.1128/IAI.65.10.4365-4365.1997; CUSHION MT, 1998, TOPLEY WILSONS MICRO, V4, P645; DeiCas E, 1996, PARASITOL TODAY, V12, P245, DOI 10.1016/0169-4758(96)80812-X; DEICAS E, 2004, PNEUMOCYSTIS PNEUMON, P61; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Durand-Joly I, 2002, J CLIN MICROBIOL, V40, P1862, DOI 10.1128/JCM.40.5.1862-1865.2002; Eriksson OE, 1997, MYCONET, V1, P1; Ezov TK, 2006, GENETICS, V174, P1455, DOI 10.1534/genetics.106.062745; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Gerstein AC, 2008, BIOL LETTERS, V4, P91, DOI 10.1098/rsbl.2007.0476; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Haase SB, 2002, CELL CYCLE, V1, P132, DOI 10.4161/cc.1.2.114; Hauser P, 2009, EMERG INFECT DIS, V15, P506, DOI 10.3201/eid1503.081350; Herrero Enrique, 2005, Revista Iberoamericana de Micologia, V22, P217; Hiraoka Y, 2000, CHROMOSOMA, V109, P103, DOI 10.1007/s004120050417; HONG ST, 1990, J CLIN MICROBIOL, V28, P1785, DOI 10.1128/JCM.28.8.1785-1795.1990; Itatani CA, 1996, J PARASITOL, V82, P163, DOI 10.2307/3284134; Liu Y, 2009, MOL BIOL EVOL, V26, P27, DOI 10.1093/molbev/msn221; LOIDL J, 1995, GENETICS, V139, P1511; Martinez A, 2009, J EUKARYOT MICROBIOL, V56, P446, DOI 10.1111/j.1550-7408.2009.00423.x; MATSUMOTO Y, 1984, J PROTOZOOL, V31, P420, DOI 10.1111/j.1550-7408.1984.tb02989.x; Miller RF, 2001, J CLIN MICROBIOL, V39, P3877, DOI 10.1128/JCM.39.11.3877-3882.2001; Morris A, 2008, CLIN INFECT DIS, V46, P634, DOI 10.1086/526779; Morris A, 2009, J CLIN MICROBIOL, V47, P3773, DOI 10.1128/JCM.01712-09; PALLUAULT F, 1992, PARASITOL RES, V78, P437, DOI 10.1007/BF00931702; PALLUAULT F, 1991, J PROTOZOOL, V38, P407, DOI 10.1111/j.1550-7408.1991.tb01378.x; PALLUAULT F, 1991, J PROTOZOOL, V38, P402, DOI 10.1111/j.1550-7408.1991.tb01377.x; Parfrey LW, 2008, MOL BIOL EVOL, V25, P787, DOI 10.1093/molbev/msn032; RICHARDSON JD, 1989, J PROTOZOOL, V36, pS27, DOI 10.1111/j.1550-7408.1989.tb05817.x; Rivero L, 2008, EMERG INFECT DIS, V14, P1116, DOI 10.3201/eid1407.071431; RUFFOLO JJ, 1994, PNEUMOCYSTIS CARINII, P25; Sabatinos Sarah A., 2009, V521, P449, DOI [10.1007/978-1-60327-815-7_25, 10.1007/978-1-60327-817-5_25]; Sesterhenn TM, 2010, MOL GENET GENOMICS, V283, P63, DOI 10.1007/s00438-009-0498-7; Storchova Z, 2008, J CELL SCI, V121, P3859, DOI 10.1242/jcs.039537; Stringer JR, 1998, FEMS IMMUNOL MED MIC, V22, P15, DOI 10.1111/j.1574-695X.1998.tb01183.x; Sugiyama J, 2006, MYCOLOGIA, V98, P996, DOI 10.3852/mycologia.98.6.996; SUKURA A, 1994, APMIS, V102, P901, DOI 10.1111/j.1699-0463.1994.tb05251.x; Thomas CF, 2007, NAT REV MICROBIOL, V5, P298, DOI 10.1038/nrmicro1621; VAVRA J, 1970, J PROTOZOOL, V17, P463, DOI 10.1111/j.1550-7408.1970.tb04715.x; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Wyder MA, 1998, J EUKARYOT MICROBIOL, V45, P233, DOI 10.1111/j.1550-7408.1998.tb04531.x; YAMADA M, 1986, ZBL BAKT-INT J MED M, V262, P240; YOSHIDA Y, 1984, ZBL BAKT-INT J MED M, V256, P390; YOSHIDA Y, 1989, J PROTOZOOL, V36, P53	58	18	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20935	10.1371/journal.pone.0020935	http://dx.doi.org/10.1371/journal.pone.0020935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695077	gold, Green Published, Green Submitted			2022-12-25	WOS:000291682300021
J	Xu, CX; Li, YK; Yue, P; Owonikoko, TK; Ramalingam, SS; Khuri, FR; Sun, SY				Xu, Cheng-Xiong; Li, Yikun; Yue, Ping; Owonikoko, Taofeek K.; Ramalingam, Suresh S.; Khuri, Fadlo R.; Sun, Shi-Yong			The Combination of RAD001 and NVP-BEZ235 Exerts Synergistic Anticancer Activity against Non-Small Cell Lung Cancer In Vitro and In Vivo	PLOS ONE			English	Article							MAMMALIAN TARGET; MTOR INHIBITION; CARCINOMA CELLS; ACTIVATION; PATHWAYS; THERAPY; MUTATIONS; APOPTOSIS; EFFICACY; GROWTH	The phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) signaling axis has emerged as a novel target for cancer therapy. Agents that inhibit PI3K, mTOR or both are currently under development. The mTOR allosteric inhibitor, RAD001, and the PI3K/mTOR dual kinase inhibitor, BEZ235, are examples of these agents. We were interested in developing strategies to enhance mTOR-targeted caner therapy. In this study, we found that BEZ235 alone effectively inhibited the growth of rapamycin-resistant cancer cells. Interestingly, the combination of sub-optimal concentrations of RAD001 and BEZ235 exerted synergistic inhibition of the growth of human lung cancer cells along with induction of apoptosis and G1 arrest. Furthermore, the combination was also more effective than either agent alone in inhibiting the growth of lung cancer xenografts in mice. The combination showed enhanced effects on inhibiting mTOR signaling and reducing the expression of c-Myc and cyclin D1. Taken together, our results suggest that the combination of RAD001 and BEZ235 is a novel strategy for cancer therapy.	[Xu, Cheng-Xiong] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; Winship Canc Inst, Atlanta, GA USA	Emory University	Xu, CX (corresponding author), Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	ssun@emory.edu	Xu, Cheng-Xiong/AAV-7733-2021; Xu, Cheng-Xiong/ACD-3271-2022; Ramalingam, Suresh/AAV-7478-2020; Khuri, Fadlo R./AAU-4942-2020; Owonikoko, Taofeek/C-3012-2011	Xu, Cheng-Xiong/0000-0001-5714-8207; Khuri, Fadlo R./0000-0002-8638-7618; Owonikoko, Taofeek/0000-0002-7724-7728	NIH [R01 CA118450, P01 CA116676]; Department of Defense [W81XWH-05-0027, W81XWH-06-1-0303, DAMD17-01-1-0689]; NATIONAL CANCER INSTITUTE [P01CA116676, R01CA118450] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the Georgia Cancer Coalition Distinguished Cancer Scholar award, NIH R01 CA118450 and P01 CA116676 (Project 1), Department of Defense IMPACT (Imaging and Molecular Markers for Patients with Lung Cancer: Approaches with Molecular Targets, Complementary/Innovative Treatments, and Therapeutic Modalities) award W81XWH-05-0027 (Project 5), BATTLE (Biomarker-based Approaches of Targeted Therapy for Lung Cancer Elimination) award W81XWH-06-1-0303 (Project 4) and BESCT (Biology, Education, Screening, Chemoprevention and Therapy) award DAMD17-01-1-0689 (Project 2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2007, CLIN CANCER RES, V13, P3109, DOI 10.1158/1078-0432.CCR-06-2798; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Konstantinidou G, 2009, CANCER RES, V69, P7644, DOI 10.1158/0008-5472.CAN-09-0823; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Liu XG, 2004, JNCI-J NATL CANCER I, V96, P1769, DOI 10.1093/jnci/djh322; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Makowski L, 2008, BRIT J CANCER, V99, P683, DOI 10.1038/sj.bjc.6604515; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Sun SY, 1999, ONCOGENE, V18, P2357, DOI 10.1038/sj.onc.1202543; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Sun SY, 1997, CANCER RES, V57, P4931; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wang XR, 2009, EXPERT OPIN THER TAR, V13, P1193, DOI 10.1517/14728220903225008; Wang XR, 2008, CANCER BIOL THER, V7, P1952, DOI 10.4161/cbt.7.12.6944	21	58	62	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20899	10.1371/journal.pone.0020899	http://dx.doi.org/10.1371/journal.pone.0020899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695126	Green Published, Green Submitted, gold			2022-12-25	WOS:000291682300018
J	Vecsler, M; Ben Zeev, B; Nudelman, I; Anikster, Y; Simon, AJ; Amariglio, N; Rechavi, G; Baasov, T; Gak, E				Vecsler, Manuela; Ben Zeev, Bruria; Nudelman, Igor; Anikster, Yair; Simon, Amos J.; Amariglio, Ninette; Rechavi, Gideon; Baasov, Timor; Gak, Eva			Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; SEVERE MENTAL-RETARDATION; CPG-BINDING PROTEIN-2; NEUROLOGICAL SYMPTOMS; GENTAMICIN TREATMENT; HISTONE DEACETYLASE; NEUROTROPHIC FACTOR; GENETIC-DISORDERS; CYSTIC-FIBROSIS; STOP MUTATIONS	Background: Nonsense mutations in the X-linked methyl CpG-binding protein 2 (MECP2) comprise a significant proportion of causative MECP2 mutations in Rett syndrome (RTT). Naturally occurring aminoglycosides, such as gentamicin, have been shown to enable partial suppression of nonsense mutations related to several human genetic disorders, however, their clinical applicability has been compromised by parallel findings of severe toxic effects. Recently developed synthetic NB aminoglycosides have demonstrated significantly improved effects compared to gentamicin evident in substantially higher suppression and reduced acute toxicity in vitro. Results: We performed comparative study of suppression effects of the novel NB54 and gentamicin on three MECP2 nonsense mutations (R294X, R270X and R168X) common in RTT, using ex vivo treatment of primary fibroblasts from RTT patients harboring these mutations and testing for the C-terminal containing full-length MeCP2. We observed that NB54 induces dose-dependent suppression of MECP2 nonsense mutations more efficiently than gentamicin, which was evident at concentrations as low as 50 mu g/ml. NB54 read-through activity was mutation specific, with maximal full-length MeCP2 recovery in R168X (38%), R270X (27%) and R294X (18%). In addition, the recovered MeCP2 was translocated to the cell nucleus and moreover led to parallel increase in one of the most important MeCP2 downstream effectors, the brain derived neurotrophic factor (BDNF). Conclusion: Our findings suggest that NB54 may induce restoration of the potentially functional MeCP2 in primary RTT fibroblasts and encourage further studies of NB54 and other rationally designed aminoglycoside derivatives as potential therapeutic agents for nonsense MECP2 mutations in RTT.	[Vecsler, Manuela; Gak, Eva] Chaim Sheba Med Ctr, Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel; [Vecsler, Manuela; Rechavi, Gideon; Gak, Eva] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben Zeev, Bruria; Anikster, Yair] Edmond & Lilly Safra Pediat Hosp, Sheba Med Ctr, Tel Hashomer, Israel; [Nudelman, Igor; Baasov, Timor] Technion Israel Inst Technol, Edith & Joseph Fisher Enzyme Inhibitors Lab, Schulich Fac Chem, Haifa, Israel; [Simon, Amos J.; Amariglio, Ninette; Rechavi, Gideon] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Technion Israel Institute of Technology; Chaim Sheba Medical Center	Vecsler, M (corresponding author), Chaim Sheba Med Ctr, Sagol Neurosci Ctr, IL-52621 Tel Hashomer, Israel.	eva.gak@sheba.health.gov.il	Baasov, Timor/L-5173-2019	Baasov, Timor/0000-0002-1427-2619	Chief Scientist Office of the Israeli Ministry of Health [3_4791]	Chief Scientist Office of the Israeli Ministry of Health	This study was supported (in part) by grant no. 3_4791 from the Chief Scientist Office of the Israeli Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Amir RE, 2000, ANN NEUROL, V47, P670, DOI 10.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6; Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866; Bidou L, 2004, GENE THER, V11, P619, DOI 10.1038/sj.gt.3302211; Brendel C, 2011, J MOL MED, V89, P389, DOI 10.1007/s00109-010-0704-4; Brendel C, 2009, PEDIATR RES, V65, P520, DOI 10.1203/PDR.0b013e31819d9ebc; BURKE JF, 1985, NUCLEIC ACIDS RES, V13, P6265, DOI 10.1093/nar/13.17.6265; Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Christodoulou J, 2003, HUM MUTAT, V21, P466, DOI 10.1002/humu.10194; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Culbertson MR, 1999, TRENDS GENET, V15, P74, DOI 10.1016/S0168-9525(98)01658-8; Du M, 2002, J MOL MED, V80, P595, DOI 10.1007/s00109-002-0363-1; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Goldmann T, 2010, INVEST OPHTH VIS SCI, V51, P6671, DOI 10.1167/iovs.10-5741; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hagberg B, 1997, EUR CHILD ADOLES PSY, V6, P5; Hainrichson M, 2008, ORG BIOMOL CHEM, V6, P227, DOI 10.1039/b712690p; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Howard MT, 2000, ANN NEUROL, V48, P164, DOI 10.1002/1531-8249(200008)48:2<164::AID-ANA5>3.3.CO;2-2; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Kaufman RJ, 1999, J CLIN INVEST, V104, P367, DOI 10.1172/JCI8055; Keeling K. M., 2005, Current Pharmacogenomics, V3, P259, DOI 10.2174/157016005774913149; Kerem E, 2004, CURR OPIN PULM MED, V10, P547, DOI 10.1097/01.mcp.0000141247.22078.46; Kline DD, 2010, J NEUROSCI, V30, P5303, DOI 10.1523/JNEUROSCI.5503-09.2010; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Laccone F, 2001, HUM MUTAT, V17, P183, DOI 10.1002/humu.3; Lee SSJ, 2001, BRAIN DEV-JPN, V23, pS138; Linde L, 2007, J CLIN INVEST, V117, P683, DOI 10.1172/JCI28523; Malik V, 2010, ANN NEUROL, V67, P771, DOI 10.1002/ana.22024; Manuvakhova M, 2000, RNA, V6, P1044, DOI 10.1017/S1355838200000716; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Monteggia LM, 2004, P NATL ACAD SCI USA, V101, P10827, DOI 10.1073/pnas.0402141101; Nan XS, 1996, MOL CELL BIOL, V16, P414; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Petel-Galil Y, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041285; Politano L, 2003, Acta Myol, V22, P15; Popescu AC, 2010, J NEUROSCI RES, V88, P2316, DOI 10.1002/jnr.22409; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Skene PJ, 2010, MOL CELL, V37, P457, DOI 10.1016/j.molcel.2010.01.030; Trappe R, 2001, AM J HUM GENET, V68, P1093, DOI 10.1086/320109; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Vecsler M, 2010, EPIGENETICS-US, V5, P61, DOI 10.4161/epi.5.1.10630; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	54	35	45	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20733	10.1371/journal.pone.0020733	http://dx.doi.org/10.1371/journal.pone.0020733			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695138	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300015
J	Bobrov, P; Frolov, A; Cantor, C; Fedulova, I; Bakhnyan, M; Zhavoronkov, A				Bobrov, Pavel; Frolov, Alexander; Cantor, Charles; Fedulova, Irina; Bakhnyan, Mikhail; Zhavoronkov, Alexander			Brain-Computer Interface Based on Generation of Visual Images	PLOS ONE			English	Article							SINGLE-TRIAL EEG; COMMUNICATION; CLASSIFICATION; PERFORMANCE; SIGNAL	This paper examines the task of recognizing EEG patterns that correspond to performing three mental tasks: relaxation and imagining of two types of pictures: faces and houses. The experiments were performed using two EEG headsets: BrainProducts ActiCap and Emotiv EPOC. The Emotiv headset becomes widely used in consumer BCI application allowing for conducting large-scale EEG experiments in the future. Since classification accuracy significantly exceeded the level of random classification during the first three days of the experiment with EPOC headset, a control experiment was performed on the fourth day using ActiCap. The control experiment has shown that utilization of high-quality research equipment can enhance classification accuracy (up to 68% in some subjects) and that the accuracy is independent of the presence of EEG artifacts related to blinking and eye movement. This study also shows that computationally-inexpensive Bayesian classifier based on covariance matrix analysis yields similar classification accuracy in this problem as a more sophisticated Multi-class Common Spatial Patterns (MCSP) classifier.	[Bobrov, Pavel; Frolov, Alexander] Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Bobrov, Pavel] Tech Univ Ostrava, Ostrava, Czech Republic; [Cantor, Charles] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Cantor, Charles] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92717 USA; [Fedulova, Irina] Moscow MV Lomonosov State Univ, Dept Computat Math & Cybernet, Moscow, Russia; [Bakhnyan, Mikhail] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Zhavoronkov, Alexander] Russian State Med Univ, Moscow 117437, Russia	Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Technical University of Ostrava; Boston University; University of California System; University of California Irvine; Lomonosov Moscow State University; Lomonosov Moscow State University; Pirogov Russian National Research Medical University	Bobrov, P (corresponding author), Russian Acad Sci, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia.	azhavoronkov@phys.msu.ru	Frolov, Alexander/C-8305-2014; Zhavoronkov, Alex/HCI-9762-2022; Bobrov, Pavel/D-1123-2014; Zhavoronkov, Alex/X-6241-2019	Zhavoronkov, Alex/0000-0001-7067-8966; Fedulova, Irina/0000-0002-5959-5382; Zhavoronkov, Alexander/0000-0001-5009-3848	Presidium of RAS	Presidium of RAS(Russian Academy of Sciences)	The work was partly supported by program of the Presidium of RAS "Basic research for medicine." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison BZ, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026007; ANG K, 2008, FILTER BANK COMMON S, P2390; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; BERG P, 1991, CLIN PHYS PHYSIOL M, V12, P49, DOI 10.1088/0143-0815/12/A/010; Besserve M, 2007, BIOL RES, V40, P415, DOI [10.4067/S0716-97602007000500005, /S0716-97602007000500005]; Blankertz B, 2007, NEUROIMAGE, V37, P539, DOI 10.1016/j.neuroimage.2007.01.051; Boly M, 2007, NEUROIMAGE, V36, P979, DOI 10.1016/j.neuroimage.2007.02.047; Campbell A., 2010, NEUROPHONE BRAIN MOB, P3; Cerf M, 2010, NATURE, V467, P1104, DOI 10.1038/nature09510; Crammer K, 2002, J MACH LEARN RES, V2, P265, DOI 10.1162/15324430260185628; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dornhege G, 2004, ADV NEUR IN, V16, P733; *EM SYST, EM BRAIN COMP INT TE; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; FORMAGGIO E, 2010, MAGNETIC RESONANCE I; Fruitet J, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016003; GALLANT J, 2009, BAYESIAN RECONSTRUCT, P390; Georghiades AS, 2001, IEEE T PATTERN ANAL, V23, P643, DOI 10.1109/34.927464; Grech R, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-25; Grosse-Wentrup M, 2008, IEEE T BIO-MED ENG, V55, P1991, DOI 10.1109/TBME.2008.921154; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Ishai A, 2000, NEURON, V28, P979, DOI 10.1016/S0896-6273(00)00168-9; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Krauledat M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002967; Krepki R, 2007, INT J HUM-COMPUT ST, V65, P460, DOI 10.1016/j.ijhcs.2006.11.010; Leuthardt EC, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0979; Microsoft Research, MICR RES CAMBR OBJ R; MILLAN J, 1998, ADAPTIVE BRAIN INTER, P2008; Millan JDR, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00161; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Niedermeyer Ernst, ELECTROENCEPHALOGRAP; Nijholt A, 2008, LECT NOTES COMPUT SC, V5309, P225; NIKOLAEV AR, 1998, HUMAN PHYSL, V24, P261; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Pfurtscheller G, 1997, ELECTROEN CLIN NEURO, V103, P642, DOI 10.1016/S0013-4694(97)00080-1; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; PFURTSCHELLER G, 1993, J MICROCOMPUT APPL, V16, P293, DOI 10.1006/jmca.1993.1030; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; ZHAO Q, 2009, MULTILINEAR GEN COMM, P525	44	79	93	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20674	10.1371/journal.pone.0020674	http://dx.doi.org/10.1371/journal.pone.0020674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695206	Green Published, gold			2022-12-25	WOS:000291612600017
J	Boudot, A; Kerdivel, G; Habauzit, D; Eeckhoute, J; Le Dily, F; Flouriot, G; Samson, M; Pakdel, F				Boudot, Antoine; Kerdivel, Gwenneg; Habauzit, Denis; Eeckhoute, Jerome; Le Dily, Francois; Flouriot, Gilles; Samson, Michel; Pakdel, Farzad			Differential Estrogen-Regulation of CXCL12 Chemokine Receptors, CXCR4 and CXCR7, Contributes to the Growth Effect of Estrogens in Breast Cancer Cells	PLOS ONE			English	Article							PROMOTER HYPERMETHYLATION; DOWN-REGULATION; BINDING-SITES; T-LYMPHOCYTES; TUMOR-CELLS; FACTOR-I; EXPRESSION; MIGRATION; INVASION; METASTASIS	CXCR4 and CXCR7 are the two receptors for the chemokine CXCL12, a key mediator of the growth effect of estrogens (E2) in estrogen receptor (ER)-positive breast cancers. In this study we examined E2-regulation of the CXCL12 axis components and their involvement in the growth of breast cancer cells. CXCR4 and CXCR7 were differentially regulated by E2 which enhanced the expression of both CXCL12 and CXCR4 but repressed the expression of CXCR7. Formaldehyde-associated isolation of regulatory elements (FAIRE) revealed that E2-mediated transcriptional regulation of these genes is linked to the control of the compaction state of chromatin at their promoters. This effect could be accomplished via several distal ERbinding sites in the regions surrounding these genes, all of which are located 20-250 kb from the transcription start site. Furthermore, individual down-regulation of CXCL12, CXCR4 or CXCR7 expression as well as the inhibition of their activity significantly decreases the rate of basal cell growth. In contrast, E2-induced cell growth was differentially affected. Unlike CXCR7, the inhibition of the expression or activity of either CXCL12 or CXCR4 significantly blunted the E2-mediated stimulation of cellular growth. Besides, CXCR7 over-expression increased the basal MCF-7 cell growth rate and decreased the growth effect of E2. These findings indicate that E2 regulation of the CXCL12 signaling axis is important for the E2mediated growth effect of breast cancer cells. These data also provide support for distinct biological functions of CXCR4 and CXCR7 and suggest that targeting CXCR4 and/or CXCR7 would have distinct molecular effects on ER-positive breast tumors.	[Boudot, Antoine; Kerdivel, Gwenneg; Habauzit, Denis; Eeckhoute, Jerome; Le Dily, Francois; Flouriot, Gilles; Pakdel, Farzad] Univ Rennes 1, CNRS, IRSET, UMR 6026,IFR 140, Rennes, France; [Samson, Michel] Univ Rennes 1, EA4427, SeRAIC, IFR 140,IRSET, Rennes, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Universite de Rennes	Boudot, A (corresponding author), Univ Rennes 1, CNRS, IRSET, UMR 6026,IFR 140, Rennes, France.	farzad.pakdel@univ-rennes1.fr	Pakdel, Farzad/K-1700-2015; Le Dily, François/J-9448-2015; Kerdivel, Gwenneg/AAN-9195-2020; Habauzit, Denis/K-1779-2015; Le Dily, François/GNH-3646-2022; Eeckhoute, Jerome/AAN-8219-2021; Samson, Michel/F-8356-2013; Flouriot, Gilles/K-1833-2015	Pakdel, Farzad/0000-0002-3067-3156; Le Dily, François/0000-0002-8324-7927; Habauzit, Denis/0000-0001-8101-3839; Le Dily, François/0000-0002-8324-7927; Eeckhoute, Jerome/0000-0002-7222-9264; Flouriot, Gilles/0000-0001-6250-4173	Ministere de l'Enseignement et de la Recherche and la Region de Bretagne; La Ligue contre le Cancer; CRITT-Sante Bretagne [08007968, IFR140]; Agence National de la Recherche [CES 2008-011]; INERIS [189]; CNRS; University of Rennes I	Ministere de l'Enseignement et de la Recherche and la Region de Bretagne(Region Bretagne); La Ligue contre le Cancer(Ligue nationale contre le cancer); CRITT-Sante Bretagne; Agence National de la Recherche(French National Research Agency (ANR)); INERIS; CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Rennes I	This work was supported by fellowships from the Ministere de l'Enseignement et de la Recherche and la Region de Bretagne (to AB and to GK) and funds from La Ligue contre le Cancer, CRITT-Sante Bretagne (contrat no 08007968), IFR140, Agence National de la Recherche (NEED, CES 2008-011), INERIS (NEMO, 189), the CNRS and the University of Rennes I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Balabanian K, 2005, J BIOL CHEM, V280, P35760, DOI 10.1074/jbc.M508234200; Bergamaschi A, 2009, MOL ONCOL; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Charn TH, 2010, MOL ENDOCRINOL, V24, P47, DOI 10.1210/me.2009-0252; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dewan MZ, 2006, BIOMED PHARMACOTHER, V60, P273, DOI 10.1016/j.biopha.2006.06.004; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Eeckhoute J, 2009, GENOME RES, V19, P372, DOI 10.1101/gr.084582.108; Foster JS, 2001, TRENDS ENDOCRIN MET, V12, P320, DOI 10.1016/S1043-2760(01)00436-2; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Hall JM, 2003, MOL ENDOCRINOL, V17, P792, DOI 10.1210/me.2002-0438; Hartmann TN, 2008, J LEUKOCYTE BIOL, V84, P1130, DOI 10.1189/jlb.0208088; Kang H, 2005, BREAST CANCER RES, V7, pR402, DOI 10.1186/bcr1022; Kishimoto H, 2005, CARCINOGENESIS, V26, P1706, DOI 10.1093/carcin/bgi137; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Kubarek L, 2007, FEBS LETT, V581, P1441, DOI 10.1016/j.febslet.2007.02.070; Kucia M, 2004, J MOL HISTOL, V35, P233; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Liang ZX, 2007, BIOCHEM BIOPH RES CO, V363, P542, DOI 10.1016/j.bbrc.2007.09.007; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Luker KE, 2010, ONCOGENE, V29, P4599, DOI 10.1038/onc.2010.212; Luker KE, 2006, CANCER LETT, V238, P30, DOI 10.1016/j.canlet.2005.06.021; Luker KE, 2009, FASEB J, V23, P823, DOI 10.1096/fj.08-116749; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Miller RJ, 2008, J NEUROIMMUNOL, V198, P31, DOI 10.1016/j.jneuroim.2008.04.008; Morrow PKH, 2009, ANNU REV MED, V60, P153, DOI 10.1146/annurev.med.60.061107.145152; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nagy PL, 2003, P NATL ACAD SCI USA, V100, P6364, DOI 10.1073/pnas.1131966100; Platet N, 2000, MOL ENDOCRINOL, V14, P999, DOI 10.1210/me.14.7.999; RENNSTAM K, 2009, BREAST CANC RES TREA; Rochefort H, 1998, J STEROID BIOCHEM, V65, P163, DOI 10.1016/S0960-0760(98)00010-7; Sengupta S, 2009, BREAST CANCER RES TR, V117, P243, DOI 10.1007/s10549-008-0186-z; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Sohy D, 2007, J BIOL CHEM, V282, P30062, DOI 10.1074/jbc.M705302200; Sommer S, 2001, SEMIN CANCER BIOL, V11, P339, DOI 10.1006/scbi.2001.0389; Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005; Su YC, 2006, BREAST, V15, P533, DOI 10.1016/j.breast.2005.08.034; Thelen M, 2008, J NEUROIMMUNOL, V198, P9, DOI 10.1016/j.jneuroim.2008.04.020; Wang JH, 2008, J BIOL CHEM, V283, P4283, DOI 10.1074/jbc.M707465200; Wendt MK, 2008, ONCOGENE, V27, P1461, DOI 10.1038/sj.onc.1210751; Wickerham DL, 2009, RECENT RESULTS CANC, V181, P113; YOSHIDA D, 2009, J NEUROENDOCRINOL; Zabel BA, 2009, J IMMUNOL, V183, P3204, DOI 10.4049/jimmunol.0900269; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003; Zhou W, 2008, J NEUROSCI RES, V86, P3002, DOI 10.1002/jnr.21746; Zhou W, 2009, J CANCER RES CLIN, V135, P91, DOI 10.1007/s00432-008-0435-x; Zhu Y, 2006, CANCER RES, V66, P7991, DOI 10.1158/0008-5472.CAN-05-4397	54	79	89	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20898	10.1371/journal.pone.0020898	http://dx.doi.org/10.1371/journal.pone.0020898			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695171	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600034
J	Kassanjee, R; Welte, A; McWalter, TA; Keating, SM; Vermeulen, M; Stramer, SL; Busch, MP				Kassanjee, Reshma; Welte, Alex; McWalter, Thomas A.; Keating, Sheila M.; Vermeulen, Marion; Stramer, Susan L.; Busch, Michael P.			Seroconverting Blood Donors as a Resource for Characterising and Optimising Recent Infection Testing Algorithms for Incidence Estimation	PLOS ONE			English	Article							HIV INCIDENCE; ENZYME-IMMUNOASSAY; PREVALENCE; SUBTYPES; ASSAY	Introduction: Biomarker-based cross-sectional incidence estimation requires a Recent Infection Testing Algorithm (RITA) with an adequately large mean recency duration, to achieve reasonable survey counts, and a low false-recent rate, to minimise exposure to further bias and imprecision. Estimating these characteristics requires specimens from individuals with well-known seroconversion dates or confirmed long-standing infection. Specimens with well-known seroconversion dates are typically rare and precious, presenting a bottleneck in the development of RITAs. Methods: The mean recency duration and a 'false-recent rate' are estimated from data on seroconverting blood donors. Within an idealised model for the dynamics of false-recent results, blood donor specimens were used to characterise RITAs by a new method that maximises the likelihood of cohort-level recency classifications, rather than modelling individual sojourn times in recency. Results: For a range of assumptions about the false-recent results (0% to 20% of biomarker response curves failing to reach the threshold distinguishing test-recent and test-non-recent infection), the mean recency duration of the Vironostika-LS ranged from 154 (95% CI: 96-231) to 274 (95% CI: 234-313) days in the South African donor population (n = 282), and from 145 (95% CI: 67-226) to 252 (95% CI: 194-308) days in the American donor population (n = 106). The significance of gender and clade on performance was rejected (p-value = 10%), and utility in incidence estimation appeared comparable to that of a BED-like RITA. Assessment of the Vitros-LS (n = 108) suggested potentially high false-recent rates. Discussion: The new method facilitates RITA characterisation using widely available specimens that were previously overlooked, at the cost of possible artefacts. While accuracy and precision are insufficient to provide estimates suitable for incidence surveillance, a low-cost approach for preliminary assessments of new RITAs has been demonstrated. The Vironostika-LS and Vitros-LS warrant further analysis to provide greater precision of estimates.	[Kassanjee, Reshma; Welte, Alex; McWalter, Thomas A.] Univ Stellenbosch, S African DST NRF Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa; [Kassanjee, Reshma; McWalter, Thomas A.] Univ Witwatersrand, Sch Computat & Appl Math, Johannesburg, South Africa; [Keating, Sheila M.; Busch, Michael P.] Blood Syst Res Inst, San Francisco, CA USA; [Vermeulen, Marion] S African Natl Blood Serv, Johannesburg, South Africa; [Stramer, Susan L.] Amer Red Cross, Sci Support Off, Gaithersburg, MD USA	National Research Foundation - South Africa; Stellenbosch University; University of Witwatersrand; Vitalant; Vitalant Research Institute; American Red Cross	Kassanjee, R (corresponding author), Univ Stellenbosch, S African DST NRF Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa.	r.kassanjee@gmail.com	Keating, Sheila/B-1652-2013	McWalter, Thomas/0000-0002-2163-4112; Vermeulen, Marion/0000-0003-4383-4526; Keating, Sheila/0000-0002-8324-3694; Kassanjee, Reshma/0000-0002-1200-8726	Canadian International Development Agency	Canadian International Development Agency	This work was supported in part by a grant from the Canadian International Development Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AV INC, 2009, AV HIV 1 MICR SYST P; Balasubramanian R, 2010, BIOMETRICS, V66, P1, DOI 10.1111/j.1541-0420.2009.01242.x; Barnighausen T, 2010, EPIDEMIOLOGY, V21, P685, DOI 10.1097/EDE.0b013e3181e9e978; Brennan CA, 2009, TRANSFUSION, V49, P125, DOI 10.1111/j.1537-2995.2008.01935.x; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; BUSCH MP, 2009, 16 C RETR OPP INF 20; *CAL BIOM CORP, 2008, AW BED EIA HIV 1 INC; Cox D.R, 2006, PRINCIPLES STAT INFE; Delwart EL, 2003, AIDS RES HUM RETROV, V19, P1065, DOI 10.1089/088922203771881149; Department of Health, 2008, 2008 NAT ANT SENT HI; Fang CT, 2003, VOX SANG, V85, P9, DOI 10.1046/j.1423-0410.2003.00311.x; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hart J.D., 1997, NONPARAMETRIC SMOOTH; Kaplan EH, 1999, OPER RES, V47, P29, DOI 10.1287/opre.47.1.29; KASSANJEE R, 2009, 5 IAS C HIV PATH TRE; KEATING SM, 2010, HIV DIAGN C 2010 FLO; Kothe D, 2003, JAIDS-J ACQ IMM DEF, V33, P625, DOI 10.1097/00126334-200308150-00012; Le Vu S, 2008, EUROSURVEILLANCE, V13, P11; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; McWalter TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007368; McWalter TA, 2010, J MATH BIOL, V60, P687, DOI 10.1007/s00285-009-0282-7; Murphy G, 2008, Euro Surveill, V13; Osmanov S, 2002, J ACQ IMMUN DEF SYND, V29, P184, DOI 10.1097/00042560-200202010-00013; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Parekh BS, 2001, AIDS REV, V3, P183; Rawal BD, 2003, JAIDS-J ACQ IMM DEF, V33, P349, DOI 10.1097/00126334-200307010-00009; Remis RS, 2009, AIDS, V23, P493, DOI 10.1097/QAD.0b013e328323ad5f; Schreiber GB, 2002, TRANSFUSION, V42, P414, DOI 10.1046/j.1525-1438.2002.00084.x; Schwarcz S, 2007, JAIDS-J ACQ IMM DEF, V44, P112, DOI 10.1097/01.qai.0000247228.30128.dc; Statistics South Africa, 2009, MID POP EST 2009 STA; Wang R, 2010, BIOMETRICS, V66, P864, DOI 10.1111/j.1541-0420.2009.01356.x; Wang R, 2009, JAIDS-J ACQ IMM DEF, V52, P538, DOI 10.1097/QAI.0b013e3181c080a7; Welte A, 2010, EURO SURVEILL, V15, p[pii, 19589]; Welte A, 2008, S AFR J SCI, V104, P199; Young CL, 2003, AIDS RES HUM RETROV, V19, P481, DOI 10.1089/088922203766774522; 2009, 5 IAS C HIV PATH TRE	36	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20027	10.1371/journal.pone.0020027	http://dx.doi.org/10.1371/journal.pone.0020027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694760	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900004
J	Radfar, MH; Wong, W; Morris, Q				Radfar, M. Hossein; Wong, Willy; Morris, Quaid			Computational Prediction of Intronic microRNA Targets using Host Gene Expression Reveals Novel Regulatory Mechanisms	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; MAMMALIAN MICRORNAS; SITE ACCESSIBILITY; MIRNA PROMOTERS; PROFILES; RECOGNITION; TRANSLATION; INFERENCE; GENOME; IMPACT	Approximately half of known human miRNAs are located in the introns of protein coding genes. Some of these intronic miRNAs are only expressed when their host gene is and, as such, their steady state expression levels are highly correlated with those of the host gene's mRNA. Recently host gene expression levels have been used to predict the targets of intronic miRNAs by identifying other mRNAs that they have consistent negative correlation with. This is a potentially powerful approach because it allows a large number of expression profiling studies to be used but needs refinement because mRNAs can be targeted by multiple miRNAs and not all intronic miRNAs are co-expressed with their host genes. Here we introduce InMiR, a new computational method that uses a linear-Gaussian model to predict the targets of intronic miRNAs based on the expression profiles of their host genes across a large number of datasets. Our method recovers nearly twice as many true positives at the same fixed false positive rate as a comparable method that only considers correlations. Through an analysis of 140 Affymetrix datasets from Gene Expression Omnibus, we build a network of 19,926 interactions among 57 intronic miRNAs and 3,864 targets. InMiR can also predict which host genes have expression profiles that are good surrogates for those of their intronic miRNAs. Host genes that InMiR predicts are bad surrogates contain significantly more miRNA target sites in their 3' UTRs and are significantly more likely to have predicted Pol II and Pol III promoters in their introns. We provide a dataset of 1,935 predicted mRNA targets for 22 intronic miRNAs. These prediction are supported both by sequence features and expression. By combining our results with previous reports, we distinguish three classes of intronic miRNAs: Those that are tightly regulated with their host gene; those that are likely to be expressed from the same promoter but whose host gene is highly regulated by miRNAs; and those likely to have independent promoters.	[Radfar, M. Hossein; Wong, Willy] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Radfar, M. Hossein; Wong, Willy] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Radfar, M. Hossein; Morris, Quaid] Univ Toronto, Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Dept Comp Sci, Toronto, ON, Canada; [Morris, Quaid] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Radfar, MH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada.	h.radfar@utoronto.ca; quaid.morris@utoronto.ca	Morris, Quaid/ABE-8343-2020	Morris, Quaid/0000-0002-2760-6999	Natural Sciences and Engineering Research Council (NSERC) of Canada; NSERC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This project was funded by a Natural Sciences and Engineering Research Council (NSERC) of Canada fellowship to M. H. R. and partially funded by NSERC operating grants to Q. M. and W. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Babak T, 2004, RNA, V10, P1813, DOI 10.1261/rna.7119904; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bargaje R, 2010, RNA, V16, P16, DOI 10.1261/rna.1688110; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; Corcoran DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005279; Ernst J, 2010, GENOME RES, V20, P526, DOI 10.1101/gr.096305.109; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gabor B, 2009, BIOINFORMATICS, V25, P1063, DOI 10.1093/bioinformatics/btp018; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Golan D, 2010, BIOINFORMATICS, V26, P992, DOI 10.1093/bioinformatics/btq077; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109; Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412; Huang JC, 2007, J COMPUT BIOL, V14, P550, DOI 10.1089/cmb.2007.R002; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Huang JC, 2006, LECT NOTES COMPUT SC, V3909, P114; Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102; Ioshikhes I, 2007, DNA CELL BIOL, V26, P265, DOI 10.1089/dna.2006.0566; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li SC, 2007, DNA CELL BIOL, V26, P195, DOI 10.1089/dna.2006.0558; Liang Y, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-166; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; Martinez NJ, 2008, GENOME RES, V18, P2005, DOI 10.1101/gr.083055.108; Min H, 2010, EXP MOL MED, V42, P233, DOI 10.3858/emm.2010.42.4.032; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Ohler U, 2004, RNA, V10, P1309, DOI 10.1261/rna.5206304; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Peter ME, 2010, ONCOGENE, V29, P2161, DOI 10.1038/onc.2010.59; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Ritchie W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000513; Ritchie W, 2009, NAT METHODS, V6, P397, DOI 10.1038/nmeth0609-397; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ronchetti D, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-37; Ruike Y, 2008, J HUM GENET, V53, P515, DOI 10.1007/s10038-008-0279-x; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Thomas M, 2010, NAT STRUCT MOL BIOL, V17, P1169, DOI 10.1038/nsmb.1921; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004421; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang XW, 2009, GENOME RES, V19, P266, DOI 10.1101/gr.081638.108; YUPING W, 2009, BMC GENOMICS, V10, DOI DOI 10.1186/1471-2164-10-218; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	71	28	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e19312	10.1371/journal.pone.0019312	http://dx.doi.org/10.1371/journal.pone.0019312			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694770	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900003
J	Zheng, SZ; Chang, S; Lu, JL; Chen, ZH; Xie, L; Nie, Y; He, B; Zou, SQ; Gu, ZW				Zheng, Shunzhen; Chang, Shuang; Lu, Jinli; Chen, Zhihui; Xie, Li; Nie, Yu; He, Bin; Zou, Shengquan; Gu, Zhongwei			Characterization of 9-Nitrocamptothecin Liposomes: Anticancer Properties and Mechanisms on Hepatocellular Carcinoma In Vitro and In Vivo	PLOS ONE			English	Article							CELL-CYCLE; POTENTIAL MEDIATOR; SOLID TUMOR; CANCER; APOPTOSIS; P53; MICELLES; DELIVERY; RETINOBLASTOMA; CAMPTOTHECIN	Background: Hepatocellular carcinoma (HCC) is the third most common cause of cancer related mortality worldwide. 9-Nitrocamptothecin (9NC) is a potent topoisomerase-I inhibitor with strong anticancer effect. To increase the solubility and stability, we synthesized a novel 9NC loaded liposomes (9NC-LP) via incorporating 9NC into liposomes. In the present study, we determined the effects of 9NC and 9NC-LP on in vitro and in vivo, and the underlying mechanisms. Methodology/Principal Findings: We first analyzed the characteristics of 9NC-LP. Then we compared the effects of 9NC and 9NC-LP on the proliferation and apoptosis of HepG2, Bel-7402, Hep3B and L02 cells in vitro. We also investigated their anticancer properties in nude mice bearing HCC xenograft in vivo. 9NC-LP has a uniform size (around 190 nm) and zeta potential (similar to-11 mV), and exhibited a steady sustained-release pattern profile in vitro. Both 9NC and 9NC-LP could cause cell cycle arrest and apoptosis in a dose-dependent and p53-dependent manner. However, this effect was not ubiquitous in all cell lines. Exposure to 9NC-LP led to increased expression of p53, p21, p27, Bax, caspase-3, caspase-8, caspase-9 and apoptosis-inducing factor, mitochondrion-associated 1 and decreased expression of Bcl-2, cyclin E, cyclin A, Cdk2 and cyclin D1. Furthermore, 9NC-LP exhibited a more potent antiproliferative effect and less side effects in vivo. Western blot analysis of the xenograft tumors in nude mice showed similar changes in protein expression in vivo. Conclusions/Significance: In conclusion, 9NC and 9NC-LP can inhibit HCC growth via cell cycle arrest and induction of apoptosis. 9NC-LP has a more potent anti-tumor effect and fewer side effects in vivo, which means it is a promising reagent for cancer therapy via intravenous administration.	[Zheng, Shunzhen; Lu, Jinli; Chen, Zhihui; Zou, Shengquan] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China; [Chang, Shuang; Xie, Li; Nie, Yu; He, Bin; Gu, Zhongwei] Sichuan Univ, Natl Engn Res Ctr Biomat, Chengdu 610064, Peoples R China	Huazhong University of Science & Technology; Sichuan University	Zheng, SZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Gen Surg, Wuhan 430074, Peoples R China.	sqzou05@yahoo.com.cn; zwgu@scu.edu.cn			Hi3-Tech Research and Development of Program of China [2007AA021801]	Hi3-Tech Research and Development of Program of China	This study was supported by a grant from the Hi3-Tech Research and Development of Program of China (No. 2007AA021801) (http://program.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2007, ADV DRUG DELIVER REV, V59, P75, DOI 10.1016/j.addr.2007.03.005; Alexis Frank, 2010, Handb Exp Pharmacol, P55, DOI 10.1007/978-3-642-00477-3_2; Anand S, 2009, CLIN CANCER RES, V15, P3333, DOI 10.1158/1078-0432.CCR-08-3054; Bianchi R, 2006, CLIN CANCER RES, V12, P2607, DOI 10.1158/1078-0432.CCR-05-2177; Cha CH, 2010, CURR PROB SURG, V47, P10, DOI 10.1067/j.cpsurg.2009.09.003; Chan KT, 2010, CANCER LETT, V294, P118, DOI 10.1016/j.canlet.2010.01.029; Chen J, 2006, DRUG DEV IND PHARM, V32, P719, DOI 10.1080/03639040500529077; Chow DSL, 2000, ANN NY ACAD SCI, V922, P164; Cukierman E, 2010, BIOCHEM PHARMACOL, V80, P762, DOI 10.1016/j.bcp.2010.04.020; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Gabizon AA, 2001, CLIN CANCER RES, V7, P223; GIOVANELLA BC, 1991, CANCER RES, V51, P3052; Hobbs SK, 1998, P NATL ACAD SCI USA, V95, P4607, DOI 10.1073/pnas.95.8.4607; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khan DR, 2008, CHEM BIOL DRUG DES, V71, P3, DOI 10.1111/j.1747-0285.2007.00610.x; Koo OM, 2005, NANOMED-NANOTECHNOL, V1, P77, DOI 10.1016/j.nano.2004.11.002; Kumagi T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5039; Maeda H, 2001, J CONTROL RELEASE, V74, P47, DOI 10.1016/S0168-3659(01)00309-1; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Malam Y, 2009, TRENDS PHARMACOL SCI, V30, P592, DOI 10.1016/j.tips.2009.08.004; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Meeran SM, 2008, FRONT BIOSCI-LANDMRK, V13, P2191, DOI 10.2741/2834; Nitiss JL, 1996, MOL PHARMACOL, V50, P1095; Opanasopit P, 2004, PHARM RES-DORDR, V21, P2001, DOI 10.1023/B:PHAM.0000048190.53439.eb; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Padma S, 2009, J SURG ONCOL, V100, P619, DOI 10.1002/jso.21364; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; PUISIEUX A, 1993, FASEB J, V7, P1407, DOI 10.1096/fasebj.7.14.8224613; Rivera E, 2003, ONCOLOGIST, V8, P3; Senderowicz AM, 2004, CURR OPIN CELL BIOL, V16, P670, DOI 10.1016/j.ceb.2004.09.014; Sezgin Z, 2007, INT J PHARMACEUT, V332, P161, DOI 10.1016/j.ijpharm.2006.09.030; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Stahler F, 1998, ONCOGENE, V17, P3507, DOI 10.1038/sj.onc.1202245; Strieth S, 2008, CLIN CANCER RES, V14, P4603, DOI 10.1158/1078-0432.CCR-07-4738; Unezaki S, 1996, INT J PHARM, V144, P11, DOI 10.1016/S0378-5173(96)04674-1; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wang JYJ, 2001, BIOCHEM SOC T, V29, P666, DOI 10.1042/0300-5127:0290666; You J, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/04/045102; Zhang YX, 2000, CANCER RES, V60, P2025	42	8	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e21064	10.1371/journal.pone.0021064	http://dx.doi.org/10.1371/journal.pone.0021064			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695227	Green Submitted, gold, Green Published			2022-12-25	WOS:000291612900052
J	Hasenpusch, G; Pfeifer, C; Aneja, MK; Wagner, K; Reinhardt, D; Gilon, M; Ohana, P; Hochberg, A; Rudolph, C				Hasenpusch, Guenther; Pfeifer, Corinna; Aneja, Manish Kumar; Wagner, Kai; Reinhardt, Dietrich; Gilon, Michal; Ohana, Patricia; Hochberg, Avraham; Rudolph, Carsten			Aerosolized BC-819 Inhibits Primary but Not Secondary Lung Cancer Growth	PLOS ONE			English	Article							H19 NONCODING RNA; GENE-THERAPY; TUMOR-GROWTH; DELIVERY; PLASMID; MICE; METASTASIS; EXPRESSION; COMPLEXES; CARCINOMA	Despite numerous efforts, drug based treatments for patients suffering from lung cancer remains poor. As a promising alternative, we investigated the therapeutic potential of BC-819 for the treatment of lung cancer in mouse tumor models. BC-819 is a novel plasmid DNA which encodes for the A-fragment of Diphtheria toxin and has previously been shown to successfully inhibit tumor growth in human clinical study of bladder carcinoma. In a first set of experiments, we examined in vitro efficacy of BC-819 in human lung cancer cell-lines NCI-H460, NCI-H358 and A549, which revealed >90% reduction of cell growth. In vivo efficacy was examined in an orthotopic mouse xenograft lung cancer model and in a lung metastasis model using luminescent A549-C8-luc adenocarcinoma cells. These cells resulted in peri-and intra-bronchiolar tumors upon intrabronchial application and parenchymal tumors upon intravenous injection, respectively. Mice suffering from these lung tumors were treated with BC-819, complexed to branched polyethylenimine (PEI) and aerosolized to the mice once per week for a period of 10 weeks. Using this regimen, growth of intrabronchially induced lung tumors was significantly inhibited (p = 0.01), whereas no effect could be observed in mice suffering from lung metastasis. In summary, we suggest that aerosolized PEI/BC-819 is capable of reducing growth only in tumors arising from the luminal part of the airways and are therefore directly accessible for inhaled BC-819.	[Hasenpusch, Guenther; Pfeifer, Corinna; Aneja, Manish Kumar; Reinhardt, Dietrich; Rudolph, Carsten] Univ Munich, Dept Pediat, Munich, Germany; [Wagner, Kai] Univ Munich, Inst Pathol, D-8000 Munich, Germany; [Gilon, Michal; Ohana, Patricia; Hochberg, Avraham] Hebrew Univ Jerusalem, Inst Life Sci, Dept Biol Chem, IL-91904 Jerusalem, Israel	University of Munich; University of Munich; Hebrew University of Jerusalem	Hasenpusch, G (corresponding author), Univ Munich, Dept Pediat, Munich, Germany.	Carsten.Rudolph@med.uni-muenchen.de			BMBF [FKZ0311898]; LMUexcellent (Investitionsfonds); DFG [RU 911/9-1]; Emma Thaler Foundation;  [13N9182]	BMBF(Federal Ministry of Education & Research (BMBF)); LMUexcellent (Investitionsfonds); DFG(German Research Foundation (DFG)); Emma Thaler Foundation; 	This work was supported by the BMBF BioFuture programme (FKZ0311898), the programme 13N9182, LMUexcellent (Investitionsfonds), DFG RU 911/9-1 and Emma Thaler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja MK, 2009, EXPERT OPIN DRUG DEL, V6, P567, DOI 10.1517/17425240902927841; ARIEL I, 1995, UROLOGY, V45, P335, DOI 10.1016/0090-4295(95)80030-1; Barsyte-Lovejoy D, 2006, CANCER RES, V66, P5330, DOI 10.1158/0008-5472.CAN-06-0037; BUCKLEY SM, 2008, HUM GENE THER; Davies JC, 2005, ADV GENET, V54, P291, DOI 10.1016/S0065-2660(05)54012-4; Davies LA, 2008, MOL THER, V16, P1283, DOI 10.1038/mt.2008.96; Densmore CL, 2003, CURR CANCER DRUG TAR, V3, P275, DOI 10.2174/1568009033481886; Densmore CL, 2001, CANCER GENE THER, V8, P619, DOI 10.1038/sj.cgt.7700343; Erdmann VA, 2001, NUCLEIC ACIDS RES, V29, P189, DOI 10.1093/nar/29.1.189; Gautam A, 2001, GENE THER, V8, P254, DOI 10.1038/sj.gt.3301369; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Hershey AE, 1999, CLIN CANCER RES, V5, P2653; Jenkins DE, 2003, CLIN EXP METASTAS, V20, P733, DOI 10.1023/B:CLIN.0000006815.49932.98; Koshkina NV, 2001, CLIN CANCER RES, V7, P3258; Leblond AL, 2009, HUM GENE THER, V20, P1329, DOI 10.1089/hum.2009.035; Lesina E, 2010, J CONTROL RELEASE, V143, P243, DOI 10.1016/j.jconrel.2010.01.003; Lesina E, 2010, EUR J PHARM BIOPHARM, V74, P427, DOI 10.1016/j.ejpb.2009.11.013; Mase K, 2002, LUNG CANCER-J IASLC, V36, P271, DOI 10.1016/S0169-5002(02)00004-1; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Ohana P, 2002, INT J CANCER, V98, P645, DOI 10.1002/ijc.10243; Otterson GA, 2007, CLIN CANCER RES, V13, P1246, DOI 10.1158/1078-0432.CCR-06-1096; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Rudolph C, 2005, MOL THER, V12, P493, DOI 10.1016/j.ymthe.2005.03.002; Rudolph C, 2005, J GENE MED, V7, P59, DOI 10.1002/jgm.646; Sidi AA, 2008, J UROLOGY, V180, P2379, DOI 10.1016/j.juro.2008.08.006; Toloza EM, 2006, J CELL BIOCHEM, V99, P1, DOI 10.1002/jcb.20851; Vachani A, 2010, AM J RESP CELL MOL, V42, P385, DOI 10.1165/rcmb.2010-0026RT	27	32	32	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20760	10.1371/journal.pone.0020760	http://dx.doi.org/10.1371/journal.pone.0020760			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687669	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500040
J	Szczesny, P; Iacovache, I; Muszewska, A; Ginalski, K; van der Goot, FG; Grynberg, M				Szczesny, Pawel; Iacovache, Ioan; Muszewska, Anna; Ginalski, Krzysztof; van der Goot, F. Gisou; Grynberg, Marcin			Extending the Aerolysin Family: From Bacteria to Vertebrates	PLOS ONE			English	Article							SEPTICUM ALPHA-TOXIN; GAMMA-CRYSTALLIN SUPERFAMILY; BACILLUS-ANTHRACIS; AMARANTHUS-CAUDATUS; CYTOLYTIC PROTEIN; BINDING DOMAIN; LECTIN; SEQUENCE; VIRULENCE; PLASMID	A number of bacterial virulence factors have been observed to adopt structures similar to that of aerolysin, the principal toxin of Aeromonas species. However, a comprehensive description of architecture and structure of the aerolysin-like superfamily has not been determined. In this study, we define a more compact aerolysin-like domain - or aerolysin fold and show that this domain is far more widely spread than anticipated since it can be found throughout kingdoms. The aerolysin-fold could be found in very diverse domain and functional contexts, although a toxic function could often be assigned. Due to this diversity, the borders of the superfamily could not be set on a sequence level. As a border-defining member, we therefore chose pXO2-60 - a protein from the pathogenic pXO2 plasmid of Bacillus anthracis. This fascinating protein, which harbors a unique ubiquitin-like fold domain at the C-terminus of the aerolysin-domain, nicely illustrates the diversity of the superfamily. Its putative role in the virulence of B. anthracis and its three dimensional model are discussed.	[Szczesny, Pawel; Muszewska, Anna; Grynberg, Marcin] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Szczesny, Pawel] Univ Warsaw, Inst Expt Plant Biol, Warsaw, Poland; [Iacovache, Ioan; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Fac Life Sci, Global Hlth Inst, Lausanne, Switzerland; [Ginalski, Krzysztof] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling	Szczesny, P (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	greenb@ibb.waw.pl	Muszewska, Anna/S-9406-2019; van der Goot, Gisou G/B-2279-2012	Muszewska, Anna/0000-0002-4578-844X; van der Goot, Gisou G/0000-0002-8522-274X; Szczesny, Pawel/0000-0001-8442-0157; Grynberg, Marcin/0000-0003-1887-7209; iacovache, ioan/0000-0001-8470-5056	Foundation for Polish Science (FNP); European Molecular Biology Organization (EMBO)	Foundation for Polish Science (FNP)(Foundation for Polish Science); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	P.S. and K.G. acknowledge the support from Foundation for Polish Science (FNP). K.G. acknowledges the support from European Molecular Biology Organization (EMBO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 2005, TRENDS MICROBIOL, V13, P72, DOI 10.1016/j.tim.2004.12.004; Akiba T, 2009, J MOL BIOL, V386, P121, DOI 10.1016/j.jmb.2008.12.002; Al-Shangiti AM, 2004, INFECT IMMUN, V72, P4261, DOI 10.1128/IAI.72.7.4261-4270.2004; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Augusteyn RC, 1998, PROG POLYM SCI, V23, P375, DOI 10.1016/S0079-6700(98)80008-7; BALLARD J, 1993, MOL MICROBIOL, V10, P627, DOI 10.1111/j.1365-2958.1993.tb00934.x; Beisel HG, 1999, EMBO J, V18, P2313, DOI 10.1093/emboj/18.9.2313; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bischofberger M, 2009, CURR OPIN CELL BIOL, V21, P589, DOI 10.1016/j.ceb.2009.04.003; Bittencourt SET, 2003, FEBS LETT, V549, P47, DOI 10.1016/S0014-5793(03)00763-4; BORK P, 1994, J MOL BIOL, V242, P309, DOI 10.1006/jmbi.1994.1582; Bottino D, 2002, J CELL SCI, V115, P367; Bourgogne A, 2003, INFECT IMMUN, V71, P2736, DOI 10.1128/IAI.71.5.2736-2743.2003; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Buttery SM, 2003, MOL BIOL CELL, V14, P5082, DOI 10.1091/mbc.E03-04-0246; Chand HS, 2009, INFECT IMMUN, V77, P429, DOI 10.1128/IAI.00647-08; Cole AR, 2004, NAT STRUCT MOL BIOL, V11, P797, DOI 10.1038/nsmb804; D'Alessio G, 2002, EUR J BIOCHEM, V269, P3122, DOI 10.1046/j.1432-1033.2002.03004.x; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Ginalski K, 2003, PROTEINS, V53, P410, DOI 10.1002/prot.10548; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Gordon VM, 1999, J BIOL CHEM, V274, P27274, DOI 10.1074/jbc.274.38.27274; Grant RP, 2005, J MOL BIOL, V347, P583, DOI 10.1016/j.jmb.2005.01.054; GREEN BD, 1985, INFECT IMMUN, V49, P291, DOI 10.1128/IAI.49.2.291-297.1985; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Hadders MA, 2007, SCIENCE, V317, P1552, DOI 10.1126/science.1147103; HAYASHI S, 1990, J BIOENERG BIOMEMBR, V22, P451, DOI 10.1007/BF00763177; Heninger S, 2006, INFECT IMMUN, V74, P6067, DOI 10.1128/IAI.00719-06; Hong YJ, 2002, EMBO J, V21, P5047, DOI 10.1093/emboj/cdf508; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Italiano JE, 1996, CELL, V84, P105, DOI 10.1016/S0092-8674(00)80997-6; Jaenicke R, 2001, CRIT REV BIOCHEM MOL, V36, P435, DOI 10.1080/20014091074237; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Luo H, 2004, MYCOLOGIA, V96, P1218, DOI 10.2307/3762137; Magalhaes GS, 2005, BIOCHIMIE, V87, P687, DOI 10.1016/j.biochi.2005.03.016; Mancheno JM, 2005, J BIOL CHEM, V280, P17251, DOI 10.1074/jbc.M413933200; Mancheno JM, 2010, ADV EXP MED BIOL, V677, P67; Mues A, 1998, FEBS LETT, V428, P111, DOI 10.1016/S0014-5793(98)00501-8; MURZIN AG, 1992, NATURE, V360, P635, DOI 10.1038/360635a0; Nakayama K, 1999, MOL MICROBIOL, V31, P399, DOI 10.1046/j.1365-2958.1999.01158.x; Ogawa M, 1998, DEV GROWTH DIFFER, V40, P465; Ogawa M, 1997, DEV GENES EVOL, V206, P417, DOI 10.1007/s004270050071; Okino N, 1995, J BIOL CHEM, V270, P31008, DOI 10.1074/jbc.270.52.31008; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piatigorsky Joram, 2003, Journal of Structural and Functional Genomics, V3, P131; Ponting CP, 2001, GENOME RES, V11, P1996, DOI 10.1101/gr.198701; Puthoff DP, 2005, MOL PLANT PATHOL, V6, P411, DOI 10.1111/J.1364-3703.2005.00289.X; RAMAGE R, 1994, BIOCHEM J, V299, P151, DOI 10.1042/bj2990151; RINDERLE SJ, 1990, BIOCHEMISTRY-US, V29, P10555, DOI 10.1021/bi00498a019; RINDERLE SJ, 1989, J BIOL CHEM, V264, P16123; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Rossjohn J, 1997, EMBO J, V16, P3426, DOI 10.1093/emboj/16.12.3426; Sher D, 2005, J BIOL CHEM, V280, P22847, DOI 10.1074/jbc.M503242200; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; SOUSA MV, 1994, J PROTEIN CHEM, V13, P659, DOI 10.1007/BF01886950; TAKABATAKE T, 1992, DEV GROWTH DIFFER, V34, P277; TAKABATAKE T, 1991, DEV GROWTH DIFFER, V33, P277; Tomita T, 1998, BIOCHEM J, V333, P129, DOI 10.1042/bj3330129; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; UCHIDA I, 1985, J GEN MICROBIOL, V131, P363; Velasco R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001326; WELKOS SL, 1991, MICROB PATHOGENESIS, V10, P183, DOI 10.1016/0882-4010(91)90053-D; WELKOS SL, 1993, MICROB PATHOGENESIS, V14, P381, DOI 10.1006/mpat.1993.1037	70	83	86	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20349	10.1371/journal.pone.0020349	http://dx.doi.org/10.1371/journal.pone.0020349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687664	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500017
J	Xiong, N; Xiong, J; Khare, G; Chen, CN; Huang, JS; Zhao, Y; Zhang, ZT; Qiao, X; Feng, Y; Reesaul, H; Zhang, YX; Sun, SG; Lin, ZC; Wang, T				Xiong, Nian; Xiong, Jing; Khare, Ghanshyam; Chen, Chunnuan; Huang, Jinsha; Zhao, Ying; Zhang, Zhentao; Qiao, Xian; Feng, Yuan; Reesaul, Harrish; Zhang, Yongxue; Sun, Shenggang; Lin, Zhicheng; Wang, Tao			Edaravone Guards Dopamine Neurons in a Rotenone Model for Parkinson's Disease	PLOS ONE			English	Article							VESICULAR MONOAMINE TRANSPORTER-2; TRANSIENT FOCAL ISCHEMIA; FREE-RADICAL SCAVENGER; OXIDATIVE STRESS; MITOCHONDRIAL IMPAIRMENT; SUBSTANTIA-NIGRA; PROTECTS; DEATH; NEUROPROTECTION; NEUROTOXICITY	3-methyl-1-phenyl-2-pyrazolin-5-one (edaravone), an effective free radical scavenger, provides neuroprotection in stroke models and patients. In this study, we investigated its neuroprotective effects in a chronic rotenone rat model for Parkinson's disease. Here we showed that a five-week treatment with edaravone abolished rotenone's activity to induce catalepsy, damage mitochondria and degenerate dopamine neurons in the midbrain of rotenone-treated rats. This abolishment was attributable at least partly to edaravone's inhibition of rotenone-induced reactive oxygen species production or apoptotic promoter Bax expression and its up-regulation of the vesicular monoamine transporter 2 (VMAT2) expression. Collectively, edaravone may provide novel clinical therapeutics for PD.	[Xiong, Nian; Xiong, Jing; Khare, Ghanshyam; Chen, Chunnuan; Huang, Jinsha; Zhang, Zhentao; Qiao, Xian; Feng, Yuan; Reesaul, Harrish; Sun, Shenggang; Wang, Tao] Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Hubei, Peoples R China; [Xiong, Nian; Zhao, Ying; Lin, Zhicheng] Harvard Univ, Sch Med, Dept Psychiat, Div Alcohol & Drug Abuse, Belmont, MA 02178 USA; [Xiong, Nian; Zhao, Ying; Lin, Zhicheng] Harvard Univ, Sch Med, Harvard NeuroDiscovery Ctr, Div Alcohol & Drug Abuse, Belmont, MA 02178 USA; [Xiong, Nian; Zhao, Ying; Lin, Zhicheng] McLean Hosp, Mailman Res Ctr, Belmont, MA 02178 USA; [Zhang, Yongxue] Huazhong Univ Sci & Technol, Dept Nucl Med, Union Hosp, Tongji Med Coll,Hubei Prov Key Lab Mol Imaging, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Harvard University; Harvard University; Harvard University; McLean Hospital; Huazhong University of Science & Technology	Xiong, N (corresponding author), Huazhong Univ Sci & Technol, Dept Neurol, Union Hosp, Tongji Med Coll, Hubei, Peoples R China.	zhicheng_lin@hms.harvard.edu; wangtaowh@yahoo.cn	冯, 媛/F-7295-2012	冯, 媛/0000-0002-6369-0737; Zhang, Zhentao/0000-0001-6708-1472	National Natural Science Foundation of China [30870866]; Wuhan Science and Technology Bureau, China [20066002100]; Hubei Provincial Science & Technology Department, China [2006ABA130]; National Institutes of Health [R01DA021409]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021409] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Wuhan Science and Technology Bureau, China; Hubei Provincial Science & Technology Department, China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Natural Science Foundation of China (30870866), the Wuhan Science and Technology Bureau, China (20066002100) and the Hubei Provincial Science & Technology Department, China (2006ABA130) and U. S. National Institutes of Health grant R01DA021409 (to Z.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2004, BEHAV BRAIN RES, V153, P439, DOI 10.1016/j.bbr.2003.12.021; Alam M, 2002, BEHAV BRAIN RES, V136, P317, DOI 10.1016/S0166-4328(02)00180-8; Alam M, 2009, TOXICOL APPL PHARM, V240, P198, DOI 10.1016/j.taap.2009.07.010; Amemiya S, 2005, EUR J PHARMACOL, V516, P125, DOI 10.1016/j.ejphar.2005.04.036; Beurrier C, 2009, FASEB J, V23, P3619, DOI 10.1096/fj.09-131789; Chen CXQ, 2005, NEUROBIOL DIS, V19, P419, DOI 10.1016/j.nbd.2005.01.014; Chen H, 2008, J NEUROCHEM, V106, P2345, DOI 10.1111/j.1471-4159.2008.05573.x; Dohi K, 2006, J NEUROTRAUM, V23, P1591, DOI 10.1089/neu.2006.23.1591; Dreiem A, 2002, NEUROTOXICOLOGY, V23, P701, DOI 10.1016/S0161-813X(02)00010-4; Feng Yuan, 2006, Neurosci Bull, V22, P288; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Glatt CE, 2006, HUM MOL GENET, V15, P299, DOI 10.1093/hmg/ddi445; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Ito H, 2008, EXP NEUROL, V213, P448, DOI 10.1016/j.expneurol.2008.07.017; Itoh T, 2009, NEUROTOX RES, V16, P378, DOI 10.1007/s12640-009-9081-6; Itoh Y, 2006, CLIN HEMORHEOL MICRO, V34, P163; Kawasaki T, 2007, GLIA, V55, P1325, DOI 10.1002/glia.20541; Kawasaki T, 2007, J PHARMACOL EXP THER, V322, P274, DOI 10.1124/jpet.106.119206; Kim ST, 2010, BRAIN RES, V1306, P176, DOI 10.1016/j.brainres.2009.09.103; LaVoie MJ, 2005, NAT MED, V11, P1214, DOI 10.1038/nm1314; LIN Z, 2010, FASEB J; Lin ZC, 2005, HUM MOL GENET, V14, P1393, DOI 10.1093/hmg/ddi148; Lin ZC, 2010, FASEB J, V24, P2191, DOI 10.1096/fj.09-140368; Liu SC, 2010, TOXICOLOGY, V267, P172, DOI 10.1016/j.tox.2009.11.012; Lopez S, 2007, J NEUROSCI, V27, P6701, DOI 10.1523/JNEUROSCI.0299-07.2007; Martinez-Vicente M, 2008, J CLIN INVEST, V118, P777, DOI 10.1172/JCI32806; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Munakata A, 2009, NEUROSURGERY, V64, P423, DOI 10.1227/01.NEU.0000338067.83059.EB; Nakamura T, 2008, STROKE, V39, P463, DOI 10.1161/STROKEAHA.107.486654; Noor JI, 2005, STROKE, V36, P2468, DOI 10.1161/01.STR.0000185653.49740.c6; Nunomura A., 2007, CNS & Neurological Disorders-Drug Targets, V6, P411, DOI 10.2174/187152707783399201; Okamura N, 2010, J NUCL MED, V51, P223, DOI 10.2967/jnumed.109.070094; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Price DA, 2009, EUR J NEUROSCI, V29, P2177, DOI 10.1111/j.1460-9568.2009.06764.x; Qi X, 2004, J PHARMACOL EXP THER, V311, P388, DOI 10.1124/jpet.104.069088; Rajesh KG, 2003, AM J PHYSIOL-HEART C, V285, pH2171, DOI 10.1152/ajpheart.00143.2003; Rammal H, 2008, BRAIN BEHAV IMMUN, V22, P1156, DOI 10.1016/j.bbi.2008.06.005; Sarugaser R, 2005, STEM CELLS, V23, P220, DOI 10.1634/stemcells.2004-0166; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sherer TB, 2002, J NEUROSCI, V22, P7006; Sun F, 2007, PHARMACOL THERAPEUT, V114, P327, DOI 10.1016/j.pharmthera.2007.04.001; Wang YM, 1997, NEURON, V19, P1285, DOI 10.1016/S0896-6273(00)80419-5; Watabe M, 2008, MOL PHARMACOL, V74, P933, DOI 10.1124/mol.108.048546; Xiao B, 2007, NEUROTOX RES, V12, P155, DOI 10.1007/BF03033912; Xiong N, 2011, GENE THER, V18, P394, DOI 10.1038/gt.2010.152; Xiong NA, 2012, NEUROBIOL AGING, V33, P1777, DOI 10.1016/j.neurobiolaging.2011.03.007; Xiong NA, 2010, BIOL BLOOD MARROW TR, V16, P1519, DOI 10.1016/j.bbmt.2010.06.004; Xiong NA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007878; Yagi K, 2009, STROKE, V40, P626, DOI 10.1161/STROKEAHA.108.520262; Yuan WJ, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-75; Zhang SM, 2002, NEUROLOGY, V59, P1161, DOI 10.1212/01.WNL.0000028688.75881.12; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1; Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102	53	58	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20677	10.1371/journal.pone.0020677	http://dx.doi.org/10.1371/journal.pone.0020677			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677777	Green Submitted, Green Published, gold			2022-12-25	WOS:000291355500032
J	Wang, X; Venugopal, C; Manoranjan, B; McFarlane, N; O'Farrell, E; Nolte, S; Gunnarsson, T; Hollenberg, R; Kwiecien, J; Northcott, P; Taylor, MD; Hawkins, C; Singh, SK				Wang, X.; Venugopal, C.; Manoranjan, B.; McFarlane, N.; O'Farrell, E.; Nolte, S.; Gunnarsson, T.; Hollenberg, R.; Kwiecien, J.; Northcott, P.; Taylor, M. D.; Hawkins, C.; Singh, S. K.			Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells	ONCOGENE			English	Article						Bmi1; sonic hedgehog; medulloblastoma; brain tumor-initiating cells; CD133; chromatin immunoprecipitation	STEM-LIKE CELLS; BETA-CATENIN STATUS; MOUSE MODEL; SELF-RENEWAL; CHILDHOOD MEDULLOBLASTOMA; GENETIC PROFILES; N-MYC; PATHWAY; CANCER; GROWTH	Bmi1 is a key stem cell regulatory gene implicated in the pathogenesis of many aggressive cancers, including medulloblastoma. Overexpression of Bmi1 promotes cell proliferation and is required for hedgehog (Hh) pathway-driven tumorigenesis. This study aimed to determine if Sonic hedgehog (Shh) modulates the key stem cell regulatory gene Bmi1 in childhood medulloblastoma brain tumor-initiating cells (BTICs). Although current literature suggests that there is a correlation between Shh pathway genes and Bmi1 expression, it is unclear whether there is indeed a direct regulatory mechanism. To address whether Shh induces expression of Bmi1, stem cell-enriched populations from medulloblastoma cell lines and primary samples were treated with Shh ligand and KAAD-cyclopamine (Shh antagonist). Our data indicate that Bmi1 expression positively correlates with increasing Shh ligand concentrations. Chromatin immunoprecipitation reveals that Gli1 preferentially binds to the Bmi1 promoter, and Bmi1 transcript levels are increased and decreased by Gli1 overexpression and down-regulation, respectively. Knockdown experiments of Bmi1 in vitro and in vivo demonstrate that Hh signaling not only drives Bmi1 expression, but a feedback mechanism exists wherein downstream effectors of Bmi1 may, in turn, activate Hh pathway genes. These findings implicate Bmi1 and Hh as mutually indispensable pathways in medulloblastoma BTIC maintenance. Recent molecular characterization of medulloblastoma also reveals that Bmi1 is overexpressed across all subgroups of medulloblastoma, particularly in the most aggressive subtypes. Lastly, despite recent identification of BTIC markers, the molecular characterization of these cell populations remains unclear. In this work, we propose that the BTIC marker CD133 may segregate a cell population with a Hh-receptor phenotype, thus demonstrating a cell-cell interaction between the CD133+ Hh receptor cells and the CD133- Hh-secreting cells. Oncogene (2012) 31, 187-199; doi:10.1038/onc.2011.232; published online 20 June 2011	[Wang, X.; Venugopal, C.; Manoranjan, B.; McFarlane, N.; O'Farrell, E.; Nolte, S.; Singh, S. K.] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Singh, S. K.] McMaster Univ, Dept Surg, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Kwiecien, J.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; [Northcott, P.; Taylor, M. D.] Hosp Sick Children, Dept Surg, Toronto, ON M5G 1X8, Canada; [Northcott, P.; Taylor, M. D.; Hawkins, C.] Hosp Sick Children, Arthur & Sonia Labatt Brain Tumor Res Ctr, Toronto, ON M5G 1X8, Canada; [Northcott, P.; Taylor, M. D.; Hawkins, C.] Univ Toronto, Toronto, ON, Canada; [Hawkins, C.] Hosp Sick Children, Dept Pediat Lab Med, Toronto, ON M5G 1X8, Canada; [Singh, S. K.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Singh, S. K.] McMaster Univ, Fac Hlth Sci, Dept Neurosci, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University	Singh, SK (corresponding author), McMaster Univ, Dept Surg, Stem Cell & Canc Res Inst, MDCL 5027,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	ssingh@mcmaster.ca	Wang, Xin/U-7221-2017; Northcott, Paul A/N-4022-2018; Hawkins, Cynthia/M-2571-2019; Singh, Sheila K/W-2799-2018; Wang, Xin/O-8779-2019; Gunnarsson, Thorsteinn/AAA-1238-2019	Wang, Xin/0000-0001-6292-3087; Northcott, Paul A/0000-0002-1220-5252; Singh, Sheila K/0000-0003-1272-5300; Wang, Xin/0000-0001-6292-3087; Wang, Xin/0000-0001-8783-4080; Taylor, Michael/0000-0001-7009-3466; Gunnarsson, Thorsteinn/0000-0001-6657-4187	Department of Surgery at McMaster University; Ontario Institute for Cancer Research (OICR); JP Bickell Foundation; Stem Cell Network	Department of Surgery at McMaster University; Ontario Institute for Cancer Research (OICR); JP Bickell Foundation; Stem Cell Network	We are very grateful to Atsushi Iwama for kind provision of Bmi1 shRNA lentiviral construct. We thank Merry Wang for artistic illustrations. This work was supported by funds from the Department of Surgery at McMaster University, the Ontario Institute for Cancer Research (OICR) and the JP Bickell Foundation. XW held a training award from the Stem Cell Network.	Altaba ARI, 2002, NAT REV NEUROSCI, V3, P24; Annabi B, 2008, MOL CANCER RES, V6, P907, DOI 10.1158/1541-7786.MCR-07-2184; Annabi B, 2010, MOL CARCINOGEN, V49, P710, DOI 10.1002/mc.20645; Ayrault O, 2010, CANCER RES, V70, P5618, DOI 10.1158/0008-5472.CAN-09-3740; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Ellison DW, 2010, ACTA NEUROPATHOL, V120, P305, DOI 10.1007/s00401-010-0726-6; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fattet S, 2009, J PATHOL, V218, P86, DOI 10.1002/path.2514; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Gilbertson RJ, 2004, LANCET ONCOL, V5, P209, DOI 10.1016/S1470-2045(04)01424-X; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Huse JT, 2010, NAT REV CANCER, V10, P319, DOI 10.1038/nrc2818; Johnson R, 2009, CURR ONCOL REP, V11, P68, DOI 10.1007/s11912-009-0011-9; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Kool M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003088; Lee A, 2005, NAT NEUROSCI, V8, P723, DOI 10.1038/nn1473; Lee EY, 2010, P NATL ACAD SCI USA, V107, P9736, DOI 10.1073/pnas.1004602107; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; Michael LE, 2008, NEOPLASIA, V10, P1343, DOI 10.1593/neo.81078; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Pallini R, 2010, CANCER, V117, P162; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pistollato F, 2010, STEM CELLS, V28, P1918, DOI 10.1002/stem.518; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Rao G, 2004, ONCOGENE, V23, P6156, DOI 10.1038/sj.onc.1207818; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Subkhankulova T, 2010, MOL CELL NEUROSCI, V45, P151, DOI 10.1016/j.mcn.2010.06.006; Sutter R, 2010, ONCOGENE, V29, P1845, DOI 10.1038/onc.2009.472; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Thomas WD, 2009, ONCOGENE, V28, P1605, DOI 10.1038/onc.2009.3; Thompson MC, 2006, J CLIN ONCOL, V24, P1924, DOI 10.1200/JCO.2005.04.4974; Thon N, 2010, MOL CELL NEUROSCI, V43, P51, DOI 10.1016/j.mcn.2008.07.022; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wiederschain D, 2007, MOL CELL BIOL, V27, P4968, DOI 10.1128/MCB.02244-06; Yan XW, 2011, P NATL ACAD SCI USA, V108, P1591, DOI 10.1073/pnas.1018696108; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Yu CC, 2010, CHILD NERV SYST, V26, P897, DOI 10.1007/s00381-010-1087-0; Zakrzewska M, 2011, CHILD NERV SYST, V27, P79, DOI 10.1007/s00381-010-1260-5	69	92	96	2	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	2					187	199		10.1038/onc.2011.232	http://dx.doi.org/10.1038/onc.2011.232			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21685941				2022-12-25	WOS:000299307400005
J	Sawa, J; Malet, H; Krojer, T; Canellas, F; Ehrmann, M; Clausen, T				Sawa, Justyna; Malet, Helene; Krojer, Tobias; Canellas, Flavia; Ehrmann, Michael; Clausen, Tim			Molecular Adaptation of the DegQ Protease to Exert Protein Quality Control in the Bacterial Cell Envelope	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HTRA FAMILY; PDZ DOMAIN; REGULATED PROTEOLYSIS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; SERINE PROTEASES; STRESS-RESPONSE; IN-VIVO; CHAPERONE; VIRULENCE	To react to distinct stress situations and to prevent the accumulation of misfolded proteins, all cells employ a number of proteases and chaperones, which together set up an efficient protein quality control system. The functionality of proteins in the cell envelope of Escherichia coli is monitored by the HtrA proteases DegS, DegP, and DegQ. In contrast with DegP and DegS, the structure and function of DegQ has not been addressed in detail. Here, we show that substrate binding triggers the conversion of the resting DegQ hexamer into catalytically active 12- and 24-mers. Interestingly, substrate-induced oligomer reassembly and protease activation depends on the first PDZ domain but not on the second. Therefore, the regulatory mechanism originally identified in DegP should be a common feature of HtrA proteases, most of which encompass only a single PDZ domain. Using a DegQ mutant lacking the second PDZ domain, we determined the high resolution crystal structure of a dodecameric HtrA complex. The nearly identical domain orientation of protease and PDZ domains within 12and 24-meric HtrA complexes reveals a conserved PDZ1 -> L3 -> LD/L1/L2 signaling cascade, in which loop L3 senses the repositioned PDZ1 domain of higher order, substrate-engaged particles and activates protease function. Furthermore, our in vitro and in vivo data imply a pH-related function of DegQ in the bacterial cell envelope.	[Sawa, Justyna; Krojer, Tobias; Canellas, Flavia; Clausen, Tim] Inst Mol Pathol, A-1030 Vienna, Austria; [Malet, Helene] Univ London Birkbeck Coll, Inst Struct Mol Biol, Dept Biol Sci, London WC1E 7HX, England; [Ehrmann, Michael] Univ Duisburg Essen, Fac Biol & Geog, Ctr Med Biotechnol, D-45117 Essen, Germany	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of London; Birkbeck University London; University of Duisburg Essen	Clausen, T (corresponding author), Inst Mol Pathol, A-1030 Vienna, Austria.	clausen@imp.univie.ac.at	Ehrmann, Michael/A-7307-2012; Krojer, Tobias/ABE-3829-2021	Ehrmann, Michael/0000-0002-1927-260X; MALET, Helene/0000-0002-2834-7386; Krojer, Tobias/0000-0003-0661-0814; Clausen, Tim/0000-0003-1582-6924	ERA-Net (NEURON) [FWF I 235-B09]; Boehringer Ingelheim; Austrian Science Fund (FWF) [I 235] Funding Source: researchfish	ERA-Net (NEURON); Boehringer Ingelheim(Boehringer Ingelheim); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by an ERA-Net (NEURON, FWF I 235-B09) studentship (to F. C.). The Institute of Molecular Pathology is funded by Boehringer Ingelheim.	Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Baldi A, 2008, PHARMACOGENOMICS, V9, P1069, DOI 10.2217/14622416.9.8.1069; Bhuiyan MS, 2009, CURR DRUG TARGETS, V10, P372, DOI 10.2174/138945009787846399; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campioni M, 2010, MOL CANCER RES, V8, P1248, DOI 10.1158/1541-7786.MCR-09-0473; Chassin Y, 2002, PLANT PHYSIOL, V130, P857, DOI 10.1104/pp.007922; Chien J, 2009, CURR CANCER DRUG TAR, V9, P451, DOI 10.2174/156800909788486704; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Cortes G, 2002, INFECT IMMUN, V70, P4772, DOI 10.1128/IAI.70.9.4772-4776.2002; DANESE PN, 1995, GENE DEV, V9, P387, DOI 10.1101/gad.9.4.387; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; EVANS DF, 1988, GUT, V29, P1035, DOI 10.1136/gut.29.8.1035; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Hasenbein S, 2007, GENE DEV, V21, P6, DOI 10.1101/gad.1507807; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; HAUSER M, 1995, PLANT PHYSIOL, V108, P1059, DOI 10.1104/pp.108.3.1059; Haussuhl K, 2001, EMBO J, V20, P713, DOI 10.1093/emboj/20.4.713; Ibrahim YM, 2004, INFECT IMMUN, V72, P3584, DOI 10.1128/IAI.72.6.3584-3591.2004; Itzhaki H, 1998, J BIOL CHEM, V273, P7094, DOI 10.1074/jbc.273.12.7094; Jiang JS, 2008, P NATL ACAD SCI USA, V105, P11939, DOI 10.1073/pnas.0805464105; Jones CH, 2001, INFECT IMMUN, V69, P5538, DOI 10.1128/IAI.69.9.5538-5545.2001; Jones JM, 2003, NATURE, V425, P721, DOI 10.1038/nature02052; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Kirk R., 2010, SENSORY MECH BACTERI; Kolmar H, 1996, J BACTERIOL, V178, P5925, DOI 10.1128/jb.178.20.5925-5929.1996; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lewis C, 2009, MICROBIOL-SGM, V155, P873, DOI 10.1099/mic.0.023754-0; Li WY, 2002, NAT STRUCT BIOL, V9, P436, DOI 10.1038/nsb795; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; Macario AJL, 2005, NEW ENGL J MED, V353, P1489, DOI 10.1056/NEJMra050111; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meltzer M, 2009, RES MICROBIOL, V160, P660, DOI 10.1016/j.resmic.2009.07.012; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Mo E, 2006, MICROB PATHOGENESIS, V41, P174, DOI 10.1016/j.micpath.2006.07.004; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x; PFUNDEL EE, 1994, PLANT PHYSIOL, V106, P1647, DOI 10.1104/pp.106.4.1647; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Raivio TL, 2005, MOL MICROBIOL, V56, P1119, DOI 10.1111/j.1365-2958.2005.04625.x; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Shridhar V, 2002, CANCER RES, V62, P262; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Waller PRH, 1996, J BACTERIOL, V178, P1146, DOI 10.1128/jb.178.4.1146-1153.1996; Walsh NP, 2003, CELL, V113, P61, DOI 10.1016/S0092-8674(03)00203-4; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Wilson RL, 2006, INFECT IMMUN, V74, P765, DOI 10.1128/IAI.74.1.765-768.2006; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811	60	41	42	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30680	30690		10.1074/jbc.M111.243832	http://dx.doi.org/10.1074/jbc.M111.243832			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21685389	Green Published, hybrid			2022-12-25	WOS:000294283600048
J	Jensen, JK; Thompson, LC; Bucci, JC; Nissen, P; Gettins, PGW; Peterson, CB; Andrease, PA; Morth, JP				Jensen, Jan K.; Thompson, Lawrence C.; Bucci, Joel C.; Nissen, Poul; Gettins, Peter G. W.; Peterson, Cynthia B.; Andrease, Peter A.; Morth, J. Preben			Crystal Structure of Plasminogen Activator Inhibitor-1 in an Active Conformation with Normal Thermodynamic Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE-CENTER LOOP; METALS AFFECT; SERPIN; PAI-1; VITRONECTIN; MECHANISM; TARGET; FIBRINOLYSIS; FORM	The serpin plasminogen activator inhibitor-1 (PAI-1) is a crucial regulator in fibrinolysis and tissue remodeling. PAI-1 has been associated with several pathological conditions and is a validated prognostic marker in human cancers. However, structural information about the native inhibitory form of PAI-1 has been elusive because of its inherent conformational instability and rapid conversion to a latent, inactive structure. Here we report the crystal structure of PAI-1 W175F at 2.3 angstrom resolution as the first model of the metastable native molecule. Structural comparison with a quadruple mutant (14-1B) previously used as representative of the active state uncovered key differences. The most striking differences occur near the region that houses three of the four mutations in the 14-1B PAI-1 structure. Prominent changes are localized within a loop connecting beta-strand 3A with the F helix, in which a previously observed 3(10)-helix is absent in the new structure. Notably these structural changes are found near the binding site for the cofactor vitronectin. Because vitronectin is the only known physiological regulator of PAI-1 that slows down the latency conversion, the structure of this region is important. Furthermore, the previously identified chloride-binding site close to the F-helix is absent from the present structure and likely to be artifactual, because of its dependence on the 14-1B mutations. Instead we found a different chlorine-binding site that is likely to be present in wild type PAI-1 and that more satisfactorily accounts for the chlorine stabilizing effect on PAI-1.	[Jensen, Jan K.; Nissen, Poul; Andrease, Peter A.; Morth, J. Preben] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Jensen, Jan K.; Andrease, Peter A.] Aarhus Univ, Danish Chinese Ctr Proteases & Canc, DK-8000 Aarhus C, Denmark; [Nissen, Poul; Morth, J. Preben] Aarhus Univ, Struct Biol Ctr, DK-8000 Aarhus C, Denmark; [Thompson, Lawrence C.; Bucci, Joel C.; Peterson, Cynthia B.] Univ Tennessee, Dept Biochem & Cellular & Mol Biol, Knoxville, TN 37996 USA; [Gettins, Peter G. W.] Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA; [Morth, J. Preben] Univ Oslo, Nord EMBL Partnership, Ctr Mol Med, N-0318 Oslo, Norway	Aarhus University; Aarhus University; Aarhus University; University of Tennessee System; University of Tennessee Knoxville; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Oslo	Jensen, JK (corresponding author), Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark.	jkj@mb.au.dk	Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Nissen, Poul/0000-0003-0948-6628	Danish National Research Foundation; American Heart Association [10GRNT4430033]; Lundbeck Foundation; Carlsbergfondet; Lundbeck Foundation [R34-2009-3616] Funding Source: researchfish	Danish National Research Foundation(Danmarks Grundforskningsfond); American Heart Association(American Heart Association); Lundbeck Foundation(Lundbeckfonden); Carlsbergfondet(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden)	This work was supported by a center of excellence grant from the Danish National Research Foundation (to P. A. A. and P. N.) and by American Heart Association Grant 10GRNT4430033 (to C. B. P.).; Supported by the Lundbeck Foundation.; Supported by Carlsbergfondet.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andreasen PA, 2007, CURR DRUG TARGETS, V8, P1030, DOI 10.2174/138945007781662346; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BERKENPAS MB, 1995, EMBO J, V14, P2969, DOI 10.1002/j.1460-2075.1995.tb07299.x; Blouse GE, 2003, BIOCHEMISTRY-US, V42, P12260, DOI 10.1021/bi034737n; Chuang YJ, 2001, BIOCHEMISTRY-US, V40, P6670, DOI 10.1021/bi002933d; DAY DD, 2006, Patent No. 7015021; De Taeye B, 2004, THROMB HAEMOSTASIS, V92, P898, DOI 10.1160/TH04-05-0269; Dupont DM, 2009, FRONT BIOSCI-LANDMRK, V14, P1337, DOI 10.2741/3312; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gettins PGW, 2002, FEBS LETT, V523, P2, DOI 10.1016/S0014-5793(02)02924-1; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gils A, 2004, THROMB HAEMOSTASIS, V91, P425, DOI 10.1160/TH03-12-0764; Gorlatova NV, 2003, J BIOL CHEM, V278, P16329, DOI 10.1074/jbc.M208420200; Hagglof P, 2004, J MOL BIOL, V335, P823, DOI 10.1016/j.jmb.2003.11.005; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Jensen JK, 2008, PROTEIN SCI, V17, P1844, DOI 10.1110/ps.036707.108; Johnson DJD, 2006, J BIOL CHEM, V281, P35478, DOI 10.1074/jbc.M607204200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; LAWRENCE DA, 1994, BIOCHEMISTRY-US, V33, P3643, DOI 10.1021/bi00178a022; Li SH, 2008, J BIOL CHEM, V283, P18147, DOI 10.1074/jbc.M709455200; Minor KH, 2005, J BIOL CHEM, V280, P28711, DOI 10.1074/jbc.M500478200; Mosca R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-352; MOTTONEN J, 1992, NATURE, V355, P270, DOI 10.1038/355270a0; Nar H, 2000, J MOL BIOL, V297, P683, DOI 10.1006/jmbi.2000.3604; Schar CR, 2008, J BIOL CHEM, V283, P10297, DOI 10.1074/jbc.M708017200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Sharp AM, 1999, STRUCTURE, V7, P111, DOI 10.1016/S0969-2126(99)80018-5; Stout TJ, 2000, BIOCHEMISTRY-US, V39, P8460, DOI 10.1021/bi000290w; Thompson LC, 2011, PROTEIN SCI, V20, P353, DOI 10.1002/pro.568; Thompson LC, 2011, PROTEIN SCI, V20, P366, DOI 10.1002/pro.567; Verhamme I, 1999, J BIOL CHEM, V274, P17511, DOI 10.1074/jbc.274.25.17511; Ye S, 2001, NAT STRUCT BIOL, V8, P979, DOI 10.1038/nsb1101-979; Zhou AW, 2003, NAT STRUCT BIOL, V10, P541, DOI 10.1038/nsb943	34	29	29	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29709	29717		10.1074/jbc.M111.236554	http://dx.doi.org/10.1074/jbc.M111.236554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21697084	Green Published, hybrid			2022-12-25	WOS:000294046600030
J	Peltier, J; Courtin, P; El Meouche, I; Lemee, L; Chapot-Chartier, MP; Pons, JL				Peltier, Johann; Courtin, Pascal; El Meouche, Imane; Lemee, Ludovic; Chapot-Chartier, Marie-Pierre; Pons, Jean-Louis			Clostridium difficile Has an Original Peptidoglycan Structure with a High Level of N-Acetylglucosamine Deacetylation and Mainly 3-3 Cross-links	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-LACTAM RESISTANCE; PENICILLIN-BINDING PROTEINS; BACILLUS-SUBTILIS 168; ESCHERICHIA-COLI; ENTEROCOCCUS-FAECIUM; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL-PEPTIDOGLYCAN; GENUS CLOSTRIDIUM; TRANSPEPTIDATION; L,D-TRANSPEPTIDATION	The structure of the vegetative cell wall peptidoglycan of Clostridium difficile was determined by analysis of its constituent muropeptides with a combination of reverse-phase high pressure liquid chromatography separation of muropeptides, amino acid analysis, mass spectrometry and tandem mass spectrometry. The structures assigned to 36 muropeptides evidenced several original features in C. difficile vegetative cell peptidoglycan. First, it is characterized by a strikingly high level of N-acetylglucosamine deacetylation. In addition, the majority of dimers (around 75%) contains A(2)pm(3) -> A(2)pm(3) (A(2)pm, 2,6-diaminopimelic acid) cross-links and only a minority of the more classical Ala(4) -> A(2)pm(3) cross-links. Moreover, a significant amount of muropeptides contains a modified tetrapeptide stem ending in Gly instead of D-Ala(4). Two L,D-transpeptidases homologues encoding genes present in the genome of C. difficile 630 and named ldt(cd1) and ldt(cd2), were inactivated. The inactivation of either ldt(cd1) or ldt(cd2) significantly decreased the abundance of 3-3 cross-links, leading to a marked decrease of peptidoglycan reticulation and demonstrating that both ldt(cd1)-and ldt(cd2)-encoded proteins have a redundant L, D-transpeptidase activity. The contribution of 3-3 cross-links to peptidoglycan synthesis increased in the presence of ampicillin, indicating that this drug does not inhibit the L,D-transpeptidation pathway in C. difficile.	[Peltier, Johann; El Meouche, Imane; Lemee, Ludovic; Pons, Jean-Louis] Rouen Univ Hosp, Lab GRAM, IFR 23, EA 2656, F-76183 Rouen, France; [Courtin, Pascal; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, F-78350 Jouy En Josas, France; [Courtin, Pascal; Pons, Jean-Louis] AgroParisTech, UMR Michalis, F-78350 Jouy En Josas, France	CHU de Rouen; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay	Pons, JL (corresponding author), Univ Rouen, Grp Rech Antimicrobiens & Microorganismes, UPRES EA2656, IFR23, 22 Blvd Gambetta, F-76183 Rouen, France.	jean-louis.pons@univ-rouen.fr	Peltier, Johann/Q-2001-2017	Peltier, Johann/0000-0003-3207-9465; El Meouche, Imane/0000-0002-0886-6752; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519	University of Rouen; Rouen University Hospital	University of Rouen; Rouen University Hospital	This work was supported by the University of Rouen and Rouen University Hospital.	Atrih A, 1999, J BACTERIOL, V181, P3956, DOI 10.1128/JB.181.13.3956-3966.1999; Atrih A, 1996, J BACTERIOL, V178, P6173, DOI 10.1128/jb.178.21.6173-6183.1996; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; Boneca IG, 2007, P NATL ACAD SCI USA, V104, P997, DOI 10.1073/pnas.0609672104; Citron DM, 2003, ANTIMICROB AGENTS CH, V47, P2334, DOI 10.1128/AAC.47.7.2334-2338.2003; COLLINS MD, 1994, INT J SYST BACTERIOL, V44, P812, DOI 10.1099/00207713-44-4-812; Courtin P, 2006, J BACTERIOL, V188, P5293, DOI 10.1128/JB.00285-06; Depardieu F, 2003, MOL MICROBIOL, V50, P931, DOI 10.1046/j.1365-2958.2003.03737.x; Dhalluin A, 2005, MICROBIOL-SGM, V151, P2343, DOI 10.1099/mic.0.27878-0; FINEGOLD SM, 1986, SCAND J INFECT DIS, P160; GLAUNER B, 1988, J BIOL CHEM, V263, P10088; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; Hussain HA, 2005, J MED MICROBIOL, V54, P137, DOI 10.1099/jmm.0.45790-0; Kelly CP, 1998, ANNU REV MED, V49, P375; Lavollay M, 2008, J BACTERIOL, V190, P4360, DOI 10.1128/JB.00239-08; Lavollay M, 2011, J BACTERIOL, V193, P778, DOI 10.1128/JB.00606-10; Lavollay M, 2009, MOL MICROBIOL, V74, P650, DOI 10.1111/j.1365-2958.2009.06887.x; Magnet S, 2008, J BACTERIOL, V190, P4782, DOI 10.1128/JB.00025-08; Magnet S, 2007, J BACTERIOL, V189, P3927, DOI 10.1128/JB.00084-07; Mainard JL, 2002, J BIOL CHEM, V277, P35801, DOI 10.1074/jbc.M204319200; Mainardi JL, 2008, FEMS MICROBIOL REV, V32, P386, DOI 10.1111/j.1574-6976.2007.00097.x; Mainardi JL, 2005, J BIOL CHEM, V280, P38146, DOI 10.1074/jbc.M507384200; Mainardi JL, 2000, J BIOL CHEM, V275, P16490, DOI 10.1074/jbc.M909877199; PISABARRO AG, 1985, J BACTERIOL, V161, P238, DOI 10.1128/JB.161.1.238-242.1985; Psylinakis E, 2005, J BIOL CHEM, V280, P30856, DOI 10.1074/jbc.M407426200; Sacco E, 2010, MOL MICROBIOL, V75, P874, DOI 10.1111/j.1365-2958.2009.07014.x; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Viswanathan VK, 2010, GUT MICROBES, V1, P234, DOI 10.4161/gmic.1.4.12706; Vollmer W, 2000, J BIOL CHEM, V275, P20496, DOI 10.1074/jbc.M910189199; Vollmer W, 2002, INFECT IMMUN, V70, P7176, DOI 10.1128/IAI.70.12.7176-7178.2002; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; WARTH AD, 1972, BIOCHEMISTRY-US, V11, P1389, DOI 10.1021/bi00758a010; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x; ZIPPERLE GF, 1984, CAN J MICROBIOL, V30, P553, DOI 10.1139/m84-083	42	84	85	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29053	29062		10.1074/jbc.M111.259150	http://dx.doi.org/10.1074/jbc.M111.259150			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21685382	hybrid, Green Published			2022-12-25	WOS:000293837000042
J	Tian, XB; Ye, JB; Alonso-Basanta, M; Hahn, SM; Koumenis, C; Dorsey, JF				Tian, Xiaobing; Ye, Jiangbin; Alonso-Basanta, Michelle; Hahn, Stephen M.; Koumenis, Constantinos; Dorsey, Jay F.			Modulation of CCAAT/Enhancer Binding Protein Homologous Protein (CHOP)-dependent DR5 Expression by Nelfinavir Sensitizes Glioblastoma Multiforme Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN-MELANOMA CELLS; MALIGNANT GLIOMA-CELLS; UP-REGULATION; CANCER-CELLS; DEATH RECEPTORS; APO2 LIGAND; ER STRESS; INHIBITOR; HYPOXIA	Human glioblastoma multiforme cells demonstrate varying levels of sensitivity to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Endoplasmic reticulum (ER) stress has been shown to trigger cell death through apoptosis. We therefore pursued a strategy of integrating clinically relevant investigational agents that cooperate mechanistically through the regulation of ER stress and apoptosis pathways. Nelfinavir belongs to the protease inhibitor class of drugs currently used to treat patients with HIV and is in clinical trials as an anti-tumor agent. We found that Nelfinavir treatment led to ER stress-induced up-regulation of the DR5 receptor. This transactivation was mediated by the transcription factor CCAAT/enhancer binding protein homologous protein (CHOP). We also determined that ER stress-induced ATF4 up-regulation was responsible for modulation of CHOP. In contrast, DR4 receptor expression was unchanged by Nelfinavir treatment. Combining Nelfinavir with TRAIL led to a significantly enhanced level of apoptosis that was abrogated by siRNA silencing of DR5. We provide evidence that Nelfinavir-induced ER stress modulates DR5 expression in human glioblastoma multiforme cells and can enhance TRAIL efficacy. These studies provide a potential mechanistic rationale for the use of the Food and Drug Administration-approved agent Nelfinavir in combination with DR5 agonists to induce apoptosis in human malignancies.	[Dorsey, Jay F.] Univ Penn, Sch Med, Dept Radiat Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Radiat Biol & Imaging Program, Abramson Canc Ctr, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Dorsey, JF (corresponding author), Univ Penn, Sch Med, Dept Radiat Oncol, 180-1 John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.	JayD@uphs.upenn.edu	Ye, Jiangbin/A-1094-2007; Koumenis, Constantinos/B-2002-2008	Ye, Jiangbin/0000-0003-1117-4869; Koumenis, Costas/0000-0001-5945-4726	Burroughs Wellcome Career Award for Medical Scientists [1006792]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS076548] Funding Source: NIH RePORTER	Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Burroughs Wellcome Career Award for Medical Scientists 1006792 ( to J. F. D.).	Arakawa Y, 2005, ACTA NEUROPATHOL, V109, P294, DOI 10.1007/s00401-004-0956-6; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2008, NAT REV DRUG DISCOV, V7, P1001, DOI 10.1038/nrd2637; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bruning A, 2009, CANCER BIOL THER, V8, P222; Bruning A, 2008, BIOCHEM BIOPH RES CO, V377, P1309, DOI 10.1016/j.bbrc.2008.10.167; Chen LH, 2007, CARCINOGENESIS, V28, P2328, DOI 10.1093/carcin/bgm173; ELBEIN AD, 1987, ANNU REV BIOCHEM, V56, P497, DOI 10.1146/annurev.biochem.56.1.497; Elrod HA, 2008, CANCER BIOL THER, V7, P163, DOI 10.4161/cbt.7.2.5335; Gills J, 2007, CLIN CANCER RES, V13, P5183, DOI 10.1158/1078-0432.CCR-07-0161; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; Hao CH, 2001, CANCER RES, V61, P1162; Hetschko H, 2008, FEBS J, V275, P1925, DOI 10.1111/j.1742-4658.2008.06351.x; Ikezoe T, 2004, MOL CANCER THER, V3, P473; Jang YJ, 2003, CANCER LETT, V194, P107, DOI 10.1016/S0304-3835(02)00680-8; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Jiang W, 2007, CANCER RES, V67, P1221, DOI 10.1158/0008-5472.CAN-06-3377; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Li YC, 2006, CLIN CANCER RES, V12, P2716, DOI 10.1158/1078-0432.CCR-05-1980; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Pore N, 2006, CANCER RES, V66, P9252, DOI 10.1158/0008-5472.CAN-06-1239; Pyrko P, 2007, CANCER RES, V67, P10920, DOI 10.1158/0008-5472.CAN-07-0796; Rich JN, 2004, NAT REV DRUG DISCOV, V3, P430, DOI 10.1038/nrd1380; Rieger J, 1998, FEBS LETT, V427, P124, DOI 10.1016/S0014-5793(98)00409-8; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rzymski T, 2010, ONCOGENE, V29, P4424, DOI 10.1038/onc.2010.191; SAGARA Y, 1991, J BIOL CHEM, V266, P13503; Shiraishi T, 2005, CANCER RES, V65, P6364, DOI 10.1158/0008-5472.CAN-05-0312; Steinbach JP, 2004, J NEURO-ONCOL, V70, P245, DOI 10.1007/s11060-004-2753-4; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Ye JB, 2010, EMBO J, V29, P2082, DOI 10.1038/emboj.2010.81; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zou W, 2004, CANCER RES, V64, P7570, DOI 10.1158/0008-5472.CAN-04-1238; Zou W, 2008, CANCER RES, V68, P7484, DOI 10.1158/0008-5472.CAN-08-1318	41	45	46	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29408	29416		10.1074/jbc.M110.197665	http://dx.doi.org/10.1074/jbc.M110.197665			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697087	hybrid, Green Published			2022-12-25	WOS:000293837000075
J	Xiao, X; Wu, ZC; Chou, KC				Xiao, Xuan; Wu, Zhi-Cheng; Chou, Kuo-Chen			A Multi-Label Classifier for Predicting the Subcellular Localization of Gram-Negative Bacterial Proteins with Both Single and Multiple Sites	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; NEURAL DISCRIMINANT MODEL; TURN TYPES PREDICTION; LOCATION PREDICTION; STRUCTURAL CLASSES; GENE ONTOLOGY; SORTING SIGNALS; ANNOTATION; REPRESENTATION; STATISTICS	Prediction of protein subcellular localization is a challenging problem, particularly when the system concerned contains both singleplex and multiplex proteins. In this paper, by introducing the "multi-label scale" and hybridizing the information of gene ontology with the sequential evolution information, a novel predictor called iLoc-Gneg is developed for predicting the subcellular localization of Gram-positive bacterial proteins with both single-location and multiple-location sites. For facilitating comparison, the same stringent benchmark dataset used to estimate the accuracy of Gneg-mPLoc was adopted to demonstrate the power of iLoc-Gneg. The dataset contains 1,392 Gram-negative bacterial proteins classified into the following eight locations: (1) cytoplasm, (2) extracellular, (3) fimbrium, (4) flagellum, (5) inner membrane, (6) nucleoid, (7) outer membrane, and (8) periplasm. Of the 1,392 proteins, 1,328 are each with only one subcellular location and the other 64 are each with two subcellular locations, but none of the proteins included has >= 25% pairwise sequence identity to any other in a same subset (subcellular location). It was observed that the overall success rate by jackknife test on such a stringent benchmark dataset by iLoc-Gneg was over 91%, which is about 6% higher than that by Gneg-mPLoc. As a user-friendly web-server, iLoc-Gneg is freely accessible to the public at http://icpr.jci.edu.cn/bioinfo/iLoc-Gneg. Meanwhile, a step-by-step guide is provided on how to use the web-server to get the desired results. Furthermore, for the user's convenience, the iLoc-Gneg web-server also has the function to accept the batch job submission, which is not available in the existing version of Gneg-mPLoc web-server. It is anticipated that iLoc-Gneg may become a useful high throughput tool for Molecular Cell Biology, Proteomics, System Biology, and Drug Development.	[Xiao, Xuan; Wu, Zhi-Cheng] Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China; [Xiao, Xuan; Chou, Kuo-Chen] Gordon Life Sci Inst, San Diego, CA USA	Jingdezhen Ceramic Institute	Xiao, X (corresponding author), Jing De Zhen Ceram Inst, Dept Comp, Jing De Zhen, Peoples R China.	xiaoxuan0326@yahoo.com.cn	Chou, Kuo-Chen/A-8340-2009		National Natural Science Foundation of China [60961003]; Chinese Ministry of Education [210116]; Province National Natural Science Foundation of JiangXi [2009GZS0064, 2010GZS0122]; Department of Education of Jiang-Xi Province [GJJ09271]; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Province National Natural Science Foundation of JiangXi; Department of Education of Jiang-Xi Province; plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province	This work was supported by grants from the National Natural Science Foundation of China (No. 60961003), the Key Project of Chinese Ministry of Education (No. 210116), the Province National Natural Science Foundation of JiangXi (2009GZS0064 and 2010GZS0122), the Department of Education of Jiang-Xi Province (No. GJJ09271), and the plan for training youth scientists (stars of Jing-Gang) of Jiangxi Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SE, 1997, THEORETICAL AND COMPUTATIONAL METHODS IN GENOME RESEARCH, P1; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Cai YD, 2010, PROTEIN PEPTIDE LETT, V17, P464, DOI 10.2174/092986610790963654; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Camon E, 2003, GENOME RES, V13, P662, DOI 10.1101/gr.461403; Cedano J, 1997, J MOL BIOL, V266, P594, DOI 10.1006/jmbi.1996.0804; Chen C, 2008, J THEOR BIOL, V253, P388, DOI 10.1016/j.jtbi.2008.03.009; Chen C, 2009, PROTEIN PEPTIDE LETT, V16, P27, DOI 10.2174/092986609787049420; Chen K, 2008, J COMPUT CHEM, V29, P1596, DOI 10.1002/jcc.20918; Chou K.-C., 2010, NAT SCI IRVINE, V2, P1090, DOI [10.4236/ns.2010.210136, DOI 10.4236/NS.2010.210136]; Chou KC, 2004, CURR MED CHEM, V11, P2105, DOI 10.2174/0929867043364667; CHOU KC, 1995, FEBS LETT, V363, P123, DOI 10.1016/0014-5793(95)00240-A; Chou KC, 1999, PROTEIN ENG, V12, P107, DOI 10.1093/protein/12.2.107; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; CHOU KC, 1995, PROTEINS, V21, P319, DOI 10.1002/prot.340210406; CHOU KC, 1994, J BIOL CHEM, V269, P22014; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; CHOU KC, 2009, NAT SCI, V2, P63, DOI DOI 10.4236/NS.2009.12011; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2007, ANAL BIOCHEM, V370, P1, DOI 10.1016/j.ab.2007.07.006; Chou KC, 2006, J PROTEOME RES, V5, P3420, DOI 10.1021/pr060404b; Chou KC, 2011, J THEOR BIOL, V273, P236, DOI 10.1016/j.jtbi.2010.12.024; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011335; Ding H, 2009, PROTEIN PEPTIDE LETT, V16, P351, DOI 10.2174/092986609787848045; Du PF, 2009, J THEOR BIOL, V261, P330, DOI 10.1016/j.jtbi.2009.08.004; Fang Y, 2008, AMINO ACIDS, V34, P103, DOI 10.1007/s00726-007-0568-2; Gao QB, 2009, ANAL BIOCHEM, V387, P54, DOI 10.1016/j.ab.2009.01.018; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gardy JL, 2003, NUCLEIC ACIDS RES, V31, P3613, DOI 10.1093/nar/gkg602; Gerstein M, 2003, CURR OPIN STRUC BIOL, V13, P341, DOI 10.1016/S0959-440X(03)00080-0; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Jahandideh S, 2007, J THEOR BIOL, V249, P785, DOI 10.1016/j.jtbi.2007.09.002; Jahandideh S, 2007, BIOPHYS CHEM, V128, P87, DOI 10.1016/j.bpc.2007.03.006; Jahandideh S, 2009, J THEOR BIOL, V259, P517, DOI 10.1016/j.jtbi.2009.04.016; Kannan S, 2008, PROTEIN PEPTIDE LETT, V15, P1107, DOI 10.2174/092986608786071085; Li FM, 2008, PROTEIN PEPTIDE LETT, V15, P612, DOI 10.2174/092986608784966930; Lin H, 2008, J THEOR BIOL, V252, P350, DOI 10.1016/j.jtbi.2008.02.004; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Mahalanobis P.C., 1936, P NAT I SCI INDIA, V2, P49; Mardia K.V., 1979, MULTIVARIATE ANAL, P322; Masso M, 2010, J THEOR BIOL, V266, P560, DOI 10.1016/j.jtbi.2010.07.026; Millar AH, 2009, PLANT CELL, V21, P1625, DOI 10.1105/tpc.109.066019; Mohabatkar H, 2010, PROTEIN PEPTIDE LETT, V17, P1207, DOI 10.2174/092986610792231564; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Pillai KCS, 1985, ENCY STATISTICAL SCI, P176; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Sahu SS, 2010, COMPUT BIOL CHEM, V34, P320, DOI 10.1016/j.compbiolchem.2010.09.002; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shen HB, 2010, J THEOR BIOL, V264, P326, DOI 10.1016/j.jtbi.2010.01.018; SMITH C, 2008, SUBCELLULAR TARGETIN; WOOTTON JC, 1993, COMPUT CHEM, V17, P149, DOI 10.1016/0097-8485(93)85006-X; Zhou GP, 2003, PROTEINS, V50, P44, DOI 10.1002/prot.10251; Zou DS, 2011, J COMPUT CHEM, V32, P271, DOI 10.1002/jcc.21616	56	175	179	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20592	10.1371/journal.pone.0020592	http://dx.doi.org/10.1371/journal.pone.0020592			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698097	Green Submitted, Green Published, gold			2022-12-25	WOS:000291737600011
J	Huffman, MD; Rao, KD; Pichon-Riviere, A; Zhao, D; Harikrishnan, S; Ramaiya, K; Ajay, VS; Goenka, S; Calcagno, JI; Caporale, JE; Niu, SL; Li, Y; Liu, J; Thankappan, KR; Daivadanam, M; van Esch, J; Murphy, A; Moran, AE; Gaziano, TA; Suhrcke, M; Reddy, KS; Leeder, S; Prabhakaran, D				Huffman, Mark D.; Rao, Krishna D.; Pichon-Riviere, Andres; Zhao, Dong; Harikrishnan, S.; Ramaiya, Kaushik; Ajay, V. S.; Goenka, Shifalika; Calcagno, Juan I.; Caporale, Joaquin E.; Niu, Shaoli; Li, Yan; Liu, Jing; Thankappan, K. R.; Daivadanam, Meena; van Esch, Jan; Murphy, Adrianna; Moran, Andrew E.; Gaziano, Thomas A.; Suhrcke, Marc; Reddy, K. Srinath; Leeder, Stephen; Prabhakaran, Dorairaj			A Cross-Sectional Study of the Microeconomic Impact of Cardiovascular Disease Hospitalization in Four Low- and Middle-Income Countries	PLOS ONE			English	Article							CATASTROPHIC HEALTH EXPENDITURE; PROTECTION; CHINA	Objective: To estimate individual and household economic impact of cardiovascular disease (CVD) in selected low-and middle-income countries (LMIC). Background: Empirical evidence on the microeconomic consequences of CVD in LMIC is scarce. Methods and Findings: We surveyed 1,657 recently hospitalized CVD patients (66% male; mean age 55.8 years) from Argentina, China, India, and Tanzania to evaluate the microeconomic and functional/productivity impact of CVD hospitalization. Respondents were stratified into three income groups. Median out-of-pocket expenditures for CVD treatment over 15 month follow-up ranged from 354 international dollars (2007 INT$, Tanzania, low-income) to INT$2,917 (India, high-income). Catastrophic health spending (CHS) was present in >50% of respondents in China, India, and Tanzania. Distress financing (DF) and lost income were more common in low-income respondents. After adjustment, lack of health insurance was associated with CHS in Argentina (OR 4.73 [2.56, 8.76], India (OR 3.93 [2.23, 6.90], and Tanzania (OR 3.68 [1.86, 7.26] with a marginal association in China (OR 2.05 [0.82, 5.11]). These economic effects were accompanied by substantial decreases in individual functional health and productivity. Conclusions: Individuals in selected LMIC bear significant financial burdens following CVD hospitalization, yet with substantial variation across and within countries. Lack of insurance may drive much of the financial stress of CVD in LMIC patients and their families.	[Huffman, Mark D.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Huffman, Mark D.] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Huffman, Mark D.; Ajay, V. S.; Prabhakaran, Dorairaj] Ctr Chron Dis Control, New Delhi, India; [Rao, Krishna D.; Ajay, V. S.; Goenka, Shifalika; Reddy, K. Srinath; Prabhakaran, Dorairaj] Publ Hlth Fdn India, New Delhi, India; [Pichon-Riviere, Andres; Calcagno, Juan I.; Caporale, Joaquin E.] Inst Clin Effectiveness Res & Hlth Policy, Buenos Aires, DF, Argentina; [Pichon-Riviere, Andres; Zhao, Dong; Ajay, V. S.; Goenka, Shifalika; Reddy, K. Srinath; Leeder, Stephen; Prabhakaran, Dorairaj] Initiat Cardiovasc Hlth Res Developing Countries, New Delhi, India; [Zhao, Dong; Li, Yan; Liu, Jing] Capital Med Univ, Dept Epidemiol, Beijing Anzhen Hosp, Beijing, Peoples R China; [Zhao, Dong; Li, Yan; Liu, Jing] Beijing Inst Heart Lung & Blood Vessel Dis, Beijing, Peoples R China; [Harikrishnan, S.; Thankappan, K. R.; Daivadanam, Meena] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Ramaiya, Kaushik; van Esch, Jan] Muhimbili Univ Hlth & Allied Sci, Shree Hindu Mandal Hosp, Dept Internal Med, Dar Es Salaam, Tanzania; [Niu, Shaoli] Navy Gen Hosp, Cadre Ward, Beijing, Peoples R China; [Murphy, Adrianna] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Moran, Andrew E.] Columbia Univ, Med Ctr, Div Gen Med, New York, NY USA; [Gaziano, Thomas A.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Suhrcke, Marc] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Leeder, Stephen] Univ Sydney, Menzies Ctr Hlth Policy, Sydney, NSW 2006, Australia	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Public Health Foundation of India; Capital Medical University; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Muhimbili University of Health & Allied Sciences; Sixth Medical Center of Chinese PLA General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University; Harvard University; Brigham & Women's Hospital; University of East Anglia; University of Sydney	Huffman, MD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA.	dprabhakaran@ccdcindia.org	Zhao, D/AAX-5040-2021; Suhrcke, Marc/AAE-9024-2019; Liu, Jing/AAH-8079-2021; S, Harikrishnan/AAT-8083-2021; Daivadanam, Meena/F-1747-2018; Prabhakaran, Dorairaj/B-4147-2011; Thankappan, Kr/ABC-9551-2021	Liu, Jing/0000-0002-3311-0818; Daivadanam, Meena/0000-0002-9532-6059; Prabhakaran, Dorairaj/0000-0002-3172-834X; Goenka, Shifalika/0000-0001-6993-2883; , KR/0000-0002-4536-2684; Pichon-Riviere, Andres/0000-0001-6052-025X; S, Harikrishnan/0000-0002-7509-0712; Huffman, Mark/0000-0001-7412-2519; Suhrcke, Marc/0000-0001-7263-8626; Ajay, Vamadevan S/0000-0002-4102-0505; Reddy, K Srinath/0000-0003-3416-3548	Global Forum for Health Research; World Bank; International Union for Health Promotion and Education; NIH FICR-F [R24TW007988]; NHLBI [5T32HL069771]; World Bank via the Global Forum for Health Research; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089675, T32HL069771] Funding Source: NIH RePORTER	Global Forum for Health Research; World Bank(The World Bank India); International Union for Health Promotion and Education; NIH FICR-F(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); World Bank via the Global Forum for Health Research; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Global Forum for Health Research, World Bank, and International Union for Health Promotion and Education. MDH was supported by the NIH FICR-F program (R24TW007988) and is supported by an NHLBI training grant in cardiovascular epidemiology (5T32HL069771). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was partially funded by the World Bank via the Global Forum for Health Research. Otherwise, the authors have no other relevant declarations relating to employment, consultancy, patents, products in development or marketed products related to this manuscript. The authors confirm that the inclusion of the World Bank as a partial funder does not not alter their adherence to all the PLoS ONE policies on sharing data and materials.	*AG HEALTHC RES QU, 2006, MED EXP PAN SURV; [Anonymous], GLOB BURD DIS 2004 U; [Anonymous], 2005, PREV CHRON DIS VIT I; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Kawabata K, 2002, B WORLD HEALTH ORGAN, V80, P612; Knaul FM, 2006, LANCET, V368, P1828, DOI 10.1016/S0140-6736(06)69565-2; Leeder S, 2004, RACE TIME CHALLENGE; Makinen M, 2000, B WORLD HEALTH ORGAN, V78, P55; WAGSTAFF A, 2007, WORLD BANK IMPACT EV, V12; Wagstaff A., 2009, 4821 WPS WORLD BANK; Wagstaff A, 2008, J HEALTH ECON, V27, P990, DOI 10.1016/j.jhealeco.2008.02.002; Wagstaff A, 2007, J HEALTH ECON, V26, P505, DOI 10.1016/j.jhealeco.2006.10.006; Wagstaff A, 2009, J HEALTH ECON, V28, P322, DOI 10.1016/j.jhealeco.2008.10.011; Waters HR, 2004, HEALTH POLICY, V69, P339, DOI 10.1016/j.healthpol.2004.01.003; *WHO, 2003, COP HEALTHC COSTS IM; World Health Organization, 2001, WORLD HLTH REP 2000; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972	18	118	118	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20821	10.1371/journal.pone.0020821	http://dx.doi.org/10.1371/journal.pone.0020821			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778EB	21695127	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000291682300013
J	Asperti, C; Astro, V; Pettinato, E; Paris, S; Bachi, A; de Curtis, I				Asperti, Claudia; Astro, Veronica; Pettinato, Emanuela; Paris, Simona; Bachi, Angela; de Curtis, Ivan			Biochemical and Functional Characterization of the Interaction between Liprin-alpha 1 and GIT1: Implications for the Regulation of Cell Motility	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; PROTRUSIVE ACTIVITY; LIPRIN-ALPHA; ADHESION; PAXILLIN; PIX; FAMILY; ACTIN; MIGRATION; COMPLEX	We have previously identified the scaffold protein liprin-alpha 1 as an important regulator of integrin-mediated cell motility and tumor cell invasion. Liprin-alpha 1 may interact with different proteins, and the functional significance of these interactions in the regulation of cell motility is poorly known. Here we have addressed the involvement of the liprin-alpha 1 partner GIT1 in liprin-alpha 1-mediated effects on cell spreading and migration. GIT1 depletion inhibited spreading by affecting the lamellipodia, and prevented liprin-alpha 1-enhanced spreading. Conversely inhibition of the formation of the liprin-alpha 1-GIT complex by expression of liprin-Delta CC3 could still enhance spreading, although to a lesser extent compared to full length liprin-alpha 1. No cumulative effects were observed after depletion of both liprin-alpha 1 and GIT1, suggesting that the two proteins belong to the same signaling network in the regulation of cell spreading. Our data suggest that liprin-alpha 1 may compete with paxillin for binding to GIT1, while binding of beta PIX to GIT1 was unaffected by the presence of liprin-alpha 1. Interestingly, GIT and liprin-alpha 1 reciprocally regulated their subcellular localization, since liprin-alpha 1 overexpression, but not the GIT binding-defective liprin-Delta CC3 mutant, affected the localization of endogenous GIT at peripheral and mature central focal adhesions, while the expression of a truncated, active form of GIT1 enhanced the localization of endogenous liprin-alpha 1 at the edge of spreading cells. Moreover, GIT1 was required for liprin-alpha 1-enhanced haptotatic migration, although the direct interaction between liprin-alpha 1 and GIT1 was not needed. Our findings show that the functional interaction between liprin-alpha 1 and GIT1 cooperate in the regulation of integrin-dependent cell spreading and motility on extracellular matrix. These findings and the possible competition of liprin-alpha 1 with paxillin for binding to GIT1 suggest that alternative binding of GIT1 to either liprin-alpha 1 or paxillin plays distinct roles in different phases of the protrusive activity in the cell.	[Asperti, Claudia; Astro, Veronica; Pettinato, Emanuela; Paris, Simona; de Curtis, Ivan] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Asperti, Claudia; Astro, Veronica; Pettinato, Emanuela; Paris, Simona; de Curtis, Ivan] San Raffaele Univ, Milan, Italy; [Bachi, Angela] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Asperti, C (corresponding author), Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy.	decurtis.ivan@hsr.it	Pettinato, Emanuela/AAN-5932-2020; Asperti, Claudia/ABG-5481-2020; bachi, angela/B-3527-2015	bachi, angela/0000-0003-4842-6556; DE CURTIS, Ivanmatteo/0000-0002-7651-1515	AIRC, Italian Asssociation for Cancer Research [10321]; Fondazione Cariplo; Telethon-Italy [GGP09078]; FIRC, Italian Foundation for Cancer Research	AIRC, Italian Asssociation for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariplo(Fondazione Cariplo); Telethon-Italy(Fondazione Telethon); FIRC, Italian Foundation for Cancer Research(Fondazione AIRC per la ricerca sul cancro)	The following sources of funding to Ivan de Curtis have supported this work: AIRC, Italian Asssociation for Cancer Research, grant n.10321 (http://www.airc.it/) Fondazione Cariplo (http://www.fondazionecariplo.it/portal/sv1.do) Telethon-Italy, grant GGP09078 (http://www.telethon.it/). Moreover, a fellowship from FIRC, Italian Foundation for Cancer Research (http://www.fondazionefirc.it/) supported Veronica Astro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asperti C, 2010, EXP CELL RES, V316, P915, DOI 10.1016/j.yexcr.2010.01.017; Asperti C, 2009, J CELL SCI, V122, P3225, DOI 10.1242/jcs.054155; Astro V, 2011, ONCOGENE, V30, P1841, DOI 10.1038/onc.2010.562; Cattelino A, 1999, MOL BIOL CELL, V10, P373, DOI 10.1091/mbc.10.2.373; Cau JL, 2005, J CELL SCI, V118, P2579, DOI 10.1242/jcs.02385; de Curtis I, 2001, EMBO REP, V2, P277, DOI 10.1093/embo-reports/kve072; de Curtis I, 2011, EXP CELL RES, V317, P1, DOI 10.1016/j.yexcr.2010.09.014; Digman MA, 2008, BIOPHYS J, V94, P2819, DOI 10.1529/biophysj.107.104984; Frank SR, 2006, EMBO J, V25, P1848, DOI 10.1038/sj.emboj.7601092; Gavina M, 2010, BIOL CELL, V102, P231, DOI 10.1042/BC20090074; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Ko J, 2003, J BIOL CHEM, V278, P42377, DOI 10.1074/jbc.M307561200; Ko J, 2003, J NEUROSCI, V23, P1667; Le Clainche C, 2008, PHYSIOL REV, V88, P489, DOI 10.1152/physrev.00021.2007; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Manabe R, 2002, J CELL SCI, V115, P1497; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Matafora V, 2001, J CELL SCI, V114, P4509; Mazaki Y, 2006, NAT IMMUNOL, V7, P724, DOI 10.1038/ni1349; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nishiya N, 2005, NAT CELL BIOL, V7, P343, DOI 10.1038/ncb1234; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Sabe H, 2006, CURR OPIN CELL BIOL, V18, P558, DOI 10.1016/j.ceb.2006.08.002; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Serra-Pages C, 1998, J BIOL CHEM, V273, P15611, DOI 10.1074/jbc.273.25.15611; SERRAPAGES C, 1995, EMBO J, V14, P2827, DOI 10.1002/j.1460-2075.1995.tb07282.x; Shen JC, 2007, CANCER RES, V67, P2552, DOI 10.1158/0008-5472.CAN-06-3870; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Totaro A, 2007, MOL BIOL CELL, V18, P5124, DOI 10.1091/mbc.E07-06-0550; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb DJ, 2006, BIOCHEM BIOPH RES CO, V346, P1284, DOI 10.1016/j.bbrc.2006.06.036; Yin GY, 2005, J BIOL CHEM, V280, P27705, DOI 10.1074/jbc.M502271200; Yu JXA, 2009, MOL BIOL CELL, V20, P4706, DOI 10.1091/mbc.E09-07-0548; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996; Zhang WZ, 2000, ANAL CHEM, V72, P2482, DOI 10.1021/ac991363o; Zhang ZWM, 2008, J BIOL CHEM, V283, P18685, DOI 10.1074/jbc.M801274200; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000	41	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20757	10.1371/journal.pone.0020757	http://dx.doi.org/10.1371/journal.pone.0020757			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695141	Green Published, gold, Green Submitted			2022-12-25	WOS:000291663300018
J	Castandet, B; Araya, A				Castandet, Benoit; Araya, Alejandro			The RNA Editing Pattern of cox2 mRNA Is Affected by Point Mutations in Plant Mitochondria	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; PPR PROTEIN; SITE RECOGNITION; CROSS-COMPETITION; MULTIPLE SITES; DYW PROTEIN; REVEALS; GENOME; GENE; ELECTROPORATION	The mitochondrial transcriptome from land plants undergoes hundreds of specific C-to-U changes by RNA editing. These events are important since most of them occur in the coding region of mRNAs. One challenging question is to understand the mechanism of recognition of a selected C residue (editing sites) on the transcript. It has been reported that a short region surrounding the target C forms the cis-recognition elements, but individual residues on it do not play similar roles for the different editing sites. Here, we studied the role of the -1 and +1 nucleotide in wheat cox2 editing site recognition using an in organello approach. We found that four different recognition patterns can be distinguished: (a) +1 dependency, (b) -1 dependency, (c) +1/-1 dependency, and (d) no dependency on nearest neighbor residues. A striking observation was that whereas a 23 nt cis region is necessary for editing, some mutants affect the editing efficiency of unmodified distant sites. As a rule, mutations or pre-edited variants of the transcript have an impact on the complete set of editing targets. When some Cs were changed into Us, the remaining editing sites presented a higher efficiency of C-to-U conversion than in wild type mRNA. Our data suggest that the complex response observed for cox2 mRNA may be a consequence of the fate of the transcript during mitochondrial gene expression.	CNRS, Lab Microbiol Cellulaire & Mol & Pathogenicite MC, Bordeaux, France; Univ Bordeaux, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Castandet, B (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	aaraya@reger.u-bordeaux2.fr			Centre National de la Recherche Scientifique; Universite Victor Segalen Bordeaux, France; PICS [3641]; French Ministere de l'Enseignement Superieur et de la Recherche; Conseil Re'gional d'Aquitaine [20030304002FA, 20040305003FA]; European Union, FEDER [2003227]	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Victor Segalen Bordeaux, France; PICS; French Ministere de l'Enseignement Superieur et de la Recherche; Conseil Re'gional d'Aquitaine(Region Nouvelle-Aquitaine); European Union, FEDER(European Commission)	Work was supported by the Centre National de la Recherche Scientifique, the Universite Victor Segalen Bordeaux 2, France, and the PICS program no 3641. B.C. was supported by a Doctoral fellowship from the French Ministere de l'Enseignement Superieur et de la Recherche. DNA sequencing was performed at the Genotyping and Sequencing Facility of Bordeaux supported by grants from the Conseil Re'gional d'Aquitaine no 20030304002FA and 20040305003FA and from the European Union, FEDER no 2003227. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGU D, 1990, PLANT CELL, V2, P1283, DOI 10.1105/tpc.2.12.1283; Bentolila S, 2010, PLANT PHYSIOL, V154, P1966, DOI 10.1104/pp.110.165969; BLANC V, 1995, FEBS LETT, V373, P56, DOI 10.1016/0014-5793(95)00991-H; Brennicke A, 1999, FEMS MICROBIOL REV, V23, P297, DOI 10.1111/j.1574-6976.1999.tb00401.x; Castandet B, 2010, NUCLEIC ACIDS RES, V38, P7112, DOI 10.1093/nar/gkq591; Chateigner-Boutin AL, 2002, MOL CELL BIOL, V22, P8448, DOI 10.1128/MCB.22.24.8448-8456.2002; Chateigner-Boutin AL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm640; CHAUDHURI S, 1995, EMBO J, V14, P2951, DOI 10.1002/j.1460-2075.1995.tb07295.x; Choury D, 2004, NUCLEIC ACIDS RES, V32, P6397, DOI 10.1093/nar/gkh969; Choury D, 2006, CURR GENET, V50, P405, DOI 10.1007/s00294-006-0100-3; COVELLO PS, 1990, NUCLEIC ACIDS RES, V18, P5189, DOI 10.1093/nar/18.17.5189; Doniwa Y, 2010, GENE, V454, P39, DOI 10.1016/j.gene.2010.01.008; Farre JC, 2001, MOL CELL BIOL, V21, P6731, DOI 10.1128/MCB.21.20.6731-6737.2001; Farre JC, 2007, METHOD ENZYMOL, V424, P483, DOI 10.1016/S0076-6879(07)24022-4; Giege P, 1999, P NATL ACAD SCI USA, V96, P15324, DOI 10.1073/pnas.96.26.15324; Hammani K, 2009, PLANT CELL, V21, P3686, DOI 10.1105/tpc.109.071472; Handa H, 2003, NUCLEIC ACIDS RES, V31, P5907, DOI 10.1093/nar/gkg795; Heller WP, 2008, J BIOL CHEM, V283, P7314, DOI 10.1074/jbc.M709595200; HERNOULD M, 1993, P NATL ACAD SCI USA, V90, P2370, DOI 10.1073/pnas.90.6.2370; IWABUCHI M, 1993, EMBO J, V12, P1437, DOI 10.1002/j.1460-2075.1993.tb05787.x; Kim SR, 2009, PLANT J, V59, P738, DOI 10.1111/j.1365-313X.2009.03909.x; Kotera E, 2005, NATURE, V433, P326, DOI 10.1038/nature03229; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Mower JP, 2006, MOL GENET GENOMICS, V276, P285, DOI 10.1007/s00438-006-0139-3; Mulligan RM, 2007, MOL BIOL EVOL, V24, P1971, DOI 10.1093/molbev/msm125; Neuwirt J, 2005, RNA, V11, P1563, DOI 10.1261/rna.2740905; Notsu Y, 2002, MOL GENET GENOMICS, V268, P434, DOI 10.1007/s00438-002-0767-1; Ohtani S, 2010, PLANT CELL PHYSIOL, V51, P1942, DOI 10.1093/pcp/pcq142; Okuda K, 2006, J BIOL CHEM, V281, P37661, DOI 10.1074/jbc.M608184200; Picardi E, 2010, NUCLEIC ACIDS RES, V38, P4755, DOI 10.1093/nar/gkq202; Salmans ML, 2010, CURR GENET, V56, P439, DOI 10.1007/s00294-010-0312-4; Staudinger M, 2005, MOL GENET GENOMICS, V273, P130, DOI 10.1007/s00438-005-1117-x; Sung TY, 2010, PLANT J, V63, P499, DOI 10.1111/j.1365-313X.2010.04258.x; Takenaka M, 2004, NUCLEIC ACIDS RES, V32, P4137, DOI 10.1093/nar/gkh763; Takenaka M, 2010, J BIOL CHEM, V285, P27122, DOI 10.1074/jbc.M110.128611; Takenaka M, 2010, PLANT PHYSIOL, V152, P939, DOI 10.1104/pp.109.151175; Tang JW, 2010, PLANT J, V61, P456, DOI 10.1111/j.1365-313X.2009.04082.x; Tasaki E, 2010, PLANT J, V62, P560, DOI 10.1111/j.1365-313X.2010.04175.x; van der Merwe JA, 2006, FEBS LETT, V580, P268, DOI 10.1016/j.febslet.2005.12.011; Verbitskiy D, 2008, J BIOL CHEM, V283, P24374, DOI 10.1074/jbc.M803292200; Verbitskiy D, 2006, PLANT J, V47, P408, DOI 10.1111/j.1365-313X.2006.02794.x; Verbitskiy D, 2010, PLANT J, V61, P446, DOI 10.1111/j.1365-313X.2009.04076.x; Zehrmann A, 2009, PLANT CELL, V21, P558, DOI 10.1105/tpc.108.064535	43	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20867	10.1371/journal.pone.0020867	http://dx.doi.org/10.1371/journal.pone.0020867			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695137	Green Submitted, gold, Green Published			2022-12-25	WOS:000291663300027
J	Hao, LM; Efimenko, E; Swoboda, P; Scholey, JM				Hao, Limin; Efimenko, Evgeni; Swoboda, Peter; Scholey, Jonathan M.			The Retrograde IFT Machinery of C. elegans Cilia: Two IFT Dynein Complexes?	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; INTRAFLAGELLAR TRANSPORT IFT; KINESIN-LIKE PROTEIN; SENSORY CILIA; CYTOPLASMIC DYNEIN; CHEMOSENSORY NEURONS; HEAVY-CHAIN; CHLAMYDOMONAS; MOTORS; GENES	We analyzed the relatively poorly understood IFT-dynein (class DYNC2)-driven retrograde IFT pathway in C. elegans cilia, which yielded results that are surprising in the context of current models of IFT. Assays of C. elegans dynein gene expression and intraflagellar transport (IFT) suggest that conventional IFT-dynein contains essential heavy (CHE-3), light-intermediate (XBX-1), plus three light polypeptide chains that participate in IFT, but no "essential" intermediate chain. IFT assays of XBX1::YFP suggest that IFT-dynein is transported as cargo to the distal tip of the cilium by kinesin-2 motors, but independent of the IFT-particle/BBSome complexes. Finally, we were surprised to find that the subset of cilia present on the OLQ (outer labial quadrant) neurons assemble independently of conventional "CHE-3" IFT-dynein, implying that there is a second IFT-dynein acting in these cilia. We have found a novel gene encoding a dynein heavy chain, DHC-3, and two light chains, in OLQ neurons, which could constitute an IFT-dynein complex in OLQ neuronal cilia. Our results underscore several surprising features of retrograde IFT that require clarification.	[Hao, Limin; Scholey, Jonathan M.] Univ Calif Davis, Dept Mol & Cell Biol, Davis, CA 95616 USA; [Efimenko, Evgeni; Swoboda, Peter] Karolinska Inst, Novum, Dept Biosci & Nutr, Ctr Biosci, Huddinge, Sweden	University of California System; University of California Davis; Karolinska Institutet	Hao, LM (corresponding author), Univ Calif Davis, Dept Mol & Cell Biol, Davis, CA 95616 USA.	peter.swoboda@ki.se; jmscholey@ucdavis.edu		Swoboda, Peter/0000-0001-6416-8572	National Institutes of Health (NIH) [GM50718]; Swedish Research Council (VR); Swedish Foundation for Strategic Research (SSF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050718] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council (VR)(Swedish Research Council); Swedish Foundation for Strategic Research (SSF)(Swedish Foundation for Strategic Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant GM50718 to J.M.S. Work in the laboratory of P. S. was supported by grants from the Swedish Research Council (VR) and from the Swedish Foundation for Strategic Research (SSF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H; BRENNER S, 1974, GENETICS, V77, P71; Cole DG, 1998, J CELL BIOL, V141, P993, DOI 10.1083/jcb.141.4.993; COLE DG, 1993, NATURE, V366, P268, DOI 10.1038/366268a0; CULOTTI JG, 1978, GENETICS, V90, P243; Dolphin CT, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl352; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Efimenko E, 2006, MOL BIOL CELL, V17, P4801, DOI 10.1091/mbc.E06-04-0260; Evans JE, 2006, J CELL BIOL, V172, P663, DOI 10.1083/jcb.200509115; GIBBONS BH, 1994, MOL BIOL CELL, V5, P57, DOI 10.1091/mbc.5.1.57; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hao LM, 2009, METHOD CELL BIOL, V93, P235, DOI 10.1016/S0091-679X(08)93013-2; Hao LM, 2009, J CELL SCI, V122, P889, DOI 10.1242/jcs.023861; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; O'Rourke SM, 2007, PLOS GENET, V3, P1339, DOI 10.1371/journal.pgen.0030128; Orozco JT, 1999, NATURE, V398, P674, DOI 10.1038/19448; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Ou G, 2007, MOL BIOL CELL, V18, P1554, DOI 10.1091/mbc.E06-09-0805; Pan XY, 2006, J CELL BIOL, V174, P1035, DOI 10.1083/jcb.200606003; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Pigino G, 2009, J CELL BIOL, V187, P135, DOI 10.1083/jcb.200905103; Porter ME, 1999, MOL BIOL CELL, V10, P693, DOI 10.1091/mbc.10.3.693; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Rompolas P, 2007, J CELL SCI, V120, P3653, DOI 10.1242/jcs.012773; Schafer JC, 2003, MOL BIOL CELL, V14, P2057, DOI 10.1091/mbc.E02-10-0677; SHAKIR MA, 1993, NEUROREPORT, V4, P891, DOI 10.1097/00001756-199307000-00013; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Snow JJ, 2004, NAT CELL BIOL, V6, P1109, DOI 10.1038/ncb1186; STARICH TA, 1995, GENETICS, V139, P171; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; WARD S, 1975, J COMP NEUROL, V160, P313, DOI 10.1002/cne.901600305; WARE RW, 1975, J COMP NEUROL, V162, P71, DOI 10.1002/cne.901620106; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686; Wickstead B, 2007, TRAFFIC, V8, P1708, DOI 10.1111/j.1600-0854.2007.00646.x	44	38	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20995	10.1371/journal.pone.0020995	http://dx.doi.org/10.1371/journal.pone.0020995			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695221	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612600040
J	Serpeloni, M; Moraes, CB; Muniz, JRC; Motta, MCM; Ramos, ASP; Kessler, RL; Inoue, AH; daRocha, WD; Yamada-Ogatta, SF; Fragoso, SP; Goldenberg, S; Freitas, LH; Avila, AR				Serpeloni, Mariana; Borsoi Moraes, Carolina; Carvalho Muniz, Joao Renato; Machado Motta, Maria Cristina; Peixoto Ramos, Augusto Savio; Kessler, Rafael Luis; Inoue, Alexandre Haruo; daRocha, Wanderson Duarte; Yamada-Ogatta, Sueli Fumie; Fragoso, Stenio Perdigao; Goldenberg, Samuel; Freitas-Junior, Lucio H.; Avila, Andrea Rodrigues			An Essential Nuclear Protein in Trypanosomes Is a Component of mRNA Transcription/Export Pathway	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; SPLICING FACTOR; POLYCISTRONIC TRANSCRIPTION; CHROMOSOME TERRITORIES; MAMMALIAN-CELLS; GENE-REGULATION; EXPORT PATHWAY; POLYMERASE-II; YEAST HOMOLOG; CRUZI	In eukaryotic cells, different RNA species are exported from the nucleus via specialized pathways. The mRNA export machinery is highly integrated with mRNA processing, and includes a different set of nuclear transport adaptors as well as other mRNA binding proteins, RNA helicases, and NPC-associated proteins. The protozoan parasite Trypanosoma cruzi is the causative agent of Chagas disease, a widespread and neglected human disease which is endemic to Latin America. Gene expression in Trypanosoma has unique characteristics, such as constitutive polycistronic transcription of protein-encoding genes and mRNA processing by trans-splicing. In general, post-transcriptional events are the major points for regulation of gene expression in these parasites. However, the export pathway of mRNA from the nucleus is poorly understood. The present study investigated the function of TcSub2, which is a highly conserved protein ortholog to Sub2/UAP56, a component of the (T) under bar ranscription/(E) under bar xport (TREX) multiprotein complex connecting transcription with mRNA export in yeast/human. Similar to its orthologs, TcSub2 is a nuclear protein, localized in dispersed foci all over the nuclei -except the fibrillar center of nucleolus-and at the interface between dense and non-dense chromatin areas, proposing the association of TcSub2 with transcription/processing sites. These findings were analyzed further by BrUTP incorporation assays and confirmed that TcSub2 is physically associated with active RNA polymerase II (RNA pol II), but not RNA polymerase I (RNA pol I) or Spliced Leader (SL) transcription, demonstrating participation particularly in nuclear mRNA metabolism in T. cruzi. The double knockout of the TcSub2 gene is lethal in T. cruzi, suggesting it has an essential function. Alternatively, RNA interference assays were performed in Trypanosoma brucei. It allowed demonstrating that besides being an essential protein, its knockdown causes mRNA accumulation in the nucleus and decrease of translation levels, reinforcing that Trypanosoma-Sub2 (Tryp-Sub2) is a component of mRNA transcription/ export pathway in trypanosomes.	[Serpeloni, Mariana; Kessler, Rafael Luis; Inoue, Alexandre Haruo] Univ Fed Parana UFPR, Dept Biol Celular & Mol, Curitiba, Parana, Brazil; [Serpeloni, Mariana; Peixoto Ramos, Augusto Savio; Kessler, Rafael Luis; Inoue, Alexandre Haruo; Fragoso, Stenio Perdigao; Goldenberg, Samuel; Avila, Andrea Rodrigues] Inst Carlos Chagas ICC, Lab Regulacao Expressao Genica, Curitiba, Parana, Brazil; [Borsoi Moraes, Carolina; Freitas-Junior, Lucio H.] Inst Pasteur Korea IPK, Ctr Neglected Dis Drug Discovery CND3, Gyeonggi Do, South Korea; [Carvalho Muniz, Joao Renato] Univ Oxford, Oxford, England; [Machado Motta, Maria Cristina] Univ Fed Rio Janeiro UFRJ, Inst Biofis Carlos Chagas Filho, Dept Biol Celular & Parasitol, Rio De Janeiro, Brazil; [daRocha, Wanderson Duarte] Univ Fed Parana UFPR, Dept Bioquim, Curitiba, Parana, Brazil; [Yamada-Ogatta, Sueli Fumie] Univ Estadual Londrina UEL, Dept Microbiol, Ctr Ciencias Biol, Londrina, Brazil	Universidade Federal do Parana; University of Oxford; Universidade Federal do Rio de Janeiro; Universidade Federal do Parana; Universidade Estadual de Londrina	Serpeloni, M (corresponding author), Univ Fed Parana UFPR, Dept Biol Celular & Mol, Curitiba, Parana, Brazil.	aravila@fiocruz.br	DaRocha, Wanderson Duarte/AAB-9319-2021; Freitas-Junior, Lucio H/C-8677-2011; Moraes, Carolina Borsoi/I-4408-2014; Publica, Inct Saude/J-9544-2013; Kessler, Rafael/E-9291-2018; Ramos, Augusto/H-5402-2019; Fragoso, Stenio/AAB-4703-2019; GOLDENBERG, SAMUEL/B-4116-2009; Muniz, Joao R/B-7782-2016; Yamada-Ogatta, Sueli Fumie/C-7020-2019; Goldenberg, Samuel/ABD-8908-2022; Motta, Maria Cristina M/I-3140-2014; P, CM/B-1358-2013; DaRocha, Wanderson/A-8918-2013	DaRocha, Wanderson Duarte/0000-0002-8722-5143; Freitas-Junior, Lucio H/0000-0002-8904-7897; Moraes, Carolina Borsoi/0000-0002-0689-2770; Kessler, Rafael/0000-0002-6365-8251; Ramos, Augusto/0000-0003-3925-2507; Fragoso, Stenio/0000-0002-0909-7940; GOLDENBERG, SAMUEL/0000-0002-4892-163X; Muniz, Joao R/0000-0003-2731-3966; Yamada-Ogatta, Sueli Fumie/0000-0003-1183-146X; DaRocha, Wanderson/0000-0002-8722-5143; Motta, Maria Cristina/0000-0002-0947-4830	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Araucaria; Fiocruz; CNPq; CAPES; CBM; Ministry of Education, Science and Technology (MEST); Gyeonggi government; Korean Institute of Science and Technology Information from South Korea	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Araucaria(Fundacao Araucaria de Apoio ao Desenvolvimento Cientifico e Tecnologico do Estado do Parana FAFundacao de Amparo a Pesquisa e Inovacoo Estado de Santa Catarina (FAPESC)); Fiocruz; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CBM; Ministry of Education, Science and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Gyeonggi government; Korean Institute of Science and Technology Information from South Korea	This work was funded by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Araucaria to ARA, grants to SG from Fiocruz and CNPq. MS was funded by a studenship from CNPq and AHI by a studentship from CAPES and CBM and LHFJ were funded by the Ministry of Education, Science and Technology (MEST), the Gyeonggi government, and the Korean Institute of Science and Technology Information from South Korea. SG, SPF and MCMM are research fellows from CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera A, 2005, CURR OPIN CELL BIOL, V17, P242, DOI 10.1016/j.ceb.2005.03.001; Avila AR, 2001, MOL BIOCHEM PARASIT, V117, P169, DOI 10.1016/S0166-6851(01)00346-2; Batista M, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-259; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Campbell DA, 2003, MICROBES INFECT, V5, P1231, DOI 10.1016/j.micinf.2003.09.005; Cassola A, 2009, J BIOL CHEM, V284, P35015, DOI 10.1074/jbc.M109.031633; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Clayton CE, 2002, EMBO J, V21, P1881, DOI 10.1093/emboj/21.8.1881; Cmarko D, 1999, MOL BIOL CELL, V10, P211, DOI 10.1091/mbc.10.1.211; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Cremer T, 2001, NAT REV GENET, V2, P292, DOI 10.1038/35066075; Cuevas IC, 2005, MOL BIOCHEM PARASIT, V139, P15, DOI 10.1016/j.molbiopara.2004.11.002; Dhalia R, 2006, NUCLEIC ACIDS RES, V34, P2495, DOI 10.1093/nar/gkl290; Dias AP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1103; Djikeng A, 2004, METH MOL B, V270, P287; Dossin FD, 2005, EUKARYOT CELL, V4, P960, DOI 10.1128/EC.4.5.960-970.2005; Du TG, 2007, SEMIN CELL DEV BIOL, V18, P171, DOI 10.1016/j.semcdb.2007.01.010; Elias MCQB, 2001, MOL BIOCHEM PARASIT, V112, P79, DOI 10.1016/S0166-6851(00)00349-2; Figueiredo LM, 2009, NAT REV MICROBIOL, V7, P504, DOI 10.1038/nrmicro2149; Freire ER, 2011, MOL BIOCHEM PARASIT, V176, P25, DOI 10.1016/j.molbiopara.2010.11.011; Gatfield D, 2001, CURR BIOL, V11, P1716, DOI 10.1016/S0960-9822(01)00532-2; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hautbergue GM, 2009, CURR BIOL, V19, P1918, DOI 10.1016/j.cub.2009.09.041; Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; HULL RN, 1962, J EXP MED, V115, P903, DOI 10.1084/jem.115.5.903; Iborra FJ, 1996, J CELL SCI, V109, P1427; Kapadia F, 2006, GENE, V384, P37, DOI 10.1016/j.gene.2006.07.010; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Kiesler E, 2005, J CELL BIOL, V168, P1013, DOI 10.1083/jcb.200407173; Kiesler E, 2002, CURR BIOL, V12, P859, DOI 10.1016/S0960-9822(02)00840-0; Kistler AL, 2001, GENE DEV, V15, P42, DOI 10.1101/gad.851301; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kota KP, 2008, J CELL SCI, V121, P1526, DOI 10.1242/jcs.021055; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; LU HY, 1991, MOL BIOCHEM PARASIT, V44, P109, DOI 10.1016/0166-6851(91)90226-V; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MacMorris M, 2003, RNA, V9, P847, DOI 10.1261/rna.5480803; Martinez-Calvillo S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525241; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nardelli SC, 2009, CHROMOSOMA, V118, P487, DOI 10.1007/s00412-009-0213-9; Percipalle P, 2003, P NATL ACAD SCI USA, V100, P6475, DOI 10.1073/pnas.1131933100; de Souza FSP, 2010, MOL BIOCHEM PARASIT, V172, P90, DOI 10.1016/j.molbiopara.2010.03.014; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Redmond S, 2003, MOL BIOCHEM PARASIT, V128, P115, DOI 10.1016/S0166-6851(03)00045-8; Respuela P, 2008, J BIOL CHEM, V283, P15884, DOI 10.1074/jbc.M802081200; Sahni A, 2010, BIOCHEM BIOPH RES CO, V393, P106, DOI 10.1016/j.bbrc.2010.01.093; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santos-Rosa H, 1998, MOL CELL BIOL, V18, P6826, DOI 10.1128/MCB.18.11.6826; SCHENKMAN S, 1991, CELL, V65, P1117, DOI 10.1016/0092-8674(91)90008-M; Schwede A, 2009, NUCLEIC ACIDS RES, V37, P5511, DOI 10.1093/nar/gkp571; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Serpeloni M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-7; Shankar J, 2008, ARCH BIOCHEM BIOPHYS, V478, P143, DOI 10.1016/j.abb.2008.07.027; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strasser K, 2001, NATURE, V413, P648, DOI 10.1038/35098113; Teixeira Santuza M.R., 2003, Genetics and Molecular Research, V2, pUnpaginated; Tolivia J, 2006, ANAL QUANT CYTOL, V28, P43; Villanova GV, 2009, INT J PARASITOL, V39, P665, DOI 10.1016/j.ijpara.2008.11.013; Vazquez M, 2003, MOL BIOCHEM PARASIT, V128, P77, DOI 10.1016/S0166-6851(03)00007-0; Verschure PJ, 1999, J CELL BIOL, V147, P13, DOI 10.1083/jcb.147.1.13; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Worthen C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000678; Yamazaki T, 2010, MOL BIOL CELL, V21, P2953, DOI 10.1091/mbc.E09-10-0913; Zhang M, 2001, GENE DEV, V15, P30, DOI 10.1101/gad.851701; Zhao R, 2009, CURR OPIN GENET DEV, V19, P172, DOI 10.1016/j.gde.2009.02.007	76	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20730	10.1371/journal.pone.0020730	http://dx.doi.org/10.1371/journal.pone.0020730			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687672	gold, Green Published, Green Submitted			2022-12-25	WOS:000291611500039
J	Tagliani-Ribeiro, A; Oliveira, M; Sassi, AK; Rodrigues, MR; Zagonel-Oliveira, M; Steinman, G; Matte, U; Fagundes, NJR; Schuler-Faccini, L				Tagliani-Ribeiro, Alice; Oliveira, Mariana; Sassi, Adriana K.; Rodrigues, Maira R.; Zagonel-Oliveira, Marcelo; Steinman, Gary; Matte, Ursula; Fagundes, Nelson J. R.; Schuler-Faccini, Lavinia			Twin Town in South Brazil: A Nazi's Experiment or a Genetic Founder Effect?	PLOS ONE			English	Article							POPULATION; FREQUENCY; SURNAMES	Candido Godoi (CG) is a small municipality in South Brazil with approximately 6,000 inhabitants. It is known as the "Twins' Town" due to its high rate of twin births. Recently it was claimed that such high frequency of twinning would be connected to experiments performed by the German Nazi doctor Joseph Mengele. It is known, however, that this town was founded by a small number of families and therefore a genetic founder effect may represent an alternatively explanation for the high twinning prevalence in CG. In this study, we tested specific predictions of the "Nazi's experiment" and of the "founder effect" hypotheses. We surveyed a total of 6,262 baptism records from 1959-2008 in CG catholic churches, and identified 91 twin pairs and one triplet. Contrary to the "Nazi's experiment hypothesis", there is no spurt in twinning between the years (1964-1968) when Mengele allegedly was in CG (P = 0.482). Moreover, there is no temporal trend for a declining rate of twinning since the 1960s (P = 0.351), and no difference in twinning among CG districts considering two different periods: 1927-1958 and 1959-2008 (P = 0.638). On the other hand, the "founder effect hypothesis" is supported by an isonymy analysis that shows that women who gave birth to twins have a higher inbreeding coefficient when compared to women who never had twins (0.0148, 0.0081, respectively, P = 0.019). In summary, our results show no evidence for the "Nazi's experiment hypothesis" and strongly suggest that the "founder effect hypothesis" is a much more likely alternative for explaining the high prevalence of twinning in CG. If this hypothesis is correct, then this community represents a valuable population where genetic factors linked to twinning may be identified.	[Tagliani-Ribeiro, Alice; Zagonel-Oliveira, Marcelo; Schuler-Faccini, Lavinia] Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil; [Tagliani-Ribeiro, Alice; Oliveira, Mariana; Sassi, Adriana K.; Zagonel-Oliveira, Marcelo; Matte, Ursula; Fagundes, Nelson J. R.; Schuler-Faccini, Lavinia] Natl Inst Sci & Technol Populat Med Genet INAGEMP, Porto Alegre, RS, Brazil; [Oliveira, Mariana; Sassi, Adriana K.] Univ Fed Pampa, Sao Gabriel, RS, Brazil; [Rodrigues, Maira R.; Fagundes, Nelson J. R.] Univ Fed Minas Gerais, Inst Biociencias, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Matte, Ursula; Schuler-Faccini, Lavinia] Hosp Clin Porto Alegre, Porto Alegre, RS, Brazil; [Steinman, Gary] Touro Coll Osteopath Med, Dept Biochem, New York, NY USA	Universidade Federal do Rio Grande do Sul; Universidade Federal do Pampa; Universidade Federal de Minas Gerais	Tagliani-Ribeiro, A (corresponding author), Univ Fed Rio Grande do Sul, Inst Biociencias, Dept Genet, BR-90049 Porto Alegre, RS, Brazil.	lavinia.faccini@ufrgs.br	Da Silveira Matte umatte, Ursula/U-3912-2019; SCHULER-FACCINI, LAVINIA/C-8309-2013; SCHULER-FACCINI, LAVINIA/K-2927-2016; Matte, Ursula/J-4589-2012; Inagemp, Inct/J-9451-2013; Fagundes, Nelson/F-7490-2014	Da Silveira Matte umatte, Ursula/0000-0003-4977-6662; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; SCHULER-FACCINI, LAVINIA/0000-0002-2428-0460; Fagundes, Nelson/0000-0003-0456-0323; Zagonel de Oliveira, Marcelo/0000-0003-4006-4052	National Research Council (Brazil) [573993/2008-4]	National Research Council (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was funded by the National Research Council (Brazil), grant number 573993/2008-4. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hendy A, 2000, LANCET, V356, P914; Ayres M., 2007, BIOESTAT APLICACOES; Barrai I, 2000, ANN HUM BIOL, V27, P607; Beemsterboer SN, 2006, HUM REPROD, V21, P1531, DOI 10.1093/humrep/del009; Bronberg RA, 2009, HUM BIOL, V81, P447, DOI 10.3378/027.081.0404; Camarasa J, 2008, J MENGELE ANJO MORTE; CHARROW J, 2004, FAM CANCER, V4, P201; CROW JF, 1965, EUGEN QUART, V12, P199, DOI 10.1080/19485565.1965.9987630; Ericson A, 2001, Twin Res, V4, P63, DOI 10.1375/twin.4.2.63; ERIKSSON A W, 1973, Commentationes Biologicae Societas Scientiarum Fennica, V64, P1; Fauser BCJM, 2005, LANCET, V365, P1807, DOI 10.1016/S0140-6736(05)66478-1; Fellman J, 2006, HUM BIOL, V78, P253, DOI 10.1353/hub.2006.0044; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Hall JG, 1996, CURR OPIN GENET DEV, V6, P343, DOI 10.1016/S0959-437X(96)80012-8; Hasbargen U, 2000, HUM REPROD, V15, P2659, DOI 10.1093/humrep/15.12.2659; Hoekstra C, 2008, HUM REPROD UPDATE, V14, P37, DOI 10.1093/humupd/dmm036; Imaizumi Y., 1998, Acta Geneticae Medicae et Gemellologiae, V47, P101; Imaizumi Y, 2007, TWIN RES HUM GENET, V10, P638, DOI 10.1375/twin.10.4.638; Laberge AM, 2005, CLIN GENET, V68, P287, DOI 10.1111/j.1399-0004.2005.00497.x; Li Z, 2003, LANCET, V361, P380, DOI 10.1016/S0140-6736(03)12390-2; Loyo MA, 2004, ANN HUM BIOL, V31, P669, DOI 10.1080/03014460400019760; Lumley J, 2001, BRIT J OBSTET GYNAEC, V108, P937, DOI 10.1111/j.1471-0528.2001.00228.x; Lummaa V, 1998, NATURE, V394, P533, DOI 10.1038/28977; Martin Joyce A, 2005, Natl Vital Stat Rep, V54, P1; Matte U., 1996, Acta Geneticae Medicae et Gemellologiae, V45, P431; Montgomery GW, 2004, TWIN RES, V7, P548, DOI 10.1375/1369052042663823; MURPHY S, 1980, LANCET, V2, P502; Rodriguez-Larralde A, 2000, AM J HUM BIOL, V12, P352, DOI 10.1002/(SICI)1520-6300(200005/06)12:3<352::AID-AJHB5>3.0.CO;2-S; Scapoli C, 2007, THEOR POPUL BIOL, V71, P37, DOI 10.1016/j.tpb.2006.06.010; Steinman G, 2006, LANCET, V367, P1461, DOI 10.1016/S0140-6736(06)68623-6; Steinman G, 2000, Twin Res, V3, P337; Steinman G, 2007, WOMB MATES MODERN GU; Tarskaia L, 2009, AM J PHYS ANTHROPOL, V138, P190, DOI 10.1002/ajpa.20918; Tong S, 1997, LANCET, V349, P843, DOI 10.1016/S0140-6736(96)10003-9; WARE J, 1986, MENGELE COMPLETE STO; WEINBERG W, 1934, GENETICA, V16, P282; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zappu A, 2010, GENET TEST MOL BIOMA, V14, P399, DOI 10.1089/gtmb.2010.0024; Zlotogora J, 2007, EUR J HUM GENET, V15, P272, DOI 10.1038/sj.ejhg.5201760	39	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20328	10.1371/journal.pone.0020328	http://dx.doi.org/10.1371/journal.pone.0020328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687665	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500016
J	An, J; Golech, S; Klaewsongkram, J; Zhang, YQ; Subedi, K; Huston, GE; Wood, WH; Wersto, RP; Becker, KG; Swain, SL; Weng, NP				An, Jie; Golech, Susanne; Klaewsongkram, Jettanong; Zhang, Yongqing; Subedi, Kalpana; Huston, Gail E.; Wood, William H., III; Wersto, Robert P.; Becker, Kevin G.; Swain, Susan L.; Weng, Nanping			Kruppel-like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL-17 expression during Th17 differentiation	FASEB JOURNAL			English	Article						transcription factor; T-cell homeostasis; autoimmune disease	T-CELL DEVELOPMENT; ROR-GAMMA-T; TRANSCRIPTION FACTOR; DOWN-REGULATION; T-H-17 CELLS; TGF-BETA; LINEAGE; SURVIVAL; ALPHA; GROWTH	Kruppel-like factor 4 (KLF4), a transcription factor, plays a key role in the pluripotency of stem cells. We sought to determine the function of KLF4 in T-cell development and differentiation by using T-cell-specific Klf4-knockout (KO) mice. We found that KLF4 was highly expressed in thymocytes and mature T cells and was rapidly down-regulated in mature T cells after activation. In Klf4-KO mice, we observed a modest reduction of thymocytes (27%) due to the reduced proliferation of double-negative (DN) thymocytes. We demonstrated that a direct repression of Cdkn1b by KLF4 was a cause of decreased DN proliferation. During in vitro T-cell differentiation, we observed significant reduction of IL-17-expressing CD4(+) T cells (Th17; 24%) but not in other types of Th differentiation. The reduction of Th17 cells resulted in a significant attenuation of the severity (35%) of experimental autoimmune encephalomyelitis in vivo in Klf4-KO mice as compared with the Klf4 wild-type littermates. Finally, we demonstrated that KLF4 directly binds to the promoter of Il17a and positively regulates its expression. In summary, these findings identify KLF4 as a critical regulator in T-cell development and Th17 differentiation.-An, J., Golech, S., Klaewsongkram, J., Zhang, Y., Subedi, K., Huston, G. E., Wood, W. H., III, Wersto, R. P., Becker, K. G., Swain, S. L., Weng, N. Kruppel-like factor 4 (KLF4) directly regulates proliferation in thymocyte development and IL-17 expression during Th17 differentiation. FASEB J. 25, 3634-3645 (2011). www.fasebj.org	[An, Jie; Golech, Susanne; Klaewsongkram, Jettanong; Subedi, Kalpana; Weng, Nanping] NIA, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Zhang, Yongqing; Wood, William H., III; Becker, Kevin G.] NIA, DNA Array Unit, NIH, Baltimore, MD 21224 USA; [Wersto, Robert P.] NIA, Flow Cytometry Unit, NIH, Baltimore, MD 21224 USA; [Huston, Gail E.] Trudeau Inst, New York, NY USA; [Swain, Susan L.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Trudeau Institute; University of Massachusetts System; University of Massachusetts Worcester	Weng, NP (corresponding author), 251 Bayview Blvd,Ste 100, Baltimore, MD 21224 USA.	wengn@mail.nih.gov	Klaewsongkram, Jettanong/AAI-6245-2021; Weng, Nan-ping/AAC-5037-2020	Klaewsongkram, Jettanong/0000-0001-6063-2403; Becker, Kevin/0000-0002-6794-6656; Subedi, kalpana/0000-0002-1808-3268	National Institute on Aging; National Institute on Aging, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046530, R01AI076534] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000757, ZICAG000618, ZICAG000616] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Drs. Richard Hodes and Joyti Sen for critical reading of the manuscript, Andrea Wurster and Qing Yu for help with Th2- and Th17-cell differentiation, Jun Ho Lee for help with the EAE mouse model, Cuong Nguyen and Tonya Wolf of the Flow Cytometry Unit for cell sorting, the staff of the National Institute on Aging animal facility for support and assistance, and Ana Lustig for proofreading the manuscript. This research was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. J.A and S. G. designed and performed experiments, analyzed the data, and contributed to the writing of the manuscript. J.K., Y.Z., K.S., G.E.H., W.H.W., R.P.W., and K.G.B. contributed to some of the experiments and data analysis. S.L.S and N.W. directed the experiments and wrote the manuscript. N.W. conceived the research, designed the experiments, and funded the research. The authors declare no competing financial interests.	Araki Y, 2008, J IMMUNOL, V180, P8102, DOI 10.4049/jimmunol.180.12.8102; Beeton Christine, 2007, J Vis Exp, P527, DOI 10.3791/527; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Cheadle C, 2003, J MOL DIAGN, V5, P73, DOI 10.1016/S1525-1578(10)60455-2; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Hayday AC, 2007, NAT IMMUNOL, V8, P137, DOI 10.1038/ni1436; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; Klaewsongkram J, 2007, J IMMUNOL, V179, P4679, DOI 10.4049/jimmunol.179.7.4679; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kurebayashi S, 2000, P NATL ACAD SCI USA, V97, P10132, DOI 10.1073/pnas.97.18.10132; Laky K, 2007, J EXP MED, V204, P2115, DOI 10.1084/jem.20070550; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Lebson L, 2010, J IMMUNOL, V185, P7161, DOI 10.4049/jimmunol.1002750; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Moisan J, 2007, J EXP MED, V204, P2825, DOI 10.1084/jem.20070994; Mosmann TR, 2005, J IMMUNOL, V175, P5; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Reynolds JM, 2010, IMMUNITY, V32, P692, DOI 10.1016/j.immuni.2010.04.010; ROWLAND BD, 2005, NAT CELL BIOL; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Shields JM, 1998, NUCLEIC ACIDS RES, V26, P796, DOI 10.1093/nar/26.3.796; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tabrizifard S, 2004, J IMMUNOL, V173, P1094, DOI 10.4049/jimmunol.173.2.1094; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tsukiyama T, 2001, J IMMUNOL, V166, P304, DOI 10.4049/jimmunol.166.1.304; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; VONBOEHMER H, 1992, BONE MARROW TRANSPL, V9, P46; Wei DY, 2008, CANCER RES, V68, P4631, DOI 10.1158/0008-5472.CAN-07-5953; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xi HK, 2004, J IMMUNOL, V172, P964, DOI 10.4049/jimmunol.172.2.964; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou MX, 2007, J IMMUNOL, V178, P5496, DOI 10.4049/jimmunol.178.9.5496; Zhu JF, 2009, J EXP MED, V206, P329, DOI 10.1084/jem.20081666	51	42	50	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3634	3645		10.1096/fj.11-186924	http://dx.doi.org/10.1096/fj.11-186924			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21685331	Green Published			2022-12-25	WOS:000295356400033
J	Sarig, H; Ohana, D; Epand, RF; Mor, A; Epand, RM				Sarig, Hadar; Ohana, Dafna; Epand, Raquel F.; Mor, Amram; Epand, Richard M.			Functional studies of cochleate assemblies of an oligo-acyl-lysyl with lipid mixtures for combating bacterial multidrug resistance	FASEB JOURNAL			English	Article						drug encapsulation in lipids; drug delivery; drug synergy; membrane fusion	LYSINE OLIGOMERS; STAPHYLOCOCCUS-AUREUS; EFFLUX; PROTEINS; TRANSPORTER; FAMILY; PUMPS	The cationic antimicrobial oligo-acyl-lysyls (OAKs) interact with lipid mixtures mimicking the composition of bacterial cytoplasmic membranes. We have reported the ability of one such OAK, C(12)K-7 alpha(8), to cluster anionic lipids and to promote a structural change with lipid bilayers to form rolled cylindrical structures or cochleates, without requiring divalent cations for their assembly. These assemblies can be exploited for drug delivery, permitting their synergistic use with antibiotics in systemic therapy to increase efficacy and reduce toxicity. Our previous studies of the biophysical properties of these systems led us to select mixtures with the goal of optimizing their potential for enhancing effectiveness in combating bacterial multidrug resistance. Here, we further investigate the properties of such mixtures that result in enhanced in vivo activity. The role of erythromycin in the assembly of cochleates with OAK in the gel and the liquid crystalline states were assessed, as well as the encapsulation efficiency of the systems chosen. In addition, we found that erythromycin did not undermine the ability of OAKs to induce fusion of vesicles, fusion being an essential component of cochleate formation. The in vivo activity of the new assemblies tested resulted in higher survival rates of animals infected with multidrug resistant bacteria.-Sarig, H., Ohana, D., Epand, R. F., Mor, A., Epand, R. M. Functional studies of cochleate assemblies of an oligo-acyl-lysyl with lipid mixtures for combating bacterial multidrug resistance. FASEB J. 25, 3336-3343 (2011). www.fasebj.org	[Epand, Raquel F.; Epand, Richard M.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Sarig, Hadar; Ohana, Dafna; Mor, Amram] Technion Israel Inst Technol, Dept Biotechnol & Food Engn, Haifa, Israel	McMaster University; Technion Israel Institute of Technology	Epand, RM (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.	amor@tx.technion.ac.il; epand@mcmaster.ca	, Richard/R-2316-2019	, Richard/0000-0002-9602-9558	Canadian Institute of Health Research [MOP 86608]; Israel Science Foundation [283/08]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Israel Science Foundation(Israel Science Foundation)	This research was partly supported by the Canadian Institute of Health Research (grant MOP 86608) and the Israel Science Foundation (grant 283/08).	DeMarco CE, 2007, ANTIMICROB AGENTS CH, V51, P3235, DOI 10.1128/AAC.00430-07; Epand RF, 2011, J PHYS CHEM B, V115, P2287, DOI 10.1021/jp111242q; Epand RM, 2008, J AM CHEM SOC, V130, P14346, DOI 10.1021/ja8062327; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; KATES M, 1993, LIPIDS, V28, P877, DOI 10.1007/BF02537494; Li XZ, 2009, DRUGS, V69, P1555, DOI 10.2165/11317030-000000000-00000; Livne L, 2010, FASEB J, V24, P5092, DOI 10.1096/fj.10-167809; Miyamae S, 2001, ANTIMICROB AGENTS CH, V45, P3341, DOI 10.1128/AAC.45.12.3341-3346.2001; Mor A, 2010, ADV M C M, P100, DOI 10.1079/9781845936570.0100; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Paulsen IT, 1996, MICROBIOL REV, V60, P575, DOI 10.1128/MMBR.60.4.575-608.1996; Paulsen IT, 1996, MOL MICROBIOL, V19, P1167, DOI 10.1111/j.1365-2958.1996.tb02462.x; Paulsen IT, 1996, P NATL ACAD SCI USA, V93, P3630, DOI 10.1073/pnas.93.8.3630; Prinz WA, 2009, CRIT REV BIOCHEM MOL, V44, P278, DOI 10.1080/10409230903183472; Radzishevsky I, 2007, ANTIMICROB AGENTS CH, V51, P1753, DOI 10.1128/AAC.01288-06; Radzishevsky IS, 2008, CHEM BIOL, V15, P354, DOI 10.1016/j.chembiol.2008.03.006; Radzishevsky IS, 2007, NAT BIOTECHNOL, V25, P657, DOI 10.1038/nbt1309; Schuldiner S, 2001, NEWS PHYSIOL SCI, V16, P130; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023	21	18	18	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3336	3343		10.1096/fj.11-183764	http://dx.doi.org/10.1096/fj.11-183764			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21676947				2022-12-25	WOS:000295356400006
J	Klier, M; Schuler, C; Halestrap, AP; Sly, WS; Deitmer, JW; Becker, HM				Klier, Michael; Schueler, Christina; Halestrap, Andrew P.; Sly, William S.; Deitmer, Joachim W.; Becker, Holger M.			Transport Activity of the High-affinity Monocarboxylate Transporter MCT2 Is Enhanced by Extracellular Carbonic Anhydrase IV but Not by Intracellular Carbonic Anhydrase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS-LAEVIS OOCYTES; CENTRAL-NERVOUS-SYSTEM; LACTATE TRANSPORT; ANCILLARY PROTEIN; SKELETAL-MUSCLE; O-18 EXCHANGE; PH REGULATION; BINDING-SITE; GLIAL-CELLS; BICARBONATE	The ubiquitous enzyme carbonic anhydrase isoform II (CAII) has been shown to enhance transport activity of the proton-coupled monocarboxylate transporters MCT1 and MCT4 in a non-catalytic manner. In this study, we investigated the role of cytosolic CAII and of the extracellular, membrane-bound CA isoform IV (CAIV) on the lactate transport activity of the high-affinity monocarboxylate transporter MCT2, heterologously expressed in Xenopus oocytes. In contrast to MCT1 and MCT4, transport activity of MCT2 was not altered by CAII. However, coexpression of CAIV with MCT2 resulted in a significant increase in MCT2 transport activity when the transporter was coexpressed with its associated ancillary protein GP70 (embigin). The CAIV-mediated augmentation of MCT2 activity was independent of the catalytic activity of the enzyme, as application of the CA-inhibitor ethoxyzolamide or coexpressing the catalytically inactive mutant CAIV-V165Y did not suppress CAIV-mediated augmentation of MCT2 transport activity. Furthermore, exchange of His-88, mediating an intramolecular H+ -shuttle in CAIV, to alanine resulted only in a slight decrease in CAIV-mediated augmentation of MCT2 activity. The data suggest that extracellular membrane-bound CAIV, but not cytosolic CAII, augments transport activity of MCT2 in a non-catalytic manner, possibly by facilitating a proton pathway other than His-88.	[Klier, Michael; Becker, Holger M.] TU Kaiserslautern, FB Biol, Arbeitsgrp Zool Membrantransport, D-67653 Kaiserslautern, Germany; [Klier, Michael; Schueler, Christina; Deitmer, Joachim W.] TU Kaiserslautern, FB Biol, Abt Allgemeine Zool, D-67653 Kaiserslautern, Germany; [Halestrap, Andrew P.] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England; [Sly, William S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	University of Kaiserslautern; University of Kaiserslautern; University of Bristol; Saint Louis University	Becker, HM (corresponding author), TU Kaiserslautern, FB Biol, Arbeitsgrp Zool Membrantransport, POB 3049, D-67653 Kaiserslautern, Germany.	h.becker@biologie.uni-kl.de	Halestrap, Andrew P/G-7275-2011; Becker, Holger/AAB-4322-2020	Halestrap, Andrew/0000-0001-5374-2778	Deutsche Forschungsgemeinschaft [DE 231/24-1]; Landesschwerpunkt Membrantransport	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Landesschwerpunkt Membrantransport	The work was funded by the Deutsche Forschungsgemeinschaft Grant DE 231/24-1 (to J. W. D.) and by the Landesschwerpunkt Membrantransport (to H. B. and J. W. D.).	Almquist J, 2010, J COMPUT SCI SYST BI, V3, P107, DOI DOI 10.4172/JCSB.1000066; Alvarez BV, 2003, BIOCHEMISTRY-US, V42, P12321, DOI 10.1021/bi0353124; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Becker HM, 2004, BIOPHYS J, V86, P235, DOI 10.1016/S0006-3495(04)74099-0; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2007, J BIOL CHEM, V282, P13508, DOI 10.1074/jbc.M700066200; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Bergersen L, 2001, EXP BRAIN RES, V136, P523, DOI 10.1007/s002210000600; Bolanos Juan P, 2010, Front Neuroenergetics, V2, P1, DOI 10.3389/neuro.14.001.2010; Broer S, 1999, BIOCHEM J, V341, P529, DOI 10.1042/0264-6021:3410529; Broer S, 1998, BIOCHEM J, V333, P167, DOI 10.1042/bj3330167; CAMMER W, 1979, J NEUROCHEM, V32, P651, DOI 10.1111/j.1471-4159.1979.tb00401.x; Deitmer JW, 1996, PROG NEUROBIOL, V48, P73, DOI 10.1016/0301-0082(95)00039-9; DEITMER JW, 1991, J GEN PHYSIOL, V98, P637, DOI 10.1085/jgp.98.3.637; Di Fiore A, 2008, BIOORG MED CHEM LETT, V18, P2669, DOI 10.1016/j.bmcl.2008.03.023; FOSSUM S, 1991, EUR J IMMUNOL, V21, P671, DOI 10.1002/eji.1830210320; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hallerdei J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015137; Hurt JD, 1997, J BIOL CHEM, V272, P13512, DOI 10.1074/jbc.272.21.13512; Jackson VN, 1997, BIOCHEM J, V324, P447, DOI 10.1042/bj3240447; Juel C, 2003, J PHYSIOL-LONDON, V548, P639, DOI 10.1113/jphysiol.2002.035899; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Li XJ, 2002, J BIOL CHEM, V277, P36085, DOI 10.1074/jbc.M111952200; McMurtrie HL, 2004, J ENZYM INHIB MED CH, V19, P231, DOI 10.1080/14756360410001704443; Messonnier L, 2007, J APPL PHYSIOL, V102, P1936, DOI 10.1152/japplphysiol.00691.2006; Ovens MJ, 2010, BIOCHEM J, V431, P217, DOI 10.1042/BJ20100890; Pellerin L, 1998, DEV NEUROSCI-BASEL, V20, P291, DOI 10.1159/000017324; Pierre K, 2005, J NEUROCHEM, V94, P1, DOI 10.1111/j.1471-4159.2005.03168.x; Pushkin A, 2004, J PHYSIOL-LONDON, V559, P55, DOI 10.1113/jphysiol.2004.065110; Ro HA, 2004, J BIOL CHEM, V279, P37115, DOI 10.1074/jbc.M403099200; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sterling D, 2002, J BIOL CHEM, V277, P25239, DOI 10.1074/jbc.M202562200; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Supuran CT, 2007, BIOORGAN MED CHEM, V15, P4336, DOI 10.1016/j.bmc.2007.04.020; Supuran CT, 2009, DRUG DESIGN ZINC ENZ, P15; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; Svichar N, 2003, GLIA, V41, P415, DOI 10.1002/glia.10187; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Vaughan-Jones RD, 2002, BIOCHEM CELL BIOL, V80, P579, DOI 10.1139/O02-157; Vince JW, 2000, BIOCHEMISTRY-US, V39, P13344, DOI 10.1021/bi0015111; Vince JW, 1998, J BIOL CHEM, V273, P28430, DOI 10.1074/jbc.273.43.28430; Voipio J, 1997, J PHYSIOL-LONDON, V499, P527, DOI 10.1113/jphysiol.1997.sp021946; Wetzel P, 2001, J PHYSIOL-LONDON, V531, P743, DOI 10.1111/j.1469-7793.2001.0743h.x; Wilson MC, 2009, J BIOL CHEM, V284, P20011, DOI 10.1074/jbc.M109.014217; Wilson MC, 2005, J BIOL CHEM, V280, P27213, DOI 10.1074/jbc.M411950200; Wilson MC, 2002, J BIOL CHEM, V277, P3666, DOI 10.1074/jbc.M109658200	49	45	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27781	27791		10.1074/jbc.M111.255331	http://dx.doi.org/10.1074/jbc.M111.255331			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21680735	Green Published, hybrid			2022-12-25	WOS:000293268700070
J	Biswas, N; Liu, SF; Ronni, T; Aussenberg, SE; Liu, WQ; Fujita, T; Wang, TY				Biswas, Nabanita; Liu, Shufeng; Ronni, Tapani; Aussenberg, Steven E.; Liu, Weiqun; Fujita, Takashi; Wang, Tianyi			The Ubiquitin-Like Protein PLIC-1 or Ubiquilin 1 Inhibits TLR3-Trif Signaling	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; HEPATITIS-C-VIRUS; NF-KAPPA-B; INTERFERON REGULATORY FACTOR-3; DOUBLE-STRANDED-RNA; ADAPTER PROTEIN; NEGATIVE REGULATOR; INNATE IMMUNITY; CELL-SURVIVAL; PATHWAY	Background: The innate immune responses to virus infection are initiated by either Toll-like receptors (TLR3/7/8/9) or cytoplasmic double-stranded RNA (dsRNA)-recognizing RNA helicases RIG-I and MDA5. To avoid causing injury to the host, these signaling pathways must be switched off in time by negative regulators. Methodology/Principal Findings: Through yeast-two hybrid screening, we found that an ubiquitin-like protein named protein linking integrin-associated protein to cytoskeleton 1(PLIC-1 or Ubiquilin 1) interacted with the Toll/interleukin-1 receptor (TIR) domain of TLR4. Interestingly, PLIC-1 had modest effect on TLR4-mediated signaling, but strongly suppressed the transcriptional activation of IFN-beta promoter through the TLR3-Trif-dependent pathway. Concomitantly, reduction of endogenous PLIC-1 by short-hairpin interfering RNA (shRNA) enhanced TLR3 activation both in luciferase reporter assays as well as in new castle disease virus (NDV) infected cells. An interaction between PLIC-1 and Trif was confirmed in co-immunoprecipitation (Co-IP) and GST-pull-down assays. Subsequent confocal microscopic analysis revealed that PLIC-1 and Trif colocalized with the autophagosome marker LC3 in punctate subcellular structures. Finally, overexpression of PLIC-1 decreased Trif protein abundance in a Nocodazole-sensitive manner. Conclusions: Our results suggest that PLIC-1 is a novel inhibitor of the TLR3-Trif antiviral pathway by reducing the abundance of Trif.	[Biswas, Nabanita; Liu, Shufeng; Aussenberg, Steven E.; Liu, Weiqun; Wang, Tianyi] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Ronni, Tapani] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA USA; [Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 606, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; Kyoto University	Biswas, N (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	tywang@pitt.edu			National Institutes of Health [R21AI068784]; Fogarty training grant [5D43TW001038]; FOGARTY INTERNATIONAL CENTER [D43TW001038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI068784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty training grant; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant R21AI068784. N.B. was supported by the Fogarty training grant 5D43TW001038. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, CR BIOL, V327, P581, DOI 10.1016/j.crvi.2004.04.002; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; Fearns C, 2006, J BIOL CHEM, V281, P34592, DOI 10.1074/jbc.M604019200; Foy E, 2003, SCIENCE, V300, P1145, DOI 10.1126/science.1082604; Funami K, 2008, J BIOL CHEM, V283, P18283, DOI 10.1074/jbc.M801013200; Funami K, 2007, J IMMUNOL, V179, P6867, DOI 10.4049/jimmunol.179.10.6867; Gao L, 2003, J VIROL, V77, P4149, DOI 10.1128/JVI.77.7.4149-4159.2003; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Heir R, 2006, EMBO REP, V7, P1252, DOI 10.1038/sj.embor.7400823; Johnsen IB, 2006, EMBO J, V25, P3335, DOI 10.1038/sj.emboj.7601222; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Matsumoto M, 2002, BIOCHEM BIOPH RES CO, V293, P1364, DOI 10.1016/S0006-291X(02)00380-7; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Modlin RL, 2002, ANN ALLERG ASTHMA IM, V88, P543, DOI 10.1016/S1081-1206(10)61883-2; N'Diaye EN, 2009, EMBO REP, V10, P173, DOI 10.1038/embor.2008.238; N'Diaye EN, 2003, J CELL BIOL, V163, P1157, DOI 10.1083/jcb.200307155; Nakhaei P, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000650; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P7668, DOI 10.1074/jbc.M610946200; Regan-Klapisz E, 2005, J CELL SCI, V118, P4437, DOI 10.1242/jcs.02571; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Webb JL, 2004, INT J BIOCHEM CELL B, V36, P2541, DOI 10.1016/j.biocel.2004.02.003; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wu AL, 1999, MOL CELL, V4, P619, DOI 10.1016/S1097-2765(00)80212-9; Wu SL, 2002, BBA-MOL CELL RES, V1542, P41, DOI 10.1016/S0167-4889(01)00164-1; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu Y, 2006, J BIOL CHEM, V281, P19179, DOI 10.1074/jbc.M513377200; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	48	15	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21153	10.1371/journal.pone.0021153	http://dx.doi.org/10.1371/journal.pone.0021153			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695056	gold, Green Submitted, Green Published			2022-12-25	WOS:000291737600048
J	Sudarshan, S; Shanmugasundaram, K; Naylor, SL; Lin, S; Livi, CB; O'Neill, CF; Parekh, DJ; Yeh, IT; Sun, LZ; Block, K				Sudarshan, Sunil; Shanmugasundaram, Karthigayan; Naylor, Susan L.; Lin, Shu; Livi, Carolina B.; O'Neill, Christine F.; Parekh, Dipen J.; Yeh, I-Tien; Sun, Lu-Zhe; Block, Karen			Reduced Expression of Fumarate Hydratase in Clear Cell Renal Cancer Mediates HIF-2 alpha Accumulation and Promotes Migration and Invasion	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTORS; TUMOR SUPPRESSION; HIF-ALPHA; MUTATIONS; GENE; VHL; OVEREXPRESSION; SUSCEPTIBILITY; HIF1-ALPHA; PATHWAYS	Germline mutations of FH, the gene that encodes for the tricarboxylic acid TCA (TCA) cycle enzyme fumarate hydratase, are associated with an inherited form of cancer referred to as Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC). Individuals with HLRCC are predisposed to the development of highly malignant and lethal renal cell carcinoma (RCC). The mechanisms of tumorigenesis proposed have largely focused on the biochemical consequences of loss of FH enzymatic activity. While loss of the tumor suppressor gene von Hippel Lindau (VHL) is thought to be an initiating event for the majority of RCCs, a role for FH in sporadic renal cancer has not been explored. Here we report that FH mRNA and protein expression are reduced in clear cell renal cancer, the most common histologic variant of kidney cancer. Moreover, we demonstrate that reduced FH leads to the accumulation of hypoxia inducible factor-2 alpha (HIF-2 alpha), a transcription factor known to promote renal carcinogenesis. Finally, we demonstrate that overexpression of FH in renal cancer cells inhibits cellular migration and invasion. These data provide novel insights into the tumor suppressor functions of FH in sporadic kidney cancer.	[Sudarshan, Sunil; Shanmugasundaram, Karthigayan; O'Neill, Christine F.; Parekh, Dipen J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA; [Naylor, Susan L.; Lin, Shu; Sun, Lu-Zhe] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Livi, Carolina B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA; [Livi, Carolina B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Yeh, I-Tien] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA; [Block, Karen] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Sudarshan, Sunil; Shanmugasundaram, Karthigayan; Naylor, Susan L.; Lin, Shu; Livi, Carolina B.; O'Neill, Christine F.; Parekh, Dipen J.; Yeh, I-Tien; Sun, Lu-Zhe; Block, Karen] S Texas Vet Hlth Care Syst, Audie L Murphy Mem Hosp Div, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Sudarshan, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Urol, San Antonio, TX 78229 USA.	sudarshan@uthscsa.edu	Lin, Shu/C-3790-2013; , LuZhe/AAW-4095-2021	Livi, Carolina/0000-0001-8389-2830	Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center (National Institutes of Health ) [P30 CA054174-17]; NIH, AUA Foundation, HEB [K08 CA138774]; CTRC; NIH [U01 CA86402, R01 CA079683, R01 NCI CA131272]; Veterans Administration [CDA-2]; NATIONAL CANCER INSTITUTE [R01CA079683, R01CA131272, K08CA138774, U01CA086402, P30CA054174] Funding Source: NIH RePORTER	Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center (National Institutes of Health )(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, AUA Foundation, HEB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTRC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Cancer Therapy and Research Center (CTRC) at the University of Texas Health Science Center (National Institutes of Health P30 CA054174-17). SS is supported by NIH K08 CA138774, Voelcker Fund Young Investigator Award, AUA Foundation/Astellas Rising Star Award, and a special gift from Mr. Charles Butt and the employees of HEB. SLN is supported by the CTRC and NIH U01 CA86402. LZS is supported by NIH R01 CA079683. KB is supported by Veterans Administration Career Development Award (CDA-2) and NIH R01 NCI CA131272. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astuti D, 2001, AM J HUM GENET, V69, P49, DOI 10.1086/321282; Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Block K, 2010, AM J PATHOL, V176, P2447, DOI 10.2353/ajpath.2010.090606; Bratslavsky G, 2007, CLIN CANCER RES, V13, P4667, DOI 10.1158/1078-0432.CCR-06-2510; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chen YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007033; Chen Z, 2010, ONCOGENE, V29, P4362, DOI 10.1038/onc.2010.193; Cho DC, 2010, CLIN CANCER RES, V16, P3628, DOI 10.1158/1078-0432.CCR-09-3022; Costa B, 2010, FASEB J, V24, P2680, DOI 10.1096/fj.09-146928; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; Dulaimi E, 2004, CLIN CANCER RES, V10, P3972, DOI 10.1158/1078-0432.CCR-04-0175; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; GNARRA JR, 1994, NAT GENET, V7, P85, DOI 10.1038/ng0594-85; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; Grubb RL, 2007, J UROLOGY, V177, P2074, DOI 10.1016/j.juro.2007.01.155; Hughes MD, 2007, CANCER CELL INT, V7, DOI 10.1186/1475-2867-7-13; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JANEWAY KA, 2010, P NATL ACAD SCI US; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Launonen V, 2001, P NATL ACAD SCI USA, V98, P3387, DOI 10.1073/pnas.051633798; Lehtonen HJ, 2007, HUM PATHOL, V38, P793, DOI 10.1016/j.humpath.2006.10.011; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Morris MR, 2004, J CLIN PATHOL, V57, P706, DOI 10.1136/jcp.2003.011767; Niemann S, 2000, NAT GENET, V26, P268, DOI 10.1038/81551; O'Flaherty L, 2010, HUM MOL GENET, V19, P3844, DOI 10.1093/hmg/ddq305; Petrella BL, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-66; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Sudarshan S, 2009, MOL CELL BIOL, V29, P4080, DOI 10.1128/MCB.00483-09; Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849; Toschi A, 2008, J BIOL CHEM, V283, P34495, DOI 10.1074/jbc.C800170200; Wang RW, 2006, CELL SIGNAL, V18, P1722, DOI 10.1016/j.cellsig.2006.01.020; Wiesener MS, 2001, CANCER RES, V61, P5215; Yogev O, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000328; Zhang Ning, 2006, Zhonghua Yi Xue Za Zhi, V86, P1526	42	38	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21037	10.1371/journal.pone.0021037	http://dx.doi.org/10.1371/journal.pone.0021037			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695080	gold, Green Published, Green Submitted			2022-12-25	WOS:000291682300024
J	Hsieh, CH; Liu, CY; Hsieh, YJ; Tai, HC; Wang, LY; Tsai, TH; Chen, YJ				Hsieh, Chen-Hsi; Liu, Chia-Yuan; Hsieh, Yen-Ju; Tai, Hung-Chi; Wang, Li-Ying; Tsai, Tung-Hu; Chen, Yu-Jen			Matrix Metalloproteinase-8 Mediates the Unfavorable Systemic Impact of Local Irradiation on Pharmacokinetics of Anti-Cancer Drug 5-Fluorouracil	PLOS ONE			English	Article							ALPHA-PARTICLES; ADJUVANT CHEMOTHERAPY; RADIATION-THERAPY; CERVICAL-CANCER; HUMAN-CELLS; IN-VITRO; RADIOTHERAPY; LIVER; COLLAGENASE; EXPRESSION	Concurrent chemoradiation with 5-fluorouracil (5-FU) is widely accepted for cancer treatment. However, the interactions between radiation and 5-FU remain unclear. Here, we evaluated the influence of local irradiation on the pharmacokinetics of 5-FU in rats. The single-fraction radiation was delivered to the whole pelvic fields of Sprague-Dawley rats after computerized tomography-based planning. 5-FU at 100 mg/kg was prescribed 24 hours after radiation. A high-performance liquid chromatography system was used to measure 5-FU in the blood. Matrix metalloproteinase-8 (MMP-8) inhibitor I was administered to examine whether or not RT modulation of 5-FU pharmacokinetic parameters could be blocked. Compared with sham-irradiated controls, whole pelvic irradiation reduced the area under the concentration versus time curve (AUC) of 5-FU in plasma and, in contrast, increased in bile with a radiation dose-dependent manner. Based on protein array analysis, the amount of plasma MMP-8 was increased by whole pelvic irradiation (2.8-fold by 0.5 Gy and 5.3-fold by 2 Gy) in comparison with controls. Pretreatment with MMP-8 inhibitor reversed the effect of irradiation on AUC of 5-FU in plasma. Our findings first indicate that local irradiation modulate the systemic pharmacokinetics of 5-FU through stimulating the release of MMP-8. The pharmacokinetics of 5-FU during concurrent chemoradiaiton therapy should be rechecked and the optimal 5-FU dose should be reevaluated, and adjusted if necessary, during CCRT.	[Hsieh, Chen-Hsi; Liu, Chia-Yuan; Hsieh, Yen-Ju; Tsai, Tung-Hu; Chen, Yu-Jen] Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan; [Hsieh, Chen-Hsi] Far Eastern Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Tai, Hung-Chi; Chen, Yu-Jen] Mackay Mem Hosp, Dept Radiat Oncol, Taipei, Taiwan; [Liu, Chia-Yuan] Mackay Mem Hosp, Dept Gastrointestinal Div, Taipei, Taiwan; [Chen, Yu-Jen] Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan; [Tsai, Tung-Hu] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Wang, Li-Ying] Natl Taiwan Univ, Coll Med, Sch Phys Therapy, Taipei 10764, Taiwan; [Wang, Li-Ying] Natl Taiwan Univ, Coll Med, Grad Inst Phys Therapy, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; Far Eastern Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Mackay Memorial Hospital; Taipei City Hospital; National Taiwan University; National Taiwan University	Hsieh, CH (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Tradit Med, Taipei 112, Taiwan.	thtsai@ym.edu.tw; chenmdphd@gmail.com	Tsai, Tung-Hu/AAG-4558-2021	Tsai, Tung-Hu/0000-0002-9007-2547; WANG, LI-YING/0000-0003-3075-6872				AMBRE JJ, 1971, J LAB CLIN MED, V78, P343; Balbin M, 1998, J BIOL CHEM, V273, P23959, DOI 10.1074/jbc.273.37.23959; Bocci G, 2000, CLIN CANCER RES, V6, P3032; Casale F, 2004, PHARMACOL RES, V50, P173, DOI 10.1016/j.phrs.2004.01.006; Chou CH, 2007, CLIN CANCER RES, V13, P851, DOI 10.1158/1078-0432.CCR-06-2459; Di Paolo A, 2008, CLIN CANCER RES, V14, P2749, DOI 10.1158/1078-0432.CCR-07-1529; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Elsasser T, 2007, RADIAT RES, V167, P319, DOI 10.1667/RR0467.1; FISHER B, 1988, JNCI-J NATL CANCER I, V80, P21, DOI 10.1093/jnci/80.1.21; Fisher GJ, 2001, J INVEST DERMATOL, V117, P219, DOI 10.1046/j.0022-202x.2001.01432.x; FU KK, 1991, HEMATOL ONCOL CLIN N, V5, P737, DOI 10.1016/S0889-8588(18)30413-1; Gamelin E, 1999, CRIT REV ONCOL HEMAT, V30, P71, DOI 10.1016/S1040-8428(98)00036-5; Garnett CT, 2004, CANCER RES, V64, P7985, DOI 10.1158/0008-5472.CAN-04-1525; Gusella M, 2005, THER DRUG MONIT, V27, P816, DOI 10.1097/01.ftd.0000183384.89275.f4; HERSKOVIC A, 1992, NEW ENGL J MED, V326, P1593, DOI 10.1056/NEJM199206113262403; Hsieh CH, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-29; Hsieh CH, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-62; HULIN A, THERAPIE, V65, P151; Iyer R, 2000, CANCER RES, V60, P1290; Jarugula VR, 1997, J PHARM SCI, V86, P756, DOI 10.1021/js960451a; Kaminski JM, 2005, CANCER TREAT REV, V31, P159, DOI 10.1016/j.ctrv.2005.03.004; Lehnert BE, 1997, CANCER RES, V57, P2164; LU ZH, 1993, CANCER RES, V53, P5433; Macdonald JS, 2001, NEW ENGL J MED, V345, P725, DOI 10.1056/NEJMoa010187; Madan M, 2007, ATHEROSCLEROSIS, V190, P62, DOI 10.1016/j.atherosclerosis.2006.02.026; Milano G, 1999, BRIT J CANCER, V79, P627, DOI 10.1038/sj.bjc.6690098; MITA AC, CLIN CANC RES, V16, P3044; Morgan WF, 2003, RADIAT RES, V159, P567, DOI 10.1667/0033-7587(2003)159[0567:NADEOE]2.0.CO;2; Moriconi F, 2008, RADIAT RES, V169, P162, DOI 10.1667/RR1006.1; MORROW CJ, CANC RES, V70, P5931; Mothersill C, 2004, NAT REV CANCER, V4, P158, DOI 10.1038/nrc1277; Narayanan PK, 1999, RADIAT RES, V152, P57, DOI 10.2307/3580049; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Peters G. J., 1995, OXFORD TXB ONCOLOGY, V1, P524; Shao C, 2003, CANCER RES, V63, P8437; Shueng PW, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-71; Swystun V, 2005, AM J PHYSIOL-LUNG C, V288, pL820, DOI 10.1152/ajplung.00396.2004; Tai HC, 2009, ACTA OTO-LARYNGOL, V129, P311, DOI 10.1080/00016480802163366; Teitz-Tennenbaum S, 2003, CANCER RES, V63, P8466; THRIFT RN, 1986, J LIPID RES, V27, P236; VRIESENDORP HM, 1984, RESPONSE TOTAL BODY; Zhou HN, 2005, P NATL ACAD SCI USA, V102, P14641, DOI 10.1073/pnas.0505473102	43	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e21000	10.1371/journal.pone.0021000	http://dx.doi.org/10.1371/journal.pone.0021000			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695264	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900044
J	Ren, P; Zhang, HP; Qiu, F; Liu, YQ; Gu, HY; O'Dowd, DK; Zhou, QY; Hu, WP				Ren, Ping; Zhang, Huiping; Qiu, Fang; Liu, Yu-Qiang; Gu, Huaiyu; O'Dowd, Diane K.; Zhou, Qun-Yong; Hu, Wang-Ping			Prokineticin 2 Regulates the Electrical Activity of Rat Suprachiasmatic Nuclei Neurons	PLOS ONE			English	Article							PROTEIN-KINASE-C; INHIBITORY SYNAPTIC-TRANSMISSION; MAMMALIAN CIRCADIAN CLOCK; IN-VITRO; MICE LACKING; GABA; EXCITABILITY; MODULATION; EXPRESSION; RECEPTORS	Neuropeptide signaling plays roles in coordinating cellular activities and maintaining robust oscillations within the mammalian suprachiasmatic nucleus (SCN). Prokineticin2 (PK2) is a signaling molecule from the SCN and involves in the generation of circadian locomotor activity. Prokineticin receptor 2 (PKR2), a receptor for PK2, has been shown to be expressed in the SCN. However, very little is known about the cellular action of PK2 within the SCN. In the present study, we investigated the effect of PK2 on spontaneous firing and miniature inhibitory postsynaptic currents (mIPSCs) using whole cell patch-clamp recording in the SCN slices. PK2 dose-dependently increased spontaneous firing rates in most neurons from the dorsal SCN. PK2 acted postsynaptically to reduce c-aminobutyric acid (GABA)-ergic function within the SCN, and PK2 reduced the amplitude but not frequency of mIPSCs. Furthermore, PK2 also suppressed exogenous GABA-induced currents. And the inhibitory effect of PK2 required PKC activation in the postsynaptic cells. Our data suggest that PK2 could alter cellular activities within the SCN and may influence behavioral and physiological rhythms.	[Ren, Ping; Qiu, Fang; Liu, Yu-Qiang; Hu, Wang-Ping] Xianning Coll, Dept Pharmacol, Xianning, Hubei, Peoples R China; [Zhang, Huiping] Huazhong Univ Sci & Technol, Family Planning Res Inst, Tongji Med Coll, Wuhan 430074, Peoples R China; [Gu, Huaiyu; O'Dowd, Diane K.] Univ Calif Irvine, Dept Anat, Irvine, CA USA; [Gu, Huaiyu; O'Dowd, Diane K.] Univ Calif Irvine, Dept Neurobiol Dev & Cell Biol, Irvine, CA USA; [Zhou, Qun-Yong] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA	Huazhong University of Science & Technology; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Ren, P (corresponding author), Xianning Coll, Dept Pharmacol, Xianning, Hubei, Peoples R China.	wangping_hu@yahoo.com	Zhang, Hui/HHN-8494-2022; Hu, Wang-Ping/AAS-9314-2021	Liu, Yuqiang/0000-0002-0350-3071	National Natural Science Foundation of China [30970944]; Chinese Ministry of Education [210142]; Natural Science Foundation of Hubei Province of China [2009CDB125]; Team of Outstanding Young Scientific and Technological Innovation of the Higher Education Institutions of Hubei Province [T201113]; Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027501, R56NS027501] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Natural Science Foundation of Hubei Province of China(Natural Science Foundation of Hubei Province); Team of Outstanding Young Scientific and Technological Innovation of the Higher Education Institutions of Hubei Province; Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Natural Science Foundation of China (No. 30970944) to WPH, Key Project of Chinese Ministry of Education (210142) to WPH, Natural Science Foundation of Hubei Province of China (No. 2009CDB125) to WPH, Team of Outstanding Young Scientific and Technological Innovation of the Higher Education Institutions of Hubei Province (T201113) to WPH, and Scientific Research Staring Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China to WPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Belle MDC, 2009, SCIENCE, V326, P281, DOI 10.1126/science.1169657; Brown TM, 2008, NEUROSCIENCE, V154, P839, DOI 10.1016/j.neuroscience.2008.03.068; Brown TM, 2008, NEUROSCI LETT, V448, P273, DOI 10.1016/j.neulet.2008.10.058; Brown TM, 2007, PROG NEUROBIOL, V82, P229, DOI 10.1016/j.pneurobio.2007.05.002; Brunig I, 2001, EUR J NEUROSCI, V13, P1320, DOI 10.1046/j.0953-816x.2001.01506.x; Chapell R, 1998, J BIOL CHEM, V273, P32595, DOI 10.1074/jbc.273.49.32595; Cheng MY, 2006, J COMP NEUROL, V498, P796, DOI 10.1002/cne.21087; Cheng MY, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-17; Cheng MY, 2002, NATURE, V417, P405, DOI 10.1038/417405a; Connolly CN, 1999, J BIOL CHEM, V274, P36565, DOI 10.1074/jbc.274.51.36565; Cottrell GT, 2004, J NEUROSCI, V24, P2375, DOI 10.1523/JNEUROSCI.5187-03.2004; De Jeu M, 2002, J NEUROPHYSIOL, V87, P834, DOI 10.1152/jn.00241.2001; Fatehi M, 2008, NEUROPSYCHOPHARMACOL, V33, P1354, DOI 10.1038/sj.npp.1301523; Filippova N, 2000, MOL PHARMACOL, V57, P847; Gillette MA, 1996, J NEUROPHYSIOL, V76, P3070, DOI 10.1152/jn.1996.76.5.3070; Gribkoff VK, 1999, J BIOL RHYTHM, V14, P126, DOI 10.1177/074873099129000515; Henneberger C, 2002, J NEUROPHYSIOL, V88, P595, DOI 10.1152/jn.2002.88.2.595; Hu WP, 2007, SLEEP, V30, P247; Hu WP, 2006, MOL PAIN, V2, DOI 10.1186/1744-8069-2-35; Huang CS, 1997, NEUROPHARMACOLOGY, V36, P1631, DOI 10.1016/S0028-3908(97)00172-X; Ingves MV, 2010, AM J PHYSIOL-REG I, V298, pR617, DOI 10.1152/ajpregu.00620.2009; INOUYE ST, 1979, P NATL ACAD SCI USA, V76, P5962, DOI 10.1073/pnas.76.11.5962; Inyushkin AN, 2009, J NEUROENDOCRINOL, V21, P705, DOI 10.1111/j.1365-2826.2009.01889.x; Itri J, 2004, J NEUROPHYSIOL, V92, P311, DOI 10.1152/jn.01078.2003; Itri J, 2003, J NEUROPHYSIOL, V90, P1589, DOI 10.1152/jn.00332.2003; Jiang ZG, 1997, J PHYSIOL-LONDON, V499, P141, DOI 10.1113/jphysiol.1997.sp021917; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; KRISHEK BJ, 1994, NEURON, V12, P1081, DOI 10.1016/0896-6273(94)90316-6; Kuhlman SJ, 2006, J BIOL RHYTHM, V21, P470, DOI 10.1177/0748730406294316; Kwak Y, 2008, J BIOL RHYTHM, V23, P150, DOI 10.1177/0748730407313355; Li JD, 2006, J NEUROSCI, V26, P11615, DOI 10.1523/JNEUROSCI.3679-06.2006; Lin DCH, 2002, J BIOL CHEM, V277, P19276, DOI 10.1074/jbc.M202139200; Liu C, 2000, NEURON, V25, P123, DOI 10.1016/S0896-6273(00)80876-4; MASON R, 1991, BRAIN RES, V552, P53, DOI 10.1016/0006-8993(91)90659-J; Masumoto K, 2006, EUR J NEUROSCI, V23, P2959, DOI 10.1111/j.1460-9568.2006.04834.x; Moga MM, 1997, J COMP NEUROL, V389, P508, DOI 10.1002/(SICI)1096-9861(19971222)389:3<508::AID-CNE11>3.0.CO;2-H; MOORE RY, 1983, FED PROC, V42, P2783; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Ngan ESW, 2008, INT J BIOCHEM CELL B, V40, P1679, DOI 10.1016/j.biocel.2008.03.010; Nygard M, 2009, NEUROREPORT, V20, P213, DOI 10.1097/WNR.0b013e32831f1ca2; Prosser HM, 2007, P NATL ACAD SCI USA, V104, P648, DOI 10.1073/pnas.0606884104; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Scott FF, 2010, J NEUROENDOCRINOL, V22, P1148, DOI 10.1111/j.1365-2826.2010.02063.x; Silver R, 1996, NATURE, V382, P810, DOI 10.1038/382810a0; Strecker GJ, 1997, J NEUROPHYSIOL, V78, P2217, DOI 10.1152/jn.1997.78.4.2217; Wang YC, 2006, J NEUROPHYSIOL, V96, P109, DOI 10.1152/jn.01369.2005; Xiong YC, 2010, NEUROPHARMACOLOGY, V59, P589, DOI 10.1016/j.neuropharm.2010.08.014; Yamazaki S, 1998, J NEUROSCI, V18, P10709; Yang JJ, 2010, J NEUROPHYSIOL, V103, P1397, DOI 10.1152/jn.00877.2009; Yuill EA, 2007, EUR J NEUROSCI, V25, P425, DOI 10.1111/j.1460-9568.2006.05293.x; Zhang CK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007151; Zhou QY, 2005, FEBS J, V272, P5703, DOI 10.1111/j.1742-4658.2005.04984.x	54	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20263	10.1371/journal.pone.0020263	http://dx.doi.org/10.1371/journal.pone.0020263			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687716	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500013
J	Saraux, C; Viblanc, VA; Hanuise, N; Le Maho, Y; Le Bohec, C				Saraux, Claire; Viblanc, Vincent A.; Hanuise, Nicolas; Le Maho, Yvon; Le Bohec, Celine			Effects of Individual Pre-Fledging Traits and Environmental Conditions on Return Patterns in Juvenile King Penguins	PLOS ONE			English	Article							POPULATION-DYNAMICS; FITNESS CONSEQUENCES; REPRODUCTIVE SUCCESS; 2004 TSUNAMI; SURVIVAL; AGE; CLIMATE; DATE; SIZE; MASS	Despite the importance of early life stages in individuals' life history and population dynamics, very few studies have focused on the constraints to which these juvenile traits are subjected. Based on 10 years of automatic monitoring of over 2500 individuals, we present the first study on the effects of environmental conditions and individual pre-fledging traits on the post-fledging return of non-banded king penguins to their natal colony. Juvenile king penguins returned exclusively within one of the three austral summers following their departure. A key finding is that return rates (range 68-87%) were much higher than previously assumed for this species, importantly meaning that juvenile survival is very close to that of adults. Such high figures suggest little juvenile dispersal, and selection occurring mostly prior to fledging in king penguins. Pre-fledging conditions had a strong quadratic impact on juvenile return rates. As expected, cohorts reared under very unfavourable years (as inferred by the breeding success of the colony) exhibited low return rates but surprisingly, so did those fledged under very favourable conditions. Juvenile sojourns away from the colony were shorter under warm conditions and subsequent return rates higher, suggesting a positive effect of climate warming. The longer the post-fledging trip (1, 2 or 3 years), the earlier in the summer birds returned to their natal colony and the longer they stayed before leaving for the winter journey. The presence of juveniles in the colony was more than twice the duration required for moulting purposes, yet none attempted breeding in the year of their first return. Juvenile presence in the colony may be important for acquiring knowledge on the social and physical colonial environment and may play an important part in the learning process of mating behaviour. Further studies are required to investigate its potential implications on other life-history traits such as recruitment age.	[Saraux, Claire; Viblanc, Vincent A.; Hanuise, Nicolas; Le Maho, Yvon] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France; [Saraux, Claire; Viblanc, Vincent A.; Hanuise, Nicolas; Le Maho, Yvon] CNRS, Unite Mixte Rech 7178, Strasbourg, France; [Saraux, Claire] AgroParisTech ENGREF, Paris, France; [Le Bohec, Celine] Univ Oslo, Dept Biol, Ctr Ecol & Evolutionary Synth, Blindern, Norway	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; AgroParisTech; University of Oslo	Saraux, C (corresponding author), Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Strasbourg, France.	claire.saraux@c-strasbourg.fr	LE BOHEC, CELINE/AAD-3589-2022; saraux, claire/AAX-8709-2020; Viblanc, Vincent Alexandre/A-7455-2014	saraux, claire/0000-0001-5061-4009; Viblanc, Vincent Alexandre/0000-0002-4953-659X; LE BOHEC, Celine/0000-0003-0149-6477	French Polar Institute (Institut Paul-Emile Victor); Fondation Bettencourt-Schueller; Centre National de la Recherche Scientifique; European Commission; Norwegian Research Council	French Polar Institute (Institut Paul-Emile Victor); Fondation Bettencourt-Schueller; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); European Commission(European CommissionEuropean Commission Joint Research Centre); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This work was supported by the French Polar Institute (Institut Paul-Emile Victor), the Fondation Bettencourt-Schueller and the Centre National de la Recherche Scientifique through the program "Zone Atelier des recherches sur l'Environnement Antarctique et Subantarctique." Some authors were also supported by grants from the European Commission (Marie Curie, to C. L. B.) and the Norwegian Research Council through the YGGDRASIL programme (to C. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrat A, 1976, COM NAT FR RECH ANTA, V40, P9, DOI DOI 10.1016/J.ATHEROSCLEROSIS.2014.12.010; Beauplet G, 2007, P R SOC B, V274, P1877, DOI 10.1098/rspb.2007.0454; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Boulinier T, 2008, BIOL LETTERS, V4, P538, DOI 10.1098/rsbl.2008.0291; Boyd IL, 2001, J ANIM ECOL, V70, P747, DOI 10.1046/j.0021-8790.2001.00534.x; Braasch A, 2009, J ORNITHOL, V150, P401, DOI 10.1007/s10336-008-0362-2; Cam E, 2003, J ANIM ECOL, V72, P411, DOI 10.1046/j.1365-2656.2003.00708.x; Charrassin JB, 2001, MAR ECOL PROG SER, V221, P285, DOI 10.3354/meps221285; CLUTTONBROCK TH, 1987, J ANIM ECOL, V56, P53, DOI 10.2307/4799; Corbel H, 2009, ANIM BEHAV, V78, P829, DOI 10.1016/j.anbehav.2009.06.019; Danchin E, 1998, ECOLOGY, V79, P2415, DOI 10.2307/176832; DAVIES N, 1976, ANIM BEHAV, V24, P223; Descamps Sebastien, 2002, Avian Science, V2, P87; DESER C, 1987, J GEOPHYS RES-OCEANS, V92, P14189, DOI 10.1029/JC092iC13p14189; Durant JM, 2009, CLIM RES, V39, P115, DOI 10.3354/cr00798; Fahlman A, 2006, POLAR BIOL, V29, P609, DOI 10.1007/s00300-005-0096-z; Festa-Bianchet M, 1998, AM NAT, V152, P367, DOI 10.1086/286175; Froget G, 1998, POLAR BIOL, V20, P409, DOI 10.1007/s003000050322; Gaston AJ, 1997, IBIS, V139, P673, DOI 10.1111/j.1474-919X.1997.tb04690.x; Gauthier-Clerc M, 2004, P ROY SOC B-BIOL SCI, V271, pS423, DOI 10.1098/rsbl.2004.0201; Gendner JP, 2005, J FIELD ORNITHOL, V76, P138, DOI 10.1648/0273-8570-76.2.138; Gregg WW, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL016889; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Gruebler MU, 2010, J AVIAN BIOL, V41, P282, DOI 10.1111/j.1600-048X.2009.04865.x; HARRELL FE, 2001, REGRESSION MODELING, P335; Harris MP, 2007, IBIS, V149, P472, DOI 10.1111/j.1474-919X.2007.00667.x; HEDGREN S, 1981, ORNIS SCAND, V12, P51, DOI 10.2307/3675904; JARVIS MJF, 1974, J ANIM ECOL, V43, P1, DOI 10.2307/3154; Krishnankutty N, 2006, CURR SCI INDIA, V90, P772; Lack D., 1954, P343; Le Bohec C, 2008, P NATL ACAD SCI USA, V105, P2493, DOI 10.1073/pnas.0712031105; LEMAHO Y, 1993, MAR ECOL PROG SER, V95, P1, DOI 10.3354/meps095001; LINDEN M, 1992, ECOLOGY, V73, P336, DOI 10.2307/1938745; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; MARCHETTI K, 1989, BIOL REV, V64, P51, DOI 10.1111/j.1469-185X.1989.tb00638.x; MARTIN K, 1995, AM ZOOL, V35, P340; MAUCK RA, 1995, ANIM BEHAV, V49, P999, DOI 10.1006/anbe.1995.0129; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Naef-Daenzer B, 2001, J ANIM ECOL, V70, P730, DOI 10.1046/j.0021-8790.2001.00533.x; NEWTON I, LIFETIME REPROD BIRD; Nicolaus M, 2007, POLAR BIOL, V31, P53, DOI 10.1007/s00300-007-0332-9; Nicolaus M, 2008, ARDEA, V96, P286, DOI 10.5253/078.096.0215; Nisbet ICT, 2009, J AVIAN BIOL, V40, P296, DOI 10.1111/j.1600-048X.2008.04563.x; Oli MK, 2004, ECOLOGY, V85, P2446, DOI 10.1890/03-0513; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; Partridge L., 1985, P207; PERRINS CM, 1973, IBIS, V115, P535, DOI 10.1111/j.1474-919X.1973.tb01991.x; Saraux C, 2011, NATURE, V469, P203, DOI 10.1038/nature09630; Satheesh S, 2009, ENVIRON MONIT ASSESS, V156, P131, DOI 10.1007/s10661-008-0469-1; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; Schulte-Hostedde AI, 2005, ECOLOGY, V86, P155, DOI 10.1890/04-0232; Schwagmeyer PL, 2008, ANIM BEHAV, V75, P291, DOI 10.1016/j.anbehav.2007.05.023; SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033; SPEAR L, 1994, J ANIM ECOL, V63, P283, DOI 10.2307/5547; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Stenseth NC, 2005, J ANIM ECOL, V74, P1195, DOI 10.1111/j.1365-2656.2005.01005.x; Stenseth NC, 2002, SCIENCE, V297, P1292, DOI 10.1126/science.1071281; Stonehouse B, 1960, SCI REPT FALKLAND IS, V23, P1; SULLIVAN KA, 1989, J ANIM ECOL, V58, P275, DOI 10.2307/5000; TINBERGEN JM, 1990, J ANIM ECOL, V59, P1113, DOI 10.2307/5035; Van der Jeugd HP, 1998, J ANIM ECOL, V67, P953, DOI 10.1046/j.1365-2656.1998.6760953.x; Viera VM, 2006, POLAR BIOL, V29, P713, DOI 10.1007/s00300-006-0128-3; WEIMERSKIRCH H, 1992, IBIS, V134, P107, DOI 10.1111/j.1474-919X.1992.tb08387.x; Wilson PR, 2001, MAR ECOL PROG SER, V213, P301, DOI 10.3354/meps213301; WUNDERLE JM, 1991, CURR ORNITHOL, V8, P273	65	38	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20407	10.1371/journal.pone.0020407	http://dx.doi.org/10.1371/journal.pone.0020407			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687715	gold, Green Published, Green Submitted			2022-12-25	WOS:000291611500022
J	Solomon, JA; Tarnopolsky, MA; Hamadeh, MJ				Solomon, Jesse A.; Tarnopolsky, Mark A.; Hamadeh, Mazen J.			One Universal Common Endpoint in Mouse Models of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							CU/ZN-SUPEROXIDE-DISMUTASE; DELAYS DISEASE PROGRESSION; MOTOR-NEURON DISEASE; G93A TRANSGENIC MICE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MEMANTINE PROLONGS SURVIVAL; ANIMAL-MODEL; LIFE-SPAN; ALS MICE; EXTENDS SURVIVAL	There is no consensus among research laboratories around the world on the criteria that define endpoint in studies involving rodent models of amyotrophic lateral sclerosis (ALS). Data from 4 nutrition intervention studies using 162 G93A mice, a model of ALS, were analyzed to determine if differences exist between the following endpoint criteria: CS 4 (functional paralysis of both hindlimbs), CS 4+ (CS 4 in addition to the earliest age of body weight loss, body condition deterioration or righting reflex), and CS 5 (CS 4 plus righting reflex >20 s). The age (d; mean +/- SD) at which mice reached endpoint was recorded as the unit of measurement. Mice reached CS 4 at 123.9 +/- 10.3 d, CS 4+ at 126.6 +/- 9.8 d and CS 5 at 127.6 +/- 9.8 d, all significantly different from each other (P<0.001). There was a significant positive correlation between CS 4 and CS 5 (r = 0.95, P<0.001), CS 4 and CS 4+ (r = 0.96, P<0.001), and CS 4+ and CS 5 (r = 0.98, P<0.001), with the Bland-Altman plot showing an acceptable bias between all endpoints. Logrank tests showed that mice reached CS 4 24% and 34% faster than CS 4+ (P = 0.046) and CS 5 (P = 0.006), respectively. Adopting CS 4 as endpoint would spare a mouse an average of 4 days (P<0.001) from further neuromuscular disability and poor quality of life compared to CS 5. Alternatively, CS 5 provides information regarding proprioception and severe motor neuron death, both could be important parameters in establishing the efficacy of specific treatments. Converging ethics and discovery, would adopting CS 4 as endpoint compromise the acquisition of insight about the effects of interventions in animal models of ALS?	[Solomon, Jesse A.; Hamadeh, Mazen J.] York Univ, Sch Kinesiol & Hlth Sci, Fac Hlth, Toronto, ON M3J 2R7, Canada; [Tarnopolsky, Mark A.; Hamadeh, Mazen J.] McMaster Univ, Dept Pediat, Hamilton, ON, Canada; [Tarnopolsky, Mark A.] McMaster Univ, Dept Med, Hamilton, ON, Canada	York University - Canada; McMaster University; McMaster University	Solomon, JA (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Fac Hlth, Toronto, ON M3J 2R7, Canada.	hamadeh@yorku.ca		Hamadeh, Mazen/0000-0002-3511-4345	Natural Sciences and Engineering Research Council of Canada (NSERC); Hamilton Health Sciences Foundation; Faculty of Health - York University	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Hamilton Health Sciences Foundation; Faculty of Health - York University	This study was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC; http://www.nserc-crsng.gc.ca/index_eng.asp), Hamilton Health Sciences Foundation and Faculty of Health - York University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANTE DJ, 2010, AMYOTROPH LATER 0622; Amodio R, 2006, ANN NY ACAD SCI, V1089, P88, DOI 10.1196/annals.1386.026; Andreassen OA, 2000, NEUROREPORT, V11, P2491, DOI 10.1097/00001756-200008030-00029; Andreassen OA, 2001, J NEUROCHEM, V77, P383, DOI 10.1046/j.1471-4159.2001.00188.x; Andreassen OA, 2001, EXP NEUROL, V168, P419, DOI 10.1006/exnr.2001.7633; Azari MF, 2005, EUR J NEUROL, V12, P357, DOI 10.1111/j.1468-1331.2004.00987.x; Azzouz M, 2004, NATURE, V429, P413, DOI 10.1038/nature02544; Barbeito AG, 2010, NEUROBIOL DIS, V37, P574, DOI 10.1016/j.nbd.2009.11.007; Bruce KM, 2004, CHEMOTHERAPY, V50, P138, DOI 10.1159/000077888; Bruestle DA, 2009, NEUROMOL MED, V11, P58, DOI 10.1007/s12017-009-8064-3; Butterfield RJ, 1999, J IMMUNOL, V162, P3096; Canadian Council on Animal Care, 1998, CCAC GUID CHOOS APPR; Caraganis A, 2008, AMYOTROPH LATERAL SC, V9, P354, DOI 10.1080/17482960802103040; Chiba T, 2006, BIOCHEM BIOPH RES CO, V343, P793, DOI 10.1016/j.bbrc.2006.02.184; Choi CI, 2008, J NEUROL SCI, V268, P40, DOI 10.1016/j.jns.2007.10.024; Chritin M, 2006, AMYOTROPH LATERAL SC, V7, P32, DOI 10.1080/14660820510012022; Ciriza J, 2008, RESTOR NEUROL NEUROS, V26, P459; Corti S, 2007, BRAIN, V130, P1289, DOI 10.1093/brain/awm043; Crochemore C, 2009, MUSCLE NERVE, V39, P548, DOI 10.1002/mus.21260; Crow JP, 2005, ANN NEUROL, V58, P258, DOI 10.1002/ana.20552; DALCANTO MC, 1994, AM J PATHOL, V145, P1271; Del Signore SJ, 2009, AMYOTROPH LATERAL SC, V10, P85, DOI 10.1080/17482960802226148; Derave W, 2003, NEUROBIOL DIS, V13, P264, DOI 10.1016/S0969-9961(03)00041-X; Ende N, 2000, LIFE SCI, V67, P53, DOI 10.1016/S0024-3205(00)00602-0; Ermilova IP, 2005, NEUROSCI LETT, V379, P42, DOI 10.1016/j.neulet.2004.12.045; Esposito E, 2000, ANN NEUROL, V48, P686, DOI 10.1002/1531-8249(200010)48:4<686::AID-ANA21>3.0.CO;2-H; Esposito E, 2007, BRAIN RES, V1168, P90, DOI 10.1016/j.brainres.2007.06.095; Ferrante RJ, 2001, J MOL NEUROSCI, V17, P89, DOI 10.1385/JMN:17:1:89; Fischer LR, 2005, NEUROBIOL DIS, V19, P293, DOI 10.1016/j.nbd.2005.01.008; Fleming KK, 2005, J NEUROIMMUNOL, V170, P71, DOI 10.1016/j.jneuroim.2005.08.020; Ghoddoussi F, 2010, J NEUROL SCI, V290, P41, DOI 10.1016/j.jns.2009.11.013; Gifondorwa DJ, 2007, J NEUROSCI, V27, P13173, DOI 10.1523/JNEUROSCI.4057-07.2007; Groeneveld GJ, 2004, BRAIN RES, V1021, P128, DOI 10.1016/j.brainres.2004.06.024; Groeneveld GJ, 2003, NEUROSCI LETT, V352, P175, DOI 10.1016/j.neulet.2003.08.062; Gros-Louis F, 2010, J NEUROCHEM, V113, P1188, DOI 10.1111/j.1471-4159.2010.06683.x; Guo YS, 2009, EXP MOL MED, V41, P140, DOI 10.3858/emm.2009.41.3.017; Gurney ME, 1998, NEUROLOGY, V50, P62, DOI 10.1212/WNL.50.1.62; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Gurney ME, 1996, ANN NEUROL, V39, P147, DOI 10.1002/ana.410390203; Habisch HJ, 2007, EXP NEUROL, V206, P288, DOI 10.1016/j.expneurol.2007.05.007; Haenggeli C, 2007, NEUROBIOL DIS, V26, P146, DOI 10.1016/j.nbd.2006.12.013; Hamadeh MJ, 2006, MUSCLE NERVE, V34, P709, DOI 10.1002/mus.20630; Hamadeh MJ, 2005, MUSCLE NERVE, V31, P214, DOI 10.1002/mus.20255; HIRANO A, 1967, ARCH NEUROL-CHICAGO, V16, P232, DOI 10.1001/archneur.1967.00470210008002; Holzbaur ELF, 2006, NEUROBIOL DIS, V23, P697, DOI 10.1016/j.nbd.2006.05.009; Ito H, 2008, EXP NEUROL, V213, P448, DOI 10.1016/j.expneurol.2008.07.017; Jaarsma D, 1998, ANN NEUROL, V44, P293, DOI 10.1002/ana.410440229; Jiang F, 2000, J NEUROL SCI, V180, P52, DOI 10.1016/S0022-510X(00)00421-4; Joo IS, 2007, J CLIN NEUROL, V3, P181, DOI 10.3988/jcn.2007.3.4.181; Kalmar B, 2008, J NEUROCHEM, V107, P339, DOI 10.1111/j.1471-4159.2008.05595.x; KAWAMURA Y, 1981, J NEUROPATH EXP NEUR, V40, P667, DOI 10.1097/00005072-198111000-00008; Kiaei M, 2005, EXP NEUROL, V191, P331, DOI 10.1016/j.expneurol.2004.10.007; Kieran D, 2004, NAT MED, V10, P402, DOI 10.1038/nm1021; Kim K, 2006, EUR J PHARMACOL, V542, P100, DOI 10.1016/j.ejphar.2006.05.025; Kira Y, 2006, BRAIN RES, V1070, P206, DOI 10.1016/j.brainres.2005.11.052; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Klivenyi P, 1999, NAT MED, V5, P347, DOI 10.1038/6568; Koh SH, 2007, EXP NEUROL, V205, P336, DOI 10.1016/j.expneurol.2007.03.004; Koh SH, 2007, EUR J NEUROSCI, V25, P1923, DOI 10.1111/j.1460-9568.2007.05471.x; Koh SH, 2006, NEUROSCI LETT, V395, P103, DOI 10.1016/j.neulet.2005.10.056; Lee JH, 2009, BIOCHEM BIOPH RES CO, V384, P524, DOI 10.1016/j.bbrc.2009.05.015; Liebetanz D, 2004, EUR J NEUROSCI, V20, P3115, DOI 10.1111/j.1460-9568.2004.03769.x; Mahoney DJ, 2004, MUSCLE NERVE, V29, P656, DOI 10.1002/mus.20004; Martin LJ, 1999, J NEUROPATH EXP NEUR, V58, P459, DOI 10.1097/00005072-199905000-00005; Martinez JA, 2008, NEUROSCIENCE, V157, P908, DOI 10.1016/j.neuroscience.2008.08.073; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; Mattson MP, 2007, NEUROMOL MED, V9, P17, DOI 10.1385/NMM:9:1:17; Moges H, 2009, LASER SURG MED, V41, P52, DOI 10.1002/lsm.20732; Nagano S, 1999, NEUROSCI LETT, V265, P159, DOI 10.1016/S0304-3940(99)00227-X; Nagano S, 2003, EXP NEUROL, V179, P176, DOI 10.1016/S0014-4886(02)00014-6; Neymotin A, 2009, EXP NEUROL, V220, P191, DOI 10.1016/j.expneurol.2009.08.028; Ohnishi S, 2009, BRAIN RES, V1296, P216, DOI 10.1016/j.brainres.2009.08.012; Ohta Y, 2008, J NEUROSCI RES, V86, P3028, DOI 10.1002/jnr.21747; ORRELL RW, 1995, J NEUROL NEUROSUR PS, V59, P266, DOI 10.1136/jnnp.59.3.266; Pamphlett R, 2003, J NEUROL SCI, V216, P95, DOI 10.1016/S0022-510X(03)00216-8; Park JH, 2007, NEUROSCI LETT, V413, P265, DOI 10.1016/j.neulet.2006.11.058; Patel BP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009386; Pedersen WA, 1999, BRAIN RES, V833, P117, DOI 10.1016/S0006-8993(99)01471-7; Petri S, 2006, NEUROBIOL DIS, V22, P40, DOI 10.1016/j.nbd.2005.09.013; Petri S, 2007, J NEUROCHEM, V102, P991, DOI 10.1111/j.1471-4159.2007.04604.x; Petri S, 2006, J NEUROL SCI, V251, P44, DOI 10.1016/j.jns.2006.08.013; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440; Poduslo JF, 2000, ANN NEUROL, V48, P943, DOI 10.1002/1531-8249(200012)48:6<943::AID-ANA18>3.0.CO;2-1; Reinholz MM, 1999, EXP NEUROL, V159, P204, DOI 10.1006/exnr.1999.7142; Rembach A, 2004, J NEUROSCI RES, V77, P573, DOI 10.1002/jnr.20191; Ryu H, 2005, J NEUROCHEM, V93, P1087, DOI 10.1111/j.1471-4159.2005.03077.x; Sasaki S, 2007, ACTA NEUROPATHOL, V114, P633, DOI 10.1007/s00401-007-0299-1; SEEVARATNAM R, 2009, FASEB J, V23; Sekiya M, 2009, BIOL PHARM BULL, V32, P382, DOI 10.1248/bpb.32.382; Shaw PJ, 1999, BMJ-BRIT MED J, V318, P1118, DOI 10.1136/bmj.318.7191.1118; Shimojo Y, 2010, J NEUROSCI RES, V88, P896, DOI 10.1002/jnr.22242; Shoemaker JL, 2007, J NEUROCHEM, V101, P87, DOI 10.1111/j.1471-4159.2006.04346.x; Snow RJ, 2003, NEUROSCIENCE, V119, P661, DOI 10.1016/S0306-4522(03)00212-4; Suchy J, 2010, NEUROMOL MED, V12, P86, DOI 10.1007/s12017-009-8089-7; Sugai F, 2004, EUR J NEUROSCI, V20, P3179, DOI 10.1111/j.1460-9568.2004.03765.x; Suzuki M, 2008, J NEUROL SCI, V268, P140, DOI 10.1016/j.jns.2007.11.020; Tateishi T, 2010, ACTA NEUROPATHOL, V119, P355, DOI 10.1007/s00401-009-0621-1; Teng YD, 2006, NEUROSCI LETT, V397, P155, DOI 10.1016/j.neulet.2005.12.007; Thakker P, 2007, J IMMUNOL, V178, P2589, DOI 10.4049/jimmunol.178.4.2589; Tokuda E, 2008, EXP NEUROL, V213, P122, DOI 10.1016/j.expneurol.2008.05.011; Turner BJ, 2004, J NEUROSCI RES, V78, P193, DOI 10.1002/jnr.20256; Turner BJ, 2003, J NEUROSCI RES, V74, P605, DOI 10.1002/jnr.10796; Turner BJ, 2009, NEUROBIOL DIS, V34, P511, DOI 10.1016/j.nbd.2009.03.005; Van Damme P, 2003, NEUROSCI LETT, V343, P81, DOI 10.1016/S0304-3940(03)00314-8; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4; Vercelli A, 2008, NEUROBIOL DIS, V31, P395, DOI 10.1016/j.nbd.2008.05.016; Waibel S, 2004, J NEUROL, V251, P1080, DOI 10.1007/s00415-004-0481-5; Wang RG, 2005, EUR J NEUROSCI, V22, P2376, DOI 10.1111/j.1460-9568.2005.04431.x; Weishaupt JH, 2006, J PINEAL RES, V41, P313, DOI 10.1111/j.1600-079X.2006.00377.x; West M, 2004, J NEUROCHEM, V91, P133, DOI 10.1111/j.1471-4159.2004.02700.x; Wu AS, 2003, J NEUROCHEM, V85, P142, DOI 10.1046/j.1471-4159.2003.01639.x; Xu ZH, 2006, NEUROCHEM RES, V31, P1263, DOI 10.1007/s11064-006-9166-z; Zhang XJ, 2008, NEUROPHARMACOLOGY, V54, P1112, DOI 10.1016/j.neuropharm.2008.02.020; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	115	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20582	10.1371/journal.pone.0020582	http://dx.doi.org/10.1371/journal.pone.0020582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687686	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500033
J	Hoefling, M; Monti, S; Corni, S; Gottschalk, KE				Hoefling, Martin; Monti, Susanna; Corni, Stefano; Gottschalk, Kay Eberhard			Interaction of beta-Sheet Folds with a Gold Surface	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; HUMAN FIBRONECTIN; SECONDARY STRUCTURE; INTEGRIN BINDING; III DOMAINS; FORCE-FIELD; ADSORPTION; NANOPARTICLES; CONFORMATIONS; FLUORESCENCE	The adsorption of proteins on inorganic surfaces is of fundamental biological importance. Further, biomedical and nanotechnological applications increasingly use interfaces between inorganic material and polypeptides. Yet, the underlying adsorption mechanism of polypeptides on surfaces is not well understood and experimentally difficult to analyze. Therefore, we investigate here the interactions of polypeptides with a gold(111) surface using computational molecular dynamics (MD) simulations with a polarizable gold model in explicit water. Our focus in this paper is the investigation of the interaction of polypeptides with beta-sheet folds. First, we concentrate on a beta-sheet forming model peptide. Second, we investigate the interactions of two domains with high beta-sheet content of the biologically important extracellular matrix protein fibronectin (FN). We find that adsorption occurs in a stepwise mechanism both for the model peptide and the protein. The positively charged amino acid Arg facilitates the initial contact formation between protein and gold surface. Our results suggest that an effective gold-binding surface patch is overall uncharged, but contains Arg for contact initiation. The polypeptides do not unfold on the gold surface within the simulation time. However, for the two FN domains, the relative domain-domain orientation changes. The observation of a very fast and strong adsorption indicates that in a biological matrix, no bare gold surfaces will be present. Hence, the bioactivity of gold surfaces (like bare gold nanoparticles) will critically depend on the history of particle administration and the proteins present during initial contact between gold and biological material. Further, gold particles may act as seeds for protein aggregation. Structural reorganization and protein aggregation are potentially of immunological importance.	[Hoefling, Martin] Max Planck Inst Biophys Chem, Gottingen, Germany; [Monti, Susanna] CNR Ist Chim Composti OrganoMetall ICCOM, Pisa, Italy; [Corni, Stefano] CNR Ist Nanosci, Ctr S3, Modena, Italy; [Gottschalk, Kay Eberhard] Ernst Moritz Arndt Univ Greifswald, ZIK HIKE Ctr Humoral Immune React Cardiovasc Dis, Greifswald, Germany	Max Planck Society; Consiglio Nazionale delle Ricerche (CNR); Isituto di Chimica dei Composti Organometallici (ICCOM-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Ernst Moritz Arndt Universitat Greifswald	Hoefling, M (corresponding author), Max Planck Inst Biophys Chem, Gottingen, Germany.	kay.gottschalk@uni-greifswald.de	Corni, Stefano/A-6198-2012; Gottschalk, Kay/D-6503-2012; Hoefling, Martin/A-7495-2011	Gottschalk, Kay/0000-0002-7951-0972; Corni, Stefano/0000-0001-6707-108X; Monti, Susanna/0000-0002-3419-7118	European Commission [FP6-NEST-028331]; Fonds der Chemischen Industrie; International Doctorate Program NanoBioTechnology (IDK-NBT); German-Israeli Foundation [1000-89.9/2008]; IIT; Unternehmen Regio Initiative of the BMBF [03Z2CN11]	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); International Doctorate Program NanoBioTechnology (IDK-NBT); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); IIT(Istituto Italiano di Tecnologia - IIT); Unternehmen Regio Initiative of the BMBF(Federal Ministry of Education & Research (BMBF))	This work is sponsored by the European Commission Sixth Framework Programme, project Prosurf (FP6-NEST-028331) and by the Fonds der Chemischen Industrie. MH is supported by the International Doctorate Program NanoBioTechnology (IDK-NBT) and German-Israeli Foundation Agreement No 1000-89.9/2008. SC is supported by IIT under the Seed project MOPROSURF MIUR under the FIRB Italnanonet. KEG is supported by Grant 03Z2CN11 of the Unternehmen Regio Initiative of the BMBF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola AP, 2009, BIOMATERIALS, V30, P3766, DOI 10.1016/j.biomaterials.2009.03.031; Altroff H, 2003, J BIOL CHEM, V278, P491, DOI 10.1074/jbc.M209992200; Antia M, 2006, BIOMATERIALS, V27, P679, DOI 10.1016/j.biomaterials.2005.06.014; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baugh L, 2004, J BIOMED MATER RES A, V69A, P525, DOI 10.1002/jbm.a.30026; Cohavi O, 2010, J MOL RECOGNIT, V23, P259, DOI 10.1002/jmr.993; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Di Felice R, 2003, J PHYS CHEM B, V107, P1151, DOI 10.1021/jp0272421; Dolker N, 2010, BIOPHYS J, V98, P2653, DOI 10.1016/j.bpj.2010.02.049; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Gobin AM, 2007, NANO LETT, V7, P1929, DOI 10.1021/nl070610y; Harding JH, 2008, CHEM REV, V108, P4823, DOI 10.1021/cr078278y; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hnilova M, 2008, LANGMUIR, V24, P12440, DOI 10.1021/la801468c; Hoefling M, 2010, CHEMPHYSCHEM, V11, P1763, DOI 10.1002/cphc.200900990; Hoefling M, 2010, LANGMUIR, V26, P8347, DOI 10.1021/la904765u; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Iori F, 2008, J COMPUT CHEM, V29, P1656, DOI 10.1002/jcc.20928; Iori F, 2009, J COMPUT CHEM, V30, P1465, DOI 10.1002/jcc.21165; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kokh DB, 2010, J CHEM THEORY COMPUT, V6, P1753, DOI 10.1021/ct100086j; Krammer A, 2002, MATRIX BIOL, V21, P139, DOI 10.1016/S0945-053X(01)00197-4; Kubiak-Ossowska K, 2010, LANGMUIR, V26, P7690, DOI 10.1021/la101276v; Lacerda SHD, 2010, ACS NANO, V4, P365, DOI 10.1021/nn9011187; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; Leiss M, 2008, CURR OPIN CELL BIOL, V20, P502, DOI 10.1016/j.ceb.2008.06.001; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I., 2006, DETECTING CRYPTIC EP, V2006, DOI [10.1126/stke.3272006pe14, DOI 10.1126/STKE.3272006PE14]; MARDON HJ, 1994, FEBS LETT, V340, P197, DOI 10.1016/0014-5793(94)80137-1; Matthes D, 2009, BIOPHYS J, V97, P599, DOI 10.1016/j.bpj.2009.04.061; Meadows PY, 2005, LANGMUIR, V21, P4096, DOI 10.1021/la047241v; Monti S, 2007, J PHYS CHEM C, V111, P16962, DOI 10.1021/jp075154g; Narmoneva DA, 2005, BIOMATERIALS, V26, P4837, DOI 10.1016/j.biomaterials.2005.01.005; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Notman R, 2009, LANGMUIR, V25, P1638, DOI 10.1021/la803324x; Oren EE, 2010, LANGMUIR, V26, P11003, DOI 10.1021/la100049s; Park J, 2006, BIOPHYS J, V90, P2510, DOI 10.1529/biophysj.105.074906; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peelle BR, 2005, LANGMUIR, V21, P6929, DOI 10.1021/la050261s; Ratner BD, 2004, ANNU REV BIOMED ENG, V6, P41, DOI 10.1146/annurev.bioeng.6.040803.140027; Reichmann D, 2007, CURR OPIN STRUC BIOL, V17, P67, DOI 10.1016/j.sbi.2007.01.004; Rief M, 1998, BIOPHYS J, V75, P3008, DOI 10.1016/S0006-3495(98)77741-0; Sarikaya M, 2003, NAT MATER, V2, P577, DOI 10.1038/nmat964; Shukla R, 2005, LANGMUIR, V21, P10644, DOI 10.1021/la0513712; Snow CD, 2002, NATURE, V420, P102, DOI 10.1038/nature01160; Stumpe MC, 2009, BIOPHYS J, V96, P3744, DOI 10.1016/j.bpj.2009.01.051; Zhdanov VP, 2002, SURF SCI, V496, P251, DOI 10.1016/S0039-6028(01)01604-1	50	52	53	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20925	10.1371/journal.pone.0020925	http://dx.doi.org/10.1371/journal.pone.0020925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687744	Green Published, Green Submitted, gold			2022-12-25	WOS:000291607000030
J	Azari, H; Osborne, GW; Yasuda, T; Golmohammadi, MG; Rahman, M; Deleyrolle, LP; Esfandiari, E; Adams, DJ; Scheffler, B; Steindler, DA; Reynolds, BA				Azari, Hassan; Osborne, Geoffrey W.; Yasuda, Takahiro; Golmohammadi, Mohammad G.; Rahman, Maryam; Deleyrolle, Loic P.; Esfandiari, Ebrahim; Adams, David J.; Scheffler, Bjorn; Steindler, Dennis A.; Reynolds, Brent A.			Purification of Immature Neuronal Cells from Neural Stem Cell Progeny	PLOS ONE			English	Article							SPINAL-CORD-INJURY; RAT MODEL; DIRECTED DIFFERENTIATION; HUNTINGTONS-DISEASE; TUMOR-FORMATION; FETAL-BRAIN; TRANSPLANTATION; PRECURSORS; LINEAGE; GRAFTS	Large-scale proliferation and multi-lineage differentiation capabilities make neural stem cells (NSCs) a promising renewable source of cells for therapeutic applications. However, the practical application for neuronal cell replacement is limited by heterogeneity of NSC progeny, relatively low yield of neurons, predominance of astrocytes, poor survival of donor cells following transplantation and the potential for uncontrolled proliferation of precursor cells. To address these impediments, we have developed a method for the generation of highly enriched immature neurons from murine NSC progeny. Adaptation of the standard differentiation procedure in concert with flow cytometry selection, using scattered light and positive fluorescent light selection based on cell surface antibody binding, provided a near pure (97%) immature neuron population. Using the purified neurons, we screened a panel of growth factors and found that bone morphogenetic protein-4 (BMP-4) demonstrated a strong survival effect on the cells in vitro, and enhanced their functional maturity. This effect was maintained following transplantation into the adult mouse striatum where we observed a 2-fold increase in the survival of the implanted cells and a 3-fold increase in NeuN expression. Additionally, based on the neural-colony forming cell assay (N-CFCA), we noted a 64 fold reduction of the bona fide NSC frequency in neuronal cell population and that implanted donor cells showed no signs of excessive or uncontrolled proliferation. The ability to provide defined neural cell populations from renewable sources such as NSC may find application for cell replacement therapies in the central nervous system.	[Azari, Hassan; Osborne, Geoffrey W.; Yasuda, Takahiro; Golmohammadi, Mohammad G.; Adams, David J.; Reynolds, Brent A.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Azari, Hassan] Shiraz Univ Med Sci, Lab Stem Cell Res, Dept Anat Sci, Shiraz, Iran; [Azari, Hassan; Rahman, Maryam; Deleyrolle, Loic P.; Steindler, Dennis A.; Reynolds, Brent A.] Univ Florida, McKnight Brain Inst, Dept Neurosurg, Gainesville, FL USA; [Yasuda, Takahiro; Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Bundoora, Vic, Australia; [Golmohammadi, Mohammad G.] Ardebil Univ Med Sci, Dept Anat Sci, Ardebil, Iran; [Esfandiari, Ebrahim] Isfahan Univ Med Sci, Dept Anat Sci, Esfahan, Iran; [Scheffler, Bjorn] Univ Bonn, Inst Reconstruct Neurobiol, D-5300 Bonn, Germany	University of Queensland; Shiraz University of Medical Science; State University System of Florida; University of Florida; Royal Melbourne Institute of Technology (RMIT); Ardabil University of Medical Sciences; Isfahan University Medical Science; University of Bonn	Azari, H (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	brent.reynolds@neurosurgery.ufl.edu	golmohammadi, mohammad ghasem/J-9340-2017; Adams, David/J-9125-2014; Scheffler, Björn/AAA-9361-2021; Osborne, Geoffrey/G-4873-2010; Steindler, Dennis/AAJ-5811-2020; Adams, David John/K-3578-2019; Azari, Hassan/V-6092-2017; Esfandiari, Ebrahim/E-7334-2012	golmohammadi, mohammad ghasem/0000-0002-8454-6558; Adams, David/0000-0002-7030-2288; Osborne, Geoffrey/0000-0003-0472-6610; Adams, David John/0000-0002-7030-2288; Azari, Hassan/0000-0002-8021-3166; Esfandiari, Ebrahim/0000-0001-6436-5672; Scheffler, Bjorn/0000-0001-8316-6556	National Health and Medical Research Council (NHMRC) [511091]; Brain and Spinal Cord Injury Research Trust; Overstreet Foundation	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Brain and Spinal Cord Injury Research Trust; Overstreet Foundation	This work was supported from a National Health and Medical Research Council (NHMRC) Project Grant (#511091) to DJA and BAR, a grant from the Brain and Spinal Cord Injury Research Trust Fund to BAR and the Overstreet Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; Alessandri G, 2004, LANCET, V364, P1872, DOI 10.1016/S0140-6736(04)17443-6; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Azari H, 2011, JOVE-J VIS EXP, DOI 10.3791/2457; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Baraban SC, 2009, P NATL ACAD SCI USA, V106, P15472, DOI 10.1073/pnas.0900141106; Baracskay KL, 2007, GLIA, V55, P1001, DOI 10.1002/glia.20519; Belkadi AM, 1997, EXP NEUROL, V144, P369, DOI 10.1006/exnr.1997.6414; Bliss T, 2007, STROKE, V38, P817, DOI 10.1161/01.STR.0000247888.25985.62; Boucherie C, 2009, J NEUROSCI RES, V87, P2034, DOI 10.1002/jnr.22038; Braun SMG, 2010, CELL STEM CELL, V6, P189, DOI 10.1016/j.stem.2010.02.004; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chung S, 2006, J NEUROCHEM, V97, P1467, DOI 10.1111/j.1471-4159.2006.03841.x; Daadi MM, 2010, STROKE, V41, P516, DOI 10.1161/STROKEAHA.109.573691; Donaldson AE, 2005, MOL CELL NEUROSCI, V30, P601, DOI 10.1016/j.mcn.2005.06.010; Foroni C, 2007, CANCER RES, V67, P3725, DOI 10.1158/0008-5472.CAN-06-4577; Freeman TB, 2000, P NATL ACAD SCI USA, V97, P13877, DOI 10.1073/pnas.97.25.13877; Fukuda H, 2006, STEM CELLS, V24, P763, DOI 10.1634/stemcells.2005-0137; Goldman SA, 2006, PHILOS T R SOC B, V361, P1463, DOI 10.1098/rstb.2006.1886; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Haas S, 2005, CURR OPIN NEUROL, V18, P59, DOI 10.1097/00019052-200502000-00012; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Jandial R, 2009, NAT MED, V15, P999, DOI 10.1038/nm0909-999; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Keene CD, 2009, ACTA NEUROPATHOL, V117, P329, DOI 10.1007/s00401-008-0465-0; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lobo MVT, 2003, J HISTOCHEM CYTOCHEM, V51, P89, DOI 10.1177/002215540305100111; Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Morizane A, 2006, J NEUROSCI RES, V83, P1015, DOI 10.1002/jnr.20799; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Mukhida K, 2007, STEM CELLS, V25, P2874, DOI 10.1634/stemcells.2007-0326; Pennartz S, 2004, MOL CELL NEUROSCI, V25, P692, DOI 10.1016/j.mcn.2003.12.011; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; ROZENTAL R, 1995, DEV BRAIN RES, V85, P161, DOI 10.1016/0165-3806(94)00204-D; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Salewski RPF, 2010, J CELL PHYSIOL, V222, P515, DOI 10.1002/jcp.21995; Sanberg PR, 2005, ANN NY ACAD SCI, V1049, P67, DOI 10.1196/annals.1334.008; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Schmandt T, 2005, STEM CELLS DEV, V14, P55, DOI 10.1089/scd.2005.14.55; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Waldau B, 2010, STEM CELLS, V28, P1153, DOI 10.1002/stem.446; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; West MJ, 1999, TRENDS NEUROSCI, V22, P51, DOI 10.1016/S0166-2236(98)01362-9; Xu LY, 2006, TRANSPLANTATION, V82, P865, DOI 10.1097/01.tp.0000235532.00920.7a; Yan J, 2007, PLOS MED, V4, P318, DOI 10.1371/journal.pmed.0040039	50	29	31	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20941	10.1371/journal.pone.0020941	http://dx.doi.org/10.1371/journal.pone.0020941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21687800	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500049
J	van 't Veer, C; van den Pangaart, PS; Kruijswijk, D; Florquin, S; de Vos, AF; van der Poll, T				van 't Veer, Cornelis; van den Pangaart, Petra S.; Kruijswijk, Danielle; Florquin, Sandrine; de Vos, Alex F.; van der Poll, Tom			Delineation of the Role of Toll-like Receptor Signaling during Peritonitis by a Gradually Growing Pathogenic Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE SEPSIS; PEPTIDOGLYCAN-ASSOCIATED LIPOPROTEIN; ACCELERATED BACTERIAL CLEARANCE; IFN-GAMMA PRODUCTION; INTRAABDOMINAL INFECTIONS; CYTOKINE SIGNALING-1; HOST RESPONSE; IN-VIVO; IRAK-M; MICE	In a mouse model of Escherichia coli sepsis characterized by a primary peritoneal infection with 10(4) E. coli and a gradually growing bacterial load, we here show that the early cytokine response and antibacterial defense are dominated by TLR4 via a cooperative action of MyD88 and Trif. Although MyD88(-/-) mice succumbed earlier than WT mice in this E. coli peritonitis model, Trif(-/-) mice displayed a small but significant survival advantage. Despite a large early deficit in antimicrobial defense, TLR4(-/-) mice showed an unaltered survival with normal neutrophil attraction to the peritoneal cavity and normal or even elevated late cytokine release. TLR2 compensated for the lack of TLR4 because TLR2(-/-)/TLR4(-/-) mice did show decreased neutrophil attraction and increased mortality compared with WT mice. Nearly normal early peritoneal TNF alpha production and lack of early counterregulating systemic levels of the chemoattractant KC were associated with normal peritoneal neutrophil attraction in TLR4(-/-) mice. Late stage increased TNF, IL-1 beta, IFN-beta, and typical IFN-gamma production in TLR4(-/-) mice prompted us to evaluate expression of the negative feedback regulator SOCS-1. Lack of early hepatic SOCS-1 expression in TLR4(-/-) mice explained the late innate production of IFN-gamma by the liver in TLR4(-/-) mice in this low dose E. coli peritonitis model. In contrast, early TLR4-induced IFN-gamma production is described as a hallmark in high dose E. coli peritonitis models. The present study displays how the kinetics of pro-and anti-inflammatory mechanisms are regulated by TLRs during peritonitis by a gradually growing E. coli load and how these kinetics may affect outcome.	[van 't Veer, Cornelis] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [van 't Veer, Cornelis; van den Pangaart, Petra S.; Kruijswijk, Danielle; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Ctr Infect & Immun Amsterdam, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; University of Amsterdam	van 't Veer, C (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, G2-131,Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	c.vantveer@amc.uva.nl	Florquin, Sandrine/B-8242-2012	Florquin, Sandrine/0000-0002-9676-1722				Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ami K, 2002, J IMMUNOL, V169, P4437, DOI 10.4049/jimmunol.169.8.4437; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brook I, 2008, DIGEST DIS SCI, V53, P2585, DOI 10.1007/s10620-007-0194-6; Brysha M, 2001, J BIOL CHEM, V276, P22086, DOI 10.1074/jbc.M102737200; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Chong MMW, 2005, BLOOD, V106, P1668, DOI 10.1182/blood-2004-08-3049; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; CROSS A, 1995, J CLIN INVEST, V96, P676, DOI 10.1172/JCI118110; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Hajishengallis G, 2005, INFECT IMMUN, V73, P1343, DOI 10.1128/IAI.73.3.1343-1349.2005; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Haziot A, 2001, J IMMUNOL, V166, P1075, DOI 10.4049/jimmunol.166.2.1075; Hellman J, 2002, J BIOL CHEM, V277, P14274, DOI 10.1074/jbc.M109696200; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirotani T, 2005, BIOCHEM BIOPH RES CO, V328, P383, DOI 10.1016/j.bbrc.2004.12.184; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; HOLZHEIMER RG, 1991, INFECTION, V19, P447, DOI 10.1007/BF01726463; Hong KJ, 2007, INFECT IMMUN, V75, P5338, DOI 10.1128/IAI.00561-07; Hoshino K, 1999, J IMMUNOL, V162, P3749; Knapp S, 2007, J IMMUNOL, V178, P993, DOI 10.4049/jimmunol.178.2.993; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Liang MD, 2005, J INFECT DIS, V191, P939, DOI 10.1086/427815; MCCLEAN KL, 1994, CLIN INFECT DIS, V19, P100, DOI 10.1093/clinids/19.1.100; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Nazareth H, 2007, INFECT IMMUN, V75, P2776, DOI 10.1128/IAI.01095-06; Newman N, 2009, SCAND J INFECT DIS, V41, P720, DOI 10.1080/00365540903159261; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Renckens R, 2006, J IMMUNOL, V177, P1189, DOI 10.4049/jimmunol.177.2.1189; Sewnath ME, 2001, J IMMUNOL, V166, P6323, DOI 10.4049/jimmunol.166.10.6323; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; van Westerloo DJ, 2005, J INFECT DIS, V191, P2138, DOI 10.1086/430323; van 't Veer C, 2007, J IMMUNOL, V179, P7110, DOI 10.4049/jimmunol.179.10.7110; Wang MC, 2009, CLIN MICROBIOL INFEC, V15, P372, DOI 10.1111/j.1469-0691.2009.02708.x; Weijer S, 2003, INFECT IMMUN, V71, P5488, DOI 10.1128/IAI.71.10.5488-5497.2003; Wiersinga WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003494; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Zhao Q, 2006, J EXP MED, V203, P131, DOI 10.1084/jem.20051794	47	17	17	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2011	286	42					36603	36618		10.1074/jbc.M110.189126	http://dx.doi.org/10.1074/jbc.M110.189126			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841UC	21690093	Green Published, hybrid			2022-12-25	WOS:000296538300044
J	Depil, K; Beyl, S; Stary-Weinzinger, A; Hohaus, A; Timin, E; Hering, S				Depil, Katrin; Beyl, Stanislav; Stary-Weinzinger, Anna; Hohaus, Annette; Timin, Eugen; Hering, Steffen			Timothy Mutation Disrupts the Link between Activation and Inactivation in Ca(V)1.2 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNEL; STRUCTURAL DETERMINANTS; MOLECULAR DETERMINANTS; GATING MECHANISMS; BETA-SUBUNIT; PORE DOMAIN; IIS6; EXPRESSION; ALIGNMENT; SEQUENCE	The Timothy syndrome mutations G402S and G406R abolish inactivation of Ca(V)1.2 and cause multiorgan dysfunction and lethal arrhythmias. To gain insights into the consequences of the G402S mutation on structure and function of the channel, we systematically mutated the corresponding Gly-432 of the rabbit channel and applied homology modeling. All mutations of Gly-432 (G432A/M/N/V/W) diminished channel inactivation. Homology modeling revealed that Gly-432 forms part of a highly conserved structure motif (G/A/G/A) of small residues in homologous positions of all four domains (Gly-432 (IS6), Ala-780 (IIS6), Gly-1193 (IIIS6), Ala-1503 (IVS6)). Corresponding mutations in domains II, III, and IV induced, in contrast, parallel shifts of activation and inactivation curves indicating a preserved coupling between both processes. Disruption between coupling of activation and inactivation was specific for mutations of Gly-432 in domain I. Mutations of Gly-432 removed inactivation irrespective of the changes in activation. In all four domains residues G/A/G/A are in close contact with larger bulky amino acids from neighboring S6 helices. These interactions apparently provide adhesion points, thereby tightly sealing the activation gate of Ca(V)1.2 in the closed state. Such a structural hypothesis is supported by changes in activation gating induced by mutations of the G/A/G/A residues. The structural implications for Ca(V)1.2 activation and inactivation gating are discussed.	[Depil, Katrin; Beyl, Stanislav; Stary-Weinzinger, Anna; Hohaus, Annette; Timin, Eugen; Hering, Steffen] Univ Vienna, Dept Pharmacol & Toxicol, A-1090 Vienna, Austria	University of Vienna	Hering, S (corresponding author), Univ Vienna, Dept Pharmacol & Toxicol, Althanstr 14, A-1090 Vienna, Austria.	steffen.hering@univie.ac.at	Stary-Weinzinger, Anna/A-3629-2014	Stary-Weinzinger, Anna/0000-0002-9202-0484	Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund) [P22600, W1232, P19614]; Austrian Science Fund (FWF) [P 22600, P 19614] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The work was supported by Fonds zur Forderung der Wissenschaftlichen Forschung (Austrian Science Fund) Grants P22600 (to S. B.), W1232 (to S. H.), and P19614 (to S. H.).	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Beyl S, 2011, PFLUG ARCH EUR J PHY, V461, P53, DOI 10.1007/s00424-010-0885-2; Bruhova I, 2010, J GEN PHYSIOL, V135, P261, DOI 10.1085/jgp.200910288; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cuello LG, 2010, NATURE, V466, P272, DOI 10.1038/nature09136; ELLIS SB, 1988, SCIENCE, V241, P1661, DOI 10.1126/science.2458626; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Grabner M, 1998, P NATL ACAD SCI USA, V95, P1903, DOI 10.1073/pnas.95.4.1903; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Harmar AJ, 2009, NUCLEIC ACIDS RES, V37, pD680, DOI 10.1093/nar/gkn728; Hering S, 2000, J PHYSIOL-LONDON, V528, P237, DOI 10.1111/j.1469-7793.2000.t01-1-00237.x; Hohaus A, 2005, J BIOL CHEM, V280, P38471, DOI 10.1074/jbc.M507013200; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Irizarry SN, 2002, BIOCHEMISTRY-US, V41, P13653, DOI 10.1021/bi026393r; Kudrnac M, 2009, J BIOL CHEM, V284, P12276, DOI 10.1074/jbc.M808402200; Lipkind GM, 2001, BIOCHEMISTRY-US, V40, P6786, DOI 10.1021/bi010269a; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; Paynter JJ, 2008, CHANNELS, V2, P413, DOI 10.4161/chan.2.6.6874; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Raybaud A, 2006, J BIOL CHEM, V281, P39424, DOI 10.1074/jbc.M607405200; Shafrir Y, 2008, BIOPHYS J, V95, P3650, DOI 10.1529/biophysj.108.135327; Shi CZ, 2002, J BIOL CHEM, V277, P6813, DOI 10.1074/jbc.M110524200; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Stary A, 2008, CHANNELS, V2, P216, DOI 10.4161/chan.2.3.6160; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Stotz SC, 2001, TRENDS NEUROSCI, V24, P176, DOI 10.1016/S0166-2236(00)01738-0; Tikhonov DB, 2011, J BIOL CHEM, V286, P2998, DOI 10.1074/jbc.M110.175406; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Vitko I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003560; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yarotskyy V, 2009, J PHYSIOL-LONDON, V587, P551, DOI 10.1113/jphysiol.2008.161737	36	23	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31557	31564		10.1074/jbc.M111.255273	http://dx.doi.org/10.1074/jbc.M111.255273			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21685391	Green Published, hybrid			2022-12-25	WOS:000294487500050
J	Ranganathan, S; Cao, CZ; Catania, J; Migliorini, M; Zhang, L; Strickland, DK				Ranganathan, Sripriya; Cao, Chunzhang; Catania, Jason; Migliorini, Molly; Zhang, Li; Strickland, Dudley K.			Molecular Basis for the Interaction of Low Density Lipoprotein Receptor-related Protein 1 (LRP1) with Integrin alpha(M)beta(2) IDENTIFICATION OF BINDING SITES WITHIN alpha(M)beta(2) FOR LRP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTROPHIL INHIBITORY FACTOR; LIGAND-BINDING; ALPHA-2-MACROGLOBULIN RECEPTOR; TYROSINE PHOSPHORYLATION; CORECEPTOR FUNCTION; CYTOPLASMIC DOMAIN; CR3 CD11B/CD18; I-DOMAIN; MAC-1; RECOGNITION	The LDL receptor-related protein 1 (LRP1) is a large endocytic receptor that controls macrophage migration in part by interacting with beta(2) integrin receptors. However, the molecular mechanism underlying LRP1 integrin recognition is poorly understood. Here, we report that LRP1 specifically recognizes alpha(M)beta(2) but not its homologous receptor alpha(L)beta(2). The interaction between these two cellular receptors in macrophages is significantly enhanced upon alpha(M)beta(2) activation by LPS and is mediated by multiple regions in both LRP1 and alpha(M)beta(2). Specifically, we find that both the heavy and light chains of LRP1 are involved in alpha(M)beta(2) binding. Within the heavy chain, the binding is mediated primarily via the second and fourth ligand binding repeats. For alpha(M)beta(2), we find that the alpha(M)-I domain represents a major LRP1 recognition site. Indeed, substitution of the I domain of the alpha(L)beta(2) receptor with that of alpha(M) confers the alpha(L)beta(2) receptor with the ability to interact with LRP1. Furthermore, we show that residues (160)EQLKKSKTL(170) within the alpha(M)-I domain represent a major LRP1 recognition site. Given that perturbation of this specific sequence leads to altered adhesive activity of alpha(M)beta(2), our finding suggests that binding of LRP1 to alpha(M)beta(2) could alter integrin function. Indeed, we further demonstrate that the soluble form of LRP1 (sLRP1) inhibits alpha(M)beta(2)-mediated adhesion of cells to fibrinogen. These studies suggest that sLRP1 may attenuate inflammation by modulating integrin function.	[Ranganathan, Sripriya; Cao, Chunzhang; Catania, Jason; Migliorini, Molly; Zhang, Li; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Cao, Chunzhang; Zhang, Li; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Ranganathan, Sripriya; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Zhang, L (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 W Baltimore St,R216, Baltimore, MD 21201 USA.	LiZhang@som.umaryland.edu; dstrickland@som.umaryland.edu			National Institutes of Health [P01 HL054710, HL050784, HL072929]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072929, R01HL050784, P01HL054710, R01HL061589] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL054710 (to D. K. S. and L. Z.) and HL050784 and HL072929 (to D. K. S.).	ANDERSON DC, 1986, J IMMUNOL, V137, P15; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Boucher P, 2002, J BIOL CHEM, V277, P15507, DOI 10.1074/jbc.M200428200; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cao CZ, 2005, BLOOD, V106, P3234, DOI 10.1182/blood-2005-03-1288; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gorovoy M, 2010, J LEUKOCYTE BIOL, V88, P769, DOI 10.1189/jlb.0410220; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; HERZ J, 1990, EMBO J, V9, P1769, DOI 10.1002/j.1460-2075.1990.tb08301.x; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu L, 2006, ARTERIOSCL THROM VAS, V26, P2710, DOI 10.1161/01.ATV.0000249641.96896.e6; Kounnas MZ, 1996, J BIOL CHEM, V271, P6523, DOI 10.1074/jbc.271.11.6523; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; LEE JO, 1995, CELL, V80, P631, DOI 10.1016/0092-8674(95)90517-0; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lillis AP, 2008, J IMMUNOL, V181, P364, DOI 10.4049/jimmunol.181.1.364; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Loukinova E, 2002, J BIOL CHEM, V277, P15499, DOI 10.1074/jbc.M200427200; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; MUCHOWSKI PJ, 1994, J BIOL CHEM, V269, P26419; Newton CS, 2005, J BIOL CHEM, V280, P27872, DOI 10.1074/jbc.M505410200; Overton CD, 2007, CIRC RES, V100, P670, DOI 10.1161/01.RES.0000260204.40510.aa; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Quinn KA, 1997, J BIOL CHEM, V272, P23946, DOI 10.1074/jbc.272.38.23946; Ranganathan S, 2004, J BIOL CHEM, V279, P40536, DOI 10.1074/jbc.M407592200; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Spijkers PPEM, 2005, BLOOD, V105, P170, DOI 10.1182/blood-2004-02-0498; STRICKLAND DK, 1991, J BIOL CHEM, V266, P13364; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; UEDA T, 1994, P NATL ACAD SCI USA, V91, P10680, DOI 10.1073/pnas.91.22.10680; VANSTRIJP JAG, 1993, J IMMUNOL, V151, P3324; Vetvicka V, 1996, J CLIN INVEST, V98, P50, DOI 10.1172/JCI118777; WILLNOW TE, 1994, J BIOL CHEM, V269, P15827; WITTHAUT R, 1994, J LEUKOCYTE BIOL, V55, P105, DOI 10.1002/jlb.55.1.105; Zhang L, 1999, BIOCHEMISTRY-US, V38, P8064, DOI 10.1021/bi990141h; Zhang L, 1996, J BIOL CHEM, V271, P29953, DOI 10.1074/jbc.271.47.29953; Zhang L, 1997, J BIOL CHEM, V272, P17558, DOI 10.1074/jbc.272.28.17558; Zhang L, 1996, J BIOL CHEM, V271, P18211, DOI 10.1074/jbc.271.30.18211; ZHOU LB, 1994, J BIOL CHEM, V269, P17075	44	29	31	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30535	30541		10.1074/jbc.M111.265413	http://dx.doi.org/10.1074/jbc.M111.265413			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21676865	hybrid, Green Published			2022-12-25	WOS:000294283600032
J	Bertero, T; Gastaldi, C; Bourget-Ponzio, I; Imbert, V; Loubat, A; Selva, E; Busca, R; Mari, B; Hofman, P; Barbry, P; Meneguzzi, G; Ponzio, G; Rezzonico, R				Bertero, Thomas; Gastaldi, Cecile; Bourget-Ponzio, Isabelle; Imbert, Veronique; Loubat, Agnes; Selva, Eric; Busca, Roser; Mari, Bernard; Hofman, Paul; Barbry, Pascal; Meneguzzi, Guerrino; Ponzio, Gilles; Rezzonico, Roger			miR-483-3p controls proliferation in wounded epithelial cells	FASEB JOURNAL			English	Article						microRNA; skin; MK2; YAP1	IN-VITRO; EPIDERMAL-KERATINOCYTES; HUMAN FIBROBLASTS; MICRORNAS; EXPRESSION; INHIBITION; IDENTIFICATION; BINDING; TARGET; GENES	The mechanisms that regulate keratinocyte migration and proliferation in wound healing remain largely unraveled, notably regarding possible involvements of microRNAs (miRNAs). Here we disclose upregulation of miR-483-3p in 2 distinct models of wound healing: scratch-injured cultures of human keratinocytes and wounded skin in mice. miR-483-3p accumulation peaks at the final stage of the wound closure process, consistent with a role in the arrest of "healing" progression. Using an in vitro wound-healing model, videomicroscopy, and 5-bromo-2'-uridine incorporation, we observed that overexpression of miR-483-3p inhibits keratinocyte migration and proliferation, whereas delivery of anti-miR-483-3p oligonucleotides sustains keratinocyte proliferation beyond the closure of the wound, compared with irrelevant anti-miR treatment. Expression profiling of keratinocytes transfected with miR-483-3p identified 39 transcripts that were both predicted targets of miR-483-3p and down-regulated after miR-483-3p overexpression. Luciferase reporter assays, Western blot analyses, and silencing by specific siRNAs finally established that kinase MK2, cell proliferation marker MKI67, and transcription factor YAP1 are direct targets of miR-483-3p that control keratinocyte proliferation. miR-483-3p-mediated down-regulation of MK2, MKI67, and YAP1 thus represents a novel mechanism controlling keratinocyte growth arrest at the final steps of reepithelialization.-Bertero, T., Gastaldi, C., Bourget-Ponzio, I., Imbert, V., Loubat, A., Selva, E., Busca, R., Mari, B., Hofman, P., Barbry, P., Meneguzzi, G., Ponzio, G., Rezzonico, R. miR-483-3p controls proliferation in wounded epithelial cells. FASEB J. 25, 3092-3105 (2011). www.fasebj.org	[Bertero, Thomas; Gastaldi, Cecile; Bourget-Ponzio, Isabelle; Loubat, Agnes; Busca, Roser; Meneguzzi, Guerrino; Ponzio, Gilles; Rezzonico, Roger] Fac Med Nice, INSERM, U634, IFR50, F-06107 Nice 02, France; [Bertero, Thomas; Gastaldi, Cecile; Bourget-Ponzio, Isabelle; Imbert, Veronique; Loubat, Agnes; Selva, Eric; Busca, Roser; Mari, Bernard; Hofman, Paul; Barbry, Pascal; Meneguzzi, Guerrino; Ponzio, Gilles; Rezzonico, Roger] Univ Nice Sophia Antipolis, Nice, France; [Imbert, Veronique] Fac Med Nice, INSERM, U895, C3M, F-06034 Nice, France; [Mari, Bernard; Barbry, Pascal] CNRS, Inst Pharmacol Mol & Cellulaire, UMR 6097, F-06560 Valbonne, France; [Selva, Eric; Hofman, Paul] Pasteur Hosp, Fac Med, INSERM,ERI21, Lab Clin & Expt Pathol & Human Biobank,EA4319, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Rezzonico, R (corresponding author), Fac Med Nice, INSERM, U634, IFR50, 28 Ave Valombrose, F-06107 Nice 02, France.	rezzonic@unice.fr	Mari, Bernard P/GVS-3100-2022; REZZONICO, Roger/N-9626-2016; Barbry, Pascal/O-5021-2016; Hofman, Paul/P-7654-2018; Mari, Bernard P/F-8960-2013; Ponzio, Gilles/Q-1256-2016; Mari, Bernard P/D-7445-2015; Mari, Bernard/Q-5832-2019; Imbert, Véronique/I-6093-2016	Mari, Bernard P/0000-0002-0422-9182; REZZONICO, Roger/0000-0002-8460-1641; Barbry, Pascal/0000-0001-9632-6483; Hofman, Paul/0000-0003-0431-9353; Mari, Bernard P/0000-0002-0422-9182; Ponzio, Gilles/0000-0003-2741-0248; Mari, Bernard P/0000-0002-0422-9182; Mari, Bernard/0000-0002-0422-9182; Imbert, Véronique/0000-0003-2103-6718; Meneguzzi, Guerrino/0000-0002-1609-6540; BOURGET, Isabelle/0000-0001-6369-8176; BERTERO, Thomas/0000-0002-4801-9902	Association pour la Recherche sur le Cancer (ARC) [3840]; French Society of Dermatology (SFD) [2005]; EC [FP7/2007-2011, 201279]; INSERM/Provence-Alpes-Cote d'Azur region	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); French Society of Dermatology (SFD); EC(European CommissionEuropean Commission Joint Research Centre); INSERM/Provence-Alpes-Cote d'Azur region(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Provence-Alpes-Cote d'Azur)	The authors thank N. Techer and L. Fantin for skillful technical assistance. This work was supported by the Association pour la Recherche sur le Cancer (ARC; grant 3840), the French Society of Dermatology (SFD; grant 2005) and the EC Seventh Framework Program FP7/2007-2011 under grant 201279. C. G. was recipient of an INSERM/Provence-Alpes-Cote d'Azur region fellowship. The authors declare no conflicts of interest.	Banerjee J, 2011, PHYSIOL GENOMICS, V43, P543, DOI 10.1152/physiolgenomics.00157.2010; Biswas S, 2010, P NATL ACAD SCI USA, V107, P6976, DOI 10.1073/pnas.1001653107; Blakytny Robert, 2000, Journal of Pathology, V190, P589, DOI 10.1002/(SICI)1096-9896(200004)190:5<589::AID-PATH553>3.0.CO;2-T; Brest P, 2011, NAT GENET, V43, P242, DOI 10.1038/ng.762; D'Addario I, 2010, HISTOCHEM CELL BIOL, V134, P265, DOI 10.1007/s00418-010-0728-4; Doghman M, 2010, CANCER RES, V70, P4666, DOI 10.1158/0008-5472.CAN-09-3970; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fitsialos G, 2008, J CELL SCI, V121, P2992, DOI 10.1242/jcs.029256; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Gu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r42; Guled M, 2009, GENE CHROMOSOME CANC, V48, P615, DOI 10.1002/gcc.20669; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Kausch I, 2003, INT J CANCER, V105, P710, DOI 10.1002/ijc.11111; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Le Brigand K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl485; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu AM, 2010, BIOCHEM BIOPH RES CO, V394, P623, DOI 10.1016/j.bbrc.2010.03.036; Loryman C, 2008, WOUND REPAIR REGEN, V16, P45, DOI 10.1111/j.1524-475X.2007.00290.x; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luscher-Firzlaff J, 2008, CANCER RES, V68, P749, DOI 10.1158/0008-5472.CAN-07-3158; Moreilhon C, 2005, PHYSIOL GENOMICS, V20, P244, DOI 10.1152/physiolgenomics.00135.2004; Muller-Decker K, 2005, J INVEST DERMATOL, V124, P553, DOI 10.1111/j.0022-202X.2004.23598.x; Olson P, 2009, GENE DEV, V23, P2152, DOI 10.1101/gad.1820109; Pena JTG, 2009, NAT METHODS, V6, P139, DOI [10.1038/NMETH.1294, 10.1038/nmeth.1294]; Pottier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006718; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; San Miguel SM, 2005, J BIOL CHEM, V280, P37495, DOI 10.1074/jbc.M503861200; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Shilo S, 2007, DNA CELL BIOL, V26, P227, DOI 10.1089/dna.2006.0568; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Sonkoly E, 2010, J INVEST DERMATOL, V130, P124, DOI 10.1038/jid.2009.294; Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262; Thuraisingam T, 2010, J INVEST DERMATOL, V130, P278, DOI 10.1038/jid.2009.209; Turchi L, 2002, J INVEST DERMATOL, V119, P56, DOI 10.1046/j.1523-1747.2002.01805.x; Tzur G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007511; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Veronese A, 2010, CANCER RES, V70, P3140, DOI 10.1158/0008-5472.CAN-09-4456; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001; Zheng JN, 2006, LIFE SCI, V78, P724, DOI 10.1016/j.lfs.2005.05.064; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056; Zibert JR, 2010, J DERMATOL SCI, V58, P177, DOI 10.1016/j.jdermsci.2010.03.004	51	74	78	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2011	25	9					3092	3105		10.1096/fj.10-168401	http://dx.doi.org/10.1096/fj.10-168401			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	814GD	21676945				2022-12-25	WOS:000294435200023
J	Necchi, V; Sommi, P; Vanoli, A; Manca, R; Ricci, V; Solcia, E				Necchi, Vittorio; Sommi, Patrizia; Vanoli, Alessandro; Manca, Rachele; Ricci, Vittorio; Solcia, Enrico			Proteasome Particle-Rich Structures Are Widely Present in Human Epithelial Neoplasms: Correlative Light, Confocal and Electron Microscopy Study	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR RECEPTOR; HELICOBACTER-PYLORI; REGULATED KINASES; RAS MUTATIONS; CAGA PROTEIN; CANCER; CARCINOMA; AUTOPHAGY; BRAF	A novel cytoplasmic structure has been recently characterized by confocal and electron microscopy in H. pylori-infected human gastric epithelium, as an accumulation of barrel-like proteasome reactive particles colocalized with polyubiquitinated proteins, H. pylori toxins and the NOD1 receptor. This proteasome particle-rich cytoplasmic structure (PaCS), a sort of focal proteasome hyperplasia, was also detected in dysplastic cells and was found to be enriched in SHP2 and ERK proteins, known to play a role in H. pylori-mediated gastric carcinogenesis. However, no information is available on its occurrence in neoplastic growths. In this study, surgical specimens of gastric cancer and various other human epithelial neoplasms have been investigated for PaCSs by light, confocal and electron microscopy including correlative confocal and electron microscopy (CCEM). PaCSs were detected in gastric cohesive, pulmonary large cell and bronchioloalveolar, thyroid papillary, parotid gland, hepatocellular, ovarian serous papillary, uterine cervix and colon adenocarcinomas, as well as in pancreatic serous microcystic adenoma. H. pylori bodies, their virulence factors (VacA, CagA, urease, and outer membrane proteins) and the NOD1 bacterial proteoglycan receptor were selectively concentrated inside gastric cancer PaCSs, but not in PaCSs from other neoplasms which did, however, retain proteasome and polyubiquitinated proteins reactivity. No evidence of actual microbial infection was obtained in most PaCS-positive neoplasms, except for H. pylori in gastric cancer and capsulated bacteria in a colon cancer case. Particle lysis and loss of proteasome distinctive immunoreactivities were seen in some tumour cell PaCSs, possibly ending in sequestosomes or autophagic bodies. It is concluded that PaCSs are widely represented in human neoplasms and that both non-infectious and infectious factors activating the ubiquitin-proteasome system are likely to be involved in their origin. PaCS detection might help clarify the role of the ubiquitin-proteasome system in carcinogenesis.	[Necchi, Vittorio; Vanoli, Alessandro; Solcia, Enrico] Univ Pavia, Dept Human Pathol & Genet, I-27100 Pavia, Italy; [Necchi, Vittorio] Univ Pavia, Ctr Grandi Strumenti, I-27100 Pavia, Italy; [Sommi, Patrizia; Manca, Rachele; Solcia, Enrico] Fdn IRCCS Policlin San Matteo, Serv Anat Pathol, Pavia, Italy; [Sommi, Patrizia; Ricci, Vittorio] Univ Pavia, Dept Physiol, I-27100 Pavia, Italy	University of Pavia; University of Pavia; IRCCS Fondazione San Matteo; University of Pavia	Necchi, V (corresponding author), Univ Pavia, Dept Human Pathol & Genet, Via Palestro 3, I-27100 Pavia, Italy.	vricci@unipv.it; solciae@smatteo.pv.it	Vanoli, Alessandro/J-4469-2016	Vanoli, Alessandro/0000-0002-2976-7032	Italian Ministry of Health; University of Pavia	Italian Ministry of Health(Ministry of Health, Italy); University of Pavia	This work was supported by grants from the Italian Ministry of Health to Fondazione IRCCS Policlinico San Matteo (to ES) and from the University of Pavia (to VR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brose MS, 2002, CANCER RES, V62, P6997; Denk H, 2006, J PATHOL, V208, P653, DOI 10.1002/path.1946; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Fiocca R, 1999, J PATHOL, V188, P220, DOI 10.1002/(SICI)1096-9896(199906)188:2<220::AID-PATH307>3.0.CO;2-C; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Handa O, 2007, BIOCHEM PHARMACOL, V73, P1697, DOI 10.1016/j.bcp.2006.10.022; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Ito Y, 1998, HEPATOLOGY, V27, P951, DOI 10.1002/hep.510270409; Keates S, 2007, J INFECT DIS, V196, P95, DOI 10.1086/518440; Kimura ET, 2003, CANCER RES, V63, P1454; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kuboki Y, 2010, MODERN PATHOL, V23, P1127, DOI 10.1038/modpathol.2010.97; Meyer-ter-Vehn T, 2000, J BIOL CHEM, V275, P16064, DOI 10.1074/jbc.M000959200; Necchi V, 2007, GASTROENTEROLOGY, V132, P1009, DOI 10.1053/j.gastro.2007.01.049; Necchi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009716; RIVETT J, 1992, J HISTOCHEM CITOCHEM, V40, P1165; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schmitz KJ, 2007, VIRCHOWS ARCH, V450, P151, DOI 10.1007/s00428-006-0342-y; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Sieben NLG, 2004, J PATHOL, V202, P336, DOI 10.1002/path.1521; Szeto J, 2006, AUTOPHAGY, V2, P189, DOI 10.4161/auto.2731; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131	25	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21317	10.1371/journal.pone.0021317	http://dx.doi.org/10.1371/journal.pone.0021317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695063	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600059
J	Stegen, JC; Hurlbert, AH				Stegen, James C.; Hurlbert, Allen H.			Inferring Ecological Processes from Taxonomic, Phylogenetic and Functional Trait beta-Diversity	PLOS ONE			English	Article							SPECIES RICHNESS; ASSEMBLY RULES; DESERT RODENTS; COMMUNITIES; PATTERNS; NICHE; FOREST; COMPETITION; SIMILARITY; NEUTRALITY	Understanding the influences of dispersal limitation and environmental filtering on the structure of ecological communities is a major challenge in ecology. Insight may be gained by combining phylogenetic, functional and taxonomic data to characterize spatial turnover in community structure (beta-diversity). We develop a framework that allows rigorous inference of the strengths of dispersal limitation and environmental filtering by combining these three types of beta-diversity. Our framework provides model-generated expectations for patterns of taxonomic, phylogenetic and functional b-diversity across biologically relevant combinations of dispersal limitation and environmental filtering. After developing the framework we compared the model-generated expectations to the commonly used "intuitive" expectation that the variance explained by the environment or by space will, respectively, increase monotonically with the strength of environmental filtering or dispersal limitation. The model-generated expectations strongly departed from these intuitive expectations: the variance explained by the environment or by space was often a unimodal function of the strength of environmental filtering or dispersal limitation, respectively. Therefore, although it is commonly done in the literature, one cannot assume that the strength of an underlying process is a monotonic function of explained variance. To infer the strength of underlying processes, one must instead compare explained variances to model-generated expectations. Our framework provides these expectations. We show that by combining the three types of b-diversity with model-generated expectations our framework is able to provide rigorous inferences of the relative and absolute strengths of dispersal limitation and environmental filtering. Phylogenetic, functional and taxonomic b-diversity can therefore be used simultaneously to infer processes by comparing their empirical patterns to the expectations generated by frameworks similar to the one developed here.	[Stegen, James C.; Hurlbert, Allen H.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Stegen, JC (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	stegen@email.unc.edu	Stegen, James/Q-3078-2016	Stegen, James/0000-0001-9135-7424; Hurlbert, Allen/0000-0002-5678-9907	NSF [DBI-0906005]; University of North Carolina	NSF(National Science Foundation (NSF)); University of North Carolina	J.C.S. was supported by an NSF Postdoctoral Fellowship in Bioinformatics (DBI-0906005) and University of North Carolina institutional funds provided via A. H. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; ANDERSON MJ, 2010, ECOLOGY LETT; Bacaro G, 2007, J VEG SCI, V18, P793, DOI 10.1111/j.1654-1103.2007.tb02595.x; Bennett JR, 2010, GLOBAL ECOL BIOGEOGR, V19, P724, DOI 10.1111/j.1466-8238.2010.00548.x; Brown BL, 2010, J ANIM ECOL, V79, P571, DOI 10.1111/j.1365-2656.2010.01668.x; Brown JH, 2000, AM NAT, V156, P314, DOI 10.1086/303385; Brown JH, 2002, AM NAT, V160, P815, DOI 10.1086/343882; Bryant JA, 2008, P NATL ACAD SCI USA, V105, P11505, DOI 10.1073/pnas.0801920105; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chase JM, 2007, P NATL ACAD SCI USA, V104, P17430, DOI 10.1073/pnas.0704350104; Chase JM, 2009, ECOL LETT, V12, P1210, DOI 10.1111/j.1461-0248.2009.01362.x; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Colwell RK, 2010, PHILOS T R SOC B, V365, P3695, DOI 10.1098/rstb.2010.0293; CONNOR EF, 1983, OIKOS, V41, P455, DOI 10.2307/3544105; CONNOR EF, 1979, ECOLOGY, V60, P1132, DOI 10.2307/1936961; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Diamond J.M, 1975, ECOLOGY EVOLUTION CO; DIAMOND JM, 1982, OECOLOGIA, V52, P64, DOI 10.1007/BF00349013; Duivenvoorden JF, 2002, SCIENCE, V295, P636, DOI 10.1126/science.295.5555.636; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Gilbert B, 2004, P NATL ACAD SCI USA, V101, P7651, DOI 10.1073/pnas.0400814101; Gilbert B, 2010, J APPL ECOL, V47, P1071, DOI 10.1111/j.1365-2664.2010.01861.x; Gotelli NJ, 2009, ECOL LETT, V12, P873, DOI 10.1111/j.1461-0248.2009.01353.x; Graham CH, 2008, ECOL LETT, V11, P1265, DOI 10.1111/j.1461-0248.2008.01256.x; Graham CH, 2009, P NATL ACAD SCI USA, V106, P19673, DOI 10.1073/pnas.0901649106; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Grimm V, 2005, SCIENCE, V310, P987, DOI 10.1126/science.1116681; Heino J, 2010, OIKOS, V119, P129, DOI 10.1111/j.1600-0706.2009.17778.x; Hubbell Stephen P., 2001, V32, pi; Izsak C, 2001, MAR ECOL PROG SER, V215, P69, DOI 10.3354/meps215069; KEMBEL SW, 2009, ECOLOGY LET IN PRESS; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kraft NJB, 2007, AM NAT, V170, P271, DOI 10.1086/519400; Kraft NJB, 2010, ECOL MONOGR, V80, P401, DOI 10.1890/09-1672.1; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Legendre P, 2008, J PLANT ECOL, V1, P3, DOI 10.1093/jpe/rtm001; Legendre P, 2009, ECOLOGY, V90, P663, DOI 10.1890/07-1880.1; MAC ARTHUR ROBERT H., 1967; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Rangel TFLVB, 2007, AM NAT, V170, P602, DOI 10.1086/521315; Ricotta C, 2008, PRESLIA, V80, P61; Ricotta C, 2009, ECOL INDIC, V9, P719, DOI 10.1016/j.ecolind.2008.09.003; Rominger AJ, 2009, OECOLOGIA, V161, P791, DOI 10.1007/s00442-009-1420-z; Scheckenbach F, 2010, P NATL ACAD SCI USA, V107, P115, DOI 10.1073/pnas.0908816106; Smith TW, 2010, ECOGRAPHY, V33, P648, DOI 10.1111/j.1600-0587.2009.06105.x; Soininen J, 2007, ECOGRAPHY, V30, P3, DOI 10.1111/j.2006.0906-7590.04817.x; Soininen J, 2009, FUND APPL LIMNOL, V174, P205, DOI 10.1127/1863-9135/2009/0174-0205; Stone L, 2000, AM NAT, V156, P322, DOI 10.1086/303384; Thompson R, 2006, J ANIM ECOL, V75, P476, DOI 10.1111/j.1365-2656.2006.01068.x; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Urban MC, 2004, ECOLOGY, V85, P2971, DOI 10.1890/03-0631; Verberk WCEP, 2010, J ANIM ECOL, V79, P589, DOI 10.1111/j.1365-2656.2010.01660.x; Webb CO, 2000, AM NAT, V156, P145, DOI 10.1086/303378; Weiher E., 1999, ECOLOGICAL ASSEMBLY; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106	58	54	56	5	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20906	10.1371/journal.pone.0020906	http://dx.doi.org/10.1371/journal.pone.0020906			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698111	Green Published, gold			2022-12-25	WOS:000291737600031
J	Manchanda, S; Saikia, B; Gupta, N; Chowdhary, S; Puliyel, JM				Manchanda, Samiksha; Saikia, Bedangshu; Gupta, Neeraj; Chowdhary, Sona; Puliyel, Jacob M.			Sex Ratio at Birth in India, Its Relation to Birth Order, Sex of Previous Children and Use of Indigenous Medicine	PLOS ONE			English	Article							SELECTIVE ABORTIONS; INFANTICIDE; MORTALITY	Objective: Sex-ratio at birth in families with previous girls is worse than those with a boy. Our aim was to prospectively study in a large maternal and child unit sex-ratio against previous birth sex and use of traditional medicines for sex selection. Main Outcome Measures: Sex-ratio among mothers in families with a previous girl and in those with a previous boy, prevalence of indigenous medicine use and sex-ratio in those using medicines for sex selection. Results: Overall there were 806 girls to 1000 boys. The sex-ratio was 720:1000 if there was one previous girl and 178:1000 if there were two previous girls. In second children of families with a previous boy 1017 girls were born per 1000 boys. Sex-ratio in those with one previous girl, who were taking traditional medicines for sex selection, was 928:1000. Conclusion: Evidence from the second children clearly shows the sex-ratio is being manipulated by human interventions. More mothers with previous girls tend to use traditional medicines for sex selection, in their subsequent pregnancies. Those taking such medication do not seem to be helped according to expectations. They seem to rely on this method and so are less likely use more definitive methods like sex selective abortions. This is the first such prospective investigation of sex ratio in second children looked at against the sex of previous children. More studies are needed to confirm the findings.	[Manchanda, Samiksha; Saikia, Bedangshu; Gupta, Neeraj; Chowdhary, Sona; Puliyel, Jacob M.] St Stephen Hosp, Dept Neonatol & Pediat, Delhi, India	St. Stephen's Hospital	Manchanda, S (corresponding author), St Stephen Hosp, Dept Neonatol & Pediat, Delhi, India.	manchandasami@yahoo.com						Bandyopadhyay S, 2007, IND J COMMUN MED, V32, P32; Biggar RJ, 1999, AM J EPIDEMIOL, V150, P957; Census of India, 2001, PROV POP TOT; Chatterjee M, 1990, REPORT INDIAN WOMEN; GANGADHARAN S, 1991, EC TIMES        0418; GEORGE S, 1998, SEARCH B, V12, P18; GEORGE S, 1997, FEMALE INFANTICIDE T; George SM, 2002, REPROD HEALTH MATTER, V10, P190, DOI 10.1016/S0968-8080(02)00034-4; GHOSH S, 1987, B NUTR FDN INDIA, V8, P4; Grover A, 2006, LANCET, V367, P1726, DOI 10.1016/S0140-6736(06)68760-6; GUPTA MD, 1997, POPULATION STUDIES, V51, P307; HESKETH T, 2006, ABNORMAL SEX RATIO H; Jha P, 2006, LANCET, V367, P211, DOI 10.1016/S0140-6736(06)67930-0; Khanna R, 2003, BRIT MED J, V327, P126, DOI 10.1136/bmj.327.7407.126; LEIDL P, 2005, SILENT SPRINGS TRAGE; Levy N, 2007, SOUTH MED J, V100, P107, DOI 10.1097/SMJ.0b013e31802e6138; Sahni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002224; Sen A, 2003, BMJ-BRIT MED J, V327, P1297, DOI 10.1136/bmj.327.7427.1297; Sen Amartya, 2001, FRONTLINE, V18, P4; Sudha S, 1999, DEV CHANGE, V30, P585, DOI 10.1111/1467-7660.00130; VISARIA P, 1991, EC TIMES        0418; ZENG Y, 1993, POPUL DEV REV, V19, P283	22	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20097	10.1371/journal.pone.0020097	http://dx.doi.org/10.1371/journal.pone.0020097			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21697990	gold, Green Published			2022-12-25	WOS:000291730000008
J	Caniato, FF; Guimaraes, CT; Hamblin, M; Billot, C; Rami, JF; Hufnagel, B; Kochian, LV; Liu, JP; Garcia, AAF; Hash, CT; Ramu, P; Mitchell, S; Kresovich, S; Oliveira, AC; de Avellar, G; Borem, A; Glaszmann, JC; Schaffert, RE; Magalhaes, JV				Caniato, Fernanda F.; Guimaraes, Claudia T.; Hamblin, Martha; Billot, Claire; Rami, Jean-Francois; Hufnagel, Barbara; Kochian, Leon V.; Liu, Jiping; Garcia, Antonio Augusto F.; Hash, C. Tom; Ramu, Punna; Mitchell, Sharon; Kresovich, Stephen; Oliveira, Antonio Carlos; de Avellar, Gisela; Borem, Aluizio; Glaszmann, Jean-Christophe; Schaffert, Robert E.; Magalhaes, Jurandir V.			The Relationship between Population Structure and Aluminum Tolerance in Cultivated Sorghum	PLOS ONE			English	Article							REGULATES MULTIPLE GENES; ABC TRANSPORTER; ACID SOILS; MALATE TRANSPORTERS; ACTIVATED CITRATE; ARABIDOPSIS; DIVERSITY; RESISTANCE; EVOLUTION; ENCODES	Background: Acid soils comprise up to 50% of the world's arable lands and in these areas aluminum (Al) toxicity impairs root growth, strongly limiting crop yield. Food security is thereby compromised in many developing countries located in tropical and subtropical regions worldwide. In sorghum, SbMATE, an Al-activated citrate transporter, underlies the Alt(SB) locus on chromosome 3 and confers Al tolerance via Al-activated root citrate release. Methodology: Population structure was studied in 254 sorghum accessions representative of the diversity present in cultivated sorghums. Al tolerance was assessed as the degree of root growth inhibition in nutrient solution containing Al. A genetic analysis based on markers flanking Alt(SB) and SbMATE expression was undertaken to assess a possible role for Alt(SB) in Al tolerant accessions. In addition, the mode of gene action was estimated concerning the Al tolerance trait. Comparisons between models that include population structure were applied to assess the importance of each subpopulation to Al tolerance. Conclusion/Significance: Six subpopulations were revealed featuring specific racial and geographic origins. Al tolerance was found to be rather rare and present primarily in guinea and to lesser extent in caudatum subpopulations. Alt(SB) was found to play a role in Al tolerance in most of the Al tolerant accessions. A striking variation was observed in the mode of gene action for the Al tolerance trait, which ranged from almost complete recessivity to near complete dominance, with a higher frequency of partially recessive sources of Al tolerance. A possible interpretation of our results concerning the origin and evolution of Al tolerance in cultivated sorghum is discussed. This study demonstrates the importance of deeply exploring the crop diversity reservoir both for a comprehensive view of the dynamics underlying the distribution and function of Al tolerance genes and to design efficient molecular breeding strategies aimed at enhancing Al tolerance.	[Caniato, Fernanda F.; Guimaraes, Claudia T.; Hufnagel, Barbara; Oliveira, Antonio Carlos; de Avellar, Gisela; Schaffert, Robert E.; Magalhaes, Jurandir V.] Embrapa Maize & Sorghum, Sete Lagoas, MG, Brazil; [Hamblin, Martha; Mitchell, Sharon; Kresovich, Stephen] Cornell Univ, Inst Genom Divers, Ithaca, NY USA; [Billot, Claire; Rami, Jean-Francois; Glaszmann, Jean-Christophe] Ctr Cooperat Int Rech Agron Dev CIRAD, UMR Ameliorat Genet & Adaptat Plantes Mediterrane, Montpellier, France; [Hufnagel, Barbara] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Kochian, Leon V.; Liu, Jiping] Cornell Univ, USDA ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Garcia, Antonio Augusto F.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Piracicaba, Brazil; [Hash, C. Tom; Ramu, Punna] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Borem, Aluizio] Univ Fed Vicosa, Vicosa, MG, Brazil	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cornell University; CIRAD; Universidade Federal de Minas Gerais; Cornell University; United States Department of Agriculture (USDA); Universidade de Sao Paulo; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Universidade Federal de Vicosa	Caniato, FF (corresponding author), Embrapa Maize & Sorghum, Sete Lagoas, MG, Brazil.	jurandir@cnpms.embrapa.br	Hufnagel, Barbara/H-4815-2015; Magalhaes, Jurandir/AAH-4349-2020; Hufnagel, Bárbara/AAI-6635-2021; Kochian, Leon/ABH-6148-2020; Garcia, Antonio A F/A-4538-2010; Hufnagel, Barbara/O-3746-2019	Hufnagel, Barbara/0000-0002-3515-2122; Magalhaes, Jurandir/0000-0002-6673-6497; Kochian, Leon/0000-0003-3416-089X; Garcia, Antonio A F/0000-0003-0634-3277; Hufnagel, Barbara/0000-0002-3515-2122; LIU, JIPING/0000-0002-7558-0025	CGIAR [G3007.04]; McKnight Foundation; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); National Council for Scientific and Technological Development (CNPq)	CGIAR(CGIAR); McKnight Foundation; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to acknowledge funding from the CGIAR Generation Challenge Program (project G3007.04) and the McKnight Foundation Collaborative Crop Research Program. The authors are also thankful to the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) for a PhD and a post-doctoral fellowship granted to FFC and to The National Council for Scientific and Technological Development (CNPq) for support to JVM and CTG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourguet D, 1997, GENETICS, V147, P1225; Bourguet D, 1999, HEREDITY, V83, P1, DOI 10.1038/sj.hdy.6885600; Bourguet D, 1996, GENETICS, V143, P407; Camus-Kulandaivelu L, 2006, GENETICS, V172, P2449, DOI 10.1534/genetics.105.048603; Caniato FF, 2007, THEOR APPL GENET, V114, P863, DOI 10.1007/s00122-006-0485-x; Collins NC, 2008, GENETICS, V179, P669, DOI 10.1534/genetics.107.083451; Dahlberg J., 2000, SORGHUM ORIGIN HIST, P99; Deu M, 2006, GENOME, V49, P168, DOI 10.1139/G05-092; DEWET JMJ, 1971, ECON BOT, V25, P128, DOI 10.1007/BF02860074; DEWET JMJ, 1978, AM J BOT, V65, P477, DOI 10.2307/2442706; DOEBLEY J, 1995, GENETICS, V141, P333; Doggett H., 1988, ECON BOT, V2nd ed.; Doumbia MD, 1998, ARID SOIL RES REHAB, V12, P179, DOI 10.1080/15324989809381507; DOUMBIA MD, 1993, ARID SOIL RES REHAB, V7, P335, DOI 10.1080/15324989309381366; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Figueiredo LFD, 2008, GENETICS, V179, P997, DOI 10.1534/genetics.108.087312; Fisher RA, 1928, AM NAT, V62, P115, DOI 10.1086/280193; Folkertsma RT, 2005, THEOR APPL GENET, V111, P399, DOI 10.1007/s00122-005-1949-0; Furukawa J, 2007, PLANT CELL PHYSIOL, V48, P1081, DOI 10.1093/pcp/pcm091; Garvin D. F., 2003, Handbook of soil acidity, P387; HARLAN JR, 1972, CROP SCI, V12, P172, DOI 10.2135/cropsci1972.0011183X001200020005x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hedrick P. W., 2011, GENETICS POPULATIONS; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Hotelling H, 1936, BIOMETRIKA, V28, P321, DOI 10.1093/biomet/28.3-4.321; Huang CF, 2009, PLANT CELL, V21, P655, DOI 10.1105/tpc.108.064543; Huang CF, 2010, PLANT PHYSIOL, V153, P1669, DOI 10.1104/pp.110.155028; Iuchi S, 2007, P NATL ACAD SCI USA, V104, P9900, DOI 10.1073/pnas.0700117104; JIN L, 1994, MOL BIOL EVOL, V11, P120; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Larsen PB, 2007, PLANTA, V225, P1447, DOI 10.1007/s00425-006-0452-4; Larsen PB, 2005, PLANT J, V41, P353, DOI 10.1111/j.1365-313X.2004.02306.x; Ligaba A, 2006, PLANT PHYSIOL, V142, P1294, DOI 10.1104/pp.106.085233; Lin J, 2008, HEREDITY, V101, P341, DOI 10.1038/hdy.2008.59; Liu JP, 2009, PLANT J, V57, P389, DOI 10.1111/j.1365-313X.2008.03696.x; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Magalhaes JV, 2007, NAT GENET, V39, P1156, DOI 10.1038/ng2074; Magalhaes JV, 2004, GENETICS, V167, P1905, DOI 10.1534/genetics.103.023580; Maron LG, 2010, PLANT J, V61, P728, DOI 10.1111/j.1365-313X.2009.04103.x; Parker D. R., 1995, Chemical equilibrium and reaction models. Proceedings San Antonio, Texas, USA, 23 and 24 October, 1990., P253; Platt A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000843; Prada D, 2009, J EXP BOT, V60, P2541, DOI 10.1093/jxb/erp130; Pritchard JK, 2000, GENETICS, V155, P945; Reddy BVS, 2006, GEN RESOUR CHROM ENG, V2, P309; Ryan PR, 2009, PLANT PHYSIOL, V149, P340, DOI 10.1104/pp.108.129155; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Sanchez PA, 2003, GEODERMA, V114, P157, DOI 10.1016/S0016-7061(03)00040-5; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Sawaki Y, 2009, PLANT PHYSIOL, V150, P281, DOI 10.1104/pp.108.134700; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SCOTT AJ, 1974, BIOMETRICS, V30, P507, DOI 10.2307/2529204; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Weltzien E., 2006, Enhancing the use of crop genetic diversity to manage abiotic stress in agricultural production systems. Proceedings of a workshop, Budapest, Hungary, 23-27 May, 2005, P31; Wet J. M. J. de, 1972, East African Agricultural and Forestry Journal, V38, P114; Xia JX, 2010, P NATL ACAD SCI USA, V107, P18381, DOI 10.1073/pnas.1004949107; Yamaji N, 2009, PLANT CELL, V21, P3339, DOI 10.1105/tpc.109.070771; Yokosho K, 2010, FUNCT PLANT BIOL, V37, P296, DOI 10.1071/FP09265; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	60	29	29	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20830	10.1371/journal.pone.0020830	http://dx.doi.org/10.1371/journal.pone.0020830			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695088	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000291682300014
J	Karn, RC; Laukaitis, CM				Karn, Robert C.; Laukaitis, Christina M.			Positive Selection Shaped the Convergent Evolution of Independently Expanded Kallikrein Subfamilies Expressed in Mouse and Rat Saliva Proteomes	PLOS ONE			English	Article							BINDING-PROTEIN ABP; GC-CONTENT EVOLUTION; MULTIPLE SEQUENCE ALIGNMENT; PROSTATE-SPECIFIC ANTIGEN; SUB-MANDIBULAR GLANDS; SUBMANDIBULAR-GLAND; GENE CONVERSION; REPRODUCTIVE PROTEINS; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD	We performed proteomics studies of salivas from the genome mouse (C57BL/6 strain) and the genome rat (BN/SsNHsd/Mcwi strain). Our goal was to identify salivary proteins with one or more of three characteristics that may indicate that they have been involved in adaptation: 1) rapid expansion of their gene families; 2) footprints of positive selection; and/or 3) sex-limited expression. The results of our proteomics studies allow direct comparison of the proteins expressed and their levels between the sexes of the two rodent species. Twelve members of the Mus musculus species-specific kallikrein subfamily Klk1b showed sex-limited expression in the mouse saliva proteomes. By contrast, we did not find any of the Rattus norvegicus species-specific kallikrein subfamily Klk1c proteins in male or female genome rat, nor transcripts in their submandibular glands. On the other hand, we detected expression of this family as transcripts in the submandibular glands of both sexes of Sprague-Dawley rats. Using the CODEML program in the PAML package, we demonstrate that the two rodent kallikrein subfamilies have apparently evolved rapidly under the influence of positive selection that continually remodeled the amino acid sites on the same face in the members of the subfamilies. Thus, although their kallikrein subfamily expansions were independent, this evolutionary pattern has occurred in parallel in the two rodent species, suggesting a form of convergent evolution at the molecular level. On the basis of this new data, we suggest that the previous speculative function of the species-specific rodent kallikreins as important solely in wound healing in males be investigated further. In addition to or instead of that function, we propose that their sex-limited expression, coupled with their rapid evolution may be clues to an as-yet-undetermined interaction between the sexes.	[Karn, Robert C.; Laukaitis, Christina M.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85721 USA	University of Arizona	Karn, RC (corresponding author), Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85721 USA.	rkarn@butler.edu	Laukaitis, Christina/ABF-1739-2021; Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina M/AAL-5865-2021	Laukaitis, Christina M/0000-0003-1466-7941	University of Arizona SPORE in GI Cancer [P50 CA95060]; Cancer Center [CA 023074]; NATIONAL CANCER INSTITUTE [P30CA023074] Funding Source: NIH RePORTER	University of Arizona SPORE in GI Cancer; Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	CML received salary support from the University of Arizona SPORE in GI Cancer (P50 CA95060). Laboratory space was supported by a Cancer Center Support Grant (CA 023074). No direct support for this project was available so materials had to be funded out of CML's laboratory startup money. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKA T, 1980, J HISTOCHEM CYTOCHEM, V28, P836, DOI 10.1177/28.8.7003006; BERG T, 1992, J HISTOCHEM CYTOCHEM, V40, P83, DOI 10.1177/40.1.1309555; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Canzian F, 1997, GENOME RES, V7, P262, DOI 10.1101/gr.7.3.262; CHEN YP, 1988, BIOCHEMISTRY-US, V27, P7189, DOI 10.1021/bi00419a005; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; CLEMENTS JA, 1988, J BIOL CHEM, V263, P16132; CUTLER LS, 1975, AM J ANAT, V143, P201, DOI 10.1002/aja.1001430204; Dean MD, 2009, MOL BIOL EVOL, V26, P1733, DOI 10.1093/molbev/msp094; DLOUHY SR, 1983, BIOCHEM GENET, V21, P1057, DOI 10.1007/BF00488459; DLOUHY SR, 1984, BIOCHEM GENET, V22, P657, DOI 10.1007/BF00485851; DLOUHY SR, 1987, GENETICS, V115, P535; DOONAN S, 1978, INT J BIOCHEM, V9, P235, DOI 10.1016/0020-711X(78)90004-6; DRINKWATER CC, 1987, BIOCHEMISTRY-US, V26, P6750, DOI 10.1021/bi00395a026; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Galtier N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1; Galtier N, 2001, GENETICS, V159, P907; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Gao L, 2010, EXP CELL RES, V316, P376, DOI 10.1016/j.yexcr.2009.10.022; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRESIK EW, 1994, MICROSC RES TECHNIQ, V27, P1, DOI 10.1002/jemt.1070270102; GRESIK EW, 1980, J HISTOCHEM CYTOCHEM, V28, P860, DOI 10.1177/28.8.6160181; GRESIK EW, 1979, AM J ANAT, V156, P83, DOI 10.1002/aja.1001560108; Hoopmann MR, 2009, J PROTEOME RES, V8, P1870, DOI 10.1021/pr800828p; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Inenaga K, 2009, J MED INVESTIG, V56, P277, DOI 10.2152/jmi.56.224; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; JUNQUEIRA LC, 1949, J CELL COMPAR PHYSL, V34, P129, DOI 10.1002/jcp.1030340109; KARN RC, 1982, BIOCHEM GENET, V20, P493, DOI 10.1007/BF00484700; KARN RC, 1981, BIOCHEM GENET, V19, P355, DOI 10.1007/BF00504280; Karn RC, 2008, MOL BIOL EVOL, V25, P2301, DOI 10.1093/molbev/msn182; Karn RC, 2009, GENOME BIOL EVOL, V1, P494, DOI 10.1093/gbe/evp049; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Kita M, 2004, P NATL ACAD SCI USA, V101, P7542, DOI 10.1073/pnas.0402517101; Klucky B, 2007, CANCER RES, V67, P8198, DOI 10.1158/0008-5472.CAN-07-0607; KRINKE G, LAB RAT; Kudla G, 2004, MOL BIOL EVOL, V21, P1438, DOI 10.1093/molbev/msh146; Lamy E, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-65; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-40; Laukaitis CM, 2005, BIOL J LINN SOC, V84, P493, DOI 10.1111/j.1095-8312.2005.00450.x; Lawrence MG, 2010, ENDOCR REV, V31, P407, DOI 10.1210/er.2009-0034; LEVI-MONTALCINI RITA, 1964, INT SER MONOGR ORAL BIOL, V3, P129; Lundwall A, 2008, CELL MOL LIFE SCI, V65, P2019, DOI 10.1007/s00018-008-8024-3; Lundwall A, 2006, BIOL CHEM, V387, P637, DOI 10.1515/BC.2006.082; MacDonald RJ, 1996, J BIOL CHEM, V271, P13684, DOI 10.1074/jbc.271.23.13684; MEHANSHO H, 1985, J BIOL CHEM, V260, P4418; Miczek KA, 2001, BEHAV BRAIN RES, V125, P167, DOI 10.1016/S0166-4328(01)00298-4; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Ogawa S, 2004, ANN NY ACAD SCI, V1036, P257, DOI 10.1196/annals.1330.016; Olsson AY, 2004, GENOMICS, V84, P147, DOI 10.1016/j.ygeno.2004.01.009; ORSTAVIK TB, 1977, ARCH ORAL BIOL, V22, P495, DOI 10.1016/0003-9969(77)90043-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pavlopoulou A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013781; PENSCHOW JD, 1991, MOL CELL ENDOCRINOL, V81, P135, DOI 10.1016/0303-7207(91)90212-B; PENSCHOW JD, 1991, J HISTOCHEM CYTOCHEM, V39, P835, DOI 10.1177/39.6.2033241; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; SHAI SY, 1989, BIOCHEMISTRY-US, V28, P5334, DOI 10.1021/bi00439a005; SHIH HC, 1986, BIOCHEM J, V238, P145, DOI 10.1042/bj2380145; SUCKOW M, LAB RAT, P2; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANLEEUWEN BH, 1986, J BIOL CHEM, V261, P5529; VANLEEUWEN BH, 1987, EMBO J, V6, P1705, DOI 10.1002/j.1460-2075.1987.tb02421.x; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wilmarth PA, 2004, J PROTEOME RES, V3, P1017, DOI 10.1021/pr049911o; WINES DR, 1989, J BIOL CHEM, V264, P7653; WINES DR, 1991, J MOL EVOL, V32, P476, DOI 10.1007/BF02102650; Yamada A, 2006, BIOCHEM BIOPH RES CO, V346, P386, DOI 10.1016/j.bbrc.2006.05.154; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	83	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20979	10.1371/journal.pone.0020979	http://dx.doi.org/10.1371/journal.pone.0020979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695125	gold, Green Published, Green Submitted			2022-12-25	WOS:000291682300023
J	Mehta, P; Wavreille, AS; Justiniano, SE; Marsh, RL; Yu, JH; Burry, RW; Jarjoura, D; Eubank, T; Caligiuri, MA; Butchar, JP; Tridandapani, S				Mehta, Payal; Wavreille, Anne-Sophie; Justiniano, Steven E.; Marsh, Rachel L.; Yu, Jianhua; Burry, Richard W.; Jarjoura, David; Eubank, Timothy; Caligiuri, Michael A.; Butchar, Jonathan P.; Tridandapani, Susheela			LyGDI, a Novel SHIP-Interacting Protein, Is a Negative Regulator of Fc gamma R-Mediated Phagocytosis	PLOS ONE			English	Article							GDP-DISSOCIATION INHIBITOR; INOSITOL POLYPHOSPHATE 5-PHOSPHATASE; B-CELLS; ACTIN POLYMERIZATION; MURINE MACROPHAGES; PHOSPHATASE SHIP2; BINDING PROTEIN; ADAPTER PROTEIN; RHO-GTPASES; LY-GDI	SHIP and SHIP-2 are inositol phosphatases that regulate Fc gamma R-mediated phagocytosis through catalytic as well as noncatalytic mechanisms. In this study we have used two-dimensional fluorescence difference gel electrophoresis (DIGE) analysis to identify downstream signaling proteins that uniquely associate with SHIP or SHIP-2 upon Fc gamma R clustering in human monocytes. We identified LyGDI as a binding partner of SHIP, associating inducibly with the SHIP/Grb2/Shc complex. Immunodepletion and competition experiments with recombinant SHIP domains revealed that Grb2 and the proline-rich domain of SHIP were necessary for SHIP-LyGDI association. Functional studies in primary human monocytes showed that LyGDI sequesters Rac in the cytosol, preventing it from localizing to the membrane. Consistent with this, suppression of LyGDI expression resulted in significantly enhanced Fc gamma R-mediated phagocytosis.	[Mehta, Payal; Tridandapani, Susheela] Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA; [Wavreille, Anne-Sophie; Justiniano, Steven E.; Marsh, Rachel L.; Eubank, Timothy; Caligiuri, Michael A.; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Yu, Jianhua] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Burry, Richard W.] Ohio State Univ, Campus Microscopy & Imaging Facil, Columbus, OH 43210 USA; [Jarjoura, David] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Eubank, Timothy; Caligiuri, Michael A.; Butchar, Jonathan P.; Tridandapani, Susheela] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Mehta, P (corresponding author), Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA.	tridandapani.2@osu.edu	Butchar, Jonathan/E-2825-2011; Tridandapani, Susheela/E-4209-2011; Eubank, Tim/E-3043-2011	Justiniano, Steven/0000-0003-1381-9309	NIH [P01 CA095426, R01 AI059406, T32 60013191]; AHA [09PRE2170054]; American Cancer Society, Ohio Division; NATIONAL CANCER INSTITUTE [P01CA095426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059406] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); American Cancer Society, Ohio Division(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants P01 CA095426 and R01 AI059406; AHA predoctoral fellowship 09PRE2170054 (PM); Postdoctoral fellowship from the American Cancer Society, Ohio Division (JPB) and NIH postdoctoral fellowship T32 60013191 (SEJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Ai J, 2006, BLOOD, V107, P813, DOI 10.1182/blood-2005-05-1841; Allen LAH, 2005, J LEUKOCYTE BIOL, V78, P220, DOI 10.1189/jlb.0205091; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Bokoch GM, 2009, ANTIOXID REDOX SIGN, V11, P2429, DOI [10.1089/ars.2009.2590, 10.1089/ARS.2009.2590]; Chen LJ, 2008, AGING CELL, V7, P866, DOI 10.1111/j.1474-9726.2008.00432.x; Cox D, 2001, J EXP MED, V193, P61, DOI 10.1084/jem.193.1.61; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Damen JE, 2001, BLOOD, V97, P1343, DOI 10.1182/blood.V97.5.1343; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dunant NM, 2000, CELL SIGNAL, V12, P317, DOI 10.1016/S0898-6568(00)00073-5; Dyson JM, 2001, J CELL BIOL, V155, P1065, DOI 10.1083/jcb.200104005; Erneux C, 1998, BBA-MOL CELL BIOL L, V1436, P185, DOI 10.1016/S0005-2760(98)00132-5; Eubank TD, 2009, CANCER RES, V69, P2133, DOI 10.1158/0008-5472.CAN-08-1405; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Ganesan LP, 2006, BLOOD, V108, P718, DOI 10.1182/blood-2005-09-3889; Goplen D, 2006, CANCER RES, V66, P9895, DOI 10.1158/0008-5472.CAN-05-4589; Groysman M, 2002, J BIOL CHEM, V277, P50121, DOI 10.1074/jbc.M204299200; HEJNA JA, 1995, GENOMICS, V29, P285, DOI 10.1006/geno.1995.1247; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Kamen LA, 2007, MOL BIOL CELL, V18, P2463, DOI 10.1091/mbc.e07-01-0061; Kavanaugh WM, 1996, CURR BIOL, V6, P438, DOI 10.1016/S0960-9822(02)00511-0; Koch A, 2005, ONCOGENE, V24, P3436, DOI 10.1038/sj.onc.1208558; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; LEFFERS H, 1993, EXP CELL RES, V209, P165, DOI 10.1006/excr.1993.1298; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; Li YS, 2007, J IMMUNOL, V178, P1938, DOI 10.4049/jimmunol.178.3.1938; Lioubin MN, 1996, GENE DEV, V10, P1084, DOI 10.1101/gad.10.9.1084; Muraille E, 2000, IMMUNOL LETT, V72, P7, DOI 10.1016/S0165-2478(00)00162-0; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; PARMLEY SF, 1992, J CLIN MICROBIOL, V30, P1127, DOI 10.1128/JCM.30.5.1127-1133.1992; Pengal RA, 2003, J BIOL CHEM, V278, P22657, DOI 10.1074/jbc.M302907200; Prasad N, 2002, J CELL SCI, V115, P3807, DOI 10.1242/jcs.00070; Prasad N, 2001, MOL CELL BIOL, V21, P1416, DOI 10.1128/MCB.21.4.1416-1428.2001; Robens JM, 2010, MOL CELL BIOL, V30, P829, DOI 10.1128/MCB.01574-08; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Siberil S, 2007, CRIT REV ONCOL HEMAT, V62, P26, DOI 10.1016/j.critrevonc.2006.12.003; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Su RJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-20; Tak H, 2007, CELL SIGNAL, V19, P2379, DOI 10.1016/j.cellsig.2007.07.016; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; Tridandapani S, 1998, MOL IMMUNOL, V35, P1135, DOI 10.1016/S0161-5890(98)00097-2; Tridandapani S, 2003, J IMMUNOL, V170, P4572, DOI 10.4049/jimmunol.170.9.4572; Tridandapani S, 1999, J IMMUNOL, V162, P1408; Tu Z, 2001, BLOOD, V98, P2028, DOI 10.1182/blood.V98.7.2028; Van den Bergh G, 2004, CURR OPIN BIOTECH, V15, P38, DOI 10.1016/j.copbio.2003.12.001; Wisniewski D, 1999, BLOOD, V93, P2707, DOI 10.1182/blood.V93.8.2707.408k17_2707_2720; Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	52	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21175	10.1371/journal.pone.0021175	http://dx.doi.org/10.1371/journal.pone.0021175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695085	Green Published, Green Submitted, gold			2022-12-25	WOS:000291682300032
J	Winden, KD; Karsten, SL; Bragin, A; Kudo, LC; Gehman, L; Ruidera, J; Geschwind, DH; Engel, J				Winden, Kellen D.; Karsten, Stanislav L.; Bragin, Anatol; Kudo, Lili C.; Gehman, Lauren; Ruidera, Josephine; Geschwind, Daniel H.; Engel, Jerome, Jr.			A Systems Level, Functional Genomics Analysis of Chronic Epilepsy	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; BINDING PROTEIN HUD; MESSENGER-RNA; TRANSCRIPTION FACTOR; STATUS EPILEPTICUS; OXIDATIVE STRESS; KINDLING MODEL; UP-REGULATION; KAINIC ACID; EXPRESSION	Neither the molecular basis of the pathologic tendency of neuronal circuits to generate spontaneous seizures (epileptogenicity) nor anti-epileptogenic mechanisms that maintain a seizure-free state are well understood. Here, we performed transcriptomic analysis in the intrahippocampal kainate model of temporal lobe epilepsy in rats using both Agilent and Codelink microarray platforms to characterize the epileptic processes. The experimental design allowed subtraction of the confounding effects of the lesion, identification of expression changes associated with epileptogenicity, and genes upregulated by seizures with potential homeostatic anti-epileptogenic effects. Using differential expression analysis, we identified several hundred expression changes in chronic epilepsy, including candidate genes associated with epileptogenicity such as Bdnf and Kcnj13. To analyze these data from a systems perspective, we applied weighted gene co-expression network analysis (WGCNA) to identify groups of co-expressed genes (modules) and their central (hub) genes. One such module contained genes upregulated in the epileptogenic region, including multiple epileptogenicity candidate genes, and was found to be involved the protection of glial cells against oxidative stress, implicating glial oxidative stress in epileptogenicity. Another distinct module corresponded to the effects of chronic seizures and represented changes in neuronal synaptic vesicle trafficking. We found that the network structure and connectivity of one hub gene, Sv2a, showed significant changes between normal and epileptogenic tissue, becoming more highly connected in epileptic brain. Since Sv2a is a target of the antiepileptic levetiracetam, this module may be important in controlling seizure activity. Bioinformatic analysis of this module also revealed a potential mechanism for the observed transcriptional changes via generation of longer alternatively polyadenlyated transcripts through the upregulation of the RNA binding protein HuD. In summary, combining conventional statistical methods and network analysis allowed us to interpret the differentially regulated genes from a systems perspective, yielding new insight into several biological pathways underlying homeostatic anti-epileptogenic effects and epileptogenicity.	[Winden, Kellen D.; Geschwind, Daniel H.] Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA; [Winden, Kellen D.; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet, Los Angeles, CA USA; [Winden, Kellen D.; Karsten, Stanislav L.; Bragin, Anatol; Kudo, Lili C.; Ruidera, Josephine; Geschwind, Daniel H.; Engel, Jerome, Jr.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Engel, Jerome, Jr.] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA; [Bragin, Anatol; Engel, Jerome, Jr.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Geschwind, Daniel H.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Gehman, Lauren] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA; [Kudo, Lili C.] NeuroIndx Inc, Signal Hill, CA USA; [Karsten, Stanislav L.] Harbor UCLA Med Ctr, Dept Neurol, Div Neurosci Res, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center	Winden, KD (corresponding author), Univ Calif Los Angeles, Interdept Program Neurosci, Los Angeles, CA 90095 USA.	dhg@ucla.edu; engel@ucla.edu	Karsten, Stan/AAI-4076-2021	Karsten, Stanislav/0000-0001-7387-4874; Bragin, Anatol/0000-0003-1207-8481	NIH [5R37NS033310-12]; NIGMS [GM08042]; Neurobehavioral Genetics Training Grant [T32MH073526-01A1]; Medical Scientist Training Program; UCLA School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH073526] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033310] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Neurobehavioral Genetics Training Grant; Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA School of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from NIH grants 5R37NS033310-12 (KDW, AB, DHG, JE), NIGMS GM08042 (KDW), Neurobehavioral Genetics Training Grant T32MH073526-01A1 (KDW), Medical Scientist Training Program (KW), and Aesculapians Fund of the UCLA School of Medicine (KW). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Lili C. Kudo is President/CEO of NeuroInDx Inc. and helped perform the experiments.	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; An JJ, 2008, CELL, V134, P175, DOI 10.1016/j.cell.2008.05.045; Arabadzisz D, 2005, EXP NEUROL, V194, P76, DOI 10.1016/j.expneurol.2005.01.029; Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bolognani F, 2007, NEUROCHEM RES, V32, P2142, DOI 10.1007/s11064-007-9388-8; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Bolognani F, 2010, NUCLEIC ACIDS RES, V38, P117, DOI 10.1093/nar/gkp863; Bragin A, 2005, EPILEPSIA, V46, P1592, DOI 10.1111/j.1528-1167.2005.00268.x; Bragin A, 1999, EPILEPSIA, V40, P1210, DOI 10.1111/j.1528-1157.1999.tb00849.x; Burger C, 2008, NEUROBIOL LEARN MEM, V89, P379, DOI 10.1016/j.nlm.2007.11.006; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CALVO JL, 1991, BRAIN RES, V566, P333, DOI 10.1016/0006-8993(91)91720-L; Chang WP, 2009, J NEUROSCI, V29, P883, DOI 10.1523/JNEUROSCI.4521-08.2009; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Crowder KM, 1999, P NATL ACAD SCI USA, V96, P15268, DOI 10.1073/pnas.96.26.15268; CURRAN T, 1995, J NEUROBIOL, V26, P403, DOI 10.1002/neu.480260312; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Deschenes-Furry J, 2006, BIOESSAYS, V28, P822, DOI 10.1002/bies.20449; Dudek FE, 2007, PROG BRAIN RES, V163, P755, DOI 10.1016/S0079-6123(07)63041-6; EdwaldsGilbert G, 1997, NUCLEIC ACIDS RES, V25, P2547, DOI 10.1093/nar/25.13.2547; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; Engel J, 2009, EPILEPSIA, V50, P598, DOI 10.1111/j.1528-1167.2008.01917.x; Faundez V, 1998, CELL, V93, P423, DOI 10.1016/S0092-8674(00)81170-8; Faundez V, 1997, J CELL BIOL, V138, P505, DOI 10.1083/jcb.138.3.505; Geschwind DH, 2001, NEURON, V29, P325, DOI 10.1016/S0896-6273(01)00209-4; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Goussakov IV, 2000, J NEUROSCI, V20, P3434, DOI 10.1523/JNEUROSCI.20-09-03434.2000; HATTIANGADY B, 2009, HIPPOCAMPUS; Hattiangady B, 2008, EPILEPSIA, V49, P26, DOI 10.1111/j.1528-1167.2008.01635.x; Hedera P, 2007, NEUROLOGY, V68, P2107, DOI 10.1212/01.wnl.0000261246.75977.89; Heuvingh J, 2007, P NATL ACAD SCI USA, V104, P16928, DOI 10.1073/pnas.0704749104; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hovorka J, 1997, EPILEPSY RES, V28, P225, DOI 10.1016/S0920-1211(97)00048-X; Hubbs AF, 2007, AM J PATHOL, V170, P2068, DOI 10.2353/ajpath.2007.060898; Jarrett SG, 2008, NEUROBIOL DIS, V30, P130, DOI 10.1016/j.nbd.2007.12.009; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kalachikov S, 2002, NAT GENET, V30, P335, DOI 10.1038/ng832; Keating GL, 2008, NEUROPEPTIDES, V42, P199, DOI 10.1016/j.npep.2007.11.005; Kim DS, 2005, BRAIN RES, V1055, P122, DOI 10.1016/j.brainres.2005.06.081; Konopka G, 2009, NATURE, V462, P213, DOI 10.1038/nature08549; Kraft AD, 2006, J NEUROCHEM, V98, P1852, DOI 10.1111/j.1471-4159.2006.04019.x; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li WG, 2009, MOL CARCINOGEN, V48, P91, DOI 10.1002/mc.20465; Liang LP, 2004, FREE RADICAL BIO MED, V36, P542, DOI 10.1016/j.freeradbiomed.2003.11.029; Liu HT, 1999, P NATL ACAD SCI USA, V96, P5286, DOI 10.1073/pnas.96.9.5286; Lukasiuk K, 2004, NEUROCHEM RES, V29, P1169, DOI 10.1023/B:NERE.0000023604.91584.6c; Lukasiuk K, 2002, EPILEPSIA, V43, P137, DOI 10.1046/j.1528-1157.43.s.5.20.x; Lynch BA, 2004, P NATL ACAD SCI USA, V101, P9861, DOI 10.1073/pnas.0308208101; MATHERN GW, 1995, BRAIN, V118, P105, DOI 10.1093/brain/118.1.105; MATHERN GW, 1993, ELECTROEN CLIN NEURO, V87, P326, DOI 10.1016/0013-4694(93)90186-Y; Murshid A, 2006, J NEUROCHEM, V98, P1746, DOI 10.1111/j.1471-4159.2006.04066.x; Noebels JL, 2003, ANNU REV NEUROSCI, V26, P599, DOI 10.1146/annurev.neuro.26.010302.081210; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Oldham MC, 2006, P NATL ACAD SCI USA, V103, P17973, DOI 10.1073/pnas.0605938103; OTTMAN R, 1989, EPILEPSIA, V30, P107, DOI 10.1111/j.1528-1157.1989.tb05290.x; OTTMAN R, 1989, EPILEPSIA, V30, P157, DOI 10.1111/j.1528-1157.1989.tb05448.x; Patel M, 2004, FREE RADICAL BIO MED, V37, P1951, DOI 10.1016/j.freeradbiomed.2004.08.021; Pitkanen A, 2005, EPILEPSY RES, V63, P27, DOI 10.1016/j.eplepsyres.2004.10.003; Potschka H, 2002, EUR J NEUROSCI, V16, P2157, DOI 10.1046/j.1460-9568.2002.02265.x; Salazar G, 2005, MOL BIOL CELL, V16, P3692, DOI 10.1091/mbc.E05-01-0020; Scheuber A, 2006, P NATL ACAD SCI USA, V103, P16562, DOI 10.1073/pnas.0603511103; Shetty AK, 2003, J NEUROCHEM, V87, P147, DOI 10.1046/j.1471-4159.2003.01979.x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sugino K, 2006, NAT NEUROSCI, V9, P99, DOI 10.1038/nn1618; Tanner DC, 2008, HIPPOCAMPUS, V18, P814, DOI 10.1002/hipo.20442; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Voglmaier SM, 2006, NEURON, V51, P71, DOI 10.1016/j.neuron.2006.05.027; Watanabe Y, 1996, J NEUROSCI, V16, P3827; Westmark CJ, 2005, J NEUROPATH EXP NEUR, V64, P1037, DOI 10.1097/01.jnen.0000189835.71574.e1; Winden KD, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.46; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang JH, 2002, NAT GENET, V30, P416, DOI 10.1038/ng859; Zhu H, 2007, J BIOL CHEM, V282, P2203, DOI 10.1074/jbc.M609349200; Zhu YL, 2009, NEURON, V61, P397, DOI 10.1016/j.neuron.2008.12.024	77	57	58	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20763	10.1371/journal.pone.0020763	http://dx.doi.org/10.1371/journal.pone.0020763			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695113	Green Published, gold			2022-12-25	WOS:000291682300011
J	Gao, J; Wang, J; Wang, YM; Dai, W; Lu, L				Gao, Jie; Wang, Jie; Wang, Yumei; Dai, Wei; Lu, Luo			Regulation of Pax6 by CTCF during Induction of Mouse ES Cell Differentiation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CCCTC BINDING-FACTOR; QUANTITATIVE METHYLATION ANALYSIS; DNA METHYLATION; TRANSCRIPTION FACTORS; RADIAL GLIA; NEURONS; DISEASE; GENE; NEUROGENESIS	Pax6 plays an important role in embryonic cell (ES) differentiation during embryonic development. Expression of Pax6 undergoes from a low level to high levels following ES cell differentiation to neural stem cells, and then fades away in most of the differentiated cell types. There is a limited knowledge concerning how Pax6 is regulated in ES cell differentiation. We report that Pax6 expression in mouse ES cells was controlled by CCCTC binding factor (CTCF) through a promoter repression mechanism. Pax6 expression was significantly enhanced while CTCF activity was kept in the constant during ES cell differentiation to radial glial cells. Instead, the interaction of CTCF with Pax6 gene was regulated by decreased CTCF occupancy in its binding motifs upstream from Pax6 P0 promoter following the course of ES cell differentiation. Reduced occupancy of CTCF in the binding motif region upstream from the P0 promoter was due to increased DNA methylations in the CpG sites identified in the region. Furthermore, changes in DNA methylation levels in vitro and in vivo effectively altered methylation status of these identified CpG sites, which affected ability of CTCF to interact with the P0 promoter, resulting in increases in Pax6 expression. We conclude that there is an epigenetic mechanism involving regulations of Pax6 gene during ES cell differentiation to neural stem cells, which is through increases or decreases in methylation levels of Pax6 gene to effectively alter the ability of CTCF in control of Pax6 expression, respectively.	[Gao, Jie; Wang, Jie; Wang, Yumei; Lu, Luo] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Div Mol Med, Torrance, CA USA; [Dai, Wei] NYU, Sch Med, Dept Environm Med, Tuxedo Pk, NY USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; New York University	Gao, J (corresponding author), Univ Calif Los Angeles, Dept Med, David Geffen Sch Med, Div Mol Med, Torrance, CA USA.	lluou@ucla.edu		Dai, Wei/0000-0003-0169-8327	National Institutes of Health (NIH) [EY015282]; NATIONAL EYE INSTITUTE [R01EY015281] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from National Institutes of Health (NIH) (EY015282) to L.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexanian AR, 2007, J CELL BIOCHEM, V100, P362, DOI 10.1002/jcb.21029; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Canto-Soler MV, 2008, DEV DYNAM, V237, P758, DOI 10.1002/dvdy.21420; Filippova GN, 1996, MOL CELL BIOL, V16, P2802; Fukuda H, 2005, EXPERT OPIN BIOL TH, V5, P1273, DOI 10.1517/14712598.5.10.1273; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; Gonzalgo ML, 2002, METHODS, V27, P128, DOI 10.1016/S1046-2023(02)00064-6; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NEURON, V46, P369, DOI 10.1016/j.neuron.2005.04.012; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Li T, 2005, J BIOL CHEM, V280, P12988, DOI 10.1074/jbc.M412458200; Li T, 2004, J BIOL CHEM, V279, P27575, DOI 10.1074/jbc.M313942200; Li T, 2007, EXP CELL RES, V313, P3057, DOI 10.1016/j.yexcr.2007.05.018; Li T, 2006, INVEST OPHTH VIS SCI, V47, P5218, DOI 10.1167/iovs.06-0254; LU L, J BIOL CHEM, V285, P9373; Malatesta P, 2008, CELL TISSUE RES, V331, P165, DOI 10.1007/s00441-007-0481-8; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mitjavila-Garcia MT, 2005, ADV DRUG DELIVER REV, V57, P1935, DOI 10.1016/j.addr.2005.06.001; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; OHLSSON R, BIOESSAYS, V32, P37; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; PLAZA S, 1993, CELL GROWTH DIFFER, V4, P1041; PLAZA S, 1995, MOL CELL BIOL, V15, P3344; Renaud S, 2007, NUCLEIC ACIDS RES, V35, P1245, DOI 10.1093/nar/gkl1125; Sansom SN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000511; Shahhoseini M, 2010, BIOCHEM CELL BIOL, V88, P527, DOI [10.1139/O09-181, 10.1139/o09-181]; Shen Y, 2006, HUM MOL GENET, V15, P2623, DOI 10.1093/hmg/ddl188; Shibata M, 2011, J NEUROSCI, V31, P3407, DOI 10.1523/JNEUROSCI.5085-10.2011; Sugaya K, 2006, PANMINERVA MED, V48, P87; Warnecke PM, 1998, GENOMICS, V51, P182, DOI 10.1006/geno.1998.5371; Warnecke PM, 1997, NUCLEIC ACIDS RES, V25, P4422, DOI 10.1093/nar/25.21.4422; Witcher M, 2009, MOL CELL, V34, P271, DOI 10.1016/j.molcel.2009.04.001; Wu D, 2006, INVEST OPHTH VIS SCI, V47, P2422, DOI 10.1167/iovs.05-0536; Xu PX, 1999, DEVELOPMENT, V126, P383; Yeo S, 2007, BIOCHEM BIOPH RES CO, V359, P536, DOI 10.1016/j.bbrc.2007.05.120; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; ZHANG X, CELL STEM CELL, V7, P90	43	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20954	10.1371/journal.pone.0020954	http://dx.doi.org/10.1371/journal.pone.0020954			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695148	Green Published, gold, Green Submitted			2022-12-25	WOS:000291663300031
J	Keller, A; Harz, C; Matzas, M; Meder, B; Katus, HA; Ludwig, N; Fischer, U; Meese, E				Keller, Andreas; Harz, Christian; Matzas, Mark; Meder, Benjamin; Katus, Hugo A.; Ludwig, Nicole; Fischer, Ulrike; Meese, Eckart			Identification of Novel SNPs in Glioblastoma Using Targeted Resequencing	PLOS ONE			English	Article							TUMOR-REJECTION ANTIGEN; GENOME-WIDE ASSOCIATION; GENETIC PATHWAYS; EXPRESSION; GLIOMA; SART1; LOCI; SUSCEPTIBILITY; AMPLIFICATIONS; AMPLICONS	High-throughput sequencing opens avenues to find genetic variations that may be indicative of an increased risk for certain diseases. Linking these genomic data to other "omics" approaches bears the potential to deepen our understanding of pathogenic processes at the molecular level. To detect novel single nucleotide polymorphisms (SNPs) for glioblastoma multiforme (GBM), we used a combination of specific target selection and next generation sequencing (NGS). We generated a microarray covering the exonic regions of 132 GBM associated genes to enrich target sequences in two GBM tissues and corresponding leukocytes of the patients. Enriched target genes were sequenced with Illumina and the resulting reads were mapped to the human genome. With this approach we identified over 6000 SNPs, including over 1300 SNPs located in the targeted genes. Integrating the genome-wide association study (GWAS) catalog and known disease associated SNPs, we found that several of the detected SNPs were previously associated with smoking behavior, body mass index, breast cancer and high-grade glioma. Particularly, the breast cancer associated allele of rs660118 SNP in the gene SART1 showed a near doubled frequency in glioblastoma patients, as verified in an independent control cohort by Sanger sequencing. In addition, we identified SNPs in 20 of 21 GBM associated antigens providing further evidence that genetic variations are significantly associated with the immunogenicity of antigens.	[Keller, Andreas; Matzas, Mark] Biomarker Discovery Ctr Heidelberg, Heidelberg, Germany; [Harz, Christian; Ludwig, Nicole; Fischer, Ulrike; Meese, Eckart] Univ Saarland, Sch Med, Dept Human Genet, D-6650 Homburg, Germany; [Meder, Benjamin; Katus, Hugo A.] Univ Heidelberg, Dept Internal Med, D-6900 Heidelberg, Germany	Saarland University; Ruprecht Karls University Heidelberg	Keller, A (corresponding author), Biomarker Discovery Ctr Heidelberg, Heidelberg, Germany.	hgemee@uniklinikum-saarland.de	Keller, Andreas/ABB-6412-2021; Meese, Eckart Ulrich/ABD-1983-2021	Keller, Andreas/0000-0002-5361-0895; 	German Ministry of Research Education (BMBF) [01EX0806]	German Ministry of Research Education (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by funding from the German Ministry of Research Education (BMBF) under contract 01EX0806. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bredel M, 2005, CANCER RES, V65, P8679, DOI 10.1158/0008-5472.CAN-05-1204; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Fischer U, 2008, MOL CANCER RES, V6, P576, DOI 10.1158/1541-7786.MCR-07-0283; Fischer U, 2010, INT J CANCER, V126, P2594, DOI 10.1002/ijc.24971; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Hosokawa M, 2005, ANTICANCER RES, V25, P1983; Imaizumi T, 1999, INT J CANCER, V83, P760, DOI 10.1002/(SICI)1097-0215(19991210)83:6<760::AID-IJC11>3.0.CO;2-R; Ishida H, 2000, INT J ONCOL, V17, P29; Keller A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-539; Kleihues P, 2007, WHO CLASSIFICATION T, P33; Lee S. T., 2010, J NEUROONCOL; LUDWIG N, 2010, INT J CANC; Ludwig N, 2008, CLIN CANCER RES, V14, P4767, DOI 10.1158/1078-0432.CCR-07-4715; Ludwig N, 2009, NEOPLASIA, V11, P1383, DOI 10.1593/neo.91018; Nord H, 2009, NEURO-ONCOLOGY, V11, P803, DOI 10.1215/15228517-2009-013; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Olson JE, 2010, BREAST CANCER RES TR, V119, P423, DOI 10.1007/s10549-009-0386-1; Rao SK, 2010, J NEURO-ONCOL, V96, P169, DOI 10.1007/s11060-009-9959-4; Reifenberger G, 2004, J MOL MED, V82, P656, DOI 10.1007/s00109-004-0564-x; Ronaghi M, 2001, GENOME RES, V11, P3, DOI 10.1101/gr.11.1.3; Sasatomi T, 2000, DIS COLON RECTUM, V43, P1754, DOI 10.1007/BF02236863; Schracke N, 2009, NEW BIOTECHNOL, V26, P229, DOI 10.1016/j.nbt.2009.08.013; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Shintaku I, 2000, UROL RES, V28, P178, DOI 10.1007/s002400000103; Stadler MB, 2005, EUR J IMMUNOL, V35, P371, DOI 10.1002/eji.200425481; Stupp R, 2010, J CLIN ONCOL, V28, P2712, DOI 10.1200/JCO.2009.26.6650; Summerer D, 2009, GENOME RES, V19, P1616, DOI 10.1101/gr.091942.109; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Team RDC, 2009, R LANG ENV STAT COMP; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Uemura M, 2003, CANCER, V97, P2474, DOI 10.1002/cncr.11374; UJIFUKU K, 2010, CANC LETT; Wrensch M, 2009, NAT GENET, V41, P905, DOI 10.1038/ng.408	38	14	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e18158	10.1371/journal.pone.0018158	http://dx.doi.org/10.1371/journal.pone.0018158			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695249	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600001
J	Lugowska, A; Poninska, J; Krajewski, P; Broda, G; Ploski, R				Lugowska, Agnieszka; Poninska, Joanna; Krajewski, Pawel; Broda, Grazyna; Ploski, Rafal			Population Carrier Rates of Pathogenic ARSA Gene Mutations: Is Metachromatic Leukodystrophy Underdiagnosed?	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISEASES; HIGH-FREQUENCY; GERMANY; POLAND	Background: Metachromatic leukodystrophy (MLD) is a severe neurometabolic disease caused mainly by deficiency of arylsulfatase A encoded by the ARSA gene. Based on epidemiological surveys the incidence of MLD per 100 000 live births varied from 0.6 to 2.5. Our purpose was to estimate the birth prevalence of MLD in Poland by determining population frequency of the common pathogenic ARSA gene mutations and to compare this estimate with epidemiological data. Methodology: We studied two independently ascertained cohorts from the Polish background population (N similar to 3000 each) and determined carrier rates of common ARSA gene mutations: c.459+1G>A, p.P426L, p.I179S (cohort 1) and c.459+1G>A, p.I179S (cohort 2). Principal Findings: Taking into account ARSA gene mutation distribution among 60 Polish patients, the expected MLD birth prevalence in the general population (assuming no selection against homozygous fetuses) was estimated as 4.0/100 000 and 4.1/100 000, respectively for the 1(st) and the 2(nd) cohort with a pooled estimate of 4.1/100 000 (CI: 1.8-9.4) which was higher than the estimate of 0.38 per 100 000 live births based on diagnosed cases. The p. I179S mutation was relatively more prevalent among controls than patients (OR = 3.6, P = 0.0082, for a comparison of p.I179S frequency relative to c.459+1G>A between controls vs. patients). Conclusions/Significance: The observed discrepancy between the measured incidence of metachromatic leukodystrophy and the predicted carriage rates suggests that MLD is substantially underdiagnosed in the Polish population. The underdiagnosis rate may be particularly high among patients with p. I179S mutation whose disease is characterized mainly by psychotic symptoms.	[Lugowska, Agnieszka] Inst Psychiat & Neurol, Dept Genet, Warsaw, Poland; [Poninska, Joanna; Ploski, Rafal] Warsaw Med Univ, Dept Med Genet, Warsaw, Poland; [Krajewski, Pawel] Warsaw Med Univ, Dept Forens Med, Warsaw, Poland; [Krajewski, Pawel] Inst Cardiol, Dept Cardiovasc Epidemiol & Prevent & Hlth Promot, Warsaw, Poland	Institute of Psychiatry & Neurology; Medical University of Warsaw; Medical University of Warsaw; Institute of Cardiology - Poland	Lugowska, A (corresponding author), Inst Psychiat & Neurol, Dept Genet, Warsaw, Poland.	alugipin@yahoo.com; rploski@wp.pl		Ploski, Rafal/0000-0001-6286-5526; Lugowska, Agnieszka/0000-0002-2848-6407; Poninska, Joanna/0000-0002-0890-611X; krajewski, Pawel/0000-0001-8352-4077	Institute of Psychiatry and Neurology (Warsaw, Poland) [40/2009]; Medical University in Warsaw [1WY/WB1/10]	Institute of Psychiatry and Neurology (Warsaw, Poland); Medical University in Warsaw	This work was supported by Institute of Psychiatry and Neurology (Warsaw, Poland; www.ipin.edu.pl); grant no. 40/2009 and Medical University in Warsaw (www.wum.edu.pl) grant no. 1WY/WB1/10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRODA G, 2005, POL POPUL REV, V27, P29; CLAUSSEN M, 1992, AM J MED GENET, V42, P536, DOI 10.1002/ajmg.1320420422; FARRELL DF, 1981, HUM GENET, V59, P129, DOI 10.1007/BF00293061; GUIBAUD P, 1973, LYON MED, V229, P1215; GUSTAVSON KH, 1971, ACTA PAEDIATR SCAND, V60, P585, DOI 10.1111/j.1651-2227.1971.tb06994.x; Heim P, 1997, AM J MED GENET, V71, P475, DOI 10.1002/(SICI)1096-8628(19970905)71:4<475::AID-AJMG20>3.0.CO;2-C; HEINISCH U, 1995, AM J HUM GENET, V56, P51; Kayser M, 2005, HUM GENET, V117, P428, DOI 10.1007/s00439-005-1333-9; Kostrzewa G, 2008, MOL GENET METAB, V94, P259, DOI 10.1016/j.ymgme.2008.02.003; Lugowska A, 2005, CLIN GENET, V68, P48, DOI 10.1111/j.1399-0004.2005.00451.x; Lugowska A, 2010, J HUM GENET, V55, P394, DOI 10.1038/jhg.2010.25; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Mueller-Malesinska M, 2001, J AUDIOLOGICAL MED, V10, P136; Ozkara HA, 2004, BRAIN DEV-JPN, V26, P363, DOI 10.1016/S0387-7604(03)00195-5; PASTORSOLER NM, 1995, J INHERIT METAB DIS, V18, P326, DOI 10.1007/BF00710424; PASTORSOLER NM, 1994, HUM MUTAT, V4, P199, DOI 10.1002/humu.1380040305; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; Ploski R, 2002, HUM GENET, V110, P592, DOI 10.1007/s00439-002-0728-0; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; TYLKISZYMANSKA A, 1996, NEUROLOGY, V67, P859; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695; ZDZIENICKA E, 2004, OTEPIENIE, P438; ZLOTOGORA J, 1980, AM J HUM GENET, V32, P663	24	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20218	10.1371/journal.pone.0020218	http://dx.doi.org/10.1371/journal.pone.0020218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695197	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600006
J	Zhang, L; Bell, RJA; Kiebish, MA; Seyfried, TN; Han, XL; Gross, RW; Chuang, JH				Zhang, Lu; Bell, Robert J. A.; Kiebish, Michael A.; Seyfried, Thomas N.; Han, Xianlin; Gross, Richard W.; Chuang, Jeffrey H.			A Mathematical Model for the Determination of Steady-State Cardiolipin Remodeling Mechanisms Using Lipidomic Data	PLOS ONE			English	Article							INTERFACIAL CATALYSIS; SHOTGUN LIPIDOMICS; BRAIN; METABOLISM; REVEALS; CELLS; BIOINFORMATICS; ABNORMALITIES; BIOSYNTHESIS; ENZYMES	Technical advances in lipidomic analysis have generated tremendous amounts of quantitative lipid molecular species data, whose value has not been fully explored. We describe a novel computational method to infer mechanisms of de novo lipid synthesis and remodeling from lipidomic data. We focus on the mitochondrial-specific lipid cardiolipin (CL), a polyglycerol phospholipid with four acyl chains. The lengths and degree of unsaturation of these acyl chains vary across CL molecules, and regulation of these differences is important for mitochondrial energy metabolism. We developed a novel mathematical approach to determine mechanisms controlling the steady-state distribution of acyl chain combinations in CL. We analyzed mitochondrial lipids from 18 types of steady-state samples, each with at least 3 replicates, from mouse brain, heart, lung, liver, tumor cells, and tumors grown in vitro. Using a mathematical model for the CL remodeling mechanisms and a maximum likelihood approach to infer parameters, we found that for most samples the four chain positions have an independent and identical distribution, indicating they are remodeled by the same processes. Furthermore, for most brain samples and liver, the distribution of acyl chains is well-fit by a simple linear combination of the pools of acyl chains in phosphatidylcholine (PC), phosphatidylethanolamine (PE), and phosphatidylglycerol (PG). This suggests that headgroup chemistry is the key determinant of acyl donation into CL, with chain length/saturation less important. This canonical remodeling behavior appears damaged in some tumor samples, which display a consistent excess of CL molecules having particular masses. For heart and lung, the "proportional incorporation" assumption is not adequate to explain the CL distribution, suggesting additional acyl CoA-dependent remodeling that is chain-type specific. Our findings indicate that CL remodeling processes can be described by a small set of quantitative relationships, and that bioinformatic approaches can help determine these processes from high-throughput lipidomic data.	[Zhang, Lu; Seyfried, Thomas N.; Chuang, Jeffrey H.] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Bell, Robert J. A.] Univ Calif San Francisco, Dept Biomed Sci, San Francisco, CA 94143 USA; [Kiebish, Michael A.; Gross, Richard W.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; [Han, Xianlin] Sanford Burnham Med Res Inst, Diabet & Obes Res Ctr, Orlando, FL USA	Boston College; University of California System; University of California San Francisco; Washington University (WUSTL); Sanford Burnham Prebys Medical Discovery Institute	Zhang, L (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	chuangj@bc.edu		Seyfried, Thomas/0000-0003-1491-3989; Chuang, Jeffrey/0000-0002-3298-2358	Boston College Biology Department	Boston College Biology Department	This work was supported by startup funds from the Boston College Biology Department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Callender HL, 2010, J THEOR BIOL, V262, P679, DOI 10.1016/j.jtbi.2009.10.030; Cheng H, 2008, BIOCHEMISTRY-US, V47, P5869, DOI 10.1021/bi7023282; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Danos M, 2008, BIOCHEM CELL BIOL, V86, P11, DOI [10.1139/O07-156, 10.1139/o07-156]; Das S, 2001, TRENDS PARASITOL, V17, P316, DOI 10.1016/S1471-4922(01)01901-8; Fahy E, 2007, METHOD ENZYMOL, V432, P247, DOI 10.1016/S0076-6879(07)32011-9; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; GHOMASHCHI F, 1991, BIOCHEMISTRY-US, V30, P7318, DOI 10.1021/bi00243a037; Gupta S, 2009, BIOPHYS J, V96, P4542, DOI 10.1016/j.bpj.2009.03.011; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2005, MASS SPECTROM REV, V24, P367, DOI 10.1002/mas.20023; Hauff KD, 2006, PROG LIPID RES, V45, P91, DOI 10.1016/j.plipres.2005.12.001; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Houtkooper RH, 2009, BBA-BIOMEMBRANES, V1788, P2003, DOI 10.1016/j.bbamem.2009.07.009; Huysentruyt LC, 2008, INT J CANCER, V123, P73, DOI 10.1002/ijc.23492; Ivanova PT, 2009, CURR OPIN CHEM BIOL, V13, P526, DOI 10.1016/j.cbpa.2009.08.011; JAIN MK, 1992, BIOCHEMISTRY-US, V31, P7841, DOI 10.1021/bi00149a014; Kiebish MA, 2008, J LIPID RES, V49, P2545, DOI 10.1194/jlr.M800319-JLR200; Kiebish MA, 2008, LIPIDS, V43, P951, DOI 10.1007/s11745-008-3197-y; Kiebish MA, 2008, J NEUROCHEM, V106, P299, DOI 10.1111/j.1471-4159.2008.05383.x; Kiebish MA, 2010, J LIPID RES, V51, P2153, DOI 10.1194/jlr.M004796; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; Malhotra A, 2009, BBA-MOL CELL BIOL L, V1791, P314, DOI 10.1016/j.bbalip.2009.01.004; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Mancuso DJ, 2007, J BIOL CHEM, V282, P34611, DOI 10.1074/jbc.M707795200; Niemela PS, 2009, J CHROMATOGR B, V877, P2855, DOI 10.1016/j.jchromb.2009.01.025; Rappley I, 2009, J NEUROCHEM, V111, P15, DOI 10.1111/j.1471-4159.2009.06290.x; Rouzer CA, 2006, BIOCHEMISTRY-US, V45, P14795, DOI 10.1021/bi061723j; Saini-Chohan HK, 2009, J LIPID RES, V50, P1600, DOI 10.1194/jlr.M800561-JLR200; Schlame M, 2000, PROG LIPID RES, V39, P257, DOI 10.1016/S0163-7827(00)00005-9; Schlame M, 2005, CHEM PHYS LIPIDS, V138, P38, DOI 10.1016/j.chemphyslip.2005.08.002; SCHLAME M, 1990, BIOCHEM J, V272, P589, DOI 10.1042/bj2720589; Schlame M, 2006, FEBS LETT, V580, P5450, DOI 10.1016/j.febslet.2006.07.022; Schlame M, 2009, BBA-MOL CELL BIOL L, V1791, P321, DOI 10.1016/j.bbalip.2009.01.018; Schmelzer K, 2007, METHOD ENZYMOL, V432, P171, DOI 10.1016/S0076-6879(07)32007-7; SEYFRIED TN, 1992, MOL CHEM NEUROPATHOL, V17, P147, DOI 10.1007/BF03159989; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Sparagna GC, 2009, J CARDIOVASC PHARM, V53, P290, DOI 10.1097/FJC.0b013e31819b5461; Taylor WA, 2009, J BIOL CHEM, V284, P30360, DOI 10.1074/jbc.M109.048322; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; VANCE DE, 2002, NEW COMPREHENSIVE BI, V36, P205; Wasserman L., 2004, ALL STAT CONCISE COU, V26; Xu Y, 2003, J BIOL CHEM, V278, P51380, DOI 10.1074/jbc.M307382200; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u	48	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21170	10.1371/journal.pone.0021170	http://dx.doi.org/10.1371/journal.pone.0021170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695174	Green Published, gold			2022-12-25	WOS:000291612600049
J	Herrmann, F; Garriga-Canut, M; Baumstark, R; Fajardo-Sanchez, E; Cotterell, J; Minoche, A; Himmelbauer, H; Isalan, M				Herrmann, Frank; Garriga-Canut, Mireia; Baumstark, Rebecca; Fajardo-Sanchez, Emmanuel; Cotterell, James; Minoche, Andre; Himmelbauer, Heinz; Isalan, Mark			p53 Gene Repair with Zinc Finger Nucleases Optimised by Yeast 1-Hybrid and Validated by Solexa Sequencing	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; HOMOLOGOUS RECOMBINATION; CAENORHABDITIS-ELEGANS; RESTRICTION ENZYMES; DNA-RECOGNITION; KNOCKOUT RATS; IN-VIVO; CELLS; GENOME; PROTEINS	The tumor suppressor gene p53 is mutated or deleted in over 50% of human tumors. As functional p53 plays a pivotal role in protecting against cancer development, several strategies for restoring wild-type (wt) p53 function have been investigated. In this study, we applied an approach using gene repair with zinc finger nucleases (ZFNs). We adapted a commercially-available yeast one-hybrid (Y1H) selection kit to allow rapid building and optimization of 4-finger constructs from randomized PCR libraries. We thus generated novel functional zinc finger nucleases against two DNA sites in the human p53 gene, near cancer mutation 'hotspots'. The ZFNs were first validated using in vitro cleavage assays and in vivo episomal gene repair assays in HEK293T cells. Subsequently, the ZFNs were used to restore wt-p53 status in the SF268 human cancer cell line, via ZFN-induced homologous recombination. The frequency of gene repair and mutation by non-homologous end-joining was then ascertained in several cancer cell lines, using a deep sequencing strategy. Our Y1H system facilitates the generation and optimisation of novel, sequence-specific four-to six-finger peptides, and the p53-specific ZFN described here can be used to mutate or repair p53 in genomic loci.	[Herrmann, Frank; Garriga-Canut, Mireia; Baumstark, Rebecca; Fajardo-Sanchez, Emmanuel; Cotterell, James; Isalan, Mark] Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Herrmann, Frank; Garriga-Canut, Mireia; Baumstark, Rebecca; Fajardo-Sanchez, Emmanuel; Cotterell, James; Minoche, Andre; Himmelbauer, Heinz; Isalan, Mark] UPF, Barcelona, Spain; [Minoche, Andre] Max Planck Inst Mol Genet, Berlin, Germany; [Minoche, Andre; Himmelbauer, Heinz] Ctr Genom Regulat, Ultrasequencing Unit, Barcelona, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Max Planck Society; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Herrmann, F (corresponding author), Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain.	mark.isalan@crg.eu		Himmelbauer, Heinz/0000-0001-8897-2928; Fajardo-Sanchez, Emmanuel/0000-0002-0020-5087; Isalan, Mark/0000-0002-4652-0365	EC [FP6-012948-Netsensor]; ERC [201249]; ZINC-HUBS; Ministerio de Ciencia e Innovacion; MEC-EMBL; Juan de la Cierva Fellowship [2007-43-786];  [MICINN BFU2010-17953]	EC(European CommissionEuropean Commission Joint Research Centre); ERC(European Research Council (ERC)European Commission); ZINC-HUBS; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MEC-EMBL; Juan de la Cierva Fellowship; 	Initial funding was provided by EC Grant FP6-012948-Netsensor. MI is funded by FP7 ERC 201249 ZINC-HUBS, Ministerio de Ciencia e Innovacion Grant MICINN BFU2010-17953 and the MEC-EMBL agreement. FH was funded by a Juan de la Cierva Fellowship 2007-43-786. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alwin S, 2005, MOL THER, V12, P610, DOI 10.1016/j.ymthe.2005.06.094; Bae KH, 2003, NAT BIOTECHNOL, V21, P275, DOI 10.1038/nbt796; Beerli RR, 2002, NAT BIOTECHNOL, V20, P135, DOI 10.1038/nbt0202-135; Beumer KJ, 2008, P NATL ACAD SCI USA, V105, P19821, DOI 10.1073/pnas.0810475105; Bibikova M, 2001, MOL CELL BIOL, V21, P289, DOI 10.1128/MCB.21.1.289-297.2001; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; Bibikova M, 2002, GENETICS, V161, P1169; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; CARBERY ID, GENETICS, V186, P451; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Carroll Dana, 2008, V435, P63, DOI 10.1007/978-1-59745-232-8_5; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Chen F, 2010, BIOCHEM PHARMACOL, V80, P724, DOI 10.1016/j.bcp.2010.04.031; CHEN PC, 1995, CANCER GENET CYTOGEN, V82, P106, DOI 10.1016/0165-4608(94)00213-U; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Doyon Y, 2010, NAT METHODS, V7, P459, DOI [10.1038/NMETH.1456, 10.1038/nmeth.1456]; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Elliott B, 1998, MOL CELL BIOL, V18, P93, DOI 10.1128/MCB.18.1.93; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Greisman HA, 1997, SCIENCE, V275, P657, DOI 10.1126/science.275.5300.657; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Hurt JA, 2003, P NATL ACAD SCI USA, V100, P12271, DOI 10.1073/pnas.2135381100; Isalan M, 2001, NAT BIOTECHNOL, V19, P656, DOI 10.1038/90264; ISALAN M, ZINC FINGERS, P435; Isalan M, 2006, NAT PROTOC, V1, P468, DOI 10.1038/nprot.2006.68; Kandavelou K, 2009, BIOCHEM BIOPH RES CO, V388, P56, DOI 10.1016/j.bbrc.2009.07.112; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; Lloyd A, 2005, P NATL ACAD SCI USA, V102, P2232, DOI 10.1073/pnas.0409339102; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lu C, 2009, APOPTOSIS, V14, P597, DOI 10.1007/s10495-009-0330-1; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mandell JG, 2006, NUCLEIC ACIDS RES, V34, pW516, DOI 10.1093/nar/gkl209; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Moore M, 2001, P NATL ACAD SCI USA, V98, P1437, DOI 10.1073/pnas.98.4.1437; Morton J, 2006, P NATL ACAD SCI USA, V103, P16370, DOI 10.1073/pnas.0605633103; Osakabe K, 2010, P NATL ACAD SCI USA, V107, P12034, DOI 10.1073/pnas.1000234107; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pearson H, 2008, NATURE, V455, P160, DOI [10.1038/455160a, 10.1038/453150a]; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; PORTEUS M, 2010, COLD SPRING HARB PRO, DOI DOI 10.1101/PDB.TOP1193; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Sander JD, 2007, NUCLEIC ACIDS RES, V35, pW599, DOI 10.1093/nar/gkm349; Sera T, 2002, BIOCHEMISTRY-US, V41, P7074, DOI 10.1021/bi020095c; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Smith J, 2000, NUCLEIC ACIDS RES, V28, P3361, DOI 10.1093/nar/28.17.3361; Smith J, 1999, NUCLEIC ACIDS RES, V27, P674, DOI 10.1093/nar/27.2.674; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wera S, 1999, BIOTECHNIQUES, V27, P772, DOI 10.2144/99274st08; Wright DA, 2005, PLANT J, V44, P693, DOI 10.1111/j.1365-313X.2005.02551.x; Wright DA, 2006, NAT PROTOC, V1, P1637, DOI 10.1038/nprot.2006.259; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	66	28	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20913	10.1371/journal.pone.0020913	http://dx.doi.org/10.1371/journal.pone.0020913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695267	Green Submitted, gold, Green Published			2022-12-25	WOS:000291612900037
J	Oberg, AL; French, AJ; Sarver, AL; Subramanian, S; Morlan, BW; Riska, SM; Borralho, PM; Cunningham, JM; Boardman, LA; Wang, L; Smyrk, TC; Asmann, Y; Steer, CJ; Thibodeau, SN				Oberg, Ann L.; French, Amy J.; Sarver, Aaron L.; Subramanian, Subbaya; Morlan, Bruce W.; Riska, Shaun M.; Borralho, Pedro M.; Cunningham, Julie M.; Boardman, Lisa A.; Wang, Liang; Smyrk, Thomas C.; Asmann, Yan; Steer, Clifford J.; Thibodeau, Stephen N.			miRNA Expression in Colon Polyps Provides Evidence for a Multihit Model of Colon Cancer	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; MICRORNA EXPRESSION; COLORECTAL-CANCER; DIFFERENTIAL EXPRESSION; MISMATCH REPAIR; GENE; IMMUNOHISTOCHEMISTRY; HYPERMETHYLATION; IDENTIFICATION; PROLIFERATION	Changes in miRNA expression are a common feature in colon cancer. Those changes occurring in the transition from normal to adenoma and from adenoma to carcinoma, however, have not been well defined. Additionally, miRNA changes among tumor subgroups of colon cancer have also not been adequately evaluated. In this study, we examined the global miRNA expression in 315 samples that included 52 normal colonic mucosa, 41 tubulovillous adenomas, 158 adenocarcinomas with proficient DNA mismatch repair (pMMR) selected for stage and age of onset, and 64 adenocarcinomas with defective DNA mismatch repair (dMMR) selected for sporadic (n = 53) and inherited colon cancer (n = 11). Sporadic dMMR tumors all had MLH1 inactivation due to promoter hypermethylation. Unsupervised PCA and cluster analysis demonstrated that normal colon tissue, adenomas, pMMR carcinomas and dMMR carcinomas were all clearly discernable. The majority of miRNAs that were differentially expressed between normal and polyp were also differentially expressed with a similar magnitude in the comparison of normal to both the pMMR and dMMR tumor groups, suggesting a stepwise progression for transformation from normal colon to carcinoma. Among the miRNAs demonstrating the largest fold up-or down-regulated changes (>= 4), four novel (miR-31, miR-1, miR-9 and miR-99a) and two previously reported (miR-137 and miR-135b) miRNAs were identified in the normal/adenoma comparison. All but one of these (miR-99a) demonstrated similar expression differences in the two normal/carcinoma comparisons, suggesting that these early tumor changes are important in both the pMMR- and dMMR-derived cancers. The comparison between pMMR and dMMR tumors identified four miRNAs (miR-31, miR-552, miR-592 and miR-224) with statistically significant expression differences (>= 2-fold change).	[Oberg, Ann L.; Morlan, Bruce W.; Riska, Shaun M.; Asmann, Yan] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [French, Amy J.; Cunningham, Julie M.; Wang, Liang; Smyrk, Thomas C.; Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN USA; [Sarver, Aaron L.] Univ Minnesota, Masonis Canc Ctr, Minneapolis, MN USA; [Subramanian, Subbaya] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Borralho, Pedro M.] Univ Lisbon, Fac Pharm, iMed UL, P-1699 Lisbon, Portugal; [Boardman, Lisa A.] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA; [Steer, Clifford J.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universidade de Lisboa; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Oberg, AL (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	sthibodeau@mayo.edu	iMed.ULisboa, CellFun/A-4244-2014; Borralho, Pedro M/C-2727-2011	Borralho, Pedro M/0000-0003-4488-7240; Subramanian, Subbaya/0000-0002-2544-480X	Minnesota Partnership for Biotechnology and Medical Genomics [Medical Foundation] [2006-100412]	Minnesota Partnership for Biotechnology and Medical Genomics [Medical Foundation]	This work was supported by a grant from the Minnesota Partnership for Biotechnology and Medical Genomics [Medical Foundation 2006-100412]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Baudhuin LM, 2005, FAM CANCER, V4, P255, DOI 10.1007/s10689-004-1447-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; Bolstad B, 2005, BIOINFORMATICS COMPU; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn387; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cunningham JM, 1998, CANCER RES, V58, P3455; Cunningham JM, 2001, AM J HUM GENET, V69, P780, DOI 10.1086/323658; Cunningham JM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-57; Diosdado B, 2009, BRIT J CANCER, V101, P707, DOI 10.1038/sj.bjc.6605037; Dukes C, 1937, Proc R Soc Med, V30, P371; Earle JSL, 2010, J MOL DIAGN, V12, P433, DOI 10.2353/jmoldx.2010.090154; Eckel JE, 2005, BIOINFORMATICS, V21, P1078, DOI 10.1093/bioinformatics/bti105; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; Grady WM, 2004, CANCER METAST REV, V23, P11, DOI 10.1023/A:1025861527711; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kemp Z, 2004, HUM MOL GENET, V13, pR177, DOI 10.1093/hmg/ddh247; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lanza G, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-54; Lindor NM, 2002, J CLIN ONCOL, V20, P1043, DOI 10.1200/JCO.20.4.1043; Michael MZ, 2003, MOL CANCER RES, V1, P882; Motoyama K, 2009, INT J ONCOL, V34, P1069, DOI 10.3892/ijo_00000233; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Onnis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012960; *PART INC, 2008, PART GEN SUIT REV 63; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; R Core Team, 2022, R LANG ENV STAT COMP; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Sarver AL, 2010, LAB INVEST, V90, P753, DOI 10.1038/labinvest.2010.53; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schmitz KJ, 2009, VIRCHOWS ARCH, V455, P49, DOI 10.1007/s00428-009-0804-0; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Slaby O, 2007, ONCOLOGY-BASEL, V72, P397, DOI 10.1159/000113489; Slattery ML, 2011, GENE CHROMOSOME CANC, V50, P196, DOI 10.1002/gcc.20844; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Staub E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-37; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Subramanian S, 2008, ONCOGENE, V27, P2015, DOI 10.1038/sj.onc.1210836; Takahashi N, 2009, HUM MOL GENET, V18, P1879, DOI 10.1093/hmg/ddp108; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Valastyan S, 2010, CELL CYCLE, V9, P2124, DOI 10.4161/cc.9.11.11843; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	55	112	121	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20465	10.1371/journal.pone.0020465	http://dx.doi.org/10.1371/journal.pone.0020465			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694772	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900010
J	Sankaranarayanan, K; Timofeeff, MN; Spathis, R; Lowenstein, TK; Lum, JK				Sankaranarayanan, Krithivasan; Timofeeff, Michael N.; Spathis, Rita; Lowenstein, Tim K.; Lum, J. Koji			Ancient Microbes from Halite Fluid Inclusions: Optimized Surface Sterilization and DNA Extraction	PLOS ONE			English	Article							HALOTOLERANT BACTERIUM; DEATH-VALLEY; SALT; POPULATIONS; PROKARYOTES; ALIGNMENT	Fluid inclusions in evaporite minerals (halite, gypsum, etc.) potentially preserve genetic records of microbial diversity and changing environmental conditions of Earth's hydrosphere for nearly one billion years. Here we describe a robust protocol for surface sterilization and retrieval of DNA from fluid inclusions in halite that, unlike previously published methods, guarantees removal of potentially contaminating surface-bound DNA. The protocol involves microscopic visualization of cell structures, deliberate surface contamination followed by surface sterilization with acid and bleach washes, and DNA extraction using Amicon centrifugal filters. Methods were verified on halite crystals of four different ages from Saline Valley, California (modern, 36 ka, 64 ka, and 150 ka), with retrieval of algal and archaeal DNA, and characterization of the algal community using ITS1 sequences. The protocol we developed opens up new avenues for study of ancient microbial ecosystems in fluid inclusions, understanding microbial evolution across geological time, and investigating the antiquity of life on earth and other parts of the solar system.	[Sankaranarayanan, Krithivasan; Lum, J. Koji] SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA; [Sankaranarayanan, Krithivasan; Spathis, Rita; Lum, J. Koji] SUNY Binghamton, Lab Evolutionary Anthropol & Hlth, Binghamton, NY USA; [Timofeeff, Michael N.; Lowenstein, Tim K.] SUNY Binghamton, Dept Geol Sci & Environm Studies, Binghamton, NY USA; [Spathis, Rita; Lum, J. Koji] SUNY Binghamton, Dept Anthropol, Binghamton, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Sankaranarayanan, K (corresponding author), SUNY Binghamton, Dept Biol Sci, Binghamton, NY 13902 USA.	ksankar1@binghamton.edu			Evolutionary Studies grant (EvoS grant, SUNY Binghamton); Interdisciplinary Collaboration Grant (ICG, SUNY Binghamton); Division Of Earth Sciences [1024692] Funding Source: National Science Foundation	Evolutionary Studies grant (EvoS grant, SUNY Binghamton); Interdisciplinary Collaboration Grant (ICG, SUNY Binghamton); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was funded by an Evolutionary Studies grant (EvoS grant, SUNY Binghamton, 2009) and an Interdisciplinary Collaboration Grant (ICG, SUNY Binghamton, 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Benison KC, 1999, CHEM GEOL, V154, P113, DOI 10.1016/S0009-2541(98)00127-2; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; CASAS E, 1989, J SEDIMENT PETROL, V59, P724; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fish SA, 2002, NATURE, V417, P432, DOI 10.1038/417432a; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANNI C, 1995, NUCLEIC ACIDS RES, V23, P881, DOI 10.1093/nar/23.5.881; HARDIE LA, 1985, P 6 INT S SALT, P11; Hebsgaard MB, 2005, TRENDS MICROBIOL, V13, P212, DOI 10.1016/j.tim.2005.03.010; Johnson SS, 2007, P NATL ACAD SCI USA, V104, P14401, DOI 10.1073/pnas.0706787104; Kemp BM, 2005, FORENSIC SCI INT, V154, P53, DOI 10.1016/j.forsciint.2004.11.017; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Lliros M, 2008, FEMS MICROBIOL ECOL, V66, P331, DOI 10.1111/j.1574-6941.2008.00583.x; Lowenstein T, 2002, DEV PALEOENVIRON RES, V2, P189; Lowenstein T. K., 2011, GSA TODAY, V21, P4, DOI DOI 10.1130/GSATG81A.1; LOWENSTEIN TK, 1988, GEOL SOC AM BULL, V100, P592, DOI 10.1130/0016-7606(1988)100<0592:OODCIA>2.3.CO;2; Lowenstein TK, 2005, GEOCHIM COSMOCHIM AC, V69, P1701, DOI 10.1016/j.gca.2004.09.015; McGenity TJ, 2000, ENVIRON MICROBIOL, V2, P243, DOI 10.1046/j.1462-2920.2000.00105.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NEI M, 1974, GENETICS, V76, P379; Park JS, 2009, GEOBIOLOGY, V7, P515, DOI 10.1111/j.1472-4669.2009.00218.x; RUANO G, 1989, NUCLEIC ACIDS RES, V17, P5407, DOI 10.1093/nar/17.13.5407; Satterfield CL, 2005, J SEDIMENT RES, V75, P534, DOI 10.2110/jsr.2005.044; Satterfield CL, 2005, GEOLOGY, V33, P265, DOI 10.1130/G21106.1; Schubert BA, 2010, ENVIRON MICROBIOL, V12, P440, DOI 10.1111/j.1462-2920.2009.02086.x; Schubert BA, 2010, GEOMICROBIOL J, V27, P61, DOI 10.1080/01490450903232207; Schubert BA, 2009, GEOLOGY, V37, P1059, DOI 10.1130/G30448A.1; Schubert BA, 2009, ASTROBIOLOGY, V9, P467, DOI 10.1089/ast.2008.0282; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VIGILANT L, 1991, SCIENCE, V253, P1503, DOI 10.1126/science.1840702; Vreeland RH, 2000, NATURE, V407, P897, DOI 10.1038/35038060; White T.J., 1990, PCR PROTOCOLS GUIDE, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Willerslev E, 2004, TRENDS ECOL EVOL, V19, P141, DOI 10.1016/j.tree.2003.11.010	36	17	18	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20683	10.1371/journal.pone.0020683	http://dx.doi.org/10.1371/journal.pone.0020683			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694765	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900019
J	Friebe, D; Loffler, D; Schonberg, M; Bernhard, F; Buttner, P; Landgraf, K; Kiess, W; Korner, A				Friebe, Daniela; Loeffler, Dennis; Schoenberg, Maria; Bernhard, Falk; Buettner, Petra; Landgraf, Kathrin; Kiess, Wieland; Koerner, Antje			Impact of Metabolic Regulators on the Expression of the Obesity Associated Genes FTO and NAMPT in Human Preadipocytes and Adipocytes	PLOS ONE			English	Article							INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; ADULT OBESITY; ENERGY-INTAKE; VISFATIN; CELLS; DIFFERENTIATION; ADIPONECTIN; VARIANT; GLUCOSE	Background: FTO and NAMPT/PBEF/visfatin are thought to play a role in obesity but their transcriptional regulation in adipocytes is not fully understood. In this study, we evaluated the transcriptional regulation of FTO and NAMPT in preadipocytes and adipocytes by metabolic regulators. Methodology and Principal Findings: We assessed FTO mRNA expression during human adipocyte differentiation of Simpson-Golabi-Behmel syndrome (SGBS) cells and primary subcutaneous preadipocytes in vitro and evaluated the effect of the metabolic regulators glucose, insulin, dexamethasone, IGF-1 and isoproterenol on FTO and NAMPT mRNA expression in SGBS preadipocytes and adipocytes. FTO mRNA levels were not significantly modulated during adipocyte differentiation. Also, metabolic regulators had no impact on FTO expression in preadipocytes or adipocytes. In SGBS preadipocytes NAMPT expression was more than 3fold induced by dexamethasone and isoproterenol and 1.6fold by dexamethasone in adipocytes. Complete glucose restriction caused an increase in NAMPT mRNA expression by more than 5fold and 1.4fold in SGBS preadipocytes and adipocytes, respectively. Conclusion: FTO mRNA expression is not significantly affected by differentiation or metabolic regulators in human adipocytes. The stimulation of NAMPT expression by dexamethasone, isoproterenol and complete glucose restriction may indicate a regulation of NAMPT by metabolic stress, which was more pronounced in preadipocytes compared to mature adipocytes.	[Friebe, Daniela; Loeffler, Dennis; Schoenberg, Maria; Bernhard, Falk; Buettner, Petra; Landgraf, Kathrin; Kiess, Wieland; Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, Leipzig, Germany; [Loeffler, Dennis; Landgraf, Kathrin; Koerner, Antje] Univ Leipzig, Med Ctr, IFB Adipos Dis, Leipzig, Germany	Leipzig University; Leipzig University	Friebe, D (corresponding author), Univ Leipzig, Univ Hosp Children & Adolescents, Leipzig, Germany.	antje.koerner@medizin.uni-leipzig.de	Büttner, Petra/ADR-1721-2022; Landgraf, Kathrin/J-4937-2016; Körner, Antje/B-3988-2015	Landgraf, Kathrin/0000-0002-6878-6033; Körner, Antje/0000-0001-6001-0356	German Research Council (DFG) [KFO 152 "Atherobesity" KO3512/1]; German Diabetes Association; Else Kroner-Fresenius Foundation; Integrated Research and Treatment Centre (IFB) Adiposity Diseases	German Research Council (DFG)(German Research Foundation (DFG)); German Diabetes Association; Else Kroner-Fresenius Foundation; Integrated Research and Treatment Centre (IFB) Adiposity Diseases	This work was supported by grants from the German Research Council (DFG) KFO 152 "Atherobesity" KO3512/1 (to AK), the German Diabetes Association (to DF and AK), the Else Kroner-Fresenius Foundation (to AK) and the Integrated Research and Treatment Centre (IFB) Adiposity Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; de Kreutzenberg SV, 2010, DIABETES, V59, P1006, DOI 10.2337/db09-1187; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; FRIEBE D, 2011, DIABETOLOGIA; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Gao X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014005; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Haider DG, 2006, DIABETOLOGIA, V49, P1909, DOI 10.1007/s00125-006-0303-7; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Hsu CP, 2009, CIRC RES, V105, P481, DOI 10.1161/CIRCRESAHA.109.203703; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jowett JBM, 2010, DIABETES, V59, P726, DOI 10.2337/db09-1277; Koerner A, 2005, BEST PRACT RES CL EN, V19, P525, DOI 10.1016/j.beem.2005.07.008; Korner A, 2005, BIOCHEM BIOPH RES CO, V337, P540, DOI 10.1016/j.bbrc.2005.09.064; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Kralisch S, 2005, AM J PHYSIOL-ENDOC M, V289, pE586, DOI 10.1152/ajpendo.00090.2005; MacLaren R, 2007, DIABETES OBES METAB, V9, P490, DOI 10.1111/j.1463-1326.2006.00625.x; McCarthy TL, 2000, ENDOCRINOLOGY, V141, P127, DOI 10.1210/en.141.1.127; Moschen AR, 2010, MUTAT RES-FUND MOL M, V690, P95, DOI 10.1016/j.mrfmmm.2009.06.012; OBERMAIER B, 1987, DIABETOLOGIA, V30, P93; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Richon VM, 1997, J BIOL CHEM, V272, P10117, DOI 10.1074/jbc.272.15.10117; Sakoda H, 2000, DIABETES, V49, P1700, DOI 10.2337/diabetes.49.10.1700; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; TEWS D, 2010, REGULATION FTO FTM E, DOI DOI 10.1055/S-0030-1265130; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; Wahlen K, 2008, J LIPID RES, V49, P607, DOI 10.1194/jlr.M700448-JLR200; Wu Q, 2010, BIOCHEM BIOPH RES CO, V401, P390, DOI 10.1016/j.bbrc.2010.09.064; Yang RZ, 2003, BIOCHEM BIOPH RES CO, V310, P927, DOI 10.1016/j.bbrc.2003.09.093; Yu YH, 2004, AM J PHYSIOL-ENDOC M, V286, pE402, DOI 10.1152/ajpendo.00247.2003; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0	45	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e19526	10.1371/journal.pone.0019526	http://dx.doi.org/10.1371/journal.pone.0019526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687707	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500002
J	Ibekwe, AM; Murinda, SE; Graves, AK				Ibekwe, A. Mark; Murinda, Shelton E.; Graves, Alexandria K.			Genetic Diversity and Antimicrobial Resistance of Escherichia coli from Human and Animal Sources Uncovers Multiple Resistances from Human Sources	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; SOURCE TRACKING; LAKE-SUPERIOR; WATER-QUALITY; BACTERIA; VIRULENCE; INTEGRONS; PROFILES; ONTARIO; GROWTH	Escherichia coli are widely used as indicators of fecal contamination, and in some cases to identify host sources of fecal contamination in surface water. Prevalence, genetic diversity and antimicrobial susceptibility were determined for 600 generic E. coli isolates obtained from surface water and sediment from creeks and channels along the middle Santa Ana River (MSAR) watershed of southern California, USA, after a 12 month study. Evaluation of E. coli populations along the creeks and channels showed that E. coli were more prevalent in sediment compared to surface water. E. coli populations were not significantly different (P = 0.05) between urban runoff sources and agricultural sources, however, E. coli genotypes determined by pulsed-field gel electrophoresis (PFGE) were less diverse in the agricultural sources than in urban runoff sources. PFGE also showed that E. coli populations in surface water were more diverse than in the sediment, suggesting isolates in sediment may be dominated by clonal populations. Twenty four percent (144 isolates) of the 600 isolates exhibited resistance to more than one antimicrobial agent. Most multiple resistances were associated with inputs from urban runoff and involved the antimicrobials rifampicin, tetracycline, and erythromycin. The occurrence of a greater number of E. coli with multiple antibiotic resistances from urban runoff sources than agricultural sources in this watershed provides useful evidence in planning strategies for water quality management and public health protection.	[Ibekwe, A. Mark] ARS, US Salin Lab, USDA, Riverside, CA USA; [Murinda, Shelton E.] Calif State Polytech Univ Pomona, Dept Anim & Vet Sci, Pomona, CA 91768 USA; [Graves, Alexandria K.] N Carolina State Univ, Dept Soil Sci, Raleigh, NC 27695 USA	United States Department of Agriculture (USDA); California State University System; California State Polytechnic University Pomona; University of North Carolina; North Carolina State University	Ibekwe, AM (corresponding author), ARS, US Salin Lab, USDA, Riverside, CA USA.	Mark.Ibekwe@ars.usda.gov		Ibekwe, Abasiofiok/0000-0003-3352-759X	United States Department of Agriculture-Agriculture research Service (USDA-ARS)	United States Department of Agriculture-Agriculture research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by the 206 Manure and Byproduct Utilization Project of the United States Department of Agriculture-Agriculture research Service (USDA-ARS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MA, 2006, APPL ENVIRON MICROB, V72, P6914, DOI 10.1128/AEM.01029-06; BEJ AK, 1991, APPL ENVIRON MICROB, V57, P1013, DOI 10.1128/AEM.57.4.1013-1017.1991; Beversdorf LJ, 2007, J APPL MICROBIOL, V102, P1372, DOI 10.1111/j.1365-2672.2006.03177.x; Boerlin P, 2005, APPL ENVIRON MICROB, V71, P6753, DOI 10.1128/AEM.71.11.6753-6761.2005; Byappanahalli MN, 1998, WATER SCI TECHNOL, V38, P171, DOI 10.1016/S0273-1223(98)00820-8; Byappanahalli MN, 2006, ENVIRON MICROBIOL, V8, P504, DOI 10.1111/j.1462-2920.2005.00916.x; *CLIN LAB STAND I, 2006, M02A9 CLIN LAB STAND; Eaton A.D., 1998, STANDARD METHOD EXAM; Finkel SE, 2000, BACTERIAL STRESS RESPONSES, P231; *FOOD DRUG ADM, 2003, GUID IND 152 EV SAF; Gow SP, 2008, APPL ENVIRON MICROB, V74, P3658, DOI 10.1128/AEM.02505-07; Graves AK, 2007, WATER RES, V41, P3729, DOI 10.1016/j.watres.2007.04.020; Graves AK, 2002, J ENVIRON QUAL, V31, P1300, DOI 10.2134/jeq2002.1300; HAREL J, 1991, J CLIN MICROBIOL, V29, P745, DOI 10.1128/JCM.29.4.745-752.1991; Ibekwe AM, 2008, J WATER HEALTH, V6, P411, DOI 10.2166/wh.2008.058; Ibekwe AM, 2003, APPL ENVIRON MICROB, V69, P5060, DOI 10.1128/AEM.69.9.5060-5069.2003; Ishii S, 2006, APPL ENVIRON MICROB, V72, P612, DOI 10.1128/AEM.72.1.612-621.2006; Ishii S, 2008, MICROBES ENVIRON, V23, P101, DOI 10.1264/jsme2.23.101; Ishii S, 2007, APPL ENVIRON MICROB, V73, P5703, DOI 10.1128/AEM.00275-07; IZBICKI J, 2004, 20045116 US GEOL SUR; Jacoby George A., 1994, Trends in Microbiology, V2, P357, DOI 10.1016/0966-842X(94)90611-4; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kerrn MB, 2002, J ANTIMICROB CHEMOTH, V50, P513, DOI 10.1093/jac/dkf164; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Ksoll WB, 2007, APPL ENVIRON MICROB, V73, P3771, DOI 10.1128/AEM.02654-06; Lanz R, 2003, VET MICROBIOL, V91, P73, DOI 10.1016/S0378-1135(02)00263-8; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Lu LG, 2004, WATER RES, V38, P3899, DOI 10.1016/j.watres.2004.06.020; Mathew AG, 2007, FOODBORNE PATHOG DIS, V4, P115, DOI 10.1089/fpd.2006.0066; Maynard C, 2004, J CLIN MICROBIOL, V42, P5444, DOI 10.1128/JCM.42.12.5444-5452.2004; Murinda SE, 2005, FOODBORNE PATHOG DIS, V2, P348, DOI 10.1089/fpd.2005.2.348; NASS T, 1994, GENETICS, V13, P721; Orman BE, 2002, ANTIMICROB AGENTS CH, V46, P3963, DOI 10.1128/AAC.46.12.3963-3970.2002; RICE WB, 2005, SANTA ANA REGIONAL W; Riehle MM, 2001, P NATL ACAD SCI USA, V98, P525, DOI 10.1073/pnas.021448998; Roberts MC, 1996, FEMS MICROBIOL REV, V19, P1, DOI 10.1111/j.1574-6976.1996.tb00251.x; Roberts MC, 2005, FEMS MICROBIOL LETT, V245, P195, DOI 10.1016/j.femsle.2005.02.034; ROSE JB, 1995, WATER QUALITY CONTRO, P8; SAS Institute, 2009, SAS STAT US GUID REL; Sharma R, 2008, APPL ENVIRON MICROB, V74, P6178, DOI 10.1128/AEM.00704-08; Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899; Stine OC, 2007, INT J ANTIMICROB AG, V29, P348, DOI 10.1016/j.ijantimicag.2006.11.015; Sunde M, 2005, J ANTIMICROB CHEMOTH, V56, P1019, DOI 10.1093/jac/dki377; TENOVER FC, 1998, MANUAL CLIN MICROBIO, P1578; Topp E, 2003, FEMS MICROBIOL ECOL, V44, P303, DOI 10.1016/S0168-6496(03)00055-2; Travis RM, 2006, J ANTIMICROB CHEMOTH, V58, P173, DOI 10.1093/jac/dkl207; *USEPA, 2001, 841R00002 USEPA; Whitman RL, 2003, APPL ENVIRON MICROB, V69, P5555, DOI 10.1128/AEM.69.9.5555-5562.2003; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003	50	70	70	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20819	10.1371/journal.pone.0020819	http://dx.doi.org/10.1371/journal.pone.0020819			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687635	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500048
J	Li, IC; Chan, CT; Lu, YF; Wu, YT; Chen, YC; Li, GB; Lin, CY; Hwang, SPL				Li, I-Chen; Chan, Chein-Tso; Lu, Yu-Fen; Wu, Yi-Ting; Chen, Yi-Chung; Li, Guo-Bin; Lin, Che-Yi; Hwang, Sheng-Ping L.			Zebrafish Kruppel-Like Factor 4a Represses Intestinal Cell Proliferation and Promotes Differentiation of Intestinal Cell Lineages	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; SIGNALING PATHWAY; EXPRESSION; GENE; KLF4; CANCER; KRUPPEL-LIKE-FACTOR-4; TRANSCRIPTION; EPITHELIUM; REQUIREMENT	Background: Mouse kruppel-like factor 4 (Klf4) is a zinc finger-containing transcription factor required for terminal differentiation of goblet cells in the colon. However, studies using either Klf4(-/-) mice or mice with conditionally deleted Klf4 in their gastric epithelia showed different results in the role of Klf4 in epithelial cell proliferation. We used zebrafish as a model organism to gain further understanding of the role of Klf4 in the intestinal cell proliferation and differentiation. Methodology/Principal Findings: We characterized the function of klf4a, a mammalian klf4 homologue by antisense morpholino oligomer knockdown. Zebrafish Klf4a shared high amino acid similarities with human and mouse Klf4. Phylogenetic analysis grouped zebrafish Klf4a together with both human and mouse Klf4 in a branch with high bootstrap value. In zebrafish, we demonstrate that Klf4a represses intestinal cell proliferation based on results of BrdU incorporation, p-Histone 3 immunostaining, and transmission electron microscopy analyses. Decreased PepT1 expression was detected in intestinal bulbs of 80- and 102-hours post fertilization (hpf) klf4a morphants. Significant reduction of alcian blue-stained goblet cell number was identified in intestines of 102- and 120-hpf klf4a morphants. Embryos treated with c-secretase inhibitor showed increased klf4a expression in the intestine, while decreased klf4a expression and reduction in goblet cell number were observed in embryos injected with Notch intracellular domain (NICD) mRNA. We were able to detect recovery of goblet cell number in 102-hpf embryos that had been co-injected with both klf4a and Notch 1a NICD mRNA. Conclusions/Significance: This study provides in vivo evidence showing that zebrafih Klf4a is essential for the repression of intestinal cell proliferation. Zebrafish Klf4a is required for the differentiation of goblet cells and the terminal differentiation of enterocytes. Moreover, the regulation of differentiation of goblet cells in zebrafish intestine by Notch signaling at least partially mediated through Klf4a.	[Li, I-Chen] Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan; [Lu, Yu-Fen; Wu, Yi-Ting; Chen, Yi-Chung; Hwang, Sheng-Ping L.] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Chan, Chein-Tso; Li, Guo-Bin; Lin, Che-Yi; Hwang, Sheng-Ping L.] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Keelung, Taiwan	National Tsing Hua University; Academia Sinica - Taiwan; National Taiwan Ocean University	Li, IC (corresponding author), Natl Tsing Hua Univ, Inst Mol & Cellular Biol, Hsinchu, Taiwan.	zoslh@gate.sinica.edu.tw	Hwang, Sheng-Ping/F-2882-2014; Lin, Che-Yi/AGC-9726-2022	Chen, Yi-Chun/0000-0002-2237-9416	National Science Council [NSC 95-2311-B-001-038, NSC 98-2321-B-001-028-MY3]; Academia Sinica [AS-97-TP-B06]	National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by grants from National Science Council (NSC 95-2311-B-001-038 and NSC 98-2321-B-001-028-MY3) and Academia Sinica (AS-97-TP-B06) to SPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoyel M, 2005, DEVELOPMENT, V132, P775, DOI 10.1242/dev.01616; Chen J, 2005, GENE DEV, V19, P2900, DOI 10.1101/gad.1366405; Chen XM, 2003, J MOL BIOL, V326, P665, DOI 10.1016/S0022-2836(02)01449-3; Chen XM, 2001, J BIOL CHEM, V276, P30423, DOI 10.1074/jbc.M101194200; Chen YH, 2009, DEV DYNAM, V238, P1021, DOI 10.1002/dvdy.21908; Cheng PY, 2008, DEVELOPMENT, V135, P941, DOI 10.1242/dev.010595; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Dang DT, 2003, ONCOGENE, V22, P3424, DOI 10.1038/sj.onc.1206413; Dang DT, 2000, FEBS LETT, V476, P203, DOI 10.1016/S0014-5793(00)01727-0; Ding Y, 2008, J CELL BIOL, V182, P865, DOI 10.1083/jcb.200803147; Evans PM, 2007, J BIOL CHEM, V282, P33994, DOI 10.1074/jbc.M701847200; Foster KW, 1999, CELL GROWTH DIFFER, V10, P423; Gardiner MR, 2005, DEV DYNAM, V234, P992, DOI 10.1002/dvdy.20571; GarrettSinha LA, 1996, J BIOL CHEM, V271, P31384, DOI 10.1074/jbc.271.49.31384; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Ghaleb AM, 2010, DEV BIOL; Ghaleb AM, 2008, MOL CANCER RES, V6, P1920, DOI 10.1158/1541-7786.MCR-08-0224; Hardison AL, 2005, MECH DEVELOP, V122, P949, DOI 10.1016/j.mod.2005.03.009; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Jiang Z, 2008, PLOS BIOL, V6, P2450, DOI 10.1371/journal.pbio.0060293; KARAM SM, 1999, FRONT BIOSCI, V4, P286; Katoh Y, 2006, INT J MOL MED, V18, P1019; Katz JP, 2005, GASTROENTEROLOGY, V128, P935, DOI 10.1053/j.gastro.2005.02.022; Katz JP, 2002, DEVELOPMENT, V129, P2619; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liuzzi JP, 2009, AM J PHYSIOL-GASTR L, V296, pG517, DOI 10.1152/ajpgi.90568.2008; Muncan V, 2007, EMBO REP, V8, P966, DOI 10.1038/sj.embor.7401071; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Pearson R, 2008, INT J BIOCHEM CELL B, V40, P1996, DOI 10.1016/j.biocel.2007.07.018; Peng MY, 2002, MOL REPROD DEV, V63, P422, DOI 10.1002/mrd.10201; Ro H, 2009, NAT CELL BIOL, V11, P1121, DOI 10.1038/ncb1926; Rowland BD, 2006, NAT REV CANCER, V6, P11, DOI 10.1038/nrc1780; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Verri T, 2003, FEBS LETT, V549, P115, DOI 10.1016/S0014-5793(03)00759-2; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wilson CW, 2009, NATURE, V459, P98, DOI 10.1038/nature07883; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Yoon HS, 2004, J BIOL CHEM, V279, P5035, DOI 10.1074/jbc.M307631200; Zariwala MA, 2007, ANNU REV PHYSIOL, V69, P423, DOI 10.1146/annurev.physiol.69.040705.141301; Zhang W, 2006, MOL CELL BIOL, V26, P2055, DOI 10.1128/MCB.26.6.2055-2064.2006; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Zhao WD, 2004, ONCOGENE, V23, P395, DOI 10.1038/sj.onc.1207067; Zheng H, 2009, AM J PHYSIOL-GASTR L, V296, pG490, DOI 10.1152/ajpgi.90393.2008; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276	49	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20974	10.1371/journal.pone.0020974	http://dx.doi.org/10.1371/journal.pone.0020974			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687630	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500054
J	Powell, RD; Whitworth, WC; Bernardo, J; Moonan, PK; Mazurek, GH				Powell, Richard D., III; Whitworth, William C.; Bernardo, John; Moonan, Patrick K.; Mazurek, Gerald H.			Unusual Interferon Gamma Measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube Tests	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS INFECTION; RELEASE ASSAYS; SKIN-TEST; DIAGNOSIS; DISEASE	Introduction: Interferon gamma (IFN-gamma) release assays, such as QuantiFERON (R)-TB Gold test (QFT-G) and QuantiFERON (R)-TB Gold In-Tube test (QFT-GIT) are designed to detect M. tuberculosis (Mtb) infection. Recognition of unusual IFN-gamma measurements may help indicate inaccurate results. Methods: We examined QFT-G and QFT-GIT results from subjects who had two or more tests completed. We classified unusual IFN-gamma measurements as: 1) High Nil Concentration (HNC) when IFN-gamma concentration in plasma from unstimulated blood exceeded 0.7 IU/mL; 2) Low Mitogen Response (LMR) when Mitogen Response was <0.5 IU/mL; 3) Very Low Mitogen Response (VLMR) when Mitogen Response was <=-0.5 IU/mL; and 4) Very Low Antigen Response (VLAR) when the response to a Mtb antigen was <=-0.35 IU/mL and <=-0.5 times the IFN-gamma concentration in plasma from unstimulated blood. Results: Among 5,309 results from 1,728 subjects, HNC occurred in 234 (4.4%) tests for 162 subjects, LMR in 108 (2.0%) tests for 85 subjects, VLMR in 22 (0.4%) tests for 21 subjects, and VLAR in 41 (0.8%) tests for 39 subjects. QFT-GIT had fewer HNC, VLMR, and VLAR (p = 0.042, 0.004, and 0.067 respectively); QFT-G had fewer LMR (p = 0.005). Twenty-four (51.6%) of 47 subjects with positive results and HNC were negative or indeterminate by all other tests. Thirteen (61.9%) of 21 subjects with positive results and LMR were negative or indeterminate by all other tests. Conclusion: Unusual IFN-gamma measurements including HNC, LMR, VLMR, and VLAR were encountered in small numbers, and in most instances were not seen on simultaneously or subsequently performed tests. To avoid erroneous diagnosis of Mtb infection, IGRAs with unusual IFN-gamma measurements should be repeated with another blood sample and interpreted with caution if they recur.	[Powell, Richard D., III; Whitworth, William C.; Moonan, Patrick K.; Mazurek, Gerald H.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA; [Bernardo, John] Boston Univ, Sch Med, Ctr Pulm, Boston, MA 02118 USA	Centers for Disease Control & Prevention - USA; Boston University	Powell, RD (corresponding author), Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA 30333 USA.	gym6@cdc.gov	Moonan, Patrick K/F-4307-2014; Moonan, Patrick/AAD-2169-2021	Moonan, Patrick/0000-0002-3550-2065; Bernardo, John/0000-0002-3922-0559				Aagaard C, 2004, J INFECT DIS, V189, P812, DOI 10.1086/381679; *AUSTRALIACELLESTI, 2010, QUANTIFERON TB GOLD; *AUSTRALIACELLESTI, 2007, QUANTIFERON TB GOLD; Brock I, 2004, J CLIN MICROBIOL, V42, P2379, DOI 10.1128/JCM.42.6.2379-2387.2004; Brock I, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-56; Cobanoglu N, 2007, INT J TUBERC LUNG D, V11, P1177; Diel R, 2008, AM J RESP CRIT CARE, V177, P1164, DOI 10.1164/rccm.200711-1613OC; Ferrara G, 2005, AM J RESP CRIT CARE, V172, P631, DOI 10.1164/rccm.200502-196OC; Kampmann B, 2005, J CLIN INVEST, V115, P2480, DOI 10.1172/JCI19316; Leyten EMS, 2006, J CLIN MICROBIOL, V44, P1197, DOI 10.1128/JCM.44.3.1197-1201.2006; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; Mazurek GH, 2007, CLIN INFECT DIS, V45, P826, DOI 10.1086/521106; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Mori T, 2004, AM J RESP CRIT CARE, V170, P59, DOI 10.1164/rccm.200402-179OC; National Institute for Health and Clinical Excellence, 2011, TUB CLIN DIAGN MAN T, V117; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Winthrop KL, 2008, CLIN J AM SOC NEPHRO, V3, P1357, DOI 10.2215/CJN.01010208; ZWERLING A, 2011, THORAX IN PRESS	19	24	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20061	10.1371/journal.pone.0020061	http://dx.doi.org/10.1371/journal.pone.0020061			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687702	Green Published, gold			2022-12-25	WOS:000291611500007
J	Stepanov, AV; Belogurov, AA; Ponomarenko, NA; Stremovskiy, OA; Kozlov, LV; Bichucher, AM; Dmitriev, SE; Smirnov, IV; Shamborant, OG; Balabashin, DS; Sashchenko, LP; Tonevitsky, AG; Friboulet, A; Gabibov, AG; Deyev, SM				Stepanov, Alexey V.; Belogurov, Alexey A., Jr.; Ponomarenko, Natalia A.; Stremovskiy, Oleg A.; Kozlov, Leonid V.; Bichucher, Anna M.; Dmitriev, Sergey E.; Smirnov, Ivan V.; Shamborant, Olga G.; Balabashin, Dmitry S.; Sashchenko, Lidia P.; Tonevitsky, Alexander G.; Friboulet, Alain; Gabibov, Alexander G.; Deyev, Sergey M.			Design of Targeted B Cell Killing Agents	PLOS ONE			English	Article							IN-VITRO; DEPENDENT TRANSLATION; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; DEPLETION; PROTEIN; AUTOANTIBODIES; ANTIBODIES; BARNASE; RIBONUCLEASE	B cells play an important role in the pathogenesis of both systemic and organ-specific autoimmune diseases. Autoreactive B cells not only produce autoantibodies, but also are capable to efficiently present specific autoantigens to T cells. Furthermore, B cells can secrete proinflammatory cytokines and amplify the vicious process of self-destruction. B cell-directed therapy is a potentially important approach for treatment of various autoimmune diseases. The depletion of B cells by anti-CD20/19 monoclonal antibody Retuximab (R) used in autoimmune diseases therapy leads to systemic side effects and should be significantly improved. In this study we designed a repertoire of genetically engineered B cell killers that specifically affected one kind of cells carrying a respective B cell receptor. We constructed immunotoxins (ITs), fused with c-myc epitope as a model targeting sequence, based on barnase, Pseudomonas toxin, Shiga-like toxin E. coli and Fc domain of human antibody IgG gamma 1. C-MYC hybridoma cell line producing anti-c-myc IgG was chosen as a model for targeted cell depletion. C-myc sequence fused with toxins provided addressed delivery of the toxic agent to the target cells. We demonstrated functional activity of designed ITs in vitro and showed recognition of the fusion molecules by antibodies produced by targeted hybridoma. To study specificity of the proposed B cells killing molecules, we tested a set of created ITs ex vivo, using C-MYC and irrelevant hybridoma cell lines. Pseudomonas-containing IT showed one of the highest cytotoxic effects on the model cells, however, possessed promiscuous specificity. Shiga-like toxin construct demonstrated mild both cytotoxicity and specificity. Barnase and Fc-containing ITs revealed excellent balance between their legibility and toxic properties. Moreover, barnase and Fc molecules fused with c-myc epitope were able to selectively deplete c-myc-specific B cells and decrease production of anti-c-myc antibodies in culture of native splenocytes, suggesting their highest therapeutic potential as targeted B cell killing agents.	[Stepanov, Alexey V.; Belogurov, Alexey A., Jr.; Ponomarenko, Natalia A.; Stremovskiy, Oleg A.; Smirnov, Ivan V.; Shamborant, Olga G.; Gabibov, Alexander G.; Deyev, Sergey M.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia; [Belogurov, Alexey A., Jr.; Sashchenko, Lidia P.; Gabibov, Alexander G.] Russian Acad Sci, Inst Gene Biol, Moscow, Russia; [Kozlov, Leonid V.; Bichucher, Anna M.] GN Gabrichevsky Res Inst Epidemiol & Microbiol, Moscow, Russia; [Dmitriev, Sergey E.; Tonevitsky, Alexander G.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Balabashin, Dmitry S.] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia; [Friboulet, Alain] Univ Technol Compiegne, F-60206 Compiegne, France	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences; G.N. Gabrichevsky Institute for Epidemiology & Microbiology; Lomonosov Moscow State University; Lomonosov Moscow State University; Picardie Universites; Universite de Technologie de Compiegne	Stepanov, AV (corresponding author), Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow, Russia.	gabibov@mx.ibch.ru; deyev@ibch.ru	Tonevitsky, Alexander/R-5596-2019; Deyev, Sergey M/F-8191-2014; Dmitriev, Sergey/D-9694-2011; Smirnov, Ivan/N-5635-2017; Belogurov, Alexey/L-5859-2017; Smirnov, Ivan V/B-2491-2014; Tonevitsky, Alexander G/F-8640-2014; Stepanov, Alexey/AAN-8721-2020	Deyev, Sergey M/0000-0002-3952-0631; Dmitriev, Sergey/0000-0002-1774-8475; Smirnov, Ivan/0000-0002-0384-6568; Belogurov, Alexey/0000-0002-2033-9621; Smirnov, Ivan V/0000-0002-0384-6568; Stepanov, Alexey/0000-0003-1616-4408; Ponomarenko, Natalia/0000-0003-3129-3515; Tonevitsky, Alexander/0000-0002-7079-7145	Russian Foundation of Basic Research [09-04-01201, 10-04-00673-a, ICGEB- CRP/RUS09-01]; Presidium of Russian Academy of Sciences [22]; Russian Federation [MK-5309.2011.4]; PICS CNRS [N 4238]; Russian Academy of Sciences; Russian Federal Agency for Science and Innovation	Russian Foundation of Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); PICS CNRS(Centre National de la Recherche Scientifique (CNRS)); Russian Academy of Sciences(Russian Academy of Sciences); Russian Federal Agency for Science and Innovation(Federal Agency for Science & Innovations (FASI))	This work was performed in frames of the Skolkovo program and supported by Russian Foundation of Basic Research grants #09-04-01201, 10-04-00673-a, ICGEB- CRP/RUS09-01, Program of Presidium of Russian Academy of Sciences No. 22, Nanotechnologies & Nanomaterials - "Fundamental Science to Medicine", U.M.N.I.K. Program, grant of the President of the Russian Federation MK-5309.2011.4, PICS CNRS N 4238 France-Russia, Russian Academy of Sciences Program Molecular and Cellular Biology, Russian Federal Agency for Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreev DE, 2009, NUCLEIC ACIDS RES, V37, P6135, DOI 10.1093/nar/gkp665; Belogurov AA, 2008, J IMMUNOL, V180, P1258, DOI 10.4049/jimmunol.180.2.1258; Belogurov A, 2009, BIOESSAYS, V31, P1161, DOI 10.1002/bies.200900020; Bizzaro N, 2008, CLIN REV ALLERG IMMU, V34, P326, DOI 10.1007/s12016-007-8059-5; Brenner T, 1999, IMMUNOL LETT, V68, P403, DOI 10.1016/S0165-2478(99)00089-9; Browning JL, 2006, NAT REV DRUG DISCOV, V5, P564, DOI 10.1038/nrd2085; Chatenoud L, 2005, INT REV IMMUNOL, V24, P247, DOI 10.1080/08830180590934994; Cheung MC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-28; Cohen SB, 2006, J RHEUMATOL, V33, P12; Dass S, 2007, ARTHRITIS RHEUM, V56, P2715, DOI 10.1002/art.22811; Deyev SM, 2003, NAT BIOTECHNOL, V21, P1486, DOI 10.1038/nbt916; Di Paolo C, 2003, CLIN CANCER RES, V9, P2837; Dmitriev SE, 2009, MOL BIOL+, V43, P108, DOI 10.1134/S0026893309010154; Dorner T, 2008, CURR OPIN RHEUMATOL, V20, P263, DOI 10.1097/BOR.0b013e3282f5e08d; Edelweiss E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002434; Edwards JCW, 2006, NAT REV IMMUNOL, V6, P394, DOI 10.1038/nri1838; Engedal N, 2011, MICROB BIOTECHNOL, V4, P32, DOI 10.1111/j.1751-7915.2010.00180.x; Goetz M, 2007, INFLAMM BOWEL DIS, V13, P1365, DOI 10.1002/ibd.20215; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Harris DP, 2000, NAT IMMUNOL, V1, P475, DOI 10.1038/82717; Hikada Masaki, 2010, Nat Immunol, V11, P1065, DOI 10.1038/ni1210-1065; IVANOV AE, 1991, BIOMED CHROMATOGR, V5, P90, DOI 10.1002/bmc.1130050210; Jang YJ, 2003, CELL MOL LIFE SCI, V60, P309, DOI 10.1007/s000180300026; Kaveri SV, 2008, NEW ENGL J MED, V359, P307, DOI 10.1056/NEJMcibr0803649; Kreitman RJ, 2006, AAPS J, V8, pE532, DOI 10.1208/aapsj080363; Kurkova IN, 2009, DOKL BIOCHEM BIOPHYS, V425, P94, DOI 10.1134/S1607672909020100; Leslie D, 2001, J CLIN INVEST, V108, P1417, DOI 10.1172/JCI14452; Li YM, 2008, J IMMUNOL, V181, P2961, DOI 10.4049/jimmunol.181.5.2961; Marriott JJ, 2010, REV RECENT CLIN TRIA, V5, P179, DOI 10.2174/157488710792007275; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Matsushita T, 2008, J CLIN INVEST, V118, P3420, DOI 10.1172/JCI36030; Mauri C, 2008, TRENDS IMMUNOL, V29, P34, DOI 10.1016/j.it.2007.10.004; Miga A., 2000, Immunological Investigations, V29, P111, DOI 10.3109/08820130009062292; MOSSAKOWSKA DE, 1989, BIOCHEMISTRY-US, V28, P3843, DOI 10.1021/bi00435a033; Nachreiner T, 2008, J NEUROIMMUNOL, V195, P28, DOI 10.1016/j.jneuroim.2008.01.001; Ng LG, 2005, MOL IMMUNOL, V42, P763, DOI 10.1016/j.molimm.2004.06.041; Ostergaard M, 2010, ARTHRITIS RHEUM-US, V62, P2227, DOI 10.1002/art.27524; Ouarzane Meryem, 2007, Methods Mol Biol, V361, P285; Schreiber G, 2000, METH MOL B, V160, P213; Shimomura Y, 2008, INT IMMUNOL, V20, P729, DOI 10.1093/intimm/dxn031; Tanimizu N, 2002, J BIOSCI BIOENG, V94, P39, DOI 10.1263/jbb.94.39; Tian J, 2001, J IMMUNOL, V167, P1081, DOI 10.4049/jimmunol.167.2.1081; Vorob'ev I I, 2001, Bioorg Khim, V27, P257; Wentworth P, 2002, SCIENCE, V298, P2195, DOI 10.1126/science.1077642; Zhang L, 1995, Ther Immunol, V2, P191; Zocher M, 2003, INT IMMUNOL, V15, P789, DOI 10.1093/intimm/dxg076	46	32	38	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20991	10.1371/journal.pone.0020991	http://dx.doi.org/10.1371/journal.pone.0020991			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21677771	gold, Green Published, Green Submitted			2022-12-25	WOS:000291356400039
J	Zeck, G; Lambacher, A; Fromherz, P				Zeck, Guenther; Lambacher, Armin; Fromherz, Peter			Axonal Transmission in the Retina Introduces a Small Dispersion of Relative Timing in the Ganglion Cell Population Response	PLOS ONE			English	Article							CONDUCTION-VELOCITY; OPTIC-NERVE; FIRING PATTERNS; EYE-MOVEMENTS; INFORMATION; CAT; DIAMETER; NEURONS; LATENCY; MONKEY	Background: Visual stimuli elicit action potentials in tens of different retinal ganglion cells. Each ganglion cell type responds with a different latency to a given stimulus, thus transforming the high-dimensional input into a temporal neural code. The timing of the first spikes between different retinal projection neurons cells may further change along axonal transmission. The purpose of this study is to investigate if intraretinal conduction velocity leads to a synchronization or dispersion of the population signal leaving the eye. Methodology/Principal Findings: We 'imaged' the initiation and transmission of light-evoked action potentials along individual axons in the rabbit retina at micron-scale resolution using a high-density multi-transistor array. We measured unimodal conduction velocity distributions (1.3 +/- 0.3 m/sec, mean +/- SD) for axonal populations at all retinal eccentricities with the exception of the central part that contains myelinated axons. The velocity variance within each piece of retina is caused by ganglion cell types that show narrower and slightly different average velocity tuning. Ganglion cells of the same type respond with similar latency to spatially homogenous stimuli and conduct with similar velocity. For ganglion cells of different type intraretinal conduction velocity and response latency to flashed stimuli are negatively correlated, indicating that differences in first spike timing increase (up to 10 msec). Similarly, the analysis of pair-wise correlated activity in response to white-noise stimuli reveals that conduction velocity and response latency are negatively correlated. Conclusion/Significance: Intraretinal conduction does not change the relative spike timing between ganglion cells of the same type but increases spike timing differences among ganglion cells of different type. The fastest retinal ganglion cells therefore act as indicators of new stimuli for postsynaptic neurons. The intraretinal dispersion of the population activity will not be compensated by variability in extraretinal conduction times, estimated from data in the literature.	[Zeck, Guenther] Max Planck Inst Neurobiol, Dept Syst & Computat Neurosci, Martinsried, Germany; [Zeck, Guenther] Univ Tubingen, Nat & Med Sci Inst, Neurochip Res Grp, Reutlingen, Germany; [Lambacher, Armin; Fromherz, Peter] Max Planck Inst Biochem, Dept Membrane & Neurophys, D-82152 Martinsried, Germany	Max Planck Society; Eberhard Karls University of Tubingen; Max Planck Society	Zeck, G (corresponding author), Max Planck Inst Neurobiol, Dept Syst & Computat Neurosci, Martinsried, Germany.	guenther.zeck@nmi.de	Zeck, Günther/H-7419-2013	Zeck, Günther/0000-0003-3998-9883	Max Planck Society; German Science Foundation [DFG ZE535/4-1]	Max Planck Society(Max Planck SocietyFoundation CELLEX); German Science Foundation(German Research Foundation (DFG))	This study was supported by the Max Planck Society and by a grant from the German Science Foundation (DFG ZE535/4-1) to G.Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMTHOR FR, 1989, J COMP NEUROL, V280, P72, DOI 10.1002/cne.902800107; Berry MJ, 1997, P NATL ACAD SCI USA, V94, P5411, DOI 10.1073/pnas.94.10.5411; Berson D., 2008, SENSES COMPREHENSIVE, P491, DOI DOI 10.1016/B978-012370880-9.00280-2; BISHOP PO, 1953, J PHYSIOL-LONDON, V121, P415, DOI 10.1113/jphysiol.1953.sp004955; BOLZ J, 1982, J PHYSIOL-LONDON, V328, P171, DOI 10.1113/jphysiol.1982.sp014258; CALDWELL JH, 1978, J PHYSIOL-LONDON, V276, P257, DOI 10.1113/jphysiol.1978.sp012232; Chase SM, 2007, P NATL ACAD SCI USA, V104, P5175, DOI 10.1073/pnas.0610368104; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; DeVries SH, 1997, J NEUROPHYSIOL, V78, P2048, DOI 10.1152/jn.1997.78.4.2048; DeVries SH, 1999, J NEUROPHYSIOL, V81, P908, DOI 10.1152/jn.1999.81.2.908; Eversmann B, 2003, IEEE J SOLID-ST CIRC, V38, P2306, DOI 10.1109/JSSC.2003.819174; Field GD, 2007, ANNU REV NEUROSCI, V30, P1, DOI 10.1146/annurev.neuro.30.051606.094252; Foffani G, 2009, J NEUROSCI, V29, P5964, DOI 10.1523/JNEUROSCI.4416-08.2009; FUKUDA Y, 1988, NEUROSCI RES, V6, P53, DOI 10.1016/0168-0102(88)90006-5; Gawne TJ, 1996, J NEUROPHYSIOL, V76, P1356, DOI 10.1152/jn.1996.76.2.1356; Gollisch T, 2008, SCIENCE, V319, P1108, DOI 10.1126/science.1149639; Greschner M, 2002, NAT NEUROSCI, V5, P341, DOI 10.1038/nn821; HODGKIN AL, 1954, J PHYSIOL-LONDON, V125, P221, DOI 10.1113/jphysiol.1954.sp005152; HOFFMEISTER B, 1991, NEUROSCIENCE, V42, P603, DOI 10.1016/0306-4522(91)90402-A; HONJIN R, 1977, ARCH HISTOL JAPON, V40, P321, DOI 10.1679/aohc1950.40.321; HSIAO CF, 1984, BRAIN RES, V309, P357; Jacobs AL, 2009, P NATL ACAD SCI USA, V106, P5936, DOI 10.1073/pnas.0900573106; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Karwoski CJ, 1999, VISUAL NEUROSCI, V16, P369, DOI 10.1017/S0952523899162163; Koch K, 2004, CURR BIOL, V14, P1523, DOI 10.1016/j.cub.2004.08.060; Lambacher A, 2004, APPL PHYS A-MATER, V79, P1607, DOI 10.1007/s00339-004-2991-5; Lambacher A, 2011, APPL PHYS A-MATER, V102, P1, DOI 10.1007/s00339-010-6046-9; Litke AM, 2004, IEEE T NUCL SCI, V51, P1434, DOI 10.1109/TNS.2004.832706; Masland RH, 2001, NAT NEUROSCI, V4, P877, DOI 10.1038/nn0901-877; MASTRONARDE DN, 1989, TRENDS NEUROSCI, V12, P75, DOI 10.1016/0166-2236(89)90140-9; Maunsell JHR, 1999, VISUAL NEUROSCI, V16, P1, DOI 10.1017/S0952523899156177; MEISTER M, 1994, J NEUROSCI METH, V51, P95, DOI 10.1016/0165-0270(94)90030-2; Menzler J, 2011, J NEUROSCI, V31, P2280, DOI 10.1523/JNEUROSCI.4238-10.2011; Nelken I, 2005, J COMPUT NEUROSCI, V19, P199, DOI 10.1007/s10827-005-1739-3; OYSTER CW, 1968, J PHYSIOL-LONDON, V199, P613, DOI 10.1113/jphysiol.1968.sp008671; Perge JA, 2009, J NEUROSCI, V29, P7917, DOI 10.1523/JNEUROSCI.5200-08.2009; Petrusca D, 2007, J NEUROSCI, V27, P11019, DOI 10.1523/JNEUROSCI.2836-07.2007; Pillow JW, 2008, NATURE, V454, P995, DOI 10.1038/nature07140; Plonsey R., 2007, BIOELECTRICITY QUANT; Reich DS, 1997, J NEUROPHYSIOL, V77, P2836, DOI 10.1152/jn.1997.77.5.2836; REICHENBACH A, 1991, ANAT EMBRYOL, V183, P287; Rockhill RL, 2002, J NEUROSCI, V22, P3831; ROWE MH, 1976, EXP BRAIN RES, V25, P339; SANCHEZ RM, 1986, INVEST OPHTH VIS SCI, V27, P1342; Schnitzer MJ, 2003, NEURON, V37, P499, DOI 10.1016/S0896-6273(03)00004-7; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Shlens J, 2008, CURR OPIN NEUROBIOL, V18, P396, DOI 10.1016/j.conb.2008.09.010; STANFORD LR, 1987, SCIENCE, V238, P358, DOI 10.1126/science.3659918; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Usrey WM, 2000, J PHYSIOL-LONDON, V523, P755, DOI 10.1111/j.1469-7793.2000.00755.x; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; VANEY DI, 1980, J COMP NEUROL, V189, P215, DOI 10.1002/cne.901890202; VANEY DI, 1981, EXP BRAIN RES, V44, P27; WASSLE H, 1975, EXP NEUROL, V49, P246, DOI 10.1016/0014-4886(75)90208-3; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; WILLIAMS RW, 1983, J NEUROSCI, V3, P1554; Zeck GM, 2005, EUR J NEUROSCI, V22, P2016, DOI 10.1111/j.1460-9568.2005.04390.x; Zeck GM, 2007, EUR J NEUROSCI, V26, P367, DOI 10.1111/j.1460-9568.2007.05670.x	59	31	31	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20810	10.1371/journal.pone.0020810	http://dx.doi.org/10.1371/journal.pone.0020810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674067	Green Published, gold			2022-12-25	WOS:000291310600034
J	Epstein, JM; Pankajakshan, R; Hammond, RA				Epstein, Joshua M.; Pankajakshan, Ramesh; Hammond, Ross A.			Combining Computational Fluid Dynamics and Agent-Based Modeling: A New Approach to Evacuation Planning	PLOS ONE			English	Article								We introduce a novel hybrid of two fields-Computational Fluid Dynamics (CFD) and Agent-Based Modeling (ABM)-as a powerful new technique for urban evacuation planning. CFD is a predominant technique for modeling airborne transport of contaminants, while ABM is a powerful approach for modeling social dynamics in populations of adaptive individuals. The hybrid CFD-ABM method is capable of simulating how large, spatially-distributed populations might respond to a physically realistic contaminant plume. We demonstrate the overall feasibility of CFD-ABM evacuation design, using the case of a hypothetical aerosol release in Los Angeles to explore potential effectiveness of various policy regimes. We conclude by arguing that this new approach can be powerfully applied to arbitrary population centers, offering an unprecedented preparedness and catastrophic event response tool.	[Epstein, Joshua M.] Johns Hopkins Univ, Dept Emergency Med, Ctr Adv Modeling, Baltimore, MD 21218 USA; [Epstein, Joshua M.] Santa Fe Inst, External Fac, Santa Fe, NM 87501 USA; [Epstein, Joshua M.] Univ Pittsburgh, Grad Sch Publ Hlth, Pittsburgh, PA USA; [Pankajakshan, Ramesh] Univ Tennessee, SimCtr Natl Ctr Computat Engn, Chattanooga, TN USA; [Hammond, Ross A.] Brookings Inst, Econ Studies Program, Ctr Social Dynam & Policy, Washington, DC 20036 USA	Johns Hopkins University; The Santa Fe Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Tennessee System; University of Tennessee at Chattanooga; Brookings Institution	Epstein, JM (corresponding author), Johns Hopkins Univ, Dept Emergency Med, Ctr Adv Modeling, Baltimore, MD 21218 USA.	jepste15@jhmi.edu			National Center for the Study of Preparedness and Catastrophic Event Response (PACER) at the Johns Hopkins University, through the U.S. Department of Homeland Security [N00014-06-1-0991]; Center for Public Health Practice by the Centers for Disease Control and Prevention [1P01TP000304]; Office of the Director, National Institutes of Health [DP1OD003874]; Tennessee Higher Education Commission [SES-0729262]; National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003874] Funding Source: NIH RePORTER	National Center for the Study of Preparedness and Catastrophic Event Response (PACER) at the Johns Hopkins University, through the U.S. Department of Homeland Security; Center for Public Health Practice by the Centers for Disease Control and Prevention; Office of the Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tennessee Higher Education Commission; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this effort was provided in part by The National Center for the Study of Preparedness and Catastrophic Event Response (PACER) at the Johns Hopkins University, through the U.S. Department of Homeland Security Grant N00014-06-1-0991 and through the Center for Public Health Practice by the Centers for Disease Control and Prevention (cooperative agreement 1P01TP000304). This project was also supported by Pioneer Award Number DP1OD003874 awarded to J.M. Epstein by the Office of the Director, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Office of the Director, National Institutes of Health or the National Institutes of Health, or the Office of Naval Research. This paper was also supported by a grant from the Tennessee Higher Education Commission and grant number SES-0729262 from the National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boris J, 2004, P SOC PHOTO-OPT INS, V5416, P1, DOI 10.1117/12.542852; Briley WR, 2003, J COMPUT PHYS, V184, P79, DOI 10.1016/S0021-9991(02)00018-9; Eley J., 2000, OFFICE SPACE PLANNIN; Epstein J.M., 1996, GROWING ARTIFICIAL S; Epstein J.M., 2006, GENERATIVE SOCIAL SC; Glass TA, 2002, CLIN INFECT DIS, V34, P217, DOI 10.1086/338711; Glimcher PW, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P1; Longini IM, 2007, INT J INFECT DIS, V11, P98, DOI 10.1016/j.ijid.2006.03.002; McEntire D., 2006, DISASTER RESPONSE RE; Simon H. A., 1982, MODELS BOUNDED RATIO; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	16	27	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 31	2011	6	5							e20139	10.1371/journal.pone.0020139	http://dx.doi.org/10.1371/journal.pone.0020139			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	770OP	21687788	Green Published, gold, Green Accepted			2022-12-25	WOS:000291097600023
J	Pergola, C; Rogge, A; Dodt, G; Northoff, H; Weinigel, C; Barz, D; Radmark, O; Sautebin, L; Werz, O				Pergola, Carlo; Rogge, Anja; Dodt, Gabriele; Northoff, Hinnak; Weinigel, Christina; Barz, Dagmar; Radmark, Olof; Sautebin, Lidia; Werz, Oliver			Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes	FASEB JOURNAL			English	Article						sex hormones; inflammation; extracellular signal-regulated kinases; 5-lipoxygenase	BLOOD MONONUCLEAR-CELLS; PROTEIN-KINASE; 5-LIPOXYGENASE; ACTIVATION; GENERATION; CALCIUM; MEN; ATHEROSCLEROSIS; INFLAMMATION; STIMULATION	Sex disparities in inflammation have been reported, but the cellular and molecular basis for these discrepancies is unknown. Monocytes are central effector cells in immunity and possess high capacities to produce proinflammatory leukotrienes (LTs). Here, we investigated sex differences in the activation of 5-lipoxygenase (5-LO), the key enzyme in LT biosynthesis, in human peripheral monocytes. In cells from females, 5-LO product formation was 1.8-fold higher than in cells from males, as evaluated by HPLC. When female monocytes were resuspended in plasma from males, 5-LO products were significantly lower than in female plasma. Interestingly, 5 alpha-dihydrotestosterone (5 alpha-DHT, 10 nM) repressed LT synthesis in female cells down to the levels observed in males, while estradiol (100 nM) was without effect, and progesterone (100 nM) caused only a slight inhibition. 5 alpha-DHT (10 nM) caused ERK phosphorylation and inhibition of phospholipase D (PLD), as evaluated by Western blot and measurement of PLD activity via radioenzymatic diacylglyceride (DAG) and nonradioactive choline assays. Accordingly, PLD activity and DAG formation were 1.4- to 1.8-fold lower in male vs. female monocytes connected to increased ERK phosphorylation. Our data indicate that ERK activation by androgens in monocytes represses PLD activity, resulting in impaired 5-LO product formation due to lack of activating DAGs.-Pergola, C., Rogge, A., Dodt, G., Northoff, H., Weinigel, C., Barz, D., Radmark, O., Sautebin, L., Werz, O. Testosterone suppresses phospholipase D, causing sex differences in leukotriene biosynthesis in human monocytes. FASEB J. 25, 3377-3387 (2011). www.fasebj.org	[Pergola, Carlo; Rogge, Anja; Werz, Oliver] Univ Jena, Inst Pharm, Dept Pharmaceut & Med Chem, D-07743 Jena, Germany; [Dodt, Gabriele] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Northoff, Hinnak] Univ Tubingen Hosp, Inst Clin & Expt Transfus Med, Tubingen, Germany; [Weinigel, Christina; Barz, Dagmar] Univ Hosp Jena, Inst Transfus Med, Jena, Germany; [Radmark, Olof] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 2, Stockholm, Sweden; [Sautebin, Lidia] Univ Naples Federico II, Dept Expt Pharmacol, Naples, Italy	Friedrich Schiller University of Jena; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Friedrich Schiller University of Jena; Karolinska Institutet; University of Naples Federico II	Werz, O (corresponding author), Univ Jena, Inst Pharm, Dept Pharmaceut & Med Chem, Philosophenweg 14, D-07743 Jena, Germany.	oliver.werz@uni-jena.de			Deutsche Forschungsgemeinschaft; Carl-Zeiss stipend	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Carl-Zeiss stipend	The authors thank Bianca Jazzar for expert technical assistance. This work was supported by the Deutsche Forschungsgemeinschaft. C.P. received a Carl-Zeiss stipend. The authors declare no conflicts of interest.	Albert D, 2003, BBA-MOL CELL BIOL L, V1631, P85, DOI 10.1016/S1388-1981(02)00359-1; Albert D, 2008, J LEUKOCYTE BIOL, V83, P1019, DOI 10.1189/jlb.0807531; Arain FA, 2009, CIRC J, V73, P1774, DOI 10.1253/circj.CJ-09-0588; Bae YS, 2000, J IMMUNOL, V164, P4089, DOI 10.4049/jimmunol.164.8.4089; Benten WPM, 1999, FASEB J, V13, P123, DOI 10.1096/fasebj.13.1.123; Chiang N, 2006, ARTERIOSCL THROM VAS, V26, pE14, DOI 10.1161/01.ATV.0000196729.98651.bf; Choi BG, 2007, ENDOCRIN METAB CLIN, V36, P365, DOI 10.1016/j.ecl.2007.03.011; Cutolo M, 2005, ARTHRITIS RES THER, V7, pR1124, DOI 10.1186/ar1791; CUTOLO M, 1991, ARTHRITIS RHEUM, V34, P1, DOI 10.1002/art.1780340102; Djerdjouri B, 1999, BIOCHEM BIOPH RES CO, V264, P371, DOI 10.1006/bbrc.1999.1533; English KM, 2000, CIRCULATION, V102, P1906, DOI 10.1161/01.CIR.102.16.1906; English KM, 2000, EUR HEART J, V21, P890, DOI 10.1053/euhj.1999.1873; Esser J, 2010, BIOCHEM J, V425, P265, DOI 10.1042/BJ20090856; Estrada M, 2003, ENDOCRINOLOGY, V144, P3586, DOI 10.1210/en.2002-0164; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goetzl EJ, 2010, FASEB J, V24, P3580, DOI 10.1096/fj.10-160911; Gosselin J, 1997, BLOOD, V89, P2122, DOI 10.1182/blood.V89.6.2122; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Haribabu B, 2000, J EXP MED, V192, P433, DOI 10.1084/jem.192.3.433; Horning C, 2005, J BIOL CHEM, V280, P26913, DOI 10.1074/jbc.M500068200; Kanda N, 1997, ARTHRITIS RHEUM-US, V40, P1703, DOI 10.1002/art.1780400921; Luo M, 2004, J BIOL CHEM, V279, P41512, DOI 10.1074/jbc.M312568200; Malkin CJ, 2003, J ENDOCRINOL, V178, P373, DOI 10.1677/joe.0.1780373; MIYAGI M, 1993, J PERIODONTOL, V64, P1075, DOI 10.1902/jop.1993.64.11.1075; Morishita M, 1999, J PERIODONTOL, V70, P757, DOI 10.1902/jop.1999.70.7.757; Murray AJ, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.122re4; O'Connor MF, 2007, AM J PHYSIOL-REG I, V293, pR145, DOI 10.1152/ajpregu.00752.2006; Osman M, 2003, ARCH DIS CHILD, V88, P587, DOI 10.1136/adc.88.7.587; Paruch S, 2005, FASEB J, V19, P142, DOI 10.1096/fj.05-3881fje; Pergola C, 2008, P NATL ACAD SCI USA, V105, P19881, DOI 10.1073/pnas.0809120105; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Poeckel D, 2009, J BIOL CHEM, V284, P21077, DOI 10.1074/jbc.M109.000901; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Rosano GMC, 1999, CIRCULATION, V99, P1666, DOI 10.1161/01.CIR.99.13.1666; SONDELL K, 1990, MECH AGEING DEV, V51, P55, DOI 10.1016/0047-6374(90)90161-8; Surette ME, 1996, J LEUKOCYTE BIOL, V59, P709, DOI 10.1002/jlb.59.5.709; Werz O, 2000, P NATL ACAD SCI USA, V97, P5261, DOI 10.1073/pnas.050588997; Werz O, 2002, FASEB J, V16, P1441, DOI 10.1096/fj.01-0909fje; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935	43	67	67	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3377	3387		10.1096/fj.11-182758	http://dx.doi.org/10.1096/fj.11-182758			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21693622				2022-12-25	WOS:000295356400010
J	Xu, Z; Adrover, M; Pastore, A; Prigent, S; Mouthon, F; Comoy, E; Rezaei, H; Deslys, JP				Xu, Zhou; Adrover, Miquel; Pastore, Annalisa; Prigent, Stephanie; Mouthon, Franck; Comoy, Emmanuel; Rezaei, Human; Deslys, Jean-Philippe			Mechanistic insights into cellular alteration of prion by poly-D-lysine: the role of H2H3 domain	FASEB JOURNAL			English	Article						misfolding; amyloid; PrP conversion	HETERONUCLEAR CORRELATION SPECTRA; SCRAPIE PRION; BRANCHED POLYAMINES; NMR-SPECTROSCOPY; PROTEIN; CELLS; IDENTIFICATION; THERAPEUTICS; AGGREGATION; CHAPERONE	Misfolding of the prion protein (PrP) is the central feature of prion diseases. The conversion of the normal alpha-helical PrP(C) into a pathological beta-enriched PrP(Sc) constitutes an early event in the infectious process. Several hypotheses, involving different regions of the protein, endeavor to delineate the structural mechanism underlying this change of conformation. All current working hypotheses, however, are based on biophysical and modeling studies, the biological relevance of which still needs to be assessed. We have studied the effect of positively charged polymers on the conversion, using polylysine as a model system, and have investigated a possible mechanism of structural stabilization. We have shown that poly-D-lysine removes proteinase K-resistant PrP from prion-infected SN56 neuroblastoma cells without affecting PrP(C). The effect is enantiospecific since the levorotary isomer, poly-L-lysine, has a markedly weaker effect, likely because of its higher susceptibility to degradation. In vitro cross-linking and NMR studies confirm a direct interaction between polylysine and PrP, which mainly maps to the PrP region containing helices 2 and 3 (H2H3). Interaction prevents conformational conversion and protein aggregation. Our results establish a central role of H2H3 in PrP(Sc) amyloidogenesis and replication and provide biological relevance for the pathological misfolding of this domain.-Xu, Z., Adrover, M., Pastore, A., Prigent, S., Mouthon, F., Comoy, E., Rezaei, H., Deslys, J. -P. Mechanistic insights into cellular alteration of prion by poly-D-lysine: the role of H2H3 domain. FASEB J. 25, 3426-3435 (2011). www.fasebj.org	[Pastore, Annalisa; Prigent, Stephanie; Rezaei, Human] INRA, Equipe Biol Physicochim Prions, F-78350 Jouy En Josas, France; [Xu, Zhou; Mouthon, Franck; Comoy, Emmanuel; Deslys, Jean-Philippe] Commiss Energie Atom, Serv Etud Prions & Infect Atyp, Inst Emerging Dis & Innovat Therapies, F-92265 Fontenay Aux Roses, France; [Adrover, Miquel] Univ Illes Balears, Dept Quim, Inst Univ Invest Ciencies Salut, E-07071 Palma de Mallorca, Spain; [Pastore, Annalisa] Natl Inst Med Res, Med Res Council, London NW7 1AA, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay; Universitat de les Illes Balears; MRC National Institute for Medical Research; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Rezaei, H (corresponding author), INRA, Equipe Biol Physicochim Prions, F-78350 Jouy En Josas, France.	human.rezaei@jouy.inra.fr; jpdeslys@cea.fr	Xu, Zhou/F-8513-2011	Xu, Zhou/0000-0001-9468-1406; Adrover, Miquel/0000-0002-4211-9013	MRC [MC_U117584256, MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117584256, MC_U117533887] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adrover M, 2010, J BIOL CHEM, V285, P21004, DOI 10.1074/jbc.M110.111815; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BROWN DR, 1994, NEUROREPORT, V5, P2057, DOI 10.1097/00001756-199410270-00017; Cashikar AG, 2002, MOL CELL, V9, P751, DOI 10.1016/S1097-2765(02)00499-9; CAUGHEY BW, 1991, BIOCHEMISTRY-US, V30, P7672, DOI 10.1021/bi00245a003; Chakroun N, 2010, FASEB J, V24, P3222, DOI 10.1096/fj.09-153924; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Cordeiro Y, 2001, J BIOL CHEM, V276, P49400, DOI 10.1074/jbc.M106707200; DAVIS AL, 1992, J MAGN RESON, V98, P207, DOI 10.1016/0022-2364(92)90126-R; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Eghiaian F, 2007, P NATL ACAD SCI USA, V104, P7414, DOI 10.1073/pnas.0607745104; Goddard T. D., 2008, SPARKY 3; HAMMOND DN, 1990, BRAIN RES, V512, P190, DOI 10.1016/0006-8993(90)90626-M; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kocisko DA, 2006, ANTIMICROB AGENTS CH, V50, P1034, DOI 10.1128/AAC.50.3.1034-1044.2006; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Li AM, 2007, EMBO J, V26, P548, DOI 10.1038/sj.emboj.7601507; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Marc D, 2007, CELL MOL LIFE SCI, V64, P815, DOI 10.1007/s00018-007-6370-1; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; Nguyen KV, 2002, BIOCHEM BIOPH RES CO, V291, P764, DOI 10.1006/bbrc.2002.6514; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rezaei H, 2000, EUR J BIOCHEM, V267, P2833, DOI 10.1046/j.1432-1033.2000.01347.x; Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x; Schatzl HM, 1997, J VIROL, V71, P8821; SNOW AD, 1989, ACTA NEUROPATHOL, V77, P337, DOI 10.1007/BF00687367; Solforosi L, 2004, SCIENCE, V303, P1514, DOI 10.1126/science.1094273; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; Supattapone S, 1999, P NATL ACAD SCI USA, V96, P14529, DOI 10.1073/pnas.96.25.14529; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vogtherr M, 2003, J MED CHEM, V46, P3563, DOI 10.1021/jm034093h	41	10	10	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3426	3435		10.1096/fj.11-187534	http://dx.doi.org/10.1096/fj.11-187534			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21697549				2022-12-25	WOS:000295356400014
J	Liu, ZM; Blattner, SM; Tu, YZ; Tisherman, R; Wang, JH; Rastaldi, MP; Kretzler, M; Wu, CY				Liu, Zhongmin; Blattner, Simone Monika; Tu, Yizeng; Tisherman, Robert; Wang, James H.; Rastaldi, Maria Pia; Kretzler, Matthias; Wu, Chuanyue			alpha-Actinin-4 and CLP36 Protein Deficiencies Contribute to Podocyte Defects in Multiple Human Glomerulopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; ACTIN CYTOSKELETON; MUTANT ALPHA-ACTININ-4; GLOMERULAR-DISEASES; STRESS FIBERS; SMOOTH-MUSCLE; CELL BIOLOGY; ADHESION; EXPRESSION; DYNAMICS	Genetic alterations of alpha-actinin-4 can cause podocyte injury through multiple mechanisms. Although a mechanism involving gain-of-alpha-actinin-4 function was well described and is responsible for a dominantly inherited form of human focal segmental glomerulosclerosis (FSGS), evidence supporting mechanisms involving loss-of-alpha-actinin-4 function in human glomerular diseases remains elusive. Here we show that alpha-actinin-4 deficiency occurs in multiple human primary glomerulopathies including sporadic FSGS, minimal change disease, and IgA nephropathy. Furthermore, we identify a close correlation between the levels of alpha-actinin-4 and CLP36, which form a complex in normal podocytes, in human glomerular diseases. siRNA-mediated depletion of alpha-actinin-4 in human podocytes resulted in a marked reduction of the CLP36 level. Additionally, two FSGS-associated alpha-actinin-4 mutations (R310Q and Q348R) inhibited the complex formation between alpha-actinin-4 and CLP36. Inhibition of the alpha-actinin-4-CLP36 complex, like loss of alpha-actinin-4, markedly reduced the level of CLP36 in podocytes. Finally, reduction of the CLP36 level or disruption of the alpha-actinin-4-CLP36 complex significantly inhibited RhoA activity and generation of traction force in podocytes. Our studies reveal a critical role of the alpha-actinin-4-CLP36 complex in podocytes and provide an explanation as to how alpha-actinin-4 deficiency or mutations found in human patients could contribute to podocyte defects and glomerular failure through a loss-of-function mechanism.	[Liu, Zhongmin; Tu, Yizeng; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Blattner, Simone Monika; Kretzler, Matthias] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Tisherman, Robert; Wang, James H.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Rastaldi, Maria Pia] Fdn DAmico Ric Malattie Renali, I-20122 Milan, Italy; [Rastaldi, Maria Pia] Fdn IRCCS Osped Maggiore Policlin, Renal Res Lab, I-20122 Milan, Italy	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; IRCCS Ca Granda Ospedale Maggiore Policlinico	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu		Tisherman, Robert/0000-0002-9710-808X	National Institutes of Health [DK54639, DK079912]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639, R01DK079912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54639 (to C.W.) and DK079912 (to M.K.).	Bauer K, 2000, BLOOD, V96, P4236; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Cheng HF, 2010, INT J BIOCHEM CELL B, V42, P1380, DOI 10.1016/j.biocel.2010.05.014; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Cybulsky AV, 2009, AM J PHYSIOL-RENAL, V297, pF987, DOI 10.1152/ajprenal.00055.2009; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Endlich N, 2006, EUR J CELL BIOL, V85, P229, DOI 10.1016/j.ejcb.2005.09.006; Faul C, 2007, TRENDS CELL BIOL, V17, P428, DOI 10.1016/j.tcb.2007.06.006; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Henderson JM, 2009, J AM SOC NEPHROL, V20, P961, DOI 10.1681/ASN.2008060613; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Jalanko H, 2001, ANN MED, V33, P526, DOI 10.3109/07853890108995962; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Lowik MM, 2009, EUR J PEDIATR, V168, P1291, DOI 10.1007/s00431-009-1017-x; Machuca E, 2009, HUM MOL GENET, V18, pR185, DOI 10.1093/hmg/ddp328; Mathieson PW, 2010, NEPHROL DIAL TRANSPL, V25, P1772, DOI 10.1093/ndt/gfq121; McCarthy HJ, 2011, NEPHRON EXP NEPHROL, V118, pE1, DOI 10.1159/000320878; Michaud JLR, 2006, KIDNEY INT, V70, P1054, DOI 10.1038/sj.ki.5001665; Michaud JLR, 2007, CLIN SCI, V112, P325, DOI 10.1042/CS20060143; Michaud JLR, 2009, CELL MOTIL CYTOSKEL, V66, P166, DOI 10.1002/cm.20339; Michaud JL, 2003, J AM SOC NEPHROL, V14, P1200, DOI 10.1097/01.ASN.0000059864.88610.5E; Moller CC, 2006, ADV CHRONIC KIDNEY D, V13, P166, DOI 10.1053/j.ackd.2006.01.009; Padiyar A, 2005, CURR MOL MED, V5, P497, DOI 10.2174/1566524054553487; Patrakka J, 2009, NAT REV NEPHROL, V5, P463, DOI 10.1038/nrneph.2009.108; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Pollak MR, 2008, CURR OPIN NEPHROL HY, V17, P138, DOI 10.1097/MNH.0b013e3282f5dbe4; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Rastaldi MP, 1996, J AM SOC NEPHROL, V7, P2419; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Shiu YT, 2004, BIOPHYS J, V86, P2558, DOI 10.1016/S0006-3495(04)74311-8; Tamura N, 2007, BIOCHEM BIOPH RES CO, V364, P589, DOI 10.1016/j.bbrc.2007.10.064; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Wang JHC, 2009, METHODS MOL BIOL, V586, P301, DOI 10.1007/978-1-60761-376-3_17; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706; Weins A, 2007, P NATL ACAD SCI USA, V104, P16080, DOI 10.1073/pnas.0702451104; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yang YQ, 2005, J AM SOC NEPHROL, V16, P1966, DOI 10.1681/ASN.2004121112; Yao J, 2004, PLOS BIOL, V2, P787, DOI 10.1371/journal.pbio.0020167; Zhang WW, 2006, J PHYSIOL-LONDON, V572, P659, DOI 10.1113/jphysiol.2006.106518; Zhang YJ, 2006, J BIOL CHEM, V281, P12397, DOI 10.1074/jbc.M512107200	46	14	16	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30795	30805		10.1074/jbc.M111.255984	http://dx.doi.org/10.1074/jbc.M111.255984			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21680739	Green Published, hybrid			2022-12-25	WOS:000294283600059
J	Wu, CY; Kang, HY; Yang, WL; Wu, J; Jeong, YS; Wang, J; Chan, CH; Lee, SW; Zhang, X; Lamothe, B; Campos, AD; Darnay, BG; Lin, HK				Wu, Ching-Yuan; Kang, Hong-Yo; Yang, Wei-Lei; Wu, Juan; Jeong, Yun Seong; Wang, Jing; Chan, Chia-Hsin; Lee, Szu-Wei; Zhang, Xian; Lamothe, Betty; Campos, Alejandro D.; Darnay, Bryant G.; Lin, Hui-Kuan			Critical Role of Monoubiquitination of Histone H2AX Protein in Histone H2AX Phosphorylation and DNA Damage Response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; UBIQUITINATION; UBIQUITYLATION; GAMMA-H2AX; ATM; RECOGNITION; FOCI; PK	DNA damage response is an important surveillance mechanism used to maintain the integrity of the human genome in response to genotoxic stress. Histone variant H2AX is a critical sensor that undergoes phosphorylation at serine 139 upon genotoxic stress, which provides a docking site to recruit the mediator of DNA damage checkpoint protein 1 (MDC1) and DNA repair protein complex to sites of DNA breaks for DNA repair. Here, we show that monoubiquitination of H2AX is induced upon DNA double strand breaks and plays a critical role in H2AX Ser-139 phosphorylation (gamma-H2AX), in turn facilitating the recruitment of MDC1 to DNA damage foci. Mechanistically, we show that monoubiquitination of H2AX induced by RING finger protein 2 (RNF2) is required for the recruitment of active ataxia telangiectasia mutated to DNA damage foci, thus affecting the formation of gamma-H2AX. Importantly, a defect in monoubiquitination of H2AX profoundly enhances ionizing radiation sensitivity. Our study therefore suggests that monoubiquitination of H2AX is an important step for DNA damage response and may have important clinical implications for the treatment of cancers.	[Wu, Ching-Yuan; Kang, Hong-Yo] Kaohsiung Chang Gung Mem Hosp, Grad Inst Clin Med Sci, Kaohsiung 833, Taiwan; [Wu, Ching-Yuan; Kang, Hong-Yo] Chang Gung Univ, Coll Med, Kaohsiung 833, Taiwan; [Wu, Ching-Yuan; Yang, Wei-Lei; Wu, Juan; Jeong, Yun Seong; Wang, Jing; Chan, Chia-Hsin; Lee, Szu-Wei; Zhang, Xian; Lin, Hui-Kuan] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Wu, Ching-Yuan] Kaohsiung Chang Gung Mem Hosp, Dept Chinese Med, Kaohsiung 833, Taiwan; [Yang, Wei-Lei; Jeong, Yun Seong; Lee, Szu-Wei; Zhang, Xian; Lin, Hui-Kuan] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Wu, Juan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Wu, Juan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Lamothe, Betty; Campos, Alejandro D.; Darnay, Bryant G.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	Chang Gung Memorial Hospital; Chang Gung University; University of Texas System; UTMD Anderson Cancer Center; Chang Gung Memorial Hospital; University of Texas System; University of Texas Health Science Center Houston; Sun Yat Sen University; Sun Yat Sen University; University of Texas System; UTMD Anderson Cancer Center	Kang, HY (corresponding author), Kaohsiung Chang Gung Mem Hosp, Grad Inst Clin Med Sci, Kaohsiung 833, Taiwan.	hkang3@adm.cgmh.org.tw; hklin@mdanderson.org	Chan, Chia-Hsin/AAT-7782-2020; Yang, Wei-Lei/E-2598-2012; Kang, Hong-Yo/W-9031-2019	Kang, Hong-Yo/0000-0003-0626-5037; Zhang, Xian/0000-0001-9674-7886; Chan, Chia-Hsin/0000-0001-8506-7500	National Institutes of Health [1RO1CA149321-01, 1R01CA136787-01A2]; M.D. Anderson Cancer Center; Department of Defense [PC081292]; NATIONAL CANCER INSTITUTE [R01CA149321, R01CA136787] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.D. Anderson Cancer Center; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1CA149321-01 and 1R01CA136787-01A2. This work was also supported by the Trust Scholar Fund from M.D. Anderson Cancer Center and New Investigator Award PC081292 from the Department of Defense (to H.K.L.).	Ayoub N, 2009, CELL CYCLE, V8, P1494, DOI 10.4161/cc.8.10.8501; Bassing CH, 2004, CELL CYCLE, V3, P149; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; HUEN MSSY, 2010, MOL CELLS, V11, P457; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kuhne M, 2004, CANCER RES, V64, P500, DOI 10.1158/0008-5472.CAN-03-2384; Leatherbarrow EL, 2006, INT J RADIAT BIOL, V82, P111, DOI 10.1080/09553000600599783; Lin HK, 2004, NATURE, V431, P205, DOI 10.1038/nature02783; Lin HK, 2009, NAT CELL BIOL, V11, P420, DOI 10.1038/ncb1849; Lukas C, 2004, EMBO J, V23, P2674, DOI 10.1038/sj.emboj.7600269; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Pan MR, 2011, J BIOL CHEM, V286, P28599, DOI 10.1074/jbc.M111.256297; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wu JX, 2009, MOL CELL BIOL, V29, P849, DOI 10.1128/MCB.01302-08; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065	31	66	71	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30806	30815		10.1074/jbc.M111.257469	http://dx.doi.org/10.1074/jbc.M111.257469			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21690091	hybrid, Green Published			2022-12-25	WOS:000294283600060
J	Harvey, H; Kus, JV; Tessier, L; Kelly, J; Burrows, LL				Harvey, Hanjeong; Kus, Julianne V.; Tessier, Luc; Kelly, John; Burrows, Lori L.			Pseudomonas aeruginosa D-Arabinofuranose Biosynthetic Pathway and Its Role in Type IV Pilus Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-RIBOSE 2'-EPIMERASE; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA-1244 PILIN; ESCHERICHIA-COLI; D-ARABINOSE; D-ARAF; GLYCOSYLATION; EXPRESSION; SEQUENCE; MUTANTS	Pseudomonas aeruginosa strains PA7 and Pa5196 glycosylate their type IVa pilins with alpha 1,5-linked D-arabinofuranose (D-Araf), a rare sugar configuration identical to that found in cell wall polymers of the Corynebacterineae. Despite this chemical identity, the pathway for biosynthesis of alpha 1,5-D-Araf in Gram-negative bacteria is unknown. Bioinformatics analyses pointed to a cluster of seven P. aeruginosa genes, including homologues of the Mycobacterium tuberculosis genes Rv3806c, Rv3790, and Rv3791, required for synthesis of a polyprenyl-linked D-ribose precursor and its epimerization to D-Araf. Pa5196 mutants lacking the orthologues of those genes had non-arabinosylated pilins, poor twitching motility, and significantly fewer surface pili than the wild type even in a retraction-deficient (pilT) background. The Pa5196 pilus system assembled heterologous nonglycosylated pilins efficiently, demonstrating that it does not require post-translationally modified subunits. Together the data suggest that pilins of group IV strains need to be glycosylated for productive subunit-subunit interactions. A recombinant P. aeruginosa PAO1 strain co-expressing the genes for D-Araf biosynthesis, the pilin modification enzyme TfpW, and the acceptor PilA(IV) produced arabinosylated pili, confirming that the Pa5196 genes identified are both necessary and sufficient. A P. aeruginosa epimerase knock-out could be complemented with the corresponding Mycobacterium smegmatis gene, demonstrating conservation between the systems of the Corynebacterineae and Pseudomonas. This work describes a novel Gram-negative pathway for biosynthesis of D-Araf, a key therapeutic target in Corynebacterineae.	[Burrows, Lori L.] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hlth Sci Ctr 4H18, Hamilton, ON L8N 3Z5, Canada; [Burrows, Lori L.] McMaster Univ, Dept Biochem & Biomed Sci, Hlth Sci Ctr 4H18, Hamilton, ON L8N 3Z5, Canada; [Kus, Julianne V.] Univ Toronto, Fac Dent, Toronto, ON M5G 1G5, Canada; [Tessier, Luc; Kelly, John] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	McMaster University; McMaster University; University of Toronto; National Research Council Canada	Burrows, LL (corresponding author), McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hlth Sci Ctr 4H18, 1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	burrowl@mcmaster.ca			Canadian Institutes of Health [Grant MOP-86639]	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP-86639 (to L. L. B.).	Asikyan ML, 2008, J BACTERIOL, V190, P7022, DOI 10.1128/JB.00938-08; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; CASTRIC P, 1995, MICROBIOL-UK, V141, P1247, DOI 10.1099/13500872-141-5-1247; Castric P, 2001, J BIOL CHEM, V276, P26479, DOI 10.1074/jbc.M102685200; Christophe T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000645; DEANGELIS PL, 1993, J BIOL CHEM, V268, P14568; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Gallant CV, 2005, MOL MICROBIOL, V58, P1012, DOI 10.1111/j.1365-2958.2005.04892.x; Giltner CL, 2011, ENVIRON MICROBIOL, V13, P250, DOI 10.1111/j.1462-2920.2010.02327.x; Hoang TT, 1998, GENE, V212, P77, DOI 10.1016/S0378-1119(98)00130-9; Huang HR, 2005, J BIOL CHEM, V280, P24539, DOI 10.1074/jbc.M504068200; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Keenleyside WJ, 1996, J BIOL CHEM, V271, P28581, DOI 10.1074/jbc.271.45.28581; King JD, 2009, FEBS J, V276, P2686, DOI 10.1111/j.1742-4658.2009.06993.x; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Kus JV, 2004, MICROBIOL-SGM, V150, P1315, DOI 10.1099/mic.0.26822-0; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manina G, 2010, CURR MED CHEM, V17, P3099, DOI 10.2174/092986710791959693; Mergaert P, 1997, MOL PLANT MICROBE IN, V10, P683, DOI 10.1094/MPMI.1997.10.5.683; Mikusova K, 2005, J BACTERIOL, V187, P8020, DOI 10.1128/JB.187.23.8020-8025.2005; Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Smedley JG, 2005, INFECT IMMUN, V73, P7922, DOI 10.1128/IAI.73.12.7922-7931.2005; Trefzer C, 2010, J AM CHEM SOC, V132, P13663, DOI 10.1021/ja106357w; Voisin S, 2007, J BACTERIOL, V189, P151, DOI 10.1128/JB.01224-06; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; Winsor GL, 2009, NUCLEIC ACIDS RES, V37, pD483, DOI 10.1093/nar/gkn861; WOLUCKA BA, 1994, J BIOL CHEM, V269, P23328; Wolucka BA, 2008, FEBS J, V275, P2691, DOI 10.1111/j.1742-4658.2008.06395.x	35	19	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28128	28137		10.1074/jbc.M111.255794	http://dx.doi.org/10.1074/jbc.M111.255794			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676874	Green Published, hybrid			2022-12-25	WOS:000293557800031
J	McMillin, SM; Heusel, M; Liu, T; Costanzi, S; Wess, J				McMillin, Sara M.; Heusel, Moritz; Liu, Tong; Costanzi, Stefano; Wess, Juergen			Structural Basis of M-3 Muscarinic Receptor Dimer/Oligomer Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RESONANCE ENERGY-TRANSFER; ACETYLCHOLINE-RECEPTORS; QUANTITATIVE-ANALYSIS; INTERNATIONAL UNION; SECRETIN RECEPTOR; REVEALS OLIGOMERS; HORMONE RECEPTOR; MOLECULAR-BASIS; DRUG DISCOVERY	Class A G protein-coupled receptors (GPCRs) are known to form dimers and/or oligomeric arrays in vitro and in vivo. These complexes are thought to play important roles in modulating class A GPCR function. Many studies suggest that residues located on the "outer" (lipid-facing) surface of the transmembrane (TM) receptor core are critically involved in the formation of class A receptor dimers (oligomers). However, no clear consensus has emerged regarding the identity of the TM helices or TM subsegments involved in this process. To shed light on this issue, we have used the M-3 muscarinic acetylcholine receptor (M3R), a prototypic class A GPCR, as a model system. Using a comprehensive and unbiased approach, we subjected all outward-facing residues (70 amino acids total) of the TM helical bundle (TM1-7) of the M3R to systematic alanine substitution mutagenesis. We then characterized the resulting mutant receptors in radioligand binding and functional studies and determined their ability to form dimers (oligomers) in bioluminescence resonance energy transfer saturation assays. We found that M3R/M3R interactions are not dependent on the presence of one specific structural motif but involve the outer surfaces of multiple TM subsegments (TM1-5 and -7) located within the central and endofacial portions of the TM receptor core. Moreover, we demonstrated that the outward-facing surfaces of most TM helices play critical roles in proper receptor folding and/or function. Guided by the bioluminescence resonance energy transfer data, molecular modeling studies suggested the existence of multiple dimeric/oligomeric M3R arrangements, which may exist in a dynamic equilibrium. Given the high structural homology found among all class A GPCRs, our results should be of considerable general relevance.	[Wess, Juergen] NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bethesda, MD 20892 USA; [Costanzi, Stefano] NIDDK, Lab Biol Modeling, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wess, J (corresponding author), NIDDK, Mol Signaling Sect, Bioorgan Chem Lab, NIH, Bldg 8A,Rm B1A-05,8 Ctr Dr,MSC 0810, Bethesda, MD 20892 USA.	jwess@helix.nih.gov	Costanzi, Stefano/G-8990-2013	Costanzi, Stefano/0000-0003-3183-7332	National Institutes of Health, NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK013025, ZIADK031129] Funding Source: NIH RePORTER	National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program, NIDDK.	Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Angers S, 2002, ANNU REV PHARMACOL, V42, P409, DOI 10.1146/annurev.pharmtox.42.091701.082314; [Anonymous], 2010, PRIM VERS 2 2; [Anonymous], 2010, MAESTR VERS 9 1; Ayoub MA, 2004, MOL PHARMACOL, V66, P312, DOI 10.1124/mol.104.000398; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; BLUML K, 1994, J BIOL CHEM, V269, P402; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Breit A, 2004, J BIOL CHEM, V279, P28756, DOI 10.1074/jbc.M313310200; Carrillo JJ, 2004, MOL PHARMACOL, V66, P1123, DOI 10.1124/mol.104.001586; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Ciruela F, 2010, TRENDS BIOTECHNOL, V28, P407, DOI 10.1016/j.tibtech.2010.05.002; Davies A, 2001, J MOL BIOL, V314, P455, DOI 10.1006/jmbi.2001.5167; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Filizola M, 2005, FEBS J, V272, P2926, DOI 10.1111/j.1742-4658.2005.04730.x; Fonseca JM, 2009, MOL PHARMACOL, V75, P1296, DOI 10.1124/mol.108.053876; Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2; Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a; Fung JJ, 2009, EMBO J, V28, P3315, DOI 10.1038/emboj.2009.267; Gao F, 2009, MOL PHARMACOL, V76, P264, DOI 10.1124/mol.109.055756; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gautam D, 2009, P NATL ACAD SCI USA, V106, P6398, DOI 10.1073/pnas.0900977106; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102; Guo W, 2003, J BIOL CHEM, V278, P4385, DOI 10.1074/jbc.C200679200; Guo W, 2008, EMBO J, V27, P2293, DOI 10.1038/emboj.2008.153; Gurevich VV, 2008, TRENDS PHARMACOL SCI, V29, P234, DOI 10.1016/j.tips.2008.02.004; Han Y, 2009, NAT CHEM BIOL, V5, P688, DOI 10.1038/nchembio.199; Harikumar KG, 2007, J BIOL CHEM, V282, P30363, DOI 10.1074/jbc.M702325200; Hebert TE, 1996, J BIOL CHEM, V271, P16384, DOI 10.1074/jbc.271.27.16384; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Hernanz-Falcon P, 2004, NAT IMMUNOL, V5, P216, DOI 10.1038/ni1027; Hu JX, 2010, NAT CHEM BIOL, V6, P541, DOI [10.1038/NCHEMBIO.385, 10.1038/nchembio.385]; Klco JM, 2009, FEBS J, V276, P2786, DOI 10.1111/j.1742-4658.2009.07002.x; Klco JM, 2003, J BIOL CHEM, V278, P35345, DOI 10.1074/jbc.M305606200; Kota P, 2006, P NATL ACAD SCI USA, V103, P3054, DOI 10.1073/pnas.0510982103; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Li B, 2005, J BIOL CHEM, V280, P5664, DOI 10.1074/jbc.M411623200; Li B, 2007, NAT METHODS, V4, P169, DOI 10.1038/nmeth990; Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200; Lodowski DT, 2007, J STRUCT BIOL, V158, P455, DOI 10.1016/j.jsb.2007.01.017; Lopez-Gimenez JF, 2007, MOL PHARMACOL, V71, P1015, DOI 10.1124/mol.106.033035; MAGGIO R, 1993, P NATL ACAD SCI USA, V90, P3103, DOI 10.1073/pnas.90.7.3103; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Mercier JF, 2002, J BIOL CHEM, V277, P44925, DOI 10.1074/jbc.M205767200; Milligan G, 2007, BBA-BIOMEMBRANES, V1768, P825, DOI 10.1016/j.bbamem.2006.09.021; Milligan G, 2010, CURR OPIN PHARMACOL, V10, P23, DOI 10.1016/j.coph.2009.09.010; Oki T, 2005, MOL BRAIN RES, V133, P6, DOI 10.1016/j.molbrainres.2004.09.012; Palczewski K, 2010, TRENDS BIOCHEM SCI, V35, P595, DOI 10.1016/j.tibs.2010.05.002; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pin JP, 2009, J PHYSIOL-LONDON, V587, P5337, DOI 10.1113/jphysiol.2009.179978; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Pioszak AA, 2010, J BIOL CHEM, V285, P12435, DOI 10.1074/jbc.M109.093138; Pisterzi LF, 2010, J BIOL CHEM, V285, P16723, DOI 10.1074/jbc.M109.069443; Raufman JP, 2008, CANCER RES, V68, P3573, DOI 10.1158/0008-5472.CAN-07-6810; Rovira X, 2010, TRENDS PHARMACOL SCI, V31, P15, DOI 10.1016/j.tips.2009.10.008; SCHONEBERG T, 1995, J BIOL CHEM, V270, P18000; Shi Y, 2010, CELL METAB, V11, P231, DOI 10.1016/j.cmet.2010.01.005; Song GJ, 2007, P NATL ACAD SCI USA, V104, P18303, DOI 10.1073/pnas.0702857104; Terrillon S, 2003, MOL ENDOCRINOL, V17, P677, DOI 10.1210/me.2002-0222; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; WESS J, 1993, EMBO J, V12, P331, DOI 10.1002/j.1460-2075.1993.tb05661.x; Wess J, 1996, CRIT REV NEUROBIOL, V10, P69, DOI 10.1615/CritRevNeurobiol.v10.i1.40; Wess J, 1998, PHARMACOL THERAPEUT, V80, P231, DOI 10.1016/S0163-7258(98)00030-8; Wess J, 2007, NAT REV DRUG DISCOV, V6, P721, DOI 10.1038/nrd2379; White JF, 2007, P NATL ACAD SCI USA, V104, P12199, DOI 10.1073/pnas.0705312104; Whorton MR, 2008, J BIOL CHEM, V283, P4387, DOI 10.1074/jbc.M703346200; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487	71	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28584	28598		10.1074/jbc.M111.259788	http://dx.doi.org/10.1074/jbc.M111.259788			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685385	Green Published, hybrid			2022-12-25	WOS:000293557800073
J	Lewis, SM; Kuhlman, BA				Lewis, Steven M.; Kuhlman, Brian A.			Anchored Design of Protein-Protein Interfaces	PLOS ONE			English	Article							COMPUTATIONAL REDESIGN; BINDING-SPECIFICITY; MOLECULAR RECOGNITION; HIGH-AFFINITY; LOOP CLOSURE; III DOMAIN; HOT-SPOTS; RECEPTOR; ROSETTA; IMPROVEMENT	Background: Few existing protein-protein interface design methods allow for extensive backbone rearrangements during the design process. There is also a dichotomy between redesign methods, which take advantage of the native interface, and de novo methods, which produce novel binders. Methodology: Here, we propose a new method for designing novel protein reagents that combines advantages of redesign and de novo methods and allows for extensive backbone motion. This method requires a bound structure of a target and one of its natural binding partners. A key interaction in this interface, the anchor, is computationally grafted out of the partner and into a surface loop on the design scaffold. The design scaffold's surface is then redesigned with backbone flexibility to create a new binding partner for the target. Careful choice of a scaffold will bring experimentally desirable characteristics into the new complex. The use of an anchor both expedites the design process and ensures that binding proceeds against a known location on the target. The use of surface loops on the scaffold allows for flexible-backbone redesign to properly search conformational space. Conclusions and Significance: This protocol was implemented within the Rosetta3 software suite. To demonstrate and evaluate this protocol, we have developed a benchmarking set of structures from the PDB with loop-mediated interfaces. This protocol can recover the correct loop-mediated interface in 15 out of 16 tested structures, using only a single residue as an anchor.	[Lewis, Steven M.; Kuhlman, Brian A.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Lewis, SM (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	bkuhlman@email.unc.edu			United States National Institutes of Health [GM073960]; Defense Advanced Research Projects Agency; W.M. Keck Foundation; University of North Carolina Pogue; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073960] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); W.M. Keck Foundation(W.M. Keck Foundation); University of North Carolina Pogue; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health (GM073960), the Defense Advanced Research Projects Agency, and the W.M. Keck Foundation. SML was supported by a University of North Carolina Pogue Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batori V, 2002, PROTEIN ENG, V15, P1015, DOI 10.1093/protein/15.12.1015; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Canutescu AA, 2003, PROTEIN SCI, V12, P963, DOI 10.1110/ps.0242703; Chevalier BS, 2002, MOL CELL, V10, P895, DOI 10.1016/S1097-2765(02)00690-1; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Coutsias EA, 2006, INT J QUANTUM CHEM, V106, P176, DOI 10.1002/qua.20751; Daily MD, 2005, PROTEINS, V60, P181, DOI 10.1002/prot.20555; Fleishman SJ, 2010, PROTEINS, V78, P3212, DOI 10.1002/prot.22784; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; GULYANI A, NATURE CHEM IN PRESS; Haidar JN, 2009, PROTEINS, V74, P948, DOI 10.1002/prot.22203; Hu XZ, 2007, P NATL ACAD SCI USA, V104, P17668, DOI 10.1073/pnas.0707977104; Huang PS, 2007, PROTEIN SCI, V16, P2770, DOI 10.1110/ps.073125207; Janin J, 2010, MOL BIOSYST, V6, P2351, DOI 10.1039/c005060c; Jha RK, 2010, J MOL BIOL, V400, P257, DOI 10.1016/j.jmb.2010.05.006; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Karatan E, 2004, CHEM BIOL, V11, P835, DOI 10.1016/j.chembiol.2004.04.009; Kaufmann KW, 2010, BIOCHEMISTRY-US, V49, P2987, DOI 10.1021/bi902153g; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Koide A, 2002, P NATL ACAD SCI USA, V99, P1253, DOI 10.1073/pnas.032665299; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Mandell DJ, 2009, CURR OPIN BIOTECH, V20, P420, DOI 10.1016/j.copbio.2009.07.006; Mandell DJ, 2009, NAT CHEM BIOL, V5, P797, DOI 10.1038/nchembio.251; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Meireles LMC, 2010, NUCLEIC ACIDS RES, V38, pW407, DOI 10.1093/nar/gkq502; Murphy PM, 2009, P NATL ACAD SCI USA, V106, P9215, DOI 10.1073/pnas.0811070106; Potapov V, 2008, J MOL BIOL, V384, P109, DOI 10.1016/j.jmb.2008.08.078; Reynolds KA, 2008, J MOL BIOL, V382, P1265, DOI 10.1016/j.jmb.2008.05.051; Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629; ROHL CA, 2004, METHODS ENZYMOL, V383; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Schmidt AE, 2005, J BIOL CHEM, V280, P27832, DOI 10.1074/jbc.M504105200; Liu S, 2007, P NATL ACAD SCI USA, V104, P5330, DOI 10.1073/pnas.0606198104; Shifman JM, 2003, P NATL ACAD SCI USA, V100, P13274, DOI 10.1073/pnas.2234277100; Shifman JM, 2002, J MOL BIOL, V323, P417, DOI 10.1016/S0022-2836(02)00881-1; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Song G, 2006, J BIOL CHEM, V281, P5042, DOI 10.1074/jbc.M510454200; Stanfield RL, 2007, J MOL BIOL, V367, P358, DOI 10.1016/j.jmb.2006.12.045; Wallen JR, 2008, BIOCHEMISTRY-US, V47, P5182, DOI 10.1021/bi8002204; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050	50	59	62	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20872	10.1371/journal.pone.0020872	http://dx.doi.org/10.1371/journal.pone.0020872			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698112	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600024
J	Marrazzo, G; Bellner, L; Halilovic, A; Volti, GL; Drago, F; Dunn, MW; Schwartzman, ML				Marrazzo, Giuseppina; Bellner, Lars; Halilovic, Adna; Volti, Giovanni Li; Drago, Filippo; Dunn, Michael W.; Schwartzman, Michal Laniado			The Role of Neutrophils in Corneal Wound Healing in HO-2 Null Mice	PLOS ONE			English	Article							HEME OXYGENASE SYSTEM; CELLULAR PROLIFERATION; INFLAMMATORY RESPONSE; EPITHELIAL ABRASION; BILIVERDIN; MIGRATION; CYTOKINE; PATHWAY; INJURY; REPAIR	Our studies demonstrated that Heme oxygenase (HO), in particular, the constitutive HO-2, is critical for a self-resolving inflammatory and repair response in the cornea. Epithelial injury in HO-2 null mice leads to impaired wound closure and chronic inflammation in the cornea. This study was undertaken to examine the possible relationship between HO-2 and the recruitment of neutrophils following a corneal surface injury in wild type (WT) and HO-2 knockout (HO-2(-/-)) mice treated with Gr-1 monoclonal antibody to deplete peripheral neutrophils. Epithelial injury was performed by removing the entire corneal epithelium. Infiltration of inflammatory cell into the cornea in response to injury was higher in HO-2(-/-) than in WT. However, the rate of corneal wound closure following neutrophil depletion was markedly inhibited in both WT and HO-2(-/-) mice by 60% and 85%, respectively. Neutropenia induced HO-1 expression in WT but not in HO-2(-/-) mice. Moreover, endothelial cells lacking HO-2 expressed higher levels of the Midkine and VE-cadherin and displayed strong adhesion to neutrophils suggesting that perturbation in endothelial cell function caused by HO-2 depletion underlies the increased infiltration of neutrophils into the HO-2(-/-) cornea. Moreover, the fact that neutropenia worsened epithelial healing of the injured cornea in both WT and HO-2(-/-) mice suggest that cells other than neutrophils contribute to the exaggerated inflammation and impaired wound healing seen in the HO-2 null cornea.	[Marrazzo, Giuseppina; Bellner, Lars; Halilovic, Adna; Dunn, Michael W.; Schwartzman, Michal Laniado] New York Med Coll, Dept Pharmacol & Ophthalmol, Valhalla, NY 10595 USA; [Marrazzo, Giuseppina; Volti, Giovanni Li] Univ Catania, Dept Drug Sci, Biochem Sect, Catania, Italy; [Drago, Filippo] Univ Catania, Dept Expt & Clin Pharmacol, Catania, Italy	New York Medical College; University of Catania; University of Catania	Marrazzo, G (corresponding author), New York Med Coll, Dept Pharmacol & Ophthalmol, Valhalla, NY 10595 USA.	giuseppina_marrazzo@nymc.edu; michal_schwartzman@nymc.edu	Drago, Filippo/AAC-5090-2022; Drago, Francesco/H-7563-2019; Volti, Giovanni Li/A-2435-2008; Drago, Filippo/K-5619-2018	Volti, Giovanni Li/0000-0002-8678-2183; Drago, Filippo/0000-0003-2887-5223	National Eye Institutes [EY06513]; University of Catania Medical School, Catania, Italy; NATIONAL EYE INSTITUTE [R01EY006513] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034300] Funding Source: NIH RePORTER	National Eye Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); University of Catania Medical School, Catania, Italy; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This manuscript was supported in part by a grant from the National Eye Institutes EY06513. Dr. Giuseppina Marrazzo was supported by the International Ph.D. Program in Neuropharmacology, University of Catania Medical School, Catania, Italy. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Ahmadi Arash J., 2002, International Ophthalmology Clinics, V42, P13; BELLNER L, 2011, INVEST OPHTHALMOL VI; Bellner L, 2008, EXP EYE RES, V87, P268, DOI 10.1016/j.exer.2008.06.007; Bellner L, 2009, J PHARMACOL EXP THER, V331, P925, DOI 10.1124/jpet.109.158352; Burns AR, 2005, OCUL SURF, V3, pS173; CONNERS MS, 1995, INVEST OPHTH VIS SCI, V36, P841; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Fahmy RG, 2006, NAT BIOTECHNOL, V24, P856, DOI 10.1038/nbt1225; Gagen D, 2010, EXP EYE RES, V91, P676, DOI 10.1016/j.exer.2010.08.007; Gan L, 2001, ACTA OPHTHALMOL SCAN, V79, P488, DOI 10.1034/j.1600-0420.2001.790512.x; Gan L, 1999, INVEST OPHTH VIS SCI, V40, P575; Gronert K, 2005, J BIOL CHEM, V280, P15267, DOI 10.1074/jbc.M410638200; Hanselmann C, 2001, BIOCHEM J, V353, P459, DOI 10.1042/0264-6021:3530459; Kampfer H, 2001, MOL MED, V7, P488, DOI 10.1007/BF03401854; Li ZJ, 2006, INVEST OPHTH VIS SCI, V47, P1947, DOI 10.1167/iovs.05-1193; Ma CZ, 2009, WOUND REPAIR REGEN, V17, P387, DOI 10.1111/j.1524-475X.2009.00478.x; Marmon S, 2009, EXP DERMATOL, V18, P88, DOI 10.1111/j.1600-0625.2008.00796.x; Martin P, 2005, TRENDS CELL BIOL, V15, P599, DOI 10.1016/j.tcb.2005.09.002; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Morse D, 2003, J BIOL CHEM, V278, P36993, DOI 10.1074/jbc.M302942200; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; O'Brien TP, 1998, ARCH OPHTHALMOL-CHIC, V116, P1470, DOI 10.1001/archopht.116.11.1470; Patil K, 2008, INVEST OPHTH VIS SCI, V49, P3379, DOI 10.1167/iovs.07-1515; Petrescu MS, 2007, INVEST OPHTH VIS SCI, V48, P5023, DOI 10.1167/iovs.07-0562; POSS KD, 1995, NEURON, V15, P867, DOI 10.1016/0896-6273(95)90177-9; Rogers B, 2003, FREE RADICAL BIO MED, V35, P872, DOI 10.1016/S0891-5849(03)00431-3; Sarady-Andrews JK, 2005, AM J PHYSIOL-LUNG C, V289, pL1131, DOI 10.1152/ajplung.00458.2004; Sato W, 2001, J IMMUNOL, V167, P3463, DOI 10.4049/jimmunol.167.6.3463; SCHWARTZMAN ML, 1997, BIOCHEM PHARMACOL, V53, P1069; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Seta F, 2006, AM J PATHOL, V169, P1612, DOI 10.2353/ajpath.2006.060555; Takada T, 1997, J BIOCHEM-TOKYO, V122, P453; Ueno M, 2005, INVEST OPHTH VIS SCI, V46, P4097, DOI 10.1167/iovs.05-0548; van Buul JD, 2009, INT J BIOL SCI, V5, P695; Wagener FADTG, 1999, J PHARMACOL EXP THER, V291, P416; Wagener FADTG, 2003, PHARMACOL REV, V55, P551, DOI 10.1124/pr.55.3.5; Wagener FADTG, 2003, BLOOD, V102, P521, DOI 10.1182/blood-2002-07-2248; Wegiel B, 2009, J BIOL CHEM, V284, P21369, DOI 10.1074/jbc.M109.027433; Willoughby DA, 2000, INT J IMMUNOPHARMACO, V22, P1131, DOI 10.1016/S0192-0561(00)00064-3; Wilson SE, 2001, PROG RETIN EYE RES, V20, P625, DOI 10.1016/S1350-9462(01)00008-8	41	27	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21180	10.1371/journal.pone.0021180	http://dx.doi.org/10.1371/journal.pone.0021180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695050	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600051
J	Nakamura, M; Tsuji, O; Bregman, BS; Toyama, Y; Okano, H				Nakamura, Masaya; Tsuji, Osahiko; Bregman, Barbara S.; Toyama, Yoshiaki; Okano, Hideyuki			Mimicking the Neurotrophic Factor Profile of Embryonic Spinal Cord Controls the Differentiation Potential of Spinal Progenitors into Neuronal Cells	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LEUKEMIA INHIBITORY FACTOR; NEURAL STEM-CELLS; PRECURSOR CELLS; SIGNALING PATHWAYS; FACTOR CNTF; RAT; SURVIVAL; CNS; INJURY	Recent studies have indicated that the choice of lineage of neural progenitor cells is determined, at least in part, by environmental factors, such as neurotrophic factors. Despite extensive studies using exogenous neurotrophic factors, the effect of endogenous neurotrophic factors on the differentiation of progenitor cells remains obscure. Here we show that embryonic spinal cord derived-progenitor cells express both ciliary neurotrophic factor (CNTF) and brain-derived neurotrophic factor (BDNF) mRNA before differentiation. BDNF gene expression significantly decreases with their differentiation into the specific lineage, whereas CNTF gene expression significantly increases. The temporal pattern of neurotrophic factor gene expression in progenitor cells is similar to that of the spinal cord during postnatal development. Approximately 50% of spinal progenitor cells differentiated into astrocytes. To determine the effect of endogenous CNTF on their differentiation, we neutralized endogenous CNTF by administration of its polyclonal antibody. Neutralization of endogenous CNTF inhibited the differentiation of progenitor cells into astrocytes, but did not affect the numbers of neurons or oligodendrocytes. Furthermore, to mimic the profile of neurotrophic factors in the spinal cord during embryonic development, we applied BDNF or neurotrophin (NT)-3 exogenously in combination with the anti-CNTF antibody. The exogenous application of BDNF or NT-3 promoted the differentiation of these cells into neurons or oligodendrocytes, respectively. These findings suggest that endogenous CNTF and exogenous BDNF and NT-3 play roles in the differentiation of embryonic spinal cord derived progenitor cells into astrocytes, neurons and oligodendrocytes, respectively.	[Nakamura, Masaya; Tsuji, Osahiko; Toyama, Yoshiaki] Keio Univ, Dept Orthopaed Surg, Tokyo, Japan; [Bregman, Barbara S.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Okano, Hideyuki] Keio Univ, Dept Physiol, Tokyo, Japan	Keio University; Georgetown University; Keio University	Nakamura, M (corresponding author), Keio Univ, Dept Orthopaed Surg, Tokyo, Japan.	masa@sc.itc.keio.ac.jp	Toyama, Yoshiaki/K-5743-2013; Okano, Hideyuki/I-7584-2019; Tsuji, Osahiko/AHB-2622-2022; Nakamura, Masaya/K-4111-2013		JSPS; Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Keio Gijuku Academic Development Funds	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Keio Gijuku Academic Development Funds	This work was supported by grants from Grants-in-Aid for Scientific Research from JSPS and the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT), the project for realization of regenerative medicine and support for the core institutes for iPS cell research from MEXT; Research Fellowships for Young Scientists from the Japan Society for the Promotion of Science; Keio Gijuku Academic Development Funds; and by a Grant-in-aid for the Global COE program from MEXT to Keio University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED S, 1995, J NEUROSCI, V15, P5765; ARAKAWA Y, 1990, J NEUROSCI, V10, P3507; Barnabe-Heider F, 2003, J NEUROSCI, V23, P5149; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; DE CT, 1995, CELL, V83, P313; FREDERIKSEN K, 1988, J NEUROSCI, V8, P1144; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; GHOSH A, 1995, NEURON, V15, P89, DOI 10.1016/0896-6273(95)90067-5; Horner PJ, 2000, J NEUROSCI, V20, P2218; IP NY, 1991, J NEUROSCI, V11, P3124; Ishii K, 2006, J NEUROSCI RES, V84, P1669, DOI 10.1002/jnr.21079; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Jean I, 2003, BRAIN RES, V972, P110, DOI 10.1016/S0006-8993(03)02510-1; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kalyani A, 1997, DEV BIOL, V186, P202, DOI 10.1006/dbio.1997.8592; KIRSCHENBAUM B, 1995, P NATL ACAD SCI USA, V92, P210, DOI 10.1073/pnas.92.1.210; Lachyankar MB, 1997, EXP NEUROL, V144, P350, DOI 10.1006/exnr.1997.6434; Lillien L, 1998, CURR OPIN NEUROBIOL, V8, P37, DOI 10.1016/S0959-4388(98)80006-8; LING EA, 1976, ACTA ANAT, V96, P188; LOUIS JC, 1993, SCIENCE, V259, P689, DOI 10.1126/science.8430320; MARTINOU JC, 1992, NEURON, V8, P737, DOI 10.1016/0896-6273(92)90094-T; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; MAYER M, 1994, DEVELOPMENT, V120, P143; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; McTigue DM, 1998, J NEUROSCI, V18, P5354, DOI 10.1523/JNEUROSCI.18-14-05354.1998; Nagao M, 2007, MOL CELL BIOL, V27, P3982, DOI 10.1128/MCB.00170-07; Nakamura M, 2001, EXP NEUROL, V169, P407, DOI 10.1006/exnr.2001.7670; Nakashima K, 1999, J NEUROSCI, V19, P5429; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; NORNES HO, 1974, BRAIN RES, V73, P121, DOI 10.1016/0006-8993(74)91011-7; Oyesiku NM, 1997, J NEUROBIOL, V32, P251, DOI 10.1002/(SICI)1097-4695(199703)32:3<251::AID-NEU1>3.0.CO;2-6; Rajan P, 1998, J NEUROSCI, V18, P3620; Rao MS, 1998, P NATL ACAD SCI USA, V95, P3996, DOI 10.1073/pnas.95.7.3996; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Rosser AE, 1997, DEV BRAIN RES, V98, P291, DOI 10.1016/S0165-3806(96)00189-7; SVENDSEN CN, 1995, EXP BRAIN RES, V102, P407; THALER CD, 1994, DEV BIOL, V161, P338, DOI 10.1006/dbio.1994.1035; VICARIOABEJON C, 1995, NEURON, V15, P105, DOI 10.1016/0896-6273(95)90068-3; VON VJ, 1994, EXP NEUROL, V128, P34; WARE CB, 1995, DEVELOPMENT, V121, P1283; Weiss S, 1996, J NEUROSCI, V16, P7599; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7	45	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20717	10.1371/journal.pone.0020717	http://dx.doi.org/10.1371/journal.pone.0020717			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698095	Green Submitted, Green Published, gold			2022-12-25	WOS:000291737600015
J	Yin, YP; Tang, LN; Zhang, JB; Tang, B; Li, ZY				Yin, Yupeng; Tang, Lina; Zhang, Jiabao; Tang, Bo; Li, Ziyi			Molecular Cloning and Gene Expression Analysis of Ercc6l in Sika Deer (Cervus nippon hortulorum)	PLOS ONE			English	Article							SNF2 FAMILY; PROTEIN FAMILY; RNA HELICASES; REPAIR; CANCER; RISK; DNA	Background: One important protein family that functions in nucleotide excision repair (NER) factors is the SNF2 family. A newly identified mouse ERCC6-like gene, Ercc6l (excision repair cross-complementing rodent repair deficiency, complementation group 6-like), has been shown to be another developmentally related member of the SNF2 family. Methodology/Principal Findings: In this study, Sika deer Ercc6l cDNA was first cloned and then sequenced. The full-length cDNA of the Sika deer Ercc6l gene is 4197 bp and contains a 3732 bp open reading frame that encodes a putative protein of 1243 amino acids. The similarity of Sika deer Ercc6l to Bos taurus Ercc6l is 94.05% at the amino acid sequence level. The similarity, however, is reduced to 68.42-82.21% when compared to Ercc6l orthologs in other mammals and to less than 50% compared to orthologs in Gallus gallus and Xenopus. Additionally, the expression of Ercc6l mRNA was investigated in the organs of fetal and adult Sika deer (FSD and ASD, respectively) by quantitative RT-PCR. The common expression level of Ercc6l mRNA in the heart, liver, spleen, lung, kidney, and stomach from six different developmental stages of 18 Sika deer were examined, though the expression levels in each organ varied among individual Sika deer. During development, there was a slight trend toward decreased Ercc61 mRNA expression. The highest Ercc6l expression levels were seen at 3 months old in every organ and showed the highest level of detection in the spleen of FSD. The lowest Ercc6l expression levels were seen at 3 years old. Conclusions/Significance: We are the first to successfully clone Sika deer Ercc6l mRNA. Ercc6l transcript is present in almost every organ. During Sika deer development, there is a slight trend toward decreased Ercc61 mRNA expression. It is possible that Ercc6l has other roles in embryonic development and in maintaining the growth of animals.	[Yin, Yupeng; Tang, Lina; Zhang, Jiabao; Tang, Bo; Li, Ziyi] Jilin Univ, Coll Anim Sci & Vet Med, Ctr Anim Embryo Engn Jilin Prov, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Jilin, Peoples R China; [Tang, Lina] Jilin Univ, Coll Life Sci, Minist Educ, Key Lab Enzyme Engn, Changchun 130023, Jilin, Peoples R China	Jilin University; Jilin University	Yin, YP (corresponding author), Jilin Univ, Coll Anim Sci & Vet Med, Ctr Anim Embryo Engn Jilin Prov, Jilin Prov Key Lab Anim Embryo Engn, Changchun 130023, Jilin, Peoples R China.	tang_bo@jlu.edu.cn; ziyi@jlu.edu.cn			China Postdoctoral Science Foundation [20090451135]; Changchun Science and Technology Support Program [2007BAD55B03]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Changchun Science and Technology Support Program	This work was supported by grants from the China Postdoctoral Science Foundation (No. 20090451135) and the Changchun Science and Technology Support Program (No. 2007BAD55B03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berndt SI, 2006, CANCER EPIDEM BIOMAR, V15, P2263, DOI 10.1158/1055-9965.EPI-06-0449; BORK P, 1993, NUCLEIC ACIDS RES, V21, P751, DOI 10.1093/nar/21.3.751; Boulikas T, 1997, ANTICANCER RES, V17, P843; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; Chen XG, 2004, PROG BIOCHEM BIOPHYS, V31, P443; Chiu CF, 2008, ORAL ONCOL, V44, P582, DOI 10.1016/j.oraloncology.2007.07.006; Christiansen M, 2003, NUCLEIC ACIDS RES, V31, P963, DOI 10.1093/nar/gkg164; Churbanov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-261; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P4713, DOI 10.1093/nar/17.12.4713; Gu J, 2005, CLIN CANCER RES, V11, P1408, DOI 10.1158/1078-0432.CCR-04-1101; Huang C, 2003, CURR OPIN GENET DEV, V13, P246, DOI 10.1016/S0959-437X(03)00054-6; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin ZN, 2008, HUM MUTAT, V29, P113, DOI 10.1002/humu.20610; Linder B, 2004, GENE, V326, P59, DOI 10.1016/j.gene.2003.09.053; Orren DK, 1996, NUCLEIC ACIDS RES, V24, P3317, DOI 10.1093/nar/24.17.3317; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x; Tanner NK, 2001, MOL CELL, V8, P251, DOI 10.1016/S1097-2765(01)00329-X; WASSARMAN DA, 1991, NATURE, V349, P463, DOI 10.1038/349463a0; Xu YJ, 2005, TOXICOL LETT, V157, P233, DOI 10.1016/j.toxlet.2005.02.013	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20929	10.1371/journal.pone.0020929	http://dx.doi.org/10.1371/journal.pone.0020929			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695076	gold, Green Published, Green Submitted			2022-12-25	WOS:000291682300020
J	Cardinal, S; Danforth, BN				Cardinal, Sophie; Danforth, Bryan N.			The Antiquity and Evolutionary History of Social Behavior in Bees	PLOS ONE			English	Article							ANCESTRAL CHARACTER STATES; EVALUATING ALTERNATIVE HYPOTHESES; ALLODAPINE BEES; MOLECULAR PHYLOGENETICS; XYLOCOPA-PUBESCENS; BAYESIAN-ESTIMATION; HYMENOPTERA APIDAE; CORBICULATE BEES; CARPENTER BEE; TIME SCALES	A long-standing controversy in bee social evolution concerns whether highly eusocial behavior has evolved once or twice within the corbiculate Apidae. Corbiculate bees include the highly eusocial honey bees and stingless bees, the primitively eusocial bumble bees, and the predominantly solitary or communal orchid bees. Here we use a model-based approach to reconstruct the evolutionary history of eusociality and date the antiquity of eusocial behavior in apid bees, using a recent molecular phylogeny of the Apidae. We conclude that eusociality evolved once in the common ancestor of the corbiculate Apidae, advanced eusociality evolved independently in the honey and stingless bees, and that eusociality was lost in the orchid bees. Fossil-calibrated divergence time estimates reveal that eusociality first evolved at least 87 Mya (78 to 95 Mya) in the corbiculates, much earlier than in other groups of bees with less complex social behavior. These results provide a robust new evolutionary framework for studies of the organization and genetic basis of social behavior in honey bees and their relatives.	[Cardinal, Sophie; Danforth, Bryan N.] Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA	Cornell University	Cardinal, S (corresponding author), Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA.	scc44@cornell.edu		Danforth, Bryan/0000-0002-6495-428X	National Science Foundation [DEB 0709956, DEB 0814544]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grants DEB 0709956 to SC and DEB 0814544 to BND (http://www.nsf.gov/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascher JS, 2001, MOL PHYLOGENET EVOL, V19, P76, DOI 10.1006/mpev.2001.0911; Augusto SC, 2009, GENET MOL RES, V8, P525, DOI 10.4238/vol8-2kerr004; Augusto SC, 2004, INSECT SOC, V51, P400, DOI 10.1007/s00040-004-0760-2; Ben-Shahar Y, 2002, SCIENCE, V296, P741, DOI 10.1126/science.1069911; Brady SG, 2006, P NATL ACAD SCI USA, V103, P18172, DOI 10.1073/pnas.0605858103; Brady SG, 2006, P ROY SOC B-BIOL SCI, V273, P1643, DOI 10.1098/rspb.2006.3496; Brothers Denis J., 1993, Journal of Hymenoptera Research, V2, P227; Cameron SA, 2004, ANNU REV ENTOMOL, V49, P377, DOI 10.1146/annurev.ento.49.072103.115855; CAMERON SA, 1993, P NATL ACAD SCI USA, V90, P8687, DOI 10.1073/pnas.90.18.8687; Cameron SA, 2001, SYST BIOL, V50, P194, DOI 10.1080/10635150151125851; Cardinal S, 2007, CLADISTICS, V23, P99, DOI 10.1111/j.1096-0031.2006.00137.x; Cardinal S, 2010, P NATL ACAD SCI USA, V107, P16207, DOI 10.1073/pnas.1006299107; CHAVARRIA G, 1994, CLADISTICS, V10, P229, DOI 10.1006/clad.1994.1017; Chenoweth LB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-246; Chenoweth LB, 2007, ANN ENTOMOL SOC AM, V100, P311, DOI 10.1603/0013-8746(2007)100[311:SBOTMH]2.0.CO;2; Pech ME, 2008, INSECT SOC, V55, P428, DOI 10.1007/s00040-008-1023-4; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Danforth BN, 2003, SYST BIOL, V52, P23, DOI 10.1080/10635150390132687; DODSON C. H., 1966, J KANS ENTOMOL SOC, V39, P607; DRESSLER RL, 1982, ANNU REV ECOL SYST, V13, P373, DOI 10.1146/annurev.es.13.110182.002105; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dunn T, 2003, BEHAV ECOL, V14, P417, DOI 10.1093/beheco/14.3.417; EBERHARD WG, 1988, J KANSAS ENTOMOL SOC, V61, P406; Engel Michael S., 2000, American Museum Novitates, V3296, P1, DOI 10.1206/0003-0082(2000)3296<0001:ANIOTO>2.0.CO;2; Engel MS, 2001, B AM MUS NAT HIST, P1, DOI 10.1206/0003-0090(2001)259<0001:AMOTBA>2.0.CO;2; Frisch K. v., 1923, Zoologische Jahrbuecher Jena Abteilungen f Allgemeine Zoologie, V40, P1; Frisch K. v., 1967, DANCE LANGUAGE ORIEN; GAROFALO CA, 1985, ENTOMOL GEN, V11, P77; Grimaldi D, 1999, ANN MO BOT GARD, V86, P373, DOI 10.2307/2666181; Grimaldi David, 2005, pi; Hines HM, 2008, SYST BIOL, V57, P58, DOI 10.1080/10635150801898912; Hines HM, 2007, P NATL ACAD SCI USA, V104, P3295, DOI 10.1073/pnas.0610140104; HOGENDOORN K, 1995, INSECT SOC, V42, P427, DOI 10.1007/BF01242171; HOGENDOORN K, 1993, BEHAV ECOL SOCIOBIOL, V32, P247, DOI 10.1007/BF00166514; HOUSTON TF, 1977, T R SOC S, V100, P99; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Huelsenbeck JP, 2000, SCIENCE, V288, P2349, DOI 10.1126/science.288.5475.2349; Hughes WOH, 2008, SCIENCE, V320, P1213, DOI 10.1126/science.1156108; Kawakita A, 2008, APIDOLOGIE, V39, P163, DOI 10.1051/apido:2007046; Koulianos S, 1999, J EVOLUTION BIOL, V12, P380, DOI 10.1046/j.1420-9101.1999.00043.x; Lin CP, 2004, SYST BIOL, V53, P400, DOI 10.1080/10635150490445869; Lockhart PJ, 2001, TRENDS ECOL EVOL, V16, P84, DOI 10.1016/S0169-5347(00)02054-1; McLeish MJ, 2007, AUST J ENTOMOL, V46, P300, DOI 10.1111/j.1440-6055.2007.00617.x; Michener C.D., 1990, University of Kansas Science Bulletin, V54, P75; Michener C.D., 2000, BEES WORLD, V1st; Michener CD, 1944, B AM MUS NAT HIST, V82, P152; MICHENER CD, 1974, SOCIAL BEHAV BEES; MICHENER CD, 1988, AM MUS NOVIT, P1; Moreau CS, 2006, SCIENCE, V312, P101, DOI 10.1126/science.1124891; Noll FB, 2002, CLADISTICS, V18, P137, DOI 10.1111/j.1096-0031.2002.tb00146.x; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pilgrim EM, 2008, ZOOL SCR, V37, P539, DOI 10.1111/j.1463-6409.2008.00340.x; Prentice M., 1991, P51; Ramirez SR, 2010, BIOL J LINN SOC, V100, P552, DOI 10.1111/j.1095-8312.2010.01440.x; Ramirez SR, 2010, MOL PHYLOGENET EVOL, V56, P519, DOI 10.1016/j.ympev.2010.04.026; RamirezArriaga E, 1996, J KANSAS ENTOMOL SOC, V69, P144; Rasmussen C, 2010, BIOL J LINN SOC, V99, P206, DOI 10.1111/j.1095-8312.2009.01341.x; RASNITSYN AP, 1991, ANN ENTOMOL SOC AM, V84, P583, DOI 10.1093/aesa/84.6.583; Rehan SM, 2009, J KANSAS ENTOMOL SOC, V82, P194, DOI 10.2317/JKES809.22.1; RITZKOWSKI S., 1997, METALLA BOCHUM, V66, P19; Roig-Alsina Arturo, 1993, University of Kansas Science Bulletin, V55, P124; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Sakagami S. F., 1967, Annotationes Zoologicae Japonenses, V40, P45; SAKAGAMI SF, 1984, J KANSAS ENTOMOL SOC, V57, P639; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; Schultz Ted R., 1999, University of Kansas Museum of Natural History Special Publication, V24, P125; Schultz TR, 2001, J KANSAS ENTOMOL SOC, V74, P10; Schwarz MP, 2007, ANNU REV ENTOMOL, V52, P127, DOI 10.1146/annurev.ento.51.110104.150950; Schwarz MP, 2006, SYST BIOL, V55, P31, DOI 10.1080/10635150500431148; Schwarz MP, 2005, ANN ENTOMOL SOC AM, V98, P126, DOI 10.1603/0013-8746(2005)098[0126:BPACCO]2.0.CO;2; Seeley T., 1995, WISDOM HIVE SOCIAL P; Thompson GJ, 2004, MOL PHYLOGENET EVOL, V33, P452, DOI 10.1016/j.ympev.2004.06.016; Tierney SM, 2008, APIDOLOGIE, V39, P3, DOI 10.1051/apido:2007045; Tierney SM, 2002, BIOL J LINN SOC, V76, P211, DOI 10.1046/j.1095-8312.2002.00059.x; VANDERBLOM J, 1988, ETHOLOGY, V79, P281, DOI 10.1111/j.1439-0310.1988.tb00717.x; Ware JL, 2010, ARTHROPOD STRUCT DEV, V39, P204, DOI 10.1016/j.asd.2009.11.003; Wcislo WT, 1997, TRENDS ECOL EVOL, V12, P468, DOI 10.1016/S0169-5347(97)01198-1; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WENZEL J W, 1990, Psyche (Cambridge), V97, P21, DOI 10.1155/1990/24696; Whitfield CW, 2003, SCIENCE, V302, P296, DOI 10.1126/science.1086807; Wilson EO, 2005, P NATL ACAD SCI USA, V102, P13367, DOI 10.1073/pnas.0505858102; WINSTON ML, 1977, P NATL ACAD SCI USA, V74, P1135, DOI 10.1073/pnas.74.3.1135; Woodard SH, 2011, P NATL ACAD SCI USA, V108, P7472, DOI 10.1073/pnas.1103457108; Zucchi R., 1969, Journal of the Faculty of Science Hokkaido University Zoology (6), V17, P271	86	133	135	1	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e21086	10.1371/journal.pone.0021086	http://dx.doi.org/10.1371/journal.pone.0021086			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695157	gold, Green Submitted, Green Published			2022-12-25	WOS:000291663300038
J	Cheli, S; Francois, S; Bodega, B; Ferrari, F; Tenedini, E; Roncaglia, E; Ferrari, S; Ginelli, E; Meneveri, R				Cheli, Stefania; Francois, Stephanie; Bodega, Beatrice; Ferrari, Francesco; Tenedini, Elena; Roncaglia, Enrica; Ferrari, Sergio; Ginelli, Enrico; Meneveri, Raffaella			Expression Profiling of FSHD-1 and FSHD-2 Cells during Myogenic Differentiation Evidences Common and Distinctive Gene Dysregulation Patterns	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; SKELETAL-MUSCLE; OXIDATIVE STRESS; PROTEINS; PAX3; PROLIFERATION; TRANSLATION; CAVEOLIN-3; MYOBLASTS; SUPPORTS	Background: Determine global gene dysregulation affecting 4q-linked (FSHD-1) and non 4q-linked (FSHD-2) cells during early stages of myogenic differentiation. This approach has been never applied to FSHD pathogenesis. Methodology/Principal Findings: By in vitro differentiation of FSHD-1 and FSHD-2 myoblasts and gene chip analysis we derived that gene expression profile is altered only in FSHD-1 myoblasts and FSHD-2 myotubes. The changes seen in FSHD-1 regarded a general defect in cell cycle progression, probably due to the upregulation of myogenic markers PAX3 and MYOD1, and a deficit of factors (SUV39H1 and HMGB2) involved in D4Z4 chromatin conformation. On the other hand, FSHD-2 mytubes were characterized by a general defect in RNA metabolism, protein synthesis and degradation and, to a lesser extent, in cell cycle. Common dysregulations regarded genes involved in response to oxidative stress and in sterol biosynthetic process. Interestingly, our results also suggest that miRNAs might be implied in both FSHD-1 and FSHD-2 gene dysregulation. Finally, in both cell differentiation systems, we did not observe a gradient of altered gene expression throughout the 4q35 chromosome. Conclusions/Significance: FSHD-1 and FSHD-2 cells showed, in different steps of myogenic differentiation, a global deregulation of gene expression rather than an alteration of expression of 4q35 specific genes. In general, FSHD-1 and FSHD-2 global gene deregulation interested common and distinctive biological processes. In this regard, defects of cell cycle progression (FSHD-1 and to a lesser extent FSHD-2), protein synthesis and degradation (FSHD-2), response to oxidative stress (FSHD-1 and FSHD-2), and cholesterol homeostasis (FSHD-1 and FSHD-2) may in general impair a correct myogenesis. Taken together our results recapitulate previously reported defects of FSHD-1, and add new insights into the gene deregulation characterizing both FSHD-1 and FSHD-2, in which miRNAs may play a role.	[Cheli, Stefania; Bodega, Beatrice; Ginelli, Enrico] Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy; [Francois, Stephanie; Meneveri, Raffaella] Univ Milano Bicocca, Dept Expt Med, Monza, Italy; [Ferrari, Francesco; Tenedini, Elena; Roncaglia, Enrica; Ferrari, Sergio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Modena, Italy	University of Milan; University of Milano-Bicocca; Universita di Modena e Reggio Emilia	Cheli, S (corresponding author), Univ Milan, Dept Biol & Genet Med Sci, Milan, Italy.	raffaella.meneveri@unimib.it	Bodega, Beatrice/I-4644-2018; Ferrari, Sergio/A-1110-2010; tenedini, elena/ABB-3411-2020; Ferrari, Francesco/H-5007-2012	Bodega, Beatrice/0000-0003-0527-9234; Ferrari, Sergio/0000-0002-4822-2521; Ferrari, Francesco/0000-0002-9811-3753; TENEDINI, Elena/0000-0003-0285-765X; cheli, stefania/0000-0002-2837-5248	Telethon [GGP07078, GTB07001F]; Association Francaise contre les Myopathies (AFM) [13160, 14464]; Italian Ministry of University and Scientific Research [PRIN08]	Telethon(Fondazione Telethon); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This study was supported by grants from Telethon (no. GGP07078 to EG and no. GTB07001F to Marina Mora), the Association Francaise contre les Myopathies (AFM) (no. 13160 and 14464 to EG), and the Italian Ministry of University and Scientific Research (PRIN08 to EG and to RM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arashiro P, 2009, P NATL ACAD SCI USA, V106, P6220, DOI 10.1073/pnas.0901573106; Barro M, 2010, J CELL MOL MED, V14, P275, DOI 10.1111/j.1582-4934.2008.00368.x; Bodega B, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-41; Bosnakovski D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007003; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; De Falco G, 2006, ONCOGENE, V25, P5244, DOI 10.1038/sj.onc.1209623; de Greef JC, 2010, NEUROLOGY, V75, P1548, DOI 10.1212/WNL.0b013e3181f96175; de Greef JC, 2009, HUM MUTAT, V30, P1449, DOI 10.1002/humu.21091; de Greef JC, 2008, MUTAT RES-FUND MOL M, V647, P94, DOI 10.1016/j.mrfmmm.2008.07.011; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; Engel A., 2004, MYOLOGY BASIC CLIN; EPSTEIN JA, 1995, J BIOL CHEM, V270, P11719, DOI 10.1074/jbc.270.20.11719; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gazzerro E, 2010, EUR J HUM GENET, V18, P137, DOI 10.1038/ejhg.2009.103; GILBERT JR, 1993, AM J HUM GENET, V53, P401; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huichalaf C, 2009, J NEUROSCI, V29, P9042, DOI 10.1523/JNEUROSCI.1983-09.2009; Kramerova I, 2009, HUM MOL GENET, V18, P3194, DOI 10.1093/hmg/ddp257; LEE JH, 1995, MUSCLE NERVE, pS27; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Li WQ, 2007, FASEB J, V21, P3606, DOI 10.1096/fj.07-8159com; Maroto M, 1997, CELL, V89, P139, DOI 10.1016/S0092-8674(00)80190-7; Miller PJ, 2007, BBA-GEN SUBJECTS, V1770, P1450, DOI 10.1016/j.bbagen.2007.06.016; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Padberg G W, 1991, Neuromuscul Disord, V1, P231, DOI 10.1016/0960-8966(91)90094-9; PADBERG GW, 1995, MUSCLE NERVE, pS81, DOI 10.1002/mus.880181315; Ridgeway AG, 2001, J BIOL CHEM, V276, P19033, DOI 10.1074/jbc.M011491200; Rusconi F, 2010, NEUROBIOL DIS, V38, P273, DOI 10.1016/j.nbd.2010.01.017; Salisbury E, 2009, AM J PATHOL, V175, P748, DOI 10.2353/ajpath.2009.090047; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Snider L, 2009, HUM MOL GENET, V18, P2414, DOI 10.1093/hmg/ddp180; Tawil R, 2006, MUSCLE NERVE, V34, P1, DOI 10.1002/mus.20522; Thomas JO, 2001, BIOCHEM SOC T, V29, P395, DOI 10.1042/BST0290395; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Volonte D, 2003, MOL BIOL CELL, V14, P4075, DOI 10.1091/mbc.E03-03-0161; Winokur ST, 2003, NEUROMUSCULAR DISORD, V13, P322, DOI 10.1016/S0960-8966(02)00284-5; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; ZATZ M, 1995, AM J HUM GENET, V56, P99; Zeng WH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000559	46	35	35	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20966	10.1371/journal.pone.0020966	http://dx.doi.org/10.1371/journal.pone.0020966			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695143	Green Published, gold, Green Submitted			2022-12-25	WOS:000291663300034
J	Yoffou, PH; Edjekouane, L; Meunier, L; Tremblay, A; Provencher, DM; Mes-Masson, AM; Carmona, E				Yoffou, Paule Helena; Edjekouane, Lydia; Meunier, Liliane; Tremblay, Andre; Provencher, Diane Michele; Mes-Masson, Anne-Marie; Carmona, Euridice			Subtype Specific Elevated Expression of Hyaluronidase-1 (HYAL-1) in Epithelial Ovarian Cancer	PLOS ONE			English	Article							SUPPRESSES TUMOR-FORMATION; HYALURONAN FRAGMENTS; ORAL-CONTRACEPTIVES; PROSTATE-CANCER; HISTOLOGIC-TYPE; ESTROGEN; RECEPTOR; ACTIVATION; MARKERS; GENES	Background: Epithelial ovarian cancer (EOC) is morphologically heterogeneous being classified as serous, endometrioid, clear cell, or mucinous. Molecular genetic analysis has suggested a role for tumor suppressor genes located at chromosome 3p in serous EOC pathogenesis. Our objective was to evaluate the expression of HYAL1, located at chromosome 3p21.3, in these EOC subtypes, and to investigate its correlation with the expression of steroid hormone receptors. Methodology/Principal Findings: We determined the mRNA expression of HYAL1, estrogen receptor (ER)-alpha, ER beta and progesterone receptor (PR) in EOC tumor samples and cell lines using quantitative RT-PCR. We also examined the expression of these genes in a publicly available microarray dataset. HYAL-1 enzyme activity was measured in EOC cell lines and in plasma samples from patients. We found that HYAL1 mRNA expression was elevated in clear cell and mucinous EOC tissue samples, but not in serous and endometrioid samples, normal ovaries or benign tumors. Similar results were obtained by two different techniques and with tissue sample cohorts from two independent institutions. Concordantly, HYAL1 mRNA levels and enzymatic activity were elevated only in EOC cell lines derived from clear cell and mucinous subtypes. We also showed that HYAL1 mRNA was inversely correlated to that of ER alpha specifically in clear cell and mucinous EOCs. Additionally, ectopic expression of ERa in a clear cell EOC cell line (ER- and PR-negative) induced 50% reduction of HYAL1 mRNA expression, supporting a role of ER alpha in HYAL1 gene regulation. Significantly, HYAL-1 activity was also high in the plasma of patients with these EOC subtypes. Conclusions/Significance: This is the first report showing high HYAL-1 levels in EOC and demonstrating HYAL1 gene repression by ER alpha. Our results identify Hyaluronidase-1 as a potential target/biomarker for clear cell and mucinous EOCs and especially in tumors with low ER alpha levels.	[Yoffou, Paule Helena; Edjekouane, Lydia; Carmona, Euridice] Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada; [Mes-Masson, Anne-Marie; Carmona, Euridice] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Tremblay, Andre; Provencher, Diane Michele; Mes-Masson, Anne-Marie] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ H3C 3J7, Canada; [Tremblay, Andre] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Meunier, Liliane; Provencher, Diane Michele; Mes-Masson, Anne-Marie] Univ Montreal, Ctr Rech, Ctr Hosp, Inst Canc Montreal, Montreal, PQ H3C 3J7, Canada; [Tremblay, Andre] Univ Ste Justine, Res Ctr, Ctr Hosp, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Yoffou, PH (corresponding author), Maisonneuve Rosemont Hosp Res Ctr, Montreal, PQ, Canada.	ecarmona.hmr@ssss.gouv.qc.ca		Mes-Masson, Anne-Marie/0000-0002-6498-266X	Natural Sciences and Engineering Research Council of Canada [262142]; Banque de tissues et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Banque de tissues et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec	This work was funded by the Natural Sciences and Engineering Research Council of Canada (grant #262142 to EC). Tumor banking was supported by the Banque de tissues et de donnees of the Reseau de recherche sur le cancer of the Fonds de la recherche en sante du Quebec affiliated with the Canadian Tumor Repository Network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anttila MA, 2000, CANCER RES, V60, P150; Aunoble B, 2000, INT J ONCOL, V16, P567; Birch AH, 2008, MOL CARCINOGEN, V47, P56, DOI 10.1002/mc.20361; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Buchynska L. G., 2009, Experimental Oncology, V31, P48; Chan KKL, 2008, OBSTET GYNECOL, V111, P144, DOI 10.1097/01.AOG.0000296715.07705.e9; Chen GG, 2008, MED RES REV, V28, P954, DOI 10.1002/med.20131; Cho KR, 2009, ANNU REV PATHOL-MECH, V4, P287, DOI 10.1146/annurev.pathol.4.110807.092246; Choi JH, 2007, ENDOCR REV, V28, P440, DOI 10.1210/er.2006-0036; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Delpech B, 2002, ANTICANCER RES, V22, P2423; DESALEGU.M, 1967, ARCH BIOCHEM BIOPHYS, V120, P60, DOI 10.1016/0003-9861(67)90598-X; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Feeley KM, 2001, HISTOPATHOLOGY, V38, P87, DOI 10.1046/j.1365-2559.2001.01042.x; Fiszer-Szafarz Berta, 1995, Acta Biochimica Polonica, V42, P31; FISZERSZAFARZ B, 1990, BIOL CELL, V68, P95, DOI 10.1016/0248-4900(90)90293-C; Franzmann EJ, 2003, INT J CANCER, V106, P438, DOI 10.1002/ijc.11252; Ghosh MG, 2000, CANCER RES, V60, P6367; Gilks CB, 2009, HUM PATHOL, V40, P1213, DOI 10.1016/j.humpath.2009.04.017; Greer JB, 2005, OBSTET GYNECOL, V105, P731, DOI 10.1097/01.AOG.0000154152.12088.48; Hemming R, 2008, GLYCOBIOLOGY, V18, P280, DOI 10.1093/glycob/cwn006; Hess V, 2004, J CLIN ONCOL, V22, P1040, DOI 10.1200/JCO.2004.08.078; Hiltunen ELJ, 2002, CANCER RES, V62, P6410; Ho Shuk-Mei, 2003, Reprod Biol Endocrinol, V1, P73, DOI 10.1186/1477-7827-1-73; Hoglund M, 2003, CANCER RES, V63, P3378; Huhtaniemi I, 2010, MOL CELL ENDOCRINOL, V329, P56, DOI 10.1016/j.mce.2010.04.028; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Lacey JV, 2002, JAMA-J AM MED ASSOC, V288, P334, DOI 10.1001/jama.288.3.334; Le Page C, 2006, INT J CANCER, V118, P1750, DOI 10.1002/ijc.21521; Le Page C, 2008, CANCER EPIDEM BIOMAR, V17, P913, DOI 10.1158/1055-9965.EPI-07-0692; Lee P, 2005, GYNECOL ONCOL, V96, P671, DOI 10.1016/j.ygyno.2004.11.010; Lin G, 2001, CANCER LETT, V163, P95, DOI 10.1016/S0304-3835(00)00669-8; Liu CM, 2005, NEW ENGL J MED, V352, P1268; Lokeshwar VB, 2000, J UROLOGY, V163, P348, DOI 10.1016/S0022-5347(05)68050-0; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Lokeshwar VB, 2005, CANCER RES, V65, P2243, DOI 10.1158/0008-5472.CAN-04-2805; Lokeshwar VB, 2008, SEMIN CANCER BIOL, V18, P281, DOI 10.1016/j.semcancer.2008.03.008; LOUNIS H, 1994, EXP CELL RES, V215, P303, DOI 10.1006/excr.1994.1346; Manderson EN, 2002, GENOME RES, V12, P112, DOI 10.1101/gr.174202; Martin-DeLeon PA, 2006, MOL CELL ENDOCRINOL, V250, P114, DOI 10.1016/j.mce.2005.12.033; Mertens F, 1997, CANCER RES, V57, P2765; Meyer T, 2000, BRIT J CANCER, V82, P1535; Morch LS, 2009, JAMA-J AM MED ASSOC, V302, P298, DOI 10.1001/jama.2009.1052; MORI K, 1990, J BIOCHEM, V107, P73, DOI 10.1093/oxfordjournals.jbchem.a123014; Nykopp TK, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-143; Orimoto AM, 2008, ENDOCRINOLOGY, V149, P5835, DOI 10.1210/en.2008-0175; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Ouellet V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-152; Parrott JA, 2001, MOL CELL ENDOCRINOL, V172, P213, DOI 10.1016/S0303-7207(00)00340-3; Pectasides D, 2006, GYNECOL ONCOL, V102, P285, DOI 10.1016/j.ygyno.2005.12.038; PEJOVIC T, 1992, GENE CHROMOSOME CANC, V4, P58, DOI 10.1002/gcc.2870040108; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; REISSIG JL, 1955, J BIOL CHEM, V217, P959; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Schildkraut JM, 2002, JNCI-J NATL CANCER I, V94, P32; Seidman JD, 2004, INT J GYNECOL PATHOL, V23, P41, DOI 10.1097/01.pgp.0000101080.35393.16; Senchenko VN, 2004, ONCOGENE, V23, P5719, DOI 10.1038/sj.onc.1207760; Sharma R, 2009, J CLIN LAB ANAL, V23, P29, DOI 10.1002/jcla.20285; Soslow RA, 2008, INT J GYNECOL PATHOL, V27, P161, DOI 10.1097/PGP.0b013e31815ea812; Stern R, 2008, SEMIN CANCER BIOL, V18, P238, DOI 10.1016/j.semcancer.2008.03.014; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.3.CO;2-X; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Tammi RH, 2008, SEMIN CANCER BIOL, V18, P288, DOI 10.1016/j.semcancer.2008.03.005; Tan JX, 2011, INT J CANCER, V128, P1303, DOI 10.1002/ijc.25460; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Trimble EL, 2006, GYNECOL ONCOL, V103, pS23, DOI 10.1016/j.ygyno.2006.08.022; Tse C, 2002, CANCER RES, V62, P542; Tuhkanen H, 2004, INT J CANCER, V109, P247, DOI 10.1002/ijc.11733; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Walton TJ, 2009, PROSTATE, V69, P810, DOI 10.1002/pros.20929; Wang XY, 2009, CHINESE MED J-PEKING, V122, P1300, DOI 10.3760/cma.j.issn.0366-6999.2009.11.012; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Xiang RH, 2002, CANCER RES, V62, P2637; Yamashita H, 2008, INT J CLIN ONCOL, V13, P380, DOI 10.1007/s10147-008-0818-7	79	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20705	10.1371/journal.pone.0020705	http://dx.doi.org/10.1371/journal.pone.0020705			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695196	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600018
J	Goudot, C; Etchebest, C; Devaux, F; Lelandais, G				Goudot, Christel; Etchebest, Catherine; Devaux, Frederic; Lelandais, Gaelle			The Reconstruction of Condition-Specific Transcriptional Modules Provides New Insights in the Evolution of Yeast AP-1 Proteins	PLOS ONE			English	Article							CIS-REGULATORY ELEMENTS; OXIDATIVE STRESS-RESPONSE; PATHOGEN CANDIDA-ALBICANS; WIDE EXPRESSION PATTERNS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; MULTIDRUG-RESISTANCE; CHEMICAL STRESS; MICROARRAY DATA; ANALYSIS TOOLS	AP-1 proteins are transcription factors (TFs) that belong to the basic leucine zipper family, one of the largest families of TFs in eukaryotic cells. Despite high homology between their DNA binding domains, these proteins are able to recognize diverse DNA motifs. In yeasts, these motifs are referred as YRE (Yap Response Element) and are either seven (YRE-Overlap) or eight (YRE-Adjacent) base pair long. It has been proposed that the AP-1 DNA binding motif preference relies on a single change in the amino acid sequence of the yeast AP-1 TFs (an arginine in the YRE-O binding factors being replaced by a lysine in the YRE-A binding Yaps). We developed a computational approach to infer condition-specific transcriptional modules associated to the orthologous AP-1 protein Yap1p, Cgap1p and Cap1p, in three yeast species: the model yeast Saccharomyces cerevisiae and two pathogenic species Candida glabrata and Candida albicans. Exploitation of these modules in terms of predictions of the protein/DNA regulatory interactions changed our vision of AP-1 protein evolution. Cis-regulatory motif analyses revealed the presence of a conserved adenine in 59 position of the canonical YRE sites. While Yap1p, Cgap1p and Cap1p shared a remarkably low number of target genes, an impressive conservation was observed in the YRE sequences identified by Yap1p and Cap1p. In Candida glabrata, we found that Cgap1p, unlike Yap1p and Cap1p, recognizes YRE-O and YRE-A motifs. These findings were supported by structural data available for the transcription factor Pap1p (Schizosaccharomyces pombe). Thus, whereas arginine and lysine substitutions in Cgap1p and Yap1p proteins were reported as responsible for a specific YRE-O or YRE-A preference, our analyses rather suggest that the ancestral yeast AP-1 protein could recognize both YRE-O and YRE-A motifs and that the arginine/lysine exchange is not the only determinant of the specialization of modern Yaps for one motif or another.	[Goudot, Christel; Etchebest, Catherine; Lelandais, Gaelle] INSERM, U665, Paris, France; [Goudot, Christel; Etchebest, Catherine; Lelandais, Gaelle] Univ Paris Diderot, UMR S665, Paris, France; [Goudot, Christel; Etchebest, Catherine; Lelandais, Gaelle] INTS, Paris, France; [Devaux, Frederic] Univ Paris 06, CNRS, UMR7238, Lab Genom Microorganismes, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Goudot, C (corresponding author), INSERM, U665, Paris, France.	gaelle.lelandais@univ-paris-diderot.fr	DEVAUX, Frédéric/N-2288-2019; etchebest, catherine/O-2485-2019	DEVAUX, Frédéric/0000-0002-0039-9096; etchebest, catherine/0000-0002-5871-2372	ANR; UPMC	ANR(French National Research Agency (ANR)); UPMC(University of Pittsburgh)	This work was supported by ANR "Jeunes Chercheurs" program and the program "Emergence" of UPMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarco AM, 1999, J BACTERIOL, V181, P700, DOI 10.1128/JB.181.3.700-708.1999; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arnaud MB, 2009, TRENDS MICROBIOL, V17, P295, DOI 10.1016/j.tim.2009.04.007; Arnaud MB, 2005, NUCLEIC ACIDS RES, V33, pD358, DOI 10.1093/nar/gki003; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bar-Joseph Z, 2003, NAT BIOTECHNOL, V21, P1337, DOI 10.1038/nbt890; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bergmann S, 2004, PLOS BIOL, V2, P85, DOI 10.1371/journal.pbio.0020009; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Carlson JM, 2007, NUCLEIC ACIDS RES, V35, pW259, DOI 10.1093/nar/gkm310; Carlson JM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-254; Carlson JM, 2006, J COMPUT BIOL, V13, P686, DOI 10.1089/cmb.2006.13.686; Chakravarty A, 2007, BIOINFORMATICS, V23, P1029, DOI 10.1093/bioinformatics/btm041; Chen KH, 2007, GENE, V386, P63, DOI 10.1016/j.gene.2006.08.010; Christie KR, 2004, NUCLEIC ACIDS RES, V32, pD311, DOI 10.1093/nar/gkh033; Defrance M, 2008, NAT PROTOC, V3, P1589, DOI 10.1038/nprot.2008.98; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Enjalbert B, 2006, MOL BIOL CELL, V17, P1018, DOI 10.1091/mbc.E05-06-0501; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Fitch WM, 2000, TRENDS GENET, V16, P227, DOI 10.1016/S0168-9525(00)02005-9; Fujii Y, 2000, NAT STRUCT BIOL, V7, P889; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gupta K, 2004, BIOCHEMISTRY-US, V43, P6645, DOI 10.1021/bi036112v; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; He XJ, 2005, MOL MICROBIOL, V58, P1454, DOI 10.1111/j.1365-2958.2005.04917.x; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Ihmels J, 2005, PLOS GENET, V1, P380, DOI 10.1371/journal.pgen.0010039; Jaffrezic F, 2007, GENET RES, V89, P19, DOI 10.1017/S0016672307008646; Jeanmougin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012336; Kato M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-8-r56; Kuo D, 2010, GENOME RES, V20, P1672, DOI 10.1101/gr.111765.110; Lelandais G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r164; Lelandais G, 2006, BIOINFORMATICS, V22, P1359, DOI 10.1093/bioinformatics/btl087; Lemmens K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r37; Lucau-Danila A, 2005, MOL CELL BIOL, V25, P1860, DOI 10.1128/MCB.25.5.1860-1868.2005; Martin-Magniette ML, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-216; MOYEROWLEY WS, 1989, GENE DEV, V3, P283, DOI 10.1101/gad.3.3.283; Nguyen DT, 2001, J BIOL CHEM, V276, P1138, DOI 10.1074/jbc.M008377200; Nicholls S, 2004, EUKARYOT CELL, V3, P1111, DOI 10.1128/EC.3.5.1111-1123.2004; Nugent R, 2010, METHODS MOL BIOL, V620, P369, DOI 10.1007/978-1-60761-580-4_12; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Parkinson H, 2011, NUCLEIC ACIDS RES, V39, pD1002, DOI 10.1093/nar/gkq1040; Quackenbush J, 2006, METHOD INFORM MED, V45, P91; Rodrigues-Pousada C, 2010, YEAST, V27, P245, DOI 10.1002/yea.1752; Rognon B, 2006, MICROBIOL-SGM, V152, P3701, DOI 10.1099/mic.0.29277-0; Salerno WJ, 2004, NUCLEIC ACIDS RES, V32, pW566, DOI 10.1093/nar/gkh434; Salin H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-333; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sherman D, 2006, NUCLEIC ACIDS RES, V34, pD432, DOI 10.1093/nar/gkj160; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105; Tirosh I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100198; TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60; Tuch BB, 2008, PLOS BIOL, V6, P352, DOI 10.1371/journal.pbio.0060038; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Helden J, 2003, NUCLEIC ACIDS RES, V31, P3593, DOI 10.1093/nar/gkg567; Wapinski I, 2007, BIOINFORMATICS, V23, pI549, DOI 10.1093/bioinformatics/btm193; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Zhou XHJ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-232; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Znaidi S, 2009, EUKARYOT CELL, V8, P806, DOI 10.1128/EC.00002-09	66	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20924	10.1371/journal.pone.0020924	http://dx.doi.org/10.1371/journal.pone.0020924			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695268	gold, Green Published			2022-12-25	WOS:000291612900039
J	Hertel, F; Switalski, A; Mintert-Jancke, E; Karavassilidou, K; Bender, K; Pott, L; Kienitz, MC				Hertel, Fabian; Switalski, Agathe; Mintert-Jancke, Elisa; Karavassilidou, Katharina; Bender, Kirsten; Pott, Lutz; Kienitz, Marie-Cecile			A Genetically Encoded Tool Kit for Manipulating and Monitoring Membrane Phosphatidylinositol 4,5-Bisphosphate in Intact Cells	PLOS ONE			English	Article							RAT ATRIAL MYOCYTES; RECEPTOR-MEDIATED INHIBITION; PROTEIN-KINASE-C; K+ CHANNELS; LIVING CELLS; MUSCARINIC RECEPTOR; POTASSIUM CHANNELS; PHOSPHOLIPASE-C; MULTIPLE PROTEINS; VOLTAGE SENSOR	Background: Most ion channels are regulated by phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P(2)) in the cell membrane by diverse mechanisms. Important molecular tools to study ion channel regulation by PtdIns(4,5)P(2) in living cells have been developed in the past. These include fluorescent PH-domains as sensors for Forster resonance energy transfer (FRET), to monitor changes in plasma membrane. For controlled and reversible depletion of PtdIns(4,5)P(2), voltage-sensing phosphoinositide phosphatases (VSD) have been demonstrated as a superior tool, since they are independent of cellular signaling pathways. Combining these methods in intact cells requires multiple transfections. We used self-cleaving viral 2A-peptide sequences for adenovirus driven expression of the PH-domain of phospholipase-C delta 1 (PLC delta 1) fused to ECFP and EYFP respectively and Ciona intestinalis VSP (Ci-VSP), from a single open reading frame (ORF) in adult rat cardiac myocytes. Methods and Results: Expression and correct targeting of ECFP-PH-PLC delta 1, EYFP-PH-PLC delta 1, and Ci-VSP from a single tricistronic vector containing 2A-peptide sequences first was demonstrated in HEK293 cells by voltage-controlled FRET measurements and Western blotting. Adult rat cardiac myocytes expressed Ci-VSP and the two fluorescent PH-domains within 4 days after gene transfer using the vector integrated into an adenoviral construct. Activation of Ci-VSP by depolarization resulted in rapid changes in FRET ratio indicating depletion of PtdIns(4,5)P(2) in the plasma membrane. This was paralleled by inhibition of endogenous G protein activated K(+) (GIRK) current. By comparing changes in FRET and current, a component of GIRK inhibition by adrenergic receptors unrelated to depletion of PtdIns(4,5)P(2) was identified. Conclusions: Expression of a FRET sensor pair and Ci-VSP from a single ORF provides a useful approach to study regulation of ion channels by phosphoinositides in cell lines and transfection-resistant postmitotic cells. Generally, adenoviral constructs containing self-cleaving 2A-peptide sequences are highly suited for simultaneous transfer of multiple genes in adult cardiac myocytes.	[Hertel, Fabian; Switalski, Agathe; Mintert-Jancke, Elisa; Karavassilidou, Katharina; Bender, Kirsten; Pott, Lutz; Kienitz, Marie-Cecile] Ruhr Univ Bochum, Inst Physiol, D-4630 Bochum, Germany	Ruhr University Bochum	Hertel, F (corresponding author), Ruhr Univ Bochum, Inst Physiol, D-4630 Bochum, Germany.	lutz.pott@rub.de	Hertel, Fabian/AAF-9022-2020; Pott, Lutz/E-5304-2011	Hertel, Fabian/0000-0003-2825-1138; Pott, Lutz/0000-0002-4000-4132	Deutsche Stiftung fur Herzforschung [F/14/07]; FoRUM [F658-09]	Deutsche Stiftung fur Herzforschung; FoRUM	This work was supported by the Deutsche Stiftung fur Herzforschung to MCK (F/14/07) and FoRUM (F658-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECHEM M, 1983, EUR J CELL BIOL, V31, P366; Bender K, 2004, J PHYSIOL-LONDON, V561, P471, DOI 10.1113/jphysiol.2004.072462; Bender K, 2002, FEBS LETT, V529, P356, DOI 10.1016/S0014-5793(02)03426-9; Bender K, 2008, J PHYSIOL-LONDON, V586, P2049, DOI 10.1113/jphysiol.2007.148346; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Brown SG, 2005, AM J PHYSIOL-CELL PH, V289, pC543, DOI 10.1152/ajpcell.00025.2005; Bunemann M, 1996, J PHYSIOL-LONDON, V494, P351; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Cho H, 2005, P NATL ACAD SCI USA, V102, P4643, DOI 10.1073/pnas.0408844102; Cho H, 2001, J BIOL CHEM, V276, P159, DOI 10.1074/jbc.M004826200; Cockcroft S, 2007, BBA-MOL CELL BIOL L, V1771, P677, DOI 10.1016/j.bbalip.2007.03.009; de Felipe P, 2006, TRENDS BIOTECHNOL, V24, P68, DOI 10.1016/j.tibtech.2005.12.006; de Felipe P, 2003, J BIOL CHEM, V278, P11441, DOI 10.1074/jbc.M211644200; Deane JA, 2004, ANNU REV IMMUNOL, V22, P563, DOI 10.1146/annurev.immunol.22.012703.104721; Decher N, 2008, EMBO J, V27, P3164, DOI 10.1038/emboj.2008.231; Delmas P, 2005, NAT REV NEUROSCI, V6, P850, DOI 10.1038/nrn1785; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Ding WG, 2004, J BIOL CHEM, V279, P50726, DOI 10.1074/jbc.M409374200; Doronina VA, 2008, MOL CELL BIOL, V28, P4227, DOI 10.1128/MCB.00421-08; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P99, DOI 10.1085/jgp.200910345; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Gamper N, 2007, NAT REV NEUROSCI, V8, P921, DOI 10.1038/nrn2257; Halaszovich CR, 2009, J BIOL CHEM, V284, P2106, DOI 10.1074/jbc.M803543200; Halet G, 2005, BIOL CELL, V97, P501; Hasegawa K, 2007, STEM CELLS, V25, P1707, DOI 10.1634/stemcells.2006-0813; Hernandez CC, 2008, J PHYSIOL-LONDON, V586, P1811, DOI 10.1113/jphysiol.2007.148304; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Hilgemann DW, 2007, J PHYSIOL-LONDON, V582, P903, DOI 10.1113/jphysiol.2007.132746; Hilgemann DW, 1996, SCIENCE, V273, P956, DOI 10.1126/science.273.5277.956; HORIE M, 1987, AM J PHYSIOL, V253, pH210, DOI 10.1152/ajpheart.1987.253.1.H210; Hossain MI, 2008, J BIOL CHEM, V283, P18248, DOI 10.1074/jbc.M706184200; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Iwasaki H, 2008, P NATL ACAD SCI USA, V105, P7970, DOI 10.1073/pnas.0803936105; Jensen JB, 2009, J GEN PHYSIOL, V133, P347, DOI 10.1085/jgp.200810075; Keselman I, 2007, CHANNELS, V1, P113, DOI 10.4161/chan.4321; KRAPIVINSKY G, 1995, J BIOL CHEM, V270, P28777, DOI 10.1074/jbc.270.48.28777; Leaney JL, 2001, J PHYSIOL-LONDON, V534, P367, DOI 10.1111/j.1469-7793.2001.00367.x; Lengler J, 2005, ANAL BIOCHEM, V343, P116, DOI 10.1016/j.ab.2005.05.004; Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135; LUTTRELL LM, 1995, J BIOL CHEM, V270, P12984, DOI 10.1074/jbc.270.22.12984; Mao JZ, 2004, P NATL ACAD SCI USA, V101, P1087, DOI 10.1073/pnas.0304827101; Matsushita Y, 2009, AM J PHYSIOL-CELL PH, V296, pC1079, DOI 10.1152/ajpcell.00668.2008; Meyer T, 2001, J BIOL CHEM, V276, P5650, DOI 10.1074/jbc.M009179200; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Murata Y, 2007, J PHYSIOL-LONDON, V583, P875, DOI 10.1113/jphysiol.2007.134775; Shui Z, 2002, AM J PHYSIOL-HEART C, V283, pH819, DOI 10.1152/ajpheart.00515.2001; Sohn JW, 2007, J PHYSIOL-LONDON, V582, P1037, DOI 10.1113/jphysiol.2007.137265; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Suh BC, 2004, J GEN PHYSIOL, V123, P663, DOI 10.1085/jgp.200409029; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Suh BC, 2006, SCIENCE, V314, P1454, DOI 10.1126/science.1131163; Suh BC, 2010, NEURON, V67, P224, DOI 10.1016/j.neuron.2010.07.001; Sui JL, 1998, P NATL ACAD SCI USA, V95, P1307, DOI 10.1073/pnas.95.3.1307; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Szymanska E, 2008, EUR J IMMUNOL, V38, P260, DOI 10.1002/eji.200737170; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009; van der Wal J, 2001, J BIOL CHEM, V276, P15337, DOI 10.1074/jbc.M007194200; Varnai P, 1999, J BIOL CHEM, V274, P10983, DOI 10.1074/jbc.274.16.10983; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; YAMADA M, 1995, J BIOL CHEM, V270, P9289, DOI 10.1074/jbc.270.16.9289; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9	62	17	17	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20855	10.1371/journal.pone.0020855	http://dx.doi.org/10.1371/journal.pone.0020855			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695261	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900033
J	Soriano, FX; Hardingham, GE				Soriano, Francesc X.; Hardingham, Giles E.			In Cortical Neurons HDAC3 Activity Suppresses RD4-Dependent SMRT Export	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; NUCLEAR RECEPTOR; GENE-EXPRESSION; TRANSCRIPTIONAL ACTIVATION; COREPRESSOR COMPLEX; PROTEIN COMPLEXES; REPRESSION; ACETYLATION; PATHWAY; BINDING	The transcriptional corepressor SMRT controls neuronal responsiveness of several transcription factors and can regulate neuroprotective and neurogenic pathways. SMRT is a multi-domain protein that complexes with HDAC3 as well as being capable of interactions with HDACs 1, 4, 5 and 7. We previously showed that in rat cortical neurons, nuclear localisation of SMRT requires histone deacetylase activity: Inhibition of class I/II HDACs by treatment with trichostatin A (TSA) causes redistribution of SMRT to the cytoplasm, and potentiates the activation of SMRT-repressed nuclear receptors. Here we have sought to identify the HDAC(s) and region(s) of SMRT responsible for anchoring it in the nucleus under normal circumstances and for mediating nuclear export following HDAC inhibition. We show that in rat cortical neurons SMRT export can be triggered by treatment with the class I-preferring HDAC inhibitor valproate and the HDAC2/3-selective inhibitor apicidin, and by HDAC3 knockdown, implicating HDAC3 activity as being required to maintain SMRT in the nucleus. HDAC3 interaction with SMRT's deacetylation activation domain (DAD) is known to be important for activation of HDAC3 deacetylase function. Consistent with a role for HDAC3 activity in promoting SMRT nuclear localization, we found that inactivation of SMRT's DAD by deletion or point mutation triggered partial redistribution of SMRT to the cytoplasm. We also investigated whether other regions of SMRT were involved in mediating nuclear export following HDAC inhibition. TSA- and valproate-induced SMRT export was strongly impaired by deletion of its repression domain-4 (RD4). Furthermore, over-expression of a region of SMRT containing the RD4 region suppressed TSA-induced export of full-length SMRT. Collectively these data support a model whereby SMRT's RD4 region can recruit factors capable of mediating nuclear export of SMRT, but whose function and/or recruitment is suppressed by HDAC3 activity. Furthermore, they underline the fact that HDAC inhibitors can cause reorganization and redistribution of corepressor complexes.	[Soriano, Francesc X.; Hardingham, Giles E.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Soriano, Francesc X.] Univ Barcelona, Fac Biol, Dept Cell Biol, Barcelona, Spain	University of Edinburgh; University of Barcelona	Soriano, FX (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	Giles.Hardingham@ed.ac.uk	Soriano, Francesc X/U-7552-2017	Soriano, Francesc X/0000-0003-1678-7162; Hardingham, Giles/0000-0002-7629-5314	Biotechnology and Biological Sciences Research Council [BB_BB/D011388/1]; Wellcome Trust; Royal Society University; MRC; BBSRC [BB/D011388/1] Funding Source: UKRI; MRC [G0902044] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D011388/1] Funding Source: researchfish; Medical Research Council [G0902044] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society University(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biotechnology and Biological Sciences Research Council (BB_BB/D011388/1), the Wellcome Trust, a Royal Society University Research Fellowship and a MRC Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bruserud O, 2007, CURR PHARM BIOTECHNO, V8, P388, DOI 10.2174/138920107783018417; Cheng XW, 2009, J BIOL CHEM, V284, P36395, DOI 10.1074/jbc.M109.062109; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Downes M, 2000, P NATL ACAD SCI USA, V97, P10330, DOI 10.1073/pnas.97.19.10330; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Hardingham GE, 2001, NAT NEUROSCI, V4, P261, DOI 10.1038/85109; Hoberg JE, 2004, MOL CELL, V16, P245, DOI 10.1016/j.molcel.2004.10.010; Hong SH, 2000, MOL CELL BIOL, V20, P6612, DOI 10.1128/MCB.20.17.6612-6625.2000; Huang EY, 2000, GENE DEV, V14, P45; Ishizuka T, 2005, MOL ENDOCRINOL, V19, P1443, DOI 10.1210/me.2005-0009; Jepsen K, 2002, J CELL SCI, V115, P689; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Jonas BA, 2007, MOL ENDOCRINOL, V21, P1924, DOI 10.1210/me.2007-0035; Kao HY, 2000, GENE DEV, V14, P55; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kawaguchi Y, 2006, J BIOL CHEM, V281, P1394, DOI 10.1074/jbc.M505772200; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Ki SH, 2005, MOL CELL BIOL, V25, P4150, DOI 10.1128/MCB.25.10.4150-4165.2005; Kumar S, 2006, MOL CELL ENDOCRINOL, V246, P147, DOI 10.1016/j.mce.2005.11.028; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Langley B, 2008, J NEUROSCI, V28, P163, DOI 10.1523/JNEUROSCI.3200-07.2008; Lee JW, 2001, CELL MOL LIFE SCI, V58, P289, DOI 10.1007/PL00000856; Leveille F, 2010, J NEUROSCI, V30, P2623, DOI 10.1523/JNEUROSCI.5115-09.2010; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Mckenzie GJ, 2005, J NEUROCHEM, V93, P171, DOI 10.1111/j.1471-4159.2005.03010.x; Papadia S, 2005, J NEUROSCI, V25, P4279, DOI 10.1523/JNEUROSCI.5019-04.2005; Perissi V, 2004, CELL, V116, P511, DOI 10.1016/S0092-8674(04)00133-3; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Shimazu T, 2007, J BIOL CHEM, V282, P4470, DOI 10.1074/jbc.M609745200; Sleiman SF, 2009, EXPERT OPIN INV DRUG, V18, P573, DOI [10.1517/13543780902810345, 10.1517/13543780902810345 ]; Soriano FX, 2011, ANTIOXID REDOX SIGN, V14, P1425, DOI 10.1089/ars.2010.3568; Spange S, 2009, INT J BIOCHEM CELL B, V41, P185, DOI 10.1016/j.biocel.2008.08.027; Stanya KJ, 2008, J CELL BIOL, V183, P49, DOI 10.1083/jcb.200806172; Thevenet L, 2004, EMBO J, V23, P3336, DOI 10.1038/sj.emboj.7600352; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; VARLAKHANOVA N, 2010, MOL CELL ENDOCRINOL; Wu XY, 2001, J BIOL CHEM, V276, P24177, DOI 10.1074/jbc.M100412200; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhou YY, 2001, MOL CELL BIOCHEM, V220, P1, DOI 10.1023/A:1011087910699	50	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e21056	10.1371/journal.pone.0021056	http://dx.doi.org/10.1371/journal.pone.0021056			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695276	gold, Green Submitted, Green Published			2022-12-25	WOS:000291612900051
J	Brim, H; Kumar, K; Nazarian, J; Hathout, Y; Jafarian, A; Lee, E; Green, W; Smoot, D; Park, J; Nouraie, M; Ashktorab, H				Brim, Hassan; Kumar, Krishan; Nazarian, Javad; Hathout, Yetrib; Jafarian, Amir; Lee, Edward; Green, William; Smoot, Duane; Park, Jong; Nouraie, Mehdi; Ashktorab, Hassan			SLC5A8 Gene, A Transporter of Butyrate: A Gut Flora Metabolite, Is Frequently Methylated in African American Colon Adenomas	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; MICROSATELLITE INSTABILITY; CLINICOPATHOLOGICAL FEATURES; COLORECTAL CANCERS; EXPRESSION; HYPERMETHYLATION; PATHWAYS; POLYPS	Background: Colon cancer is one of the leading causes of cancer related deaths. Its impact on African Americans (AAs) is higher than in the general population both in the incidence and mortality from the disease. Colon cancer aggressiveness in AAs as well as non-frequent check-ups and follow up in this population have been proposed as ways to explain the observed discrepancies. These facts made the detection of early carcinogenesis markers in this population a priority. Materials and Methods: Here, we analyzed 50 colon adenomas from AA patients for both microsatellite instability (MSI) and the methylation status of SLC5A8 gene. This gene's product is involved in the transport of butyrate that has anti-proliferative properties through its effects on histone acetylation and gene expression. A proteomic analysis to check the expressed histones in adenoma and normal tissues was also performed. Results: The analyzed samples displayed 82% (n = 41) methylation level of SLC5A8 gene in adenomas. The MSI-H (high) adenoma were about 18% (n = 9) while the rest were mostly MSS (microsatellite stable) with few MSI-L (Low). No association was found between SLC5A8 methylation and the MSI status. Also, there was no association between SLC5A8 methylation and the sex and age of the patients. However, there were more right sided adenomas with SLC5A8 methylation than the left sided ones. The proteomic analysis revealed distinct histone expression profiles between normal and adenoma tissues. Conclusion: SLC5A8 is highly methylated in AA colon adenomas which points to its potential use as a marker for early detection. The MSI rate is similar to that found in colon cancer tumors in AAs. These findings suggest that both processes stem from the same epigenetic and genetic events occurring at an early stage in colon carcinogenesis in AAs.	[Brim, Hassan; Kumar, Krishan; Jafarian, Amir; Lee, Edward; Green, William; Smoot, Duane; Nouraie, Mehdi; Ashktorab, Hassan] Howard Univ, Coll Med, Dept Med, Washington, DC 20059 USA; [Brim, Hassan; Kumar, Krishan; Jafarian, Amir; Lee, Edward; Green, William; Smoot, Duane; Nouraie, Mehdi; Ashktorab, Hassan] Howard Univ, Coll Med, Dept Pathol, Ctr Canc, Washington, DC USA; [Nazarian, Javad; Hathout, Yetrib] Childrens Natl Med Ctr, Med Genet Res Ctr, Washington, DC 20010 USA; [Park, Jong] Univ S Florida, H Lee Moffitt Canc Ctr, Div Canc Prevent & Control, Tampa, FL 33682 USA	Howard University; Howard University; Children's National Health System; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida	Brim, H (corresponding author), Howard Univ, Coll Med, Dept Med, Washington, DC 20059 USA.	hbrim@howard.edu; hashktorab@howard.edu	Ashktorab, hassan/AAJ-2908-2020; Nouraie, Seyed Mehdi/O-4071-2018	Nouraie, Seyed Mehdi/0000-0001-7465-0581; jafarian, Amir Hossein/0000-0003-4004-262X; Nazarian, Javad/0000-0002-1951-9828	National Cancer Institute, National Institutes of Health and Research Centers in Minority Institutions [CA102681]; NATIONAL CANCER INSTITUTE [R01CA102681] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health and Research Centers in Minority Institutions(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grant #CA102681, funded by the National Cancer Institute, National Institutes of Health and Research Centers in Minority Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashktorab H, 2005, INT J CANCER, V116, P914, DOI 10.1002/ijc.21062; Ashktorab H, 2003, CLIN CANCER RES, V9, P1112; ASHKTORAB H, 2008, GASTROENTEROLOGY, P134; Ashktorab H, 2009, DIGEST DIS SCI, V54, P2109, DOI 10.1007/s10620-008-0601-7; Bennett KL, 2008, CANCER RES, V68, P4494, DOI 10.1158/0008-5472.CAN-07-6509; Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68; Deng G, 2008, EUR J CANCER, V44, P1290, DOI 10.1016/j.ejca.2008.03.014; Dong SM, 2005, MODERN PATHOL, V18, P170, DOI 10.1038/modpathol.3800261; El-Maarri O, 2007, HUM GENET, V122, P505, DOI 10.1007/s00439-007-0430-3; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P146, DOI 10.1309/87BD0C6UCGUG126J; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2010, CANCER EPIDEM BIOMAR, V19, P1893, DOI 10.1158/1055-9965.EPI-10-0437; Kim HS, 2009, NAT STRUCT MOL BIOL, V16, P1286, DOI 10.1038/nsmb.1688; KUMAR K, 2009, CLIN CANC R IN PRESS; Kumar K, 2009, CAN1 GENE METHYLATIO; Li H, 2008, ANIM GENET, V39, P407, DOI 10.1111/j.1365-2052.2008.01744.x; Li H, 2003, P NATL ACAD SCI USA, V100, P8412, DOI 10.1073/pnas.1430846100; Li RW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-234; Nazarian J, 2008, PROTEOM CLIN APPL, V2, P915, DOI 10.1002/prca.200780061; Nouraie M, 2010, DIGEST DIS SCI, V55, P1442, DOI 10.1007/s10620-010-1133-5; Park JY, 2008, PANCREAS, V36, pE32, DOI 10.1097/MPA.0b013e3181630ffe; Park JY, 2007, CANCER DETECT PREV, V31, P359, DOI 10.1016/j.cdp.2007.09.002; Schuebel KE, 2007, PLOS GENET, V3, P1709, DOI 10.1371/journal.pgen.0030157; THANGARAJU M, 2008, J GASTROINTEST SURG; Ueno M, 2004, TUMOR BIOL, V25, P134, DOI 10.1159/000079145; Whitman SP, 2008, BLOOD, V112, P2013, DOI 10.1182/blood-2008-01-128595	27	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20216	10.1371/journal.pone.0020216	http://dx.doi.org/10.1371/journal.pone.0020216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687703	gold, Green Submitted, Green Published			2022-12-25	WOS:000291611500009
J	Meng, XB; Brachova, P; Yang, SJ; Xiong, Z; Zhang, YP; Thiel, KW; Leslie, KK				Meng, Xiangbing; Brachova, Pavla; Yang, Shujie; Xiong, Zhi; Zhang, Yuping; Thiel, Kristina W.; Leslie, Kimberly K.			Knockdown of MTDH Sensitizes Endometrial Cancer Cells to Cell Death Induction by Death Receptor Ligand TRAIL and HDAC Inhibitor LBH589 Co-Treatment	PLOS ONE			English	Article							ASTROCYTE ELEVATED GENE-1; HISTONE DEACETYLASE INHIBITORS; INDUCED APOPTOSIS; CALBINDIN D-28K; BREAST-CANCER; METASTASIS; CARCINOMA; BCCIP; MONOPHOSPHATASE; CHEMORESISTANCE	Understanding the molecular underpinnings of chemoresistance is vital to design therapies to restore chemosensitivity. In particular, metadherin (MTDH) has been demonstrated to have a critical role in chemoresistance. Over-expression of MTDH correlates with poor clinical outcome in breast cancer, neuroblastoma, hepatocellular carcinoma and prostate cancer. MTDH is also highly expressed in advanced endometrial cancers, a disease for which new therapies are urgently needed. In this present study, we focused on the therapeutic benefit of MTDH depletion in endometrial cancer cells to restore sensitivity to cell death. Cells were treated with a combination of tumor necrosis factor-a-related apoptosis-inducing ligand (TRAIL), which promotes death of malignant cells of the human reproductive tract, and histone deacetylase (HDAC) inhibitors, which have been shown to increase the sensitivity of cancer cells to TRAIL-induced apoptosis. Our data indicate that depletion of MTDH in endometrial cancer cells resulted in sensitization of cells that were previously resistant in response to combinatorial treatment with TRAIL and the HDAC inhibitor LBH589. MTDH knockdown reduced the proportion of cells in S and increased cell arrest in G2/M in cells treated with LBH589 alone or LBH589 in combination with TRAIL, suggesting that MTDH functions at the cell cycle checkpoint to accomplish resistance. Using microarray technology, we identified 57 downstream target genes of MTDH, including calbindin 1 and galectin-1, which may contribute to MTDH-mediated therapeutic resistance. On the other hand, in MTDH depleted cells, inhibition of PDK1 and AKT phosphorylation along with increased Bim expression and XIAP degradation correlated with enhanced sensitivity to cell death in response to TRAIL and LBH589. These findings indicate that targeting or depleting MTDH is a potentially novel avenue for reversing therapeutic resistance in patients with endometrial cancer.	[Meng, Xiangbing; Brachova, Pavla; Yang, Shujie; Xiong, Zhi; Zhang, Yuping; Thiel, Kristina W.; Leslie, Kimberly K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Meng, Xiangbing; Leslie, Kimberly K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA USA	University of Iowa; University of Iowa	Meng, XB (corresponding author), Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.	xiangbing-meng@uiowa.edu	Brachova, Pavla/AAA-1477-2021	Brachova, Pavla/0000-0002-9014-132X; Thiel, Kristina/0000-0001-8295-864X; Leslie, Kimberly/0000-0002-2704-8990; Yang, Shujie/0000-0003-1753-3068; meng, xiangbing/0000-0002-9612-6438	National Institutes of Health (NIH) [R01CA99908]; Department of Obstetrics and Gynecology; American Cancer Society [IRG-77-004-31]; NATIONAL CANCER INSTITUTE [R01CA099908] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology; American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH) Grant R01CA99908 to K. K. L., and in part by the Department of Obstetrics and Gynecology Research Development Fund, the Institutional Research Grant Number IRG-77-004-31 from the American Cancer Society to XM, administered through the Holden Comprehensive Cancer Center at the University of Iowa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Berggard T, 2002, J BIOL CHEM, V277, P41954, DOI 10.1074/jbc.M203492200; Bluethner T, 2007, WORLD J GASTROENTERO, V13, P4761, DOI 10.3748/wjg.v13.i35.4761; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Camby I, 2006, GLYCOBIOLOGY, V16, p137R, DOI 10.1093/glycob/cwl025; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Dai DH, 2005, CANCER RES, V65, P9517, DOI 10.1158/0008-5472.CAN-05-1613; DARVAS K, 2010, INT J CANC; Dolcet X, 2005, LAB INVEST, V85, P885, DOI 10.1038/labinvest.3700286; Fulda S, 2008, CURR CANCER DRUG TAR, V8, P132, DOI 10.2174/156800908783769355; Gadducci A, 2008, GYNECOL ENDOCRINOL, V24, P239, DOI 10.1080/09513590801953556; Holoch PA, 2009, EUR J PHARMACOL, V625, P63, DOI 10.1016/j.ejphar.2009.06.066; Hu GH, 2009, CLIN CANCER RES, V15, P5615, DOI 10.1158/1078-0432.CCR-09-0049; Hu GH, 2009, CANCER CELL, V15, P9, DOI 10.1016/j.ccr.2008.11.013; Kauh J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010376; Kwong LN, 2009, CANCER CELL, V15, P1, DOI 10.1016/j.ccr.2008.12.007; Lee SG, 2008, ONCOGENE, V27, P1114, DOI 10.1038/sj.onc.1210713; Li J, 2009, ONCOGENE, V28, P3188, DOI 10.1038/onc.2009.171; Liu HY, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-19; Llobet D, 2008, ONCOGENE, V27, P2513, DOI 10.1038/sj.onc.1210924; Meng X, 2007, ONCOGENE, V26, P6253, DOI 10.1038/sj.onc.1210460; Meng XB, 2004, CELL CYCLE, V3, P1457, DOI 10.4161/cc.3.11.1213; Meng XB, 2007, J BIOL CHEM, V282, P1570, DOI 10.1074/jbc.M607520200; Ngamwongsatit P, 2008, J MICROBIOL METH, V73, P211, DOI 10.1016/j.mimet.2008.03.002; Pallares J, 2009, AM J PATHOL, V174, P287, DOI 10.2353/ajpath.2009.080552; Park JH, 2008, J MOL MED, V86, P117, DOI 10.1007/s00109-007-0260-8; Sadarangani A, 2007, APOPTOSIS, V12, P73, DOI 10.1007/s10495-006-0492-z; SAFRANY ST, 1992, EUR J PHARM-MOLEC PH, V226, P265, DOI 10.1016/0922-4106(92)90071-3; Sarkar D, 2009, CANCER RES, V69, P8529, DOI 10.1158/0008-5472.CAN-09-1846; Schuler S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-80; Shamir A, 2005, BIPOLAR DISORD, V7, P42, DOI 10.1111/j.1399-5618.2004.00162.x; Suehiro Y, 2000, GENE CHROMOSOME CANC, V29, P75, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1010>3.3.CO;2-T; Thirkettle HJ, 2009, ONCOGENE, V28, P3663, DOI 10.1038/onc.2009.223; VanOosten RL, 2007, APOPTOSIS, V12, P561, DOI 10.1007/s10495-006-0009-9; Wei Y, 2009, CELL CYCLE, V8, P2132; Wu MH, 2009, MOL CANCER RES, V7, P311, DOI 10.1158/1541-7786.MCR-08-0297; Yoo BK, 2009, P NATL ACAD SCI USA, V106, P12938, DOI 10.1073/pnas.0901451106	37	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20920	10.1371/journal.pone.0020920	http://dx.doi.org/10.1371/journal.pone.0020920			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687633	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500052
J	Poirel, N; Simon, G; Cassotti, M; Leroux, G; Perchey, G; Lanoe, C; Lubin, A; Turbelin, MR; Rossi, S; Pineau, A; Houde, O				Poirel, Nicolas; Simon, Gregory; Cassotti, Mathieu; Leroux, Gaelle; Perchey, Guy; Lanoe, Celine; Lubin, Amelie; Turbelin, Marie-Renee; Rossi, Sandrine; Pineau, Arlette; Houde, Olivier			The Shift from Local to Global Visual Processing in 6-Year-Old Children Is Associated with Grey Matter Loss	PLOS ONE			English	Article							HIERARCHICAL PATTERNS; HEMISPHERIC-SPECIALIZATION; COGNITIVE-DEVELOPMENT; WILLIAMS-SYNDROME; BRAIN; ORGANIZATION; PARIETAL; MEANINGFULNESS; SCHIZOPHRENIA; RECOGNITION	Background: A real-world visual scene consists of local elements (e. g. trees) that are arranged coherently into a global configuration (e.g. a forest). Children show psychological evolution from a preference for local visual information to an adult-like preference for global visual information, with the transition in visual preference occurring around 6 years of age. The brain regions involved in this shift in visual preference have not been described. Methods and Results: We used voxel-based morphometry (VBM) to study children during this developmental window to investigate changes in gray matter that underlie the shift from a bias for local to global visual information. Six-year-old children were assigned to groups according to their judgment on a global/local task. The first group included children who still presented with local visual processing biases, and the second group included children who showed global visual processing biases. VBM results indicated that compared to children with local visual processing biases, children with global visual processing biases had a loss of gray matter in the right occipital and parietal visuospatial areas. Conclusions: These anatomical findings are in agreement with previous findings in children with neurodevelopmental disorders and represent the first structural identification of brain regions that allow healthy children to develop a global perception of the visual world.	[Poirel, Nicolas; Simon, Gregory; Cassotti, Mathieu; Leroux, Gaelle; Perchey, Guy; Lanoe, Celine; Lubin, Amelie; Turbelin, Marie-Renee; Rossi, Sandrine; Pineau, Arlette; Houde, Olivier] Univ Caen, CEA, CNRS, CI NAPS,UMR 6232, Paris, France; [Poirel, Nicolas; Simon, Gregory; Cassotti, Mathieu; Leroux, Gaelle; Perchey, Guy; Lanoe, Celine; Lubin, Amelie; Turbelin, Marie-Renee; Rossi, Sandrine; Pineau, Arlette; Houde, Olivier] Paris Descartes Univ, Paris, France; [Cassotti, Mathieu] Mines ParisTech, Ctr Gest Sci, Paris, France; [Perchey, Guy; Turbelin, Marie-Renee] Ctr Hosp Univ, Caen, France; [Houde, Olivier] Inst Univ France, Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; MINES ParisTech; CHU de Caen NORMANDIE; Institut Universitaire de France	Poirel, N (corresponding author), Univ Caen, CEA, CNRS, CI NAPS,UMR 6232, Paris, France.	nicolas.poirel@parisdescartes.fr	Rossi, Sandrine/B-8667-2008; simon, gregory/B-7275-2008; LUBIN, Amélie/B-8865-2008	Rossi, Sandrine/0000-0001-9285-2152; simon, gregory/0000-0001-6506-9349; LUBIN, Amélie/0000-0002-5277-6172; Poirel, Nicolas/0000-0002-3972-2575; Garbui, Maria Cristina/0000-0003-2100-9461; Cassotti, Mathieu/0000-0003-4837-4442; Leroux, Gaelle/0000-0003-2729-4945				Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Beaucousin V, 2011, NEUROPSYCHOLOGIA, V49, P1258, DOI 10.1016/j.neuropsychologia.2011.01.039; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; DELIS DC, 1986, NEUROPSYCHOLOGIA, V24, P205, DOI 10.1016/0028-3932(86)90053-9; Doniger GM, 2002, ARCH GEN PSYCHIAT, V59, P1011, DOI 10.1001/archpsyc.59.11.1011; Dukette D, 2001, DEVELOPMENTAL SCI, V4, P233, DOI 10.1111/1467-7687.00168; EDELMAN GM, 1993, NEURON, V10, P115, DOI 10.1016/0896-6273(93)90304-A; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Han SH, 2002, NEUROIMAGE, V17, P1290, DOI 10.1006/nimg.2002.1255; Himmelbach M, 2009, NEUROPSYCHOLOGIA, V47, P1173, DOI 10.1016/j.neuropsychologia.2008.10.025; Jung WH, 2009, EUR ARCH PSY CLIN N, V259, P46, DOI 10.1007/s00406-008-0833-8; Kimchi R, 2005, PSYCHOL SCI, V16, P282, DOI 10.1111/j.0956-7976.2005.01529.x; KIMCHI R, 1992, PSYCHOL BULL, V112, P24, DOI 10.1037/0033-2909.112.1.24; KIMCHI R, 1982, J EXP PSYCHOL HUMAN, V8, P521, DOI 10.1037/0096-1523.8.4.521; Koffka K, 1935, PRINCIPLES GESTALT P; Lemaire C, 2009, J MAGN RESON IMAGING, V30, P649, DOI 10.1002/jmri.21870; Martinez A, 1997, NEUROREPORT, V8, P1685, DOI 10.1097/00001756-199705060-00025; Mevorach C, 2006, NAT NEUROSCI, V9, P740, DOI 10.1038/nn1709; Mobbs D, 2007, DEV MED CHILD NEUROL, V49, P433, DOI 10.1111/j.1469-8749.2007.00433.x; Moses P, 2002, NEUROIMAGE, V16, P415, DOI 10.1006/nimg.2002.1064; O'Hare E. D., 2008, HDB DEV COGNITIVE NE, V2, P23; Pani JR, 1999, PSYCHOL SCI, V10, P453, DOI 10.1111/1467-9280.00186; Peyrin C, 2004, NEUROIMAGE, V23, P698, DOI 10.1016/j.neuroimage.2004.06.020; Poirel N, 2008, DEV PSYCHOL, V44, P245, DOI 10.1037/0012-1649.44.1.245; Poirel N, 2010, NEUROPSYCHOLOGIA, V48, P3062, DOI 10.1016/j.neuropsychologia.2010.06.017; Rapoport JL, 2011, INT J DEV NEUROSCI, V29, P251, DOI 10.1016/j.ijdevneu.2010.10.003; ROBERTSON LC, 1991, COGNITIVE PSYCHOL, V23, P299, DOI 10.1016/0010-0285(91)90012-D; Robertson LC, 1996, J EXP PSYCHOL GEN, V125, P227, DOI 10.1037/0096-3445.125.3.227; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Stiles J, 2005, TRENDS COGN SCI, V9, P136, DOI 10.1016/j.tics.2005.01.002; VURPILLOT E, 1968, J EXP CHILD PSYCHOL, V6, P632, DOI 10.1016/0022-0965(68)90108-2; Weissman DH, 2005, CEREB CORTEX, V15, P870, DOI 10.1093/cercor/bhh187	32	45	46	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20879	10.1371/journal.pone.0020879	http://dx.doi.org/10.1371/journal.pone.0020879			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687636	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500050
J	Whitehead, SN; Chan, KHN; Gangaraju, S; Slinn, J; Li, JJ; Hou, ST				Whitehead, Shawn N.; Chan, Kenneth H. N.; Gangaraju, Sandhya; Slinn, Jacqueline; Li, Jianjun; Hou, Sheng T.			Imaging Mass Spectrometry Detection of Gangliosides Species in the Mouse Brain following Transient Focal Cerebral Ischemia and Long-Term Recovery	PLOS ONE			English	Article							ANCHORED PROTEINS; SIALIC ACIDS; EXPRESSION; CHAIN; REDISTRIBUTION; EXTRACTION; GM2	Gangliosides, a member of the glycosphingolipid family, are heterogeneously expressed in biological membranes and are particularly enriched within the central nervous system. Gangliosides consist of mono-or poly-sialylated oligosaccharide chains of variable lengths attached to a ceramide unit and are found to be intimately involved in brain disease development. The purpose of this study is to examine the spatial profile of ganglioside species using matrix-assisted laser desorption/ionization (MALDI) imaging (IMS) following middle cerebral artery occlusion (MCAO) reperfusion injury in the mouse. IMS is a powerful method to not only discriminate gangliosides by their oligosaccharide components, but also by their carbon length within their sphingosine base. Mice were subjected to a 30 min unilateral MCAO followed by long-term survival (up to 28 days of reperfusion). Brain sections were sprayed with the matrix 5-Chloro-2-mercaptobenzothiazole, scanned and analyzed for a series of ganglioside molecules using an Applied Biosystems 4800 MALDI TOF/TOF. Traditional histological and immunofluorescence techniques were performed to assess brain tissue damage and verification of the expression of gangliosides of interest. Results revealed a unique anatomical profile of GM1, GD1 and GT1b (d18:1, d20:1 as well as other members of the glycosphingolipid family). There was marked variability in the ratio of expression between ipsilateral and contralateral cortices for the various detected ganglioside species following MCAO-reperfusion injury. Most interestingly, MCAO resulted in the transient induction of both GM2 and GM3 signals within the ipsilateral hemisphere; at the border of the infarcted tissue. Taken together, the data suggest that brain region specific expression of gangliosides, particularly with respect to hydrocarbon length, may play a role in neuronal responses to injury.	[Whitehead, Shawn N.; Gangaraju, Sandhya; Slinn, Jacqueline; Hou, Sheng T.] Natl Res Council Canada, Inst Biol Sci, Expt NeuroTherapeut Lab, Ottawa, ON K1A 0R6, Canada; [Chan, Kenneth H. N.; Li, Jianjun] Natl Res Council Canada, Inst Biol Sci, Mass Spectrometry Glycoanal Lab, Ottawa, ON K1A 0R6, Canada; [Hou, Sheng T.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	National Research Council Canada; National Research Council Canada; University of Ottawa	Whitehead, SN (corresponding author), Univ Western Ontario, Dept Clin Neurol Sci, London, ON, Canada.	Shawn.Whitehead@nrc-cnrc.gc.ca; Sheng.hou@nrc-cnrc.gc.ca	Hou, Sheng Tao/O-3202-2018; Whitehead, Shawn/E-3772-2016; Hou, Sheng Tao/AAM-7756-2020	Whitehead, Shawn/0000-0003-4728-8067; Hou, Sheng Tao/0000-0001-9736-342X; Li, Jianjun/0000-0002-6531-3687	Heart and Stroke Foundation of Ontario [T5760, T6706]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This research is supported by the Heart and Stroke Foundation of Ontario grant No. T5760 and T6706 to S.T.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasako Y, 2011, NEUROSCI LETT, V488, P199, DOI 10.1016/j.neulet.2010.11.029; Chan K, 2009, ANAL CHIM ACTA, V639, P57, DOI 10.1016/j.aca.2009.02.051; CONZELMANN E, 1978, P NATL ACAD SCI USA, V75, P3979, DOI 10.1073/pnas.75.8.3979; DEPOSSE CE, 2010, FEBS LETT, V584, P1748; Gupta G, 2010, FEBS LETT, V584, P1634, DOI 10.1016/j.febslet.2009.11.070; Haughey NJ, 2010, BBA-MOL CELL BIOL L, V1801, P878, DOI 10.1016/j.bbalip.2010.05.003; Heffer-Lauc M, 2005, BBA-MOL CELL BIOL L, V1686, P200, DOI 10.1016/j.bbalip.2004.10.002; Heffer-Lauc M, 2007, J HISTOCHEM CYTOCHEM, V55, P805, DOI 10.1369/jhc.7A7195.2007; Hou ST, 2008, BIOCHEM BIOPH RES CO, V367, P109, DOI 10.1016/j.bbrc.2007.12.103; Iwabuchi K, 2010, FEBS LETT, V584, P1642, DOI 10.1016/j.febslet.2009.10.043; Jiang SX, 2010, J BIOL CHEM, V285, P9908, DOI 10.1074/jbc.M109.080689; Kawashima N, 2009, J NEUROCHEM, V111, P1031, DOI 10.1111/j.1471-4159.2009.06391.x; Kiernan J.A., 1999, HISTOLOGICAL HISTOCH, V3rd ed; Koizumi S, 2010, NEUROSCIENCE, V168, P219, DOI 10.1016/j.neuroscience.2010.03.056; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Molander M, 2000, J NEUROSCI RES, V60, P531, DOI 10.1002/(SICI)1097-4547(20000515)60:4<531::AID-JNR12>3.0.CO;2-6; NORTON WT, 1973, J NEUROCHEM, V21, P759, DOI 10.1111/j.1471-4159.1973.tb07520.x; Ohmi Y, 2009, P NATL ACAD SCI USA, V106, P22405, DOI 10.1073/pnas.0912336106; Paxinos G. F, MOUSE BRAIN STEREOTA; Powell AK, 1996, RAPID COMMUN MASS SP, V10, P1027; Ryan SD, 2008, J LIPID RES, V49, P2250, DOI 10.1194/jlr.M800263-JLR200; Sandhoff R, 2010, FEBS LETT, V584, P1907, DOI 10.1016/j.febslet.2009.12.032; Schnaar RL, 2010, FEBS LETT, V584, P1741, DOI 10.1016/j.febslet.2009.10.011; Sekiya S, 2005, ANAL CHEM, V77, P4962, DOI 10.1021/ac050287o; Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052; Sugiura Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003232; Sugiyama E, 1997, GLYCOBIOLOGY, V7, P719, DOI 10.1093/glycob/7.5.719; Tai T, 1997, PURE APPL CHEM, V69, P1903, DOI 10.1351/pac199769091903; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Whitehead SN, 2010, BRAIN RES, V1366, P246, DOI 10.1016/j.brainres.2010.10.008; Yu RK, 2010, FEBS LETT, V584, P1694, DOI 10.1016/j.febslet.2009.08.026	31	65	68	6	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20808	10.1371/journal.pone.0020808	http://dx.doi.org/10.1371/journal.pone.0020808			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687673	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500046
J	Chandra, V; Swetha, G; Muthyala, S; Jaiswal, AK; Bellare, JR; Nair, PD; Bhonde, RR				Chandra, Vikash; Swetha, G.; Muthyala, Sudhakar; Jaiswal, Amit K.; Bellare, Jayesh R.; Nair, Prabha D.; Bhonde, Ramesh R.			Islet-Like Cell Aggregates Generated from Human Adipose Tissue Derived Stem Cells Ameliorate Experimental Diabetes in Mice	PLOS ONE			English	Article							INSULIN-PRODUCING CELLS; HUMAN UMBILICAL-CORD; LOW-PROTEIN DIET; IN-VITRO; PANCREATIC-ISLETS; TRANSPLANTATION; DIFFERENTIATION; EXPRESSION; ENDODERM; CLUSTERS	Background: Type 1 Diabetes Mellitus is caused by auto immune destruction of insulin producing beta cells in the pancreas. Currently available treatments include transplantation of isolated islets from donor pancreas to the patient. However, this method is limited by inadequate means of immuno-suppression to prevent islet rejection and importantly, limited supply of islets for transplantation. Autologous adult stem cells are now considered for cell replacement therapy in diabetes as it has the potential to generate neo-islets which are genetically part of the treated individual. Adopting methods of islet encapsulation in immuno-isolatory devices would eliminate the need for immuno-suppressants. Methodology/Principal Findings: In the present study we explore the potential of human adipose tissue derived adult stem cells (h-ASCs) to differentiate into functional islet like cell aggregates (ICAs). Our stage specific differentiation protocol permit the conversion of mesodermic h-ASCs to definitive endoderm (Hnf3 beta, TCF2 and Sox17) and to PDX1, Ngn3, NeuroD, Pax4 positive pancreatic endoderm which further matures in vitro to secrete insulin. These ICAs are shown to produce human C-peptide in a glucose dependent manner exhibiting in-vitro functionality. Transplantation of mature ICAs, packed in immuno-isolatory biocompatible capsules to STZ induced diabetic mice restored near normoglycemia within 3-4 weeks. The detection of human C-peptide, 1155+/-165 pM in blood serum of experimental mice demonstrate the efficacy of our differentiation approach. Conclusions: h-ASC is an ideal population of personal stem cells for cell replacement therapy, given that they are abundant, easily available and autologous in origin. Our findings present evidence that h-ASCs could be induced to differentiate into physiologically competent functional islet like cell aggregates, which may provide as a source of alternative islets for cell replacement therapy in type 1 diabetes.	[Chandra, Vikash; Swetha, G.; Bhonde, Ramesh R.] Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune, Maharashtra, India; [Muthyala, Sudhakar; Nair, Prabha D.] Sree Chitra Tirunal Inst Med Sci & Technol, Biomed Technol Wing, Thiruvananthapuram, Kerala, India; [Jaiswal, Amit K.; Bellare, Jayesh R.] Indian Inst Technol, Dept Chem Engn, Bombay 400076, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Chandra, V (corresponding author), Natl Ctr Cell Sci, Tissue Engn & Banking Lab, Pune, Maharashtra, India.	rrbhonde@hotmail.com	Bellare, Jayesh/AAO-8713-2020; Nair, Prabha/AAE-4517-2019; Jaiswal, Amit Kumar/S-9640-2019	Bellare, Jayesh/0000-0002-6792-8327; Jaiswal, Amit Kumar/0000-0002-6566-3580; Chandra, Vikash/0000-0002-2713-1831; Gopalakrishnan, Swetha/0000-0002-4717-4521	National Center for Cell Science, Department of Biotechnology, Government of India; University Grants Commission, Government of India	National Center for Cell Science, Department of Biotechnology, Government of India(Department of Science & Technology (India)); University Grants Commission, Government of India(University Grants Commission, India)	This research was supported by the Intramural Research Program of the National Center for Cell Science, Department of Biotechnology, Government of India to RRB. VC and SG are supported by fellowships from University Grants Commission, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Barbacci E, 1999, DEVELOPMENT, V126, P4795; Berney T, 2006, DIABETES METAB, V32, P503, DOI 10.1016/S1262-3636(06)72803-8; Boujendar S, 2003, J NUTR, V133, P2820, DOI 10.1093/jn/133.9.2820; Chandra V, 2009, STEM CELLS, V27, P1941, DOI 10.1002/stem.117; Chang CM, 2007, BIOCHEM BIOPH RES CO, V357, P414, DOI 10.1016/j.bbrc.2007.03.157; Chao KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001451; Cherif H, 1998, J ENDOCRINOL, V159, P341, DOI 10.1677/joe.0.1590341; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DEKRIJGER RR, 1992, DEV BIOL, V153, P368, DOI 10.1016/0012-1606(92)90121-V; Feng S, 2006, AM J TRANSPLANT, V6, P1759, DOI 10.1111/j.1600-6143.2006.01402.x; Fujikawa T, 2010, P NATL ACAD SCI USA, V107, P17391, DOI 10.1073/pnas.1008025107; George S, 2002, J BIOMATER APPL, V16, P327, DOI 10.1106/088532802024249; Hansson M, 2004, DIABETES, V53, P2603, DOI 10.2337/diabetes.53.10.2603; Hardikar AA, 2003, P NATL ACAD SCI USA, V100, P7117, DOI 10.1073/pnas.1232230100; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Lee J, 2008, BIOCHEM BIOPH RES CO, V375, P547, DOI 10.1016/j.bbrc.2008.08.064; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; Maedler K, 2004, P NATL ACAD SCI USA, V101, P8138, DOI 10.1073/pnas.0305683101; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Morini S, 2006, J ANAT, V209, P381, DOI 10.1111/j.1469-7580.2006.00620.x; Noguchi H, 2010, TRANSPL P, V42, P2081, DOI 10.1016/j.transproceed.2010.05.097; Phadnis SM, 2011, CYTOTHERAPY, V13, P279, DOI 10.3109/14653249.2010.523108; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; Rabe K, 2008, MOL MED, V14, P741, DOI 10.2119/2008-00058.Rabe; Rajagopal J, 2003, SCIENCE, V299, P363; Rider DA, 2008, STEM CELLS, V26, P1598, DOI 10.1634/stemcells.2007-0480; SASAKI H, 1993, DEVELOPMENT, V118, P47; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sun B, 2007, BIOCHEM BIOPH RES CO, V354, P919, DOI 10.1016/j.bbrc.2007.01.069; Tateishi K, 2008, J BIOL CHEM, V283, P31601, DOI 10.1074/jbc.M806597200; Timper K, 2006, BIOCHEM BIOPH RES CO, V341, P1135, DOI 10.1016/j.bbrc.2006.01.072; Tran TT, 2010, NAT REV ENDOCRINOL, V6, P195, DOI 10.1038/nrendo.2010.20; Xie QP, 2009, DIFFERENTIATION, V77, P483, DOI 10.1016/j.diff.2009.01.001; Yang LJ, 2002, P NATL ACAD SCI USA, V99, P8078, DOI 10.1073/pnas.122210699; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	41	92	98	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20615	10.1371/journal.pone.0020615	http://dx.doi.org/10.1371/journal.pone.0020615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687731	Green Published, Green Submitted, gold			2022-12-25	WOS:000291607000014
J	Javaherian, S; O'Donnell, KA; McGuigan, AP				Javaherian, Sahar; O'Donnell, Kylie A.; McGuigan, Alison P.			A Fast and Accessible Methodology for Micro-Patterning Cells on Standard Culture Substrates Using Parafilm (TM) Inserts	PLOS ONE			English	Article							CONTACT; MODEL	Micropatterning techniques provide direct control over the spatial organization of cells at the sub-mm scale. Regulation of these spatial parameters is important for controlling cell fate and cell function. While micropatterning has proved a powerful technique for understanding the impact of cell organization on cell behaviour, current methods for micropatterning cells require complex, specialized equipment that is not readily accessible in most biological and bioengineering laboratories. In addition, currently available methods require significant protocol optimization to ensure reliable and reproducible patterning. The inaccessibility of current methods has severely limited the widespread use of micropatterning as a tool in both biology and tissue engineering laboratories. Here we present a simple, cheap, and fast method to micropattern mammalian cells into stripes and circular patterns using Parafilm (TM), a common material found in most biology and bioengineering laboratories. Our method does not require any specialized equipment and does not require significant method optimization to ensure reproducible patterning. Although our method is limited to simple patterns, these geometries are sufficient for addressing a wide range of biological problems. Specifically, we demonstrate i) that using our Parafilm (TM) insert method we can pattern and co-pattern ARPE-19 and MDCK epithelial cells into circular and stripe micropatterns in tissue culture polystyrene (TCPS) wells and on glass slides, ii) that we can contain cells in the desired patterns for more than one month and iii) that upon removal of the Parafilm (TM) insert we can release the cells from the containment pattern and allow cell migration outward from the original pattern. We also demonstrate that we can exploit this confinement release feature to conduct an epithelial cell wound healing assay. This novel micropatterning method provides a reliable and accessible tool with the flexibility to address a wide range of biological and engineering problems that require control over the spatial and temporal organization of cells.	[Javaherian, Sahar; O'Donnell, Kylie A.; McGuigan, Alison P.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada; [McGuigan, Alison P.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University of Toronto	Javaherian, S (corresponding author), Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON, Canada.	alison.mcguigan@utoronto.ca	McGuigan, Alison/B-4744-2010	McGuigan, Alison/0000-0003-2803-0917	Natural Science and Engineering Research Council of Canada (NSERC); NSERC USRA	Natural Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC USRA(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Natural Science and Engineering Research Council of Canada (NSERC - http://www.nserc-crsng.gc.ca/) Discovery grant to AM, an NSERC graduate award to SJ and an NSERC USRA award to KO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauwens CL, 2008, STEM CELLS, V26, P2300, DOI 10.1634/stemcells.2008-0183; Bhatia SN, 1998, BIOTECHNOL PROGR, V14, P378, DOI 10.1021/bp980036j; Block ER, 2004, J BIOL CHEM, V279, P24307, DOI 10.1074/jbc.M401058200; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Folch A, 1999, J BIOMECH ENG-T ASME, V121, P28, DOI 10.1115/1.2798038; GOMEZ EW, J CELL BIOCH, V110, P44; Ho CT, 2006, LAB CHIP, V6, P724, DOI 10.1039/b602036d; Hui EE, 2007, P NATL ACAD SCI USA, V104, P5722, DOI 10.1073/pnas.0608660104; Hui EE, 2007, LANGMUIR, V23, P4103, DOI 10.1021/la0630559; Hyun JH, 2006, BIOMATERIALS, V27, P1444, DOI 10.1016/j.biomaterials.2005.08.018; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; Nelson CM, 2002, FEBS LETT, V514, P238, DOI 10.1016/S0014-5793(02)02370-0; Nikolic DL, 2006, AM J PHYSIOL-CELL PH, V291, pC68, DOI 10.1152/ajpcell.00411.2005; Nishizawa M, 2002, LANGMUIR, V18, P3645, DOI 10.1021/la011576k; Peerani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006438; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Roth EA, 2004, BIOMATERIALS, V25, P3707, DOI 10.1016/j.biomaterials.2003.10.052; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751	19	49	50	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20909	10.1371/journal.pone.0020909	http://dx.doi.org/10.1371/journal.pone.0020909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687691	gold, Green Submitted, Green Published			2022-12-25	WOS:000291607000026
J	Boeke, J; Bag, I; Ramaiah, MJ; Vetter, I; Kremmer, E; Pal-Bhadra, M; Bhadra, U; Imhof, A				Boeke, Joern; Bag, Indira; Ramaiah, M. Janaki; Vetter, Irene; Kremmer, Elisabeth; Pal-Bhadra, Manika; Bhadra, Utpal; Imhof, Axel			The RNA Helicase Rm62 Cooperates with SU(VAR)3-9 to Re-Silence Active Transcription in Drosophila melanogaster	PLOS ONE			English	Article							HEAT-SHOCK GENES; POSITION-EFFECT VARIEGATION; POLYMERASE-II; HISTONE H3; CHROMATIN-STRUCTURE; IN-VIVO; HETEROCHROMATIN PROTEIN-1; SACCHAROMYCES-CEREVISIAE; HSP70 GENE; DNASE-I	Gene expression is highly dynamic and many genes show a wide range in expression over several orders of magnitude. This regulation is often mediated by sequence specific transcription factors. In addition, the tight packaging of DNA into chromatin can provide an additional layer of control resulting in a dynamic range of gene expression covering several orders of magnitude. During transcriptional activation, chromatin barriers have to be eliminated to allow an efficient progression of the RNA polymerase. This repressive chromatin structure has to be re-established quickly after it has been activated in order to tightly regulate gene activity. We show that the DExD/H box containing RNA helicase Rm62 is targeted to a site of rapid induction of transcription where it is responsible for an increased degree of methylation at H3K9 at the heat shock locus after removal of the heat shock stimulus. The RNA helicase interacts with the well-characterized histone methyltransferase SU(VAR)3-9 via its N-terminus, which provides a potential mechanism for the targeting of H3K9 methylation to highly regulated genes. The recruitment of SU(VAR)3-9 through interaction with a RNA helicase to a site of active transcription might be a general mechanism that allows an efficient silencing of highly regulated genes thereby enabling a cell to fine tune its gene activity over a wide range.	[Boeke, Joern; Vetter, Irene; Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany; [Boeke, Joern; Vetter, Irene; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, Munich, Germany; [Bag, Indira; Ramaiah, M. Janaki; Pal-Bhadra, Manika] Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, Andhra Pradesh, India; [Ramaiah, M. Janaki; Bhadra, Utpal] Ctr Cellular & Mol Biol, Funct Genom & Gene Silencing Grp, Hyderabad 500007, Andhra Pradesh, India; [Kremmer, Elisabeth] Helmholtz Zentrum Munich, Inst Mol Immunol, Munich, Germany	University of Munich; University of Munich; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Technology (IICT); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Boeke, J (corresponding author), Univ Munich, Munich Ctr Integrated Prot Sci, Munich, Germany.	Imhof@lmu.de	Imhof, Axel/AAU-5313-2021; RAMAIAH, JANAKI/AAL-9074-2020	Imhof, Axel/0000-0003-2993-8249; Ramaiah, Janaki/0000-0003-1814-2819	European Union [LSHG-CT2006-037415]; Deutsche Forschungsgemeinschaft [IM23/4-3]; Senior International Wellcome Trust [GAP 0158, GAP 0065]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Senior International Wellcome Trust	This work was funded by grants from the European Union (LSHG-CT2006-037415) and the Deutsche Forschungsgemeinschaft (IM23/4-3) and partly by the Senior International Wellcome Trust Fellowships to MP-B (GAP 0158) and UB (GAP 0065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Ayyanathan K, 2003, GENE DEV, V17, P1855, DOI 10.1101/gad.1102803; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Boeke J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010042; Bryant GO, 2008, PLOS BIOL, V6, P2928, DOI 10.1371/journal.pbio.0060317; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buszczak M, 2006, GENE DEV, V20, P977, DOI 10.1101/gad.1396306; Chen ES, 2008, NATURE, V451, P734, DOI 10.1038/nature06561; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; COSTLOW N, 1984, MOL CELL BIOL, V4, P1853, DOI 10.1128/MCB.4.9.1853; Cryderman DE, 2005, DEV DYNAM, V232, P767, DOI 10.1002/dvdy.20310; CSINK AK, 1994, GENETICS, V138, P153; Deng H, 2008, DEVELOPMENT, V135, P699, DOI 10.1242/dev.015362; Ebert A, 2004, GENE DEV, V18, P2973, DOI 10.1101/gad.323004; Eskeland R, 2004, BIOCHEMISTRY-US, V43, P3740, DOI 10.1021/bi035964s; Fanti L, 2008, CURR OPIN GENET DEV, V18, P169, DOI 10.1016/j.gde.2008.01.009; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; GIARDINA C, 1992, GENE DEV, V6, P2190, DOI 10.1101/gad.6.11.2190; Gilmour DS, 2009, CHROMOSOMA, V118, P1, DOI 10.1007/s00412-008-0182-4; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Krauss V, 2000, GENETICS, V156, P1157; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li BY, 1996, MOL CELL BIOL, V16, P5433; Lindsley D.L., 1992, GENOME DROSOPHILA ME, P1133; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lu BY, 2000, GENETICS, V155, P699; Melcher M, 2000, MOL CELL BIOL, V20, P3728, DOI 10.1128/MCB.20.10.3728-3741.2000; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Piacentini L, 2003, J CELL BIOL, V161, P707, DOI 10.1083/jcb.200303012; RASMUSSEN EB, 1995, J MOL BIOL, V252, P522, DOI 10.1006/jmbi.1995.0517; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; REUTER G, 1982, CHROMOSOMA, V85, P539, DOI 10.1007/BF00327349; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Schotta G, 2003, SEMIN CELL DEV BIOL, V14, P67, DOI 10.1016/S1084-9521(02)00138-6; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; SIMON JA, 1985, CELL, V40, P805, DOI 10.1016/0092-8674(85)90340-X; Sims RJ, 2004, CURR OPIN CELL BIOL, V16, P263, DOI 10.1016/j.ceb.2004.04.004; Smith ER, 2008, MOL CELL BIOL, V28, P1041, DOI 10.1128/MCB.01504-07; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Watanabe M, 2001, EMBO J, V20, P1341, DOI 10.1093/emboj/20.6.1341; WEBER JA, 1995, NUCLEIC ACIDS RES, V23, P3327, DOI 10.1093/nar/23.16.3327; Workman JL, 2006, GENE DEV, V20, P2009, DOI 10.1101/gad.1435706; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; WU C, 1987, SCIENCE, V238, P1247, DOI 10.1126/science.3685975; XIAO H, 1991, CELL, V64, P585, DOI 10.1016/0092-8674(91)90242-Q; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	56	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20761	10.1371/journal.pone.0020761	http://dx.doi.org/10.1371/journal.pone.0020761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674064	gold, Green Published, Green Submitted			2022-12-25	WOS:000291310600031
J	Narbona, E; Ortiz, PL; Arista, M				Narbona, Eduardo; Ortiz, Pedro L.; Arista, Montserrat			Linking Self-Incompatibility, Dichogamy, and Flowering Synchrony in Two Euphorbia Species: Alternative Mechanisms for Avoiding Self-Fertilization?	PLOS ONE			English	Article							INFLORESCENCE BOUNDARY; INBREEDING DEPRESSION; TEMPORAL DIOECISM; SEXUAL-DIMORPHISM; BREEDING SYSTEM; MATING SYSTEMS; FRUIT-SET; EVOLUTION; PLANTS; ANGIOSPERMS	Background: Plant species have several mechanisms to avoid selfing such as dichogamy or a self-incompatibility response. Dichogamy in a single flower may reduce autogamy but, to avoid geitonogamy, plants must show flowering synchronization among all their flowers (i.e. synchronous dichogamy). It is hypothesized that one species would not simultaneously show synchronous dichogamy and self-incompatibility because they are redundant mechanisms to reduce selfing; however, this has not been accurately assessed. Methodology/Principal Findings: This expectation was tested over two years in two natural populations of the closely related Mediterranean spurges Euphorbia boetica and E. nicaeensis, which completely avoid autogamy by protogyny at the cyathia level. Both spurges showed a high population synchrony (Z<79), and their inflorescences flower synchronously. In E. nicaeensis, there was no overlap among the cyathia in anthesis of successive inflorescence levels and the overlap between sexual phases of cyathia of the same inflorescence level was uncommon (4-16%). In contrast, E. boetica showed a high overlap among consecutive inflorescence levels (74-93%) and between sexual phases of cyathia of the same inflorescence level (48-80%). The flowering pattern of both spurges was consistent in the two populations and over the two successive years. A hand-pollination experiment demonstrated that E. nicaeensis was strictly self-compatible whereas E. boetica was partially self-incompatible. Conclusions/Significance: We propose that the complex pattern of synchronized protogyny in E. nicaeensis prevents geitonogamous crosses and, consequently, avoids selfing and inbreeding depression. In E. boetica, a high probability of geitonogamous crosses may occur but, alternatively, this plant escapes selfing through a self-incompatibility response. We posit that synchronous dichogamy and physiological self-incompatibility do not co-occur in the same species because each process is sufficiently effective in avoiding self-fertilization.	[Narbona, Eduardo] Univ Pablo de Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain; [Ortiz, Pedro L.; Arista, Montserrat] Univ Seville, Dept Biol Vegetal & Ecol, Seville, Spain	Universidad Pablo de Olavide; University of Sevilla	Narbona, E (corresponding author), Univ Pablo de Olavide, Dept Biol Mol & Ingn Bioquim, Seville, Spain.	enarfer@upo.es	Arista, Montserrat/D-1096-2018; Ballesteros, Pedro Luis Ortiz/G-3099-2015; Fernández, Francisco Eduardo Narbona/G-5276-2015	Arista, Montserrat/0000-0003-0914-9525; Ballesteros, Pedro Luis Ortiz/0000-0002-4150-565X; Fernández, Francisco Eduardo Narbona/0000-0003-1790-6821	FEDER funds; Spanish Ministerio de Ciencia y Tecnologia [CGL2005-03731, CGL2008-02533-E, CGL2009-08257]	FEDER funds(European Commission); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported with FEDER funds and grants from the Spanish Ministerio de Ciencia y Tecnologia to PLO (CGL2005-03731; CGL2008-02533-E) and to MA(CGL2009-08257). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen A. M., 2008, P73, DOI 10.1007/978-3-540-68486-2_4; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; AUGSPURGER CK, 1983, BIOTROPICA, V15, P257, DOI 10.2307/2387650; Barrett SCH, 2002, NAT REV GENET, V3, P274, DOI 10.1038/nrg776; Barrett SCH, 2003, PHILOS T R SOC B, V358, P991, DOI 10.1098/rstb.2003.1301; BARRETT SCH, 1984, ANN MO BOT GARD, V71, P278, DOI 10.2307/2399071; BECERRA JX, 1992, EVOLUTION, V46, P458, DOI 10.1111/j.1558-5646.1992.tb02051.x; BERTIN RI, 1993, BOT REV, V59, P112, DOI 10.1007/BF02856676; BERTIN RI, 1993, AM J BOT, V80, P557, DOI 10.2307/2445372; Bhardwaj M, 2001, AM J BOT, V88, P2204, DOI 10.2307/3558382; Blancafort X, 2005, ACTA OECOL, V28, P49, DOI 10.1016/j.actao.2005.02.004; BRUNET J, 1995, EVOLUTION, V49, P70, DOI [10.2307/2410293, 10.1111/j.1558-5646.1995.tb05959.x]; Bruyns PV, 2006, TAXON, V55, P397, DOI 10.2307/25065587; Castellan NJ, 1988, NONPARAMETRIC STAT B; Charlesworth D., 1985, EVOLUTION ESSAYS HON, P237; Charlesworth D, 2006, CURR BIOL, V16, pR726, DOI 10.1016/j.cub.2006.07.068; Crawley MJ., 2007, R BOOK; CRUDEN RW, 1988, BOT GAZ, V149, P1, DOI 10.1086/337684; CRUDEN RW, 1977, EVOLUTION, V31, P863, DOI 10.1111/j.1558-5646.1977.tb01079.x; Cruz-Mazo G, 2009, MOL PHYLOGENET EVOL, V53, P835, DOI 10.1016/j.ympev.2009.08.001; Dai C, 2011, FUNCT ECOL, V25, P271, DOI 10.1111/j.1365-2435.2010.01795.x; DEJONG TJ, 1993, TRENDS ECOL EVOL, V8, P321, DOI 10.1016/0169-5347(93)90239-L; DICKINSON HG, 1973, PROC R SOC SER B-BIO, V183, P21, DOI 10.1098/rspb.1973.0002; Dudash MR, 2001, AM J BOT, V88, P1953, DOI 10.2307/3558422; DUMAS C, 1983, THEOR APPL GENET, V67, P1, DOI 10.1007/BF00303914; EAST E. M., 1940, PROC AMER PHIL SOC, V82, P449; EHRENFELD JG, 1979, AM MIDL NAT, V101, P87, DOI 10.2307/2424904; Ferrer MM, 2007, NEW PHYTOL, V173, P401, DOI 10.1111/j.1469-8137.2006.01905.x; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; Harder LD, 2004, FUNCT ECOL, V18, P467, DOI 10.1111/j.0269-8463.2004.00859.x; Hiscock SJ, 2002, INT J PLANT SCI, V163, P1, DOI 10.1086/324530; Jordan CY, 2006, AM NAT, V167, P496, DOI 10.1086/501142; LEVIN D A, 1971, Taxon, V20, P91, DOI 10.2307/1218538; LLOYD DG, 1980, EVOLUTION, V34, P123, DOI 10.1111/j.1558-5646.1980.tb04795.x; LLOYD DG, 1986, NEW ZEAL J BOT, V24, P135, DOI 10.1080/0028825X.1986.10409725; Loo AHB, 2006, MOL PHYLOGENET EVOL, V39, P598, DOI 10.1016/j.ympev.2005.12.006; Mahoro S, 2002, CAN J BOT, V80, P82, DOI 10.1139/b01-136; Michalski SG, 2007, ANN BOT-LONDON, V100, P1271, DOI 10.1093/aob/mcm206; Narbona E, 2005, ANN BOT-LONDON, V95, P779, DOI 10.1093/aob/mci077; Narbona E, 2002, ANN BOT-LONDON, V89, P571, DOI 10.1093/aob/mcf099; Narbona E, 2008, ANN BOT-LONDON, V101, P717, DOI 10.1093/aob/mcn011; Nettancourt, 2001, INCOMPATIBILITY INCO; Prenner G, 2007, AM J BOT, V94, P1612, DOI 10.3732/ajb.94.10.1612; Prenner G, 2011, J EXP BOT, V62, P345, DOI 10.1093/jxb/erq275; R Core Team, 2022, R LANG ENV STAT COMP; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Routley MB, 2006, EVOL ECOL, V20, P331, DOI 10.1007/s10682-006-0005-0; Routley MB, 2004, INT J PLANT SCI, V165, P983, DOI 10.1086/423881; Sargent RD, 2004, EVOL ECOL RES, V6, P1183; Sargent RD, 2006, EVOLUTION, V60, P934, DOI 10.1111/j.0014-3820.2006.tb01172.x; Schlessman MA, 2002, INT J PLANT SCI, V163, P409, DOI 10.1086/339513; Schurch S, 2000, OIKOS, V88, P6, DOI 10.1034/j.1600-0706.2000.880102.x; Selbo SM, 1999, CAN J BOT, V77, P1684, DOI 10.1139/cjb-77-11-1684; Silva NF, 2001, CELL MOL LIFE SCI, V58, P1988, DOI 10.1007/PL00000832; Spencer Stanley C., 1995, Plant Species Biology, V10, P65, DOI 10.1111/j.1442-1984.1995.tb00123.x; STOUT A. B., 1928, BULL TORREY BOT CLUB, V55, P141, DOI 10.2307/2480605; Takayama S, 2005, ANNU REV PLANT BIOL, V56, P467, DOI 10.1146/annurev.arplant.56.032604.144249; THOMSON JD, 1981, EVOLUTION, V35, P1094, DOI 10.1111/j.1558-5646.1981.tb04979.x; Vogler DW, 2001, EVOLUTION, V55, P202, DOI 10.1111/j.0014-3820.2001.tb01285.x; WEBB CJ, 1981, NEW ZEAL J BOT, V19, P335, DOI 10.1080/0028825X.1981.10426389; Zar JH, 1999, BIOSTATISTICAL ANAL; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	67	17	19	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20668	10.1371/journal.pone.0020668	http://dx.doi.org/10.1371/journal.pone.0020668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674062	Green Published, Green Submitted, gold			2022-12-25	WOS:000291310600025
J	Koenig, X; Dysek, S; Kimbacher, S; Mike, AK; Cervenka, R; Lukacs, P; Nagl, K; Dang, XB; Todt, H; Bittner, RE; Hilber, K				Koenig, Xaver; Dysek, Sandra; Kimbacher, Stefanie; Mike, Agnes K.; Cervenka, Rene; Lukacs, Peter; Nagl, Katrin; Dang, Xuan B.; Todt, Hannes; Bittner, Reginald E.; Hilber, Karlheinz			Voltage-Gated Ion Channel Dysfunction Precedes Cardiomyopathy Development in the Dystrophic Heart	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; MDX MOUSE; DILATED CARDIOMYOPATHY; DEFICIENT MICE; EXPRESSION; CONDUCTION; MODEL; UTROPHIN; NA(V)1.5; MUTATION	Background: Duchenne muscular dystrophy (DMD), caused by mutations in the dystrophin gene, is associated with severe cardiac complications including cardiomyopathy and cardiac arrhythmias. Recent research suggests that impaired voltage-gated ion channels in dystrophic cardiomyocytes accompany cardiac pathology. It is, however, unknown if the ion channel defects are primary effects of dystrophic gene mutations, or secondary effects of the developing cardiac pathology. Methodology/Principal Findings: To address this question, we first investigated sodium channel impairments in cardiomyocytes derived from dystrophic neonatal mice prior to cardiomyopahty development, by using the whole cell patch clamp technique. Besides the most common model for DMD, the dystrophin-deficient mdx mouse, we also used mice additionally carrying an utrophin mutation. In neonatal cardiomyocytes, dystrophin-deficiency generated a 25% reduction in sodium current density. In addition, extra utrophin-deficiency significantly altered sodium channel gating parameters. Moreover, also calcium channel inactivation was considerably reduced in dystrophic neonatal cardiomyocytes, suggesting that ion channel abnormalities are universal primary effects of dystrophic gene mutations. To assess developmental changes, we also studied sodium channel impairments in cardiomyocytes derived from dystrophic adult mice, and compared them with the respective abnormalities in dystrophic neonatal cells. Here, we found a much stronger sodium current reduction in adult cardiomyocytes. The described sodium channel impairments slowed the upstroke of the action potential in adult cardiomyocytes, and only in dystrophic adult mice, the QRS interval of the electrocardiogram was prolonged. Conclusions/Significance: Ion channel impairments precede pathology development in the dystrophic heart, and may thus be considered potential cardiomyopathy triggers.	[Koenig, Xaver; Kimbacher, Stefanie; Mike, Agnes K.; Cervenka, Rene; Lukacs, Peter; Nagl, Katrin; Dang, Xuan B.; Todt, Hannes; Hilber, Karlheinz] Med Univ Vienna, Dept Neurophysiol & Pharmacol, Ctr Physiol & Pharmacol, Vienna, Austria; [Dysek, Sandra; Kimbacher, Stefanie; Bittner, Reginald E.] Med Univ Vienna, Dept Neuromuscular Res, Ctr Anat & Cell Biol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Koenig, X (corresponding author), Med Univ Vienna, Dept Neurophysiol & Pharmacol, Ctr Physiol & Pharmacol, Vienna, Austria.	karlheinz.hilber@meduniwien.ac.at	Koenig, Xaver/Y-5588-2019	Koenig, Xaver/0000-0002-2423-4966; Hilber, Karlheinz/0000-0002-3033-0874	Austrian Science Fund (FWF) [P19352-B11, P21006-B11]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by the Austrian Science Fund (FWF) [P19352-B11 to K. H. and P21006-B11 to H. T.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba T, 2010, CURR OPIN CARDIOL, V25, P29, DOI 10.1097/HCO.0b013e328333d3d6; Albesa M, 2011, CARDIOVASC RES, V89, P320, DOI 10.1093/cvr/cvq326; Au CG, 2011, INT J EXP PATHOL, V92, P57, DOI 10.1111/j.1365-2613.2010.00750.x; Beynon RP, 2008, QJM-INT J MED, V101, P337, DOI 10.1093/qjmed/hcm124; Bostick B, 2008, HUM GENE THER, V19, P851, DOI 10.1089/hum.2008.058; Bostick B, 2008, CIRC RES, V102, P121, DOI 10.1161/CIRCRESAHA.107.162982; Bushby K, 2010, LANCET NEUROL, V9, P177, DOI 10.1016/S1474-4422(09)70272-8; Capote J, 2010, AM J PHYSIOL-CELL PH, V298, pC1077, DOI 10.1152/ajpcell.00428.2009; Colussi C, 2010, CARDIOVASC RES, V87, P73, DOI 10.1093/cvr/cvq035; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Gavillet B, 2006, CIRC RES, V99, P407, DOI 10.1161/01.RES.0000237466.13252.5e; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; Hainsey TA, 2003, NEUROMUSCULAR DISORD, V13, P294, DOI 10.1016/S0960-8966(02)00286-9; Hesse M, 2007, CARDIOVASC RES, V75, P498, DOI 10.1016/j.cardiores.2007.04.009; Janssen PML, 2005, AM J PHYSIOL-HEART C, V289, pH2373, DOI 10.1152/ajpheart.00448.2005; Leoni AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009298; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; McNally EM, 2005, NAT CLIN PRACT CARD, V2, P301, DOI 10.1038/ncpcardio0213; Meadows LS, 2005, CARDIOVASC RES, V67, P448, DOI 10.1016/j.cardiores.2005.04.003; Mille M, 2009, PFLUG ARCH EUR J PHY, V457, P1023, DOI 10.1007/s00424-008-0570-x; Muth JN, 2001, CIRCULATION, V103, P140; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Ou YJ, 2003, J BIOL CHEM, V278, P1915, DOI 10.1074/jbc.M209938200; Pedrotty DM, 2009, CARDIOVASC RES, V83, P688, DOI 10.1093/cvr/cvp164; PERLOFF JK, 1984, J AM COLL CARDIOL, V3, P1263, DOI 10.1016/S0735-1097(84)80186-2; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007; Sadeghi A, 2002, AM J PHYSIOL-CELL PH, V282, pC1502, DOI 10.1152/ajpcell.00435.2001; Sarma S, 2010, P NATL ACAD SCI USA, V107, P13165, DOI 10.1073/pnas.1004509107; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Thomas SA, 1998, CIRCULATION, V97, P686, DOI 10.1161/01.CIR.97.7.686; TORRES LFB, 1987, BRAIN, V110, P269, DOI 10.1093/brain/110.2.269; Vaidya D, 2001, CIRC RES, V88, P1196, DOI 10.1161/hh1101.091107; YOTSUKURA M, 1992, J ELECTROCARDIOL, V25, P345, DOI 10.1016/0022-0736(92)90041-W	36	44	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	MAY 23	2011	6	5							e20300	10.1371/journal.pone.0020300	http://dx.doi.org/10.1371/journal.pone.0020300			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	769ID	21677768	Green Published, gold, Green Submitted			2022-12-25	WOS:000291005200051
J	Fenouille, N; Puissant, A; Tichet, M; Zimniak, G; Abbe, P; Mallavialle, A; Rocchi, S; Ortonne, JP; Deckert, M; Ballotti, R; Tartare-Deckert, S				Fenouille, N.; Puissant, A.; Tichet, M.; Zimniak, G.; Abbe, P.; Mallavialle, A.; Rocchi, S.; Ortonne, J-P; Deckert, M.; Ballotti, R.; Tartare-Deckert, S.			SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival	ONCOGENE			English	Article						melanoma; p53; signaling; tumor biology	INTEGRIN-LINKED KINASE; TUMOR-SUPPRESSOR P53; MALIGNANT-MELANOMA; THERAPEUTIC TARGET; CYSTEINE SPARC; UP-REGULATION; CANCER CELLS; E-CADHERIN; APOPTOSIS; EXPRESSION	Aberrant expression of Secreted Protein Acidic and Rich in Cysteine (SPARC)/osteonectin has been associated with an invasive tumor cell phenotype and poor outcome in human melanomas. Although it is known that SPARC controls melanoma tumorigenesis, the precise role of SPARC in melanoma cell survival is still unclear. Here, we show that SPARC has a cell-autonomous survival activity, which requires Akt-dependent regulation of p53. Suppression of SPARC by RNA interference in several human melanoma cells and xenografted A375 tumors triggers apoptotic cell death through the mitochondrial intrinsic pathway and activation of caspase-3. Cell death induced by depletion of SPARC is dependent on p53 and induction of Bax, and results in the generation of ROS. Stabilization of p53 in SPARC-depleted cells is associated with a decrease in Akt-mediated activating phosphorylation of MDM2. Inhibition of Akt signaling pathway is important for the observed changes as overexpression of constitutively active Akt protects cells against apoptosis induced by SPARC depletion. Conversely, increased expression of SPARC stimulates Akt and MDM2 phosphorylation, thus facilitating p53 degradation. Finally, we show that overexpression of SPARC renders cells more resistant to the p53-mediated cytotoxic effects of the DNA-damaging drug actinomycin-D. Our study indicates that SPARC functions through activation of Akt and MDM2 to limit p53 levels and that acquired expression of SPARC during melanoma development would confer survival advantages through suppression of p53-dependent apoptotic pathways. Oncogene (2011) 30, 4887-4900; doi: 10.1038/onc.2011.198; published online 20 June 2011	[Fenouille, N.; Tichet, M.; Zimniak, G.; Abbe, P.; Rocchi, S.; Ortonne, J-P; Ballotti, R.; Tartare-Deckert, S.] INSERM, Ctr Mediterraneene Med Mole C3M, U895, F-06204 Nice 3, France; [Fenouille, N.; Puissant, A.; Tichet, M.; Zimniak, G.; Abbe, P.; Mallavialle, A.; Rocchi, S.; Ortonne, J-P; Deckert, M.; Ballotti, R.; Tartare-Deckert, S.] Univ Nice Sophia Antipolis, Fac Med, Inst Signalisat & Pathol IFR50, Nice, France; [Mallavialle, A.; Deckert, M.] INSERM, U576, F-06204 Nice 3, France; [Rocchi, S.; Ballotti, R.; Tartare-Deckert, S.] Hop Archet, CHU Nice, Dept Dermatol, Nice, France; [Deckert, M.] Hop Archet, CHU Nice, Dept Clin Hematol, Nice, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; CHU Nice	Tartare-Deckert, S (corresponding author), INSERM, Ctr Mediterraneene Med Mole C3M, U895, Equipe 1,151 Route St Antoine Ginestiere,BP 23194, F-06204 Nice 3, France.	tartare@unice.fr	PUISSANT, ALEXANDRE/O-9575-2016; TARTARE-DECKERT, Sophie/P-6057-2015; Deckert, Marcel/T-3566-2019; Deckert, Marcel/M-4998-2016; Fenouille, Nina/AAI-1027-2021; BALLOTTI, Robert/F-8825-2013; Puissant, Alexandre/AAF-3875-2021; Rocchi, Stephane/O-4152-2016	PUISSANT, ALEXANDRE/0000-0002-3997-9282; TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Deckert, Marcel/0000-0003-2094-559X; Puissant, Alexandre/0000-0002-3997-9282; Rocchi, Stephane/0000-0002-0943-1304; mallavialle, aude/0000-0002-9380-6788; Tichet, Melanie/0000-0001-7128-4061; BALLOTTI, Robert/0000-0002-7322-4908	INSERM (Institut National de la Santeet de la Recherche Medicale); ARC (Association pour la Recherche sur le Cancer) [1136]	INSERM (Institut National de la Santeet de la Recherche Medicale)(Institut National de la Sante et de la Recherche Medicale (Inserm)); ARC (Association pour la Recherche sur le Cancer)(Fondation ARC pour la Recherche sur le Cancer)	This work was supported in part by INSERM (Institut National de la Santeet de la Recherche Medicale) and grant 1136 from ARC (Association pour la Recherche sur le Cancer). S Tartare-Deckert is a recipient of a Contrat d'Interface Clinique, Service de Dermatologie, CHU de Nice.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Ashcroft M, 2002, ONCOGENE, V21, P1955, DOI 10.1038/sj.onc.1205276; Bailet O, 2009, CANCER RES, V69, P2748, DOI 10.1158/0008-5472.CAN-08-2690; Barker TH, 2005, J BIOL CHEM, V280, P36483, DOI 10.1074/jbc.M504663200; Bornstein P, 2002, CURR OPIN CELL BIOL, V14, P608, DOI 10.1016/S0955-0674(02)00361-7; Briggs J, 2002, ONCOGENE, V21, P7077, DOI 10.1038/sj.onc.1205857; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Choong ML, 2009, CELL CYCLE, V8, P2810, DOI 10.4161/cc.8.17.9503; De S, 2003, J BIOL CHEM, V278, P39044, DOI 10.1074/jbc.M304494200; Fenouille N, 2011, PIGM CELL MELANOMA R, V24, P219, DOI 10.1111/j.1755-148X.2010.00790.x; Fenouille N, 2010, CANCER RES, V70, P9659, DOI 10.1158/0008-5472.CAN-10-2034; Fukunaga-Kalabis M, 2008, CANCER MICROENVIRON, V1, P93, DOI 10.1007/s12307-008-0009-0; Gaggioli C, 2005, ONCOGENE, V24, P1423, DOI 10.1038/sj.onc.1208318; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Horie K, 2010, CANCER SCI, V101, P913, DOI 10.1111/j.1349-7006.2009.01476.x; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Khwaja FW, 2006, ONCOGENE, V25, P7650, DOI 10.1038/sj.onc.1209969; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Ledda F, 1997, J INVEST DERMATOL, V108, P210, DOI 10.1111/1523-1747.ep12334263; Ledda MF, 1997, NAT MED, V3, P171, DOI 10.1038/nm0297-171; Madhunapantula SV, 2009, PIGM CELL MELANOMA R, V22, P400, DOI 10.1111/j.1755-148X.2009.00585.x; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Massi D, 1999, HUM PATHOL, V30, P339, DOI 10.1016/S0046-8177(99)90014-X; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; METTOUCHI A, 1994, EMBO J, V13, P5668, DOI 10.1002/j.1460-2075.1994.tb06905.x; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; MIYASHITA T, 1995, CELL, V80, P293; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Nie J, 2008, STEM CELLS, V26, P2735, DOI 10.1634/stemcells.2008-0212; Nie J, 2009, J CELL COMMUN SIGNAL, V3, P247, DOI 10.1007/s12079-009-0064-4; Ogawara Y, 2002, J BIOL CHEM, V277, P21843, DOI 10.1074/jbc.M109745200; Portela M, 2010, DEV CELL, V19, P562, DOI 10.1016/j.devcel.2010.09.004; Robert G, 2006, CANCER RES, V66, P7516, DOI 10.1158/0008-5472.CAN-05-3189; SAGE H, 1986, J CELL PHYSIOL, V127, P373, DOI 10.1002/jcp.1041270305; Sangaletti S, 2008, CANCER RES, V68, P9050, DOI 10.1158/0008-5472.CAN-08-1327; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Shi Q, 2007, ONCOGENE, V26, P4084, DOI 10.1038/sj.onc.1210181; Shi Q, 2004, J BIOL CHEM, V279, P52200, DOI 10.1074/jbc.M409630200; Smalley KSM, 2007, CANCER RES, V67, P209, DOI 10.1158/0008-5472.CAN-06-1538; Smit DJ, 2007, INT J CANCER, V121, P2653, DOI 10.1002/ijc.23039; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Stromblad S, 1996, J CLIN INVEST, V98, P426, DOI 10.1172/JCI118808; Sturm RA, 2002, CANCER RES, V62, P226; Tang MJ, 2007, J BIOL CHEM, V282, P34457, DOI 10.1074/jbc.M704459200; Tuveson DA, 2003, CANCER CELL, V4, P95, DOI 10.1016/S1535-6108(03)00189-2; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weaver MS, 2008, J BIOL CHEM, V283, P22826, DOI 10.1074/jbc.M706563200; WEISS J, 1993, INT J CANCER, V54, P693, DOI 10.1002/ijc.2910540427; Yiu GK, 2001, AM J PATHOL, V159, P609, DOI 10.1016/S0002-9440(10)61732-4; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	53	49	49	3	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	DEC	2011	30	49					4887	4900		10.1038/onc.2011.198	http://dx.doi.org/10.1038/onc.2011.198			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	865YI	21685937				2022-12-25	WOS:000298346400005
J	Feldner, A; Otto, H; Rewerk, S; Hecker, M; Korff, T				Feldner, Anja; Otto, Hannes; Rewerk, Stephan; Hecker, Markus; Korff, Thomas			Experimental hypertension triggers varicosis-like maladaptive venous remodeling through activator protein-1	FASEB JOURNAL			English	Article						smooth muscle cells; MMP-2; gelatinase activity; circumferential wall tension	SMOOTH-MUSCLE-CELLS; TRANSCRIPTION FACTOR; RODENT MODEL; LEUKOCYTE CONCENTRATION; VEINS; EXPRESSION; METALLOPROTEINASES; PATHOGENESIS; DISEASE; FIBERS	An increase in circumferential wall tension (CWT) is an important determinant of vascular remodeling during hypertension or arteriosclerosis but also arteriogenesis. Although pivotal for such processes, the effect of this biomechanical force on venous remodeling has not yet been delineated. To this end, we raised the filling pressure in veins of the mouse auricle, which led to a 2.5-fold enlargement of these blood vessels within 4 d along with an increase in smooth muscle cell proliferation, matrix metalloproteinase 2 (MMP-2) expression and gelatinase activity. These changes were likewise observed in tissue samples of human varicose veins. Topical treatment of the auricles with a decoy oligonucleotide- neutralizing activator protein 1 (AP-1) inhibited these effects. Likewise, proliferation, MMP-2 expression, and gelatinase activity in both native and cultured venous smooth muscle cells exposed to enhanced stretch was decreased by up to 80% through inhibiting AP-1. In contrast, mutant control oligonucleotides had no effect on smooth muscle cell activation. These findings indicate that an increase in venous filling pressure and thus CWT is sufficient to activate AP-1, which, in turn, triggers varicose remodeling through fuelling MMP-2 activity and smooth muscle cell hyperplasia in the venous vessel wall.-Feldner, A., Otto, H., Rewerk, S., Hecker, M., Korff, T. Experimental hypertension triggers varicosis-like maladaptive venous remodeling through activator protein-1. FASEB J. 25, 3613-3621 (2011). www.fasebj.org	[Feldner, Anja; Otto, Hannes; Hecker, Markus; Korff, Thomas] Univ Heidelberg, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, D-69120 Heidelberg, Germany; [Rewerk, Stephan] Ctr Vasc Med, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Korff, T (corresponding author), Univ Heidelberg, Inst Physiol & Pathophysiol, Div Cardiovasc Physiol, Neuenheimer Feld 230, D-69120 Heidelberg, Germany.	korff@physiologie.uni-heidelberg.de						Aunapuu M, 2005, VASA-J VASCULAR DIS, V34, P170, DOI 10.1024/0301-1526.34.3.170; Beebe-Dimmer JL, 2005, ANN EPIDEMIOL, V15, P175, DOI 10.1016/j.annepidem.2004.05.015; Bergan JJ, 2008, J VASC SURG, V47, P183, DOI 10.1016/j.jvs.2007.09.028; Bergman MR, 2003, BIOCHEM J, V369, P485, DOI 10.1042/BJ20020707; Buchwald AB, 2002, J AM COLL CARDIOL, V39, P732, DOI 10.1016/S0735-1097(01)01797-1; BURKITT DP, 1976, LANCET, V2, P202; Demicheva E, 2008, CIRC RES, V103, P477, DOI 10.1161/CIRCRESAHA.108.177782; Grote K, 2003, CIRC RES, V92, pE80, DOI 10.1161/01.RES.0000077044.60138.7C; Hahn TL, 1999, J SURG RES, V81, P38, DOI 10.1006/jsre.1998.5518; Hahn TL, 2000, J SURG RES, V88, P150, DOI 10.1006/jsre.1999.5766; *I AN LAB RES, 1996, NIH PUBL, V8523; Ishikawa Y, 2000, VIRCHOWS ARCH, V437, P138, DOI 10.1007/s004280000200; Kowalewski R, 2004, INT ANGIOL, V23, P164; Lalka SG, 1998, J SURG RES, V74, P59, DOI 10.1006/jsre.1997.5189; Lee AJ, 2003, J CLIN EPIDEMIOL, V56, P171, DOI 10.1016/S0895-4356(02)00518-8; Lim CS, 2009, BRIT J SURG, V96, P1231, DOI 10.1002/bjs.6798; Mann MJ, 2000, J CLIN INVEST, V106, P1071, DOI 10.1172/JCI11459; NORTH KAK, 1958, CIRC RES, V6, P721, DOI 10.1161/01.RES.6.6.721; Pascarella L, 2005, J VASC SURG, V41, P303, DOI 10.1016/j.jvs.2004.10.038; Porto LC, 2002, ANGIOLOGY, V53, P131; Raffetto JD, 2008, PHLEBOLOGY, V23, P85, DOI 10.1258/phleb.2007.007027; Sansilvestri-Morel P, 2002, CIRCULATION, V106, P479, DOI 10.1161/01.CIR.0000022846.22923.46; Somers P, 2006, ANGIOLOGY, V57, P546, DOI 10.1177/0003319706293115; Wali MA, 2002, INT ANGIOL, V21, P337; Woodside KJ, 2003, J VASC SURG, V38, P162, DOI 10.1016/S0741-5214(03)00134-4; Wu X, 2007, AM J PHYSIOL-ENDOC M, V293, pE1789, DOI 10.1152/ajpendo.00249.2007; Wung BS, 1997, CIRC RES, V81, P1, DOI 10.1161/01.RES.81.1.1	27	23	25	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3613	3621		10.1096/fj.11-185975	http://dx.doi.org/10.1096/fj.11-185975			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21685329				2022-12-25	WOS:000295356400031
J	Kissner, TL; Moisan, L; Mann, E; Alam, S; Ruthel, G; Ulrich, RG; Rebek, M; Rebek, J; Saikh, KU				Kissner, Teri L.; Moisan, Lionel; Mann, Enrique; Alam, Shahabuddin; Ruthel, Gordon; Ulrich, Robert G.; Rebek, Mitra; Rebek, Julius, Jr.; Saikh, Kamal U.			A Small Molecule That Mimics the BB-loop in the Toll Interleukin-1 (IL-1) Receptor Domain of MyD88 Attenuates Staphylococcal Enterotoxin B-induced Pro-inflammatory Cytokine Production and Toxicity in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-II MOLECULES; MHC CLASS-II; INTENSIVE-CARE UNITS; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; DENDRITIC CELLS; SHOCK-SYNDROME; LETHAL SHOCK; T-CELLS; SUPERANTIGEN	Toxic shock syndrome (TSS) is a clinical consequence of the profound amplification of host pro-inflammatory cytokine signaling that results from staphylococcal enterotoxin (SE) exposure. We recently reported that MyD88(-/-) mice were resistant to SEA or SEB toxic shock and displayed reduced levels of pro-inflammatory cytokines in their serum. Here we report that SEB stimulation of total mononuclear cells up-regulated MyD88 in monocytes and T cells. Further, MyD88 gene silencing in primary human cells using siRNA prevented SEB or SEB plus lipopolysaccharide (LPS) induction of interleukin-1 beta (IL-1 beta) transcriptional activation, suggesting that MyD88-mediated signaling is an essential component of SEB toxicity. We synthesized small molecules that mimic the conserved BB-loop in the Toll/IL-1 receptor (TIR) domain of MyD88. In primary human cells, these mimetics attenuated SEB-induced pro-inflammatory cytokine production. SEB stimulation of primary cells with mimetic affected newly synthesized MyD88 and downstream signaling components. Furthermore, LPS-induced MyD88 signaling was likewise inhibited in a cell-based reporter assay. More importantly, administration of mimetic reduced cytokine responses and increased survivability in a murine SEB challenge model. Collectively, these results suggest that MyD88 BB-loop mimetics interfere with SEB-induced pro-inflammatory signaling and toxicity, thus offering a potential approach in the therapy of toxic shock.	[Kissner, Teri L.; Alam, Shahabuddin; Ruthel, Gordon; Ulrich, Robert G.; Saikh, Kamal U.] USA, Dept Immunol, Med Res Inst Infect Dis, Frederick, MD 21702 USA; [Moisan, Lionel; Mann, Enrique; Rebek, Mitra; Rebek, Julius, Jr.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Moisan, Lionel; Mann, Enrique; Rebek, Mitra; Rebek, Julius, Jr.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Saikh, KU (corresponding author), 1425 Porter St, Frederick, MD 21702 USA.	kamal.saikh@amedd.army.mil	Ruthel, Gordon/GYU-9133-2022; Mann, Enrique/K-6594-2014	Mann, Enrique/0000-0002-2050-4295; Ruthel, Gordon/0000-0001-9193-5589	Defense Threat Reduction Agency; Skaggs Institute; Spanish Ministerio de Educacion y Ciencia	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); Skaggs Institute; Spanish Ministerio de Educacion y Ciencia(Spanish Government)	This work was supported by the Defense Threat Reduction Agency (to K. U. S.) and the Skaggs Institute.; Supported by a Spanish Ministerio de Educacion y Ciencia fellowship.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barr TA, 2009, J IMMUNOL, V183, P1005, DOI 10.4049/jimmunol.0803706; Bartfai T, 2003, P NATL ACAD SCI USA, V100, P7971, DOI 10.1073/pnas.0932746100; Beno DWA, 2001, AM J PHYSIOL-GASTR L, V280, pG866, DOI 10.1152/ajpgi.2001.280.5.G866; Blank C, 1997, EUR J IMMUNOL, V27, P825, DOI 10.1002/eji.1830270405; Buatois V, 2003, J IMMUNOL, V171, P5812, DOI 10.4049/jimmunol.171.11.5812; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; DUNNE A, 2003, SCI STKE, V3, P171; FAASSEN AE, 1995, J IMMUNOL, V155, P1737; Han KJ, 2010, J BIOL CHEM, V285, P12543, DOI 10.1074/jbc.M109.072231; Hassan GS, 2011, NAT IMMUNOL, V12, P375, DOI 10.1038/ni.2023; HAUSCHILDT S, 1993, EUR J IMMUNOL, V23, P2988, DOI 10.1002/eji.1830231139; He B, 2010, NAT IMMUNOL, V11, P836, DOI 10.1038/ni.1914; Honda K, 2004, P NATL ACAD SCI USA, V101, P15416, DOI 10.1073/pnas.0406933101; Jefferies CA, 2003, J BIOL CHEM, V278, P26258, DOI 10.1074/jbc.M301484200; Kissner TL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015985; Kissner TL, 2010, IMMUNOLOGY, V130, P516, DOI 10.1111/j.1365-2567.2010.03249.x; KISSNER TL, INNATE IMMUN-LONDON, DOI DOI 10.1177/1753425910374092; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; McGettrick AF, 2004, MOL IMMUNOL, V41, P577, DOI 10.1016/j.molimm.2004.04.006; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; MIETHKE T, 1993, EUR J IMMUNOL, V23, P1494, DOI 10.1002/eji.1830230715; Mills Kingston H G, 2009, Nat Med, V15, P1363, DOI 10.1038/nm1209-1363; Richards MJ, 1999, CRIT CARE MED, V27, P887, DOI 10.1097/00003246-199905000-00020; Saikh KU, 2004, J IMMUNOL, V173, P7426, DOI 10.4049/jimmunol.173.12.7426; Saikh KU, 2001, CLIN EXP IMMUNOL, V126, P447, DOI 10.1046/j.1365-2249.2001.01672.x; SCHOLL P, 1989, P NATL ACAD SCI USA, V86, P4210, DOI 10.1073/pnas.86.11.4210; SPERTINI F, 1992, J IMMUNOL, V149, P65; STILES BG, 1993, INFECT IMMUN, V61, P5333, DOI 10.1128/IAI.61.12.5333-5338.1993; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Ulrich RG, 1995, TRENDS MICROBIOL, V3, P463, DOI 10.1016/S0966-842X(00)89011-3; VINCENT JL, 1995, JAMA-J AM MED ASSOC, V274, P639, DOI 10.1001/jama.274.8.639; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600	34	29	31	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31385	31396		10.1074/jbc.M110.204982	http://dx.doi.org/10.1074/jbc.M110.204982			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21693701	Green Published, hybrid			2022-12-25	WOS:000294487500033
J	Fledel-Alon, A; Leffler, EM; Guan, YT; Stephens, M; Coop, G; Przeworski, M				Fledel-Alon, Adi; Leffler, Ellen Miranda; Guan, Yongtao; Stephens, Matthew; Coop, Graham; Przeworski, Molly			Variation in Human Recombination Rates and Its Genetic Determinants	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MEIOTIC RECOMBINATION; QUANTITATIVE TRAITS; PRDM9; POPULATIONS; SELECTION; HOTSPOTS; SEX; MAP; SPOT	Background: Despite the fundamental role of crossing-over in the pairing and segregation of chromosomes during human meiosis, the rates and placements of events vary markedly among individuals. Characterizing this variation and identifying its determinants are essential steps in our understanding of the human recombination process and its evolution. Study Design/Results: Using three large sets of European-American pedigrees, we examined variation in five recombination phenotypes that capture distinct aspects of crossing-over patterns. We found that the mean recombination rate in males and females and the historical hotspot usage are significantly heritable and are uncorrelated with one another. We then conducted a genome-wide association study in order to identify loci that influence them. We replicated associations of RNF212 with the mean rate in males and in females as well as the association of Inversion 17q21.31 with the female mean rate. We also replicated the association of PRDM9 with historical hotspot usage, finding that it explains most of the genetic variance in this phenotype. In addition, we identified a set of new candidate regions for further validation. Significance: These findings suggest that variation at broad and fine scales is largely separable and that, beyond three known loci, there is no evidence for common variation with large effects on recombination phenotypes.	[Fledel-Alon, Adi; Leffler, Ellen Miranda; Guan, Yongtao; Stephens, Matthew; Przeworski, Molly] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Guan, Yongtao; Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA; [Coop, Graham] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Coop, Graham] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Przeworski, Molly] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Przeworski, Molly] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of California System; University of California Davis; University of California System; University of California Davis; University of Chicago; Howard Hughes Medical Institute; University of Chicago	Fledel-Alon, A (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	gmcoop@ucdavis.edu; mfp@uchicago.edu	Leffler, Ellen/I-3010-2019	Leffler, Ellen/0000-0002-1614-9366; Coop, Graham/0000-0001-8431-0302	National Institutes of Health (NIH) [HG02585, GM083098]; American Recovery and Reinvestment Act Supplement; Sloan Fellowship in Computational and Evolutionary Molecular Biology; University of California; Genetics and Regulation Training Grant [T32 GM07197]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007197, R01GM083098] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act Supplement; Sloan Fellowship in Computational and Evolutionary Molecular Biology; University of California(University of California System); Genetics and Regulation Training Grant; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) HG02585 to MS, a Rosalind Franklin Young Investigator Award, NIH GM083098 and an American Recovery and Reinvestment Act Supplement to MP, as well as a Sloan Fellowship in Computational and Evolutionary Molecular Biology and University of California Davis start-up funds to GC. EL was supported by the Genetics and Regulation Training Grant (T32 GM07197). MP is a Howard Hughes Medical Institute Early Career Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2000, AM J HUM GENET, V66, P629, DOI 10.1086/302759; Abney M, 2002, AM J HUM GENET, V70, P920, DOI 10.1086/339705; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET, V42, P859, DOI 10.1038/ng.658; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bouma GJ, 2007, GENE EXPR PATTERNS, V7, P113, DOI 10.1016/j.modgep.2006.05.011; Broman KW, 1998, AM J HUM GENET, V63, P861, DOI 10.1086/302011; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Dumont BL, 2009, GENETICS, V182, P1345, DOI 10.1534/genetics.109.105114; Fallahi M, 2010, GENES-BASEL, V1, P469, DOI 10.3390/genes1030469; FELSENSTEIN J, 1976, GENETICS, V83, P845; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2004, NAT GENET, V36, P1203, DOI 10.1038/ng1445; Kong A, 2008, SCIENCE, V319, P1398, DOI 10.1126/science.1152422; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lenormand T, 2005, PLOS BIOL, V3, P396, DOI 10.1371/journal.pbio.0030063; Lenzi ML, 2005, AM J HUM GENET, V76, P112, DOI 10.1086/427268; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McMahon AP, 2008, J AM SOC NEPHROL, V19, P667, DOI 10.1681/ASN.2007101078; McVean G, 2010, NAT GENET, V42, P821, DOI 10.1038/ng1010-821; Muller HJ, 1916, AM NAT, V50, P421, DOI 10.1086/279553; MURDOCH B, MAMM GENOME, V21, P550; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; MYERS S, 2008, NAT GENET; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Otto SP, 2001, EVOLUTION, V55, P1921, DOI 10.1111/j.0014-3820.2001.tb01310.x; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Pan L, 2007, GENET EPIDEMIOL, V31, P338, DOI 10.1002/gepi.20214; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Pichler I, 2010, EUR J HUM GENET, V18, P463, DOI 10.1038/ejhg.2009.172; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rzymski T, 2008, CYTOGENET GENOME RES, V121, P232, DOI 10.1159/000138890; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; STURTEVANT AH, 1915, MOL GEN GENETICS MGG, V13, P234; SUCHINDRAN S, PLOS GENET, V6; Thomas JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008505; True JR, 1996, GENETICS, V142, P507; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834	51	81	83	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20321	10.1371/journal.pone.0020321	http://dx.doi.org/10.1371/journal.pone.0020321			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698098	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600004
J	Jang, ES; Goldman, JE				Jang, Eun Sook; Goldman, James E.			Pax6 Expression Is Sufficient to Induce a Neurogenic Fate in Glial Progenitors of the Neonatal Subventricular Zone	PLOS ONE			English	Article							SONIC HEDGEHOG; FOREBRAIN; MIGRATION; NEURONS; CELLS; OLIGODENDROCYTES; ASTROCYTES; DISTINCT; ROLES; GENE	Background: The forebrain subventricular zone (SVZ) of neonatal mammals contains a large, heterogeneous population of migratory and proliferating precursors of interneurons and glia. These cell types are produced in large numbers in the immediate postnatal period, the glioblasts populating the hemispheres with astrocytes and oligodendrocytes, the neuroblasts migrating to the olfactory bulb to become interneurons. How cell fate decisions are determined or stabilized in this mixed population is not clear, although previous studies indicate the importance of two transcription factors, Pax6 in neurons and Olig2 in glia, and suggest there may be reciprocal repression between these genes. Methodology/Principal Findings: In examining the SVZ of neonatal mouse and rat brain, we find that the very large majority of SVZ cells express either Pax6 or Olig2, but few express both. We have used in vivo retro- and lenti-virus injections into the neonatal SVZ and in vitro gene transfer to demonstrate that pax6 over-expression is sufficient to down-regulate olig2 and to promote a neuronal lineage development and migration pattern in olig2-expressing cells. Furthermore, we provide evidence that Pax6 binds to the olig2 promoter and that an HEB sequence in the promoter is required for the Pax6 repression of olig2 transcription. Lastly, we constructed a lentivirus to target olig2-expressing cells in the SVZ to trace their fates, and found that the very large majority developed into glia. Conclusions/Significance: We provide evidence for a direct repression of olig2 by Pax6. Since SVZ cells can display developmental plasticity in vitro, the cross-repression promotes a stabilization of cell fates. This repression may be critical in a germinal zone in which immature cells are highly migratory and are not organized into an epithelium.	[Jang, Eun Sook] Columbia Univ, Integrated CMBS Grad Program, New York, NY 10027 USA; [Jang, Eun Sook] Columbia Univ, Pathol Grad Program, New York, NY USA; [Goldman, James E.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; Columbia University; Columbia University	Jang, ES (corresponding author), Columbia Univ, Integrated CMBS Grad Program, New York, NY 10027 USA.	jeg5@columbia.edu			NIH [NS17125]; Samsung Scholars Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017125] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Samsung Scholars Foundation(Samsung); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by NIH Grant NS17125 and a Fellowship from the Samsung Scholars Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Chauhan BK, 2004, INVEST OPHTH VIS SCI, V45, P385, DOI 10.1167/iovs.03-0968; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Duncan MK, 1998, MOL CELL BIOL, V18, P5579, DOI 10.1128/MCB.18.9.5579; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Holm PC, 2007, MOL CELL NEUROSCI, V34, P99, DOI 10.1016/j.mcn.2006.10.008; Inta D, 2008, P NATL ACAD SCI USA, V105, P20994, DOI 10.1073/pnas.0807059105; Jablonska B, 2010, NAT NEUROSCI, V13, P541, DOI 10.1038/nn.2536; Kakita A, 1999, NEURON, V23, P461, DOI 10.1016/S0896-6273(00)80800-4; Kohwi M, 2005, J NEUROSCI, V25, P6997, DOI 10.1523/JNEUROSCI.1435-05.2005; Komitova M, 2009, J COMP NEUROL, V512, P702, DOI 10.1002/cne.21917; Levison SW, 1997, J NEUROSCI RES, V48, P83, DOI 10.1002/(SICI)1097-4547(19970415)48:2<83::AID-JNR1>3.0.CO;2-8; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Lu QR, 2000, NEURON, V25, P317, DOI 10.1016/S0896-6273(00)80897-1; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; LUSKIN MB, 1994, GLIA, V11, P211, DOI 10.1002/glia.440110302; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; Marshall CAG, 2002, J NEUROSCI, V22, P9821; Mayes DA, 2006, CANCER RES, V66, P9809, DOI 10.1158/0008-5472.CAN-05-3877; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Osumi N, 2008, STEM CELLS, V26, P1663, DOI 10.1634/stemcells.2007-0884; Parnavelas JG, 1999, EXP NEUROL, V156, P418, DOI 10.1006/exnr.1999.7044; Schwarz M, 2000, DEVELOPMENT, V127, P4325; Staugaitis SM, 2001, J NEUROSCI, V21, P6195, DOI 10.1523/JNEUROSCI.21-16-06195.2001; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Sugimori M, 2007, DEVELOPMENT, V134, P1617, DOI 10.1242/dev.001255; Sussman CR, 2002, GLIA, V40, P55, DOI 10.1002/glia.10114; Suzuki SO, 2003, J NEUROSCI, V23, P4240; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Tang HK, 1998, J BIOL CHEM, V273, P7210, DOI 10.1074/jbc.273.13.7210; TURQUE N, 1994, MOL ENDOCRINOL, V8, P929, DOI 10.1210/me.8.7.929; Ventura RE, 2007, J NEUROSCI, V27, P4297, DOI 10.1523/JNEUROSCI.0399-07.2007; Yang Y, 2005, J MOL BIOL, V351, P453, DOI 10.1016/j.jmb.2005.05.072; ZERLIN M, 1995, J NEUROSCI, V15, P7238; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	38	29	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20894	10.1371/journal.pone.0020894	http://dx.doi.org/10.1371/journal.pone.0020894			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698109	Green Submitted, gold, Green Published			2022-12-25	WOS:000291737600028
J	League, GP; Nam, SC				League, Garrett P.; Nam, Sang-Chul			Role of Kinesin Heavy Chain in Crumbs Localization along the Rhabdomere Elongation in Drosophila Photoreceptor	PLOS ONE			English	Article							AXONAL-TRANSPORT; EPITHELIAL-CELLS; LIGHT-CHAIN; PROTEIN; POLARITY; BAZOOKA; EYE; MORPHOGENESIS; NEUROBLASTS; DIFFERENTIATION	Background: Crumbs (Crb), a cell polarity gene, has been shown to provide a positional cue for the extension of the apical membrane domain, adherens junction (AJ), and rhabdomere along the growing proximal-distal axis during Drosophila photoreceptor morphogenesis. In developing Drosophila photoreceptors, a stabilized microtubule structure was discovered and its presence was linked to polarity protein localization. It was therefore hypothesized that the microtubules may provide trafficking routes for the polarity proteins during photoreceptor morphogenesis. This study has examined whether Kinesin heavy chain (Khc), a subunit of the microtubule-based motor Kinesin-1, is essential in polarity protein localization in developing photoreceptors. Methodology/Principal Findings: Because a genetic interaction was found between crb and khc, Crb localization was examined in the developing photoreceptors of khc mutants. khc was dispensable during early eye differentiation and development. However, khc mutant photoreceptors showed a range of abnormalities in the apical membrane domain depending on the position along the proximal-distal axis in pupal photoreceptors. The khc mutant showed a progressive mislocalization in the apical domain along the distal-proximal axis during rhabdomere elongation. The khc mutation also led to a similar progressive defect in the stabilized microtubule structures, strongly suggesting that Khc is essential for microtubule structure and Crb localization during distal to proximal rhabdomere elongation in pupal morphogenesis. This role of Khc in apical domain control was further supported by khc's gain-of-function phenotype. Khc overexpression in photoreceptors caused disruption of the apical membrane domain and the stabilized microtubules in the developing photoreceptors. Conclusions/Significance: In summary, we examined the role of khc in the regulation of the apical Crb domain in developing photoreceptors. Since the rhabdomeres in developing pupal eyes grow along the distal-proximal axis, these phenotypes suggest that Khc is essential for the microtubule structures and apical membrane domains during the distal-proximal elongation of photoreceptors, but is dispensable for early eye development.	[League, Garrett P.; Nam, Sang-Chul] Baylor Univ, Dept Biol, Waco, TX 76798 USA	Baylor University	Nam, SC (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.	Sang-Chul_Nam@baylor.edu	Nam, Sang-Chul/J-5518-2014	Nam, Sang-Chul/0000-0001-7176-601X	Knights Templar Eye Foundation; University Research Committee of Baylor University	Knights Templar Eye Foundation; University Research Committee of Baylor University	This study was supported by grants from the Knights Templar Eye Foundation (http://www.knightstemplar.org/ktef/) and the University Research Committee of Baylor University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann A, 2001, NATURE, V414, P638, DOI 10.1038/414638a; Barkus RV, 2008, MOL BIOL CELL, V19, P274, DOI 10.1091/mbc.E07-03-0261; Bhat MA, 1999, CELL, V96, P833, DOI 10.1016/S0092-8674(00)80593-0; BLOCHLINGER K, 1990, GENE DEV, V4, P1322, DOI 10.1101/gad.4.8.1322; Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brendza RP, 2000, MOL BIOL CELL, V11, P1329, DOI 10.1091/mbc.11.4.1329; Chen G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016127; Chen G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009480; Chen TW, 2009, GENESIS, V47, P744, DOI 10.1002/dvg.20555; Choi KW, 2007, FLY, V1, P235, DOI 10.4161/fly.4954; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; GAUGER AK, 1993, J BIOL CHEM, V268, P13657; Gindhart JG, 1998, J CELL BIOL, V141, P443, DOI 10.1083/jcb.141.2.443; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hong Y, 2003, P NATL ACAD SCI USA, V100, P12712, DOI 10.1073/pnas.2135347100; Hong Y, 2001, NATURE, V414, P634, DOI 10.1038/414634a; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720; Johnson K, 2002, CURR BIOL, V12, P1675, DOI 10.1016/S0960-9822(02)01180-6; Jolly AL, 2010, P NATL ACAD SCI USA, V107, P12151, DOI 10.1073/pnas.1004736107; Klebes A, 2000, CURR BIOL, V10, P76, DOI 10.1016/S0960-9822(99)00277-8; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; Kumar JP, 1995, DEVELOPMENT, V121, P4359; Li R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003475; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; LONGLEY RL, 1995, DEV BIOL, V171, P415, DOI 10.1006/dbio.1995.1292; Medina PMB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003054; Morais-de-Sa E, 2010, CELL, V141, P509, DOI 10.1016/j.cell.2010.02.040; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Mukhopadhyay B, 2010, GENESIS, V48, P522, DOI 10.1002/dvg.20642; Nam SC, 2007, DEV BIOL, V306, P624, DOI 10.1016/j.ydbio.2007.03.522; Nam SC, 2006, DEV DYNAM, V235, P1501, DOI 10.1002/dvdy.20726; Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648; ODA H, 1994, DEV BIOL, V165, P716, DOI 10.1006/dbio.1994.1287; ONEILL EM, 1994, CELL, V78, P137, DOI 10.1016/0092-8674(94)90580-0; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Petronczki M, 2001, NAT CELL BIOL, V3, P43, DOI 10.1038/35050550; RIGGLEMAN B, 1990, CELL, V63, P549, DOI 10.1016/0092-8674(90)90451-J; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Sherwood NT, 2004, PLOS BIOL, V2, P2094, DOI 10.1371/journal.pbio.0020429; Straube A, 2006, MOL BIOL CELL, V17, P907, DOI 10.1091/mbc.E05-06-0542; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; TOMLINSON A, 1987, CELL, V51, P143, DOI 10.1016/0092-8674(87)90019-5; Torroja L, 1999, CURR BIOL, V9, P489, DOI 10.1016/S0960-9822(99)80215-2; Walther RF, 2010, CURR BIOL, V20, P1065, DOI 10.1016/j.cub.2010.04.049; Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Wodarz A, 1999, NATURE, V402, P544, DOI 10.1038/990128; XU T, 1993, DEVELOPMENT, V117, P1223; Zimyanin V, 2007, CURR BIOL, V17, P353, DOI 10.1016/j.cub.2006.12.044	53	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21218	10.1371/journal.pone.0021218	http://dx.doi.org/10.1371/journal.pone.0021218			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695062	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600054
J	Shimazaki, M; Fujita, K; Kobayashi, H; Suzuki, S				Shimazaki, Mamiko; Fujita, Keiko; Kobayashi, Hironori; Suzuki, Shunji			Pink-Colored Grape Berry Is the Result of Short Insertion in Intron of Color Regulatory Gene	PLOS ONE			English	Article							VITIS-VINIFERA L.; SKIN COLOR; CULTIVARS; CLONING; MUTATION; DELETION; VVMYBA1; ALLELE; LOCUS	We report here that pink grape berries were obtained by a short insertion in the intron of the MybA1 gene, a gene that regulates grape berry color. Genetic variation was detected among the MybA1 genes from grapes cultivated worldwide. PCR analysis of the MybA1 gene demonstrated that the size of the MybA1 gene in the red allele differs among grapes. Oriental V. vinifera bearing pink berries has the longest MybA1 gene among grapes, whereas the shortest MybA1 gene was detected in occidental V. vinifera grapes. The nucleotide sequences of the MybA1 genes demonstrated that oriental V. vinifera has two additional gene fragments (44 bp and 111 bp) in the promoter region of the MybA1 gene in the red allele and another 33 bp fragment in the second intron of the MybA1 gene in the red allele. The short insertion in the intron decreased the transcription activity in the model system and retained MybA1 transcripts with unspliced intron in the total RNA. From the experiments using deletion mutants of the 33 bp short insertion, 16 bp of the 39 end in the insertion is a key structure for a defect in splicing of MybA1 transcripts. Thus, a weakly colored grape berry might be a result of the short insertion in the intron of a color regulatory gene. This is new evidence concerning the molecular mechanism of the fate of grape berry color. These findings are expected to contribute to the further understanding of the color variation in grape berries, which is correlated with the evolutional events occurring in the MybA1 gene of grapes.	[Shimazaki, Mamiko; Fujita, Keiko; Kobayashi, Hironori; Suzuki, Shunji] Univ Yamanashi, Inst Enol & Viticulture, Yamanashi, Japan; [Kobayashi, Hironori] Mercian Corp, Prod Dev Res Lab, Kanagawa, Japan	University of Yamanashi	Shimazaki, M (corresponding author), Univ Yamanashi, Inst Enol & Viticulture, Yamanashi, Japan.	suzukis@yamanashi.ac.jp	Fujita, Keiko/HGU-4137-2022		Ministry of Education, Culture, Sports, Science and Technology of Japan [19580026]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Grant-in-Aid for Scientific Research (C) No. 19580026 from the Ministry of Education, Culture, Sports, Science and Technology of Japan to SS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azuma A, 2008, THEOR APPL GENET, V117, P1009, DOI 10.1007/s00122-008-0840-1; Ford CM, 1998, J BIOL CHEM, V273, P9224, DOI 10.1074/jbc.273.15.9224; Fujita K, 2009, AM J ENOL VITICULT, V60, P490; Furiya T, 2009, AM J ENOL VITICULT, V60, P66; Goto-Yamamoto N, 2006, AM J ENOL VITICULT, V57, P105; Katoh H, 2009, PLANT PHYSIOL BIOCH, V47, P291, DOI 10.1016/j.plaphy.2008.12.003; Kobayashi H, 2009, AM J ENOL VITICULT, V60, P362; Kobayashi S, 2004, SCIENCE, V304, P982, DOI 10.1126/science.1095011; Lijavetzky D, 2006, MOL GENET GENOMICS, V276, P427, DOI 10.1007/s00438-006-0149-1; LUEHRSEN KR, 1992, NUCLEIC ACIDS RES, V20, P5181, DOI 10.1093/nar/20.19.5181; Mitani N, 2009, VITIS, V48, P55; Negrul AM, 1938, CR ACAD SCI URSS, V18, P585; This P, 2007, THEOR APPL GENET, V114, P723, DOI 10.1007/s00122-006-0472-2; Verries C, 2000, GENOME, V43, P366, DOI 10.1139/gen-43-2-366; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Walker AR, 2006, PLANT MOL BIOL, V62, P623, DOI 10.1007/s11103-006-9043-9; Yakushiji H, 2006, BIOSCI BIOTECH BIOCH, V70, P1506, DOI 10.1271/bbb.50647	17	31	38	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21308	10.1371/journal.pone.0021308	http://dx.doi.org/10.1371/journal.pone.0021308			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695059	Green Submitted, Green Published, gold			2022-12-25	WOS:000291737600057
J	Harris, A; Adolphs, R; Camerer, C; Rangel, A				Harris, Alison; Adolphs, Ralph; Camerer, Colin; Rangel, Antonio			Dynamic Construction of Stimulus Values in the Ventromedial Prefrontal Cortex	PLOS ONE			English	Article							BLIND SOURCE SEPARATION; DECISION-MAKING; ORBITOFRONTAL CORTEX; MACAQUE MONKEY; NEURAL BASIS; GOAL VALUES; EEG; NETWORKS; NEUROBIOLOGY; COMPUTATIONS	Signals representing the value assigned to stimuli at the time of choice have been repeatedly observed in ventromedial prefrontal cortex (vmPFC). Yet it remains unknown how these value representations are computed from sensory and memory representations in more posterior brain regions. We used electroencephalography (EEG) while subjects evaluated appetitive and aversive food items to study how event-related responses modulated by stimulus value evolve over time. We found that value-related activity shifted from posterior to anterior, and from parietal to central to frontal sensors, across three major time windows after stimulus onset: 150-250 ms, 400-550 ms, and 700-800 ms. Exploratory localization of the EEG signal revealed a shifting network of activity moving from sensory and memory structures to areas associated with value coding, with stimulus value activity localized to vmPFC only from 400 ms onwards. Consistent with these results, functional connectivity analyses also showed a causal flow of information from temporal cortex to vmPFC. Thus, although value signals are present as early as 150 ms after stimulus onset, the value signals in vmPFC appear relatively late in the choice process, and seem to reflect the integration of incoming information from sensory and memory related regions.	[Harris, Alison; Adolphs, Ralph; Camerer, Colin; Rangel, Antonio] CALTECH, Pasadena, CA 91125 USA	California Institute of Technology	Harris, A (corresponding author), CALTECH, Pasadena, CA 91125 USA.	aharris@alum.mit.edu		Harris, Alison/0000-0002-0559-2821	Gordon and Betty Moore Foundation; NSF; NATIONAL INSTITUTE ON AGING [R21AG038866] Funding Source: NIH RePORTER	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Financial support from the Gordon and Betty Moore Foundation (AR, CC, RA) and NSF (AR, RA) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apergis-Schoute J, 2006, EUR J NEUROSCI, V24, P135, DOI 10.1111/j.1460-9568.2006.04894.x; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; BECKER GM, 1964, BEHAV SCI, V9, P226, DOI 10.1002/bs.3830090304; Beckmann M, 2009, J NEUROSCI, V29, P1175, DOI 10.1523/JNEUROSCI.3328-08.2009; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; BLAIR RC, 1993, PSYCHOPHYSIOLOGY, V30, P518, DOI 10.1111/j.1469-8986.1993.tb02075.x; Boorman ED, 2009, NEURON, V62, P733, DOI 10.1016/j.neuron.2009.05.014; BRESSLER SL, 2010, WIENERGRANGER CAUSAL; Carmichael ST, 1996, J COMP NEUROL, V371, P179, DOI 10.1002/(SICI)1096-9861(19960722)371:2<179::AID-CNE1>3.0.CO;2-#; Cavada C, 2000, CEREB CORTEX, V10, P220, DOI 10.1093/cercor/10.3.220; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; Fellows LK, 2007, CEREB CORTEX, V17, P2669, DOI 10.1093/cercor/bhl176; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Friston KJ, 2008, NEUROIMAGE, V39, P1104, DOI 10.1016/j.neuroimage.2007.09.048; GERBRANDT LK, 1973, ELECTROEN CLIN NEURO, V34, P461, DOI 10.1016/0013-4694(73)90064-3; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Gow DW, 2008, NEUROIMAGE, V43, P614, DOI 10.1016/j.neuroimage.2008.07.027; Grill-Spector K, 2004, ANNU REV NEUROSCI, V27, P649, DOI 10.1146/annurev.neuro.27.070203.144220; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Hare TA, 2010, J NEUROSCI, V30, P583, DOI 10.1523/JNEUROSCI.4089-09.2010; Hare TA, 2009, SCIENCE, V324, P646, DOI 10.1126/science.1168450; Holland PC, 2004, CURR OPIN NEUROBIOL, V14, P148, DOI 10.1016/j.conb.2004.03.007; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kable JW, 2007, NAT NEUROSCI, V10, P1625, DOI 10.1038/nn2007; Kable JW, 2010, J NEUROPHYSIOL, V103, P2513, DOI 10.1152/jn.00177.2009; Kable JW, 2009, NEURON, V63, P733, DOI 10.1016/j.neuron.2009.09.003; Karnath HO, 2001, NAT REV NEUROSCI, V2, P568, DOI 10.1038/35086057; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kennerley SW, 2009, J COGNITIVE NEUROSCI, V21, P1162, DOI 10.1162/jocn.2009.21100; Knutson B, 2007, NEURON, V53, P147, DOI 10.1016/j.neuron.2006.11.010; Lage-Castellanos A, 2010, STAT MED, V29, P63, DOI 10.1002/sim.3784; LEVY I, 2010, J NEUROPHYS IN PRESS; LITT A, 2010, CEREB CORTEX; Litvak V, 2008, NEUROIMAGE, V42, P1490, DOI 10.1016/j.neuroimage.2008.06.022; LUCK SJ, 2005, INTRO EVENT RELATED, pR12; Milosavljevic M, 2010, JUDGM DECIS MAK, V5, P437; Montague PR, 2002, NEURON, V36, P265, DOI 10.1016/S0896-6273(02)00974-1; Ongur D, 2000, CEREB CORTEX, V10, P206, DOI 10.1093/cercor/10.3.206; Padoa-Schioppa C, 2006, NATURE, V441, P223, DOI 10.1038/nature04676; Paz R, 2007, J NEUROSCI, V27, P6542, DOI 10.1523/JNEUROSCI.1077-07.2007; Philiastides MG, 2010, P NATL ACAD SCI USA, V107, P9430, DOI 10.1073/pnas.1001732107; Pizzagalli DA, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P56, DOI 10.1017/CBO9780511546396.003; Plassmann H, 2007, J NEUROSCI, V27, P9984, DOI 10.1523/JNEUROSCI.2131-07.2007; Plassmann H, 2010, J NEUROSCI, V30, P10799, DOI 10.1523/JNEUROSCI.0788-10.2010; Platt M, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P441, DOI 10.1016/B978-0-12-374176-9.00029-4; Platt ML, 1999, NATURE, V400, P233, DOI 10.1038/22268; Rangel A, 2008, NAT REV NEUROSCI, V9, P545, DOI 10.1038/nrn2357; Rangel A, 2010, CURR OPIN NEUROBIOL, V20, P262, DOI 10.1016/j.conb.2010.03.001; ROLLS ET, 1989, J EXP BIOL, V146, P141; Saleem KS, 2008, J COMP NEUROL, V506, P659, DOI 10.1002/cne.21577; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Tang AC, 2005, NEUROIMAGE, V25, P539, DOI 10.1016/j.neuroimage.2004.11.027; THICKBROOM GW, 1985, BRAIN RES, V339, P271, DOI 10.1016/0006-8993(85)90092-7; Toepel U, 2009, NEUROIMAGE, V44, P967, DOI 10.1016/j.neuroimage.2008.10.005; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; TORO C, 1994, ELECTROEN CLIN NEURO, V93, P380, DOI 10.1016/0168-5597(94)90126-0; Urbano A, 1998, EUR J NEUROSCI, V10, P765, DOI 10.1046/j.1460-9568.1998.00072.x; VAUGHAN HG, 1968, ELECTROEN CLIN NEURO, V25, P1, DOI 10.1016/0013-4694(68)90080-1; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334	60	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21074	10.1371/journal.pone.0021074	http://dx.doi.org/10.1371/journal.pone.0021074			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695081	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000291682300028
J	Petruccelli, LA; Dupere-Richer, D; Pettersson, F; Retrouvey, H; Skoulikas, S; Miller, WH				Petruccelli, Luca A.; Dupere-Richer, Daphne; Pettersson, Filippa; Retrouvey, Helene; Skoulikas, Sophia; Miller, Wilson H., Jr.			Vorinostat Induces Reactive Oxygen Species and DNA Damage in Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; HYDROXAMIC ACID SAHA; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; DEPENDENT APOPTOSIS; HDAC INHIBITORS; DOWN-REGULATION; TUMOR-CELLS; CANCER; REPAIR	Histone deacetylase inhibitors (HDACi) are promising anti-cancer agents, however, their mechanisms of action remain unclear. In acute myeloid leukemia (AML) cells, HDACi have been reported to arrest growth and induce apoptosis. In this study, we elucidate details of the DNA damage induced by the HDACi vorinostat in AML cells. At clinically relevant concentrations, vorinostat induces double-strand breaks and oxidative DNA damage in AML cell lines. Additionally, AML patient blasts treated with vorinostat display increased DNA damage, followed by an increase in caspase-3/7 activity and a reduction in cell viability. Vorinostat-induced DNA damage is followed by a G2-M arrest and eventually apoptosis. We found that pre-treatment with the antioxidant N-acetyl cysteine (NAC) reduces vorinostat-induced DNA double strand breaks, G2-M arrest and apoptosis. These data implicate DNA damage as an important mechanism in vorinostat-induced growth arrest and apoptosis in both AML cell lines and patient-derived blasts. This supports the continued study and development of vorinostat in AMLs that may be sensitive to DNA-damaging agents and as a combination therapy with ionizing radiation and/or other DNA damaging agents.	[Petruccelli, Luca A.; Dupere-Richer, Daphne; Pettersson, Filippa; Retrouvey, Helene; Skoulikas, Sophia; Miller, Wilson H., Jr.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University	Petruccelli, LA (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ H3T 1E2, Canada.	wmiller@ldi.jgh.mcgill.ca	qiao, zhixin/I-3408-2012; Dupéré-Richer, Daphne/AAF-9922-2021		Canadian Institutes of Health Research (CIHR) [MOP-12863]; Merck	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Merck(Merck & Company)	This research was supported by Canadian Institutes of Health Research (CIHR) grant # MOP-12863 (www.cihr.ca). Merck provided Vorinostat and financial support (www.merck.com). Wilson H. Miller Jr. is a Chercheur National of the Fonds de la Recherche en Sante Quebec (FRSQ) (www.frsq.gouv.qc.ca). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimoolam S, 2007, P NATL ACAD SCI USA, V104, P19482, DOI 10.1073/pnas.0707828104; Amin HM, 2001, BRIT J HAEMATOL, V115, P287, DOI 10.1046/j.1365-2141.2001.03123.x; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boyle GM, 2005, PIGM CELL RES, V18, P160, DOI 10.1111/j.1600-0749.2005.00228.x; Campas-Moya C, 2009, DRUG TODAY, V45, P787, DOI 10.1358/dot.2009.45.11.1437052; Carew JS, 2008, CANCER LETT, V269, P7, DOI 10.1016/j.canlet.2008.03.037; Chen CS, 2007, CANCER RES, V67, P5318, DOI 10.1158/0008-5472.CAN-06-3996; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Conti C, 2010, CANCER RES, V70, P4470, DOI 10.1158/0008-5472.CAN-09-3028; Cote S, 2002, BLOOD, V100, P2586, DOI 10.1182/blood-2002-02-0614; Demple B, 2002, ONCOGENE, V21, P8926, DOI 10.1038/sj.onc.1206178; DICKSON MA, 2010, INVEST NEW DRUGS; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Eot-Houllier G, 2009, CANCER LETT, V274, P169, DOI 10.1016/j.canlet.2008.06.005; Garcia-Manero G, 2008, BLOOD, V111, P1060, DOI 10.1182/blood-2007-06-098061; Gaymes TJ, 2006, MOL CANCER RES, V4, P563, DOI 10.1158/1541-7786.MCR-06-0111; Glaser KB, 2007, BIOCHEM PHARMACOL, V74, P659, DOI 10.1016/j.bcp.2007.04.007; Hamer G, 2003, BIOL REPROD, V68, P628, DOI 10.1095/biolreprod.102.008672; He LZ, 2001, J CLIN INVEST, V108, P1321, DOI 10.1172/JCI200111537; Hrzenjak A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-49; Ibrado AM, 1998, LEUKEMIA, V12, P1930, DOI 10.1038/sj.leu.2401218; Inoue T, 2007, CELL CYCLE, V6, P1011, DOI 10.4161/cc.6.9.4219; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Kim MS, 2003, CANCER RES, V63, P7291; Kramer OH, 2008, ONCOGENE, V27, P732, DOI 10.1038/sj.onc.1210677; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Marks PA, 2000, JNCI-J NATL CANCER I, V92, P1210, DOI 10.1093/jnci/92.15.1210; Martens JHA, 2010, FEBS LETT, V584, P2662, DOI 10.1016/j.febslet.2010.04.002; Martirosyan A, 2006, J PHARMACOL EXP THER, V317, P546, DOI 10.1124/jpet.105.096891; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Moon DO, 2007, INT IMMUNOPHARMACOL, V7, P36, DOI 10.1016/j.intimp.2006.08.009; Munshi A, 2005, CLIN CANCER RES, V11, P4912, DOI 10.1158/1078-0432.CCR-04-2088; Murga M, 2007, J CELL BIOL, V178, P1101, DOI 10.1083/jcb.200704140; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Ozaki K, 2008, CANCER SCI, V99, P376, DOI 10.1111/j.1349-7006.2007.00669.x; Pan LN, 2007, CELL MOL IMMUNOL, V4, P337; Pandolfi PP, 2001, ONCOGENE, V20, P3116, DOI 10.1038/sj.onc.1204299; Rahmani M, 2005, CANCER RES, V65, P2422, DOI 10.1158/0008-5472.CAN-04-2440; Ramalingam SS, 2007, CLIN CANCER RES, V13, P3605, DOI 10.1158/1078-0432.CCR-07-0162; Richon VM, 1998, P NATL ACAD SCI USA, V95, P3003, DOI 10.1073/pnas.95.6.3003; Ruefli AA, 2002, INT J CANCER, V99, P292, DOI 10.1002/ijc.10327; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Sargeant AM, 2008, CANCER RES, V68, P3999, DOI 10.1158/0008-5472.CAN-08-0203; Schaefer EW, 2009, HAEMATOL-HEMATOL J, V94, P1375, DOI 10.3324/haematol.2009.009217; Tamburini BA, 2005, MOL CELL BIOL, V25, P4903, DOI 10.1128/MCB.25.12.4903-4913.2005; Vrana JA, 1999, ONCOGENE, V18, P7016, DOI 10.1038/sj.onc.1203176; Xu WS, 2006, P NATL ACAD SCI USA, V103, P15540, DOI 10.1073/pnas.0607518103; Yi X, 2008, BIOCHEM PHARMACOL, V75, P1697, DOI 10.1016/j.bcp.2007.10.035; Zhang Y, 2007, RADIAT RES, V168, P115, DOI 10.1667/RR0811.1	50	92	95	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20987	10.1371/journal.pone.0020987	http://dx.doi.org/10.1371/journal.pone.0020987			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695163	gold, Green Submitted, Green Published			2022-12-25	WOS:000291612600038
J	Cheng, C; Ho, WE; Goh, FY; Guan, SP; Kong, LR; Lai, WQ; Leung, BP; Wong, WSF				Cheng, Chang; Ho, W. Eugene; Goh, Fera Y.; Guan, Shou Ping; Kong, Li Ren; Lai, Wen-Qi; Leung, Bernard P.; Wong, W. S. Fred			Anti-Malarial Drug Artesunate Attenuates Experimental Allergic Asthma via Inhibition of the Phosphoinositide 3-Kinase/Akt Pathway	PLOS ONE			English	Article							NF-KAPPA-B; GROWTH-FACTOR RECEPTOR; NITRIC-OXIDE SYNTHASE; AIRWAY SMOOTH-MUSCLE; ANTIINFLAMMATORY ROLE; EPITHELIAL-CELLS; TNF-ALPHA; IN-VITRO; INFLAMMATION; MICE	Background: Phosphoinositide 3-kinase (PI3K)/Akt pathway is linked to the development of asthma. Anti-malarial drug artesunate is a semi-synthetic derivative of artemisinin, the principal active component of a medicinal plant Artemisia annua, and has been shown to inhibit PI3K/Akt activity. We hypothesized that artesunate may attenuate allergic asthma via inhibition of the PI3K/Akt signaling pathway. Methodology/Principal Findings: Female BALB/c mice sensitized and challenged with ovalbumin (OVA) developed airway inflammation. Bronchoalveolar lavage fluid was assessed for total and differential cell counts, and cytokine and chemokine levels. Lung tissues were examined for cell infiltration and mucus hypersecretion, and the expression of inflammatory biomarkers. Airway hyperresponsiveness was monitored by direct airway resistance analysis. Artesunate dose-dependently inhibited OVA-induced increases in total and eosinophil counts, IL-4, IL-5, IL-13 and eotaxin levels in bronchoalveolar lavage fluid. It attenuated OVA-induced lung tissue eosinophilia and airway mucus production, mRNA expression of E-selectin, IL-17, IL-33 and Muc5ac in lung tissues, and airway hyperresponsiveness to methacholine. In normal human bronchial epithelial cells, artesunate blocked epidermal growth factor-induced phosphorylation of Akt and its downstream substrates tuberin, p70S6 kinase and 4E-binding protein 1, and transactivation of NF-kappa B. Similarly, artesunate blocked the phosphorylation of Akt and its downstream substrates in lung tissues from OVA-challenged mice. Anti-inflammatory effect of artesunate was further confirmed in a house dust mite mouse asthma model. Conclusion/Significance: Artesunate ameliorates experimental allergic airway inflammation probably via negative regulation of PI3K/Akt pathway and the downstream NF-kappa B activity. These findings provide a novel therapeutic value for artesunate in the treatment of allergic asthma.	[Cheng, Chang; Ho, W. Eugene; Goh, Fera Y.; Guan, Shou Ping; Kong, Li Ren; Wong, W. S. Fred] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore; [Lai, Wen-Qi; Leung, Bernard P.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Physiol, Singapore, Singapore; [Cheng, Chang; Ho, W. Eugene; Goh, Fera Y.; Guan, Shou Ping; Wong, W. S. Fred] Natl Univ Singapore, Inst Life Sci, Program Immunol, Singapore 117548, Singapore	National University of Singapore; National University of Singapore; National University of Singapore	Cheng, C (corresponding author), Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore.	phcwongf@nus.edu.sg	Leung, Bernard/O-2409-2013; Wong, Wai Shui Fred/D-8205-2013	Leung, Bernard/0000-0002-1119-4934; Wong, Wai Shiu Fred/0000-0001-7010-3759; Kong, Li Ren/0000-0001-7980-4666; Ho, Wanxing Eugene/0000-0002-0110-4886	National University of Singapore [R-184-000-130-112]; BioMedical Research Council of Singapore [06/1/21/19/443, 09/1/21/19/595]	National University of Singapore(National University of Singapore); BioMedical Research Council of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported in part by an ARF grant R-184-000-130-112 from the National University of Singapore and by BMRC grants 06/1/21/19/443 and 09/1/21/19/595 from the BioMedical Research Council of Singapore (WSFW). The new grant 09/1/21/19/595 supported the authors' revision experiments of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao Z, 2009, AM J RESP CRIT CARE, V179, P657, DOI 10.1164/rccm.200809-1516OC; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Burgel PR, 2008, EUR RESPIR J, V32, P1068, DOI 10.1183/09031936.00172007; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Cockcroft DW, 2006, J ALLERGY CLIN IMMUN, V118, P551, DOI 10.1016/j.jaci.2006.07.012; Doukas J, 2009, J PHARMACOL EXP THER, V328, P758, DOI 10.1124/jpet.108.144311; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Efferth T, 2008, CLIN INFECT DIS, V47, P804, DOI 10.1086/591195; Farghaly HSM, 2008, MOL PHARMACOL, V73, P1530, DOI 10.1124/mol.108.045419; Fruman DA, 2009, IMMUNOL REV, V228, P253, DOI 10.1111/j.1600-065X.2008.00750.x; Fujitani Y, 2003, AM J RESP CRIT CARE, V167, P193, DOI 10.1164/rccm.200205-455OC; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Galli SJ, 2008, NATURE, V454, P445, DOI 10.1038/nature07204; Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327; Gustin JA, 2004, J BIOL CHEM, V279, P1615, DOI 10.1074/jbc.M306976200; Halayko AJ, 2004, AM J RESP CELL MOL, V31, P266, DOI 10.1165/rcmb.2003-0272OC; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Hou JM, 2008, CLIN CANCER RES, V14, P5519, DOI 10.1158/1078-0432.CCR-08-0197; Kearley J, 2009, AM J RESP CRIT CARE, V179, P772, DOI 10.1164/rccm.200805-666OC; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kelly-Welch AE, 2003, SCIENCE, V300, P1527, DOI 10.1126/science.1085458; Kim MS, 2008, TRENDS IMMUNOL, V29, P493, DOI 10.1016/j.it.2008.07.004; Krishna S, 2008, TRENDS PHARMACOL SCI, V29, P520, DOI 10.1016/j.tips.2008.07.004; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kwak YG, 2003, J CLIN INVEST, V111, P1083, DOI 10.1172/JCI200316440; Lane C, 2004, THORAX, V59, P757, DOI 10.1136/thx.2003.014894; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Li B, 2008, INT IMMUNOPHARMACOL, V8, P379, DOI 10.1016/j.intimp.2007.10.024; Li WD, 2006, INT IMMUNOPHARMACOL, V6, P1243, DOI 10.1016/j.intimp.2006.03.004; Li-Weber M, 2003, NAT REV IMMUNOL, V3, P534, DOI 10.1038/nri1128; Lim DH, 2009, AM J PHYSIOL-LUNG C, V296, pL210, DOI 10.1152/ajplung.90275.2008; Medoff BD, 2008, ANNU REV IMMUNOL, V26, P205, DOI 10.1146/annurev.immunol.26.021607.090312; Meyer-Hoffert U, 2003, INT ARCH ALLERGY IMM, V131, P264, DOI 10.1159/000072138; Muller T, 2011, AM J RESP CELL MOL, V44, P456, DOI 10.1165/rcmb.2010-0129OC; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Ricciardolo FLM, 2004, PHYSIOL REV, V84, P731, DOI 10.1152/physrev.00034.2003; Rosenthal PJ, 2008, NEW ENGL J MED, V358, P1829, DOI 10.1056/NEJMct0709050; Sakai K, 2006, J BIOL CHEM, V281, P17736, DOI 10.1074/jbc.M601896200; Sano M, 2005, AM J RESP CELL MOL, V33, P65, DOI 10.1165/rcmb.2005-0076OC; Shiraishi Y, 2009, J ALLERGY CLIN IMMUN, V123, pS56, DOI 10.1016/j.jaci.2008.11.047; Suresh V, 2007, AM J RESP CELL MOL, V37, P97, DOI 10.1165/rcmb.2006-0419OC; Takatsu K, 2008, CURR OPIN IMMUNOL, V20, P288, DOI 10.1016/j.coi.2008.04.001; Tamaoka M, 2008, EUR RESPIR J, V32, P1213, DOI 10.1183/09031936.00166907; Thomas M, 2009, IMMUNOLOGY, V126, P413, DOI 10.1111/j.1365-2567.2008.02908.x; Turner J, 2009, BIOCHEM SOC T, V37, P877, DOI 10.1042/BST0370877; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wang ZJ, 2007, J IMMUNOL, V179, P5958, DOI 10.4049/jimmunol.179.9.5958; Webb DC, 2001, J BIOL CHEM, V276, P41969, DOI 10.1074/jbc.M106223200; Wills-Karp M, 2004, IMMUNOL REV, V202, P175, DOI 10.1111/j.0105-2896.2004.00215.x; Woodrow CJ, 2005, POSTGRAD MED J, V81, P71, DOI 10.1136/pgmj.2004.028399; Xu H, 2007, RHEUMATOLOGY, V46, P920, DOI 10.1093/rheumatology/kem014; Yang CJ, 2008, CLIN IMMUNOL, V127, pS44, DOI 10.1016/j.clim.2008.03.117; Zhao J, 2005, PROTEOMICS, V5, P2799, DOI 10.1002/pmic.200401169; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; Zhou BH, 2005, NAT IMMUNOL, V6, P1047, DOI 10.1038/ni1247; Zhou LM, 2005, AM J RESP CELL MOL, V33, P195, DOI 10.1165/rcmb.2004-0411OC	58	77	89	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20932	10.1371/journal.pone.0020932	http://dx.doi.org/10.1371/journal.pone.0020932			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695271	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900040
J	Filichkin, SA; Breton, G; Priest, HD; Dharmawardhana, P; Jaiswal, P; Fox, SE; Michael, TP; Chory, J; Kay, SA; Mockler, TC				Filichkin, Sergei A.; Breton, Ghislain; Priest, Henry D.; Dharmawardhana, Palitha; Jaiswal, Pankaj; Fox, Samuel E.; Michael, Todd P.; Chory, Joanne; Kay, Steve A.; Mockler, Todd C.			Global Profiling of Rice and Poplar Transcriptomes Highlights Key Conserved Circadian-Controlled Pathways and cis-Regulatory Modules	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS-THALIANA; DATABASE; CCA1; SEQUENCE; NETWORK; GROWTH; LHY	Background: Circadian clocks provide an adaptive advantage through anticipation of daily and seasonal environmental changes. In plants, the central clock oscillator is regulated by several interlocking feedback loops. It was shown that a substantial proportion of the Arabidopsis genome cycles with phases of peak expression covering the entire day. Synchronized transcriptome cycling is driven through an extensive network of diurnal and clock-regulated transcription factors and their target cis-regulatory elements. Study of the cycling transcriptome in other plant species could thus help elucidate the similarities and differences and identify hubs of regulation common to monocot and dicot plants. Methodology/Principal Findings: Using a combination of oligonucleotide microarrays and data mining pipelines, we examined daily rhythms in gene expression in one monocotyledonous and one dicotyledonous plant, rice and poplar, respectively. Cycling transcriptomes were interrogated under different diurnal (driven) and circadian (free running) light and temperature conditions. Collectively, photocycles and thermocycles regulated about 60% of the expressed nuclear genes in rice and poplar. Depending on the condition tested, up to one third of oscillating Arabidopsis-poplar-rice orthologs were phased within three hours of each other suggesting a high degree of conservation in terms of rhythmic gene expression. We identified clusters of rhythmically co-expressed genes and searched their promoter sequences to identify phase-specific cis-elements, including elements that were conserved in the promoters of Arabidopsis, poplar, and rice. Conclusions/Significance: Our results show that the cycling patterns of many circadian clock genes are highly conserved across poplar, rice, and Arabidopsis. The expression of many orthologous genes in key metabolic and regulatory pathways is diurnal and/or circadian regulated and phased to similar times of day. Our results confirm previous findings in Arabidopsis of three major classes of cis-regulatory modules within the plant circadian network: the morning (ME, GBOX), evening (EE, GATA), and midnight (PBX/TBX/SBX) modules. Identification of identical overrepresented motifs in the promoters of cycling genes from different species suggests that the core diurnal/circadian cis-regulatory network is deeply conserved between mono-and dicotyledonous species.	[Filichkin, Sergei A.; Priest, Henry D.; Dharmawardhana, Palitha; Jaiswal, Pankaj; Fox, Samuel E.; Mockler, Todd C.] Oregon State Univ, Dept Bot & Plant Pathol, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Breton, Ghislain] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Michael, Todd P.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA; [Chory, Joanne] Howard Hughes Med Inst, La Jolla, CA USA; [Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	Oregon State University; University of California System; University of California San Diego; Rutgers State University New Brunswick; Howard Hughes Medical Institute; Salk Institute	Filichkin, SA (corresponding author), Oregon State Univ, Dept Bot & Plant Pathol, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA.	tmockler@cgrb.oregonstate.edu	Jaiswal, Pankaj/H-7599-2016; Mockler, Todd C/L-2609-2013; Kay, Steve A/F-6025-2011; Breton, Ghislain/F-7266-2016; Jaiswal, Pankaj/R-4214-2019	Jaiswal, Pankaj/0000-0002-1005-8383; Mockler, Todd C/0000-0002-0462-5775; Kay, Steve A/0000-0002-0402-2878; Breton, Ghislain/0000-0001-6400-3858; Jaiswal, Pankaj/0000-0002-1005-8383; Michael, Todd/0000-0001-6272-2875; Priest, Henry/0000-0002-0998-8137	National Science Foundation (NSF) [DBI-0605240, 0703908]; United States Department of Agriculture, National Institute of Food and Agriculture [2008-01077]; United States Department of Energy Plant Feedstock Genomics for Bioenergy [DE-FG02-08ER64630]	National Science Foundation (NSF)(National Science Foundation (NSF)); United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); United States Department of Energy Plant Feedstock Genomics for Bioenergy(United States Department of Energy (DOE))	This work was supported by the National Science Foundation Plant Genome Research Program, grant # DBI-0605240 to TCM, JC and SK, the United States Department of Agriculture, National Institute of Food and Agriculture National Research Initiative Competitive Grant no. 2008-01077 to TCM and SAF, and United States Department of Energy Plant Feedstock Genomics for Bioenergy grant DE-FG02-08ER64630 to TCM and TPM. PJ and PD were supported by the NSF Plant Genome Research Resource grant award # 0703908. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alabadi D, 2002, CURR BIOL, V12, P757, DOI 10.1016/S0960-9822(02)00815-1; Alabadi D, 2001, SCIENCE, V293, P880, DOI 10.1126/science.1061320; ANDERSON SL, 1995, P NATL ACAD SCI USA, V92, P1500, DOI 10.1073/pnas.92.5.1500; Andronis C, 2008, MOL PLANT, V1, P58, DOI 10.1093/mp/ssm005; ASCHOFF J, 1960, COLD SPRING HARB SYM, V25, P11, DOI 10.1101/SQB.1960.025.01.004; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Edwards KD, 2005, GENETICS, V170, P387, DOI 10.1534/genetics.104.035238; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gao G, 2006, BIOINFORMATICS, V22, P1286, DOI 10.1093/bioinformatics/btl107; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Hudson ME, 2003, PLANT PHYSIOL, V133, P1605, DOI 10.1104/pp.103.030437; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jaiswal P, 2011, METHODS MOL BIOL, V678, P247, DOI 10.1007/978-1-60761-682-5_18; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; MENKENS AE, 1995, TRENDS BIOCHEM SCI, V20, P506, DOI 10.1016/S0968-0004(00)89118-5; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Michael TP, 2003, SCIENCE, V302, P1049, DOI 10.1126/science.1082971; Michael TP, 2003, PLANT PHYSIOL, V132, P629, DOI 10.1104/pp.021006; Michael TP, 2003, P NATL ACAD SCI USA, V100, P6878, DOI 10.1073/pnas.1131995100; Michael TP, 2002, PLANT PHYSIOL, V130, P627, DOI 10.1104/pp.004929; Mizoguchi T, 2002, DEV CELL, V2, P629, DOI 10.1016/S1534-5807(02)00170-3; Mockler TC, 2007, COLD SPRING HARB SYM, V72, P353, DOI 10.1101/sqb.2007.72.006; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Priest HD, 2009, CURR OPIN PLANT BIOL, V12, P643, DOI 10.1016/j.pbi.2009.07.016; Pruneda-Paz JL, 2010, TRENDS PLANT SCI, V15, P259, DOI 10.1016/j.tplants.2010.03.003; Pruneda-Paz JL, 2009, SCIENCE, V323, P1481, DOI 10.1126/science.1167206; Schaffer R, 2001, PLANT CELL, V13, P113, DOI 10.1105/tpc.13.1.113; SCHINDLER U, 1990, EMBO J, V9, P3415, DOI 10.1002/j.1460-2075.1990.tb07549.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Zdepski Anna, 2008, Trop Plant Biol, V1, P236, DOI 10.1007/s12042-008-9020-3; Zhu QH, 2007, BIOINFORMATICS, V23, P1307, DOI 10.1093/bioinformatics/btm113	39	131	135	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e16907	10.1371/journal.pone.0016907	http://dx.doi.org/10.1371/journal.pone.0016907			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694767	Green Submitted, gold, Green Published			2022-12-25	WOS:000291612900001
J	Wohr, M; Roullet, FI; Hung, AY; Sheng, M; Crawley, JN				Woehr, Markus; Roullet, Florence I.; Hung, Albert Y.; Sheng, Morgan; Crawley, Jacqueline N.			Communication Impairments in Mice Lacking Shank1: Reduced Levels of Ultrasonic Vocalizations and Scent Marking Behavior	PLOS ONE			English	Article							MUS-DOMESTICUS RUTTY; FEMALE HOUSE MICE; TF/J MOUSE MODEL; POSTSYNAPTIC DENSITY; DEVELOPMENTAL INFLUENCES; URINE MARKING; GENETIC INFLUENCES; UNUSUAL REPERTOIRE; SYNAPTIC PROTEINS; BINDING-PROTEIN	Autism is a neurodevelopmental disorder with a strong genetic component. Core symptoms are abnormal reciprocal social interactions, qualitative impairments in communication, and repetitive and stereotyped patterns of behavior with restricted interests. Candidate genes for autism include the SHANK gene family, as mutations in SHANK2 and SHANK3 have been detected in several autistic individuals. SHANK genes code for a family of scaffolding proteins located in the postsynaptic density of excitatory synapses. To test the hypothesis that a mutation in SHANK1 contributes to the symptoms of autism, we evaluated Shank1(-/-) null mutant mice for behavioral phenotypes with relevance to autism, focusing on social communication. Ultrasonic vocalizations and the deposition of scent marks appear to be two major modes of mouse communication. Our findings revealed evidence for low levels of ultrasonic vocalizations and scent marks in Shank1(-/-) mice as compared to wildtype Shank1(+/+) littermate controls. Shank1(-/-) pups emitted fewer vocalizations than Shank1(+/+) pups when isolated from mother and littermates. In adulthood, genotype affected scent marking behavior in the presence of female urinary pheromones. Adult Shank1(-/-) males deposited fewer scent marks in proximity to female urine than Shank1(+/+) males. Call emission in response to female urinary pheromones also differed between genotypes. Shank1(+/+) mice changed their calling pattern dependent on previous female interactions, while Shank1(-/-) mice were unaffected, indicating a failure of Shank1(-/-) males to learn from a social experience. The reduced levels of ultrasonic vocalizations and scent marking behavior in Shank1(-/-) mice are consistent with a phenotype relevant to social communication deficits in autism.	[Woehr, Markus; Roullet, Florence I.; Crawley, Jacqueline N.] NIMH, Lab Behav Neurosci, Bethesda, MD 20892 USA; [Hung, Albert Y.; Sheng, Morgan] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Massachusetts Institute of Technology (MIT); Northwell Health	Wohr, M (corresponding author), NIMH, Lab Behav Neurosci, Bethesda, MD 20892 USA.	markus.woehr@staff.uni-marburg.de; crawleyj@mail.nih.gov	Wöhr, Markus/AAA-2316-2021; Roullet, Florence I./GQI-3800-2022	Wöhr, Markus/0000-0001-6986-5684; Sheng, Morgan/0000-0002-8703-5366	National Institute of Mental Health; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002179] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health Intramural Research Program and Simons Foundation (M. S. & A. H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; [Anonymous], 2000, DIAGNOSTIC STAT MANU, V4th; [Anonymous], 2014, PHEROMONES ANIMAL BE; Arakawa H, 2008, NEUROSCI BIOBEHAV R, V32, P1236, DOI 10.1016/j.neubiorev.2008.05.012; Arakawa H, 2008, BEHAV BRAIN RES, V190, P97, DOI 10.1016/j.bbr.2008.02.009; Arakawa H, 2007, BEHAV BRAIN RES, V182, P73, DOI 10.1016/j.bbr.2007.05.007; BELL RW, 1979, AM ZOOL, V19, P413; BENTON D, 1988, PSYCHOPHARMACOLOGY, V95, P99; Berkel S, 2010, NAT GENET, V42, P489, DOI 10.1038/ng.589; Bockers TM, 2004, MOL CELL NEUROSCI, V26, P182, DOI 10.1016/j.mcn.2004.01.009; Boeckers TM, 1999, BIOCHEM BIOPH RES CO, V264, P247, DOI 10.1006/bbrc.1999.1489; Boeckers TM, 1999, J NEUROSCI, V19, P6506; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; CAROOM D, 1971, PHYSIOL BEHAV, V7, P659, DOI 10.1016/0031-9384(71)90126-0; Chadman KK, 2008, AUTISM RES, V1, P147, DOI 10.1002/aur.22; CIRULLI F, 1994, DEV PSYCHOBIOL, V27, P301, DOI 10.1002/dev.420270505; Costantini Fabrizio, 2006, Acta Zoologica Sinica, V52, P619; DAVIES VJ, 1972, J ENDOCRINOL, V55, P11, DOI 10.1677/joe.0.0550011; DESJARDINS C, 1973, SCIENCE, V182, P939, DOI 10.1126/science.182.4115.939; DIZINNO G, 1978, BEHAV BIOL, V22, P104, DOI 10.1016/S0091-6773(78)92094-1; Douglas LA, 2004, DEV PSYCHOBIOL, V45, P153, DOI 10.1002/dev.20025; DRICKAMER LC, 1992, ANIM BEHAV, V43, P868, DOI 10.1016/S0003-3472(05)80212-X; Du YR, 1998, MOL CELL BIOL, V18, P5838, DOI 10.1128/MCB.18.10.5838; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; EHRET G, 1982, J COMP PHYSIOL, V148, P245, DOI 10.1007/BF00619131; EHRET G, 1974, NATURWISSENSCHAFTEN, V61, P506, DOI 10.1007/BF00622976; EHRET G, 1987, NATURE, V325, P249, DOI 10.1038/325249a0; EHRET G, 1992, ANIM BEHAV, V43, P409, DOI 10.1016/S0003-3472(05)80101-0; Enard W, 2009, CELL, V137, P961, DOI 10.1016/j.cell.2009.03.041; Fish EW, 2000, PSYCHOPHARMACOLOGY, V149, P277, DOI 10.1007/s002130000370; FOLSTEIN S, 1977, NATURE, V265, P726, DOI 10.1038/265726a0; FOX M. W., 1965, ANIM BEHAV, V13, P234; FRITH U, 1994, PHILOS T ROY SOC B, V346, P97, DOI 10.1098/rstb.1994.0133; Fujita E, 2008, P NATL ACAD SCI USA, V105, P3117, DOI 10.1073/pnas.0712298105; Gaub S, 2010, GENES BRAIN BEHAV, V9, P390, DOI 10.1111/j.1601-183X.2010.00570.x; Gauthier J, 2009, AM J MED GENET B, V150B, P421, DOI 10.1002/ajmg.b.30822; Groszer M, 2008, CURR BIOL, V18, P354, DOI 10.1016/j.cub.2008.01.060; Guo ZS, 2007, CHEM SENSES, V32, P463, DOI 10.1093/chemse/bjm015; Hahn ME, 2002, BEHAV GENET, V32, P267, DOI 10.1023/A:1019728813891; Hahn ME, 1998, BEHAV GENET, V28, P315, DOI 10.1023/A:1021679615792; Hahn ME, 1997, BEHAV GENET, V27, P133, DOI 10.1023/A:1025637408900; HAHN ME, 1987, BEHAV GENET, V17, P155, DOI 10.1007/BF01065994; Hammerschmidt K, 2009, BIOL LETTERS, V5, P589, DOI 10.1098/rsbl.2009.0317; Hill Joanna M., 2008, V39, P131, DOI 10.1007/978-1-60327-099-1_10; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hung AY, 2008, J NEUROSCI, V28, P1697, DOI 10.1523/JNEUROSCI.3032-07.2008; HURST JL, 1989, ANIM BEHAV, V37, P705, DOI 10.1016/0003-3472(89)90057-2; HURST JL, 1990, ANIM BEHAV, V40, P233, DOI 10.1016/S0003-3472(05)80918-2; HURST JL, 1990, ANIM BEHAV, V40, P209, DOI 10.1016/S0003-3472(05)80916-9; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Jiang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012278; JONES RB, 1973, PHYSIOL BEHAV, V10, P221, DOI 10.1016/0031-9384(73)90301-6; Kasai H, 2003, TRENDS NEUROSCI, V26, P360, DOI 10.1016/S0166-2236(03)00162-0; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kreienkamp H-J., 2008, V186, P365, DOI 10.1007/978-3-540-72843-6_15; Kurz A, 2010, NEUROSCIENCE, V17, P287; Lamprecht R, 2004, NAT REV NEUROSCI, V5, P45, DOI 10.1038/nrn1301; Laviola G, 2006, PSYCHOPHARMACOLOGY, V187, P331, DOI 10.1007/s00213-006-0426-z; LeCouteur A, 1996, J CHILD PSYCHOL PSYC, V37, P785; Lim S, 1999, J BIOL CHEM, V274, P29510, DOI 10.1074/jbc.274.41.29510; Lord C, 2006, ARCH GEN PSYCHIAT, V63, P694, DOI 10.1001/archpsyc.63.6.694; Lord C, 2001, AM J MED GENET, V105, P36, DOI 10.1002/1096-8628(20010108)105:1<36::AID-AJMG1053>3.3.CO;2-W; Losh M, 2007, J CHILD PSYCHOL PSYC, V48, P105, DOI 10.1111/j.1469-7610.2006.01594.x; MAGGIO JC, 1983, PHYSIOL BEHAV, V31, P269, DOI 10.1016/0031-9384(83)90186-5; Malkesman O, 2010, BIOL PSYCHIAT, V67, P864, DOI 10.1016/j.biopsych.2009.10.018; MARUNIAK JA, 1974, PHYSIOL BEHAV, V12, P1035, DOI 10.1016/0031-9384(74)90151-6; Mattson BJ, 2005, NEUROSCIENCE, V135, P315, DOI 10.1016/j.neuroscience.2005.06.045; MEISEL RL, 1994, PHYSIOL BEHAV, V56, P1115, DOI 10.1016/0031-9384(94)90352-2; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Moles A, 2004, SCIENCE, V304, P1983, DOI 10.1126/science.1095943; Moles A, 2007, BEHAV BRAIN RES, V182, P223, DOI 10.1016/j.bbr.2007.01.020; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024; NASTITI K, 1991, BEHAV PHARMACOL, V2, P121; NYBY J, 1983, BEHAV NEURAL BIOL, V38, P32, DOI 10.1016/S0163-1047(83)90354-0; NYBY J, 1977, ANIM BEHAV, V25, P333, DOI 10.1016/0003-3472(77)90009-4; NYBY J, 1978, NEUROSCI BIOBEHAV R, V2, P1, DOI 10.1016/0149-7634(78)90003-9; NYBY J, 1979, J COMP PHYSIOL PSYCH, V93, P957, DOI 10.1037/h0077623; Panksepp JB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000351; Peca J, 2011, NATURE, V472, P437, DOI 10.1038/nature09965; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; POMERANTZ SM, 1973, PHYSIOL BEHAV, V31, P91; Portfors CV, 2007, J AM ASSOC LAB ANIM, V46, P28; Qualmann B, 2004, J NEUROSCI, V24, P2481, DOI 10.1523/JNEUROSCI.5479-03.2004; Radyushkin K, 2009, GENES BRAIN BEHAV, V8, P416, DOI 10.1111/j.1601-183X.2009.00487.x; REYNOLDS E, 1971, NATURE, V234, P481, DOI 10.1038/234481a0; Rich TJ, 1999, ANIM BEHAV, V58, P1027, DOI 10.1006/anbe.1999.1217; ROBERTS, 2007, RODENT SOC ECOLOGICA, P255; Roubertoux PL, 1996, BEHAV GENET, V26, P427, DOI 10.1007/BF02359487; Roullet FI, 2011, BEHAV BRAIN RES, V216, P19, DOI 10.1016/j.bbr.2010.06.004; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Scattoni ML, 2008, BEHAV BRAIN RES, V187, P371, DOI 10.1016/j.bbr.2007.09.034; Scattoni ML, 2011, GENES BRAIN BEHAV, V10, P44, DOI 10.1111/j.1601-183X.2010.00623.x; Scattoni ML, 2009, NEUROSCI BIOBEHAV R, V33, P508, DOI 10.1016/j.neubiorev.2008.08.003; Scattoni ML, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003067; SCOTT JW, 1970, PHYSIOL BEHAV, V5, P407, DOI 10.1016/0031-9384(70)90243-X; SEWELL GD, 1970, NATURE, V227, P410, DOI 10.1038/227410a0; SEWELL GD, 1967, NATURE, V215, P512, DOI 10.1038/215512a0; Sheng M, 2000, J CELL SCI, V113, P1851; Shu WG, 2005, P NATL ACAD SCI USA, V102, P9643, DOI 10.1073/pnas.0503739102; Silverman JL, 2011, BRAIN RES, V1380, P120, DOI 10.1016/j.brainres.2010.09.026; Silverman JL, 2010, NAT REV NEUROSCI, V11, P490, DOI 10.1038/nrn2851; SIPOS ML, 1995, PHYSIOL BEHAV, V58, P529, DOI 10.1016/0031-9384(95)00089-2; SIPOS ML, 1992, BEHAV NEURAL BIOL, V58, P138, DOI 10.1016/0163-1047(92)90375-E; SMITH JC, 1976, J COMP PHYSIOL PSYCH, V90, P1105, DOI 10.1037/h0077287; Takahashi A, 2009, PSYCHOPHARMACOLOGY, V204, P61, DOI 10.1007/s00213-008-1437-8; Thornton LM, 2005, BEHAV GENET, V35, P73, DOI 10.1007/s10519-004-0857-4; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Tu JC, 1999, NEURON, V23, P583, DOI 10.1016/S0896-6273(00)80810-7; Wang HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001893; WHITNEY G, 1974, ANIM LEARN BEHAV, V2, P13, DOI 10.3758/BF03199109; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Winslow JT, 2000, HORM BEHAV, V37, P145, DOI 10.1006/hbeh.1999.1566; Wohr M, 2011, GENES BRAIN BEHAV, V10, P35, DOI 10.1111/j.1601-183X.2010.00582.x; Wohr M, 2008, BEHAV GENET, V38, P579, DOI 10.1007/s10519-008-9221-4; Wohr M, 2008, BEHAV NEUROSCI, V122, P310, DOI 10.1037/0735-7044.122.2.310; Wohr M, 2011, SOC NEUROSCI-UK, V6, P76, DOI 10.1080/17470911003765560; Wohr M, 2010, HBK BEHAV NEUROSCI, V19, P159, DOI 10.1016/B978-0-12-374593-4.00016-4; WYSOCKI CJ, 1979, J COMP PHYSIOL PSYCH, V93, P957; Young DM, 2010, P NATL ACAD SCI USA, V107, P11074, DOI 10.1073/pnas.1005620107; ZIPPELIUS HM, 1956, NATURWISSENSCHAFTEN, V43, P501	123	156	158	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20631	10.1371/journal.pone.0020631	http://dx.doi.org/10.1371/journal.pone.0020631			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695253	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000291612900018
J	Yu, D; Zhan, XGH; Niu, SQ; Mikhailenko, I; Strickland, DK; Zhu, JW; Cao, M; Zhan, X				Yu, Dan; Zhan, Xiaoguo H.; Niu, Shuqiong; Mikhailenko, Irina; Strickland, Dudley K.; Zhu, Jianwei; Cao, Meng; Zhan, Xi			Murine Missing in Metastasis (MIM) Mediates Cell Polarity and Regulates the Motility Response to Growth Factors	PLOS ONE			English	Article							BAR DOMAIN; ACTIN POLYMERIZATION; STRUCTURAL BASIS; SUPPRESSOR GENE; HOMOLOGY DOMAIN; BLADDER-CANCER; IN-METASTASIS; RHO GTPASES; MEMBRANE; PROTEIN	Background: Missing in metastasis (MIM) is a member of the inverse BAR-domain protein family, and in vitro studies have implied MIM plays a role in deforming membrane curvature into filopodia-like protrusions and cell dynamics. Yet, the physiological role of the endogenous MIM in mammalian cells remains undefined. Principal Findings: We have examined mouse embryonic fibroblasts (MEFs) derived from mice in which the MIM locus was targeted by a gene trapping vector. MIM-/- MEFs showed a less polarized architecture characterized by smooth edges and fewer cell protrusions as compared to wild type cells, although the formation of filopodia-like microprotrusions appeared to be normal. Immunofluorescent staining further revealed that MIM-/- cells were partially impaired in the assembly of stress fibers and focal adhesions but were enriched with transverse actin filaments at the periphery. Poor assembly of stress fibers was apparently correlated with attenuation of the activity of Rho GTPases and partially relieved upon overexpressing of Myc-RhoA(Q63L), a constitutively activated RhoA mutant. MIM-/- cells were also spread less effectively than wild type cells during attachment to dishes and substratum. Upon treatment with PDGF MIM-/- cells developed more prominent dorsal ruffles along with increased Rac1 activity. Compared to wild type cells, MIM-/- cells had a slower motility in the presence of a low percentage of serum-containing medium but migrated normally upon adding growth factors such as 10% serum, PDGF or EGF. MIM-/- cells were also partially impaired in the internalization of transferrin, fluorescent dyes, foreign DNAs and PDGF receptor alpha. On the other hand, the level of tyrosine phosphorylation of PDGF receptors was more elevated in MIM depleted cells than wild type cells upon PDGF treatment. Conclusions: Our data suggests that endogenous MIM protein regulates globally the cell architecture and endocytosis that ultimately influence a variety of cellular behaviors, including cell polarity, motility, receptor signaling and membrane ruffling.	[Yu, Dan; Zhan, Xiaoguo H.; Niu, Shuqiong; Mikhailenko, Irina; Strickland, Dudley K.; Cao, Meng; Zhan, Xi] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Mikhailenko, Irina; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Zhu, Jianwei] Nantong Univ, Affiliated Hosp, Dept Gen Surg, Jiangsu 226007, Peoples R China; [Zhan, Xi] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA; [Zhan, Xi] Univ Maryland, Sch Med, Marlene Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Nantong University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Yu, D (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.	xzhan@som.umaryland.edu	Niu, Shuqiong/D-7783-2015	Niu, Shuqiong/0000-0001-7004-3768	National Institutes of Health [CA113809, CA CA091984]; Maryland Stem Cell Foundation; NATIONAL CANCER INSTITUTE [R01CA091984, R01CA113809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Institutes of Health: CA113809, CA CA091984, and Maryland Stem Cell Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir W, 2008, J CELL SCI, V121, P379, DOI 10.1242/jcs.010272; Andersson F, 2010, SYNAPSE, V64, P556, DOI 10.1002/syn.20772; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Bompard G, 2005, J CELL SCI, V118, P5393, DOI 10.1242/jcs.02640; Borm B, 2005, EXP CELL RES, V302, P83, DOI 10.1016/j.yexcr.2004.08.034; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Douglas LM, 2009, INFECT IMMUN, V77, P4150, DOI 10.1128/IAI.00683-09; Fiorentini C, 2001, MOL BIOL CELL, V12, P2061, DOI 10.1091/mbc.12.7.2061; Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010; Gallop JL, 2005, BIOCHEM SOC SYMP, V72, P223, DOI 10.1042/bss0720223; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gonzalez-Quevedo R, 2005, J CELL BIOL, V168, P453, DOI 10.1083/jcb.200409078; HEDBERG KM, 1993, CELL MOTIL CYTOSKEL, V24, P139, DOI 10.1002/cm.970240207; Kruth HS, 2005, J BIOL CHEM, V280, P2352, DOI 10.1074/jbc.M407167200; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Lin JX, 2005, ONCOGENE, V24, P2059, DOI 10.1038/sj.onc.1208412; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Miki H, 2000, NATURE, V408, P732, DOI 10.1038/35047107; Millard TH, 2005, EMBO J, V24, P240, DOI 10.1038/sj.emboj.7600535; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nixdorf S, 2004, CANCER LETT, V215, P209, DOI 10.1016/j.canlet.2004.05.002; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Quinones GA, 2010, J CELL BIOL, V189, P353, DOI 10.1083/jcb.200910136; RIDLEY AJ, 1992, COLD SPRING HARB SYM, V57, P661, DOI 10.1101/SQB.1992.057.01.072; Roberts-Galbraith RH, 2010, CELL CYCLE, V9, P4091, DOI 10.4161/cc.9.20.13587; Ryan TA, 2006, CURR OPIN CELL BIOL, V18, P416, DOI 10.1016/j.ceb.2006.06.013; Saarikangas J, 2011, J CELL SCI, V124, P1245, DOI 10.1242/jcs.082610; Saarikangas J, 2009, CURR BIOL, V19, P95, DOI 10.1016/j.cub.2008.12.029; Scita G, 2008, TRENDS CELL BIOL, V18, P52, DOI 10.1016/j.tcb.2007.12.002; Suetsugu S, 2003, DEV CELL, V5, P595, DOI 10.1016/S1534-5807(03)00297-1; Suetsugu S, 2006, J BIOL CHEM, V281, P35347, DOI 10.1074/jbc.M606814200; Toguchi M, 2010, BIOL CELL, V102, P215, DOI 10.1042/BC20090033; VAN DM, 2007, CYTOGENET GENOME RES, V118, P130; Veltman DM, 2011, BIOCHEM J, V436, P45, DOI 10.1042/BJ20101684; Wang Y, 2007, CANCER INVEST, V25, P79, DOI 10.1080/07357900701205457; Wang Y, 2007, J BIOL CHEM, V282, P7624, DOI 10.1074/jbc.M608448200; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Yamagishi A, 2004, J BIOL CHEM, V279, P14929, DOI 10.1074/jbc.M309408200; Youn JY, 2010, MOL BIOL CELL, V21, P3054, DOI 10.1091/mbc.E10-03-0181; Yu D, 2010, EXP CELL RES, V316, P848, DOI 10.1016/j.yexcr.2009.11.018; ZHAO H, 2010, CURR OPIN CELL BIOL; Zheng DT, 2010, BIOCHEM BIOPH RES CO, V401, P527, DOI 10.1016/j.bbrc.2010.09.087; Zigmond SH, 1996, CURR OPIN CELL BIOL, V8, P66, DOI 10.1016/S0955-0674(96)80050-0	45	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20845	10.1371/journal.pone.0020845	http://dx.doi.org/10.1371/journal.pone.0020845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695258	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900031
J	Li, N; Nguyen, H; Byrom, M; Ellington, AD				Li, Na; Hong Hanh Nguyen; Byrom, Michelle; Ellington, Andrew D.			Inhibition of Cell Proliferation by an Anti-EGFR Aptamer	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR COMMON; PROSTATE-CANCER CELLS; NUCLEIC-ACID LIGANDS; MONOCLONAL-ANTIBODY; TARGETED THERAPY; SIRNA DELIVERY; RNA INHIBITORS; PHOSPHORYLATION; IDENTIFICATION	Aptamers continue to receive interest as potential therapeutic agents for the treatment of diseases, including cancer. In order to determine whether aptamers might eventually prove to be as useful as other clinical biopolymers, such as antibodies, we selected aptamers against an important clinical target, human epidermal growth factor receptor (hEGFR). The initial selection yielded only a single clone that could bind to hEGFR, but further mutation and optimization yielded a family of tight-binding aptamers. One of the selected aptamers, E07, bound tightly to the wild-type receptor (K-d = 2.4 nM). This aptamer can compete with EGF for binding, binds to a novel epitope on EGFR, and also binds a deletion mutant, EGFRvIII, that is commonly found in breast and lung cancers, and especially in grade IV glioblastoma multiforme, a cancer which has for the most part proved unresponsive to current therapies. The aptamer binds to cells expressing EGFR, blocks receptor autophosphorylation, and prevents proliferation of tumor cells in three-dimensional matrices. In short, the aptamer is a promising candidate for further development as an anti-tumor therapeutic. In addition, Aptamer E07 is readily internalized into EGFR-expressing cells, raising the possibility that it might be used to escort other anti-tumor or contrast agents.	[Li, Na] AM Biotechnol, Houston, TX USA; [Hong Hanh Nguyen] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Ellington, Andrew D.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Austin, TX 78712 USA	University of California System; University of California Los Angeles; University of Texas System; University of Texas Austin	Li, N (corresponding author), AM Biotechnol, Houston, TX USA.	andy.ellington@mail.utexas.edu			National Institutes of Health [R21 CA135315]; Susan G. Komen Foundation [29748/98288845]; Welch Foundation [F-1654]; NATIONAL CANCER INSTITUTE [R21CA135315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by The National Institutes of Health (http://grants.nih.gov) Grant #R21 CA135315, The Susan G. Komen Foundation (http://ww5.komen.org/) Grant # 29748/98288845, and The Welch Foundation(http://www.welch1.org/) Grant #F-1654. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aifa Sami, 2008, Recent Pat Biotechnol, V2, P181, DOI 10.2174/187220808786240980; Allerson CR, 2005, J MED CHEM, V48, P901, DOI 10.1021/jm049167j; Bagalkot V, 2006, ANGEW CHEM INT EDIT, V45, P8149, DOI 10.1002/anie.200602251; Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; Cerchia L, 2005, PLOS BIOL, V3, P697, DOI 10.1371/journal.pbio.0030123; Chen CHB, 2003, P NATL ACAD SCI USA, V100, P9226, DOI 10.1073/pnas.1332660100; Chen CHB, 2008, P NATL ACAD SCI USA, V105, P15908, DOI 10.1073/pnas.0808360105; Chu TC, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl388; Chu TC, 2006, CANCER RES, V66, P5989, DOI 10.1158/0008-5472.CAN-05-4583; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Dassie JP, 2009, NAT BIOTECHNOL, V27, P839, DOI 10.1038/nbt.1560; Dietz A, 2008, EUR ARCH OTO-RHINO-L, V265, pS3, DOI 10.1007/s00405-008-0697-6; Farokhzad OC, 2004, CANCER RES, V64, P7668, DOI 10.1158/0008-5472.CAN-04-2550; Ferguson KM, 2004, BIOCHEM SOC T, V32, P742, DOI 10.1042/BST0320742; Flynn JF, 2009, J ONCOL, V2009, DOI 10.1155/2009/526963; Forsbach A, 2008, J IMMUNOL, V180, P3729, DOI 10.4049/jimmunol.180.6.3729; Frederick L, 2000, CANCER RES, V60, P1383; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Green LS, 1996, BIOCHEMISTRY-US, V35, P14413, DOI 10.1021/bi961544+; GREEN LS, 1995, CHEM BIOL, V2, P683, DOI 10.1016/1074-5521(95)90032-2; Groner B, 2004, CURR MOL MED, V4, P539, DOI 10.2174/1566524043360483; Hamid Oday, 2004, J Am Pharm Assoc (2003), V44, P52, DOI 10.1331/154434504322713237; Huang HJS, 1997, J BIOL CHEM, V272, P2927, DOI 10.1074/jbc.272.5.2927; Hynes NE, 2009, CURR OPIN CELL BIOL, V21, P177, DOI 10.1016/j.ceb.2008.12.010; Jaramillo ML, 2006, EXP CELL RES, V312, P2778, DOI 10.1016/j.yexcr.2006.05.008; Javier DJ, 2008, BIOCONJUGATE CHEM, V19, P1309, DOI 10.1021/bc8001248; JELLINEK D, 1995, BIOCHEMISTRY-US, V34, P11363, DOI 10.1021/bi00036a009; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Jutten B, 2009, RADIOTHER ONCOL, V92, P393, DOI 10.1016/j.radonc.2009.06.021; Khati M, 2003, J VIROL, V77, P12692, DOI 10.1128/JVI.77.23.12692-12698.2003; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Layzer JM, 2004, RNA, V10, P766, DOI 10.1261/rna.5239604; Li N, 2009, J PROTEOME RES, V8, P2438, DOI 10.1021/pr801048z; Li N, 2008, NUCLEIC ACIDS RES, V36, P6739, DOI 10.1093/nar/gkn775; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liao HJ, 2009, CANCER RES, V69, P6179, DOI 10.1158/0008-5472.CAN-09-0049; Liu YM, 2009, BIOL CHEM, V390, P137, DOI 10.1515/BC.2009.022; Lupold SE, 2002, CANCER RES, V62, P4029; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Mendelsohn J, 2000, ONCOGENE, V19, P6550, DOI 10.1038/sj.onc.1204082; NISHIKAWA R, 1994, P NATL ACAD SCI USA, V91, P7727, DOI 10.1073/pnas.91.16.7727; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Pagratis NC, 1997, NAT BIOTECHNOL, V15, P68, DOI 10.1038/nbt0197-68; Patel D, 2007, ANTICANCER RES, V27, P3355; Ricciardi S, 2009, CLIN LUNG CANCER, V10, P28, DOI 10.3816/CLC.2009.n.004; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; SUNADA H, 1986, P NATL ACAD SCI USA, V83, P3825, DOI 10.1073/pnas.83.11.3825; Thiel KW, 2009, OLIGONUCLEOTIDES, V19, P209, DOI 10.1089/oli.2009.0199; White RR, 2000, J CLIN INVEST, V106, P929, DOI 10.1172/JCI11325; Zhou JH, 2008, MOL THER, V16, P1481, DOI 10.1038/mt.2008.92; Zhou Jiehua, 2010, Silence, V1, P4, DOI 10.1186/1758-907X-1-4	53	127	150	4	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20299	10.1371/journal.pone.0020299	http://dx.doi.org/10.1371/journal.pone.0020299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687663	Green Submitted, gold, Green Published			2022-12-25	WOS:000291611500014
J	Jansen, S; Collins, A; Yang, CS; Rebowski, G; Svitkina, T; Dominguez, R				Jansen, Silvia; Collins, Agnieszka; Yang, Changsong; Rebowski, Grzegorz; Svitkina, Tatyana; Dominguez, Roberto			Mechanism of Actin Filament Bundling by Fascin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							F-ACTIN; EVOLUTIONARY CONSERVATION; PROTEIN; EXPRESSION	Fascin is the main actin filament bundling protein in filopodia. Because of the important role filopodia play in cell migration, fascin is emerging as a major target for cancer drug discovery. However, an understanding of the mechanism of bundle formation by fascin is critically lacking. Fascin consists of four beta-trefoil domains. Here, we show that fascin contains two major actin-binding sites, coinciding with regions of high sequence conservation in beta-trefoil domains 1 and 3. The site in beta-trefoil-1 is located near the binding site of the fascin inhibitor macro-ketone and comprises residue Ser-39, whose phosphorylation by protein kinase C down-regulates actin bundling and formation of filopodia. The site in beta-trefoil-3 is related by pseudo-2-fold symmetry to that in beta-trefoil-1. The two sites are similar to 5 nm apart, resulting in a distance between actin filaments in the bundle of similar to 8.1 nm. Residue mutations in both sites disrupt bundle formation in vitro as assessed by co-sedimentation with actin and electron microscopy and severely impair formation of filopodia in cells as determined by rescue experiments in fascin-depleted cells. Mutations of other areas of the fascin surface also affect actin bundling and formation of filopodia albeit to a lesser extent, suggesting that, in addition to the two major actin-binding sites, fascin makes secondary contacts with other filaments in the bundle. In a high resolution crystal structure of fascin, molecules of glycerol and polyethylene glycol are bound in pockets located within the two major actin-binding sites. These molecules could guide the rational design of new anticancer fascin inhibitors.	[Svitkina, Tatyana] Univ Penn, Dept Biol, Leidy Labs 221, Philadelphia, PA 19104 USA; [Dominguez, Roberto] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Svitkina, T (corresponding author), Univ Penn, Dept Biol, Leidy Labs 221, 3740 Hamilton Walk, Philadelphia, PA 19104 USA.	svitkina@sas.upenn.edu; droberto@mail.med.upenn.edu			National Institutes of Health [MH087950, HL086655, GM070898, S10 RR-224820898]; Research Foundation of Flanders; United States Department of Energy [W-31-109-Eng-38]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR022482] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087950] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Foundation of Flanders(FWO); United States Department of Energy(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants MH087950 and HL086655 (to R. D.) and GM070898 (to T. S.). This work was also supported by a fellowship from the Research Foundation of Flanders (to S. J.).; We thank Farida Korobova for help with the expression of fascin mutants in cells. Use of the Industrial Macromolecular Crystallography Association Collaborative Access Team beamline 17-ID was supported by the Industrial Macromolecular Crystallography Association through a contract with the Hauptman-Woodward Medical Research Institute. The Advanced Photon Source was supported by United States Department of Energy Contract W-31-109-Eng-38. The transmission electron microscope was supported by National Institutes of Health Shared Instrumentation Grant S10 RR-22482 (to T. S.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Broderick MJF, 2005, ADV PROTEIN CHEM, V70, P203, DOI 10.1016/S0065-3233(04)70007-8; Cant K, 1996, GENETICS, V143, P249; Chen L, 2010, NATURE, V464, P1062, DOI 10.1038/nature08978; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; EDWARDS RA, 1995, J BIOL CHEM, V270, P10764, DOI 10.1074/jbc.270.18.10764; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; Galkin VE, 2008, P NATL ACAD SCI USA, V105, P1494, DOI 10.1073/pnas.0708667105; Graceffa P, 2003, J BIOL CHEM, V278, P34172, DOI 10.1074/jbc.M303689200; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Holmes KC, 2009, NATURE, V457, P389, DOI 10.1038/457389a; Ishikawa R, 2003, J NEUROCHEM, V87, P676, DOI 10.1046/j.1471-4159.2003.02058.x; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Machesky Laura M, 2010, Commun Integr Biol, V3, P263; MOSIALOS G, 1994, J VIROL, V68, P7320, DOI 10.1128/JVI.68.11.7320-7328.1994; Ono S, 1997, J BIOL CHEM, V272, P2527; Sedeh RS, 2010, J MOL BIOL, V400, P589, DOI 10.1016/j.jmb.2010.04.043; Sukow C, 1998, J MOL BIOL, V284, P1039, DOI 10.1006/jmbi.1998.2211; Tao YS, 1996, J CELL BIOL, V134, P1271, DOI 10.1083/jcb.134.5.1271; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; YAMASHIROMATSUMURA S, 1985, J BIOL CHEM, V260, P5087; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zhang J, 2009, SCIENCE, V325, P1250, DOI 10.1126/science.1174921	26	120	120	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30087	30096		10.1074/jbc.M111.251439	http://dx.doi.org/10.1074/jbc.M111.251439			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21685497	hybrid, Green Published			2022-12-25	WOS:000294046600066
J	Olzmann, JA; Kopito, RR				Olzmann, James A.; Kopito, Ron R.			Lipid Droplet Formation Is Dispensable for Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN; UBIQUITIN-LIGASE; ER LUMEN; YEAST; DISLOCATION; CYTOSOL; RETROTRANSLOCATION; PEROXISOMES; HRD1P	Proteins that fail to fold or assemble in the endoplasmic reticulum (ER) are destroyed by cytoplasmic proteasomes through a process known as ER-associated degradation. Substrates of this pathway are initially sequestered within the ER lumen and must therefore be dislocated across the ER membrane to be degraded. It has been proposed that generation of bicellar structures during lipid droplet formation may provide an "escape hatch" through which misfolded proteins, toxins, and viruses can exit the ER. We have directly tested this hypothesis by exploiting yeast strains defective in lipid droplet formation. Our data demonstrate that lipid droplet formation is dispensable for the dislocation of a plant toxin and the degradation of both soluble and integral membrane glycoproteins.	[Olzmann, James A.; Kopito, Ron R.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University	Kopito, RR (corresponding author), 337 Campus Dr, Stanford, CA 94305 USA.	kopito@stanford.edu		Olzmann, James/0000-0001-7751-8316	National Institutes of Health [GM074874]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074874, F32GM086026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM074874 (to R. R. K.).	Bagola K, 2011, BBA-BIOMEMBRANES, V1808, P925, DOI 10.1016/j.bbamem.2010.06.025; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Carvalho P, 2010, CELL, V143, P579, DOI 10.1016/j.cell.2010.10.028; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Hartman IZ, 2010, J BIOL CHEM, V285, P19288, DOI 10.1074/jbc.M110.134213; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2006, J VIROL, V80, P8739, DOI 10.1128/JVI.00791-06; MCNEW JA, 1994, J CELL BIOL, V127, P1245, DOI 10.1083/jcb.127.5.1245; Meinecke M, 2010, NAT CELL BIOL, V12, P273, DOI 10.1038/ncb2027; Ohsaki Y, 2006, MOL BIOL CELL, V17, P2674, DOI 10.1091/mbc.E05-07-0659; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1998, J BIOL CHEM, V273, P32848, DOI 10.1074/jbc.273.49.32848; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Sandager L, 2002, J BIOL CHEM, V277, P6478, DOI 10.1074/jbc.M109109200; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; SHERMAN F, 1991, METHODS ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sorger D, 2004, J BIOL CHEM, V279, P31190, DOI 10.1074/jbc.M403251200; Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785; Tirosh B, 2003, J BIOL CHEM, V278, P6664, DOI 10.1074/jbc.M210158200; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; WALTON PA, 1995, MOL BIOL CELL, V6, P675, DOI 10.1091/mbc.6.6.675; Wolf DH, 2005, CURR TOP MICROBIOL, V300, P41; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	31	43	43	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27872	27874		10.1074/jbc.C111.266452	http://dx.doi.org/10.1074/jbc.C111.266452			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21693705	Green Published, hybrid			2022-12-25	WOS:000293557800005
J	Tremblay, R; Lemay, JF; Blouin, S; Mulhbacher, J; Bonneau, E; Legault, P; Dupont, P; Penedo, JC; Lafontaine, DA				Tremblay, Renaud; Lemay, Jean-Francois; Blouin, Simon; Mulhbacher, Jerome; Bonneau, Eric; Legault, Pascale; Dupont, Paul; Penedo, J. Carlos; Lafontaine, Daniel A.			Constitutive Regulatory Activity of an Evolutionarily Excluded Riboswitch Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; 4-WAY DNA JUNCTION; SAM-I RIBOSWITCH; APTAMER DOMAIN; PURINE RIBOSWITCH; BACILLUS-SUBTILIS; RNA STRUCTURE; ADENINE RIBOSWITCH; STRUCTURAL BASIS; GENE-EXPRESSION	The exquisite specificity of the adenine-responsive riboswitch toward its cognate metabolite has been shown to arise from the formation of a Watson-Crick interaction between the adenine ligand and residue U65. A recent crystal structure of a U65C adenine aptamer variant has provided a rationale for the phylogenetic conservation observed at position 39 for purine aptamers. The G39-C65 variant adopts a compact ligand-free structure in which G39 is accommodated by the ligand binding site and is base-paired to the cytosine at position 65. Here, we demonstrate using a combination of biochemical and biophysical techniques that the G39-C65 base pair not only severely impairs ligand binding but also disrupts the functioning of the riboswitch in vivo by constitutively activating gene expression. Folding studies using single-molecule FRET revealed that the G39-C65 variant displays a low level of dynamic heterogeneity, a feature reminiscent of ligand-bound wild-type complexes. A restricted conformational freedom together with an ability to significantly fold in monovalent ions are exclusive to the G39-C65 variant. This work provides a mechanistic framework to rationalize the evolutionary exclusion of certain nucleotide combinations in favor of sequences that preserve ligand binding and gene regulation functionalities.	[Dupont, Paul; Penedo, J. Carlos] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Tremblay, Renaud; Lemay, Jean-Francois; Blouin, Simon; Mulhbacher, Jerome; Lafontaine, Daniel A.] Univ Sherbrooke, Fac Sci, Dept Biol, Grp ARN,RNA Grp, Sherbrooke, PQ J1K 2R1, Canada; [Bonneau, Eric; Legault, Pascale] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	University of St Andrews; University of Sherbrooke; Universite de Montreal	Penedo, JC (corresponding author), Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland.	jcp10@st-andrews.ac.uk; Daniel.Lafontaine@USherbrooke.ca	Penedo, Carlos/B-5568-2009	Penedo, Carlos/0000-0002-5807-5385; Legault, Pascale/0000-0003-1782-5204; Blouin, Simon/0000-0001-8433-4654	National Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes for Health Research (CIHR) [MOP-86502, MOP-166290]; University of St. Andrews; Scottish Universities Physics Alliance (SUPA); Universite de Montreal	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); University of St. Andrews; Scottish Universities Physics Alliance (SUPA); Universite de Montreal	This work was supported by a grant from the National Sciences and Engineering Research Council of Canada (NSERC) (to E. B.), and by Canadian Institutes for Health Research (CIHR) Grants MOP-86502 (to P. L.), and MOP-166290 (to D. A. L.).; Supported by the University of St. Andrews and the Scottish Universities Physics Alliance (SUPA).; Supported by the graduate scholarship from the Universite de Montreal.	Bassi GS, 1997, EMBO J, V16, P7481, DOI 10.1093/emboj/16.24.7481; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blouin S, 2011, NUCLEIC ACIDS RES, V39, P3373, DOI 10.1093/nar/gkq1247; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Brenner MD, 2010, BIOCHEMISTRY-US, V49, P1596, DOI 10.1021/bi9019912; Christiansen LC, 1997, J BACTERIOL, V179, P2540, DOI 10.1128/jb.179.8.2540-2550.1997; CLEGG RM, 1992, BIOCHEMISTRY-US, V31, P4846, DOI 10.1021/bi00135a016; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delfosse V, 2010, NUCLEIC ACIDS RES, V38, P2057, DOI 10.1093/nar/gkp1080; Edwards AL, 2009, J MOL BIOL, V385, P938, DOI 10.1016/j.jmb.2008.10.074; Garst AD, 2008, J BIOL CHEM, V283, P22347, DOI 10.1074/jbc.C800120200; Gilbert SD, 2007, BIOCHEMISTRY-US, V46, P13297, DOI 10.1021/bi700410g; Gilbert SD, 2006, CHEM BIOL, V13, P805, DOI 10.1016/j.chembiol.2006.08.002; Gilbert SD, 2006, J MOL BIOL, V359, P754, DOI 10.1016/j.jmb.2006.04.003; Heppell B, 2011, NAT CHEM BIOL, V7, P384, DOI [10.1038/NCHEMBIO.563, 10.1038/nchembio.563]; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kim JN, 2009, ACS CHEM BIOL, V4, P915, DOI 10.1021/cb900146k; Lafontaine DA, 2002, EMBO J, V21, P2461, DOI 10.1093/emboj/21.10.2461; Lafontaine DA, 2002, J MOL BIOL, V323, P23, DOI 10.1016/S0022-2836(02)00910-5; Lafontaine DA, 2001, EMBO J, V20, P1415, DOI 10.1093/emboj/20.6.1415; Lemay JF, 2007, RNA, V13, P339, DOI 10.1261/rna.142007; Lemay JF, 2006, CHEM BIOL, V13, P857, DOI 10.1016/j.chembiol.2006.06.010; Lemay JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001278; Macke TJ, 2001, NUCLEIC ACIDS RES, V29, P4724, DOI 10.1093/nar/29.22.4724; Mandal M, 2004, NAT STRUCT MOL BIOL, V11, P29, DOI 10.1038/nsmb710; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Montange RK, 2008, ANNU REV BIOPHYS, V37, P117, DOI 10.1146/annurev.biophys.37.032807.130000; Mulhbacher J, 2007, NUCLEIC ACIDS RES, V35, P5568, DOI 10.1093/nar/gkm572; Mulhbacher J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000865; MURCHIE AIH, 1989, NATURE, V341, P763, DOI 10.1038/341763a0; Noeske J, 2007, NUCLEIC ACIDS RES, V35, P5262, DOI 10.1093/nar/gkm565; Nudler E, 2006, CELL, V126, P19, DOI 10.1016/j.cell.2006.06.024; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pleiss JA, 1998, RNA, V4, P1313, DOI 10.1017/S135583829800106X; Roth A, 2009, ANNU REV BIOCHEM, V78, P305, DOI 10.1146/annurev.biochem.78.070507.135656; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2009, CURR OPIN STRUC BIOL, V19, P251, DOI 10.1016/j.sbi.2009.02.002; Stoddard CD, 2008, RNA, V14, P675, DOI 10.1261/rna.736908; Stoddard CD, 2010, STRUCTURE, V18, P787, DOI 10.1016/j.str.2010.04.006; WARD DC, 1969, J BIOL CHEM, V244, P1228; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006; ZHANG OW, 1994, J BIOMOL NMR, V4, P845, DOI 10.1007/BF00398413	49	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27406	27415		10.1074/jbc.M111.229047	http://dx.doi.org/10.1074/jbc.M111.229047			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676871	hybrid, Green Published			2022-12-25	WOS:000293268700036
J	Boccia, D; Hargreaves, J; De Stavola, BL; Fielding, K; Schaap, A; Godfrey-Faussett, P; Ayles, H				Boccia, Delia; Hargreaves, James; De Stavola, Bianca Lucia; Fielding, Katherine; Schaap, Ab; Godfrey-Faussett, Peter; Ayles, Helen			The Association between Household Socioeconomic Position and Prevalent Tuberculosis in Zambia: A Case-Control Study	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGY; DETERMINANTS; SUCCESS; POVERTY; HIV	Background: Although historically tuberculosis (TB) has been associated with poverty, few analytical studies from developing countries have tried to: 1. assess the relative impact of poverty on TB after the emergence of HIV; 2. explore the causal mechanism underlying this association; and 3. estimate how many cases of TB could be prevented by improving household socioeconomic position (SEP). Methods and Findings: We undertook a case-control study nested within a population-based TB and HIV prevalence survey conducted in 2005-2006 in two Zambian communities. Cases were defined as persons (15+ years of age) culture positive for M. tuberculosis. Controls were randomly drawn from the TB-free participants enrolled in the prevalence survey. We developed a composite index of household SEP combining variables accounting for four different domains of household SEP. The analysis of the mediation pathway between household SEP and TB was driven by a pre-defined conceptual framework. Adjusted Population Attributable Fractions (aPAF) were estimated. Prevalent TB was significantly associated with lower household SEP [aOR = 6.2, 95% CI: 2.0-19.2 and aOR = 3.4, 95% CI: 1.8-7.6 respectively for low and medium household SEP compared to high]. Other risk factors for prevalent TB included having a diet poor in proteins [aOR = 3.1, 95% CI: 1.1-8.7], being HIV positive [aOR = 3.1, 95% CI: 1.7-5.8], not BCG vaccinated [aOR = 7.7, 95% CI: 2.8-20.8], and having a history of migration [aOR = 5.2, 95% CI: 2.7-10.2]. These associations were not confounded by household SEP. The association between household SEP and TB appeared to be mediated by inadequate consumption of protein food. Approximately the same proportion of cases could be attributed to this variable and HIV infection (aPAF = 42% and 36%, respectively). Conclusions: While the fight against HIV remains central for TB control, interventions addressing low household SEP and, especially food availability, may contribute to strengthen our control efforts.	[Boccia, Delia; Hargreaves, James; Fielding, Katherine; Schaap, Ab] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England; [De Stavola, Bianca Lucia] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Med Stat, London WC1, England; [Schaap, Ab; Ayles, Helen] Univ Zambia, ZAMBART Project, Lusaka, Zambia; [Godfrey-Faussett, Peter; Ayles, Helen] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of Zambia; University of London; London School of Hygiene & Tropical Medicine	Boccia, D (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London WC1, England.	Delia.Boccia@lshtm.ac.uk		Hargreaves, James/0000-0002-3509-3572; Ayles, Helen/0000-0003-4108-2842; De Stavola, Bianca Lucia/0000-0001-7853-0528	Bill & Melinda Gates Foundation [19790.01]; UK Department for International Development [ITDCHB26]; ESRC [ES/I000178/1] Funding Source: UKRI; MRC [G0700837] Funding Source: UKRI; Economic and Social Research Council [ES/I000178/1] Funding Source: researchfish; Medical Research Council [G0700837] Funding Source: researchfish	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Department for International Development; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research project was funded by the Bill & Melinda Gates Foundation as part of the Consortium to Respond Effectively to the AIDS-TB Epidemic (CREATE) project (Grant to Johns Hopkins University 19790.01) and the UK Department for International Development Grant Number: ITDCHB26. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All findings and opinions are those of the authors.	Al-Maniri A, 2007, INT J TUBERC LUNG D, V11, P175; AMRIT S, 2002, PLAGUE POVERTY; Andersen P, 2005, NAT REV MICROBIOL, V3, P656, DOI 10.1038/nrmicro1211; Ayles H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005602; BARTHOLOMEW DJS, 2002, PRINCIPAL COMPONENT, P115; Bhugra D, 2004, ACTA PSYCHIAT SCAND, V109, P243, DOI 10.1046/j.0001-690X.2003.00246.x; Boccia D, 2009, AM J TROP MED HYG, V80, P1004, DOI 10.4269/ajtmh.2009.80.1004; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Cegielski JP, 2004, INT J TUBERC LUNG D, V8, P286; *CENTR STAT OFF RE, 2004, LIV COND MON SURV RE; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; Corbett EL, 2009, INT J TUBERC LUNG D, V13, P1231; Corbett EL, 2004, AM J RESP CRIT CARE, V170, P673, DOI 10.1164/rccm.200405-590OC; Corbett EL, 2007, PLOS MED, V4, P164, DOI 10.1371/journal.pmed.0040022; Crampin AC, 2009, INT J TUBERC LUNG D, V13, P153; Dai GX, 1998, INFECT IMMUN, V66, P3562, DOI 10.1128/IAI.66.8.3562-3568.1998; Ximenes RAD, 2009, INT J EPIDEMIOL, V38, P1285, DOI 10.1093/ije/dyp224; Dye C, 2007, INT J TUBERC LUNG D, V11, P1225; Dye C, 2009, B WORLD HEALTH ORGAN, V87, P683, DOI 10.2471/BLT.08.058453; Falkingham J, 2002, MEASURING HLTH POVER; Farmer P, 1997, SOC SCI MED, V44, P347, DOI 10.1016/S0277-9536(96)00143-8; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; FILMER D, 2008, 4605 WORLD BANK DEV; Glynn JR, 2000, T ROY SOC TROP MED H, V94, P500, DOI 10.1016/S0035-9203(00)90065-8; GOLDMAN JM, 1994, THORAX, V49, P184, DOI 10.1136/thx.49.2.184; Grange JM, 2001, INT J TUBERC LUNG D, V5, P208; Hafeman DM, 2009, INT J EPIDEMIOL, V38, P838, DOI 10.1093/ije/dyn372; Harling G, 2008, SOC SCI MED, V66, P492, DOI 10.1016/j.socscimed.2007.08.026; HENRY C, 2000, ASSESSING RELATIVE P; Hoa NB, 2010, INT J TUBERC LUNG D, V14, P1303; Huong NT, 2006, INT J TUBERC LUNG D, V10, P963; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Karyadi E., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P338; Kaulagekar Aarti, 2007, Indian J Tuberc, V54, P17; Lonnroth K, 2009, INT J TUBERC LUNG D, V13, P171; Lonnroth K, 2008, SEMIN RESP CRIT CARE, V29, P481, DOI 10.1055/s-0028-1085700; Lonnroth K, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P219; Lynch JW., 2000, SOCIAL EPIDEMIOLOGY, P13; MacKinnon D.P., 2012, INTRO STAT MEDIATION; Muniyandi M, 2007, INT J TUBERC LUNG D, V11, P1042; Obermeyer Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001721; Pai M, 2006, EXPERT REV MOL DIAGN, V6, P413, DOI 10.1586/14737159.6.3.413; Sanchez-Perez HJ, 2001, INT J EPIDEMIOL, V30, P386, DOI 10.1093/ije/30.2.386; SCHOEMAN JH, 1991, INT J EPIDEMIOL, V20, P435, DOI 10.1093/ije/20.2.435; SIMATELE SM, 2007, AFR MIGR WORKSH 18 2; Simwaka BN, 2007, INT J TUBERC LUNG D, V11, P65; Soemantri S, 2007, INT J TUBERC LUNG D, V11, P398; *USAID, 2008, NUTR TUB REV LIT CON; van der Werf MJ, 2008, INT J TUBERC LUNG D, V12, P1255; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; *WHO, 2007, ASS TUB PREV THROUGH; WHO, 2005, ADDR POV TB CONTR OP; World Bank, 2005, ZAMB POV VULN ASS	54	52	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20824	10.1371/journal.pone.0020824	http://dx.doi.org/10.1371/journal.pone.0020824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778VR	21698146	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000291737600018
J	Balogh, G; Maulucci, G; Gombos, I; Horvath, I; Torok, Z; Peter, M; Fodor, E; Pali, T; Benko, S; Parasassi, T; De Spirito, M; Harwood, JL; Vigh, L				Balogh, Gabor; Maulucci, Giuseppe; Gombos, Imre; Horvath, Ibolya; Toeroek, Zsolt; Peter, Maria; Fodor, Elfrieda; Pali, Tibor; Benko, Sandor; Parasassi, Tiziana; De Spirito, Marco; Harwood, John L.; Vigh, Laszlo			Heat Stress Causes Spatially-Distinct Membrane Re-Modelling in K562 Leukemia Cells	PLOS ONE			English	Article							PLASMA-MEMBRANE; SHOCK RESPONSE; GENERALIZED POLARIZATION; FLUORESCENCE MICROSCOPY; HEAT-SHOCK-PROTEIN-70 HSP70; LAURDAN FLUORESCENCE; PROTEIN RESPONSE; MAMMALIAN-CELLS; PHOSPHOLIPASE-C; BLOOD-PLATELETS	Cellular membranes respond rapidly to various environmental perturbations. Previously we showed that modulations in membrane fluidity achieved by heat stress (HS) resulted in pronounced membrane organization alterations which could be intimately linked to the expression and cellular distribution of heat shock proteins. Here we examine heat-induced membrane changes using several visualisation methods. With Laurdan two-photon microscopy we demonstrate that, in contrast to the enhanced formation of ordered domains in surface membranes, the molecular disorder is significantly elevated within the internal membranes of cells preexposed to mild HS. These results were compared with those obtained by anisotropy, fluorescence lifetime and electron paramagnetic resonance measurements. All probes detected membrane changes upon HS. However, the structurally different probes revealed substantially distinct alterations in membrane heterogeneity. These data call attention to the careful interpretation of results obtained with only a single label. Subtle changes in membrane microstructure in the decision-making of thermal cell killing could have potential application in cancer therapy.	[Balogh, Gabor; Gombos, Imre; Horvath, Ibolya; Toeroek, Zsolt; Peter, Maria; Fodor, Elfrieda; Vigh, Laszlo] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Pali, Tibor] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Benko, Sandor] Univ Szeged, Albert Szent Gyorgyi Clin Ctr, Dept Internal Med 1, Szeged, Hungary; [Parasassi, Tiziana] CNR, Inst Translat Pharmacol, Rome, Italy; [Maulucci, Giuseppe; De Spirito, Marco] Univ Cattolica Sacro Cuore, Ist Fis, Rome, Italy; [Harwood, John L.] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Cardiff University	Balogh, G (corresponding author), Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary.	Harwood@cardiff.ac.uk; vigh@brc.hu	Balogh, Gábor/AIC-8192-2022; De Spirito, Marco/C-5386-2008; Harwood, John L/A-4308-2010; Maulucci, Giuseppe/C-7400-2009; De Spirito, Marco/U-3817-2019	Balogh, Gábor/0000-0002-4565-6850; De Spirito, Marco/0000-0003-4260-5107; Maulucci, Giuseppe/0000-0002-2154-319X; De Spirito, Marco/0000-0003-4260-5107; Harwood, John/0000-0003-2377-2612; Pali, Tibor/0000-0003-1649-1097; Parasassi, Tiziana/0000-0002-9795-0568; Fodor, Elfrieda/0000-0002-5695-6162	European Union [HEALTH-F4-2008-202272]; Hungarian National Scientific Research Foundation (OTKA) [NN 76716, K68804]; Hungarian National Development Agency [TAMOP-4.2.2/08/1-2008-0005, TAMOP-4.2.2/08/1-2008-0002, TAMOP-4.2.2/08/1-2008-0013]	European Union(European Commission); Hungarian National Scientific Research Foundation (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian National Development Agency	This work was funded by the European Union Project LipidomicNet (HEALTH-F4-2008-202272), Hungarian National Scientific Research Foundation (OTKA NN 76716 and K68804), and the Hungarian National Development Agency TAMOP-4.2.2/08/1-2008-0005, TAMOP-4.2.2/08/1-2008-0002 and TAMOP-4.2.2/08/1-2008-0013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Makdissy N, 2003, CELL SIGNAL, V15, P1019, DOI 10.1016/S0898-6568(03)00070-6; Bagatolli LA, 2006, BBA-BIOMEMBRANES, V1758, P1541, DOI 10.1016/j.bbamem.2006.05.019; Balogh G, 2005, FEBS J, V272, P6077, DOI 10.1111/j.1742-4658.2005.04999.x; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; CALDERWOOD SK, 1993, J CELL PHYSIOL, V155, P248, DOI 10.1002/jcp.1041550205; CALDERWOOD SK, 1993, J CELL PHYSIOL, V156, P153, DOI 10.1002/jcp.1041560121; Calderwood SK, 2008, INT J HYPERTHER, V24, P31, DOI 10.1080/02656730701858305; Carratu L, 1996, P NATL ACAD SCI USA, V93, P3870, DOI 10.1073/pnas.93.9.3870; COLLARD JG, 1978, EXP CELL RES, V116, P447, DOI 10.1016/0014-4827(78)90467-6; Coupin GT, 1999, J CELL SCI, V112, P2431; Dempsey NC, 2010, CANCER LETT, V296, P257, DOI 10.1016/j.canlet.2010.04.016; Dixon N, 2004, BBA-BIOMEMBRANES, V1665, P177, DOI 10.1016/j.bbamem.2004.08.001; Duda E, 1994, ADV PSYCHONEUROIMMUN, P181; DYNLACHT JR, 1992, RADIAT RES, V130, P55, DOI 10.2307/3578479; DYNLACHT JR, 1992, RADIAT RES, V130, P48, DOI 10.2307/3578478; Escriba PV, 2008, J CELL MOL MED, V12, P829, DOI 10.1111/j.1582-4934.2008.00281.x; Gallegos AM, 2004, BIOCHEM J, V382, P451, DOI 10.1042/BJ20031562; Gaus K, 2005, J CELL BIOL, V171, P121, DOI 10.1083/jcb.200505047; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Grassme H, 2007, PROG LIPID RES, V46, P161, DOI 10.1016/j.plipres.2007.03.002; GRATTON E, 1983, BIOPHYS J, V44, P315, DOI 10.1016/S0006-3495(83)84305-7; GRIMM MJ, 2009, PROKARYOTIC EUKARYOT; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Horvath I, 1998, P NATL ACAD SCI USA, V95, P3513, DOI 10.1073/pnas.95.7.3513; Horvath I, 2008, BBA-BIOMEMBRANES, V1778, P1653, DOI 10.1016/j.bbamem.2008.02.012; ILLINGER D, 1995, BBA-BIOMEMBRANES, V1239, P58, DOI 10.1016/0005-2736(95)00135-P; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kiang JG, 1998, PHARMACOL THERAPEUT, V80, P183, DOI 10.1016/S0163-7258(98)00028-X; Kim HM, 2007, CHEMBIOCHEM, V8, P553, DOI 10.1002/cbic.200700003; Kindzelskii AL, 2004, J IMMUNOL, V172, P4681, DOI 10.4049/jimmunol.172.8.4681; Kirkegaard T, 2010, NATURE, V463, P549, DOI 10.1038/nature08710; KITAGAWA S, 1991, J MEMBRANE BIOL, V119, P221, DOI 10.1007/BF01868727; KITAGAWA S, 1992, BIOCHIM BIOPHYS ACTA, V1112, P14, DOI 10.1016/0005-2736(92)90247-J; Kota Z, 2002, P NATL ACAD SCI USA, V99, P12149, DOI 10.1073/pnas.192463899; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; MAEDA T, 1983, BIOCHIM BIOPHYS ACTA, V731, P115, DOI 10.1016/0005-2736(83)90404-2; Marsh D, 1981, Mol Biol Biochem Biophys, V31, P51; Maula T, 2009, BBA-BIOMEMBRANES, V1788, P2454, DOI 10.1016/j.bbamem.2009.08.024; Meex RCR, 2009, AM J PHYSIOL-REG I, V297, pR913, DOI 10.1152/ajpregu.91053.2008; Moulin M, 2007, APOPTOSIS, V12, P1703, DOI 10.1007/s10495-007-0096-2; Multhoff G, 2007, METHODS, V43, P229, DOI 10.1016/j.ymeth.2007.06.006; Multhoff G, 2009, INT J HYPERTHER, V25, P169, DOI 10.1080/02656730902902001; Nagy E, 2007, P NATL ACAD SCI USA, V104, P7945, DOI 10.1073/pnas.0702557104; Pali T, 2003, CELL MOL LIFE SCI, V60, P1591, DOI 10.1007/s00018-003-3173-x; Pali T, 1999, BIOCHEMISTRY-US, V38, P14311, DOI 10.1021/bi991459c; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; Parasassi T, 1997, BIOPHYS J, V72, P2413, DOI 10.1016/S0006-3495(97)78887-8; PARASASSI T, 1992, INT J RADIAT BIOL, V61, P791, DOI 10.1080/09553009214551661; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; PESSIN JE, 1978, BIOCHEMISTRY-US, V17, P1997, DOI 10.1021/bi00603a031; REVATHI CJ, 1994, BIOCHEM MOL BIOL INT, V32, P941; RODES JF, 1995, CYTOMETRY, V19, P217, DOI 10.1002/cyto.990190305; Shigapova N, 2005, BIOCHEM BIOPH RES CO, V328, P1216, DOI 10.1016/j.bbrc.2005.01.081; Sklar L. A., 1984, MEMBRANE FLUIDITY, P99; Spandl J, 2009, TRAFFIC, V10, P1579, DOI 10.1111/j.1600-0854.2009.00980.x; Stangl S, 2011, P NATL ACAD SCI USA, V108, P733, DOI 10.1073/pnas.1016065108; STORCH J, 1989, J BIOL CHEM, V264, P10527; Torok Z, 1997, P NATL ACAD SCI USA, V94, P2192, DOI 10.1073/pnas.94.6.2192; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; Vest R, 2006, J MEMBRANE BIOL, V211, P15, DOI 10.1007/s00232-005-7008-6; Vigh L, 2005, PROG LIPID RES, V44, P303, DOI 10.1016/j.plipres.2005.08.001; Vigh L, 2007, ANN NY ACAD SCI, V1113, P40, DOI 10.1196/annals.1391.027; Vigh L, 2007, TRENDS BIOCHEM SCI, V32, P357, DOI 10.1016/j.tibs.2007.06.009; Vigh L, 2007, ADV EXP MED BIOL, V594, P114; YATVIN MB, 1979, SCIENCE, V205, P195, DOI 10.1126/science.451588; Yu WM, 1996, BIOPHYS J, V70, P626, DOI 10.1016/S0006-3495(96)79646-7	67	55	56	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21182	10.1371/journal.pone.0021182	http://dx.doi.org/10.1371/journal.pone.0021182			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698159	Green Submitted, Green Published, gold, Green Accepted			2022-12-25	WOS:000291734100064
J	Qu, HQ; Li, Q; Rentfro, AR; Fisher-Hoch, SP; McCormick, JB				Qu, Hui-Qi; Li, Quan; Rentfro, Anne R.; Fisher-Hoch, Susan P.; McCormick, Joseph B.			The Definition of Insulin Resistance Using HOMA-IR for Americans of Mexican Descent Using Machine Learning	PLOS ONE			English	Article							FATTY LIVER-DISEASE; INFLAMMATION; GLUCOSE	Objective: The lack of standardized reference range for the homeostasis model assessment-estimated insulin resistance (HOMA-IR) index has limited its clinical application. This study defines the reference range of HOMA-IR index in an adult Hispanic population based with machine learning methods. Methods: This study investigated a Hispanic population of 1854 adults, randomly selected on the basis of 2000 Census tract data in the city of Brownsville, Cameron County. Machine learning methods, support vector machine (SVM) and Bayesian Logistic Regression (BLR), were used to automatically identify measureable variables using standardized values that correlate with HOMA-IR; K-means clustering was then used to classify the individuals by insulin resistance. Results: Our study showed that the best cutoff of HOMA-IR for identifying those with insulin resistance is 3.80. There are 39.1% individuals in this Hispanic population with HOMA-IR>3.80. Conclusions: Our results are dramatically different using the popular clinical cutoff of 2.60. The high sensitivity and specificity of HOMA-IR>3.80 for insulin resistance provide a critical fundamental for our further efforts to improve the public health of this Hispanic population.	[Qu, Hui-Qi; Fisher-Hoch, Susan P.; McCormick, Joseph B.] Univ Texas Brownsville, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Brownsville, TX 78520 USA; [Li, Quan] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Endocrine Genet Lab, Montreal, PQ H3H 1P3, Canada; [Rentfro, Anne R.] Univ Texas Brownsville & Texas Southmost Coll, Coll Nursing, Brownsville, TX 78520 USA	University of Texas System; University of Texas Rio Grande Valley; McGill University; University of Texas System; University of Texas Rio Grande Valley	Qu, HQ (corresponding author), Univ Texas Brownsville, Sch Publ Hlth, Div Epidemiol Human Genet & Environm Sci, Brownsville Reg Campus, Brownsville, TX 78520 USA.	Joseph.B.McCormick@uth.tmc.edu	Li, Quan/B-3605-2009; Qu, Hui-Qi/B-4719-2009	Qu, Hui-Qi/0000-0001-9317-4488; McCormick, Joseph/0000-0002-5844-8102	National Center on Minority Health and Health Disparities (NCMHD) [MD000170 P20]; National Center for Research Resources (NCRR) [1U54RR023417-01]; National Institute on Minority Health and Health Disparities [P20MD000170] Funding Source: NIH RePORTER	National Center on Minority Health and Health Disparities (NCMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by MD000170 P20 from the National Center on Minority Health and Health Disparities (NCMHD), and the University of Texas Houston Health Sciences Center, Center for Clinical and Translational Science CCTS-CTSA award 1U54RR023417-01 funded by the National Center for Research Resources (NCRR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Ascaso JF, 2003, DIABETES CARE, V26, P3320, DOI 10.2337/diacare.26.12.3320; Fan RE, 2005, J MACH LEARN RES, V6, P1889; Fisher-Hoch SP, 2010, PREV CHRONIC DIS, V7; GREENFIELD MS, 1981, DIABETES, V30, P387, DOI 10.2337/diabetes.30.5.387; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McAuley KA, 2001, DIABETES CARE, V24, P460, DOI 10.2337/diacare.24.3.460; Polyzos SA, 2009, CURR MOL MED, V9, P299, DOI 10.2174/156652409787847191; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Vanni E, 2009, HEPATOLOGY, V49, P1790, DOI 10.1002/hep.23036; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487	13	117	119	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21041	10.1371/journal.pone.0021041	http://dx.doi.org/10.1371/journal.pone.0021041			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695082	Green Published, gold, Green Submitted			2022-12-25	WOS:000291682300026
J	Senyuk, V; Premanand, K; Xu, P; Qian, ZJ; Nucifora, G				Senyuk, Vitalyi; Premanand, Kavitha; Xu, Peng; Qian, Zhijian; Nucifora, Giuseppina			The Oncoprotein EVI1 and the DNA Methyltransferase Dnmt3 Co-Operate in Binding and De Novo Methylation of Target DNA	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; TRANSCRIPTION FACTOR; MYELOID-LEUKEMIA; ERYTHROID-DIFFERENTIATION; SILENCE TRANSCRIPTION; FORCED EXPRESSION; SELF-RENEWAL; GENE; HISTONE; HYPERMETHYLATION	EVI1 has pleiotropic functions during murine embryogenesis and its targeted disruption leads to prenatal death by severely affecting the development of virtually all embryonic organs. However, its functions in adult tissues are still unclear. When inappropriately expressed, EVI1 becomes one of the most aggressive oncogenes associated with human hematopoietic and solid cancers. The mechanisms by which EVI1 transforms normal cells are unknown, but we showed recently that EVI1 indirectly upregulates self-renewal and cell-cycling genes by inappropriate methylation of CpG dinucleotides in the regulatory regions of microRNA-124-3 (miR-124-3), leading to the repression of this small gene that controls normal differentiation and cell cycling of somatic cells. We used the regulatory regions of miR-124-3 as a read-out system to investigate how EVI1 induces de novo methylation of DNA. Here we show that EVI1 physically interacts with DNA methyltransferases 3a and 3b (Dnmt3a/b), which are the only de novo DNA methyltransferases identified to date in mouse and man, and that it forms an enzymatically active protein complex that induces de novo DNA methylation in vitro. This protein complex targets and binds to a precise region of miR-124-3 that is necessary for repression of a reporter gene by EVI1. Based on our findings, we propose that in cooperation with Dnmt3a/b EVI1 regulates the methylation of DNA as a sequence-specific mediator of de novo DNA methylation and that inappropriate EVI1 expression contributes to carcinogenesis through improper DNA methylation.	[Senyuk, Vitalyi; Premanand, Kavitha; Xu, Peng; Qian, Zhijian; Nucifora, Giuseppina] Univ Illinois, Dept Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Senyuk, V (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	vsenyuk@uic.edu			National Institutes of Health (NIH) [HL082935, HL079580, CA096448]; NATIONAL CANCER INSTITUTE [R01CA096448, R01CA140979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079580, R01HL082935] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) grants HL082935, HL079580, and CA096448 (GN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Brooks DJ, 1996, BRIT J CANCER, V74, P1518, DOI 10.1038/bjc.1996.583; Buonamici S, 2005, J BIOL CHEM, V280, P428, DOI 10.1074/jbc.M410836200; Cattaneo F, 2008, J CELL BIOCHEM, V105, P344, DOI 10.1002/jcb.21869; Chakraborty S, 2001, J BIOL CHEM, V276, P44936, DOI 10.1074/jbc.M106733200; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Choi YW, 2007, LUNG CANCER, V55, P43, DOI 10.1016/j.lungcan.2006.09.018; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Dickstein J, 2010, P NATL ACAD SCI USA, V107, P9783, DOI 10.1073/pnas.1004297107; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Gopalakrishnan S, 2009, HUM MOL GENET, V18, P3178, DOI 10.1093/hmg/ddp256; Goyama S, 2008, CELL STEM CELL, V3, P207, DOI 10.1016/j.stem.2008.06.002; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Izraeli S, 2004, BRIT J HAEMATOL, V126, P3, DOI 10.1111/j.1365-2141.2004.04986.x; Jazaeri AA, 2010, GYNECOL ONCOL, V118, P189, DOI 10.1016/j.ygyno.2010.04.007; Jeong S, 2009, MOL CELL BIOL, V29, P5366, DOI 10.1128/MCB.00484-09; Jia D, 2007, NATURE, V449, P248, DOI 10.1038/nature06146; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kareta MS, 2006, J BIOL CHEM, V281, P25893, DOI 10.1074/jbc.M603140200; Laricchia-Robbio L, 2008, BLOOD CELL MOL DIS, V40, P141, DOI 10.1016/j.bcmd.2007.07.012; Laricchia-Robbio L, 2006, MOL CELL BIOL, V26, P7658, DOI 10.1128/MCB.00363-06; Laricchia-Robbio L, 2009, CANCER RES, V69, P1633, DOI 10.1158/0008-5472.CAN-08-2562; Liu Y, 2006, ONCOGENE, V25, P3565, DOI 10.1038/sj.onc.1209403; Lugthart S, 2011, BLOOD, V117, P234, DOI 10.1182/blood-2010-04-281337; MATSUGI T, 1995, ONCOGENE, V11, P191; Mead PE, 2005, GENE EXPR PATTERNS, V5, P601, DOI 10.1016/j.modgep.2005.03.007; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; MUCENSKI ML, 1988, ONCOGENE RES, V2, P219; Nucifora G, 1997, LEUKEMIA, V11, P2022, DOI 10.1038/sj.leu.2400880; Ogata K, 2003, CURR OPIN STRUC BIOL, V13, P40, DOI 10.1016/S0959-440X(03)00012-5; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Pabst T, 2007, ONCOGENE, V26, P6829, DOI 10.1038/sj.onc.1210765; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Senyuk V, 2002, ONCOGENE, V21, P3232, DOI 10.1038/sj.onc.1205436; Senyuk V, 2007, CANCER RES, V67, P5658, DOI 10.1158/0008-5472.CAN-06-3962; Sitailo S, 1999, LEUKEMIA, V13, P1639, DOI 10.1038/sj.leu.2401585; Sood R, 1999, LEUKEMIA, V13, P348, DOI 10.1038/sj.leu.2401360; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Testoni N, 1999, HAEMATOLOGICA, V84, P690; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, P4246, DOI 10.1093/nar/gkq147; Zhao Q, 2009, NAT STRUCT MOL BIOL, V16, P304, DOI 10.1038/nsmb.1568	49	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20793	10.1371/journal.pone.0020793	http://dx.doi.org/10.1371/journal.pone.0020793			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695170	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600027
J	Aguilar, HN; Tracey, CN; Tsang, SCF; McGinnis, JM; Mitchell, BF				Aguilar, Hector N.; Tracey, Curtis N.; Tsang, Siu Cheung F.; McGinnis, Justin M.; Mitchell, Bryan F.			Phos-Tag-Based Analysis of Myosin Regulatory Light Chain Phosphorylation in Human Uterine Myocytes	PLOS ONE			English	Article							SMOOTH-MUSCLE MYOSIN; PROTEIN-KINASE-C; SDS-PAGE; HEAVY-MEROMYOSIN; RAT UTERUS; SITES; PHOSPHATASE; RHO; CONTRACTION; QUANTIFICATION	Background: The 'phosphate-binding tag' (phos-tag) reagent enables separation of phospho-proteins during SDS-PAGE by impeding migration proportional to their phosphorylation stoichiometry. Western blotting can then be used to detect and quantify the bands corresponding to the phospho-states of a target protein. We present a method for quantification of data regarding phospho-states derived from phos-tag SDS-PAGE. The method incorporates corrections for lane-to-lane loading variability and for the effects of drug vehicles thus enabling the comparison of multiple treatments by using the untreated cellular set-point as a reference. This method is exemplified by quantifying the phosphorylation of myosin regulatory light chain (RLC) in cultured human uterine myocytes. Methodology/Principal Findings: We have evaluated and validated the concept that, when using an antibody (Ab) against the total-protein, the sum of all phosphorylation states in a single lane represents a 'closed system' since all possible phospho-states and phosphoisotypes are detected. Using this approach, we demonstrate that oxytocin (OT) and calpeptin (Calp) induce RLC kinase (MLCK)- and rho-kinase (ROK)-dependent enhancements in phosphorylation of RLC at T18 and S19. Treatment of myocytes with a phorbol ester (PMA) induced phosphorylation of S1-RLC, which caused a mobility shift in the phos-tag matrices distinct from phosphorylation at S19. Conclusion/Significance: We have presented a method for analysis of phospho-state data that facilitates quantitative comparison to a reference control without the use of a traditional 'loading' or 'reference' standard. This analysis is useful for assessing effects of putative agonists and antagonists where all phospho-states are represented in control and experimental samples. We also demonstrated that phosphorylation of RLC at S1 is inducible in intact uterine myocytes, though the signal in the resting samples was not sufficiently abundant to allow quantification by the approach used here.	[Aguilar, Hector N.; Tracey, Curtis N.; Tsang, Siu Cheung F.; McGinnis, Justin M.; Mitchell, Bryan F.] Univ Alberta, Dept Physiol, Fac Med & Dent, Edmonton, AB, Canada; [Mitchell, Bryan F.] Univ Alberta, Dept Obstet & Gynecol, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta; University of Alberta	Aguilar, HN (corresponding author), Univ Alberta, Dept Physiol, Fac Med & Dent, Edmonton, AB, Canada.	brymitch@ualberta.ca		McGinnis, Justin M./0000-0001-7671-4921	Canadian Institutes of Health Research [MOP 81384]; Alberta Innovates - Health Solutions	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates - Health Solutions	This research was supported by the Canadian Institutes of Health Research (http://www.cihr.ca/e/) through a fellowship to HNA and Operating Grant (#MOP 81384) to BFM, by Alberta Innovates - Health Solutions (http://www.ahfmr.ab.ca/) through a fellowship to HNA, the Major Equipment Grant Program and the Team Grant Program to study Preterm Birth and Healthy Outcomes (PreHOT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar HN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009965; BARANY K, 1987, BIOCHIM BIOPHYS ACTA, V911, P369, DOI 10.1016/0167-4838(87)90079-3; BENGUR AR, 1987, J BIOL CHEM, V262, P7613; BRADLEY AB, 1987, J PHYSIOL-LONDON, V385, P437, DOI 10.1113/jphysiol.1987.sp016500; COLBURN JC, 1988, J BIOL CHEM, V263, P19166; CSABINA S, 1987, COMP BIOCHEM PHYS B, V87, P271, DOI 10.1016/0305-0491(87)90139-8; CSABINA S, 1986, BIOCHIM BIOPHYS ACTA, V871, P311, DOI 10.1016/0167-4838(86)90213-X; Deswal S, 2010, IMMUNOL LETT, V130, P51, DOI 10.1016/j.imlet.2009.12.012; ERDODI F, 1988, ARCH BIOCHEM BIOPHYS, V266, P583, DOI 10.1016/0003-9861(88)90291-3; HAEBERLE JR, 1985, J BIOL CHEM, V260, P9965; HAEBERLE JR, 1988, J BIOL CHEM, V263, P4424; Hosokawa T, 2010, MOL CELL PROTEOMICS, V9, P1133, DOI 10.1074/mcp.M900578-MCP200; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; IKEBE M, 1987, J BIOL CHEM, V262, P9569; IKEBE M, 1988, J BIOL CHEM, V263, P6432; IKEBE M, 1985, J BIOL CHEM, V260, P27; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kim HR, 2008, J CELL MOL MED, V12, P2165, DOI 10.1111/j.1582-4934.2008.00552.x; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; KINOSHITA E, 2010, PROTEOMICS; Kinoshita E, 2008, PROTEOMICS, V8, P2994, DOI 10.1002/pmic.200800243; Kinoshita E, 2009, NAT PROTOC, V4, P1513, DOI 10.1038/nprot.2009.154; KITAZAWA T, 1989, J BIOL CHEM, V264, P5339; LEBOWITZ EA, 1979, J BIOCHEM-TOKYO, V85, P1489, DOI 10.1093/oxfordjournals.jbchem.a132477; NISHIKAWA M, 1984, J BIOL CHEM, V259, P8808; NISHIKAWA M, 1983, J BIOL CHEM, V258, P4069; NODA M, 1995, FEBS LETT, V367, P246, DOI 10.1016/0014-5793(95)00573-R; Ono-Saito N, 1999, PHARMACOL THERAPEUT, V82, P123, DOI 10.1016/S0163-7258(98)00070-9; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Schoenwaelder SM, 2000, CURR BIOL, V10, P1523, DOI 10.1016/S0960-9822(00)00831-9; Schoenwaelder SM, 1999, J BIOL CHEM, V274, P14359, DOI 10.1074/jbc.274.20.14359; SOBIESZEK A, 1977, EUR J BIOCHEM, V73, P477, DOI 10.1111/j.1432-1033.1977.tb11340.x; Somlyo AP, 1998, ACTA PHYSIOL SCAND, V164, P437; SOMLYO AP, 1994, NATURE, V372, P231, DOI 10.1038/372231a0; SUTTON TA, 1990, J BIOL CHEM, V265, P2749; Takashima S, 2009, CIRC J, V73, P208, DOI 10.1253/circj.CJ-08-1041; Takeya K, 2008, AM J PHYSIOL-RENAL, V294, pF1487, DOI 10.1152/ajprenal.00060.2008; Tamura M, 2005, BBA-PROTEINS PROTEOM, V1754, P245, DOI 10.1016/j.bbapap.2005.06.015; TASHIRO Y, 1984, ARCH BIOCHEM BIOPHYS, V233, P540, DOI 10.1016/0003-9861(84)90477-6; Thingholm TE, 2009, PROTEOMICS, V9, P1451, DOI 10.1002/pmic.200800454; Turbedsky K, 1997, BIOCHEMISTRY-US, V36, P2063, DOI 10.1021/bi9624651; UMEMOTO S, 1989, J BIOL CHEM, V264, P1431; VANDUUREN BL, 1979, CANCER RES, V39, P2644; Wilson DP, 2005, BIOCHEM J, V392, P641, DOI 10.1042/BJ20051173; Yang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011621	45	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20903	10.1371/journal.pone.0020903	http://dx.doi.org/10.1371/journal.pone.0020903			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695279	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612900036
J	Case, DT; Zhao, XW; Gillespie, DC				Case, Daniel T.; Zhao, Xiwu; Gillespie, Deda C.			Functional Refinement in the Projection from Ventral Cochlear Nucleus to Lateral Superior Olive Precedes Hearing Onset in Rat	PLOS ONE			English	Article							LONG-TERM DEPRESSION; AUDITORY BRAIN-STEM; NR2B-CONTAINING NMDA-RECEPTORS; INNER HAIR-CELLS; SYNAPTIC PLASTICITY; SUBUNIT COMPOSITION; SYNAPSES; NEURONS; CONNECTIONS; LOCALIZATION	Principal neurons of the lateral superior olive (LSO) compute the interaural intensity differences necessary for localizing high-frequency sounds. To perform this computation, the LSO requires precisely tuned, converging excitatory and inhibitory inputs that are driven by the two ears and that are matched for stimulus frequency. In rodents, the inhibitory inputs, which arise from the medial nucleus of the trapezoid body (MNTB), undergo extensive functional refinement during the first postnatal week. Similar functional refinement of the ascending excitatory pathway, which arises in the anteroventral cochlear nucleus (AVCN), has been assumed but has not been well studied. Using whole-cell voltage clamp in acute brainstem slices of neonatal rats, we examined developmental changes in input strength and pre- and post-synaptic properties of the VCN-LSO pathway. A key question was whether functional refinement in one of the two major input pathways might precede and then guide refinement in the opposite pathway. We find that elimination and strengthening of VCN inputs to the LSO occurs over a similar period to that seen for the ascending inhibitory (MNTB-LSO) pathway. During this period, the fractional contribution provided by NMDA receptors (NMDARs) declines while the contribution from AMPA receptors (AMPARs) increases. In the NMDAR-mediated response, GluN2B-containing NMDARs predominate in the first postnatal week and decline sharply thereafter. Finally, the progressive decrease in paired-pulse depression between birth and hearing onset allows these synapses to follow progressively higher frequencies. Our data are consistent with a model in which the excitatory and inhibitory projections to LSO are functionally refined in parallel during the first postnatal week, and they further suggest that GluN2B-containing NMDARs may mediate early refinement in the VCN-LSO pathway.	[Case, Daniel T.; Gillespie, Deda C.] McMaster Univ, Grad Program Neurosci, Hamilton, ON, Canada; [Zhao, Xiwu; Gillespie, Deda C.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON, Canada	McMaster University; McMaster University	Case, DT (corresponding author), McMaster Univ, Grad Program Neurosci, Hamilton, ON, Canada.	dgillespie@mcmaster.ca			CIHR [77705]	CIHR(Canadian Institutes of Health Research (CIHR))	This work was supported by a CIHR operating grant (ref #77705). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Beutner D, 2001, J NEUROSCI, V21, P4593, DOI 10.1523/JNEUROSCI.21-13-04593.2001; BLEDSOE SC, 1990, BRAIN RES, V517, P189, DOI 10.1016/0006-8993(90)91025-C; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Caicedo A, 1999, EUR J NEUROSCI, V11, P51, DOI 10.1046/j.1460-9568.1999.00410.x; CAIRD D, 1983, EXP BRAIN RES, V52, P385; CANT NB, 1986, J COMP NEUROL, V247, P457, DOI 10.1002/cne.902470406; Caspary DM, 1991, NEUROBIOLOGY HEARING, VII, P141; COOPER AP, 2011, J COMP NEUROL; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Deeg KE, 2009, J NEUROPHYSIOL, V102, P3392, DOI 10.1152/jn.00632.2009; Ehrlich I, 1999, J PHYSIOL-LONDON, V520, P121, DOI 10.1111/j.1469-7793.1999.00121.x; Ene FA, 2007, J NEUROPHYSIOL, V97, P3365, DOI 10.1152/jn.00686.2006; Ene FA, 2003, J NEUROPHYSIOL, V90, P2581, DOI 10.1152/jn.00238.2003; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; Kakazu Y, 1999, J NEUROSCI, V19, P2843; KANDLER K, 1995, J NEUROSCI, V15, P6890; KANDLER K, 1993, J COMP NEUROL, V328, P161, DOI 10.1002/cne.903280202; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kim G, 2010, NEUROSCIENCE, V171, P924, DOI 10.1016/j.neuroscience.2010.09.054; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Knudsen EI, 2002, NATURE, V417, P322, DOI 10.1038/417322a; Kotak VC, 1996, J NEUROSCI, V16, P1836; Kros CJ, 1998, NATURE, V394, P281, DOI 10.1038/28401; Kullmann PHM, 2001, DEV BRAIN RES, V131, P143, DOI 10.1016/S0165-3806(01)00271-1; LIPPE WR, 1994, J NEUROSCI, V14, P1486, DOI 10.1523/JNEUROSCI.14-03-01486.1994; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; Liu SQJ, 2000, NATURE, V405, P454, DOI 10.1038/35013064; Lorteije JAM, 2009, J NEUROSCI, V29, P13770, DOI 10.1523/JNEUROSCI.3285-09.2009; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; MOORE MJ, 1983, J NEUROSCI, V3, P237; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Oertel D, 1999, ANNU REV PHYSIOL, V61, P497, DOI 10.1146/annurev.physiol.61.1.497; Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0; Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027; Prybylowski K, 2005, NEURON, V47, P845, DOI 10.1016/j.neuron.2005.08.016; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; SANES DH, 1993, EUR J NEUROSCI, V5, P570, DOI 10.1111/j.1460-9568.1993.tb00522.x; SANES DH, 1988, J NEUROSCI, V8, P682; Sanes DH, 2000, HEARING RES, V147, P46, DOI 10.1016/S0378-5955(00)00119-2; Scimemi A, 2009, J NEUROSCI, V29, P14581, DOI 10.1523/JNEUROSCI.4845-09.2009; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; Tollin DJ, 2003, NEUROSCIENTIST, V9, P127, DOI 10.1177/1073858403252228; Tovar KR, 1999, J NEUROSCI, V19, P4180; Triplett JW, 2009, CELL, V139, P175, DOI 10.1016/j.cell.2009.08.028; Tritsch NX, 2007, NATURE, V450, P50, DOI 10.1038/nature06233; Tritsch NX, 2010, J NEUROSCI, V30, P1539, DOI 10.1523/JNEUROSCI.3875-09.2010; Vicini S, 1998, J NEUROPHYSIOL, V79, P555, DOI 10.1152/jn.1998.79.2.555; Wang LY, 2008, J NEUROSCI, V28, P14450, DOI 10.1523/JNEUROSCI.4245-08.2008; WU SH, 1992, J NEUROSCI, V12, P3084, DOI 10.1523/JNEUROSCI.12-08-03084.1992	57	19	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20756	10.1371/journal.pone.0020756	http://dx.doi.org/10.1371/journal.pone.0020756			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694776	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900023
J	Marques-Vidal, P; Bochud, M; Bastardot, F; Luscher, T; Ferrero, F; Gaspoz, JM; Paccaud, F; Urwyler, A; von Kanel, R; Hock, C; Waeber, G; Preisig, M; Vollenweider, P				Marques-Vidal, Pedro; Bochud, Murielle; Bastardot, Francois; Luescher, Thomas; Ferrero, Francois; Gaspoz, Jean-Michel; Paccaud, Fred; Urwyler, Adrian; von Kaenel, Roland; Hock, Christoph; Waeber, Gerard; Preisig, Martin; Vollenweider, Peter			Levels and Determinants of Inflammatory Biomarkers in a Swiss Population-Based Sample (CoLaus Study)	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NECROSIS-FACTOR-ALPHA; CARDIOVASCULAR RISK-FACTORS; CORONARY-HEART-DISEASE; METABOLIC SYNDROME; CYTOKINE LEVELS; ADIPOSE-TISSUE; INTERLEUKIN-6; EXERCISE; MARKERS	Objective: to assess the levels and determinants of interleukin (IL)-1 beta, IL-6, tumour necrosis factor (TNF)-alpha and C-reactive protein (CRP) in a healthy Caucasian population. Methods: population sample of 2884 men and 3201 women aged 35 to 75. IL-1 beta, IL-6 and TNF-alpha were assessed by a multiplexed particle-based flow cytometric assay and CRP by an immunometric assay. Results: Spearman rank correlations between duplicate cytokine measurements (N = 80) ranged between 0.89 and 0.96; intra-class correlation coefficients ranged between 0.94 and 0.97, indicating good reproducibility. Among the 6085 participants, 2289 (37.6%), 451 (7.4%) and 43 (0.7%) had IL-1 beta, IL-6 and TNF-alpha levels below detection limits, respectively. Median (interquartile range) for participants with detectable values were 1.17 (0.48-3.90) pg/ml for IL-1 beta; 1.47 (0.71-3.53) pg/ml for IL-6; 2.89 (1.82-4.53) pg/ml for TNF-alpha and 1.3 (0.6-2.7) ng/ml for CRP. On multivariate analysis, greater age was the only factor inversely associated with IL-1 beta levels. Male sex, increased BMI and smoking were associated with greater IL-6 levels, while no relationship was found for age and leisure-time PA. Male sex, greater age, increased BMI and current smoking were associated with greater TNF-alpha levels, while no relationship was found with leisure-time PA. CRP levels were positively related to age, BMI and smoking, and inversely to male sex and physical activity. Conclusion: Population-based levels of several cytokines were established. Increased age and BMI, and to a lesser degree sex and smoking, significantly and differentially impact cytokine levels, while leisure-time physical activity has little effect.	[Marques-Vidal, Pedro; Bochud, Murielle; Paccaud, Fred] CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Marques-Vidal, Pedro; Bochud, Murielle; Bastardot, Francois; Paccaud, Fred; Waeber, Gerard; Vollenweider, Peter] Fac Biol & Med, Lausanne, Switzerland; [Luescher, Thomas] Univ Zurich, Dept Med, Zurich, Switzerland; [Ferrero, Francois] Univ Geneva, Dept Psychiat, Geneva, Switzerland; [Gaspoz, Jean-Michel] Univ Geneva, Dept Community Med, Geneva, Switzerland; [Urwyler, Adrian] Cytolab, Dallikon, Switzerland; [von Kaenel, Roland] Univ Bern, Inselspital, Div Psychosomat Med, Univ Hosp Bern, CH-3010 Bern, Switzerland; [Hock, Christoph] Univ Zurich Hosp, Dept Psychiat, CH-8091 Zurich, Switzerland; [Preisig, Martin] CHUV, Dept Psychiat, Lausanne, Switzerland; [von Kaenel, Roland] Univ Bern, Bern, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Zurich; University of Geneva; University of Geneva; University of Bern; University Hospital of Bern; University of Zurich; University Zurich Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Bern	Marques-Vidal, P (corresponding author), CHUV, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	Pedro-Manuel.Marques-Vidal@chuv.ch	Marques-Vidal, Pedro M/C-9449-2009; paccaud, fred/M-7516-2019; Bochud, Murielle/A-3981-2010; Colaus, PsyColaus/K-6607-2013; Bastardot, François/P-7809-2019; Bastardot, Francois/J-4013-2017; von Känel, Roland/B-1811-2019	Marques-Vidal, Pedro M/0000-0002-4548-8500; Bochud, Murielle/0000-0002-5727-0218; Bastardot, François/0000-0003-4060-0353; Bastardot, Francois/0000-0003-4060-0353; von Känel, Roland/0000-0002-8929-5129; Preisig, Martin/0000-0001-5689-4259; Waeber, Gerard/0000-0003-4193-788X	Swiss National Science Foundation [33CSCO-122661]; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss School of Public Health Plus (SSPH+)	The CoLaus study was supported by research grants from the Swiss National Science Foundation (grant no: 33CSCO-122661) from GlaxoSmithKline and the Faculty of Biology and Medicine of Lausanne, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors express their gratitude to the participants in the Lausanne CoLaus study and to the investigators who have contributed to the recruitment, in particular Yolande Barreau, Anne-Lise Bastian, Binasa Ramic, Martine Moranville, Martine Baumer, Marcy Sagette, Jeanne Ecoffey and Sylvie Mermoud for data collection. M Bochud is supported by the Swiss School of Public Health Plus (SSPH+).	Balbay Y, 2001, ANGIOLOGY, V52, P109, DOI 10.1177/000331970105200204; Bermudez EA, 2002, ARTERIOSCL THROM VAS, V22, P1668, DOI 10.1161/01.ATV.0000029781.31325.66; Bouman A, 2004, AM J REPROD IMMUNOL, V52, P19, DOI 10.1111/j.1600-0897.2004.00177.x; Cartier A, 2009, METABOLISM, V58, P1452, DOI 10.1016/j.metabol.2009.04.025; Cartier A, 2009, AM J CLIN NUTR, V89, P1307, DOI 10.3945/ajcn.2008.27030; Chowdhury F, 2009, J IMMUNOL METHODS, V340, P55, DOI 10.1016/j.jim.2008.10.002; Colbert LH, 2004, J AM GERIATR SOC, V52, P1098, DOI 10.1111/j.1532-5415.2004.52307.x; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; DeRijk R, 1997, J CLIN ENDOCR METAB, V82, P2182, DOI 10.1210/jc.82.7.2182; duPont NC, 2005, J REPROD IMMUNOL, V66, P175, DOI 10.1016/j.jri.2005.03.005; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Fichorova RN, 2008, ANAL CHEM, V80, P4741, DOI 10.1021/ac702628q; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Fischer CP, 2007, SCAND J MED SCI SPOR, V17, P580, DOI 10.1111/j.1600-0838.2006.00602.x; Flower L, 2000, CYTOKINE, V12, P1712, DOI 10.1006/cyto.2000.0764; Friebe A, 2008, ARCH PATHOL LAB MED, V132, P1802, DOI 10.1043/1543-2165-132.11.1802; HAGER K, 1994, NEUROBIOL AGING, V15, P771, DOI 10.1016/0197-4580(94)90066-3; Hornung RW, 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Moon YS, 2004, METABOLISM, V53, P863, DOI 10.1016/j.metabol.2004.02.007; Petersen AMW, 2005, J APPL PHYSIOL, V98, P1154, DOI 10.1152/japplphysiol.00164.2004; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Roubenoff R, 1998, J GERONTOL A-BIOL, V53, pM20, DOI 10.1093/gerona/53A.1.M20; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Scuteri A, 2011, ATHEROSCLEROSIS, V215, P459, DOI 10.1016/j.atherosclerosis.2010.12.023; Skeppholm M, 2008, CLIN CHEM LAB MED, V46, P1175, DOI 10.1515/CCLM.2008.219; Spranger J, 2003, DIABETES, V52, P812, DOI 10.2337/diabetes.52.3.812; Stewart LK, 2007, MED SCI SPORT EXER, V39, P1714, DOI 10.1249/mss.0b013e31811ece1c; Stowe RP, 2010, J GERONTOL A-BIOL, V65, P429, DOI 10.1093/gerona/glp198; Vignali DAA, 2000, J IMMUNOL METHODS, V243, P243, DOI 10.1016/S0022-1759(00)00238-6; Welsh P, 2008, BRIT J HAEMATOL, V141, P852, DOI 10.1111/j.1365-2141.2008.07133.x; Wong HL, 2008, CANCER EPIDEM BIOMAR, V17, P3450, DOI 10.1158/1055-9965.EPI-08-0311; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972	34	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e21002	10.1371/journal.pone.0021002	http://dx.doi.org/10.1371/journal.pone.0021002			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695270	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900045
J	Dong, B; Zhang, P; Chen, XW; Liu, L; Wang, YF; He, SM; Chen, RS				Dong, Bo; Zhang, Peng; Chen, Xiaowei; Liu, Li; Wang, Yunfei; He, Shunmin; Chen, Runsheng			Predicting Housekeeping Genes Based on Fourier Analysis	PLOS ONE			English	Article							YEAST-CELL CYCLE; EXPRESSION PROFILES; PROTEIN; TOOL; IDENTIFICATION; SELECTION; DENSITY; TISSUES	Housekeeping genes (HKGs) generally have fundamental functions in basic biochemical processes in organisms, and usually have relatively steady expression levels across various tissues. They play an important role in the normalization of microarray technology. Using Fourier analysis we transformed gene expression time-series from a Hela cell cycle gene expression dataset into Fourier spectra, and designed an effective computational method for discriminating between HKGs and non-HKGs using the support vector machine (SVM) supervised learning algorithm which can extract significant features of the spectra, providing a basis for identifying specific gene expression patterns. Using our method we identified 510 human HKGs, and then validated them by comparison with two independent sets of tissue expression profiles. Results showed that our predicted HKG set is more reliable than three previously identified sets of HKGs.	[Dong, Bo; Zhang, Peng; Chen, Xiaowei; Wang, Yunfei; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Bioinformat Lab, Beijing 100080, Peoples R China; [Dong, Bo; Zhang, Peng; Chen, Xiaowei; Wang, Yunfei; Chen, Runsheng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Liu, Li; He, Shunmin] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Dong, Bo; Zhang, Peng; Chen, Xiaowei; Liu, Li; Wang, Yunfei] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Dong, B (corresponding author), Chinese Acad Sci, Inst Biophys, Bioinformat Lab, Beijing 100080, Peoples R China.	heshunmin@gmail.com; crs@sun5.ibp.ac.cn	He, Shunmin/B-8037-2011; Chen, Runsheng/S-9834-2017	He, Shunmin/0000-0002-7294-0865; Chen, Runsheng/0000-0001-6049-8347; Zhang, Peng/0000-0001-9303-1639	National Key Basic Research and Development Program (973) [2009CB825401, 2007CB946901]; National Sciences Foundation of China [30630040]	National Key Basic Research and Development Program (973)(National Basic Research Program of China); National Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Basic Research and Development Program (973) under Grant Nos. 2009CB825401 and 2007CB946901, National Sciences Foundation of China under Grant Nos. 30630040. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Breeden LL, 2003, CURR BIOL, V13, pR31, DOI 10.1016/S0960-9822(02)01386-6; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Greer S, 2010, J IMMUNOL METHODS, V355, P76, DOI 10.1016/j.jim.2010.02.006; Hsiao LL, 2001, PHYSIOL GENOMICS, V7, P97, DOI 10.1152/physiolgenomics.00040.2001; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim BR, 2008, GENETICS, V180, P821, DOI 10.1534/genetics.108.093690; Kim BR, 2010, J COMPUT BIOL, V17, P1067, DOI 10.1089/cmb.2009.0270; Lawson MJ, 2008, GENE, V407, P54, DOI 10.1016/j.gene.2007.09.017; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vinogradov AE, 2004, TRENDS GENET, V20, P248, DOI 10.1016/j.tig.2004.03.006; Vinogradov AE, 2003, NUCLEIC ACIDS RES, V31, P5212, DOI 10.1093/nar/gkg699; Warrington JA, 2000, PHYSIOL GENOMICS, V2, P143, DOI 10.1152/physiolgenomics.2000.2.3.143; Wei, 2006, TIME SERIES ANAL UNI; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Whitfield ML, 2000, MOL CELL BIOL, V20, P4188, DOI 10.1128/MCB.20.12.4188-4198.2000; Yamada T, 2005, J BIOL CHEM, V280, P18283, DOI 10.1074/jbc.M413957200; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	26	39	42	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e21012	10.1371/journal.pone.0021012	http://dx.doi.org/10.1371/journal.pone.0021012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687628	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500058
J	Gee, ST; Milgram, SL; Kramer, KL; Conlon, FL; Moody, SA				Gee, Stephen T.; Milgram, Sharon L.; Kramer, Kenneth L.; Conlon, Frank L.; Moody, Sally A.			Yes-Associated Protein 65 (YAP) Expands Neural Progenitors and Regulates Pax3 Expression in the Neural Plate Border Zone	PLOS ONE			English	Article							WW DOMAIN; TRANSCRIPTION FACTOR; CRANIAL PLACODES; XENOPUS-EMBRYOS; GENE; INDUCTION; CREST; ENHANCER; HOMOLOG; LAEVIS	Yes-associated protein 65 (YAP) contains multiple protein-protein interaction domains and functions as both a transcriptional co-activator and as a scaffolding protein. Mouse embryos lacking YAP did not survive past embryonic day 8.5 and showed signs of defective yolk sac vasculogenesis, chorioallantoic fusion, and anterior-posterior (A-P) axis elongation. Given that the YAP knockout mouse defects might be due in part to nutritional deficiencies, we sought to better characterize a role for YAP during early development using embryos that develop externally. YAP morpholino (MO)mediated loss-of-function in both frog and fish resulted in incomplete epiboly at gastrulation and impaired axis formation, similar to the mouse phenotype. In frog, germ layer specific genes were expressed, but they were temporally delayed. YAP MO-mediated partial knockdown in frog allowed a shortened axis to form. YAP gain-of-function in Xenopus expanded the progenitor populations in the neural plate (sox2(+)) and neural plate border zone (pax3(+)), while inhibiting the expression of later markers of tissues derived from the neural plate border zone (neural crest, pre-placodal ectoderm, hatching gland), as well as epidermis and somitic muscle. YAP directly regulates pax3 expression via association with TEAD1 (N-TEF) at a highly conserved, previously undescribed, TEAD-binding site within the 59 regulatory region of pax3. Structure/function analyses revealed that the PDZ-binding motif of YAP contributes to the inhibition of epidermal and somitic muscle differentiation, but a complete, intact YAP protein is required for expansion of the neural plate and neural plate border zone progenitor pools. These results provide a thorough analysis of YAP mediated gene expression changes in loss-and gain-of-function experiments. Furthermore, this is the first report to use YAP structure-function analyzes to determine which portion of YAP is involved in specific gene expression changes and the first to show direct in vivo evidence of YAP's role in regulating pax3 neural crest expression.	[Gee, Stephen T.] Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA; [Gee, Stephen T.; Milgram, Sharon L.; Kramer, Kenneth L.] NHLBI, NIH, Bethesda, MD 20892 USA; [Conlon, Frank L.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Conlon, Frank L.] Univ N Carolina, Dept Genet, Chapel Hill, NC USA; [Moody, Sally A.] George Washington Univ, Dept Anat & Regenerat Biol, Washington, DC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; George Washington University	Gee, ST (corresponding author), Univ N Carolina, Sch Med, Dept Cell & Dev Biol, Chapel Hill, NC 27515 USA.	samoody@gwu.edu	Moody, Sally A./AAI-3660-2020	Moody, Sally A./0000-0003-4192-1087	NSF [IOS-0817902]; NIH; University of North Carolina at Chapel Hill;  [HL-65755]; Direct For Biological Sciences [0817902] Funding Source: National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065755, R01HL089641, ZIAHL005108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018825] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of North Carolina at Chapel Hill; ; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by HL-65755 (SLM), NSF IOS-0817902 (SAM), and the NIH Intramural Research Program (NIH-IRP) (STG and SLM). STG was supported by the NIH-IRP and the University of North Carolina at Chapel Hill as a member of the NIH Graduate Partnerships Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BORK P, 1994, TRENDS BIOCHEM SCI, V19, P531, DOI 10.1016/0968-0004(94)90053-1; Brugmann SA, 2004, DEVELOPMENT, V131, P5871, DOI 10.1242/dev.01516; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; CHEN Z, 1994, GENE DEV, V8, P2293, DOI 10.1101/gad.8.19.2293; CHITNIS A, 1995, NATURE, V375, P761, DOI 10.1038/375761a0; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; COFFMAN CR, 1993, CELL, V73, P659, DOI 10.1016/0092-8674(93)90247-N; Ferrigno O, 2002, ONCOGENE, V21, P4879, DOI 10.1038/sj.onc.1205623; Hardcastle Z, 2000, DEVELOPMENT, V127, P1303; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Hiraoka Y, 1997, GENE, V197, P65, DOI 10.1016/S0378-1119(97)00242-4; Hong CS, 2007, MOL BIOL CELL, V18, P2192, DOI 10.1091/mbc.E06-11-1047; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Howell M, 2004, J BIOL CHEM, V279, P26300, DOI 10.1074/jbc.M401070200; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; Jiang Q, 2009, BIOCHEM BIOPH RES CO, V384, P114, DOI 10.1016/j.bbrc.2009.04.070; JONAS E, 1985, P NATL ACAD SCI USA, V82, P5413, DOI 10.1073/pnas.82.16.5413; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Komuro A, 2003, J BIOL CHEM, V278, P33334, DOI 10.1074/jbc.M305597200; Kukalev A, 2005, NAT STRUCT MOL BIOL, V12, P238, DOI 10.1038/nsmb904; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Ladher R, 1996, DEVELOPMENT, V122, P2385; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Litsiou A, 2005, DEVELOPMENT, V132, P4051, DOI 10.1242/dev.01964; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Macias MJ, 1996, NATURE, V382, P646, DOI 10.1038/382646a0; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Milewski RC, 2004, DEVELOPMENT, V131, P829, DOI 10.1242/dev.00975; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Mohler PJ, 1999, J CELL BIOL, V147, P879, DOI 10.1083/jcb.147.4.879; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; MOODY SA, 1987, DEV BIOL, V119, P560, DOI 10.1016/0012-1606(87)90059-5; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Naye F, 2007, INT J DEV BIOL, V51, P745, DOI 10.1387/ijdb.072375fn; NEJIGANE S, 2010, INT J DEV B IN PRESS; Nejigane S, 2011, INT J DEV BIOL, V55, P121, DOI 10.1387/ijdb.103130sn; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Omerovic J, 2004, EXP CELL RES, V294, P469, DOI 10.1016/j.yexcr.2003.12.002; Pandur PD, 2000, MECH DEVELOP, V96, P253, DOI 10.1016/S0925-4773(00)00396-8; Ryan K, 1996, CELL, V87, P989, DOI 10.1016/S0092-8674(00)81794-8; Sasai N, 2001, DEVELOPMENT, V128, P2525; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Sawada A, 2005, DEVELOPMENT, V132, P4719, DOI 10.1242/dev.02059; Sawada A, 2008, MOL CELL BIOL, V28, P3177, DOI 10.1128/MCB.01759-07; Schlosser G, 2008, DEV BIOL, V320, P199, DOI 10.1016/j.ydbio.2008.05.523; Schlosser G, 2006, DEV BIOL, V294, P303, DOI 10.1016/j.ydbio.2006.03.009; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Steventon B, 2009, DEVELOPMENT, V136, P771, DOI 10.1242/dev.029017; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; SUDOL M, 1994, ONCOGENE, V9, P2145; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Taranova OV, 2006, GENE DEV, V20, P1187, DOI 10.1101/gad.1407906; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Wallingford JB, 2001, DEVELOPMENT, V128, P2581; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	62	66	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20309	10.1371/journal.pone.0020309	http://dx.doi.org/10.1371/journal.pone.0020309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687713	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500015
J	Kingsbury, MA; Kelly, AM; Schrock, SE; Goodson, JL				Kingsbury, Marcy A.; Kelly, Aubrey M.; Schrock, Sara E.; Goodson, James L.			Mammal-Like Organization of the Avian Midbrain Central Gray and a Reappraisal of the Intercollicular Nucleus	PLOS ONE			English	Article							VASOACTIVE INTESTINAL POLYPEPTIDE; CAT PERIAQUEDUCTAL GRAY; CHICKENS GALLUS-GALLUS; ELECTRICAL-STIMULATION; DOPAMINE NEURONS; BRAIN-STEM; C-FOS; PEPTIDERGIC ORGANIZATION; TORUS SEMICIRCULARIS; EMOTIONAL EXPRESSION	In mammals, rostrocaudal columns of the midbrain periaqueductal gray (PAG) regulate diverse behavioral and physiological functions, including sexual and fight-or-flight behavior, but homologous columns have not been identified in non-mammalian species. In contrast to mammals, in which the PAG lies ventral to the superior colliculus and surrounds the cerebral aqueduct, birds exhibit a hypertrophied tectum that is displaced laterally, and thus the midbrain central gray (CG) extends mediolaterally rather than dorsoventrally as in mammals. We therefore hypothesized that the avian CG is organized much like a folded open PAG. To address this hypothesis, we conducted immunohistochemical comparisons of the midbrains of mice and finches, as well as Fos studies of aggressive dominance, subordinance, non-social defense and sexual behavior in territorial and gregarious finch species. We obtained excellent support for our predictions based on the folded open model of the PAG and further showed that birds possess functional and anatomical zones that form longitudinal columns similar to those in mammals. However, distinguishing characteristics of the dorsal/dorsolateral PAG, such as a dense peptidergic innervation, a longitudinal column of neuronal nitric oxide synthase neurons, and aggression-induced Fos responses, do not lie within the classical avian CG, but in the laterally adjacent intercollicular nucleus (ICo), suggesting that much of the ICo is homologous to the dorsal PAG.	[Kingsbury, Marcy A.; Kelly, Aubrey M.; Schrock, Sara E.; Goodson, James L.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Kingsbury, MA (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	mk24@indiana.edu		Kelly, Aubrey/0000-0002-6013-3943	NIH [MH062656]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062656] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The work was funded by NIH grant MH062656, http://grants.nih.gov/grants/oer.htm. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADKINSREGAN E, 1993, J COMP PSYCHOL, V107, P223; ARMITAGE SE, 1978, J PHYSIOL-LONDON, V278, pP24; Atoji Y, 2001, J CHEM NEUROANAT, V21, P1, DOI 10.1016/S0891-0618(00)00103-4; BANDLER R, 1994, TRENDS NEUROSCI, V17, P379, DOI 10.1016/0166-2236(94)90047-7; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; BERK ML, 1981, J COMP NEUROL, V203, P379, DOI 10.1002/cne.902030305; Bharati IS, 2006, NEUROSCIENCE, V143, P661, DOI 10.1016/j.neuroscience.2006.08.046; BROWN JL, 1965, SCIENCE, V149, P1002, DOI 10.1126/science.149.3687.1002; CANTERAS NS, 1994, J COMP NEUROL, V348, P41, DOI 10.1002/cne.903480103; Charlier TD, 2005, NEUROSCIENCE, V131, P13, DOI 10.1016/j.neuroscience.2004.09.068; Comoli E, 2003, BEHAV BRAIN RES, V138, P17, DOI 10.1016/S0166-4328(02)00197-3; Covenas R, 1999, ANAT EMBRYOL, V199, P161, DOI 10.1007/s004290050217; Delville Y, 2000, BRAIN BEHAV EVOLUT, V55, P53, DOI 10.1159/000006642; DEMSKI LS, 1972, ANIM BEHAV, V20, P507, DOI 10.1016/S0003-3472(72)80015-0; Dubbeldam JL, 2002, BRAIN RES BULL, V57, P349, DOI 10.1016/S0361-9230(01)00689-X; Dubbeldam JL, 1998, ACTA ANAT, V163, P157; Flores JA, 2006, NEUROPSYCHOPHARMACOL, V31, P1475, DOI 10.1038/sj.npp.1300946; Goodson JL, 2009, BIOL LETTERS, V5, P554, DOI 10.1098/rsbl.2009.0316; Goodson JL, 2009, P NATL ACAD SCI USA, V106, P8737, DOI 10.1073/pnas.0811821106; Goodson JL, 2009, HORM BEHAV, V55, P197, DOI 10.1016/j.yhbeh.2008.10.007; Goodson JL, 2005, NEUROREPORT, V16, P1719, DOI 10.1097/01.wnr.0000183898.47160.15; Goodson JL, 2004, J COMP NEUROL, V473, P293, DOI 10.1002/cne.20061; Goodson JL, 2002, J COMP NEUROL, V448, P298, DOI 10.1002/cne.10258; Gotti S, 2005, MICROSC RES TECHNIQ, V68, P13, DOI 10.1002/jemt.20219; Greco B, 1996, NEUROSCIENCE, V75, P161, DOI 10.1016/0306-4522(96)00183-2; Haller J, 2006, PHYSIOL BEHAV, V88, P173, DOI 10.1016/j.physbeh.2006.03.030; HAZLETT JC, 1972, J COMP NEUROL, V146, P95, DOI 10.1002/cne.901460107; Ho JM, 2010, HORM BEHAV, V58, P368, DOI 10.1016/j.yhbeh.2010.03.021; JURGENS U, 1994, BEHAV BRAIN RES, V62, P107, DOI 10.1016/0166-4328(94)90017-5; JURGENS U, 1970, EXP BRAIN RES, V10, P532; Kabelik D, 2010, BRAIN BEHAV EVOLUT, V75, P71, DOI 10.1159/000297522; Kabelik D, 2009, HORM BEHAV, V56, P101, DOI 10.1016/j.yhbeh.2009.03.017; Karten H J, 1989, J Cogn Neurosci, V1, P291, DOI 10.1162/jocn.1989.1.4.291; KARTEN HARVEY J., 1967, BRAIN RES, V6, P409, DOI 10.1016/0006-8993(67)90055-8; KARTEN HJ, 1969, ANN NY ACAD SCI, V167, P164, DOI 10.1111/j.1749-6632.1969.tb20442.x; KENNEDY MC, 1975, BRAIN RES, V91, P321, DOI 10.1016/0006-8993(75)90556-9; LARSON CR, 1994, J NEUROPHYSIOL, V71, P2294, DOI 10.1152/jn.1994.71.6.2294; LOVICK TA, 1993, PROG NEUROBIOL, V40, P631, DOI 10.1016/0301-0082(93)90036-R; Magoun HW, 1937, J NEUROL PSYCHOPATHO, V17, P241; Meddle SL, 1997, BEHAV BRAIN RES, V85, P143, DOI 10.1016/S0166-4328(97)87581-X; MEHLER WR, 1969, ANN NY ACAD SCI, V167, P424, DOI 10.1111/j.1749-6632.1969.tb20460.x; Moreira FA, 2008, PHYSIOL BEHAV, V94, P316, DOI 10.1016/j.physbeh.2008.01.015; MOSS MS, 1983, J NEUROSCI, V3, P603; MOSS MS, 1983, J NEUROSCI, V3, P1437; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; NASHOLD BS, 1969, J NEUROSURG, V30, P14, DOI 10.3171/jns.1969.30.1.0014; ONSTOTT D, 1993, BRAIN RES, V610, P317, DOI 10.1016/0006-8993(93)91416-P; PHILLIPS RE, 1971, ANIM BEHAV, V19, P757, DOI 10.1016/S0003-3472(71)80180-X; PHILLIPS RE, 1972, ANIM BEHAV, V20, P689, DOI 10.1016/S0003-3472(72)80141-6; Popa GT, 1933, P R SOC LOND B-CONTA, V113, P191, DOI 10.1098/rspb.1933.0040; POTASH LM, 1970, BEHAVIOUR, V36, P149, DOI 10.1163/156853970X00286; PUELLES L, 1994, J COMP NEUROL, V340, P98, DOI 10.1002/cne.903400108; PUELLES L, CHICK BRAIN STEREOTA; ROBARDS MJ, 1976, J COMP NEUROL, V170, P499, DOI 10.1002/cne.901700408; Ruiz-Torner A, 2001, J CHEM NEUROANAT, V21, P295, DOI 10.1016/S0891-0618(01)00119-3; SCHROEDER DM, 1971, J COMP NEUROL, V142, P309, DOI 10.1002/cne.901420305; SCHROEDER DM, 1976, BRAIN BEHAV EVOLUT, V13, P125, DOI 10.1159/000123805; SELLER TJ, 1981, TRENDS NEUROSCI, V4, P301, DOI 10.1016/0166-2236(81)90094-1; SELLER TJ, 1980, BEHAV BRAIN RES, V1, P257; Sem-Jacobsen C. W., 1960, ELECTRICAL STUDIES U, P275; Sewards TV, 2003, BRAIN RES BULL, V61, P25, DOI 10.1016/S0361-9230(03)00069-8; Shiba K, 1997, EXP BRAIN RES, V115, P513, DOI 10.1007/PL00005721; SMITH GST, 1994, J COMP NEUROL, V350, P23, DOI 10.1002/cne.903500103; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; SUGA N, 1973, J ACOUST SOC AM, V54, P793, DOI 10.1121/1.1913662; VanderHorst VGJM, 2000, J COMP NEUROL, V424, P251, DOI 10.1002/1096-9861(20000821)424:2<251::AID-CNE5>3.0.CO;2-D; VanderHorst VGJM, 1996, PROG BRAIN RES, V107, P327; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041; VICARIO DS, 1993, NEUROREPORT, V4, P983, DOI 10.1097/00001756-199307000-00037; Wild JM, 2009, J COMP NEUROL, V512, P768, DOI 10.1002/cne.21932; WILD JM, 1989, J COMP NEUROL, V287, P1, DOI 10.1002/cne.902870102; WILD JM, 1995, J COMP NEUROL, V358, P465, DOI 10.1002/cne.903580402; Wild JM, 2000, J COMP NEUROL, V416, P429; YAJIMA Y, 1980, BRAIN RES, V198, P446, DOI 10.1016/0006-8993(80)90759-3; Zhang SP, 1995, J NEUROPHYSIOL, V74, P2500, DOI 10.1152/jn.1995.74.6.2500	75	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20720	10.1371/journal.pone.0020720	http://dx.doi.org/10.1371/journal.pone.0020720			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21694758	Green Published, gold			2022-12-25	WOS:000291607000019
J	Garcia-Gimenez, JL; Gimeno, A; Gonzalez-Cabo, P; Dasi, F; Bolinches-Amoros, A; Molla, B; Palau, F; Pallardo, FV				Luis Garcia-Gimenez, Jose; Gimeno, Amparo; Gonzalez-Cabo, Pilar; Dasi, Francisco; Bolinches-Amoros, Arantxa; Molla, Belen; Palau, Francesc; Pallardo, Federico V.			Differential Expression of PGC-1 alpha and Metabolic Sensors Suggest Age-Dependent Induction of Mitochondrial Biogenesis in Friedreich Ataxia Fibroblasts	PLOS ONE			English	Article							OXIDATIVE STRESS; TRANSCRIPTION FACTOR; UP-REGULATION; FRATAXIN; IRON; DNA; ANTIOXIDANT; BINDING; PROTEIN; CARDIOMYOPATHY	Background: Friedreich's ataxia (FRDA) is a mitochondrial rare disease, which molecular origin is associated with defect in the expression of frataxin. The pathological consequences are degeneration of nervous system structures and cardiomyopathy with necrosis and fibrosis, among others. Principal Findings: Using FRDA fibroblasts we have characterized the oxidative stress status and mitochondrial biogenesis. We observed deficiency of MnSOD, increased ROS levels and low levels of ATP. Expression of PGC-1 alpha and mtTFA was increased and the active form of the upstream signals p38 MAPK and AMPK in fibroblasts from two patients. Interestingly, the expression of energetic factors correlated with the natural history of disease of the patients, the age when skin biopsy was performed and the size of the GAA expanded alleles. Furthermore, idebenone inhibit mitochondriogenic responses in FRDA cells. Conclusions: The induction of mitochondrial biogenesis in FRDA may be a consequence of the mitochondrial impairment associated with disease evolution. The increase of ROS and the involvement of the oxidative phosphorylation may be an early event in the cell pathophysiology of frataxin deficiency, whereas increase of mitochondriogenic response might be a later phenomenon associated to the individual age and natural history of the disease, being more evident as the patient age increases and disease evolves. This is a possible explanation of heart disease in FRDA.	[Luis Garcia-Gimenez, Jose; Gimeno, Amparo; Gonzalez-Cabo, Pilar; Bolinches-Amoros, Arantxa; Molla, Belen; Palau, Francesc; Pallardo, Federico V.] CIBERER, Valencia, Spain; [Luis Garcia-Gimenez, Jose; Gimeno, Amparo; Dasi, Francisco; Pallardo, Federico V.] FIHCUV Incliva, Fdn Hosp Clin Univ Valencia, Valencia, Spain; [Gonzalez-Cabo, Pilar; Bolinches-Amoros, Arantxa; Molla, Belen; Palau, Francesc] Inst Biomed Valencia, Valencia, Spain; [Pallardo, Federico V.] Univ Valencia, Sch Med, Dept Physiol, Valencia, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biomedicina de Valencia (IBV); University of Valencia	Garcia-Gimenez, JL (corresponding author), CIBERER, Valencia, Spain.	pallardo@uv.es	González-Cabo, Pilar/ABG-5080-2020; Moliner, Belén Mollá/H-8792-2015; Pallardo, Federico V./T-1156-2017; Gonzalez-Cabo, Pilar/H-1862-2015; Palau, Francesc/A-9391-2014; Dasi, Francisco/D-1885-2012	González-Cabo, Pilar/0000-0003-3131-6334; Moliner, Belén Mollá/0000-0002-2208-2268; Pallardo, Federico V./0000-0003-3715-1980; Gonzalez-Cabo, Pilar/0000-0003-3131-6334; Palau, Francesc/0000-0002-8635-5421; Dasi, Francisco/0000-0003-2938-2965; Garcia-Gimenez, Jose Luis/0000-0001-7547-7872	Ministerio de Ciencia e Innovacion [SAF2008-01338, SAF2006-01047, SAF2009-07063]; CIBERER (Biomedical Network Research Center for Rare Diseases); Conselleria de Educacion of the Generalitat Valenciana [GVPRE/2008/154]; JAE-CSIC	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); CIBERER (Biomedical Network Research Center for Rare Diseases); Conselleria de Educacion of the Generalitat Valenciana; JAE-CSIC	This work was supported by grants SAF2008-01338, SAF2006-01047 and SAF2009-07063 from the Ministerio de Ciencia e Innovacion and financial support from the CIBERER (Biomedical Network Research Center for Rare Diseases). A. G. thanks the Conselleria de Educacion of the Generalitat Valenciana for the financial support by grants GVPRE/2008/154. A.B.-A. is the recipient of a JAE-CSIC predoctoral fellowship. The CIBERER is an initiative of the Instituto de Salud Carlos III and INGENIO 2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; Calabrese V, 2005, J NEUROL SCI, V233, P145, DOI 10.1016/j.jns.2005.03.012; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chantrel-Groussard K, 2001, HUM MOL GENET, V10, P2061, DOI 10.1093/hmg/10.19.2061; Cooper JM, 2003, BIOFACTORS, V18, P163, DOI 10.1002/biof.5520180219; Coppola G, 2009, HUM MOL GENET, V18, P2452, DOI 10.1093/hmg/ddp183; DAVIES KJA, 1982, BIOCHEM BIOPH RES CO, V107, P1198, DOI 10.1016/S0006-291X(82)80124-1; Durr A, 1996, NEW ENGL J MED, V335, P1169, DOI 10.1056/NEJM199610173351601; Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204; FISHER RP, 1991, J BIOL CHEM, V266, P9153; Garesse R, 2001, GENE, V263, P1, DOI 10.1016/S0378-1119(00)00582-5; Gomez-Cabrera MC, 2008, AM J CLIN NUTR, V87, P142, DOI 10.1093/ajcn/87.1.142; Hardie DG, 2004, MED SCI SPORT EXER, V36, P28, DOI 10.1249/01.MSS.0000106171.38299.64; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jauslin ML, 2002, HUM MOL GENET, V11, P3055, DOI 10.1093/hmg/11.24.3055; Jiralerspong S, 2001, FEBS LETT, V509, P101, DOI 10.1016/S0014-5793(01)03140-4; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; LAMARCHE JB, 1980, CAN J NEUROL SCI, V7, P389, DOI 10.1017/S0317167100022927; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Lee HC, 2000, BIOCHEM J, V348, P425, DOI 10.1042/0264-6021:3480425; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lodi R, 1999, P NATL ACAD SCI USA, V96, P11492, DOI 10.1073/pnas.96.20.11492; Marmolino D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010025; Miranda S, 1999, BIOCHEM BIOPH RES CO, V258, P44, DOI 10.1006/bbrc.1999.0580; Monros E, 1997, AM J HUM GENET, V61, P101, DOI 10.1086/513887; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Piemonte F, 2001, EUR J CLIN INVEST, V31, P1007, DOI 10.1046/j.1365-2362.2001.00922.x; Puccio H, 2001, NAT GENET, V27, P181, DOI 10.1038/84818; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Schulz JB, 2000, NEUROLOGY, V55, P1719, DOI 10.1212/WNL.55.11.1719; Sebastiani M, 2007, J AM COLL CARDIOL, V50, P1362, DOI 10.1016/j.jacc.2007.06.035; Seznec H, 2004, HUM MOL GENET, V13, P1017, DOI 10.1093/hmg/ddh114; Shoichet SA, 2002, HUM MOL GENET, V11, P815, DOI 10.1093/hmg/11.7.815; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suzuki H, 1998, BIOCHEM BIOPH RES CO, V249, P542, DOI 10.1006/bbrc.1998.9181; Yoshida Y, 2003, CANCER RES, V63, P3729	49	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20666	10.1371/journal.pone.0020666	http://dx.doi.org/10.1371/journal.pone.0020666			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687738	Green Submitted, gold, Green Published			2022-12-25	WOS:000291607000018
J	Zhou, HH; Zha, Z; Liu, Y; Zhang, HT; Zhu, JJ; Hu, SY; Shen, GD; Cheng, LS; Niu, LW; Greene, MI; Teng, MK; Liu, J				Zhou, Huihao; Zha, Zhao; Liu, Yang; Zhang, Hongtao; Zhu, Juanjuan; Hu, Siyi; Shen, Guodong; Cheng, Liansheng; Niu, Liwen; Greene, Mark I.; Teng, Maikun; Liu, Jing			Structural Insights into the Down-regulation of Overexpressed p185(her2/neu) Protein of Transformed Cells by the Antibody chA21	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; METASTATIC BREAST-CANCER; MONOCLONAL-ANTIBODY; CRYSTAL-STRUCTURE; ERBB RECEPTORS; EXTRACELLULAR REGION; TYROSINE KINASES; PHASE-II; HER2; TRASTUZUMAB	p185(her2/neu) belongs to the ErbB receptor tyrosine kinase family, which has been associated with human breast, ovarian, and lung cancers. Targeted therapies employing ectodomain-specific p185(her2/neu) monoclonal antibodies (mAbs) have demonstrated clinical efficacy for breast cancer. Our previous studies have shown that p185(her2/neu) mAbs are able to disable the kinase activity of homomeric and heteromeric kinase complexes and induce the conversion of the malignant to normal phenotype. We previously developed a chimeric antibody chA21 that specifically inhibits the growth of p185(her2/neu)-overexpressing cancer cells in vitro and in vivo. Herein, we report the crystal structure of the single-chain Fv of chA21 in complex with an N-terminal fragment of p185(her2/neu), which reveals that chA21 binds a region opposite to the dimerization interface, indicating that chA21 does not directly disrupt the dimerization. In contrast, the bivalent chA21 leads to internalization and down-regulation of p185(her2/neu). We propose a structure-based model in which chA21 cross-links two p185(her2/neu) molecules on separate homo- or heterodimers to form a large oligomer in the cell membrane. This model reveals a mechanism for mAbs to drive the receptors into the internalization/degradation path from the inactive hypophosphorylated tetramers formed dynamically by active dimers during a "physiologic process."	[Zhou, Huihao; Zha, Zhao; Liu, Yang; Zhu, Juanjuan; Hu, Siyi; Shen, Guodong; Cheng, Liansheng; Niu, Liwen; Teng, Maikun; Liu, Jing] Univ Sci & Technol China, Chinese Acad Sci, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Zhou, Huihao; Niu, Liwen; Teng, Maikun] Univ Sci & Technol China, Chinese Acad Sci, Key Lab Struct Biol, Hefei 230027, Anhui, Peoples R China; [Zhang, Hongtao; Greene, Mark I.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Pennsylvania	Teng, MK (corresponding author), Univ Sci & Technol China, Chinese Acad Sci, Hefei Natl Lab Phys Sci Microscale, Sch Life Sci, 96 Jinzhai Rd, Hefei 230027, Anhui, Peoples R China.	mkteng@ustc.edu.cn; jliu@ustc.edu.cn	沈, 国栋/ABA-5925-2021; ZHOU, HUIHAO/L-6133-2016	沈, 国栋/0000-0003-2521-8738; ZHOU, HUIHAO/0000-0002-9675-5007; Zhang, Hongtao/0000-0001-9173-0049	National Natural Science Foundation of China [30570362, 30121001, 30025012, 30571066]; Hi-Tech Research and Development Program ("863" Program) of China [2006AA02A245]; Ministry of Science and Technology of China [2006CB806500, 2006CB910200, 2006AA02A318]; Chinese Academy of Sciences [KSCX2-YW-R-60]; National Major Special Science and Technology Project of China [2009ZX09102-223]; NATIONAL CANCER INSTITUTE [R01CA089481, R01CA149425] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hi-Tech Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); National Major Special Science and Technology Project of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Grants from the National Natural Science Foundation of China (Grants 30570362, 30121001, 30025012, and 30571066), Hi-Tech Research and Development Program ("863" Program) of China (Grant 2006AA02A245), Ministry of Science and Technology of China (Grants 2006CB806500, 2006CB910200, and 2006AA02A318), Chinese Academy of Sciences (Grant KSCX2-YW-R-60), and National Major Special Science and Technology Project of China (Grant 2009ZX09102-223).	AlLazikani B, 1997, J MOL BIOL, V273, P927, DOI 10.1006/jmbi.1997.1354; Baselga J, 1996, J CLIN ONCOL, V14, P737, DOI 10.1200/JCO.1996.14.3.737; Baulida J, 1997, EXP CELL RES, V232, P167, DOI 10.1006/excr.1997.3515; Baulida J, 1996, J BIOL CHEM, V271, P5251; Ben-Kasus T, 2009, P NATL ACAD SCI USA, V106, P3294, DOI 10.1073/pnas.0812059106; BHAT TN, 1994, P NATL ACAD SCI USA, V91, P1089, DOI 10.1073/pnas.91.3.1089; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; Cai Z, 2008, ONCOGENE, V27, P3870, DOI 10.1038/onc.2008.13; Chandarlapaty S, 2010, ONCOGENE, V29, P325, DOI 10.1038/onc.2009.337; Cheng LS, 2003, CELL RES, V13, P35, DOI 10.1038/sj.cr.7290149; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; Franklin MC, 2004, CANCER CELL, V5, P317, DOI 10.1016/S1535-6108(04)00083-2; Friedman LM, 2005, P NATL ACAD SCI USA, V102, P1915, DOI 10.1073/pnas.0409610102; Furuuchi K, 2007, J IMMUNOL, V178, P1021, DOI 10.4049/jimmunol.178.2.1021; Garrett TPJ, 2003, MOL CELL, V11, P495, DOI 10.1016/S1097-2765(03)00048-0; Hu SY, 2008, PROTEINS, V70, P938, DOI 10.1002/prot.21551; HUDZIAK RM, 1989, MOL CELL BIOL, V9, P1165, DOI 10.1128/MCB.9.3.1165; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Klapper LN, 1997, ONCOGENE, V14, P2099, DOI 10.1038/sj.onc.1201029; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; LESCAR J, 1995, J BIOL CHEM, V270, P18067, DOI 10.1074/jbc.270.30.18067; Li X, 2007, CANCER RES, V67, P8716, DOI 10.1158/0008-5472.CAN-06-3731; Liu Y, 2009, ACTA CRYSTALLOGR F, V65, P692, DOI 10.1107/S1744309109020107; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Molina MA, 2001, CANCER RES, V61, P4744; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; O'Rourke DM, 1998, P NATL ACAD SCI USA, V95, P10842, DOI 10.1073/pnas.95.18.10842; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; QIAN XL, 1995, ONCOGENE, V10, P211; Ritter CA, 2007, CLIN CANCER RES, V13, P4909, DOI 10.1158/1078-0432.CCR-07-0701; Scaltriti M, 2007, J NATL CANCER I, V99, P628, DOI 10.1093/jnci/djk134; Shen GD, 2011, CANCER IMMUNOL IMMUN, V60, P339, DOI 10.1007/s00262-010-0937-7; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; WADA T, 1990, ONCOGENE, V5, P489; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; WILSON IA, 1991, CIBA F SYMP, V159, P13; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; XU FG, 1993, INT J CANCER, V53, P401, DOI 10.1002/ijc.2910530310; Yip YL, 2003, INT J CANCER, V104, P303, DOI 10.1002/ijc.10951; Zhang AL, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-20	48	24	36	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31676	31683		10.1074/jbc.M111.235184	http://dx.doi.org/10.1074/jbc.M111.235184			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21680730	Green Published, hybrid			2022-12-25	WOS:000294487500060
J	Crottes, D; Martial, S; Rapetti-Mauss, R; Pisani, DF; Loriol, C; Pellissier, B; Martin, P; Chevet, E; Borgese, F; Soriani, O				Crottes, David; Martial, Sonia; Rapetti-Mauss, Raphael; Pisani, Didier F.; Loriol, Celine; Pellissier, Bernard; Martin, Patrick; Chevet, Eric; Borgese, Franck; Soriani, Olivier			Sig1R Protein Regulates hERG Channel Expression through a Post-translational Mechanism in Leukemic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PITUITARY MELANOTROPE CELLS; SIGMA-1 RECEPTOR; POTASSIUM CHANNEL; I-KR; K+ CHANNEL; ION CHANNELS; LIPID RAFTS; SURFACE; CANCER; SITES	Sig1R (Sigma-1receptor) is a 25-kDa protein structurally unrelated to other mammalian proteins. Sig1R is present in brain, liver, and heart and is overexpressed in cancer cells. Studies using exogenous sigma ligands have shown that Sig1R interacts with a variety of ion channels, but its intrinsic function and mechanism of action remain unclear. The human ether-a-gogo related gene (hERG) encodes a cardiac channel that is also abnormally expressed in many primary human cancers, potentiating tumor progression through the modulation of extracellular matrix adhesive interactions. We show herein that sigma ligands inhibit hERG current density and cell adhesion to fibronectin in K562 myeloid leukemia cells. Heterologous expression in Xenopus oocytes demonstrates that Sig1R potentiates hERG current by stimulating channel subunit biosynthesis. Silencing Sig1R in leukemic K562 cells depresses hERG current density and cell adhesion to fibronectin by reducing hERG membrane expression. In K562 cells, Sig1R silencing does not modify hERG mRNA contents but reduces hERG mature form densities. In HEK cells expressing hERG and Sig1R, both proteins co-immunoprecipitate, demonstrating a physical association. Finally, Sig1R expression enhances both channel protein maturation and stability. Altogether, these results demonstrate for the first time that Sig1R controls ion channel expression through the regulation of subunit trafficking activity.	[Crottes, David; Martial, Sonia; Rapetti-Mauss, Raphael; Pisani, Didier F.; Pellissier, Bernard; Martin, Patrick; Borgese, Franck; Soriani, Olivier] CNRS, UMR 6543, F-06108 Nice 2, France; [Crottes, David; Martial, Sonia; Rapetti-Mauss, Raphael; Pisani, Didier F.; Pellissier, Bernard; Martin, Patrick; Borgese, Franck; Soriani, Olivier] Univ Nice, UMR 6543, F-06108 Nice 2, France; [Loriol, Celine] CNRS, Inst Pharmacol Mol & Cellulaire, Inst Neuromed Mol, F-06560 Valbonne, France; [Chevet, Eric] Univ Bordeaux 2, INSERM, U1053, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Soriani, O (corresponding author), CNRS, UMR 6543, F-06108 Nice 2, France.	soriani@unice.fr	Pisani, Didier/AAC-2997-2019; chevet, eric/E-4992-2016; Martial, Sonia/L-8270-2019; RAPETTI-MAUSS, Raphael/A-6486-2010; Rapetti-Mauss, Raphael/P-3437-2016	Pisani, Didier/0000-0001-5879-8527; chevet, eric/0000-0001-5855-4522; Martial, Sonia/0000-0002-6732-0936; RAPETTI-MAUSS, Raphael/0000-0002-3518-4845; soriani, olivier/0000-0001-9485-3992; BORGESE, Franck/0000-0001-7718-2111	University of Nice-Sophia Antipolis; CNRS; Association Ti'Toine Normandie; Region PACA; Vaincre la Mucoviscidose	University of Nice-Sophia Antipolis; CNRS(Centre National de la Recherche Scientifique (CNRS)); Association Ti'Toine Normandie; Region PACA(Region Provence-Alpes-Cote d'Azur); Vaincre la Mucoviscidose	This work was supported by the University of Nice-Sophia Antipolis, the CNRS and the Association Ti'Toine Normandie.; Recipient of a fellowship from Region PACA and CNRS.; Recipient of a fellowship from Vaincre la Mucoviscidose.	Albagli-Curiel O, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-85; Aydar E, 2002, NEURON, V34, P399, DOI 10.1016/S0896-6273(02)00677-3; Cameron PH, 2009, J BIOL CHEM, V284, P34570, DOI 10.1074/jbc.M109.053165; Carnally SM, 2010, BIOPHYS J, V98, P1182, DOI 10.1016/j.bpj.2009.12.4293; Cavarra MS, 2007, J MEMBRANE BIOL, V219, P49, DOI 10.1007/s00232-007-9060-x; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Fraser SP, 2008, EMBO REP, V9, P512, DOI 10.1038/embor.2008.75; Ganapathi SB, 2010, AM J PHYSIOL-CELL PH, V299, pC74, DOI 10.1152/ajpcell.00462.2009; Guasti L, 2008, MOL CELL BIOL, V28, P5043, DOI 10.1128/MCB.00304-08; Guizouarn H, 2007, BLOOD, V110, P2158, DOI 10.1182/blood-2006-12-063420; Guo J, 2009, J CLIN INVEST, V119, P2745, DOI 10.1172/JCI39027; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hayashi T, 2003, J PHARMACOL EXP THER, V306, P726, DOI 10.1124/jpet.103.051292; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Herrera Y, 2008, J PHARMACOL EXP THER, V327, P491, DOI 10.1124/jpet.108.143974; Hofmann G, 2001, J BIOL CHEM, V276, P4923, DOI 10.1074/jbc.M005682200; Jean-Yves L, 2007, RECENT PAT ANTI-CANC, V2, P189, DOI 10.2174/157489207782497244; Jones EMC, 2004, J BIOL CHEM, V279, P44690, DOI 10.1074/jbc.M408344200; Mavlyutov TA, 2010, NEUROSCIENCE, V167, P247, DOI 10.1016/j.neuroscience.2010.02.022; Mavlyutov Timur A, 2007, J Mol Signal, V2, P8, DOI 10.1186/1750-2187-2-8; McDonald TV, 1997, NATURE, V388, P289, DOI 10.1038/40882; Meng XB, 2005, J CELL SCI, V118, P4009, DOI 10.1242/jcs.02520; Monnet FP, 2006, J PHARMACOL SCI, V100, P93, DOI 10.1254/jphs.CR0050032; Morin-Surun MP, 1999, P NATL ACAD SCI USA, V96, P8196, DOI 10.1073/pnas.96.14.8196; Palmer CP, 2007, CANCER RES, V67, P11166, DOI 10.1158/0008-5472.CAN-07-1771; Petrecca K, 1999, J PHYSIOL-LONDON, V515, P41, DOI 10.1111/j.1469-7793.1999.041ad.x; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Pillozzi S, 2011, BLOOD, V117, P902, DOI 10.1182/blood-2010-01-262691; Pillozzi S, 2010, ADV EXP MED BIOL, V674, P55; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Renaudo A, 2004, J PHARMACOL EXP THER, V311, P1105, DOI 10.1124/jpet.104.072413; Renaudo A, 2007, J BIOL CHEM, V282, P2259, DOI 10.1074/jbc.M607915200; ROMAN FJ, 1990, J PHARM PHARMACOL, V42, P439, DOI 10.1111/j.2042-7158.1990.tb06588.x; Sale H, 2008, CIRC RES, V103, pE81, DOI 10.1161/CIRCRESAHA.108.185249; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Soriani O, 1998, J PHARMACOL EXP THER, V286, P163; Soriani O, 1999, J PHARMACOL EXP THER, V289, P321; Soriani O, 1999, AM J PHYSIOL-ENDOC M, V277, pE73, DOI 10.1152/ajpendo.1999.277.1.E73; Spruce BA, 2004, CANCER RES, V64, P4875, DOI 10.1158/0008-5472.CAN-03-3180; Su TP, 2010, TRENDS PHARMACOL SCI, V31, P557, DOI 10.1016/j.tips.2010.08.007; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Tsai Shang-Yi, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P184; Vernon-Wilson EF, 2007, J LEUKOCYTE BIOL, V82, P1278, DOI 10.1189/jlb.0507283	48	49	50	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27947	27958		10.1074/jbc.M111.226738	http://dx.doi.org/10.1074/jbc.M111.226738			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680736	Green Published, hybrid			2022-12-25	WOS:000293557800013
J	Mandic, SA; Skelin, M; Johansson, JU; Rupnik, MS; Berggren, PO; Bark, C				Mandic, Slavena A.; Skelin, Masa; Johansson, Jenny U.; Rupnik, Marjan S.; Berggren, Per-Olof; Bark, Christina			Munc18-1 and Munc18-2 Proteins Modulate beta-Cell Ca2+ Sensitivity and Kinetics of Insulin Exocytosis Differently	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETION; SYNTAXIN; SNARE; INTERACTS; MUNC-18; ROLES; IDENTIFICATION; ISOFORM; RELEASE; GLUCOSE	Fast neurotransmission and slower hormone release share the same core fusion machinery consisting of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins. In evoked neurotransmission, interactions between SNAREs and the Munc18-1 protein, a member of the Sec1/Munc18 (SM) protein family, are essential for exocytosis, whereas other SM proteins are dispensable. To address if the exclusivity of Munc18-1 demonstrated in neuroexocytosis also applied to fast insulin secretion, we characterized the presence and function of Munc18-1 and its closest homologue Munc18-2 in beta-cell stimulus-secretion coupling. We show that pancreatic beta-cells express both Munc18-1 and Munc18-2. The two Munc18 homologues exhibit different subcellular localization, and only Munc18-1 redistributes in response to glucose stimulation. However, both Munc18-1 and Munc18-2 augment glucose-stimulated hormone release. Ramp-like photorelease of caged Ca2+ and high resolution whole-cell patch clamp recordings show that Munc18-1 and Munc18-2 overexpression shift the Ca2+ sensitivity of the fastest phase of insulin exocytosis differently. In addition, we reveal that Ca2+ sensitivity of exocytosis in beta-cells depends on the phosphorylation status of the Munc18 proteins. Even though Munc18-1 emerges as the key SM-protein determining the Ca2+ threshold for triggering secretory activity in a stimulated beta-cell, Munc18-2 has the ability to increase Ca2+ sensitivity and thus mediates the release of fusion-competent granules requiring a lower cytoplasmic-free Ca2+ concentration, [Ca2+](i). Hence, Munc18-1 and Munc18-2 display distinct subcellular compartmentalization and can coordinate the insulin exocytotic process differently as a consequence of the actual [Ca2+](i).	[Mandic, Slavena A.; Berggren, Per-Olof; Bark, Christina] Karolinska Inst, Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, SE-17176 Stockholm, Sweden; [Skelin, Masa; Rupnik, Marjan S.] Univ Maribor, Inst Physiol, Fac Med, SLO-2000 Maribor, Slovenia; [Johansson, Jenny U.] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA	Karolinska Institutet; Karolinska University Hospital; University of Maribor; Stanford University	Berggren, PO (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, L1-03, SE-17176 Stockholm, Sweden.	Per-Olof.Berggren@ki.se	Rupnik, Marjan Slak/R-4738-2019; Slak Rupnik, Marjan/E-6246-2015	Rupnik, Marjan Slak/0000-0002-3744-4882; Slak Rupnik, Marjan/0000-0002-3744-4882; Bark, Christina/0000-0002-0724-6017; Berggren, Per-Olof/0000-0001-8991-413X	Swedish Research Council; Novo Nordisk Foundation; Swedish Council for Working Life and Social Research; Stockholm County Council; Karolinska Institutet; Anders Otto Swards/Ulrika Eklunds Foundations; Family Erling-Persson Foundation; Swedish Diabetes Association; Berth von Kantzows Foundation; Euro-Dia; Family Knut and Alice Wallenberg Foundation; VIBRANT [FP7-228933-2]; Skandia Insurance Company Ltd.; Slovenian Research Agency [J3-7618-2334]; Max-Planck International Partner Group; Novo Nordisk Fonden [NNF11OC1014706] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Anders Otto Swards/Ulrika Eklunds Foundations; Family Erling-Persson Foundation; Swedish Diabetes Association; Berth von Kantzows Foundation; Euro-Dia; Family Knut and Alice Wallenberg Foundation; VIBRANT; Skandia Insurance Company Ltd.; Slovenian Research Agency(Slovenian Research Agency - Slovenia); Max-Planck International Partner Group; Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by The Swedish Research Council, The Novo Nordisk Foundation, The Swedish Council for Working Life and Social Research, The Stockholm County Council, Funds from Karolinska Institutet, Anders Otto Swards/Ulrika Eklunds Foundations, the Family Erling-Persson Foundation, The Swedish Diabetes Association, The Berth von Kantzows Foundation, Euro-Dia, The Family Knut and Alice Wallenberg Foundation, VIBRANT (FP7-228933-2), Skandia Insurance Company Ltd., Strategic Research Program in Diabetes at Karolinska Institutet, Slovenian Research Agency Grant J3-7618-2334, and Max-Planck International Partner Group scheme.	Burgoyne RD, 2009, ANN NY ACAD SCI, V1152, P76, DOI 10.1111/j.1749-6632.2008.03987.x; Cote M, 2009, J CLIN INVEST, V119, P3765, DOI 10.1172/JCI40732; Dhavan R, 2001, NAT REV MOL CELL BIO, V2, P749, DOI 10.1038/35096019; Dong YM, 2007, BIOCHEM BIOPH RES CO, V360, P609, DOI 10.1016/j.bbrc.2007.06.107; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fisher RJ, 2001, SCIENCE, V291, P875, DOI 10.1126/science.291.5505.875; Fukuda M, 2005, J BIOL CHEM, V280, P39175, DOI 10.1074/jbc.M505759200; Gauthier BR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1279, DOI 10.1152/ajpendo.90568.2008; Halachmi N, 1996, J NEUROCHEM, V66, P889; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1995, J BIOL CHEM, V270, P13022, DOI 10.1074/jbc.270.22.13022; HELLMAN B, 1965, ANN NY ACAD SCI, V131, P541, DOI 10.1111/j.1749-6632.1965.tb34819.x; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Imai A, 2004, ARCH BIOCHEM BIOPHYS, V422, P175, DOI 10.1016/j.abb.2003.12.021; JACOBSSON G, 1994, P NATL ACAD SCI USA, V91, P12487, DOI 10.1073/pnas.91.26.12487; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Kang Y, 2002, DIABETOLOGIA, V45, P231, DOI 10.1007/s00125-001-0718-0; KATAGIRI H, 1995, J BIOL CHEM, V270, P4963, DOI 10.1074/jbc.270.10.4963; Ko J, 2001, J NEUROSCI, V21, P6758; Kortevveg N, 2005, BIOL CELL, V97, P445, DOI 10.1042/BC20040101; Korteweg N, 2004, EUR J NEUROSCI, V19, P2944, DOI 10.1111/j.0953-816X.2004.03383.x; Lalioti V, 2010, CELL CYCLE, V9, P284, DOI 10.4161/cc.9.2.10466; Lam PPL, 2007, MOL BIOL CELL, V18, P2473, DOI 10.1091/mbc.E06-10-0950; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lilja L, 2004, J BIOL CHEM, V279, P29534, DOI 10.1074/jbc.M312711200; Lilja L, 2001, J BIOL CHEM, V276, P34199, DOI 10.1074/jbc.M103776200; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Morgan A, 2005, BIOCHEM SOC T, V33, P1341, DOI 10.1042/BST0331341; Nigam R, 2005, BBA-GENE STRUCT EXPR, V1728, P77, DOI 10.1016/j.bbaexp.2005.01.018; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Oh E, 2009, DIABETES, V58, P1165, DOI 10.2337/db08-1059; Peng RW, 2010, METAB ENG, V12, P18, DOI 10.1016/j.ymben.2009.08.007; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Riento K, 1996, EUR J BIOCHEM, V239, P638, DOI 10.1111/j.1432-1033.1996.0638u.x; Rosales JL, 2006, BIOESSAYS, V28, P1023, DOI 10.1002/bies.20473; Rose T, 2007, J GEN PHYSIOL, V129, P493, DOI 10.1085/jgp.200609604; Schutz D, 2005, EUR J NEUROSCI, V21, P2419, DOI 10.1111/j.1460-9568.2005.04095.x; Sedej S, 2004, J PHYSIOL-LONDON, V555, P769, DOI 10.1113/jphysiol.2003.058271; Skelin M, 2011, CELL CALCIUM, V49, P89, DOI 10.1016/j.ceca.2010.12.005; Snyder DA, 2006, CELL BIOCHEM BIOPHYS, V45, P111, DOI 10.1385/CBB:45:1:111; Speier S, 2003, PFLUG ARCH EUR J PHY, V446, P553, DOI 10.1007/s00424-003-1097-9; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tang D, 1996, Prog Cell Cycle Res, V2, P205; Tellam JT, 1997, J BIOL CHEM, V272, P6179, DOI 10.1074/jbc.272.10.6179; Tomas A, 2008, TRAFFIC, V9, P813, DOI 10.1111/j.1600-0854.2008.00709.x; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Wan QF, 2004, J GEN PHYSIOL, V124, P653, DOI 10.1085/jgp.200409082; Yang Y, 2004, J GEN PHYSIOL, V124, P641, DOI 10.1085/jgp.200409081; Zhang W, 2000, J BIOL CHEM, V275, P41521, DOI 10.1074/jbc.M005479200; Zhang Y, 2009, J BIOL CHEM, V284, P20840, DOI 10.1074/jbc.M109.017467	54	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28026	28040		10.1074/jbc.M111.235366	http://dx.doi.org/10.1074/jbc.M111.235366			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21690086	Green Published, hybrid			2022-12-25	WOS:000293557800021
J	Pan, MR; Peng, G; Hung, WC; Lin, SY				Pan, Mei-Ren; Peng, Guang; Hung, Wen-Chun; Lin, Shiaw-Yih			Monoubiquitination of H2AX Protein Regulates DNA Damage Response Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HISTONE H2AX; GENOMIC INSTABILITY; UBIQUITIN; REPAIR; MDC1; BMI1; UBIQUITYLATION; RECRUITMENT; GAMMA-H2AX	Double strand breaks (DSBs) are the most deleterious of the DNA lesions that initiate genomic instability and promote tumorigenesis. Cells have evolved a complex protein network to detect, signal, and repair DSBs. In mammalian cells, a key component in this network is H2AX, which becomes rapidly phosphorylated at Ser(139) (gamma-H2AX) at DSBs. Here we show that monoubiquitination of H2AX mediated by the RNF2-BMI1 complex is critical for the efficient formation of gamma-H2AX and functions as a proximal regulator in DDR (DNA damage response). RNF2-BMI1 interacts with H2AX in a DNA damage-dependent manner and is required for monoubiquitination of H2AX at Lys(119)/Lys(120). As a functional consequence, we show that the H2AX K120R mutant abolishes H2AX monoubiquitination, impairs the recruitment of p-ATM (Ser(1981)) to DSBs, and thereby reduces the formation of gamma-H2AX and the recruitment of MDC1 to DNA damage sites. These data suggest that monoubiquitination of H2AX plays a critical role in initiating DNA damage signaling. Consistent with these observations, impairment of RNF2-BMI1 function by siRNA knockdown or overexpression of the ligase-dead RNF2 mutant all leads to significant defects both in accumulation of gamma-H2AX, p-ATM, and MDC1 at DSBs and in activation of NBS1 and CHK2. Additionally, the regulatory effect of RNF2-BMI1 on gamma-H2AX formation is dependent on ATM. Lacking their ability to properly activate the DNA damage signaling pathway, RNF2-BMI1 complex-depleted cells exhibit impaired DNA repair and increased sensitivity to ionizing radiation. Together, our findings demonstrate a distinct monoubiquitination-dependent mechanism that is required for H2AX phosphorylation and the initiation of DDR.	[Pan, Mei-Ren; Peng, Guang; Lin, Shiaw-Yih] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA; [Hung, Wen-Chun] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan 70456, Taiwan	University of Texas System; UTMD Anderson Cancer Center; National Health Research Institutes - Taiwan	Lin, SY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, 7435 Fannin St, Houston, TX 77054 USA.	sylin@mdanderson.org	Hung, Wen-Chun/F-4846-2011; Pan, Mei-Ren/I-2021-2013					Alajez NM, 2009, CELL DEATH DIFFER, V16, P1469, DOI 10.1038/cdd.2009.85; Bassing CH, 2003, CELL, V114, P359, DOI 10.1016/S0092-8674(03)00566-X; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Fernandez-Capetillo O, 2004, DNA REPAIR, V3, P959, DOI 10.1016/j.dnarep.2004.03.024; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ismail IH, 2010, J CELL BIOL, V191, P45, DOI 10.1083/jcb.201003034; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lukas J, 2009, NATURE, V458, P581, DOI 10.1038/458581a; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Messick TE, 2009, J CELL BIOL, V187, P319, DOI 10.1083/jcb.200908074; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Rai R, 2006, CANCER CELL, V10, P145, DOI 10.1016/j.ccr.2006.07.002; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stucki M, 2006, DNA REPAIR, V5, P534, DOI 10.1016/j.dnarep.2006.01.012; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Uziel T, 2003, EMBO J, V22, P5612, DOI 10.1093/emboj/cdg541; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005	35	112	117	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28599	28607		10.1074/jbc.M111.256297	http://dx.doi.org/10.1074/jbc.M111.256297			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676867	Green Published, hybrid			2022-12-25	WOS:000293557800074
J	Klein, M; Morillas, M; Vendrell, A; Brive, L; Gebbia, M; Wallace, IM; Giaever, G; Nislow, C; Posas, F; Grotli, M				Klein, Michael; Morillas, Montse; Vendrell, Alexandre; Brive, Lars; Gebbia, Marinella; Wallace, Iain M.; Giaever, Guri; Nislow, Corey; Posas, Francesc; Grotli, Morten			Design, Synthesis and Characterization of a Highly Effective Inhibitor for Analog-Sensitive (as) Kinases	PLOS ONE			English	Article							HOG1 MAP KINASE; PROTEIN-KINASE; OSMOTIC-STRESS; ACTIVATION; MICROWAVE; DISCOVERY; PLATFORM; ALLELE; ASSAYS	Highly selective, cell-permeable and fast-acting inhibitors of individual kinases are sought-after as tools for studying the cellular function of kinases in real time. A combination of small molecule synthesis and protein mutagenesis, identified a highly potent inhibitor (1-Isopropyl-3-(phenylethynyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine) of a rationally engineered Hog1 serine/threonine kinase (Hog1(T100G)). This inhibitor has been successfully used to study various aspects of Hog1 signaling, including a transient cell cycle arrest and gene expression changes mediated by Hog1 in response to stress. This study also underscores that the general applicability of this approach depends, in part, on the selectivity of the designed the inhibitor with respect to activity versus the engineered and wild type kinases. To explore this specificity in detail, we used a validated chemogenetic assay to assess the effect of this inhibitor on all gene products in yeast in parallel. The results from this screen emphasize the need for caution and for case-by-case assessment when using the Analog-Sensitive Kinase Allele technology to assess the physiological roles of kinases.	[Klein, Michael; Grotli, Morten] Univ Gothenburg, Dept Chem, Gothenburg, Sweden; [Morillas, Montse; Vendrell, Alexandre; Posas, Francesc] Univ Pompeu Fabra UPF, Cell Signalling Unit, Dept Ciencies Expt & Salut, Barcelona, Spain; [Brive, Lars] Univ Gothenburg, Dept Cell & Mol Biol, Gothenburg, Sweden; [Gebbia, Marinella; Wallace, Iain M.; Giaever, Guri] Univ Toronto, Dept Pharmaceut Sci, Toronto, ON, Canada; [Nislow, Corey] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada	University of Gothenburg; Pompeu Fabra University; University of Gothenburg; University of Toronto; University of Toronto	Klein, M (corresponding author), Univ Gothenburg, Dept Chem, Gothenburg, Sweden.	grotli@chem.gu.se	Morillas, Montserrat/G-6080-2015; Grötli, Morten/A-8735-2010; Posas, Francesc/K-1364-2013; Giaever, Guri/D-3930-2009; Wallace, Iain/B-9464-2009	Grötli, Morten/0000-0003-3621-4222; Posas, Francesc/0000-0002-4164-7076; Wallace, Iain/0000-0002-9491-7025; Morillas, Montserrat/0000-0001-7068-3167; Nislow, Corey/0000-0002-4016-8874	European Commission (QUASI) [LSHG-CT2003-503230, 043310]; Canadian Institutes for Health Research [84305]; Canadian Cancer Society [020380]; UNICELLSYS [201142]; Fundacion Marcelino Botin (FMB)	European Commission (QUASI)(European CommissionEuropean Commission Joint Research Centre); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); UNICELLSYS; Fundacion Marcelino Botin (FMB)	This work was financed by the European Commission (QUASI, contract LSHG-CT2003-503230 and CellComput, contract 043310). CN is supported by a grant from the Canadian Institutes for Health Research (#84305) and from the Canadian Cancer Society (grant #020380) to GG. FP's laboratory is also supported by the FP7 UNICELLSYS grant (#201142) and the Fundacion Marcelino Botin (FMB). FP is the recipient of an ICREA Academia (Generalitat de Catalunya). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JJ, 2007, NAT METHODS, V4, P511, DOI 10.1038/nmeth1048; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bilsland-Marchesan E, 2000, MOL CELL BIOL, V20, P3887, DOI 10.1128/MCB.20.11.3887-3895.2000; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Canutescu AA, 2005, BIOINFORMATICS, V21, P2914, DOI 10.1093/bioinformatics/bti438; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; COTTAM HB, 1993, J MED CHEM, V36, P3424, DOI 10.1021/jm00074a024; de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158; De Nadal E, 2007, TRENDS CELL BIOL, V17, P571, DOI 10.1016/j.tcb.2007.10.001; Ericson E, 2010, METHOD ENZYMOL, V470, P233, DOI 10.1016/S0076-6879(10)70010-0; ESCOTE X, 2004, NATURE CELL BIOL, V6; Fraley ME, 2002, BIOORG MED CHEM LETT, V12, P2767, DOI 10.1016/S0960-894X(02)00525-5; Goldstein DM, 2008, NAT REV DRUG DISCOV, V7, P391, DOI 10.1038/nrd2541; Hanefeld U, 1996, J CHEM SOC PERK T 1, P1545, DOI 10.1039/p19960001545; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hohmann S, 2002, MICROBIOLOGY MOL BIO, V66; Hoon S, 2008, NAT CHEM BIOL, V4, P498, DOI 10.1038/nchembio.100; Kim S, 2007, FEBS LETT, V581, P1209, DOI 10.1016/j.febslet.2007.02.032; Macia J, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000056; Mas G, 2009, EMBO J, V28, P326, DOI 10.1038/emboj.2008.299; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Proft M, 2001, EMBO J, V20, P1123, DOI 10.1093/emboj/20.5.1123; RADINOV R, 1991, J ORG CHEM, V56, P4793, DOI 10.1021/jo00015a041; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Singh BK, 2008, ORG PROCESS RES DEV, V12, P468, DOI 10.1021/op800047f; Specht KM, 2002, CURR OPIN CELL BIOL, V14, P155, DOI 10.1016/S0955-0674(02)00317-4; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Traxler P, 2001, MED RES REV, V21, P499, DOI 10.1002/med.1022; Wang ZL, 1997, P NATL ACAD SCI USA, V94, P2327, DOI 10.1073/pnas.94.6.2327; Westfall PJ, 2006, EUKARYOT CELL, V5, P1215, DOI 10.1128/EC.00037-06; Wu TYH, 2003, ORG LETT, V5, P3587, DOI 10.1021/ol035226w	35	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20789	10.1371/journal.pone.0020789	http://dx.doi.org/10.1371/journal.pone.0020789			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698101	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600017
J	Wang, YY; Tong, J; Li, SP; Zhang, R; Chen, L; Wang, YH; Zheng, M; Wang, ML; Liu, G; Dai, YP; Zhao, YF; Li, N				Wang, Yuanyuan; Tong, Jia; Li, Shuping; Zhang, Ran; Chen, Li; Wang, Yuhui; Zheng, Min; Wang, Meili; Liu, George; Dai, Yunping; Zhao, Yaofeng; Li, Ning			Over-Expression of Human Lipoprotein Lipase in Mouse Mammary Glands Leads to Reduction of Milk Triglyceride and Delayed Growth of Suckling Pups	PLOS ONE			English	Article							MUSCLE-SPECIFIC OVEREXPRESSION; TRANSGENIC MICE; DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; ADIPOSE-TISSUE; LACTATING RATS; FATTY-ACIDS; GOAT MILK; PLASMA; MORTALITY	Background: The mammary gland is a conserved site of lipoprotein lipase expression across species and lipoprotein lipase attachment to the luminal surface of mammary gland vascular endothelial cells has been implicated in the direction of circulating triglycerides into milk synthesis during lactation. Principal Findings: Here we report generation of transgenic mice harboring a human lipoprotein lipase gene driven by a mammary gland-specific promoter. Lipoprotein lipase levels in transgenic milk was raised to 0.16 mg/ml, corresponding to an activity of 8772.95 mU/ml. High lipoprotein lipase activity led to a significant reduction of triglyceride concentration in milk, but other components were largely unchanged. Normal pups fed with transgenic milk showed inferior growth performances compared to those fed with normal milk. Conclusion: Our study suggests a possibility to reduce the triglyceride content of cow milk using transgenic technology.	[Wang, Yuanyuan; Tong, Jia; Li, Shuping; Zhang, Ran; Chen, Li; Zhao, Yaofeng; Li, Ning] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Wang, Yuhui; Liu, George] Peking Univ, Inst Cardiovasc Sci, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Zheng, Min; Wang, Meili; Dai, Yunping] GenProt Biotech Ltd, Beijing, Peoples R China	China Agricultural University; Peking University	Wang, YY (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	nlicau@163.com	王, 宇慧/GXZ-7548-2022		National S & T Major Project [2009ZX08007-001B]	National S & T Major Project	This work was supported by National S & T Major Project (2009ZX08007-001B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickerton AST, 2007, DIABETES, V56, P168, DOI 10.2337/db06-0822; BRAUN JEA, 1992, BIOCHEM J, V287, P337, DOI 10.1042/bj2870337; Chilliard Y, 2003, J DAIRY SCI, V86, P1751, DOI 10.3168/jds.S0022-0302(03)73761-8; CHILLIARD Y, 1984, J DAIRY SCI, V67, P2216, DOI 10.3168/jds.S0022-0302(84)81569-6; CRYER A, 1981, INT J BIOCHEM, V13, P525, DOI 10.1016/0020-711X(81)90177-4; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; EHLE PN, 1976, J LIPID RES, V17, P536; Ferreira LDMCB, 2001, DIABETES, V50, P1064, DOI 10.2337/diabetes.50.5.1064; FRAYN KN, 1994, AM J PHYSIOL, V266, pE308, DOI 10.1152/ajpendo.1994.266.3.E308; HAMOSH M, 1970, BIOCHIM BIOPHYS ACTA, V210, P473, DOI 10.1016/0005-2760(70)90044-5; Hoefler G, 1997, BIOCHIMIE, V79, P163, DOI 10.1016/S0300-9084(97)81509-X; IVERSON SJ, 1995, J COMP PHYSIOL B, V165, P384, DOI 10.1007/BF00387309; JENSEN DR, 1991, J LIPID RES, V32, P733; JENSEN DR, 1994, BIOCHEM J, V298, P321, DOI 10.1042/bj2980321; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; LevakFrank S, 1997, J BIOL CHEM, V272, P17182, DOI 10.1074/jbc.272.27.17182; LEVAKFRANK S, 1995, J CLIN INVEST, V96, P976, DOI 10.1172/JCI118145; LIU MS, 1994, J BIOL CHEM, V269, P11417; Neville MC, 1997, ANNU REV NUTR, V17, P159, DOI 10.1146/annurev.nutr.17.1.159; Olivecrona G, 2010, J LIPID RES, V51, P1535, DOI 10.1194/jlr.M002717; Ringseis R, 2004, J NUTR, V134, P3327, DOI 10.1093/jn/134.12.3327; Rudolph MC, 2007, PHYSIOL GENOMICS, V28, P323, DOI 10.1152/physiolgenomics.00020.2006; SHIMADA M, 1994, J BIOL CHEM, V269, P11673; WANG CS, 1992, BIOCHIM BIOPHYS ACTA, V1123, P1, DOI 10.1016/0005-2760(92)90165-R; Yu SY, 2006, J VIROL, V80, P4183, DOI 10.1128/JVI.80.8.4183-4186.2006; Zhang R, 2009, TRANSGENIC RES, V18, P445, DOI 10.1007/s11248-008-9241-0; ZSIGMOND E, 1994, J BIOL CHEM, V269, P18757	27	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20895	10.1371/journal.pone.0020895	http://dx.doi.org/10.1371/journal.pone.0020895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698114	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600029
J	Zhou, H; Roy, S; Cochran, E; Zouaoui, R; Chu, CL; Duffner, J; Zhao, GL; Smith, S; Galcheva-Gargova, Z; Karlgren, J; Dussault, N; Kwan, RYQ; Moy, E; Barnes, M; Long, A; Honan, C; Qi, YW; Shriver, Z; Ganguly, T; Schultes, B; Venkataraman, G; Kishimoto, TK				Zhou, He; Roy, Sucharita; Cochran, Edward; Zouaoui, Radouane; Chu, Chia Lin; Duffner, Jay; Zhao, Ganlin; Smith, Sean; Galcheva-Gargova, Zoya; Karlgren, Juliane; Dussault, Nancy; Kwan, Rain Y. Q.; Moy, Erick; Barnes, Marishka; Long, Alison; Honan, Chris; Qi, Yi Wei; Shriver, Zachary; Ganguly, Tanmoy; Schultes, Birgit; Venkataraman, Ganesh; Kishimoto, Takashi Kei			M402, a Novel Heparan Sulfate Mimetic, Targets Multiple Pathways Implicated in Tumor Progression and Metastasis	PLOS ONE			English	Article							MOLECULAR-WEIGHT HEPARIN; FIBROBLAST-GROWTH-FACTOR; P-SELECTIN; ADVANCED CANCER; CLINICAL-TRIAL; MYELOID CELLS; LUNG-CANCER; ANGIOGENESIS; THERAPY; INHIBITOR	Heparan sulfate proteoglycans (HSPGs) play a key role in shaping the tumor microenvironment by presenting growth factors, cytokines, and other soluble factors that are critical for host cell recruitment and activation, as well as promoting tumor progression, metastasis, and survival. M402 is a rationally engineered, non-cytotoxic heparan sulfate (HS) mimetic, designed to inhibit multiple factors implicated in tumor-host cell interactions, including VEGF, FGF2, SDF-1 alpha, P-selectin, and heparanase. A single s.c. dose of M402 effectively inhibited seeding of B16F10 murine melanoma cells to the lung in an experimental metastasis model. Fluorescent-labeled M402 demonstrated selective accumulation in the primary tumor. Immunohistological analyses of the primary tumor revealed a decrease in microvessel density in M402 treated animals, suggesting anti-angiogenesis to be one of the mechanisms involved in-vivo. M402 treatment also normalized circulating levels of myeloid derived suppressor cells in tumor bearing mice. Chronic administration of M402, alone or in combination with cisplatin or docetaxel, inhibited spontaneous metastasis and prolonged survival in an orthotopic 4T1 murine mammary carcinoma model. These data demonstrate that modulating HSPG biology represents a novel approach to target multiple factors involved in tumor progression and metastasis.	[Zhou, He; Roy, Sucharita; Cochran, Edward; Zouaoui, Radouane; Chu, Chia Lin; Duffner, Jay; Zhao, Ganlin; Smith, Sean; Galcheva-Gargova, Zoya; Karlgren, Juliane; Dussault, Nancy; Kwan, Rain Y. Q.; Moy, Erick; Barnes, Marishka; Long, Alison; Honan, Chris; Qi, Yi Wei; Shriver, Zachary; Ganguly, Tanmoy; Schultes, Birgit; Venkataraman, Ganesh; Kishimoto, Takashi Kei] Momenta Pharmaceut Inc, Cambridge, MA USA		Zhou, H (corresponding author), Momenta Pharmaceut Inc, Cambridge, MA USA.	kkishimoto@momentapharma.com			Momenta Pharmaceuticals	Momenta Pharmaceuticals	This study is funded by Momenta Pharmaceuticals. The funding source does not compromise the objectivity or validity of the research, analyses, and interpretations presented in the paper. The funders had no role in data collection and analysis. The funders approved study designs for some experiments and agreed to the decision to publish the manuscript.	Borsig L, 2001, P NATL ACAD SCI USA, V98, P3352, DOI 10.1073/pnas.061615598; Casu B, 2004, J MED CHEM, V47, P838, DOI 10.1021/jm030893g; Casu B, 2007, PATHOPHYSIOL HAEMO T, V36, P195, DOI 10.1159/000175157; Dredge K, 2011, BRIT J CANCER, V104, P635, DOI 10.1038/bjc.2011.11; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Folkman J, 1985, Important Adv Oncol, P42; FOLKMAN J, 1988, AM J PATHOL, V130, P393; FOLKMAN J, 1985, BIOCHEM PHARMACOL, V34, P905, DOI 10.1016/0006-2952(85)90588-X; Goon PKY, 2006, NEOPLASIA, V8, P79, DOI 10.1593/neo.05592; Griffiths GO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-355; Hamon M, 2004, GLYCOBIOLOGY, V14, P311, DOI 10.1093/glycob/cwh038; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Hoogewerf AJ, 1997, BIOCHEMISTRY-US, V36, P13570, DOI 10.1021/bi971125s; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kakkar AK, 2004, J CLIN ONCOL, V22, P1944, DOI 10.1200/JCO.2004.10.002; Khasraw M, 2010, ANN ONCOL, V21, P1302, DOI 10.1093/annonc/mdp524; Kim JB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009364; Korff T, 1999, J CELL SCI, V112, P3249; Kuderer NM, 2009, J CLIN ONCOL, V27, P4902, DOI 10.1200/JCO.2009.22.4584; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Ludwig RJ, 2004, CANCER RES, V64, P2743, DOI 10.1158/0008-5472.CAN-03-1054; Mayer RJ, 2009, NEW ENGL J MED, V360, P623, DOI 10.1056/NEJMe0809343; NAGASAWA K, 1977, CARBOHYD RES, V58, P47, DOI 10.1016/S0008-6215(00)83402-3; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Omuro AMP, 2008, CURR OPIN INVEST DR, V9, P1287; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Raman R, 2003, P NATL ACAD SCI USA, V100, P2357, DOI 10.1073/pnas.0437842100; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; ROY S, 2011, GLYCOBIOLOG IN PRESS; Sasisekharan R, 2002, NAT REV CANCER, V2, P521, DOI 10.1038/nrc842; Sasisekharan R, 2000, CURR OPIN CHEM BIOL, V4, P626, DOI 10.1016/S1367-5931(00)00145-9; SENGER DR, 1986, CANCER RES, V46, P5629; SHAFAT I, 2010, J CELL MOL MED; Shojaei F, 2007, NAT BIOTECHNOL, V25, P911, DOI 10.1038/nbt1323; Sideras K, 2006, MAYO CLIN PROC, V81, P758, DOI 10.4065/81.6.758; Smorenburg SM, 2001, PHARMACOL REV, V53, P93; STONE JP, 1993, J CLIN INVEST, V92, P804, DOI 10.1172/JCI116654; Varki NM, 2002, SEMIN THROMB HEMOST, V28, P53, DOI 10.1055/s-2002-20564; Vlodavsky I, 2006, PATHOPHYSIOL HAEMO T, V35, P116, DOI 10.1159/000093553; WATSON SA, 1993, EUR J CANCER, V29A, P1740, DOI 10.1016/0959-8049(93)90117-X; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Yang L, 2008, CANCER CELL, V13, P23, DOI 10.1016/j.ccr.2007.12.004; Zacharski LR, 2000, SEMIN THROMB HEMOST, V26, P69, DOI 10.1055/s-2000-9499	46	122	127	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21106	10.1371/journal.pone.0021106	http://dx.doi.org/10.1371/journal.pone.0021106			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698156	gold, Green Published, Green Submitted			2022-12-25	WOS:000291734100056
J	Rafferty, AR; Tomillo, PS; Spotila, JR; Paladino, FV; Reina, RD				Rafferty, Anthony R.; Tomillo, Pilar Santidrian; Spotila, James R.; Paladino, Frank V.; Reina, Richard D.			Embryonic Death Is Linked to Maternal Identity in the Leatherback Turtle (Dermochelys coriacea)	PLOS ONE			English	Article							INDUCED GENE-EXPRESSION; SEA-TURTLES; HYPOXIA; CONSEQUENCES; CONSERVATION; CONSTRAINTS; TEMPERATURE; POPULATION; MORTALITY; EVOLUTION	Leatherback turtles have an average global hatching success rate of similar to 50%, lower than other marine turtle species. Embryonic death has been linked to environmental factors such as precipitation and temperature, although, there is still a lot of variability that remains to be explained. We examined how nesting season, the time of nesting each season, the relative position of each clutch laid by each female each season, maternal identity and associated factors such as reproductive experience of the female (new nester versus remigrant) and period of egg retention between clutches (interclutch interval) affected hatching success and stage of embryonic death in failed eggs of leatherback turtles nesting at Playa Grande, Costa Rica. Data were collected during five nesting seasons from 2004/05 to 2008/09. Mean hatching success was 50.4%. Nesting season significantly influenced hatching success in addition to early and late stage embryonic death. Neither clutch position nor nesting time during the season had a significant affect on hatching success or the stage of embryonic death. Some leatherback females consistently produced nests with higher hatching success rates than others. Remigrant females arrived earlier to nest, produced more clutches and had higher rates of hatching success than new nesters. Reproductive experience did not affect stage of death or the duration of the interclutch interval. The length of interclutch interval had a significant affect on the proportion of eggs that failed in each clutch and the developmental stage they died at. Intrinsic factors such as maternal identity are playing a role in affecting embryonic death in the leatherback turtle.	[Rafferty, Anthony R.; Reina, Richard D.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia; [Tomillo, Pilar Santidrian; Spotila, James R.] Drexel Univ, Dept Biosci & Biotechnol, Philadelphia, PA 19104 USA; [Paladino, Frank V.] Purdue Univ, Dept Biol, Ft Wayne, IN USA	Monash University; Drexel University	Rafferty, AR (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	Anthony.Rafferty@sci.monash.edu.au	Santidrián Tomillo, Pilar/N-5406-2014; Reina, Richard/AAC-7017-2019	Santidrián Tomillo, Pilar/0000-0002-6895-7218; 	Betz Endowment of Drexel University; Earthwatch Institute; Leatherback Trust	Betz Endowment of Drexel University; Earthwatch Institute; Leatherback Trust	Financial support was provided by the Betz Endowment of Drexel University, the Earthwatch Institute (www.earthwatch.org), and The Leatherback Trust (www.leatherback.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN RA, 1981, PHYSIOL ZOOL, V54, P316, DOI 10.1086/physzool.54.3.30159946; Andrews RM, 2000, BIOSCIENCE, V50, P227, DOI 10.1641/0006-3568(2000)050[0227:NHORDC]2.3.CO;2; Andrews RM, 2002, PHYSIOL BIOCHEM ZOOL, V75, P145, DOI 10.1086/339388; Bell BA, 2004, BIOL CONSERV, V115, P131, DOI 10.1016/S0006-3207(03)00102-2; BELL D.D., 2002, COMMERCIAL CHICKEN M, V5th; Briskie JV, 2004, P NATL ACAD SCI USA, V101, P558, DOI 10.1073/pnas.0305103101; Buhlmann KA, 1995, HERPETOLOGICA, V51, P457; Buhlmann Kurt A., 1995, Herpetological Review, V26, P209; Carter AM, 2005, J ENDOCRINOL, V184, P179, DOI 10.1677/joe.1.05781; CAUT S, 2006, CAN J ZOOL, V84, P522; Chan Eng-Heng, 1996, Chelonian Conservation and Biology, V2, P196; CONGDON JD, 1989, PHYSIOL ZOOL, V62, P356, DOI 10.1086/physzool.62.2.30156175; Crain D. A., 1990, GEN COMP ENDOCR, V98, P26, DOI [DOI 10.1006/GCEN.1995.1041, 10.1006/gcen.1995.1041]; Crawley MJ., 2007, R BOOK; Dutton Peter, 1994, Marine Turtle Newsletter, V67, P13; ECKERT KL, 1987, HERPETOLOGICA, V43, P315; ECKERT KL, 1990, BIOL CONSERV, V53, P37, DOI 10.1016/0006-3207(90)90061-S; Eckert SA, 2006, MAR BIOL, V149, P1257, DOI 10.1007/s00227-006-0262-z; EWERT M, 1985, BIOL REPTILIA A, P14; Frazier HN, 2009, CURR BIOL, V19, P859, DOI 10.1016/j.cub.2009.03.066; Galloway LF, 2005, NEW PHYTOL, V166, P93, DOI 10.1111/j.1469-8137.2004.01314.x; Garrett Kendra, 2010, Endangered Species Research, V11, P147, DOI 10.3354/esr00273; Gilbert Scott F., 1988, DEV BIOL; Girondot M, 2007, CHELONIAN CONSERV BI, V6, P37, DOI 10.2744/1071-8443(2007)6[37:MATQLN]2.0.CO;2; Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993; Guillette Jr L. J., 1991, BIOL REPROD S1, V44, P58; GUILLETTE LJ, 1989, LIFE SCI R, V45, P219; Hays GC, 2004, NATURE, V429, P522, DOI 10.1038/429522a; Hewavisenthi S, 2002, J HERPETOL, V36, P43, DOI 10.2307/1565800; HILTERMAN ML, 2005, ANN REPORT 2004 LEAT; HILTONTAYLOR C, 2002, 2000 IUCN RED LIST T; HUGHES GR, 1967, LAMMERGEYER, V3, P6; JAMIESON IG, 1999, CAUSES LOW REPROD SU; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Leslie Alison J., 1996, Chelonian Conservation and Biology, V2, P159; LIMPUS CJ, 1979, HERPETOLOGICA, V35, P335; LIVINGSTONE SR, 2006, SEA TURTLE ECOLOGY C; LYNN WG, 1945, BIOL BULL, V88, P112, DOI 10.2307/1538039; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; Miller DL, 2009, CURR BIOL, V19, P1233, DOI 10.1016/j.cub.2009.05.066; MILLER J, 1985, BIOL REPTILIA A, V14; Miller J.D., 1982, DEV MARINE TURTLES; Miller Jeffrey D., 1997, P51; PALMER B, 1988, AM ZOOLOGIST, V28; PALMER B, 1991, EGG INCUBATION ITS E; Phillott AD, 2001, J EXP ZOOL, V289, P317, DOI 10.1002/1097-010X(20010415/30)289:5<317::AID-JEZ5>3.0.CO;2-0; Plotkin PT, 1997, J HERPETOL, V31, P17, DOI 10.2307/1565323; PRITCHARD P, 1982, COPEIA, P858; PRITCHARD P, 1969, STUDIES SYSTEMATICS; Ralph CR, 2005, AUST J ZOOL, V53, P289, DOI 10.1071/ZO04062; Reina RD, 2002, COPEIA, P653; Risley P., 1944, ANAT REC, V88; Tomillo PS, 2007, CHELONIAN CONSERV BI, V6, P54; Martinez LS, 2007, CHELONIAN CONSERV BI, V6, P70, DOI 10.2744/1071-8443(2007)6[70:CABOTL]2.0.CO;2; SARTMARTINEZ A, 2000, IUCN 2007 2007 RED L; Schlueter PJ, 2007, CELL DEATH DIFFER, V14, P1095, DOI 10.1038/sj.cdd.4402109; Shillinger GL, 2008, PLOS BIOL, V6, P1408, DOI 10.1371/journal.pbio.0060171; Spotila James R., 1996, Chelonian Conservation and Biology, V2, P209; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Steyermark AC, 2001, COPEIA, P1050, DOI 10.1643/0045-8511(2001)001[1050:BTAMIA]2.0.CO;2; Steyermark AC, 2001, FUNCT ECOL, V15, P624, DOI 10.1046/j.0269-8463.2001.00564.x; Steyermark Anthony C., 1996, Chelonian Conservation and Biology, V2, P173; Tomillo PS, 2009, MAR BIOL, V156, P2021, DOI 10.1007/s00227-009-1234-x; TURTLE E, 2007, NMFSSEFSC555 NOAA, P116; Verhage B, 2006, 4 YEARS MARINE TURTL; Wallace BP, 2004, PHYSIOL BIOCHEM ZOOL, V77, P423, DOI 10.1086/420951; Wallace BP, 2007, OECOLOGIA, V152, P37, DOI 10.1007/s00442-006-0641-7; WHITMORE CP, 1985, BIOL CONSERV, V34, P251, DOI 10.1016/0006-3207(85)90095-3; Witt MJ, 2009, BIOL CONSERV, V142, P1719, DOI 10.1016/j.biocon.2009.03.009; Wolf JB, 2009, PHILOS T R SOC B, V364, P1107, DOI 10.1098/rstb.2008.0238; Zuur Alain F., 2009, P1	71	41	42	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21038	10.1371/journal.pone.0021038	http://dx.doi.org/10.1371/journal.pone.0021038			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695086	gold, Green Published, Green Submitted			2022-12-25	WOS:000291682300025
J	Sausbier, U; Dullin, C; Missbach-Guentner, J; Kabagema, C; Flockerzie, K; Kuscher, GM; Stuehmer, W; Neuhuber, W; Ruth, P; Alves, F; Sausbier, M				Sausbier, Ulrike; Dullin, Christian; Missbach-Guentner, Jeannine; Kabagema, Clement; Flockerzie, Katarina; Kuscher, Gerd Marten; Stuehmer, Walter; Neuhuber, Winfried; Ruth, Peter; Alves, Frauke; Sausbier, Matthias			Osteopenia Due to Enhanced Cathepsin K Release by BK Channel Ablation in Osteoclasts	PLOS ONE			English	Article							POTASSIUM CHANNEL; BONE TURNOVER; BIOCHEMICAL MARKERS; OSTEOBLASTIC CELLS; DEFICIENT MICE; EPILEPSY; CHANNELOPATHIES; DIFFERENTIATION; OSTEOPOROSIS; ACTIVATION	Background: The process of bone resorption by osteoclasts is regulated by Cathepsin K, the lysosomal collagenase responsible for the degradation of the organic bone matrix during bone remodeling. Recently, Cathepsin K was regarded as a potential target for therapeutic intervention of osteoporosis. However, mechanisms leading to osteopenia, which is much more common in young female population and often appears to be the clinical pre-stage of idiopathic osteoporosis, still remain to be elucidated, and molecular targets need to be identified. Methodology/Principal Findings: We found, that in juvenile bone the large conductance, voltage and Ca2+-activated (BK) K+ channel, which links membrane depolarization and local increases in cytosolic calcium to hyperpolarizing K+ outward currents, is exclusively expressed in osteoclasts. In juvenile BK-deficient (BK-/-) female mice, plasma Cathepsin K levels were elevated two-fold when compared to wild-type littermates. This increase was linked to an osteopenic phenotype with reduced bone mineral density in long bones and enhanced porosity of trabecular meshwork in BK-/- vertebrae as demonstrated by high-resolution flat-panel volume computed tomography and micro-CT. However, plasma levels of sRANKL, osteoprotegerin, estrogene, Ca2+ and triiodthyronine as well as osteoclastogenesis were not altered in BK-/- females. Conclusion/Significance: Our findings suggest that the BK channel controls resorptive osteoclast activity by regulating Cathepsin K release. Targeted deletion of BK channel in mice resulted in an osteoclast-autonomous osteopenia, becoming apparent in juvenile females. Thus, the BK-/- mouse-line represents a new model for juvenile osteopenia, and revealed the BK channel as putative new target for therapeutic controlling of osteoclast activity.	[Sausbier, Ulrike; Kabagema, Clement; Flockerzie, Katarina; Ruth, Peter; Sausbier, Matthias] Univ Tubingen, Dept Pharmacol & Toxicol, Inst Pharm, Tubingen, Germany; [Dullin, Christian; Missbach-Guentner, Jeannine] Univ Med Ctr Gottingen, Dept Diagnost Radiol, Gottingen, Germany; [Kuscher, Gerd Marten; Stuehmer, Walter; Alves, Frauke] Max Planck Inst Expt Med, Dept Mol Biol Neuronal Signals, D-37075 Gottingen, Germany; [Neuhuber, Winfried] Univ Erlangen Nurnberg, Inst Anat, Erlangen, Germany; [Alves, Frauke] Univ Med Ctr Gottingen, Dept Hematol & Oncol, Gottingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Gottingen; Max Planck Society; University of Erlangen Nuremberg; University of Gottingen	Sausbier, U (corresponding author), Univ Tubingen, Dept Pharmacol & Toxicol, Inst Pharm, Tubingen, Germany.	matthias.sausbier@uni-tuebingen.de	Stuehmer, Walter/A-2176-2009	Stuehmer, Walter/0000-0002-0642-7764; Dullin, Christian/0000-0003-4297-8077	University of Tubingen; University Medical Center Gottingen; Max-Planck-Institute for Experimental Medicine Gottingen; University of Erlangen-Nurnberg	University of Tubingen; University Medical Center Gottingen; Max-Planck-Institute for Experimental Medicine Gottingen; University of Erlangen-Nurnberg	The work was exclusively financed by the universities involved: University of Tubingen, University Medical Center Gottingen, Max-Planck-Institute for Experimental Medicine Gottingen and University of Erlangen-Nurnberg. The funders had no role in study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abbott GW, 2006, CURR PHARM DESIGN, V12, P3631, DOI 10.2174/138161206778522065; Arimura Kimiyoshi, 2006, Suppl Clin Neurophysiol, V59, P275; Bernard G, 2008, PEDIATR NEUROL, V38, P73, DOI 10.1016/j.pediatrneurol.2007.09.007; Boyce Brendan F, 2007, Curr Osteoporos Rep, V5, P98; BROWNE DL, 1994, NAT GENET, V8, P136, DOI 10.1038/ng1094-136; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Cooper EC, 1999, P NATL ACAD SCI USA, V96, P4759, DOI 10.1073/pnas.96.9.4759; Delmas PD, 2000, OSTEOPOROSIS INT, V11, P2, DOI 10.1007/s001980070002; Du W, 2005, NAT GENET, V37, P733, DOI 10.1038/ng1585; Duffy SM, 2007, EUR J IMMUNOL, V37, P1653, DOI 10.1002/eji.200637024; Dullin C, 2007, PLOS GENET, V3, P1232, DOI 10.1371/journal.pgen.0030118; Espinosa L, 2002, J CELL SCI, V115, P3837, DOI 10.1242/jcs.00062; Hanna MG, 2006, NAT CLIN PRACT NEURO, V2, P252, DOI 10.1038/ncpneuro0178; Henney NC, 2009, AM J PHYSIOL-CELL PH, V297, pC1397, DOI 10.1152/ajpcell.00311.2009; Heron SE, 2007, NEUROTHERAPEUTICS, V4, P295, DOI 10.1016/j.nurt.2007.01.009; Herson PS, 2003, NAT NEUROSCI, V6, P378, DOI 10.1038/nn1025; Iki M, 2007, J BONE MINER METAB, V25, P122, DOI 10.1007/s00774-006-0736-6; Jenkinson DH, 2006, BRIT J PHARMACOL, V147, pS63, DOI 10.1038/sj.bjp.0706447; Kajiya H, 2003, AM J PHYSIOL-CELL PH, V285, pC457, DOI 10.1152/ajpcell.00033.2003; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Langsetmo L, 2010, MENOPAUSE, V17, P1010, DOI 10.1097/gme.0b013e3181da4b7d; LEE TC, 1994, CVGIP-GRAPH MODEL IM, V56, P462, DOI 10.1006/cgip.1994.1042; Li JP, 2007, ENDOCRINOLOGY, V148, P2116, DOI 10.1210/en.2006-1321; LIEBER MA, 1987, J BONE MINER RES, V2, P595; Missbach-Guentner J, 2007, NEOPLASIA, V9, P755, DOI 10.1593/neo.07466; Moreau R, 1996, J MEMBRANE BIOL, V150, P175, DOI 10.1007/s002329900042; Rezzonico R, 2003, J BONE MINER RES, V18, P1863, DOI 10.1359/jbmr.2003.18.10.1863; Robinson LJ, 2010, ANN NY ACAD SCI, V1192, P351, DOI 10.1111/j.1749-6632.2009.05219.x; Rogawski MA, 2000, TRENDS NEUROSCI, V23, P393, DOI 10.1016/S0166-2236(00)01629-5; Sausbier M, 2005, CIRCULATION, V112, P60, DOI 10.1161/01.CIR.0000156448.74296.FE; Sausbier M, 2004, P NATL ACAD SCI USA, V101, P9474, DOI 10.1073/pnas.0401702101; Sausbier M, 2007, FASEB J, V21, P812, DOI 10.1096/fj.06-7167com; Sausbier U, 2006, HISTOCHEM CELL BIOL, V125, P725, DOI 10.1007/s00418-005-0124-7; Singh NA, 1998, NAT GENET, V18, P25, DOI 10.1038/ng0198-25; Spreafico A, 2006, PROTEOMICS, V6, P3520, DOI 10.1002/pmic.200500858; Sprossmann F, 2009, FEBS J, V276, P1680, DOI 10.1111/j.1742-4658.2009.06900.x; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Wehren LE, 2003, INT J FERTIL WOMEN M, V48, P117; Weidema AF, 2000, BONE, V27, P5, DOI 10.1016/S8756-3282(00)00287-8; WEIDEMA AF, 1993, BIOCHIM BIOPHYS ACTA, V1149, P63, DOI 10.1016/0005-2736(93)90025-U; Weskamp M, 2000, J MEMBRANE BIOL, V178, P11, DOI 10.1007/s002320010010; Wu SN, 2001, J INVEST MED, V49, P522, DOI 10.2310/6650.2001.33629; Xing LP, 2005, BIOCHEM BIOPH RES CO, V328, P709, DOI 10.1016/j.bbrc.2004.11.072; Zhao HB, 2008, DEV CELL, V14, P914, DOI 10.1016/j.devcel.2008.03.022	49	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21168	10.1371/journal.pone.0021168	http://dx.doi.org/10.1371/journal.pone.0021168			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695131	Green Published, gold			2022-12-25	WOS:000291682300031
J	Hix, LM; Shi, YH; Brutkiewicz, RR; Stein, PL; Wang, CR; Zhang, M				Hix, Laura M.; Shi, Yihui H.; Brutkiewicz, Randy R.; Stein, Paul L.; Wang, Chyung-Ru; Zhang, Ming			CD1d-Expressing Breast Cancer Cells Modulate NKT Cell-Mediated Antitumor Immunity in a Murine Model of Breast Cancer Metastasis	PLOS ONE			English	Article							KILLER-T-CELLS; CLASS-I MOLECULES; HUMAN CD1D GENE; ANTIGEN PRESENTATION; BONE METASTASIS; TUMOR-IMMUNITY; LYTIC ACTIVITY; EXPRESSION; MICE; IMMUNOSURVEILLANCE	Background: Tumor tolerance and immune suppression remain formidable obstacles to the efficacy of immunotherapies that harness the immune system to eradicate breast cancer. A novel syngeneic mouse model of breast cancer metastasis was developed in our lab to investigate mechanisms of immune regulation of breast cancer. Comparative analysis of low-metastatic vs. highly metastatic tumor cells isolated from these mice revealed several important genetic alterations related to immune control of cancer, including a significant downregulation of cd1d1 in the highly metastatic tumor cells. The cd1d1 gene in mice encodes the MHC class I-like molecule CD1d, which presents glycolipid antigens to a specialized subset of T cells known as natural killer T (NKT) cells. We hypothesize that breast cancer cells, through downregulation of CD1d and subsequent evasion of NKT-mediated antitumor immunity, gain increased potential for metastatic tumor progression. Methodology/Principal Findings: In this study, we demonstrate in a mouse model of breast cancer metastasis that tumor downregulation of CD1d inhibits iNKT-mediated antitumor immunity and promotes metastatic breast cancer progression in a CD1d-dependent manner in vitro and in vivo. Using NKT-deficient transgenic mouse models, we demonstrate important differences between type I and type II NKT cells in their ability to regulate antitumor immunity of CD1d-expressing breast tumors. Conclusions/Significance: The results of this study emphasize the importance of determining the CD1d expression status of the tumor when tailoring NKT-based immunotherapies for the prevention and treatment of metastatic breast cancer.	[Hix, Laura M.; Shi, Yihui H.; Zhang, Ming] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA; [Brutkiewicz, Randy R.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Walther Oncol Ctr, Indianapolis, IN USA; [Brutkiewicz, Randy R.] Indiana Univ Sch Med, Inst Canc, Indianapolis, IN USA; [Stein, Paul L.] Northwestern Univ, Dept Dermatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Wang, Chyung-Ru] Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Indiana University System; Indiana University Bloomington; Walther Cancer Institute; Indiana University System; Indiana University Bloomington; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Hix, LM (corresponding author), Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Feinberg Sch Med, Chicago, IL 60611 USA.	m-zhang@northwestern.edu		Brutkiewicz, Randy/0000-0002-7396-480X	Susan G. Komen Breast Cancer Foundation [BCTR58006]; National Institutes of Health [RO1 CA79736, CA86867, T32 CA956023]; Northwestern University; NATIONAL CANCER INSTITUTE [R01CA086867, R01CA079736] Funding Source: NIH RePORTER	Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Susan G. Komen Breast Cancer Foundation BCTR58006 and National Institutes of Health RO1 CA79736 to MZ, CA86867 to PLS, and National Institutes of Health training grant T32 CA956023 to LMH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the NIH tetramer Core facility for supplying the PBS-57-loaded CD1d tetramers. This work was supported by the Northwestern University Interdepartmental ImmunoBiology Flow Cytometry Core Facility.	Algarra I, 2004, CANCER IMMUNOL IMMUN, V53, P904, DOI 10.1007/s00262-004-0517-9; BAND V, 1989, P NATL ACAD SCI USA, V86, P1249, DOI 10.1073/pnas.86.4.1249; BENDELAC A, 1994, SCIENCE, V263, P1774, DOI 10.1126/science.7907820; Berzofsky JA, 2009, CURR MOL MED, V9, P667, DOI 10.2174/156652409788970706; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; BRINKLEY BR, 1980, CANCER RES, V40, P3118; Brossay L, 1997, J IMMUNOL, V159, P1216; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; CANCHIS PW, 1993, IMMUNOLOGY, V80, P561; Carson F, 1992, HISTOTECHNOLOGY SELF; Cerundolo V, 2009, NAT REV IMMUNOL, V9, P28, DOI 10.1038/nri2451; Chen QY, 2004, J IMMUNOL, V172, P5512, DOI 10.4049/jimmunol.172.9.5512; Chen QY, 2003, TISSUE ANTIGENS, V62, P442, DOI 10.1034/j.1399-0039.2003.00116.x; Chiu YH, 2002, NAT IMMUNOL, V3, P55, DOI 10.1038/ni740; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Crowe NY, 2005, J EXP MED, V202, P1279, DOI 10.1084/jem.20050953; Crowe NY, 2002, J EXP MED, V196, P119, DOI 10.1084/jem.20020092; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Dhodapkar KM, 2004, INT J CANCER, V109, P893, DOI 10.1002/ijc.20050; Dhodapkar MV, 2009, FRONT BIOSCI-LANDMRK, V14, P796, DOI 10.2741/3278; Dhodapkar MV, 2003, J EXP MED, V197, P1667, DOI 10.1084/jem.20021650; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Eberl G, 2000, J IMMUNOL, V165, P4305, DOI 10.4049/jimmunol.165.8.4305; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Fiedler T, 2002, INT J CANCER, V98, P389, DOI 10.1002/ijc.10141; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Gross S, 2008, IMMUNOL LETT, V116, P7, DOI 10.1016/j.imlet.2007.11.012; Haraguchi K, 2006, LEUKEMIA LYMPHOMA, V47, P2218, DOI 10.1080/10428190600682688; Hong C, 2009, CANCER RES, V69, P4301, DOI 10.1158/0008-5472.CAN-08-1721; IMAI K, 1986, P NATL ACAD SCI USA, V83, P8708, DOI 10.1073/pnas.83.22.8708; Jager D, 2001, J CLIN PATHOL, V54, P669, DOI 10.1136/jcp.54.9.669; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kawano T, 1998, P NATL ACAD SCI USA, V95, P5690, DOI 10.1073/pnas.95.10.5690; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; KITTRELL FS, 1992, CANCER RES, V52, P1924; Li YS, 2001, CANCER RES, V61, P6906; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Mendiratta SK, 1997, IMMUNITY, V6, P469, DOI 10.1016/S1074-7613(00)80290-3; Metelitsa LS, 2003, LEUKEMIA, V17, P1068, DOI 10.1038/sj.leu.2402943; METELITSA LS, 2010, CLIN IMMUNOL; Miura S, 2010, J VIROL, V84, P11614, DOI 10.1128/JVI.01053-10; Miyagi T, 2003, INT J CANCER, V106, P81, DOI 10.1002/ijc.11163; Molling JW, 2007, J CLIN ONCOL, V25, P862, DOI 10.1200/JCO.2006.08.5787; Nagarajan NA, 2007, J IMMUNOL, V178, P2706, DOI 10.4049/jimmunol.178.5.2706; Nowak M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011311; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Reome JB, 2004, CLIN IMMUNOL, V111, P69, DOI 10.1016/j.clim.2003.11.013; Roberts TJ, 2002, J IMMUNOL, V168, P5409, DOI 10.4049/jimmunol.168.11.5409; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shi HY, 2001, CANCER RES, V61, P6945; Stanic AK, 2003, P NATL ACAD SCI USA, V100, P1849, DOI 10.1073/pnas.0430327100; Tachibana T, 2005, CLIN CANCER RES, V11, P7322, DOI 10.1158/1078-0432.CCR-05-0877; TANAKA K, 1986, CANCER IMMUNOL IMMUN, V22, P37; Taniguchi M, 2003, ANNU REV IMMUNOL, V21, P483, DOI 10.1146/annurev.immunol.21.120601.141057; Teng MWL, 2009, J IMMUNOL, V183, P1911, DOI 10.4049/jimmunol.0900796; Teng MWL, 2009, J IMMUNOL, V182, P3366, DOI 10.4049/jimmunol.0802964; Terabe M, 2005, J EXP MED, V202, P1627, DOI 10.1084/jem.20051381; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vincent MS, 2003, NAT IMMUNOL, V4, P517, DOI 10.1038/ni0603-517; Watarai H, 2008, NAT PROTOC, V3, P70, DOI 10.1038/nprot.2007.515; WEIDMANN E, 1995, ANN HEMATOL, V70, P153, DOI 10.1007/s002770050049; Yue SC, 2005, P NATL ACAD SCI USA, V102, P11811, DOI 10.1073/pnas.0503366102; Zhou JH, 2004, CELL MOL IMMUNOL, V1, P247	65	68	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20702	10.1371/journal.pone.0020702	http://dx.doi.org/10.1371/journal.pone.0020702			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695190	Green Submitted, Green Published, gold			2022-12-25	WOS:000291663300012
J	Kirsten, I; Sewangi, J; Kunz, A; Dugange, F; Ziske, J; Jordan-Harder, B; Harms, G; Theuring, S				Kirsten, Inga; Sewangi, Julius; Kunz, Andrea; Dugange, Festo; Ziske, Judith; Jordan-Harder, Brigitte; Harms, Gundel; Theuring, Stefanie			Adherence to Combination Prophylaxis for Prevention of Mother-to-Child-Transmission of HIV in Tanzania	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; IMMUNODEFICIENCY-VIRUS TYPE-1; SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; PMTCT PROGRAM; SOUTH-AFRICA; VIRAL LOAD; ZIDOVUDINE; RESISTANCE; UGANDA	Background: Since 2008, Tanzanian guidelines for prevention of mother-to-child-transmission of HIV (PMTCT) recommend combination regimen for mother and infant starting in gestational week 28. Combination prophylaxis is assumed to be more effective and less prone to resistance formation compared to single-drug interventions, but the required continuous collection and intake of drugs might pose a challenge on adherence especially in peripheral resource-limited settings. This study aimed at analyzing adherence to combination prophylaxis under field conditions in a rural health facility in Kyela, Tanzania. Methods and Findings: A cohort of 122 pregnant women willing to start combination prophylaxis in Kyela District Hospital was enrolled in an observational study. Risk factors for decline of prophylaxis were determined, and adherence levels before, during and after delivery were calculated. In multivariate analysis, identified risk factors for declining pre-delivery prophylaxis included maternal age below 24 years, no income-generating activity, and enrolment before 24.5 gestational weeks, with odds ratios of 5.8 (P = 0.002), 4.4 (P = 0.015) and 7.8 (P = 0.001), respectively. Women who stated to have disclosed their HIV status were significantly more adherent in the pre-delivery period than women who did not (P = 0.004). In the intra-and postpartum period, rather low drug adherence rates during hospitalization indicated unsatisfactory staff performance. Only ten mother-child pairs were at least 80% adherent during all intervention phases; one single mother-child pair met a 95% adherence threshold. Conclusions: Achieving adherence to combination prophylaxis has shown to be challenging in this rural study setting. Our findings underline the need for additional supervision for PMTCT staff as well as for clients, especially by encouraging them to seek social support through status disclosure. Prophylaxis uptake might be improved by preponing drug intake to an earlier gestational age. Limited structural conditions of a healthcare setting should be taken into serious account when implementing PMTCT combination prophylaxis.	[Kirsten, Inga; Kunz, Andrea; Ziske, Judith; Jordan-Harder, Brigitte; Harms, Gundel; Theuring, Stefanie] Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany; [Sewangi, Julius] Minist Hlth & Social Welf, Reg AIDS Control Program Mbeya Reg, Dar Es Salaam, Tanzania; [Dugange, Festo] Kyela Dist Hosp, Minist Hlth & Social Welf, Dar Es Salaam, Tanzania	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kirsten, I (corresponding author), Charite, Inst Trop Med & Int Hlth, D-13353 Berlin, Germany.	stefanie.theuring@charite.de			German Ministry of Economic Cooperation	German Ministry of Economic Cooperation	The study was supported by the German Ministry of Economic Cooperation through the GTZ Sector Project "Strengthening the German Contribution to the Global AIDS Response". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2022, WORLD HLTH STAT; Arrive E, 2007, INT J EPIDEMIOL, V36, P1009, DOI 10.1093/ije/dym104; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Chi BH, 2009, INT J EPIDEMIOL, V38, P746, DOI 10.1093/ije/dyp004; Conkling M, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-10; Dabis F, 2005, AIDS, V19, P309; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Garcia PM, 1999, NEW ENGL J MED, V341, P394, DOI 10.1056/NEJM199908053410602; Gill CJ, 2005, AIDS, V19, P1243, DOI 10.1097/01.aids.0000180094.04652.3b; *GOV KEN, 2009, GUID PREV MOTH CHILD; *GOV MAL, 2008, PREV MOTH CHILD TRAN; Gross R, 2001, AIDS, V15, P2109, DOI 10.1097/00002030-200111090-00006; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Hall M., 2009, SIGKDD EXPLOR, V11, P10, DOI [DOI 10.1145/1656274.1656278, 10.1145/1656274.1656278]; Karcher Heiko, 2006, J Int AIDS Soc, V8, P12, DOI 10.1186/1758-2652-8-2-12; Karcher H, 2007, TROP MED INT HEALTH, V12, P687, DOI 10.1111/j.1365-3156.2007.01830.x; Lallemant M, 2000, NEW ENGL J MED, V343, P982, DOI 10.1056/NEJM200010053431401; Levy JM, 2009, REPROD HEALTH MATTER, V17, P152, DOI 10.1016/S0968-8080(09)33436-9; Maga G, 1997, J MOL BIOL, V274, P738, DOI 10.1006/jmbi.1997.1427; Maman S, 2004, GENDER DIMENSIONS HI; McIntyre JA, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000172; Meda N, 2002, AIDS, V16, P2323, DOI 10.1097/00002030-200211220-00013; Meda N, 2011, LANCET INFECT DIS, V11, P171, DOI 10.1016/S1473-3099(10)70288-7; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; Mugusi F, 2009, TROP MED INT HEALTH, V14, P1226, DOI 10.1111/j.1365-3156.2009.02359.x; Nachega JB, 2004, AIDS RES HUM RETROV, V20, P1053, DOI 10.1089/aid.2004.20.1053; *NBS, 2008, TANZ HIV MAL IND SUR; Norman A, 2007, AM J PUBLIC HEALTH, V97, P1775, DOI 10.2105/AJPH.2005.082511; Nuwagaba-Biribonwoha H, 2007, J PUBLIC HEALTH-UK, V29, P269, DOI 10.1093/pubmed/fdm025; SARNA A, 2006, CURRENT RES GOOD PRA; Sikka R, 2005, AM J MANAG CARE, V11, P453; Smith RJ, 2006, P ROY SOC B-BIOL SCI, V273, P617, DOI 10.1098/rspb.2005.3352; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Theuring S, 2009, AIDS BEHAV, V13, pS92, DOI 10.1007/s10461-009-9543-0; Tonwe-Gold B, 2007, PLOS MED, V4, P1362, DOI 10.1371/journal.pmed.0040257; *UN DEV PROGR, 2008, HUM DEV IND; *UN REP TANZ, 2007, PREV MOTH TO CHILD T; UNAIDS, 2010, GLOB REP UNAIDS REP; *UNAIDS, 2004, UN REP TANZ EP FACT; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; WHO, 2006, ANT DRUGS TREAT PREG; *WHO, 2007, CHRON HIV CAR ARV TH; *WHO GLOB DAT BANK, 2009, TANZ DEM HLTH SURV 2; World Health Organization, 2021, ANT DRUGS TREAT PREG; Wouters E, 2008, AIDS, V22, P2545, DOI 10.1097/QAD.0b013e32831c5562	49	61	61	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21020	10.1371/journal.pone.0021020	http://dx.doi.org/10.1371/journal.pone.0021020			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695214	Green Published, gold			2022-12-25	WOS:000291612600041
J	Giessel, AJ; Sabatini, BL				Giessel, Andrew J.; Sabatini, Bernardo L.			Boosting of Synaptic Potentials and Spine Ca Transients by the Peptide Toxin SNX-482 Requires Alpha-1E-Encoded Voltage-Gated Ca Channels	PLOS ONE			English	Article							DENDRITIC SPINES; SK CHANNELS; CALCIUM-CHANNELS; RECEPTORS; PLASTICITY; NEURONS	The majority of glutamatergic synapses formed onto principal neurons of the mammalian central nervous system are associated with dendritic spines. Spines are tiny protuberances that house the proteins that mediate the response of the postsynaptic cell to the presynaptic release of glutamate. Postsynaptic signals are regulated by an ion channel signaling cascade that is active in individual dendritic spines and involves voltage-gated calcium (Ca) channels, small conductance (SK)-type Ca-activated potassium channels, and NMDA-type glutamate receptors. Pharmacological studies using the toxin SNX-482 indicated that the voltage-gated Ca channels that signal within spines to open SK channels belong to the class Ca(V)2.3, which is encoded by the Alpha-1E pore-forming subunit. In order to specifically test this conclusion, we examined the effects of SNX-482 on synaptic signals in acute hippocampal slices from knock-out mice lacking the Alpha-1E gene. We find that in these mice, application of SNX-482 has no effect on glutamate-uncaging evoked synaptic potentials and Ca influx, indicating that that SNX-482 indeed acts via the Alpha-1E-encoded Ca(V)2.3 channel.	[Giessel, Andrew J.; Sabatini, Bernardo L.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Giessel, AJ (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Neurobiol, Boston, MA 02115 USA.	bsabatini@hms.harvard.edu		Giessel, Andrew/0000-0002-0334-2984	National Institute of Neurological Disorders and Stroke [NS046579, F31 NS065647]; Quan Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS065647, R37NS046579, R01NS046579] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Quan Predoctoral Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institute of Neurological Disorders and Stroke (NS046579 to BLS and F31 NS065647 to AJG). AJG was also supported by a Quan Predoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloodgood BL, 2007, NEURON, V53, P249, DOI 10.1016/j.neuron.2006.12.017; Bloodgood BL, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000190; Bourinet E, 2001, BIOPHYS J, V81, P79, DOI 10.1016/S0006-3495(01)75681-0; Buchanan KA, 2010, NEURON, V68, P948, DOI 10.1016/j.neuron.2010.11.018; Busetto G, 2008, J PHYSIOL-LONDON, V586, P1519, DOI 10.1113/jphysiol.2007.149336; Carter AG, 2004, NEURON, V44, P483, DOI 10.1016/j.neuron.2004.10.013; Faber ESL, 2005, NAT NEUROSCI, V8, P635, DOI 10.1038/nn1450; Giessel AJ, 2010, NEURON, V68, P936, DOI 10.1016/j.neuron.2010.09.004; Newcomb R, 1998, BIOCHEMISTRY-US, V37, P15353, DOI 10.1021/bi981255g; Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Stackman RW, 2002, J NEUROSCI, V22, P10163; Wilson SM, 2000, J NEUROSCI, V20, P8566	13	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20939	10.1371/journal.pone.0020939	http://dx.doi.org/10.1371/journal.pone.0020939			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695265	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900041
J	Stelter, C; Kappeli, R; Konig, C; Krah, A; Hardt, WD; Stecher, B; Bumann, D				Stelter, Christian; Kaeppeli, Rina; Koenig, Claudia; Krah, Alexander; Hardt, Wolf-Dietrich; Stecher, Baerbel; Bumann, Dirk			Salmonella-Induced Mucosal Lectin RegIII beta Kills Competing Gut Microbiota	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; PEPTIDOGLYCAN RECOGNITION; INTESTINAL COLONIZATION; PATHOGENICITY ISLAND-1; DIGESTIVE-TRACT; GENE-EXPRESSION; MOUSE MODEL; MICE; LACTOBACILLUS	Intestinal inflammation induces alterations of the gut microbiota and promotes overgrowth of the enteric pathogen Salmonella enterica by largely unknown mechanisms. Here, we identified a host factor involved in this process. Specifically, the C-type lectin RegIII beta is strongly upregulated during mucosal infection and released into the gut lumen. In vitro, RegIII beta kills diverse commensal gut bacteria but not Salmonella enterica subspecies I serovar Typhimurium (S. Typhimurium). Protection of the pathogen was attributable to its specific cell envelope structure. Co-infection experiments with an avirulent S. Typhimurium mutant and a RegIII beta-sensitive commensal E. coli strain demonstrated that feeding of RegIII beta was sufficient for suppressing commensals in the absence of all other changes inflicted by mucosal disease. These data suggest that RegIII beta production by the host can promote S. Typhimurium infection by eliminating inhibitory gut microbiota.	[Stelter, Christian; Bumann, Dirk] Hannover Med Sch, Inst Immunol, Jr Grp, D-3000 Hannover, Germany; [Kaeppeli, Rina; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8092 Zurich, Switzerland; [Koenig, Claudia; Krah, Alexander; Bumann, Dirk] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Stecher, Baerbel] Max von Pettenkofer Inst, Arbeitsgrp Mikrobiota & Infektionen, Munich, Germany; [Bumann, Dirk] Univ Basel, Biozentrum, Basel, Switzerland	Hannover Medical School; Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society; University of Munich; University of Basel	Stelter, C (corresponding author), Hannover Med Sch, Inst Immunol, Jr Grp, D-3000 Hannover, Germany.	Dirk.Bumann@unibas.ch	Stecher, Barbel/B-9940-2019; Stecher, Bärbel/A-2911-2015	Stecher, Bärbel/0000-0002-7445-5193; Hardt, Wolf-Dietrich/0000-0002-9892-6420	DFG [SFB621-A9]; ETH Zurich Research foundation [ETH-08 08-3]	DFG(German Research Foundation (DFG)); ETH Zurich Research foundation(ETH Zurich)	This work was supported by DFG grants SFB621-A9 (DB), and the ETH Zurich Research foundation (ETH-08 08-3; WDH). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Altmeyer M, 2010, INFECT IMMUN, V78, P3420, DOI 10.1128/IAI.00211-10; Ashbolt NJ, 2004, TOXICOLOGY, V198, P229, DOI 10.1016/j.tox.2004.01.030; Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; BOHNHOFF M, 1964, J EXP MED, V120, P805, DOI 10.1084/jem.120.5.805; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Cash HL, 2006, PROTEIN EXPRES PURIF, V48, P151, DOI 10.1016/j.pep.2006.01.014; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; COLLINS FM, 1978, INFECT IMMUN, V21, P41, DOI 10.1128/IAI.21.1.41-47.1978; Coombes BK, 2005, INFECT IMMUN, V73, P7161, DOI 10.1128/IAI.73.11.7161-7169.2005; Cursino L, 2006, J APPL MICROBIOL, V100, P821, DOI 10.1111/j.1365-2672.2006.02834.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dessein R, 2009, GUT, V58, P771, DOI 10.1136/gut.2008.168443; ENDT K, 2010, PLOS PATHOG, P6; Filho-Lima JVM, 2000, J APPL MICROBIOL, V88, P365, DOI 10.1046/j.1365-2672.2000.00973.x; Fischbach MA, 2006, P NATL ACAD SCI USA, V103, P16502, DOI 10.1073/pnas.0604636103; GORDON MA, 2009, NONTYPHOID SALMONE S, V3, P2; Halle S, 2007, INFECT IMMUN, V75, P1577, DOI 10.1128/IAI.01392-06; Hantke K, 2003, P NATL ACAD SCI USA, V100, P3677, DOI 10.1073/pnas.0737682100; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; HEMME D, 1980, ANN INST PASTEUR MIC, VA131, P297; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; HONE D, 1987, J INFECT DIS, V156, P167, DOI 10.1093/infdis/156.1.167; Ilg K, 2009, INFECT IMMUN, V77, P2568, DOI 10.1128/IAI.01537-08; KANDLER O, 1968, J BACTERIOL, V96, P1935, DOI 10.1128/JB.96.6.1935-1939.1968; KANIGA K, 1994, MOL MICROBIOL, V13, P555, DOI 10.1111/j.1365-2958.1994.tb00450.x; Keilbaugh SA, 2005, GUT, V54, P623, DOI 10.1136/gut.2004.056028; Lawley TD, 2008, INFECT IMMUN, V76, P403, DOI 10.1128/IAI.01189-07; Lawley TD, 2009, INFECT IMMUN, V77, P3661, DOI 10.1128/IAI.00558-09; Layton Abigail N., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000373; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Lim JH, 2006, J BIOL CHEM, V281, P8286, DOI 10.1074/jbc.M513030200; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Ma AT, 2010, P NATL ACAD SCI USA, V107, P4365, DOI 10.1073/pnas.0915156107; Millette M, 2008, APPL ENVIRON MICROB, V74, P1997, DOI 10.1128/AEM.02150-07; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rodenburg W, 2007, PHYSIOL GENOMICS, V30, P123, DOI 10.1152/physiolgenomics.00190.2006; Rodenburg W, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-84; Sansonetti PJ, 2008, CURR OPIN GASTROEN, V24, P435, DOI 10.1097/MOG.0b013e32830007f7; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stecher B, 2011, CURR OPIN MICROBIOL, V14, P82, DOI 10.1016/j.mib.2010.10.003; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Stoycheva Mariana V, 2006, Folia Med (Plovdiv), V48, P5; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103; Trent MS, 2001, J BIOL CHEM, V276, P9083, DOI 10.1074/jbc.M010730200; Tu X, 2006, P NATL ACAD SCI USA, V103, P13503, DOI 10.1073/pnas.0606026103; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; VANDERWAAIJ D, 1971, J HYG-CAMB, V69, P405, DOI 10.1017/S0022172400021653; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Whitfield C, 2003, J ENDOTOXIN RES, V9, P244, DOI 10.1179/096805103225001440; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415	65	89	93	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20749	10.1371/journal.pone.0020749	http://dx.doi.org/10.1371/journal.pone.0020749			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694778	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900022
J	Auersperg, AMI; von Bayern, AMP; Gajdon, GK; Huber, L; Kacelnik, A				Auersperg, Alice M. I.; von Bayern, Auguste M. P.; Gajdon, Gyula K.; Huber, Ludwig; Kacelnik, Alex			Flexibility in Problem Solving and Tool Use of Kea and New Caledonian Crows in a Multi Access Box Paradigm	PLOS ONE			English	Article							NESTOR-NOTABILIS; EVOLUTION; INTELLIGENCE; BIRDS; MANUFACTURE; CULTURE; OBJECTS; ROOKS	Parrots and corvids show outstanding innovative and flexible behaviour. In particular, kea and New Caledonian crows are often singled out as being exceptionally sophisticated in physical cognition, so that comparing them in this respect is particularly interesting. However, comparing cognitive mechanisms among species requires consideration of non-cognitive behavioural propensities and morphological characteristics evolved from different ancestry and adapted to fit different ecological niches. We used a novel experimental approach based on a Multi-Access-Box (MAB). Food could be extracted by four different techniques, two of them involving tools. Initially all four options were available to the subjects. Once they reached criterion for mastering one option, this task was blocked, until the subjects became proficient in another solution. The exploratory behaviour differed considerably. Only one (of six) kea and one (of five) NCC mastered all four options, including a first report of innovative stick tool use in kea. The crows were more efficient in using the stick tool, the kea the ball tool. The kea were haptically more explorative than the NCC, discovered two or three solutions within the first ten trials (against a mean of 0.75 discoveries by the crows) and switched more quickly to new solutions when the previous one was blocked. Differences in exploration technique, neophobia and object manipulation are likely to explain differential performance across the set of tasks. Our study further underlines the need to use a diversity of tasks when comparing cognitive traits between members of different species. Extension of a similar method to other taxa could help developing a comparative cognition research program.	[Auersperg, Alice M. I.; Gajdon, Gyula K.; Huber, Ludwig] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Auersperg, Alice M. I.; Gajdon, Gyula K.] Konrad Lorenz Inst Ethol, Vienna, Austria; [von Bayern, Auguste M. P.; Kacelnik, Alex] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Vienna; University of Oxford	Auersperg, AMI (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	alice_bayern@hotmail.com		von Bayern, Auguste/0000-0002-0981-9456; Huber, Ludwig/0000-0002-0217-136X; Auersperg, Alice/0000-0001-7405-9791	Fond zur Forderung der Wissenschaftlichen Forschung in Osterreich, FWF [19087]; EU; European Science Foundation, ESF	Fond zur Forderung der Wissenschaftlichen Forschung in Osterreich, FWF(Austrian Science Fund (FWF)); EU(European Commission); European Science Foundation, ESF(European Science Foundation (ESF))	Involved in funding the kea studies were the FWF; Fond zur Forderung der Wissenschaftlichen Forschung in Osterreich (Project 19087 to Ludwig Huber) as well as the EU (ERC grant SOMACCA to T. Fitch). The crow studies presented were supported by the ESF; European Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperg AMI, 2010, ANIM BEHAV, V80, P783, DOI 10.1016/j.anbehav.2010.08.007; Auersperg AMI, 2009, BIOL LETTERS, V5, P455, DOI 10.1098/rsbl.2009.0114; BALDA RP, 1989, ANIM BEHAV, V38, P486, DOI 10.1016/S0003-3472(89)80041-7; Bird CD, 2009, P NATL ACAD SCI USA, V106, P10370, DOI 10.1073/pnas.0901008106; BITTERMAN ME, 1965, SCI AM, V212, P92, DOI 10.1038/scientificamerican0165-92; Bluff LA, 2007, COMP COGN BEHAV REV, V2, P1; Bluff LA, 2010, BIOL J LINN SOC, V101, P767, DOI 10.1111/j.1095-8312.2010.01527.x; Bugnyar T, 1997, ANIM BEHAV, V54, P817, DOI 10.1006/anbe.1996.0497; DAWSON BV, 1965, ANIM BEHAV, V13, P470, DOI 10.1016/0003-3472(65)90108-9; Diamond J., 1999, KEA BIRD PARADOX EVO; Emery NJ, 2009, CURR OPIN NEUROBIOL, V19, P27, DOI 10.1016/j.conb.2009.02.003; Emery NJ, 2006, PHILOS T R SOC B, V361, P23, DOI 10.1098/rstb.2005.1736; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; GAJDON GK, INTERACTION IN PRESS; Greenberg R, 2001, CURR ORNITHOL, V16, P119; Hansell M, 2008, TRENDS ECOL EVOL, V23, P73, DOI 10.1016/j.tree.2007.10.006; Herrmann E, 2010, PSYCHOL SCI, V21, P102, DOI 10.1177/0956797609356511; Heyes C., 1990, MIND LANG, V5, P87, DOI DOI 10.1111/J.1468-0017.1990.TB00154.X; Huber L, 2001, ANIM BEHAV, V62, P945, DOI 10.1006/anbe.2001.1822; Huber L, 2006, ANIM COGN, V9, P295, DOI 10.1007/s10071-006-0033-8; Hunt GR, 1996, NATURE, V379, P249, DOI 10.1038/379249a0; Jackson J. R., 1963, Notornis, V10, P319; Kamil AC, 1988, COMP PERSPECTIVES MO, P230; Kenward B, 2005, NATURE, V433, P121, DOI 10.1038/433121a; Kenward B, 2006, ANIM BEHAV, V72, P1329, DOI 10.1016/j.anbehav.2006.04.007; Kulemeyer C, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-2; Lefebvre L, 1997, ANIM BEHAV, V53, P549, DOI 10.1006/anbe.1996.0330; Lefebvre Louis, 1996, P107, DOI 10.1016/B978-012273965-1/50007-8; Liedtke J, 2011, ANIM COGN, V14, P143, DOI 10.1007/s10071-010-0347-4; MYIATA H, 2010, ANIMAL COGNITION, V14, P45; Overington SE, 2009, ANIM BEHAV, V78, P1001, DOI 10.1016/j.anbehav.2009.06.033; Pepperberg I., 1999, THE ALEX STUDIES; Rutz C, 2010, SCIENCE, V329, P1523, DOI 10.1126/science.1192053; Schloegl C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006368; Shettleworth S.J., 2009, COGNITION EVOLUTION; Striedter G.F., 2005, PRINCIPLES BRAIN EVO; Taylor AH, 2009, P R SOC B, V276, P247, DOI 10.1098/rspb.2008.1107; Taylor AH, 2007, CURR BIOL, V17, P1504, DOI 10.1016/j.cub.2007.07.057; Tebbich S, 2001, P ROY SOC B-BIOL SCI, V268, P2189, DOI 10.1098/rspb.2001.1738; Tebbich S, 2007, ANIM COGN, V10, P225, DOI 10.1007/s10071-006-0061-4; Tebbich S, 2010, PHILOS T R SOC B, V365, P1099, DOI 10.1098/rstb.2009.0291; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; von Bayern AMP, 2009, CURR BIOL, V19, P1965, DOI 10.1016/j.cub.2009.10.037; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Werdenich D, 2006, ANIM BEHAV, V71, P855, DOI 10.1016/j.anbehav.2005.06.018; Whiten A, 1996, J COMP PSYCHOL, V110, P3, DOI 10.1037/0735-7036.110.1.3; Wimpenny JH, 2011, ANIM COGN, V14, P459, DOI 10.1007/s10071-010-0366-1; Wimpenny JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006471	48	122	124	2	139	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20231	10.1371/journal.pone.0020231	http://dx.doi.org/10.1371/journal.pone.0020231			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687666	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500010
J	Huang, CQ; Andres, AM; Ratliff, EP; Hernandez, G; Lee, P; Gottlieb, RA				Huang, Chengqun; Andres, Allen M.; Ratliff, Eric P.; Hernandez, Genaro; Lee, Pamela; Gottlieb, Roberta A.			Preconditioning Involves Selective Mitophagy Mediated by Parkin and p62/SQSTM1	PLOS ONE			English	Article							AUTOPHAGY; MITOCHONDRIA; PINK1; DEGRADATION; PROTECTION; INDUCTION; DISEASE; INJURY; VDAC1	Autophagy-dependent mitochondrial turnover in response to cellular stress is necessary for maintaining cellular homeostasis. However, the mechanisms that govern the selective targeting of damaged mitochondria are poorly understood. Parkin, an E3 ubiquitin ligase, has been shown to be essential for the selective clearance of damaged mitochondria. Parkin is expressed in the heart, yet its function has not been investigated in the context of cardioprotection. We previously reported that autophagy is required for cardioprotection by ischemic preconditioning (IPC). In the present study, we used simulated ischemia (sI) in vitro and IPC of hearts to investigate the role of Parkin in mediating cardioprotection ex vivo and in vivo. In HL-1 cells, sI induced Parkin translocation to mitochondria and mitochondrial elimination. IPC induced Parkin translocation to mitochondria in Langendorff-perfused rat hearts and in vivo in mice subjected to regional IPC. Mitochondrial depolarization with an uncoupling agent similarly induced Parkin translocation to mitochondria in cells and Langendorff-perfused rat hearts. Mitochondrial loss was blunted in Atg5-deficient cells, revealing the requirement for autophagy in mitochondrial elimination. Consistent with previous reports indicating a role for p62/SQSTM1 in mitophagy, we found that depletion of p62 attenuated mitophagy and exacerbated cell death in HL-1 cardiomyocytes subjected to sI. While wild type mice showed p62 translocation to mitochondria and an increase in ubiquitination, Parkin knockout mice exhibited attenuated IPC-induced p62 translocation to the mitochondria. Importantly, ablation of Parkin in mice abolished the cardioprotective effects of IPC. These results reveal for the first time the crucial role of Parkin and mitophagy in cardioprotection.	[Huang, Chengqun; Andres, Allen M.; Ratliff, Eric P.; Hernandez, Genaro; Lee, Pamela; Gottlieb, Roberta A.] San Diego State Univ, BioSci Ctr, San Diego, CA 92182 USA	California State University System; San Diego State University	Huang, CQ (corresponding author), San Diego State Univ, BioSci Ctr, San Diego, CA 92182 USA.	robbieg@sciences.sdsu.edu		Hernandez, Genaro/0000-0003-3666-8769; Gottlieb, Roberta/0000-0002-1432-006X	NIH [5R01HL060590-14, 5R01AG033283-04]; SDSU MBRS/IMSD [2R25GM058906-09A2];  [3R01AG033283-02S1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060590] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM058906] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033283] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SDSU MBRS/IMSD; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH 5R01HL060590-14 and 5R01AG033283-04 to RAG. AA is supported by 3R01AG033283-02S1 and GH is supported by SDSU MBRS/IMSD Program 2R25GM058906-09A2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Brennan JP, 2006, CARDIOVASC RES, V72, P313, DOI 10.1016/j.cardiores.2006.07.019; Bueler H, 2010, APOPTOSIS, V15, P1336, DOI 10.1007/s10495-010-0465-0; Carreira RS, 2010, AUTOPHAGY, V6, P462, DOI 10.4161/auto.6.4.11553; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; DECKER RS, 1980, AM J PATHOL, V98, P425; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Dodson MW, 2007, CURR OPIN NEUROBIOL, V17, P331, DOI 10.1016/j.conb.2007.04.010; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GOTTLIEB RA, 2010, BIOCH BIOPH IN PRESS; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hausenloy DJ, 2009, BASIC RES CARDIOL, V104, P189, DOI 10.1007/s00395-009-0010-x; HUANG C, 2009, AM J PHYSL HEART CIR; HUANG C, 2010, J CARDIOVASC TRANSL; HUANG C, J CARDIOVASCULAR TRA, V3, P365; Huang CQ, 2010, J CARDIOVASC TRANSL, V3, P365, DOI 10.1007/s12265-010-9189-3; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; KIM I, AM J PHYSL CELL PHYS; KIM I, ANTIOXID REDOX SIGNA; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kitada T, 2000, MAMM GENOME, V11, P417, DOI 10.1007/s003350010080; Korge P, 2002, P NATL ACAD SCI USA, V99, P3312, DOI 10.1073/pnas.052713199; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Narendra D, 2009, AUTOPHAGY, V5, P706, DOI 10.4161/auto.5.5.8505; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Poole AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010054; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Sybers H D, 1976, Recent Adv Stud Cardiac Struct Metab, V12, P453; Vives-Bauza C, 2010, AUTOPHAGY, V6, P315, DOI 10.4161/auto.6.2.11199; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Willis MS, 2010, CIRCULATION, V122, P1740, DOI 10.1161/CIRCULATIONAHA.110.942250; Yuan H, 2009, AM J PHYSIOL-HEART C, V296, pH470, DOI 10.1152/ajpheart.01051.2008; Zesiewicz TA, 2004, PARKINSONISM RELAT D, V10, P417, DOI 10.1016/j.parkreldis.2004.04.001; Ziviani E, 2010, P NATL ACAD SCI USA, V107, P5018, DOI 10.1073/pnas.0913485107	45	246	259	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20975	10.1371/journal.pone.0020975	http://dx.doi.org/10.1371/journal.pone.0020975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687634	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500055
J	Symons, N; Svensson, PA; Wong, BBM				Symons, Nicholas; Svensson, P. Andreas; Wong, Bob B. M.			Do Male Desert Gobies Compromise Offspring Care to Attract Additional Mating Opportunities?	PLOS ONE			English	Article							MALE PARENTAL CARE; SEXUAL SELECTION; MALE COMPETITION; FEMALE CHOICE; PATERNAL CARE; SAND GOBY; POMATOSCHISTUS-MINUTUS; REPRODUCTIVE SUCCESS; DWELLING FISH; BENEFITS	Males often play a critical role in offspring care but the time and energy invested in looking after young can potentially limit their ability to seek out additional mating opportunities. Recent studies, however, suggest that a conflict between male parental effort and mating effort may not always be inevitable, especially if breeding occurs near the nest, or if parental behaviours are under sexual selection. Accordingly, we set out to experimentally investigate male care and courtship in the desert goby Chlamydogobius eremius, a nest-guarding fish with exclusive paternal care. Despite courtship occurring near the nest, we found that when egg-tending males were given the opportunity to attract additional females, they fanned their eggs less often, engaged in shorter fanning bouts, and spent more of their time outside their nests courting. Our findings highlight the importance of understanding the circumstances under which reproductive tradeoffs are expected to occur and how these, in turn, operate to influence male reproductive decisions.	[Symons, Nicholas; Svensson, P. Andreas; Wong, Bob B. M.] Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia	Monash University	Symons, N (corresponding author), Monash Univ, Sch Biol Sci, Melbourne, Vic 3004, Australia.	bob.wong@monash.edu	Svensson, P Andreas/D-2517-2015	Svensson, P Andreas/0000-0002-1426-0036; Wong, Bob/0000-0001-9352-6500	Australian Research Council; Nature Conservation South Australia	Australian Research Council(Australian Research Council); Nature Conservation South Australia	This work was funded by an Australian Research Council grant to BBMW and a Nature Conservation South Australia grant to BBMW and PAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BISAZZA A, 1989, ANIM BEHAV, V38, P406, DOI 10.1016/S0003-3472(89)80033-8; Bjelvenmark J, 2003, BEHAVIOUR, V140, P55, DOI 10.1163/156853903763999890; BURLEY N, 1986, AM NAT, V127, P415, DOI 10.1086/284493; Forsgren E, 1996, BEHAV ECOL SOCIOBIOL, V39, P91, DOI 10.1007/s002650050270; Glover CJM, 1971, THESIS U ADELAIDE; Hale RE, 2007, ANIM BEHAV, V74, P577, DOI 10.1016/j.anbehav.2006.12.013; HASTINGS PA, 1988, ANIM BEHAV, V36, P115, DOI 10.1016/S0003-3472(88)80254-9; Jones JC, 1999, ANIM BEHAV, V57, P189, DOI 10.1006/anbe.1998.0940; KEENLEYSIDE MHA, 1983, ANIM BEHAV, V31, P683, DOI 10.1016/S0003-3472(83)80223-1; KNAPP RA, 1991, BEHAV ECOL, V2, P295, DOI 10.1093/beheco/2.4.295; Kokko H, 2008, J EVOLUTION BIOL, V21, P919, DOI 10.1111/j.1420-9101.2008.01540.x; KUNZLER R, 2000, P ROY SOC LOND B BIO, V267, P994; Lindstrom K, 2006, BEHAV ECOL SOCIOBIOL, V60, P46, DOI 10.1007/s00265-005-0138-0; LINDSTROM K, 1992, MAR BIOL, V113, P475, DOI 10.1007/BF00349174; Lindstrom K, 1998, BEHAV ECOL SOCIOBIOL, V42, P101, DOI 10.1007/s002650050417; Magrath MJL, 1997, P ROY SOC B-BIOL SCI, V264, P1731, DOI 10.1098/rspb.1997.0240; Magrath MJL, 2003, TRENDS ECOL EVOL, V18, P424, DOI 10.1016/S0169-5347(03)00124-1; MARCONATO A, 1993, BEHAV ECOL SOCIOBIOL, V32, P229; Moller AP, 2001, NATURWISSENSCHAFTEN, V88, P401, DOI 10.1007/s001140100255; Ostlund S, 1998, ANIM BEHAV, V56, P1177, DOI 10.1006/anbe.1998.0878; Pampoulie C, 2004, BEHAV ECOL, V15, P199, DOI 10.1093/beheco/arg107; Pryke SR, 2010, BEHAV ECOL, V21, P226, DOI 10.1093/beheco/arp180; Qvarnstrom A, 1997, P ROY SOC B-BIOL SCI, V264, P1225, DOI 10.1098/rspb.1997.0169; R Development Core Team, 2009, R FDN STAT COMP; Reguera P, 1999, BEHAV ECOL, V10, P541, DOI 10.1093/beheco/10.5.541; Requena GS, 2009, ANIM BEHAV, V78, P1169, DOI 10.1016/j.anbehav.2009.07.035; Sheldon BC, 2000, TRENDS ECOL EVOL, V15, P397, DOI 10.1016/S0169-5347(00)01953-4; Stiver KA, 2009, ETHOLOGY, V115, P1101, DOI 10.1111/j.1439-0310.2009.01707.x; Svensson PA, 2010, BEHAV ECOL SOCIOBIOL, V64, P1967, DOI 10.1007/s00265-010-1007-z; Thompson GG, 2002, COMP BIOCHEM PHYS A, V131, P871, DOI 10.1016/S1095-6433(02)00035-1; Wong BBM, 2004, ANIM BEHAV, V67, P583, DOI 10.1016/j.anbehav.2003.08.015; Wong BBM, 2009, BEHAV ECOL SOCIOBIOL, V63, P543, DOI 10.1007/s00265-008-0689-y	33	7	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20576	10.1371/journal.pone.0020576	http://dx.doi.org/10.1371/journal.pone.0020576			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687677	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500030
J	Voineskos, AN; Lett, TAP; Lerch, JP; Tiwari, AK; Ameis, SH; Rajji, TK; Muller, DJ; Mulsant, BH; Kennedy, JL				Voineskos, Aristotle N.; Lett, Tristram A. P.; Lerch, Jason P.; Tiwari, Arun K.; Ameis, Stephanie H.; Rajji, Tarek K.; Mueller, Daniel J.; Mulsant, Benoit H.; Kennedy, James L.			Neurexin-1 and Frontal Lobe White Matter: An Overlapping Intermediate Phenotype for Schizophrenia and Autism Spectrum Disorders	PLOS ONE			English	Article							COPY NUMBER VARIATION; ADOLESCENT-ONSET SCHIZOPHRENIA; EXCITATORY SYNAPSE FORMATION; DEVELOPMENTAL DISORDERS; STRUCTURAL VARIANTS; NICOTINE DEPENDENCE; ASPERGERS-SYNDROME; PREFRONTAL CORTEX; BIPOLAR DISORDER; BRAIN ANATOMY	Background: Structural variation in the neurexin-1 (NRXN1) gene increases risk for both autism spectrum disorders (ASD) and schizophrenia. However, the manner in which NRXN1 gene variation may be related to brain morphology to confer risk for ASD or schizophrenia is unknown. Method/Principal Findings: 53 healthy individuals between 18-59 years of age were genotyped at 11 single nucleotide polymorphisms of the NRXN1 gene. All subjects received structural MRI scans, which were processed to determine cortical gray and white matter lobar volumes, and volumes of striatal and thalamic structures. Each subject's sensorimotor function was also assessed. The general linear model was used to calculate the influence of genetic variation on neural and cognitive phenotypes. Finally, in silico analysis was conducted to assess potential functional relevance of any polymorphisms associated with brain measures. A polymorphism located in the 39 untranslated region of NRXN1 significantly influenced white matter volumes in whole brain and frontal lobes after correcting for total brain volume, age and multiple comparisons. Follow-up in silico analysis revealed that this SNP is a putative microRNA binding site that may be of functional significance in regulating NRXN1 expression. This variant also influenced sensorimotor performance, a neurocognitive function impaired in both ASD and schizophrenia. Conclusions: Our findings demonstrate that the NRXN1 gene, a vulnerability gene for SCZ and ASD, influences brain structure and cognitive function susceptible in both disorders. In conjunction with our in silico results, our findings provide evidence for a neural and cognitive susceptibility mechanism by which the NRXN1 gene confers risk for both schizophrenia and ASD.	[Voineskos, Aristotle N.; Lett, Tristram A. P.; Tiwari, Arun K.; Rajji, Tarek K.; Mueller, Daniel J.; Mulsant, Benoit H.; Kennedy, James L.] Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Lerch, Jason P.; Ameis, Stephanie H.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Voineskos, AN (corresponding author), Univ Toronto, Ctr Addict & Mental Hlth, Toronto, ON, Canada.	Aristotle_Voineskos@camh.net	Kennedy, James Lowery/AAZ-6947-2020; Tiwari, Arun/AAM-4761-2021; Rajji, Tarek K/K-1543-2015; Ameis, Stephanie H./Q-4822-2018; Müller, Daniel J./L-4159-2016; Voineskos, Aristotle/J-5014-2013; Mueller, Daniel Josef/GVT-7899-2022	Kennedy, James Lowery/0000-0002-8733-3806; Müller, Daniel J./0000-0003-4978-4400; Mueller, Daniel Josef/0000-0003-4978-4400; Tiwari, Arun/0000-0001-9209-2456; Voineskos, Aristotle/0000-0003-0156-0395; Lett, Tristram/0000-0002-0731-9626	Canadian Institutes of Health Research; APA/APIRE Astra-Zeneca; NARSAD; Centre for Addiction and Mental Health; Ontario Mental Health Foundation; Bristo-Meyers Squibb; Eli-Lilly; Pfizer	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); APA/APIRE Astra-Zeneca(AstraZeneca); NARSAD(NARSAD); Centre for Addiction and Mental Health; Ontario Mental Health Foundation; Bristo-Meyers Squibb; Eli-Lilly(Eli Lilly); Pfizer(Pfizer)	This work was supported by the Canadian Institutes of Health Research Clinician Scientist Award (ANV); APA/APIRE Astra-Zeneca Young Minds in Psychiatry Award (ANV), NARSAD (ANV, AKT, TKR) and the Centre for Addiction and Mental Health (AKT). Dr. Muller is supported by the Canadian Institutes of Health Research, Ontario Mental Health Foundation, and NARSAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: JKL: one time honorarium from Eli Lilly Corporation. BHM: research support (medications for federally-funded clinical trials) from Bristo-Meyers Squibb, Eli-Lilly, and Pfizer. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Acosta Maria T, 2004, Semin Pediatr Neurol, V11, P205, DOI 10.1016/j.spen.2004.07.004; Ad-Dabbagh Y, 2006, CIVET IMAGE PROCESSI; Barnea-Goraly N, 2004, BIOL PSYCHIAT, V55, P323, DOI 10.1016/j.biopsych.2003.10.022; Barnea-Goraly N, 2005, CEREB CORTEX, V15, P1848, DOI 10.1093/cercor/bhi062; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bierut LJ, 2007, HUM MOL GENET, V16, P24, DOI 10.1093/hmg/ddl441; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Brambilla P, 2003, BRAIN RES BULL, V61, P557, DOI 10.1016/j.brainresbull.2003.06.001; Brickman AM, 2004, SCHIZOPHR RES, V71, P473, DOI 10.1016/j.schres.2004.03.011; Carroll LS, 2009, GENOME MED, V1, DOI 10.1186/gm102; Chakravarty MM, 2008, MED IMAGE ANAL, V12, P713, DOI 10.1016/j.media.2008.04.003; Ching MSL, 2010, AM J MED GENET B, V153B, P937, DOI 10.1002/ajmg.b.31063; COLLINS D, 1994, NEW ZEAL MED J, V107, P40; Collins DL, 1995, HUM BRAIN MAPP, V3, P190, DOI 10.1002/hbm.460030304; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Coyle JT, 1996, HARVARD REV PSYCHIAT, V3, P241, DOI 10.3109/10673229609017192; CURCIO F, 1978, J AUTISM CHILD SCHIZ, V8, P281, DOI 10.1007/BF01539631; Danos P, 2003, SCHIZOPHR RES, V60, P141, DOI 10.1016/S0920-9964(02)00307-9; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Di X, 2009, PROG NEURO-PSYCHOPH, V33, P1390, DOI 10.1016/j.pnpbp.2009.08.020; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Dumontheil I, 2008, DEV MED CHILD NEUROL, V50, P168, DOI 10.1111/j.1469-8749.2008.02026.x; Etherton MR, 2009, P NATL ACAD SCI USA, V106, P17998, DOI 10.1073/pnas.0910297106; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; First SR MB, 1995, STRUCUTURED CLIN INT; Flashman LA, 1996, AM J PSYCHIAT, V153, P526; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GEYER MA, 1990, BRAIN RES BULL, V25, P485, DOI 10.1016/0361-9230(90)90241-Q; Glessner JT, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-236; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Goldman S, 2009, DEV MED CHILD NEUROL, V51, P30, DOI 10.1111/j.1469-8749.2008.03178.x; GoldmanRakic PS, 1997, SCHIZOPHRENIA BULL, V23, P437, DOI 10.1093/schbul/23.3.437; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Herbert MR, 2004, ANN NEUROL, V55, P530, DOI 10.1002/ana.20032; Herbert MR, 2003, BRAIN, V126, P1182, DOI 10.1093/brain/awg110; Hollingshead A.B., 1975, 4 FACTOR INDEX SOCIA; Honey GD, 2005, BRAIN, V128, P2597, DOI 10.1093/brain/awh632; Ikeda M, 2010, BIOL PSYCHIAT, V67, P283, DOI 10.1016/j.biopsych.2009.08.034; James AC, 2004, AM J PSYCHIAT, V161, P1023, DOI 10.1176/appi.ajp.161.6.1023; Jones EG, 1997, SCHIZOPHRENIA BULL, V23, P483, DOI 10.1093/schbul/23.3.483; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HG, 2008, AM J HUM GENET, V82, P199, DOI 10.1016/j.ajhg.2007.09.011; Kirov G, 2009, SCHIZOPHRENIA BULL, V35, P851, DOI 10.1093/schbul/sbp079; Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Magri C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013422; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Mazziotta J, 2001, J AM MED INFORM ASSN, V8, P401, DOI 10.1136/jamia.2001.0080401; McAlonan GM, 2009, PSYCHOL MED, V39, P1885, DOI 10.1017/S0033291709005728; McAlonan GM, 2002, BRAIN, V125, P1594, DOI 10.1093/brain/awf150; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; McCarley RW, 1999, BIOL PSYCHIAT, V45, P1099, DOI 10.1016/S0006-3223(99)00018-9; McIntosh AM, 2004, BIOL PSYCHIAT, V56, P544, DOI 10.1016/j.biopsych.2004.07.020; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; MENGOTTI P, 2010, BRAIN RES B; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Minshew NJ, 2010, CURR OPIN NEUROL, V23, P124, DOI 10.1097/WCO.0b013e32833782d4; Moreau MP, 2011, BIOL PSYCHIAT, V69, P188, DOI 10.1016/j.biopsych.2010.09.039; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Mostofsky SH, 2009, BRAIN, V132, P2413, DOI 10.1093/brain/awp088; Need AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000373; Novak G, 2009, WORLD J BIOL PSYCHIA, V10, P929, DOI 10.1080/15622970903079499; Nussbaum J, 2008, HUM MOL GENET, V17, P1569, DOI 10.1093/hmg/ddn044; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; PENG RY, 1990, NEUROPSYCHOPHARMACOL, V3, P211; PETTERSSONYEO W, 2010, NEUROSCIENCE BIOBEHA; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Radua J, 2011, PSYCHOL MED, V41, P1539, DOI 10.1017/S0033291710002187; Rajji TK, 2008, SCHIZOPHR RES, V102, P122, DOI 10.1016/j.schres.2008.03.015; Reitan R.M., 1993, HALSTEADREITAN NEURO; Reitan RM, 1985, HALSTEAD REITAN NEUR; Rose SE, 2006, NEUROIMAGE, V32, P16, DOI 10.1016/j.neuroimage.2006.03.003; Rujescu D, 2009, HUM MOL GENET, V18, P988, DOI 10.1093/hmg/ddn351; Scott-Van Zeeland AA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001344; Shah AK, 2010, NEUROSCI LETT, V475, P80, DOI 10.1016/j.neulet.2010.03.047; Shenton ME, 2001, SCHIZOPHR RES, V49, P1, DOI 10.1016/S0920-9964(01)00163-3; Shukla DK, 2010, J AM ACAD CHILD PSY, V49, P1269, DOI 10.1016/j.jaac.2010.08.018; Siddiqui TJ, 2010, J NEUROSCI, V30, P7495, DOI 10.1523/JNEUROSCI.0470-10.2010; SIGMAN M, 1981, J ABNORM CHILD PSYCH, V9, P149, DOI 10.1007/BF00919111; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sundaram SK, 2008, CEREB CORTEX, V18, P2659, DOI 10.1093/cercor/bhn031; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Takarae Y, 2007, PSYCHIAT RES-NEUROIM, V156, P117, DOI 10.1016/j.pscychresns.2007.03.008; TAN GCY, 2010, NEUROIMAGE; Tan HY, 2008, MOL PSYCHIATR, V13, P233, DOI 10.1038/sj.mp.4002145; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Thyagarajan A, 2010, CELL, V143, P456, DOI 10.1016/j.cell.2010.09.025; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Vrijenhoek T, 2008, AM J HUM GENET, V83, P504, DOI 10.1016/j.ajhg.2008.09.011; Welham J, 2009, SCHIZOPHRENIA BULL, V35, P603, DOI 10.1093/schbul/sbn084; Williams DL, 2007, NEUROIMAG CLIN N AM, V17, P495, DOI 10.1016/j.nic.2007.07.007; Yan J, 2008, NEUROSCI LETT, V438, P368, DOI 10.1016/j.neulet.2008.04.074; Yang HC, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S30; Zahir FR, 2008, J MED GENET, V45, P239, DOI 10.1136/jmg.2007.054437; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283; Zweier C, 2009, AM J HUM GENET, V85, P655, DOI 10.1016/j.ajhg.2009.10.004	98	49	51	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20982	10.1371/journal.pone.0020982	http://dx.doi.org/10.1371/journal.pone.0020982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687627	gold, Green Published, Green Submitted			2022-12-25	WOS:000291611500056
J	Edin, ML; Wang, ZJ; Bradbury, JA; Graves, JP; Lih, FB; DeGraff, LM; Foley, JF; Torphy, R; Ronnekleiv, OK; Tomer, KB; Lee, CR; Zeldin, DC				Edin, Matthew L.; Wang, ZhongJing; Bradbury, J. Alyce; Graves, Joan P.; Lih, Fred B.; DeGraff, Laura M.; Foley, Julie F.; Torphy, Robert; Ronnekleiv, Oline K.; Tomer, Kenneth B.; Lee, Craig R.; Zeldin, Darryl C.			Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart	FASEB JOURNAL			English	Article						CYP2J2; EETs; reactive oxygen species; leukotoxin; Langendorff	SOLUBLE EPOXIDE HYDROLASE; EPOXYEICOSATRIENOIC ACIDS; ARACHIDONIC-ACID; LINOLEIC-ACID; MYOCARDIAL-INFARCTION; POSTISCHEMIC RECOVERY; ATHEROSCLEROSIS RISK; CONTRACTILE FUNCTION; GENETIC-VARIATION; DISEASE RISK	Cytochrome P450 (CYP) epoxygenases CYP2C8 and CYP2J2 generate epoxyeicosatrienoic acids (EETs) from arachidonic acid. Mice with expression of CYP2J2 in cardiomyocytes (alpha MHC-CYP2J2 Tr) or treated with synthetic EETs have increased functional recovery after ischemia/reperfusion (I/R); however, no studies have examined the role of cardiomyocyte-vs. endothelial-derived EETs or compared the effects of different CYP epoxygenase isoforms in the ischemic heart. We generated transgenic mice with increased endothelial EET biosynthesis (Tie2-CYP2C8 Tr and Tie2-CYP2J2 Tr) or EET hydrolysis (Tie2-sEH Tr). Compared to wild-type (WT), alpha MHC-CYP2J2 Tr hearts showed increased recovery of left ventricular developed pressure (LVDP) and decreased infarct size after I/R. In contrast, LVDP recovery and infarct size were unchanged in Tie2-CYP2J2 Tr and Tie2-sEH Tr hearts. Surprisingly, compared to WT, Tie2-CYP2C8 Tr hearts had significantly reduced LVDP recovery (from 21 to 14%) and increased infarct size after I/R (from 51 to 61%). Tie2-CYP2C8 Tr hearts also exhibited increased reactive oxygen species (ROS) generation, dihydroxyoctadecenoic acid (DiHOME) formation, and coronary resistance after I/R. ROS scavengers and CYP2C8 inhibition reversed the detrimental effects of CYP2C8 expression in Tie2-CYP2C8 Tr hearts. Treatment of WT hearts with 250 nM 9,10-DiHOME decreased LVDP recovery compared to vehicle (16 vs. 31%, respectively) and increased coronary resistance after I/R. These data demonstrate that increased ROS generation and enhanced DiHOME synthesis by endothelial CYP2C8 impair functional recovery and mask the beneficial effects of increased EET production following I/R.-Edin, M. L., Wang, Z. J., Bradbury, J. A., Graves, J. P., Lih, F. B., DeGraff, L. M., Foley, J. F., Torphy, R., Ronnekleiv, O. K., Tomer, K. B., Lee, C. R., Zeldin, D. C. Endothelial expression of human cytochrome P450 epoxygenase CYP2C8 increases susceptibility to ischemia-reperfusion injury in isolated mouse heart. FASEB J. 25, 3436-3447 (2011). www.fasebj.org	[Edin, Matthew L.; Wang, ZhongJing; Bradbury, J. Alyce; Graves, Joan P.; Lih, Fred B.; DeGraff, Laura M.; Foley, Julie F.; Torphy, Robert; Tomer, Kenneth B.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Ronnekleiv, Oline K.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA; [Ronnekleiv, Oline K.] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Lee, Craig R.] Univ N Carolina, Eshelman Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Oregon Health & Science University; Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill	Zeldin, DC (corresponding author), 111 TW Alexander Dr,Bldg 101,Rm A222, Res Triangle Pk, NC 27709 USA.	zeldin@niehs.nih.gov	Edin, Matthew/AAI-1934-2019; Tomer, Kenneth B/E-8018-2013; Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307; Lee, Craig/0000-0003-3595-5301; Edin, Matthew/0000-0002-7042-500X; Torphy, Robert J/0000-0003-3941-0886	NIH, NIEHS [Z01 ES050167, Z01 ES025034, R01 GM088199]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIGES102505, ZIAES050167, ZIAES025034] Funding Source: NIH RePORTER	NIH, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Bruce Hammock (University of California, Davis, CA, USA) for providing the sEH antibody, Dr. Joyce Goldstein [U.S. National Institutes of Health (NIH)/National Institute for Environmental Health Sciences (NIEHS), Research Triangle Park, NC, USA] for providing the CYP2C8 antibody, and Dr. Tom Sato (University of Texas Southwestern Medical Center, Dallas, TX, USA) for providing the Tie2 promoter construct. The authors also thank staff at Xenogen Biosciences (Cranberry, NJ, USA) for assistance with pronuclear injections and staff in the NIEHS Laboratory of Experimental Pathology (Natasha Clayton and Tiwanda Masinde) for assistance with immunohistochemistry. This work was supported with funds from the Intramural Research Program of the NIH, NIEHS, to K.B.T. (Z01 ES050167), D.C.Z. (Z01 ES025034), and C.R.L. (R01 GM088199).	Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; Campbell WB, 1996, CIRC RES, V78, P415, DOI 10.1161/01.RES.78.3.415; Chaudhary KR, 2010, J CARDIOVASC PHARM, V55, P67, DOI 10.1097/FJC.0b013e3181c37d69; Chaudhary KR, 2009, CARDIOVASC RES, V83, P362, DOI 10.1093/cvr/cvp134; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Chen JY, 1999, MOL PHARMACOL, V55, P288, DOI 10.1124/mol.55.2.288; DAIKH BE, 1994, J PHARMACOL EXP THER, V271, P1427; Deng YM, 2011, FASEB J, V25, P703, DOI 10.1096/fj.10-171488; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; FUKUSHIMA A, 1988, CARDIOVASC RES, V22, P213, DOI 10.1093/cvr/22.3.213; Granville DJ, 2004, P NATL ACAD SCI USA, V101, P1321, DOI 10.1073/pnas.0308185100; Greene JF, 2000, CHEM RES TOXICOL, V13, P217, DOI 10.1021/tx990162c; Gross GJ, 2010, AM J PHYSIOL-HEART C, V298, pH2201, DOI 10.1152/ajpheart.00815.2009; Gross GJ, 2009, CURR OPIN INVEST DR, V10, P253; Gustafsson AB, 2008, CARDIOVASC RES, V77, P334, DOI 10.1093/cvr/cvm005; HANAKI Y, 1991, JPN J MED, V30, P224; Hunter AL, 2005, VASC PHARMACOL, V43, P213, DOI 10.1016/j.vph.2005.07.005; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Katragadda D, 2009, J MOL CELL CARDIOL, V46, P867, DOI 10.1016/j.yjmcc.2009.02.028; King LM, 2002, MOL PHARMACOL, V61, P840, DOI 10.1124/mol.61.4.840; King Lorraine M, 2005, Pharmacogenet Genomics, V15, P7, DOI 10.1097/01213011-200501000-00002; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; KONKEL A, BIOCH BIOPHYS ACTA, V1814, P210; KOSAKA K, 1994, MOL CELL BIOCHEM, V139, P141, DOI 10.1007/BF01081737; Kusmic C, 2006, AM J PHYSIOL-HEART C, V291, pH1814, DOI 10.1152/ajpheart.00220.2006; Lee CR, 2006, HUM MOL GENET, V15, P1640, DOI 10.1093/hmg/ddl085; Lee CR, 2007, PHARMACOGENET GENOM, V17, P349, DOI 10.1097/FPC.0b013e32809913ea; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Li PL, 1997, CIRC RES, V80, P877; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Marciante KD, 2008, PHARMACOGENET GENOM, V18, P535, DOI 10.1097/FPC.0b013e3282fd1287; Michaelis UR, 2005, J CELL SCI, V118, P5489, DOI 10.1242/jcs.02674; Mitchell Lex A, 2002, Cardiovasc Toxicol, V2, P219; Mobert J, 1997, J CARDIOVASC PHARM, V29, P789, DOI 10.1097/00005344-199706000-00012; Moran JH, 1997, TOXICOL APPL PHARM, V146, P53, DOI 10.1006/taap.1997.8197; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Nithipatikom K, 2006, AM J PHYSIOL-HEART C, V291, pH537, DOI 10.1152/ajpheart.00071.2006; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Poyton RO, 2009, TRENDS ENDOCRIN MET, V20, P332, DOI 10.1016/j.tem.2009.04.001; SATOH T, 1993, J CLIN INVEST, V91, P409, DOI 10.1172/JCI116215; Schlaeger TM, 1997, P NATL ACAD SCI USA, V94, P3058, DOI 10.1073/pnas.94.7.3058; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; SIEGFRIED MR, 1990, LIFE SCI, V46, P427, DOI 10.1016/0024-3205(90)90086-7; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60; SUGIYAMA S, 1987, LIFE SCI, V40, P225, DOI 10.1016/0024-3205(87)90336-5; Theken KN, 2007, PHARMACOGENOMICS, V8, P1369, DOI 10.2217/14622416.8.10.1369; Viswanathan S, 2003, J AM COLL NUTR, V22, P502, DOI 10.1080/07315724.2003.10719328; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Wen X, 2002, DRUG METAB DISPOS, V30, P631, DOI 10.1124/dmd.30.6.631; Wong PYK, 1997, J LIPID MEDIAT CELL, V16, P155, DOI 10.1016/S0929-7855(97)00005-9; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Yasar U, 2003, PHARMACOGENETICS, V13, P715, DOI [10.1097/00008571-200312000-00002, 10.1097/01.fpc.0000054141.14659.28]; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438	56	94	98	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3436	3447		10.1096/fj.11-188300	http://dx.doi.org/10.1096/fj.11-188300			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21697548	Green Published			2022-12-25	WOS:000295356400015
J	Nam, KH; Kurinov, I; Ke, AL				Ki Hyun Nam; Kurinov, Igor; Ke, Ailong			Crystal Structure of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-associated Csn2 Protein Revealed Ca2+-dependent Double-stranded DNA Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROVIDES ACQUIRED-RESISTANCE; IMMUNE-SYSTEM; SMALL RNA; CRISPR; BACTERIA; SEQUENCE; DEFENSE; CONSERVATION	Clustered regularly interspaced short palindromic repeats (CRISPR) and their associated protein genes (cas genes) are widespread in bacteria and archaea. They form a line of RNA-based immunity to eradicate invading bacteriophages and malicious plasmids. A key molecular event during this process is the acquisition of new spacers into the CRISPR loci to guide the selective degradation of the matching foreign genetic elements. Csn2 is a Nmeni subtype-specific cas gene required for new spacer acquisition. Here we characterize the Enterococcus faecalis Csn2 protein as a double-stranded (ds-) DNA-binding protein and report its 2.7 angstrom tetrameric ring structure. The inner circle of the Csn2 tetrameric ring is similar to 26 angstrom wide and populated with conserved lysine residues poised for nonspecific interactions with ds-DNA. Each Csn2 protomer contains an alpha/beta domain and an alpha-helical domain; significant hinge motion was observed between these two domains. Ca2+ was located at strategic positions in the oligomerization interface. We further showed that removal of Ca2+ ions altered the oligomerization state of Csn2, which in turn severely decreased its affinity for ds-DNA. In summary, our results provided the first insight into the function of the Csn2 protein in CRISPR adaptation by revealing that it is a ds-DNA-binding protein functioning at the quaternary structure level and regulated by Ca2+ ions.	[Ki Hyun Nam; Ke, Ailong] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA; [Kurinov, Igor] Cornell Univ, NE CAT, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Cornell University; Cornell University	Ke, AL (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA.	ak425@cornell.edu	Nam, Ki Hyun/N-6812-2019	Nam, Ki Hyun/0000-0003-3268-354X	National Institutes of Health [GM-086766, GM-059604]; Korean Ministry of Education, Science and Technology [NRF-2010-357-C00106]; National Center for Research Resources at the National Institutes of Health [RR-15301]; U.S. DOE [DE-AC02-06CH11357]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086766, R01GM059604, R01GM102543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Center for Research Resources at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); U.S. DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM-086766 and GM-059604 throughout the Public Health Service (to A.K.). This work was also supported by the National Research Foundation of Korea Grant NRF-2010-357-C00106 from the Korean Ministry of Education, Science and Technology (to K.H.N.).; We thank the beam line staff at Advanced Photon Source ID24 and Macromolecular Diffraction at Cornell High Energy Synchrotron Source for assistance in data collection and Matthew Bratkowski for helpful discussions and comments on the manuscript. This work is based upon research conducted at the Advanced Photon Source on the Northeastern Collaborative Access Team beam lines, which are supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health. Use of the Advanced Photon Source, an Office of Science User Facility operated for the United States Department of Energy (U.S. DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Babu M, 2011, MOL MICROBIOL, V79, P484, DOI 10.1111/j.1365-2958.2010.07465.x; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deveau H, 2010, ANNU REV MICROBIOL, V64, P475, DOI 10.1146/annurev.micro.112408.134123; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Rodriguez R, 2011, MOL MICROBIOL, V79, P584, DOI 10.1111/j.1365-2958.2010.07482.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rousseau C, 2009, BIOINFORMATICS, V25, P3317, DOI 10.1093/bioinformatics/btp586; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2	38	38	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 2	2011	286	35					30759	30768		10.1074/jbc.M111.256263	http://dx.doi.org/10.1074/jbc.M111.256263			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	812HT	21697083	Green Published, hybrid			2022-12-25	WOS:000294283600056
J	Bas, T; Gao, GY; Lvov, A; Chandrasekhar, KD; Gilmore, R; Kobertz, WR				Bas, Tuba; Gao, Grace Y.; Lvov, Anatoli; Chandrasekhar, Kshama D.; Gilmore, Reid; Kobertz, William R.			Post-translational N-Glycosylation of Type I Transmembrane KCNE1 Peptides IMPLICATIONS FOR MEMBRANE PROTEIN BIOGENESIS AND DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM CHANNEL; AMINO-ACID; INTEGRATION; OLIGOSACCHARYLTRANSFERASE; MUTAGENESIS; K(V)LQT1; DISTANCE; SEQUONS; KCNQ1; SITE	N-Glycosylation of membrane proteins is critical for their proper folding, co-assembly and subsequent matriculation through the secretory pathway. Here, we examine the kinetics of N-glycan addition to type I transmembrane KCNE1 K+ channel beta-subunits, where point mutations that prevent N-glycosylation at one consensus site give rise to disorders of the cardiac rhythm and congenital deafness. We show that KCNE1 has two distinct N-glycosylation sites: a typical co-translational site and a consensus site similar to 20 residues away that unexpectedly acquires N-glycans after protein synthesis (post-translational). Mutations that ablate the co-translational site concomitantly reduce glycosylation at the post-translational site, resulting in unglycosylated KCNE1 subunits that cannot reach the cell surface with their cognate K+ channel. This long range inhibition is highly specific for post-translational N-glycosylation because mutagenic conversion of the KCNE1 post-translational site into a co-translational site restored both monoglycosylation and anterograde trafficking. These results directly explain how a single point mutation can prevent N-glycan attachment at multiple sites, providing a new biogenic mechanism for human disease.	Univ Massachusetts, Sch Med, Dept Mol Pharmacol & Biochem, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01605 USA; Univ Massachusetts, Sch Med, Program Chem Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Kobertz, WR (corresponding author), 364 Plantat St, Worcester, MA 01605 USA.	william.kobertz@umassmed.edu			National Institutes of Health [DC-007669]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043768, R01GM070650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC007669] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by Grant DC-007669 from the National Institutes of Health.	Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Ben-Dor S, 2004, GLYCOBIOLOGY, V14, P95, DOI 10.1093/glycob/cwh004; Bolt G, 2005, GLYCOBIOLOGY, V15, P541, DOI 10.1093/glycob/cwi032; Breuer W, 2001, FEBS LETT, V501, P106, DOI 10.1016/S0014-5793(01)02641-2; CHANDRASEKHAR KD, 2011, J PHYSL IN PRESS; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Cheung JC, 2007, METHODS, V41, P451, DOI 10.1016/j.ymeth.2006.10.002; Do H, 1996, CELL, V85, P369, DOI 10.1016/S0092-8674(00)81115-0; Duvet S, 2002, GLYCOBIOLOGY, V12, P95, DOI 10.1093/glycob/12.2.95; Finley MR, 2002, AM J PHYSIOL-HEART C, V283, pH126, DOI 10.1152/ajpheart.00622.2001; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HERSHEY JWB, 1991, ANNU REV BIOCHEM, V60, P717, DOI 10.1146/annurev.bi.60.070191.003441; Kasturi L, 1997, BIOCHEM J, V323, P415, DOI 10.1042/bj3230415; Kolhekar AS, 1998, J BIOL CHEM, V273, P23012, DOI 10.1074/jbc.273.36.23012; Krumerman A, 2004, AM J PHYSIOL-CELL PH, V286, pC1453, DOI 10.1152/ajpcell.00275.2003; MARSHALL RD, 1972, ANNU REV BIOCHEM, V41, P673, DOI 10.1146/annurev.bi.41.070172.003325; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; NILSSON I, 1993, J BIOL CHEM, V268, P5798; Park KH, 2003, FASEB J, V17, DOI 10.1096/fj.03-0577fje; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SchulzeBahr E, 1997, NAT GENET, V17, P267, DOI 10.1038/ng1197-267; Sesti F, 2000, P NATL ACAD SCI USA, V97, P10613, DOI 10.1073/pnas.180223197; ShakinEshleman SH, 1996, J BIOL CHEM, V271, P6363, DOI 10.1074/jbc.271.11.6363; Silberstein S, 1996, FASEB J, V10, P849, DOI 10.1096/fasebj.10.8.8666161; Teixeira M, 2006, J BIOL CHEM, V281, P10496, DOI 10.1074/jbc.M512254200; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wu DM, 2006, HEART RHYTHM, V3, P1469, DOI 10.1016/j.hrthm.2006.08.019	32	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28150	28159		10.1074/jbc.M111.235168	http://dx.doi.org/10.1074/jbc.M111.235168			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676880	Green Published, hybrid			2022-12-25	WOS:000293557800033
J	Alves, E; Faustino, MAF; Tome, JPC; Neves, MGPMS; Tome, AC; Cavaleiro, JAS; Cunha, A; Gomes, NCM; Almeida, A				Alves, Eliana; Faustino, Maria A. F.; Tome, Joao P. C.; Neves, Maria G. P. M. S.; Tome, Augusto C.; Cavaleiro, Jose A. S.; Cunha, Angela; Gomes, Newton C. M.; Almeida, Adelaide			Photodynamic Antimicrobial Chemotherapy in Aquaculture: Photoinactivation Studies of Vibrio fischeri	PLOS ONE			English	Article							GNOTOBIOTIC ARTEMIA-FRANCISCANA; PORPHYRIN DERIVATIVES; ESCHERICHIA-COLI; WASTE-WATER; THERAPY; BACTERIA; FISH; PHOTOSENSITIZERS; DISINFECTION; INACTIVATION	fischeri Background: Photodynamic antimicrobial chemotherapy (PACT) combines light, a light-absorbing molecule that initiates a photochemical or photophysical reaction, and oxygen. The combined action of these three components originates reactive oxygen species that lead to microorganisms' destruction. The aim was to evaluate the efficiency of PACT on Vibrio fischeri: 1) with buffer solution, varying temperature, pH, salinity and oxygen concentration values; 2) with aquaculture water, to reproduce photoinactivation (PI) conditions in situ. Methodology/Principal Findings: To monitor the PI kinetics, the bioluminescence of V. fischeri was measured during the experiments. A tricationic meso-substituted porphyrin (Tri-Py+-Me-PF) was used as photosensitizer (5 mu M in the studies with buffer solution and 10-50 mu M in the studies with aquaculture water); artificial white light (4 mW cm(-2)) and solar irradiation (40 mW cm(-2)) were used as light sources; and the bacterial concentration used for all experiments was approximate to 10(7) CFU mL(-1) (corresponding to a bioluminescence level of 10(5) relative light units - RLU). The variations in pH (6.5-8.5), temperature (10-25 degrees C), salinity (20-40 g L-1) and oxygen concentration did not significantly affect the PI of V. fischeri, once in all tested conditions the bioluminescent signal decreased to the detection limit of the method (approximate to 7 log reduction). The assays using aquaculture water showed that the efficiency of the process is affected by the suspended matter. Total PI of V. fischeri in aquaculture water was achieved under solar light in the presence of 20 mu M of Tri-Py+-Me-PF. Conclusions/Significance: If PACT is to be used in environmental applications, the matrix containing target microbial communities should be previously characterized in order to establish an efficient protocol having into account the photosensitizer concentration, the light source and the total light dose delivered. The possibility of using solar light in PACT to treat aquaculture water makes this technology cost-effective and attractive.	[Alves, Eliana; Cunha, Angela; Gomes, Newton C. M.; Almeida, Adelaide] Univ Aveiro, Ctr Environm & Marine Studies, Dept Biol, P-3800 Aveiro, Portugal; [Faustino, Maria A. F.; Tome, Joao P. C.; Neves, Maria G. P. M. S.; Tome, Augusto C.; Cavaleiro, Jose A. S.] Univ Aveiro, Dept Chem, P-3800 Aveiro, Portugal	Universidade de Aveiro; Universidade de Aveiro	Alves, E (corresponding author), Univ Aveiro, Ctr Environm & Marine Studies, Dept Biol, P-3800 Aveiro, Portugal.	aalmeida@ua.pt	Cunha, Angela/E-9537-2011; Cunha, Angela/AAC-3830-2019; Alves, Eliana/K-3158-2013; Faustino, Maria Amparo/J-5787-2012; Tomé, Augusto C./K-7184-2014; Almeida, Adelaide/D-9899-2011; Neves, Maria/M-1560-2014; Gomes, Newton CM/F-7430-2012; Alves, Eliana/AAD-3520-2019; Gomes, Newton Carlos Marcial/AAV-4603-2021; Gomes, Newton Carlos Marcial/K-3211-2015; Tome, Joao P. C./K-6782-2014	Cunha, Angela/0000-0002-9118-3521; Cunha, Angela/0000-0002-9118-3521; Alves, Eliana/0000-0001-5396-6536; Faustino, Maria Amparo/0000-0003-4423-3802; Tomé, Augusto C./0000-0003-4331-714X; Almeida, Adelaide/0000-0002-8422-8664; Neves, Maria/0000-0002-7953-8166; Gomes, Newton CM/0000-0003-1934-0091; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Tome, Joao P. C./0000-0001-6057-4936; Cavaleiro, Jose/0000-0001-5495-5126; Tome Saraiva, Joao/0000-0001-7672-3369	University of Aveiro; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/41806/2007]; FEDER; CESAM (Centro de Estudos do Ambiente e do Mar)	University of Aveiro(European Commission); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission); CESAM (Centro de Estudos do Ambiente e do Mar)	The authors are thankful to University of Aveiro, Fundacao para a Ciencia e a Tecnologia (FCT) and FEDER for funding the Organic Chemistry Research Unit (QOPNA) and to CESAM (Centro de Estudos do Ambiente e do Mar) for funding the Microbiology Research Group. Eliana Alves is also grateful to FCT for her PhD grant (SFRH/BD/41806/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHER AJ, 1994, WATER RES, V28, P1153, DOI 10.1016/0043-1354(94)90202-X; Alouini Z, 2001, J ENVIRON MONITOR, V3, P548, DOI 10.1039/b103471p; Alves E, 2008, J IND MICROBIOL BIOT, V35, P1447, DOI 10.1007/s10295-008-0446-2; Arijo S, 2005, J FISH DIS, V28, P33, DOI 10.1111/j.1365-2761.2004.00597.x; BERTOLONI G, 1989, J GEN MICROBIOL, V135, P957; Bonnett R, 2006, WATER RES, V40, P1269, DOI 10.1016/j.watres.2006.01.014; Cabello FC, 2006, ENVIRON MICROBIOL, V8, P1137, DOI 10.1111/j.1462-2920.2006.01054.x; Carvalho CMB, 2010, ACS NANO, V4, P7133, DOI 10.1021/nn1026092; Carvalho CMB, 2009, J PORPHYR PHTHALOCYA, V13, P574, DOI 10.1142/S1088424609000528; Carvalho GG, 2009, J MICROBIOL, V47, P619, DOI 10.1007/s12275-009-0059-0; Costa L, 2010, PHOTOCH PHOTOBIO SCI, V9, P1126, DOI 10.1039/c0pp00051e; Defoirdt T, 2007, TRENDS BIOTECHNOL, V25, P472, DOI 10.1016/j.tibtech.2007.08.001; Defoirdt T, 2006, AQUACULTURE, V261, P804, DOI 10.1016/j.aquaculture.2006.06.038; Defoirdt T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000989; Gabor F, 2001, RADIAT ENVIRON BIOPH, V40, P145, DOI 10.1007/s004110100092; Halet D, 2007, FEMS MICROBIOL ECOL, V60, P363, DOI 10.1111/j.1574-6941.2007.00305.x; Jemli M, 2002, J ENVIRON MONITOR, V4, P511, DOI 10.1039/b204637g; Jori G, 2006, LASER SURG MED, V38, P468, DOI 10.1002/lsm.20361; Klein G, 1998, MOL GEN GENET, V259, P179, DOI 10.1007/s004380050803; Lio-Po GD, 2005, AQUACULTURE, V250, P1, DOI 10.1016/j.aquaculture.2005.01.029; Maestrin APJ, 2004, J BRAZIL CHEM SOC, V15, P923, DOI 10.1590/S0103-50532004000600021; Magaraggia M, 2006, J ENVIRON MONITOR, V8, P923, DOI 10.1039/b606975d; Maisch T, 2009, MINI-REV MED CHEM, V9, P974, DOI 10.2174/138955709788681582; Moriarty DJW, 1998, AQUACULTURE, V164, P351, DOI 10.1016/S0044-8486(98)00199-9; Moriarty DJW, 1999, P 8 INT S MICR EC; Muroga K, 2001, AQUACULTURE, V202, P23, DOI 10.1016/S0044-8486(01)00597-X; O'Connor AE, 2009, PHOTOCHEM PHOTOBIOL, V85, P1053, DOI 10.1111/j.1751-1097.2009.00585.x; Olafsen JA, 2001, AQUACULTURE, V200, P223, DOI 10.1016/S0044-8486(01)00702-5; Ortner MA, 2009, CURR OPIN GASTROEN, V25, P472, DOI 10.1097/MOG.0b013e32832e6e1f; Prates RA, 2009, LASER PHYS, V19, P1038, DOI 10.1134/S1054660X09050284; REED PA, 1996, FA31 U FLOR I FOOD A; Romalde Jesus L., 2002, International Microbiology, V5, P3, DOI 10.1007/s10123-002-0051-6; Rotomskis R, 1997, J PHOTOCH PHOTOBIO B, V39, P172, DOI 10.1016/S1011-1344(96)00014-0; Shao ZZJ, 2001, ADV DRUG DELIVER REV, V50, P229, DOI 10.1016/S0169-409X(01)00159-4; Shivu MM, 2007, ENVIRON MICROBIOL, V9, P322, DOI 10.1111/j.1462-2920.2006.01140.x; Smits T, 2009, J PHOTOCH PHOTOBIO B, V96, P159, DOI 10.1016/j.jphotobiol.2009.06.003; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Tome JPC, 2004, J MED CHEM, V47, P6649, DOI 10.1021/jm040802v; Toranzo AE, 2005, AQUACULTURE, V246, P37, DOI 10.1016/j.aquaculture.2005.01.002; Vadstein O, 1997, AQUACULTURE, V155, P401, DOI 10.1016/S0044-8486(97)00114-2; WATTS RJ, 1995, WATER RES, V29, P95, DOI 10.1016/0043-1354(94)E0122-M; WEST CML, 1988, INT J RADIAT BIOL, V54, P621, DOI 10.1080/09553008814552061	42	59	60	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20970	10.1371/journal.pone.0020970	http://dx.doi.org/10.1371/journal.pone.0020970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698119	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600035
J	Jin, JL; Zhao, YM; Tan, X; Guo, C; Yang, ZJ; Miao, DS				Jin, Jianliang; Zhao, Yingming; Tan, Xiao; Guo, Chun; Yang, Zhijian; Miao, Dengshun			An Improved Transplantation Strategy for Mouse Mesenchymal Stem Cells in an Acute Myocardial Infarction Model	PLOS ONE			English	Article							BONE-MARROW; INDUCED APOPTOSIS; PROGENITOR CELLS; REGENERATION; DIFFERENTIATION; HEART; AKT; ANGIOGENESIS; CONTRIBUTES; ACTIVATION	To develop an effective therapeutic strategy for cardiac regeneration using bone marrow mesenchymal stem cells (BM-MSCs), the primary mouse BM-MSCs (1(st) BM-MSCs) and 5(th) passage BM-MSCs from beta-galactosidase transgenic mice were respectively intramyocardially transplanted into the acute myocardial infarction (AMI) model of wild type mice. At the 6(th) week, animals/tissues from the 1(st) BM-MSCs group, the 5(th) passage BM-MSCs group, control group were examined. Our results revealed that, compared to the 5(th) passage BM-MSCs, the 1(st) BM-MSCs had better therapeutic effects in the mouse MI model. The 1 st BM-MSCs maintained greater differentiation potentials towards cardiomocytes or vascular endothelial cells in vitro. This is indicated by higher expressions of cardiomyocyte and vascular endothelial cell mature markers in vitro. Furthermore, we identified that 24 proteins were down-regulated and 3 proteins were up-regulated in the 5(th) BM-MSCs in comparison to the 1(st) BM-MSCs, using mass spectrometry following two-dimensional electrophoresis. Our data suggest that transplantation of the 1(st) BM-MSCs may be an effective therapeutic strategy for cardiac tissue regeneration following AMI, and altered protein expression profiles between the 1(st) BM-MSCs and 5(th) passage BM-MSCs may account for the difference in their maintenance of stemness and their therapeutic effects following AMI.	[Jin, Jianliang; Guo, Chun; Miao, Dengshun] Nanjing Med Univ, Res Ctr Bone & Stem Cells, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China; [Zhao, Yingming; Tan, Xiao; Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Jin, JL (corresponding author), Nanjing Med Univ, Res Ctr Bone & Stem Cells, Dept Anat Histol & Embryol, Nanjing, Jiangsu, Peoples R China.	zhijianyangnj@yahoo.com.cn; dsmiao@njmu.edu.cn	Guo, Chun/AAM-5894-2020	Guo, Chun/0000-0002-1540-3166; Miao, Dengshun/0000-0002-2682-3502	Jiangsu Foundation of Science and Technology [BK2006729]	Jiangsu Foundation of Science and Technology	This work was supported by Jiangsu Foundation of Science and Technology (no. BK2006729) to Z. Yang and D. Miao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Airey JA, 2004, CIRCULATION, V109, P1401, DOI 10.1161/01.CIR.0000124222.16321.26; Avramidou A, 2007, CELL DEATH DIFFER, V14, P1936, DOI 10.1038/sj.cdd.4402206; Bianco P, 2001, STEM CELLS, V19, P180, DOI 10.1634/stemcells.19-3-180; Boiret N, 2003, EXP HEMATOL, V31, P1275, DOI 10.1016/j.exphem.2003.08.010; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Dawn B, 2008, STEM CELLS, V26, P1646, DOI 10.1634/stemcells.2007-0715; Feliers D, 2007, AM J PHYSIOL-RENAL, V293, pF607, DOI 10.1152/ajprenal.00497.2006; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Guo YH, 2008, ARCH MED RES, V39, P179, DOI 10.1016/j.arcmed.2007.11.001; Hipp Jason, 2004, J Exp Clin Assist Reprod, V1, P3, DOI 10.1186/1743-1050-1-3; Imanishi Y, 2008, J MOL CELL CARDIOL, V44, P662, DOI 10.1016/j.yjmcc.2007.11.001; Jo JI, 2007, TISSUE ENG, V13, P313, DOI 10.1089/ten.2006.0133; Kretlow JD, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-60; Kucia M, 2006, LEUKEMIA, V20, P857, DOI 10.1038/sj.leu.2404171; Li WZ, 2007, STEM CELLS, V25, P2118, DOI 10.1634/stemcells.2006-0771; Liang GB, 2009, BIORESOURCE TECHNOL, V100, P350, DOI 10.1016/j.biortech.2008.06.012; Lim SY, 2006, CARDIOVASC RES, V70, P530, DOI 10.1016/j.cardiores.2006.02.016; Ling Q, 2004, J CLIN INVEST, V113, P38, DOI 10.1172/JCI200419684; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Masuda Y, 2004, J BIOL CHEM, V279, P42503, DOI 10.1074/jbc.M404256200; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Murry CE, 2005, CIRCULATION, V112, P3174, DOI 10.1161/CIRCULATIONAHA.105.546218; Park JE, 2005, BIOCHEM BIOPH RES CO, V337, P1283, DOI 10.1016/j.bbrc.2005.10.004; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Popov BV, 2007, TISSUE ENG, V13, P2441, DOI 10.1089/ten.2007.0001; Pountos I, 2007, INJURY, V38, pS23, DOI 10.1016/S0020-1383(08)70006-8; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; Shih SC, 2002, AM J PATHOL, V161, P35, DOI 10.1016/S0002-9440(10)64154-5; Shiota M, 2007, EXP CELL RES, V313, P1008, DOI 10.1016/j.yexcr.2006.12.017; Siepe M, 2005, EUR J CARDIO-THORAC, V28, P318, DOI 10.1016/j.ejcts.2005.03.044; Stolzing A, 2006, FREE RADICAL BIO MED, V41, P326, DOI 10.1016/j.freeradbiomed.2006.04.018; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Strauer BE, 2001, DEUT MED WOCHENSCHR, V126, P932, DOI 10.1055/s-2001-16579-1; Sun W, 2010, DEVELOPMENT, V137, P985, DOI 10.1242/dev.045898; Tang YL, 2005, ANN THORAC SURG, V80, P229, DOI 10.1016/j.athoracsur.2005.02.072; Valiunas V, 2004, J PHYSIOL-LONDON, V555, P617, DOI 10.1113/jphysiol.2003.058719; Wang L, 2005, J MOL MED, V83, P812, DOI 10.1007/s00109-005-0676-y; You Z, 2005, NUCLEIC ACIDS RES, V33, P3033, DOI 10.1093/nar/gki607; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhang ZL, 2009, BONE MARROW TRANSPL, V43, P69, DOI 10.1038/bmt.2008.260; Zhu YF, 2006, J PROTEOME RES, V5, P2217, DOI 10.1021/pr0600733	44	13	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21005	10.1371/journal.pone.0021005	http://dx.doi.org/10.1371/journal.pone.0021005			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698117	Green Accepted, Green Published, gold			2022-12-25	WOS:000291737600037
J	Li, QR; Zhang, Q; Wang, CY; Tang, C; Zhang, YM; Li, N; Li, JS				Li, Qiurong; Zhang, Qiang; Wang, Chenyang; Tang, Chun; Zhang, Yanmei; Li, Ning; Li, Jieshou			Fish Oil Enhances Recovery of Intestinal Microbiota and Epithelial Integrity in Chronic Rejection of Intestinal Transplant	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SMALL-BOWEL TRANSPLANTATION; TIGHT-JUNCTION; ESCHERICHIA-COLI; PROINFLAMMATORY CYTOKINES; BARRIER FUNCTION; CROHNS-DISEASE; INFLAMMATION; SURVIVAL; MODEL	Background: The intestinal chronic rejection (CR) is the major limitation to long-term survival of transplanted organs. This study aimed to investigate the interaction between intestinal microbiota and epithelial integrity in chronic rejection of intestinal transplantation, and to find out whether fish oil enhances recovery of intestinal microbiota and epithelial integrity. Methods/Principal Findings: The luminal and mucosal microbiota composition of CR rats were characterized by DGGE analysis at 190 days after intestinal transplant. The specific bacterial species were determined by sequence analysis. Furthermore, changes in the localization of intestinal TJ proteins were examined by immunofluorescent staining. PCR-DGGE analysis revealed that gut microbiota in CR rats had a shift towards Escherichia coli, Bacteroides spp and Clostridium spp and a decrease in the abundance of Lactobacillales bacteria in the intestines. Fish oil supplementation could enhance the recovery of gut microbiota, showing a significant decrease of gut bacterial proportions of E. coli and Bacteroides spp and an increase of Lactobacillales spp. In addition, CR rats showed pronounced alteration of tight junction, depicted by marked changes in epithelial cell ultrastructure and redistribution of occuldin and claudins as well as disruption in TJ barrier function. Fish oil administration ameliorated disruption of epithelial integrity in CR, which was associated with an improvement of the mucosal structure leading to improved tight junctions. Conclusions/Significance: Our study have presented novel evidence that fish oil is involved in the maintenance of epithelial TJ integrity and recovery of gut microbiota, which may have therapeutic potential against CR in intestinal transplantation.	[Li, Qiurong; Zhang, Qiang; Wang, Chenyang; Tang, Chun; Zhang, Yanmei; Li, Ning; Li, Jieshou] Nanjing Univ, Dept Surg, Jinling Hosp, Sch Med, Nanjing 210008, Peoples R China	Nanjing University	Li, QR (corresponding author), Nanjing Univ, Dept Surg, Jinling Hosp, Sch Med, Nanjing 210008, Peoples R China.	liqiurong@yahoo.com	Li, jie/GXG-4583-2022		Ministry of Science & Technology of China [2009CB522405, 2007CB513005, 30830098, 81070375, BK2009317, 2008BAI60B06]; Deutscher Akademischer Austauschdienst	Ministry of Science & Technology of China(Ministry of Science and Technology, China); Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by the National Basic Research Program (973 Program) in China (2009CB522405 and No. 2007CB513005), the Key Project of National Natural Science Foundation in China (30830098), National Natural Science Foundation in China (81070375), Scientific Research Fund in Jiangsu Province (BK2009317), National Key Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China (2008BAI60B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Deutscher Akademischer Austauschdienst Researcher Fellowship (Bioscience Special Program, Germany) for Dr. Qiurong Li.	Abu-Elmagd K, 2001, ANN SURG, V234, P404, DOI 10.1097/00000658-200109000-00014; Balda MS, 2000, SEMIN CELL DEV BIOL, V11, P281, DOI 10.1006/scdb.2000.0177; Beelen DW, 1999, BLOOD, V93, P3267, DOI 10.1182/blood.V93.10.3267.410k22_3267_3275; Belluzzi A, 1996, NEW ENGL J MED, V334, P1557, DOI 10.1056/NEJM199606133342401; Bomba A, 2002, BRIT J NUTR, V88, pS95, DOI 10.1079/BJN2002634; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Chen Y, 2007, TRANSPLANTATION, V83, P1351, DOI 10.1097/01.tp.0000262568.73590.81; Darfeuille-Michaud A, 2004, GASTROENTEROLOGY, V127, P412, DOI 10.1053/j.gastro.2004.04.061; Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013; Freedman SD, 2004, NEW ENGL J MED, V350, P560, DOI 10.1056/NEJMoa021218; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Goodenough DA, 1999, P NATL ACAD SCI USA, V96, P319, DOI 10.1073/pnas.96.2.319; Grimminger F, 1996, CIRCULATION, V93, P365, DOI 10.1161/01.CIR.93.2.365; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Kankaanpaa PE, 2001, FEMS MICROBIOL LETT, V194, P149, DOI 10.1016/S0378-1097(00)00519-X; Kuehl CJ, 2005, INFECT IMMUN, V73, P6952, DOI 10.1128/IAI.73.10.6852-6961.2005; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li QR, 2008, FEBS J, V275, P6022, DOI 10.1111/j.1742-4658.2008.06731.x; Li QR, 2008, MOL IMMUNOL, V45, P1356, DOI 10.1016/j.molimm.2007.09.003; Li QR, 2008, CLIN IMMUNOL, V126, P67, DOI 10.1016/j.clim.2007.08.017; Li QR, 2010, CLIN IMMUNOL, V136, P375, DOI 10.1016/j.clim.2010.05.004; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Ma H, 2007, PEDIATR TRANSPLANT, V11, P173, DOI 10.1111/j.1399-3046.2006.00636.x; Murase N, 2000, TRANSPLANTATION, V70, P1632, DOI 10.1097/00007890-200012150-00016; Niv Y, 1999, AM J GASTROENTEROL, V94, P3126; OTTO DA, 1990, TRANSPLANTATION, V50, P193, DOI 10.1097/00007890-199008000-00004; Pscheidl E, 2002, CLIN NUTR, V21, P47; Qu LL, 2009, TRANSPLANTATION, V88, P766, DOI 10.1097/TP.0b013e3181b47c61; Reid G, 2001, TRENDS MICROBIOL, V9, P424, DOI 10.1016/S0966-842X(01)02132-1; Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587; Sudan DL, 2000, AM J GASTROENTEROL, V95, P1506; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Teitelbaum JE, 2001, J NUTR BIOCHEM, V12, P21, DOI 10.1016/S0955-2863(00)00141-8; Tsukita S, 1999, TRENDS CELL BIOL, V9, P268, DOI 10.1016/S0962-8924(99)01578-0; VOLLAARD EJ, 1994, ANTIMICROB AGENTS CH, V38, P409, DOI 10.1128/AAC.38.3.409; Whiting CV, 2005, INFLAMM BOWEL DIS, V11, P340, DOI 10.1097/01.MIB.0000164016.98913.7c; Zahraoui A, 2000, J CELL BIOL, V151, pF31, DOI 10.1083/jcb.151.5.F31; Zhang Q, 2010, MICROB PATHOGENESIS, V48, P28, DOI 10.1016/j.micpath.2009.10.002	40	30	34	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20460	10.1371/journal.pone.0020460	http://dx.doi.org/10.1371/journal.pone.0020460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698145	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600005
J	Lai, MC; Lombardo, MV; Pasco, G; Ruigrok, ANV; Wheelwright, SJ; Sadek, SA; Chakrabarti, B; Baron-Cohen, S				Lai, Meng-Chuan; Lombardo, Michael V.; Pasco, Greg; Ruigrok, Amber N. V.; Wheelwright, Sally J.; Sadek, Susan A.; Chakrabarti, Bhismadev; Baron-Cohen, Simon		MRC AIMS Consortium	A Behavioral Comparison of Male and Female Adults with High Functioning Autism Spectrum Conditions	PLOS ONE			English	Article							PERVASIVE DEVELOPMENTAL DISORDERS; DIAGNOSTIC OBSERVATION SCHEDULE; SEX-DIFFERENCES; CHILDHOOD-AUTISM; ASPERGER-SYNDROME; INFANTILE-AUTISM; EMPATHY QUOTIENT; REVISED VERSION; RATING-SCALE; FOLLOW-UP	Autism spectrum conditions (ASC) affect more males than females in the general population. However, within ASC it is unclear if there are phenotypic sex differences. Testing for similarities and differences between the sexes is important not only for clinical assessment but also has implications for theories of typical sex differences and of autism. Using cognitive and behavioral measures, we investigated similarities and differences between the sexes in age-and IQ-matched adults with ASC (high-functioning autism or Asperger syndrome). Of the 83 (45 males and 38 females) participants, 62 (33 males and 29 females) met Autism Diagnostic Interview-Revised (ADI-R) cut-off criteria for autism in childhood and were included in all subsequent analyses. The severity of childhood core autism symptoms did not differ between the sexes. Males and females also did not differ in self-reported empathy, systemizing, anxiety, depression, and obsessive-compulsive traits/symptoms or mentalizing performance. However, adult females with ASC showed more lifetime sensory symptoms (p = 0.036), fewer current socio-communication difficulties (p = 0.001), and more self-reported autistic traits (p = 0.012) than males. In addition, females with ASC who also had developmental language delay had lower current performance IQ than those without developmental language delay (p < 0.001), a pattern not seen in males. The absence of typical sex differences in empathizing-systemizing profiles within the autism spectrum confirms a prediction from the extreme male brain theory. Behavioral sex differences within ASC may also reflect different developmental mechanisms between males and females with ASC. We discuss the importance of the superficially better socio-communication ability in adult females with ASC in terms of why females with ASC may more often go under-recognized, and receive their diagnosis later, than males.	[Lai, Meng-Chuan; Lombardo, Michael V.; Pasco, Greg; Ruigrok, Amber N. V.; Wheelwright, Sally J.; Sadek, Susan A.; Chakrabarti, Bhismadev; Baron-Cohen, Simon] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England; [Chakrabarti, Bhismadev] Univ Reading, Sch Psychol & Clin Language Sci, Ctr Integrat Neurosci & Neurodynam, Reading, Berks, England	University of Cambridge; University of Reading	Lai, MC (corresponding author), Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England.	mcl45@cam.ac.uk	Bailey, Anthony/J-2860-2014; Ecker, Christine/E-5194-2010; Lombardo, Michael V/J-1773-2012; Williams, Steve C/D-6979-2011; daly, eileen m/B-6716-2011; Murphy, Clodagh M/F-1464-2010; Lai, Meng-Chuan/K-7407-2016; Catani, Marco/H-7801-2012	Bailey, Anthony/0000-0003-4257-972X; Ecker, Christine/0000-0002-1003-5931; Lombardo, Michael V/0000-0001-6780-8619; Williams, Steve C/0000-0003-4299-1941; Murphy, Clodagh M/0000-0002-6350-0155; Lai, Meng-Chuan/0000-0002-9593-5508; Ruigrok, Amber/0000-0001-7711-8056; Craig, Michael/0000-0002-5311-8673; Baron-Cohen, Simon/0000-0001-9217-2544; Happe, Francesca/0000-0001-9226-4000; Henty, Julian/0000-0001-8694-451X; Chakrabarti, Bhismadev/0000-0002-6649-7895; Wheelwright, Sally/0000-0003-0657-2483; Catani, Marco/0000-0002-5488-6463	Medical Research Council, United Kingdom; MRC [G0600977, G0400061, G0800298] Funding Source: UKRI; Medical Research Council [G0800298, G0600977, G0400061] Funding Source: researchfish; National Institute for Health Research [RP-PG-0606-1045, NF-SI-0510-10268] Funding Source: researchfish	Medical Research Council, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Medical Research Council, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison C, 2008, J AUTISM DEV DISORD, V38, P1414, DOI 10.1007/s10803-007-0509-7; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; American Psychiatric Association, 2010, DSM 5 DEV PROP REV A; Asperger H, 1944, ARCH PSYCHIAT NERVEN, V117, P76, DOI 10.1007/BF01837709; Attwood T, 2006, PATTERN ABILITIES DE; Attwood T., 2007, COMPLETE GUIDE ASPER; Auyeung B, 2008, J AUTISM DEV DISORD, V38, P1230, DOI 10.1007/s10803-007-0504-z; Auyeung B, 2009, J AUTISM DEV DISORD, V39, P1509, DOI 10.1007/s10803-009-0772-x; Baird G, 2006, LANCET, V368, P210, DOI 10.1016/S0140-6736(06)69041-7; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 2008, AUTISM ASPERGER SYND; Baron-Cohen S, 2006, J AUTISM DEV DISORD, V36, P343, DOI 10.1007/s10803-006-0073-6; Baron-Cohen S, 2009, BRIT J PSYCHIAT, V194, P500, DOI 10.1192/bjp.bp.108.059345; Bastiaansen JA, 2011, J AUTISM DEV DISORD, V41, P1256, DOI 10.1007/s10803-010-1157-x; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Ben-Sasson A, 2009, J AUTISM DEV DISORD, V39, P1, DOI 10.1007/s10803-008-0593-3; Carter AS, 2007, J AUTISM DEV DISORD, V37, P86, DOI 10.1007/s10803-006-0331-7; Crick NR, 2003, DEV PSYCHOPATHOL, V15, P719, DOI 10.1017/S095457940300035X; Ernsperger L., 2007, GIRLS UMBRELLA AUTIS; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Fombonne E., 2005, HDB AUTISM PERVASIVE, V1, P42; Gillberg C., 2002, GUIDE ASPERGER SYNDR; Gillberg C, 2000, BIOL AUTISTIC SYNDRO, V3rd; Gotham K, 2007, J AUTISM DEV DISORD, V37, P613, DOI 10.1007/s10803-006-0280-1; Gotham K, 2009, J AUTISM DEV DISORD, V39, P693, DOI 10.1007/s10803-008-0674-3; Hartley SL, 2009, J AUTISM DEV DISORD, V39, P1715, DOI 10.1007/s10803-009-0810-8; Hofvander B, 2009, BMC PSYCHIATRY, V9, DOI 10.1186/1471-244X-9-35; Holtmann M, 2007, DEV MED CHILD NEUROL, V49, P361, DOI 10.1111/j.1469-8749.2007.00361.x; Iarocci G, 2006, J AUTISM DEV DISORD, V36, P77, DOI 10.1007/s10803-005-0044-3; Jones W, 2009, J AM ACAD CHILD PSY, V48, P471, DOI 10.1097/CHI.0b013e31819f6c0d; Kanner L, 1943, NERV CHILD, V2, P217; Kopp S., 1992, EUROPEAN CHILD ADOLE, V1, P89, DOI DOI 10.1007/BF02091791; LECOUTEUR A, 1989, J AUTISM DEV DISORD, V19, P363, DOI 10.1007/BF02212936; Lombardo MV, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000883; Lombardo MV, 2010, BRAIN, V133, P611, DOI 10.1093/brain/awp306; LORD C, 1985, J AUTISM DEV DISORD, V15, P185, DOI 10.1007/BF01531604; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; LORD C, 1982, J AUTISM DEV DISORD, V12, P317, DOI 10.1007/BF01538320; Lotter V., 1966, SOC PSYCHIATR, V1, P124, DOI [10.1007/BF00584048, https://doi.org/10.1007/BF00584048]; Markram H, 2007, FRONT NEUROSCI-SWITZ, V1, P77, DOI 10.3389/neuro.01.1.1.006.2007; MCLENNAN JD, 1993, J AUTISM DEV DISORD, V23, P217, DOI 10.1007/BF01046216; MESIBOV GB, 1989, J AM ACAD CHILD PSY, V28, P538, DOI 10.1097/00004583-198907000-00012; Miller Jean Kearns, 2003, WOMEN ANOTHER PLANET; Mottron L, 2006, J AUTISM DEV DISORD, V36, P27, DOI 10.1007/s10803-005-0040-7; Murphy DGM, 2011, BRAIN RES, V1380, P22, DOI 10.1016/j.brainres.2010.10.042; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Parke R., 2008, CHILD PSYCHOL CONT V; Pilowsky T, 1998, J AUTISM DEV DISORD, V28, P143, DOI 10.1023/A:1026092632466; Ring H, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-11; RITVO ER, 1971, J AUTISM CHILD SCHIZ, V1, P297; Russell AJ, 2005, BRIT J PSYCHIAT, V186, P525, DOI 10.1192/bjp.186.6.525; Ruta L, 2010, EUR CHILD ADOLES PSY, V19, P17, DOI 10.1007/s00787-009-0035-6; RUTTER M, 1967, BRIT J PSYCHIAT, V113, P1169, DOI 10.1192/bjp.113.504.1169; Schwarz E, 2011, MOL PSYCHIATR, V16, P1213, DOI 10.1038/mp.2010.102; Simone R, 2010, ASPERGIRLS EMPOWERIN; Skuse DH, 2007, TRENDS GENET, V23, P387, DOI 10.1016/j.tig.2007.06.003; Skuse DH, 2005, HUM MOL GENET, V14, pR27, DOI 10.1093/hmg/ddi112; TSAI L, 1981, J AUTISM DEV DISORD, V11, P165, DOI 10.1007/BF01531682; TSAI LY, 1983, BRIT J PSYCHIAT, V142, P373, DOI 10.1192/bjp.142.4.373; United Kingdom Department of Health, 2010, FULF REW LIV STRAT A; VOLKMAR FR, 1993, J AUTISM DEV DISORD, V23, P579, DOI 10.1007/BF01046103; VOLKMAR FR, 1988, AM J PSYCHIAT, V145, P1404; Wechsler D., 1999, WECHSLER ABBREVIATED; Wheelwright S, 2006, BRAIN RES, V1079, P47, DOI 10.1016/j.brainres.2006.01.012; Willey LH., 1999, PRETENDING BE NORMAL; Williams JG, 2008, J AUTISM DEV DISORD, V38, P1731, DOI 10.1007/s10803-008-0558-6; WING L, 1981, PSYCHIAT RES, V5, P129, DOI 10.1016/0165-1781(81)90043-3; WING L, 1984, J AUTISM DEV DISORD, V14, P211, DOI 10.1007/BF02409664; WING L, 1979, J AUTISM DEV DISORD, V9, P11, DOI 10.1007/BF01531288; Wing L, 2011, RES DEV DISABIL, V32, P768, DOI 10.1016/j.ridd.2010.11.003; WOLFF S, 1995, J CHILD PSYCHOL PSYC, V36, P793, DOI 10.1111/j.1469-7610.1995.tb01330.x; World Health Organisation, 1993, ICD 10 CLASS MENT BE; Zahn-Waxler C, 2008, ANNU REV CLIN PSYCHO, V4, P275, DOI 10.1146/annurev.clinpsy.3.022806.091358	79	333	334	4	140	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20835	10.1371/journal.pone.0020835	http://dx.doi.org/10.1371/journal.pone.0020835			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777ZG	21695147	Green Accepted, gold, Green Published			2022-12-25	WOS:000291663300023
J	Spyra, M; Kluwe, L; Hagel, C; Nguyen, R; Panse, J; Kurtz, A; Mautner, VF; Rabkin, SD; Demestre, M				Spyra, Melanie; Kluwe, Lan; Hagel, Christian; Nguyen, Rosa; Panse, Jens; Kurtz, Andreas; Mautner, Victor Felix; Rabkin, Samuel David; Demestre, Maria			Cancer Stem Cell-Like Cells Derived from Malignant Peripheral Nerve Sheath Tumors	PLOS ONE			English	Article							MAMMALIAN NEURAL CREST; IDENTIFICATION; GLIOBLASTOMA	This study aims to examine whether or not cancer stem cells exist in malignant peripheral nerve sheath tumors ( MPNST). Cells of established lines, primary cultures and freshly dissected tumors were cultured in serum free conditions supplemented with epidermal and fibroblast growth factors. From one established human MPNST cell line, S462, cells meeting the criteria for cancer stem cells were isolated. Clonal spheres were obtained, which could be passaged multiple times. Enrichment of stem cell-like cells in these spheres was also supported by increased expression of stem cell markers such as CD133, Oct4, Nestin and NGFR, and decreased expression of mature cell markers such as CD90 and NCAM. Furthermore, cells of these clonal S462 spheres differentiated into Schwann cells, smooth muscle/fibroblast and neurons-like cells under specific differentiation-inducing cultural conditions. Finally, subcutaneous injection of the spheres into immunodeficient nude mice led to tumor formation at a higher rate compared to the parental adherent cells (66% versus 10% at 2.5x10(5)). These results provide evidence for the existence of cancer stem cell-like cells in malignant peripheral nerve sheath tumors.	[Spyra, Melanie; Kluwe, Lan; Nguyen, Rosa; Mautner, Victor Felix; Demestre, Maria] Univ Med Ctr Hamburg Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany; [Hagel, Christian] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Panse, Jens] Univ Med Ctr Hamburg Eppendorf, Dept Hematol & Oncol, Hamburg, Germany; [Kurtz, Andreas] Charite, Berlin Brandenburg Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Kurtz, Andreas] Seoul Natl Univ, Coll Vet Med, Seoul, South Korea; [Rabkin, Samuel David] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Rabkin, Samuel David] Harvard Univ, Sch Med, Boston, MA USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Seoul National University (SNU); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Spyra, M (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Maxillofacial Surg, Hamburg, Germany.	andreas.kurtz@charite.de.com; mariademestre@hotmail.com	rabkin, samuel/C-2443-2012	rabkin, samuel/0000-0003-2344-2795; Kurtz, Andreas/0000-0003-3301-6546; Demestre, Maria/0000-0002-3672-5703	Department of Defense [W81XWH-07-0359 to SDR]; "Bundesministerium fur Bildung und Forschung'' (BMBF) [01GM0480]	Department of Defense(United States Department of Defense); "Bundesministerium fur Bildung und Forschung'' (BMBF)(Federal Ministry of Education & Research (BMBF))	These studies were supported in part by a grant from the Department of Defense neurofibromatosis program (W81XWH-07-0359 to SDR) and "Bundesministerium fur Bildung und Forschung'' (BMBF) (01GM0480 to AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Demestre M, 2009, PHYTOTHER RES, V23, P226, DOI 10.1002/ptr.2594; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Evans DGR, 2002, J MED GENET, V39, P311, DOI 10.1136/jmg.39.5.311; Frahm S, 2004, NEUROBIOL DIS, V16, P85, DOI 10.1016/j.nbd.2004.01.006; Frank NY, 2010, J CLIN INVEST, V120, P41, DOI 10.1172/JCI41004; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Gutmann DH, 1997, JAMA-J AM MED ASSOC, V278, P51, DOI 10.1001/jama.278.1.51; Hirose T, 2003, MODERN PATHOL, V16, P293, DOI 10.1097/01.MP.0000062654.83617.B7; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Naber U, 2011, J NEURO-ONCOL, V103, P239, DOI 10.1007/s11060-010-0385-4; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Piccirillo SGM, 2009, J MOL MED, V87, P1087, DOI 10.1007/s00109-009-0535-3; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Singh SK, 2003, CANCER RES, V63, P5821; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Williams JP, 2008, CELL STEM CELL, V3, P658, DOI 10.1016/j.stem.2008.10.003; Williams VC, 2009, PEDIATRICS, V123, P124, DOI 10.1542/peds.2007-3204	18	38	39	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e21099	10.1371/journal.pone.0021099	http://dx.doi.org/10.1371/journal.pone.0021099			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695156	gold, Green Submitted, Green Published			2022-12-25	WOS:000291663300041
J	Ibarz-Pavon, AB; Morais, L; Sigauque, B; Mandomando, I; Bassat, Q; Nhacolo, A; Quinto, L; Soriano-Gabarro, M; Alonso, PL; Roca, A				Belen Ibarz-Pavon, Ana; Morais, Luis; Sigauque, Betuel; Mandomando, Inacio; Bassat, Quique; Nhacolo, Ariel; Quinto, Llorenc; Soriano-Gabarro, Montse; Alonso, Pedro L.; Roca, Anna			Epidemiology, Molecular Characterization and Antibiotic Resistance of Neisseria meningitidis from Patients <= 15 Years in Manhica Rural Mozambique	PLOS ONE			English	Article							X MENINGOCOCCAL MENINGITIS; ACUTE BACTERIAL-MENINGITIS; SEROGROUP W135; BURKINA-FASO; CONJUGATE VACCINE; SOUTH-AFRICA; CHILDREN; DISEASE; RISK; SURVEILLANCE	Background: The epidemiology of meningococcal disease in Mozambique and other African countries located outside the "meningitis belt" remains widely unknown. With the event of upcoming vaccines microbiological and epidemiological information is urgently needed. Methods: Prospective surveillance for invasive bacterial infections was conducted at the Manhica District hospital (rural Mozambique) among hospitalized children below 15 years of age. Available Neisseria meningitidis isolates were serogrouped and characterized by Multilocus Sequence Typing (MLST). Antibiotic resistance was also determined. Results: Between 1998 and 2008, sixty-three cases of confirmed meningococcal disease (36 meningitis, 26 sepsis and 1 conjunctivitis) were identified among hospitalized children. The average incidence rate of meningococcal disease was 11.6/100,000 (8/100,000 for meningitis and 3.7/100,000 for meningococcemia, respectively). There was a significant rise on the number of meningococcal disease cases in 2005-2006 that was sustained till the end of the surveillance period. Serogroup was determined for 43 of the 63 meningococcal disease cases: 38 serogroup W-135, 3 serogroup A and 2 serogroup Y. ST-11 was the most predominant sequence type and strongly associated with serogroup W-135. Two of the three serogroup A isolates were ST-1, and both serogroup Y isolates were ST-175. N. meningitidis remained highly susceptible to all antibiotics used for treatment in the country, although the presence of isolates presenting intermediate resistance to penicillin advocates for continued surveillance. Conclusions: Our data show a high rate of meningococcal disease in Manhica, Mozambique, mainly caused by serogroup W-135 ST-11 strains, and advocates for the implementation of a vaccination strategy covering serogroup W-135 meningococci in the country.	[Belen Ibarz-Pavon, Ana; Sigauque, Betuel; Bassat, Quique; Quinto, Llorenc; Alonso, Pedro L.; Roca, Anna] Univ Barcelona, CRESIB, Barcelona, Spain; [Belen Ibarz-Pavon, Ana; Morais, Luis; Sigauque, Betuel; Mandomando, Inacio; Bassat, Quique; Nhacolo, Ariel; Alonso, Pedro L.; Roca, Anna] Ctr Invest Saude Manhica CISM, Manhica, Mozambique; [Belen Ibarz-Pavon, Ana] CIBER Epidemiol & Salud Publ CIBERESP, Inst Salud Carlos 3, Madrid, Spain; [Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [Soriano-Gabarro, Montse] GlaxoSmithKline Biol, Rixensart, Belgium	ISGlobal; CRESIB; University of Barcelona; Centro de Investigacao em Saude de Manhica; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Instituto de Salud Carlos III; GlaxoSmithKline	Ibarz-Pavon, AB (corresponding author), Univ Barcelona, CRESIB, Barcelona, Spain.	anabelen.ibarz@cresib.cat; aroca@clinic.ub.es	Alonso, Pedro L/AAZ-3645-2020; Mandomando, Inacio/ABD-8007-2020; Bassat, Quique/P-2341-2016	Alonso, Pedro L/0000-0003-3292-3443; Mandomando, Inacio/0000-0002-1078-2187; Bassat, Quique/0000-0003-0875-7596; Quinto, Llorenc/0000-0001-9992-6951	GlaxoSmithKline; Spanish Agency for International Cooperation; PneumoAdip at John Hopkins University; GAVI alliance; Vaccine Fund; CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; Spanish Ministry of Education and Science [RYC-2008-02777]	GlaxoSmithKline(GlaxoSmithKline); Spanish Agency for International Cooperation(Spanish Government); PneumoAdip at John Hopkins University; GAVI alliance; Vaccine Fund; CIBER Epidemiologia y Salud Publica (CIBERESP), Spain; Spanish Ministry of Education and Science(Spanish Government)	GlaxoSmithKline provided economic support for the molecular characterization of N. meningitidis isolates. The CISM core funding was provided by the Spanish Agency for International Cooperation. The meningitis surveillance was financed by PneumoAdip at John Hopkins University. The PneumoADIP is funded in full by the GAVI alliance and The Vaccine Fund. ABI acknowledges support to this research from the CIBER Epidemiologia y Salud Publica (CIBERESP), Spain. AR was supported by a grant from the Spanish Ministry of Education and Science (Ramon y Cajal: RYC-2008-02777). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala'Aldeen DAA, 2000, J CLIN MICROBIOL, V38, P2311; ALONSO PL, 2011, MANHICA DEMOGRAPHIC; Campagne G, 1999, B SOC PATHOL EXOT, V92, P118; Coulson GB, 2007, EMERG INFECT DIS, V13, P273, DOI 10.3201/eid1302.051553; Cuevas LE, 2007, VACCINE, V25, pA12, DOI 10.1016/j.vaccine.2007.04.034; Decosas J, 2002, LANCET INFECT DIS, V2, P763, DOI 10.1016/S1473-3099(02)00455-3; Djibo S, 2003, TROP MED INT HEALTH, V8, P1118, DOI 10.1046/j.1360-2276.2003.01126.x; du Chatelet IP, 2005, CLIN INFECT DIS, V40, P17, DOI 10.1086/426436; du Plessis M, 2008, J CLIN MICROBIOL, V46, P3208, DOI 10.1128/JCM.00221-08; Fiorito SM, 2001, SEX TRANSM DIS, V28, P29, DOI 10.1097/00007435-200101000-00007; Forgor AA, 2005, TROP MED INT HEALTH, V10, P1229, DOI 10.1111/j.1365-3156.2005.01520.x; Fox AJ, 2007, FEMS MICROBIOL REV, V31, P84, DOI 10.1111/j.1574-6976.2006.00048.x; Gagneux S, 2002, EMERG INFECT DIS, V8, P462, DOI 10.3201/eid0805.010227; Harrison LH, 2009, VACCINE, V27, pB51, DOI 10.1016/j.vaccine.2009.04.063; Jani JV, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-29; LaForce FM, 2009, VACCINE, V27, pB13, DOI 10.1016/j.vaccine.2009.04.062; MacLennan JM, 2000, LANCET, V356, P1078, DOI 10.1016/S0140-6736(00)02734-3; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Menendez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001934; Miller E, 2001, VACCINE, V20, pS58, DOI 10.1016/S0264-410X(01)00299-7; Molesworth AM, 2003, EMERG INFECT DIS, V9, P1287; Molesworth AM, 2002, T ROY SOC TROP MED H, V96, P242, DOI 10.1016/S0035-9203(02)90089-1; Mueller JE, 2007, EMERG INFECT DIS, V13, P847, DOI 10.3201/eid1306.061395; Mutonga DM, 2009, AM J TROP MED HYG, V80, P619; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Nicolas P, 2007, VACCINE, V25, pA53, DOI 10.1016/j.vaccine.2007.04.041; Njanpop-Lafourcade BM, 2005, MICROBES INFECT, V7, P645, DOI 10.1016/j.micinf.2005.01.003; Okoko BJ, 2009, VACCINE, V27, P2023, DOI 10.1016/j.vaccine.2008.11.092; Peltola H, 2001, CLIN INFECT DIS, V32, P64, DOI 10.1086/317534; Roca A, 2009, CLIN INFECT DIS, V48, pS172, DOI 10.1086/596497; ROCA A, 2008, INVASIVE HAEMOPHILUS; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Sacarlal J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-67; Sigauque B, 2008, ACTA TROP, V105, P21, DOI 10.1016/j.actatropica.2007.01.006; Snape MD, 2006, CLIN INFECT DIS, V43, P1387, DOI 10.1086/508776; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000; Taha MK, 2002, J CLIN MICROBIOL, V40, P1083, DOI 10.1128/JCM.40.3.1083-1084.2002; Taha MK, 2000, LANCET, V356, P2159, DOI 10.1016/S0140-6736(00)03502-9; Thomson MC, 2006, TROP MED INT HEALTH, V11, P781, DOI 10.1111/j.1365-3156.2006.01630.x; Traore Y, 2006, CLIN INFECT DIS, V43, P817, DOI 10.1086/507339; Trotter CL, 2004, LANCET, V364, P365, DOI 10.1016/S0140-6736(04)16725-1; von Gottberg A, 2008, CLIN INFECT DIS, V46, P377, DOI 10.1086/525260; Zimba TF, 2009, J INFECT DEV COUNTR, V3, P723	43	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e19717	10.1371/journal.pone.0019717	http://dx.doi.org/10.1371/journal.pone.0019717			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695194	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000291612600002
J	Cheung, C; McAlonan, GM; Fung, YY; Fung, G; Yu, KK; Tai, KS; Sham, PC; Chua, SE				Cheung, Charlton; McAlonan, Grainne M.; Fung, Yee Y.; Fung, Germaine; Yu, Kevin K.; Tai, Kin-Shing; Sham, Pak C.; Chua, Siew E.			MRI Study of Minor Physical Anomaly in Childhood Autism Implicates Aberrant Neurodevelopment in Infancy	PLOS ONE			English	Article							GENERALIZED SOCIAL PHOBIA; VOXEL-BASED MRI; CONGENITAL-RUBELLA; BRAIN-DEVELOPMENT; AMYGDALA VOLUME; WHITE-MATTER; SCHIZOPHRENIA; DISORDER; CHILDREN; GROWTH	Background: MPAs (minor physical anomalies) frequently occur in neurodevelopmental disorders because both face and brain are derived from neuroectoderm in the first trimester. Conventionally, MPAs are measured by evaluation of external appearance. Using MRI can help overcome inherent observer bias, facilitate multi-centre data acquisition, and explore how MPAs relate to brain dysmorphology in the same individual. Optical MPAs exhibit a tightly synchronized trajectory through fetal, postnatal and adult life. As head size enlarges with age, inter-orbital distance increases, and is mostly completed before age 3 years. We hypothesized that optical MPAs might afford a retrospective 'window' to early neurodevelopment; specifically, inter-orbital distance increase may represent a biomarker for early brain dysmaturation in autism. Methods: We recruited 91 children aged 7-16; 36 with an autism spectrum disorder and 55 age- and gender-matched typically developing controls. All children had normal IQ. Inter-orbital distance was measured on T1-weighted MRI scans. This value was entered into a voxel-by-voxel linear regression analysis with grey matter segmented from a bimodal MRI data-set. Age and total brain tissue volume were entered as covariates. Results: Intra-class coefficient for measurement of the inter-orbital distance was 0.95. Inter-orbital distance was significantly increased in the autism group (p = 0.03, 2-tailed). The autism group showed a significant relationship between inter-orbital distance grey matter volume of bilateral amygdalae extending to the unci and inferior temporal poles. Conclusions: Greater inter-orbital distance in the autism group compared with healthy controls is consistent with infant head size expansion in autism. Inter-orbital distance positively correlated with volume of medial temporal lobe structures, suggesting a link to "social brain" dysmorphology in the autism group. We suggest these data support the role of optical MPAs as a "fossil record" of early aberrant neurodevelopment, and potential biomarker for brain dysmaturation in autism.	[Cheung, Charlton; McAlonan, Grainne M.; Fung, Germaine; Yu, Kevin K.; Sham, Pak C.; Chua, Siew E.] Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China; [Tai, Kin-Shing] Univ Hong Kong, Dept Radiol, Pokfulam, Hong Kong, Peoples R China; [McAlonan, Grainne M.; Sham, Pak C.; Chua, Siew E.] Univ Hong Kong, State Key Lab Cognit Neurosci, Hong Kong, Hong Kong, Peoples R China; [Fung, Yee Y.] Harvard Univ, Harvard Sch Dent Med, Boston, MA 02115 USA	University of Hong Kong; University of Hong Kong; University of Hong Kong; Harvard University; Harvard School of Dental Medicine	Cheung, C (corresponding author), Univ Hong Kong, Dept Psychiat, Pokfulam, Hong Kong, Peoples R China.	mcalonan@hkucc.hku.hk	; McAlonan, Grainne/G-1541-2011	Yu, Kevin/0000-0002-2019-8160; McAlonan, Grainne/0000-0002-4466-2343	ING Asia-Pacific; University of Hong Kong	ING Asia-Pacific; University of Hong Kong(University of Hong Kong)	Dr G McAlonan received funding donation for autism research from ING Asia-Pacific. The authors acknowledge a generous donation from ING Asia Pacific to support autism research in Department of Psychiatry, University of Hong Kong and University of Hong Kong funding support. No other external funding exists for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, J COGNITIVE NEUROSCI, V14, P1264, DOI 10.1162/089892902760807258; Amaral DG, 2008, TRENDS NEUROSCI, V31, P137, DOI 10.1016/j.tins.2007.12.005; ATLADOTTIR HO, 2010, J AUTISM DEV DISORD; Aylward EH, 1999, NEUROLOGY, V53, P2145, DOI 10.1212/WNL.53.9.2145; Baron-Cohen S, 2005, ANNU REV NEUROSCI, V28, P109, DOI 10.1146/annurev.neuro.27.070203.144137; Baron-Cohen S, 2000, NEUROSCI BIOBEHAV R, V24, P355, DOI 10.1016/S0149-7634(00)00011-7; Baron-Cohen S, 2004, J NEUROL NEUROSUR PS, V75, P945, DOI 10.1136/jnnp.2003.018713; Beversdorf DQ, 2005, J AUTISM DEV DISORD, V35, P471, DOI 10.1007/s10803-005-5037-8; Boas F, 1905, SCIENCE, V21, P0862, DOI 10.1126/science.21.544.862-a; Boyes J, 2001, SCHIZOPHR RES, V50, P1, DOI 10.1016/S0920-9964(00)00152-3; Brothers L., 1990, CONCEPTS NEUROSCIENC, V1, P27, DOI DOI 10.1093/SCHBUL/SBQ012; BRYSON SE, 1988, J CHILD PSYCHOL PSYC, V29, P433, DOI 10.1111/j.1469-7610.1988.tb00735.x; Bullmore ET, 1999, IEEE T MED IMAGING, V18, P32, DOI 10.1109/42.750253; CHESS S, 1978, J PEDIATR-US, V93, P699, DOI 10.1016/S0022-3476(78)80921-4; CHESS S, 1971, J AUTISM CHILD SCHIZ, V1, P33, DOI 10.1007/BF01537741; CHESS S, 1977, J AUTISM CHILD SCHIZ, V7, P69, DOI 10.1007/BF01531116; Chua SE, 2007, SCHIZOPHR RES, V89, P12, DOI 10.1016/j.schres.2006.09.009; Cohen MM, 2002, AM J MED GENET, V115, P245, DOI 10.1002/ajmg.10982; Cohen MM, 1995, INT J ORAL MAX SURG, V24, P387, DOI 10.1016/S0901-5027(05)80465-5; Courchesne E, 2004, MENT RETARD DEV D R, V10, P106, DOI 10.1002/mrdd.20020; Courchesne E, 2002, MOL PSYCHIATR, V7, pS21, DOI 10.1038/sj.mp.4001169; Courchesne E, 2001, NEUROLOGY, V57, P245, DOI 10.1212/WNL.57.2.245; Dean K, 2006, BRIT J PSYCHIAT, V189, P221, DOI 10.1192/bjp.bp.105.016337; DENG MY, 2009, PSYCHOPHARMACOLOGY B; DICKS D, 1969, SCIENCE, V165, P69, DOI 10.1126/science.165.3888.69; DIEWERT VM, 1993, J CRAN GENET DEV BIO, V13, P193; Dollfus HN, 2004, SURV OPHTHALMOL, V49, P547, DOI 10.1016/j.survophthal.2004.08.001; FIRESTONE P, 1978, J CHILD PSYCHOL PSYC, V19, P155, DOI 10.1111/j.1469-7610.1978.tb00456.x; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Gourion D, 2004, SCHIZOPHR RES, V67, P23, DOI 10.1016/S0920-9964(03)00099-9; Grelotti DJ, 2005, NEUROPSYCHOLOGIA, V43, P373, DOI 10.1016/j.neuropsychologia.2004.06.015; Hardan AY, 2006, J AUTISM DEV DISORD, V36, P607, DOI 10.1007/s10803-006-0103-4; Haznedar MM, 2000, AM J PSYCHIAT, V157, P1994, DOI 10.1176/appi.ajp.157.12.1994; Ho TP, 2005, J CHILD PSYCHOL PSYC, V46, P1135, DOI 10.1111/j.1469-7610.2005.01435.x; Ismail B, 2000, J PSYCHIAT RES, V34, P45, DOI 10.1016/S0022-3956(99)00034-5; Joseph R, 1999, CHILD PSYCHIAT HUM D, V29, P189, DOI 10.1023/A:1022660923605; Kinney DK, 2008, NEUROSCI BIOBEHAV R, V32, P1519, DOI 10.1016/j.neubiorev.2008.06.004; Kinney DK, 2008, J AUTISM DEV DISORD, V38, P481, DOI 10.1007/s10803-007-0414-0; Libbey JE, 2005, J NEUROVIROL, V11, P1, DOI 10.1080/13550280590900553; Lorberbaum JP, 2004, NEUROREPORT, V15, P2701; MARDEN PM, 1964, J PEDIATR-US, V64, P357, DOI 10.1016/S0022-3476(64)80188-8; McAlonan GM, 2005, BRAIN, V128, P268, DOI 10.1093/brain/awh332; MCALONAN GM, 2009, PSYCHOL MED, P1; MCALONAN GM, 2008, J CHILD PSYCHOL PSYC; MCALONAN GM, 2010, NEUROSIGNAL IN PRESS; McAlonan GM, 2007, PSYCHIAT RES-NEUROIM, V154, P171, DOI 10.1016/j.pscychresns.2006.09.006; McNeil TE, 2000, AUST NZ J PSYCHIAT, V34, pS65, DOI 10.1080/000486700225; Miles JH, 2000, AM J MED GENET, V91, P245, DOI 10.1002/(SICI)1096-8628(20000410)91:4<245::AID-AJMG1>3.3.CO;2-U; MORIN JD, 1963, AM J OPHTHALMOL, V56, P895, DOI 10.1016/0002-9394(63)92325-0; Mosconi MW, 2009, ARCH GEN PSYCHIAT, V66, P509, DOI 10.1001/archgenpsychiatry.2009.19; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; OMOTADE OO, 1990, J MED GENET, V27, P358, DOI 10.1136/jmg.27.6.358; Ortiz-Mantilla S, 2010, NEUROIMAGE, V49, P2791, DOI 10.1016/j.neuroimage.2009.10.029; OZGEN H, 2008, MOL PSYCHIAT; PASAMANICK B, 1956, AM J PSYCHIAT, V112, P613, DOI 10.1176/ajp.112.8.613; RAPOPORT JL, 1974, AM J PSYCHIAT, V131, P386; Schumann CM, 2009, BIOL PSYCHIAT, V66, P942, DOI 10.1016/j.biopsych.2009.07.007; SMITH DW, 1976, RECOGNIZABLE PATTERN; Stein MB, 2002, ARCH GEN PSYCHIAT, V59, P1027, DOI 10.1001/archpsyc.59.11.1027; Sweeten TL, 2004, J AUTISM DEV DISORD, V34, P583, DOI 10.1007/s10803-004-2552-y; SWENNEN GR, 2005, 3 D CEPHALOMETRY COL; Tripi G, 2008, EARLY HUM DEV, V84, P217, DOI 10.1016/j.earlhumdev.2007.04.005; Trixler M, 1997, AM J PSYCHIAT, V154, P691; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P885, DOI 10.1109/42.811268; Van Leemput K, 1999, IEEE T MED IMAGING, V18, P897, DOI 10.1109/42.811270; Waddington JL, 1998, J PSYCHIATR RES, V32, P179; WALDROP MF, 1976, J CHILD PSYCHOL PSYC, V17, P113, DOI 10.1111/j.1469-7610.1976.tb00383.x; WALKER HA, 1977, J AUTISM CHILD SCHIZ, V7, P165, DOI 10.1007/BF01537727; WARKANY J, 1961, AM J DIS CHILD, V102, P249, DOI 10.1001/archpedi.1961.02080010251018; Zimmermann AA, 1934, ANAT REC, V59, P109, DOI 10.1002/ar.1090590110	70	23	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20246	10.1371/journal.pone.0020246	http://dx.doi.org/10.1371/journal.pone.0020246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687660	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500012
J	Methling, C; Tudorache, C; Skov, PV; Steffensen, JF				Methling, Caroline; Tudorache, Christian; Skov, Peter V.; Steffensen, John F.			Pop Up Satellite Tags Impair Swimming Performance and Energetics of the European Eel (Anguilla anguilla)	PLOS ONE			English	Article							BLUEFIN TUNA; SILVER EELS; TELEMETRY TRANSMITTERS; SPAWNING MIGRATION; OXYGEN-CONSUMPTION; OSCILLATING FOILS; ATLANTIC SALMON; SOCKEYE SALMON; RAINBOW-TROUT; ARCHIVAL TAGS	Pop-up satellite archival tags (PSATs) have recently been applied in attempts to follow the oceanic spawning migration of the European eel. PSATs are quite large, and in all likelihood their hydraulic drag constitutes an additional cost during swimming, which remains to be quantified, as does the potential implication for successful migration. Silver eels (L(T)=598.6 +/- 29 mm SD, N = 9) were subjected to swimming trials in a Steffensen-type swim tunnel at increasing speeds of 0.3-0.9 body lengths s(-1), first without and subsequently with, a scaled down PSAT dummy attached. The tag significantly increased oxygen consumption (MO(2)) during swimming and elevated minimum cost of transport (COT(min)) by 26%. Standard (SMR) and active metabolic rate (AMR) as well as metabolic scope remained unaffected, suggesting that the observed effects were caused by increased drag. Optimal swimming speed (U(opt)) was unchanged, whereas critical swimming speed (U(crit)) decreased significantly. Swimming with a PSAT altered swimming kinematics as verified by significant changes to tail beat frequency (f), body wave speed (v) and Strouhal number (St). The results demonstrate that energy expenditure, swimming performance and efficiency all are significantly affected in migrating eels with external tags.	[Methling, Caroline; Steffensen, John F.] Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark; [Tudorache, Christian] Leiden Univ, Inst Biol, Leiden, Netherlands; [Skov, Peter V.] Tech Univ Denmark, Natl Inst Aquat Resources, Aquaculture Sect, Hirtshals, Denmark; [Steffensen, John F.] Tech Univ Denmark, Natl Inst Aquat Resources, DTU Aqua, Charlottenlund, Denmark	University of Copenhagen; Leiden University; Leiden University - Excl LUMC; Technical University of Denmark; Technical University of Denmark	Methling, C (corresponding author), Univ Copenhagen, Marine Biol Sect, Helsingor, Denmark.	cmethling@bio.ku.dk	Skov, Peter V/C-2388-2011; Methling, Caroline/A-2807-2015; Steffensen, John F/F-6778-2010	Skov, Peter V/0000-0001-7900-4431; Steffensen, John F/0000-0002-4477-8039; Tudorache, Christian/0000-0002-6208-9608	Danish Agency for Science Technology and Innovation; The Elisabeth and Knud Petersen Foundation; The Faculty of Science, University of Copenhagen	Danish Agency for Science Technology and Innovation; The Elisabeth and Knud Petersen Foundation; The Faculty of Science, University of Copenhagen	This study was funded by the Danish Agency for Science Technology and Innovation, The Elisabeth and Knud Petersen Foundation, and The Faculty of Science, University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Beamish F.W., 1979, FISH PHYSL LOCOMOTIO, P101, DOI DOI 10.1139/cjfas-2015-0209; BELL WH, 1970, FISHERIES RES BOARD, V195, P69; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; BRETT JR, 1971, AM ZOOL, V11, P99; BRETT JR, 1964, J FISH RES BOARD CAN, V21, P1183, DOI 10.1139/f64-103; Castonguay Martin, 1994, Fisheries Oceanography, V3, P197, DOI 10.1111/j.1365-2419.1994.tb00097.x; CULIK B, 1991, J EXP BIOL, V158, P355; DEGANI G, 1989, J FISH BIOL, V34, P19, DOI 10.1111/j.1095-8649.1989.tb02953.x; Durif C, 2005, J FISH BIOL, V66, P1025, DOI 10.1111/j.0022-1112.2005.00662.x; FRICKE H, 1995, NATURWISSENSCHAFTEN, V82, P32, DOI 10.1007/s001140050136; Grusha, 2005, THESIS COLL WILLIAM; HARO AJ, 1991, ENVIRON BIOL FISH, V31, P171, DOI 10.1007/BF00001018; Jellyman D, 2002, MAR ECOL PROG SER, V233, P207, DOI 10.3354/meps233207; Kiessling A, 2009, AQUACULTURE, V286, P301, DOI 10.1016/j.aquaculture.2008.09.037; LEWIS AE, 1984, J FISH BIOL, V25, P577, DOI 10.1111/j.1095-8649.1984.tb04904.x; Marcinek DJ, 2001, MAR BIOL, V138, P869, DOI 10.1007/s002270000492; McCleave JD, 1999, ICES J MAR SCI, V56, P510, DOI 10.1006/jmsc.1999.0478; MCCLEAVE JD, 1979, NATURE, V278, P782, DOI 10.1038/278782a0; MELLAS EJ, 1985, CAN J FISH AQUAT SCI, V42, P488, DOI 10.1139/f85-066; Moser M.L., 1990, American Fisheries Society Symposium, P353; Palstra AP, 2007, J EXP MAR BIOL ECOL, V352, P244, DOI 10.1016/j.jembe.2007.08.003; Palstra A, 2008, COMP BIOCHEM PHYS A, V151, P37, DOI 10.1016/j.cbpa.2008.05.011; Peake SJ, 2004, J EXP BIOL, V207, P1563, DOI 10.1242/jeb.00927; Quintella BR, 2010, J APPL ICHTHYOL, V26, P432, DOI 10.1111/j.1439-0426.2010.01457.x; RANDALL D, 1991, J EXP BIOL, V160, P113; Read DA, 2003, J FLUID STRUCT, V17, P163, DOI 10.1016/S0889-9746(02)00115-9; Ropert-Coudert Y, 2007, MAR ECOL PROG SER, V333, P281, DOI 10.3354/meps333281; Schmidt J, 1923, NATURE, V111, P51, DOI 10.1038/111051a0; SCHMIDT J, 1925, BREEDING PLACES EEL, P279; Schurmann H, 1997, J FISH BIOL, V50, P1166, DOI 10.1006/jfbi.1997.0387; Seitz AC, 2002, J FISH BIOL, V60, P1597, DOI 10.1006/jfbi.2002.2009; STEFFENSEN JF, 1984, COMP BIOCHEM PHYS A, V79, P437, DOI 10.1016/0300-9629(84)90541-3; STEFFENSEN JF, 1989, FISH PHYSIOL BIOCHEM, V6, P49, DOI 10.1007/BF02995809; Steinhausen MF, 2006, J FISH BIOL, V69, P951, DOI 10.1111/j.1095-8649.2006.01143.x; Svedang H, 1997, J FISH BIOL, V50, P475, DOI 10.1111/j.1095-8649.1997.tb01943.x; Tesch F.-W., 1989, Aquatic Living Resources, V2, P9, DOI 10.1051/alr:1989002; TESCH F-W, 1978, Environmental Biology of Fishes, V3, P203, DOI 10.1007/BF00691944; TESCH FW, 1995, B SEA FISHERIES I, V2, P23; Thorstad EB, 2000, J FISH BIOL, V57, P531, DOI 10.1006/jfbi.2000.1315; TRIANTAFYLLOU GS, 1993, J FLUID STRUCT, V7, P205, DOI 10.1006/jfls.1993.1012; Triantafyllou MS, 2000, ANNU REV FLUID MECH, V32, P33, DOI 10.1146/annurev.fluid.32.1.33; Tudorache C, 2007, J FISH BIOL, V71, P1630, DOI 10.1111/j.1095-8649.2007.01620.x; Tudorache C, 2010, J FISH BIOL, V76, P729, DOI 10.1111/j.1095-8649.2009.02513.x; Tytell ED, 2004, J EXP BIOL, V207, P3265, DOI 10.1242/jeb.01139; van den Thillart G, 2004, J FISH BIOL, V65, P312, DOI 10.1111/j.0022-1112.2004.00447.x; Van den Thillart G, 2007, J MAR SCI TECH-TAIW, V15, P1; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; van Ginneken VJT, 2000, NATURE, V403, P156, DOI 10.1038/35003110; WALSH PJ, 1983, PHYSIOL ZOOL, V56, P532, DOI 10.1086/physzool.56.4.30155876; Weng KC, 2004, FISH B-NOAA, V102, P221; Wilson SG, 2005, MAR BIOL, V146, P409, DOI 10.1007/s00227-004-1445-0; Winter J.D., 1983, P371	54	46	46	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20797	10.1371/journal.pone.0020797	http://dx.doi.org/10.1371/journal.pone.0020797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687674	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500045
J	Lerman, G; Avivi, C; Mardoukh, C; Barzilai, A; Tessone, A; Gradus, B; Pavlotsky, F; Barshack, I; Polak-Charcon, S; Orenstein, A; Hornstein, E; Sidi, Y; Avni, D				Lerman, Galya; Avivi, Camila; Mardoukh, Corine; Barzilai, Aviv; Tessone, Ariel; Gradus, Ben; Pavlotsky, Felix; Barshack, Iris; Polak-Charcon, Sylvie; Orenstein, Arie; Hornstein, Eran; Sidi, Yechezkel; Avni, Dror			MiRNA Expression in Psoriatic Skin: Reciprocal Regulation of hsa-miR-99a and IGF-1R	PLOS ONE			English	Article							FACTOR-I RECEPTOR; KERATINOCYTE DIFFERENTIATION; CELL-LINE; MICRORNAS; MORPHOGENESIS; PATHOGENESIS; MUTAGENESIS; MECHANISMS; EPIDERMIS; GENETICS	Background: Psoriasis is a complex disease at the cellular, genomic and genetic levels. The role of microRNAs in skin development was shown in a keratinocyte-specific Dicer knockout mouse model. Considering that two main characteristics of psoriasis are keratinocytes hyperproliferation and abnormal skin differentiation, we hypothesized that aberrant microRNA expression contributes to the psoriatic phenotype. Here, we describe the differential expression of miRNAs in psoriatic involved and uninvolved skin as compared to normal skin, revealing an additional aspect of this complex disorder. Methodology/Principal Findings: Expression arrays were used to compare microRNA expression in normal skin versus psoriatic involved and uninvolved skin. Fourteen differentially expressed microRNAs were identified, including hsa-miR-99a, hsa-miR-150, hsa-miR-423 and hsa-miR-197. The expression of these microRNAs was reevaluated by qPCR. IGF-1R, which is involved in skin development and the pathogenesis of psoriasis, is a predicted target of hsa-miR-99a. In an in situ hybridization assay, we found that IGF-1R and miR-99a are reciprocally expressed in the epidermis. Using a reporter assay, we found that IGF-1R is targeted by hsa-miR-99a. Moreover, over expression of miR-99a in primary keratinocytes down-regulates the expression of the endogenous IGF-1R protein. Over expression of miR-99a also inhibits keratinocyte proliferation and increases Keratin 10 expression. These findings suggest that overexpression of hsa-miR-99a in keratinocytes drives them towards differentiation. In primary keratinocytes grown in high Ca++, miR-99a expression increases over time. Finally, we found that IGF1 increases the expression of miR-99a. Conclusions/Significance: We identified several microRNAs that are expressed differentially in normal and psoriatic skin. One of these miRNAs is miR-99a that regulates the expression of IGF-1R. Moreover, miR-99a seems to play a role in the differentiation of keratinocytes. We suggest that miR-99a is one of the regulators of the IGF-1R signaling pathway in keratinocytes. Activation of IGF1 signaling results in elevation of miR-99a which represses the expression of IGF-1R.	[Lerman, Galya; Sidi, Yechezkel; Avni, Dror] Ctr Canc Res, Mol Cell Biol Lab, Tel Hashomer, Israel; [Lerman, Galya; Sidi, Yechezkel; Avni, Dror] Sheba Med Ctr, Dept Internal Med C, Tel Hashomer, Israel; [Lerman, Galya; Sidi, Yechezkel] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Avivi, Camila; Mardoukh, Corine; Barshack, Iris; Polak-Charcon, Sylvie] Sheba Med Ctr, Inst Pathol, Tel Hashomer, Israel; [Barzilai, Aviv; Pavlotsky, Felix] Sheba Med Ctr, Dept Dermatol, Tel Hashomer, Israel; [Tessone, Ariel; Orenstein, Arie] Sheba Med Ctr, Dept Plast & Reconstruct Surg & Burns, Tel Hashomer, Israel; [Gradus, Ben; Hornstein, Eran] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Weizmann Institute of Science	Lerman, G (corresponding author), Ctr Canc Res, Mol Cell Biol Lab, Tel Hashomer, Israel.	ysidi@sheba.health.gov.il; droravni@msn.com	Avni, Dror/GRE-8325-2022; HORNSTEIN, ERAN/K-1340-2012	HORNSTEIN, ERAN/0000-0002-5534-1924; Avni, Dror/0000-0002-8738-1840; sidi, yechezkel/0000-0001-7781-6153	Israel Science Foundation [277/07]; Israel Cancer Association [20090085]; Chief Scientist Office of Israel Ministry of Health [4898]	Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Chief Scientist Office of Israel Ministry of Health	This research was supported by grants from the Israel Science Foundation (Grant No. 277/07), the Israel Cancer Association (Grant No. 20090085) and the Chief Scientist Office of Israel Ministry of Health, (Grant No. 4898) to D. Avni and Y. Sidi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Ausubel F. M., 1999, SHORT PROTOCOLS MOL; Barker JNWN, 2001, CLIN EXP DERMATOL, V26, P321, DOI 10.1046/j.1365-2230.2001.00830.x; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bonifati C, 1997, CLIN IMMUNOL IMMUNOP, V83, P41, DOI 10.1006/clin.1996.4313; Bowcock AM, 2005, ANNU REV GENOM HUM G, V6, P93, DOI 10.1146/annurev.genom.6.080604.162324; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Bowcock AM, 2001, HUM MOL GENET, V10, P1793, DOI 10.1093/hmg/10.17.1793; Colosimo A, 1999, BIOTECHNIQUES, V26, P870, DOI 10.2144/99265bm15; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; EBERT MS, 2010, RNA; Elder JT, 2001, ARCH DERMATOL, V137, P1447; Galadari I, 2005, CLIN DERMATOL, V23, P491, DOI 10.1016/j.clindermatol.2005.01.009; Giardina Emiliano, 2004, Current Drug Targets - Inflammation and Allergy, V3, P129, DOI 10.2174/1568010043343877; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Gudjonsson JE, 2004, CLIN EXP IMMUNOL, V135, P1, DOI 10.1111/j.1365-2249.2004.02310.x; Hodak E, 1996, J INVEST DERMATOL, V106, P564, DOI 10.1111/1523-1747.ep12344044; Hwu WL, 2005, J MED GENET, V42, P152, DOI 10.1136/jmg.2004.018564; Jiang WY, 2001, INT J DERMATOL, V40, P699, DOI 10.1046/j.1365-4362.2001.01262.x; KRANE JF, 1992, J EXP MED, V175, P1081, DOI 10.1084/jem.175.4.1081; Lai R, 2003, BIOTECHNIQUES, V34, P52, DOI 10.2144/03341bm07; Lilling G, 2000, CANCER LETT, V161, P27, DOI 10.1016/S0304-3835(00)00579-6; Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 1999, J CLIN INVEST, V104, P1161, DOI 10.1172/JCI8633; Nickoloff BJ, 2007, CLIN REV ALLERG IMMU, V33, P45, DOI 10.1007/s12016-007-0039-2; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; RHEINWALD JG, 1975, CELL, V6, P317, DOI 10.1016/0092-8674(75)90183-X; Sadagurski M, 2006, MOL CELL BIOL, V26, P2675, DOI 10.1128/MCB.26.7.2675-2687.2006; Sagoo GS, 2004, J DERMATOL SCI, V35, P171, DOI 10.1016/j.jdermsci.2004.02.009; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; SONKOLY E, 2009, J INVEST DERMATOL; Sonkoly E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000610; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wagner LA, 1999, EUR J IMMUNOL, V29, P2530, DOI 10.1002/(SICI)1521-4141(199908)29:08<2530::AID-IMMU2530>3.0.CO;2-2; Wraight CJ, 2000, NAT BIOTECHNOL, V18, P521, DOI 10.1038/75382; WU Q, BIOCH BIOPHYS RES CO, V392, P340; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642	44	104	110	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20916	10.1371/journal.pone.0020916	http://dx.doi.org/10.1371/journal.pone.0020916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687694	gold, Green Submitted, Green Published			2022-12-25	WOS:000291607000027
J	Yuan, K; Qin, W; Wang, GH; Zeng, F; Zhao, LY; Yang, XJ; Liu, P; Liu, JX; Sun, JB; von Deneen, KM; Gong, QY; Liu, YJ; Tian, J				Yuan, Kai; Qin, Wei; Wang, Guihong; Zeng, Fang; Zhao, Liyan; Yang, Xuejuan; Liu, Peng; Liu, Jixin; Sun, Jinbo; von Deneen, Karen M.; Gong, Qiyong; Liu, Yijun; Tian, Jie			Microstructure Abnormalities in Adolescents with Internet Addiction Disorder	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; RESPONSE-INHIBITION; PREFRONTAL CORTEX; DIFFUSION TENSOR; ORBITOFRONTAL CORTEX; VOXELWISE ANALYSIS; BRAIN; ROBUST; TASK; OPTIMIZATION	Background: Recent studies suggest that internet addiction disorder (IAD) is associated with structural abnormalities in brain gray matter. However, few studies have investigated the effects of internet addiction on the microstructural integrity of major neuronal fiber pathways, and almost no studies have assessed the microstructural changes with the duration of internet addiction. Methodology/Principal Findings: We investigated the morphology of the brain in adolescents with IAD (N = 18) using an optimized voxel-based morphometry (VBM) technique, and studied the white matter fractional anisotropy (FA) changes using the diffusion tensor imaging (DTI) method, linking these brain structural measures to the duration of IAD. We provided evidences demonstrating the multiple structural changes of the brain in IAD subjects. VBM results indicated the decreased gray matter volume in the bilateral dorsolateral prefrontal cortex (DLPFC), the supplementary motor area (SMA), the orbitofrontal cortex (OFC), the cerebellum and the left rostral ACC (rACC). DTI analysis revealed the enhanced FA value of the left posterior limb of the internal capsule (PLIC) and reduced FA value in the white matter within the right parahippocampal gyrus (PHG). Gray matter volumes of the DLPFC, rACC, SMA, and white matter FA changes of the PLIC were significantly correlated with the duration of internet addiction in the adolescents with IAD. Conclusions: Our results suggested that long-term internet addiction would result in brain structural alterations, which probably contributed to chronic dysfunction in subjects with IAD. The current study may shed further light on the potential brain effects of IAD.	[Yuan, Kai; Qin, Wei; Wang, Guihong; Yang, Xuejuan; Liu, Peng; Liu, Jixin; Sun, Jinbo; von Deneen, Karen M.; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Wang, Guihong] Xidian Univ, Dept Appl Math, Xian, Shaanxi, Peoples R China; [Zeng, Fang] Chengdu Univ Tradit Chinese Med, Teaching Hosp 3, Chengdu, Sichuan, Peoples R China; [Zhao, Liyan] Peking Univ, Natl Inst Drug Dependence, Beijing 100871, Peoples R China; [Gong, Qiyong] Sichuan Univ, Dept Radiol, Ctr Med Imaging, Huaxi MR Res Ctr HMRRC,W China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Xidian University; Chengdu University of Traditional Chinese Medicine; Peking University; Sichuan University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Automation, CAS	Yuan, K (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	yijunliu@ufl.edu; tian@ieee.org	Yuan, Kai/I-4150-2016; tian, jie/M-6336-2013; 66, anshiquanshu/L-7012-2016; 秦, 伟/J-9770-2016; Yuan, Kai/M-9403-2013; JinBo, Sun/GLT-2082-2022; Life, PAM/M-9552-2013; Gong, Qiyong/W-3052-2019; Tian, Jie/H-1190-2011	Yuan, Kai/0000-0002-3098-1124; 秦, 伟/0000-0003-4583-0406; Gong, Qiyong/0000-0002-5912-4871; Tian, Jie/0000-0003-0498-0432	CAS; National Natural Science Foundation of China [30970774, 60901064, 30873462, 30870685, 81000641, 81000640, 81071217, 31028010, 81071137]; Project for the National Key Basic Research and Development Program (973) [2011CB707700, 2011CB707702]; 863 program [2008AA01Z411]; Fundamental Research Funds for the Central Universities	CAS(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project for the National Key Basic Research and Development Program (973)(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This paper is supported by CAS Hundred Talents Program, the National Natural Science Foundation of China under grant nos. 30970774, 60901064, 30873462, 30870685, 81000641, 81000640, 81071217, 31028010, 81071137, the Project for the National Key Basic Research and Development Program (973) under grant nos. 2011CB707700, 2011CB707702, and 863 program under grant no. 2008AA01Z411, the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ANDERSEN RA, 1980, J COMP NEUROL, V194, P663, DOI 10.1002/cne.901940312; Andersson Jesper L. R., 2007, FMRIB ANAL GROUP TEC; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Barber AD, 2005, CEREB CORTEX, V15, P899, DOI 10.1093/cercor/bhh189; Beard KW, 2005, CYBERPSYCHOL BEHAV, V8, P7, DOI 10.1089/cpb.2005.8.7; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Botvinick M, 1999, NATURE, V402, P179, DOI 10.1038/46035; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Boyke J, 2008, J NEUROSCI, V28, P7031, DOI 10.1523/JNEUROSCI.0742-08.2008; Burwell RD, 2000, ANN NY ACAD SCI, V911, P25; Cao FL, 2007, EUR PSYCHIAT, V22, P466, DOI 10.1016/j.eurpsy.2007.05.004; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Casey BJ, 2005, TRENDS COGN SCI, V9, P104, DOI 10.1016/j.tics.2005.01.011; Chou C, 2005, EDUC PSYCHOL REV, V17, P363, DOI 10.1007/s10648-005-8138-1; Christakis DA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-61; CSIKSZENTMIHALYI M, 1977, J YOUTH ADOLESCENCE, V6, P281, DOI 10.1007/BF02138940; Culver JD, 1997, J GEN INTERN MED, V12, P466, DOI 10.1046/j.1525-1497.1997.00084.x; Cummings JL, 1995, ANN NY ACAD SCI, V769, P1, DOI 10.1111/j.1749-6632.1995.tb38127.x; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Desmond JE, 2001, INT REV PSYCHIATR, V13, P283, DOI 10.1080/09540260127529; Dong GH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014703; Dong GH, 2010, NEUROSCI LETT, V485, P138, DOI 10.1016/j.neulet.2010.09.002; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Engle RW, 2004, PSYCHOL LEARN MOTIV, V44, P145; Ernst M, 2005, NEUROIMAGE, V25, P1279, DOI 10.1016/j.neuroimage.2004.12.038; Ernst M, 2006, PSYCHOL MED, V36, P299, DOI 10.1017/S0033291705005891; Flisher C, 2010, J PAEDIATR CHILD H, V46, P557, DOI 10.1111/j.1440-1754.2010.01879.x; Forman SD, 2004, BIOL PSYCHIAT, V55, P531, DOI 10.1016/j.biopsych.2003.09.011; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Galvan A, 2006, J NEUROSCI, V26, P6885, DOI 10.1523/JNEUROSCI.1062-06.2006; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Groenewegen HJ, 2000, PROG BRAIN RES, V126, P3; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JUN L, 2010, CHINESE MED J, V123, P1904; JUN L, CHINESE MED J, V123, P1904; Kaufman JN, 2003, J NEUROSCI, V23, P7839; Ko CH, 2010, PSYCHIAT RES, V175, P121, DOI 10.1016/j.psychres.2008.10.004; Ko CH, 2009, COMPR PSYCHIAT, V50, P378, DOI 10.1016/j.comppsych.2007.05.019; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Levitt JJ, 2010, PSYCHIAT RES-NEUROIM, V184, P143, DOI 10.1016/j.pscychresns.2010.08.004; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Luck D, 2010, BRAIN COGNITION, V72, P255, DOI 10.1016/j.bandc.2009.09.009; MacDonald AW, 2000, SCIENCE, V288, P1835, DOI 10.1126/science.288.5472.1835; May JC, 2004, BIOL PSYCHIAT, V55, P359, DOI 10.1016/j.biopsych.2003.11.008; Morahan-Martin J, 2000, COMPUT HUM BEHAV, V16, P13, DOI 10.1016/S0747-5632(99)00049-7; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Parent A., 1996, CARPENTERS HUMAN NEU, V9th. Edn; Pine D S, 2001, CNS Spectr, V6, P27; Powell HWR, 2004, NEUROIMAGE, V22, P740, DOI 10.1016/j.neuroimage.2004.01.011; Raymond JL, 1996, SCIENCE, V272, P1126, DOI 10.1126/science.272.5265.1126; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Scherer K, 1997, J COLL STUDENT DEV, V38, P655; Schmahmann JD, 1998, BRAIN, V121, P561, DOI 10.1093/brain/121.4.561; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; SHIBASAKI H, 1993, BRAIN, V116, P1387, DOI 10.1093/brain/116.6.1387; Silveri MM, 2004, ANN NY ACAD SCI, V1021, P363, DOI 10.1196/annals.1308.046; Simmonds DJ, 2008, NEUROPSYCHOLOGIA, V46, P224, DOI 10.1016/j.neuropsychologia.2007.07.015; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2007, NAT PROTOC, V2, P499, DOI 10.1038/nprot.2007.45; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Steinberg L, 2005, TRENDS COGN SCI, V9, P69, DOI 10.1016/j.tics.2004.12.005; Tulving E, 1996, CEREB CORTEX, V6, P71, DOI 10.1093/cercor/6.1.71; Vanderhasselt MA, 2009, PSYCHON B REV, V16, P609, DOI 10.3758/PBR.16.3.609; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Werring DJ, 1998, J NEUROL NEUROSUR PS, V65, P863, DOI 10.1136/jnnp.65.6.863; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Winer JA, 2001, J COMP NEUROL, V430, P27; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young K S., 1999, INNOVATIONS CLIN PRA, P19; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Yuan K, 2010, NEUROSCI LETT, V475, P20, DOI 10.1016/j.neulet.2010.03.033; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; ZHOU Y, 2009, EUROPEAN J RADIOLOGY, DOI DOI 10.1016/J.EJRAD.2009.1010.1025; ZHU X, 2010, BRAIN RES, V1396, P223	89	179	185	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20708	10.1371/journal.pone.0020708	http://dx.doi.org/10.1371/journal.pone.0020708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677775	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500036
J	Zhu, J; Garcia-Barcelo, MM; Tam, PKH; Lui, VCH				Zhu, Jiang; Garcia-Barcelo, Maria-Mercedes; Tam, Paul Kwong Hang; Lui, Vincent Chi Hang			HOXB5 Cooperates with NKX2-1 in the Transcription of Human RET	PLOS ONE			English	Article							ENTERIC NERVOUS-SYSTEM; RNA-POLYMERASE-II; HIRSCHSPRUNGS-DISEASE; C-RET; PROTOONCOGENE PROMOTER; GENE-EXPRESSION; CORE PROMOTER; 2.1 PROTEIN; STEM-CELL; MUTATIONS	The enteric nervous system (ENS) regulates peristaltic movement of the gut, and abnormal ENS causes Hirschsprung's disease (HSCR) in newborns. HSCR is a congenital complex genetic disorder characterised by a lack of enteric ganglia along a variable length of the intestine. The receptor tyrosine kinase gene (RET) is the major HSCR gene and its expression is crucial for ENS development. We have previously reported that (i) HOXB5 transcription factor mediates RET expression, and (ii) mouse with defective HOXB5 activity develop HSCR phenotype. In this study, we (i) elucidate the underlying mechanisms that HOXB5 mediate RET expression, and (ii) examine the interactions between HOXB5 and other transcription factors implicated in RET expression. We show that human HOXB5 binds to the promoter region 59 upstream of the binding site of NKX2-1 and regulates RET expression. HOXB5 and NKX2-1 form a protein complex and mediate RET expression in a synergistic manner. HSCR associated SNPs at the NKX2-1 binding site (-5G>A rs10900296; -1A>C rs10900297), which reduce NKX2-1 binding, abolish the synergistic trans-activation of RET by HOXB5 and NKX2-1. In contrast to the synergistic activation of RET with NKX2-1, HOXB5 cooperates in an additive manner with SOX10, PAX3 and PHOX2B in trans-activation of RET promoter. Taken together, our data suggests that HOXB5 in coordination with other transcription factors mediates RET expression. Therefore, defects in cis- or trans-regulation of RET by HOXB5 could lead to reduction of RET expression and contribute to the manifestation of the HSCR phenotype.	[Zhu, Jiang; Garcia-Barcelo, Maria-Mercedes; Tam, Paul Kwong Hang; Lui, Vincent Chi Hang] Univ Hong Kong, Dept Surg Dev & Growth, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Garcia-Barcelo, Maria-Mercedes; Tam, Paul Kwong Hang; Lui, Vincent Chi Hang] Univ Hong Kong, Ctr Reprod Dev & Growth, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Zhu, J (corresponding author), Univ Hong Kong, Dept Surg Dev & Growth, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.	vchlui@hkucc.hku.hk	; /C-4359-2009; /C-4405-2009	Zhu, Joe/0000-0003-4416-7040; /0000-0002-1758-8854; /0000-0001-6231-3035	Hong Kong Research Grants Council [HKU7713/08M, HKU7654/07M]; University of Hong Kong [200811159088]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong(University of Hong Kong)	This work was supported by research grants from the Hong Kong Research Grants Council (HKU7713/08M and HKU7654/07M to VCHL and MMGB respectively) and the University of Hong Kong Seed Funding Programme for Basic Research (200811159088) to VCHL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Andrew SD, 2000, GENE, V256, P283, DOI 10.1016/S0378-1119(00)00302-4; ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351; DEFELICE M, 1995, J BIOL CHEM, V270, P26649, DOI 10.1074/jbc.270.44.26649; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; Fitze G, 2003, HUM MOL GENET, V12, P3207, DOI 10.1093/hmg/ddg354; Fu M, 2003, DEV DYNAM, V228, P1, DOI 10.1002/dvdy.10350; Garcia-Barcelo M, 2005, HUM MOL GENET, V14, P191, DOI 10.1093/hmg/ddi015; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P526, DOI 10.1111/j.1469-1809.2007.00347.x; Garcia-Barcelo MM, 2007, ANN HUM GENET, V71, P746, DOI 10.1111/j.1469-1809.2007.00384.x; Griseri P, 2005, HUM MUTAT, V25, P189, DOI 10.1002/humu.20135; Griseri P, 2003, GUT, V52, P1154, DOI 10.1136/gut.52.8.1154; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Iwashita T, 2003, SCIENCE, V301, P972, DOI 10.1126/science.1085649; KURATANI SC, 1992, DEV DYNAM, V195, P15, DOI 10.1002/aja.1001950103; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Lang D, 2000, J CLIN INVEST, V106, P963, DOI 10.1172/JCI10828; Leon TYY, 2009, J PEDIATR SURG, V44, P1904, DOI 10.1016/j.jpedsurg.2008.11.055; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Lui VCH, 2005, CLIN CHEM, V51, P1552, DOI 10.1373/clinchem.2005.051904; Lui VCH, 2008, GASTROENTEROLOGY, V134, P1104, DOI 10.1053/j.gastro.2008.01.028; Miao XP, 2010, HUM MOL GENET, V19, P1461, DOI 10.1093/hmg/ddq020; Natarajan D, 2002, DEVELOPMENT, V129, P5151; Pachnis V, 1998, AM J PHYSIOL-GASTR L, V275, pG183, DOI 10.1152/ajpgi.1998.275.2.G183; PACHNIS V, 1993, DEVELOPMENT, V119, P1005; Pitera JE, 1999, GASTROENTEROLOGY, V117, P1339, DOI 10.1016/S0016-5085(99)70284-2; Puppo F, 2002, FEBS LETT, V523, P123, DOI 10.1016/S0014-5793(02)02957-5; ROMEO G, 1994, NATURE, V367, P377, DOI 10.1038/367377a0; Sancandi M, 2003, J MED GENET, V40, P714, DOI 10.1136/jmg.40.9.714; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Tam Paul K H, 2004, Semin Pediatr Surg, V13, P236, DOI 10.1053/j.sempedsurg.2004.10.011; Tam PKH, 2009, PEDIATR SURG INT, V25, P543, DOI 10.1007/s00383-009-2402-2; WALL NA, 1992, MECH DEVELOP, V37, P111, DOI 10.1016/0925-4773(92)90073-S	36	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20815	10.1371/journal.pone.0020815	http://dx.doi.org/10.1371/journal.pone.0020815			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677782	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500045
J	Boyman, L; Hagen, BM; Giladi, M; Hiller, R; Lederer, WJ; Khananshvili, D				Boyman, Liron; Hagen, Brian M.; Giladi, Moshe; Hiller, Reuben; Lederer, W. Jonathan; Khananshvili, Daniel			Proton-sensing Ca2+ Binding Domains Regulate the Cardiac Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-CALCIUM EXCHANGE; RAT VENTRICULAR MYOCYTES; NA+-CA2+ EXCHANGER; GUINEA-PIG; INTRACELLULAR PH; CA2+-BINDING DOMAIN; CYTOPLASMIC PROTONS; HEART-FAILURE; NCX1 PROTEIN; CYTOSOLIC CA	The cardiac Na+/Ca2(+) exchanger (NCX) regulates cellular [Ca2+](i) and plays a central role in health and disease, but its molecular regulation is poorly understood. Here we report on how protons affect this electrogenic transporter by modulating two critically important NCX C-2 regulatory domains, Ca2+ binding domain-1 (CBD1) and CBD2. The NCX transport rate in intact cardiac ventricular myocytes was measured as a membrane current, I-NCX, whereas [H+](i) was varied using an ammonium chloride "rebound" method at constant extracellular pH 7.4. At pH(i) = 7.2 and [Ca2(+)](i) < 120 nM, I-NCX was less than 4% that of its maximally Ca2+-activated value. I-NCX increases steeply at [Ca2+](i) between 130-150 nM with a Hill coefficient (n(H)) of 8.0 +/- 0.7 and K-0.5 = 310 +/- 5 nM. At pH(i) = 6.87, the threshold of Ca2+-dependent activation of I-NCX was shifted to much higher [Ca2+](i) (600-700 nM), and the relationship was similarly steep (n(H) = 8.0 +/- 0.8) with K-0.5 = 1042 +/- 15 nM. The V-max of Ca2+-dependent activation of I-NCX was not significantly altered by low pHi. The Ca2+ affinities for CBD1 (0.39 +/- 0.06 mu M) and CBD2 (K-d = 18.4 +/- 6 mu M) were exquisitely sensitive to [H+], decreasing 1.3-2.3-fold as pH(i) decreased from 7.2 to 6.9. This work reveals for the first time that NCX can be switched off by physiologically relevant intracellular acidification and that this depends on the competitive binding of protons to its C-2 regulatory domains CBD1 and CBD2.	[Boyman, Liron; Giladi, Moshe; Hiller, Reuben; Khananshvili, Daniel] Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, IL-69978 Ramat Aviv, Israel; [Boyman, Liron; Hagen, Brian M.; Lederer, W. Jonathan] Univ Maryland, Mol Cardiol Lab, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA	Tel Aviv University; Sackler Faculty of Medicine; University System of Maryland; University of Maryland Baltimore	Khananshvili, D (corresponding author), Tel Aviv Univ, Dept Physiol & Pharmacol, Sackler Sch Med, IL-69978 Ramat Aviv, Israel.	dhanan@post.tau.ac.il		Khananshvili, Daniel/0000-0002-4202-9966; Giladi, Moshe/0000-0002-8589-6920	National Institutes of Health (NHLBI) [P01 HL67849, R01-HL36974]; Israeli Ministry of Health [2010-3-6266]; USA-Israeli Binational Research Grant [2009-334]; Israel Science Foundation [23/10]; Shteicher Foundation; Leducq North American-European Atrial Fibrillation Research Alliance; European Union; Dr. Miriam and Sheldon G. Edelson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067849, R01HL036974] Funding Source: NIH RePORTER	National Institutes of Health (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Israeli Ministry of Health; USA-Israeli Binational Research Grant; Israel Science Foundation(Israel Science Foundation); Shteicher Foundation; Leducq North American-European Atrial Fibrillation Research Alliance; European Union(European Commission); Dr. Miriam and Sheldon G. Edelson Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 HL67849 and R01-HL36974 (NHLBI). This work was also supported by Israeli Ministry of Health Grant 2010-3-6266, USA-Israeli Binational Research Grant 2009-334, Israel Science Foundation Grant 23/10, the Shteicher Foundation, the Leducq North American-European Atrial Fibrillation Research Alliance, and the European Union Seventh Framework Program (FP7) "Identification and Therapeutic Targeting of Common Arrhythmia Trigger Mechanisms."; Supported by the Dr. Miriam and Sheldon G. Edelson Foundation.	Bers DM, 2000, CIRC RES, V87, P275, DOI 10.1161/01.RES.87.4.275; Bers DM, 2007, ANN NY ACAD SCI, V1099, P326, DOI 10.1196/annals.1387.060; Besserer GM, 2007, P NATL ACAD SCI USA, V104, P18467, DOI 10.1073/pnas.0707417104; BLANK PS, 1992, AM J PHYSIOL, V263, pH276, DOI 10.1152/ajpheart.1992.263.1.H276; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boyman L, 2008, BIOCHEMISTRY-US, V47, P6602, DOI 10.1021/bi8004279; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Cannell MB, 1997, BIOPHYS J, V73, P112, DOI 10.1016/S0006-3495(97)78052-4; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; Chaptal Vincent, 2007, Channels (Austin), V1, P397; Chaptal V, 2009, J BIOL CHEM, V284, P14688, DOI 10.1074/jbc.C900037200; Choi HS, 2000, J PHYSIOL-LONDON, V529, P661, DOI 10.1111/j.1469-7793.2000.00661.x; CRESPO LM, 1990, NATURE, V345, P618, DOI 10.1038/345618a0; DIPOLO R, 1982, BIOCHIM BIOPHYS ACTA, V688, P237, DOI 10.1016/0005-2736(82)90599-5; DOERING AE, 1993, J PHYSIOL-LONDON, V466, P481; DOERING AE, 1994, J PHYSIOL-LONDON, V480, P9, DOI 10.1113/jphysiol.1994.sp020336; Doering AE, 1996, ANN NY ACAD SCI, V779, P182, DOI 10.1111/j.1749-6632.1996.tb44786.x; GARLICK PB, 1979, BIOCHEM J, V184, P547, DOI 10.1042/bj1840547; Giladi M, 2010, J BIOL CHEM, V285, P28117, DOI 10.1074/jbc.M110.127001; HARRISON SM, 1992, AM J PHYSIOL, V262, pC348; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2009, P NATL ACAD SCI USA, V106, P14333, DOI 10.1073/pnas.0902171106; HILGEMANN DW, 1992, J GEN PHYSIOL, V100, P933, DOI 10.1085/jgp.100.6.933; John SA, 2011, P NATL ACAD SCI USA, V108, P1699, DOI 10.1073/pnas.1016114108; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; KHANANSHVILI D, 1994, BIOCHEMISTRY-US, V33, P312, DOI 10.1021/bi00167a041; KIMURA J, 1986, NATURE, V319, P596, DOI 10.1038/319596a0; Leem CH, 1998, J PHYSIOL-LONDON, V509, P471, DOI 10.1111/j.1469-7793.1998.471bn.x; Maack C, 2005, CIRC RES, V96, P91, DOI 10.1161/01.RES.0000151334.48676.68; Malmberg NJ, 2004, BIOCHEMISTRY-US, V43, P16320, DOI 10.1021/bi0482405; MIURA Y, 1989, J GEN PHYSIOL, V93, P1129, DOI 10.1085/jgp.93.6.1129; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; PHILIPSON KD, 1982, CIRC RES, V50, P287, DOI 10.1161/01.RES.50.2.287; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; REEVES JP, 1984, J BIOL CHEM, V259, P7733; Rhee JS, 2005, P NATL ACAD SCI USA, V102, P18664, DOI 10.1073/pnas.0509153102; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Sobie EA, 2002, BIOPHYS J, V83, P59, DOI 10.1016/S0006-3495(02)75149-7; Soeller C, 1997, BIOPHYS J, V73, P97, DOI 10.1016/S0006-3495(97)78051-2; Srivastava J, 2007, PHYSIOLOGY, V22, P30, DOI 10.1152/physiol.00035.2006; Trafford AW, 1999, PFLUG ARCH EUR J PHY, V437, P501, DOI 10.1007/s004240050808; Weber CR, 2003, CIRCULATION, V108, P2224, DOI 10.1161/01.CIR.0000095274.72486.94; Weber CR, 2001, J GEN PHYSIOL, V117, P119, DOI 10.1085/jgp.117.2.119; Yamamoto T, 2005, J PHYSIOL-LONDON, V562, P455, DOI 10.1113/jphysiol.2004.071068	47	47	47	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28811	28820		10.1074/jbc.M110.214106	http://dx.doi.org/10.1074/jbc.M110.214106			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21680748	Green Published, hybrid			2022-12-25	WOS:000293837000019
J	Chanda, D; Kim, DK; Li, TG; Kim, YH; Koo, SH; Lee, CH; Chiang, JYL; Choi, HS				Chanda, Dipanjan; Kim, Don-Kyu; Li, Tiangang; Kim, Yong-Hoon; Koo, Seung-Hoi; Lee, Chul-Ho; Chiang, John Y. L.; Choi, Hueng-Sik			Cannabinoid Receptor Type 1 (CB1R) Signaling Regulates Hepatic Gluconeogenesis via Induction of Endoplasmic Reticulum-bound Transcription Factor cAMP-responsive Element-binding Protein H (CREBH) in Primary Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOCANNABINOID SYSTEM; RISK-FACTORS; ER STRESS; OVERWEIGHT PATIENTS; ACTIVATION; RIMONABANT; DYSREGULATION; ANTAGONIST; INSULIN; BLOCKER	Activated cannabinoid 1 receptor (CB1R) signaling has been implicated in the development of phenotypes associated with fatty liver, insulin resistance, and impaired suppression of hepatic glucose output. Endoplasmic reticulum stress-associated liver-specific transcription factor CREBH is emerging as a critical player in various hepatic metabolic pathways and regulates hepatic gluconeogenesis in diet-induced obese settings. In this study, we elucidated the critical role of CREBH in mediating CB1R signaling to regulate glucose homeostasis in primary rat and human hepatocytes. mRNA and protein levels and glucose production were analyzed in primary rat and human hepatocytes. ChIP assays were performed together with various transcriptional analyses using standard techniques. CB1R activation by 2-arachidonoylglycerol (2-AG) specifically induced CREBH gene expression via phosphorylation of the JNK signaling pathway and c-Jun binding to the AP-1 binding site in the CREBH gene promoter. 2-AG treatment significantly induced hepatic gluconeogenic gene expression and glucose production in primary hepatocytes, and we demonstrated that the CREBH binding site mutant significantly attenuated 2-AG-mediated activation of the gluconeogenic gene promoter. Endogenous knockdown of CREBH led to ablation of 2-AG-induced gluconeogenic gene expression and glucose production, and the CB1R antagonist AM251 or insulin exhibited repression of CREBH gene induction and subsequently inhibited gluconeogenesis in both rat and human primary hepatocytes. These results demonstrate a novel mechanism of action of activated CB1R signaling to induce hepatic gluconeogenesis via direct activation of CREBH, thereby contributing to a better understanding of the endocannabinoid signaling mechanism involved in regulating the hepatic glucose metabolism.	[Chanda, Dipanjan; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Sch Med, Res Inst Med Sci, Dept Biomed Sci, Kwangju 501746, South Korea; [Li, Tiangang; Chiang, John Y. L.] NE Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH 44272 USA; [Kim, Yong-Hoon; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Suwon 440746, Gyeonggi Do, South Korea	Chonnam National University; Chonnam National University; Northeast Ohio Medical University (NEOMED); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU)	Choi, HS (corresponding author), Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Chiang, John Y. L./G-2658-2011; Koo, Seung-Hoi/E-2763-2015; Chanda, Dipanjan/AAU-3996-2021	Chiang, John Y. L./0000-0001-9360-7650; Koo, Seung-Hoi/0000-0001-8769-2879; Chanda, Dipanjan/0000-0003-0685-187X	National Institutes of Health [DK44442, DK58379]; Ministry of Education, Science, and Technology [2010-0019512]; Ministry for Health, Welfare, and Family Affairs, Republic of Korea [A100588]; Korean Ministry of Education, Science and Technology [20110018305]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058379, R37DK058379, R01DK044442, R56DK044442] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health, Welfare, and Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK44442 and DK58379 (to J. Y. L. C.). This work was also supported by Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology Grant 2010-0019512 (to H.-S. C.); by Korea Healthcare Technology R&D Project, Ministry for Health, Welfare, and Family Affairs, Republic of Korea Grant A100588 (to H.-S. C.); and by National Creative Research Initiatives Grant 20110018305 funded by the Korean Ministry of Education, Science and Technology (to H.-S. C.).	Bluher M, 2006, DIABETES, V55, P3053, DOI 10.2337/db06-0812; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Chanda D, 2009, J BIOL CHEM, V284, P28510, DOI 10.1074/jbc.M109.022244; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Despres JP, 2005, NEW ENGL J MED, V353, P2121, DOI 10.1056/NEJMoa044537; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Eckardt K, 2009, DIABETOLOGIA, V52, P664, DOI 10.1007/s00125-008-1240-4; Engeli S, 2005, DIABETES, V54, P2838, DOI 10.2337/diabetes.54.10.2838; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Irwin N, 2008, EUR J PHARMACOL, V581, P226, DOI 10.1016/j.ejphar.2007.12.003; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; Nogueiras R, 2008, DIABETES, V57, P2977, DOI 10.2337/db08-0161; Nogueiras R, 2009, PHARMACOL RES, V60, P93, DOI 10.1016/j.phrs.2009.04.004; Osei-Hyiaman D, 2005, J CLIN INVEST, V115, P1298, DOI 10.1172/JCI200523057; Osei-Hyiaman D, 2008, J CLIN INVEST, V118, P3160, DOI 10.1172/JCI34827; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Trillou CR, 2003, AM J PHYSIOL-REG I, V284, pR345, DOI 10.1152/ajpregu.00545.2002; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Wang D, 2006, ENDOCRINOLOGY, V147, P350, DOI 10.1210/en.2005-1014; Wang YG, 2009, NATURE, V460, P534, DOI 10.1038/nature08111; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	29	46	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27971	27979		10.1074/jbc.M111.224352	http://dx.doi.org/10.1074/jbc.M111.224352			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21693703	hybrid, Green Published			2022-12-25	WOS:000293557800015
J	Zhu, M; Torres, MP; Kelley, JB; Dohlman, HG; Wang, YQ				Zhu, Ming; Torres, Matthew P.; Kelley, Joshua B.; Dohlman, Henrik G.; Wang, Yuqi			Pheromone- and RSP5-dependent Ubiquitination of the G Protein beta Subunit Ste4 in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; RGS PROTEINS; MECHANISMS; INSIGHTS; PHOSPHORYLATION; UBIQUITYLATION; SPECIFICITY; ACTIVATION; TRANSIENT; PATHWAYS	Ste4 is the beta subunit of a heterotrimeric G protein that mediates mating responses in Saccharomyces cerevisiae. Here we show that Ste4 undergoes ubiquitination in response to pheromone stimulation. Ubiquitination of Ste4 is dependent on the E3 ligase Rsp5. Disrupting the activity of Rsp5 abolishes ubiquitination of Ste4 in vivo, and recombinant Rsp5 is capable of ubiquitinating Ste4 in vitro. We find also that Lys-340 is a major ubiquitination site on Ste4, as pheromone-induced ubiquitination of the protein is prevented when this residue is mutated to an arginine. Functionally, ubiquitination does not appear to regulate the stability of Ste4, as blocking ubiquitination has no apparent effect on either the abundance or the half-life of the protein. However, when presented with a concentration gradient of pheromone, Ste4(K340R) mutant cells polarize significantly faster than wild-type cells, indicating that ubiquitination limits pheromone-directed polarized growth. Together, these findings reveal a novel stimulus-dependent posttranslational modification of a G beta subunit, establish Ste4 as a new substrate of the E3 ligase Rsp5, and demonstrate a role for G protein ubiquitination in cell polarization.	[Zhu, Ming; Wang, Yuqi] St Louis Univ, Dept Biol, St Louis, MO 63103 USA; [Torres, Matthew P.; Kelley, Joshua B.; Dohlman, Henrik G.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Saint Louis University; University of North Carolina; University of North Carolina Chapel Hill	Wang, YQ (corresponding author), St Louis Univ, Dept Biol, 128 Macelwane Hall,3507 Laclede Ave, St Louis, MO 63103 USA.	ywang8@slu.edu	Kelley, Joshua Brian/S-1031-2019	Kelley, Joshua Brian/0000-0002-5700-1173; Torres, Matthew/0000-0001-7296-4536; Dohlman, Henrik/0000-0003-2443-0729	National Institutes of Health [R15GM093313-01, K99 GM094533-01, R01 GM073180]; American Heart Association [0635271N]; Sigma Xi; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073180, R01GM080739, R01GM059167, K99GM094533, R15GM093313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Sigma Xi; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R15GM093313-01 (to Y. W.), K99 GM094533-01 (to M. T.), and R01 GM073180 (to H. G. D.). This work was also supported by American Heart Association Scientist Development Grant 0635271N (to Y. W.) and a research grant from Sigma Xi (to M. Z.).	Bar EE, 2003, J BIOL CHEM, V278, P21798, DOI 10.1074/jbc.M212636200; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; CIECHANOVER A, 1984, J CELL BIOCHEM, V24, P27, DOI 10.1002/jcb.240240104; COLE GM, 1991, CELL, V64, P703, DOI 10.1016/0092-8674(91)90500-X; Dohlman HG, 2002, ANNU REV PHYSIOL, V64, P129, DOI 10.1146/annurev.physiol.64.081701.133448; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Dohlman HG, 1997, J BIOL CHEM, V272, P3871, DOI 10.1074/jbc.272.7.3871; Dunn R, 2001, J BIOL CHEM, V276, P25974, DOI 10.1074/jbc.M104113200; Esch RK, 2006, EUKARYOT CELL, V5, P2147, DOI 10.1128/EC.00270-06; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hamilton MH, 2003, P NATL ACAD SCI USA, V100, P5081, DOI 10.1073/pnas.0831228100; Hao N, 2003, J BIOL CHEM, V278, P46506, DOI 10.1074/jbc.M308432200; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hoffman GA, 2002, METHOD ENZYMOL, V344, P617; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Laine Aaron, 2005, Sci STKE, V2005, pre5, DOI 10.1126/stke.2812005re5; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Li E, 1998, MOL GEN GENET, V258, P608, DOI 10.1007/s004380050774; Madden K, 1998, ANNU REV MICROBIOL, V52, P687, DOI 10.1146/annurev.micro.52.1.687; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Naviglio S, 2004, CELL SIGNAL, V16, P1229, DOI 10.1016/j.cellsig.2004.03.012; Obin M, 2002, J BIOL CHEM, V277, P44566, DOI 10.1074/jbc.M205308200; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Portiz MA, 2001, YEAST, V18, P1331, DOI 10.1002/yea.777; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Sasaki AT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001518; Schnell JD, 2003, J BIOL CHEM, V278, P35857, DOI 10.1074/jbc.R300018200; Shcherbik N, 2004, J BIOL CHEM, V279, P53892, DOI 10.1074/jbc.M410325200; Shenoy SK, 2007, CIRC RES, V100, P1142, DOI 10.1161/01.RES.0000261939.88744.5a; Siekhaus DE, 2003, NAT CELL BIOL, V5, P231, DOI 10.1038/ncb941; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Slessareva JE, 2006, CELL, V126, P191, DOI 10.1016/j.cell.2006.04.045; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Suchkov DV, 2010, MOL BIOL CELL, V21, P1737, DOI 10.1091/mbc.E09-08-0706; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Torres MP, 2009, J BIOL CHEM, V284, P8931, DOI 10.1074/jbc.M809058200; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wang YQ, 2006, CIRC RES, V99, P1305, DOI 10.1161/01.RES.0000251641.57410.81; Wang YQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007456; WHITEWAY M, 1990, MOL CELL BIOL, V10, P217, DOI 10.1128/MCB.10.1.217	53	12	12	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27147	27155		10.1074/jbc.M111.254193	http://dx.doi.org/10.1074/jbc.M111.254193			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21685393	Green Published, hybrid			2022-12-25	WOS:000293268700010
J	Collins-Fairclough, AM; Charurat, M; Nadai, Y; Pando, M; Avila, MM; Blattner, WA; Carr, JK				Collins-Fairclough, Aneisha M.; Charurat, Manhattan; Nadai, Yuka; Pando, Maria; Avila, Maria M.; Blattner, William A.; Carr, Jean K.			Significantly Longer Envelope V2 Loops Are Characteristic of Heterosexually Transmitted Subtype B HIV-1 in Trinidad	PLOS ONE			English	Article							PRIMARY INFECTION; BUENOS-AIRES; TYPE-1; TRANSMISSION; MEN; GLYCOPROTEINS; SEQUENCES; PATTERNS; VIRUSES; COHORT	Background: In Trinidad and the wider Caribbean, subtype B Human Immunodeficiency Virus-type 1 (HIV-1B) overwhelmingly accounts for HIV infection among heterosexuals; this contrasts with the association of HIV-1B with homosexual transmission and injecting drug use globally. The HIV envelope contains genetic determinants of cell tropism and evasion from immune attack. In this study we investigate the genetic properties of the env V1-C4 of HIV-1B soon after transmission to Trinidadian heterosexuals. This will reveal distinctive genetic features of the strains that cause the HIV-1B epidemic in Trinidad and generate insights to better understand their properties. Methodology/Principal Findings: Quasispecies sampling was performed on the env V1-C4 of HIV-1B strains soon after transmission to heterosexual Trinidadians in a cohort of seroconverters. Phylogenetic relationships were determined for these quasispecies and the length and number of asparagine (N) linked glycosylation sites (NLGS) in their variable loops compared to that for HIV-1B globally. Signature amino acids within the constant domains of the env V1-C4 were identified for heterosexually transmitted HIV-1B from Trinidad relative to HIV-1B globally. HIV-1B obtained from Trinidadian heterosexuals soon after seroconversion had significantly longer V2 loops with one more glycosylation site, shorter V3 loops and no significant difference in V1 or V4 when compared to HIV-1B obtained soon after seroconversion from infected individuals in the rest of the world. HIV-1B soon after seroconversion and during chronic infection of Trinidadians was not significantly different, suggesting that distinctly long V2 loops are characteristic of HIV-1B in Trinidad. A threonine deletion at position 319 (T319-) along with the substitutions R315K and S440R were found to be distinctly associated with HIV-1B from Trinidad compared to HIV-1B globally. Conclusions: This finding of distinctive genetic features that are characteristic of HIV-1B strains from Trinidad is consistent with the Trinidad epidemic being established by a founder strain or closely related founder strains of HIV-1B.	[Collins-Fairclough, Aneisha M.] Univ Technol, Div Biol, Fac Sci & Sport, Kingston, Jamaica; [Charurat, Manhattan; Nadai, Yuka; Blattner, William A.; Carr, Jean K.] Univ Maryland, Inst Human Virol, Baltimore, MD 21201 USA; [Pando, Maria; Avila, Maria M.] Univ Buenos Aires, Ctr Nacl Referencia Sida, Fac Med, Buenos Aires, DF, Argentina	University of Technology - Jamaica; University System of Maryland; University of Maryland Baltimore; University of Buenos Aires	Collins-Fairclough, AM (corresponding author), Univ Technol, Div Biol, Fac Sci & Sport, Kingston, Jamaica.	aneishacollins@gmail.com		Collins-Fairclough, Aneisha/0000-0003-0326-8451	National Institutes of Health's Fogarty International Center [5-D43 TW 01041]; NIH [R21-AI071821-01A2]; National Institute of Allergy and Infectious Disease [PO1-AI32393]; Institute of Human Virology, University of Maryland, Baltimore AITRP in Brazil, Caribbean and Nigeria, NIH [5K43TW001041];  [62787A S17 H B0002]; FOGARTY INTERNATIONAL CENTER [D43TW001041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071821, R01AI032393] Funding Source: NIH RePORTER	National Institutes of Health's Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute of Human Virology, University of Maryland, Baltimore AITRP in Brazil, Caribbean and Nigeria, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by research grant 5-D43 TW 01041, IHV University of Maryland AIRTRP in Brazil, the Caribbean and Nigeria, provided by the National Institutes of Health's Fogarty International Center. Funding was also obtained through NIH Grant R21-AI071821-01A2. Work Unit Number 62787A S17 H B0002 supported the collection of the Argentine samples. Collection of the early Trinidad seroconverter samples was supported by National Institute of Allergy and Infectious Disease grant PO1-AI32393. Collection of the prevalent Trinidad samples was supported by Institute of Human Virology, University of Maryland, Baltimore AITRP in Brazil, Caribbean and Nigeria, NIH grant 5K43TW001041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMEW C, 1987, JAMA-J AM MED ASSOC, V257, P2604, DOI 10.1001/jama.257.19.2604; Bernardin F, 2003, AIDS RES HUM RETROV, V19, P1009, DOI 10.1089/088922203322588369; Carr JK, 2006, CURR OPIN HIV AIDS, V1, P294, DOI 10.1097/01.COH.0000232344.23533.be; Cleghorn FR, 2000, P NATL ACAD SCI USA, V97, P10532, DOI 10.1073/pnas.97.19.10532; Dacheux L, 2004, J VIROL, V78, P12625, DOI 10.1128/JVI.78.22.12625-12637.2004; Daniels RS, 2003, AIDS RES HUM RETROV, V19, P631, DOI 10.1089/088922203322280847; Gao F, 1996, J VIROL, V70, P1651, DOI 10.1128/JVI.70.3.1651-1667.1996; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Gottlieb GS, 2008, J INFECT DIS, V197, P1011, DOI 10.1086/529206; Guo Q, 2003, J VIROL, V77, P10528, DOI 10.1128/JVI.77.19.10528-10536.2003; HATADA MK, 2009, J GEN VIROL; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kothe DL, 2007, VIROLOGY, V360, P218, DOI 10.1016/j.virol.2006.10.017; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Liu Y, 2008, VIROLOGY, V374, P229, DOI 10.1016/j.virol.2008.01.029; Liu Y, 2006, J VIROL, V80, P9519, DOI 10.1128/JVI.00575-06; Nadai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004814; Pando MA, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-59; Prabakaran P, 2007, ADV PHARMACOL, V55, P33, DOI 10.1016/S1054-3589(07)55002-7; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rose PP, 2000, BIOINFORMATICS, V16, P400, DOI 10.1093/bioinformatics/16.4.400; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Segura M, 2007, AIDS RES HUM RETROV, V23, P1322, DOI 10.1089/aid.2007.0063; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106	26	6	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e19995	10.1371/journal.pone.0019995	http://dx.doi.org/10.1371/journal.pone.0019995			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698149	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600002
J	Gu, JB; Liu, M; Deng, YH; Peng, HJ; Chen, XG				Gu, Jinbao; Liu, Min; Deng, Yuhua; Peng, Hongjuan; Chen, Xiaoguang			Development of an Efficient Recombinant Mosquito Densovirus-Mediated RNA Interference System and Its Preliminary Application in Mosquito Control	PLOS ONE			English	Article							AEDES-AEGYPTI; H+V-ATPASE; EXPRESSION; VECTOR; GENE; MIDGUT; VIRUS; PATHOGENICITY; ALBOPICTUS; DELIVERY	The Aedes aegypti densovirus (AeDNV) has potential as a delivery vector for foreign nucleic acids into mosquito cells. In this study, we investigated the ability of plasmids containing recombinant viral transducing genome to induce RNA interference (RNAi) effects in C6/C36 cells. We then evaluated the efficiency of a recombinant AeDNV vector to induce RNAi in Aedes albopictus larvae. We found that the expression of V-ATPase was inhibited by up to 90% at 96 h post-transfection in transfected C6/C36 cells. In addition, the bioinsecticidal activities of various RNAi-expressing AeDNV vectors used to infect Ae. albopictus larvae were also tested. We found that when Ae. albopictus larvae were infected with recombinant AeDNV, expression of V-ATPase was downregulated by nearly 70% compared to controls. Furthermore, the median survival time bioassays demonstrated that recombinant AeDNV caused more serious pathogenic effects than the wild type virus. This is the first report showing that recombinant virus plasmid and corresponding recombinant AeDNV can be used as an effective in vitro and in vivo RNAi delivery system, respectively.	[Gu, Jinbao; Liu, Min; Deng, Yuhua; Peng, Hongjuan; Chen, Xiaoguang] So Med Univ, Sch Publ Hlth & Trop Med, Key Lab Prevent & Control Emerging Infect Dis, Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Chen, XG (corresponding author), So Med Univ, Sch Publ Hlth & Trop Med, Key Lab Prevent & Control Emerging Infect Dis, Guangdong Higher Educ Inst, Guangzhou, Guangdong, Peoples R China.	xgchen@fimmu.com	Peng, Hongjuan/GYV-5462-2022; Gu, Jinbao/AAE-6764-2021	Liu, Min/0000-0002-3159-8039	National Natural Science Foundation of China [30800957, U0832004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by the National Natural Science Foundation of China (Grant No. 30800957, No. U0832004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFANASIEV BN, 1994, EXP PARASITOL, V79, P322, DOI 10.1006/expr.1994.1095; Akhtar S, 2007, J CLIN INVEST, V117, P3623, DOI 10.1172/JCI33494; Amarzguioui M, 2005, FEBS LETT, V579, P5974, DOI 10.1016/j.febslet.2005.08.070; Attaran A, 2000, NAT MED, V6, P729, DOI 10.1038/77438; Barreau C, 1996, J INVERTEBR PATHOL, V68, P299, DOI 10.1006/jipa.1996.0100; BARREAU C, 1994, J VIROL METHODS, V49, P153, DOI 10.1016/0166-0934(94)90039-6; Bartsch D, 2002, J BIOTECHNOL, V98, P71, DOI 10.1016/S0168-1656(02)00087-1; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Boisson B, 2006, FEBS LETT, V580, P1988, DOI 10.1016/j.febslet.2006.02.069; BOTHWELL ALM, 1981, CELL, V24, P625, DOI 10.1016/0092-8674(81)90089-1; Brown AE, 2003, J EXP BIOL, V206, P1817, DOI 10.1242/jeb.00360; Carlson J, 2006, ADV VIRUS RES, V68, P361, DOI 10.1016/S0065-3527(06)68010-X; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; Deng L, 2009, BMC GASTROENTEROL, V9, DOI 10.1186/1471-230X-9-73; Dimopoulos G, 1996, P NATL ACAD SCI USA, V93, P13066, DOI 10.1073/pnas.93.23.13066; Donini A, 2005, J EXP BIOL, V208, P603, DOI 10.1242/jeb.01422; EDWARDS HA, 1983, TISSUE CELL, V15, P271, DOI 10.1016/0040-8166(83)90022-8; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Gill SS, 1998, ARCH INSECT BIOCHEM, V37, P80, DOI 10.1002/(SICI)1520-6327(1998)37:1&lt;80::AID-ARCH10&gt;3.0.CO;2-6; GREEN MR, 1991, ANNU REV CELL BIOL, V7, P559, DOI 10.1146/annurev.cellbio.7.1.559; Gu JB, 2010, AM J TROP MED HYG, V83, P614, DOI 10.4269/ajtmh.2010.10-0074; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Huang CG, 2006, J EUKARYOT MICROBIOL, V53, P127, DOI 10.1111/j.1550-7408.2005.00086.x; Hunter CP, 2006, COLD SPRING HARB SYM, V71, P95, DOI 10.1101/sqb.2006.71.060; Isoe J, 2007, INSECT MOL BIOL, V16, P83, DOI 10.1111/j.1365-2583.2006.00704.x; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Kim YJ, 2008, VIRUS GENES, V36, P141, DOI 10.1007/s11262-007-0192-y; Konet DS, 2007, INSECT MOL BIOL, V16, P199, DOI 10.1111/j.1365-2583.2006.00714.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YB, 2007, NAT BIOTECHNOL, V25, P1307, DOI 10.1038/nbt1352; Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; ROBERTS DR, 1994, AM J TROP MED HYG, V50, P21, DOI 10.4269/ajtmh.1994.50.21; Rossi JJ, 2008, HUM GENE THER, V19, P313, DOI 10.1089/hum.2008.026; Shimizu S, 2010, BLOOD, V115, P1534, DOI 10.1182/blood-2009-04-215855; Sliva K, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-248; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001; Tomoyasu Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-1-r10; Ward TW, 2001, INSECT MOL BIOL, V10, P397, DOI 10.1046/j.0962-1075.2001.00276.x; Wieczorek H, 1999, BIOESSAYS, V21, P637, DOI 10.1002/(SICI)1521-1878(199908)21:8<637::AID-BIES3>3.3.CO;2-N; Zhuang ZP, 1999, J EXP BIOL, V202, P2449	43	42	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21329	10.1371/journal.pone.0021329	http://dx.doi.org/10.1371/journal.pone.0021329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698129	gold, Green Published, Green Submitted			2022-12-25	WOS:000291734100080
J	Lee, H; Rotolo, JA; Mesicek, J; Penate-Medina, T; Rimner, A; Liao, WC; Yin, XL; Ragupathi, G; Ehleiter, D; Gulbins, E; Zhai, DY; Reed, JC; Haimovitz-Friedman, A; Fuks, Z; Kolesnick, R				Lee, Hyunmi; Rotolo, Jimmy A.; Mesicek, Judith; Penate-Medina, Tuula; Rimner, Andreas; Liao, Wen-Chieh; Yin, Xianglei; Ragupathi, Govind; Ehleiter, Desiree; Gulbins, Erich; Zhai, Dayong; Reed, John C.; Haimovitz-Friedman, Adriana; Fuks, Zvi; Kolesnick, Richard			Mitochondrial Ceramide-Rich Macrodomains Functionalize Bax upon Irradiation	PLOS ONE			English	Article							RADIATION-INDUCED APOPTOSIS; CYTOCHROME-C RELEASE; PERMEABILITY TRANSITION PORE; PROAPOPTOTIC PROTEIN BAX; ACID SPHINGOMYELINASE; CONFORMATIONAL-CHANGE; HELA-CELLS; MEMBRANE DOMAINS; LIPID RAFTS; ACTIVATION	Background: Evidence indicates that Bax functions as a "lipidic" pore to regulate mitochondrial outer membrane permeabilization (MOMP), the apoptosis commitment step, through unknown membrane elements. Here we show mitochondrial ceramide elevation facilitates MOMP-mediated cytochrome c release in HeLa cells by generating a previously-unrecognized mitochondrial ceramide-rich macrodomain (MCRM), which we visualize and isolate, into which Bax integrates. Methodology/Principal Findings: MCRMs, virtually non-existent in resting cells, form upon irradiation coupled to ceramide synthase-mediated ceramide elevation, optimizing Bax insertion/oligomerization and MOMP. MCRMs are detected by confocal microscopy in intact HeLa cells and isolated biophysically as a light membrane fraction from HeLa cell lysates. Inhibiting ceramide generation using a well-defined natural ceramide synthase inhibitor, Fumonisin B1, prevented radiation-induced Bax insertion, oligomerization and MOMP. MCRM deconstruction using purified mouse hepatic mitochondria revealed ceramide alone is non-apoptogenic. Rather Bax integrates into MCRMs, oligomerizing therein, conferring 1-2 log enhanced cytochrome c release. Consistent with this mechanism, MCRM Bax isolates as high molecular weight "pore-forming" oligomers, while non-MCRM membrane contains exclusively MOMP-incompatible monomeric Bax. Conclusions/Significance: Our recent studies in the C. elegans germline indicate that mitochondrial ceramide generation is obligate for radiation-induced apoptosis, although a mechanism for ceramide action was not delineated. Here we demonstrate that ceramide, generated in the mitochondrial outer membrane of mammalian cells upon irradiation, forms a platform into which Bax inserts, oligomerizes and functionalizes as a pore. We posit conceptualization of ceramide as a membrane-based stress calibrator, driving membrane macrodomain organization, which in mitochondria regulates intensity of Bax-induced MOMP, and is pharmacologically tractable in vitro and in vivo.	[Lee, Hyunmi; Rotolo, Jimmy A.; Mesicek, Judith; Penate-Medina, Tuula; Rimner, Andreas; Yin, Xianglei; Kolesnick, Richard] Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, New York, NY 10021 USA; [Liao, Wen-Chieh; Ehleiter, Desiree; Haimovitz-Friedman, Adriana; Fuks, Zvi] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA; [Ragupathi, Govind] Mem Sloan Kettering Canc Ctr, Lab Tumor Vaccinol, New York, NY 10021 USA; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany; [Zhai, Dayong; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Duisburg Essen; Sanford Burnham Prebys Medical Discovery Institute	Lee, H (corresponding author), Mem Sloan Kettering Canc Ctr, Lab Signal Transduct, 1275 York Ave, New York, NY 10021 USA.	r-kolesnick@ski.mskcc.org	Gulbins, Erich/L-6989-2014	Gulbins, Erich/0000-0002-3117-1342; Rimner, Andreas/0000-0002-1214-3856; Rotolo, Jim/0000-0003-4195-6167; Penate Medina, Tuula/0000-0002-5899-7005	National Institutes of Health [R01CA085704, R01CA052462, R01CA105125]; NATIONAL CANCER INSTITUTE [R01CA085704, R01CA052462, R01CA105125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01CA085704 to Richard Kolesnick, R01CA052462 to Zvi Fuks and R01CA105125 to Adriana Haimovitz-Friedman from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1999, J CELL BIOL, V147, P175, DOI 10.1083/jcb.147.1.175; Alegre-Cebollada J, 2006, FEBS J, V273, P863, DOI 10.1111/j.1742-4658.2006.05122.x; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Ardail D, 2009, INT J RADIAT ONCOL, V73, P1211, DOI 10.1016/j.ijrobp.2008.11.033; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Bock J, 2003, BIOCHEM BIOPH RES CO, V305, P890, DOI 10.1016/S0006-291X(03)00763-0; Bollinger CR, 2005, BBA-MOL CELL RES, V1746, P284, DOI 10.1016/j.bbamcr.2005.09.001; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; BUTOR C, 1991, EUR J CELL BIOL, V56, P269; Ch'ang HJ, 2005, NAT MED, V11, P484, DOI 10.1038/nm1237; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; del Pulgar TG, 2002, BIOCHEM J, V363, P183, DOI 10.1042/0264-6021:3630183; Deng XZ, 2008, SCIENCE, V322, P110, DOI 10.1126/science.1158111; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dumitru CA, 2006, ONCOGENE, V25, P5612, DOI 10.1038/sj.onc.1209568; Eskes R, 1998, J CELL BIOL, V143, P217, DOI 10.1083/jcb.143.1.217; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Ganesan V, 2010, APOPTOSIS, V15, P553, DOI 10.1007/s10495-009-0449-0; Garcia-Saez AJ, 2004, BIOCHEMISTRY-US, V43, P10930, DOI 10.1021/bi036044c; Gilbert RJC, 2002, CELL MOL LIFE SCI, V59, P832, DOI 10.1007/s00018-002-8471-1; Goni FM, 2006, BBA-BIOMEMBRANES, V1758, P1902, DOI 10.1016/j.bbamem.2006.09.011; Grassme H, 2003, ONCOGENE, V22, P5457, DOI 10.1038/sj.onc.1206540; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; HAMILTON WB, 1993, INT J CANCER, V53, P566, DOI 10.1002/ijc.2910530407; HAREL R, 1993, J BIOL CHEM, V268, P14476; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Hwang D, 2005, ORAL SURG ORAL MED O, V100, P321, DOI 10.1016/j.tripleo.2004.09.018; Kashkar H, 2005, J BIOL CHEM, V280, P20804, DOI 10.1074/jbc.M410869200; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kluck RM, 1997, EMBO J, V16, P4639, DOI 10.1093/emboj/16.15.4639; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Liao WC, 1999, J BIOL CHEM, V274, P17908, DOI 10.1074/jbc.274.25.17908; MALLIKARJUNESWA.VR, 1975, CLIN CHEM, V21, P260; Manes S, 2003, NAT REV IMMUNOL, V3, P557, DOI 10.1038/nri1129; Martinez-Abundis E, 2009, FEBS J, V276, P5579, DOI 10.1111/j.1742-4658.2009.07239.x; Matsko CM, 2001, BIOCHEM BIOPH RES CO, V287, P1112, DOI 10.1006/bbrc.2001.5696; MERRILL AH, 1993, J BIOL CHEM, V268, P27299; Mesicek J, 2010, CELL SIGNAL, V22, P1300, DOI 10.1016/j.cellsig.2010.04.006; Mikhailov V, 2003, J BIOL CHEM, V278, P5367, DOI 10.1074/jbc.M203392200; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Pastorino JG, 1999, J BIOL CHEM, V274, P31734, DOI 10.1074/jbc.274.44.31734; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rotolo JA, 2005, J BIOL CHEM, V280, P26425, DOI 10.1074/jbc.M414569200; Roucou X, 2001, CELL DEATH DIFFER, V8, P875, DOI 10.1038/sj.cdd.4400910; RuizArguello MB, 1996, J BIOL CHEM, V271, P26616, DOI 10.1074/jbc.271.43.26616; Schraw W, 2002, J BIOL CHEM, V277, P34642, DOI 10.1074/jbc.M203466200; SHIAO YJ, 1995, J BIOL CHEM, V270, P11190, DOI 10.1074/jbc.270.19.11190; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Sobko AA, 2006, J BIOL CHEM, V281, P14408, DOI 10.1074/jbc.M513634200; Sot J, 2005, BBA-BIOMEMBRANES, V1711, P12, DOI 10.1016/j.bbamem.2005.02.014; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Stiban J, 2008, J LIPID RES, V49, P625, DOI 10.1194/jlr.M700480-JLR200; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Tafani M, 2001, CANCER RES, V61, P2459; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Truman JP, 2005, J BIOL CHEM, V280, P23262, DOI 10.1074/jbc.M503701200; Uchida Y, 2003, J INVEST DERMATOL, V120, P662, DOI 10.1046/j.1523-1747.2003.12098.x; Uehara K, 2003, J PHARMACOL EXP THER, V305, P232, DOI 10.1124/jpet.102.045195; van der Goot FG, 2001, SEMIN IMMUNOL, V13, P89, DOI 10.1006/smim.2000.0300; Van Loo G, 2002, CELL DEATH DIFFER, V9, P301, DOI 10.1038/sj.cdd.4400966; Vance JE, 2003, PROG NUCLEIC ACID RE, V75, P69, DOI 10.1016/S0079-6603(03)75003-X; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANCE JE, 1990, MITOCHONDRION, V6, P11825; Veiga MP, 1999, BIOPHYS J, V76, P342, DOI 10.1016/S0006-3495(99)77201-2; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Zakharov SD, 2004, BBA-BIOMEMBRANES, V1666, P239, DOI 10.1016/j.bbamem.2004.07.001; Zha HB, 1996, J BIOL CHEM, V271, P7440, DOI 10.1074/jbc.271.13.7440; Zha HB, 1996, MOL CELL BIOL, V16, P6494; Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200	77	106	109	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e19783	10.1371/journal.pone.0019783	http://dx.doi.org/10.1371/journal.pone.0019783			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695182	Green Submitted, Green Published, gold			2022-12-25	WOS:000291663300004
J	Grasselli, G; Mandolesi, G; Strata, P; Cesare, P				Grasselli, Giorgio; Mandolesi, Georgia; Strata, Piergiorgio; Cesare, Paolo			Impaired Sprouting and Axonal Atrophy in Cerebellar Climbing Fibres following In Vivo Silencing of the Growth-Associated Protein GAP-43	PLOS ONE			English	Article							HIPPOCAMPAL MOSSY FIBERS; ADULT-RAT BRAIN; TIME RT-PCR; PURKINJE-CELLS; GENE-EXPRESSION; INFERIOR OLIVE; MESSENGER-RNA; STRUCTURAL PLASTICITY; NERVOUS-SYSTEM; MOLECULAR-MECHANISMS	The adult mammalian central nervous system has a limited ability to establish new connections and to recover from traumatic or degenerative events. The olivo-cerebellar network represents an excellent model to investigate neuroprotection and repair in the brain during adulthood, due to its high plasticity and ordered synaptic organization. To shed light on the molecular mechanisms involved in these events, we focused on the growth-associated protein GAP-43 (also known as B-50 or neuromodulin). During development, this protein plays a crucial role in growth and in branch formation of neurites, while in the adult it is only expressed in a few brain regions, including the inferior olive (IO) where climbing fibres (CFs) originate. Following axotomy GAP-43 is usually up-regulated in association with regeneration. Here we describe an in vivo lentiviral-mediated gene silencing approach, used for the first time in the olivo-cerebellar system, to efficiently and specifically downregulate GAP-43 in rodents CFs. We show that lack of GAP-43 causes an atrophy of the CF in non-traumatic conditions, consisting in a decrease of its length, branching and number of synaptic boutons. We also investigated CF regenerative ability by inducing a subtotal lesion of the IO. Noteworthy, surviving CFs lacking GAP-43 were largely unable to sprout on surrounding Purkinje cells. Collectively, our results demonstrate that GAP-43 is essential both to maintain CFs structure in non-traumatic condition and to promote sprouting after partial lesion of the IO.	[Grasselli, Giorgio; Mandolesi, Georgia; Strata, Piergiorgio; Cesare, Paolo] Santa Lucia Fdn IRCCS, Rome, Italy; [Strata, Piergiorgio; Cesare, Paolo] Univ Turin, Natl Inst Neurosci Italy, Turin, Italy	IRCCS Santa Lucia; University of Turin	Grasselli, G (corresponding author), Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA.	g.grasselli@hsantalucia.it	Grasselli, Giorgio/G-5094-2012; Mandolesi, Georgia/G-6595-2011	Grasselli, Giorgio/0000-0002-2942-9615; Mandolesi, Georgia/0000-0003-3612-6820; Cesare, Paolo/0000-0003-1324-5974	Italian Ministry of Universities and Research; European Community [LSHM-CT-2004-512039, 21 4003-2]	Italian Ministry of Universities and Research(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission)	This work was supported by grants from the Italian Ministry of Universities and Research, and the European Community (contracts LSHM-CT-2004-512039 and 21 4003-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Alvarez VA, 2006, J NEUROSCI, V26, P7820, DOI 10.1523/JNEUROSCI.1957-06.2006; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Benowitz LI, 2007, DEV NEUROBIOL, V67, P1148, DOI 10.1002/dneu.20515; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Bonfanti L, 2006, PROG NEUROBIOL, V80, P129, DOI 10.1016/j.pneurobio.2006.08.003; Bravin M, 1999, P NATL ACAD SCI USA, V96, P1704, DOI 10.1073/pnas.96.4.1704; Bridge AJ, 2003, NAT GENET, V34, P263, DOI 10.1038/ng1173; Buffo A, 1997, J NEUROSCI, V17, P8778; Buffo A, 2003, EUR J NEUROSCI, V18, P2146, DOI 10.1046/j.1460-9568.2003.02940.x; Butz M, 2009, BRAIN RES REV, V60, P287, DOI 10.1016/j.brainresrev.2008.12.023; Carulli D, 2004, PROG NEUROBIOL, V72, P373, DOI 10.1016/j.pneurobio.2004.03.007; Cesa R, 2007, J NEUROSCI, V27, P4603, DOI 10.1523/JNEUROSCI.5617-06.2007; Chakravarthy B, 2008, BIOCHEM BIOPH RES CO, V371, P679, DOI 10.1016/j.bbrc.2008.04.119; ConsoleBram LM, 1996, DEV BRAIN RES, V95, P97, DOI 10.1016/0165-3806(96)00079-X; Denny JB, 2006, CURR NEUROPHARMACOL, V4, P293, DOI 10.2174/157015906778520782; Ditlevsen DK, 2008, J NEUROSCI RES, V86, P727, DOI 10.1002/jnr.21551; Dixon KJ, 2006, EXP NEUROL, V202, P44, DOI 10.1016/j.expneurol.2006.05.010; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Eccles JC, 1967, CEREBELLUM NEURONAL; FOSCARIN S, 2009, EUR J NEUROSCI; Gianola S, 2004, EUR J NEUROSCI, V19, P819, DOI 10.1111/j.0953-816X.2004.03190.x; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Hilliard MA, 2009, J NEUROCHEM, V108, P23, DOI 10.1111/j.1471-4159.2008.05754.x; Hisano S, 2002, MOL BRAIN RES, V107, P23, DOI 10.1016/S0169-328X(02)00442-4; Holahan M, 2008, HIPPOCAMPUS, V18, P1099, DOI 10.1002/hipo.20486; Holahan MR, 2010, HIPPOCAMPUS, V20, P58, DOI 10.1002/hipo.20635; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Horinouchi K, 2005, J COMP NEUROL, V482, P386, DOI 10.1002/cne.20398; Hulo S, 2002, EUR J NEUROSCI, V15, P1976, DOI 10.1046/j.1460-9568.2002.02026.x; Ito M, 1984, CEREBELLUM NEURAL CO; KRUGER L, 1993, J COMP NEUROL, V333, P417, DOI 10.1002/cne.903330308; LLINAS R, 1975, SCIENCE, V190, P1230, DOI 10.1126/science.128123; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Maier DL, 1999, P NATL ACAD SCI USA, V96, P9397, DOI 10.1073/pnas.96.16.9397; Mandolesi G, 2010, NEUROL SCI, V31, P255, DOI 10.1007/s10072-010-0369-3; Mandolesi G, 2009, NEUROSCIENCE, V164, P1084, DOI 10.1016/j.neuroscience.2009.08.067; Mandolesi G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005243; McNamara RK, 1997, J COMP NEUROL, V379, P48; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meiri KF, 1998, J NEUROSCI, V18, P10429; Mosevitsky MI, 2005, INT REV CYTOL, V245, P245, DOI 10.1016/S0074-7696(05)45007-X; Munakata H, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-7; Nishiyama H, 2007, NEURON, V56, P472, DOI 10.1016/j.neuron.2007.09.010; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Oestreicher AB, 1997, PROG NEUROBIOL, V53, P627, DOI 10.1016/S0301-0082(97)00043-9; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pielage J, 2005, CURR BIOL, V15, P918, DOI 10.1016/j.cub.2005.04.030; Qiu Z, 2008, NEURON, V60, P775, DOI 10.1016/j.neuron.2008.09.040; Rekart JL, 2005, HIPPOCAMPUS, V15, P1, DOI 10.1002/hipo.20045; Rekart JL, 2010, HIPPOCAMPUS, V20, P46, DOI 10.1002/hipo.20668; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Riederer BM, 1999, MOL BRAIN RES, V71, P345, DOI 10.1016/S0169-328X(99)00179-5; ROSSI F, 1991, J COMP NEUROL, V308, P513, DOI 10.1002/cne.903080403; ROSSI F, 1993, NEUROSCIENCE, V53, P759, DOI 10.1016/0306-4522(93)90622-M; ROSSI F, 1991, J COMP NEUROL, V308, P536, DOI 10.1002/cne.903080404; Rossi S., 2010, BRAIN BEHAV IMMUN; Routtenberg A, 2000, P NATL ACAD SCI USA, V97, P7657, DOI 10.1073/pnas.97.13.7657; Schonfeld-Dado E, 2009, J NEUROCHEM, V110, P1203, DOI 10.1111/j.1471-4159.2009.06204.x; Shen YP, 2002, J NEUROSCI, V22, P239, DOI 10.1523/JNEUROSCI.22-01-00239.2002; Sherrard RM, 2003, NEUROREPORT, V14, P1713, DOI 10.1097/00001756-200309150-00011; SHOLL DA, 1953, J ANAT, V87, P387; Strata P, 1998, TRENDS NEUROSCI, V21, P407, DOI 10.1016/S0166-2236(98)01305-8; STRITTMATTER SM, 1995, CELL, V80, P445, DOI 10.1016/0092-8674(95)90495-6; Sugihara I, 2006, CEREBELLUM, V5, P15, DOI 10.1080/14734220500527385; Szulc J, 2006, NAT METHODS, V3, P109, DOI 10.1038/NMETH846; Tiscornia G, 2004, P NATL ACAD SCI USA, V101, P7347, DOI 10.1073/pnas.0402107101; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P14883, DOI 10.1073/pnas.0505164102; Zhang Y, 2007, EUR J NEUROSCI, V25, P351, DOI 10.1111/j.1460-9568.2007.05311.x	72	38	39	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20791	10.1371/journal.pone.0020791	http://dx.doi.org/10.1371/journal.pone.0020791			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695168	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600026
J	Palomares, M; Smith, PR; Pitts, CH; Carter, BM				Palomares, Melanie; Smith, Paul R.; Pitts, Carole Holley; Carter, Breana M.			The Effect of Viewing Eccentricity on Enumeration	PLOS ONE			English	Article							PERIPHERAL-VISION; DISCRIMINATION; INTEGRATION; ATTENTION; NUMBERS; PHASE	Visual acuity and contrast sensitivity progressively diminish with increasing viewing eccentricity. Here we evaluated how visual enumeration is affected by visual eccentricity, and whether subitizing capacity, the accurate enumeration of a small number (similar to 3) of items, decreases with more eccentric viewing. Participants enumerated gratings whose (1) stimulus size was constant across eccentricity, and (2) whose stimulus size scaled by a cortical magnification factor across eccentricity. While we found that enumeration accuracy and precision decreased with increasing eccentricity, cortical magnification scaling of size neutralized the deleterious effects of increasing eccentricity. We found that size scaling did not affect subitizing capacities, which were nearly constant across all eccentricities. We also found that size scaling modulated the variation coefficients, a normalized metric of enumeration precision, defined as the standard deviation divided by the mean response. Our results show that the inaccuracy and imprecision associated with increasing viewing eccentricity is due to limitations in spatial resolution. Moreover, our results also support the notion that the precise number system is restricted to small numerosities (represented by the subitizing limit), while the approximate number system extends across both small and large numerosities (indexed by variation coefficients) at large eccentricities.	[Palomares, Melanie; Smith, Paul R.; Pitts, Carole Holley; Carter, Breana M.] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Palomares, M (corresponding author), Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA.	paloma@sc.edu		Pitts Arnold, C. Holley/0000-0002-6314-0014	University of South Carolina; Research Consortium on Children and Families	University of South Carolina; Research Consortium on Children and Families	This work was supported by the University of South Carolina Undergraduate Explorer's Award (B. M. C.), University of South Carolina Promising Investigator Award and the Research Consortium on Children and Families (M. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON J, 1976, PERCEPTION, V5, P335, DOI 10.1068/p050335; BALAKRISHNAN JD, 1992, PSYCHOL RES-PSYCH FO, V54, P80, DOI 10.1007/BF00937136; BALAKRISHNAN JD, 1991, PERCEPT PSYCHOPHYS, V50, P555, DOI 10.3758/BF03207540; BENNETT PJ, 1987, NATURE, V326, P873, DOI 10.1038/326873a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Burr DC, 2010, J VISION, V10, DOI 10.1167/10.6.20; BURR DC, 2011, SEEING PERCEIVING; Carrasco M, 1997, VISION RES, V37, P63, DOI 10.1016/S0042-6989(96)00102-2; Chung STL, 2002, INVEST OPHTH VIS SCI, V43, P1270; Chung STL, 2009, J VISION, V9, DOI 10.1167/9.9.16; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Cowan N, 2001, BEHAV BRAIN SCI, V24, P87, DOI 10.1017/S0140525X01003922; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Egeth HE, 2008, VIS COGN, V16, P463, DOI 10.1080/13506280801937939; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; HESS RF, 1985, VISION RES, V25, P1577, DOI 10.1016/0042-6989(85)90128-2; JEVONS WS, 1871, NATURE, V3, P281, DOI DOI 10.1038/003281A0; KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Kuai SG, 2006, J VISION, V6, P1412, DOI 10.1167/6.12.7; Levi DM, 2009, J VISION, V9, DOI 10.1167/9.1.22; LEVI DM, 1984, VISION RES, V24, P789, DOI 10.1016/0042-6989(84)90150-0; LEVI DM, 1987, VISION RES, V27, P581, DOI 10.1016/0042-6989(87)90044-7; Logan GD, 2003, PSYCHON B REV, V10, P676, DOI 10.3758/BF03196531; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; MORRONE MC, 1989, VISION RES, V29, P433, DOI 10.1016/0042-6989(89)90007-2; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nieder A, 2004, J COGNITIVE NEUROSCI, V16, P889, DOI 10.1162/089892904970807; OLIVERS CNL, 2008, VISUAL COGNITION, V16; Palomares M, 2010, VISION RES, V50, P2000, DOI 10.1016/j.visres.2010.07.011; PARTH P, 1984, BEHAV BRAIN RES, V11, P241, DOI 10.1016/0166-4328(84)90216-X; Pelli DG, 2007, J VISION, V7, DOI 10.1167/7.2.20; Pelli DG, 2004, J VISION, V4, P1136, DOI 10.1167/4.12.12; PYLYSHYN Z, 1994, CAN J EXP PSYCHOL, V48, P260, DOI 10.1037/1196-1961.48.2.260; Railo H, 2008, COGNITION, V107, P82, DOI 10.1016/j.cognition.2007.08.004; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; ROVAMO J, 1982, INVEST OPHTH VIS SCI, V23, P666; SAARINEN J, 1988, VISION RES, V28, P755, DOI 10.1016/0042-6989(88)90054-5; Sharma V, 2000, NAT NEUROSCI, V3, P496, DOI 10.1038/74872; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Vetter P, 2011, J COGNITIVE NEUROSCI, V23, P728, DOI 10.1162/jocn.2010.21472; Vetter P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003269; WHITAKER D, 1992, VISION RES, V32, P1913, DOI 10.1016/0042-6989(92)90051-J	43	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20779	10.1371/journal.pone.0020779	http://dx.doi.org/10.1371/journal.pone.0020779			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777JU	21695212	gold, Green Submitted, Green Published			2022-12-25	WOS:000291612600022
J	Gouspillou, G; Rouland, R; Calmettes, G; Deschodt-Arsac, V; Franconi, JM; Bourdel-Marchasson, I; Diolez, P				Gouspillou, Gilles; Rouland, Richard; Calmettes, Guillaume; Deschodt-Arsac, Veronique; Franconi, Jean-Michel; Bourdel-Marchasson, Isabelle; Diolez, Philippe			Accurate Determination of the Oxidative Phosphorylation Affinity for ADP in Isolated Mitochondria	PLOS ONE			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; LIVER-MITOCHONDRIA; PHYSICAL-ACTIVITY; PROTON LEAK; IN-SITU; CELLS; ATP; RESPIRATION; METABOLISM; EFFICIENCY	Background: Mitochondrial dysfunctions appear strongly implicated in a wide range of pathologies. Therefore, there is a growing need in the determination of the normal and pathological integrated response of oxidative phosphorylation to cellular ATP demand. The present study intends to address this issue by providing a method to investigate mitochondrial oxidative phosphorylation affinity for ADP in isolated mitochondria. Methodology/Principal Findings: The proposed method is based on the simultaneous monitoring of substrate oxidation (determined polarographically) and phosphorylation (determined using the glucose - hexokinase - glucose-6-phosphate dehydrogenase - NADP(+) enzymatic system) rates, coupled to the determination of actual ADP and ATP concentrations by bioluminescent assay. This enzymatic system allows the study of oxidative phosphorylation during true steady states in a wide range of ADP concentrations. We demonstrate how the application of this method allows an accurate determination of mitochondrial affinity for ADP from both oxidation (K(mVox)) and phosphorylation (K(mVp)) rates. We also demonstrate that determination of K(mVox) leads to an important overestimation of the mitochondrial affinity for ADP, indicating that mitochondrial affinity for ADP should be determined using phosphorylation rate. Finally, we show how this method allows the direct and precise determination of the mitochondrial coupling efficiency. Data obtained from rat skeletal muscle and liver mitochondria illustrate the discriminating capabilities of this method. Conclusions/Significance: Because the proposed method allows the accurate determination of mitochondrial oxidative phosphorylation affinity for ADP in isolated mitochondria, it also opens the route to a better understanding of functional consequences of mitochondrial adaptations/dysfunctions arising in various physiological/pathophysiological conditions.	[Gouspillou, Gilles; Rouland, Richard; Calmettes, Guillaume; Deschodt-Arsac, Veronique; Franconi, Jean-Michel; Bourdel-Marchasson, Isabelle; Diolez, Philippe] Univ Bordeaux 2, CNRS, Lab Resonance Magnet Syst Biol, UMR 5536, F-33076 Bordeaux, France; [Bourdel-Marchasson, Isabelle] Hop Xavier Arnozan, CHU Bordeaux Pole Gerontol Clin, Pessac, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux	Gouspillou, G (corresponding author), Univ Bordeaux 2, CNRS, Lab Resonance Magnet Syst Biol, UMR 5536, F-33076 Bordeaux, France.	gilles.gouspillou@gmail.com; philippe.diolez@u-bordeaux2.fr		Deschodt-Arsac, Veronique/0000-0002-9244-9862; Gouspillou, Gilles/0000-0002-8543-3619; Diolez, Philippe/0000-0002-7548-2070	CNRS; Universite Bordeaux Segalen	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen	Research has been funded by CNRS and Universite Bordeaux Segalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affourtit C, 2006, BIOCHEM J, V393, P151, DOI 10.1042/BJ20051280; Affourtit Charles, 2007, Novartis Found Symp, V287, P70; Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRAND MD, 1994, BIOCHEM J, V297, P27, DOI 10.1042/bj2970027; Brand MD, 2005, BIOCHEM SOC T, V33, P897, DOI 10.1042/BST0330897; BRAND MD, 1993, BIOCHEM J, V291, P739, DOI 10.1042/bj2910739; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Cairns CB, 1998, AM J PHYSIOL-REG I, V274, pR1376, DOI 10.1152/ajpregu.1998.274.5.R1376; Cannon B, 1979, Methods Enzymol, V55, P65; CHANCE B, 1955, J BIOL CHEM, V217, P383; Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x; Dirks AJ, 2006, AGEING RES REV, V5, P179, DOI 10.1016/j.arr.2006.03.002; Dufour S, 1996, BIOCHEM J, V314, P743, DOI 10.1042/bj3140743; Figueiredo PA, 2008, BIOGERONTOLOGY, V9, P67, DOI 10.1007/s10522-007-9121-7; Gnaiger E, 2009, INT J BIOCHEM CELL B, V41, P1837, DOI 10.1016/j.biocel.2009.03.013; Gouspillou G, 2010, BBA-BIOENERGETICS, V1797, P143, DOI 10.1016/j.bbabio.2009.09.004; KESSELER A, 1994, EUR J BIOCHEM, V225, P907, DOI 10.1111/j.1432-1033.1994.0907b.x; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Mogensen M, 2005, ACTA PHYSIOL SCAND, V185, P229, DOI 10.1111/j.1365-201X.2005.01488.x; Moreira PI, 2010, BBA-MOL BASIS DIS, V1802, P2, DOI 10.1016/j.bbadis.2009.10.006; Ouhabi R, 1998, ANAL BIOCHEM, V263, P169, DOI 10.1006/abio.1998.2776; PASSARELLA S, 1988, BIOCHEM BIOPH RES CO, V156, P978, DOI 10.1016/S0006-291X(88)80940-9; Schapira AHV, 1999, BBA-BIOENERGETICS, V1410, P159, DOI 10.1016/S0005-2728(98)00164-9; ter Veld F, 2005, FEBS J, V272, P956, DOI 10.1111/j.1742-4658.2004.04529.x; Tonkonogi M, 1999, AM J PHYSIOL-CELL PH, V277, pC288, DOI 10.1152/ajpcell.1999.277.2.C288; Weiss JN, 2006, J LIPID RES, V47, P2355, DOI 10.1194/jlr.R600023-JLR200; Zoll J, 2003, J CELL PHYSIOL, V194, P186, DOI 10.1002/jcp.10224; Zoll J, 2002, J PHYSIOL-LONDON, V543, P191, DOI 10.1113/jphysiol.2002.019661	30	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20709	10.1371/journal.pone.0020709	http://dx.doi.org/10.1371/journal.pone.0020709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694779	gold, Green Published			2022-12-25	WOS:000291612900020
J	Sershen, CL; Mell, JC; Madden, SM; Benham, CJ				Sershen, Cheryl L.; Mell, Joshua C.; Madden, Sally M.; Benham, Craig J.			Superhelical Duplex Destabilization and the Recombination Position Effect	PLOS ONE			English	Article							GENE-EXPRESSION; GENOMIC DNA; SEQUENCE; REGION; MODEL; DENATURATION; PREDICTION; BINDING; SITES; OCCUR	The susceptibility to recombination of a plasmid inserted into a chromosome varies with its genomic position. This recombination position effect is known to correlate with the average G+C content of the flanking sequences. Here we propose that this effect could be mediated by changes in the susceptibility to superhelical duplex destabilization that would occur. We use standard nonparametric statistical tests, regression analysis and principal component analysis to identify statistically significant differences in the destabilization profiles calculated for the plasmid in different contexts, and correlate the results with their measured recombination rates. We show that the flanking sequences significantly affect the free energy of denaturation at specific sites interior to the plasmid. These changes correlate well with experimentally measured variations of the recombination rates within the plasmid. This correlation of recombination rate with superhelical destabilization properties of the inserted plasmid DNA is stronger than that with average G+C content of the flanking sequences. This model suggests a possible mechanism by which flanking sequence base composition, which is not itself a context-dependent attribute, can affect recombination rates at positions within the plasmid.	[Sershen, Cheryl L.] Baylor Coll Med, Houston, TX 77030 USA; [Mell, Joshua C.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Madden, Sally M.] UC Davis Genome Ctr, Davis, CA USA; [Benham, Craig J.] Univ Calif Davis, Dept Math, Davis, CA 95616 USA; [Benham, Craig J.] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA	Baylor College of Medicine; University of British Columbia; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Sershen, CL (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	sershen@bcm.edu	Benham, Craig J/G-1512-2013		National Science Foundation [DBI-04-16764, DBI-08-50214]; Vigre Grant Fellowship [DMS-0636297]	National Science Foundation(National Science Foundation (NSF)); Vigre Grant Fellowship	This work was supported by grant DBI-04-16764 and DBI-08-50214 to C. J. Benham from the National Science Foundation and by a Vigre Grant Fellowship to C. Sershen DMS-0636297. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 1998, J VIROL, V72, P3720, DOI 10.1128/JVI.72.5.3720-3728.1998; Ak P, 2005, PLOS COMPUT BIOL, V1, P41, DOI 10.1371/journal.pcbi.0010007; Anselmi C, 2000, BIOPHYS J, V79, P601, DOI 10.1016/S0006-3495(00)76319-3; Bartlett MS, 1950, B J PSYCHOL-STAT SEC, V3, P77, DOI 10.1111/j.2044-8317.1950.tb00285.x; Benham C, 1997, J MOL BIOL, V274, P181, DOI 10.1006/jmbi.1997.1385; BENHAM CJ, 1993, P NATL ACAD SCI USA, V90, P2999, DOI 10.1073/pnas.90.7.2999; Benham CJ, 1996, J MOL BIOL, V255, P425, DOI 10.1006/jmbi.1996.0035; Benham CJ, 2004, J COMPUT BIOL, V11, P519, DOI 10.1089/cmb.2004.11.519; BENHAM CJ, 2001, PACIFIC S BIOCOMPUTI, V6, P103; Bi CP, 2004, BIOINFORMATICS, V20, P1477, DOI 10.1093/bioinformatics/bth304; Bode J, 2006, J MOL BIOL, V358, P597, DOI 10.1016/j.jmb.2005.11.073; Borde V, 1999, MOL CELL BIOL, V19, P4832; DeGroot M.H., 2002, PROBABILITY STAT; Fye RM, 1999, PHYS REV E, V59, P3408, DOI 10.1103/PhysRevE.59.3408; GARDLIK R, 2005, MED SCI MONITOR, V11, P121; Hatfield GW, 2002, ANNU REV GENET, V36, P175, DOI 10.1146/annurev.genet.36.032902.111815; Huang YL, 2003, NUCLEIC ACIDS RES, V31, P3819, DOI 10.1093/nar/gkg562; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jolliffe I. T., 2002, PRINCIPAL COMPONENT, V2nd; Kouzine F, 2008, NAT STRUCT MOL BIOL, V15, P146, DOI 10.1038/nsmb.1372; Kouzine F, 2007, FRONT BIOSCI-LANDMRK, V12, P4409, DOI 10.2741/2398; LEHMAN GW, 1968, J CHEM PHYS, V49, P3170, DOI 10.1063/1.1670566; Petes TD, 2002, GENETICS, V162, P2049; PEYRARD M, 1989, PHYS REV LETT, V62, P2755, DOI 10.1103/PhysRevLett.62.2755; Polonskaya Z, 2004, VIROLOGY, V328, P282, DOI 10.1016/j.virol.2004.07.023; Potaman VN, 2003, J MOL BIOL, V326, P1095, DOI 10.1016/S0022-2836(03)00037-8; Sheridan SD, 1998, J BIOL CHEM, V273, P21298, DOI 10.1074/jbc.273.33.21298; SINDEN R. R., 1994, DNA STRUCTURE FUNCTI; VOLOGODSKII A, 1977, BIOPOLYMERS, V16, P2693; VOLOGODSKII AV, 1978, NUCLEIC ACIDS RES, V5, P2547, DOI 10.1093/nar/5.7.2547; WAHLS WP, 1994, GENE DEV, V8, P1693, DOI 10.1101/gad.8.14.1693; Walther W, 2000, DRUGS, V60, P249, DOI 10.2165/00003495-200060020-00002; Wang HQ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-248; Wang H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040017; Woynarowski JM, 2001, J BIOL CHEM, V276, P40555, DOI 10.1074/jbc.M103390200	35	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20798	10.1371/journal.pone.0020798	http://dx.doi.org/10.1371/journal.pone.0020798			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695263	gold, Green Submitted, Green Published			2022-12-25	WOS:000291612900027
J	Liu, G; Tarbet, B; Song, LZ; Reiserova, L; Weaver, B; Chen, Y; Li, H; Hou, F; Liu, XY; Parent, J; Umlauf, S; Shaw, A; Tussey, L				Liu, Ge; Tarbet, Bart; Song, Langzhou; Reiserova, Lucia; Weaver, Bruce; Chen, Yan; Li, Hong; Hou, Fu; Liu, Xiangyu; Parent, Jason; Umlauf, Scott; Shaw, Alan; Tussey, Lynda			Immunogenicity and Efficacy of Flagellin-Fused Vaccine Candidates Targeting 2009 Pandemic H1N1 Influenza in Mice	PLOS ONE			English	Article							LETHAL CHALLENGE; VIRUS; RESPONSES; SAFETY; ANTIBODIES; IMMUNITY; FERRETS; ADULTS; TRIAL	We have previously demonstrated that the globular head of the hemagglutinin (HA) antigen fused to flagellin of Salmonella typhimurium fljB (STF2, a TLR5 ligand) elicits protective immunity to H1N1 and H5N1 lethal influenza infections in mice (Song et al., 2008, PLoS ONE 3, e2257; Song et al., 2009, Vaccine 27, 5875-5888). These fusion proteins can be efficiently and economically manufactured in E. coli fermentation systems as next generation pandemic and seasonal influenza vaccines. Here we report immunogenicity and efficacy results of three vaccine candidates in which the HA globular head of A/California/07/2009 (H1N1) was fused to STF2 at the C-terminus (STF2. HA1), in replace of domain 3 (STF2R3.HA1), or in both positions (STF2R3.2xHA1). For all three vaccines, two subcutaneous immunizations of BALB/c mice with doses of either 0.3 or 3 mu g elicit robust neutralizing (HAI) antibodies, that lead to > = 2 Log(10) unit reduction in day 4 lung virus titer and full protection against a lethal A/California/04/2009 challenge. Vaccination with doses as low as 0.03 mg results in partial to full protection. Each candidate, particularly the STF2R3.HA1 and STF2R3.2xHA1 candidates, elicits robust neutralizing antibody responses that last for at least 8 months. The STF2R3.HA1 candidate, which was intermediately protective in the challenge models, is more immunogenic than the H1N1 components of two commercially available trivalent inactivated influenza vaccines (TIVs) in mice. Taken together, the results demonstrate that all three vaccine candidates are highly immunogenic and efficacious in mice, and that the STF2R3.2xHA1 format is the most effective candidate vaccine format.	[Liu, Ge; Song, Langzhou; Reiserova, Lucia; Weaver, Bruce; Chen, Yan; Li, Hong; Hou, Fu; Liu, Xiangyu; Parent, Jason; Umlauf, Scott; Shaw, Alan; Tussey, Lynda] VaxInnate Corp, Cranbury, NJ USA; [Tarbet, Bart] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Liu, G (corresponding author), VaxInnate Corp, Cranbury, NJ USA.	ge.liu@vaxinnate.com		Tarbet, Bart/0000-0002-4255-9094	VaxInnate Corporation	VaxInnate Corporation	This work was funded by VaxInnate Corporation. All authors, except Dr. Bart Tarbet, are employees of VaxInnate and were jointly involved in the study design and execution, decision to publish, or preparation of the manuscript.	Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Bright RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001501; COX N, 2010, OPTIONS CONTROL INFL, V7; Hessel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012217; HOCART MJ, 1989, J GEN VIROL, V70, P2439, DOI 10.1099/0022-1317-70-9-2439; Huber VC, 2001, J IMMUNOL, V166, P7381, DOI 10.4049/jimmunol.166.12.7381; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Ilyushina NA, 2010, J VIROL, V84, P8607, DOI 10.1128/JVI.00159-10; Khurana S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011548; Lalor PA, 2008, J INFECT DIS, V197, P1643, DOI 10.1086/588431; Lambert LC, 2010, NEW ENGL J MED, V363, P2036, DOI 10.1056/NEJMra1002842; Langley JM, 2010, J INFECT DIS, V201, P1644, DOI 10.1086/652701; Mahmood K, 2008, VACCINE, V26, P5393, DOI 10.1016/j.vaccine.2008.07.084; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sasaki S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002975; Sidwell RW, 2001, ANTIMICROB AGENTS CH, V45, P749, DOI 10.1128/AAC.45.3.749-757.2001; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Song LZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002257; Song L, 2009, VACCINE, V27, P5875, DOI 10.1016/j.vaccine.2009.07.060; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Tamura SI, 2004, JPN J INFECT DIS, V57, P236; Treanor JJ, 2007, JAMA-J AM MED ASSOC, V297, P1577, DOI 10.1001/jama.297.14.1577; Treanor JJ, 2010, VACCINE, V28, P8268, DOI 10.1016/j.vaccine.2010.10.009	25	44	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20928	10.1371/journal.pone.0020928	http://dx.doi.org/10.1371/journal.pone.0020928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687743	Green Published, gold, Green Submitted			2022-12-25	WOS:000291607000032
J	Bobrowska, A; Paganetti, P; Matthias, P; Bates, GP				Bobrowska, Anna; Paganetti, Paolo; Matthias, Patrick; Bates, Gillian P.			Hdac6 Knock-Out Increases Tubulin Acetylation but Does Not Modify Disease Progression in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; UBIQUITIN-PROTEASOME SYSTEM; NEUROTROPHIC FACTOR; MUTANT HUNTINGTIN; GENE-EXPRESSION; TRANSGENIC MICE; BRAIN; PROTEIN; TRANSPORT; HISTONE-DEACETYLASE-6	Huntington's disease (HD) is a progressive neurodegenerative disorder for which there is no effective disease modifying treatment. Following-on from studies in HD animal models, histone deacetylase (HDAC) inhibition has emerged as an attractive therapeutic option. In parallel, several reports have demonstrated a role for histone deacetylase 6 (HDAC6) in the modulation of the toxicity caused by the accumulation of misfolded proteins, including that of expanded polyglutamine in an N-terminal huntingtin fragment. An important role for HDAC6 in kinesin-1 dependent transport of brain-derived neurotrophic factor (BDNF) from the cortex to the striatum has also been demonstrated. To elucidate the role that HDAC6 plays in HD progression, we evaluated the effects of the genetic depletion of HDAC6 in the R6/2 mouse model of HD. Loss of HDAC6 resulted in a marked increase in tubulin acetylation throughout the brain. Despite this, there was no effect on the onset and progression of a wide range of behavioural, physiological, molecular and pathological HD-related phenotypes. We observed no change in the aggregate load or in the levels of soluble mutant exon 1 transprotein. HDAC6 genetic depletion did not affect the efficiency of BDNF transport from the cortex to the striatum. Therefore, we conclude that HDAC6 inhibition does not modify disease progression in R6/2 mice and HDAC6 should not be prioritized as a therapeutic target for HD.	[Bobrowska, Anna; Bates, Gillian P.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Paganetti, Paolo] Novartis Inst BioMed Res, Basel, Switzerland; [Matthias, Patrick] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Basel, Switzerland	University of London; King's College London; Novartis; Friedrich Miescher Institute for Biomedical Research; Novartis	Bobrowska, A (corresponding author), Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England.	gillian.bates@kcl.ac.uk	Bates, Gillian P/E-1146-2012; Paganetti, Paolo/AAF-8039-2020	Bates, Gillian P/0000-0002-4041-6305; Bobrowska, Anna/0000-0002-5001-7981; Paganetti, Paolo/0000-0003-1896-6324	European Commission Marie Curie Initial Training Network [215618]; CHDI Foundation	European Commission Marie Curie Initial Training Network; CHDI Foundation	This work was supported by a European Commission Marie Curie Initial Training Network (215618) Fellowship (AB) and the CHDI Foundation. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript. At the time that this study was performed, PP was an employee of Novartis Institutes for BioMedical Research and helped with experimental design, data analysis, and reading of the manuscript.	Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885; Apostol BL, 2008, MOL CELL NEUROSCI, V39, P8, DOI 10.1016/j.mcn.2008.04.007; Bates EA, 2006, J NEUROSCI, V26, P2830, DOI 10.1523/JNEUROSCI.3344-05.2006; BATES G, 2002, HUNTINGTONS DIS; Benn CL, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-17; Benn CL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005747; Butler R, 2006, NAT REV NEUROSCI, V7, P784, DOI 10.1038/nrn1989; Canals JM, 2004, J NEUROSCI, V24, P7727, DOI 10.1523/JNEUROSCI.1197-04.2004; Cepeda C., 2010, PLOS CURR, V2; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ding HP, 2008, J NEUROCHEM, V106, P2119, DOI 10.1111/j.1471-4159.2008.05564.x; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Du GP, 2010, MOL BIOL CELL, V21, P2128, DOI 10.1091/mbc.E10-03-0200; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gharami K, 2008, J NEUROCHEM, V105, P369, DOI 10.1111/j.1471-4159.2007.05137.x; Grozinger CM, 1999, P NATL ACAD SCI USA, V96, P4868, DOI 10.1073/pnas.96.9.4868; Hockly E, 2006, NEUROBIOL DIS, V21, P228, DOI 10.1016/j.nbd.2005.07.007; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Hockly E, 2003, BRAIN RES BULL, V61, P469, DOI 10.1016/S0361-9230(03)00185-0; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kopito RR, 2000, TRENDS CELL BIOL, V10, P524, DOI 10.1016/S0962-8924(00)01852-3; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mahlknecht U, 2001, CYTOGENET CELL GENET, V93, P135, DOI 10.1159/000056967; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin EJ, 1999, J COMP NEUROL, V403, P421; Moffitt H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008025; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Pallos J, 2008, HUM MOL GENET, V17, P3767, DOI 10.1093/hmg/ddn273; Pandey UB, 2007, AUTOPHAGY, V3, P643, DOI 10.4161/auto.5050; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Sathasivam K, 2001, HUM MOL GENET, V10, P2425, DOI 10.1093/hmg/10.21.2425; Sathasivam K, 2010, HUM MOL GENET, V19, P65, DOI 10.1093/hmg/ddp467; Seigneurin-Berny D, 2001, MOL CELL BIOL, V21, P8035, DOI 10.1128/MCB.21.23.8035-8044.2001; Seo H, 2008, HUM MOL GENET, V17, P3144, DOI 10.1093/hmg/ddn211; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Szapacs ME, 2004, J NEUROSCI METH, V140, P81, DOI 10.1016/j.jneumeth.2004.03.026; Tabrizi SJ, 2011, LANCET NEUROL, V10, P31, DOI 10.1016/S1474-4422(10)70276-3; Tabrizi SJ, 2009, LANCET NEUROL, V8, P791, DOI 10.1016/S1474-4422(09)70170-X; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Weiss A, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-11; Woodman B, 2007, BRAIN RES BULL, V72, P83, DOI 10.1016/j.brainresbull.2006.11.004; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zhang Y, 2008, MOL CELL BIOL, V28, P1688, DOI 10.1128/MCB.01154-06; Zuccato C, 2010, PHYSIOL REV, V90, P905, DOI 10.1152/physrev.00041.2009; Zuccato C, 2009, NAT REV NEUROL, V5, P311, DOI 10.1038/nrneurol.2009.54	62	87	93	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20696	10.1371/journal.pone.0020696	http://dx.doi.org/10.1371/journal.pone.0020696			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677773	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500035
J	Russell, C; Wessnitzer, J; Young, JM; Armstrong, JD; Webb, B				Russell, Cheryl; Wessnitzer, Jan; Young, Joanna M.; Armstrong, J. Douglas; Webb, Barbara			Dietary Salt Levels Affect Salt Preference and Learning in Larval Drosophila	PLOS ONE			English	Article							LOCUSTA-MIGRATORIA; AVERSIVE MEMORY; SODIUM-CHLORIDE; NEURONS; TASTE; MELANOGASTER; BEHAVIOR; CHOICE; NYMPHS; SUGAR	Drosophila larvae change from exhibiting attraction to aversion as the concentration of salt in a substrate is increased. However, some aversive concentrations appear to act as positive reinforcers, increasing attraction to an odour with which they have been paired. We test whether this surprising dissociation between the unconditioned and conditioned response depends on the larvae's experience of salt concentration in their food. We find that although the point at which a NaCl concentration becomes aversive shifts with different rearing experience, the dissociation remains evident. Testing larvae using a substrate 0.025M above the NaCl concentration on which the larvae were reared consistently results in aversive choice behaviour but appetitive reinforcement effects.	[Russell, Cheryl; Wessnitzer, Jan; Young, Joanna M.; Webb, Barbara] Univ Edinburgh, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland; [Young, Joanna M.; Armstrong, J. Douglas] Univ Edinburgh, Inst Adapt & Neural Computat, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Russell, C (corresponding author), Univ Edinburgh, Inst Percept Act & Behav, Edinburgh, Midlothian, Scotland.	jwessnit@inf.ed.ac.uk; bwebb@inf.ed.ac.uk	Young, Joanna/ABE-5495-2020	Armstrong, Douglas/0000-0002-5397-3864; Young, Joanna/0000-0002-4172-9389	EPSRC; EPSRC [EP/F030673/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F030673/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EPSRC (http://www.epsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA K, 1987, NATURE, V330, P62, DOI 10.1038/330062a0; Bader R, 2007, J COMP NEUROL, V502, P848, DOI 10.1002/cne.21342; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Chapman RF, 2003, ANNU REV ENTOMOL, V48, P455, DOI 10.1146/annurev.ento.48.091801.112629; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; CONTRERAS RJ, 1980, BEHAV NEURAL BIOL, V29, P303, DOI 10.1016/S0163-1047(80)90183-1; CONTRERAS RJ, 1983, J NUTR, V113, P1051, DOI 10.1093/jn/113.5.1051; Gerber B, 2004, CURR OPIN NEUROBIOL, V14, P737, DOI 10.1016/j.conb.2004.10.014; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; Gerber B, 2006, P ROY SOC B-BIOL SCI, V273, P2965, DOI 10.1098/rspb.2006.3673; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Hiroi M, 2004, J NEUROBIOL, V61, P333, DOI 10.1002/neu.20063; Hiroi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002610; HOLLAND PC, 1979, J EXP PSYCHOL ANIM B, V5, P65, DOI 10.1037/0097-7403.5.1.65; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Honjo K, 2009, J NEUROSCI, V29, P852, DOI 10.1523/JNEUROSCI.1315-08.2009; Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Liu L, 2003, NEURON, V39, P133, DOI 10.1016/S0896-6273(03)00394-5; MIYAKAWA Y, 1982, J INSECT PHYSIOL, V28, P405, DOI 10.1016/0022-1910(82)90066-X; MIYOSHI Y, 1961, GENETICS, V46, P935; Mizunami M, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00172; Mizunami M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-46; Niewalda T, 2008, CHEM SENSES, V33, P685, DOI 10.1093/chemse/bjn037; Niv Y, 2008, TRENDS COGN SCI, V12, P265, DOI 10.1016/j.tics.2008.03.006; Pauls D, 2010, J NEUROSCI, V30, P10655, DOI 10.1523/JNEUROSCI.1281-10.2010; R Development Core Team, 2010, MIXTURE HIDDEN MARKO; RESCORLA RA, 1988, AM PSYCHOL, V43, P151, DOI 10.1037/0003-066X.43.3.151; Scherer S, 2003, LEARN MEMORY, V10, P217, DOI 10.1101/lm.57903; Schipanski A, 2008, CHEM SENSES, V33, P563, DOI 10.1093/chemse/bjn024; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Stergiopoulos K, 2009, PHYSIOL GENOMICS, V37, P1, DOI 10.1152/physiolgenomics.90360.2008; TRUMPER S, 1993, J INSECT PHYSIOL, V39, P857, DOI 10.1016/0022-1910(93)90118-B; TRUMPER S, 1994, PHYSIOL ENTOMOL, V19, P203, DOI 10.1111/j.1365-3032.1994.tb01044.x	34	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 1	2011	6	6							e20100	10.1371/journal.pone.0020100	http://dx.doi.org/10.1371/journal.pone.0020100			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773LX	21687789	Green Published, Green Submitted, gold			2022-12-25	WOS:000291309900003
J	Chatterjee, S; Ju, ZL; Hassan, R; Volpi, SA; Emelyanov, AV; Birshtein, BK				Chatterjee, Sanjukta; Ju, Zhongliang; Hassan, Rabih; Volpi, Sabrina A.; Emelyanov, Alexander V.; Birshtein, Barbara K.			Dynamic Changes in Binding of Immunoglobulin Heavy Chain 3 ' Regulatory Region to Protein Factors during Class Switching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATION-INDUCED DEAMINASE; NF-KAPPA-B; IGH LOCUS; CHROMATIN ARCHITECTURE; INTRONIC ENHANCER; GENE-EXPRESSION; HS4 ENHANCER; CTCF SITES; IN-VIVO; RECOMBINATION	The 3' regulatory region (3' RR) of the Igh locus works at long distances on variable region (V-H) and switch region (I) region promoters to initiate germ line (non-coding) transcription (GT) and promote class switch recombination (CSR). The 3' RR contains multiple elements, including enhancers (hs3a, hs1.2, hs3b, and hs4) and a proposed insulator region containing CTCF (CCCTC-binding factor) binding sites, i.e. hs5/6/7 and the downstream region ("38"). Notably, deletion of each individual enhancer (hs3a-hs4) has no significant phenotypic consequence, suggesting that the 3' RR has considerable structural flexibility in its function. To better understand how the 3' RR functions, we identified transcription factor binding sites and used chromatin immunoprecipitation (ChIP) assays to monitor their occupancy in splenic B cells that initiate GT and undergo CSR (LPS +/- IL4), are deficient inGTand CSR (p50(-/-)), or do not undergo CSR despite efficient GT (anti-IgM + IL4). Like 3' RR enhancers, hs5-7 and the 38 region were observed to contain multiple Pax5 binding sites (in addition to multiple CTCF sites). We found that the Pax5 binding profile to the 3' RR dynamically changed during CSR independent of the specific isotype to which switching was induced, and binding focused on hs1.2, hs4, and hs7. CTCF-associated and CTCF-independent cohesin interactions were also identified. Our observations are consistent with a scaffold model in which a platform of active protein complexes capable of facilitating GT and CSR can be formed by varying constellations of 3' RR elements.	[Chatterjee, Sanjukta; Ju, Zhongliang; Hassan, Rabih; Volpi, Sabrina A.; Emelyanov, Alexander V.; Birshtein, Barbara K.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Birshtein, BK (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.	barbara.birshtein@einstein.yu.edu			National Institutes of Health [AI13509]; Albert Einstein Cancer Center [P30 CA13330]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013509, R37AI013509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI13509. This work was also supported by Albert Einstein Cancer Center Grant P30 CA13330.	Afshar R, 2006, J IMMUNOL, V176, P2439, DOI 10.4049/jimmunol.176.4.2439; Bebin AG, 2010, J IMMUNOL, V184, P3710, DOI 10.4049/jimmunol.0901978; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; CHEN JZ, 1993, EMBO J, V12, P4635, DOI 10.1002/j.1460-2075.1993.tb06152.x; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; Cogne M, 2004, MOL BIOL B CELLS, P289; CZERNY T, 1993, GENE DEV, V7, P2048, DOI 10.1101/gad.7.10.2048; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Degner SC, 2009, J IMMUNOL, V182, P44, DOI 10.4049/jimmunol.182.1.44; Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Dunnick WA, 2005, J EXP MED, V201, P1459, DOI 10.1084/jem.20041988; Dunnick WA, 2009, J EXP MED, V206, P2613, DOI 10.1084/jem.20091280; Ebert A, 2011, IMMUNITY, V34, P175, DOI 10.1016/j.immuni.2011.02.005; Emelyanov AV, 2002, J BIOL CHEM, V277, P11156, DOI 10.1074/jbc.M111763200; FERRIER P, 1990, EMBO J, V9, P117, DOI 10.1002/j.1460-2075.1990.tb08087.x; Garrett FE, 2005, MOL CELL BIOL, V25, P1511, DOI 10.1128/MCB.25.4.1511-1525.2005; Helternes-Harris LM, 2008, MOL IMMUNOL, V45, P1799, DOI 10.1016/j.molimm.2007.09.020; Horcher M, 2001, IMMUNITY, V14, P779, DOI 10.1016/S1074-7613(01)00153-4; Jabara HH, 2008, J ALLERGY CLIN IMMUN, V121, P191, DOI 10.1016/j.jaci.2007.08.008; Ju ZL, 2007, J BIOL CHEM, V282, P35169, DOI 10.1074/jbc.M705719200; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; KOZMIK Z, 1992, MOL CELL BIOL, V12, P2662, DOI 10.1128/MCB.12.6.2662; Lieberson R, 1995, EMBO J, V14, P6229, DOI 10.1002/j.1460-2075.1995.tb00313.x; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manis JP, 1998, J EXP MED, V188, P1421, DOI 10.1084/jem.188.8.1421; Max E E., 2003, FUNDAMENTAL IMMUNOLO, P107; McManus S, 2011, EMBO J, V30, P2388, DOI 10.1038/emboj.2011.140; Michaelson JS, 1996, J IMMUNOL, V156, P2828; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Perlot T, 2005, P NATL ACAD SCI USA, V102, P14362, DOI 10.1073/pnas.0507090102; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Sepulveda MA, 2004, J IMMUNOL, V172, P1054, DOI 10.4049/jimmunol.172.2.1054; Singh M, 1996, P NATL ACAD SCI USA, V93, P4392, DOI 10.1073/pnas.93.9.4392; SINGH M, 1993, MOL CELL BIOL, V13, P3611, DOI 10.1128/MCB.13.6.3611; Snapper CM, 1996, J IMMUNOL, V156, P183; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Stevens S, 2000, J IMMUNOL, V164, P5306, DOI 10.4049/jimmunol.164.10.5306; Tran TH, 2010, NAT IMMUNOL, V11, P148, DOI 10.1038/ni.1829; Vincent-Fabert C, 2010, BLOOD, V116, P1895, DOI 10.1182/blood-2010-01-264689; Vincent-Fabert C, 2009, J IMMUNOL, V182, P6926, DOI 10.4049/jimmunol.0900214; Wang LL, 2006, EUR J IMMUNOL, V36, P3315, DOI 10.1002/eji.200636294; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wuerffe R, 2007, IMMUNITY, V27, P711, DOI 10.1016/j.immuni.2007.09.007; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zhang BY, 2007, J IMMUNOL, V178, P6297, DOI 10.4049/jimmunol.178.10.6297	50	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29303	29312		10.1074/jbc.M111.243543	http://dx.doi.org/10.1074/jbc.M111.243543			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21685395	Green Published, hybrid			2022-12-25	WOS:000293837000065
J	Shimozu, Y; Hirano, K; Shibata, T; Shibata, N; Uchida, K				Shimozu, Yuuki; Hirano, Keita; Shibata, Takahiro; Shibata, Noriyuki; Uchida, Koji			4-Hydroperoxy-2-nonenal Is Not Just an Intermediate but a Reactive Molecule That Covalently Modifies Proteins to Generate Unique Intramolecular Oxidation Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-PEROXIDATION; 9-AND 13-HYDROPEROXIDES; LINOLENIC ACIDS; ALDEHYDES; ATHEROSCLEROSIS; HYDROPEROXIDES; TRANSFORMATION; DECOMPOSITION; MALONALDEHYDE; MECHANISMS	alpha,beta-Unsaturated aldehydes generated during lipid peroxidation, such as 4-oxoalkenals and 4-hydroxyalkenals, can give rise to protein degeneration in a variety of pathological states. Although the covalent modification of proteins by these end products has been well studied, the reactivity of unstable intermediates possessing a hydroperoxy group, such as 4-hydroperoxy-2-nonenal (HPNE), with protein has received little attention. We have now established a unique protein modification in which the 4-hydroperoxy group of HPNE is involved in the formation of structurally unusual lysine adducts. In addition, we showed that one of the HPNE-specific lysine adducts constitutes the epitope of a monoclonal antibody raised against the HPNE-modified protein. Upon incubation with bovine serum albumin, HPNE preferentially reacted with the lysine residues. By employing N-alpha-benzoylglycyl-lysine, we detected two major products containing one HPNE molecule per peptide. Based on the chemical and spectroscopic evidence, the products were identified to be the N-alpha-benzoylglycyl derivatives of N-epsilon-4-hydroxynonanoic acid-lysine and N-epsilon-4-hydroxy-(2Z)-nonenoyllysine, both of which are suggested to be formed through mechanisms in which the initial HPNE-lysine adducts undergo Baeyer-Villiger-like reactions proceeding through an intramolecular oxidation catalyzed by the hydroperoxy group. On the other hand, using an HPNE-modified protein as the immunogen, we raised a monoclonal antibody against the HPNE-modified protein and identified one of the HPNE-specific lysine adducts, N-epsilon-4-hydroxynonanoic acid-lysine, as an intrinsic epitope of the monoclonal antibody. Furthermore, we demonstrated that the HPNE-specific epitopes were produced not only in the oxidized low density lipoprotein in vitro but also in the atherosclerotic lesions. These results indicated that HPNE is not just an intermediate but also a reactive molecule that could covalently modify proteins in biological systems.	[Shimozu, Yuuki; Hirano, Keita; Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Shibata, Noriyuki] Tokyo Womens Med Univ, Dept Pathol, Tokyo 1628666, Japan	Nagoya University; Tokyo Women's Medical University	Uchida, K (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan.	uchidak@agr.nagoya-u.ac.jp	Shimozu, Yuuki/AAW-1504-2021; Shibata, Takahiro/I-6872-2014	Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X				CHIO KS, 1969, BIOCHEMISTRY-US, V8, P2821, DOI 10.1021/bi00835a019; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; GARDNER HW, 1993, J BIOL CHEM, V268, P6971; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; GREIN B, 1993, J AGR FOOD CHEM, V41, P2385, DOI 10.1021/jf00036a032; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; Ishino K, 2010, J BIOL CHEM, V285, P15302, DOI 10.1074/jbc.M109.068023; Itakura K, 1998, J ORG CHEM, V63, P185, DOI 10.1021/jo971239+; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Lee SH, 2000, CHEM RES TOXICOL, V13, P698, DOI 10.1021/tx000101a; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; PATAI S, 1964, CHEM ALKENES, P565; REDDY S, 1995, BIOCHEMISTRY-US, V34, P10872, DOI 10.1021/bi00034a021; Rindgen D, 1999, CHEM RES TOXICOL, V12, P1195, DOI 10.1021/tx990034o; SAYRE LM, 1993, CHEM RES TOXICOL, V6, P19, DOI 10.1021/tx00031a002; Schneider C, 2005, LIPIDS, V40, P1155, DOI 10.1007/s11745-005-1480-3; Schneider C, 2001, J BIOL CHEM, V276, P20831, DOI 10.1074/jbc.M101821200; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STEINBERG D, 1995, LANCET, V346, P36, DOI 10.1016/S0140-6736(95)92657-7; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; SZWEDA LI, 1993, J BIOL CHEM, V268, P3342; Tijet N, 2001, ARCH BIOCHEM BIOPHYS, V386, P281, DOI 10.1006/abbi.2000.2218; Uchida K, 2000, FREE RADICAL BIO MED, V28, P1685, DOI 10.1016/S0891-5849(00)00226-4; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Uchida K, 1997, ARCH BIOCHEM BIOPHYS, V346, P45, DOI 10.1006/abbi.1997.0266; West JD, 2004, CHEM RES TOXICOL, V17, P453, DOI 10.1021/tx034248o; Xu GZ, 1998, CHEM RES TOXICOL, V11, P247, DOI 10.1021/tx980003d; Zhu XC, 2007, CHEM RES TOXICOL, V20, P165, DOI 10.1021/tx600295j	30	25	26	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29313	29324		10.1074/jbc.M111.255737	http://dx.doi.org/10.1074/jbc.M111.255737			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21690609	hybrid, Green Published			2022-12-25	WOS:000293837000066
J	Gerdts, J; Sasaki, Y; Vohra, B; Marasa, J; Milbrandt, J				Gerdts, Josiah; Sasaki, Yo; Vohra, Bhupinder; Marasa, Jayne; Milbrandt, Jeffrey			Image-based Screening Identifies Novel Roles for I kappa B Kinase and Glycogen Synthase Kinase 3 in Axonal Degeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; WALLERIAN DEGENERATION; METAMORPHOSIS; KINASE-3-BETA; DEGRADATION; MECHANISMS; WITHDRAWAL; NEURONS; PATHWAY; CELLS	Axon degeneration is an active, evolutionarily conserved self-destruction program by which compromised axons fragment in response to varied insults. Unlike programmed cell death, axon degeneration is poorly understood. We have combined robotic liquid handling with automated microscopy and image analysis to create a robust screening platform to measure axon degeneration in mammalian primary neuronal cultures. Using this assay, we performed an unbiased screen of 480 bioactive compounds, identifying 11 that reproducibly delay fragmentation of severed axons in vitro, including two inhibitors of glycogen synthase kinase 3 and two inhibitors of I kappa B kinase. Knockdown of each of these targets by shRNA lentivirus also delays axon degeneration in vitro, further supporting their role in the axon degeneration program.	[Gerdts, Josiah; Sasaki, Yo; Milbrandt, Jeffrey] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Milbrandt, Jeffrey] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, Mol Imaging Ctr,Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; [Marasa, Jayne] Washington Univ, Sch Med, BRIGHT Inst, St Louis, MO 63110 USA; [Vohra, Bhupinder] Univ Cent Arkansas, Dept Biol, Conway, AR 72034 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Central Arkansas	Milbrandt, J (corresponding author), 660 S Euclid Ave,Campus Box 8232, St Louis, MO 63110 USA.	jmilbrandt@wustl.edu			National Institutes of Health [AG13730, NS065053, NS070053, P50 CA91842]; NIH Neuroscience Blueprint Center [P30 NS057105]; HOPE Center for Neurological Disorders; Craig H. Neilsen Foundation [124030]; National Institutes of Health NCI Cancer Center [P30 CA091842]; NATIONAL CANCER INSTITUTE [P30CA091842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS070053, R01NS065053, P30NS057105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Neuroscience Blueprint Center; HOPE Center for Neurological Disorders; Craig H. Neilsen Foundation; National Institutes of Health NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants AG13730 (to J. Milbrandt) and NS065053 and NS070053 (to J. Milbrandt and A. DiAntonio), NIH Neuroscience Blueprint Center Core Grant P30 NS057105 to Washington University, the HOPE Center for Neurological Disorders, and Craig H. Neilsen Foundation Grant 124030 (to J. Milbrandt).; We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital, St. Louis, MO, for the use of the High-Throughput Screening Core. The Siteman Cancer Center is supported in part by National Institutes of Health NCI Cancer Center Support Grant P30 CA091842. The Screening Core is supported by NIH Grant P50 CA91842 and an Anheuser-Busch/Emerson challenge gift. We also thank Aaron DiAntonio and Martha Bhattacharya for help with manuscript preparation, Scott Wildman for help with compound library selection, and S. Joshua Swamidass for help with the development of methods.	Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Birmingham A, 2009, NAT METHODS, V6, P569, DOI 10.1038/nmeth.1351; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Eom TY, 2007, J BIOL CHEM, V282, P22856, DOI 10.1074/jbc.M702973200; GEORGE EB, 1995, J NEUROSCI, V15, P6445; Hetman M, 2000, J NEUROSCI, V20, P2567; Ikegami K, 2004, BRAIN RES, V1030, P81, DOI 10.1016/j.brainres.2004.09.050; Kim WY, 2006, NEURON, V52, P981, DOI 10.1016/j.neuron.2006.10.031; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee HH, 2009, P NATL ACAD SCI USA, V106, P6363, DOI 10.1073/pnas.0902051106; Miller BR, 2009, NAT NEUROSCI, V12, P387, DOI 10.1038/nn.2290; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mok SA, 2009, CELL RES, V19, P546, DOI 10.1038/cr.2009.11; Moss BL, 2008, J BIOL CHEM, V283, P8687, DOI 10.1074/jbc.M706831200; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Rumpf S, 2011, DEVELOPMENT, V138, P1153, DOI 10.1242/dev.062703; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; STAMBOLIC V, 1994, BIOCHEM J, V303, P701, DOI 10.1042/bj3030701; Sun SC, 1996, MOL CELL BIOL, V16, P1058; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Zhai QW, 2003, NEURON, V39, P217, DOI 10.1016/S0896-6273(03)00429-X	25	46	47	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28011	28018		10.1074/jbc.M111.250472	http://dx.doi.org/10.1074/jbc.M111.250472			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685387	Green Published, hybrid			2022-12-25	WOS:000293557800019
J	Chatterjee, TK; Idelman, G; Blanco, V; Blomkalns, AL; Piegore, MG; Weintraub, DS; Kumar, S; Rajsheker, S; Manka, D; Rudich, SM; Tang, YL; Hui, DY; Bassel-Duby, R; Olson, EN; Lingrel, JB; Ho, SM; Weintraub, NL				Chatterjee, Tapan K.; Idelman, Gila; Blanco, Victor; Blomkalns, Andra L.; Piegore, Mark G., Jr.; Weintraub, Daniel S.; Kumar, Santosh; Rajsheker, Srinivas; Manka, David; Rudich, Steven M.; Tang, Yaoliang; Hui, David Y.; Bassel-Duby, Rhonda; Olson, Eric N.; Lingrel, Jerry B.; Ho, Shuk-Mei; Weintraub, Neal L.			Histone Deacetylase 9 Is a Negative Regulator of Adipogenic Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE CELL SIZE; GENE-EXPRESSION; ADIPOCYTE SIZE; VALPROIC ACID; MUSCLE DIFFERENTIATION; INSULIN-RESISTANCE; STEM-CELLS; OBESITY; TISSUE; BINDING	Differentiation of preadipocytes into mature adipocytes capable of efficiently storing lipids is an important regulatory mechanism in obesity. Here, we examined the involvement of histone deacetylases (HDACs) and histone acetyltransferases (HATs) in the regulation of adipogenesis. We find that among the various members of the HDAC and HAT families, only HDAC9 exhibited dramatic down-regulation preceding adipogenic differentiation. Preadipocytes from HDAC9 gene knock-out mice exhibited accelerated adipogenic differentiation, whereas HDAC9 overexpression in 3T3-L1 preadipocytes suppressed adipogenic differentiation, demonstrating its direct role as a negative regulator of adipogenesis. HDAC9 expression was higher in visceral as compared with subcutaneous preadipocytes, negatively correlating with their potential to undergo adipogenic differentiation in vitro. HDAC9 localized in the nucleus, and its negative regulation of adipogenesis segregates with the N-terminal nuclear targeting domain, whereas the C-terminal deacetylase domain is dispensable for this function. HDAC9 co-precipitates with USF1 and is recruited with USF1 at the E-box region of the C/EBP alpha gene promoter in preadipocytes. Upon induction of adipogenic differentiation, HDAC9 is down-regulated, leading to its dissociation from the USF1 complex, whereas p300HATis up-regulated to allow its association with USF1 and accumulation at the E-box site of the C/EBP alpha promoter in differentiated adipocytes. This reciprocal regulation of HDAC9 and p300HAT in the USF1 complex is associated with increased C/EBP alpha expression, a master regulator of adipogenic differentiation. These findings provide new insights into mechanisms of adipogenic differentiation and document a critical regulatory role for HDAC9 in adipogenic differentiation through a deacetylase-independent mechanism.	[Chatterjee, Tapan K.; Idelman, Gila; Piegore, Mark G., Jr.; Weintraub, Daniel S.; Kumar, Santosh; Rajsheker, Srinivas; Manka, David; Tang, Yaoliang; Weintraub, Neal L.] Univ Cincinnati, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA; [Blanco, Victor; Blomkalns, Andra L.] Univ Cincinnati, Dept Emergency Med, Cincinnati, OH 45267 USA; [Rudich, Steven M.] Univ Cincinnati, Dept Surg, Cincinnati, OH 45267 USA; [Ho, Shuk-Mei] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Lingrel, Jerry B.] Univ Cincinnati, Dept Mol Genet Biochem & Mol Biol, Cincinnati, OH 45267 USA; [Hui, David Y.] Univ Cincinnati, Metab Dis Inst, Dept Pathol, Cincinnati, OH 45215 USA; [Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Ho, Shuk-Mei] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH 45220 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Chatterjee, TK (corresponding author), Univ Cincinnati, Dept Internal Med, Div Cardiovasc Dis, Cincinnati, OH 45267 USA.	tapan.chatterjee@uc.edu		Weintraub, Neal/0000-0002-5138-3705; Tang, Yaoliang/0000-0002-8372-1545	National Institutes of Health [HL076684, HL62984, ES019480]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076684, P01HL062984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019480] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL076684, HL62984 (to N. L. W.), and ES019480 (to S. H.)	BROOK CGD, 1973, ARCH DIS CHILD, V48, P301, DOI 10.1136/adc.48.4.301; Brown R, 2008, NEUROENDOCRINOLOGY, V88, P25, DOI 10.1159/000113927; Catalioto RM, 2009, EXP CELL RES, V315, P3267, DOI 10.1016/j.yexcr.2009.09.012; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; Crepaldi L, 2009, EPIGENETICS-US, V4, P23, DOI 10.4161/epi.4.1.7604; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Haberland M, 2010, J BIOL CHEM, V285, P14663, DOI 10.1074/jbc.M109.081679; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Haumaitre C, 2009, CELL CYCLE, V8, P536, DOI 10.4161/cc.8.4.7610; HIRSCH J, 1970, FED PROC, V29, P1516; Jernas M, 2006, FASEB J, V20, P1540, DOI 10.1096/fj.05-5678fje; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Johnsson A, 2009, EMBO REP, V10, P1009, DOI 10.1038/embor.2009.127; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JW, 2007, BIOCHEM BIOPH RES CO, V354, P517, DOI 10.1016/j.bbrc.2007.01.008; KISSEBAH AH, 1982, J CLIN ENDOCR METAB, V54, P254, DOI 10.1210/jcem-54-2-254; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; Lagace DC, 2004, J BIOL CHEM, V279, P18851, DOI 10.1074/jbc.M312795200; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Lundgren M, 2007, DIABETOLOGIA, V50, P625, DOI 10.1007/s00125-006-0572-1; Marini MA, 2007, DIABETES CARE, V30, P2145, DOI 10.2337/dc07-0419; Martin M, 2009, INT J DEV BIOL, V53, P291, DOI 10.1387/ijdb.082698mm; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Monteiro R, 2006, OBES SURG, V16, P804, DOI 10.1381/096089206777346600; Muralidhar SA, 2011, J BIOL CHEM, V286, P2343, DOI 10.1074/jbc.M110.115725; Nebbioso A, 2010, J MOL ENDOCRINOL, V45, P219, DOI 10.1677/JME-10-0043; Petrie K, 2003, J BIOL CHEM, V278, P16059, DOI 10.1074/jbc.M212935200; Qian SW, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-47; Qiao LP, 2006, ENDOCRINOLOGY, V147, P865, DOI 10.1210/en.2005-1030; Rada-Iglesias A, 2008, GENOME RES, V18, P380, DOI 10.1101/gr.6880908; Ross AS, 2008, BIOCHEM BIOPH RES CO, V366, P927, DOI 10.1016/j.bbrc.2007.12.060; Saladi SV, 2010, STEM CELL REV REP, V6, P62, DOI 10.1007/s12015-010-9120-y; SALANS LB, 1968, J CLIN INVEST, V47, P153, DOI 10.1172/JCI105705; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; Smih F, 2002, DIABETES, V51, P293, DOI 10.2337/diabetes.51.2.293; Smith U, 2010, BBA-MOL CELL BIOL L, V1801, P377, DOI 10.1016/j.bbalip.2009.11.006; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Steger DJ, 2010, GENE DEV, V24, P1035, DOI 10.1101/gad.1907110; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Vincent A, 2009, DIFFERENTIATION, V78, P99, DOI 10.1016/j.diff.2009.07.002; Wang D, 1997, J BIOL CHEM, V272, P26367, DOI 10.1074/jbc.272.42.26367; Wang LQ, 2009, NAT REV DRUG DISCOV, V8, P969, DOI 10.1038/nrd3031; Weyer C, 2000, DIABETOLOGIA, V43, P1498, DOI 10.1007/s001250051560; Wong RHF, 2009, CELL, V136, P1056, DOI 10.1016/j.cell.2008.12.040; Wu SL, 2010, HUM MOL GENET, V19, P597, DOI 10.1093/hmg/ddp526; Yoo EJ, 2006, J BIOL CHEM, V281, P6608, DOI 10.1074/jbc.M508982200; Yuan ZG, 2010, J BIOL CHEM, V285, P39329, DOI 10.1074/jbc.M110.179333; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002; Zhang CL, 2001, J BIOL CHEM, V276, P35, DOI 10.1074/jbc.M007364200	49	101	107	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27836	27847		10.1074/jbc.M111.262964	http://dx.doi.org/10.1074/jbc.M111.262964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21680747	Green Published, hybrid			2022-12-25	WOS:000293268700075
J	Tanaka, H; Senda, M; Venugopalan, N; Yamamoto, A; Senda, T; Ishida, T; Horiike, K				Tanaka, Hiroyuki; Senda, Miki; Venugopalan, Nagarajan; Yamamoto, Atsushi; Senda, Toshiya; Ishida, Tetsuo; Horiike, Kihachiro			Crystal Structure of a Zinc-dependent D-Serine Dehydratase from Chicken Kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID OXIDASE; ALANINE RACEMASE; D-ASPARTATE; REACTION SPECIFICITY; THREONINE ALDOLASE; DIFFRACTION DATA; ENZYME; BRAIN; IDENTIFICATION; MECHANISM	D-Serine is a physiological co-agonist of the N-methyl-D-aspartate receptor. It regulates excitatory neurotransmission, which is important for higher brain functions in vertebrates. In mammalian brains, D-amino acid oxidase degrades D-serine. However, we have found recently that in chicken brains the oxidase is not expressed and instead a D-serine dehydratase degrades D-serine. The primary structure of the enzyme shows significant similarities to those of metal-activated D-threonine aldolases, which are fold-type III pyridoxal 5'-phosphate (PLP)-dependent enzymes, suggesting that it is a novel class of D-serine dehydratase. In the present study, we characterized the chicken enzyme biochemically and also by x-ray crystallography. The enzyme activity on D-serine decreased 20-fold by EDTA treatment and recovered nearly completely by the addition of Zn2+. None of the reaction products that would be expected from side reactions of the PLP-D-serine Schiff base were detected during the >6000 catalytic cycles of dehydration, indicating high reaction specificity. We have determined the first crystal structure of the D-serine dehydratase at 1.9 angstrom resolution. In the active site pocket, a zinc ion that coordinates His(347) and Cys(349) is located near the PLP-Lys(45) Schiff base. A theoretical model of the enzyme-D-serine complex suggested that the hydroxyl group of D-serine directly coordinates the zinc ion, and that the epsilon-NH2 group of Lys(45) is a short distance from the substrate C alpha atom. The alpha-proton abstraction from D-serine by Lys(45) and the elimination of the hydroxyl group seem to occur with the assistance of the zinc ion, resulting in the strict reaction specificity.	[Senda, Toshiya] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Tanaka, Hiroyuki; Yamamoto, Atsushi; Ishida, Tetsuo; Horiike, Kihachiro] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Shiga 5202192, Japan; [Senda, Miki] Japan Biol Informat Consortium, JBIC Res Inst, Struct Guided Drug Dev Project, Koto Ku, Tokyo 1350064, Japan; [Venugopalan, Nagarajan] NCI, Collaborat Access Team, Biosci Div, Argonne Natl Lab, Argonne, IL 60439 USA; [Venugopalan, Nagarajan] Natl Inst Gen Med Sci, Argonne, IL 60439 USA	National Institute of Advanced Industrial Science & Technology (AIST); Shiga University of Medical Science; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Argonne National Laboratory; National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS)	Senda, T (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, 2-4-7 Aomi, Tokyo 1350064, Japan.	toshiya-senda@aist.go.jp; teishida@belle.shiga-med.ac.jp		Senda, Toshiya/0000-0002-5153-928X	Ministry of Education, Culture, Sports, Science, and Technology of Japan; New Energy and Industrial Technology Development Organization of Japan; Shiga University of Medical Science	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO)); Shiga University of Medical Science(Shiga University of Medical Science)	This work was supported in part by a grant-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; by the New Energy and Industrial Technology Development Organization of Japan; and by a grant-in-aid (Heisei era 22) from the Shiga University of Medical Science.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Counago RM, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-53; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FEDERIUK CS, 1983, J BIOL CHEM, V258, P5379; Foltyn VN, 2005, J BIOL CHEM, V280, P1754, DOI 10.1074/jbc.M405726200; Goto M, 2009, J BIOL CHEM, V284, P25944, DOI 10.1074/jbc.M109.010470; GRISHIN NV, 1995, PROTEIN SCI, V4, P1291, DOI 10.1002/pro.5560040705; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; HORIIKE K, 1994, BRAIN RES, V652, P297, DOI 10.1016/0006-8993(94)90240-2; Ikushiro H, 2008, J BIOL CHEM, V283, P7542, DOI 10.1074/jbc.M706874200; Ito T, 2008, BIOCHEM J, V409, P399, DOI 10.1042/BJ20070642; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Koutmos M, 2010, P NATL ACAD SCI USA, V107, P20958, DOI 10.1073/pnas.1011448107; Liu JQ, 1998, J BIOL CHEM, V273, P16678, DOI 10.1074/jbc.273.27.16678; MARCEAU M, 1988, J BIOL CHEM, V263, P16926; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAGATA Y, 1994, BRAIN RES, V634, P291, DOI 10.1016/0006-8993(94)91932-1; Oliet SHR, 2009, NEUROSCIENCE, V158, P275, DOI 10.1016/j.neuroscience.2008.01.071; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Paiardini A, 2003, BBA-PROTEINS PROTEOM, V1647, P214, DOI 10.1016/S1570-9639(03)00050-5; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pollegioni L, 2010, CELL MOL LIFE SCI, V67, P2387, DOI 10.1007/s00018-010-0307-9; Schell MJ, 2004, PHILOS T R SOC B, V359, P943, DOI 10.1098/rstb.2003.1399; SCHNACKERZ KD, 1979, BIOCHEMISTRY-US, V18, P3557, DOI 10.1021/bi00583a019; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Senda M, 2011, ACTA CRYSTALLOGR F, V67, P147, DOI 10.1107/S1744309110048438; Stevens RC, 2001, SCIENCE, V294, P89, DOI 10.1126/science.1066011; Tanaka H, 2008, J BIOCHEM, V143, P49, DOI 10.1093/jb/mvm203; Tanaka H, 2007, ANAL BIOCHEM, V362, P83, DOI 10.1016/j.ab.2006.12.025; Toney MD, 2005, ARCH BIOCHEM BIOPHYS, V433, P279, DOI 10.1016/j.abb.2004.09.037; VALLEE BL, 1990, P NATL ACAD SCI USA, V87, P220, DOI 10.1073/pnas.87.1.220; Verrall L, 2010, MOL PSYCHIATR, V15, P122, DOI 10.1038/mp.2009.99; Watanabe A, 2002, J BIOL CHEM, V277, P19166, DOI 10.1074/jbc.M201615200; Wolosker H, 2008, FEBS J, V275, P3514, DOI 10.1111/j.1742-4658.2008.06515.x; Yamada T, 2003, BIOCHEMISTRY-US, V42, P12854, DOI 10.1021/bi035324p	42	19	21	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27548	27558		10.1074/jbc.M110.201160	http://dx.doi.org/10.1074/jbc.M110.201160			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676877	Green Published, hybrid			2022-12-25	WOS:000293268700049
J	Yao, Q; Li, H; Liu, BQ; Huang, XY; Guo, L				Yao, Qi; Li, Hui; Liu, Bing-Qian; Huang, Xin-Yun; Guo, Lin			SUMOylation-regulated Protein Phosphorylation, Evidence from Quantitative Phosphoproteomics Analyses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE-PHOSPHATASE 1B; SUMO; IDENTIFICATION; SITES	Protein modification is critical for the regulation of protein functions. Cross-talks among different types of protein modifications should yield concerted and coordinated regulatory networks for physiological functions. Here we have employed system-wide and quantitative phosphoproteomics analyses to reveal a global cross-talk for SUMOylation-modulated phosphorylation. Furthermore, as specific examples, we have shown that the alpha subunit of casein kinase II is SUMOylated and that this affects the phosphorylation of its substrates. SUMO-regulated phosphorylation is involved in cell cycle control. Our data demonstrate an interplay between protein SUMOylation and phosphorylation and imply a regulatory role for this SUMOylation-modulated phosphorylation.	[Yao, Qi; Li, Hui; Liu, Bing-Qian; Guo, Lin] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China; [Guo, Lin] Wuhan Univ, Minist Educ, Key Lab Analyt Chem Biol & Med, Wuhan 430072, Peoples R China; [Huang, Xin-Yun] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10065 USA	Wuhan University; Wuhan University; Cornell University	Guo, L (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China.	guol@whu.edu.cn			National Basic Research Program of China [2007CB914200]; National Science Foundation of China [31028015, 30921001]; PCSIRT [IRT0745]; 111 Project of China [B06018]	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); PCSIRT(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); 111 Project of China(Ministry of Education, China - 111 Project)	This work was supported by National Basic Research Program of China Grant 2007CB914200, National Science Foundation of China Grants 31028015 and 30921001, PCSIRT Grant IRT0745, and 111 Project of China Grant B06018.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Denison C, 2005, MOL CELL PROTEOMICS, V4, P246, DOI 10.1074/mcp.M400154-MCP200; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Golebiowski F, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000282; Hietakangas V, 2003, MOL CELL BIOL, V23, P2953, DOI 10.1128/MCB.23.8.2953-2968.2003; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Luo PJ, 2010, J CHROMATOGR B, V878, P207, DOI 10.1016/j.jchromb.2009.10.002; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Nie MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005905; Palamarchuk A, 2005, CANCER RES, V65, P11282, DOI 10.1158/0008-5472.CAN-05-3469; Panse VG, 2004, J BIOL CHEM, V279, P41346, DOI 10.1074/jbc.M407950200; Pinna LA, 2002, J CELL SCI, V115, P3873, DOI 10.1242/jcs.00074; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; Wu HJ, 2006, J BIOL CHEM, V281, P21848, DOI 10.1074/jbc.M603772200; Wykoff DD, 2005, MOL CELL PROTEOMICS, V4, P73, DOI 10.1074/mcp.M400166-MCP200; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zhang XD, 2008, MOL CELL, V29, P729, DOI 10.1016/j.molcel.2008.01.013	26	45	46	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27342	27349		10.1074/jbc.M111.220848	http://dx.doi.org/10.1074/jbc.M111.220848			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21685386	hybrid, Green Published			2022-12-25	WOS:000293268700030
J	Chandramohanadas, R; Park, Y; Lui, LN; Li, A; Quinn, D; Liew, K; Diez-Silva, M; Sung, Y; Dao, M; Lim, CT; Preiser, PR; Suresh, S				Chandramohanadas, Rajesh; Park, YongKeun; Lui, Lena; Li, Ang; Quinn, David; Liew, Kingsley; Diez-Silva, Monica; Sung, Yongjin; Dao, Ming; Lim, Chwee Teck; Preiser, Peter Rainer; Suresh, Subra			Biophysics of Malarial Parasite Exit from Infected Erythrocytes	PLOS ONE			English	Article							RED-BLOOD-CELLS; PLASMODIUM-FALCIPARUM; MECHANICAL-PROPERTIES; DIFFRACTION PHASE; HOST ERYTHROCYTE; MEMBRANE; MICROSCOPY; PROTEASES; RELEASE; DEFORMABILITY	Upon infection and development within human erythrocytes, P. falciparum induces alterations to the infected RBC morphology and bio-mechanical properties to eventually rupture the host cells through parasitic and host derived proteases of cysteine and serine families. We used previously reported broad-spectrum inhibitors (E64d, EGTA-AM and chymostatin) to inhibit these proteases and impede rupture to analyze mechanical signatures associated with parasite escape. Treatment of late-stage iRBCs with E64d and EGTA-AM prevented rupture, resulted in no major RBC cytoskeletal reconfiguration but altered schizont morphology followed by dramatic re-distribution of three-dimensional refractive index (3D-RI) within the iRBC. These phenotypes demonstrated several-fold increased iRBC membrane flickering. In contrast, chymostatin treatment showed no 3D-RI changes and caused elevated fluctuations solely within the parasitophorous vacuole. We show that E64d and EGTA-AM supported PV breakdown and the resulting elevated fluctuations followed non-Gaussian pattern that resulted from direct merozoite impingement against the iRBC membrane. Optical trapping experiments highlighted reduced deformability of the iRBC membranes upon rupture-arrest, more specifically in the treatments that facilitated PV breakdown. Taken together, our experiments provide novel mechanistic interpretations on the role of parasitophorous vacuole in maintaining the spherical schizont morphology, the impact of PV breakdown on iRBC membrane fluctuations leading to eventual parasite escape and the evolution of membrane stiffness properties of host cells in which merozoites were irreversibly trapped, recourse to protease inhibitors. These findings provide a comprehensive, previously unavailable, body of information on the combined effects of biochemical and biophysical factors on parasite egress from iRBCs.	[Chandramohanadas, Rajesh; Lui, Lena; Li, Ang; Liew, Kingsley; Suresh, Subra] Singapore MIT Alliance Res & Technol Ctr, Singapore, Singapore; [Park, YongKeun; Sung, Yongjin] MIT, George R Spect Lab, Cambridge, MA 02139 USA; [Quinn, David; Diez-Silva, Monica; Dao, Ming; Suresh, Subra] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Lim, Chwee Teck] Natl Univ Singapore, Singapore 117548, Singapore; [Preiser, Peter Rainer] Nanyang Technol Univ, Singapore, Singapore	Singapore-MIT Alliance for Research & Technology Centre (SMART); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Chandramohanadas, R (corresponding author), Singapore MIT Alliance Res & Technol Ctr, Singapore, Singapore.	mingdao@mit.edu; prpreiser@ntu.edu	Park, YongKeun/B-9017-2009; Dao, Ming/B-1602-2008; Quinn, David/N-3730-2019; Lim, chwee Teck/B-3307-2011; Suresh, Subra/B-8289-2008; Chandramohanadas, Rajesh/GLT-0218-2022; Preiser, Peter R/A-2201-2011	Park, YongKeun/0000-0003-0528-6661; Dao, Ming/0000-0001-5372-385X; Quinn, David/0000-0002-1411-0417; Lim, chwee Teck/0000-0003-4019-9782; Suresh, Subra/0000-0002-6223-6831; Chandramohanadas, Rajesh/0000-0002-8760-0396; , Peter/0000-0003-4331-7000; Sung, Yongjin/0000-0001-6371-8771	Singapore-MIT Alliance for Research and Technology (SMART); Singapore-MIT Alliance; Global Enterprise for Micro-Mechanics and Molecular Medicine Laboratory at the National University of Singapore [GEM4]; National Institutes of Health [R01 HL094270-01A1, 1-R01-GM076689-01, P41-RR02594-18-24]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094270] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076689] Funding Source: NIH RePORTER	Singapore-MIT Alliance for Research and Technology (SMART); Singapore-MIT Alliance; Global Enterprise for Micro-Mechanics and Molecular Medicine Laboratory at the National University of Singapore; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from the Interdisciplinary Research Groups on Infectious Diseases (ID), which is funded by the Singapore-MIT Alliance for Research and Technology (SMART), support from the Advanced Materials for Micro and Nano Systems Programme and the Computational Systems Biology Programme of the Singapore-MIT Alliance and support from Global Enterprise for Micro-Mechanics and Molecular Medicine (GEM4) Laboratory at the National University of Singapore. MD and SS acknowledge support from the National Institutes of Health (Grants R01 HL094270-01A1 and 1-R01-GM076689-01). YKP and YS were also supported by National Institutes of Health (P41-RR02594-18-24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKARIAN M, 2011, BLOOD           0204; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Ch'ng JH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.2; Chandramohanadas R, 2009, SCIENCE, V324, P794, DOI 10.1126/science.1171085; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Cossarizza A., 2001, CURR PROTOC CYTOM, DOI [10.1002/0471142956.cy0914s13, DOI 10.1002/0471142956.CY0914S13]; Crabb BS, 1997, CELL, V89, P287, DOI 10.1016/S0092-8674(00)80207-X; CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007; Dao M, 2006, MAT SCI ENG C-BIO S, V26, P1232, DOI 10.1016/j.msec.2005.08.020; Evans J, 2008, BIOPHYS J, V94, P4134, DOI 10.1529/biophysj.107.117952; Glushakova S, 2005, CURR BIOL, V15, P1645, DOI 10.1016/j.cub.2005.07.067; Glushakova S, 2009, CELL MICROBIOL, V11, P95, DOI 10.1111/j.1462-5822.2008.01242.x; Glushakova S, 2010, CURR BIOL, V20, P1117, DOI 10.1016/j.cub.2010.04.051; Greenbaum DC, 2002, SCIENCE, V298, P2002, DOI 10.1126/science.1077426; KILEJIAN A, 1979, P NATL ACAD SCI USA, V76, P4650, DOI 10.1073/pnas.76.9.4650; Koussis K, 2009, EMBO J, V28, P725, DOI 10.1038/emboj.2009.22; Kyes SA, 2007, EUKARYOT CELL, V6, P1511, DOI 10.1128/EC.00173-07; Li A, 2006, J MICROBIOL METH, V66, P434, DOI 10.1016/j.mimet.2006.01.009; Lin LCL, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2166383; Lingelbach K, 1998, J CELL SCI, V111, P1467; Liu F, 2005, J STRUCT BIOL, V150, P200, DOI 10.1016/j.jsb.2005.02.001; Miller SK, 2002, J BIOL CHEM, V277, P47524, DOI 10.1074/jbc.M206974200; Mills JP, 2007, P NATL ACAD SCI USA, V104, P9213, DOI 10.1073/pnas.0703433104; NASH GB, 1989, BLOOD, V74, P855, DOI 10.1182/blood.V74.2.855.bloodjournal742855; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Park YK, 2006, OPT EXPRESS, V14, P8263, DOI 10.1364/OE.14.008263; Park Y, 2010, P NATL ACAD SCI USA, V107, P6731, DOI 10.1073/pnas.0909533107; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Rohrbach P, 2005, J BIOL CHEM, V280, P27960, DOI 10.1074/jbc.M500777200; Russo I, 2010, NATURE, V463, P632, DOI 10.1038/nature08726; Simeonova E, 2004, PROTOPLASMA, V223, P143, DOI 10.1007/s00709-004-0039-5; Suresh S, 2005, ACTA BIOMATER, V1, P15, DOI 10.1016/j.actbio.2004.09.001; Wickham ME, 2003, J BIOL CHEM, V278, P37658, DOI 10.1074/jbc.M305252200; Wu YM, 2003, GENOME RES, V13, P601, DOI 10.1101/gr.913403; Yeoh S, 2007, CELL, V131, P1072, DOI 10.1016/j.cell.2007.10.049	37	69	71	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20869	10.1371/journal.pone.0020869	http://dx.doi.org/10.1371/journal.pone.0020869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698115	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600023
J	Vanderelst, D; Reijniers, J; Steckel, J; Peremans, H				Vanderelst, Dieter; Reijniers, Jonas; Steckel, Jan; Peremans, Herbert			Information Generated by the Moving Pinnae of Rhinolophus rouxi: Tuning of the Morphology at Different Harmonics	PLOS ONE			English	Article							GREATER HORSESHOE BAT; ECHOLOCATION BEHAVIOR; PTERONOTUS-PARNELLII; SOUND LOCALIZATION; FORAGING BEHAVIOR; SPECTRAL CUES; FERRUMEQUINUM; EAR; DIRECTIONALITY; INSECTS	Bats typically emit multi harmonic calls. Their head morphology shapes the emission and hearing sound fields as a function of frequency. Therefore, the sound fields are markedly different for the various harmonics. As the sound field provides bats with all necessary cues to locate objects in space, different harmonics might provide them with variable amounts of information about the location of objects. Also, the ability to locate objects in different parts of the frontal hemisphere might vary across harmonics. This paper evaluates this hypothesis in R. rouxi, using an information theoretic framework. We estimate the reflector position information transfer in the echolocation system of R. rouxi as a function of frequency. This analysis shows that localization performance reaches a global minimum and a global maximum at the two most energetic frequency components of R. rouxis' call indicating tuning of morphology and harmonic structure. Using the fundamental the bat is able to locate objects in a large portion of the frontal hemisphere. In contrast, using the 1(st) overtone, it can only locate objects, albeit with a slightly higher accuracy, in a small portion of the frontal hemisphere by reducing sensitivity to echoes from outside this region of interest. Hence, different harmonic components provide the bat either with a wide view or a focused view of its environment. We propose these findings can be interpreted in the context of the foraging behaviour of R. rouxi, i.e., hunting in cluttered environments. Indeed, the focused view provided by the 1(st) overtone suggests that at this frequency its morphology is tuned for clutter rejection and accurate localization in a small region of interest while the finding that overall localization performance is best at the fundamental indicates that the morphology is simultaneously tuned to optimize overall localization performance at this frequency.	[Vanderelst, Dieter; Steckel, Jan; Peremans, Herbert] Univ Antwerp, Dept MTT FTEW, Act Percept Lab, B-2020 Antwerp, Belgium; [Reijniers, Jonas] Univ Antwerp, Dept Biol, B-2020 Antwerp, Belgium	University of Antwerp; University of Antwerp	Vanderelst, D (corresponding author), Univ Antwerp, Dept MTT FTEW, Act Percept Lab, B-2020 Antwerp, Belgium.	dieter.vanderelst@ua.ac.be		Steckel, Jan/0000-0003-4489-466X	EU [FP7-ICT-2007-1, 215370]	EU(European Commission)	This work was funded by EU project ChiRoPing (FP7-ICT-2007-1 STREP project 215370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTES RA, 1978, J ACOUST SOC AM, V63, P155, DOI 10.1121/1.381707; Aytekin M, 2004, J ACOUST SOC AM, V116, P3594, DOI 10.1121/1.1811412; Bass HE, 1996, J ACOUST SOC AM, V99, P1259, DOI 10.1121/1.415223; BASS HE, 1995, J ACOUST SOC AM, V97, P680, DOI 10.1121/1.412989; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; BRAINARD MS, 1992, J ACOUST SOC AM, V91, P1015, DOI 10.1121/1.402627; Chiu C, 2007, J ACOUST SOC AM, V121, P2227, DOI 10.1121/1.2434760; De Mey F, 2008, J ACOUST SOC AM, V124, P2123, DOI 10.1121/1.2968703; ECKRICH M, 1988, J ZOOL, V215, P729, DOI 10.1111/j.1469-7998.1988.tb02407.x; FENG J, 2002, PROGR NATURAL SCI, V12, P9; Firzlaff U, 2004, HEARING RES, V197, P74, DOI 10.1016/j.heares.2004.06.009; FITZPATRICK DC, 1991, J NEUROPHYSIOL, V66, P1951, DOI 10.1152/jn.1991.66.6.1951; Fuzessery ZM, 1996, HEARING RES, V95, P1, DOI 10.1016/0378-5955(95)00223-5; Grace SM, 2008, ACTA ACUST UNITED AC, V94, P310, DOI 10.3813/AAA.918034; Greif S, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1110; GRIFFIN DR, 1962, NATURE, V196, P1185, DOI 10.1038/1961185a0; GRINNELL AD, 1977, J COMP PHYSIOL, V116, P63, DOI 10.1007/BF00605517; Jin LR, 2005, CHINESE SCI BULL, V50, P1477, DOI 10.1360/982004-831; Jones G, 1996, SYM ZOOL S, P111; JONES G, 1989, BEHAV ECOL SOCIOBIOL, V25, P183, DOI 10.1007/BF00302917; JUHL P, HENRIQUEZ 5 USING RE; KOBER R, 1990, J ACOUST SOC AM, V87, P882, DOI 10.1121/1.398898; KOSSL M, 1994, HEARING RES, V72, P59, DOI 10.1016/0378-5955(94)90206-2; Leopardi P, 2006, ELECTRON T NUMER ANA, V25, P309; LONG GR, 1975, J COMP PHYSIOL, V100, P211, DOI 10.1007/BF00614531; MOGDANS J, 1988, J ACOUST SOC AM, V84, P1676, DOI 10.1121/1.397183; NEUWEILER G, 1987, BEHAV ECOL SOCIOBIOL, V20, P53, DOI 10.1007/BF00292166; NOSOFSKY RM, 1991, J EXP PSYCHOL HUMAN, V17, P3, DOI 10.1037/0096-1523.17.1.3; OBRIST MK, 1993, J EXP BIOL, V180, P119; Otani M., 2003, Acoustical Science and Technology, V24, P259, DOI 10.1250/ast.24.259; Otani M, 2006, J ACOUST SOC AM, V119, P2589, DOI 10.1121/1.2191608; PIERCE AD, 1989, ACOUSTICS INTRO PHYS; PIETSCH G, 1987, J COMP PHYSIOL A, V160, P635, DOI 10.1007/BF00611936; PYE J, 1962, NATURE, V10; PYE JD, 1961, ENDEAVOUR, V20, P101; PYE JD, 1970, NATURE, V225, P285, DOI 10.1038/225285a0; REIJNIERS J, 2009, BIOL CYBERN, P1; Reijniers J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.148701; REIMER K, 1991, J COMP PHYSIOL A, V169, P719; Schneider H, 1960, J COMP PHYSIOL A, V44, P1; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; SCHNITZLER HU, 1985, J COMP PHYSIOL A, V157, P39, DOI 10.1007/BF00611093; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; Surlykke A, 2000, J ACOUST SOC AM, V108, P2419, DOI 10.1121/1.1315295; Vanderelst D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011893; VONDEREMDE G, 1989, J COMP PHYSIOL A, V164, P663, DOI 10.1007/BF00614509; WALKER A, 1997, THESIS U EDINBURGH; Wotton JM, 1997, J ACOUST SOC AM, V101, P1723, DOI 10.1121/1.418271; Young ED, 1996, J ACOUST SOC AM, V99, P3064, DOI 10.1121/1.414883; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000429; Zhuang Q, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218701	51	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20627	10.1371/journal.pone.0020627	http://dx.doi.org/10.1371/journal.pone.0020627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698094	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600012
J	Wille, M; Robertson, GJ; Whitney, H; Bishop, MA; Runstadler, JA; Lang, AS				Wille, Michelle; Robertson, Gregory J.; Whitney, Hugh; Bishop, Mary Anne; Runstadler, Jonathan A.; Lang, Andrew S.			Extensive Geographic Mosaicism in Avian Influenza Viruses from Gulls in the Northern Hemisphere	PLOS ONE			English	Article							A VIRUSES; HEMAGGLUTININ SUBTYPE; MIGRATORY BIRDS; WILD BIRDS; PCR; ALASKA; GENE; CHARADRIIFORMES; AMPLIFICATION; TRANSMISSION	Due to limited interaction of migratory birds between Eurasia and America, two independent avian influenza virus (AIV) gene pools have evolved. There is evidence of low frequency reassortment between these regions, which has major implications in global AIV dynamics. Indeed, all currently circulating lineages of the PB1 and PA segments in North America are of Eurasian origin. Large-scale analyses of intercontinental reassortment have shown that viruses isolated from Charadriiformes (gulls, terns, and shorebirds) are the major contributor of these outsider events. To clarify the role of gulls in AIV dynamics, specifically in movement of genes between geographic regions, we have sequenced six gull AIV isolated in Alaska and analyzed these along with 142 other available gull virus sequences. Basic investigations of host species and the locations and times of isolation reveal biases in the available sequence information. Despite these biases, our analyses reveal a high frequency of geographic reassortment in gull viruses isolated in America. This intercontinental gene mixing is not found in the viruses isolated from gulls in Eurasia. This study demonstrates that gulls are important as vectors for geographically reassorted viruses, particularly in America, and that more surveillance effort should be placed on this group of birds.	[Wille, Michelle; Lang, Andrew S.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Robertson, Gregory J.] Environm Canada, Wildlife Res Div, Mt Pearl, NF, Canada; [Whitney, Hugh] Dept Nat Resources, Div Anim Hlth, St John, NF, Canada; [Bishop, Mary Anne] Prince William Sound Sci Ctr, Cordova, AK USA; [Runstadler, Jonathan A.] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK USA	Memorial University Newfoundland; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; Natural Resources Canada; University of Alaska System; University of Alaska Fairbanks	Wille, M (corresponding author), Mem Univ Newfoundland, Dept Biol, St John, NF, Canada.	aslang@mun.ca	Wille, Michelle/F-4819-2013; Robertson, Greg/AAI-5849-2020	Wille, Michelle/0000-0002-5629-0196; Robertson, Greg/0000-0001-8452-5506; Lang, Andrew/0000-0002-4510-7683	National Institutes of Health, National Institute of Allergy and Infectious Diseases [HHSN266200700010C]; Newfoundland and Labrador Department of Natural Resources; Environment Canada; Natural Sciences and Engineering Research Council (NSERC); Memorial University; Department of Indian and Northern Affairs; Canada Foundation for Innovation; Government of Newfoundland and Labrador	National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Newfoundland and Labrador Department of Natural Resources; Environment Canada(CGIAR); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Memorial University; Department of Indian and Northern Affairs; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Government of Newfoundland and Labrador	Support for this work was received from National Institutes of Health (www.nih.gov/) National Institute of Allergy and Infectious Diseases contract number HHSN266200700010C for the Center for Research in Influenza Pathogenesis, the Newfoundland and Labrador Department of Natural Resources (www.nr.gov.nl.ca/nr/), and the Strategic Technology Applications of Genomics in the Environment program at Environment Canada (www.ec.gc.ca/scitech/default.asp?lang=En&n=BA7C049C-1). MW was supported by a CGS-M fellowship from the Natural Sciences and Engineering Research Council (NSERC) (www.nserc-crsng.gc.ca/Index_eng.asp), a merit fellowship from Memorial University (www.mun.ca/), a Michael Smith Foreign Student Supplement (NSERC), and a Northern Scientific Training Program grant from the Department of Indian and Northern Affairs (www.ainc-inac.gc.ca/nth/st/nstp/index-eng.asp). Research in ASL's lab is supported by grants from NSERC, the Canada Foundation for Innovation (www.innovation.ca/en), and the Industrial Research and Innovation Fund (www.researchnl.com/funding/academia.htm) from the Government of Newfoundland and Labrador. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahl J, 2009, VIROLOGY, V390, P289, DOI 10.1016/j.virol.2009.05.002; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; BECKER WB, 1966, J HYG-CAMB, V64, P309, DOI 10.1017/S0022172400040596; Bragstad K, 2005, VIRUS RES, V109, P181, DOI 10.1016/j.virusres.2004.12.004; Chan CH, 2006, J VIROL METHODS, V136, P38, DOI 10.1016/j.jviromet.2006.03.027; Chen RB, 2010, J MOL EVOL, V70, P98, DOI 10.1007/s00239-009-9312-8; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; Crawford PC, 2005, SCIENCE, V310, P482, DOI 10.1126/science.1117950; Dohna HZ, 2009, EMERG INFECT DIS, V15, P1040, DOI 10.3201/eid1507.090245; Dugan VG, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000076; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fusaro A, 2010, ARCH VIROL, V155, P77, DOI 10.1007/s00705-009-0550-2; GILLMOR R, 1998, BIRDS W PALEARCTIC C, V1; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; HINSHAW VS, 1982, J VIROL, V42, P865, DOI 10.1128/JVI.42.3.865-872.1982; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kawaoka Y., 2005, 8 INT COMM TAX VIR, P681; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Kou Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006926; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Kuiken T, 2004, SCIENCE, V306, P241, DOI 10.1126/science.1102287; Lebarbenchon C, 2009, J MOL GENET MED, V3, P121, DOI DOI 10.4172/1747-0862.1000023; Liu JH, 2004, VIRUS GENES, V29, P81, DOI 10.1023/B:VIRU.0000032791.26573.f1; Matrosovich Mikhail N., 2008, V27, P134; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Olsen KM, 2004, GULLS EUROPE ASIA N, P609; Parmley J, 2009, INTEGR ZOOL, V4, P409, DOI 10.1111/j.1749-4877.2009.00177.x; Pasick J, 2010, AVIAN DIS, V54, P440, DOI 10.1637/8800-040109-Reg.1; Pawar S, 2010, VIRUS GENES, V41, P14, DOI 10.1007/s11262-010-0487-2; Pearce JM, 2010, VIRUS RES, V148, P44, DOI 10.1016/j.virusres.2009.12.002; Phipps LP, 2004, J VIROL METHODS, V122, P119, DOI 10.1016/j.jviromet.2004.08.008; Pons JM, 2005, MOL PHYLOGENET EVOL, V37, P686, DOI 10.1016/j.ympev.2005.05.011; Qiu BF, 2009, J VIROL METHODS, V155, P193, DOI 10.1016/j.jviromet.2008.10.001; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Ramey AM, 2010, VIROLOGY, V406, P352, DOI 10.1016/j.virol.2010.07.031; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; ROSLAYA IG, 1984, VOP VIRUSOL+, P155; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salomon R, 2009, CELL, V136, P402, DOI 10.1016/j.cell.2009.01.029; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Velarde R, 2010, AVIAN DIS, V54, P411, DOI 10.1637/8808-040109-Reg.1; Wallensten A, 2005, ARCH VIROL, V150, P1685, DOI 10.1007/s00705-005-0543-8; Wang GH, 2008, J GEN VIROL, V89, P697, DOI 10.1099/vir.0.83419-0; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Widjaja L, 2004, J VIROL, V78, P8771, DOI 10.1128/JVI.78.16.8771-8779.2004; Winker K, 2010, AVIAN DIS, V54, P477, DOI 10.1637/8741-032509-Reg.1; Yamnikova S. S., 2009, Voprosy Virusologii, V54, P10; Yamnikova SS, 2003, AVIAN DIS, V47, P1164, DOI 10.1637/0005-2086-47.s3.1164; YAMNIKOVA SS, 1989, VOP VIRUSOL+, P568; YAMNIKOVA SS, 1989, VOP VIRUSOL+, P426; ZOU S, 1999, J CLIN MICROBIOL, V35, P2623	59	55	57	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20664	10.1371/journal.pone.0020664	http://dx.doi.org/10.1371/journal.pone.0020664			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21697989	Green Published, gold, Green Accepted			2022-12-25	WOS:000291730000018
J	He, XB; Nair, A; Mekasha, S; Alroy, J; O'Connell, CM; Ingalls, RR				He, Xianbao; Nair, Anjali; Mekasha, Samrawit; Alroy, Joseph; O'Connell, Catherine M.; Ingalls, Robin R.			Enhanced Virulence of Chlamydia muridarum Respiratory Infections in the Absence of TLR2 Activation	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-4; OBLIGATE INTRACELLULAR PATHOGEN; GENITAL-TRACT INFECTION; PASTEURELLA-PNEUMOTROPICA; TRACHOMATIS PNEUMONIA; MOUSE PNEUMONITIS; CYTOKINE RESPONSE; IN-VIVO; MICE; PATHOLOGY	Chlamydia trachomatis is a common sexually transmitted pathogen and is associated with infant pneumonia. Data from the female mouse model of genital tract chlamydia infection suggests a requirement for TLR2-dependent signaling in the induction of inflammation and oviduct pathology. We hypothesized that the role of TLR2 in moderating mucosal inflammation is site specific. In order to investigate this, we infected mice via the intranasal route with C. muridarum and observed that in the absence of TLR2 activation, mice had more severe disease, higher lung cytokine levels, and an exaggerated influx of neutrophils and T-cells into the lungs. This could not be explained by impaired bacterial clearance as TLR2-deficient mice cleared the infection similar to controls. These data suggest that TLR2 has an anti-inflammatory function in the lung during Chlamydia infection, and that the role of TLR2 in mucosal inflammation varies at different mucosal surfaces.	[He, Xianbao; Nair, Anjali; Mekasha, Samrawit; Ingalls, Robin R.] Boston Univ, Sch Med, Boston Med Ctr, Infect Dis Sect, Boston, MA 02118 USA; [Alroy, Joseph] Tufts Univ, Sch Med, Dept Pathol, Cummings Sch Vet Med, Boston, MA 02111 USA; [Alroy, Joseph] Tufts Med Ctr, Boston, MA USA; [O'Connell, Catherine M.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA	Boston Medical Center; Boston University; Tufts University; Tufts Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	He, XB (corresponding author), Boston Univ, Sch Med, Boston Med Ctr, Infect Dis Sect, Boston, MA 02118 USA.	ringalls@bu.edu	He, Xianbao/AAE-4838-2019	He, Xianbao/0000-0003-2448-8437; Ingalls, Robin/0000-0003-2197-7198; O'Connell, Catherine/0000-0002-8229-684X	National Institutes of Health [R01 AI064749, R21 AI083657]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083657, R01AI064749] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health grant R01 AI064749 to RRI, and R21 AI083657 to COC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai H, 2009, J IMMUNOL, V183, P5886, DOI 10.4049/jimmunol.0901584; BARRON AL, 1981, J INFECT DIS, V143, P63, DOI 10.1093/infdis/143.1.63; Bas S, 2008, J IMMUNOL, V180, P1158, DOI 10.4049/jimmunol.180.2.1158; BRADE L, 1986, INFECT IMMUN, V54, P568, DOI 10.1128/IAI.54.2.568-574.1986; Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004; Chapes SK, 2001, J LEUKOCYTE BIOL, V69, P381; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; COALSON JJ, 1987, BRIT J EXP PATHOL, V68, P399; COX G, 1995, AM J RESP CELL MOL, V12, P232, DOI 10.1165/ajrcmb.12.2.7865221; Darville T, 2003, J IMMUNOL, V171, P6187, DOI 10.4049/jimmunol.171.11.6187; Darville T, 1997, INFECT IMMUN, V65, P3065, DOI 10.1128/IAI.65.8.3065-3073.1997; DELAMAZA LM, 1994, INFECT IMMUN, V62, P2094, DOI 10.1128/IAI.62.5.2094-2097.1994; Derbigny WA, 2005, J IMMUNOL, V175, P6065, DOI 10.4049/jimmunol.175.9.6065; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; HAMMERSCHLAG MR, 1982, PEDIATR INFECT DIS J, V1, P395, DOI 10.1097/00006454-198211000-00007; Hart ML, 2003, INFECT IMMUN, V71, P663, DOI 10.1128/IAI.71.2.663-670.2003; Heine H, 2003, EUR J BIOCHEM, V270, P440, DOI 10.1046/j.1432-1033.2003.03392.x; INGALLS RR, 1995, INFECT IMMUN, V63, P3125, DOI 10.1128/IAI.63.8.3125-3130.1995; Love W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010739; Mueller M, 2004, IMMUNOBIOLOGY, V209, P599, DOI 10.1016/j.imbio.2004.08.003; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; O'Connell CM, 2007, J IMMUNOL, V179, P4027, DOI 10.4049/jimmunol.179.6.4027; O'Connell CM, 2006, J BIOL CHEM, V281, P1652, DOI 10.1074/jbc.M510182200; OCONNELL CM, 2011, INFECT IMMUN; Ossewaarde JM, 1996, APPL ENVIRON MICROB, V62, P328, DOI 10.1128/AEM.62.2.328-331.1996; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Russell M, 2011, INFECT IMMUN, V79, P98, DOI 10.1128/IAI.01105-10; SCHACHTER J, 1986, JAMA-J AM MED ASSOC, V255, P3374, DOI 10.1001/jama.255.24.3374; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Wang XR, 2002, J IMMUNOL, V168, P810, DOI 10.4049/jimmunol.168.2.810; WILLIAMS DM, 1993, INFECT IMMUN, V61, P3556, DOI 10.1128/IAI.61.8.3556-3558.1993; World Health Organization, 2001, GLOB PREV INC SEL CU; Zhang XY, 2009, J IMMUNOL, V183, P1291, DOI 10.4049/jimmunol.0803075; Zhou XH, 2009, INFECT IMMUN, V77, P5059, DOI 10.1128/IAI.00403-09	37	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20846	10.1371/journal.pone.0020846	http://dx.doi.org/10.1371/journal.pone.0020846			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695078	Green Submitted, gold, Green Published			2022-12-25	WOS:000291682300015
J	Sippel, T; Holdsworth, J; Dennis, T; Montgomery, J				Sippel, Tim; Holdsworth, John; Dennis, Todd; Montgomery, John			Investigating Behaviour and Population Dynamics of Striped Marlin (Kajikia audax) from the Southwest Pacific Ocean with Satellite Tags	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; AREA-RESTRICTED SEARCH; PELAGIC LONGLINE GEAR; STATE-SPACE MODEL; TETRAPTURUS-AUDAX; RECREATIONAL FISHERY; ARCHIVAL TAGS; BILLFISHES XIPHIOIDEI; POSTRELEASE SURVIVAL; HORIZONTAL MOVEMENTS	Behaviour and distribution of striped marlin within the southwest Pacific Ocean were investigated using electronic tagging data collected from 2005-2008. A continuous-time correlated random-walk Kalman filter was used to integrate double-tagging data exhibiting variable error structures into movement trajectories composed of regular time-steps. This state-space trajectory integration approach improved longitude and latitude error distributions by 38.5 km and 22.2 km respectively. Using these trajectories as inputs, a behavioural classification model was developed to infer when, and where, 'transiting' and 'area-restricted' (ARB) pseudo-behavioural states occurred. ARB tended to occur at shallower depths (108 +/- 49 m) than did transiting behaviours (127 +/- 57 m). A 16 day post-release period of diminished ARB activity suggests that patterns of behaviour were affected by the capture and/or tagging events, implying that tagged animals may exhibit atypical behaviour upon release. The striped marlin in this study dove deeper and spent greater time at >= 200 m depth than those in the central and eastern Pacific Ocean. As marlin reached tropical latitudes (20-21 degrees S) they consistently reversed directions, increased swimming speed and shifted to transiting behaviour. Reversals in the tropics also coincided with increases in swimming depth, including increased time >= 250 m. Our research provides enhanced understanding of the behavioural ecology of striped marlin. This has implications for the effectiveness of spatially explicit population models and we demonstrate the need to consider geographic variation when standardizing CPUE by depth, and provide data to inform natural and recreational fishing mortality parameters.	[Sippel, Tim; Dennis, Todd; Montgomery, John] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand; [Sippel, Tim; Holdsworth, John] Blue Water Marine Res, Whangarei, New Zealand	University of Auckland	Sippel, T (corresponding author), Univ Hawaii, Pelag Fisheries Res Program, Honolulu, HI 96822 USA.	tsippel@gmail.com	Montgomery, John C/D-4310-2009	Montgomery, John C/0000-0002-7451-3541	New Zealand Marine Research Foundation; University of Auckland; Blue Water Marine Research; National Geographic Society	New Zealand Marine Research Foundation; University of Auckland; Blue Water Marine Research; National Geographic Society(National Geographic Society)	This research was funded primarily by the New Zealand Marine Research Foundation, with contributions from the University of Auckland, Tagging of Pacific Pelagics Program (a subprogram of the Census of Marine Life), Blue Water Marine Research and the National Geographic Society. TS was financially supported by a University of Auckland Doctoral Scholarship and Blue Water Marine Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abitia Leonardo A., 1998, Revista de Biologia Marina y Oceanografia, V33, P277; Abitia-Cardenas LA, 2002, FISH RES, V57, P287, DOI 10.1016/S0165-7836(01)00350-2; AbitiaCardenas LA, 1997, FISH B-NOAA, V95, P360; [Anonymous], R LANG ENV STAT COMP; Bailey H, 2008, J EXP MAR BIOL ECOL, V356, P128, DOI 10.1016/j.jembe.2007.12.020; BAKER AN, 1966, COPEIA, P818, DOI 10.2307/1441409; Benhamou S, 2004, J THEOR BIOL, V229, P209, DOI 10.1016/j.jtbi.2004.03.016; Bertignac M, 1998, FISH OCEANOGR, V7, P326, DOI 10.1046/j.1365-2419.1998.00065.x; Bestley S, 2008, J ANIM ECOL, V77, P1223, DOI 10.1111/j.1365-2656.2008.01437.x; BOGGS CH, 1992, FISH B-NOAA, V90, P642; Brill RW, 1996, COMP BIOCHEM PHYS A, V113, P3, DOI 10.1016/0300-9629(95)02064-0; BRILL RW, 1993, MAR BIOL, V117, P567, DOI 10.1007/BF00349767; Brillinger DR, 1998, CAN J STAT, V26, P431, DOI 10.2307/3315767; Bromhead D., 2004, STRIPED MARLIN BIOL; Collette BB, 2006, B MAR SCI, V79, P455; Domeier ML, 2006, B MAR SCI, V79, P811; Domeier ML, 2003, MAR FRESHWATER RES, V54, P435, DOI 10.1071/MF01270; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Furrer R., 2010, FIELDS TOOLS SPATIAL; Graves JE, 2002, FISH B-NOAA, V100, P134; Gunn JS, 2003, MAR FRESHWATER RES, V54, P515, DOI 10.1071/MF03022; HAMPTON J, 1986, AUST J MAR FRESH RES, V37, P699; HANAMOTO E, 1977, B JPN SOC SCI FISH, V43, P649; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; HILL RD, 1994, POPULATION ECOLOGY B, P227; Holdsworth JC, 2009, MAR BIOL, V156, P505, DOI 10.1007/s00227-008-1104-y; HOLTS D, 1989, MAR REC FISH, V13, P81; Horodysky AZ, 2005, FISH B-NOAA, V103, P84; JOHNSON D, 2008, CRAWL FIT CONTINUOUS; Johnson DS, 2008, ECOLOGY, V89, P1208, DOI 10.1890/07-1032.1; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kerstetter DW, 2006, FISH B-NOAA, V104, P434; Kerstetter DW, 2004, FISH B-NOAA, V102, P750; Kerstetter DW, 2003, FISH B-NOAA, V101, P939; Kitchell JF, 2006, B MAR SCI, V79, P669; Kopf RK, 2005, NEW ZEAL J MAR FRESH, V39, P1145, DOI 10.1080/00288330.2005.9517381; Lam CH, 2008, FISH RES, V91, P15, DOI 10.1016/j.fishres.2007.11.002; LANGLEY A, 2006, SC2SAWP6 WCPFC, P7; Longhurst A. R., 2006, ECOLOGICAL GEOGRAPHY; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Musyl M, 2001, ELECT TAGGING TRACKI, P343, DOI [10.1007/978-94-017-1402-0_19, DOI 10.3354/MEPS09899]; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; NIELSEN A, 2009, UKFSST KALMAN FILTER; Nielsen A, 2007, CAN J FISH AQUAT SCI, V64, P1055, DOI 10.1139/F07-064; Ortiz M, 2003, MAR FRESHWATER RES, V54, P489, DOI 10.1071/MF02028; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; Poisson F, 2010, FISH B-NOAA, V108, P268; Prince ED, 2006, FISH OCEANOGR, V15, P451, DOI 10.1111/j.1365-2419.2005.00393.x; Schick RS, 2008, ECOL LETT, V11, P1338, DOI 10.1111/j.1461-0248.2008.01249.x; Sherrill-Mix Scott A., 2008, Endangered Species Research, V4, P187, DOI 10.3354/esr00070; Shimose T, 2010, J FISH BIOL, V76, P2418, DOI 10.1111/j.1095-8649.2010.02628.x; Sibert JR, 2003, FISH OCEANOGR, V12, P141, DOI 10.1046/j.1365-2419.2003.00228.x; SIBERT JR, 2009, REMOVING BIAS LATITU, P311; Sippel TJ, 2007, FISH OCEANOGR, V16, P459, DOI 10.1111/j.1365-2419.2007.00446.x; Skomal GB, 2007, FISHERIES MANAG ECOL, V14, P81, DOI 10.1111/j.1365-2400.2007.00528.x; SQUIRE JL, 1987, US NMFS MAR FISH REV, V49, P26; SQUIRE JL, 1988, P 2 INT BILLF S KAIL, P67; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Therneau T, 2009, SURVIVAL SURVIVAL AN; Tremblay Y, 2007, J EXP BIOL, V210, P935, DOI 10.1242/jeb.02710; TURCHIN P, 1991, ECOLOGY, V72, P1253, DOI 10.2307/1941099; UEYANAGI S, 1959, 11 NANK REG FISH RES, P130; Uozumi Y, 2003, MAR FRESHWATER RES, V54, P555, DOI 10.1071/MF01251; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Wegner NC, 2006, B MAR SCI, V79, P747; WELLS RMG, 1986, COMP BIOCHEM PHYS A, V84, P565, DOI 10.1016/0300-9629(86)90366-X; Wilson SG, 2007, FISH OCEANOGR, V16, P547, DOI 10.1111/j.1365-2419.2007.00450.x	70	30	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21087	10.1371/journal.pone.0021087	http://dx.doi.org/10.1371/journal.pone.0021087			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695132	Green Published, gold, Green Submitted			2022-12-25	WOS:000291682300029
J	Molinaro, S; Siciliano, V; Curzio, O; Denoth, F; Salvadori, S; Mariani, F				Molinaro, Sabrina; Siciliano, Valeria; Curzio, Olivia; Denoth, Francesca; Salvadori, Stefano; Mariani, Fabio			Illegal Substance Use among Italian High School Students: Trends over 11 Years (1999-2009)	PLOS ONE			English	Article							6 EUROPEAN COUNTRIES; DRUG-USE; COCAINE USE; ADOLESCENTS; SWITZERLAND; PREVALENCE; TRUANCY; HEALTH	Purpose: To monitor changes in habits in drug use among Italian high school students. Methods: Cross-sectional European School Survey Project on Alcohol and Other Drugs (ESPAD) carried out in Italy annually for 11 years (1999-2009) with representative samples of youth attending high school. The sample size considered ranges from 15,752 to 41,365 students and response rate ranged from 85.5% to 98.6%. Data were analyzed to obtain measures of life-time prevalence (LT), use in the last year (LY), use in the last 30 days (LM), frequent use. Comparisons utilized difference in proportion tests. Tests for linear trends in proportion were performed using the Royston p trend test. Results: When the time-averaged value was considered, cannabis (30% LT) was the most, and heroin the least (2%) frequently used, with cocaine (5%), hallucinogens (2%) and stimulants (2%) in between. A clear gender gap is evident for all drugs, more obvious for hallucinogens (average M/F LY prevalence ratio 2, range 1.7-2.4, p<0.05), less for cannabis (average M/F LY prevalence ratio 1.3, range 1.2-1.5, p<0.05). Data shows a change in trend between 2005 and 2008; in 2006 the trend for cannabis use and availability dropped and the price rose, while from 2005 cocaine and stimulant use prevalence showed a substantial increase and the price went down. After 2008 use of all substances seems to have decreased. Conclusions: Drug use is widespread among students in Italy, with cannabis being the most and heroin the least prevalent. Girls are less vulnerable than boys to illegal drug use. In recent years, a decrease in heroin use is overbalanced by a marked rise in hallucinogen and stimulant use.	[Molinaro, Sabrina; Siciliano, Valeria; Curzio, Olivia; Denoth, Francesca; Salvadori, Stefano; Mariani, Fabio] CNR, Inst Clin Physiol, Pisa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR)	Molinaro, S (corresponding author), CNR, Inst Clin Physiol, Pisa, Italy.	molinaro@ifc.cnr.it	Molinaro, Sabrina/F-5828-2012; SALVADORI, STEFANO/AAL-3217-2021; Curzio, Olivia/T-2078-2019; Molinaro, Sabrina/B-3710-2013	Molinaro, Sabrina/0000-0001-7221-0873; SALVADORI, STEFANO/0000-0002-1266-3931; Curzio, Olivia/0000-0003-0784-302X; Molinaro, Sabrina/0000-0002-1140-0312	Italian Ministry of Welfare; Italian Ministry of Interior; Italian Ministry of Education and Research; Italian Presidenza del Consiglio dei Ministri	Italian Ministry of Welfare; Italian Ministry of Interior; Italian Ministry of Education and Research(Ministry of Education, Universities and Research (MIUR)); Italian Presidenza del Consiglio dei Ministri	Over the years 1999-2009, the study was supported by the Italian Ministry of Welfare (www.lavoro.gov.it/Lavoro), the Italian Ministry of Interior (www.interno.it/mininterno/export/sites/default/it/), the Italian Ministry of Education and Research (www.istruzione.it/web/hub) and the Italian Presidenza del Consiglio dei Ministri (www.governo.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assanangkornchai S, 2007, DRUG ALCOHOL DEPEN, V86, P167, DOI 10.1016/j.drugalcdep.2006.06.001; Bauman A, 1999, DRUG ALCOHOL DEPEN, V55, P187, DOI 10.1016/S0376-8716(99)00016-2; Beauvais F, 2004, J ADOLESCENT HEALTH, V34, P493, DOI 10.1016/S1054-139X(03)00340-9; Chen WJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-27; Chiou WB, 2007, CYBERPSYCHOL BEHAV, V10, P663, DOI 10.1089/cpb.2007.9972; Chou LC, 2006, ADDICT BEHAV, V31, P149, DOI 10.1016/j.addbeh.2005.04.011; Csemy L, 2002, EUR ADDICT RES, V8, P159, DOI 10.1159/000066134; De Preux E, 2004, SWISS MED WKLY, V134, P313; Doubeni CA, 2009, AM J PREV MED, V36, P239, DOI 10.1016/j.amepre.2008.11.006; *DPA, 2009, REL ANN PARL STAT TO; *EMCDDA, 2009, ANN REP STAT DRUGS P; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2005, DIFF PATT DRUG US WO; Haasen C, 2004, EUR ADDICT RES, V10, P139, DOI 10.1159/000079834; Harrison L, 1997, NIDA Res Monogr, V167, P17; Hibell B, 2004, ESPAD REPORT 2003 AL; Hibell B., 2009, 2007 ESPAD REPORT SU, P1; JOHNSON CA, 1990, J CONSULT CLIN PSYCH, V58, P445; Johnston L., 2009, MONITORING FUTURE NA, VI; Kokkevi A, 2007, DRUG ALCOHOL DEPEN, V86, P67, DOI 10.1016/j.drugalcdep.2006.05.018; Kokkevi AE, 2007, DRUG ALCOHOL DEPEN, V88, P308, DOI 10.1016/j.drugalcdep.2006.10.004; Korf DJ, 2002, ADDICT BEHAV, V27, P851, DOI 10.1016/S0306-4603(02)00291-5; Michaud P, 2006, SWISS MED WKLY, V136, P318; Miller P, 1999, ALCOHOL ALCOHOLISM, V34, P886, DOI 10.1093/alcalc/34.6.886; NARRING F, 1995, SOZ PRAVENTIV MED, V40, P172, DOI 10.1007/BF01318638; Sells CW, 1996, AM J PUBLIC HEALTH, V86, P513, DOI 10.2105/AJPH.86.4.513; Tobler N.S., 2000, J PRIM PREV, V20, P275, DOI [DOI 10.1023/A:1021314704811, 10.1023/A:1021314704811]; Turnbull PJ, 2009, DRUG ALCOHOL REV, V28, P202, DOI 10.1111/j.1465-3362.2008.00045.x; van der Poel A, 2009, INT J DRUG POLICY, V20, P143, DOI 10.1016/j.drugpo.2008.02.005; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539	29	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20482	10.1371/journal.pone.0020482	http://dx.doi.org/10.1371/journal.pone.0020482			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777JU	21695199	Green Published, gold			2022-12-25	WOS:000291612600012
J	Thye, T; Niemann, S; Walter, K; Homolka, S; Intemann, CD; Chinbuah, MA; Enimil, A; Gyapong, J; Osei, I; Owusu-Dabo, E; Rusch-Gerdes, S; Horstmann, RD; Ehlers, S; Meyer, CG				Thye, Thorsten; Niemann, Stefan; Walter, Kerstin; Homolka, Susanne; Intemann, Christopher D.; Chinbuah, Margaret Amanua; Enimil, Anthony; Gyapong, John; Osei, Ivy; Owusu-Dabo, Ellis; Ruesch-Gerdes, Sabine; Horstmann, Rolf D.; Ehlers, Stefan; Meyer, Christian G.			Variant G57E of Mannose Binding Lectin Associated with Protection against Tuberculosis Caused by Mycobacterium africanum but not by M. tuberculosis	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; GENE POLYMORPHISMS; PROTEIN LEVELS; SUSCEPTIBILITY; MALARIA; DEFICIENCY; INFECTION; IMMUNITY	Structural variants of the Mannose Binding Lectin (MBL) cause quantitative and qualitative functional deficiencies, which are associated with various patterns of susceptibility to infectious diseases and other disorders. We determined genetic MBL variants in 2010 Ghanaian patients with pulmonary tuberculosis (TB) and 2346 controls and characterized the mycobacterial isolates of the patients. Assuming a recessive mode of inheritance, we found a protective association between TB and the MBL2 G57E variant (odds ratio 0.60, confidence interval 0.4-0.9, P 0.008) and the corresponding LYQC haplotype (P-corrected 0.007) which applied, however, only to TB caused by M. africanum but not to TB caused by M. tuberculosis. In vitro, M. africanum isolates bound recombinant human MBL more efficiently than did isolates of M. tuberculosis. We conclude that MBL binding may facilitate the uptake of M. africanum by macrophages, thereby promoting infection and that selection by TB may have favoured the spread of functional MBL deficiencies in regions endemic for M. africanum.	[Thye, Thorsten; Intemann, Christopher D.; Horstmann, Rolf D.; Meyer, Christian G.] Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany; [Thye, Thorsten; Intemann, Christopher D.] Univ Hosp Schleswig Holstein, Inst Med Biometry & Stat, Lubeck, Germany; [Niemann, Stefan; Homolka, Susanne; Ruesch-Gerdes, Sabine] Res Ctr Borstel, Natl Reference Ctr Mycobacteria, Borstel, Germany; [Walter, Kerstin; Ehlers, Stefan] Res Ctr Borstel, Borstel, Germany; [Chinbuah, Margaret Amanua; Gyapong, John; Osei, Ivy] Ghana Hlth Serv, Hlth Res Unit, Accra, Ghana; [Enimil, Anthony; Owusu-Dabo, Ellis] Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Deptartment Community Hlth, Kumasi, Ghana; [Ehlers, Stefan] Inst Expt Med, Kiel, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel; Forschungszentrum Borstel; Ghana Health Service; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology	Thye, T (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Med, Hamburg, Germany.	c.g.meyer@bni.uni-hamburg.de	Niemann, Stefan/C-9327-2011; Enimil, Anthony/AAV-2595-2021; Ehlers, Stefan/B-4075-2010	Niemann, Stefan/0000-0002-6604-0684; Gyapong, John/0000-0002-8415-1468	German Federal Ministry of Education and Research (BMBF); German National Genome Research Network (NGFN) [01GS0162, S17T20]; German BMBF TB network [01Kl0780]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German National Genome Research Network (NGFN); German BMBF TB network	This work was supported by the German Federal Ministry of Education and Research (BMBF), German National Genome Research Network (NGFN; projects 01GS0162 and S17T20), and the German BMBF TB network "TB or not TB" (grant 01Kl0780). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASGHARZADEH M, 2008, J BIOL SCI, V3, P13; Bellamy R, 1998, QJM-INT J MED, V91, P13, DOI 10.1093/qjmed/91.1.13; Bernig T, 2005, HUM GENET, V118, P404, DOI 10.1007/s00439-005-0053-5; Bernig T, 2004, GENES IMMUN, V5, P461, DOI 10.1038/sj.gene.6364116; Casanova JL, 2004, J EXP MED, V199, P1295, DOI 10.1084/jem.20040537; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Dahl M, 2004, J EXP MED, V199, P1391, DOI 10.1084/jem.20040111; de Jong BC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000744; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; Ehlers MRW, 1998, TRENDS MICROBIOL, V6, P328, DOI 10.1016/S0966-842X(98)01301-8; Eisen DP, 2003, CLIN INFECT DIS, V37, P1496, DOI 10.1086/379324; El Sahly HM, 2004, SCAND J INFECT DIS, V36, P106, DOI 10.1080/00365540310018860; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Garred P, 2006, GENES IMMUN, V7, P85, DOI 10.1038/sj.gene.6364283; Garred P, 2003, INFECT IMMUN, V71, P5245, DOI 10.1128/IAI.71.9.5245-5253.2003; GARRED P, 1994, EUR J IMMUNOGENET, V21, P125, DOI 10.1111/j.1744-313X.1994.tb00183.x; Hartl DL, 2004, NAT REV MICROBIOL, V2, P15, DOI 10.1038/nrmicro795; Herb F, 2008, HUM MOL GENET, V17, P1052, DOI 10.1093/hmg/ddm378; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Hoal-van Helden EG, 1999, PEDIATR RES, V45, P459, DOI 10.1203/00006450-199904010-00002; Intemann CD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000577; Jack DL, 1998, J IMMUNOL, V160, P1346; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; Lee SG, 2005, MOL IMMUNOL, V42, P969, DOI 10.1016/j.molimm.2004.09.036; Leemans JC, 2001, J IMMUNOL, V166, P4604, DOI 10.4049/jimmunol.166.7.4604; Lipscombe RJ, 1996, EUR J HUM GENET, V4, P13; Liu W, 2006, INT J TUBERC LUNG D, V10, P1098; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Lozano F, 2005, TISSUE ANTIGENS, V66, P131, DOI 10.1111/j.1399-0039.2005.00436.x; Luty AJF, 1998, J INFECT DIS, V178, P1221, DOI 10.1086/515690; Madsen HO, 1998, J IMMUNOL, V161, P3169; Matsushita M, 1998, J HEPATOL, V29, P695, DOI 10.1016/S0168-8278(98)80248-1; Neth O, 2000, INFECT IMMUN, V68, P688, DOI 10.1128/IAI.68.2.688-693.2000; Niemann S, 2004, J CLIN MICROBIOL, V42, P3958, DOI 10.1128/JCM.42.9.3958-3962.2004; Owusu-Dabo E, 2006, EMERG INFECT DIS, V12, P1170, DOI 10.3201/eid1207.051028; Polotsky VY, 1997, J INFECT DIS, V175, P1159, DOI 10.1086/520354; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Selvaraj P., 1999, Tubercle and Lung Disease, V79, P221, DOI 10.1054/tuld.1999.0204; Soborg C, 2003, J INFECT DIS, V188, P777, DOI 10.1086/377183; Tacx AN, 2003, J CLIN PATHOL, V56, P956, DOI 10.1136/jcp.56.12.956; Thye T, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.037960; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Townsend R, 2001, CLIN EXP IMMUNOL, V124, P223, DOI 10.1046/j.1365-2249.2001.01549.x; Tsutsumi A, 2005, AUTOIMMUN REV, V4, P364, DOI 10.1016/j.autrev.2005.02.004; Turner MW, 2000, HUM MOL GENET, V9, P1481, DOI 10.1093/hmg/9.10.1481; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; VANEMMERIK LC, 1994, CLIN EXP IMMUNOL, V97, P411; Verdu P, 2006, HUM MOL GENET, V15, P2650, DOI 10.1093/hmg/ddl193; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160	52	59	61	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20908	10.1371/journal.pone.0020908	http://dx.doi.org/10.1371/journal.pone.0020908			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695215	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612600036
J	Alaerts, K; Nackaerts, E; Meyns, P; Swinnen, SP; Wenderoth, N				Alaerts, Kaat; Nackaerts, Evelien; Meyns, Pieter; Swinnen, Stephan P.; Wenderoth, Nicole			Action and Emotion Recognition from Point Light Displays: An Investigation of Gender Differences	PLOS ONE			English	Article							HIGH-FUNCTIONING AUTISM; BIOLOGICAL MOTION; SEX-DIFFERENCES; MIRROR-NEURON; ASPERGER-SYNDROME; NORMAL ADULTS; MOTOR CORTEX; PERCEPTION; EMPATHY; SYSTEM	Folk psychology advocates the existence of gender differences in socio-cognitive functions such as 'reading' the mental states of others or discerning subtle differences in body-language. A female advantage has been demonstrated for emotion recognition from facial expressions, but virtually nothing is known about gender differences in recognizing bodily stimuli or body language. The aim of the present study was to investigate potential gender differences in a series of tasks, involving the recognition of distinct features from point light displays (PLDs) depicting bodily movements of a male and female actor. Although recognition scores were considerably high at the overall group level, female participants were more accurate than males in recognizing the depicted actions from PLDs. Response times were significantly higher for males compared to females on PLD recognition tasks involving (i) the general recognition of 'biological motion' versus 'non-biological' (or 'scrambled' motion); or (ii) the recognition of the 'emotional state' of the PLD-figures. No gender differences were revealed for a control test (involving the identification of a color change in one of the dots) and for recognizing the gender of the PLD-figure. In addition, previous findings of a female advantage on a facial emotion recognition test (the 'Reading the Mind in the Eyes Test' (Baron-Cohen, 2001)) were replicated in this study. Interestingly, a strong correlation was revealed between emotion recognition from bodily PLDs versus facial cues. This relationship indicates that inter-individual or gender-dependent differences in recognizing emotions are relatively generalized across facial and bodily emotion perception. Moreover, the tight correlation between a subject's ability to discern subtle emotional cues from PLDs and the subject's ability to basically discriminate biological from non-biological motion provides indications that differences in emotion recognition may - at least to some degree - be related to more basic differences in processing biological motion per se.	[Alaerts, Kaat; Nackaerts, Evelien; Meyns, Pieter; Swinnen, Stephan P.; Wenderoth, Nicole] Katholieke Univ Leuven, Grp Biomed Sci, Dept Biomed Kinesiol, Motor Control Lab,Res Ctr Movement Control & Neur, B-3001 Heverlee, Belgium	KU Leuven	Alaerts, K (corresponding author), Katholieke Univ Leuven, Grp Biomed Sci, Dept Biomed Kinesiol, Motor Control Lab,Res Ctr Movement Control & Neur, B-3001 Heverlee, Belgium.	Kaat.Alaerts@faber.kuleuven.be	Alaerts, Kaat/HGV-0661-2022; Wenderoth, Nicole/D-7262-2015	Wenderoth, Nicole/0000-0002-3246-9386; Nackaerts, Evelien/0000-0002-6580-4902; Alaerts, Kaat/0000-0001-8665-6374; Meyns, Pieter/0000-0003-2218-187X	Flanders Fund for Scientific Research [G.0749.09, 1.2.060.10.N.00]; Belgian federal government [P6/29]	Flanders Fund for Scientific Research(FWO); Belgian federal government	Support for this study was provided through grants from the Flanders Fund for Scientific Research (Project Grant G.0749.09 and Fellowship Grant 1.2.060.10.N.00)(http://www.fwo.be). This work was also supported by Grant P6/29 from the Interuniversity Attraction Poles program of the Belgian federal government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; BaronCohen S, 1997, VIS COGN, V4, P311, DOI 10.1080/713756761; Bidet-Ildei C, 2010, ACTA PSYCHOL, V134, P215, DOI 10.1016/j.actpsy.2010.02.002; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Buccino G, 2001, EUR J NEUROSCI, V13, P400, DOI 10.1046/j.1460-9568.2001.01385.x; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Carruthers P., 1996, THEORIES THEORIES MI, DOI 10.1017/CBO9780511597985; Cheng Y, 2009, NEUROSCIENCE, V158, P713, DOI 10.1016/j.neuroscience.2008.10.026; Cheng YW, 2006, NEUROREPORT, V17, P1115, DOI 10.1097/01.wnr.0000223393.59328.21; Cheng YW, 2007, NEUROREPORT, V18, P887, DOI 10.1097/WNR.0b013e3280ebb486; Cheng YW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002113; CIALDINI RB, 1987, J PERS SOC PSYCHOL, V52, P749, DOI 10.1037/0022-3514.52.4.749; Cochin S, 1998, ELECTROEN CLIN NEURO, V107, P287, DOI 10.1016/S0013-4694(98)00071-6; Cochin S, 1998, EUR J NEUROSCI, V10, P254; CUTTING JE, 1977, B PSYCHONOMIC SOC, V9, P353, DOI 10.3758/BF03337021; CUTTING JE, 1978, BEHAV RES METH INSTR, V10, P91, DOI 10.3758/BF03205105; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; DAVIS MH, 1991, J RES PERS, V25, P70, DOI 10.1016/0092-6566(91)90006-C; DAVIS N, 1995, MENTAL SIMULATION; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; DITTRICH WH, 1993, PERCEPTION, V22, P15, DOI 10.1068/p220015; Dittrich WH, 1996, PERCEPTION, V25, P727, DOI 10.1068/p250727; EISENBERG N, 1989, J PERS SOC PSYCHOL, V57, P55, DOI 10.1037/0022-3514.57.1.55; EISENBERG N, 1983, PSYCHOL BULL, V94, P100, DOI 10.1037/0033-2909.94.1.100; ERWIN RJ, 1992, PSYCHIAT RES, V42, P231, DOI 10.1016/0165-1781(92)90115-J; Fadiga L, 2005, CURR OPIN NEUROBIOL, V15, P213, DOI 10.1016/j.conb.2005.03.013; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Fogassi L, 2005, SCIENCE, V308, P662, DOI 10.1126/science.1106138; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 2009, PSYCHOANAL DIALOGUES, V19, P519, DOI 10.1080/10481880903231910; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Grimshaw GM, 2004, BRAIN COGNITION, V54, P248, DOI 10.1016/j.bandc.2004.02.029; Hall J. A., 1984, NONVERBAL SEX DIFFER; Hall J. A., 2000, GENDER EMOTION SOCIA; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; HOFFMAN ML, 1977, PSYCHOL BULL, V84, P712, DOI 10.1037/0033-2909.84.4.712; HOFFMANN H, 2010, ACTA PSYCHO IN PRESS; Hubert B, 2007, J AUTISM DEV DISORD, V37, P1386, DOI 10.1007/s10803-006-0275-y; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Ikeda H, 2009, PERCEPTION, V38, P1002, DOI 10.1068/p6250; James W., 1890, PRINCIPLES PSYCHOL; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Kessler H, 2005, NERVENHEILKUNDE, V24, P611; Lawrence EJ, 2004, PSYCHOL MED, V34, P911, DOI 10.1017/S0033291703001624; Moore DG, 1997, BRIT J DEV PSYCHOL, V15, P401, DOI 10.1111/j.2044-835X.1997.tb00738.x; Newschaffer CJ, 2007, ANNU REV PUBL HEALTH, V28, P235, DOI 10.1146/annurev.publhealth.28.021406.144007; Parron C, 2008, AUTISM, V12, P261, DOI 10.1177/1362361307089520; Pavlova M, 2010, NEUROIMAGE, V50, P1327, DOI 10.1016/j.neuroimage.2009.12.096; Pavlova M, 2009, NEUROSCI LETT, V449, P133, DOI 10.1016/j.neulet.2008.10.102; Pavlova MA, 2010, BRAIN RES, V1311, P81, DOI 10.1016/j.brainres.2009.11.046; Perry A, 2010, SOC NEUROSCI-UK, V5, P272, DOI 10.1080/17470910903395767; Pollick FE, 2003, PERCEPTION, V32, P813, DOI 10.1068/p3319; Prinz W., 2005, PERSPECT IMITATION N, V1, P141; Rahman Q, 2004, BRAIN COGNITION, V54, P179, DOI 10.1016/j.bandc.2004.01.002; RICKHAM PP, 1964, BRIT MED J, V2, P173; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Saunders DR, 2010, J VISION, V10, DOI 10.1167/10.11.9; Saygin AP, 2004, J NEUROSCI, V24, P6181, DOI 10.1523/JNEUROSCI.0504-04.2004; Saygin AP, 2007, BRAIN, V130, P2452, DOI 10.1093/brain/awm162; Schouten B, 2010, ATTEN PERCEPT PSYCHO, V72, P1256, DOI 10.3758/APP.72.5.1256; Schulte-Ruther M, 2007, J COGNITIVE NEUROSCI, V19, P1354, DOI 10.1162/jocn.2007.19.8.1354; Sinigaglia C, 2010, J ANAL PSYCHOL, V55, P3, DOI 10.1111/j.1468-5922.2009.01821.x; Strafella AP, 2000, NEUROREPORT, V11, P2289, DOI 10.1097/00001756-200007140-00044; Troje NF, 2002, J VISION, V2, P371, DOI 10.1167/2.5.2; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; Yamasue H, 2008, CEREB CORTEX, V18, P2331, DOI 10.1093/cercor/bhm254	69	113	114	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20989	10.1371/journal.pone.0020989	http://dx.doi.org/10.1371/journal.pone.0020989			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777JX	21695266	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900043
J	Robbins, MM; Gray, M; Fawcett, KA; Nutter, FB; Uwingeli, P; Mburanumwe, I; Kagoda, E; Basabose, A; Stoinski, TS; Cranfield, MR; Byamukama, J; Spelman, LH; Robbins, AM				Robbins, Martha M.; Gray, Markye; Fawcett, Katie A.; Nutter, Felicia B.; Uwingeli, Prosper; Mburanumwe, Innocent; Kagoda, Edwin; Basabose, Augustin; Stoinski, Tara S.; Cranfield, Mike R.; Byamukama, James; Spelman, Lucy H.; Robbins, Andrew M.			Extreme Conservation Leads to Recovery of the Virunga Mountain Gorillas	PLOS ONE			English	Article							POPULATION-DYNAMICS; REPRODUCTIVE SUCCESS; NATIONAL-PARK; HABITAT USE; BERINGEI; DISEASE; AFRICA; TOOL; TRANSMISSION; STRATEGIES	As wildlife populations are declining, conservationists are under increasing pressure to measure the effectiveness of different management strategies. Conventional conservation measures such as law enforcement and community development projects are typically designed to minimize negative human influences upon a species and its ecosystem. In contrast, we define "extreme" conservation as efforts targeted to deliberately increase positive human influences, including veterinary care and close monitoring of individual animals. Here we compare the impact of both conservation approaches upon the population growth rate of the critically endangered Virunga mountain gorillas (Gorilla beringei beringei), which increased by 50% since their nadir in 1981, from approximately 250 to nearly 400 gorillas. Using demographic data from 1967-2008, we show an annual decline of 0.7%+/- 0.059% for unhabituated gorillas that received intensive levels of conventional conservation approaches, versus an increase 4.1%+/- 0.088% for habituated gorillas that also received extreme conservation measures. Each group of habituated gorillas is now continuously guarded by a separate team of field staff during daylight hours and receives veterinary treatment for snares, respiratory disease, and other life-threatening conditions. These results suggest that conventional conservation efforts prevented a severe decline of the overall population, but additional extreme measures were needed to achieve positive growth. Demographic stochasticity and socioecological factors had minimal impact on variability in the growth rates. Veterinary interventions could account for up to 40% of the difference in growth rates between habituated versus unhabituated gorillas, with the remaining difference likely arising from greater protection against poachers. Thus, by increasing protection and facilitating veterinary treatment, the daily monitoring of each habituated group contributed to most of the difference in growth rates. Our results argue for wider consideration of extreme measures and offer a startling view of the enormous resources that may be needed to conserve some endangered species.	[Robbins, Martha M.; Robbins, Andrew M.] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Gray, Markye; Basabose, Augustin; Byamukama, James] Int Gorilla Conservat Programme, Kigali, Rwanda; [Fawcett, Katie A.; Stoinski, Tara S.] Dian Fossey Gorilla Fund Int, Atlanta, GA USA; [Nutter, Felicia B.; Cranfield, Mike R.; Spelman, Lucy H.] Univ Calif Davis, Sch Vet Med, Mt Gorilla Vet Program, Davis, CA 95616 USA; [Uwingeli, Prosper] Rwanda Dev Board, Gishushu, Kigali, Rwanda; [Mburanumwe, Innocent] IGCP DRC, Inst Congolais Conservat Nat, Parc Natl Virunga Sud, Gisenyi, Rwanda; [Kagoda, Edwin] Uganda Wildlife Author, Mgahinga Gorilla Natl Pk, Kampala, Uganda; [Stoinski, Tara S.] Zoo Atlanta, Atlanta, GA USA	Max Planck Society; University of California System; University of California Davis	Robbins, MM (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany.	robbins@eva.mpg.de			International Gorilla Conservation Program; Max Planck Society; Dian Fossey Gorilla Fund International; Mountain Gorilla Veterinary Program; Zoo Atlanta	International Gorilla Conservation Program; Max Planck Society(Max Planck SocietyFoundation CELLEX); Dian Fossey Gorilla Fund International; Mountain Gorilla Veterinary Program; Zoo Atlanta	International Gorilla Conservation Program, Max Planck Society, Dian Fossey Gorilla Fund International, Mountain Gorilla Veterinary Program, and Zoo Atlanta. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts Susan C., 2003, P66; [Anonymous], 2007, CRITICAL ISSUES ECOT; Armstrong DP, 2008, TRENDS ECOL EVOL, V23, P20, DOI 10.1016/j.tree.2007.10.003; Baxter PWJ, 2006, CONSERV BIOL, V20, P893, DOI 10.1111/j.1523-1739.2006.00378.x; Benton TG, 1999, TRENDS ECOL EVOL, V14, P467, DOI 10.1016/S0169-5347(99)01724-3; Bissonette JA, 2008, BIOL CONSERV, V141, P482, DOI 10.1016/j.biocon.2007.10.019; Blake S, 2007, PLOS BIOL, V5, P945, DOI 10.1371/journal.pbio.0050111; Blom A, 2004, AFR J ECOL, V42, P23, DOI 10.1111/j.0141-6707.2004.00441.x; Bottrill MC, 2008, TRENDS ECOL EVOL, V23, P649, DOI 10.1016/j.tree.2008.07.007; Breed Andrew C., 2009, P215, DOI 10.1007/978-4-431-77134-0_11; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; BUTYNSKI T, 1998, CONSERVATION BIOL RE, P292; Byrne CL, 2008, APPL ITERATIVE METHO; Caldecott J.O., 2005, WORLD ATLAS GREAT AP; Caswell H., 2001, MATRIX POPULATION MO, V2nd ed.; Chauvenet ALM, 2010, ECOL APPL, V20, P789, DOI 10.1890/08-1749.1; Cranfield MR, 2008, AM J PRIMATOL, V70, P751, DOI 10.1002/ajp.20564; Dunham AE, 2008, BIOL CONSERV, V141, P287, DOI 10.1016/j.biocon.2007.10.006; FEDIGAN L, 2010, AM J PRIMATOLOGY ADV, P1; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Forsyth DM, 2006, ECOLOGY, V87, P297, DOI 10.1890/05-0709; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Goodall J, 2009, HOPE ANIMALS THEIR W; Gough KF, 2006, ORYX, V40, P434, DOI 10.1017/S0030605306001189; Gray M, 2005, BIODIVERS CONSERV, V14, P2723, DOI 10.1007/s10531-005-8406-x; Gray M, 2010, AFR J ECOL, V48, P588, DOI 10.1111/j.1365-2028.2009.01142.x; Harcourt A.H., 2007, GORILLA SOC CONFLICT; Harcourt AH, 2001, BIODIVERS CONSERV, V10, P1011, DOI 10.1023/A:1016680327755; HARCOURT AH, 1983, AFR J ECOL, V21, P139, DOI 10.1111/j.1365-2028.1983.tb00322.x; Haydon DT, 2006, NATURE, V443, P692, DOI 10.1038/nature05177; *IUCN, 2008, RED LIST THREAT SPEC; Kalpers J, 2003, ORYX, V37, P326, DOI 10.1017/S0030605303000589; Kapos V, 2008, CONSERV LETT, V1, P155, DOI 10.1111/j.1755-263X.2008.00025.x; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Lukasik-Braum M, 2008, AM J PRIMATOL, V70, P734, DOI 10.1002/ajp.20568; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; McNeilage A., 1995, BRISTOL U BRISTOL; Mudakikwa A., 2001, MOUNTAIN GORILLAS 3, P341; Nichols JD, 2006, TRENDS ECOL EVOL, V21, P668, DOI 10.1016/j.tree.2006.08.007; Nielsen H., 2010, SUCCESS TOURISM RWAN; PALACIOS G, EMERGING INFECT DIS; PLUMPTRE AJ, 2001, MOUNTAIN GORILLAS 3, P361; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; Robbins AM, 2006, AM J PHYS ANTHROPOL, V131, P511, DOI 10.1002/ajpa.20474; Robbins MM, 2007, BEHAV ECOL SOCIOBIOL, V61, P919, DOI 10.1007/s00265-006-0321-y; Robbins MM, 2004, AM J PRIMATOL, V63, P201, DOI 10.1002/ajp.20052; Rowcliffe JM, 2004, P ROY SOC B-BIOL SCI, V271, P2631, DOI 10.1098/rspb.2004.2915; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Sandbrook C, 2006, ORYX, V40, P428, DOI 10.1017/S0030605306001323; Sibly RM, 2002, PHILOS T R SOC B, V357, P1153, DOI 10.1098/rstb.2002.1117; Smith RK, 2010, CONSERV BIOL, V24, P820, DOI 10.1111/j.1523-1739.2009.01421.x; Stearns S.C., 1992, pi; Sterck EHM, 1997, BEHAV ECOL SOCIOBIOL, V41, P291, DOI 10.1007/s002650050390; Struhsaker TT, 2005, BIOL CONSERV, V123, P45, DOI 10.1016/j.biocon.2004.10.007; Thirgood S, 2009, J APPL ECOL, V46, P454, DOI 10.1111/j.1365-2664.2009.01629.x; Walpole MJ, 2001, BIOL CONSERV, V99, P237, DOI 10.1016/S0006-3207(00)00219-6; Walsh PD, 2003, NATURE, V422, P611, DOI 10.1038/nature01566; WATTS DP, 1991, FOLIA PRIMATOL, V56, P1, DOI 10.1159/000156521; Watts DP, 1998, INT J PRIMATOL, V19, P651, DOI 10.1023/A:1020324909101; Weber B., 2001, KINGDOM GORILLAS; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224; Yamagiwa Juichi, 2004, Primate Research, V20, P73, DOI 10.2354/psj.20.73; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042	65	85	88	2	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e19788	10.1371/journal.pone.0019788	http://dx.doi.org/10.1371/journal.pone.0019788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687709	Green Published, gold			2022-12-25	WOS:000291611500004
J	Bubar, MJ; Stutz, SJ; Cunningham, KA				Bubar, Marcy J.; Stutz, Sonja J.; Cunningham, Kathryn A.			5-HT2C Receptors Localize to Dopamine and GABA Neurons in the Rat Mesoaccumbens Pathway	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; RETROGRADELY TRANSPORTED FLUOROGOLD; GAMMA-AMINOBUTYRIC-ACID; IN-VIVO MICRODIALYSIS; NUCLEUS-ACCUMBENS; SEROTONIN(2C) RECEPTOR; CATECHOLAMINERGIC NEURONS; NONDOPAMINERGIC NEURONS; SUBSTANTIA-NIGRA; SYNAPTIC INPUT	The serotonin 5-HT2C receptor (5-HT2CR) is localized to the limbic-corticostriatal circuit, which plays an integral role in mediating attention, motivation, cognition, and reward processes. The 5-HT2CR is linked to modulation of mesoaccumbens dopamine neurotransmission via an activation of gamma-aminobutyric acid (GABA) neurons in the ventral tegmental area (VTA). However, we recently demonstrated the expression of the 5-HT2CR within dopamine VTA neurons suggesting the possibility of a direct influence of the 5-HT2CR upon mesoaccumbens dopamine output. Here, we employed double-label fluorescence immunochemistry with the synthetic enzymes for dopamine (tyrosine hydroxylase; TH) and GABA (glutamic acid decarboxylase isoform 67; GAD-67) and retrograde tract tracing with FluoroGold (FG) to uncover whether dopamine and GABA VTA neurons that possess 5-HT2CR innervate the nucleus accumbens (NAc). The highest numbers of FG-labeled cells were detected in the middle versus rostral and caudal levels of the VTA, and included a subset of TH- and GAD-67 immunoreactive cells, of which >50% also contained 5-HT2CR immunoreactivity. Thus, we demonstrate for the first time that the 5-HT2CR colocalizes in DA and GABA VTA neurons which project to the NAc, describe in detail the distribution of NAc-projecting GABA VTA neurons, and identify the colocalization of TH and GAD-67 in the same NAc-projecting VTA neurons. These data suggest that the 5-HT2CR may exert direct influence upon both dopamine and GABA VTA output to the NAc. Further, the indication that a proportion of NAc-projecting VTA neurons synthesize and potentially release both dopamine and GABA adds intriguing complexity to the framework of the VTA and its postulated neuroanatomical roles.	[Bubar, Marcy J.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX USA; Univ Texas Med Branch, Addict Res Ctr, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Bubar, MJ (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX USA.	kcunning@utmb.edu	Cunningham, Kathryn A/O-2718-2013	Cunningham, Kathryn A/0000-0002-4257-1739	National Institute on Drug Abuse [DA 006511, DA 013595, DA007287, DA 024157]; NATIONAL INSTITUTE ON DRUG ABUSE [P20DA024157, F31DA015259, R01DA013595, R01DA006511] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The work in this manuscript was supported by National Institute on Drug Abuse grants DA 006511, DA 013595, DA007287 and DA 024157 to KAC and DA 015259 to MJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akema T, 2005, J NEUROENDOCRINOL, V17, P672, DOI 10.1111/j.1365-2826.2005.01358.x; Colombari DSA, 2008, BRAIN RES BULL, V76, P572, DOI 10.1016/j.brainresbull.2008.04.001; Anastasio NC, 2010, J NEUROCHEM, V113, P1504, DOI 10.1111/j.1471-4159.2010.06694.x; Berg KA, 2001, J PHARMACOL EXP THER, V299, P593; Berg KA, 2008, NEUROPHARMACOLOGY, V55, P969, DOI 10.1016/j.neuropharm.2008.06.014; BROG JS, 1993, J COMP NEUROL, V338, P255, DOI 10.1002/cne.903380209; Bubar MJ, 2007, NEUROSCIENCE, V146, P286, DOI 10.1016/j.neuroscience.2006.12.071; Bubar MJ, 2008, PROG BRAIN RES, V172, P319, DOI 10.1016/S0079-6123(08)00916-3; Bubar MJ, 2005, BRAIN RES, V1063, P105, DOI 10.1016/j.brainres.2005.09.050; Campbell CH, 2001, STEROIDS, V66, P727, DOI 10.1016/S0039-128X(01)00106-4; Clemett DA, 2000, NEUROPHARMACOLOGY, V39, P123, DOI 10.1016/S0028-3908(99)00086-6; Di Giovanni G, 2001, NEUROSCIENCE, V103, P111, DOI 10.1016/S0306-4522(00)00561-3; Di Giovanni G, 2000, SYNAPSE, V35, P53, DOI 10.1002/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2; Di Giovanni G, 2006, CURR TOP MED CHEM, V6, P1909; Di Matteo M, 2000, BRAIN RES, V865, P85, DOI 10.1016/S0006-8993(00)02246-0; Di Matteo V, 1999, NEUROPHARMACOLOGY, V38, P1195, DOI 10.1016/S0028-3908(99)00047-7; Di Matteo V, 2008, PROG BRAIN RES, V172, P7, DOI 10.1016/S0079-6123(08)00902-3; EberleWang K, 1997, J COMP NEUROL, V384, P233, DOI 10.1002/(SICI)1096-9861(19970728)384:2<233::AID-CNE5>3.0.CO;2-2; FALLON JH, 1978, J COMP NEUROL, V180, P545, DOI 10.1002/cne.901800310; Gonzalez-Hernandez T, 2001, EUR J NEUROSCI, V13, P57, DOI 10.1046/j.1460-9568.2001.01371.x; Hannon J, 2008, BEHAV BRAIN RES, V195, P198, DOI 10.1016/j.bbr.2008.03.020; Hasue RH, 2002, J COMP NEUROL, V454, P15, DOI 10.1002/cne.10420; Hedou G, 2000, J COMP NEUROL, V426, P549, DOI 10.1002/1096-9861(20001030)426:4<549::AID-CNE4>3.0.CO;2-Y; HERVE D, 1987, BRAIN RES, V435, P71, DOI 10.1016/0006-8993(87)91588-5; Ikemoto S, 2007, BRAIN RES REV, V56, P27, DOI 10.1016/j.brainresrev.2007.05.004; Ji SP, 2006, NAT MED, V12, P324, DOI 10.1038/nm1349; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; KALIVAS PW, 1988, MESOCORTICOLIMBIC DO; Keppel G., 1973, DESIGN ANAL RES HDB; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Korotkova TM, 2003, J NEUROSCI, V23, P7; KOSAKA T, 1987, EXP BRAIN RES, V66, P191; Laviolette SR, 2007, SCHIZOPHRENIA BULL, V33, P971, DOI 10.1093/schbul/sbm048; Liu S, 2007, NEUROSCIENCE, V146, P1677, DOI 10.1016/j.neuroscience.2007.02.064; Lu XY, 1998, NEUROSCIENCE, V82, P767; Navailles S, 2008, NEUROPSYCHOPHARMACOL, V33, P237, DOI 10.1038/sj.npp.1301414; Navailles S, 2006, J NEUROCHEM, V99, P1311, DOI 10.1111/j.1471-4159.2006.04188.x; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nocjar C, 2002, NEUROSCIENCE, V111, P163, DOI 10.1016/S0306-4522(01)00593-0; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Olijslagers JE, 2004, NEUROPHARMACOLOGY, V46, P504, DOI 10.1016/j.neuropharm.2003.10.003; Olson VG, 2007, SYNAPSE, V61, P87, DOI 10.1002/syn.20345; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; PICKEL VM, 1988, J COMP NEUROL, V272, P1, DOI 10.1002/cne.902720102; POMPEIANO M, 1994, MOL BRAIN RES, V23, P163, DOI 10.1016/0169-328X(94)90223-2; PRISCO S, 1994, J PHARMACOL EXP THER, V271, P83; Rossi AH, 2007, AM J PHYSIOL-LUNG C, V292, pL92, DOI 10.1152/ajplung.00081.2006; Shank EJ, 2007, BEHAV NEUROSCI, V121, P1224, DOI 10.1037/0735-7044.121.6.1224; SHELDON PW, 1991, SYNAPSE, V9, P208, DOI 10.1002/syn.890090307; SWANSON LW, 1982, BRAIN RES BULL, V9, P321, DOI 10.1016/0361-9230(82)90145-9; Theile JW, 2009, J PHARMACOL EXP THER, V329, P625, DOI 10.1124/jpet.108.147793; VANBOCKSTAELE EJ, 1994, J NEUROSCI METH, V55, P65, DOI 10.1016/0165-0270(94)90042-6; VANBOCKSTAELE EJ, 1995, BRAIN RES, V682, P215, DOI 10.1016/0006-8993(95)00334-M; VANBOCKSTAELE EJ, 1993, J COMP NEUROL, V334, P603, DOI 10.1002/cne.903340408; Yamaguchi T, 2007, EUR J NEUROSCI, V25, P106, DOI 10.1111/j.1460-9568.2006.05263.x	55	82	85	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20508	10.1371/journal.pone.0020508	http://dx.doi.org/10.1371/journal.pone.0020508			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687728	gold, Green Submitted, Green Published			2022-12-25	WOS:000291607000010
J	Lu, HY; Huang, DP; Ransohoff, RM; Zhou, L				Lu, Haiyan; Huang, Danping; Ransohoff, Richard M.; Zhou, Lan			Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair	FASEB JOURNAL			English	Article						chemokine; inflammation; IGF-1	EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR 2; GROWTH-FACTOR-I; CHEMOATTRACTANT PROTEIN-1; IGF-I; ALTERED INFLAMMATION; BONE-MARROW; CCR2-/-MICE; REGENERATION; MACROPHAGES	CC chemokine ligand 2 (CCL2), a ligand of CC chemokine receptor 2 (CCR2), is essential to mount an adequate inflammatory response to repair acute skeletal muscle injury. We studied the mechanisms by which CCL2 regulates muscle inflammation and regeneration. Mobilization of monocytes/macrophages (MOs/MPs) but not lymphocytes or neutrophils was impaired from bone marrow to blood and from blood to injured muscles in Ccl2(-/-) mice. This was accompanied by poor phagocytosis, reduced up-regulation of insulin-like growth factor-1 (IGF-1), and impaired muscle regeneration. Bone marrow transfer from wild-type mice to irradiated Ccr2(-/-) but not Ccl2(-/-) mice restored muscle inflammation. Intravenously injected CCL2-deficient bone marrow monocytes could not enter wild-type injured muscles as well as wild-type bone marrow monocytes. Intravenously injected wild-type bone marrow monocytes could not enter CCL2-deficient injured muscles as well as wild-type injured muscles. CCL2 stimulated IGF-1 expression by wild-type but not CCR2-deficient intramuscular macrophages. A single intramuscular injection of IGF-1, but not PBS, markedly improved muscle regeneration in Ccl2(-/-) mice. We conclude that CCL2 is a major ligand of CCR2 to recruit MOs/MPs into injured muscles to conduct phagocytosis and produce IGF-1 for injury repair. CCL2 needs to be expressed by bone marrow cells, circulating monocytes, and injured muscle tissue cells to recruit MOs/MPs into injured muscles. CCL2/CCR2 signaling also up-regulates IGF-1 expression by intramuscular macrophages to promote acute skeletal muscle injury repair.-Lu, H., Huang, D., Ransohoff, R. M., Zhou, L. Acute skeletal muscle injury: CCL2 expression by both monocytes and injured muscle is required for repair. FASEB J. 25, 3344-3355 (2011). www.fasebj.org	[Lu, Haiyan; Huang, Danping; Ransohoff, Richard M.; Zhou, Lan] Cleveland Clin, Neuroinflammat Res Ctr, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44195 USA; [Ransohoff, Richard M.; Zhou, Lan] Cleveland Clin, Dept Neurol, Neurol Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation	Zhou, L (corresponding author), Cleveland Clin, Neuroinflammat Res Ctr, Lerner Res Inst, Dept Neurosci, 9500 Euclid Ave S90, Cleveland, OH 44195 USA.	zhoul2@ccf.org			U.S. National Institutes of Health [K08 NS049346]; Muscular Dystrophy Association (MDA) [91682, K24 51400]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS049346] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study is supported by U.S. National Institutes of Health grant K08 NS049346 (L.Z.) and Muscular Dystrophy Association grants MDA#91682 (L.Z.) and K24 51400 (R.M.R.). The authors thank Drs. Liping Liu, Georgian Cheng, and Ping Huang and the Flow Cytometry Core of the Cleveland Clinic for superb technical support.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Belperio JA, 2001, J CLIN INVEST, V108, P547, DOI 10.1172/JCI200112214; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Cardona AE, 2008, BLOOD, V112, P256, DOI 10.1182/blood-2007-10-118497; Chang TLY, 2002, J VIROL, V76, P2245, DOI 10.1128/JVI.76.5.2245-2254.2002; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Charo IF, 2004, CIRC RES, V95, P858, DOI 10.1161/01.RES.0000146672.10582.17; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Giunti S, 2010, CURR VASC PHARMACOL, V8, P849, DOI 10.2174/157016110793563816; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hayashi S, 2004, HISTOCHEM CELL BIOL, V122, P427, DOI 10.1007/s00418-004-0704-y; Heinemeier KM, 2009, J APPL PHYSIOL, V106, P178, DOI 10.1152/japplphysiol.91092.2008; Huang DR, 2001, J EXP MED, V193, P713, DOI 10.1084/jem.193.6.713; Huo YQ, 2001, J CLIN INVEST, V108, P1307, DOI 10.1172/JCI12877; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; LIU L, J NEUROSCI, V30, P9074; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; MARTINEZ CO, 2010, AM J PHYSIOL, V299, P832; Maus U, 2002, AM J PHYSIOL-HEART C, V283, pH2584, DOI 10.1152/ajpheart.00349.2002; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Musaro A, 2005, ARCH ITAL BIOL, V143, P243; Musaro A, 2001, NAT GENET, V27, P195, DOI 10.1038/84839; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Pelosi L, 2007, FASEB J, V21, P1393, DOI 10.1096/fj.06-7690com; POWELLBRAXTON L, 1993, GENE DEV, V7, P2609, DOI 10.1101/gad.7.12b.2609; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126; ROBERTSON TA, 1993, EXP CELL RES, V207, P321, DOI 10.1006/excr.1993.1199; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Shahrara S, 2008, J IMMUNOL, V180, P3447, DOI 10.4049/jimmunol.180.5.3447; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Summan M, 2003, J INTERF CYTOK RES, V23, P237, DOI 10.1089/107999003321829953; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Xia MD, 2009, EXPERT OPIN THER PAT, V19, P295, DOI 10.1517/13543770902755129; Zhou L, 2006, NEUROMUSCULAR DISORD, V16, P32, DOI 10.1016/j.nmd.2005.09.009	48	152	155	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3344	3355		10.1096/fj.10-178939	http://dx.doi.org/10.1096/fj.10-178939			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21697550	Green Published			2022-12-25	WOS:000295356400007
J	Kanagawa, M; Satoh, T; Ikeda, A; Adachi, Y; Ohno, N; Yamaguchi, Y				Kanagawa, Mayumi; Satoh, Tadashi; Ikeda, Akemi; Adachi, Yoshiyuki; Ohno, Naohito; Yamaguchi, Yoshiki			Structural Insights into Recognition of Triple-helical beta-Glucans by an Insect Fungal Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING; PROTEIN; BETA-1,3-GLUCAN; CONFORMATION; DECTIN-1; LECTIN; DOMAIN; SPECTROSCOPY; INFECTIONS; DROSOPHILA	The innate ability to detect pathogens is achieved by pattern recognition receptors, which recognize non-self-components such as beta 1,3-glucan. beta 1,3-Glucans form a triple-helical structure stabilized by interchain hydrogen bonds. beta 1,3-Glucan recognition protein (beta GRP)/Gram-negative bacteria-binding protein 3 (GNBP3), one of the pattern recognition receptors, binds to long, structured beta 1,3-glucan to initiate innate immune response. However, binding details and how specificity is achieved in such receptors remain important unresolved issues. We solved the crystal structures of the N-terminal beta 1,3-glucan recognition domain of beta GRP/GNBP3 (beta GRP-N) in complex with the beta 1,3-linked glucose hexamer, laminarihexaose. In the crystals, three structured laminarihexaoses simultaneously interact through six glucose residues (two from each chain) with one beta GRP-N. The spatial arrangement of the laminarihexaoses bound to beta GRP-N is almost identical to that of a beta 1,3-glucan triple-helical structure. Therefore, our crystallographic structures together with site-directed mutagenesis data provide a structural basis for the unique recognition by such receptors of the triple-helical structure of beta 1,3-glucan.	[Kanagawa, Mayumi; Satoh, Tadashi; Ikeda, Akemi; Yamaguchi, Yoshiki] RIKEN, Adv Sci Inst, Dept Biol Chem, Struct Glycobiol Team,Syst Glycobiol Res Grp, Wako, Saitama 3510198, Japan; [Adachi, Yoshiyuki; Ohno, Naohito] Tokyo Univ Pharm & Life Sci, Lab Immunopharmacol Microbial Prod, Sch Pharm, Tokyo 1920392, Japan	RIKEN; Tokyo University of Pharmacy & Life Sciences	Yamaguchi, Y (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	yyoshiki@riken.jp	Yamaguchi, Yoshiki/N-5246-2015; Satoh, Tadashi/M-5157-2017	Yamaguchi, Yoshiki/0000-0003-0100-5439; Satoh, Tadashi/0000-0002-4493-4978	National Synchroton Radiation Research Center (NSRRC) (Taiwan)	National Synchroton Radiation Research Center (NSRRC) (Taiwan)	We thank Drs. Akihiro Miyanoshita and Taro Imamura (National Food Research Institute) for kindly providing P. interpunctella and Masaki Ishii for isolation of the P. interpunctella beta GRP gene. We also thank Drs. Yukishige Ito, Yoichi Takeda (RIKEN/ERATO), Shinya Hanashima (RIKEN), and Yasutoshi Sakoda and Yasushi Sakaguchi (DKSH Japan) for ITC measurements and for helpful discussions. We thank the beamline staff of Photon Factory (PF) High Energy Accelerator Research Organization (KEK) (Japan), SPring-8 (Japan), and National Synchroton Radiation Research Center (NSRRC) (Taiwan) for providing data collection facilities and support.	Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; ATKINS E, 1986, INT J BIOL MACROMOL, V8, P323, DOI 10.1016/0141-8130(86)90050-4; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brown GD, 2005, CELL MICROBIOL, V7, P471, DOI 10.1111/j.1462-5822.2005.00505.x; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Brown J, 2007, PROTEIN SCI, V16, P1042, DOI 10.1110/ps.072791207; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHUAH CT, 1983, MACROMOLECULES, V16, P1375, DOI 10.1021/ma00242a020; DILUZIO NR, 1979, INT J CANCER, V24, P773, DOI 10.1002/ijc.2910240613; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Kulicke WM, 1997, CARBOHYD RES, V297, P135, DOI 10.1016/S0008-6215(96)00273-X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee H, 2009, BMB REP, V42, P506, DOI 10.5483/BMBRep.2009.42.8.506; Ma CC, 2000, J BIOL CHEM, V275, P7505, DOI 10.1074/jbc.275.11.7505; McRee DE, 1999, J STRUCT BIOL, V125, P156, DOI 10.1006/jsbi.1999.4094; Mishima Y, 2009, J BIOL CHEM, V284, P28687, DOI 10.1074/jbc.M109.034587; Mueller A, 2000, GLYCOBIOLOGY, V10, P339, DOI 10.1093/glycob/10.4.339; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Okobira T, 2008, BIOMACROMOLECULES, V9, P783, DOI 10.1021/bm700511d; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park SH, 2011, J BIOL CHEM, V286, P1567, DOI 10.1074/jbc.M110.144006; Pazos C, 2005, J CLIN MICROBIOL, V43, P299, DOI 10.1128/JCM.43.1.299-305.2005; Qing GL, 2004, NAT BIOTECHNOL, V22, P877, DOI 10.1038/nbt984; Read SM, 1996, CARBOHYD RES, V281, P187, DOI 10.1016/0008-6215(95)00350-9; RINI JM, 1995, ANNU REV BIOPH BIOM, V24, P551, DOI 10.1146/annurev.biophys.24.1.551; Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419; Sletmoen M, 2008, BIOPOLYMERS, V89, P310, DOI 10.1002/bip.20920; Takahasi K, 2009, P NATL ACAD SCI USA, V106, P11679, DOI 10.1073/pnas.0901671106; Tzianabos AO, 2000, CLIN MICROBIOL REV, V13, P523, DOI 10.1128/CMR.13.4.523-533.2000; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; YOSHIOKA Y, 1992, CHEM PHARM BULL, V40, P1221; Young SH, 2000, J BIOL CHEM, V275, P11874, DOI 10.1074/jbc.275.16.11874	37	42	44	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29158	29165		10.1074/jbc.M111.256701	http://dx.doi.org/10.1074/jbc.M111.256701			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697086	Green Published, hybrid			2022-12-25	WOS:000293837000052
J	Flowers, S; Beck, GR; Moran, E				Flowers, Stephen; Beck, George R., Jr.; Moran, Elizabeth			Tissue-specific Gene Targeting by the Multiprotein Mammalian DREAM Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G(2)/M GENES; B-MYB; DIFFERENTIATION; TRANSCRIPTION; PRB; PROTEIN; EXPRESSION; DISTINCT; MECHANISMS; GROWTH	The mammalian DP, RB-like, E2F, and MuvB-like proteins (DREAM) complex, whose key components include p130 and E2F4, plays a fundamental role in repression of cell cycle-specific genes during growth arrest. Mammalian DREAM is well conserved with Drosophila and Caenorhabditis elegans complexes that repress pivotal developmental genes, but the mammalian complex has been thought to exist only in quiescent cells and not to be linked with development. However, new findings here identify tissue-specific promoters repressed by DREAM in proliferating precursors, revealing a new connection between control of growth arrest and terminal differentiation. Mechanistically, tissue-specific promoter occupation by DREAM is dependent on the integrity of a repressor form of the SWI/SNF chromatin-remodeling complex.	[Flowers, Stephen; Moran, Elizabeth] Univ Med & Dent New Jersey, NJMS UH Canc Ctr, Dept Orthopaed, Newark, NJ 07103 USA; [Beck, George R., Jr.] Emory Univ, Sch Med, Div Endocrinol Metab & Lipids, Atlanta, GA 30322 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Emory University	Moran, E (corresponding author), Univ Med & Dent New Jersey, NJMS UH Canc Ctr, Dept Orthopaed, 205 S Orange Ave, Newark, NJ 07103 USA.	moranel@umdnj.edu	Beck, George/AAO-2117-2020		National Institutes of Health under the United States Public Health Service [GM073257, T32-CA134268]; NATIONAL CANCER INSTITUTE [T32CA134268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073257] Funding Source: NIH RePORTER	National Institutes of Health under the United States Public Health Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM073257 (to E. M.) and T32-CA134268 (to S. F.) under the United States Public Health Service.	Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Beck GR, 2001, CELL GROWTH DIFFER, V12, P61; Beck GR, 1998, J CELL BIOCHEM, V68, P269, DOI 10.1002/(SICI)1097-4644(19980201)68:2<269::AID-JCB13>3.0.CO;2-A; Benevolenskaya EV, 2005, MOL CELL, V18, P623, DOI 10.1016/j.molcel.2005.05.012; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; DeCaprio JA, 2009, VIROLOGY, V384, P274, DOI 10.1016/j.virol.2008.12.010; DeGregori J, 2006, CURR MOL MED, V6, P739; Flowers S, 2010, CANCER RES, V70, P8282, DOI 10.1158/0008-5472.CAN-10-2205; Flowers S, 2009, J BIOL CHEM, V284, P10067, DOI 10.1074/jbc.M808782200; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Knight AS, 2009, ONCOGENE, V28, P1737, DOI 10.1038/onc.2009.22; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Lee H, 2010, MOL CELL BIOL, V30, P2563, DOI 10.1128/MCB.01075-09; Lee JS, 2006, J BONE MINER RES, V21, P921, DOI 10.1359/JBMR.060303; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Luan Y, 2007, J BIOL CHEM, V282, P16860, DOI 10.1074/jbc.M610943200; Miller ES, 2010, CELL CYCLE, V9, P2620, DOI 10.4161/cc.9.13.12108; Muller GA, 2010, FEBS J, V277, P877, DOI 10.1111/j.1742-4658.2009.07508.x; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Rizzolio F, 2010, J CELL BIOCHEM, V109, P839, DOI 10.1002/jcb.22448; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; TERAO M, 1990, BIOCHEM J, V268, P641, DOI 10.1042/bj2680641; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469	29	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27867	27871		10.1074/jbc.C111.255091	http://dx.doi.org/10.1074/jbc.C111.255091			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685383	Green Published, hybrid			2022-12-25	WOS:000293557800004
J	Sadeqzadeh, E; de Bock, CE; Zhang, XD; Shipman, KL; Scott, NM; Song, CJ; Yeadon, T; Oliveira, CS; Jin, BQ; Hersey, P; Boyd, AW; Burns, GF; Thorne, RF				Sadeqzadeh, Elham; de Bock, Charles E.; Zhang, Xu Dong; Shipman, Kristy L.; Scott, Naomi M.; Song, Chaojun; Yeadon, Trina; Oliveira, Camila S.; Jin, Boquan; Hersey, Peter; Boyd, Andrew W.; Burns, Gordon F.; Thorne, Rick F.			Dual Processing of FAT1 Cadherin Protein by Human Melanoma Cells Generates Distinct Protein Products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; ADHESION MOLECULE; PROTOCADHERIN FAT1; SIGNALING PATHWAY; ACTIN DYNAMICS; EXPRESSION; DROSOPHILA; HOMOLOG; CLONING; CD36	The giant cadherin FAT1 is one of four vertebrate orthologues of the Drosophila tumor suppressor fat. It engages in several functions, including cell polarity and migration, and in Hippo signaling during development. Homozygous deletions in oral cancer suggest that FAT1 may play a tumor suppressor role, although overexpression of FAT1 has been reported in some other cancers. Here we show using Northern blotting that human melanoma cell lines variably but universally express FAT1 and less commonly FAT2, FAT3, and FAT4. Both normal melanocytes and keratinocytes also express comparable FAT1 mRNA relative to melanoma cells. Analysis of the protein processing of FAT1 in keratinocytes revealed that, like Drosophila FAT, human FAT1 is cleaved into a non-covalent heterodimer before achieving cell surface expression. The use of inhibitors also established that such cleavage requires the proprotein convertase furin. However, in melanoma cells, the non-cleaved proform of FAT1 is also expressed at the cell surface together with the furin-cleaved heterodimer. Moreover, furin-independent processing generates a potentially functional proteolytic product in melanoma cells, a persistent 65-kDa membrane-bound cytoplasmic fragment no longer in association with the extracellular fragment. In vitro localization studies of FAT1 showed that melanoma cells display high levels of cytosolic FAT1 protein, whereas keratinocytes, despite comparable FAT1 expression levels, exhibited mainly cell-cell junctional staining. Such differences in protein distribution appear to reconcile with the different protein products generated by dual FAT1 processing. We suggest that the uncleaved FAT1 could promote altered signaling, and the novel products of alternate processing provide a dominant negative function in melanoma.	[de Bock, Charles E.; Yeadon, Trina; Boyd, Andrew W.] Queensland Inst Med Res, Leukaemia Fdn, Queensland Res Unit, Brisbane, Qld 4006, Australia; [Zhang, Xu Dong; Hersey, Peter] Calvary Mater Newcastle Hosp, Immunol & Oncol Unit, Waratah, NSW 2298, Australia; [Song, Chaojun; Jin, Boquan] Fourth Mil Med Univ, Dept Immunol, Xian 710032, Shaanxi Prov, Peoples R China; [Sadeqzadeh, Elham; de Bock, Charles E.; Shipman, Kristy L.; Scott, Naomi M.; Oliveira, Camila S.; Burns, Gordon F.; Thorne, Rick F.] Univ Newcastle, Canc Res Unit, Sch Pharm & Biomed Sci, Callaghan, NSW 2308, Australia	QIMR Berghofer Medical Research Institute; Calvary Mater Newcastle Hospital; Air Force Military Medical University; University of Newcastle	Thorne, RF (corresponding author), Canc Inst New S Wales, Westmead, NSW, Australia.	Rick.Thorne@newcastle.edu.au	Scott, Naomi/R-9951-2017; de Bock, Charles/H-7699-2019; Zhang, xiaoyu/GXA-3206-2022; zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022	de Bock, Charles/0000-0001-5182-8535; Thorne, Rick/0000-0001-7882-7081; Zhang, Xu Dong/0000-0001-9457-8003	National Health and Medical Research Council of Australia; Hunter Medical Research Institute; Cancer Institute New South Wales	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Hunter Medical Research Institute; Cancer Institute New South Wales	This work was supported in part by grants from the National Health and Medical Research Council of Australia and the Hunter Medical Research Institute (to R. F. T., X. D. Z., P. H., A. W. B., and G. F. B.).; Recipient of a career development fellowship from the Cancer Institute New South Wales.; Recipient of a career development fellowship from the Cancer Institute New South Wales. To whom correspondence should be addressed. Tel.: 61-2-49217860; Fax: 61-2-49216903; E- mail: Rick.Thorne@newcastle.edu.au.	Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045; Braun GS, 2007, J BIOL CHEM, V282, P22823, DOI 10.1074/jbc.M701758200; Bush G, 2001, DEV BIOL, V229, P494, DOI 10.1006/dbio.2000.9992; Cox B, 2000, DEV DYNAM, V217, P233, DOI 10.1002/(SICI)1097-0177(200003)217:3<233::AID-DVDY1>3.0.CO;2-O; de Bock CE, 2005, FEBS J, V272, P3572, DOI 10.1111/j.1742-4658.2005.04778.x; Down M, 2005, GENE EXPR PATTERNS, V5, P483, DOI 10.1016/j.modgep.2004.12.005; DUNNE J, 1995, GENOMICS, V30, P207, DOI 10.1006/geno.1995.9884; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Feng YQ, 2009, P NATL ACAD SCI USA, V106, P11989, DOI 10.1073/pnas.0811540106; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Hou R, 2006, J CELL BIOL, V173, P417, DOI 10.1083/jcb.200508121; Hou R, 2009, J BIOL CHEM, V284, P6955, DOI 10.1074/jbc.M809333200; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jiang CC, 2007, CANCER RES, V67, P5880, DOI 10.1158/0008-5472.CAN-07-0213; Kwaepila N, 2006, PATHOLOGY, V38, P125, DOI 10.1080/00313020600559975; Liu L, 1997, CELL SIGNAL, V9, P299, DOI 10.1016/S0898-6568(97)89891-9; Magg T, 2005, EXP CELL RES, V307, P100, DOI 10.1016/j.yexcr.2005.03.006; MAHONEY PA, 1991, CELL, V67, P853, DOI 10.1016/0092-8674(91)90359-7; Moeller MJ, 2004, EMBO J, V23, P3769, DOI 10.1038/sj.emboj.7600380; Nakaya K, 2007, ONCOGENE, V26, P5300, DOI 10.1038/sj.onc.1210330; Ponassi M, 1999, MECH DEVELOP, V80, P207, DOI 10.1016/S0925-4773(98)00217-2; Rand MD, 2000, MOL CELL BIOL, V20, P1825, DOI 10.1128/MCB.20.5.1825-1835.2000; Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Settakorn J, 2005, J CLIN PATHOL, V58, P1249, DOI 10.1136/jcp.2005.026575; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; Skouloudaki K, 2009, P NATL ACAD SCI USA, V106, P8579, DOI 10.1073/pnas.0811691106; Sopko R, 2009, CURR BIOL, V19, P1112, DOI 10.1016/j.cub.2009.05.049; Tanoue T, 2004, J CELL BIOL, V165, P517, DOI 10.1083/jcb.200403006; Thorne RF, 1997, BIOCHEM BIOPH RES CO, V240, P812, DOI 10.1006/bbrc.1997.7755; Thorne RF, 2000, J BIOL CHEM, V275, P35264, DOI 10.1074/jbc.M003969200; Thorne RF, 2006, DNA CELL BIOL, V25, P302, DOI 10.1089/dna.2006.25.302; Thorne RF, 2010, BBA-MOL CELL RES, V1803, P1298, DOI 10.1016/j.bbamcr.2010.07.002; Wang YF, 2007, CLIN CANCER RES, V13, P4934, DOI 10.1158/1078-0432.CCR-07-0665	34	44	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28181	28191		10.1074/jbc.M111.234419	http://dx.doi.org/10.1074/jbc.M111.234419			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680732	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000293557800036
J	Christensen, MHE; Dankel, SN; Nordbo, Y; Varhaug, JE; Almas, B; Lien, EA; Mellgren, G				Christensen, Monika H. E.; Dankel, Simon N.; Nordbo, Yngve; Varhaug, Jan Erik; Almas, Bjorg; Lien, Ernst A.; Mellgren, Gunnar			Primary Hyperparathyroidism Influences the Expression of Inflammatory and Metabolic Genes in Adipose Tissue	PLOS ONE			English	Article							MILD PRIMARY HYPERPARATHYROIDISM; PARATHYROID-HORMONE; INSULIN-RESISTANCE; MATRIX METALLOPROTEINASES; CARDIOVASCULAR-DISEASE; ATHEROSCLEROSIS; MATRIX-METALLOPROTEINASE-9; OBESITY; PROTEINS; DENSITY	Background: Primary hyperparathyroidism (PHPT) is characterised by increased production of parathyroid hormone (PTH) resulting in elevated serum calcium levels. The influence on bone metabolism with altered bone resorption is the most studied clinical condition in PHPT. In addition to this, patients with PHPT are at increased risk of non-skeletal diseases, such as impaired insulin sensitivity, arterial hypertension and increased risk of death by cardiovascular diseases (CVD), possibly mediated by a chronic low-grade inflammation. The aim of this study was to investigate whether adipose tissue reflects the low-grade inflammation observed in PHPT patients. Methodology/Principal Findings: Subcutaneous fat tissue from the neck was sampled from 16 non-obese patients with PHPT and from 16 patients operated for benign thyroid diseases, serving as weight-matched controls. RNA was extracted and global gene expression was analysed with Illumina BeadArray Technology. We found 608 differentially expressed genes (q-value<0.05), of which 347 were up-regulated and 261 were down-regulated. Gene ontology analysis showed that PHPT patients expressed increased levels of genes involved in immunity and defense (e.g. matrix metallopeptidase 9, S100 calcium binding protein A8 and A9, CD14, folate receptor 2), and reduced levels of genes involved in metabolic processes. Analysis of transcription factor binding sites present in the differentially expressed genes corroborated the up-regulation of inflammatory processes. Conclusions/Significance: Our findings demonstrate that PHPT strongly influences gene regulation in fat tissue, which may result in altered adipose tissue function and release of pathogenic factors that increase the risk of CVD.	[Christensen, Monika H. E.; Dankel, Simon N.; Almas, Bjorg; Lien, Ernst A.; Mellgren, Gunnar] Univ Bergen, Inst Med, Bergen, Norway; [Christensen, Monika H. E.; Dankel, Simon N.; Almas, Bjorg; Lien, Ernst A.; Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Nordbo, Yngve; Varhaug, Jan Erik] Haukeland Hosp, Dept Surg, N-5021 Bergen, Norway; [Varhaug, Jan Erik] Univ Bergen, Dept Surg Sci, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen	Christensen, MHE (corresponding author), Univ Bergen, Inst Med, Bergen, Norway.	gunnar.mellgren@med.uib.no	Mellgren, Gunnar/AAG-6573-2020	Mellgren, Gunnar/0000-0001-6282-4986; Dankel, Simon/0000-0001-6972-1824	Samarbeidsorganet Helse Vest RHF	Samarbeidsorganet Helse Vest RHF	Funding for this project was provided by Samarbeidsorganet Helse Vest RHF (http://www.helse-bergen.no/forskning/samarbeidsorganet). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blankenberg S, 2003, CIRCULATION, V107, P1579, DOI 10.1161/01.CIR.0000058700.41738.12; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Brown JM, 2008, CIRCULATION, V118, P1467, DOI 10.1161/CIRCULATIONAHA.108.793182; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chang E, 2009, MOL CELL ENDOCRINOL, V307, P77, DOI 10.1016/j.mce.2009.03.024; Christiansen P, 1999, BONE, V25, P589, DOI 10.1016/S8756-3282(99)00207-0; Chudek Jerzy, 2006, Pharmacol Rep, V58 Suppl, P81; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Fraser WD, 2009, LANCET, V374, P145, DOI 10.1016/S0140-6736(09)60507-9; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; GALIS ZS, 1994, J CLIN INVEST, V94, P2493, DOI 10.1172/JCI117619; Galis ZS, 2002, CIRC RES, V90, P251, DOI 10.1161/res.90.3.251; Gallant S, 2006, ARCH IMMUNOL THER EX, V54, P149, DOI 10.1007/s00005-006-0017-z; Gebhardt C, 2006, BIOCHEM PHARMACOL, V72, P1622, DOI 10.1016/j.bcp.2006.05.017; Hagstrom E, 2009, CIRCULATION, V119, P2765, DOI 10.1161/CIRCULATIONAHA.108.808733; Havel PJ, 2004, DIABETES, V53, pS143, DOI 10.2337/diabetes.53.2007.S143; Jorde R, 2000, J CLIN EPIDEMIOL, V53, P1164, DOI 10.1016/S0895-4356(00)00239-0; Kern PA, 2003, DIABETES, V52, P1779, DOI 10.2337/diabetes.52.7.1779; Lundgren E, 1997, SURGERY, V121, P287, DOI 10.1016/S0039-6060(97)90357-3; Mayas MD, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-3; McClelland P, 1998, J CELL BIOCHEM, V70, P391; Nakajima K, 2010, ENDOCR J, V57, P153; Ntambi JM, 2002, P NATL ACAD SCI USA, V99, P11482, DOI 10.1073/pnas.132384699; Oberkofler H, 2002, BBA-GENE STRUCT EXPR, V1575, P75, DOI 10.1016/S0167-4781(02)00279-8; Ogard CG, 2005, CLIN ENDOCRINOL, V63, P493, DOI 10.1111/j.1365-2265.2005.02363.x; Olson FJ, 2008, J INTERN MED, V263, P626, DOI 10.1111/j.1365-2796.2008.01927.x; Packard RRS, 2008, CLIN CHEM, V54, P24, DOI 10.1373/clinchem.2007.097360; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Raggatt LJ, 2008, J BIOL CHEM, V283, P6790, DOI 10.1074/jbc.M709909200; RAY D, 1992, MOL CELL BIOL, V12, P4297, DOI 10.1128/MCB.12.10.4297; Riserus U, 2005, DIABETES, V54, P1379, DOI 10.2337/diabetes.54.5.1379; Rodgers SE, 2008, CURR OPIN ONCOL, V20, P52, DOI 10.1097/CCO.0b013e3282f2838f; Rubin MR, 2005, J CLIN ENDOCR METAB, V90, P3326, DOI 10.1210/jc.2004-1400; Ryckman C, 2003, J IMMUNOL, V170, P3233, DOI 10.4049/jimmunol.170.6.3233; Smith JC, 2000, J CLIN ENDOCR METAB, V85, P3515, DOI 10.1210/jc.85.10.3515; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; Tassone F, 2009, DIABETIC MED, V26, P968, DOI 10.1111/j.1464-5491.2009.02804.x; Tayebjee MH, 2004, AM J HYPERTENS, V17, P764, DOI 10.1016/j.amjhyper.2004.05.019; Theroux P, 2006, CAN J CARDIOL, V22, p18B, DOI 10.1016/S0828-282X(06)70982-5; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wermers RA, 2006, J BONE MINER RES, V21, P171, DOI 10.1359/JBMR.050910; Wiesner P, 2010, CIRC RES, V107, P56, DOI 10.1161/CIRCRESAHA.110.218420; Yu N, 2010, CLIN ENDOCRINOL, V73, P30, DOI 10.1111/j.1365-2265.2009.03766.x; Zakrzewska A, 2010, BLOOD, V116, pE1, DOI 10.1182/blood-2010-01-262873	48	31	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20481	10.1371/journal.pone.0020481	http://dx.doi.org/10.1371/journal.pone.0020481			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698093	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600006
J	Liesenfeld, O; Parvanova, I; Zerrahn, J; Han, SJ; Heinrich, F; Munoz, M; Kaiser, F; Aebischer, T; Buch, T; Waisman, A; Reichmann, G; Utermohlen, O; von Stebut, E; von Loewenich, FD; Bogdan, C; Specht, S; Saeftel, M; Hoerauf, A; Mota, MM; Konen-Waisman, S; Kaufmann, SHE; Howard, JC				Liesenfeld, Oliver; Parvanova, Iana; Zerrahn, Jens; Han, Seong-Ji; Heinrich, Frederik; Munoz, Melba; Kaiser, Frank; Aebischer, Toni; Buch, Thorsten; Waisman, Ari; Reichmann, Gaby; Utermoehlen, Olaf; von Stebut, Esther; von Loewenich, Friederike D.; Bogdan, Christian; Specht, Sabine; Saeftel, Michael; Hoerauf, Achim; Mota, Maria M.; Koenen-Waisman, Stephanie; Kaufmann, Stefan H. E.; Howard, Jonathan C.			The IFN-gamma-Inducible GTPase, Irga6, Protects Mice against Toxoplasma gondii but Not against Plasmodium berghei and Some Other Intracellular Pathogens	PLOS ONE			English	Article							IMMUNITY-RELATED GTPASES; HOST-RESISTANCE; INTERFERON-GAMMA; CELLULAR-RESPONSE; BALB/C MICE; CELLS; INFECTION; GENE; ENCEPHALITIS; LIVER	Clearance of infection with intracellular pathogens in mice involves interferon-regulated GTPases of the IRG protein family. Experiments with mice genetically deficient in members of this family such as Irgm1(LRG-47), Irgm3(IGTP), and Irgd(IRG-47) has revealed a critical role in microbial clearance, especially for Toxoplasma gondii. The in vivo role of another member of this family, Irga6 (IIGP, IIGP1) has been studied in less detail. We investigated the susceptibility of two independently generated mouse strains deficient in Irga6 to in vivo infection with T. gondii, Mycobacterium tuberculosis, Leishmania mexicana, L. major, Listeria monocytogenes, Anaplasma phagocytophilum and Plasmodium berghei. Compared with wild-type mice, mice deficient in Irga6 showed increased susceptibility to oral and intraperitoneal infection with T. gondii but not to infection with the other organisms. Surprisingly, infection of Irga6-deficient mice with the related apicomplexan parasite, P. berghei, did not result in increased replication in the liver stage and no Irga6 (or any other IRG protein) was detected at the parasitophorous vacuole membrane in IFN-gamma-induced wild-type cells infected with P. berghei in vitro. Susceptibility to infection with T. gondii was associated with increased mortality and reduced time to death, increased numbers of inflammatory foci in the brains and elevated parasite loads in brains of infected Irga6-deficient mice. In vitro, Irga6-deficient macrophages and fibroblasts stimulated with IFN-gamma were defective in controlling parasite replication. Taken together, our results implicate Irga6 in the control of infection with T. gondii and further highlight the importance of the IRG system for resistance to this pathogen.	[Liesenfeld, Oliver; Han, Seong-Ji; Heinrich, Frederik; Munoz, Melba] Charite Univ Med Berlin, Inst Microbiol & Hyg, Berlin, Germany; [Parvanova, Iana; Buch, Thorsten; Waisman, Ari; Koenen-Waisman, Stephanie; Howard, Jonathan C.] Univ Cologne, Inst Genet, D-5000 Cologne, Germany; [Zerrahn, Jens; Kaiser, Frank; Kaufmann, Stefan H. E.] Max Planck Inst Infect Biol, Dept Immunol, Berlin, Germany; [Aebischer, Toni] Max Planck Inst Infect Biol, Dept Mol Biol, Berlin, Germany; [Reichmann, Gaby] Univ Dusseldorf, Inst Med Microbiol, Dusseldorf, Germany; [Utermoehlen, Olaf] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Cologne, Germany; [von Stebut, Esther] Johannes Gutenberg Univ Mainz, Dept Dermatol, Mainz, Germany; [von Loewenich, Friederike D.; Bogdan, Christian] Univ Hosp Freiburg, Dept Med Microbiol & Hyg, Inst Med Microbiol & Hyg, Freiburg, Germany; [Bogdan, Christian] Univ Hosp Erlangen, Microbiol Inst Clin Microbiol Immunol & Hyg, Erlangen, Germany; [Specht, Sabine; Saeftel, Michael; Hoerauf, Achim] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-5300 Bonn, Germany; [Mota, Maria M.] Univ Lisbon, Malaria Unit, Inst Mol Med, Fac Med, P-1699 Lisbon, Portugal	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; Max Planck Society; Max Planck Society; Heinrich Heine University Dusseldorf; University of Cologne; Johannes Gutenberg University of Mainz; University of Freiburg; University of Erlangen Nuremberg; University of Bonn; Universidade de Lisboa	Liesenfeld, O (corresponding author), Roche Mol Diagnost, Pleasanton, CA USA.	j.howard@uni-koeln.de	Waisman, Ari/C-7383-2015; Loewenich, Friederike/AAL-1587-2020; Mota, Maria/AAF-2048-2019; Buch, Thorsten/P-1659-2019; Kaufmann, Stefan HE/I-5454-2014	Waisman, Ari/0000-0003-4304-8234; Buch, Thorsten/0000-0002-2236-9074; Munoz, Melba/0000-0003-3386-4502; Bogdan, Christian/0000-0002-2300-0631; Mota, Maria Manuel/0000-0002-2858-1041; Howard, Jonathan/0000-0003-2756-5143; Aebischer, Toni/0000-0002-4875-8457; Kaufmann, Stefan HE/0000-0001-9866-8268	German Research Foundation (DFG) [SFB633, SPP1110, SFB670, LO 1163/1-2, SPP1110 Bo996/3-3, SFB643, A6, BU1410/1-1, SFB490]; European Science Foundation EURYI; Fundacao para a Ciencia e Tecnologia	German Research Foundation (DFG)(German Research Foundation (DFG)); European Science Foundation EURYI(European Science Foundation (ESF)); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	These studies were supported in part by the German Research Foundation (DFG) (SFB633, to O.L., SPP1110 and SFB670 to J.C.H., LO 1163/1-2 to F.D.v.L., SPP1110 Bo996/3-3 and SFB643 project A6 to C.B., BU1410/1-1 to T.B., SFB490 to A.W.), and by the European Science Foundation EURYI programme and the Fundacao para a Ciencia e Tecnologia to M.M.M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Zeer MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004588; Asanovich KM, 1997, J INFECT DIS, V176, P1029, DOI 10.1086/516529; Aschner M, 1998, TOXICOL LETT, V103, P283, DOI 10.1016/S0378-4274(98)00324-5; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Boehm U, 1998, J IMMUNOL, V161, P6715; CARLOW DA, 1995, J IMMUNOL, V154, P1724; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; Coers J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000333; Collazo CM, 2002, INFECT IMMUN, V70, P6933, DOI 10.1128/IAI.70.12.6933-6939.2002; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dunay IR, 2004, ANTIMICROB AGENTS CH, V48, P4848, DOI 10.1128/AAC.48.12.4848-4854.2004; Fagard R, 1999, PARASITOL TODAY, V15, P504, DOI 10.1016/S0169-4758(99)01568-9; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; GILLY M, 1992, J IMMUNOL, V148, P3275; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Hunn JP, 2011, MAMM GENOME, V22, P43, DOI 10.1007/s00335-010-9293-3; Hunn JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001008; Kang H, 2003, J IMMUNOL, V170, P4254, DOI 10.4049/jimmunol.170.8.4254; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Liu CH, 2006, J IMMUNOL, V177, P31, DOI 10.4049/jimmunol.177.1.31; Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Mollenkopf HJ, 2006, MICROBES INFECT, V8, P136, DOI 10.1016/j.micinf.2005.06.015; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nelson DE, 2005, P NATL ACAD SCI USA, V102, P10658, DOI 10.1073/pnas.0504198102; Parvanova I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005078; Prudencio M, 2006, NAT REV MICROBIOL, V4, P849, DOI 10.1038/nrmicro1529; Schaible UE, 2002, METHOD MICROBIOL, V31, P343, DOI 10.1016/S0580-9517(02)31020-1; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Sinai AP, 1997, ANNU REV MICROBIOL, V51, P415, DOI 10.1146/annurev.micro.51.1.415; SORACE JM, 1995, J LEUKOCYTE BIOL, V58, P477, DOI 10.1002/jlb.58.4.477; Spath GF, 2001, EXP PARASITOL, V99, P97, DOI 10.1006/expr.2001.4656; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Suzuki Y, 2002, J INFECT DIS, V186, pS234, DOI 10.1086/344276; Suzuki Y, 2002, J INFECT DIS, V185, pS58, DOI 10.1086/337999; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; SUZUKI Y, 1989, J IMMUNOL, V143, P2045; Taylor GA, 2000, P NATL ACAD SCI USA, V97, P751, DOI 10.1073/pnas.97.2.751; Taylor GA, 1996, J BIOL CHEM, V271, P20399, DOI 10.1074/jbc.271.34.20399; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; TSUJI M, 1994, PARASITOL RES, V80, P16, DOI 10.1007/BF00932618; von Loewenich FD, 2004, EUR J IMMUNOL, V34, P1789, DOI 10.1002/eji.200425250; von Stebut E, 2003, J EXP MED, V198, P191, DOI 10.1084/jem.20030159; Zeng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006787; Zerrahn J, 2002, J IMMUNOL, V168, P3428, DOI 10.4049/jimmunol.168.7.3428; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190	54	55	56	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20568	10.1371/journal.pone.0020568	http://dx.doi.org/10.1371/journal.pone.0020568			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698150	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600010
J	Charlton, BD; Reby, D				Charlton, Benjamin D.; Reby, David			Context-Related Acoustic Variation in Male Fallow Deer (Dama dama) Groans	PLOS ONE			English	Article							SOURCE-FILTER THEORY; VOCAL-TRACT LENGTH; RED DEER; GRUNT VOCALIZATIONS; MATING SUCCESS; BUCKS; CALLS; CUES; ROARS; SIZE	While social and behavioural contexts are known to affect the acoustic structure of vocal signals in several mammal species, few studies have investigated context-related acoustic variation during inter-sexual advertisement and/or intra-sexual competition. Here we recorded male fallow deer groans during the breeding season and investigated how key acoustic parameters (fundamental frequency and formant frequencies) vary as a function of the social context in which they are produced. We found that in the presence of females, male fallow deer produced groans with higher mean fundamental frequency when vocal males were also present than they did when no vocal males were in close vicinity. We attribute this to the increased arousal state typically associated with this context. In addition, groan minimum formant frequency spacing was slightly, but significantly lower (indicating marginally more extended vocal tracts) when males were alone than when potential mates and/or competitors were nearby. This indicates that, contrary to our predictions, male fallow deer do not exaggerate the acoustic impression of their body size by further lowering their formant frequencies in the presence of potential mating partners and competitors. Furthermore, since the magnitude of the variation in groan minimum formant frequency spacing remains small compared to documented inter-individual differences, our findings are consistent with the hypothesis that formants are reliable static cues to body size during intra-and inter-sexual advertisement that do not concurrently encode dynamic motivation-related information.	[Charlton, Benjamin D.] Univ Vienna, Dept Cognit Biol, Vienna, Austria; [Reby, David] Univ Sussex, Sch Psychol, Sussex, England	University of Vienna; University of Sussex	Charlton, BD (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	reby@sussex.ac.uk	reby, david/A-4227-2013	Charlton, Benjamin/0000-0002-0218-7177; Reby, David/0000-0001-9261-1711	European Research Council [230604]; Nuffield Foundation	European Research Council(European Research Council (ERC)European Commission); Nuffield Foundation	BC was supported by a European Research Council Advanced Grant SOMACCA (No. 230604) awarded to W. Tecumseh Fitch. DR was supported by a grant from the Nuffield Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger J, 1991, BEHAV ECOL, V2, P1, DOI 10.1093/beheco/2.1.1; Blumstein DT, 1997, ANIM BEHAV, V53, P143, DOI 10.1006/anbe.1996.0285; Briefer E, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-35; Burnham K.P., 1998, MODEL SELECTION INFE, DOI [10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Charlton BD, 2008, J ACOUST SOC AM, V123, P2936, DOI 10.1121/1.2896758; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2011, BIOL LETTERS, V7, P71, DOI 10.1098/rsbl.2010.0582; Charlton BD, 2010, P R SOC B, V277, P1101, DOI 10.1098/rspb.2009.1431; Charlton BD, 2009, J ACOUST SOC AM, V126, P2721, DOI 10.1121/1.3224720; Charlton BD, 2009, ANIM BEHAV, V78, P893, DOI 10.1016/j.anbehav.2009.06.029; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1988, BEHAV ECOL SOCIOBIOL, V23, P281, DOI 10.1007/BF00300575; Dabbs JM, 1999, PERS INDIV DIFFER, V27, P801, DOI 10.1016/S0191-8869(98)00272-4; Engqvist L, 2005, ANIM BEHAV, V70, P967, DOI 10.1016/j.anbehav.2005.01.016; Fischer J, 2002, J ACOUST SOC AM, V111, P1465, DOI 10.1121/1.1433807; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; Manser MB, 2002, TRENDS COGN SCI, V6, P55, DOI 10.1016/S1364-6613(00)01840-4; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; McElligott AG, 2006, J ZOOL, V270, P340, DOI 10.1111/j.1469-7998.2006.00144.x; McElligott AG, 1999, ANIM BEHAV, V57, P1159, DOI 10.1006/anbe.1999.1076; McElligott AG, 1999, ANIM BEHAV, V58, P1095, DOI 10.1006/anbe.1999.1237; MOORE NP, 1995, BEHAV ECOL SOCIOBIOL, V36, P91, DOI 10.1007/s002650050128; Notman H, 2005, ANIM BEHAV, V70, P177, DOI 10.1016/j.anbehav.2004.08.024; OHALA JJ, 1984, PHONETICA, V41, P1, DOI 10.1159/000261706; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Puts DA, 2007, EVOL HUM BEHAV, V28, P340, DOI 10.1016/j.evolhumbehav.2007.05.002; Reby D, 1998, J ZOOL, V245, P79, DOI 10.1017/S0952836998005093; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Rendall D, 1999, ANIM BEHAV, V57, P583, DOI 10.1006/anbe.1998.1031; Rendall D, 2004, J ACOUST SOC AM, V115, P411, DOI 10.1121/1.1635838; Rendall D, 2003, J ACOUST SOC AM, V113, P3390, DOI 10.1121/1.1568942; Riede T, 1999, J EXP BIOL, V202, P2859; Sanvito S, 2007, ANIM BEHAV, V73, P287, DOI 10.1016/j.anbehav.2006.08.005; Smith DRR, 2005, J ACOUST SOC AM, V117, P305, DOI 10.1121/1.1828637; Sugiura H, 2007, AM J PRIMATOL, V69, P1412, DOI 10.1002/ajp.20447; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Taylor AM, 2009, ETHOLOGY, V115, P905, DOI 10.1111/j.1439-0310.2009.01681.x; Titze IR, 1994, PRINCIPLES VOICE PRO; Vannoni E, 2007, ETHOLOGY, V113, P223, DOI 10.1111/j.1439-0310.2006.01323.x; Vannoni E, 2009, ANIM BEHAV, V78, P3, DOI 10.1016/j.anbehav.2009.03.015; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; WEILGART LS, 1990, BEHAV ECOL SOCIOBIOL, V26, P399; Yin S, 2004, ANIM BEHAV, V68, P343, DOI 10.1016/j.anbehav.2003.07.016; [No title captured]; [No title captured]; [No title captured]	49	22	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e21066	10.1371/journal.pone.0021066	http://dx.doi.org/10.1371/journal.pone.0021066			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695159	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000291663300037
J	Ferno, J; Varela, L; Skrede, S; Vazquez, MJ; Nogueiras, R; Dieguez, C; Vidal-Puig, A; Steen, VM; Lopez, M				Ferno, Johan; Varela, Luis; Skrede, Silje; Jesus Vazquez, Maria; Nogueiras, Ruben; Dieguez, Carlos; Vidal-Puig, Antonio; Steen, Vidar M.; Lopez, Miguel			Olanzapine-Induced Hyperphagia and Weight Gain Associate with Orexigenic Hypothalamic Neuropeptide Signaling without Concomitant AMPK Phosphorylation	PLOS ONE			English	Article							FATTY-ACID-METABOLISM; ACTIVATED PROTEIN-KINASE; FOOD-INTAKE; ANTIPSYCHOTIC OLANZAPINE; LIPID-METABOLISM; BODY-WEIGHT; CLOZAPINE; MODEL; RATS; HALOPERIDOL	The success of antipsychotic drug treatment in patients with schizophrenia is limited by the propensity of these drugs to induce hyperphagia, weight gain and other metabolic disturbances, particularly evident for olanzapine and clozapine. However, the molecular mechanisms involved in antipsychotic-induced hyperphagia remain unclear. Here, we investigate the effect of olanzapine administration on the regulation of hypothalamic mechanisms controlling food intake, namely neuropeptide expression and AMP-activated protein kinase (AMPK) phosphorylation in rats. Our results show that subchronic exposure to olanzapine upregulates neuropeptide Y (NPY) and agouti related protein (AgRP) and downregulates proopiomelanocortin (POMC) in the arcuate nucleus of the hypothalamus (ARC). This effect was evident both in rats fed ad libitum and in pair-fed rats. Of note, despite weight gain and increased expression of orexigenic neuropeptides, subchronic administration of olanzapine decreased AMPK phosphorylation levels. This reduction in AMPK was not observed after acute administration of either olanzapine or clozapine. Overall, our data suggest that olanzapine-induced hyperphagia is mediated through appropriate changes in hypothalamic neuropeptides, and that this effect does not require concomitant AMPK activation. Our data shed new light on the hypothalamic mechanism underlying antipsychotic-induced hyperphagia and weight gain, and provide the basis for alternative targets to control energy balance.	[Ferno, Johan; Skrede, Silje; Steen, Vidar M.] Univ Bergen, Dept Clin Med, Dr Einar Martens Res Grp Biol Psychiat, Bergen, Norway; [Ferno, Johan; Skrede, Silje; Steen, Vidar M.] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Varela, Luis; Jesus Vazquez, Maria; Nogueiras, Ruben; Dieguez, Carlos; Lopez, Miguel] Univ Santiago de Compostela, Dept Physiol, Sch Med, Inst Invest Sanitaria IDIS, Santiago De Compostela, Spain; [Varela, Luis; Jesus Vazquez, Maria; Nogueiras, Ruben; Dieguez, Carlos; Lopez, Miguel] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Santiago De Compostela, Spain; [Vidal-Puig, Antonio] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs, Cambridge CB2 2QQ, England	University of Bergen; University of Bergen; Haukeland University Hospital; Universidade de Santiago de Compostela; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ferno, J (corresponding author), Univ Bergen, Dept Clin Med, Dr Einar Martens Res Grp Biol Psychiat, Bergen, Norway.	johan.ferno@uib.no; m.lopez@usc.es	López, Miguel/ABF-4844-2021; Fernø, Johan A/D-5024-2011; Nogueiras, Ruben/AAS-9427-2021; Varela, Luis/ABG-7581-2020; Skrede, Silje/AAA-4453-2019	López, Miguel/0000-0002-7823-1648; Fernø, Johan A/0000-0002-4598-2955; Nogueiras, Ruben/0000-0002-9976-9930; Varela, Luis/0000-0001-7794-7241; Vidal-Puig, Antonio/0000-0003-4220-9577; dieguez, carlos/0000-0002-0919-4337	Research Council of Norway; Norwegian Council for Mental Health; Extrastiftelsen Helse og Rehabilitering; Helse Vest RHF; Dr. Einar Martens Fund; European Community [245009, 223713, 018734]; Xunta de Galicia [ML: 10PXIB208164PR, RN: 2010/14]; Fondo Investigationes Sanitarias [ML: PS09/01880]; Ministerio de Educacion y Ciencia [CD: BFU2008-02001, ML: RyC-2007-00211, RN: RyC-2008-02219, SAF2009-07049]; Medical Research Council; Welcome Trust; Medical Research Council [G0802051] Funding Source: researchfish; MRC [G0802051] Funding Source: UKRI	Research Council of Norway(Research Council of Norway); Norwegian Council for Mental Health; Extrastiftelsen Helse og Rehabilitering; Helse Vest RHF; Dr. Einar Martens Fund; European Community(European Commission); Xunta de Galicia(Xunta de GaliciaEuropean Commission); Fondo Investigationes Sanitarias(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia(Spanish Government); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Welcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge the research infrastructure provided by the Norwegian Microarray Consortium (NMC; www.microarray.no), a national FUGE technology platform (Functional Genomics in Norway; www.fuge.no). The present study has been supported by grants from the Research Council of Norway (incl. the FUGE program and "PSYKISK HELSE" program), Norwegian Council for Mental Health, Extrastiftelsen Helse og Rehabilitering (JF), Helse Vest RHF, Dr. Einar Martens Fund, European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements n<SUP>o</SUP> 245009 and 223713 (CD, ML and RN) and n<SUP>o</SUP> 018734 (AVP), Xunta de Galicia (ML: 10PXIB208164PR; RN: 2010/14)), Fondo Investigationes Sanitarias (ML: PS09/01880), Ministerio de Educacion y Ciencia (CD: BFU2008-02001; ML: RyC-2007-00211; RN: RyC-2008-02219 and SAF2009-07049;), Medical Research Council (AVP) and Welcome Trust (AVP). CIBER de Fisiopatologia de la Obesidad y Nutricion is an initiative of ISCIII. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Allison DB, 1999, AM J PSYCHIAT, V156, P1686; Andrews ZB, 2008, NATURE, V454, P846, DOI 10.1038/nature07181; Arjona AA, 2004, BEHAV BRAIN RES, V152, P121, DOI 10.1016/j.bbr.2003.09.040; Barrett E, 2004, OBES RES, V12, P362; Blouin M, 2008, OBESITY, V16, P1780, DOI 10.1038/oby.2008.277; Boyda HN, 2010, TRENDS PHARMACOL SCI, V31, P484, DOI 10.1016/j.tips.2010.07.002; Carling D, 2004, TRENDS BIOCHEM SCI, V29, P18, DOI 10.1016/j.tibs.2003.11.005; Chakravarthy MV, 2007, J CLIN INVEST, V117, P2539, DOI 10.1172/JCI31183; Coccurello R, 2006, PSYCHOPHARMACOLOGY, V186, P561, DOI 10.1007/s00213-006-0368-5; Coccurello R, 2008, Eat Weight Disord, V13, pe55; Coccurello R, 2008, J PHARMACOL EXP THER, V326, P905, DOI 10.1124/jpet.108.137240; Coccurello R, 2009, J CLIN PSYCHOPHARM, V29, P576, DOI 10.1097/JCP.0b013e3181bfe13e; Colton Craig W, 2006, Prev Chronic Dis, V3, pA42; Cooper GD, 2008, PROG NEURO-PSYCHOPH, V32, P428, DOI 10.1016/j.pnpbp.2007.09.012; Cooper GD, 2005, PSYCHOPHARMACOLOGY, V181, P80, DOI 10.1007/s00213-005-2224-4; Cope MB, 2005, INT J OBESITY, V29, P607, DOI 10.1038/sj.ijo.0802928; Davoodi N, 2009, PSYCHOPHARMACOLOGY, V203, P693, DOI 10.1007/s00213-008-1415-1; Fell MJ, 2004, J PSYCHOPHARMACOL, V18, P149, DOI 10.1177/0269881104042613; Ferno J, 2009, PSYCHOPHARMACOLOGY, V203, P73, DOI 10.1007/s00213-008-1370-x; Goudie AJ, 2002, J PSYCHOPHARMACOL, V16, P291, DOI 10.1177/026988110201600402; Guesdon B, 2010, BEHAV BRAIN RES, V207, P14, DOI 10.1016/j.bbr.2009.09.032; Hartfield AW, 2006, NEUROPSYCHOPHARMACOL, V31, P1938, DOI 10.1038/sj.npp.1300949; Hartfield AW, 2003, PSYCHOPHARMACOLOGY, V167, P115, DOI 10.1007/s00213-002-1368-8; Hu ZY, 2003, P NATL ACAD SCI USA, V100, P12624, DOI 10.1073/pnas.1834402100; Huang XF, 2006, NEUROPEPTIDES, V40, P213, DOI 10.1016/j.npep.2006.01.002; Jin H, 2008, SCHIZOPHR RES, V100, P70, DOI 10.1016/j.schres.2007.11.026; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim SF, 2007, P NATL ACAD SCI USA, V104, P3456, DOI 10.1073/pnas.0611417104; Kirk SL, 2006, J PSYCHOPHARMACOL, V20, P577, DOI 10.1177/0269881106061199; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lage R, 2010, FASEB J, V24, P2670, DOI 10.1096/fj.09-150672; Lane MD, 2008, INT J OBESITY, V32, pS49, DOI 10.1038/ijo.2008.123; Lopez M, 2006, DIABETES, V55, P1327, DOI 10.2337/db05-1356; Lopez M, 2005, DIABETOLOGIA, V48, P140, DOI 10.1007/s00125-004-1596-z; Lopez M, 2008, CELL METAB, V8, P176, DOI 10.1016/j.cmet.2008.08.003; Lopez M, 2008, CELL METAB, V7, P389, DOI 10.1016/j.cmet.2008.03.006; Lopez M, 2007, P NUTR SOC, V66, P131, DOI 10.1017/S0029665107005368; Lopez M, 2007, BIOESSAYS, V29, P248, DOI 10.1002/bies.20539; Lopez M, 2010, NAT MED, V16, P1001, DOI 10.1038/nm.2207; Martins PJF, 2010, DIABETES, V59, P2418, DOI 10.2337/db10-0449; Minet-Ringuet J, 2006, PSYCHOPHARMACOLOGY, V187, P447, DOI 10.1007/s00213-006-0433-0; Minet-Ringuet J, 2006, APPETITE, V46, P254, DOI 10.1016/j.appet.2006.01.008; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Nasrallah HA, 2008, MOL PSYCHIATR, V13, P27, DOI 10.1038/sj.mp.4002066; Pouzet B, 2003, PHARMACOL BIOCHEM BE, V75, P133, DOI 10.1016/S0091-3057(03)00042-X; Reynolds GP, 2010, PHARMACOL THERAPEUT, V125, P169, DOI 10.1016/j.pharmthera.2009.10.010; Sangiao-Alvarellos S, 2010, J NEUROENDOCRINOL, V22, P543, DOI 10.1111/j.1365-2826.2010.01994.x; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Varela L, 2011, J MOL ENDOCRINOL, V46, pR43, DOI 10.1677/JME-10-0068; Vazquez MJ, 2008, ENDOCRINOLOGY, V149, P4534, DOI 10.1210/en.2007-1708; Weiden PJ, 2004, SCHIZOPHR RES, V66, P51, DOI 10.1016/S0920-9964(02)00498-X	53	89	89	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20571	10.1371/journal.pone.0020571	http://dx.doi.org/10.1371/journal.pone.0020571			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695181	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300007
J	Grech, A; Coles, R				Grech, Alana; Coles, Rob			Interactions between a Trawl Fishery and Spatial Closures for Biodiversity Conservation in the Great Barrier Reef World Heritage Area, Australia	PLOS ONE			English	Article							MARINE RESERVES; FISHING EFFORT; HABITATS; PARK	Background: The Queensland East Coast Otter Trawl Fishery (ECOTF) for penaeid shrimp fishes within Australia's Great Barrier Reef World Heritage Area (GBRWHA). The past decade has seen the implementation of conservation and fisheries management strategies to reduce the impact of the ECOTF on the seabed and improve biodiversity conservation. New information from electronic vessel location monitoring systems (VMS) provides an opportunity to review the interactions between the ECOTF and spatial closures for biodiversity conservation. Methodology and Results: We used fishing metrics and spatial information on the distribution of closures and modelled VMS data in a geographical information system (GIS) to assess change in effort of the trawl fishery from 2001-2009 and to quantify the exposure of 70 reef, non-reef and deep water bioregions to trawl fishing. The number of trawlers and the number of days fished almost halved between 2001 and 2009 and new spatial closures introduced in 2004 reduced the area zoned available for trawl fishing by 33%. However, we found that there was only a relatively minor change in the spatial footprint of the fishery as a result of new spatial closures. Non-reef bioregions benefited the most from new spatial closures followed by deep and reef bioregions. Conclusions/Significance: Although the catch of non target species remains an issue of concern for fisheries management, the small spatial footprint of the ECOTF relative to the size of the GBRWHA means that the impact on benthic habitats is likely to be negligible. The decline in effort as a result of fishing industry structural adjustment, increasing variable costs and business decisions of fishers is likely to continue a trend to fish only in the most productive areas. This will provide protection for most benthic habitats without any further legislative or management intervention.	[Grech, Alana; Coles, Rob] Fisheries Queensland, Dept Employment Econ Dev & Innovat, Cairns, Qld, Australia; [Grech, Alana] James Cook Univ, Australian Res Council, Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia	James Cook University	Grech, A (corresponding author), Fisheries Queensland, Dept Employment Econ Dev & Innovat, Cairns, Qld, Australia.	alana.grech@jcu.edu.au	Grech, Alana/U-7776-2019; Grech, Alana/E-9464-2011; Coles, Robert/O-5638-2014	Grech, Alana/0000-0003-4117-3779; Grech, Alana/0000-0003-4117-3779; Coles, Robert/0000-0002-3192-3778	Fisheries Queensland (Department of Employment, Economic Development and Innovation); Commonwealth Department of Environment through the Marine and Tropical Research Facility	Fisheries Queensland (Department of Employment, Economic Development and Innovation); Commonwealth Department of Environment through the Marine and Tropical Research Facility	Funding was provided by Fisheries Queensland (Department of Employment, Economic Development and Innovation; http://www.dpi.qld.gov.au/28.htm) and the Commonwealth Department of Environment through the Marine and Tropical Research Facility (www.rrrc.org.au/mtsrf/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	DAY J, 2000, P 9 INT COR REEF S 2, P687; *DEP EMPL EC DEV I, 2010, ANN STAT REP 2010 E; Fernandes L, 2005, CONSERV BIOL, V19, P1733, DOI 10.1111/j.1523-1739.2005.00302.x; GOOD N, 2007, INNOVATIVE STOCL ASS; Gribble NA, 1998, J ENVIRON MANAGE, V52, P53, DOI 10.1006/jema.1997.0160; GUPTA S, 2010, NEW SCI         1127; Halpern BS, 2007, CONSERV BIOL, V21, P1301, DOI 10.1111/j.1523-1739.2007.00752.x; Halpern BS, 2003, ECOL APPL, V13, pS117; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kaiser MJ, 2002, FISH FISH, V3, P114, DOI 10.1046/j.1467-2979.2002.00079.x; Macintosh A, 2010, OCEAN COAST MANAGE, V53, P581, DOI 10.1016/j.ocecoaman.2010.06.012; McCook LJ, 2010, P NATL ACAD SCI USA, V107, P18278, DOI 10.1073/pnas.0909335107; Nilsson P, 2007, AQUAT CONSERV, V17, P421, DOI 10.1002/aqc.792; O'Neill MF, 2007, FISH RES, V85, P84, DOI 10.1016/j.fishres.2006.12.006; PEEL P, 2011, CANADIAN J IN PRESS; Pitcher R. C., 2007, SEABED BIODIVERSITY; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; St Martin K, 2008, MAR POLICY, V32, P779, DOI 10.1016/j.marpol.2008.03.015	18	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e21094	10.1371/journal.pone.0021094	http://dx.doi.org/10.1371/journal.pone.0021094			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695155	Green Published, gold, Green Accepted			2022-12-25	WOS:000291663300039
J	Kempes, CP; West, GB; Crowell, K; Girvan, M				Kempes, Christopher P.; West, Geoffrey B.; Crowell, Kelly; Girvan, Michelle			Predicting Maximum Tree Heights and Other Traits from Allometric Scaling and Resource Limitations	PLOS ONE			English	Article							GENERAL QUANTITATIVE THEORY; PLANT FUNCTIONAL TYPES; VEGETATION DYNAMICS; FOREST DYNAMICS; METABOLIC THEORY; BIOSPHERE MODEL; CLIMATE; ECOLOGY; GROWTH; BIOLOGY	Terrestrial vegetation plays a central role in regulating the carbon and water cycles, and adjusting planetary albedo. As such, a clear understanding and accurate characterization of vegetation dynamics is critical to understanding and modeling the broader climate system. Maximum tree height is an important feature of forest vegetation because it is directly related to the overall scale of many ecological and environmental quantities and is an important indicator for understanding several properties of plant communities, including total standing biomass and resource use. We present a model that predicts local maximal tree height across the entire continental United States, in good agreement with data. The model combines scaling laws, which encode the average, base-line behavior of many tree characteristics, with energy budgets constrained by local resource limitations, such as precipitation, temperature and solar radiation. In addition to predicting maximum tree height in an environment, our framework can be extended to predict how other tree traits, such as stomatal density, depend on these resource constraints. Furthermore, it offers predictions for the relationship between height and whole canopy albedo, which is important for understanding the Earth's radiative budget, a critical component of the climate system. Because our model focuses on dominant features, which are represented by a small set of mechanisms, it can be easily integrated into more complicated ecological or climate models.	[Kempes, Christopher P.] MIT, Dept Earth Atmosphere & Planetary Sci, Cambridge, MA 02139 USA; [Kempes, Christopher P.; West, Geoffrey B.; Girvan, Michelle] Santa Fe Inst, Santa Fe, NM 87501 USA; [Crowell, Kelly] Portage, Los Alamos, NM USA; [Girvan, Michelle] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Girvan, Michelle] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA; [Girvan, Michelle] Inst Adv Study, Princeton, NJ 08540 USA	Massachusetts Institute of Technology (MIT); The Santa Fe Institute; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Institute for Advanced Study - USA	Kempes, CP (corresponding author), MIT, Dept Earth Atmosphere & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ckempes@mit.edu	Girvan, Michelle/E-3982-2016	Girvan, Michelle/0000-0003-0299-0784; Girvan, Michelle/0000-0001-7519-2842	Colorado College; National Science Foundation [PHY0202180]; Gordon and Betty Moore Foundation; Massachusetts Institute of Technology Society of Presidential Fellows; Thaw Charitable Trust; Engineering and Physical Sciences Research Council	Colorado College; National Science Foundation(National Science Foundation (NSF)); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Massachusetts Institute of Technology Society of Presidential Fellows; Thaw Charitable Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Christopher Kempes acknowledges the Colorado College venture grant program, a National Science Foundation Research Experience for Undergraduates stipend, the Gordon and Betty Moore Foundation, the NSF Graduate Research Fellowship Program, and the Massachusetts Institute of Technology Society of Presidential Fellows for supporting this work. Geoffrey West was supported by funding from the Thaw Charitable Trust, the Engineering and Physical Sciences Research Council, and NSF Grant PHY0202180. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kelly Crowell is an employee of Portage Inc., which made available the use of ArcInfo software during final figure preparation.	[Anonymous], FOR INV AN; [Anonymous], CONT US LOW RES SOL; BEERLING DJ, 1993, ANN BOT-LONDON, V71, P231, DOI 10.1006/anbo.1993.1029; Beringer J, 2005, AGR FOREST METEOROL, V131, P143, DOI 10.1016/j.agrformet.2005.05.006; Bonan GB, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2000GB001360; Bonan GB, 2003, GLOBAL CHANGE BIOL, V9, P1543, DOI 10.1046/j.1365-2486.2003.00681.x; BOTKIN DB, 1972, J ECOL, V60, P849, DOI 10.2307/2258570; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Bugmann H, 2001, CLIMATIC CHANGE, V51, P259, DOI 10.1023/A:1012525626267; Campbell GS., 1998, INTRO ENV BIOPHYSICS, DOI [10.1007/978-1-4612-1626-1, DOI 10.1007/978-1-4612-1626-1]; CHARNEY J, 1975, SCIENCE, V187, P434, DOI 10.1126/science.187.4175.434; Coates KD, 2003, FOREST ECOL MANAG, V186, P297, DOI 10.1016/S0378-1127(03)00301-3; DALY C, 1994, J APPL METEOROL, V33, P140, DOI 10.1175/1520-0450(1994)033&lt;0140:ASTMFM&gt;2.0.CO;2; Enquist BJ, 2001, NATURE, V410, P655, DOI 10.1038/35070500; Enquist BJ, 1998, NATURE, V395, P163, DOI 10.1038/25977; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; Falster DS, 2005, OIKOS, V111, P57, DOI 10.1111/j.0030-1299.2005.13383.x; Falster DS, 2005, J ECOL, V93, P521, DOI 10.1111/j.0022-0477.2005.00992.x; Falster DS, 2003, TRENDS ECOL EVOL, V18, P337, DOI 10.1016/S0169-5347(03)00061-2; Foley JA, 1996, GLOBAL BIOGEOCHEM CY, V10, P603, DOI 10.1029/96GB02692; Haxeltine A, 1996, J VEG SCI, V7, P651, DOI 10.2307/3236377; Haxeltine A, 1996, GLOBAL BIOGEOCHEM CY, V10, P693, DOI 10.1029/96GB02344; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KING DA, 1990, AM NAT, V135, P809, DOI 10.1086/285075; Knutti R, 2008, J CLIMATE, V21, P2651, DOI 10.1175/2007JCLI2119.1; Koch GW, 2004, NATURE, V428, P851, DOI 10.1038/nature02417; MCMAHON TA, 1976, J THEOR BIOL, V59, P443, DOI 10.1016/0022-5193(76)90182-X; Medvigy D, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2008JG000812; Medvigy D, 2010, P NATL ACAD SCI USA, V107, P8275, DOI 10.1073/pnas.0912032107; MITCHELL KJ, 1975, FOREST SCI, P1; Monteith JL., 2008, PRINCIPLES ENV PHYS, V3, P229; Moorcroft PR, 2006, TRENDS ECOL EVOL, V21, P400, DOI 10.1016/j.tree.2006.04.009; Moorcroft PR, 2003, P ROY SOC B-BIOL SCI, V270, P1215, DOI 10.1098/rspb.2002.2251; Moorcroft PR, 2001, ECOL MONOGR, V71, P557, DOI 10.1890/0012-9615(2001)071[0557:AMFSVD]2.0.CO;2; Mori S, 2010, P NATL ACAD SCI USA, V107, P1447, DOI 10.1073/pnas.0902554107; Muller-Landau HC, 2006, ECOL LETT, V9, P589, DOI 10.1111/j.1461-0248.2006.00915.x; NCDC, NOAA SAT INF SERV; Niklas K.J., 1994, PLANT ALLOMETRY SCAL; Niklas KJ, 2007, TREE PHYSIOL, V27, P433, DOI 10.1093/treephys/27.3.433; Niklas KJ, 2006, AM J BOT, V93, P824, DOI 10.3732/ajb.93.6.824; Niklas KJ, 2004, BIOL REV, V79, P871, DOI 10.1017/S1464793104006499; Niklas KJ, 2004, P NATL ACAD SCI USA, V101, P15661, DOI 10.1073/pnas.0405857101; NIKLAS KJ, 1994, AM J BOT, V81, P1235, DOI 10.2307/2445398; Niklas KJ, 2001, P NATL ACAD SCI USA, V98, P2922, DOI 10.1073/pnas.041590298; Pacala SW, 1996, ECOL MONOGR, V66, P1, DOI 10.2307/2963479; PRENTICE IC, 1992, J BIOGEOGR, V19, P117, DOI 10.2307/2845499; Price CA, 2007, P NATL ACAD SCI USA, V104, P13204, DOI 10.1073/pnas.0702242104; Price CA, 2010, NEW PHYTOL, V188, P696, DOI 10.1111/j.1469-8137.2010.03442.x; Price CA, 2009, ECOL LETT, V12, P641, DOI 10.1111/j.1461-0248.2009.01316.x; Purves D, 2008, SCIENCE, V320, P1452, DOI 10.1126/science.1155359; Purves DW, 2008, P NATL ACAD SCI USA, V105, P17018, DOI 10.1073/pnas.0807754105; Purves DW, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000870; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; RUNNING SW, 1988, ECOL MODEL, V42, P125, DOI 10.1016/0304-3800(88)90112-3; RUNNING SW, 1989, ECOLOGY, V70, P1090, DOI 10.2307/1941378; Ryan MG, 1997, BIOSCIENCE, V47, P235, DOI 10.2307/1313077; Salas E, 2004, ANN FOREST SCI, V61, P337, DOI 10.1051/forest:2004027; Smith WB, 2002, ENVIRON POLLUT, V116, pS233, DOI 10.1016/S0269-7491(01)00255-X; STANHILL G, 1970, SOL ENERGY, V13, P59, DOI 10.1016/0038-092X(70)90007-1; Strigul N, 2008, ECOL MONOGR, V78, P523, DOI 10.1890/08-0082.1; Waring R. H., 2007, FOREST ECOSYSTEMS AN; West GB, 1999, NATURE, V400, P664, DOI 10.1038/23251; West GB, 1997, SCIENCE, V276, P122, DOI 10.1126/science.276.5309.122; West GB, 2009, P NATL ACAD SCI USA, V106, P7040, DOI 10.1073/pnas.0812294106	64	65	66	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20551	10.1371/journal.pone.0020551	http://dx.doi.org/10.1371/journal.pone.0020551			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695189	Green Submitted, Green Published, gold			2022-12-25	WOS:000291663300006
J	Buren, S; Ortega-Villasante, C; Blanco-Rivero, A; Martinez-Bernardini, A; Shutova, T; Shevela, D; Messinger, J; Bako, L; Villarejo, A; Samuelsson, G				Buren, Stefan; Ortega-Villasante, Cristina; Blanco-Rivero, Amaya; Martinez-Bernardini, Andrea; Shutova, Tatiana; Shevela, Dmitriy; Messinger, Johannes; Bako, Laszlo; Villarejo, Arsenio; Samuelsson, Goran			Importance of Post-Translational Modifications for Functionality of a Chloroplast-Localized Carbonic Anhydrase (CAH1) in Arabidopsis thaliana	PLOS ONE			English	Article							DEFECTIVE BRASSINOSTEROID RECEPTOR; N-LINKED OLIGOSACCHARIDES; ENDOPLASMIC-RETICULUM; SWISS-MODEL; SECRETORY PATHWAY; QUALITY-CONTROL; PROTEIN; ALPHA; EXPRESSION; PLANT	Background: The Arabidopsis CAH1 alpha-type carbonic anhydrase is one of the few plant proteins known to be targeted to the chloroplast through the secretory pathway. CAH1 is post-translationally modified at several residues by the attachment of N-glycans, resulting in a mature protein harbouring complex-type glycans. The reason of why trafficking through this non-canonical pathway is beneficial for certain chloroplast resident proteins is not yet known. Therefore, to elucidate the significance of glycosylation in trafficking and the effect of glycosylation on the stability and function of the protein, epitope-labelled wild type and mutated versions of CAH1 were expressed in plant cells. Methodology/Principal Findings: Transient expression of mutant CAH1 with disrupted glycosylation sites showed that the protein harbours four, or in certain cases five, N-glycans. While the wild type protein trafficked through the secretory pathway to the chloroplast, the non-glycosylated protein formed aggregates and associated with the ER chaperone BiP, indicating that glycosylation of CAH1 facilitates folding and ER-export. Using cysteine mutants we also assessed the role of disulphide bridge formation in the folding and stability of CAH1. We found that a disulphide bridge between cysteines at positions 27 and 191 in the mature protein was required for correct folding of the protein. Using a mass spectrometric approach we were able to measure the enzymatic activity of CAH1 protein. Under circumstances where protein N-glycosylation is blocked in vivo, the activity of CAH1 is completely inhibited. Conclusions/Significance: We show for the first time the importance of post-translational modifications such as N-glycosylation and intramolecular disulphide bridge formation in folding and trafficking of a protein from the secretory pathway to the chloroplast in higher plants. Requirements for these post-translational modifications for a fully functional native protein explain the need for an alternative route to the chloroplast.	[Buren, Stefan; Martinez-Bernardini, Andrea; Shutova, Tatiana; Messinger, Johannes; Bako, Laszlo; Samuelsson, Goran] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden; [Shevela, Dmitriy; Messinger, Johannes] Umea Univ, Dept Chem, S-90187 Umea, Sweden; [Ortega-Villasante, Cristina; Blanco-Rivero, Amaya; Martinez-Bernardini, Andrea; Villarejo, Arsenio] Univ Autonoma Madrid, Dept Biol, Madrid, Spain	Umea University; Umea University; Autonomous University of Madrid	Buren, S (corresponding author), Spanish Natl Canc Res Ctr CNIO, Madrid, Spain.	goran.samuelsson@plantphys.umu.se	Messinger, Johannes/AAC-4221-2019; Burén, Stefan/L-6705-2014; Shevela, Dmitry/AAA-2155-2019; Samuelsson, Goran/E-1824-2015; Shevela, Dmitry/AAG-6936-2019; Shevela, Dmitriy/F-1974-2011; Ortega-Villasante, Cristina/F-6719-2012	Messinger, Johannes/0000-0003-2790-7721; Burén, Stefan/0000-0002-8487-2732; Shevela, Dmitry/0000-0002-5174-083X; Ortega-Villasante, Cristina/0000-0003-1224-6676; Shutova, Tatyana/0000-0002-4095-9609; Blanco-Rivero, Amaya/0000-0002-2954-6205	Swedish Research Council (VR); Kempe Foundations; Carl Tryggers Foundation; Spanish Ministerio de Ciencia e Innovacion (MICINN) [BIO2006-08946, BIO2009-11340]	Swedish Research Council (VR)(Swedish Research Council); Kempe Foundations; Carl Tryggers Foundation; Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Swedish Research Council (VR), the Kempe Foundations and Carl Tryggers Foundation to GS, and grant numbers BIO2006-08946 and BIO2009-11340 from the Spanish Ministerio de Ciencia e Innovacion (MICINN) to AV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asatsuma S, 2005, PLANT CELL PHYSIOL, V46, P858, DOI 10.1093/pcp/pci091; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; Bencur P, 2005, BIOCHEM J, V388, P515, DOI 10.1042/BJ20042091; Chen MH, 2004, PLANT PHYSIOL, V135, P1367, DOI 10.1104/pp.104.042184; CHEN MH, 1994, PLANT J, V6, P625, DOI 10.1046/j.1365-313X.1994.6050625.x; Clausen J, 2005, PLANT PHYSIOL, V139, P1444, DOI 10.1104/pp.105.068437; Crofts AJ, 1998, PLANT CELL, V10, P813, DOI 10.1105/tpc.10.5.813; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Downing WL, 2006, PLANT BIOTECHNOL J, V4, P169, DOI 10.1111/j.1467-7652.2005.00166.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fabre N, 2007, PLANT CELL ENVIRON, V30, P617, DOI 10.1111/j.1365-3040.2007.01651.x; FAYE L, 1985, ANAL BIOCHEM, V149, P218, DOI 10.1016/0003-2697(85)90498-1; FORSAYETH JR, 1992, J CELL BIOL, V117, P841, DOI 10.1083/jcb.117.4.841; Gasparian M, 2000, PLANT PHYSIOL, V122, P25, DOI 10.1104/pp.122.1.25; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hancock KR, 1997, BIOTECHNIQUES, V22, P861, DOI 10.2144/97225bm16; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; HewettEmmett D, 1996, MOL PHYLOGENET EVOL, V5, P50, DOI 10.1006/mpev.1996.0006; Hilvo M, 2005, BIOCHEM J, V392, P83, DOI 10.1042/BJ20051102; Hong Z, 2008, PLANT CELL, V20, P3418, DOI 10.1105/tpc.108.061879; Huang SH, 1998, J MOL BIOL, V283, P301, DOI 10.1006/jmbi.1998.2077; HUSIC HD, 1991, CAN J BOT, V69, P1079, DOI 10.1139/b91-138; Jarvis P, 2004, CURR BIOL, V14, pR1064, DOI 10.1016/j.cub.2004.11.049; Jin H, 2007, MOL CELL, V26, P821, DOI 10.1016/j.molcel.2007.05.015; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kitajima A, 2009, PLANT CELL, V21, P2844, DOI 10.1105/tpc.109.068288; Kjaer S, 2003, HUM MOL GENET, V12, P2133, DOI 10.1093/hmg/ddg227; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Leung J, 2006, PLANT SCI, V171, P596, DOI 10.1016/j.plantsci.2006.06.009; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; MESSINGER J, 1995, P NATL ACAD SCI USA, V92, P3209, DOI 10.1073/pnas.92.8.3209; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Moroney JV, 2001, PLANT CELL ENVIRON, V24, P141, DOI 10.1111/j.1365-3040.2001.00669.x; Nanjo Y, 2006, PLANT CELL, V18, P2582, DOI 10.1105/tpc.105.039891; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; PRICE GD, 1994, PLANTA, V193, P331, DOI 10.1007/BF00201810; Richardson MC, 2009, J CLIN ENDOCR METAB, V94, P670, DOI 10.1210/jc.2008-2025; Samuelsson G, 2001, ADV PHOTOSYNTH, V11, P313; Sawaya MR, 2006, J BIOL CHEM, V281, P7546, DOI 10.1074/jbc.M510464200; Shental-Bechor D, 2008, P NATL ACAD SCI USA, V105, P8256, DOI 10.1073/pnas.0801340105; Song CJ, 2006, PLANT PHYSIOL, V140, P1222, DOI 10.1104/pp.105.073072; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Villarejo A, 2005, NAT CELL BIOL, V7, P1224, DOI 10.1038/ncb1330; VONSCHAEWEN A, 1993, PLANT PHYSIOL, V102, P1109, DOI 10.1104/pp.102.4.1109; Waheed A, 1996, ARCH BIOCHEM BIOPHYS, V333, P432, DOI 10.1006/abbi.1996.0412; Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856; Wujek P, 2004, J BIOL CHEM, V279, P12827, DOI 10.1074/jbc.M313173200; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	54	56	57	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21021	10.1371/journal.pone.0021021	http://dx.doi.org/10.1371/journal.pone.0021021			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695217	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612600042
J	Oliveira, IS; Lacorte, GA; Fonseca, CG; Wieloch, AH; Mayer, G				Oliveira, Ivo S.; Lacorte, Gustavo A.; Fonseca, Cleusa G.; Wieloch, Alfredo H.; Mayer, Georg			Cryptic Speciation in Brazilian Epiperipatus (Onychophora: Peripatidae) Reveals an Underestimated Diversity among the Peripatid Velvet Worms	PLOS ONE			English	Article							MITOCHONDRIAL; PHYLOGENIES; SEQUENCES; PROVIDES; SUPPORT; NUCLEAR; MARKERS	Background: Taxonomical studies of the neotropical Peripatidae (Onychophora, velvet worms) have proven difficult, due to intraspecific variation and uniformity of morphological characters across this onychophoran subgroup. We therefore used molecular approaches, in addition to morphological methods, to explore the diversity of Epiperipatus from the Minas Gerais State of Brazil. Methodology/Principal Findings: Our analyses revealed three new species. While Epiperipatus diadenoproctus sp. nov. can be distinguished from E. adenocryptus sp. nov. and E. paurognostus sp. nov. based on morphology and specific nucleotide positions in the mitochondrial cytochrome c oxidase subunit I (COI) and small ribosomal subunit RNA gene sequences (12S rRNA), anatomical differences between the two latter species are not evident. However, our phylogenetic analyses of molecular data suggest that they are cryptic species, with high Bayesian posterior probabilities and bootstrap and Bremer support values for each species clade. The sister group relationship of E. adenocryptus sp. nov. and E. paurognostus sp. nov. in our analyses correlates with the remarkable morphological similarity of these two species. To assess the species status of the new species, we performed a statistical parsimony network analysis based on 582 base pairs of the COI gene in our specimens, with the connection probability set to 95%. Our findings revealed no connections between groups of haplotypes, which have been recognized as allopatric lineages in our phylogenetic analyses, thus supporting our suggestion that they are separate species. Conclusions/Significance: Our findings suggest high cryptic species diversity and endemism among the neotropical Peripatidae and demonstrate that the combination of morphological and molecular approaches is helpful for clarifying the taxonomy and species diversity of this apparently large and diverse onychophoran group.	[Oliveira, Ivo S.; Mayer, Georg] Univ Leipzig, Inst Biol Anim Evolut & Dev, Leipzig, Germany; [Lacorte, Gustavo A.; Fonseca, Cleusa G.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Oliveira, Ivo S.; Wieloch, Alfredo H.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Zool, Belo Horizonte, MG, Brazil	Leipzig University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Oliveira, IS (corresponding author), Univ Leipzig, Inst Biol Anim Evolut & Dev, Leipzig, Germany.	ivo.sena@gmail.com	Lacorte, Gustavo Augusto/AAS-1968-2021; G.A., Lacorte/T-8904-2017; Oliveira, Ivo S./H-3727-2013; Mayer, Georg/Y-9581-2018	Lacorte, Gustavo Augusto/0000-0002-6866-348X; G.A., Lacorte/0000-0002-6866-348X; Oliveira, Ivo S./0000-0002-8340-7660; Mayer, Georg/0000-0003-0737-2440	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [481868-2007-0, 290029/2010-4]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais [APQ-01133-08]; German Research Foundation [MA 4147/3-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); German Research Foundation(German Research Foundation (DFG))	This study was supported by grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpq.br) to AHW (CNPq - Brazil: 481868-2007-0) and ISO (student fellowship CNPq-Brazil, current process 290029/2010-4), the Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (www.fapemig.br) to GAL and CGF (FAPEMIG, APQ-01133-08), and the German Research Foundation (www.dfg.de) to GM (DFG: MA 4147/3-1). GM is a Research Group Leader supported by the DFG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUVIER EL, 1905, ANN SCI NATURELLES 9, V2, P1; Brito Samuel V., 2010, Neotropical Biology and Conservation, V5, P47, DOI 10.4013/nbc.2010.51.07; BROWN RW, 1956, COMPOSITION SCI WORD, P882; BURSELL E, 1950, J EXP BIOL, V26, P335; Chen HL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009318, 10.1371/journal.pone.0012885]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CULPUMAGANA FG, 2008, ENTOMOL NEWS, V119, P545; Daniels SR, 2010, J ZOOL, V282, P171, DOI 10.1111/j.1469-7998.2010.00722.x; Daniels SR, 2009, BIOL J LINN SOC, V97, P200, DOI 10.1111/j.1095-8312.2009.01205.x; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Gleeson DM, 1998, MOL PHYLOGENET EVOL, V10, P237, DOI 10.1006/mpev.1998.0512; Goloboff PA, 2004, CLADISTICS, V20, P84; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Green Phil, 1994, PHRAP; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hart MW, 2007, BIOL LETTERS, V3, P509, DOI 10.1098/rsbl.2007.0307; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kemp Stanley, 1913, Records of the Indian Museum, V9; KUMAR S, 2007, MEGA4 MOL EVOLUTIONA; Mayer G, 2007, ZOOTAXA, P21, DOI 10.11646/zootaxa.1440.1.2; MAYR E., 1942, Systematics and the origin of species from the viewpoint of a zoologist.; Morera-Brenes B, 2010, REV BIOL TROP, V58, P1127; NIXON KC, 1990, CLADISTICS, V6, P211, DOI 10.1111/j.1096-0031.1990.tb00541.x; Oliveira Ivo de S., 2005, Lundiana, V6, P61; Oliveira ID, 2010, ZOOTAXA, P16; PECK S B, 1975, Psyche (Cambridge), V82, P341, DOI 10.1155/1975/98614; PFENNINGER M, 1997, EVOL BIOL, V7, P121; Podsiadlowski L, 2008, MOL BIOL EVOL, V25, P42, DOI 10.1093/molbev/msm223; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; READ VMS, 1988, ZOOL J LINN SOC-LOND, V93, P187, DOI 10.1111/j.1096-3642.1988.tb01361.x; READ VMS, 1988, ZOOL J LINN SOC-LOND, V93, P225, DOI 10.1111/j.1096-3642.1988.tb01362.x; Reid AL, 1996, INVERTEBR TAXON, V10, P663, DOI 10.1071/IT9960663; Rockman MV, 2001, MOL PHYLOGENET EVOL, V21, P103, DOI 10.1006/mpev.2001.0990; RUCKER A, 1900, BIOL BULL, V1, P251; Ruhberg Hilke, 2005, Zootaxa, V1039, P27; Sambrook J., 2001, MOL CLONING LAB MANU; Sampaio-Costa C, 2009, ZOOLOGIA-CURITIBA, V26, P553, DOI 10.1590/S1984-46702009005000004; Sands CJ, 2009, CONSERV GENET RESOUR, V1, P17, DOI 10.1007/s12686-009-9004-0; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sunnucks P, 1999, MOL ECOL, V8, P899; SWOFFORD DL, 2002, PAUP PHYLOGENETIC AN; Trewick SA, 1998, BIOL J LINN SOC, V63, P307, DOI 10.1006/bijl.1997.0197; Trewick SA, 1999, NEW ZEAL J ZOOL, V26, P381, DOI 10.1080/03014223.1999.9518201; Trewick SA, 2000, MOL ECOL, V9, P269, DOI 10.1046/j.1365-294x.2000.00873.x	47	30	31	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e19973	10.1371/journal.pone.0019973	http://dx.doi.org/10.1371/journal.pone.0019973			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695250	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612600004
J	Gowda, NM; Wu, XZ; Gowda, DC				Gowda, Nagaraj M.; Wu, Xianzhu; Gowda, D. Channe			The Nucleosome (Histone-DNA Complex) Is the TLR9-Specific Immunostimulatory Component of Plasmodium falciparum That Activates DCs	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; INNATE IMMUNITY; CUTTING EDGE; IN-VIVO; MALARIA; TLR9; INFECTION; VACCINE; ALPHA; PHAGOCYTOSIS	The systemic clinical symptoms of Plasmodium falciparum infection such as fever and chills correspond to the proinflammatory cytokines produced in response to the parasite components released during the synchronized rupture of schizonts. We recently demonstrated that, among the schizont-released products, merozoites are the predominant components that activate dendritic cells (DCs) by TLR9-specific recognition to induce the maturation of cells and to produce proinflammatory cytokines. We also demonstrated that DNA is the active constituent and that formation of a DNA-protein complex is essential for the entry of parasite DNA into cells for recognition by TLR9. However, the nature of endogenous protein-DNA complex in the parasite is not known. In this study, we show that parasite nucleosome constitute the major protein-DNA complex involved in the activation of DCs by parasite nuclear material. The parasite components were fractionated into the nuclear and non-nuclear materials. The nuclear material was further fractionated into chromatin and the proteins loosely bound to chromatin. Polynucleosomes and oligonucleosomes were prepared from the chromatin. These were tested for their ability to activate DCs obtained by the FLT3 ligand differentiation of bone marrow cells from the wild type, and TLR2(-/-), TLR9(-/-) and MyD88(-/-) mice. DCs stimulated with the nuclear material and polynucleosomes as well as mono-and oligonucleosomes efficiently induced the production of proinflammatory cytokines in a TLR9-dependent manner, demonstrating that nucleosomes (histone-DNA complex) represent the major TLR9-specific DC-immunostimulatory component of the malaria parasite nuclear material. Thus, our data provide a significant insight into the activation of DCs by malaria parasites and have important implications for malaria vaccine development.	[Gowda, Nagaraj M.; Wu, Xianzhu; Gowda, D. Channe] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gowda, NM (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA.	gowda@psu.edu		Gowda, Channe/0000-0002-6860-5108	NIAID, the National Institutes of Health [AI 41139]; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	NIAID, the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by grants AI 41139 from NIAID, the National Institutes of Health and, in part, under a grant with the Pennsylvania Department of Health using Tobacco CURE Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; Akira S, 2009, IMMUNOL REV, V227, P5, DOI 10.1111/j.1600-065X.2008.00739.x; Alkhalil A, 2000, J BIOL CHEM, V275, P40357, DOI 10.1074/jbc.M006399200; [Anonymous], [No title captured]; Augustine AD, 2009, NAT IMMUNOL, V10, P673, DOI 10.1038/ni0709-673; Bachoon DS, 2001, J MICROBIOL METH, V47, P73, DOI 10.1016/S0167-7012(01)00296-2; Bafica A, 2006, J IMMUNOL, V177, P3515, DOI 10.4049/jimmunol.177.6.3515; Barnwell John W., 1998, P93; Bartholomeu DC, 2008, J IMMUNOL, V181, P1333, DOI 10.4049/jimmunol.181.2.1333; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bauer S, 2009, ADV EXP MED BIOL, V653, P15; BLACKMAN MJ, 1994, METHOD CELL BIOL, V45, P213; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Brasel K, 2000, BLOOD, V96, P3029, DOI 10.1182/blood.V96.9.3029.h8003029_3029_3039; Carvalho LJM, 2002, SCAND J IMMUNOL, V56, P327, DOI 10.1046/j.1365-3083.2002.01160.x; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Cox-Singh J, 2008, TRENDS PARASITOL, V24, P406, DOI 10.1016/j.pt.2008.06.001; de Alencar BCG, 2007, VACCINE, V25, P6018, DOI 10.1016/j.vaccine.2007.05.022; Dufourcq J, 1998, FEBS LETT, V421, P7, DOI 10.1016/S0014-5793(97)01522-6; Foureau DM, 2010, J IMMUNOL, V184, P7022, DOI 10.4049/jimmunol.0901642; Gilson PR, 2009, INT J PARASITOL, V39, P91, DOI 10.1016/j.ijpara.2008.09.007; Good MF, 2005, ANNU REV IMMUNOL, V23, P69, DOI 10.1146/annurev.immunol.23.021704.115638; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hunt NH, 2003, TRENDS IMMUNOL, V24, P491, DOI 10.1016/S1471-4906(03)00229-1; Kaufmann SHE, 2002, METHOD MICROBIOL, V32, P1; KHUSMITH S, 1982, INFECT IMMUN, V35, P874, DOI 10.1128/IAI.35.3.874-879.1982; Kubo T, 2001, NUCLEOS NUCLEOT NUCL, V20, P1313, DOI 10.1081/NCN-100002544; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; KWIATKOWSKI D, 1991, P NATL ACAD SCI USA, V88, P5111, DOI 10.1073/pnas.88.12.5111; KWIATKOWSKI D, 1989, CLIN EXP IMMUNOL, V77, P361; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Longhurst HJ, 1997, PARASITOLOGY, V114, P413, DOI 10.1017/S0031182096008621; Lopez-Bravo M, 2008, IMMUNITY, V29, P343, DOI 10.1016/j.immuni.2008.08.008; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mach N, 2000, CANCER RES, V60, P3239; Manicassamy S, 2009, SEMIN IMMUNOL, V21, P185, DOI 10.1016/j.smim.2009.05.005; MARSH K, 1993, BRUCECHWATTS ESSENTI, P60; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Niidome T, 2000, J PEPT SCI, V6, P271, DOI 10.1002/1099-1387(200006)6:6<271::AID-PSC249>3.3.CO;2-6; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Pearce EJ, 2006, CHEM IMMUNOL ALLERGY, V90, P82, DOI 10.1159/000088882; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Pierce SK, 2009, J IMMUNOL, V182, P5171, DOI 10.4049/jimmunol.0804153; Sandgren S, 2004, J BIOL CHEM, V279, P17951, DOI 10.1074/jbc.M311440200; Schnitzler G. R., 2001, CURRENT PROTOCOLS MO; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Voss TS, 2002, J BIOL CHEM, V277, P17493, DOI 10.1074/jbc.M200100200; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Zhu JZ, 2009, J BIOL CHEM, V284, P15750, DOI 10.1074/jbc.M901111200	60	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20398	10.1371/journal.pone.0020398	http://dx.doi.org/10.1371/journal.pone.0020398			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687712	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500021
J	Hu, YM; Coates, ARM				Hu, Yanmin; Coates, Anthony R. M.			Mycobacterium tuberculosis acg Gene Is Required for Growth and Virulence In Vivo	PLOS ONE			English	Article							ALPHA-CRYSTALLIN; HYPOXIC RESPONSE; OXIDATIVE STRESS; STATIONARY-PHASE; CARBON-MONOXIDE; BOVIS BCG; HSPX GENE; EXPRESSION; TRANSCRIPTION; MACROPHAGES	Mycobacterium tuberculosis dosRS two-component regulatory system controls transcription of approximately 50 genes including hspX, acg and Rv2030c, in response to hypoxia and nitric oxide conditions and within macrophages and mice. The hspX lies between acg and Rv2030c. However, the functions of the dosR regulated genes in vitro and in vivo are largely unknown. Previously, we demonstrated that deletion of hspX gene produced a mutant which grew faster in macrophages and in mice. In this study, we attempted to determine the functions of acg and Rv2030c by gene inactivation. We demonstrate that Rv2030c is dispensable for virulence and growth. However, deletion of acg produced a mutant which is attenuated in both resting and activated macrophages and in acute and persistent murine infection models. Surprisingly, deletion of acg did not compromise the viability of the mutant to nitrosative and oxidative stresses in vitro and in vivo. In addition, when the WT and the acg mutants were treated with antibiotics such as the prodrugs nitrofurantoin and nitrofuran, the acg mutant became more sensitive than the WT strain to these drugs. This suggests that Acg may not function as a nitroreductase. These data indicate that acg encodes an essential virulence factor for M. tuberculosis and enables it to grow and survive in macrophages and in mouse organs.	[Hu, Yanmin; Coates, Anthony R. M.] St Georges Univ London, Div Clin Sci, Infect & Immun Res Ctr, London, England	St Georges University London	Hu, YM (corresponding author), St Georges Univ London, Div Clin Sci, Infect & Immun Res Ctr, London, England.	acoates@sgul.ac.uk		Hu, Yanmin/0000-0003-0630-5342; Coates, Anthony/0000-0001-8052-3175	European Community; Burton Medical Trust	European Community(European Commission); Burton Medical Trust	This research was supported by both the European Community's Sixth Framework Programme to the project NEWTBDRUGS and the European Community's Seventh Framework Programme to the project StopLATENT-TB. The publication reflects only the authors' views. The European Community is not liable for any use that may be made of the information herein. The financial support of the Burton Medical Trust is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brondani DJ, 2008, ARCH PHARM, V341, P655, DOI 10.1002/ardp.200700243; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse PJ, 2009, INFECT IMMUN, V77, P1230, DOI 10.1128/IAI.01117-08; de Oliveira IM, 2007, BIOCHEM BIOPH RES CO, V355, P919, DOI 10.1016/j.bbrc.2007.02.049; Florczyk MA, 2003, INFECT IMMUN, V71, P5332, DOI 10.1128/IAI.71.9.5332-5343.2003; Flynn JL, 2005, TRENDS MICROBIOL, V13, P98, DOI 10.1016/j.tim.2005.01.005; Hu YM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005150; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Hu YM, 1999, J BACTERIOL, V181, P3486, DOI 10.1128/JB.181.11.3486-3493.1999; Hu YM, 1999, J BACTERIOL, V181, P1380, DOI 10.1128/JB.181.5.1380-1387.1999; Kashanian J, 2008, BJU INT, V102, P1634, DOI 10.1111/j.1464-410X.2008.07809.x; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; LEE MH, 1991, P NATL ACAD SCI USA, V88, P3111, DOI 10.1073/pnas.88.8.3111; Master SS, 2002, MICROBIOL-SGM, V148, P3139, DOI 10.1099/00221287-148-10-3139; MCOSKER CC, 1994, J ANTIMICROB CHEMOTH, V33, P23, DOI 10.1093/jac/33.suppl_A.23; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Murugasu-Oei B, 2000, J ANTIMICROB CHEMOTH, V46, P917, DOI 10.1093/jac/46.6.917; Okado-Matsumoto A, 2007, FREE RADICAL BIO MED, V43, P830, DOI 10.1016/j.freeradbiomed.2007.05.038; Parish T, 2000, MICROBIOL-SGM, V146, P1969, DOI 10.1099/00221287-146-8-1969; Parish T, 2003, INFECT IMMUN, V71, P1134, DOI 10.1128/IAI.71.3.1134-1140.2003; PARISH TSN, 1998, ELECTROPORATION MYCO; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Purkayastha A, 2002, INFECT IMMUN, V70, P1518, DOI 10.1128/IAI.70.3.1518-1529.2002; Rustad TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001502; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Smith DA, 2001, INFECT IMMUN, V69, P1142, DOI 10.1128/IAI.69.2.1442-1150.2001; Stewart JN, 2006, MICROBIOL-SGM, V152, P233, DOI 10.1099/mic.0.28275-0; Taneja NK, 2007, J ANTIMICROB CHEMOTH, V60, P288, DOI 10.1093/jac/dkm207; Vasudeva-Rao HM, 2008, INFECT IMMUN, V76, P2478, DOI 10.1128/IAI.01443-07; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; WAYNE LG, 1994, EUR J CLIN MICROBIOL, V13, P908, DOI 10.1007/BF02111491; *WHO, 2008, GLOB TUB CONTR SURV, pR8; Yuan Y, 1998, P NATL ACAD SCI USA, V95, P9578, DOI 10.1073/pnas.95.16.9578	40	25	27	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20958	10.1371/journal.pone.0020958	http://dx.doi.org/10.1371/journal.pone.0020958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687631	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000291611500053
J	Voigt, C; Gahr, M				Voigt, Cornelia; Gahr, Manfred			Social Status Affects the Degree of Sex Difference in the Songbird Brain	PLOS ONE			English	Article							BROWED SPARROW-WEAVERS; CONTROL NUCLEUS HVC; CONTROL-SYSTEM; ZEBRA FINCH; PLOCEPASSER-MAHALI; GENE-EXPRESSION; CONTROL REGIONS; MESSENGER-RNA; REPERTOIRE; BIRDS	It is thought that neural sex differences are functionally related to sex differences in the behaviour of vertebrates. A prominent example is the song control system of songbirds. Inter-specific comparisons have led to the hypothesis that sex differences in song nuclei size correlate with sex differences in song behaviour. However, only few species with similar song behaviour in both sexes have been investigated and not all data fit the hypothesis. We investigated the proposed structure - function relationship in a cooperatively breeding and duetting songbird, the white-browed sparrow weaver (Plocepasser mahali). This species lives in groups of 2-10 individuals, with a dominant breeding pair and male and female subordinates. While all male and female group members sing duet and chorus song, a male, once it has reached the dominant position in the group, sings an additional type of song that comprises a distinct and large syllable repertoire. Here we show for both types of male - female comparisons a male-biased sex difference in neuroanatomy of areas of the song production pathway (HVC and RA) that does not correlate with the observed polymorphism in song behaviour. In contrast, in situ hybridisation of mRNA of selected genes expressed in the song nucleus HVC reveals a gene expression pattern that is either similar between sexes in female - subordinate male comparisons or female-biased in female - dominant male comparisons. Thus, the polymorphic gene expression pattern would fit the sex-and status-related song behaviour. However, this implies that once a male has become dominant it produces the duetting song with a different neural phenotype than subordinate males.	[Voigt, Cornelia; Gahr, Manfred] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany	Max Planck Society	Voigt, C (corresponding author), Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany.	cornelia.voigt@gmail.com	Voigt, Cornelia/D-7156-2012	Voigt, Cornelia/0000-0002-8835-2320	Max Planck Society	Max Planck Society(Max Planck Society)	This research was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold AP, 2008, ANNU REV GENOM HUM G, V9, P109, DOI 10.1146/annurev.genom.9.081307.164220; Ball G.F., 2008, NEUROSCIENCE BIRDSON, P320; BRENOWITZ EA, 1995, J NEUROSCI, V15, P6281; BRENOWITZ EA, 1986, J NEUROSCI, V6, P2875; Brenowitz EA, 1997, J NEUROBIOL, V33, P517, DOI 10.1002/(SICI)1097-4695(19971105)33:5<517::AID-NEU3>3.0.CO;2-7; BRENOWITZ EA, 2008, NEUROSCIENCE BIRDSON, P332; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Catchpole CK, 2008, BIRD SONG: BIOLOGICAL THEMES AND VARIATIONS, 2ND EDITION, P1, DOI 10.1017/CBO9780511754791; COLLIAS NE, 1978, AUK, V95, P472; de Vries GJ, 2009, HORM BEHAV, V55, P589, DOI 10.1016/j.yhbeh.2009.03.012; DEVOOGD TJ, 1995, J NEUROBIOL, V28, P202, DOI 10.1002/neu.480280207; du Plessis M.A., 2005, ROBERTS BIRDS SO AFR, P1006; Earle R.A., 1983, SAFRING NEWS, V12, P3; Gahr M, 1998, J NEUROSCI, V18, P1124; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; Gahr M, 2007, ADV GENET, V59, P67, DOI 10.1016/S0065-2660(07)59003-6; Gahr M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003073; Gahr Manfred, 1994, P273; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Gil D, 2006, J NEUROBIOL, V66, P1602, DOI 10.1002/neu.20312; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hall ZJ, 2010, BRAIN BEHAV EVOLUT, V76, P168, DOI 10.1159/000320971; Hamilton KS, 1997, NEUROBIOL LEARN MEM, V68, P325, DOI 10.1006/nlme.1997.3781; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Jawor JM, 2008, NEUROSCI LETT, V443, P169, DOI 10.1016/j.neulet.2008.07.085; Leitner S, 2004, J NEUROBIOL, V60, P21, DOI 10.1002/neu.10331; Leitner S, 2009, OSTRICH, V80, P99, DOI 10.2989/OSTRICH.2009.80.2.6.833; LEWIS DM, 1982, IBIS, V124, P511, DOI 10.1111/j.1474-919X.1982.tb03795.x; London SE, 2009, DEV NEUROBIOL, V69, P437, DOI 10.1002/dneu.20719; MacDougall-Shackleton SA, 1999, TRENDS NEUROSCI, V22, P432, DOI 10.1016/S0166-2236(99)01434-4; Mooney R, 2001, P NATL ACAD SCI USA, V98, P12778, DOI 10.1073/pnas.221453298; NOTTEBOHM F, 1981, BRAIN RES, V213, P99, DOI 10.1016/0006-8993(81)91250-6; Nottebohm F, 2005, PLOS BIOL, V3, P759, DOI 10.1371/journal.pbio.0030164; NOTTEBOHM F, 1986, BEHAV NEURAL BIOL, V46, P445, DOI 10.1016/S0163-1047(86)90485-1; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; Scholz B, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-12; Tobari Y, 2005, ZOOL SCI, V22, P1089, DOI 10.2108/zsj.22.1089; Tomaszycki ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-24; Voigt C, 2006, BEHAVIOUR, V143, P159, DOI 10.1163/156853906775900739; Voigt C, 2004, J COMP NEUROL, V475, P83, DOI 10.1002/cne.20151; Voigt C, 2007, P ROY SOC B-BIOL SCI, V274, P2645, DOI 10.1098/rspb.2007.0858; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; WHITFIELD HJ, 1990, CELL MOL NEUROBIOL, V10, P145, DOI 10.1007/BF00733641; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	44	9	9	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20723	10.1371/journal.pone.0020723	http://dx.doi.org/10.1371/journal.pone.0020723			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687671	gold, Green Published, Green Submitted			2022-12-25	WOS:000291611500038
J	Ku, LX; Wei, XM; Zhang, SF; Zhang, J; Guo, SL; Chen, YH				Ku, Lixia; Wei, Xiaomin; Zhang, Shaofang; Zhang, Jun; Guo, Shulei; Chen, Yanhui			Cloning and Characterization of a Putative TAC1 Ortholog Associated with Leaf Angle in Maize (Zea mays L.)	PLOS ONE			English	Article							INCREASE; GROWTH	Background: Modifying plant architecture to increase photosynthesis efficiency and reduce shade avoidance response is very important for further yield improvement when crops are grown in high density. Identification of alleles controlling leaf angle in maize is needed to provide insight into molecular mechanism of leaf development and achieving ideal plant architecture to improve grain yield. Methodology/Principal Findings: The gene cloning was done by using comparative genomics, and then performing real-time polymerase chain reaction (RT-PCR) analysis to assay gene expression. The gene function was validated by sequence dissimilarity analysis and QTL mapping using a functional cleaved amplified polymorphism (CAP). Conclusions: The leaf angle is controlled by a major quantitative trait locus, ZmTAC1 (Zea mays L. Leaf Angle Control 1). ZmTAC1 has 4 exons encoding a protein with 263 amino acids, and its domains are the same as those of the rice OsTAC1 protein. ZmTAC1 was found to be located in the region of qLA2 by using the CAP marker and the F-2:3 families from the cross between Yu82 and Shen137. Real-time PCR analysis revealed ZmTAC1 expression was the highest in the leaf-sheath pulvinus, less in the leaf and shoot apical meristem, and the lowest in the root. A nucleotide difference in the 5'-untranslated region (UTR) between the compact inbred line Yu82 ("CTCC'') and the expanded inbred line Shen137 ("CCCC'') influences the expression level of ZmTAC1, further controlling the size of the leaf angle. Sequence verification of the change in the 59-UTR revealed ZmTAC1 with "CTCC'' was present in 13 compact inbred lines and ZmTAC1 with "CCCC'' was present in 18 expanded inbred lines, indicating ZmTAC1 had been extensively utilized in breeding with regard to the improvement of the maize plant architecture.	[Ku, Lixia; Wei, Xiaomin; Zhang, Shaofang; Zhang, Jun; Guo, Shulei; Chen, Yanhui] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China; [Ku, Lixia; Wei, Xiaomin; Zhang, Shaofang; Zhang, Jun; Guo, Shulei; Chen, Yanhui] Henan Agr Univ, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Wei, Xiaomin] Zhengzhou Coll Anim Husb Engn, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Agricultural University	Ku, LX (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China.	chy9890@163.com			National Natural Science Foundation of China [31071430]; National Basic Research Program of China [2009CB118400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 31071430; http://www.nsfc.gov.cn) and the National Basic Research Program of China (No. 2009CB118400; http://www.most.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [10.1007/BF02672069, DOI 10.1007/BF02672069]; Bowman JL, 2000, TRENDS PLANT SCI, V5, P110, DOI 10.1016/S1360-1385(00)01569-7; Bowman JL, 2002, TRENDS GENET, V18, P134, DOI 10.1016/S0168-9525(01)02601-4; Ding Fang, 2007, Scientia Agricultura Sinica, V40, P379; Jin J, 2008, NAT GENET, V40, P1365, DOI 10.1038/ng.247; Ku LX, 2010, THEOR APPL GENET, V121, P951, DOI 10.1007/s00122-010-1364-z; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; LU M, 2007, HEREDITA, V29, P113; Mickelson SM, 2002, CROP SCI, V42, P1902, DOI 10.2135/cropsci2002.1902; Pelleschi S, 2006, MOL BREEDING, V17, P21, DOI 10.1007/s11032-005-1031-2; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Sanmiguel P, 1998, ANN BOT-LONDON, V82, P37, DOI 10.1006/anbo.1998.0746; SUSSEX I. M., 1955, PHYTOMORPHOLOGY [DELHI], V5, P286; SUSSEX I. M., 1955, PHYTOMORPHOLOGY, V5, P253; Tan LB, 2008, NAT GENET, V40, P1360, DOI 10.1038/ng.197; Wang S., 2007, WINDOWS QTL CARTOGRA; Wu Q, 2004, CHINESE SCI BULL, V49, P2266, DOI 10.1360/972004-227; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yu YongTao, 2006, Journal of Maize Sciences, V14, P88	20	79	96	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20621	10.1371/journal.pone.0020621	http://dx.doi.org/10.1371/journal.pone.0020621			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687735	Green Submitted, gold, Green Published			2022-12-25	WOS:000291607000015
J	Zhang, XL; Xiao, WH; Wang, LH; Tian, ZG; Zhang, J				Zhang, Xulong; Xiao, Weihua; Wang, Lihua; Tian, Zhigang; Zhang, Jian			Deactivation of Signal Transducer and Activator of Transcription 3 Reverses Chemotherapeutics Resistance of Leukemia Cells via Down-Regulating P-gp	PLOS ONE			English	Article							OVARIAN-CANCER CELLS; MULTIDRUG-RESISTANCE; HEPATOCELLULAR-CARCINOMA; MYELOID-LEUKEMIA; DRUG-RESISTANCE; MDR1 EXPRESSION; GENE-EXPRESSION; LUNG-CANCER; TUMOR-CELLS; STAT3	Multidrug resistance (MDR) caused by overexpression of p-glycoprotein is a major obstacle in chemotherapy of malignant cancer, which usually is characterized by constitutive activation of signal transducer and activator of transcription 3 (STAT3), but their relation between MDR and STAT3 remains unclear. Here, we showed that STAT3 was overexpressed and highly activated in adriamycin-resistant K562/A02 cells compared with its parental K562 cells. Blockade of activation of STAT3 by STAT3 decoy oligodeoxynucleotide (ODN) promoted the accumulation and increased their sensitivity to adriamycin by down-regulating transcription of mdr1 and expression of P-gp, which were further confirmed by using STAT3-specific inhibitor JSI-124. Inhibition of STAT3 could also decrease mdr1 promoter mediated luciferase expression by using mdr1 promoter luciferase reporter construct. Otherwise, activation of STAT3 by STAT3C improved mdr1 transcription and P-gp expression. The ChIP results demonstrated that STAT3 could bind to the potential promoter region of mdr1, and STAT3 decoy depressed the binding. Further mutation assay show +64 similar to+72 region could be the STAT3 binding site. Our data demonstrate a role of STAT3 in regulation of mdr1 gene expression in myeloid leukemia and suggest that STAT3 may be a promising therapeutic target for overcoming MDR resistance in myeloid leukemia.	[Zhang, Xulong; Wang, Lihua; Zhang, Jian] Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Peoples R China; [Zhang, Xulong] Capital Med Univ, Dept Immunol, Sch Basic Med Sci, Beijing, Peoples R China; [Zhang, Xulong; Xiao, Weihua; Tian, Zhigang] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Zhang, Xulong; Xiao, Weihua; Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Shandong University; Capital Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhang, XL (corresponding author), Shandong Univ, Sch Pharmaceut Sci, Jinan 250100, Peoples R China.	zhangj65@sdu.edu.cn	Xiao, Weihua/N-2775-2013; Tian, Zhigang/J-3512-2013; Zhang, Jian/AAQ-3068-2021	Xiao, Weihua/0000-0001-9102-6326; 	Natural Science Foundation of China [30628014, 30972692, 30900751]; Ministry of Science and Technology of China [2007AA021010, 2008ZX10002-008, 2004CB518807]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Natural Science Foundation of China (#30628014; #30972692; #30900751) and Ministry of Science and Technology of China (#2007AA021010; 2008ZX10002-008; 2004CB518807). They are the funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benderra Z, 2004, CLIN CANCER RES, V10, P7896, DOI 10.1158/1078-0432.CCR-04-0795; Bentires-Alj M, 2003, ONCOGENE, V22, P90, DOI 10.1038/sj.onc.1206056; Bewry NN, 2008, MOL CANCER THER, V7, P3169, DOI 10.1158/1535-7163.MCT-08-0314; Blaskovich MA, 2003, CANCER RES, V63, P1270; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Duan ZF, 2006, CLIN CANCER RES, V12, P5055, DOI 10.1158/1078-0432.CCR-06-0861; George JA, 2005, CANCER RES, V65, P10381, DOI 10.1158/0008-5472.CAN-05-1822; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hodge DR, 2002, BIOCHEM BIOPH RES CO, V292, P287, DOI 10.1006/bbrc.2002.6652; Hui RCY, 2008, MOL CANCER THER, V7, P670, DOI 10.1158/1535-7163.MCT-07-0397; Ikuta K, 2005, ONCOL REP, V13, P217; Kourti M, 2007, INT J HEMATOL, V86, P166, DOI 10.1532/IJH97.E0624; Lau CK, 2007, CANCER BIOL THER, V6, P1900, DOI 10.4161/cbt.6.12.4970; Lee H, 2009, CANCER CELL, V15, P283, DOI 10.1016/j.ccr.2009.02.015; Leong PL, 2003, P NATL ACAD SCI USA, V100, P4138, DOI 10.1073/pnas.0534764100; Miao ZH, 2003, INT J CANCER, V106, P108, DOI 10.1002/ijc.11174; Queiroz KCS, 2010, ONCOGENE, V29, P6314, DOI 10.1038/onc.2010.375; Schaich M, 2005, BRIT J HAEMATOL, V128, P324, DOI 10.1111/j.1365-2141.2004.05319.x; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Sredni B, 2004, CANCER RES, V64, P1843, DOI 10.1158/0008-5472.CAN-03-3179; Sun XX, 2008, CANCER LETT, V262, P201, DOI 10.1016/j.canlet.2007.12.009; Vilgelm A, 2008, ONCOGENE, V27, P2170, DOI 10.1038/sj.onc.1210862; Wartenberg M, 2005, INT J CANCER, V113, P229, DOI 10.1002/ijc.20596; WeberNordt RM, 1996, BLOOD, V88, P809; Xi SC, 2005, ONCOGENE, V24, P970, DOI 10.1038/sj.onc.1208316; YANG CZ, 1995, ACTA PHARM SINIC, V16, P333; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Zhang XL, 2010, CANCER GENET CYTOGEN, V197, P46, DOI 10.1016/j.cancergencyto.2009.10.004; Zhang X, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-235; Zhang XL, 2007, ONCOL REP, V17, P1377; Zhou J, 2010, BIOCHEM PHARMACOL, V79, P1242, DOI 10.1016/j.bcp.2009.12.014	31	47	51	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20965	10.1371/journal.pone.0020965	http://dx.doi.org/10.1371/journal.pone.0020965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BN	21677772	Green Published, gold, Green Submitted			2022-12-25	WOS:000291356400038
J	Cao, Y; Nakata, M; Okamoto, S; Takano, E; Yada, T; Minokoshi, Y; Hirata, Y; Nakajima, K; Iskandar, K; Hayashi, Y; Ogawa, W; Barsh, GS; Hosoda, H; Kangawa, K; Itoh, H; Noda, T; Kasuga, M; Nakae, J				Cao, Yongheng; Nakata, Masanori; Okamoto, Shiki; Takano, Eisuke; Yada, Toshihiko; Minokoshi, Yasuhiko; Hirata, Yukio; Nakajima, Kazunori; Iskandar, Kristy; Hayashi, Yoshitake; Ogawa, Wataru; Barsh, Gregory S.; Hosoda, Hiroshi; Kangawa, Kenji; Itoh, Hiroshi; Noda, Tetsuo; Kasuga, Masato; Nakae, Jun			PDK1-Foxo1 in Agouti-Related Peptide Neurons Regulates Energy Homeostasis by Modulating Food Intake and Energy Expenditure	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; NEUROPEPTIDE-Y; BODY-WEIGHT; AGRP NEURONS; NPY/AGRP NEURONS; ARCUATE NUCLEUS; POMC NEURONS; DNA-BINDING; IN-VIVO; PROTEIN	Insulin and leptin intracellular signaling pathways converge and act synergistically on the hypothalamic phosphatidylinositol-3-OH kinase/3-phosphoinositide-dependent protein kinase 1 (PDK1). However, little is known about whether PDK1 in agouti-related peptide (AGRP) neurons contributes to energy homeostasis. We generated AGRP neuron-specific PDK1 knockout (AGRPPdk1(-/-)) mice and mice with selective expression of transactivation-defective Foxo1 (D256Foxo1(AGRP)Pdk1(-/-)). The AGRPPdk1(-/-) mice showed reductions in food intake, body length, and body weight. The D256Foxo1(AGRP)Pdk1(-/-) mice showed increased body weight, food intake, and reduced locomotor activity. After four weeks of calorie-restricted feeding, oxygen consumption and locomotor activity were elevated in AGRPPdk1(-/-) mice and reduced in D256Foxo1(AGRP)Pdk1(-/-) mice. In vitro, ghrelin-induced changes in [Ca(2+)](i) and inhibition of ghrelin by leptin were significantly attenuated in AGRPPdk1(-/-) neurons compared to control neurons. However, ghrelin-induced [Ca(2+)](i) changes and leptin inhibition were restored in D256Foxo1(AGRP)Pdk1(-/-) mice. These results suggested that PDK1 and Foxo1 signaling pathways play important roles in the control of energy homeostasis through AGRP-independent mechanisms.	[Cao, Yongheng; Iskandar, Kristy; Hayashi, Yoshitake] Kobe Univ, Grad Sch Med, Div Mol Med & Med Genet, Int Ctr Med Res & Treatment ICMRT, Kobe, Hyogo 657, Japan; [Cao, Yongheng; Nakae, Jun] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol,21st Century COE Pr, Kobe, Hyogo 657, Japan; [Nakata, Masanori; Takano, Eisuke; Yada, Toshihiko] Jichi Med Univ, Sch Med, Dept Physiol, Div Integrat Physiol, Shimotsuke, Tochigi, Japan; [Okamoto, Shiki; Minokoshi, Yasuhiko] Natl Inst Physiol Sci, Dept Dev Physiol, Div Endocrinol & Metab, Aichi, Japan; [Ogawa, Wataru] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 657, Japan; [Barsh, Gregory S.; Kasuga, Masato] Stanford Univ, Dept Genet & Pediat, Stanford, CA 94305 USA; [Hosoda, Hiroshi; Kangawa, Kenji] Natl Cardiovasc Ctr, Res Inst, Dept Biochem, Suita, Osaka 565, Japan; [Itoh, Hiroshi; Nakae, Jun] Keio Univ, Sch Med, Dept Internal Med, Div Endocrinol Metab & Nephrol, Tokyo, Japan; [Noda, Tetsuo] Japanese Fdn Canc Res, Inst Canc, Dept Cell Biol, Tokyo 170, Japan; [Cao, Yongheng; Kasuga, Masato] Int Med Ctr Japan, Res Inst, Tokyo, Japan; [Hirata, Yukio; Nakajima, Kazunori] Keio Univ, Sch Med, Dept Anat, Tokyo, Japan	Kobe University; Kobe University; Jichi Medical University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); Kobe University; Stanford University; National Cerebral & Cardiovascular Center - Japan; Keio University; Japanese Foundation for Cancer Research; National Center for Global Health & Medicine - Japan; Keio University	Cao, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Mol Med & Med Genet, Int Ctr Med Res & Treatment ICMRT, Kobe, Hyogo 657, Japan.	jnakae35@sc.itc.keio.ac.jp	Nakajima, Kazunori/L-3396-2013; Iskandar, Kristy/GOP-1990-2022; Nakae, Jun/Q-6141-2019; Noda, Tetsuo/B-1667-2016; OGAWA, Wataru/AAQ-9586-2020; Okamoto, Shiki/X-7274-2018	Nakajima, Kazunori/0000-0003-1864-9425; Iskandar, Kristy/0000-0002-5116-3809; Okamoto, Shiki/0000-0002-2802-0527; Minokoshi, Yasuhiko/0000-0002-7119-4805	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Nippon Boehringer Ingelheim Co., Ltd.; Suzuken Memorial Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Grants-in-Aid for Scientific Research [21591190] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nippon Boehringer Ingelheim Co., Ltd.(Boehringer Ingelheim); Suzuken Memorial Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant for the 21st Century COE Program "Center of Excellence for Signal Transduction Disease: Diabetes Mellitus as a Model" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to MK), a Grant-in-Aid for Creative Scientific Research from MEXT (to MK), a grant from Nippon Boehringer Ingelheim Co., Ltd. (to HI), a grant from Suzuken Memorial Foundation (to JN) and a grant from the NOVARTIS Foundation (Japan) for the Promotion of Science (to JN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Al-Qassab H, 2009, CELL METAB, V10, P343, DOI 10.1016/j.cmet.2009.09.008; Backberg M, 2003, J NEUROENDOCRINOL, V15, P1, DOI 10.1046/j.1365-2826.2003.00843.x; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Belgardt BF, 2008, CELL METAB, V7, P291, DOI 10.1016/j.cmet.2008.01.006; Bence KK, 2006, NAT MED, V12, P917, DOI 10.1038/nm1435; Bewick GA, 2005, FASEB J, V19, P1680, DOI 10.1096/fj.04-3434fje; Boura E, 2007, J BIOL CHEM, V282, P8265, DOI 10.1074/jbc.M605682200; Bucurenciu I, 2010, NAT NEUROSCI, V13, P19, DOI 10.1038/nn.2461; Chen HY, 2004, ENDOCRINOLOGY, V145, P2607, DOI 10.1210/en.2003-1596; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gropp E, 2005, NAT NEUROSCI, V8, P1289, DOI 10.1038/nn1548; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hashimoto N, 2006, NAT GENET, V38, P589, DOI 10.1038/ng1774; Iantorno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE756, DOI 10.1152/ajpendo.00570.2006; Inoue H, 2006, CELL METAB, V3, P267, DOI 10.1016/j.cmet.2006.02.009; Iskandar K, 2010, AM J PHYSIOL-ENDOC M, V298, pE787, DOI 10.1152/ajpendo.00512.2009; Ito K, 2009, P NATL ACAD SCI USA, V106, P8689, DOI 10.1073/pnas.0900064106; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 2006, NAT MED, V12, P534, DOI 10.1038/nm1392; Kohno D, 2003, DIABETES, V52, P948, DOI 10.2337/diabetes.52.4.948; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Luquet S, 2007, PEPTIDES, V28, P214, DOI 10.1016/j.peptides.2006.08.036; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Munzberg H, 2004, ENDOCRINOLOGY, V145, P4880, DOI 10.1210/en.2004-0726; Muroya S, 2004, EUR J NEUROSCI, V19, P1524, DOI 10.1111/j.1460-9568.2004.03255.x; Nakae J, 2000, EMBO J, V19, P989, DOI 10.1093/emboj/19.5.989; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Okamoto Y, 2007, DIABETES, V56, P1000, DOI 10.2337/db06-1322; Ollmann MM, 1997, SCIENCE, V278, P135, DOI 10.1126/science.278.5335.135; Qian S, 2002, MOL CELL BIOL, V22, P5027, DOI 10.1128/MCB.22.14.5027-5035.2002; Rossi M, 1998, ENDOCRINOLOGY, V139, P4428, DOI 10.1210/en.139.10.4428; SCHWARTZ MW, 1992, ENDOCR REV, V13, P387, DOI 10.1210/er.13.3.387; Stutz AM, 2005, PEPTIDES, V26, P1771, DOI 10.1016/j.peptides.2004.12.024; TONG Q, 2008, NAT NEUROSCI; Tritos NA, 1998, DIABETES, V47, P1687, DOI 10.2337/diabetes.47.11.1687; Tsai KL, 2007, NUCLEIC ACIDS RES, V35, P6984, DOI 10.1093/nar/gkm703; Van der Heide LP, 2005, BIOCHEM J, V391, P623, DOI 10.1042/BJ20050525; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wortley KE, 2005, CELL METAB, V2, P421, DOI 10.1016/j.cmet.2005.11.004; Wu Q, 2009, CELL, V137, P1225, DOI 10.1016/j.cell.2009.04.022; Xu AW, 2005, PLOS BIOL, V3, P2168, DOI 10.1371/journal.pbio.0030415; YADA T, 1994, J BIOL CHEM, V269, P1290; YADA T, 1993, ENDOCRINOLOGY, V133, P1685, DOI 10.1210/en.133.4.1685; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Zhang XH, 2002, J BIOL CHEM, V277, P45276, DOI 10.1074/jbc.M208063200; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	52	26	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	APR 7	2011	6	4							e18324	10.1371/journal.pone.0018324	http://dx.doi.org/10.1371/journal.pone.0018324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	746IN	21694754	Green Submitted, Green Published, gold			2022-12-25	WOS:000289238700008
J	Kim, J; Roh, M; Doubinskaia, I; Algarroba, GN; Eltoum, IEA; Abdulkadir, SA				Kim, J.; Roh, M.; Doubinskaia, I.; Algarroba, G. N.; Eltoum, I-E A.; Abdulkadir, S. A.			A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53	ONCOGENE			English	Article						c-MYC; Pten; p53; prostate cancer; rate of mutations	TUMOR-SUPPRESSOR GENE; GENOMIC DELETION; TRANSGENIC MICE; ADVANCED-STAGE; IN-VIVO; MUTATIONS; EXPRESSION; CARCINOMA; PROGRESSION; TUMORIGENESIS	Human tumors are heterogeneous and evolve through a dynamic process of genetic mutation and selection. During this process, the effects of a specific mutation on the incipient cancer cell may dictate the nature of subsequent mutations that can be tolerated or selected for, affecting the rate at which subsequent mutations occur. Here we have used a new mouse model of prostate cancer that recapitulates several salient features of the human disease to examine the relative rates in which the remaining wildtype alleles of Pten and p53 tumor suppressor genes are lost. In this model, focal overexpression of c-MYC in a few prostate luminal epithelial cells provokes a mild proliferative response. In the context of compound Pten/p53 heterozygosity, c-MYC-initiated cells progress to prostatic intraepithelial neoplasia (mPIN) and adenocarcinoma lesions with marked heterogeneity within the same prostate glands. Using laser capture microdissection and gene copy number analyses, we found that the frequency of Pten loss was significantly higher than that of p53 loss in mPIN but not invasive carcinoma lesions. c-MYC overexpression, unlike Pten loss, did not activate the p53 pathway in transgenic mouse prostate cells, explaining the lack of selective pressure to lose p53 in the c-MYC-overexpressing cells. This model of heterogeneous prostate cancer based on alterations in genes relevant to the human disease may be useful for understanding pathogenesis of the disease and testing new therapeutic agents. Oncogene (2012) 31, 322-332; doi:10.1038/onc.2011.236; published online 20 June 2011	[Kim, J.; Roh, M.; Doubinskaia, I.; Algarroba, G. N.; Abdulkadir, S. A.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Algarroba, G. N.] Univ Florida, Coll Agr & Life Sci, Gainesville, FL USA; [Eltoum, I-E A.] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	Vanderbilt University; State University System of Florida; University of Florida; University of Alabama System; University of Alabama Birmingham	Abdulkadir, SA (corresponding author), Vanderbilt Univ, Sch Med, Med Ctr N, Dept Pathol, Rm B3321, Nashville, TN 37232 USA.	sarki.abdulkadir@vanderbilt.edu		Kim, Jongchan/0000-0002-9733-9881; Algarroba, Gabriela/0000-0001-9401-5905	National Cancer Institute of the National Institutes of Health [CA094858, CA123484]; NATIONAL CANCER INSTITUTE [R01CA123484, R01CA094858] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank the members of the Abdulkadir Lab for helpful discussions. This work was supported by Grants CA094858 and CA123484 (SAA) from the National Cancer Institute of the National Institutes of Health.	Abdulkadir SA, 2001, HUM PATHOL, V32, P935, DOI 10.1053/hupa.2001.27102; Abdulkadir SA, 2001, NAT MED, V7, P101, DOI 10.1038/83231; Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; BOOKSTEIN R, 1993, CANCER RES, V53, P3369; Brooks JD, 1996, CANCER RES, V56, P3814; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Cheng L, 1998, J NATL CANCER I, V90, P233, DOI 10.1093/jnci/90.3.233; Cheung TH, 2004, GYNECOL ONCOL, V93, P621, DOI 10.1016/j.ygyno.2004.03.013; CHI SG, 1994, J NATL CANCER I, V86, P926, DOI 10.1093/jnci/86.12.926; DINJENS WNM, 1994, INT J CANCER, V56, P630, DOI 10.1002/ijc.2910560504; Dong JT, 2001, CLIN CANCER RES, V7, P304; EFFERT PJ, 1993, J UROLOGY, V150, P257, DOI 10.1016/S0022-5347(17)35458-7; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Feilotter HE, 1998, ONCOGENE, V16, P1743, DOI 10.1038/sj.onc.1200205; Fenic I, 2004, J PATHOL, V203, P559, DOI 10.1002/path.1545; Fernandez-Marcos PJ, 2009, P NATL ACAD SCI USA, V106, P12962, DOI 10.1073/pnas.0813055106; GREENE DR, 1991, BRIT J UROL, V68, P499, DOI 10.1111/j.1464-410X.1991.tb15394.x; GRIZZLE WE, 1994, J CELL BIOCHEM, P259; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kim J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000542; KONISHI N, 1995, JPN J CANCER RES, V86, P57, DOI 10.1111/j.1349-7006.1995.tb02988.x; McCall P, 2008, BRIT J CANCER, V99, P1296, DOI 10.1038/sj.bjc.6604680; McMenamin ME, 1999, CANCER RES, V59, P4291; MELLON K, 1992, J UROLOGY, V147, P496, DOI 10.1016/S0022-5347(17)37287-7; Mentor-Marcel R, 2001, CANCER RES, V61, P6777; MIRCHANDANI D, 1995, AM J PATHOL, V147, P92; NAVONE NM, 1993, J NATL CANCER I, V85, P1657, DOI 10.1093/jnci/85.20.1657; Nesslinger NJ, 2003, CANCER RES, V63, P2228; Preacher KJ, 2001, CALCULATION CHI SQUA; Qian JQ, 2002, MODERN PATHOL, V15, P35, DOI 10.1038/modpathol.3880487; Roh M, 2006, GENESIS, V44, P447, DOI 10.1002/dvg.20235; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Schmitz M, 2007, INT J CANCER, V120, P1284, DOI 10.1002/ijc.22359; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; SLAUGHTER DP, 1953, CANCER, V6, P963, DOI 10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q; Suzuki H, 1998, CANCER RES, V58, P204; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; VILLERS A, 1992, CANCER, V70, P2313, DOI 10.1002/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T; VOELLER HJ, 1994, J UROLOGY, V151, P492; Wang L, 2007, HEPATOL RES, V37, P389, DOI 10.1111/j.1872-034X.2007.00042.x; Wang SI, 1998, CLIN CANCER RES, V4, P811; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Yoshimoto M, 2007, BRIT J CANCER, V97, P678, DOI 10.1038/sj.bjc.6603924	51	42	43	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	3					322	332		10.1038/onc.2011.236	http://dx.doi.org/10.1038/onc.2011.236			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21685943	Green Accepted			2022-12-25	WOS:000299542100005
J	Bryksa, BC; Bhaumik, P; Magracheva, E; De Moura, DC; Kurylowicz, M; Zdanov, A; Dutcher, JR; Wlodawer, A; Yada, RY				Bryksa, Brian C.; Bhaumik, Prasenjit; Magracheva, Eugenia; De Moura, Dref C.; Kurylowicz, Martin; Zdanov, Alexander; Dutcher, John R.; Wlodawer, Alexander; Yada, Rickey Y.			Structure and Mechanism of the Saposin-like Domain of a Plant Aspartic Protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMAGGLUTININ FUSION PEPTIDE; INFLUENZA HEMAGGLUTININ; CRYSTAL-STRUCTURE; ANTIMICROBIAL ACTIVITY; SECONDARY-STRUCTURE; PROTEINASE; CELL; ENZYMES; VISUALIZATION; ACTIVATION	Many plant aspartic proteases contain an additional sequence of similar to 100 amino acids termed the plant-specific insert, which is involved in host defense and vacuolar targeting. Similar to all saposin-like proteins, the plant-specific insert functions via protein-membrane interactions; however, the structural basis for such interactions has not been studied, and the nature of plantspecific insert-mediated membrane disruption has not been characterized. In the present study, the crystal structure of the saposin-like domain of potato aspartic protease was resolved at a resolution of 1.9 angstrom, revealing an open V-shaped configuration similar to the open structure of human saposin C. Notably, vesicle disruption activity followed Michaelis-Menten-like kinetics, a finding not previously reported for saposin-like proteins including plant-specific inserts. Circular dichroism data suggested that secondary structure was pH-dependent in a fashion similar to influenza A hemagglutinin fusion peptide. Membrane effects characterized by atomic force microscopy and light scattering indicated bilayer solubilization as well as fusogenic activity. Taken together, the present study is the first report to elucidate the membrane interaction mechanism of plant saposin-like domains whereby pH-dependent membrane interactions resulted in bilayer fusogenic activity that probably arose from a viral type pH-dependent helix-kink-helix motif at the plant-specific insert N terminus.	[Bryksa, Brian C.; De Moura, Dref C.; Yada, Rickey Y.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada; [Kurylowicz, Martin; Dutcher, John R.] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Bhaumik, Prasenjit; Zdanov, Alexander; Wlodawer, Alexander] NCI, Prot Struct Sect, Macromol Crystallog Lab, NIH, Frederick, MD 21702 USA; [Magracheva, Eugenia] NCI, Basic Res Program, SAIC Frederick, NIH, Frederick, MD 21702 USA	University of Guelph; University of Guelph; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Yada, RY (corresponding author), Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada.	ryada@uoguelph.ca	Yada, Rickey Y/A-8289-2013; Bryksa, Brian/A-8281-2013	Bryksa, Brian/0000-0001-5626-8012; Yada, Rickey/0000-0002-8648-2156	National Institutes of Health, NCI; Natural Sciences and Engineering Research Council of Canada; Canada Research Chairs Program; Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC010348] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chairs Program(Canada Research Chairs); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the Intramural Research Program of the National Institutes of Health, NCI. This work was also supported by the Natural Sciences and Engineering Research Council of Canada, the Canada Research Chairs Program, and the Center for Cancer Research.	Ahn VE, 2003, P NATL ACAD SCI USA, V100, P38, DOI 10.1073/pnas.0136947100; Ahn VE, 2006, PROTEIN SCI, V15, P1849, DOI 10.1110/ps.062256606; Alattia JR, 2006, J MOL BIOL, V362, P943, DOI 10.1016/j.jmb.2006.08.009; Anderson DH, 2003, J MOL BIOL, V325, P355, DOI 10.1016/S0022-2836(02)01234-2; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER D, 1994, STRUCTURE, V2, P907, DOI 10.1016/S0969-2126(94)00091-3; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bissonnette MLZ, 2009, J MOL BIOL, V386, P14, DOI 10.1016/j.jmb.2008.12.029; BLUNDELL TL, 1993, PROTEIN SCI, V2, P877, DOI 10.1002/pro.5560020602; Braun HP, 1999, PLANTA, V209, P267, DOI 10.1007/s004250050632; BRAUN HP, 1995, TRENDS BIOCHEM SCI, V20, P171, DOI 10.1016/S0968-0004(00)88999-9; Bruhn H, 2005, BIOCHEM J, V389, P249, DOI 10.1042/BJ20050051; Bryksa BC, 2010, PROTEIN ENG DES SEL, V23, P711, DOI 10.1093/protein/gzq039; Chernomordik LV, 1998, J CELL BIOL, V140, P1369, DOI 10.1083/jcb.140.6.1369; Ciaffoni F, 2001, J BIOL CHEM, V276, P31583, DOI 10.1074/jbc.M102736200; Ciaffoni F, 2006, J LIPID RES, V47, P1045, DOI 10.1194/jlr.M500547-JLR200; Cohen GH, 1997, J APPL CRYSTALLOGR, V30, P1160, DOI 10.1107/S0021889897006729; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; DAVIES DR, 1990, ANNU REV BIOPHYS BIO, V19, P189, DOI 10.1146/annurev.bb.19.060190.001201; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Egas C, 2000, J BIOL CHEM, V275, P38190, DOI 10.1074/jbc.M006093200; Egawa H, 1999, LANGMUIR, V15, P1660, DOI 10.1021/la980923w; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faro C, 1999, J BIOL CHEM, V274, P28724, DOI 10.1074/jbc.274.40.28724; Fiske CH, 1925, J BIOL CHEM, V66, P375; Frazao C, 1999, J BIOL CHEM, V274, P27694, DOI 10.1074/jbc.274.39.27694; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Glathe S, 1998, J BIOL CHEM, V273, P31230, DOI 10.1074/jbc.273.47.31230; Gordon LM, 2000, J PEPT RES, V55, P330, DOI 10.1034/j.1399-3011.2000.00693.x; Gray C, 1996, BIOPHYS J, V70, P2275, DOI 10.1016/S0006-3495(96)79793-X; Guevara MG, 2002, EUR J PLANT PATHOL, V108, P131, DOI 10.1023/A:1015049629736; Han X, 2000, P NATL ACAD SCI USA, V97, P13097, DOI 10.1073/pnas.230212097; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hernandez LD, 1996, ANNU REV CELL DEV BI, V12, P627, DOI 10.1146/annurev.cellbio.12.1.627; Huster D, 2000, BIOPHYS J, V78, P3011, DOI 10.1016/S0006-3495(00)76839-1; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kasson PM, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000829; Kervinen J, 1999, EMBO J, V18, P3947, DOI 10.1093/emboj/18.14.3947; Kingsley DH, 1999, MOL BIOL CELL, V10, P4191, DOI 10.1091/mbc.10.12.4191; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lai AL, 2006, J BIOL CHEM, V281, P5760, DOI 10.1074/jbc.M512280200; Lai AL, 2010, J BIOL CHEM, V285, P37467, DOI 10.1074/jbc.M110.153700; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAZAROWITZ SG, 1973, VIROLOGY, V56, P172, DOI 10.1016/0042-6822(73)90296-1; Liepinsh E, 1997, NAT STRUCT BIOL, V4, P793, DOI 10.1038/nsb1097-793; Lukatsky DB, 2004, EUR PHYS J E, V14, P3, DOI 10.1140/epje/i2004-10005-5; MACDONALD RC, 1991, BIOCHIM BIOPHYS ACTA, V1061, P297, DOI 10.1016/0005-2736(91)90295-J; Markovic I, 1998, J CELL BIOL, V143, P1155, DOI 10.1083/jcb.143.5.1155; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; MATSUZAKI K, 1989, BIOCHIM BIOPHYS ACTA, V981, P130, DOI 10.1016/0005-2736(89)90090-4; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mazorra-Manzano MA, 2010, PHYTOCHEMISTRY, V71, P515, DOI 10.1016/j.phytochem.2009.12.005; Meyer V, 2008, APPL MICROBIOL BIOT, V78, P17, DOI 10.1007/s00253-007-1291-3; Moore BD, 2004, TRENDS PLANT SCI, V9, P221, DOI 10.1016/j.tplants.2004.03.005; Munoz FF, 2010, PEPTIDES, V31, P777, DOI 10.1016/j.peptides.2010.02.001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mutlu A, 1999, PHYSIOL PLANTARUM, V105, P569, DOI 10.1034/j.1399-3054.1999.105324.x; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Payie KG, 2000, BIOTECHNOL LETT, V22, P1515, DOI 10.1023/A:1005656208075; Payie KG, 2003, BIOCHEM J, V372, P671, DOI 10.1042/BJ20021126; Petrache HI, 1998, CHEM PHYS LIPIDS, V95, P83, DOI 10.1016/S0009-3084(98)00068-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qiao H, 1999, MOL BIOL CELL, V10, P2759, DOI 10.1091/mbc.10.8.2759; Ramalho-Santos M, 1998, EUR J BIOCHEM, V255, P133, DOI 10.1046/j.1432-1327.1998.2550133.x; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Remmel N, 2007, FEBS J, V274, P3405, DOI 10.1111/j.1742-4658.2007.05873.x; Rossmann M, 2008, STRUCTURE, V16, P809, DOI 10.1016/j.str.2008.02.016; RUNEBERGROOS P, 1991, EUR J BIOCHEM, V202, P1021, DOI 10.1111/j.1432-1033.1991.tb16465.x; Schaller A, 1996, PLANT MOL BIOL, V31, P1073, DOI 10.1007/BF00040725; SHAROM FJ, 1995, J BIOL CHEM, V270, P10334, DOI 10.1074/jbc.270.17.10334; Simoes I, 2004, EUR J BIOCHEM, V271, P2067, DOI 10.1111/j.1432-1033.2004.04136.x; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Stiasny K, 2007, PLOS PATHOG, V3, P191, DOI 10.1371/journal.ppat.0030020; Tseng HK, 2011, EXPERT OPIN PHARMACO, V12, P241, DOI 10.1517/14656566.2010.517195; VACCARO AM, 1994, FEBS LETT, V349, P181, DOI 10.1016/0014-5793(94)00659-8; VACCARO AM, 1995, J BIOL CHEM, V270, P9953, DOI 10.1074/jbc.270.17.9953; Wang Y, 2003, ARCH BIOCHEM BIOPHYS, V415, P43, DOI 10.1016/S0003-9861(03)00219-4; You HX, 2003, BIOPHYS J, V84, P2043, DOI 10.1016/S0006-3495(03)75012-7; Zhai YF, 2000, BBA-REV BIOMEMBRANES, V1469, P87, DOI 10.1016/S0304-4157(00)00003-4	85	35	39	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28265	28275		10.1074/jbc.M111.252619	http://dx.doi.org/10.1074/jbc.M111.252619			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676875	Green Published, hybrid			2022-12-25	WOS:000293557800044
J	Terao, M; Ishikawa, A; Nakahara, S; Kimura, A; Kato, A; Moriwaki, K; Kamada, Y; Murota, H; Taniguchi, N; Katayama, I; Miyoshi, E				Terao, Mika; Ishikawa, Akiko; Nakahara, Susumu; Kimura, Akihiro; Kato, Arisa; Moriwaki, Kenta; Kamada, Yoshihiro; Murota, Hiroyuki; Taniguchi, Naoyuki; Katayama, Ichiro; Miyoshi, Eiji			Enhanced Epithelial-Mesenchymal Transition-like Phenotype in N-Acetylglucosaminyltransferase V Transgenic Mouse Skin Promotes Wound Healing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; ASPARAGINE-LINKED OLIGOSACCHARIDES; NECROSIS-FACTOR-ALPHA; KERATINOCYTE MIGRATION; POOR-PROGNOSIS; E-CADHERIN; EXPRESSION; METASTASIS; CANCER; GLYCOSYLATION	N-Acetylglucosaminyltransferase V (GnT-V) catalyzes the beta 1,6 branching of N-acetylglucosamine on N-glycans. GnT-V expression is elevated during malignant transformation in various types of cancer. However, the mechanism by which GnT-V promotes cancer progression is unclear. Tocharacterize the biological significance of GnT-V, we established GnT-V transgenic (Tg) mice, in which GnT-V is regulated by a beta-actin promoter. No spontaneous cancer was detected in any organs of the GnT-V Tg mice. However, GnT-V expression was up-regulated in GnT-V Tg mouse skin, and cultured keratinocytes derived from these mice showed enhanced migration, which was associated with changes in E-cadherin localization and epithelial-mesenchymal transition (EMT). Further, EMT-associated factors snail, twist, and N-cadherin were up-regulated, and cutaneous wound healing was accelerated in vivo. We further investigated the detailed mechanisms of EMT by assessing EGF signaling and found up-regulated EGF receptor signaling in GnT-V Tg mouse keratinocytes. These findings indicate that GnT-V overexpression promotes EMT and keratinocyte migration in part through enhanced EGF receptor signaling.	[Terao, Mika; Ishikawa, Akiko; Kimura, Akihiro; Kato, Arisa; Moriwaki, Kenta; Kamada, Yoshihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka 5650871, Japan; [Terao, Mika; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 5650871, Japan; [Nakahara, Susumu; Taniguchi, Naoyuki; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Biochem, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Miyoshi, E (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, 1-7 Yamada Oka, Suita, Osaka 5650871, Japan.	emiyoshi@sahs.med.osaka-u.ac.jp	Kamada, Yoshihiro/GQA-8854-2022; Kamada, Yoshihiro/AHC-1613-2022; Kamada, Yoshihiro/H-3309-2019; Terao, Mineko/AAA-6415-2020; Taniguchi, Naoyuki/A-7086-2016; Taniguchi, Naoyuki/I-4182-2014	Kamada, Yoshihiro/0000-0001-5485-902X; Kamada, Yoshihiro/0000-0001-5485-902X; Terao, Mineko/0000-0002-9976-9869; Taniguchi, Naoyuki/0000-0001-5889-5968; Kimura, Akihiro/0000-0001-5614-8547; Moriwaki, Kenta/0000-0002-8724-4715	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science [22791069, 21249038]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a grant from the Global COE program of Osaka University funded by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant-in-aid for Young Scientists (B) No. 22791069, and a Grant-in-aid for Scientific Research (A) No. 21249038 from the Japan Society for the Promotion of Science.	CHEN JD, 1995, J INVEST DERMATOL, V104, P729, DOI 10.1111/1523-1747.ep12606970; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEMETRIOU M, 1995, J CELL BIOL, V130, P383, DOI 10.1083/jcb.130.2.383; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; DENNIS JW, 1989, CANCER RES, V49, P945; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Dosaka-Akita H, 2004, CLIN CANCER RES, V10, P1773, DOI 10.1158/1078-0432.CCR-1047-3; Freytag J, 2010, J INVEST DERMATOL, V130, P2179, DOI 10.1038/jid.2010.106; Granovsky M, 2000, NAT MED, V6, P306; Guo HB, 2010, P NATL ACAD SCI USA, V107, P21116, DOI 10.1073/pnas.1013405107; Hardwicke J, 2008, SURG-J R COLL SURG E, V6, P172, DOI 10.1016/S1479-666X(08)80114-X; Hudson LG, 1998, MICROSC RES TECHNIQ, V43, P444, DOI 10.1002/(SICI)1097-0029(19981201)43:5<444::AID-JEMT10>3.0.CO;2-C; Ihara S, 2002, J BIOL CHEM, V277, P16960, DOI 10.1074/jbc.M200673200; Isaji T, 2010, METHOD ENZYMOL, V480, P445, DOI 10.1016/S0076-6879(10)80019-9; Ishimura H, 2006, CLIN CANCER RES, V12, P2506, DOI 10.1158/1078-0432.CCR-05-1938; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Katoh Y, 2008, INT J MOL MED, V22, P271, DOI 10.3892/ijmm_00000019; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; MIYOSHI E, 1993, CANCER RES, V53, P3899; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Murata K, 2000, CLIN CANCER RES, V6, P1772; NISHIKAWA A, 1990, BIOCHIM BIOPHYS ACTA, V1035, P313, DOI 10.1016/0304-4165(90)90094-D; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pastore S, 2008, J INVEST DERMATOL, V128, P1365, DOI 10.1038/sj.jid.5701184; Pinho SS, 2009, HUM MOL GENET, V18, P2599, DOI 10.1093/hmg/ddp194; PINHO SS, 2011, CELL MOL LIFE SCI; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785, DOI 10.1146/annurev.bi.57.070188.004033; SAITO H, 1994, BIOCHEM BIOPH RES CO, V198, P318, DOI 10.1006/bbrc.1994.1045; Sato Y, 2001, J BIOL CHEM, V276, P11956, DOI 10.1074/jbc.M008551200; Shirakata Y, 2005, J CELL SCI, V118, P2363, DOI 10.1242/jcs.02346; SHOREIBAH M, 1993, J BIOL CHEM, V268, P15381; SHOREIBAH MG, 1992, J BIOL CHEM, V267, P2920; Stoll S, 1997, J CLIN INVEST, V100, P1271, DOI 10.1172/JCI119641; Taniguchi N, 2001, GLYCOCONJUGATE J, V18, P859, DOI 10.1023/A:1022292223878; Terao M, 2010, EXP DERMATOL, V19, P38, DOI 10.1111/j.1600-0625.2009.00973.x; Werner S, 2007, J INVEST DERMATOL, V127, P998, DOI 10.1038/sj.jid.5700786; Wilkins-Port CE, 2007, CELLS TISSUES ORGANS, V185, P116, DOI 10.1159/000101312; Yamamoto E, 2007, BRIT J CANCER, V97, P1538, DOI 10.1038/sj.bjc.6604044; Yan CL, 2010, AM J PATHOL, V176, P2247, DOI 10.2353/ajpath.2010.090048; Yoshimura M, 1996, J BIOL CHEM, V271, P13811, DOI 10.1074/jbc.271.23.13811; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	45	51	54	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28303	28311		10.1074/jbc.M111.220376	http://dx.doi.org/10.1074/jbc.M111.220376			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21697088	Green Published, hybrid			2022-12-25	WOS:000293557800047
J	Gillingwater, K; Gutierrez, C; Bridges, A; Wu, HL; Deborggraeve, S; Ekangu, RA; Kumar, A; Ismail, M; Boykin, D; Brun, R				Gillingwater, Kirsten; Gutierrez, Carlos; Bridges, Arlene; Wu, Huali; Deborggraeve, Stijn; Ekangu, Rosine Ali; Kumar, Arvind; Ismail, Mohamed; Boykin, David; Brun, Reto			Efficacy Study of Novel Diamidine Compounds in a Trypanosoma evansi Goat Model	PLOS ONE			English	Article							INFECTION; CAMELS	Three diamidines (DB 75, DB 867 and DB 1192) were selected and their ability to cure T. evansi experimentally infected goats was investigated. A toxicity assessment and pharmacokinetic analysis of these compounds were additionally carried out. Goats demonstrated no signs of acute toxicity, when treated with four doses of 1 mg/kg/day total dose 4 mg/kg). Complete curative efficacy of experimentally infected goats was seen in the positive control group treated with diminazene at 5 mg/kg and in the DB 75 and DB 867 groups treated at 2.5 mg/kg. Drug treatment was administered once every second day for a total of seven days. Complete cure was also seen in the group of goats treated with DB 75 at 1.25 mg/kg. DB 1192 was incapable of curing goats at either four-times 2.5 mg/kg or 1.25 mg/kg. Pharmacokinetic analysis clearly demonstrated that the treatment failures of DB 1192 were due to sub-therapeutic compound levels in goat plasma, whilst compound levels for DB 75 and DB 867 remained well within the therapeutic window. In conclusion, two diamidine compounds DB 75 and DB 867) presented comparable efficacy at lower doses than the standard drug diminazene and could be considered as potential clinical candidates against T. evansi infection.	[Gillingwater, Kirsten; Brun, Reto] Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland; [Gillingwater, Kirsten; Brun, Reto] Univ Basel, Basel, Switzerland; [Gutierrez, Carlos] Univ Las Palmas, Fac Vet, Arucas, Gran Canaria, Spain; [Bridges, Arlene] Univ N Carolina, Sch Pharm, Chapel Hill, NC USA; [Wu, Huali] Univ N Carolina, Dept Pathol, Chapel Hill, NC USA; [Deborggraeve, Stijn; Ekangu, Rosine Ali] Inst Trop Med, Dept Parasitol, B-2000 Antwerp, Belgium; [Ekangu, Rosine Ali] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Kumar, Arvind; Ismail, Mohamed; Boykin, David] Georgia State Univ, Dept Chem, Atlanta, GA 30303 USA; [Ismail, Mohamed] King Faisal Univ, Dept Chem, Coll Sci, Al Hufuf, Saudi Arabia	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Universidad de Las Palmas de Gran Canaria; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Institute of Tropical Medicine (ITM); Institute Nacional de Recherche Biomedical; University System of Georgia; Georgia State University; King Faisal University	Gillingwater, K (corresponding author), Swiss Trop & Publ Hlth Inst, Dept Med Parasitol & Infect Biol, Basel, Switzerland.	Reto.Brun@unibas.ch	Gutiérrez, Carlos/E-2989-2012	Gutiérrez, Carlos/0000-0003-0764-7408; Ismail, Mohamed A./0000-0001-5855-3714; Deborggraeve, Stijn/0000-0003-1501-5355	Swiss Tropical and Public Health Institute, Basel, Switzerland	Swiss Tropical and Public Health Institute, Basel, Switzerland	This study was funded by the Swiss Tropical and Public Health Institute, Basel, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlin D, 2009, VET PARASITOL, V161, P316, DOI 10.1016/j.vetpar.2009.01.030; Brun R, 2001, TROP MED INT HEALTH, V6, P906, DOI 10.1046/j.1365-3156.2001.00775.x; Davila AMR, 2000, ANN NY ACAD SCI, V916, P199, DOI 10.1111/j.1749-6632.2000.tb05291.x; Deborggraeve S, 2006, J CLIN MICROBIOL, V44, P2884, DOI 10.1128/JCM.02594-05; Delafosse A, 2004, VET PARASITOL, V119, P155, DOI 10.1016/j.vetpar.2003.11.010; El Rayah IE, 1999, VET PARASITOL, V80, P281, DOI 10.1016/S0304-4017(98)00221-0; FOIL LD, 1989, PARASITOL TODAY, V5, P88, DOI 10.1016/0169-4758(89)90009-4; Gillingvvater K, 2010, VET PARASITOL, V169, P264, DOI 10.1016/j.vetpar.2010.01.019; Gillingwater K, 2009, ANTIMICROB AGENTS CH, V53, P5074, DOI 10.1128/AAC.00422-09; Gutierrez C, 2000, VET PARASITOL, V90, P155, DOI 10.1016/S0304-4017(00)00225-9; Gutierrez C, 2004, ANN NY ACAD SCI, V1026, P149, DOI 10.1196/annals.1307.020; Gutierrez C, 2004, ANN NY ACAD SCI, V1026, P152, DOI 10.1196/annals.1307.021; Gutierrez C, 2005, VET PARASITOL, V130, P163, DOI 10.1016/j.vetpar.2005.02.009; Reid SA, 2002, TRENDS PARASITOL, V18, P219, DOI 10.1016/S1471-4922(02)02250-X; SONGA EB, 1988, ANN SOC BELG MED TR, V68, P233; Touratier L, 2000, ANN NY ACAD SCI, V916, P237, DOI 10.1111/j.1749-6632.2000.tb05295.x; Wilson WD, 2008, BIOCHIMIE, V90, P999, DOI 10.1016/j.biochi.2008.02.017; Wilson W. David, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P389, DOI 10.2174/1568011054222319; Woo P. T. K., 1970, Acta trop., V27, P384	19	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20836	10.1371/journal.pone.0020836	http://dx.doi.org/10.1371/journal.pone.0020836			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698106	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600020
J	Grausova, L; Kromka, A; Burdikova, Z; Eckhardt, A; Rezek, B; Vacik, J; Haenen, K; Lisa, V; Bacakova, L				Grausova, Lubica; Kromka, Alexander; Burdikova, Zuzana; Eckhardt, Adam; Rezek, Bohuslav; Vacik, Jiri; Haenen, Ken; Lisa, Vera; Bacakova, Lucie			Enhanced Growth and Osteogenic Differentiation of Human Osteoblast-Like Cells on Boron-Doped Nanocrystalline Diamond Thin Films	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; ELECTRICALLY CONDUCTING POLYMER; NANOMETER SURFACE-ROUGHNESS; KELVIN FORCE MICROSCOPY; MG 63 CELLS; IN-VITRO; IMPROVED ADHESION; TITANIUM SURFACE; BONE	Intrinsic nanocrystalline diamond (NCD) films have been proven to be promising substrates for the adhesion, growth and osteogenic differentiation of bone-derived cells. To understand the role of various degrees of doping (semiconducting to metallic-like), the NCD films were deposited on silicon substrates by a microwave plasma-enhanced CVD process and their boron doping was achieved by adding trimethylboron to the CH4:H-2 gas mixture, the B: C ratio was 133, 1000 and 6700 ppm. The room temperature electrical resistivity of the films decreased from >10 M Omega (undoped films) to 55 k Omega, 0.6 k Omega, and 0.3 k Omega (doped films with 133, 1000 and 6700 ppm of B, respectively). The increase in the number of human osteoblast-like MG 63 cells in 7-day-old cultures on NCD films was most apparent on the NCD films doped with 133 and 1000 ppm of B (153,000 +/- 14,000 and 152,000 +/- 10,000 cells/cm(2), respectively, compared to 113,000 +/- 10,000 cells/cm(2) on undoped NCD films). As measured by ELISA per mg of total protein, the cells on NCD with 133 and 1000 ppm of B also contained the highest concentrations of collagen I and alkaline phosphatase, respectively. On the NCD films with 6700 ppm of B, the cells contained the highest concentration of focal adhesion protein vinculin, and the highest amount of collagen I was adsorbed. The concentration of osteocalcin also increased with increasing level of B doping. The cell viability on all tested NCD films was almost 100%. Measurements of the concentration of ICAM-1, i.e. an immunoglobuline adhesion molecule binding inflammatory cells, suggested that the cells on the NCD films did not undergo significant immune activation. Thus, the potential of NCD films for bone tissue regeneration can be further enhanced and tailored by B doping and that B doping up to metallic-like levels is not detrimental for cells.	[Grausova, Lubica; Burdikova, Zuzana; Eckhardt, Adam; Lisa, Vera; Bacakova, Lucie] Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic; [Kromka, Alexander; Rezek, Bohuslav] Acad Sci Czech Republic, Inst Phys, Prague, Czech Republic; [Vacik, Jiri] Acad Sci Czech Republic, Inst Nucl Phys, Prague, Czech Republic; [Haenen, Ken] Hasselt Univ, Inst Mat Res IMO, Diepenbeek, Belgium; [Haenen, Ken] IMEC VZW, Div IMOMEC, Diepenbeek, Belgium	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Czech Academy of Sciences; Nuclear Physics Institute of the Czech Academy of Sciences; Hasselt University; IMEC	Grausova, L (corresponding author), Acad Sci Czech Republic, Inst Physiol, Prague, Czech Republic.	lucy@biomed.cas.cz	Vacik, Jiri/G-9263-2014; Stankova, Lubica/C-2210-2012; Burdikova, Zuzana/F-9680-2014; Rezek, Bohuslav/F-7403-2014; Bacakova, Lucie/C-2664-2012; Eckhardt, Adam/C-2263-2012; Kromka, Alexander/G-9139-2014; Stankova, Lubica/AAH-5255-2021; Haenen, Ken/G-8783-2011	Vacik, Jiri/0000-0002-1875-4914; Burdikova, Zuzana/0000-0003-1866-8095; Rezek, Bohuslav/0000-0002-0378-4598; Bacakova, Lucie/0000-0002-1818-9484; Eckhardt, Adam/0000-0003-4757-5226; Kromka, Alexander/0000-0002-3531-6748; Stankova, Lubica/0000-0002-9970-5443; Haenen, Ken/0000-0001-6711-7367	Academy of Sciences of the Czech Republic [KAN400480701, KAN400100701, IAAX00100902]; Grant Agency of the Czech Republic [P108/11/0794]; Research Foundation - Flanders (FWO) [G.0068.07, G.0430.07, G.0555.10N]; Methusalem "NANO network"; project 'Quantum Effects in Clusters and Nanowires' [IAP-P6/42]	Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Research Foundation - Flanders (FWO)(FWO); Methusalem "NANO network"; project 'Quantum Effects in Clusters and Nanowires'	This study was financially supported by the Academy of Sciences of the Czech Republic (grants No. KAN400480701, KAN400100701 and IAAX00100902) and by the Grant Agency of the Czech Republic (P108/11/0794). In Belgium, the work was supported by Research Programs G.0068.07, G.0430.07 and G.0555.10N of the Research Foundation - Flanders (FWO), the Methusalem "NANO network", and by IAP-P6/42 project 'Quantum Effects in Clusters and Nanowires'. The funders had no role in the study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Amaral M, 2008, J BIOMED MATER RES A, V87A, P91, DOI 10.1002/jbm.a.31742; Aspenberg P, 1996, BIOMATERIALS, V17, P807, DOI 10.1016/0142-9612(96)81418-9; Bacakova L, 2007, DIAM RELAT MATER, V16, P2133, DOI 10.1016/j.diamond.2007.07.015; Bacakova L, 2002, VIRCHOWS ARCH, V440, P50, DOI 10.1007/s004280100463; Bacakova L, 2001, J BIOMED MATER RES, V54, P567; Bacakova L., 2008, NANOPARTICLES NEW RE, P39; Bacakova L, 2007, J MATER SCI-MATER M, V18, P1317, DOI 10.1007/s10856-006-0074-1; Bankova L, 2008, CELL GROWTH PROCESSE, P5; Bettinger CJ, 2009, BIOMATERIALS, V30, P3050, DOI 10.1016/j.biomaterials.2009.02.018; Bondar' VS, 2004, PHYS SOLID STATE+, V46, P758, DOI 10.1134/1.1711468; Braitch Manjit, 2010, Inflammation & Allergy Drug Targets, V9, P249; Chen F, 2007, J BIOMED MATER RES B, V82B, P183, DOI 10.1002/jbm.b.30720; Clem WC, 2008, BIOMATERIALS, V29, P3461, DOI 10.1016/j.biomaterials.2008.04.045; Dadsetan M, 2011, ACTA BIOMATER, V7, P2080, DOI 10.1016/j.actbio.2011.01.012; Duvall CL, 2008, ARTERIOSCL THROM VAS, V28, P290, DOI 10.1161/ATVBAHA.107.158485; Filova E, 2009, J BIOMED MATER RES A, V90A, P55, DOI 10.1002/jbm.a.32065; Fucikova A, 2009, CHEM PAP, V63, P704, DOI 10.2478/s11696-009-0075-x; Gajewski W, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.045206; Garcia R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.016103; GERSTENFELD LC, J CELL BIOCH, V62, P1; Gomez N, 2007, J BIOMED MATER RES A, V81A, P135, DOI 10.1002/jbm.a.31047; Grausova L, 2008, DIAM RELAT MATER, V17, P1405, DOI 10.1016/j.diamond.2008.02.008; Grausova L, 2009, DIAM RELAT MATER, V18, P258, DOI 10.1016/j.diamond.2008.10.023; Grausova L, 2009, J NANOSCI NANOTECHNO, V9, P3524, DOI 10.1166/jnn.2009.NS26; Grinevich A, 2009, J BIOMED MATER RES A, V88A, P952, DOI 10.1002/jbm.a.31918; Gupta S, 2007, J MATER RES, V22, P3014, DOI 10.1557/JMR.2007.0229; Hallab NJ, 2009, BULL HOSP JT DIS, V67, P182; Heitz J, 2003, J BIOMED MATER RES A, V67A, P130, DOI 10.1002/jbm.a.10043; Jacobs HO, 1998, J APPL PHYS, V84, P1168, DOI 10.1063/1.368181; JENG JR, 1993, BIOCHIM BIOPHYS ACTA, V1178, P221, DOI 10.1016/0167-4889(93)90013-F; Jeong SI, 2008, MACROMOL BIOSCI, V8, P627, DOI 10.1002/mabi.200800005; Jun I, 2009, BIOMATERIALS, V30, P2038, DOI 10.1016/j.biomaterials.2008.12.063; Kalbacova M, 2007, PHYS STATUS SOLIDI B, V244, P4356, DOI 10.1002/pssb.200776166; KARPUKHIN AV, 2010, CELL BIOL I IN PRESS; Khang D, 2008, J BIOMED MATER RES A, V86A, P253, DOI 10.1002/jbm.a.31803; Kim DH, 2010, ADV MATER, V22, P4551, DOI 10.1002/adma.201000468; Kim HJ, 2005, J BIOMED MATER RES A, V74A, P366, DOI 10.1002/jbm.a.30327; Kloss FR, 2008, BIOMATERIALS, V29, P2433, DOI 10.1016/j.biomaterials.2008.01.036; Kong XL, 2005, ANAL CHEM, V77, P259, DOI 10.1021/ac048971a; Kopecek M, 2008, PHYS STATUS SOLIDI A, V205, P2146, DOI 10.1002/pssa.200879729; Kozak H, 2009, DIAM RELAT MATER, V18, P722, DOI 10.1016/j.diamond.2009.02.010; Kromka A, 2010, DIAM RELAT MATER, V19, P190, DOI 10.1016/j.diamond.2009.10.003; Langenbach KJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-14; Lesny P, 2006, J MATER SCI-MATER M, V17, P829, DOI 10.1007/s10856-006-9842-1; Liu H, 2006, J BIOMED MATER RES A, V78A, P798, DOI 10.1002/jbm.a.30734; Liu LY, 2005, J BIOMED MATER RES A, V74A, P23, DOI 10.1002/jbm.a.30221; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Marcon L, 2010, LANGMUIR, V26, P15065, DOI 10.1021/la101757f; Mihardja SS, 2008, BIOMATERIALS, V29, P4205, DOI 10.1016/j.biomaterials.2008.07.021; Miller DC, 2004, BIOMATERIALS, V25, P53, DOI 10.1016/S0142-9612(03)00471-X; Nebel CE, 2007, J R SOC INTERFACE, V4, P439, DOI 10.1098/rsif.2006.0196; Nordsletten L, 1996, BIOMATERIALS, V17, P1521, DOI 10.1016/0142-9612(96)89777-8; Papo MJ, 2004, J MATER SCI-MATER M, V15, P773, DOI 10.1023/B:JMSM.0000032817.05997.d2; Prabhakaran MP, 2009, ACTA BIOMATER, V5, P2884, DOI 10.1016/j.actbio.2009.05.007; Price RL, 2004, J BIOMED MATER RES A, V70A, P129, DOI 10.1002/jbm.a.30073; Puzyr AP, 2005, BIOFIZIKA+, V50, P101; Rezek B, 2005, NEW DIAM FRONT C TEC, V15, P275; Rezek B, 2004, DIAM RELAT MATER, V13, P740, DOI 10.1016/j.diamond.2003.11.051; REZEK B, 2011, BIOSENSORS IN PRESS; Rezek B, 2007, PHYS STATUS SOLIDI A, V204, P2888, DOI 10.1002/pssa.200776317; Rupprecht S, 2002, INT J ORAL MAX IMPL, V17, P778; Sader MS, 2005, CLIN ORAL IMPLAN RES, V16, P667, DOI 10.1111/j.1600-0501.2005.01135.x; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schmidt CE, 1997, P NATL ACAD SCI USA, V94, P8948, DOI 10.1073/pnas.94.17.8948; Schmidt RC, 2009, J BIOMED MATER RES A, V90A, P1252, DOI 10.1002/jbm.a.32501; Schrand AM, 2007, J PHYS CHEM B, V111, P2, DOI 10.1021/jp066387v; Shevde LA, 2010, CURR MOL MED, V10, P71, DOI 10.2174/156652410791065381; Shi GX, 2008, BIOMATERIALS, V29, P3792, DOI 10.1016/j.biomaterials.2008.06.010; Shi GX, 2008, J BIOMED MATER RES A, V84A, P1026, DOI 10.1002/jbm.a.31337; Stary V., 2003, ACTA MONT, V128, P19; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; SVORCIK V, 1995, J MATER CHEM, V5, P27, DOI 10.1039/jm9950500027; Svorcik V, 2009, NUCL INSTRUM METH B, V267, P1904, DOI 10.1016/j.nimb.2009.03.099; Svorcik V, 1995, J MATER SCI LETT, V14, P1723, DOI 10.1007/BF00270988; Tan J, 2004, BIOMATERIALS, V25, P3593, DOI 10.1016/j.biomaterials.2003.10.034; Uaesoontrachoon K, 2008, INT J BIOCHEM CELL B, V40, P2303, DOI 10.1016/j.biocel.2008.03.020; Verdejo R, 2009, J BIOMED MATER RES A, V88A, P65, DOI 10.1002/jbm.a.31698; Verveniotis E, 2010, PHYS STATUS SOLIDI A, V207, P2040, DOI 10.1002/pssa.201000014; Webster TJ, 2004, BIOMATERIALS, V25, P4731, DOI 10.1016/j.biomaterials.2003.12.002; Wong LS, 2010, CHEM-EUR J, V16, P12234, DOI 10.1002/chem.200902439; Yamawaki H, 2006, AM J PHYSIOL-CELL PH, V290, pC1495, DOI 10.1152/ajpcell.00481.2005; Ye HT, 2000, J PHYS D APPL PHYS, V33, pL148, DOI 10.1088/0022-3727/33/23/103	82	58	58	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20943	10.1371/journal.pone.0020943	http://dx.doi.org/10.1371/journal.pone.0020943			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695172	Green Published, gold			2022-12-25	WOS:000291612600037
J	Velumani, S; Ho, HT; He, F; Musthaq, S; Prabakaran, M; Kwang, J				Velumani, Sumathy; Ho, Hui-Ting; He, Fang; Musthaq, Syed; Prabakaran, Mookkan; Kwang, Jimmy			A Novel Peptide ELISA for Universal Detection of Antibodies to Human H5N1 Influenza Viruses	PLOS ONE			English	Article							AVIAN INFLUENZA; MONOCLONAL-ANTIBODIES; SYNTHETIC PEPTIDES; HEMAGGLUTININ; DIAGNOSIS; EFFICACY	Background: Active serologic surveillance of H5N1 highly pathogenic avian influenza (HPAI) virus in humans and poultry is critical to control this disease. However, the need for a robust, sensitive and specific serologic test for the rapid detection of antibodies to H5N1 viruses has not been met. Methodology/Principal Findings: Previously, we reported a universal epitope (CNTKCQTP) in H5 hemagglutinin (HA) that is 100% conserved in H5N1 human isolates and 96.9% in avian isolates. Here, we describe a peptide ELISA to detect antibodies to H5N1 virus by using synthetic peptide that comprises the amino acid sequence of this highly conserved and antigenic epitope as the capture antigen. The sensitivity and specificity of the peptide ELISA were evaluated using experimental chicken antisera to H5N1 viruses from divergent clades and other subtype influenza viruses, as well as human serum samples from patients infected with H5N1 or seasonal influenza viruses. The peptide ELISA results were compared with hemagglutinin inhibition (HI), and immunofluorescence assay and immunodot blot that utilize recombinant HA1 as the capture antigen. The peptide ELISA detected antibodies to H5N1 in immunized animals or convalescent human sera whereas some degree of cross-reactivity was observed in HI, immunofluorescence assay and immunodot blot. Antibodies to other influenza subtypes tested negative in the peptide-ELISA. Conclusion/Significance: The peptide-ELISA based on the highly conserved and antigenic H5 epitope (CNTKCQTP) provides sensitive and highly specific detection of antibodies to H5N1 influenza viruses. This study highlighted the use of synthetic peptide as a capture antigen in rapid detection of antibodies to H5N1 in human and animal sera that is robust, simple and cost effective and is particularly beneficial for developing countries and rural areas.	[Velumani, Sumathy; Ho, Hui-Ting; He, Fang; Musthaq, Syed; Prabakaran, Mookkan; Kwang, Jimmy] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Kwang, Jimmy] Natl Univ Singapore, Dept Microbiol, Fac Med, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Velumani, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	kwang@tll.org.sg	Subramaniam, Velumani/X-8679-2018	Subramaniam, Velumani/0000-0002-0998-7900; Prabakaran, Mookkan/0000-0002-9816-5908	Temasek Lifesciences Laboratory	Temasek Lifesciences Laboratory(National University of Singapore)	The project was funded by Temasek Lifesciences Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaro MC, 2003, CURR PROTEIN PEPT SC, V4, P285, DOI 10.2174/1389203033487117; Aubin JT, 2005, EMERG INFECT DIS, V11, P1515; Balakrishna K, 2010, LETT APPL MICROBIOL, V50, P131, DOI 10.1111/j.1472-765X.2009.02755.x; Dundon WG, 2007, AVIAN DIS, V51, P209, DOI 10.1637/7556-033106R.1; Friesen RHE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009106; GALLGHER S, 2004, CURRENT PROTOCOLS MO; Giessauf A, 2004, J IMMUNOL METHODS, V287, P1, DOI 10.1016/j.jim.2003.12.011; Gomara MJ, 2007, CURR MED CHEM, V14, P531, DOI 10.2174/092986707780059698; He QG, 2007, CLIN VACCINE IMMUNOL, V14, P617, DOI 10.1128/CVI.00444-06; JULKUNEN I, 1985, J VIROL METHODS, V10, P75, DOI 10.1016/0166-0934(85)90091-6; Khurana S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000049; Lee CW, 2006, CLIN VACCINE IMMUNOL, V13, P395, DOI 10.1128/CVI.13.3.395-402.2006; Mahler M, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3029; NOBUSAWA E, 1991, VIROLOGY, V182, P475, DOI 10.1016/0042-6822(91)90588-3; Nwe N, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-16; OREILLY D, BACULOVIRUS EXPRESSI; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004566; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Sahini L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009268; Stelzer-Braid S, 2008, J CLIN VIROL, V43, P241, DOI 10.1016/j.jcv.2008.06.012; *UN FAO INT OFF EP, 2007, GLOB STRAT PREV CONT; *US CDCP, 1999, BIOS MICR BIOM LAB; Velumani S, 2008, J VIROL METHODS, V147, P219, DOI 10.1016/j.jviromet.2007.09.004; WEBSTER RG, 1991, VACCINE, V9, P303, DOI 10.1016/0264-410X(91)90055-B; Yang M, 2008, J VIROL METHODS, V147, P265, DOI 10.1016/j.jviromet.2007.09.016	26	35	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20737	10.1371/journal.pone.0020737	http://dx.doi.org/10.1371/journal.pone.0020737			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695200	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600020
J	Catalao, MJ; Milho, C; Gil, F; Moniz-Pereira, J; Pimentel, M				Catalao, Maria Joao; Milho, Catarina; Gil, Filipa; Moniz-Pereira, Jose; Pimentel, Madalena			A Second Endolysin Gene Is Fully Embedded In-Frame with the lysA Gene of Mycobacteriophage Ms6	PLOS ONE			English	Article							BACTERIOPHAGE ENDOLYSINS; STREPTOCOCCUS-PNEUMONIAE; BACILLUS-SUBTILIS; OUTER-MEMBRANE; EXPRESSION; ENZYME; IDENTIFICATION; PROTEINS; CLONING; GENOME	Mycobacteriophages are dsDNA viruses that infect mycobacterial hosts. The mycobacteriophage Ms6 accomplishes lysis by producing two cell wall hydrolytic enzymes, Lysin A (LysA) that possesses a central peptidoglycan recognition protein (PGRP) super-family conserved domain with the amidase catalytic site, that cleaves the amide bond between the N-acetylmuramic acid and L-alanine residues in the oligopeptide crosslinking chains of the peptidoglycan and Lysin B (LysB) a mycolylarabinogalactan esterase that hydrolyzes the mycolic acids from the mycolyl-arabinogalactan-peptidoglycan complex. Examination of the endolysin (lysA) DNA sequence revealed the existence of an embedded gene (lysA(241)) encoded in the same reading frame and preceded by a consensus ribosome-binding site. In the present work we show that, even though lysA is essential for Ms6 viability, phage mutants that express only the longer (Lysin(384)) or the shorter (Lysin(241)) endolysin are viable, but defective in the normal timing, progression and completion of host cell lysis. In addition, both endolysins have peptidoglycan hydrolase activity and demonstrated broad growth inhibition activity against various Gram-positive bacteria and mycobacteria.	[Catalao, Maria Joao; Milho, Catarina; Gil, Filipa; Moniz-Pereira, Jose; Pimentel, Madalena] Univ Lisbon, Fac Farm, Unidade Retrovirus & Infeccoes Associades, Ctr Patogenese Mol, P-1699 Lisbon, Portugal	Universidade de Lisboa	Catalao, MJ (corresponding author), Univ Lisbon, Fac Farm, Unidade Retrovirus & Infeccoes Associades, Ctr Patogenese Mol, P-1699 Lisbon, Portugal.	mpimentel@ff.ul.pt	Pimentel, Madalena/C-3582-2014; iMed.ULisboa, M2B/B-5277-2014; Milho, Catarina/AAD-7116-2021; Catalao, Maria Joao/P-3248-2019; Pimentel, Madalena/AAZ-5857-2021; iMed.ULisboa, HPI/B-4239-2014; Catalão, Maria João/B-6731-2017; Milho, Catarina/Q-4744-2018	Pimentel, Madalena/0000-0002-4598-1290; iMed.ULisboa, M2B/0000-0002-1245-3715; Catalao, Maria Joao/0000-0002-3794-457X; Pimentel, Madalena/0000-0002-4598-1290; iMed.ULisboa, HPI/0000-0001-5934-0198; Catalão, Maria João/0000-0002-3794-457X; Milho, Catarina/0000-0002-9074-8498; Milho, Catarina/0000-0002-4176-765X; /0000-0002-8779-2017	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/SAU-FCF/73017/2006, SFRH/BD/24452/2005, SFRH/BD/29167/2006]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by funds provided by Fundacao para a Ciencia e Tecnologia (FCT) (http://alfa.fct.mctes.pt/index.phtml.en)- PTDC/SAU-FCF/73017/2006. Maria Joao Catalao and Filipa Gil are the recipients of a fellowship from FCT (SFRH/BD/24452/2005) and (SFRH/BD/29167/2006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackman SA, 1998, MICROBIOL-UK, V144, P73, DOI 10.1099/00221287-144-1-73; Borysowski J, 2006, EXP BIOL MED, V231, P366, DOI 10.1177/153537020623100402; Catalao MJ, 2011, J BACTERIOL, V193, P2793, DOI 10.1128/JB.01519-10; Catalao MJ, 2010, MOL MICROBIOL, V77, P672, DOI 10.1111/j.1365-2958.2010.07239.x; Cheng Q, 2005, ANTIMICROB AGENTS CH, V49, P111, DOI 10.1128/AAC.49.1.111-117.2005; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DALE JW, 1990, MOL BIOL MYCOBACTERI, P173; Davison S, 2005, J BACTERIOL, V187, P6742, DOI 10.1128/JB.187.19.6742-6749.2005; Draper P, 2005, TUBERCULOSIS AND THE TUBERCLE BACILLUS, P261; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P579, DOI 10.1111/j.1365-2958.1993.tb01718.x; FRENKEN LGJ, 1993, MOL MICROBIOL, V9, P591, DOI 10.1111/j.1365-2958.1993.tb01719.x; Garcia M, 2002, J BACTERIOL, V184, P3034, DOI 10.1128/JB.184.11.3034-3043.2002; Gil F, 2008, MICROBIOL-SGM, V154, P1364, DOI 10.1099/mic.0.2007/014621-0; Gil F, 2010, MICROBIOL-SGM, V156, P1497, DOI 10.1099/mic.0.032821-0; Grundling A, 2001, P NATL ACAD SCI USA, V98, P9348, DOI 10.1073/pnas.151247598; HATFULL G, 2005, PHAGES THEIR ROLE BA, P238; Hatfull GF, 2006, PLOS GENET, V2, P835, DOI 10.1371/journal.pgen.0020092; Hatfull GF, 2010, ANNU REV MICROBIOL, V64, P331, DOI 10.1146/annurev.micro.112408.134233; Hatfull GF, 2010, J MOL BIOL, V397, P119, DOI 10.1016/j.jmb.2010.01.011; Henry M, 2010, FEMS MICROBIOL LETT, V311, P126, DOI 10.1111/j.1574-6968.2010.02080.x; Henry M, 2010, GENE, V453, P9, DOI 10.1016/j.gene.2009.12.007; HOBSON AH, 1993, P NATL ACAD SCI USA, V90, P5682, DOI 10.1073/pnas.90.12.5682; Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105; JOLLIFFE LK, 1981, CELL, V25, P753, DOI 10.1016/0092-8674(81)90183-5; Kakikawa M, 2002, GENE, V299, P227, DOI 10.1016/S0378-1119(02)01076-4; KOK RG, 1995, J BACTERIOL, V177, P3295, DOI 10.1128/jb.177.11.3295-3307.1995; Kumar V, 2008, TUBERCULOSIS, V88, P616, DOI 10.1016/j.tube.2008.02.007; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Loeffler JM, 2003, ANTIMICROB AGENTS CH, V47, P375, DOI 10.1128/AAC.47.1.375-377.2003; Loeffler JM, 2003, INFECT IMMUN, V71, P6199, DOI 10.1128/IAI.71.11.6199-6204.2003; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Marinelli LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003957; Mediavilla J, 2000, MOL MICROBIOL, V38, P955, DOI 10.1046/j.1365-2958.2000.02183.x; Nascimento JG, 2008, J BACTERIOL, V190, P457, DOI 10.1128/JB.01195-07; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; NIKAIDO H, 1994, J BIOL CHEM, V269, P3905; Patton TG, 2006, MOL MICROBIOL, V59, P1395, DOI 10.1111/j.1365-2958.2006.05034.x; Payne K, 2009, MOL MICROBIOL, V73, P367, DOI 10.1111/j.1365-2958.2009.06775.x; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Piuri M, 2006, MOL MICROBIOL, V62, P1569, DOI 10.1111/j.1365-2958.2006.05473.x; Pope WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016329; Portugal I, 1989, Acta Leprol, V7 Suppl 1, P243; Pritchard DG, 2004, MICROBIOL-SGM, V150, P2079, DOI 10.1099/mic.0.27063-0; RECSEI PA, 1987, P NATL ACAD SCI USA, V84, P1127, DOI 10.1073/pnas.84.5.1127; Sambrook J, 2001, MOL CLONING LAB MANU; Sao-Jos? C., 2003, RECENT RES DEV BACTE, V1, P103; Sao-Jose C, 2000, J BACTERIOL, V182, P5823, DOI 10.1128/JB.182.20.5823-5831.2000; Sao-Jose Carlos, 2007, P307; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; SHEARMAN CA, 1994, APPL ENVIRON MICROB, V60, P3063, DOI 10.1128/AEM.60.9.3063-3073.1994; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Son JS, 2010, J APPL MICROBIOL, V108, P1769, DOI 10.1111/j.1365-2672.2009.04576.x; Sun QG, 2009, NAT STRUCT MOL BIOL, V16, P1192, DOI 10.1038/nsmb.1681; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Wiker HG, 2000, MICROBIOL-SGM, V146, P1525, DOI 10.1099/00221287-146-7-1525; Wittmann J, 2010, MICROBIOL-SGM, V156, P2366, DOI 10.1099/mic.0.037291-0; Xu M, 2005, SCIENCE, V307, P113, DOI 10.1126/science.1105143; Xu M, 2004, P NATL ACAD SCI USA, V101, P6415, DOI 10.1073/pnas.0400957101; Yokoi KJ, 2005, GENE, V351, P97, DOI 10.1016/j.gene.2005.03.006; Young R, 2000, TRENDS MICROBIOL, V8, P120, DOI 10.1016/S0966-842X(00)01705-4; Young R, 2002, J MOL MICROB BIOTECH, V4, P21; Young R, 2006, BACTERIOPHAGES, P104; Young R., 2005, PHAGES THEIR ROLE BA, P92, DOI [DOI 10.1128/9781555816506.CHAP6, 10.1128/9781555816506.ch6, DOI 10.1128/9781555816506.CH6]; Zhang N, 1999, MOL GEN GENET, V262, P659, DOI 10.1007/s004380051128; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	71	32	34	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20515	10.1371/journal.pone.0020515	http://dx.doi.org/10.1371/journal.pone.0020515			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694774	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900012
J	Ingram, T; Stutz, WE; Bolnick, DI				Ingram, Travis; Stutz, William E.; Bolnick, Daniel I.			Does Intraspecific Size Variation in a Predator Affect Its Diet Diversity and Top-Down Control of Prey?	PLOS ONE			English	Article							GENETIC DIVERSITY; HABITAT USE; THREESPINE STICKLEBACK; POPULATION-DYNAMICS; ADAPTIVE DIVERGENCE; NICHE WIDTH; ECOSYSTEM; COMMUNITY; SPECIALIZATION; COMPETITION	It has long been known that intraspecific variation impacts evolutionary processes, but only recently have its potential ecological effects received much attention. Theoretical models predict that genetic or phenotypic variance within species can alter interspecific interactions, and experiments have shown that genotypic diversity in clonal species can impact a wide range of ecological processes. To extend these studies to quantitative trait variation within populations, we experimentally manipulated the variance in body size of threespine stickleback in enclosures in a natural lake environment. We found that body size of stickleback in the lake is correlated with prey size and (to a lesser extent) composition, and that stickleback can exert top-down control on their benthic prey in enclosures. However, a six-fold contrast in body size variance had no effect on the degree of diet variation among individuals, or on the abundance or composition of benthic or pelagic prey. Interestingly, post-hoc analyses revealed suggestive correlations between the degree of diet variation and the strength of top-down control by stickleback. Our negative results indicate that, unless the correlation between morphology and diet is very strong, ecological variation among individuals may be largely decoupled from morphological variance. Consequently we should be cautious in our interpretation both of theoretical models that assume perfect correlations between morphology and diet, and of empirical studies that use morphological variation as a proxy for resource use diversity.	[Ingram, Travis] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Ingram, Travis] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC, Canada; [Bolnick, Daniel I.] Univ Texas Austin, Howard Hughes Med Inst, Sect Integrat Biol, Austin, TX 78712 USA	University of British Columbia; University of British Columbia; Howard Hughes Medical Institute; University of Texas System; University of Texas Austin	Ingram, T (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	ingram@zoology.ubc.ca	Bolnick, Daniel I./G-4440-2015; Ingram, Travis/HCI-1116-2022	Bolnick, Daniel I./0000-0003-3148-6296; Ingram, Travis/0000-0003-0709-5260	David and Lucille Packard Foundation; National Science and Engineering Research Council of Canada (NSERC); Direct For Biological Sciences [1300426] Funding Source: National Science Foundation	David and Lucille Packard Foundation(The David & Lucile Packard Foundation); National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a David and Lucille Packard Foundation grant to DIB, and TI was funded by a National Science and Engineering Research Council of Canada (NSERC) PGS-D3 award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agashe D, 2009, AM NAT, V174, P255, DOI 10.1086/600085; Araujo MS, 2008, ECOLOGY, V89, P1981, DOI 10.1890/07-0630.1; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Baumgartner D, 2003, INT REV HYDROBIOL, V88, P453, DOI 10.1002/iroh.200310632; Becks L, 2010, ECOL LETT, V13, P989, DOI 10.1111/j.1461-0248.2010.01490.x; Bell T, 2003, OECOLOGIA, V134, P578, DOI 10.1007/s00442-002-1135-x; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Berner D, 2010, EVOLUTION, V64, P2265, DOI 10.1111/j.1558-5646.2010.00982.x; Bolnick DI, 2007, P NATL ACAD SCI USA, V104, P10075, DOI 10.1073/pnas.0703743104; Bolnick DI, 2011, TRENDS ECOL EVOL, V26, P183, DOI 10.1016/j.tree.2011.01.009; Bolnick DI, 2010, P ROY SOC B-BIOL SCI, V277, P1789, DOI 10.1098/rspb.2010.0018; Bolnick DI, 2009, EVOL ECOL RES, V11, P1217; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bolnick DI, 2002, ECOLOGY, V83, P2936, DOI 10.2307/3072028; Bruno JF, 2005, ECOL LETT, V8, P1048, DOI 10.1111/j.1461-0248.2005.00808.x; Byrnes J, 2006, ECOL LETT, V9, P61, DOI 10.1111/j.1461-0248.2005.00842.x; Calsbeek R, 2007, EVOLUTION, V61, P2493, DOI 10.1111/j.1558-5646.2007.00206.x; Crutsinger GM, 2006, SCIENCE, V313, P966, DOI 10.1126/science.1128326; CULVER DA, 1985, CAN J FISH AQUAT SCI, V42, P1380, DOI 10.1139/f85-173; Doebeli M, 1996, EVOLUTION, V50, P532, DOI 10.1111/j.1558-5646.1996.tb03866.x; Doebeli M, 1997, J THEOR BIOL, V188, P109, DOI 10.1006/jtbi.1997.0454; Fox GA, 2002, ECOLOGY, V83, P1928, DOI 10.2307/3071775; GRANT PR, 1981, AM ZOOL, V21, P795; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Hughes AR, 2004, P NATL ACAD SCI USA, V101, P8998, DOI 10.1073/pnas.0402642101; Lankau RA, 2007, SCIENCE, V317, P1561, DOI 10.1126/science.1147455; LAVIN PA, 1986, CAN J FISH AQUAT SCI, V43, P2455, DOI 10.1139/f86-305; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Madritch M, 2006, ECOSYSTEMS, V9, P528, DOI 10.1007/s10021-006-0008-2; Matthews B, 2010, ECOLOGY, V91, P1025, DOI 10.1890/09-0235.1; Nosil P, 2005, BIOL J LINN SOC, V86, P297, DOI 10.1111/j.1095-8312.2005.00517.x; Okuyama T, 2008, ECOL RES, V23, P665, DOI 10.1007/s11284-007-0425-5; Palkovacs EP, 2009, ECOLOGY, V90, P300, DOI 10.1890/08-1673.1; PRICE T, 1987, ECOLOGY, V68, P1015, DOI 10.2307/1938373; R Development Core Team, 2009, R FDN STAT COMP; REIMCHEN TE, 1992, EVOLUTION, V46, P1224, DOI 10.1111/j.1558-5646.1992.tb00631.x; Robinson BW, 2000, BEHAVIOUR, V137, P865, DOI 10.1163/156853900502501; ROUGHGARDEN J, 1972, AM NAT, V106, P683, DOI 10.1086/282807; Rudolf VHW, 2008, J ANIM ECOL, V77, P520, DOI 10.1111/j.1365-2656.2008.01368.x; SALONIEMI I, 1993, AM NAT, V141, P880, DOI 10.1086/285514; Sandel B, 2009, OIKOS, V118, P1284, DOI 10.1111/j.1600-0706.2009.17421.x; SCHLUTER D, 1992, AM NAT, V140, P85, DOI 10.1086/285404; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Svanback R, 2007, P ROY SOC B-BIOL SCI, V274, P839, DOI 10.1098/rspb.2006.0198; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Van VALEN LEIGH, 1965, AMER NATUR, V99, P377, DOI 10.1086/282379; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Wilson DS, 1996, COPEIA, P348, DOI 10.2307/1446850	50	31	31	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20782	10.1371/journal.pone.0020782	http://dx.doi.org/10.1371/journal.pone.0020782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687670	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500043
J	Lung'aho, MG; Mwaniki, AM; Szalma, SJ; Hart, JJ; Rutzke, MA; Kochian, LV; Glahn, RP; Hoekenga, OA				Lung'aho, Mercy G.; Mwaniki, Angela M.; Szalma, Stephen J.; Hart, Jonathan J.; Rutzke, Michael A.; Kochian, Leon V.; Glahn, Raymond P.; Hoekenga, Owen A.			Genetic and Physiological Analysis of Iron Biofortification in Maize Kernels	PLOS ONE			English	Article							CACO-2 CELL MONOLAYERS; INOSITOL PHOSPHATES; PHYTIC ACID; FOOD; ZINC; BIOAVAILABILITY; FORTIFICATION; AVAILABILITY; DEFICIENCY; ABSORPTION	Background: Maize is a major cereal crop widely consumed in developing countries, which have a high prevalence of iron (Fe) deficiency anemia. The major cause of Fe deficiency in these countries is inadequate intake of bioavailable Fe, where poverty is a major factor. Therefore, biofortification of maize by increasing Fe concentration and or bioavailability has great potential to alleviate this deficiency. Maize is also a model system for genomic research and thus allows the opportunity for gene discovery. Here we describe an integrated genetic and physiological analysis of Fe nutrition in maize kernels, to identify loci that influence grain Fe concentration and bioavailability. Methodology: Quantitative trait locus (QTL) analysis was used to dissect grain Fe concentration (FeGC) and Fe bioavailability (FeGB) from the Intermated B73xMo17 (IBM) recombinant inbred (RI) population. FeGC was determined by ion coupled argon plasma emission spectroscopy (ICP). FeGB was determined by an in vitro digestion/Caco-2 cell line bioassay. Conclusions: Three modest QTL for FeGC were detected, in spite of high heritability. This suggests that FeGC is controlled by many small QTL, which may make it a challenging trait to improve by marker assisted breeding. Ten QTL for FeGB were identified and explained 54% of the variance observed in samples from a single year/location. Three of the largest FeGB QTL were isolated in sister derived lines and their effect was observed in three subsequent seasons in New York. Single season evaluations were also made at six other sites around North America, suggesting the enhancement of FeGB was not specific to our farm site. FeGB was not correlated with FeGC or phytic acid, suggesting that novel regulators of Fe nutrition are responsible for the differences observed. Our results indicate that iron biofortification of maize grain is achievable using specialized phenotyping tools and conventional plant breeding techniques.	[Lung'aho, Mercy G.; Mwaniki, Angela M.; Hart, Jonathan J.; Rutzke, Michael A.; Kochian, Leon V.; Glahn, Raymond P.; Hoekenga, Owen A.] Cornell Univ, USDA, ARS, Robert W Holley Ctr Agr & Hlth, Ithaca, NY USA; [Lung'aho, Mercy G.; Mwaniki, Angela M.] Cornell Univ, Dept Food Sci, Ithaca, NY 14853 USA; [Szalma, Stephen J.] ARS, USDA, Plant Sci Res Unit, Raleigh, NC USA	Cornell University; United States Department of Agriculture (USDA); Cornell University; United States Department of Agriculture (USDA)	Lung'aho, MG (corresponding author), Swiss Fed Inst Technol, Zurich, Switzerland.	Owen.Hoekenga@ars.usda.gov	Kochian, Leon/ABH-6148-2020	Kochian, Leon/0000-0003-3416-089X; Hoekenga, Owen/0000-0003-4427-2000; Lungaho, Mercy/0000-0001-8867-8155	U.S. Department of Agriculture, Agricultural Research Service; NSF [0419435]	U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); NSF(National Science Foundation (NSF))	This research was supported by the U.S. Department of Agriculture, Agricultural Research Service. The derivation of NIL varieties was supported by NSF DBI #0419435. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALVAREZHERNANDEZ X, 1991, BIOCHIM BIOPHYS ACTA, V1070, P205, DOI 10.1016/0005-2736(91)90165-5; Banziger Marianne, 2000, Food and Nutrition Bulletin, V21, P397; Bentsink L, 2003, THEOR APPL GENET, V106, P1234, DOI 10.1007/s00122-002-1177-9; Boccio JR, 2003, BIOL TRACE ELEM RES, V94, P1, DOI 10.1385/BTER:94:1:1; Bouis HE, 2000, NUTRITION, V16, P701, DOI 10.1016/S0899-9007(00)00266-5; Bouis HE, 2002, J NUTR, V132, p491S, DOI 10.1093/jn/132.3.491S; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Buescher E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011081; Caballero B, 2002, ANN NUTR METAB, V46, P3, DOI 10.1159/000066400; Drakakaki G, 2005, PLANT MOL BIOL, V59, P869, DOI 10.1007/s11103-005-1537-3; Etcheverry P, 2005, INT J VITAM NUTR RES, V75, P171, DOI 10.1024/0300-9831.75.3.171; Falque M, 2005, GENETICS, V170, P1957, DOI 10.1534/genetics.104.040204; Foyer CH, 2006, PHYSIOL PLANTARUM, V126, P289, DOI 10.1111/j.1399-3054.2006.00661.x; Garcia-Casal MN, 2000, J NUTR, V130, P5; GIBSON RS, 2004, ASIA PAC J CLIN NUTR, V13, pS23; Glahn RP, 1998, J NUTR, V128, P1555, DOI 10.1093/jn/128.9.1555; Glahn RP, 1997, J NUTR, V127, P642, DOI 10.1093/jn/127.4.642; Glahn RP, 2002, J AGR FOOD CHEM, V50, P390, DOI 10.1021/jf011046u; Guzman-Maldonado SH, 2003, CROP SCI, V43, P1029, DOI 10.2135/cropsci2003.1029; Haas JD, 2005, J NUTR, V135, P2823, DOI 10.1093/jn/135.12.2823; Hunt JR, 2003, AM J CLIN NUTR, V78, p633S, DOI 10.1093/ajcn/78.3.633S; Jannink JL, 2010, BRIEF FUNCT GENOMICS, V9, P166, DOI 10.1093/bfgp/elq001; Jovani M, 2001, J AGR FOOD CHEM, V49, P3480, DOI 10.1021/jf010106t; Lawrence CJ, 2005, PLANT PHYSIOL, V138, P55, DOI 10.1104/pp.104.059196; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; LEHRFELD J, 1994, J AGR FOOD CHEM, V42, P2726, DOI 10.1021/jf00048a015; Lemke S, 2005, PUBLIC HEALTH NUTR, V8, P844, DOI 10.1079/PHN2005739; Lopez MAA, 2004, INT J FOOD SCI NUTR, V55, P597, DOI 10.1080/09637480500085820; Lucca P, 2002, J AM COLL NUTR, V21, p184S, DOI 10.1080/07315724.2002.10719264; Lucca P, 2001, THEOR APPL GENET, V102, P392, DOI 10.1007/s001220051659; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Oikeh SO, 2003, J AGR FOOD CHEM, V51, P3688, DOI 10.1021/jf0261708; Pinstrup-Andersen P, 2002, AM J AGR ECON, V84, P1201, DOI 10.1111/1467-8276.00381; Poletti S, 2004, CURR OPIN BIOTECH, V15, P162, DOI 10.1016/j.copbio.2004.03.002; Rosegrant MW, 2003, SCIENCE, V302, P1917, DOI 10.1126/science.1092958; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Skalicky A, 2006, MATERN CHILD HLTH J, V10, P177, DOI 10.1007/s10995-005-0036-0; Skoglund E, 1999, J AGR FOOD CHEM, V47, P1109, DOI 10.1021/jf980745c; STAFF SS, 2007, NATURAL RESOURCES CO; Tapia V, 1996, AM J PHYSIOL-GASTR L, V271, pG443, DOI 10.1152/ajpgi.1996.271.3.G443; Vreugdenhil D, 2004, PLANT CELL ENVIRON, V27, P828, DOI 10.1111/j.1365-3040.2004.01189.x; Wang S, 2012, WINDOWS QTL CARTOGRA; Welch RM, 2002, J NUTR, V132, p495S, DOI 10.1093/jn/132.3.495S; Welch RM, 2002, PLANT SOIL, V245, P205, DOI 10.1023/A:1020668100330; [WHO UNICEF], 2004, FOC AN INT APPR EFF; Wienk KJH, 1999, EUR J NUTR, V38, P51, DOI 10.1007/s003940050046; Yoshihara Toshihiro, 2005, Food and Nutrition Bulletin, V26, P416; Yun SM, 2004, J NUTR, V134, P2717, DOI 10.1093/jn/134.10.2717	49	55	56	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20429	10.1371/journal.pone.0020429	http://dx.doi.org/10.1371/journal.pone.0020429			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687662	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500024
J	Niboyet, A; Brown, JR; Dijkstra, P; Blankinship, JC; Leadley, PW; Le Roux, X; Barthes, L; Barnard, RL; Field, CB; Hungate, BA				Niboyet, Audrey; Brown, Jamie R.; Dijkstra, Paul; Blankinship, Joseph C.; Leadley, Paul W.; Le Roux, Xavier; Barthes, Laure; Barnard, Romain L.; Field, Christopher B.; Hungate, Bruce A.			Global Change Could Amplify Fire Effects on Soil Greenhouse Gas Emissions	PLOS ONE			English	Article							NITROUS-OXIDE; ELEVATED CO2; NITRIC-OXIDE; GRASSLAND RESPONSES; CARBON-DIOXIDE; DENITRIFICATION; PLANT; PRECIPITATION; DIVERSITY; FLUXES	Background: Little is known about the combined impacts of global environmental changes and ecological disturbances on ecosystem functioning, even though such combined impacts might play critical roles in shaping ecosystem processes that can in turn feed back to climate change, such as soil emissions of greenhouse gases. Methodology/Principal Findings: We took advantage of an accidental, low-severity wildfire that burned part of a long-term global change experiment to investigate the interactive effects of a fire disturbance and increases in CO2 concentration, precipitation and nitrogen supply on soil nitrous oxide (N2O) emissions in a grassland ecosystem. We examined the responses of soil N2O emissions, as well as the responses of the two main microbial processes contributing to soil N2O production - nitrification and denitrification - and of their main drivers. We show that the fire disturbance greatly increased soil N2O emissions over a three-year period, and that elevated CO2 and enhanced nitrogen supply amplified fire effects on soil N2O emissions: emissions increased by a factor of two with fire alone and by a factor of six under the combined influence of fire, elevated CO2 and nitrogen. We also provide evidence that this response was caused by increased microbial denitrification, resulting from increased soil moisture and soil carbon and nitrogen availability in the burned and fertilized plots. Conclusions/Significance: Our results indicate that the combined effects of fire and global environmental changes can exceed their effects in isolation, thereby creating unexpected feedbacks to soil greenhouse gas emissions. These findings highlight the need to further explore the impacts of ecological disturbances on ecosystem functioning in the context of global change if we wish to be able to model future soil greenhouse gas emissions with greater confidence.	[Niboyet, Audrey; Leadley, Paul W.; Barthes, Laure] Univ Paris 11, CNRS, AgroParisTech, Lab Ecol Systemat & Evolut,UMR 8079, F-91405 Orsay, France; [Brown, Jamie R.; Dijkstra, Paul; Blankinship, Joseph C.; Hungate, Bruce A.] No Arizona Univ, Dept Biol Sci, Flagstaff, AZ 86011 USA; [Brown, Jamie R.; Dijkstra, Paul; Blankinship, Joseph C.; Hungate, Bruce A.] No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA; [Le Roux, Xavier] Univ Lyon 1, CNRS, USC 1193, INRA,Lab Ecol Microbienne,UMR 5557, F-69622 Villeurbanne, France; [Barnard, Romain L.] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland; [Field, Christopher B.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA USA	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay; Northern Arizona University; Northern Arizona University; INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; Swiss Federal Institutes of Technology Domain; ETH Zurich; Carnegie Institution for Science	Niboyet, A (corresponding author), Univ Paris 06, CNRS, AgroParisTech, Lab Biogeochim & Ecol Milieux Continentaux,UMR 76, Thiverval Grignon, France.	audrey.niboyet@grignon.inra.fr	Barnard, Romain L./G-8190-2011; Leadley, Paul/E-4773-2012; Hungate, Bruce/F-8991-2011	Barnard, Romain L./0000-0002-6440-1159; Hungate, Bruce/0000-0002-7337-1887; Niboyet, Audrey/0000-0003-3355-706X; LE ROUX, Xavier/0000-0001-9695-0825	U.S. National Science Foundation [DEB-0092642, DEB-0445324]; U.S. Department of Energy; Carnegie Institution for Science; Jasper Ridge Biological Preserve at Stanford University; Universite Paris-Sud; Universite Lyon; CNRS; INRA	U.S. National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy(United States Department of Energy (DOE)); Carnegie Institution for Science; Jasper Ridge Biological Preserve at Stanford University; Universite Paris-Sud; Universite Lyon; CNRS(Centre National de la Recherche Scientifique (CNRS)); INRA	The Jasper Ridge Global Change Experiment was supported by the U.S. National Science Foundation (http://www.nsf.gov), the U.S. Department of Energy (http://www.energy.gov), the Carnegie Institution for Science (http://carnegiescience.edu) and the Jasper Ridge Biological Preserve at Stanford University (http://jrbp.stanford.edu). This work was supported by a CNRS - Etats Unis grant and by funding from Universite Paris-Sud 11 (http://www.u-psud.fr), Universite Lyon 1 (http://www.univ-lyon1.fr), CNRS (http://www.cnrs.fr), INRA (http://www.inra.fr) and the U.S. National Science Foundation (DEB-0092642, DEB-0445324). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON IC, 1988, J GEOPHYS RES-ATMOS, V93, P3893, DOI 10.1029/JD093iD04p03893; Arnone JA, 1998, OECOLOGIA, V116, P331, DOI 10.1007/s004420050594; Attard E, 2011, GLOBAL CHANGE BIOL, V17, P1975, DOI 10.1111/j.1365-2486.2010.02340.x; Baggs EM, 2003, SOIL BIOL BIOCHEM, V35, P729, DOI 10.1016/S0038-0717(03)00083-X; Barnard R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002282; Barnard R, 2006, FUNCT ECOL, V20, P557, DOI 10.1111/j.1365-2435.2006.01146.x; BELSER LW, 1980, APPL ENVIRON MICROB, V39, P505, DOI 10.1128/AEM.39.3.505-510.1980; Cantarel AAM, 2011, ECOSYSTEMS, V14, P223, DOI 10.1007/s10021-010-9405-7; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; Dukes J. S., 2007, CALIFORNIA GRASSLAND, P218; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; FIELD CB, 1995, PLANT CELL ENVIRON, V18, P1214, DOI 10.1111/j.1365-3040.1995.tb00630.x; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Gutknecht JLM, 2010, PEDOBIOLOGIA, V53, P283, DOI 10.1016/j.pedobi.2010.02.001; Hart S. C., 1994, METHODS SOIL ANAL 2, P985; Henry HAL, 2006, ECOSYSTEMS, V9, P1066, DOI 10.1007/s10021-005-0077-7; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Ineson P, 1998, PLANT SOIL, V198, P89, DOI 10.1023/A:1004298309606; KAMMAN C, 2001, THESIS U GIESSEN GIE; KOOL DM, 2010, THESIS WAGENINGEN U; Levine JS, 1988, GLOBAL BIOGEOCHEM CY, V2, P445, DOI 10.1029/GB002i004p00445; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; LUNCH CK, 2009, THESIS STANFORD U ST; McGill BM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011618; Melillo JM, 2001, J GEOPHYS RES-ATMOS, V106, P34179, DOI 10.1029/2000JD000036; NIBOYET A, 2008, THESIS U PARIS SUD 1; Niboyet A, 2010, PLANT SOIL, V327, P35, DOI 10.1007/s11104-009-0029-7; Norby RJ, 2007, TERRESTRIAL ECOSYSTE; Parry M. L., 2007, CLIMATE CHANGE 2007; Pinay G, 2007, SOIL BIOL BIOCHEM, V39, P33, DOI 10.1016/j.soilbio.2006.05.018; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Shaw LJ, 2006, ENVIRON MICROBIOL, V8, P214, DOI 10.1111/j.1462-2920.2005.00882.x; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Skiba U., 2000, CHEMOSPHERE GLOBAL C, V2, P379, DOI DOI 10.1016/S1465-9972(00)00016-7; Smith Keith, 2010, NITROUS OXIDE CLIMAT; SMITH MS, 1979, SOIL BIOL BIOCHEM, V11, P261, DOI 10.1016/0038-0717(79)90071-3; Stark JM, 1996, SOIL SCI SOC AM J, V60, P1846, DOI 10.2136/sssaj1996.03615995006000060033x; Tiedje J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P1011; TIEDJE JM, 1988, ENV MICROBIOLOGY ANA, P179; Weitz AM, 1998, J GEOPHYS RES-ATMOS, V103, P28047, DOI 10.1029/98JD02144; Wertz S, 2007, ENVIRON MICROBIOL, V9, P2211, DOI 10.1111/j.1462-2920.2007.01335.x; Wohlgemuth PM, 2006, FIRE IN CALIFORNIA'S ECOSYSTEMS, P75; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Yeager CM, 2005, APPL ENVIRON MICROB, V71, P2713, DOI 10.1128/AEM.71.5.2713-2722.2005; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P9892, DOI 10.1073/pnas.1732012100	48	27	32	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20105	10.1371/journal.pone.0020105	http://dx.doi.org/10.1371/journal.pone.0020105			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687708	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500008
J	van den Akker, T; van Rhenen, J; Mwagomba, B; Lommerse, K; Vinkhumbo, S; van Roosmalen, J				van den Akker, Thomas; van Rhenen, Jair; Mwagomba, Beatrice; Lommerse, Kinke; Vinkhumbo, Steady; van Roosmalen, Jos			Reduction of Severe Acute Maternal Morbidity and Maternal Mortality in Thyolo District, Malawi: The Impact of Obstetric Audit	PLOS ONE			English	Article							MANAGEMENT; HIV/AIDS; DELIVERY	Background: Critical incident audit and feedback are recommended interventions to improve the quality of obstetric care. To evaluate the effect of audit at district level in Thyolo, Malawi, we assessed the incidence of facility-based severe maternal complications (severe acute maternal morbidity (SAMM) and maternal mortality) during two years of audit and feedback. Methodology/Principal Findings: Between September 2007 and September 2009, we included all cases of maternal mortality and SAMM that occurred in Thyolo District Hospital, the main referral facility in the area, using validated disease-specific criteria. During two-to three-weekly audit sessions, health workers and managers identified substandard care factors. Resulting recommendations were implemented and followed up. Feedback was given during subsequent sessions. A linear regression analysis was performed on facility-based severe maternal complications. During the two-year study period, 386 women were included: 46 died and 340 sustained SAMM, giving a case fatality rate of 11.9%. Forty-five cases out of the 386 inclusions were audited in plenary with hospital staff. There was a reduction of 3.1 women with severe maternal complications per 1000 deliveries in the district health facilities, from 13.5 per 1000 deliveries in the beginning to 10.4 per 1000 deliveries at the end of the study period. The incidence of uterine rupture and major obstetric hemorrhage reduced considerably (from 3.5 to 0.2 and from 5.9 to 2.6 per 1000 facility deliveries respectively). Conclusions: Our findings indicate that audit and feedback have the potential to reduce serious maternal complications including maternal mortality. Complications like major hemorrhage and uterine rupture that require relatively straightforward intrapartum emergency management are easier to reduce than those which require uptake of improved antenatal care (eclampsia) or timely intravenous medication or HIV-treatment (peripartum infections).	[van den Akker, Thomas; Mwagomba, Beatrice; Lommerse, Kinke; Vinkhumbo, Steady] Minist Hlth, Thyolo Dist Hlth Off, Thyolo, Malawi; [van den Akker, Thomas; van Roosmalen, Jos] Vrije Univ Amsterdam, Med Ctr, Dept Med Humanities, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [van Rhenen, Jair; van Roosmalen, Jos] Leiden Univ, Dept Obstet, Med Ctr, Leiden, Netherlands	Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	van den Akker, T (corresponding author), Minist Hlth, Thyolo Dist Hlth Off, Thyolo, Malawi.	t.vandenakker@vumc.nl						BAKKER W, 2011, HLTH WORKERS P UNPUB; Baskett TF, 1998, BRIT J OBSTET GYNAEC, V105, P981, DOI 10.1111/j.1471-0528.1998.tb10261.x; Bemelmans M, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-1; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Drost E, 2010, BJOG-INT J OBSTET GY, V117, P1553, DOI 10.1111/j.1471-0528.2010.02691.x; Dumont A, 2006, B WORLD HEALTH ORGAN, V84, P218, DOI 10.2471/BLT.05.023903; Filippi V, 2005, ACTA OBSTET GYN SCAN, V84, P11, DOI 10.1111/j.0001-6349.2005.00636.x; *GOV MAL NAT HLTH, 2001, SUMM GUID WRIT RES P; *GOV MAL NAT RES C, 2002, PROC GUID COND RES M; Gulmezoglu A Metin, 2004, BMC Med Res Methodol, V4, P16, DOI 10.1186/1471-2288-4-16; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Kongnyuy E J, 2008, Women Birth, V21, P149, DOI 10.1016/j.wombi.2008.08.002; Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; MBARUKU G, 1995, HEALTH POLICY PLANN, V10, P71, DOI 10.1093/heapol/10.1.71; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; *NAT STAT OFF, 2005, MAL DEM HLTH SURV 20; Oladapo Olufemi T, 2005, Reprod Health, V2, P9, DOI 10.1186/1742-4755-2-9; Pattinson RC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002961.pub2; Pattinson RC, 2003, BRIT MED BULL, V67, P231, DOI 10.1093/bmb/ldg007; Penney G, 2007, CURR OPIN OBSTET GYN, V19, P145, DOI 10.1097/GCO.0b013e328014a860; Say Lale, 2004, Reprod Health, V1, P3, DOI 10.1186/1742-4755-1-3; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Shankar A, 2008, LANCET, V371, P1223, DOI 10.1016/S0140-6736(08)60536-X; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; van den Akker T, 2011, INT HEALTH, V3, P66, DOI 10.1016/j.inhe.2010.11.001; van den Akker T, 2009, INT J GYNECOL OBSTET, V107, P289, DOI 10.1016/j.ijgo.2009.09.005; Wagaarachchi PT, 2001, INT J GYNECOL OBSTET, V74, P119, DOI 10.1016/S0020-7292(01)00427-1; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089; WHO United Nations Population Fund Unicef World Bank, 2003, MAN COMPL PREGN CHIL; World Health Organisation, 2019, INT STAT CLASS DIS R; World Health Organization, 2006, PREGN CHILDB POSTP N; Zachariah R, 2009, LANCET INFECT DIS, V9, P711, DOI 10.1016/S1473-3099(09)70229-4; Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x	35	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20776	10.1371/journal.pone.0020776	http://dx.doi.org/10.1371/journal.pone.0020776			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677788	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500043
J	Goncalves, P; Valerio, E; Correia, C; de Almeida, JMGCF; Sampaio, JP				Goncalves, Paula; Valerio, Elisabete; Correia, Claudia; de Almeida, Joao M. G. C. F.; Sampaio, Jose Paulo			Evidence for Divergent Evolution of Growth Temperature Preference in Sympatric Saccharomyces Species	PLOS ONE			English	Article							SENSU-STRICTO; GENE LOSS; POPULATION GENOMICS; WILD POPULATIONS; CELL-WALL; YEAST; CEREVISIAE; DUPLICATION; HYBRIDS; KUDRIAVZEVII	The genus Saccharomyces currently includes eight species in addition to the model yeast Saccharomyces cerevisiae, most of which can be consistently isolated from tree bark and soil. We recently found sympatric pairs of Saccharomyces species, composed of one cryotolerant and one thermotolerant species in oak bark samples of various geographic origins. In order to contribute to explain the occurrence in sympatry of Saccharomyces species, we screened Saccharomyces genomic data for protein divergence that might be correlated to distinct growth temperature preferences of the species, using the dN/dS ratio as a measure of protein evolution rates and pair-wise species comparisons. In addition to proteins previously implicated in growth at suboptimal temperatures, we found that glycolytic enzymes were among the proteins exhibiting higher than expected divergence when one cryotolerant and one thermotolerant species are compared. By measuring glycolytic fluxes and glycolytic enzymatic activities in different species and at different temperatures, we subsequently show that the unusual divergence of glycolytic genes may be related to divergent evolution of the glycolytic pathway aligning its performance to the growth temperature profiles of the different species. In general, our results support the view that growth temperature preference is a trait that may have undergone divergent selection in the course of ecological speciation in Saccharomyces.	[Goncalves, Paula; Valerio, Elisabete; Correia, Claudia; de Almeida, Joao M. G. C. F.; Sampaio, Jose Paulo] Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Dept Ciencias Vida, Caparica, Portugal	Universidade Nova de Lisboa	Goncalves, P (corresponding author), Univ Nova Lisboa, Fac Ciencias & Tecnol, Ctr Recursos Microbiol CREM, Dept Ciencias Vida, Caparica, Portugal.	pmz@fct.unl.pt	Gonçalves, Paula/CAH-0730-2022; Almeida, João/B-9360-2011; Sampaio, Jose Paulo/C-5532-2011; Gonçalves, Paula/B-4016-2010	Gonçalves, Paula/0000-0003-2103-1060; Sampaio, Jose Paulo/0000-0001-8145-5274; Gonçalves, Paula/0000-0003-2103-1060; almeida, joao/0000-0003-2965-6268; Valerio, Elisabete/0000-0001-8189-244X	FCT, Portugal [PTDC/BIA-BDE/71734/2006, SFRH/BPD/46471/2008]	FCT, Portugal(Portuguese Foundation for Science and Technology)	This work was funded by FCT, Portugal, grants PTDC/BIA-BDE/71734/2006 and SFRH/BPD/46471/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aa E, 2006, FEMS YEAST RES, V6, P702, DOI 10.1111/j.1567-1364.2006.00059.x; Abe F, 2007, FEBS LETT, V581, P4993, DOI 10.1016/j.febslet.2007.09.039; Bond U., 2009, ADV APPL MICROBIOL, V69, P159, DOI DOI 10.1016/S0065-2164(09)69006-7; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Cavalieri D, 2003, J MOL EVOL, V57, pS226, DOI 10.1007/s00239-003-0031-2; Ciani M, 2004, ANTON LEEUW INT J G, V85, P159, DOI 10.1023/B:ANTO.0000020284.05802.d7; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Cliften PF, 2006, GENETICS, V172, P863, DOI 10.1534/genetics.105.048900; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; de Almeida Joao M. G. C. F., 2010, Genomics Proteomics & Bioinformatics, V8, P135, DOI 10.1016/S1672-0229(10)60015-0; DeWinde JH, 1996, EUR J BIOCHEM, V241, P633; Diezmann S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005317; Fay JC, 2005, PLOS GENET, V1, P66, DOI 10.1371/journal.pgen.0010005; Fernandez-Espinar MT, 2003, YEAST, V20, P1213, DOI 10.1002/yea.1034; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; GANTER PF, 1992, ECOLOGY, V73, P54, DOI 10.2307/1938720; Giudici P, 1998, LETT APPL MICROBIOL, V27, P31; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Homma T, 2003, CRYOBIOLOGY, V46, P230, DOI 10.1016/S0011-2240(03)00028-2; Kawahara Y, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-9; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Koufopanou V, 2006, PHILOS T R SOC B, V361, P1941, DOI 10.1098/rstb.2006.1922; Kuehne HA, 2007, CURR BIOL, V17, P407, DOI 10.1016/j.cub.2006.12.047; Kurtzman CP, 2003, FEMS YEAST RES, V4, P233, DOI 10.1016/S1567-1356(03)00175-2; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Legras JL, 2007, MOL ECOL, V16, P2091, DOI 10.1111/j.1365-294X.2007.03266.x; Li YD, 2009, J EVOLUTION BIOL, V22, P2430, DOI 10.1111/j.1420-9101.2009.01851.x; Linder P, 2003, BIOL CELL, V95, P157, DOI 10.1016/S0248-4900(03)00032-7; Liti G, 2006, GENETICS, V174, P839, DOI 10.1534/genetics.106.062166; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lopes CA, 2010, FEMS YEAST RES, V10, P412, DOI 10.1111/j.1567-1364.2010.00614.x; Lopez-Villar E, 2006, PROTEOMICS, V6, pS107, DOI 10.1002/pmic.200500479; MA H, 1986, MOL CELL BIOL, V6, P4046, DOI 10.1128/MCB.6.11.4046; Marino-Ramirez L, 2006, EVOL BIOINFORM, V2, P271; Martini A, 1993, J WINE RES, V4, P165, DOI DOI 10.1080/09571269308717966; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Motshwene P, 2003, BIOCHEM J, V369, P357, DOI 10.1042/BJ20021352; Neef DW, 2009, MOL MICROBIOL, V73, P1032, DOI 10.1111/j.1365-2958.2009.06827.x; Nguyen HV, 2005, FEMS YEAST RES, V5, P471, DOI 10.1016/j.femsyr.2004.12.004; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Piskur J, 2006, TRENDS GENET, V22, P183, DOI 10.1016/j.tig.2006.02.002; Rainieri S, 1999, FEMS MICROBIOL LETT, V177, P177, DOI 10.1111/j.1574-6968.1999.tb13729.x; Rainieri S, 2006, APPL ENVIRON MICROB, V72, P3968, DOI 10.1128/AEM.02769-05; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Replansky T, 2008, TRENDS ECOL EVOL, V23, P494, DOI 10.1016/j.tree.2008.05.005; Rivera MC, 1998, P NATL ACAD SCI USA, V95, P6239, DOI 10.1073/pnas.95.11.6239; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Salvado Z, 2011, APPL ENVIRON MICROB, V77, P2292, DOI 10.1128/AEM.01861-10; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Sawyer SL, 2006, P NATL ACAD SCI USA, V103, P17614, DOI 10.1073/pnas.0605468103; Scannell DR, 2008, GENOME RES, V18, P137, DOI 10.1101/gr.6341207; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Shcherbakov D, 2006, NUCLEIC ACIDS RES, V34, P5800, DOI 10.1093/nar/gkl751; Sniegowski Paul D., 2002, FEMS Yeast Research, V1, P299, DOI 10.1016/S1567-1356(01)00043-5; SONI R, 1992, NUCLEIC ACIDS RES, V20, P5852, DOI 10.1093/nar/20.21.5852; Sweeney JY, 2004, FEMS YEAST RES, V4, P521, DOI 10.1016/S1567-1356(03)00171-5; Tai SL, 2007, J BIOL CHEM, V282, P10243, DOI 10.1074/jbc.M610845200; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Umbreit WW, 1964, MANOMETRIC TECHNIQUE; van Hoek MJA, 2009, MOL BIOL EVOL, V26, P2441, DOI 10.1093/molbev/msp160; VANDIJKEN JP, 1993, ANTON LEEUW INT J G, V63, P343, DOI 10.1007/BF00871229; VAUGHANMARTINI A, 1995, J IND MICROBIOL, V14, P514, DOI 10.1007/BF01573967; Wang SA, 2008, INT J SYST EVOL MICR, V58, P510, DOI 10.1099/ijs.0.65331-0; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236	70	52	52	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20739	10.1371/journal.pone.0020739	http://dx.doi.org/10.1371/journal.pone.0020739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674061	Green Published, Green Submitted, gold			2022-12-25	WOS:000291310600029
J	Kim, B; Huang, G; Ho, WB; Greenspan, DS				Kim, Byoungjae; Huang, Guorui; Ho, Wen-Bin; Greenspan, Daniel S.			Bone Morphogenetic Protein-1 Processes Insulin-like Growth Factor-binding Protein 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROCOLLAGEN C-PROTEINASE; BREAST-CANCER CELLS; MESSENGER-RNAS; FUNCTIONALLY REDUNDANT; CELLULAR-LOCALIZATION; FIBROBLAST-GROWTH; DORSOVENTRAL AXIS; GENE-EXPRESSION; FACTORS IGFS; TGF-BETA	The bone morphogenetic protein-1 (BMP1)-like metalloproteinases play key roles in extracellular matrix formation, by converting precursors into mature functional proteins involved in forming the extracellular matrix. The BMP1-like proteinases also play roles in activating growth factors, such as BMP2/4, myostatin, growth differentiation factor 11, and transforming growth factor beta 1, by cleaving extracellular antagonists. The extracellular insulin-like growth factor-binding proteins (IGFBPs) are involved in regulating the effects of insulin-like growth factors (IGFs) on growth, development, and metabolism. Of the six IGFBPs, IGFBP3 has the greatest interaction with the large pool of circulating IGFs. It is also produced locally in tissues and is itself regulated by proteolytic processing. Here, we show that BMP1 cleaves human and mouse IGFBP3 at a single conserved site, resulting in markedly reduced ability of cleaved IGFBP3 to bind IGF-I or to block IGF-I-induced cell signaling. In contrast, such cleavage is shown to result in enhanced IGF-I-independent ability of cleaved IGFBP3 to block FGF-induced proliferation and to induce Smad phosphorylation. Consistent with in vivo roles for such cleavage, it is shown that, whereas wild type mouse embryo fibroblasts (MEFs) produce cleaved IGFBP3, MEFs doubly null for the Bmp1 gene and for the Tll1 gene, which encodes the related metalloproteinase mammalian Tolloid-like 1 (mTLL1), produce only unprocessed IGFBP3, thus demonstrating endogenous BMP1-related proteinases to be responsible for IGFBP3-processing activity in MEFs. Similarly, in zebrafish embryos, overexpression of Bmp1a is shown to reverse an Igfbp3-induced phenotype, consistent with the ability of BMP1-like proteinases to cleave IGFBP3 in vivo.	[Kim, Byoungjae; Huang, Guorui; Greenspan, Daniel S.] Univ Wisconsin, Dept Cell & Regenerat Biol, Madison, WI 53706 USA; [Kim, Byoungjae; Huang, Guorui; Greenspan, Daniel S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Ho, Wen-Bin] FibroGen Inc, San Francisco, CA 94158 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; FibroGen	Greenspan, DS (corresponding author), Univ Wisconsin, Dept Cell & Regenerat Biol, 600 Highland Ave, Madison, WI 53792 USA.	dsgreens@wisc.edu	Huang, Guorui/M-9641-2013	Greenspan, Daniel/0000-0001-8096-7446	National Institutes of Health [AR53815]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053815, R01AR047746] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR53815 (to D. S. G.).	BATEMAN JF, 1986, J BIOL CHEM, V261, P4198; Beattie J, 2009, BIOCHEM BIOPH RES CO, V381, P572, DOI 10.1016/j.bbrc.2009.02.088; BLAT C, 1994, EXP CELL RES, V215, P114, DOI 10.1006/excr.1994.1322; Branam AM, 2010, DEV BIOL, V341, P444, DOI 10.1016/j.ydbio.2010.03.001; Braulke T, 1996, GROWTH REGULAT, V6, P55; CERRO JA, 1993, REGUL PEPTIDES, V48, P189, DOI 10.1016/0167-0115(93)90347-B; Chau P, 2007, BIOCHEMISTRY-US, V46, P8445, DOI 10.1021/bi700028u; Chen JY, 2004, MAR BIOTECHNOL, V6, P1, DOI 10.1007/s10126-002-0115-9; Coverley JA, 1997, MOL CELL ENDOCRINOL, V128, P1, DOI 10.1016/S0303-7207(97)04032-X; Coverley JA, 2000, ENDOCRINOLOGY, V141, P564, DOI 10.1210/en.141.2.564; de los Rios P, 1999, CAN J PHYSIOL PHARM, V77, P235, DOI 10.1139/cjpp-77-4-235; Fanayan S, 2002, J BIOL CHEM, V277, P7255, DOI 10.1074/jbc.M108038200; Fanayan S, 2000, J BIOL CHEM, V275, P39146, DOI 10.1074/jbc.M006964200; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Ge GX, 2007, P NATL ACAD SCI USA, V104, P10010, DOI 10.1073/pnas.0704179104; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Grgurevic L, 2011, J AM SOC NEPHROL, V22, P681, DOI 10.1681/ASN.2010070722; Gui YT, 2001, J CLIN ENDOCR METAB, V86, P2104, DOI 10.1210/jc.86.5.2104; Han VKM, 2000, PLACENTA, V21, P289, DOI 10.1053/plac.1999.0498; Han VKM, 1996, HORM RES, V45, P160, DOI 10.1159/000184780; HOJIMA Y, 1994, ANAL BIOCHEM, V223, P173, DOI 10.1006/abio.1994.1569; Hopkins DR, 2007, MATRIX BIOL, V26, P508, DOI 10.1016/j.matbio.2007.05.004; Huang GR, 2009, J BIOL CHEM, V284, P25879, DOI 10.1074/jbc.M109.024125; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Jasuja R, 2006, MECH DEVELOP, V123, P548, DOI 10.1016/j.mod.2006.05.004; Kobayashi K, 2009, NAT CELL BIOL, V11, P46, DOI 10.1038/ncb1811; Larrain J, 2000, DEVELOPMENT, V127, P821; Lee CI, 2001, PEDIATR RES, V49, P379, DOI 10.1203/00006450-200103000-00012; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lee SB, 1997, J BIOL CHEM, V272, P19059, DOI 10.1074/jbc.272.30.19059; Levine AJ, 2006, GENE DEV, V20, P267, DOI 10.1101/gad.1363206; Li Y, 2005, J BIOL CHEM, V280, P3613, DOI 10.1074/jbc.M411479200; LindenberghKortleve DJ, 1997, MOL CELL ENDOCRINOL, V132, P81, DOI 10.1016/S0303-7207(97)00123-8; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Mishra S, 2004, J BIOL CHEM, V279, P23863, DOI 10.1074/jbc.M311919200; Miyamoto S, 2004, CANCER RES, V64, P665, DOI 10.1158/0008-5472.CAN-03-1916; Mochizuki S, 2004, BIOCHEM BIOPH RES CO, V315, P79, DOI 10.1016/j.bbrc.2004.01.022; Mullins MC, 1996, DEVELOPMENT, V123, P81; Pappano WN, 2003, MOL CELL BIOL, V23, P4428, DOI 10.1128/MCB.23.13.4428-4438.2003; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; RetschBogart GZ, 1996, AM J RESP CELL MOL, V14, P61, DOI 10.1165/ajrcmb.14.1.8534487; Sadowski T, 2003, MOL BIOL CELL, V14, P4569, DOI 10.1091/mbc.E03-01-0009; Saoncella S, 1999, P NATL ACAD SCI USA, V96, P2805, DOI 10.1073/pnas.96.6.2805; SchulteMerker S, 1997, NATURE, V387, P862, DOI 10.1038/43092; Scott IC, 2000, J BIOL CHEM, V275, P30504, DOI 10.1074/jbc.M004846200; Shi ZD, 2000, J BIOL CHEM, V275, P18574, DOI 10.1074/jbc.M002172200; Shimizu M, 2000, GEN COMP ENDOCR, V119, P26, DOI 10.1006/gcen.2000.7498; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; Stewart CEH, 1996, PHYSIOL REV, V76, P1005, DOI 10.1152/physrev.1996.76.4.1005; Veitch DP, 2003, J BIOL CHEM, V278, P15661, DOI 10.1074/jbc.M210588200; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Xu QJ, 2004, J BIOL CHEM, V279, P4269, DOI 10.1074/jbc.M311586200; Zadeh SM, 1997, ENDOCRINOLOGY, V138, P3069, DOI 10.1210/en.138.7.3069	54	19	22	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29014	29025		10.1074/jbc.M111.252585	http://dx.doi.org/10.1074/jbc.M111.252585			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697095	hybrid, Green Published			2022-12-25	WOS:000293837000038
J	Lion, E; Anguille, S; Berneman, ZN; Smits, ELJM; Van Tendeloo, VFI				Lion, Eva; Anguille, Sebastien; Berneman, Zwi N.; Smits, Evelien L. J. M.; Van Tendeloo, Viggo F. I.			Poly(I:C) Enhances the Susceptibility of Leukemic Cells to NK Cell Cytotoxicity and Phagocytosis by DC	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DOUBLE-STRANDED-RNA; ACUTE MYELOID-LEUKEMIA; HUMAN DENDRITIC CELLS; APOPTOTIC TUMOR-CELLS; POLYRIBOINOSINIC POLYRIBOCYTIDYLIC ACID; RECIPROCAL ACTIVATING INTERACTION; ANTITUMOR IMMUNE-RESPONSES; ANTIGEN-PRESENTING CELLS; IFN-GAMMA SECRETION	alpha Active specific immunotherapy aims at stimulating the host's immune system to recognize and eradicate malignant cells. The concomitant activation of dendritic cells (DC) and natural killer (NK) cells is an attractive modality for immune-based therapies. Inducing immunogenic cell death to facilitate tumor cell recognition and phagocytosis by neighbouring immune cells is of utmost importance for guiding the outcome of the immune response. We previously reported that acute myeloid leukemic (AML) cells in response to electroporation with the synthetic dsRNA analogue poly(I: C) exert improved immunogenicity, demonstrated by enhanced DC-activating and NK cell interferon-gamma-inducing capacities. To further invigorate the potential of these immunogenic tumor cells, we explored their effect on the phagocytic and cytotoxic capacity of DC and NK cells, respectively. Using single-cell analysis, we assessed these functionalities in two-and three-party cocultures. Following poly(I: C) electroporation AML cells become highly susceptible to NK cell-mediated killing and phagocytosis by DC. Moreover, the enhanced killing and the improved uptake are strongly correlated. Interestingly, tumor cell killing, but not phagocytosis, is further enhanced in three-party cocultures provided that these tumor cells were upfront electroporated with poly(I: C). Altogether, poly(I:C)-electroporated AML cells potently activate DC and NK cell functions and stimulate NK-DC cross-talk in terms of tumor cell killing. These data strongly support the use of poly(I: C) as a cancer vaccine component, providing a way to overcome immune evasion by leukemic cells.	[Lion, Eva; Anguille, Sebastien; Berneman, Zwi N.; Smits, Evelien L. J. M.; Van Tendeloo, Viggo F. I.] Univ Antwerp, Fac Med, Lab Expt Hematol, B-2020 Antwerp, Belgium; [Berneman, Zwi N.; Van Tendeloo, Viggo F. I.] Univ Antwerp Hosp, Ctr Cellular Therapy & Regenerat Med, Antwerp, Belgium	University of Antwerp; University of Antwerp	Lion, E (corresponding author), Univ Antwerp, Fac Med, Lab Expt Hematol, B-2020 Antwerp, Belgium.	eva.lion@ua.ac.be	Smits, Evelien/E-9654-2012; Van Tendeloo, Viggo FI/A-1233-2010; Smits, Evelien/A-3520-2014	Van Tendeloo, Viggo FI/0000-0003-3217-9917; Smits, Evelien/0000-0001-9255-3435; Lion, Eva/0000-0002-2420-0301; Berneman, Zwi/0000-0002-9133-4588	Fund for Scientific Research - Flanders (FWO-Vlaanderen) [G.0370.08, G.0082.08]; Foundation Against Cancer (Stichting tegen Kanker); Antwerp University [802]; Flemish Government to the Antwerp University; Belgian Governement [P6/41]; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Vlaamse Liga tegen Kanker (VLK); Fund for Scientific Research	Fund for Scientific Research - Flanders (FWO-Vlaanderen)(FWO); Foundation Against Cancer (Stichting tegen Kanker); Antwerp University; Flemish Government to the Antwerp University; Belgian Governement; Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Vlaamse Liga tegen Kanker (VLK); Fund for Scientific Research	This work was supported in part by research grants of the Fund for Scientific Research - Flanders (FWO-Vlaanderen, G.0370.08 and G.0082.08), the Foundation Against Cancer (Stichting tegen Kanker), the Antwerp University Concerted Research Action (BOF-GOA, grant no. 802), the Methusalem financement program of the Flemish Government to the Antwerp University and the Interuniversity Attraction Poles financement programme (IAP #P6/41) of the Belgian Governement. EL was funded by a PhD grant of the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen) and supported by a Stichting Emmanuel van der Schueren research grant of the Vlaamse Liga tegen Kanker (VLK). SA is a PhD fellow of the Fund for Scientific Research, Flanders (FWO-Vlaanderen). ES was funded as postdoctoral researcher by the Fund for Scientific Research. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2003, VACCINE, V21, P787, DOI 10.1016/S0264-410X(02)00599-6; Akazawa T, 2007, P NATL ACAD SCI USA, V104, P252, DOI 10.1073/pnas.0605978104; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Barrett AJ, 2010, CLIN EXP IMMUNOL, V161, P223, DOI 10.1111/j.1365-2249.2010.04197.x; Benwell RK, 2010, CELL IMMUNOL, V264, P119, DOI 10.1016/j.cellimm.2010.05.008; Bontkes HJ, 2008, CLIN IMMUNOL, V127, P375, DOI 10.1016/j.clim.2008.02.001; Boullart ACI, 2008, CANCER IMMUNOL IMMUN, V57, P1589, DOI 10.1007/s00262-008-0489-2; Carbone E, 1999, EUR J IMMUNOL, V29, P4022, DOI 10.1002/(SICI)1521-4141(199912)29:12<4022::AID-IMMU4022>3.3.CO;2-F; Costello RT, 2004, TRENDS IMMUNOL, V25, P328, DOI 10.1016/j.it.2004.04.005; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Cui ZR, 2007, PHARM RES-DORDR, V24, P1645, DOI 10.1007/s11095-007-9293-5; Cui ZR, 2006, CANCER IMMUNOL IMMUN, V55, P1267, DOI 10.1007/s00262-005-0114-6; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Degli-Esposti MA, 2005, NAT REV IMMUNOL, V5, P112, DOI 10.1038/nri1549; Durand V, 2004, IMMUNOL CELL BIOL, V82, P596, DOI 10.1111/j.0818-9641.2004.01285.x; Fauriat C, 2005, BLOOD, V106, P2186, DOI 10.1182/blood-2005-03-1270; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Ferlazzo G, 2003, EUR J IMMUNOL, V33, P306, DOI 10.1002/immu.200310004; Ferlazzo G, 2002, J EXP MED, V195, P343, DOI 10.1084/jem.20011149; Ferlazzo G, 2009, J CLIN IMMUNOL, V29, P265, DOI 10.1007/s10875-009-9283-y; Fernandez NC, 1999, NAT MED, V5, P405, DOI 10.1038/7403; Fernandez NC, 2002, EUR CYTOKINE NETW, V13, P17; Frleta D, 2009, J IMMUNOL, V182, P2766, DOI 10.4049/jimmunol.0801720; Fry TJ, 2009, CANCER IMMUNOL IMMUN, V58, P1257, DOI 10.1007/s00262-008-0638-7; Fujimoto C, 2004, INT IMMUNOL, V16, P55, DOI 10.1093/intimm/dxh025; Gallucci S, 2001, CURR OPIN IMMUNOL, V13, P114, DOI 10.1016/S0952-7915(00)00191-6; Garg AD, 2010, BBA-REV CANCER, V1805, P53, DOI 10.1016/j.bbcan.2009.08.003; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Gerosa F, 2002, J EXP MED, V195, P327, DOI 10.1084/jem.20010938; Girart MV, 2007, J IMMUNOL, V179, P3472, DOI 10.4049/jimmunol.179.6.3472; Green DR, 2009, NAT REV IMMUNOL, V9, P353, DOI 10.1038/nri2545; Hallett WHD, 2008, J IMMUNOL, V180, P163, DOI 10.4049/jimmunol.180.1.163; Henry F, 1999, CANCER RES, V59, P3329; Hoffmann TK, 2000, CANCER RES, V60, P3542; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kamath AT, 2005, J IMMUNOL, V174, P767, DOI 10.4049/jimmunol.174.2.767; Kim MJ, 2009, BIOCHEM PHARMACOL, V78, P573, DOI 10.1016/j.bcp.2009.05.016; Koh CY, 2001, BLOOD, V97, P3132, DOI 10.1182/blood.V97.10.3132; Lanier LL, 2005, J IMMUNOL, V174, P6565, DOI 10.4049/jimmunol.174.11.6565; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Le Bon A, 2008, CYTOKINE GROWTH F R, V19, P33, DOI 10.1016/j.cytogfr.2007.10.007; Lee JJ, 2008, J LEUKOCYTE BIOL, V84, P319, DOI 10.1189/jlb.1107737; Lin ML, 2008, IMMUNOL CELL BIOL, V86, P353, DOI 10.1038/icb.2008.3; Lion E, 2009, LEUKEMIA RES, V33, P539, DOI 10.1016/j.leukres.2008.08.020; Lore K, 2003, J IMMUNOL, V171, P4320, DOI 10.4049/jimmunol.171.8.4320; Lundqvist A, 2006, CANCER RES, V66, P7317, DOI 10.1158/0008-5472.CAN-06-0680; Mailliard RB, 2003, J IMMUNOL, V171, P2366, DOI 10.4049/jimmunol.171.5.2366; Malmberg KJ, 2008, CANCER IMMUNOL IMMUN, V57, P1541, DOI 10.1007/s00262-008-0492-7; Marcenaro E, 2005, J IMMUNOL, V174, P3992, DOI 10.4049/jimmunol.174.7.3992; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; McBride S, 2006, J IMMUNOL, V177, P6122, DOI 10.4049/jimmunol.177.9.6122; McCartney S, 2009, J EXP MED, V206, P2967, DOI 10.1084/jem.20091181; Moehler MH, 2005, HUM GENE THER, V16, P996, DOI 10.1089/hum.2005.16.996; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Munz C, 2005, BLOOD, V105, P266, DOI 10.1182/blood-2004-06-2492; Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585; Perrot I, 2010, J IMMUNOL, V185, P2080, DOI 10.4049/jimmunol.1000532; Pfeffer LM, 1998, CANCER RES, V58, P2489; Piccioli D, 2002, J EXP MED, V195, P335, DOI 10.1084/jem.20010934; Pietra G, 2003, EUR J IMMUNOL, V33, P3427, DOI 10.1002/eji.200324515; Pisegna S, 2004, BLOOD, V104, P4157, DOI 10.1182/blood-2004-05-1860; Prestwich RJ, 2009, J IMMUNOL, V183, P4312, DOI 10.4049/jimmunol.0901074; Rohner A, 2007, LEUKEMIA RES, V31, P1393, DOI 10.1016/j.leukres.2007.02.020; Romagnani C, 2005, EUR J IMMUNOL, V35, P2452, DOI 10.1002/eji.200526069; Ronchetti A, 1999, J IMMUNOL, V163, P130; Rovere P, 1998, J IMMUNOL, V161, P4467; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Salem ML, 2006, VACCINE, V24, P5119, DOI 10.1016/j.vaccine.2006.04.010; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salio M, 2005, CURR BIOL, V15, pR336, DOI 10.1016/j.cub.2005.04.025; Schmidt KN, 2004, J IMMUNOL, V172, P138, DOI 10.4049/jimmunol.172.1.138; Schnurr M, 2002, CANCER RES, V62, P2347; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Sheridan C, 2006, NAT BIOTECHNOL, V24, P597, DOI 10.1038/nbt0606-597; Sivori S, 2004, P NATL ACAD SCI USA, V101, P10116, DOI 10.1073/pnas.0403744101; Smits ELJM, 2007, LEUKEMIA, V21, P1691, DOI 10.1038/sj.leu.2404763; Smits ELJM, 2010, CANCER IMMUNOL IMMUN, V59, P35, DOI 10.1007/s00262-009-0721-8; Smits ELJM, 2009, ONCOLOGIST, V14, P240, DOI 10.1634/theoncologist.2008-0165; Smyth MJ, 2004, IMMUNOL REV, V202, P275, DOI 10.1111/j.0105-2896.2004.00199.x; Spisek R, 2002, CANCER RES, V62, P2861; Spisek R, 2007, BLOOD, V109, P4839, DOI 10.1182/blood-2006-10-054221; Strome SE, 2002, CANCER RES, V62, P1884; Strowig T, 2008, J IMMUNOL, V180, P7785, DOI 10.4049/jimmunol.180.12.7785; Strowig T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040027; Sutlu T, 2009, J INTERN MED, V266, P154, DOI 10.1111/j.1365-2796.2009.02121.x; Szczepanski MJ, 2010, CANCER IMMUNOL IMMUN, V59, P73, DOI 10.1007/s00262-009-0724-5; Terme M, 2008, NAT IMMUNOL, V9, P486, DOI 10.1038/ni1580; Triulzi C, 2010, CANCER RES, V70, P7431, DOI 10.1158/0008-5472.CAN-10-0493; Verdijk RM, 1999, J IMMUNOL, V163, P57; Verheyden S, 2008, LEUKEMIA, V22, P249, DOI 10.1038/sj.leu.2405040; von Euw EM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-19; Vujanovic L, 2010, BLOOD, V116, P575, DOI 10.1182/blood-2009-08-240325; Walzer T, 2005, BLOOD, V106, P2252, DOI 10.1182/blood-2005-03-1154; Wehner R, 2009, INT J CANCER, V124, P358, DOI 10.1002/ijc.23962; Wilson JL, 1999, J IMMUNOL, V163, P6365; WU L, 2011, CANC IMMUNOL IMMUNOT; Yu Y, 2001, J IMMUNOL, V166, P1590, DOI 10.4049/jimmunol.166.3.1590; Zanoni I, 2005, J IMMUNOL, V175, P286, DOI 10.4049/jimmunol.175.1.286; Zanoni I, 2007, IMMUNOL LETT, V110, P6, DOI 10.1016/j.imlet.2007.03.001; Zitvogel L, 2008, NAT REV IMMUNOL, V8, P59, DOI 10.1038/nri2216	103	29	36	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20952	10.1371/journal.pone.0020952	http://dx.doi.org/10.1371/journal.pone.0020952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698118	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600033
J	Weygandt, M; Hackmack, K; Pfuller, C; Bellmann-Strobl, J; Paul, F; Zipp, F; Haynes, JD				Weygandt, Martin; Hackmack, Kerstin; Pfueller, Caspar; Bellmann-Strobl, Judith; Paul, Friedemann; Zipp, Frauke; Haynes, John-Dylan			MRI Pattern Recognition in Multiple Sclerosis Normal-Appearing Brain Areas	PLOS ONE			English	Article							DEEP GRAY-MATTER; DIAGNOSTIC-CRITERIA; T2 HYPOINTENSITY; CORTICAL GREY; WHITE-MATTER; CLASSIFICATION; LESIONS; TISSUE	Objective: Here, we use pattern-classification to investigate diagnostic information for multiple sclerosis (MS; relapsing-remitting type) in lesioned areas, areas of normal-appearing grey matter (NAGM), and normal-appearing white matter (NAWM) as measured by standard MR techniques. Methods: A lesion mapping was carried out by an experienced neurologist for Turbo Inversion Recovery Magnitude (TIRM) images of individual subjects. Combining this mapping with templates from a neuroanatomic atlas, the TIRM images were segmented into three areas of homogenous tissue types (Lesions, NAGM, and NAWM) after spatial standardization. For each area, a linear Support Vector Machine algorithm was used in multiple local classification analyses to determine the diagnostic accuracy in separating MS patients from healthy controls based on voxel tissue intensity patterns extracted from small spherical subregions of these larger areas. To control for covariates, we also excluded group-specific biases in deformation fields as a potential source of information. Results: Among regions containing lesions a posterior parietal WM area was maximally informative about the clinical status (96% accuracy, p<10(-13)). Cerebellar regions were maximally informative among NAGM areas (84% accuracy, p<10(-7)). A posterior brain region was maximally informative among NAWM areas (91% accuracy, p<10(-10)). Interpretation: We identified regions indicating MS in lesioned, but also NAGM, and NAWM areas. This complements the current perception that standard MR techniques mainly capture macroscopic tissue variations due to focal lesion processes. Compared to current diagnostic guidelines for MS that define areas of diagnostic information with moderate spatial specificity, we identified hotspots of MS associated tissue alterations with high specificity defined on a millimeter scale.	[Weygandt, Martin; Hackmack, Kerstin; Haynes, John-Dylan] Charite, Bernstein Ctr Computat Neurosci Berlin, D-13353 Berlin, Germany; [Pfueller, Caspar; Bellmann-Strobl, Judith; Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Bellmann-Strobl, Judith; Paul, Friedemann] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Paul, Friedemann] Charite, Clin & Expt Multiple Sclerosis Res Ctr, D-13353 Berlin, Germany; [Zipp, Frauke] Johannes Gutenberg Univ Mainz, Univ Med Mainz, Dept Neurol, Mainz, Germany; [Haynes, John-Dylan] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Johannes Gutenberg University of Mainz; Max Planck Society	Weygandt, M (corresponding author), Charite, Bernstein Ctr Computat Neurosci Berlin, D-13353 Berlin, Germany.	martin.weygandt@bccn-berlin.de	Paul, Friedemann/ABF-9415-2020; Weygandt, Martin/AAX-9825-2020; Ritter, Kerstin/AFA-8746-2022; Zipp, Frauke/C-9968-2015; Haynes, John-Dylan/Q-1148-2016	Ritter, Kerstin/0000-0001-7115-0020; Zipp, Frauke/0000-0002-1231-1928; Haynes, John-Dylan/0000-0003-1786-6954; Bellmann-Strobl, Judith/0000-0003-2615-1643; paul, friedemann/0000-0002-6378-0070	BMBF [01GQ0411, 01GI0912, GRK 1589/1]; German Research Foundation [Exc 257]; Gemeinnutzige Hertie Foundation; Max Planck Society	BMBF(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); Gemeinnutzige Hertie Foundation; Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work was supported by the Bernstein Computational Neuroscience Program (BMBF: 01GQ0411 to JDH, 01GI0912 to FZ, and GRK 1589/1 to KH; http://www.bmbf.de/), the German Research Foundation (Exc 257 to FP and CP; http://www.dfg.de/index.jsp), the Gemeinnutzige Hertie Foundation (IMSF to FZ; http://www.ghst.de/), and the Max Planck Society (http://www.ghst.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, LEARNING KERNELS; Bakshi R, 2002, ARCH NEUROL-CHICAGO, V59, P62, DOI 10.1001/archneur.59.1.62; Ceccarelli A, 2009, MULT SCLER J, V15, P678, DOI 10.1177/1352458509103611; Chard DT, 2004, MULT SCLER J, V10, P387, DOI 10.1191/1352458504ms1050oa; Chard DT, 2002, BRAIN, V125, P2342, DOI 10.1093/brain/awf240; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Davatzikos C, 2008, NEUROIMAGE, V41, P1220, DOI 10.1016/j.neuroimage.2008.03.050; De Groot CJA, 2001, BRAIN, V124, P1635, DOI 10.1093/brain/124.8.1635; Filippi M, 2000, J NEUROL NEUROSUR PS, V68, P157, DOI 10.1136/jnnp.68.2.157; Filippi M., 2004, NORMAL APPEARING WHI; Fung G, 2003, NEUROCOMPUTING, V55, P39, DOI 10.1016/S0925-2312(03)00379-5; Ge YL, 2003, AM J NEURORADIOL, V24, P1935; Haynes JD, 2007, CURR BIOL, V17, P323, DOI 10.1016/j.cub.2006.11.072; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Inglese M, 2004, NEUROIMAGE, V21, P1825, DOI 10.1016/j.neuroimage.2003.12.008; Kloppel S, 2008, BRAIN, V131, P2969, DOI 10.1093/brain/awn239; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Kriegeskorte N, 2007, P NATL ACAD SCI USA, V104, P20600, DOI 10.1073/pnas.0705654104; Magnin B, 2009, NEURORADIOLOGY, V51, P73, DOI 10.1007/s00234-008-0463-x; Mainero C, 2009, NEUROLOGY, V73, P941, DOI 10.1212/WNL.0b013e3181b64bf7; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; McDonald WI, 2001, ANN NEUROL, V50, P121, DOI 10.1002/ana.1032; Montalban X, 2010, NEUROLOGY, V74, P427, DOI 10.1212/WNL.0b013e3181cec45c; Polman CH, 2005, MULT SCLER, V11, P5, DOI 10.1191/1352458505ms1135oa; Roosendaal SD, 2009, NEUROIMAGE, V44, P1397, DOI 10.1016/j.neuroimage.2008.10.026; Schmah T, 2010, NEURAL COMPUT, V22, P2729, DOI 10.1162/NECO_a_00024; Schmierer K, 2010, BRAIN, V133, P858, DOI 10.1093/brain/awp335; Valsasina P, 2005, NEUROLOGY, V65, P1126, DOI 10.1212/01.wnl.0000178982.53965.70; Vrenken H, 2006, J MAGN RESON IMAGING, V23, P628, DOI 10.1002/jmri.20564; WEYGANDT M, 2011, HUM BRAIN M IN PRESS	30	38	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21138	10.1371/journal.pone.0021138	http://dx.doi.org/10.1371/journal.pone.0021138			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695053	gold, Green Published, Green Accepted			2022-12-25	WOS:000291737600047
J	Card, JP; Kobiler, O; Ludmir, EB; Desai, V; Sved, AF; Enquist, LW				Card, J. Patrick; Kobiler, Oren; Ludmir, Ethan B.; Desai, Vedant; Sved, Alan F.; Enquist, Lynn W.			A Dual Infection Pseudorabies Virus Conditional Reporter Approach to Identify Projections to Collateralized Neurons in Complex Neural Circuits	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; LOCUS-COERULEUS; FUNCTIONAL-ORGANIZATION; FLUORESCENT PROTEINS; BRAIN; TOOLS; RAT; HERPESVIRUSES; EXPRESSION; STRESS	Replication and transneuronal transport of pseudorabies virus (PRV) are widely used to define the organization of neural circuits in rodent brain. Here we report a dual infection approach that highlights connections to neurons that collateralize within complex networks. The method combines Cre recombinase (Cre) expression from a PRV recombinant (PRV-267) and Cre-dependent reporter gene expression from a second infecting strain of PRV (PRV-263). PRV-267 expresses both Cre and a monomeric red fluorescent protein (mRFP) fused to viral capsid protein VP26 (VP26-mRFP) that accumulates in infected cell nuclei. PRV-263 carries a Brainbow cassette and expresses a red (dTomato) reporter that fills the cytoplasm. However, in the presence of Cre, the dTomato gene is recombined from the cassette, eliminating expression of the red reporter and liberating expression of either yellow (EYFP) or cyan (mCerulean) cytoplasmic reporters. We conducted proof-of-principle experiments using a well-characterized model in which separate injection of recombinant viruses into the left and right kidneys produces infection of neurons in the renal preautonomic network. Neurons dedicated to one kidney expressed the unique reporters characteristic of PRV-263 (cytoplasmic dTomato) or PRV-267 (nuclear VP26-mRFP). Dual infected neurons expressed VP26-mRFP and the cyan or yellow cytoplasmic reporters activated by Cre-mediated recombination of the Brainbow cassette. Differential expression of cyan or yellow reporters in neurons lacking VP26-mRFP provided a unique marker of neurons synaptically connected to dual infected neurons, a synaptic relationship that cannot be distinguished using other dual infection tracing approaches. These data demonstrate Cre-enabled conditional reporter expression in polysynaptic circuits that permits the identification of collateralized neurons and their presynaptic partners.	[Card, J. Patrick; Desai, Vedant; Sved, Alan F.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; [Kobiler, Oren; Ludmir, Ethan B.; Enquist, Lynn W.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Kobiler, Oren; Ludmir, Ethan B.; Enquist, Lynn W.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Princeton University; Princeton University	Card, JP (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	card@pitt.edu	Kobiler, Oren/J-2268-2012	Kobiler, Oren/0000-0001-9914-3770; Ludmir, Ethan/0000-0002-5472-5344; Card, John/0000-0002-6148-7364	NIH [1RC1NS068414, 1RO1HL093134, P40 RR018604]; NSF [0918867]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018604] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [RC1NS068414] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH grants 1RC1NS068414, 1RO1HL093134, and P40 RR018604 and NSF grant 0918867. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfield BW, 2003, J VIROL, V77, P10106, DOI 10.1128/JVI.77.18.10106-10112.2003; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Boldogkoi Z, 2004, PROG NEUROBIOL, V72, P417, DOI 10.1016/j.pneurobio.2004.03.010; Boldogkoi Z, 2009, NAT METHODS, V6, P127, DOI [10.1038/NMETH.1292, 10.1038/nmeth.1292]; Braz JM, 2009, J COMP NEUROL, V514, P145, DOI 10.1002/cne.22003; Callaway EM, 2008, CURR OPIN NEUROBIOL, V18, P617, DOI 10.1016/j.conb.2009.03.007; Campbell RE, 2007, J NEUROENDOCRINOL, V19, P561, DOI 10.1111/j.1365-2826.2007.01561.x; Campbell RE, 2007, ENDOCRINOLOGY, V148, P5884, DOI 10.1210/en.2007-0854; Cano G, 2004, J COMP NEUROL, V471, P462, DOI 10.1002/cne.20040; Card JP, 2011, P NATL ACAD SCI USA, V108, P3377, DOI 10.1073/pnas.1015033108; CARD JP, 1990, J NEUROSCI, V10, P1974; Card JP, 2001, ADV VIRUS RES, V56, P39, DOI 10.1016/S0065-3527(01)56004-2; CARD JP, 1999, TRANSNEURONAL CIRCUI; Chang MS, 2000, NEUROSCIENCE, V101, P131, DOI 10.1016/S0306-4522(00)00352-3; Curanovic D, 2009, J VIROL, V83, P1173, DOI 10.1128/JVI.02102-08; DeFalco J, 2001, SCIENCE, V291, P2608, DOI 10.1126/science.1056602; Enquist LW, 2003, CURR OPIN NEUROBIOL, V13, P603, DOI 10.1016/j.conb.2003.08.001; Enquist LW, 1999, ADV VIRUS RES, V51, P237; Itoi K, 2010, J NEUROENDOCRINOL, V22, P355, DOI 10.1111/j.1365-2826.2010.01988.x; JANSEN ASP, 1995, SCIENCE, V270, P253; Kelly RM, 2000, J NEUROSCI METH, V103, P63, DOI 10.1016/S0165-0270(00)00296-X; Kim JS, 1999, J VIROL, V73, P9521, DOI 10.1128/JVI.73.11.9521-9531.1999; Kobiler O, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1145; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Loewy AD, 1998, NEUROSCI BIOBEHAV R, V22, P679, DOI 10.1016/S0149-7634(98)00006-2; Mettenleiter Thomas C., 1995, P367, DOI 10.1016/B978-012397570-6/50022-8; Pomeranz LE, 2005, MICROBIOL MOL BIOL R, V69, P462, DOI 10.1128/MMBR.69.3.462-500.2005; PROUDFIT HK, 1991, PROG BRAIN RES, V88, P123; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; SAUER B, 1987, MOL CELLULAR BIOL, V7; Smith BN, 2000, P NATL ACAD SCI USA, V97, P9264, DOI 10.1073/pnas.97.16.9264; Smith GA, 2000, P NATL ACAD SCI USA, V97, P4873, DOI 10.1073/pnas.080502497; Smith GA, 1999, J VIROL, V73, P6405, DOI 10.1128/JVI.73.8.6405-6414.1999; Song CK, 2005, VIRUS RES, V111, P235, DOI 10.1016/j.virusres.2005.04.012; Swanson L. W, 1998, BRAIN MAPS STRUCTURE; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; YOON H, 2005, CELL, V123	37	42	47	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21141	10.1371/journal.pone.0021141	http://dx.doi.org/10.1371/journal.pone.0021141			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698154	Green Accepted, Green Published, gold			2022-12-25	WOS:000291734100060
J	Orelio, C; van der Sluis, RM; Verkuijlen, P; Nethe, M; Hordijk, PL; van den Berg, TK; Kuijpers, TW				Orelio, Claudia; van der Sluis, Renee M.; Verkuijlen, Paul; Nethe, Micha; Hordijk, Peter L.; van den Berg, Timo K.; Kuijpers, Taco W.			Altered Intracellular Localization and Mobility of SBDS Protein upon Mutation in Shwachman-Diamond Syndrome	PLOS ONE			English	Article							MITOTIC SPINDLE; NUCLEOPHOSMIN; ACTIVATION; EXPRESSION; LEUKEMIAS; INSIGHTS; FAMILY; NPM	Shwachman-Diamond Syndrome (SDS) is a rare inherited disease caused by mutations in the SBDS gene. Hematopoietic defects, exocrine pancreas dysfunction and short stature are the most prominent clinical features. To gain understanding of the molecular properties of the ubiquitously expressed SBDS protein, we examined its intracellular localization and mobility by live cell imaging techniques. We observed that SBDS full-length protein was localized in both the nucleus and cytoplasm, whereas patient-related truncated SBDS protein isoforms localize predominantly to the nucleus. Also the nucleocytoplasmic trafficking of these patient-related SBDS proteins was disturbed. Further studies with a series of SBDS mutant proteins revealed that three distinct motifs determine the intracellular mobility of SBDS protein. A sumoylation motif in the C-terminal domain, that is lacking in patient SBDS proteins, was found to play a pivotal role in intracellular motility. Our structure-function analyses provide new insight into localization and motility of the SBDS protein, and show that patient-related mutant proteins are altered in their molecular properties, which may contribute to the clinical features observed in SDS patients.	[Orelio, Claudia; van der Sluis, Renee M.; Verkuijlen, Paul; van den Berg, Timo K.; Kuijpers, Taco W.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, NL-1105 AZ Amsterdam, Netherlands; [Nethe, Micha; Hordijk, Peter L.] Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Mol Cell Biol, NL-1105 AZ Amsterdam, Netherlands; [Kuijpers, Taco W.] Emma Childrens Hosp, Acad Med Ctr, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam	Orelio, C (corresponding author), Univ Amsterdam, Acad Med Ctr, Sanquin Res & Landsteiner Lab, Dept Blood Cell Res, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.w.kuijpers@amc.uva.nl	van den Berg, Timo K/AAC-2479-2022; van der Sluis, Renee/AAG-6907-2021	van der Sluis, Renee/0000-0002-7668-2517; Hordijk, Peter/0000-0002-3348-078X	Landsteiner Foundation for Bloodtransfusions Research (LSBR) [0519]; Stichting tot Steun [2005-50]	Landsteiner Foundation for Bloodtransfusions Research (LSBR); Stichting tot Steun	This work was supported by: Landsteiner Foundation for Bloodtransfusions Research (LSBR 0519) and Stichting tot Steun (2005-50). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin KM, 2008, J CLIN INVEST, V118, P1511, DOI 10.1172/JCI33764; Austin KM, 2005, BLOOD, V106, P1253, DOI 10.1182/blood-2005-02-0807; Ball HL, 2009, HUM MOL GENET, V18, P3684, DOI 10.1093/hmg/ddp316; BODIAN M, 1964, ACTA PAEDIATR, V53, P282, DOI 10.1111/j.1651-2227.1964.tb07237.x; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; BORER RA, 1989, CELL, V56, P379, DOI 10.1016/0092-8674(89)90241-9; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Da Costa L, 2003, BLOOD, V101, P5039, DOI 10.1182/blood-2002-12-3878; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; de Oliveira JF, 2010, J MOL BIOL, V396, P1053, DOI 10.1016/j.jmb.2009.12.039; Donadieu J, 2005, HAEMATOLOGICA, V90, P45; Dror Y, 2002, BRIT J HAEMATOL, V118, P701, DOI 10.1046/j.1365-2141.2002.03585.x; Falini B, 2006, BLOOD, V108, P1999, DOI 10.1182/blood-2006-03-007013; Ganapathi KA, 2007, BLOOD, V110, P1458, DOI 10.1182/blood-2007-02-075184; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Ginzberg H, 1999, J PEDIATR-US, V135, P81, DOI 10.1016/S0022-3476(99)70332-X; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hesling C, 2007, EXP CELL RES, V313, P4180, DOI 10.1016/j.yexcr.2007.06.024; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Kawakami T, 2005, TOHOKU J EXP MED, V206, P253, DOI 10.1620/tjem.206.253; Kuijpers TW, 2005, BLOOD, V106, P356, DOI 10.1182/blood-2004-11-4371; Mariano AR, 2006, ONCOGENE, V25, P4376, DOI 10.1038/sj.onc.1209453; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Ng CL, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-32; Nicolis Elena, 2005, Hum Mutat, V25, P410, DOI 10.1002/humu.9324; Orelio C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007084; Orelio C, 2009, HAEMATOL-HEMATOL J, V94, P409, DOI 10.3324/haematol.13733; Oving IM, 2002, EUR J CLIN INVEST, V32, P448, DOI 10.1046/j.1365-2362.2002.01004.x; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; Savchenko A, 2005, J BIOL CHEM, V280, P19213, DOI 10.1074/jbc.M414421200; SCHWACHMAN H, 1964, J PEDIATR-US, V65, P645; Shammas C, 2005, J BIOL CHEM, V280, P19221, DOI 10.1074/jbc.M414656200; Stepanovic V, 2004, CELL MOTIL CYTOSKEL, V57, P158, DOI 10.1002/cm.10164; Watts FZ, 2007, CHROMOSOMA, V116, P15, DOI 10.1007/s00412-006-0079-z; Wessels D, 2006, J CELL SCI, V119, P370, DOI 10.1242/jcs.02753	40	4	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20727	10.1371/journal.pone.0020727	http://dx.doi.org/10.1371/journal.pone.0020727			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695142	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300014
J	Wu, MN; Yuan, F				Wu, Mina; Yuan, Fan			Membrane Binding of Plasmid DNA and Endocytic Pathways Are Involved in Electrotransfection of Mammalian Cells	PLOS ONE			English	Article							MEDIATED GENE DELIVERY; IN-VIVO ELECTROPORATION; LOW ELECTRIC-FIELDS; INTRACELLULAR TRAFFICKING; DIVALENT-CATIONS; CELLULAR UPTAKE; SOLID TUMORS; MUSCLE-CELLS; SINGLE-CELL; TRANSFECTION	Electric field mediated gene delivery or electrotransfection is a widely used method in various studies ranging from basic cell biology research to clinical gene therapy. Yet, mechanisms of electrotransfection are still controversial. To this end, we investigated the dependence of electrotransfection efficiency (eTE) on binding of plasmid DNA (pDNA) to plasma membrane and how treatment of cells with three endocytic inhibitors (chlorpromazine, genistein, dynasore) or silencing of dynamin expression with specific, small interfering RNA (siRNA) would affect the eTE. Our data demonstrated that the presence of divalent cations (Ca(2+) and Mg(2+)) in electrotransfection buffer enhanced pDNA adsorption to cell membrane and consequently, this enhanced adsorption led to an increase in eTE, up to a certain threshold concentration for each cation. Trypsin treatment of cells at 10 min post electrotransfection stripped off membrane-bound pDNA and resulted in a significant reduction in eTE, indicating that the time period for complete cellular uptake of pDNA (between 10 and 40 min) far exceeded the lifetime of electric field-induced transient pores (similar to 10 msec) in the cell membrane. Furthermore, treatment of cells with the siRNA and all three pharmacological inhibitors yielded substantial and statistically significant reductions in the eTE. These findings suggest that electrotransfection depends on two mechanisms: (i) binding of pDNA to cell membrane and (ii) endocytosis of membrane-bound pDNA.	[Wu, Mina; Yuan, Fan] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA	Duke University	Wu, MN (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	fyuan@duke.edu	Yuan, Fan/A-1287-2011		National Institutes of Health (NIH) [CA94019]; NIH at Duke University; NATIONAL CANCER INSTITUTE [R01CA094019] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH at Duke University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a grant from the National Institutes of Health (NIH; CA94019). MW was supported in part by a NIH training grant for the Center for Biomolecular and Tissue Engineering at Duke University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; Antov Y, 2005, BIOPHYS J, V88, P2206, DOI 10.1529/biophysj.104.051268; Antov Y, 2004, EXP CELL RES, V297, P348, DOI 10.1016/j.yexcr.2004.03.027; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Bier M, 1999, BIOELECTROMAGNETICS, V20, P194, DOI 10.1002/(SICI)1521-186X(1999)20:3<194::AID-BEM6>3.0.CO;2-0; Bureau MF, 2004, BBA-GENE STRUCT EXPR, V1676, P138, DOI 10.1016/j.bbaexp.2003.11.005; CHERNOMORDIK LV, 1990, BIOCHIM BIOPHYS ACTA, V1024, P179, DOI 10.1016/0005-2736(90)90222-A; Dauty E, 2005, J BIOL CHEM, V280, P7823, DOI 10.1074/jbc.M412374200; DIMITROV DS, 1990, BIOCHIM BIOPHYS ACTA, V1022, P381, DOI 10.1016/0005-2736(90)90289-Z; Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540; DUGUID J, 1993, BIOPHYS J, V65, P1916, DOI 10.1016/S0006-3495(93)81263-3; Escoffre JM, 2009, MOL BIOTECHNOL, V41, P286, DOI 10.1007/s12033-008-9121-0; Eynard N, 1997, BIOELECTROCH BIOENER, V44, P103, DOI 10.1016/S0302-4598(97)00038-X; Faurie C, 2010, J GENE MED, V12, P117, DOI 10.1002/jgm.1414; Favard C, 2007, CURR GENE THER, V7, P67, DOI 10.2174/156652307779940207; Frantescu A, 2005, PHYS CHEM CHEM PHYS, V7, P4126, DOI 10.1039/b510882a; Frantescu A, 2006, BIOELECTROCHEMISTRY, V68, P158, DOI 10.1016/j.bioelechem.2005.06.003; GLOGAUER M, 1993, EXP CELL RES, V208, P232, DOI 10.1006/excr.1993.1242; Golzio M, 2002, P NATL ACAD SCI USA, V99, P1292, DOI 10.1073/pnas.022646499; Gratton SEA, 2008, P NATL ACAD SCI USA, V105, P11613, DOI 10.1073/pnas.0801763105; Haberl S, 2010, BIOELECTROCHEMISTRY, V79, P265, DOI 10.1016/j.bioelechem.2010.04.001; Hay JC, 2007, EMBO REP, V8, P236, DOI 10.1038/sj.embor.7400921; Heller LC, 2006, HUM GENE THER, V17, P890, DOI 10.1089/hum.2006.17.890; Heller R, 1996, FEBS LETT, V389, P225, DOI 10.1016/0014-5793(96)00590-X; Henshaw J, 2011, CANCER GENE THER, V18, P26, DOI 10.1038/cgt.2010.51; Henshaw J, 2008, MOL CANCER THER, V7, P2566, DOI 10.1158/1535-7163.MCT-08-0435; Henshaw JW, 2008, J PHARM SCI-US, V97, P691, DOI 10.1002/jps.21000; Henshaw JW, 2007, BIOELECTROCHEMISTRY, V71, P233, DOI 10.1016/j.bioelechem.2007.07.005; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kirkham M, 2005, BBA-MOL CELL RES, V1746, P349, DOI 10.1016/j.bbamcr.2005.11.005; Krassowska W, 2007, BIOPHYS J, V92, P404, DOI 10.1529/biophysj.106.094235; Lechardeur D, 1999, GENE THER, V6, P482, DOI 10.1038/sj.gt.3300867; Liu F, 2006, J GENE MED, V8, P353, DOI 10.1002/jgm.851; Lohr F, 2001, CANCER RES, V61, P3281; Lukacs GL, 2000, J BIOL CHEM, V275, P1625, DOI 10.1074/jbc.275.3.1625; Mengistu DH, 2009, J PHYS CHEM B, V113, P12277, DOI 10.1021/jp904986j; MICHEL MR, 1988, EXPERIENTIA, V44, P199, DOI 10.1007/BF01941705; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Neumann E, 1996, BIOPHYS J, V71, P868, DOI 10.1016/S0006-3495(96)79288-3; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; Nishi T, 1996, CANCER RES, V56, P1050; PAVLIN M, 2009, IFMBE P, P158; Phez E, 2005, BBA-GEN SUBJECTS, V1724, P248, DOI 10.1016/j.bbagen.2005.04.005; Pike LJ, 2004, BIOCHEM J, V378, P281, DOI 10.1042/BJ20031672; PRAUSNITZ MR, 1995, BIOPHYS J, V68, P1864, DOI 10.1016/S0006-3495(95)80363-2; Rejman J, 2005, MOL THER, V12, P468, DOI 10.1016/j.ymthe.2005.03.038; Rols MP, 1998, NAT BIOTECHNOL, V16, P168, DOI 10.1038/nbt0298-168; ROLS MP, 1995, BIOCHEM BIOPH RES CO, V208, P26, DOI 10.1006/bbrc.1995.1300; SABELNIKOV AG, 1994, PROG BIOPHYS MOL BIO, V62, P119, DOI 10.1016/0079-6107(94)90009-4; Satkauskas S, 2001, MOL THER, V4, P317, DOI 10.1006/mthe.2001.0465; Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006; van der Aa MAEM, 2007, PHARM RES-DORDR, V24, P1590, DOI 10.1007/s11095-007-9287-3; Vaughan EE, 2006, MOL THER, V13, P422, DOI 10.1016/j.ymthe.2005.10.004; Vaughan EE, 2008, MOL THER, V16, P1841, DOI 10.1038/mt.2008.190; Weaver JC, 1996, BIOELECTROCH BIOENER, V41, P135, DOI 10.1016/S0302-4598(96)05062-3; WEAVER JC, 1993, J CELL BIOCHEM, V51, P426, DOI 10.1002/jcb.2400510407; Wells JM, 2000, GENE THER, V7, P541, DOI 10.1038/sj.gt.3301141; WILLIAMS SK, 1981, MICROVASC RES, V21, P175, DOI 10.1016/0026-2862(81)90030-3; WOLF H, 1994, BIOPHYS J, V66, P524, DOI 10.1016/S0006-3495(94)80805-7; XIE TD, 1993, BIOPHYS J, V65, P1684, DOI 10.1016/S0006-3495(93)81208-6; Zaharoff DA, 2008, EXP BIOL MED, V233, P94, DOI 10.3181/0704-RM-113; Zefirov AL, 2006, NEUROSCIENCE, V143, P905, DOI 10.1016/j.neuroscience.2006.08.025	63	65	67	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20923	10.1371/journal.pone.0020923	http://dx.doi.org/10.1371/journal.pone.0020923			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695134	gold, Green Published, Green Submitted			2022-12-25	WOS:000291663300029
J	Lucchi, S; Calebiro, D; de Filippis, T; Grassi, ES; Borghi, MO; Persani, L				Lucchi, Simona; Calebiro, Davide; de Filippis, Tiziana; Grassi, Elisa S.; Borghi, Maria Orietta; Persani, Luca			8-Chloro-Cyclic AMP and Protein Kinase A I-Selective Cyclic AMP Analogs Inhibit Cancer Cell Growth through Different Mechanisms	PLOS ONE			English	Article							REGULATORY SUBUNIT; MUTATIONS; APOPTOSIS; CAMP; ACTIVATION; PHOSPHODIESTERASE; 8-CHLORO-ADENOSINE; PROLIFERATION; HYPERPLASIA; EXPRESSION	Cyclic AMP (cAMP) inhibits the proliferation of several tumor cells. We previously reported an antiproliferative effect of PKA I-selective cAMP analogs (8-PIP-cAMP and 8-HA-cAMP) on two human cancer cell lines of different origin. 8-Cl-cAMP, another cAMP analog with known antiproliferative properties, has been investigated as a potential anticancer drug. Here, we compared the antiproliferative effect of 8-Cl-cAMP and the PKA I-selective cAMP analogs in three human cancer cell lines (ARO, NPA and WRO). 8-Cl-cAMP and the PKA I-selective cAMP analogs had similarly potent antiproliferative effects on the BRAF-positive ARO and NPA cells, but not on the BRAF-negative WRO cells, in which only 8-Cl-cAMP consistently inhibited cell growth. While treatment with the PKA I-selective cAMP analogs was associated with growth arrest, 8-Cl-cAMP induced apoptosis. To further investigate the actions of 8-Cl-cAMP and the PKA I-selective cAMP analogs, we analyzed their effects on signaling pathways involved in cell proliferation and apoptosis. Interestingly, the PKA I-selective cAMP analogs, but not 8-Cl-cAMP, inhibited ERK phosphorylation, whereas 8-Cl-cAMP alone induced a progressive phosphorylation of the p38 mitogen-activated protein kinase (MAPK), via activation of AMPK by its metabolite 8-Cl-adenosine. Importantly, the proapoptotic effect of 8-Cl-cAMP could be largely prevented by pharmacological inhibition of the p38 MAPK. Altogether, these data suggest that 8-Cl-cAMP and the PKA I-selective cAMP analogs, though of comparable antiproliferative potency, act through different mechanisms. PKA I-selective cAMP analogs induce growth arrest in cells carrying the BRAF oncogene, whereas 8-Cl-cAMP induce apoptosis, apparently through activation of the p38 MAPK pathway.	[Lucchi, Simona; de Filippis, Tiziana; Persani, Luca] Ist Auxol Italiano, Lab Endocrine & Metab Res, Milan, Italy; [Calebiro, Davide; Grassi, Elisa S.; Persani, Luca] Univ Milan, Dipartimento Sci Med, Milan, Italy; [Borghi, Maria Orietta] Ist Auxol Italiano, Immunol Lab, Milan, Italy; [Borghi, Maria Orietta] Univ Milan, Dipartimento Med Interna, Milan, Italy	IRCCS Istituto Auxologico Italiano; University of Milan; IRCCS Istituto Auxologico Italiano; University of Milan	Lucchi, S (corresponding author), Ist Auxol Italiano, Lab Endocrine & Metab Res, Milan, Italy.	davide.calebiro@yahoo.it; luca.persani@unimi.it	de Filippis, Tiziana/AAA-8511-2020; Borghi, Maria Orietta/K-8768-2016; Persani, Luca/B-6543-2008; Grassi, Elisa Stellaria/K-4402-2016	Borghi, Maria Orietta/0000-0001-8967-9678; Persani, Luca/0000-0003-2068-9581; Lucchi, Simona/0000-0001-8802-8048; calebiro, davide/0000-0002-3811-1553; Grassi, Elisa Stellaria/0000-0002-0410-1277; de Filippis, Tiziana/0000-0002-5690-6843	Istituto Auxologico Italiano	Istituto Auxologico Italiano	The work was partially supported by research funds of Istituto Auxologico Italiano. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahn YH, 2005, CANCER RES, V65, P4896, DOI 10.1158/0008-5472.CAN-04-3122; Calebiro D, 2006, MOL ENDOCRINOL, V20, P3196, DOI 10.1210/me.2005-0493; Cho-Chung Y S, 1992, Semin Cancer Biol, V3, P361; CHOCHUNG YS, 1989, CANCER INVEST, V7, P161, DOI 10.3109/07357908909038282; CHOCHUNG YS, 1990, CANCER RES, V50, P7093; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; ESTOUR B, 1989, VIRCHOWS ARCH B, V57, P167, DOI 10.1007/BF02899078; Gandhi V, 2001, CANCER RES, V61, P5474; Han JH, 2009, J CELL PHYSIOL, V218, P104, DOI 10.1002/jcp.21573; Horvath A, 2008, NEW ENGL J MED, V358, P750, DOI 10.1056/NEJMc0706182; Horvath A, 2006, NAT GENET, V38, P794, DOI 10.1038/ng1809; Kirschner LS, 2000, NAT GENET, V26, P89, DOI 10.1038/79238; Krohn K, 2002, MOL GENET METAB, V75, P202, DOI 10.1006/mgme.2001.3290; Lamb D, 2002, J CELL PHYSIOL, V192, P216, DOI 10.1002/jcp.10131; LANDIS CA, 1989, NATURE, V340, P692, DOI 10.1038/340692a0; Langeveld CH, 1997, BIOCHEM PHARMACOL, V53, P141, DOI 10.1016/S0006-2952(96)00593-X; Lania A, 2001, EUR J ENDOCRINOL, V145, P543, DOI 10.1530/eje.0.1450543; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Persani L, 2000, J CLIN ENDOCR METAB, V85, P2872, DOI 10.1210/jc.85.8.2872; Propper DJ, 1999, CLIN CANCER RES, V5, P1682; Robinson-White AJ, 2008, J CLIN ENDOCR METAB, V93, P1020, DOI 10.1210/jc.2007-2331; Schweppe RE, 2008, J CLIN ENDOCR METAB, V93, P4331, DOI 10.1210/jc.2008-1102; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Tortora G, 2002, ANN NY ACAD SCI, V968, P139, DOI 10.1111/j.1749-6632.2002.tb04332.x; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; WEINSTEIN LS, 1991, NEW ENGL J MED, V325, P1688, DOI 10.1056/NEJM199112123252403; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhuang SG, 2000, J BIOL CHEM, V275, P25939, DOI 10.1074/jbc.M001185200	30	27	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20785	10.1371/journal.pone.0020785	http://dx.doi.org/10.1371/journal.pone.0020785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695205	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600024
J	Woolley, AG; Algie, M; Samuel, W; Harfoot, R; Wiles, A; Hung, NA; Tan, PH; Hains, P; Valova, VA; Huschtscha, L; Royds, JA; Perez, D; Yoon, HS; Cohen, SB; Robinson, PJ; Bay, BH; Lasham, A; Braithwaite, AW				Woolley, Adele G.; Algie, Michael; Samuel, Weini; Harfoot, Rhodri; Wiles, Anna; Hung, Noelyn A.; Tan, Puay-Hoon; Hains, Peter; Valova, Valentina A.; Huschtscha, Lily; Royds, Janice A.; Perez, David; Yoon, Han-Seung; Cohen, Scott B.; Robinson, Phillip J.; Bay, Boon-Huat; Lasham, Annette; Braithwaite, Antony W.			Prognostic Association of YB-1 Expression in Breast Cancers: A Matter of Antibody	PLOS ONE			English	Article							BOX-BINDING-PROTEIN; GROWTH-FACTOR RECEPTOR; NUCLEAR-LOCALIZATION; P-GLYCOPROTEIN; GENE-EXPRESSION; MULTIPLE-MYELOMA; DRUG-RESISTANCE; SURVIVAL; DISEASE; BINDING-PROTEIN-1	The literature concerning the subcellular location of Y-box binding protein 1 (YB-1), its abundance in normal and cancer tissues, and its prognostic significance is replete with inconsistencies. An explanation for this could be due in part to the use of different antibodies in immunohistochemical and immunofluorescent labeling of cells and tissues. The inconsistencies could also be due to poor resolution of immunohistochemical data. We analyzed two cohorts of breast tumours for both abundance and subcellular location of YB-1 using three different antibodies; two targeting N-terminal epitopes (AB-a and AB-b) and another (AB-c) targeting a C-terminal epitope. We also investigated stress-induced nuclear translocation of YB-1 in cell culture. We report that both AB-a and AB-c detected increased YB-1 in the cytoplasm of high-grade breast cancers, and in those lacking estrogen and progesterone receptors; however the amount of YB-1 detected by AB-a in these cancers is significantly greater than that detected by AB-c. We confirm our previously published findings that AB-b is also detecting hnRNP A1, and cannot therefore be used to reliably detect YB-1 by immunohistochemistry. We also report that AB-a detected nuclear YB-1 in some tumour tissues and stress treated cells, whereas AB-c did not. To understand this, cancer cell lines were analyzed using native gel electrophoresis, which revealed that the antibodies detect different complexes in which YB-1 is a component. Our data suggest that different YB-1 antibodies show different staining patterns that are determined by the accessibility of epitopes, and this depends on the nature of the YB-1 complexes. It is important therefore to standardize the protocols if YB-1 is to be used reproducibly as a prognostic guide for different cancers.	[Woolley, Adele G.; Algie, Michael; Harfoot, Rhodri; Wiles, Anna; Hung, Noelyn A.; Royds, Janice A.; Yoon, Han-Seung; Braithwaite, Antony W.] Univ Otago, Dept Pathol, Dunedin, New Zealand; [Samuel, Weini; Hains, Peter; Valova, Valentina A.; Huschtscha, Lily; Cohen, Scott B.; Robinson, Phillip J.; Braithwaite, Antony W.] Univ Sydney, Childrens Med Res Inst, Westmead, NSW 2145, Australia; [Samuel, Weini; Hains, Peter; Valova, Valentina A.; Huschtscha, Lily; Cohen, Scott B.; Robinson, Phillip J.; Braithwaite, Antony W.] Univ Sydney, Fac Med, Westmead, NSW 2145, Australia; [Lasham, Annette] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Tan, Puay-Hoon; Bay, Boon-Huat] Natl Univ Singapore, Dept Anat, Yong Loo Lin Sch Med, Singapore 117548, Singapore; [Tan, Puay-Hoon] Singapore Gen Hosp, Dept Pathol, Singapore 0316, Singapore; [Perez, David] Dunedin Publ Hosp, Dept Oncol, Dunedin, New Zealand	University of Otago; Children's Medical Research Institute - Australia; University of Sydney; University of Sydney; University of Auckland; National University of Singapore; Singapore General Hospital; Dunedin Public Hospital	Woolley, AG (corresponding author), Univ Otago, Dept Pathol, Dunedin, New Zealand.	adele.woolley@otago.ac.nz	Robinson, Phillip J/G-4008-2011; Hains, Peter/M-4209-2019; Hains, Peter/HIK-2945-2022	Robinson, Phillip J/0000-0002-7878-0313; Hains, Peter/0000-0002-7276-1760; Algie, Michael/0000-0002-0568-331X	Health Research Council of New Zealand [HRC 04/284, 07/284, 10/872]; New Zealand Breast Cancer Research Trust; Cancer Institute of New South Wales [05/RLP/1-01]; National Health & Medical Research Council [571073, 477100]; Australian Research Council [DP1095780]; Otago District Health Board, New Zealand; Singapore National Medical Research Council [NMRC/1019/2005, NMRC/1081/2006]; Singapore Cancer Syndicate [MS0004R]; Children's Medical Research Institute Jeans-for-Genes Campaign	Health Research Council of New Zealand(Health Research Council of New Zealand); New Zealand Breast Cancer Research Trust; Cancer Institute of New South Wales; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Otago District Health Board, New Zealand; Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Cancer Syndicate; Children's Medical Research Institute Jeans-for-Genes Campaign	The research was supported by the Health Research Council of New Zealand (AGW, MA, RH, NAH, JAR, AWB, HRC 04/284, 07/284 and 10/872); the New Zealand Breast Cancer Research Trust (AL); the Cancer Institute of New South Wales (AWB, WS, LH, 05/RLP/1-01); the National Health & Medical Research Council (SBC, 571073; PJP, 477100); Australian Research Council, Discovery Project (PH, DP1095780); the Otago District Health Board, New Zealand (DP), the Singapore National Medical Research Council (B-HB, NMRC/1019/2005 and NMRC/1081/2006); the Singapore Cancer Syndicate (P-HT, MS0004R) and the Children's Medical Research Institute Jeans-for-Genes Campaign (VAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Chatterjee M, 2008, BLOOD, V111, P3714, DOI 10.1182/blood-2007-05-089151; Cobbold LC, 2010, ONCOGENE, V29, P2884, DOI 10.1038/onc.2010.31; Cohen SB, 2010, ONCOGENE, V29, P403, DOI 10.1038/onc.2009.321; Dahl E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-410; Dessauvagie BF, 2007, HUM PATHOL, V38, P284, DOI 10.1016/j.humpath.2006.08.003; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Fujita T, 2005, CLIN CANCER RES, V11, P8837, DOI 10.1158/1078-0432.CCR-05-0945; Gauci S, 2009, ANAL CHEM, V81, P4493, DOI 10.1021/ac9004309; Gessner C, 2004, EUR RESPIR J, V23, P14, DOI 10.1183/09031936.03.00033203; Gimenez-Bonafe P, 2004, PROSTATE, V59, P337, DOI 10.1002/pros.20023; Gown AM, 2008, MODERN PATHOL, V21, pS8, DOI 10.1038/modpathol.2008.34; Guay D, 2006, INT J BIOCHEM CELL B, V38, P1300, DOI 10.1016/j.biocel.2006.01.008; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Hayakawa H, 2002, BIOCHEMISTRY-US, V41, P12739, DOI 10.1021/bi0201872; Ignatiadis M, 2008, PATHOBIOLOGY, V75, P104, DOI 10.1159/000123848; Ito Y, 2003, PATHOL INT, V53, P429, DOI 10.1046/j.1440-1827.2003.01494.x; Izumi H, 2001, NUCLEIC ACIDS RES, V29, P1200, DOI 10.1093/nar/29.5.1200; Janz M, 2002, INT J CANCER, V97, P278, DOI 10.1002/ijc.1610; Jurchott K, 2003, J BIOL CHEM, V278, P27988, DOI 10.1074/jbc.M212966200; Kim JH, 2000, J MOL BIOL, V298, P395, DOI 10.1006/jmbi.2000.3687; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Koike K, 1997, FEBS LETT, V417, P390, DOI 10.1016/S0014-5793(97)01296-9; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Molina H, 2007, P NATL ACAD SCI USA, V104, P2199, DOI 10.1073/pnas.0611217104; Oda Y, 1998, CLIN CANCER RES, V4, P2273; Oda Y, 2003, J PATHOL, V199, P251, DOI 10.1002/path.1282; Ohga T, 1998, J BIOL CHEM, V273, P5997, DOI 10.1074/jbc.273.11.5997; Ohga T, 1996, CANCER RES, V56, P4224; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Onitilo AA, 2009, CLIN MED RES, V7, P4, DOI 10.3121/cmr.2009.825; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Schittek B, 2007, INT J CANCER, V120, P2110, DOI 10.1002/ijc.22512; Shibahara K, 2001, CLIN CANCER RES, V7, P3151; Skabkin MA, 2004, NUCLEIC ACIDS RES, V32, P5621, DOI 10.1093/nar/gkh889; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stratford AL, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1767; Sutherland BW, 2005, ONCOGENE, V24, P4281, DOI 10.1038/sj.onc.1208590; WOLFFE AP, 1994, BIOESSAYS, V16, P245, DOI 10.1002/bies.950160407; Wu J, 2006, CANCER RES, V66, P4872, DOI 10.1158/0008-5472.CAN-05-3561; Zhang YF, 2003, ONCOGENE, V22, P2782, DOI 10.1038/sj.onc.1206357	43	31	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20603	10.1371/journal.pone.0020603	http://dx.doi.org/10.1371/journal.pone.0020603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695211	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612600015
J	Hernandez-Corbacho, MJ; Jenkins, RW; Clarke, CJ; Hannun, YA; Obeid, LM; Snider, AJ; Siskind, LJ				Hernandez-Corbacho, Maria Jose; Jenkins, Russell W.; Clarke, Christopher J.; Hannun, Yusuf A.; Obeid, Lina M.; Snider, Ashley J.; Siskind, Leah J.			Accumulation of Long-Chain Glycosphingolipids during Aging Is Prevented by Caloric Restriction	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; MEMBRANE-ASSOCIATED SIALIDASE; OXIDATIVE STRESS; INSULIN SENSITIVITY; RAT-KIDNEY; T-CELLS; NUTRITIONAL INFLUENCES; DIABETIC-NEPHROPATHY; ALZHEIMERS-DISEASE; FISCHER-344 RATS	Background: Chronic kidney disease and end-stage renal disease are major causes of morbidity and mortality that are seen far more commonly in the aged population. Interestingly, kidney function declines during aging even in the absence of underlying renal disease. Declining renal function has been associated with age-related cellular damage and dysfunction with reports of increased levels of apoptosis, necrosis, and inflammation in the aged kidney. Bioactive sphingolipids have been shown to regulate these same cellular processes, and have also been suggested to play a role in aging and cellular senescence. Methodology/Principal Findings: We hypothesized that alterations in kidney sphingolipids play a role in the declining kidney function that occurs during aging. To begin to address this, the sphingolipid profile was measured in young (3 mo), middle aged (9 mo) and old (17 mo) C57BL/6 male mice. Interestingly, while modest changes in ceramides and sphingoid bases were evident in kidneys from older mice, the most dramatic elevations were seen in long-chain hexosylceramides (HexCer) and lactosylceramides (LacCer), with C14-and C16-lactosylceramides elevated as much as 8 and 12-fold, respectively. Increases in long-chain LacCers during aging are not exclusive to the kidney, as they also occur in the liver and brain. Importantly, caloric restriction, previously shown to prevent the declining kidney function seen in aging, inhibits accumulation of long-chain HexCer/LacCers and prevents the age-associated elevation of enzymes involved in their synthesis. Additionally, long-chain LacCers are also significantly elevated in human fibroblasts isolated from elderly individuals. Conclusion/Significance: This study demonstrates accumulation of the glycosphingolipids HexCer and LacCer in several different organs in rodents and humans during aging. In addition, data demonstrate that HexCer and LacCer metabolism is regulated by caloric restriction. Taken together, data suggest that HexCer/LacCers are important mediators of cellular processes fundamental to mammalian aging.	[Hernandez-Corbacho, Maria Jose; Obeid, Lina M.; Snider, Ashley J.; Siskind, Leah J.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Jenkins, Russell W.; Clarke, Christopher J.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.; Snider, Ashley J.; Siskind, Leah J.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Medical University of South Carolina; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Hernandez-Corbacho, MJ (corresponding author), Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA.	siskind@musc.edu		Siskind, Leah/0000-0001-5026-5187; obeid, lina/0000-0002-0734-0847	VA Merit; VA; VA REAP; American Cancer Society [IRG-97-219-11]; NIH/NCRR [P30 CA138313, P20 RR17677]; American Heart Association [AHA 081509E]; NIH [GM08716, GM-43825]; MUSC Hollings Cancer Center Abney Foundation; NIH/NIA [R01 AG016583]; NATIONAL CANCER INSTITUTE [P30CA138313] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043825, R01GM043825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016583] Funding Source: NIH RePORTER	VA Merit(US Department of Veterans Affairs); VA(US Department of Veterans Affairs); VA REAP; American Cancer Society(American Cancer Society); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MUSC Hollings Cancer Center Abney Foundation; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work is supported by: VA Merit (to L.M.O.), VA CDA-2 Awards (to L.J.S. and A.J.S.), pilot project from the VA REAP (to L.J.S., A.J.S., and L.M.O.), the American Cancer Society Institutional Research Grant # IRG-97-219-11 (subaward to L.J.S.), Lipidomics Shared Resource of the Hollings Cancer Center supported by a Cancer Center Support Grant (P30 CA138313), pilot project (to L.J.S) from the NIH/NCRR P20 RR17677 COBRE in Lipidomics and Pathobiology, American Heart Association Pre-Doctoral Fellowship (AHA 081509E - to R.W.J.), NIH MSTP Training Grant (GM08716 - to R.W.J.), MUSC Hollings Cancer Center Abney Foundation Scholarship (to R.W.J.), and NIH/NIA R01 AG016583 (L.M.O.) and NIH GM-43825 (YAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2007, DIABETES, V56, P1341, DOI 10.2337/db06-1619; Alessenko AV, 2004, BIOCHEM SOC T, V32, P144, DOI 10.1042/BST0320144; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Biswas K, 2006, CANCER RES, V66, P6816, DOI 10.1158/0008-5472.CAN-06-0250; Biswas S, 2009, J IMMUNOL, V183, P5050, DOI 10.4049/jimmunol.0900259; Breunig F, 2008, J NEPHROL, V21, P32; CADENAS S, 1994, EXP GERONTOL, V29, P77, DOI 10.1016/0531-5565(94)90064-7; Chatteriee S, 2008, BBA-GEN SUBJECTS, V1780, P370, DOI 10.1016/j.bbagen.2007.08.010; Chatterjee S, 2003, METHOD ENZYMOL, V363, P300; Chatterjee S, 1996, J LIPID RES, V37, P1334; Coughlan MT, 2008, ANN NY ACAD SCI, V1126, P190, DOI 10.1196/annals.1433.018; Covington MD, 2009, AM J PHYSIOL-RENAL, V296, pF478, DOI 10.1152/ajprenal.90477.2008; Csiszar A, 2007, ACTA PHYSIOL HUNG, V94, P107, DOI 10.1556/APhysiol.94.2007.1-2.10; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; Dave GS, 2007, CELL MOL BIOL, V53, P68, DOI 10.1170/T820; Degroote S, 2004, SEMIN CELL DEV BIOL, V15, P375, DOI 10.1016/j.semcdb.2004.03.007; DMELLO NP, 1994, J BIOL CHEM, V269, P15451; Fernandez-Checa Jose C, 2003, Ann Hepatol, V2, P69; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Garcia-Ruiz C, 2003, J CLIN INVEST, V111, P197, DOI 10.1172/JCI200316010; GIUSTO NM, 1992, LIPIDS, V27, P835, DOI 10.1007/BF02535859; Gredilla R, 2004, ANN NY ACAD SCI, V1019, P333, DOI 10.1196/annals.1297.057; GRONE EF, 1994, ATHEROSCLEROSIS, V107, P1, DOI 10.1016/0021-9150(94)90136-8; Guan F, 2009, P NATL ACAD SCI USA, V106, P7461, DOI 10.1073/pnas.0902368106; Guillas I, 2001, EMBO J, V20, P2655, DOI 10.1093/emboj/20.11.2655; GUPTA G, FEBS LETT, V584, P1634; Ha H, 2005, NEPHROLOGY, V10, pS7, DOI 10.1111/j.1440-1797.2005.00448.x; HAMMAD SM, J LIPID RES, V51, P3074; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hedlund M, 1998, MOL MICROBIOL, V29, P1297, DOI 10.1046/j.1365-2958.1998.01017.x; Huwiler A, 2001, BIOCHEM BIOPH RES CO, V284, P404, DOI 10.1006/bbrc.2001.4941; Jiang T, 2005, J AM SOC NEPHROL, V16, P2385, DOI 10.1681/ASN.2004080701; Jung JU, 2009, EXP MOL MED, V41, P935, DOI 10.3858/emm.2009.41.12.099; Jung KJ, 2009, INFLAMM RES, V58, P143, DOI 10.1007/s00011-008-7227-2; Kim HJ, 2002, EXP GERONTOL, V37, P1041, DOI 10.1016/S0531-5565(02)00082-7; Langeveld M, 2009, PROG LIPID RES, V48, P196, DOI 10.1016/j.plipres.2009.03.002; Lee JH, 2004, EXP GERONTOL, V39, P1361, DOI 10.1016/j.exger.2004.06.015; Lightle SA, 2000, MECH AGEING DEV, V120, P111, DOI 10.1016/S0047-6374(00)00191-3; Liu B, 2000, METHOD ENZYMOL, V311, P156; Lochhead KM, 1998, KIDNEY INT, V54, P373, DOI 10.1046/j.1523-1755.1998.00022.x; MAEDA H, 1985, J GERONTOL, V40, P671, DOI 10.1093/geronj/40.6.671; Martin JE, 2007, J PATHOL, V211, P198, DOI 10.1002/path.2111; Martin SF, 2006, GLYCOCONJUGATE J, V23, P147, DOI 10.1007/s10719-006-7920-8; Maruyama R, 2007, ANTICANCER RES, V27, P4345; Masoro EJ, 2005, MECH AGEING DEV, V126, P913, DOI 10.1016/j.mad.2005.03.012; MATHER AR, 2011, LANDES BIOS IN PRESS; Mei CL, 2009, SEMIN NEPHROL, V29, P555, DOI 10.1016/j.semnephrol.2009.07.002; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Muhlberg W, 1999, GERONTOLOGY, V45, P243, DOI 10.1159/000022097; NATOLI TA, NAT MED; Nikolova-Karakashian Mariana, 2008, V49, P469, DOI 10.1007/978-1-4020-8831-5_18; Ogiso M, 1999, EXP EYE RES, V68, P229, DOI 10.1006/exer.1998.0598; Rao RP, 2007, P NATL ACAD SCI USA, V104, P11364, DOI 10.1073/pnas.0705049104; Ravussin E, 2007, Journ Annu Diabetol Hotel Dieu, P111; Razzaque MS, 2007, AGEING RES REV, V6, P211, DOI 10.1016/j.arr.2007.06.001; Razzaque MS, 1998, CELL TISSUE RES, V293, P471, DOI 10.1007/s004410051139; Ruiz-Torres MP, 1998, J AM SOC NEPHROL, V9, P782; Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Sacket SJ, 2009, ACTA PHARMACOL SIN, V30, P1454, DOI 10.1038/aps.2009.136; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; Senda M, 2007, BIOCHEM J, V402, P459, DOI 10.1042/BJ20061118; Sessa A, 2001, J INHERIT METAB DIS, V24, P66, DOI 10.1023/A:1012423924648; Sinclair DA, 2005, MECH AGEING DEV, V126, P987, DOI 10.1016/j.mad.2005.03.019; Siskind LJ, 2010, J BIOL CHEM, V285, P11818, DOI 10.1074/jbc.M109.078121; Spassieva S, 2006, J BIOL CHEM, V281, P33931, DOI 10.1074/jbc.M608092200; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Susztak K, 2006, DIABETES, V55, P225, DOI 10.2337/diabetes.55.01.06.db05-0894; Thornton MV, 2004, J IMMUNOL, V172, P3480, DOI 10.4049/jimmunol.172.6.3480; Ueno S, 2006, J BIOL CHEM, V281, P7756, DOI 10.1074/jbc.M509668200; van Eijk M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004723; Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015; Vogtlander NPJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005979; VOGTLANDER NP, NEPHROL DIAL TRANSPL, V25, P478; WENNEKES T, J MED CHEM, V53, P689; Wennekes T, 2009, ANGEW CHEM INT EDIT, V48, P8848, DOI 10.1002/anie.200902620; Yamashita T, 2003, P NATL ACAD SCI USA, V100, P3445, DOI 10.1073/pnas.0635898100; YANG Q, CELL MOL LIFE SCI, V67, P1477; YEW NS, PLOS ONE, V5; YU BP, 1985, J GERONTOL, V40, P657, DOI 10.1093/geronj/40.6.657; ZADOR IZ, 1993, J CLIN INVEST, V91, P797, DOI 10.1172/JCI116299; Zager RA, 1998, J AM SOC NEPHROL, V9, P1670; Zager RA, 1998, KIDNEY INT, V53, P573, DOI 10.1046/j.1523-1755.1998.00772.x; Zager RA, 1997, KIDNEY INT, V52, P60, DOI 10.1038/ki.1997.304; Zarate YA, 2008, LANCET, V372, P1427, DOI 10.1016/S0140-6736(08)61589-5; Zhang XB, 2004, ANN CLIN LAB SCI, V34, P3; Zhao HM, 2007, DIABETES, V56, P1210, DOI 10.2337/db06-0719	88	31	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20411	10.1371/journal.pone.0020411	http://dx.doi.org/10.1371/journal.pone.0020411			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687659	gold, Green Submitted, Green Published			2022-12-25	WOS:000291611500023
J	Wu, B; Fu, F; Wang, L				Wu, Bin; Fu, Feng; Wang, Long			Imperfect Vaccine Aggravates the Long-Standing Dilemma of Voluntary Vaccination	PLOS ONE			English	Article							SELF-INTEREST; COOPERATION; DYNAMICS; GAME	Achieving widespread population immunity by voluntary vaccination poses a major challenge for public health administration and practice. The situation is complicated even more by imperfect vaccines. How the vaccine efficacy affects individuals' vaccination behavior has yet to be fully answered. To address this issue, we combine a simple yet effective game theoretic model of vaccination behavior with an epidemiological process. Our analysis shows that, in a population of self-interested individuals, there exists an overshooting of vaccine uptake levels as the effectiveness of vaccination increases. Moreover, when the basic reproductive number, R-0, exceeds a certain threshold, all individuals opt for vaccination for an intermediate region of vaccine efficacy. We further show that increasing effectiveness of vaccination always increases the number of effectively vaccinated individuals and therefore attenuates the epidemic strain. The results suggest that 'number is traded for efficiency': although increases in vaccination effectiveness lead to uptake drops due to free-riding effects, the impact of the epidemic can be better mitigated.	[Wu, Bin; Wang, Long] Peking Univ, Coll Engn, Ctr Syst & Control, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China; [Fu, Feng] Harvard Univ, Program Evolutionary Dynam, Cambridge, MA 02138 USA	Peking University; Harvard University	Wu, B (corresponding author), Peking Univ, Coll Engn, Ctr Syst & Control, State Key Lab Turbulence & Complex Syst, Beijing 100871, Peoples R China.	bin.wu@evolbio.mpg.de; fengfu@fas.harvard.edu	Gao, Y./GWZ-3665-2022; Fu, Feng/A-3376-2009; Fu, Feng/R-3686-2017; Wang, Long/A-7798-2010	Fu, Feng/0000-0001-8252-1990; Fu, Feng/0000-0001-8252-1990; Wang, Long/0000-0001-5600-8157	National Natural Science Foundation of China [10972002, 60736022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors acknowledge support by the National Natural Science Foundation of China Grants No. 10972002 and No. 60736022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; Basu S, 2008, P NATL ACAD SCI USA, V105, P19018, DOI 10.1073/pnas.0808114105; Bauch CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012594; Bauch CT, 2005, P ROY SOC B-BIOL SCI, V272, P1669, DOI 10.1098/rspb.2005.3153; Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101; Bauch CT, 2003, P NATL ACAD SCI USA, V100, P10564, DOI 10.1073/pnas.1731324100; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Brown SP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000593; Chen FH, 2006, J MATH BIOL, V53, P253, DOI 10.1007/s00285-006-0006-1; Colgrave James, 2006, STATE IMMUNITY POLIT; Cornforth DM, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001062; FINE PEM, 1986, AM J EPIDEMIOL, V124, P1012, DOI 10.1093/oxfordjournals.aje.a114471; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Hoffman SL, 1996, MALARIA VACCINE DEV; Jansen VAA, 2003, SCIENCE, V301, P804, DOI 10.1126/science.1086726; MCLEAN AR, 1993, P ROY SOC B-BIOL SCI, V253, P9, DOI 10.1098/rspb.1993.0075; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015117; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perisic A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000280; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; RELUGA T, 2011, MATH BIOSCI IN PRESS; Sudfeld CR, 2010, INT J EPIDEMIOL, V39, P48, DOI 10.1093/ije/dyq021; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000270; Traulsen A, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011909; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; van Boven M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001558; Vardavas R, 2007, PLOS COMPUT BIOL, V3, P796, DOI 10.1371/journal.pcbi.0030085; Wang Z, 2011, J THEOR BIOL, V277, P19, DOI 10.1016/j.jtbi.2011.02.016; Wu B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046106; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Zhang BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009882	40	52	56	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20577	10.1371/journal.pone.0020577	http://dx.doi.org/10.1371/journal.pone.0020577			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687680	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500031
J	Layton, RC; Gigliotti, A; Armijo, P; Myers, L; Knight, J; Donart, N; Pyles, J; Vaughan, S; Plourde, J; Fomukong, N; Harrod, KS; Gao, P; Koster, F				Layton, Robert Colby; Gigliotti, Andrew; Armijo, Penny; Myers, Leslie; Knight, Jennifer; Donart, Nathaniel; Pyles, John; Vaughan, Sarah; Plourde, Jennifer; Fomukong, Ndingsa; Harrod, Kevin S.; Gao, Peng; Koster, Frederick			Enhanced Immunogenicity, Mortality Protection, and Reduced Viral Brain Invasion by Alum Adjuvant with an H5N1 Split-Virion Vaccine in the Ferret	PLOS ONE			English	Article							AVIAN INFLUENZA-VIRUSES; RANDOMIZED CONTROLLED-TRIAL; PANDEMIC INFLUENZA; A/H5N1 VACCINE; A VIRUS; ANTIBODY-RESPONSE; SAFETY; INFECTION; HUMANS; HEMAGGLUTININ	Background: Pre-pandemic development of an inactivated, split-virion avian influenza vaccine is challenged by the lack of pre-existing immunity and the reduced immunogenicity of some H5 hemagglutinins compared to that of seasonal influenza vaccines. Identification of an acceptable effective adjuvant is needed to improve immunogenicity of a split-virion avian influenza vaccine. Methods and Findings: Ferrets (N = 118) were vaccinated twice with a split-virion vaccine preparation of A/Vietnam/1203/2004 or saline either 21 days apart (unadjuvanted: 1.9 mu g, 7.5 mu g, 30 mu g, or saline), or 28 days apart (unadjuvanted: 22.5 mu g, or alum-adjuvanted: 22.5 or 7.5 mu g). Vaccinated animals were challenged intranasally 21 or 28 days later with 10 6 EID50 of the homologous strain. Immunogenicity was measured by hemagglutination inhibition and neutralization assays. Morbidity was assessed by observed behavior, weight loss, temperature, cytopenias, histopathology, and viral load. No serum antibodies were detected after vaccination with unadjuvanted vaccine, whereas alum-adjuvanted vaccination induced a robust antibody response. Survival after unadjuvanted dose regimens of 30 mu g, 7.5 mu g and 1.9 mu g (21-day intervals) was 64%, 43%, and 43%, respectively, yet survivors experienced weight loss, fever and thrombocytopenia. Survival after unadjuvanted dose regimen of 22.5 mu g (28-day intervals) was 0%, suggesting important differences in intervals in this model. In contrast to unadjuvanted survivors, either dose of alum-adjuvanted vaccine resulted in 93% survival with minimal morbidity and without fever or weight loss. The rarity of brain inflammation in alum-adjuvanted survivors, compared to high levels in unadjuvanted vaccine survivors, suggested that improved protection associated with the alum adjuvant was due to markedly reduced early viral invasion of the ferret brain. Conclusion: Alum adjuvant significantly improves efficacy of an H5N1 split-virion vaccine in the ferret model as measured by immunogenicity, mortality, morbidity, and brain invasion.	[Layton, Robert Colby; Gigliotti, Andrew; Armijo, Penny; Myers, Leslie; Knight, Jennifer; Donart, Nathaniel; Pyles, John; Vaughan, Sarah; Plourde, Jennifer; Fomukong, Ndingsa; Harrod, Kevin S.; Gao, Peng; Koster, Frederick] Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA	Lovelace Respiratory Research Institute	Layton, RC (corresponding author), Lovelace Resp Res Inst, Program Infect Dis, Albuquerque, NM USA.	CLayton@MRIGlobal.org		Vaughan, Sarah/0000-0001-7962-4526; Harrod, Kevin/0000-0003-0780-9470	National Institute of Allergy and Infectious Diseases [HHSN 266-200-400-095I, C-22]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was funded by National Institute of Allergy and Infectious Diseases contract HHSN 266-200-400-095I, Task Order C-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atmar RL, 2009, CURR TOP MICROBIOL, V333, P323, DOI 10.1007/978-3-540-92165-3_16; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Belser JA, 2009, ADV VIRUS RES, V73, P55, DOI 10.1016/S0065-3527(09)73002-7; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Brady RC, 2009, VACCINE, V27, P5091, DOI 10.1016/j.vaccine.2009.06.057; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Chotpitayasunondh T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004028; Co MDT, 2008, VACCINE, V26, P1990, DOI 10.1016/j.vaccine.2008.02.024; Epstein SL, 2006, J INFECT DIS, V193, P49, DOI 10.1086/498980; Fang YA, 2010, J VIROL, V84, P8369, DOI 10.1128/JVI.02305-09; Garcia JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007918; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gillim-Ross L, 2007, PLOS MED, V4, P226, DOI 10.1371/journal.pmed.0040091; Govorkova EA, 2006, J VIROL, V80, P6195, DOI 10.1128/JVI.00686-06; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Grebe KM, 2008, MICROBES INFECT, V10, P1024, DOI 10.1016/j.micinf.2008.07.002; Hampson AW, 2006, J INFECT DIS, V194, P143, DOI 10.1086/505229; HARMON MW, 1988, J CLIN MICROBIOL, V26, P333, DOI 10.1128/JCM.26.2.333-337.1988; Hoffmann E, 2005, P NATL ACAD SCI USA, V102, P12915, DOI 10.1073/pnas.0506416102; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jang HM, 2009, P NATL ACAD SCI USA, V106, P14063, DOI 10.1073/pnas.0900096106; Kayali G, 2008, J CLIN VIROL, V43, P73, DOI 10.1016/j.jcv.2008.04.013; Keitel WA, 2008, J INFECT DIS, V198, P1309, DOI 10.1086/592172; Layton RC, 2009, PROCEDIA VACCINOL, V1, P30, DOI 10.1016/j.provac.2009.07.006; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Middleton D, 2009, J VIROL, V83, P7770, DOI 10.1128/JVI.00241-09; Mori I, 2001, MICROBES INFECT, V3, P475, DOI 10.1016/S1286-4579(01)01403-4; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; Palache B, 2008, VACCINE, V26, P6232, DOI 10.1016/j.vaccine.2008.07.022; Pearson RC, 1998, BIOL DIS FERRET, P487; Price GE, 2009, VACCINE, V27, P6512, DOI 10.1016/j.vaccine.2009.08.053; Riley S, 2007, PLOS MED, V4, P1032, DOI 10.1371/journal.pmed.0040218; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999; Rowe T, 2003, AVIAN DIS, V47, P1122, DOI 10.1637/0005-2086-47.s3.1122; Ruat C, 2008, J VIROL, V82, P2565, DOI 10.1128/JVI.01928-07; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Saville M, 2008, INFLUENZA OTHER RESP, V2, P229, DOI 10.1111/j.1750-2659.2008.00060.x; SHINYA K, 2011, J VIROL         0309; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; Subbarao K, 2007, NAT REV IMMUNOL, V7, P267, DOI 10.1038/nri2054; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Balish Amanda L, 2013, Curr Protoc Microbiol, VChapter 15, DOI [10.1002/0471729256.mc15g01s3, 10.1002/9780471729259.mc15g01s29]; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Treanor JJ, 2007, JAMA-J AM MED ASSOC, V297, P1577, DOI 10.1001/jama.297.14.1577; Tripp RA, 2008, CURR OPIN INVEST DR, V9, P836; Tripp RA, 2009, CURR TOP MICROBIOL, V333, P397, DOI 10.1007/978-3-540-92165-3_19; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Webby RJ, 2003, P NATL ACAD SCI USA, V100, P7235, DOI 10.1073/pnas.1232449100; YETTER RA, 1980, INFECT IMMUN, V29, P650; Zangwill KM, 2008, J INFECT DIS, V197, P580, DOI 10.1086/526537; Zitzow LA, 2002, J VIROL, V76, P4420, DOI 10.1128/JVI.76.9.4420-4429.2002	60	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20641	10.1371/journal.pone.0020641	http://dx.doi.org/10.1371/journal.pone.0020641			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687736	gold, Green Published, Green Submitted			2022-12-25	WOS:000291607000016
J	Robinson, EM; Smee, DL; Trussell, GC				Robinson, Elizabeth M.; Smee, Delbert L.; Trussell, Geoffrey C.			Green Crab (Carcinus maenas) Foraging Efficiency Reduced by Fast Flows	PLOS ONE			English	Article							PREDATOR-PREY INTERACTIONS; BLUE CRABS; CHEMICAL ORIENTATION; INTERTIDAL COMMUNITY; ENVIRONMENTAL FORCES; BED-ROUGHNESS; SHORE CRAB; FOOD; COMPETITION; CONSEQUENCES	Predators can strongly influence prey populations and the structure and function of ecosystems, but these effects can be modified by environmental stress. For example, fluid velocity and turbulence can alter the impact of predators by limiting their environmental range and altering their foraging ability. We investigated how hydrodynamics affected the foraging behavior of the green crab (Carcinus maenas), which is invading marine habitats throughout the world. High flow velocities are known to reduce green crab predation rates and our study sought to identify the mechanisms by which flow affects green crabs. We performed a series of experiments with green crabs to determine: 1) if their ability to find prey was altered by flow in the field, 2) how flow velocity influenced their foraging efficiency, and 3) how flow velocity affected their handling time of prey. In a field study, we caught significantly fewer crabs in baited traps at sites with fast versus slow flows even though crabs were more abundant in high flow areas. This finding suggests that higher velocity flows impair the ability of green crabs to locate prey. In laboratory flume assays, green crabs foraged less efficiently when flow velocity was increased. Moreover, green crabs required significantly more time to consume prey in high velocity flows. Our data indicate that flow can impose significant chemosensory and physical constraints on green crabs. Hence, hydrodynamics may strongly influence the role that green crabs and other predators play in rocky intertidal communities.	[Robinson, Elizabeth M.; Smee, Delbert L.] Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA; [Trussell, Geoffrey C.] Northeastern Univ, Ctr Marine Sci, Nahant, MA 01908 USA	Texas A&M University System; Northeastern University	Robinson, EM (corresponding author), Texas A&M Univ, Dept Life Sci, Corpus Christi, TX USA.	lee.smee@tamucc.edu	Trussell, Geoffrey/AAQ-9165-2020; Smee, Lee/B-4042-2013		NSF; Texas Research Development Fund; Darling Marine Center	NSF(National Science Foundation (NSF)); Texas Research Development Fund; Darling Marine Center	Funding for this research was provided by NSF to Smee and Trussell, the Texas Research Development Fund to Smee, and a student fellowship from the Darling Marine Center to Robinson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet D, 2008, J SHELLFISH RES, V27, P427, DOI 10.2983/0730-8000(2008)27[427:BCOANE]2.0.CO;2; Behrens Yamada S, 2001, GLOBAL INVADER EUROP; Benfield MC, 1996, ENVIRON BIOL FISH, V46, P211, DOI 10.1007/BF00005223; Bertness MD, 2002, ECOLOGY, V83, P3434, DOI 10.1890/0012-9658(2002)083[3434:DASCSE]2.0.CO;2; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Crothers J. H., 1968, Field Studies, V2, P579; CROTHERS JH, 1983, BIOL J LINN SOC, V19, P237, DOI 10.1111/j.1095-8312.1983.tb00786.x; DARE PJ, 1981, J MAR BIOL ASSOC UK, V61, P107, DOI 10.1017/S002531540004594X; Denny M. W., 1988, BIOL MECH WAVE SWEPT; deRivera CE, 2005, ECOLOGY, V86, P3364, DOI 10.1890/05-0479; ESTES JA, 1974, SCIENCE, V185, P1058, DOI 10.1126/science.185.4156.1058; Ferner MC, 2009, MAR ECOL PROG SER, V374, P13, DOI 10.3354/meps07764; Ferner MC, 2005, J EXP BIOL, V208, P809, DOI 10.1242/jeb.01438; Finelli CM, 2000, ECOLOGY, V81, P784, DOI 10.1890/0012-9658(2000)081[0784:PCOEPA]2.0.CO;2; Griffen BD, 2009, BIOL INVASIONS, V11, P927, DOI 10.1007/s10530-008-9305-3; HUNTER E, 1993, MAR ECOL PROG SER, V101, P131, DOI 10.3354/meps101131; Jackson JL, 2007, LIMNOL OCEANOGR, V52, P1883, DOI 10.4319/lo.2007.52.5.1883; JANKE K, 1990, HELGOLANDER MEERESUN, V44, P219, DOI 10.1007/BF02365466; Juanes F, 2008, MAR BIOL, V153, P523, DOI 10.1007/s00227-007-0826-6; Keller TA, 2003, MAR ECOL PROG SER, V261, P217, DOI 10.3354/meps261217; Keller TA, 2001, LIMNOL OCEANOGR, V46, P238, DOI 10.4319/lo.2001.46.2.0238; KITCHING JA, 1959, J ANIM ECOL, V28, P331, DOI 10.2307/2087; Leonard GH, 1998, ECOLOGY, V79, P1395; MacDonald JA, 2007, BIOL INVASIONS, V9, P837, DOI 10.1007/s10530-006-9085-6; McDonald PS, 2001, J EXP MAR BIOL ECOL, V258, P39, DOI 10.1016/S0022-0981(00)00344-0; MENGE BA, 1976, AM NAT, V110, P351, DOI 10.1086/283073; Menge BA, 2000, J EXP MAR BIOL ECOL, V250, P257, DOI 10.1016/S0022-0981(00)00200-8; MENGE BA, 1976, ECOL MONOGR, V46, P355, DOI 10.2307/1942563; MENGE BA, 1978, OECOLOGIA, V34, P1, DOI 10.1007/BF00346237; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Miron G, 2005, J SHELLFISH RES, V24, P579, DOI 10.2983/0730-8000(2005)24[579:PPOTIG]2.0.CO;2; MOORE PA, 1991, J CHEM ECOL, V17, P1293, DOI 10.1007/BF00983763; Moore PA, 1999, ANIM BEHAV, V58, P953, DOI 10.1006/anbe.1999.1230; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PIHL L, 1991, MAR BIOL, V108, P349, DOI 10.1007/BF01313644; Powers SP, 2002, J EXP MAR BIOL ECOL, V273, P171, DOI 10.1016/S0022-0981(02)00162-4; Rahman S, 2005, EXP FLUIDS, V38, P372, DOI 10.1007/s00348-004-0919-7; REINSEL KA, 1995, J EXP MAR BIOL ECOL, V187, P269, DOI 10.1016/0022-0981(94)00192-G; Schlichting H., 1987, BOUNDARY LAYER THEOR; Schmitz OJ, 1997, ECOLOGY, V78, P1388, DOI 10.1890/0012-9658(1997)078[1388:BMTCEO]2.0.CO;2; Smee DL, 2008, OECOLOGIA, V156, P399, DOI 10.1007/s00442-008-0995-0; Smee DL, 2006, ECOLOGY, V87, P1587, DOI 10.1890/0012-9658(2006)87[1587:CUEFDT]2.0.CO;2; Smee DL, 2010, ECOLOGY, V91, P1391, DOI 10.1890/09-0017.1; Sokal R. R., 2012, BIOMETRY; Trussell GC, 2003, ECOLOGY, V84, P629, DOI 10.1890/0012-9658(2003)084[0629:TMEIRI]2.0.CO;2; Trussell GC, 2001, GENETICA, V112, P321, DOI 10.1023/A:1013364527698; Van de Meutter F, 2005, OECOLOGIA, V144, P327, DOI 10.1007/s00442-005-0050-3; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; VICKERS NJ, 1994, J INSECT BEHAV, V7, P605, DOI 10.1007/BF01997435; VOGEL S, 1984, AM ZOOL, V24, P37; Webster DR, 2009, ANNU REV FLUID MECH, V41, P73, DOI 10.1146/annurev.fluid.010908.165240; Webster DR, 2001, LIMNOL OCEANOGR, V46, P1034, DOI 10.4319/lo.2001.46.5.1034; WEISSBURG MJ, 1994, J EXP BIOL, V197, P349; Weissburg MJ, 2003, J EXP BIOL, V206, P171, DOI 10.1242/jeb.00055; Weissburg MJ, 2002, J CHEM ECOL, V28, P1953, DOI 10.1023/A:1020741710060; WEISSBURG MJ, 1993, ECOLOGY, V74, P1428, DOI 10.2307/1940072; Weissburg MJ, 2000, BIOL BULL-US, V198, P188, DOI 10.2307/1542523; Williams A.B., 1984, SHRIMPS LOBSTERS CRA	58	25	25	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e21025	10.1371/journal.pone.0021025	http://dx.doi.org/10.1371/journal.pone.0021025			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687742	gold, Green Submitted, Green Published			2022-12-25	WOS:000291607000035
J	Yang, TD; Park, JS; Choi, Y; Choi, W; Ko, TW; Lee, KJ				Yang, Taeseok Daniel; Park, Jin-Sung; Choi, Youngwoon; Choi, Wonshik; Ko, Tae-Wook; Lee, Kyoung J.			Zigzag Turning Preference of Freely Crawling Cells	PLOS ONE			English	Article								The coordinated motion of a cell is fundamental to many important biological processes such as development, wound healing, and phagocytosis. For eukaryotic cells, such as amoebae or animal cells, the cell motility is based on crawling and involves a complex set of internal biochemical events. A recent study reported very interesting crawling behavior of single cell amoeba: in the absence of an external cue, free amoebae move randomly with a noisy, yet, discernible sequence of 'runand-turns' analogous to the 'run-and-tumbles' of swimming bacteria. Interestingly, amoeboid trajectories favor zigzag turns. In other words, the cells bias their crawling by making a turn in the opposite direction to a previous turn. This property enhances the long range directional persistence of the moving trajectories. This study proposes that such a zigzag crawling behavior can be a general property of any crawling cells by demonstrating that 1) microglia, which are the immune cells of the brain, and 2) a simple rule-based model cell, which incorporates the actual biochemistry and mechanics behind cell crawling, both exhibit similar type of crawling behavior. Almost all legged animals walk by alternating their feet. Similarly, all crawling cells appear to move forward by alternating the direction of their movement, even though the regularity and degree of zigzag preference vary from one type to the other.	[Yang, Taeseok Daniel; Park, Jin-Sung; Choi, Youngwoon; Choi, Wonshik; Lee, Kyoung J.] Korea Univ, Dept Phys, Seoul 136701, South Korea; [Yang, Taeseok Daniel; Park, Jin-Sung; Lee, Kyoung J.] Korea Univ, Ctr Cell Dynam, Seoul, South Korea; [Ko, Tae-Wook] Natl Inst Math Sci, Taejon, South Korea	Korea University; Korea University; National Institute for Mathematical Sciences (NIMS), Republic of Korea	Yang, TD (corresponding author), Korea Univ, Dept Phys, Seoul 136701, South Korea.	kyoung@korea.ac.kr			Korean Ministry of Science and Technology (KOSEF) [R17-2007-017-0100-0]	Korean Ministry of Science and Technology (KOSEF)(Korea Science and Engineering FoundationMinistry of Science & Technology (MOST), Republic of Korea)	This work was supported by the Korean Ministry of Science and Technology (KOSEF grant: R17-2007-017-0100-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnhart EL, 2010, BIOPHYS J, V98, P933, DOI 10.1016/j.bpj.2009.10.058; Bartumeus F, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.097901; BERG HC, 1973, NATURE, V245, P380, DOI 10.1038/245380a0; BONNER JT, 2008, SOCIAL AMOEBAE BIOL; CLARK P, 2004, CELL MOTILITY MOL OR; Colby R. H., 2003, POLYM PHYS; del Alamo JC, 2007, P NATL ACAD SCI USA, V104, P13343, DOI 10.1073/pnas.0705815104; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; FETLER L, 2005, NEUROSCIENCE, V309, P329; HAASTERT JMV, 2008, PLOS ONE, V4, pE5253; HARTMAN RS, 1994, BIOPHYS J, V67, P2535, DOI 10.1016/S0006-3495(94)80743-X; Honda S, 2001, J NEUROSCI, V21, P1975, DOI 10.1523/JNEUROSCI.21-06-01975.2001; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Keren K, 2008, NATURE, V453, P475, DOI 10.1038/nature06952; Li L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002093; MACKAY SA, 1979, J CELL SCI, V36, P281; Maeda YT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003734; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishimura SI, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000310; Polin M, 2009, SCIENCE, V325, P487, DOI 10.1126/science.1172667; RAPOSO EP, 2005, PHYS REV E, V72; Satulovsky J, 2008, BIOPHYS J, V94, P3671, DOI 10.1529/biophysj.107.117002; Selmeczi D, 2005, BIOPHYS J, V89, P912, DOI 10.1529/biophysj.105.061150; STOSSEL TP, 1993, SCIENCE, V260, P1086, DOI 10.1126/science.8493552; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Weijer CJ, 2003, SCIENCE, V300, P96, DOI 10.1126/science.1082830; Whitelam S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.198103	29	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20255	10.1371/journal.pone.0020255	http://dx.doi.org/10.1371/journal.pone.0020255			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687729	Green Submitted, Green Published, gold			2022-12-25	WOS:000291607000004
J	Serre, K; Benezech, C; Desanti, G; Bobat, S; Toellner, KM; Bird, R; Chan, S; Kastner, P; Cunningham, AF; MacLennan, ICM; Mohr, E				Serre, Karine; Benezech, Cecile; Desanti, Guillaume; Bobat, Saeeda; Toellner, Kai-Michael; Bird, Roger; Chan, Susan; Kastner, Philippe; Cunningham, Adam F.; MacLennan, Ian C. M.; Mohr, Elodie			Helios Is Associated with CD4 T Cells Differentiating to T Helper 2 and Follicular Helper T Cells In Vivo Independently of Foxp3 Expression	PLOS ONE			English	Article							NF-KAPPA-B; C-MAF; LYMPHOCYTE DEVELOPMENT; TRANSCRIPTION FACTORS; HELMINTH INFECTION; IKAROS GENE; TH2; RESPONSES; AIOLOS; IL-4	Background: Although in vitro IL-4 directs CD4 T cells to produce T helper 2 (Th2)-cytokines, these cytokines can be induced in vivo in the absence of IL-4-signalling. Thus, mechanism(s), different from the in vitro pathway for Th2-induction, contribute to in vivo Th2-differentiation. The pathway for in vivo IL-4-independent Th2-differentiation has yet to be characterized. Findings: Helios (ikzf2), a member of the Ikaros transcription regulator family, is expressed in thymocytes and some antigen-matured T cells as well as in regulatory T cells. It has been proposed that Helios is a specific marker for thymus-derived regulatory T cells. Here, we show that mouse ovalbumin-specific CD4 (OTII) cells responding to alum-precipitated ovalbumin (alumOVA) upregulate Th2 features - GATA-3 and IL-4 - as well as Helios mRNA and protein. Helios is also upregulated in follicular helper T (TFh) cells in this response. By contrast, OTII cells responding to the Th1 antigen - live attenuated ovalbumin-expressing Salmonella - upregulate Th1 features - T-bet and IFN-gamma - but not Helios. In addition, CD4 T cells induced to produce Th2 cytokines in vitro do not express Helios. The kinetics of Helios mRNA and protein induction mirrors that of GATA-3. The induction of IL-4, IL-13 and CXCR5 by alumOVA requires NF-kappa B1 and this is also needed for Helios upregulation. Importantly, Helios is induced in Th2 and TFh cells without parallel upregulation of Foxp3. These findings suggested a key role for Helios in Th2 and TFh development in response to alum-protein vaccines. We tested this possibility using Helios-deficient OTII cells and found this deficiency had no discernable impact on Th2 and TFh differentiation in response to alumOVA. Conclusions: Helios is selectively upregulated in CD4 T cells during Th2 and TFh responses to alum-protein vaccines in vivo, but the functional significance of this upregulation remains uncertain.	[Serre, Karine; Benezech, Cecile; Desanti, Guillaume; Bobat, Saeeda; Toellner, Kai-Michael; Bird, Roger; Cunningham, Adam F.; MacLennan, Ian C. M.; Mohr, Elodie] Univ Birmingham, Sch Immun & Infect, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England; [Chan, Susan; Kastner, Philippe] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM, Ctr Natl Rech Scientif,Unite 964,UMR 7104, Strasbourg, France	University of Birmingham; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Serre, K (corresponding author), Univ Birmingham, Sch Immun & Infect, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England.	karine@kserre.net; I.C.M.MacLennan@bham.ac.uk; emohr@igc.gulbenkian.pt	Mohr, Elodie/AAY-1727-2020; Desanti, Guillaume/ABA-6731-2020; Serre, Karine/AAK-2387-2020; Toellner, Kai-Michael/F-1519-2011	Mohr, Elodie/0000-0003-3406-7302; Desanti, Guillaume/0000-0003-4902-1868; Toellner, Kai-Michael/0000-0001-8404-645X; Benezech, Cecile/0000-0002-2613-1418; Cunningham, Adam/0000-0003-0248-964X; Serre, Karine/0000-0001-9152-4739	British Medical Research Council; MAMOCELL; European Union; University of Birmingham; Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/F022778/1] Funding Source: researchfish; Medical Research Council [G9818340, G8402371, G0701275, G9818340B] Funding Source: researchfish; BBSRC [BB/F022778/1] Funding Source: UKRI; MRC [G9818340, G8402371, G0701275] Funding Source: UKRI	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MAMOCELL; European Union(European Commission); University of Birmingham; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by a program grant from the British Medical Research Council (ICMM), MAMOCELL, a NEST project from the European Union (KMT), and from a scientific project committee grant from the University of Birmingham (KS), and from a Wellcome Trust award (KS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas AK, 1996, NATURE, V383, P787, DOI 10.1038/383787a0; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Artis D, 2005, J IMMUNOL, V174, P7154, DOI 10.4049/jimmunol.174.11.7154; Artis D, 2002, J IMMUNOL, V169, P4481, DOI 10.4049/jimmunol.169.8.4481; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bottardi S, 2009, MOL CELL BIOL, V29, P1526, DOI 10.1128/MCB.01523-08; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Cobb BS, 2005, CURR TOP MICROBIOL, V290, P29; Cortes M, 1999, CURR OPIN IMMUNOL, V11, P167, DOI 10.1016/S0952-7915(99)80028-4; Cortes M, 2004, J EXP MED, V199, P209, DOI 10.1084/jem.20031571; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Cunningham AF, 2004, EUR J IMMUNOL, V34, P2986, DOI 10.1002/eji.200425403; Cunningham AF, 2004, IMMUNOLOGY, V113, P187, DOI 10.1111/j.1365-2567.2004.01951.x; Cunningham AF, 2004, EUR J IMMUNOL, V34, P686, DOI 10.1002/eji.200324510; Cunningham AF, 2002, J IMMUNOL, V169, P2900, DOI 10.4049/jimmunol.169.6.2900; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Donovan CE, 1999, J IMMUNOL, V163, P6827; Georgopoulos K, 1997, ANNU REV IMMUNOL, V15, P155, DOI 10.1146/annurev.immunol.15.1.155; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Gregory GD, 2006, J CLIN INVEST, V116, P1327, DOI 10.1172/JCI27227; Grogan JL, 2003, J IMMUNOL, V171, P6672, DOI 10.4049/jimmunol.171.12.6672; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Horsnell WGC, 2011, MUCOSAL IMMUNOL, V4, P83, DOI 10.1038/mi.2010.46; Kelley CM, 1998, CURR BIOL, V8, P508, DOI 10.1016/S0960-9822(98)70202-7; Kim JI, 1999, IMMUNITY, V10, P745, DOI 10.1016/S1074-7613(00)80073-4; King IL, 2009, J EXP MED, V206, P1001, DOI 10.1084/jem.20090313; Kirstein F, 2010, J ALLERGY CLIN IMMUN, V126, P347, DOI 10.1016/j.jaci.2010.04.028; Kirstetter P, 2002, EUR J IMMUNOL, V32, P720, DOI 10.1002/1521-4141(200203)32:3<720::AID-IMMU720>3.0.CO;2-P; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Marillier RG, 2010, AM J PHYSIOL-GASTR L, V298, pG943, DOI 10.1152/ajpgi.00321.2009; Mohr E, 2010, P NATL ACAD SCI USA, V107, P17292, DOI 10.1073/pnas.1004879107; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Pai SY, 2004, P NATL ACAD SCI USA, V101, P1993, DOI 10.1073/pnas.0308697100; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Quirion MR, 2009, J IMMUNOL, V182, P741, DOI 10.4049/jimmunol.182.2.741; Rebollo A, 2003, IMMUNOL CELL BIOL, V81, P171, DOI 10.1046/j.1440-1711.2003.01159.x; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Sellars M, 2009, J EXP MED, V206, P1073, DOI 10.1084/jem.20082311; SERRE K, 2011, EUR J IMMUN IN PRESS; Serre K, 2008, MOL IMMUNOL, V45, P3558, DOI 10.1016/j.molimm.2008.05.010; Serre K, 2010, MOL IMMUNOL, V47, P1914, DOI 10.1016/j.molimm.2010.03.010; Serre K, 2009, EUR J IMMUNOL, V39, P1573, DOI 10.1002/eji.200838922; SHA WC, 1995, CELL, V80, P321, DOI 10.1016/0092-8674(95)90415-8; Smith KM, 2004, J IMMUNOL, V173, P1640, DOI 10.4049/jimmunol.173.3.1640; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Thomas RM, 2010, J BIOL CHEM, V285, P2545, DOI 10.1074/jbc.M109.038794; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; Umetsu SE, 2009, J IMMUNOL, V183, P5518, DOI 10.4049/jimmunol.0901284; Vinuesa CG, 2005, NAT REV IMMUNOL, V5, P853, DOI 10.1038/nri1714; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang JH, 1998, IMMUNITY, V9, P543, DOI 10.1016/S1074-7613(00)80637-8; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Yang LY, 1998, J EXP MED, V188, P1739, DOI 10.1084/jem.188.9.1739; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	71	56	58	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20731	10.1371/journal.pone.0020731	http://dx.doi.org/10.1371/journal.pone.0020731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677778	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500039
J	Marquer, C; Fruchart-Gaillard, C; Letellier, G; Marcon, E; Mourier, G; Zinn-Justin, S; Menez, A; Servent, D; Gilquin, B				Marquer, Catherine; Fruchart-Gaillard, Carole; Letellier, Guillaume; Marcon, Elodie; Mourier, Gilles; Zinn-Justin, Sophie; Menez, Andre; Servent, Denis; Gilquin, Bernard			Structural Model of Ligand-G Protein-coupled Receptor (GPCR) Complex Based on Experimental Double Mutant Cycle Data MT7 SNAKE TOXIN BOUND TO DIMERIC hM1 MUSCARINIC RECEPTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							M-1 MUSCARINIC RECEPTOR; ANGSTROM CRYSTAL-STRUCTURE; DATA-DRIVEN DOCKING; ACETYLCHOLINE-RECEPTORS; ALLOSTERIC LIGANDS; MOLECULAR-DYNAMICS; HIGH-AFFINITY; AMINO-ACIDS; MT7 TOXIN; BINDING	The snake toxin MT7 is a potent and specific allosteric modulator of the human M1 muscarinic receptor (hM1). We previously characterized by mutagenesis experiments the functional determinants of the MT7-hM1 receptor interaction (Fruchart-Gaillard, C., Mourier, G., Marquer, C., Stura, E., Birdsall, N. J., and Servent, D. (2008) Mol. Pharmacol. 74, 1554-1563) and more recently collected evidence indicating that MT7 may bind to a dimeric form of hM1 (Marquer, C., Fruchart-Gaillard, C., Mourier, G., Grandjean, O., Girard, E., le Maire, M., Brown, S., and Servent, D. (2010) Biol. Cell 102, 409-420). To structurally characterize the MT7-hM1 complex, we adopted a strategy combining double mutant cycle experiments and molecular modeling calculations. First, thirty-three ligand-receptor proximities were identified from the analysis of sixty-one double mutant binding affinities. Several toxin residues that are more than 25 angstrom apart still contact the same residues on the receptor. As a consequence, attempts to satisfy all the restraints by docking the toxin onto a single receptor failed. The toxin was then positioned onto two receptors during five independent flexible docking simulations. The different possible ligand and receptor extracellular loop conformations were described by performing simulations in explicit solvent. All the docking calculations converged to the same conformation of the MT7-hM1 dimer complex, satisfying the experimental restraints and in which (i) the toxin interacts with the extracellular side of the receptor, (ii) the tips of MT7 loops II and III contact one hM1 protomer, whereas the tip of loop I binds to the other protomer, and (iii) the hM1 dimeric interface involves the transmembrane helices TM6 and TM7. These results structurally support the high affinity and selectivity of the MT7-hM1 interaction and highlight the atypical mode of interaction of this allosteric ligand on its G protein-coupled receptor target.	[Marquer, Catherine; Fruchart-Gaillard, Carole; Marcon, Elodie; Mourier, Gilles; Servent, Denis] CEA, iBiTecS, SIMOPRO, Lab Toxinol Mol & Biotechnol, F-91191 Gif Sur Yvette, France; [Menez, Andre] Museum Natl Hist Nat, F-75005 Paris, France; [Letellier, Guillaume; Zinn-Justin, Sophie; Gilquin, Bernard] CEA, iBiTecS, SB2SM, Lab Biol Struct & Radiobiol,CNRS,URA 2096, F-91191 Gif Sur Yvette, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Museum National d'Histoire Naturelle (MNHN); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Servent, D (corresponding author), CEA, iBiTecS, SIMOPRO, Lab Toxinol Mol & Biotechnol, F-91191 Gif Sur Yvette, France.	denis.servent@cea.fr; bernard.gilquin@cea.fr	Fruchart Gaillard, Carole/GWV-2801-2022	Fruchart Gaillard, Carole/0000-0002-3149-4774; Servent, Denis/0000-0002-0774-1691				Albizu L, 2010, NAT CHEM BIOL, V6, P587, DOI [10.1038/nchembio.396, 10.1038/NCHEMBIO.396]; Andre I, 2008, P NATL ACAD SCI USA, V105, P16148, DOI 10.1073/pnas.0807576105; Avlani VA, 2007, J BIOL CHEM, V282, P25677, DOI 10.1074/jbc.M702311200; Bahadur RP, 2004, J MOL BIOL, V336, P943, DOI 10.1016/j.jmb.2003.12.073; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chabre M, 2005, BIOCHEMISTRY-US, V44, P9395, DOI 10.1021/bi050720o; Chabre M, 2003, NATURE, V426, P30, DOI 10.1038/426030b; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chung F, 2009, CHEM-EUR J, V15, P7109, DOI 10.1002/chem.200802451; Cohavi O, 2009, J MOL BIOL, V390, P503, DOI 10.1016/j.jmb.2009.05.029; Dayhoff JE, 2010, J MOL BIOL, V395, P860, DOI 10.1016/j.jmb.2009.10.052; DePristo MA, 2005, STRUCTURE, V13, P1311, DOI 10.1016/j.str.2005.06.008; Durrant JD, 2010, J MOL RECOGNIT, V23, P173, DOI 10.1002/jmr.989; Dutertre S, 2006, BIOCHEM PHARMACOL, V72, P661, DOI 10.1016/j.bcp.2006.03.027; EHLERT FJ, 1988, MOL PHARMACOL, V33, P187; Fruchart-Gaillard C, 2006, MOL PHARMACOL, V69, P1641, DOI 10.1124/mol.105.020883; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Fruchart-Gaillard C, 2008, MOL PHARMACOL, V74, P1554, DOI 10.1124/mol.108.050773; Galat A, 2008, FEBS J, V275, P3207, DOI 10.1111/j.1742-4658.2008.06473.x; Gilquin B, 2005, J BIOL CHEM, V280, P27093, DOI 10.1074/jbc.M413626200; Gilquin B, 2002, J BIOL CHEM, V277, P37406, DOI 10.1074/jbc.M206205200; Gilquin B, 2003, PROTEIN SCI, V12, P266, DOI 10.1110/ps.0227703; Goin JC, 2006, J BIOL CHEM, V281, P5416, DOI 10.1074/jbc.M507476200; Grunberg R, 2004, STRUCTURE, V12, P2125, DOI 10.1016/j.str.2004.09.014; GUILBERT C, 1995, COMPUT PHYS COMMUN, V91, P263, DOI 10.1016/0010-4655(95)00052-H; Hansen JL, 2009, J BIOL CHEM, V284, P1831, DOI 10.1074/jbc.M804607200; Harel M, 2007, J MOL BIOL, V371, P180, DOI 10.1016/j.jmb.2007.05.032; Hern JA, 2010, P NATL ACAD SCI USA, V107, P2693, DOI 10.1073/pnas.0907915107; Ilien B, 2009, J BIOL CHEM, V284, P19533, DOI 10.1074/jbc.M109.017145; Imredy JP, 2000, J MOL BIOL, V296, P1283, DOI 10.1006/jmbi.2000.3522; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jager D, 2007, J BIOL CHEM, V282, P34968, DOI 10.1074/jbc.M705563200; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Karaca E, 2010, MOL CELL PROTEOMICS, V9, P1784, DOI 10.1074/mcp.M000051-MCP201; Kukkonen A, 2004, J BIOL CHEM, V279, P50923, DOI 10.1074/jbc.M406424200; LAZARENO S, 1995, MOL PHARMACOL, V48, P362; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Marquer C, 2010, BIOL CELL, V102, P409, DOI 10.1042/BC20090171; MAX SI, 1993, MOL PHARMACOL, V44, P1171; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Murray CW, 2010, CURR OPIN STRUC BIOL, V20, P497, DOI 10.1016/j.sbi.2010.04.003; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Olianas MC, 2000, BRIT J PHARMACOL, V131, P447, DOI 10.1038/sj.bjp.0703606; Oliveira L, 2004, FEBS LETT, V564, P269, DOI 10.1016/S0014-5793(04)00320-5; Park PSH, 2003, BIOCHEMISTRY-US, V42, P12960, DOI 10.1021/bi034491m; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Prilla S, 2006, MOL PHARMACOL, V70, P181, DOI 10.1124/mol.106.023481; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Rivero-Muller A, 2010, P NATL ACAD SCI USA, V107, P2319, DOI 10.1073/pnas.0906695106; Roisman LC, 2001, P NATL ACAD SCI USA, V98, P13231, DOI 10.1073/pnas.221290398; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SCHREIBER G, 1995, J MOL BIOL, V248, P478, DOI 10.1006/jmbi.1995.0235; Schulz MN, 2009, CURR OPIN PHARMACOL, V9, P615, DOI 10.1016/j.coph.2009.04.009; Servent D, 2009, J NEUROCHEM, V109, P1193, DOI 10.1111/j.1471-4159.2009.06092.x; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Simpson LM, 2010, CURR OPIN PHARMACOL, V10, P30, DOI 10.1016/j.coph.2009.11.001; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Takeda S, 2002, FEBS LETT, V520, P97, DOI 10.1016/S0014-5793(02)02775-8; Trankle C, 2005, MOL PHARMACOL, V68, P1597, DOI 10.1124/mol.105.017707; Trankle C, 2003, MOL PHARMACOL, V64, P180, DOI 10.1124/mol.64.1.180; Valant C, 2008, J BIOL CHEM, V283, P29312, DOI 10.1074/jbc.M803801200; Valant C, 2009, MOL INTERV, V9, P125, DOI 10.1124/mi.9.3.6; van Dijk ADJ, 2005, PROTEINS, V60, P232, DOI 10.1002/prot.20563; van Dijk ADJ, 2005, FEBS J, V272, P293, DOI 10.1111/j.1742-4658.2004.04473.x; VANSCHAIK RC, 1993, J MOL BIOL, V234, P751, DOI 10.1006/jmbi.1993.1624; Vaughan CK, 1999, J MOL BIOL, V286, P1487, DOI 10.1006/jmbi.1998.2559; Venkatakrishnan AJ, 2010, BIOCHEM SOC T, V38, P879, DOI 10.1042/BST0380879; Verdier L, 2005, J BIOL CHEM, V280, P21246, DOI 10.1074/jbc.M502376200; Voigtlander U, 2003, MOL PHARMACOL, V64, P21, DOI 10.1124/mol.64.1.21; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Whorton MR, 2007, P NATL ACAD SCI USA, V104, P7682, DOI 10.1073/pnas.0611448104; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zeng FY, 1999, J BIOL CHEM, V274, P19487, DOI 10.1074/jbc.274.27.19487; Zvi A, 2000, EUR J BIOCHEM, V267, P767, DOI 10.1046/j.1432-1327.2000.01055.x	86	36	37	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP 9	2011	286	36					31661	31675		10.1074/jbc.M111.261404	http://dx.doi.org/10.1074/jbc.M111.261404			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	814WI	21685390	hybrid, Green Published			2022-12-25	WOS:000294487500059
J	Morosky, SA; Zhu, JZ; Mukherjee, A; Sarkar, SN; Coyne, CB				Morosky, Stefanie A.; Zhu, Jianzhong; Mukherjee, Amitava; Sarkar, Saumendra N.; Coyne, Carolyn B.			Retinoic Acid-induced Gene-I (RIG-I) Associates with Nucleotide-binding Oligomerization Domain-2 (NOD2) to Negatively Regulate Inflammatory Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; ANTIVIRAL INNATE IMMUNITY; CROHNS-DISEASE; ACTIN CYTOSKELETON; ADAPTER PROTEIN; ACTIVATION; SUSCEPTIBILITY; RECRUITMENT; INDUCTION	Cytoplasmic caspase recruiting domain (CARD)-containing molecules often function in the induction of potent antimicrobial responses in order to protect mammalian cells from invading pathogens. Retinoic acid-induced gene-I (RIG-I) and nucleotide binding oligomerization domain 2 (NOD2) serve as key factors in the detection of viral and bacterial pathogens, and in the subsequent initiation of innate immune signals to combat infection. RIG-I and NOD2 share striking similarities in their cellular localization, both localize to membrane ruffles in non-polarized epithelial cells and both exhibit a close association with the junctional complex of polarized epithelia. Here we show that RIG-I and NOD2 not only colocalize to cellular ruffles and cell-cell junctions, but that they also form a direct interaction that is mediated by the CARDs of RIG-I and multiple regions of NOD2. Moreover, we show that RIG-I negatively regulates ligand-induced nuclear factor-kappa B (NF-kappa B) signaling mediated by NOD2, and that NOD2 negatively regulates type I interferon induction by RIG-I. We also show that the three main Crohn disease-associated mutants of NOD2 (1007fs, R702W, G908R) form an interaction with RIG-I and negatively regulate its signaling to a greater extent than wild-type NOD2. Our results show that in addition to their role in innate immune recognition, RIG-I and NOD2 form a direct interaction at actin-enriched sites within cells and suggest that this interaction may impact RIG-I-and NOD2-dependent innate immune signaling.	[Morosky, Stefanie A.; Zhu, Jianzhong; Sarkar, Saumendra N.; Coyne, Carolyn B.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA 15219 USA; [Mukherjee, Amitava] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15219 USA; [Zhu, Jianzhong; Sarkar, Saumendra N.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Coyne, CB (corresponding author), 518 Bridgeside Point 2,450 Technol Dr, Pittsburgh, PA 15219 USA.	coynec2@pitt.edu	Sarkar, Saumendra N/B-5038-2011; Mukherjee, Amitava/AAK-4002-2020	Sarkar, Saumendra N/0000-0002-2850-6121; Mukherjee, Amitava/0000-0001-5603-5147	National Institutes of Health [R01AI081759, U24AI082673]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U24AI082673, R01AI081759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI081759 (to C. B. C.) and U24AI082673 (to S. N. S.).	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Barnich N, 2005, J CELL BIOL, V170, P21, DOI 10.1083/jcb.200502153; Begue B, 2006, J CELL PHYSIOL, V209, P241, DOI 10.1002/jcp.20739; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; Hampe J, 2002, P NATL ACAD SCI USA, V99, P321, DOI 10.1073/pnas.261567999; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hong GS, 2002, J BIOCHEM MOL BIOL, V35, P19; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Inohara N, 2001, J BIOL CHEM, V276, P2551, DOI 10.1074/jbc.M009728200; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kong L, 2009, CELL HOST MICROBE, V6, P150, DOI 10.1016/j.chom.2009.06.008; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Mukherjee A, 2009, J BIOL CHEM, V284, P6486, DOI 10.1074/jbc.M807547200; Nemeth ZH, 2004, J CELL PHYSIOL, V200, P71, DOI 10.1002/jcp.10477; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Zhu JZ, 2010, J IMMUNOL, V184, P5768, DOI 10.4049/jimmunol.0903559	31	36	36	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28574	28583		10.1074/jbc.M111.227942	http://dx.doi.org/10.1074/jbc.M111.227942			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21690088	Green Published, hybrid			2022-12-25	WOS:000293557800072
J	Alabrudzinska, M; Skoneczny, M; Skoneczna, A				Alabrudzinska, Malgorzata; Skoneczny, Marek; Skoneczna, Adrianna			Diploid-Specific Genome Stability Genes of S. cerevisiae: Genomic Screen Reveals Haploidization as an Escape from Persisting DNA Rearrangement Stress	PLOS ONE			English	Article							GROSS-CHROMOSOMAL REARRANGEMENTS; SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; PROTEASOME MATURASE; MUTATION-RATE; YEAST; IDENTIFICATION; HETEROZYGOSITY; RECOMBINATION; PLOIDY	Maintaining a stable genome is one of the most important tasks of every living cell and the mechanisms ensuring it are similar in all of them. The events leading to changes in DNA sequence (mutations) in diploid cells occur one to two orders of magnitude more frequently than in haploid cells. The majority of those events lead to loss of heterozygosity at the mutagenesis marker, thus diploid-specific genome stability mechanisms can be anticipated. In a new global screen for spontaneous loss of function at heterozygous forward mutagenesis marker locus, employing three different mutagenesis markers, we selected genes whose deletion causes genetic instability in diploid Saccharomyces cerevisiae cells. We have found numerous genes connected with DNA replication and repair, remodeling of chromatin, cell cycle control, stress response, and in particular the structural maintenance of chromosome complexes. We have also identified 59 uncharacterized or dubious ORFs, which show the genome instability phenotype when deleted. For one of the strongest mutators revealed in our screen, ctf18D/ctf18D the genome instability manifests as a tendency to lose the whole set of chromosomes. We postulate that this phenomenon might diminish the devastating effects of DNA rearrangements, thereby increasing the cell's chances of surviving stressful conditions. We believe that numerous new genes implicated in genome maintenance, together with newly discovered phenomenon of ploidy reduction, will help revealing novel molecular processes involved in the genome stability of diploid cells. They also provide the clues in the quest for new therapeutic targets to cure human genome instability-related diseases.	[Alabrudzinska, Malgorzata; Skoneczna, Adrianna] Polish Acad Sci, Inst Biochem & Biophys, Lab Mutagenesis & DNA Repair, Warsaw, Poland; [Skoneczny, Marek] Polish Acad Sci, Inst Biochem & Biophys, Dept Genet, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Alabrudzinska, M (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Lab Mutagenesis & DNA Repair, Warsaw, Poland.	ada@ibb.waw.pl	Skoneczny, Marek/S-5390-2019; Skoneczna, Adrianna/H-1734-2011	Skoneczny, Marek/0000-0001-9922-2276; Skoneczna, Adrianna/0000-0003-4059-2146	Ministry of Science and Higher Education [N302 007 31/1094, N N301 142436]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education Research Grants: N302 007 31/1094, N N301 142436 (http://www.nauka.gov.pl/finansowanie/finansowanie-nauki/projekty-badawcze/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen MR, 2008, GENETICS, V179, P1179, DOI 10.1534/genetics.108.089250; Asami K, 2000, YEAST, V16, P1359, DOI 10.1002/1097-0061(200011)16:15<1359::AID-YEA631>3.0.CO;2-E; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Chen C, 1999, NAT GENET, V23, P81, DOI 10.1038/12687; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Coic E, 2008, GENETICS, V179, P199, DOI 10.1534/genetics.108.087189; Colby G, 1998, J BIOL CHEM, V273, P27945, DOI 10.1074/jbc.273.43.27945; Desler C, 2007, MUTAT RES-FUND MOL M, V625, P112, DOI 10.1016/j.mrfmmm.2007.06.002; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; Enserink JM, 2009, J CELL BIOL, V185, P423, DOI 10.1083/jcb.200811083; Fedorova IV, 1998, GENETICS, V148, P963; Freimoser FM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r109; Gerstein AC, 2008, BIOL LETTERS, V4, P91, DOI 10.1098/rsbl.2007.0476; Gerstein AC, 2006, PLOS GENET, V2, P1396, DOI 10.1371/journal.pgen.0020145; Gerstein AC, 2009, J HERED, V100, P571, DOI 10.1093/jhered/esp057; Gupta PK, 1997, CANCER RES, V57, P1188; Haass FA, 2007, P NATL ACAD SCI USA, V104, P18079, DOI 10.1073/pnas.0708765104; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Halas A, 2002, CURR GENET, V42, P140, DOI 10.1007/s00294-002-0334-7; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hepworth SR, 1998, MOL CELL BIOL, V18, P5750, DOI 10.1128/MCB.18.10.5750; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Hiraoka M, 2000, GENETICS, V156, P1531; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Ide S, 2010, SCIENCE, V327, P693, DOI 10.1126/science.1179044; JOHNSON RE, 1992, MOL CELL BIOL, V12, P3807, DOI 10.1128/MCB.12.9.3807; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Kanellis P, 2007, PLOS GENET, V3, P1438, DOI 10.1371/journal.pgen.0030134; Kolodner RD, 2002, SCIENCE, V297, P552, DOI 10.1126/science.1075277; KOUPRINA N, 1993, YEAST, V9, P11, DOI 10.1002/yea.320090103; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; LIRAS P, 1978, GENETICS, V88, P651; Lum PY, 2004, CELL, V116, P121, DOI 10.1016/S0092-8674(03)01035-3; Ma LJ, 2010, CELL CYCLE, V9, P4399, DOI 10.4161/cc.9.21.13679; Malc E, 2009, MUTAT RES-FUND MOL M, V669, P95, DOI 10.1016/j.mrfmmm.2009.05.008; Maradeo ME, 2010, CELL CYCLE, V9, P4370, DOI 10.4161/cc.9.21.13634; Maradeo ME, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015381; Maringele Laura, 2006, Methods Mol Biol, V313, P65; Mayer ML, 2001, MOL CELL, V7, P959, DOI 10.1016/S1097-2765(01)00254-4; McIntyre J, 2006, MUTAT RES-FUND MOL M, V593, P153, DOI 10.1016/j.mrfmmm.2005.07.003; McIntyre J, 2007, CURR GENET, V52, P221, DOI 10.1007/s00294-007-0156-8; Murakami T, 2010, J BIOL CHEM, V285, P34608, DOI 10.1074/jbc.M110.166710; Murray JM, 2008, NAT REV MOL CELL BIO, V9, P177, DOI 10.1038/nrm2309; Myung KJ, 2001, CELL, V104, P397, DOI 10.1016/S0092-8674(01)00227-6; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Ogiwara H, 2007, NUCLEIC ACIDS RES, V35, P4989, DOI 10.1093/nar/gkm523; Ohnishi G, 2004, BIOCHEM BIOPH RES CO, V325, P928, DOI 10.1016/j.bbrc.2004.10.120; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Otto SP, 2008, CURR BIOL, V18, pR1121, DOI 10.1016/j.cub.2008.09.039; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pan XW, 2004, MOL CELL, V16, P487, DOI 10.1016/j.molcel.2004.09.035; PIERCE MK, 1987, MUTAT RES, V182, P65, DOI 10.1016/0165-1161(87)90055-0; Putnam Christopher D, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5492; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; Schmidlin T, 2008, FEMS YEAST RES, V8, P276, DOI 10.1111/j.1567-1364.2007.00322.x; Schmidt KH, 2006, METHOD ENZYMOL, V409, P462, DOI 10.1016/S0076-6879(05)09027-0; Smith S, 2004, P NATL ACAD SCI USA, V101, P9039, DOI 10.1073/pnas.0403093101; SPENCER F, 1990, GENETICS, V124, P237; Stambrook PJ, 1996, ENVIRON MOL MUTAGEN, V28, P471; Stepchenkova EI, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-31; Storchova Z, 2006, NATURE, V443, P541, DOI 10.1038/nature05178; SUZUKI T, 1986, J GEN MICROBIOL, V132, P443; van Haaften G, 2006, CURR BIOL, V16, P1344, DOI 10.1016/j.cub.2006.05.047; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Waghmare SK, 2005, YEAST, V22, P625, DOI 10.1002/yea.1226; Wang XJ, 2010, J MOL BIOL, V395, P1038, DOI 10.1016/j.jmb.2009.12.002; Wijnhoven SWP, 2001, MUTAT RES-FUND MOL M, V473, P23, DOI 10.1016/S0027-5107(00)00163-9; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wysocki R, 2006, NAT STRUCT MOL BIOL, V13, P908, DOI 10.1038/nsmb1139; Xu H, 2007, GENETICS, V176, P1417, DOI 10.1534/genetics.107.072876; XU LZ, 1995, MOL CELL BIOL, V15, P6572; Yuan DS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni105; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104	76	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21124	10.1371/journal.pone.0021124	http://dx.doi.org/10.1371/journal.pone.0021124			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695049	Green Submitted, gold, Green Published			2022-12-25	WOS:000291737600043
J	Rasch, B; Dodt, C; Sayk, F; Molle, M; Born, J				Rasch, Bjoern; Dodt, Christoph; Sayk, Friedhelm; Moelle, Matthias; Born, Jan			No Elevated Plasma Catecholamine Levels during Sleep in Newly Diagnosed, Untreated Hypertensives	PLOS ONE			English	Article							BLOOD-PRESSURE; HEALTHY HUMANS; NOREPINEPHRINE; EPINEPHRINE; ADULTS	The sympatho-adrenergic system is highly involved in regulating sleep, wake and arousal states, and abnormalities in this system are regarded as a key factor in the development and progression of arterial hypertension. While hypertension is associated with a hyperadrenergic state during wakefulness, the effect of hypertension on plasma-catecholamine levels during sleep is not yet known. Twelve young participants with newly diagnosed, untreated hypertension and twelve healthy controls slept for 7 hours in the sleep laboratory. Before and after sleep, subjects rested in a supine position for 3-h periods of wakefulness. We sampled blood at a fast rate (1/10 min) and monitored blood pressure and heart rate continuously. We show that plasma NE and E levels did not differ between hypertensives and normotensive during sleep as well as before and after sleep. Blood pressure was higher in hypertensives, reaching the largest group difference in the morning after sleep. Unlike in the normotensives, in the hypertensive participants the morning rise in blood pressure did not correlate with the rise in catecholamine levels at awakening. Our results suggest that hypertension in its early stages is not associated with a strong hyperadrenergic state during sleep. In showing a diminished control of blood pressure through sympatho-adrenergic signals in hypertensive participants, our data point towards a possible involvement of dysfunctional sleep-related blood pressure regulation in the development of hypertension.	[Rasch, Bjoern; Moelle, Matthias; Born, Jan] Univ Lubeck, Dept Neuroendocrinol, Lubeck, Germany; [Rasch, Bjoern] Univ Zurich, Div Biopsychol, Zurich, Switzerland; [Dodt, Christoph; Sayk, Friedhelm] Univ Lubeck, Dept Internal Med, Lubeck, Germany; [Dodt, Christoph] Munchen Bogenhausen Hosp, Div Emergency Med, Munich, Germany; [Born, Jan] Univ Tubingen, Dept Med Psychol & Neurobiol, Tubingen, Germany	University of Lubeck; University of Zurich; University of Lubeck; Munchen Klinik; Eberhard Karls University of Tubingen	Rasch, B (corresponding author), Univ Lubeck, Dept Neuroendocrinol, Lubeck, Germany.	Rasch@kfg.uni-luebeck.de; born@kfg.mu-luebeck.de	Dodt, Christoph/AAD-8717-2021; Rasch, Björn/A-3119-2015; Born, Jan/K-2596-2016	Rasch, Björn/0000-0001-7607-3415; Born, Jan/0000-0002-1847-6248	Deutsche Forschungsgemeinschaft [SFB 654]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The study was supported by the Deutsche Forschungsgemeinschaft: SFB 654 "Plasticity and Sleep". The DFG had no further role in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the paper for publication.	ANDERSON EA, 1989, HYPERTENSION, V14, P177, DOI 10.1161/01.HYP.14.2.177; BORN J, 1989, J CLIN ENDOCR METAB, V68, P904, DOI 10.1210/jcem-68-5-904; Carrington MJ, 2008, SLEEP, V31, P1701, DOI 10.1093/sleep/31.12.1701; Carrington MJ, 2005, J APPL PHYSIOL, V98, P468, DOI 10.1152/japplphysiol.00702.2004; Dodt C, 1997, HYPERTENSION, V30, P71, DOI 10.1161/01.HYP.30.1.71; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Friedman O, 2009, AM J HYPERTENS, V22, P474, DOI 10.1038/ajh.2009.43; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; GOLDSTEIN DS, 1983, HYPERTENSION, V5, P86, DOI 10.1161/01.HYP.5.1.86; GOLDSTEIN DS, 1983, HYPERTENSION, V5, P100, DOI 10.1161/01.HYP.5.1.100; GOLDSTEIN DS, 1981, LIFE SCI, V28, P467, DOI 10.1016/0024-3205(81)90139-9; Grassi G, 1998, J HYPERTENS, V16, P1979, DOI 10.1097/00004872-199816121-00019; Grassi G, 2007, HYPERTENSION, V49, P5, DOI 10.1161/01.HYP.0000251688.60327.37; Grassi G, 2010, EXP PHYSIOL, V95, P581, DOI 10.1113/expphysiol.2009.047381; Jones CR, 2001, J HUM HYPERTENS, V15, P191, DOI 10.1038/sj.jhh.1001141; Knutson KL, 2009, ARCH INTERN MED, V169, P1055, DOI 10.1001/archinternmed.2009.119; Lambert G W, 2000, Curr Hypertens Rep, V2, P302, DOI 10.1007/s11906-000-0014-2; Lombardi F, 2000, CARDIOVASC RES, V45, P200, DOI 10.1016/S0008-6363(99)00329-6; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; Rasch B, 2007, PSYCHONEUROENDOCRINO, V32, P884, DOI 10.1016/j.psyneuen.2007.06.007; Rechtschaffen A., 1968, MANUAL STANDARDIZED; Sayk F, 2007, HYPERTENSION, V49, P1070, DOI 10.1161/HYPERTENSIONAHA.106.084343	22	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21292	10.1371/journal.pone.0021292	http://dx.doi.org/10.1371/journal.pone.0021292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695061	gold, Green Submitted, Green Published			2022-12-25	WOS:000291737600056
J	Tshabalala, M; Manasa, J; Zijenah, LS; Rusakaniko, S; Kadzirange, G; Mucheche, M; Kassaye, S; Johnston, E; Katzenstein, D				Tshabalala, Mqondisi; Manasa, Justen; Zijenah, Lynn S.; Rusakaniko, Simbarashe; Kadzirange, Gerard; Mucheche, Mary; Kassaye, Seble; Johnston, Elizabeth; Katzenstein, David			Surveillance of Transmitted Antiretroviral Drug Resistance among HIV-1 Infected Women Attending Antenatal Clinics in Chitungwiza, Zimbabwe	PLOS ONE			English	Article							RECENT HIV-INFECTION; NAIVE PATIENTS; SOUTH-AFRICA; SUBTYPE C; INDIVIDUALS; PREVALENCE; TYPE-1; AIDS; MUTATIONS; EVOLUTION	The rapid scale-up of highly active antiretroviral therapy (HAART) and use of single dose Nevirapine (SD NVP) for prevention of mother-to-child transmission (pMTCT) have raised fears about the emergence of resistance to the first line antiretroviral drug regimens. A cross-sectional study was conducted to determine the prevalence of primary drug resistance (PDR) in a cohort of young (<25 yrs) HAART-naive HIV pregnant women attending antenatal clinics in Chitungwiza, Zimbabwe. Whole blood was collected in EDTA for CD4 counts, viral load, serological estimation of duration of infection using the BED Calypte assay and genotyping for drug resistance. Four hundred and seventy-one women, mean age 21 years; SD: 2.1 were enrolled into the study between 2006 and 2007. Their median CD4 count was 371cells/mu L; IQR: 255-511 cells/mu L. Two hundred and thirty-six samples were genotyped for drug resistance. Based on the BED assay, 27% were recently infected (RI) whilst 73% had long-term infection (LTI). Median CD4 count was higher (p<0.05) in RI than in women with LTI. Only 2 women had drug resistance mutations; protease I85V and reverse transcriptase Y181C. Prevalence of PDR in Chitungwiza, 4 years after commencement of the national ART program remained below WHO threshold limit (5%). Frequency of recent infection BED testing is consistent with high HIV acquisition during pregnancy. With the scale-up of long-term ART programs, maintenance of proper prescribing practices, continuous monitoring of patients and reinforcement of adherence may prevent the acquisition and transmission of PDR.	[Tshabalala, Mqondisi; Manasa, Justen; Zijenah, Lynn S.] Univ Zimbabwe, Coll Hlth Sci, Dept Immunol, Harare, Zimbabwe; [Rusakaniko, Simbarashe; Mucheche, Mary] Univ Zimbabwe, Coll Hlth Sci, Dept Community Med, Harare, Zimbabwe; [Kadzirange, Gerard] Univ Zimbabwe, Coll Hlth Sci, Dept Med, Harare, Zimbabwe; [Kassaye, Seble; Johnston, Elizabeth; Katzenstein, David] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	University of Zimbabwe; University of Zimbabwe; University of Zimbabwe; Stanford University	Tshabalala, M (corresponding author), Univ Zimbabwe, Coll Hlth Sci, Dept Immunol, Harare, Zimbabwe.	mtshabaz@gmail.com	Manasa, Justen/T-6213-2018	Manasa, Justen/0000-0002-8874-907X; katzenstein, david/0000-0002-8593-4560; tshabalala, mqondisi/0000-0003-0251-8973	National Institutes of Health [R01 AI060399]; Drug Resistance and Pathogenesis in Subtype [C-HIV-1]; Forgarty International Centre [U2R TW006878]; African Programme for Training in HIV/TB Research; International Clinical, Operational and Health Services and Training Award (ICOHRTA) Program; FOGARTY INTERNATIONAL CENTER [U2RTW006878] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Drug Resistance and Pathogenesis in Subtype; Forgarty International Centre; African Programme for Training in HIV/TB Research; International Clinical, Operational and Health Services and Training Award (ICOHRTA) Program; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a National Institutes of Health grant, R01 AI060399, Drug Resistance and Pathogenesis in Subtype C-HIV-1 to DK. JM was supported by a fellowship from the Forgarty International Centre, U2R TW006878, the African Programme for Training in HIV/TB Research, the International Clinical, Operational and Health Services and Training Award (ICOHRTA) Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegaz WE, 2008, ANTIVIR THER, V13, P89; Babic DZ, 2006, VIRUS RES, V118, P156, DOI 10.1016/j.virusres.2005.12.006; Barnighausen T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003640; Bennett DE, 2008, ANTIVIR THER S, V13, P12; Bessong PO, 2006, AIDS RES HUM RETROV, V22, P1306, DOI 10.1089/aid.2006.22.1306; Blower S, 2005, AIDS, V19, P1, DOI 10.1097/00002030-200501030-00001; *CDC, 2006, INT REOCMM US BED CA; Condra JH, 1998, ANN INTERN MED, V128, P951, DOI 10.7326/0003-4819-128-11-199806010-00017; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Department of Health and Human Services (DHHS), 2008, GUID US ANT AG HIV 1; Fox J, 2006, HIV MED, V7, P477, DOI 10.1111/j.1468-1293.2006.00412.x; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Grant RM, 2002, JAMA-J AM MED ASSOC, V288, P181, DOI 10.1001/jama.288.2.181; GUINDON S, 2003, BIOLOGY, V52, P9; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; HAMERS RL, 2010, J ACQUIR IMMUNE DEFI; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Kamoto K, 2008, ANTIVIR THER, V13, P83; KARITA E, 2007, AIDS, V21, P6; Kassaye S, 2009, JAIDS-J ACQ IMM DEF, V50, P9, DOI 10.1097/QAI.0b013e31818ffdff; Kassu A, 2007, AIDS RES HUM RETROV, V23, P564, DOI 10.1089/aid.2006.0270; Kilby JM, 2008, AIDS, V22, P957, DOI 10.1097/QAD.0b013e3282fbd1da; Laeyendecker O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013259; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Manasa J, 2007, CLIN VACCINE IMMUNOL, V14, P293, DOI 10.1128/CVI.00416-06; Maphalala G, 2008, ANTIVIR THER, V13, P95; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Miller V, 2001, AIDS, V15, P309, DOI 10.1097/00002030-200102160-00003; Nesheim S, 2005, AIDS RES HUM RETROV, V21, P537, DOI 10.1089/aid.2005.21.537; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Pillay V, 2008, ANTIVIR THER, V13, P101; Price MA, 2011, AIDS RES HUM RETROV, V27, P5, DOI 10.1089/aid.2010.0030; Ross L, 2007, HIV CLIN TRIALS, V8, P1, DOI 10.1310/hct0801-1; Somi GR, 2008, ANTIVIR THER, V13, P77; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; Velasco-Hernandez JX, 2002, LANCET INFECT DIS, V2, P487, DOI 10.1016/S1473-3099(02)00346-8; Viani RM, 2006, J INFECT DIS, V194, P1505, DOI 10.1086/508749; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Zhou ML, 2006, JAIDS-J ACQ IMM DEF, V43, P501; Zijenah LS, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-33	42	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21241	10.1371/journal.pone.0021241	http://dx.doi.org/10.1371/journal.pone.0021241			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698125	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100073
J	Yu, R; Lai, B; Vogt, S; Chandran, K				Yu, Ran; Lai, Barry; Vogt, Stefan; Chandran, Kartik			Elemental Profiling of Single Bacterial Cells As a Function of Copper Exposure and Growth Phase	PLOS ONE			English	Article							NITROSOMONAS-EUROPAEA 19718; PSEUDOMONAS-AERUGINOSA; AMMONIA MONOOXYGENASE; METHANE MONOOXYGENASE; BATCH RESPIROGRAMS; NITRITE OXIDATION; NITRIFICATION; INHIBITION; GENES; WATER	The elemental composition of single cells of Nitrosomonas europaea 19718 was studied via synchrotron X-ray fluorescence microscopy (XFM) as a function of inhibition by divalent copper (Cu(II)) and batch growth phase. Based on XFM, the intracellular Cu concentrations in exponential phase cultures of N. europaea exposed to Cu(II) were statistically higher than in stationary phase cultures at the 95% confidence interval (alpha = 0.05). However, the impact of Cu inferred from specific oxygen uptake rate (sOUR) measurements at the two physiological states was statistically not dissimilar at the Cu(II) doses tested, except at 1000 mu M Cu(II), at which exponential phase cultures were significantly more inhibited. Furthermore, the elemental composition in uninhibited exponential and stationary phase N. europaea cultures was similar. Notably, the molar fractions of Cu and Fe, relative to other elements in N. europaea cultures were statistically higher than those recently reported in Pseudomonas fluorescens possibly owing to the preponderance of metal cofactor rich catalytic enzymes (such as ammonia monooxygenase) and electron transport mechanisms in N. europaea.	[Yu, Ran; Chandran, Kartik] Columbia Univ, Dept Earth & Environm Engn, New York, NY USA; [Lai, Barry; Vogt, Stefan] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA	Columbia University; United States Department of Energy (DOE); Argonne National Laboratory	Yu, R (corresponding author), Southeast Univ, Sch Energy & Environm, Nanjing, Peoples R China.	kc2288@columbia.edu	Vogt, Stefan/B-9547-2009; Vogt, Stefan/J-7937-2013; Chandran, Kartik/O-1202-2013	Vogt, Stefan/0000-0002-8034-5513; Vogt, Stefan/0000-0002-8034-5513; Yu, Ran/0000-0002-7692-1071; Chandran, Kartik/0000-0002-7526-3724	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Use of the Advanced Photon Source at Argonne National Laboratory was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2011, ENVIRON SCI TECHNOL, V45, P2734, DOI 10.1021/es103534g; Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; [Anonymous], 2006, BROCK BIOL MICROORGA; BEDARD C, 1989, MICROBIOL REV, V53, P68; Chain P, 2003, J BACTERIOL, V185, P2759, DOI 10.1128/JB.185.9.2759-2773.2003; Chandran K, 2005, WATER RES, V39, P4969, DOI 10.1016/j.watres.2005.10.001; Chandran K, 2000, BIOTECHNOL BIOENG, V70, P54, DOI 10.1002/1097-0290(20001005)70:1<54::AID-BIT7>3.3.CO;2-8; Chandran K, 2008, APPL ENVIRON MICROB, V74, P2447, DOI 10.1128/AEM.01940-07; DISPIRITO AA, 1985, BIOCHIM BIOPHYS ACTA, V827, P320, DOI 10.1016/0167-4838(85)90217-1; Eaton A. D., 2005, STANDARD METHODS EXA; ENSIGN SA, 1993, J BACTERIOL, V175, P1971, DOI 10.1128/JB.175.7.1971-1980.1993; Finney LA, 2003, SCIENCE, V300, P931, DOI 10.1126/science.1085049; HAGEN PO, 1966, SCIENCE, V151, P1543, DOI 10.1126/science.151.3717.1543; Harrison JJ, 2008, ANTIMICROB AGENTS CH, V52, P2870, DOI 10.1128/AAC.00203-08; HOFMAN T, 1952, BIOCHEM J, V52, P140, DOI 10.1042/bj0520140; HOLMES AJ, 1995, FEMS MICROBIOL LETT, V132, P203, DOI 10.1016/0378-1097(95)00311-R; HOOPER AB, 1973, J BACTERIOL, V115, P480, DOI 10.1128/JB.115.2.480-485.1973; Hu ZQ, 2003, ENVIRON SCI TECHNOL, V37, P728, DOI 10.1021/es025977d; Kemner KM, 2004, SCIENCE, V306, P686, DOI 10.1126/science.1103524; LEES H, 1952, BIOCHEM J, V52, P134, DOI 10.1042/bj0520134; Massieux B, 2004, APPL ENVIRON MICROB, V70, P4512, DOI 10.1128/AEM.70.8.4512-4521.2004; Mattie MD, 2004, AM J PHYSIOL-CELL PH, V286, pC293, DOI 10.1152/ajpcell.00293.2003; Nielsen AK, 1997, MOL MICROBIOL, V25, P399, DOI 10.1046/j.1365-2958.1997.4801846.x; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Park H, 2010, ENVIRON SCI TECHNOL, V44, P6110, DOI 10.1021/es1002956; Park S, 2008, APPL ENVIRON MICROB, V74, P5475, DOI 10.1128/AEM.00500-08; SATO C, 1988, WATER RES, V22, P1117, DOI 10.1016/0043-1354(88)90006-1; SATO C, 1986, TOXIC ASSESS, V1, P357; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Teitzel GM, 2006, J BACTERIOL, V188, P7242, DOI 10.1128/JB.00837-06; Vogt S, 2003, J PHYS IV, V104, P635, DOI 10.1051/jp4:20030160; Yu R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-70; Yu R, 2010, ENVIRON SCI TECHNOL, V44, P1313, DOI 10.1021/es902794a	33	114	115	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21255	10.1371/journal.pone.0021255	http://dx.doi.org/10.1371/journal.pone.0021255			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698126	Green Submitted, Green Published, gold			2022-12-25	WOS:000291734100076
J	Khanam, MA; Qiu, CX; Lindeboom, W; Streatfield, PK; Kabir, ZN; Wahlin, A				Khanam, Masuma Akter; Qiu, Chengxuan; Lindeboom, Wietze; Streatfield, Peter Kim; Kabir, Zarina Nahar; Wahlin, Ake			The Metabolic Syndrome: Prevalence, Associated Factors, and Impact on Survival among Older Persons in Rural Bangladesh	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; NATIONAL-HEALTH; ASIAN INDIANS; RISK-FACTORS; POPULATION; MORTALITY; KOREA; DEFINITIONS	Objectives: To describe the prevalence of the metabolic syndrome (MetS) among older persons in rural Bangladesh, to investigate whether the prevalence varies by age, sex, literacy, marital status, nutritional status and socio-economic status, and to assess the impact of MetS on survival. Methods: The study consisted of 456 persons who were aged >= 60 years living in a rural area of Bangladesh during July 2003-March 2004. Data were collected through interview, clinical examination, and laboratory tests, and their survival status until 30(th) June 2009 was ascertained through the Matlab surveillance system. We defined MetS following the NCEP ATP III criteria, with minor modifications, i.e., presence of any three of the following: hypertension (BP >= 130/85 mm Hg); random blood glucose (RBG) level >= 7.0 mmol/L; hyper-triglyceridemia (>= 2.28 mmol/L); low level of HDL-cholesterol (<1.04 mmol/L for men and <1.29 mmol/L for women); and BMI >= 25.0 kg/m(2). Data were analysed with logistic regressions for the influential factors of MetS, and with Cox models for the association of MetS with the survival status. Findings: The overall prevalence of MetS was 19.5%, 20.8% in women, and 18.0% in men. Asset-index and nutritional status were independently associated with MetS. During 4.93 years of follow-up, 18.2% died. In the presence of high RBG, MetS has a significant negative effect on survival (69.4% vs 95.2%, log rank p = 0.02). Conclusion: This study highlights the importance of the metabolic syndrome in rural Bangladesh. Our findings suggest that there is a need for screening programmes involving the metabolic syndrome to prevent diabetes and cardiovascular diseases.	[Khanam, Masuma Akter; Lindeboom, Wietze; Streatfield, Peter Kim] ICDDR B, Dhaka, Bangladesh; [Khanam, Masuma Akter; Qiu, Chengxuan; Wahlin, Ake] Karolinska Inst, Dept Neurobiol Care Sci & Soc NVS, Aging Res Ctr, Stockholm, Sweden; [Kabir, Zarina Nahar] Karolinska Inst, NVS, Div Nursing, Stockholm, Sweden; [Wahlin, Ake] Stockholm Univ, Dept Psychol, S-10691 Stockholm, Sweden	International Centre for Diarrhoeal Disease Research (ICDDR); Karolinska Institutet; Karolinska Institutet; Stockholm University	Khanam, MA (corresponding author), ICDDR B, Dhaka, Bangladesh.	masuma@icddrb.org		Wahlin, Ake/0000-0002-8212-823X; Kabir, Zarina/0000-0003-0465-5701; Qiu, Chengxuan/0000-0003-1922-4912	Department for International Development (DfID), UK; Swedish International Development Agency; Swedish Research Council	Department for International Development (DfID), UK; Swedish International Development Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This project was funded by Department for International Development (DfID), UK and the Swedish International Development Agency, and the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu Siddique Md, 2008, Bangladesh Med Res Counc Bull, V34, P71; Aguilar-Salinas CA, 2004, ARCH MED RES, V35, P76, DOI 10.1016/j.arcmed.2003.06.006; Arikan I, 2009, SAUDI MED J, V30, P1073; Bhalodkar NC, 2004, AM J CARDIOL, V94, P1561, DOI 10.1016/j.amjcard.2004.08.040; Cameron AJ, 2004, ENDOCRIN METAB CLIN, V33, P351, DOI 10.1016/j.ecl.2004.03.005; Cassells HB, 2006, J CARDIOVASC NURS, V21, P306, DOI 10.1097/00005082-200607000-00012; Cheung BMY, 2006, BRIT J CLIN PHARMACO, V62, P260, DOI 10.1111/j.1365-2125.2006.02663.x; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Dapi LN, 2009, NUTR RES, V29, P313, DOI 10.1016/j.nutres.2009.05.002; Deepa M, 2007, DIABETES-METAB RES, V23, P127, DOI 10.1002/dmrr.658; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Enas E A, 1996, Indian Heart J, V48, P727; Enas Enas A, 2007, J Cardiometab Syndr, V2, P267, DOI 10.1111/j.1559-4564.2007.07392.x; Esteghamati A, 2009, METABOLISM, V58, P1347, DOI 10.1016/j.metabol.2009.04.019; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; Ferdous T, 2009, PUBLIC HEALTH NUTR, V12, P2270, DOI 10.1017/S1368980009005096; Gause-Nilsson I, 2006, ACTA DIABETOL, V43, P120, DOI 10.1007/s00592-006-0226-2; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Guigoz Y, 1994, FACTS RES GERONTOL, V2, P15, DOI DOI 10.1016/S0899-9007(98)00171-3; Isezuo SA, 2005, J NATL MED ASSOC, V97, P557; Isomaa B, 2001, DIABETES CARE, V24, P683, DOI 10.2337/diacare.24.4.683; Kabir ZN, 2006, PUBLIC HEALTH NUTR, V9, P968, DOI 10.1017/PHN2006990; Kamble P, 2010, INDIAN J MED RES, V132, P701; Kasliwal RR, 2004, METAB SYNDR RELAT D, V2, P169, DOI 10.1089/met.2004.2.169; Kelliny C, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-27; Magliano DJ, 2006, ANN MED, V38, P34, DOI 10.1080/07853890500300311; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; Masulli M, 2006, NUTR METAB CARDIOVAS, V16, P364, DOI 10.1016/j.numecd.2005.06.005; Morimoto A, 2008, TOHOKU J EXP MED, V216, P69, DOI 10.1620/tjem.216.69; Murray CJ, GLOBAL BURDEN DIS CO; Oh SW, 2005, DIABETES CARE, V28, P2064, DOI 10.2337/diacare.28.8.2064; Paek KW, 2006, ANN EPIDEMIOL, V16, P756, DOI 10.1016/j.annepidem.2006.04.012; Pan A, 2008, J NUTR, V138, P2413, DOI 10.3945/jn.108.097519; Park HS, 2007, DIABETES OBES METAB, V9, P50, DOI 10.1111/j.1463-1326.2005.00569.x; Ramsay SE, 2008, DIABETES CARE, V31, P2380, DOI 10.2337/dc08-1158; Razzaque Abdur, 2007, Int J Equity Health, V6, P4, DOI 10.1186/1475-9276-6-4; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Sachdev HPS, 2009, ARCH DIS CHILD, V94, P768, DOI 10.1136/adc.2008.140905; Sattar N, 2003, CIRCULATION, V108, P414, DOI 10.1161/01.CIR.0000080897.52664.94; Scuteri A, 2005, DIABETES CARE, V28, P882, DOI 10.2337/diacare.28.4.882; Shiwaku K, 2005, J OCCUP HEALTH, V47, P126, DOI 10.1539/joh.47.126; Superko H Robert, 2005, Prev Cardiol, V8, P81, DOI 10.1111/j.1520-037X.2005.3766.x; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Trevisan M, 1998, AM J EPIDEMIOL, V148, P958; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644; Zaman MM, 2006, DIABETES CARE, V29, P1456, DOI 10.2337/dc06-0431; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	48	32	34	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2011	6	6							e20259	10.1371/journal.pone.0020259	http://dx.doi.org/10.1371/journal.pone.0020259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778TS	21697988	Green Published, Green Submitted, gold			2022-12-25	WOS:000291730000010
J	Bandiera, S; Ruberg, S; Girard, M; Cagnard, N; Hanein, S; Chretien, D; Munnich, A; Lyonnet, S; Henrion-Caude, A				Bandiera, Simonetta; Rueberg, Silvia; Girard, Muriel; Cagnard, Nicolas; Hanein, Sylvain; Chretien, Dominique; Munnich, Arnold; Lyonnet, Stanislas; Henrion-Caude, Alexandra			Nuclear Outsourcing of RNA Interference Components to Human Mitochondria	PLOS ONE			English	Article							MICRORNA-DEPENDENT LOCALIZATION; 5S RIBOSOMAL-RNA; SECONDARY STRUCTURE; TARGET PREDICTION; WEB SERVER; PROTEIN; IDENTIFICATION; MEMBRANE; MIRNAS; COLOCALIZATION	MicroRNAs (miRNAs) are small non-coding RNAs that associate with Argonaute proteins to regulate gene expression at the post-transcriptional level in the cytoplasm. However, recent studies have reported that some miRNAs localize to and function in other cellular compartments. Mitochondria harbour their own genetic system that may be a potential site for miRNA mediated post-transcriptional regulation. We aimed at investigating whether nuclear-encoded miRNAs can localize to and function in human mitochondria. To enable identification of mitochondrial-enriched miRNAs, we profiled the mitochondrial and cytosolic RNA fractions from the same HeLa cells by miRNA microarray analysis. Mitochondria were purified using a combination of cell fractionation and immunoisolation, and assessed for the lack of protein and RNA contaminants. We found 57 miRNAs differentially expressed in HeLa mitochondria and cytosol. Of these 57, a signature of 13 nuclear-encoded miRNAs was reproducibly enriched in mitochondrial RNA and validated by RT-PCR for hsa-miR-494, hsa-miR-1275 and hsa-miR-1974. The significance of their mitochondrial localization was investigated by characterizing their genomic context, cross-species conservation and instrinsic features such as their size and thermodynamic parameters. Interestingly, the specificities of mitochondrial versus cytosolic miRNAs were underlined by significantly different structural and thermodynamic parameters. Computational targeting analysis of most mitochondrial miRNAs revealed not only nuclear but also mitochondrial-encoded targets. The functional relevance of miRNAs in mitochondria was supported by the finding of Argonaute 2 localization to mitochondria revealed by immunoblotting and confocal microscopy, and further validated by the co-immunoprecipitation of the mitochondrial transcript COX3. This study provides the first comprehensive view of the localization of RNA interference components to the mitochondria. Our data outline the molecular bases for a novel layer of crosstalk between nucleus and mitochondria through a specific subset of human miRNAs that we termed 'mitomiRs'.	[Bandiera, Simonetta; Girard, Muriel; Hanein, Sylvain; Chretien, Dominique; Munnich, Arnold; Lyonnet, Stanislas; Henrion-Caude, Alexandra] Hop Necker Enfants Malad, INSERM, U781, Paris, France; [Rueberg, Silvia] Miltenyi Biotec GmbH, Bergisch Gladbach, Germany; [Cagnard, Nicolas] Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Miltenyi Biotec	Bandiera, S (corresponding author), Hop Necker Enfants Malad, INSERM, U781, Paris, France.	alexandra.caude@inserm.fr	Girard, Muriel/B-7156-2018; hanein, sylvain/AAG-4933-2019; Lyonnet, Stanislas/H-5483-2017; Caude, Alexandra A Henrion/I-2778-2016; Cagnard, Nicolas/K-2754-2014	Girard, Muriel/0000-0003-0050-1035; hanein, sylvain/0000-0001-5817-6330; Lyonnet, Stanislas/0000-0001-5426-9417; Caude, Alexandra A Henrion/0000-0002-8170-2260; Cagnard, Nicolas/0000-0002-9051-1896; Bandiera, Simonetta/0000-0002-7368-8155				Adler J, 2007, J MICROSC-OXFORD, V227, P83, DOI 10.1111/j.1365-2818.2007.01788.x; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640; Bhasin M, 2004, NUCLEIC ACIDS RES, V32, pW414, DOI 10.1093/nar/gkh350; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Cikaluk DE, 1999, MOL BIOL CELL, V10, P3357, DOI 10.1091/mbc.10.10.3357; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Ekins S, 2007, METH MOL B, V356, P319; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Entelis NS, 2001, ADV DRUG DELIVER REV, V49, P199, DOI 10.1016/S0169-409X(01)00135-1; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Falkenberg M, 2007, ANNU REV BIOCHEM, V76, P679, DOI 10.1146/annurev.biochem.76.060305.152028; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; GAINES G, 1984, MOL CELL BIOL, V4, P1605, DOI 10.1128/MCB.4.8.1605; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Gruber AR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-122; Hausser J, 2009, NUCLEIC ACIDS RES, V37, pW266, DOI 10.1093/nar/gkp412; Hock J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-210; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hornig-Do HT, 2009, ANAL BIOCHEM, V389, P1, DOI 10.1016/j.ab.2009.02.040; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawamata T, TRENDS BIOCH SCI, V35, P368; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Ketting RF, 2011, DEV CELL, V20, P148, DOI 10.1016/j.devcel.2011.01.012; Kren BT, 2009, RNA BIOL, V6, P65, DOI 10.4161/rna.6.1.7534; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; LI K, 1994, J CELL BIOL, V124, P871, DOI 10.1083/jcb.124.6.871; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Lynch M, 2006, SCIENCE, V311, P1727, DOI 10.1126/science.1118884; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Malka Florence, 2007, V372, P3, DOI 10.1007/978-1-59745-365-3_1; Maniataki E, 2005, RNA, V11, P849, DOI 10.1261/rna.2210805; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; OBRIEN TW, 1990, BIOCHIM BIOPHYS ACTA, V1050, P174, DOI 10.1016/0167-4781(90)90162-U; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Olichon A, 2002, FEBS LETT, V523, P171, DOI 10.1016/S0014-5793(02)02985-X; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Pederson T, 2010, RNA, V16, P1865, DOI 10.1261/rna.2266510; Politz JCR, 2009, RNA, V15, P1705, DOI 10.1261/rna.1470409; Ritchie W, 2010, BIOINFORMATICS, V26, P223, DOI 10.1093/bioinformatics/btp649; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubio MAT, 2008, P NATL ACAD SCI USA, V105, P9186, DOI 10.1073/pnas.0804283105; Sarkar M, 2005, FEBS LETT, V579, P3449, DOI 10.1016/j.febslet.2005.05.012; Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Smirnov A, 2008, RNA, V14, P749, DOI 10.1261/rna.952208; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Tan MGK, 2004, J BIOL CHEM, V279, P45235, DOI 10.1074/jbc.M403683200; TOPPER JN, 1990, J BIOL CHEM, V265, P13254; Torchetti EM, 2010, MITOCHONDRION, V10, P263, DOI 10.1016/j.mito.2009.12.149; vanSteensel B, 1996, J CELL SCI, V109, P787; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Willkomm Dagmar K, 2006, Biochem J, V399, pe7; Yang JH, NUCL ACIDS RES, V39, pD202; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	191	200	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20746	10.1371/journal.pone.0020746	http://dx.doi.org/10.1371/journal.pone.0020746			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695135	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300016
J	Daniels, CS; Rubinsky, B				Daniels, Charlotte S.; Rubinsky, Boris			Temperature Modulation of Electric Fields in Biological Matter	PLOS ONE			English	Article							ELECTROCHEMOTHERAPY	Pulsed electric fields (PEF) have become an important minimally invasive surgical technology for various applications including genetic engineering, electrochemotherapy and tissue ablation. This study explores the hypothesis that temperature dependent electrical parameters of tissue can be used to modulate the outcome of PEF protocols, providing a new means for controlling and optimizing this minimally invasive surgical procedure. This study investigates two different applications of cooling temperatures applied during PEF. The first case utilizes an electrode which simultaneously delivers pulsed electric fields and cooling temperatures. The subsequent results demonstrate that changes in electrical properties due to temperature produced by this configuration can substantially magnify and confine the electric fields in the cooled regions while almost eliminating electric fields in surrounding regions. This method can be used to increase precision in the PEF procedure, and eliminate muscle contractions and damage to adjacent tissues. The second configuration considered introduces a third probe that is not electrically active and only applies cooling boundary conditions. This second study demonstrates that in this probe configuration the temperature induced changes in electrical properties of tissue substantially reduce the electric fields in the cooled regions. This novel treatment can potentially be used to protect sensitive tissues from the effect of the PEF. Perhaps the most important conclusion of this investigation is that temperature is a powerful and accessible mechanism to modulate and control electric fields in biological tissues and can therefore be used to optimize and control PEF treatments.	[Daniels, Charlotte S.; Rubinsky, Boris] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Rubinsky, Boris] Univ Calif Berkeley, Grad Program Biophys, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Daniels, CS (corresponding author), Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA.	daniels.charlotte@gmail.com			National Foundation (NSF)	National Foundation (NSF)	CSD was supported by a National Foundation (NSF) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARPS JJ, 1953, T AM I MIN MET ENG, V198, P327; Daniels C, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3156808; Davalos RV, 2003, BIOELECTROCHEMISTRY, V61, P99, DOI 10.1016/j.bioelechem.2003.07.001; DEODHAR A, 2011, AM J ROENTGENOLOGY, V196; Diaz-Rivera RE, 2006, BIOMED MICRODEVICES, V8, P25, DOI 10.1007/s10544-006-6379-5; DIAZRIVERA R, 2000, THESIS UC BERKELEY; EDD JF, 2008, PHYSL MEASUREMENT, V29; EDD JF, 2007, TECHNOLOGY CANC RES, V6; EDD JF, 2005, IEEE T BIOMEDICAL EN, V52; Edd JF, 2006, IEEE T BIO-MED ENG, V53, P1409, DOI 10.1109/TBME.2006.873745; Fuchs KH, 2002, ENDOSCOPY, V34, P154, DOI 10.1055/s-2002-19857; Gallo SA, 2002, BIOPHYS J, V82, P109, DOI 10.1016/S0006-3495(02)75378-2; GRANOT Y, 2007, PHYSL MEAS, V28; HAMILTON WA, 1967, BIOCHIM BIOPHYS ACTA, V148, P789, DOI 10.1016/0304-4165(67)90053-0; IVORRA A, 2007, BIOELECTROCHEMISTRY, V70; Jaroszeski MJ, 1999, ADV DRUG DELIVER REV, V35, P131, DOI 10.1016/S0169-409X(98)00068-4; Joshi RP, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.052901; KAATZE U, 1989, J CHEM ENG DATA, V34, P371, DOI 10.1021/je00058a001; Kanduser Masa, 2008, P1, DOI 10.1007/978-0-387-79374-0_1; MAZZOLENI AP, 1986, BIOELECTROMAGNETICS, V7, P95, DOI 10.1002/bem.2250070111; Miklavcic D, 2000, BBA-GEN SUBJECTS, V1523, P73, DOI 10.1016/S0304-4165(00)00101-X; MIR LM, 1991, EUR J CANCER, V27, P68, DOI 10.1016/0277-5379(91)90064-K; Mir LM, 1998, BRIT J CANCER, V77, P2336, DOI 10.1038/bjc.1998.388; NEUMANN E, 1982, EMBO J, V1, P841, DOI 10.1002/j.1460-2075.1982.tb01257.x; OKINO M, 1987, JPN J CANCER RES, V78, P1319; Rubinsky B, 2007, TECHNOL CANCER RES T, V6, P37, DOI 10.1177/153303460700600106; SALE AJH, 1968, BIOCHIM BIOPHYS ACTA, V163, P37, DOI 10.1016/0005-2736(68)90030-8; Somiari S, 2000, MOL THER, V2, P178, DOI 10.1006/mthe.2000.0124; Vernier PT, 2008, BIOELECTROCHEMISTRY, V73, P1, DOI 10.1016/j.bioelechem.2008.02.003	29	7	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20877	10.1371/journal.pone.0020877	http://dx.doi.org/10.1371/journal.pone.0020877			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695144	gold, Green Published			2022-12-25	WOS:000291663300028
J	Friederici, AD; Brauer, J; Lohmann, G				Friederici, Angela D.; Brauer, Jens; Lohmann, Gabriele			Maturation of the Language Network: From Inter- to Intrahemispheric Connectivities	PLOS ONE			English	Article							SENTENCE COMPREHENSION; SPEECH COMPREHENSION; SYNTACTIC PROCESSES; HUMAN BRAIN; WORD-ORDER; IN-VIVO; CHILDREN; FMRI; LATERALIZATION; LOCALIZATION	Language development must go hand-in-hand with brain maturation. Little is known about how the brain develops to serve language processing, in particular, the processing of complex syntax, a capacity unique to humans. Behavioral reports indicate that the ability to process complex syntax is not yet adult-like by the age of seven years. Here, we apply a novel method to demonstrate that the basic neural basis of language, as revealed by low frequency fluctuation stemming from functional MRI data, differs between six-year-old children and adults in crucial aspects. Although the classical language regions are actively in place by the age of six, the functional connectivity between these regions clearly is not. In contrast to adults who show strong connectivities between frontal and temporal language regions within the left hemisphere, children's default language network is characterized by a strong functional interhemispheric connectivity, mainly between the superior temporal regions. These data indicate a functional reorganization of the neural network underlying language development towards a system that allows a close interplay between frontal and temporal regions within the left hemisphere.	[Friederici, Angela D.; Brauer, Jens] Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany; [Lohmann, Gabriele] Max Planck Inst Human Cognit & Brain Sci, Dept Neurophys, Leipzig, Germany	Max Planck Society; Max Planck Society	Friederici, AD (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Dept Neuropsychol, Leipzig, Germany.	angelafr@cbs.mpg.de	Lohmann, Gabriele/C-3590-2008; Lohmann, Gabriele/AGE-9413-2022	Lohmann, Gabriele/0000-0002-5922-9016; 				Anwander A, 2007, CEREB CORTEX, V17, P816, DOI 10.1093/cercor/bhk034; Bahlmann J, 2007, HUM BRAIN MAPP, V28, P940, DOI 10.1002/hbm.20318; Ben-Shachar M, 2003, PSYCHOL SCI, V14, P433, DOI 10.1111/1467-9280.01459; Bianciardi M, 2009, MAGN RESON IMAGING, V27, P1019, DOI 10.1016/j.mri.2009.02.004; Bornkessel I, 2005, NEUROIMAGE, V26, P221, DOI 10.1016/j.neuroimage.2005.01.032; Bornkessel I, 2006, PSYCHOL REV, V113, P787, DOI 10.1037/0033-295X.113.4.787; Brauer J, 2008, NEUROIMAGE, V41, P1484, DOI 10.1016/j.neuroimage.2008.03.027; Brauer J, 2007, J COGNITIVE NEUROSCI, V19, P1609, DOI 10.1162/jocn.2007.19.10.1609; Brauer J, 2011, CEREB CORTEX, V21, P459, DOI 10.1093/cercor/bhq108; Broca Paul P, 1865, B SOCIETE ANTHROPOLO, V6, P377; Catani M, 2002, NEUROIMAGE, V17, P77, DOI 10.1006/nimg.2002.1136; Dittmar M, 2008, CHILD DEV, V79, P1152, DOI 10.1111/j.1467-8624.2008.01181.x; Dubois J, 2008, HUM BRAIN MAPP, V29, P14, DOI 10.1002/hbm.20363; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2003, NEUROIMAGE, V20, pS8, DOI 10.1016/j.neuroimage.2003.09.003; Friederici AD, 2003, CEREB CORTEX, V13, P170, DOI 10.1093/cercor/13.2.170; Friederici AD, 2007, NEURON, V53, P135, DOI 10.1016/j.neuron.2006.11.020; Friederici AD, 2010, HUM BRAIN MAPP, V31, P448, DOI 10.1002/hbm.20878; Friederici AD, 2009, TRENDS COGN SCI, V13, P370, DOI 10.1016/j.tics.2009.06.006; Friederici AD, 2009, TRENDS COGN SCI, V13, P175, DOI 10.1016/j.tics.2009.01.001; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Grewe T, 2007, NEUROIMAGE, V35, P343, DOI 10.1016/j.neuroimage.2006.11.045; Hagoort P, 2005, TRENDS COGN SCI, V9, P416, DOI 10.1016/j.tics.2005.07.004; Hahne A, 2004, J COGNITIVE NEUROSCI, V16, P1302, DOI 10.1162/0898929041920504; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Holland SK, 2007, INT J AUDIOL, V46, P533, DOI 10.1080/14992020701448994; Kail M, 2004, J CHILD LANG, V31, P713, DOI 10.1017/S030500090400649X; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lindner K, 2003, LINGUISTICS, V41, P213, DOI 10.1515/ling.2003.008; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; Lohmann G, 2010, CEREB CORTEX, V20, P1286, DOI 10.1093/cercor/bhp190; Lohmann G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010232; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Makuuchi M, 2009, P NATL ACAD SCI; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Meyer M, 2002, HUM BRAIN MAPP, V17, P73, DOI 10.1002/hbm.10042; Moro A, 2001, NEUROIMAGE, V13, P110, DOI 10.1006/nimg.2000.0668; Musso M, 2003, NAT NEUROSCI, V6, P774, DOI 10.1038/nn1077; Newman SD, 2010, BRAIN LANG, V113, P51, DOI 10.1016/j.bandl.2010.02.001; Obleser J, 2007, J NEUROSCI, V27, P2283, DOI 10.1523/JNEUROSCI.4663-06.2007; Poline JB, 1997, NEUROIMAGE, V5, P83, DOI 10.1006/nimg.1996.0248; Pollmann S, 2002, NEUROPSYCHOLOGY, V16, P56, DOI 10.1037//0894-4105.16.1.56; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ramscar M, 2007, TRENDS COGN SCI, V11, P274, DOI 10.1016/j.tics.2007.05.007; Roder B, 2002, NEUROIMAGE, V15, P1003, DOI 10.1006/nimg.2001.1026; Sabisch B, 2009, BRAIN RES, V1261, P37, DOI 10.1016/j.brainres.2009.01.012; Saur D, 2008, P NATL ACAD SCI USA, V105, P18035, DOI 10.1073/pnas.0805234105; Stromswold K, 1996, BEHAV BRAIN SCI, V19, P648, DOI 10.1017/S0140525X00043491; Stromswold K, 1996, BRAIN LANG, V52, P452, DOI 10.1006/brln.1996.0024; Szaflarski JP, 2006, HUM BRAIN MAPP, V27, P202, DOI 10.1002/hbm.20177; Thirion J P, 1998, Med Image Anal, V2, P243, DOI 10.1016/S1361-8415(98)80022-4; Tyler LK, 2005, NEUROPSYCHOLOGIA, V43, P1963, DOI 10.1016/j.neuropsychologia.2005.03.008; Uddin L. Q., 2010, FRONTIERS SYSTEMS NE, V4; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wernicke C., 1876, ARCH, V6, P298, DOI [10.1007/BF02230815, DOI 10.1007/BF02230815]; Xiang HD, 2010, CEREB CORTEX, V20, P549, DOI 10.1093/cercor/bhp119; Zhang JY, 2007, NEUROIMAGE, V38, P239, DOI 10.1016/j.neuroimage.2007.07.033	62	82	84	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20726	10.1371/journal.pone.0020726	http://dx.doi.org/10.1371/journal.pone.0020726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	777ZG	21695183	Green Published, gold			2022-12-25	WOS:000291663300013
J	Tokarev, K; Tiunova, A; Scharff, C; Anokhin, K				Tokarev, Kirill; Tiunova, Anna; Scharff, Constance; Anokhin, Konstantin			Food for Song: Expression of C-Fos and ZENK in the Zebra Finch Song Nuclei during Food Aversion Learning	PLOS ONE			English	Article							IMMEDIATE-EARLY GENE; PASSIVE-AVOIDANCE; NEURAL-CONTROL; EVOLUTIONARY CONVERGENCE; DIFFERENTIAL EXPRESSION; TRANSCRIPTION FACTORS; HIPPOCAMPAL-LESIONS; AUDITORY STIMULUS; DOMESTIC CHICK; AVIAN BRAIN	Background: Specialized neural pathways, the song system, are required for acquiring, producing, and perceiving learned avian vocalizations. Birds that do not learn to produce their vocalizations lack telencephalic song system components. It is not known whether the song system forebrain regions are exclusively evolved for song or whether they also process information not related to song that might reflect their 'evolutionary history'. Methodology/Principal Findings: To address this question we monitored the induction of two immediate-early genes (IEGs) c-Fos and ZENK in various regions of the song system in zebra finches (Taeniopygia guttata) in response to an aversive food learning paradigm; this involves the association of a food item with a noxious stimulus that affects the oropharyngeal-esophageal cavity and tongue, causing subsequent avoidance of that food item. The motor response results in beak and head movements but not vocalizations. IEGs have been extensively used to map neuro-molecular correlates of song motor production and auditory processing. As previously reported, neurons in two pallial vocal motor regions, HVC and RA, expressed IEGs after singing. Surprisingly, c-Fos was induced equivalently also after food aversion learning in the absence of singing. The density of c-Fos positive neurons was significantly higher than that of birds in control conditions. This was not the case in two other pallial song nuclei important for vocal plasticity, LMAN and Area X, although singing did induce IEGs in these structures, as reported previously. Conclusions/Significance: Our results are consistent with the possibility that some of the song nuclei may participate in non-vocal learning and the populations of neurons involved in the two tasks show partial overlap. These findings underscore the previously advanced notion that the specialized forebrain pre-motor nuclei controlling song evolved from circuits involved in behaviors related to feeding.	[Tokarev, Kirill; Tiunova, Anna; Anokhin, Konstantin] Russian Acad Med Sci, Dept Neurobiol Memory, PK Anokhin Inst Normal Physiol, Moscow, Russia; [Tokarev, Kirill; Scharff, Constance] Free Univ Berlin, Dept Anim Behav, Berlin, Germany	Russian Academy of Medical Sciences; Anokhin Institute of Normal Physiology; Free University of Berlin	Tokarev, K (corresponding author), Russian Acad Med Sci, Dept Neurobiol Memory, PK Anokhin Inst Normal Physiol, Moscow, Russia.	ktokaryev@ccny.cuny.edu	Scharff, Constance/HHN-0673-2022; Anokhin, Konstantin V./K-7983-2014	Anokhin, Konstantin V./0000-0003-4437-6002; Tokarev, Kirill/0000-0002-2129-1324	P. K. Anokhin Institute of Normal Physiology; Russian Academy of Medical Sciences; Lomonosov Moscow State University;  [SFB 665]	P. K. Anokhin Institute of Normal Physiology; Russian Academy of Medical Sciences(Russian Academy of Sciences); Lomonosov Moscow State University; 	The work was performed with support from the grant on 'Analysis of cellular and system mechanisms of inter-and intra-system heterochrony' (2005) provided by P. K. Anokhin Institute of Normal Physiology, Russian Academy of Medical Sciences (http://www.russmed.ru/eng/ramn.htm). KT received stipend from Lomonosov Moscow State University (http://www.msu.ru/). CS was partially funded by SFB 665 (http://www.charite.de/sfb665/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; ANOKHIN KV, 1991, BRAIN RES, V544, P101, DOI 10.1016/0006-8993(91)90890-8; Arbib MA, 2008, J PHYSIOL-PARIS, V102, P4, DOI 10.1016/j.jphysparis.2008.03.001; Arbib MA, 2006, CORTEX, V42, P507, DOI 10.1016/S0010-9452(08)70388-5; Aronov D, 2008, SCIENCE, V320, P630, DOI 10.1126/science.1155140; Bailey DJ, 2009, DEV NEUROBIOL, V69, P491, DOI 10.1002/dneu.20713; Bailey DJ, 2005, BEHAV BRAIN RES, V162, P108, DOI 10.1016/j.bbr.2005.03.016; Bailey DJ, 2003, MOL BRAIN RES, V116, P147, DOI 10.1016/S0169-328X(03)00288-2; Bischof HJ, 1999, BEHAV BRAIN RES, V98, P267, DOI 10.1016/S0166-4328(98)00093-X; Bock J, 2005, NEUROSCIENCE, V133, P625, DOI 10.1016/j.neuroscience.2005.02.048; Bolhuis JJ, 2010, NAT REV NEUROSCI, V11, P747, DOI 10.1038/nrn2931; Braun K, 1999, BEHAV BRAIN RES, V98, P211, DOI 10.1016/S0166-4328(98)00086-2; BULL R, 1976, J NEUROBIOL, V7, P37, DOI 10.1002/neu.480070105; Carr CE, 2009, J NEUROSCI, V29, P7978, DOI 10.1523/JNEUROSCI.6154-08.2009; Carr CE, 2002, BRAIN BEHAV EVOLUT, V59, P294, DOI 10.1159/000063565; Clayton DF, 1997, J NEUROBIOL, V33, P549; DAVIES DC, 1988, J NEUROSCI, V8, P4662; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Dubbeldam J. L., 1997, NETHERLANDS J ZOOLOG, V48, P199; Dubbeldam JL, 1998, ACTA ANAT, V163, P157; Fadiga L, 2006, SOC NEUROSCI-UK, V1, P77, DOI 10.1080/17470910600976430; Farries MA, 2001, BRAIN BEHAV EVOLUT, V58, P80, DOI 10.1159/000047263; Feenders G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001768; Fisher SE, 2009, TRENDS GENET, V25, P166, DOI 10.1016/j.tig.2009.03.002; Gahr M, 2000, J COMP NEUROL, V426, P182; Gentilucci M, 2008, Q J EXP PSYCHOL, V61, P944, DOI 10.1080/17470210701625683; GIBBS ME, 1979, NEUROSCI LETT, V13, P279, DOI 10.1016/0304-3940(79)91507-6; Gobes SMH, 2009, J COMP NEUROL, V516, P312, DOI 10.1002/cne.22113; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Hara E, 2007, EUR J NEUROSCI, V25, P3406, DOI 10.1111/j.1460-9568.2007.05600.x; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; Hoese WJ, 2000, J EXP BIOL, V203, P1845; Immelmann K., 1969, P61; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jarvis ED, 2004, ANN NY ACAD SCI, V1016, P749, DOI 10.1196/annals.1298.038; JARVIS ED, 1995, LEARN MEMORY, V2, P62, DOI 10.1101/lm.2.2.62; Jarvis ED, 1997, P NATL ACAD SCI USA, V94, P4097, DOI 10.1073/pnas.94.8.4097; Jin H, 1997, NEURON, V19, P1049, DOI 10.1016/S0896-6273(00)80396-7; Jurgens U, 2009, J VOICE, V23, P1, DOI 10.1016/j.jvoice.2007.07.005; Kabelik D, 2010, NEUROPHARMACOLOGY, V58, P117, DOI 10.1016/j.neuropharm.2009.06.009; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; KOSSUT M, 1984, NEUROSCIENCE, V12, P971, DOI 10.1016/0306-4522(84)90184-2; Kruse AA, 2000, NEUROBIOL LEARN MEM, V74, P179, DOI 10.1006/nlme.2000.3968; Kruse AA, 2004, NEUROBIOL LEARN MEM, V82, P99, DOI 10.1016/j.nlm.2004.05.001; Kuenzel W.J., 1988, STEREOTAXIC ATLAS BR; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; Lieshoff C, 2004, BEHAV BRAIN RES, V148, P145, DOI 10.1016/S0166-4328(03)00189-X; London SE, 2008, NAT NEUROSCI, V11, P579, DOI 10.1038/nn.2103; Long KD, 2002, J COMP PHYSIOL A, V188, P25, DOI 10.1007/s00359-001-0276-4; MARGOLIASH D, 1994, BRAIN BEHAV EVOLUT, V44, P247, DOI 10.1159/000113580; Mason JR, 1998, CROP PROT, V17, P657, DOI 10.1016/S0261-2194(98)00067-2; MAYER U, 2009, NEUROBIOL LEARN MEM; Mayer U, 2010, NEUROBIOL LEARN MEM, V93, P322, DOI 10.1016/j.nlm.2009.11.006; MELLO C, 1995, J NEUROSCI, V15, P6919; Mello CV, 1998, J COMP NEUROL, V400, P207; Mello CV, 1998, J COMP NEUROL, V395, P137; MELLO CV, 1992, P NATL ACAD SCI USA, V89, P6818, DOI 10.1073/pnas.89.15.6818; Metzger M, 1996, J COMP NEUROL, V376, P1, DOI 10.1002/(SICI)1096-9861(19961202)376:1<1::AID-CNE1>3.0.CO;2-7; Metzger M, 1998, J COMP NEUROL, V395, P380; Mileusnic R, 1996, NEUROREPORT, V7, P1269, DOI 10.1097/00001756-199605170-00010; Mistry S, 2008, PHYS MED REH CLIN N, V19, P709, DOI 10.1016/j.pmr.2008.05.002; Nishikawa KC, 2002, BRAIN BEHAV EVOLUT, V59, P240, DOI 10.1159/000063561; O'Donovan KJ, 1999, TRENDS NEUROSCI, V22, P167, DOI 10.1016/S0166-2236(98)01343-5; Ohms VR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011923; PATTERSON TA, 1990, EXP BRAIN RES, V80, P189; PATTERSON TA, 1992, BEHAV NEUROSCI, V106, P465, DOI 10.1037/0735-7044.106.3.465; Phan ML, 2010, P NATL ACAD SCI USA, V107, P2301, DOI 10.1073/pnas.0900091107; Phan ML, 2006, P NATL ACAD SCI USA, V103, P1088, DOI 10.1073/pnas.0510136103; Phillmore LS, 2003, BEHAV BRAIN RES, V147, P125, DOI 10.1016/S0166-4328(03)00155-4; Poirier R, 2008, FRONT NEUROSCI-SWITZ, V2, P47, DOI 10.3389/neuro.01.002.2008; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; Rose SPR, 2000, LEARN MEMORY, V7, P1, DOI 10.1101/lm.7.1.1; Sanders JD, 2008, NEUROSCIENCE, V157, P821, DOI 10.1016/j.neuroscience.2008.09.036; Sawczuk A, 2001, CRIT REV ORAL BIOL M, V12, P18, DOI 10.1177/10454411010120010101; Scharff C, 1998, J NEUROBIOL, V36, P81, DOI 10.1002/(SICI)1097-4695(199807)36:1<81::AID-NEU7>3.3.CO;2-8; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; SIMPSON HB, 1990, J NEUROSCI, V10, P1541; STOKES TM, 1974, J COMP NEUROL, V156, P337, DOI 10.1002/cne.901560305; Stripling R, 1997, J NEUROSCI, V17, P3883; Svec LA, 2009, NEUROSCIENCE, V160, P275, DOI 10.1016/j.neuroscience.2009.02.003; Velho TAF, 2005, EUR J NEUROSCI, V22, P1667, DOI 10.1111/j.1460-9568.2005.04369.x; Velho TAF, 2008, J NEUROSCI, V28, P11871, DOI 10.1523/JNEUROSCI.2307-08.2008; VICARIO DS, 1995, J NEUROPHYSIOL, V73, P2602, DOI 10.1152/jn.1995.73.6.2602; Vicario DS, 2004, ANN NY ACAD SCI, V1016, P246, DOI 10.1196/annals.1298.040; VICARIO DS, 1991, J NEUROBIOL, V22, P63, DOI 10.1002/neu.480220107; VICARIO DS, 1993, NEUROREPORT, V4, P983, DOI 10.1097/00001756-199307000-00037; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Watanabe S, 2004, BEHAV BRAIN RES, V155, P147, DOI 10.1016/j.bbr.2004.04.007; WHITE SA, 2009, BRAIN LANG; Wild JM, 2009, J COMP NEUROL, V512, P768, DOI 10.1002/cne.21932; Wild JM, 2004, ANN NY ACAD SCI, V1016, P438, DOI 10.1196/annals.1298.016; Wild JM, 1996, J COMP NEUROL, V365, P306, DOI 10.1002/(SICI)1096-9861(19960205)365:2<306::AID-CNE8>3.0.CO;2-9; Yamada Y, 1999, NEUROSCIENCE, V92, P473, DOI 10.1016/S0306-4522(99)00003-2; Zeigler HP, 2008, NEUROSCIENCE BIRDSON	95	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21157	10.1371/journal.pone.0021157	http://dx.doi.org/10.1371/journal.pone.0021157			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695176	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600048
J	Li, ZL; Liu, CX; Xie, ZH; Song, PY; Zhao, RCH; Guo, L; Liu, ZG; Wu, YJ				Li, Zhilong; Liu, Chenxiong; Xie, Zhenhua; Song, Pengyue; Zhao, Robert C. H.; Guo, Ling; Liu, Zhigang; Wu, Yaojiong			Epigenetic Dysregulation in Mesenchymal Stem Cell Aging and Spontaneous Differentiation	PLOS ONE			English	Article							STROMAL CELLS; MYOCARDIAL-INFARCTION; HISTONE ACETYLATION; DNA METHYLATION; CARDIAC REPAIR; SELF-RENEWAL; IN-VITRO; TRANSPLANTATION; MICE; EXPRESSION	Background: Mesenchymal stem cells (MSCs) hold great promise for the treatment of difficult diseases. As MSCs represent a rare cell population, ex vivo expansion of MSCs is indispensable to obtain sufficient amounts of cells for therapies and tissue engineering. However, spontaneous differentiation and aging of MSCs occur during expansion and the molecular mechanisms involved have been poorly understood. Methodology/Principal Findings: Human MSCs in early and late passages were examined for their expression of genes involved in osteogenesis to determine their spontaneous differentiation towards osteoblasts in vitro, and of genes involved in self-renewal and proliferation for multipotent differentiation potential. In parallel, promoter DNA methylation and hostone H3 acetylation levels were determined. We found that MSCs underwent aging and spontaneous osteogenic differentiation upon regular culture expansion, with progressive downregulation of TERT and upregulation of osteogenic genes such as Runx2 and ALP. Meanwhile, the expression of genes associated with stem cell self-renewal such as Oct4 and Sox2 declined markedly. Notably, the altered expression of these genes were closely associated with epigenetic dysregulation of histone H3 acetylation in K9 and K14, but not with methylation of CpG islands in the promoter regions of most of these genes. bFGF promoted MSC proliferation and suppressed its spontaneous osteogenic differentiation, with corresponding changes in histone H3 acetylation in TERT, Oct4, Sox2, Runx2 and ALP genes. Conclusions/Significance: Our results indicate that histone H3 acetylation, which can be modulated by extrinsic signals, plays a key role in regulating MSC aging and differentiation.	[Li, Zhilong; Liu, Chenxiong; Xie, Zhenhua; Song, Pengyue; Guo, Ling; Wu, Yaojiong] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Peoples R China; [Li, Zhilong; Liu, Chenxiong; Liu, Zhigang] Shenzhen Univ, Sch Med, State Key Lab Resp Dis Allergy, Shenzhen, Peoples R China; [Zhao, Robert C. H.] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Ctr Excellence Tissue Engn, Beijing 100730, Peoples R China; [Zhao, Robert C. H.] Peking Union Med Coll, Sch Basic Med, Beijing 100021, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Shenzhen University; State Key Laboratory of Respiratory Disease; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, ZL (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Peoples R China.	LZG@szu.edu.cn; wu.yaojiong@sz.tsinghua.edu.cn			Natural Science Foundation of China [30871273, 30971496, U1032003]; National Basic Research Program [2009CB522108]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program(National Basic Research Program of China)	This work was supported by grants from the Natural Science Foundation of China (No. 30871273, 30971496, U1032003) to Y.W. and by the National Basic Research Program (No. 2009CB522108) to L.Z.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Aguayo-Mazzucato C, 2010, NAT REV ENDOCRINOL, V6, P139, DOI 10.1038/nrendo.2009.274; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bork S, 2010, AGING CELL, V9, P54, DOI 10.1111/j.1474-9726.2009.00535.x; Breitbach M, 2007, BLOOD, V110, P1362, DOI 10.1182/blood-2006-12-063412; Chen LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007119; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Frith JE, 2010, TISSUE ENG PART C-ME, V16, P735, DOI [10.1089/ten.tec.2009.0432, 10.1089/ten.TEC.2009.0432]; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gereige LM, 2009, NAT GENET, V41, P1164, DOI 10.1038/ng1109-1164; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Horwitz EM, 2006, CYTOTHERAPY, V8, P194, DOI 10.1080/14653240600758562; Jin HK, 2002, J CLIN INVEST, V109, P1183, DOI 10.1072/JCI200214862; Joggerst SJ, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001124; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Liao LM, 2008, STEM CELLS DEV, V17, P613, DOI 10.1089/scd.2008.0183; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Liu LH, 2006, STEM CELLS DEV, V15, P349, DOI 10.1089/scd.2006.15.349; Lomvardas S, 2001, CELL, V106, P685, DOI 10.1016/S0092-8674(01)00490-1; Lyssiotis CA, 2007, P NATL ACAD SCI USA, V104, P14982, DOI 10.1073/pnas.0707044104; MacDonald VE, 2009, EPIGENETICS-US, V4, P139, DOI 10.4161/epi.4.3.8484; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Martino G, 2010, NAT REV NEUROL, V6, P247, DOI 10.1038/nrneurol.2010.35; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Nishida H, 2006, CHROMOSOME RES, V14, P203, DOI 10.1007/s10577-006-1036-7; Pelttari K, 2006, ARTHRITIS RHEUM-US, V54, P3254, DOI 10.1002/art.22136; Philippe B, 2010, STEM CELLS INT, V2010, DOI 10.4061/2010/503593; Pittenger MF, 2004, CIRC RES, V95, P9, DOI 10.1161/01.RES.0000135902.99383.6f; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Salem HK, 2010, STEM CELLS, V28, P585, DOI 10.1002/stem.269; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Sotiropoulou PA, 2006, STEM CELLS, V24, P462, DOI 10.1634/stemcells.2004-0331; Szulc P, 2005, BONE, V36, P13, DOI 10.1016/j.bone.2004.09.004; Tan J, 2008, J GENET GENOMICS, V35, P585, DOI 10.1016/S1673-8527(08)60079-X; Wang SF, 2008, J BIOL CHEM, V283, P35929, DOI 10.1074/jbc.M804091200; Wu YJ, 2007, STEM CELLS, V25, P2648, DOI 10.1634/stemcells.2007-0226; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; YU JM, 2010, AGING CELL; Zhang HJ, 2008, PLACENTA, V29, P549, DOI 10.1016/j.placenta.2008.03.003; Zhao SM, 2010, STEM CELLS DEV, V19, P607, DOI 10.1089/scd.2009.0345	47	152	164	5	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20526	10.1371/journal.pone.0020526	http://dx.doi.org/10.1371/journal.pone.0020526			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694780	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900013
J	Malik, SB; Brochu, CD; Bilic, I; Yuan, J; Hess, M; Logsdon, JM; Carlton, JM				Malik, Shehre-Banoo; Brochu, Cynthia D.; Bilic, Ivana; Yuan, Jing; Hess, Michael; Logsdon, John M., Jr.; Carlton, Jane M.			Phylogeny of Parasitic Parabasalia and Free-Living Relatives Inferred from Conventional Markers vs. Rpb1, a Single-Copy Gene	PLOS ONE			English	Article							RNA-POLYMERASE-II; AMANITIN-RESISTANCE MUTATIONS; MULTIPLE SEQUENCE ALIGNMENT; TRICHOMONAS-VAGINALIS; ALPHA-AMANITIN; TETRATRICHOMONAS-GALLINARUM; HISTOMONAS-MELEAGRIDIS; TRITRICHOMONAS-FETUS; SMALL-SUBUNIT; MOLECULAR CHARACTERIZATION	Background: Parabasalia are single-celled eukaryotes (protists) that are mainly comprised of endosymbionts of termites and wood roaches, intestinal commensals, human or veterinary parasites, and free-living species. Phylogenetic comparisons of parabasalids are typically based upon morphological characters and 18S ribosomal RNA gene sequence data (rDNA), while biochemical or molecular studies of parabasalids are limited to a few axenically cultivable parasites. These previous analyses and other studies based on PCR amplification of duplicated protein-coding genes are unable to fully resolve the evolutionary relationships of parabasalids. As a result, genetic studies of Parabasalia lag behind other organisms. Principal Findings: Comparing parabasalid EF1 alpha, alpha-tubulin, enolase and MDH protein-coding genes with information from the Trichomonas vaginalis genome reveals difficulty in resolving the history of species or isolates apart from duplicated genes. A conserved single-copy gene encodes the largest subunit of RNA polymerase II (Rpb1) in T. vaginalis and other eukaryotes. Here we directly sequenced Rpb1 degenerate PCR products from 10 parabasalid genera, including several T. vaginalis isolates and avian isolates, and compared these data by phylogenetic analyses. Rpb1 genes from parabasalids, diplomonads, Parabodo, Diplonema and Percolomonas were all intronless, unlike intron-rich homologs in Naegleria, Jakoba and Malawimonas. Conclusions/Significance: The phylogeny of Rpb1 from parasitic and free-living parabasalids, and conserved Rpb1 insertions, support Trichomonadea, Tritrichomonadea, and Hypotrichomonadea as monophyletic groups. These results are consistent with prior analyses of rDNA and GAPDH sequences and ultrastructural data. The Rpb1 phylogenetic tree also resolves species-and isolate-level relationships. These findings, together with the relative ease of Rpb1 isolation, make it an attractive tool for evaluating more extensive relationships within Parabasalia.	[Malik, Shehre-Banoo; Carlton, Jane M.] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Malik, Shehre-Banoo; Brochu, Cynthia D.; Yuan, Jing; Logsdon, John M., Jr.] Univ Iowa, Dept Biol, Roy J Carver Ctr Comparat Genom, Iowa City, IA 52242 USA; [Bilic, Ivana; Hess, Michael] Univ Vet Med, Clin Avian Reptile & Fish Med, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria	New York University; University of Iowa; University of Veterinary Medicine Vienna	Malik, SB (corresponding author), Dalhousie Univ, Ctr Comparat Genom & Evolutionary Bioinformat, Dept Biochem & Mol Biol, Halifax, NS, Canada.	sbmalik@dal.ca; jane.carlton@nyumc.org		Malik, Shehre-Banoo/0000-0003-0833-0648; Hess, Michael/0000-0002-6991-0120; Bilic, Ivana/0000-0003-3296-5117	National Institutes of Health/National Institute of Allergy and Infectious Diseases (Advancing Novel Science in Women's Health Research) [1R21AI083954-01]; National Science Foundation [EF-0431117, 0431117]; University of Iowa; Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI083954] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (Advancing Novel Science in Women's Health Research)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); University of Iowa; Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity(Canadian Institute for Advanced Research (CIFAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases grant 1R21AI083954-01 (Advancing Novel Science in Women's Health Research; http://grants.nih.gov/grants/guide/pa-files/PAS-07-381.html) to JMC; National Science Foundation grant EF-0431117 to JML (http://www.nsf.gov/awardsearch/showAward.do?AwardNumber=0431117); the Clinic for Avian, Reptile and Fish Medicine for MH (http://www.vetmeduni.ac.at/); the University of Iowa's Avis Cone Graduate Summer Fellowships to SBM (2004, 2006) and JY (2005). SBM is currently supported by a Junior Fellowship from the Canadian Institute for Advanced Research Program in Integrated Microbial Biodiversity (http://www2.cifar.ca/research/junior-academy/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; ALLEN ENA A., 1941, AMER JOUR VET RES, V2, P214; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amin A, 2010, EXP PARASITOL, V124, P202, DOI 10.1016/j.exppara.2009.09.014; Anderson NL, 2009, VET PARASITOL, V161, P178, DOI 10.1016/j.vetpar.2009.01.023; BARTOLOMEI MS, 1987, MOL CELL BIOL, V7, P586, DOI 10.1128/MCB.7.2.586; BARTOLOMEI MS, 1995, MOL GEN GENET, V246, P778, DOI 10.1007/BF00290727; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brugerolle Guy, 2002, P1196; BULLERJAHN AME, 1988, GENETICS, V120, P423; CAMP RR, 1974, J PROTOZOOL, V21, P69, DOI 10.1111/j.1550-7408.1974.tb03619.x; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Carlton JM, 2010, ANAEROBIC PARASITIC PROTOZOA: GENOMICS AND MOLECULAR BIOLOGY, P45, DOI 10.1016/B978-0-12-384876-5.00003-4; Carpenter KJ, 2010, PROTIST, V161, P122, DOI 10.1016/j.protis.2009.06.003; Cepicka I, 2005, VET PARASITOL, V128, P11, DOI 10.1016/j.vetpar.2004.11.003; Cepicka I, 2010, PROTIST, V161, P400, DOI 10.1016/j.protis.2009.11.005; Conrad M, 2011, MOL BIOCHEM PARASIT, V175, P30, DOI 10.1016/j.molbiopara.2010.08.006; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; da Silva DG, 2007, INFECT GENET EVOL, V7, P433, DOI [10.1016/j.meegid.2006.01.002, 10.1016/j.meegid.2007.01.002]; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; Dacks JB, 2008, PARASITOL INT, V57, P97, DOI 10.1016/j.parint.2007.11.004; DIAMOND LS, 1962, J PROTOZOOL, V9, P442, DOI 10.1111/j.1550-7408.1962.tb02650.x; DIAMOND LS, 1957, J PARASITOL, V43, P488, DOI 10.2307/3274682; DIAMOND LS, 1995, J EUKARYOT MICROBIOL, V42, P585, DOI 10.1111/j.1550-7408.1995.tb05911.x; Duboucher C, 2007, LUNG, V185, P295, DOI 10.1007/s00408-007-9022-1; Dufernez F, 2007, J EUKARYOT MICROBIOL, V54, P161, DOI 10.1111/j.1550-7408.2007.00247.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgcomb V, 1998, PROTIST, V149, P359, DOI 10.1016/S1434-4610(98)70042-2; Felleisen RSJ, 1997, PARASITOLOGY, V115, P111, DOI 10.1017/S0031182097001212; FENCHEL T, 1986, J MAR BIOL ASSOC UK, V66, P465, DOI 10.1017/S002531540004306X; FRIEDHOFF KT, 1991, PARASITOL RES, V77, P329, DOI 10.1007/BF00930910; Gerbod D, 2004, MOL PHYLOGENET EVOL, V31, P572, DOI 10.1016/j.ympev.2003.09.013; Gerhold RW, 2008, J PARASITOL, V94, P1335, DOI 10.1645/GE-1585.1; Gookin JL, 2005, J PARASITOL, V91, P939, DOI 10.1645/GE-474R.1; Gookin JL, 2007, VET PARASITOL, V145, P11, DOI 10.1016/j.vetpar.2006.10.020; Grabensteiner E, 2006, VET PARASITOL, V142, P223, DOI 10.1016/j.vetpar.2006.07.011; Grabensteiner E, 2010, VET PARASITOL, V172, P53, DOI 10.1016/j.vetpar.2010.04.015; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; GUNDERSON J, 1995, J EUKARYOT MICROBIOL, V42, P411, DOI 10.1111/j.1550-7408.1995.tb01604.x; Hampl V, 2005, MOL BIOL EVOL, V22, P2508, DOI 10.1093/molbev/msi245; Hampl V, 2004, MOL PHYLOGENET EVOL, V32, P711, DOI 10.1016/j.ympev.2004.03.005; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Harper JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006577; Hauck R, 2010, J PARASITOL, V96, P396, DOI 10.1645/GE-2267.1; Hauck R, 2009, PARASITOL RES, V104, P1183, DOI 10.1007/s00436-008-1309-5; Hess M, 2006, PARASITOLOGY, V133, P547, DOI 10.1017/S0031182006000758; HOLLANDER DH, 1987, J PARASITOL, V73, P1074, DOI 10.2307/3282545; HONIGBER.BM, 1968, J PROTOZOOL, V15, P419, DOI 10.1111/j.1550-7408.1968.tb02151.x; HONIGBERG BM, 1971, J PROTOZOOL, V18, P183, DOI 10.1111/j.1550-7408.1971.tb03306.x; HONIGBERG BM, 1972, J PROTOZOOL, V19, P446, DOI 10.1111/j.1550-7408.1972.tb03499.x; Horner DS, 1996, P ROY SOC B-BIOL SCI, V263, P1053, DOI 10.1098/rspb.1996.0155; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson EH, 2004, CLIN MICROBIOL REV, V17, P553, DOI 10.1128/CMR.17.3.553-570.2004; Keeling PJ, 2004, J MOL EVOL, V58, P550, DOI 10.1007/s00239-003-2577-4; KULDA J, 1969, J PROTOZOOL, V16, P479, DOI 10.1111/j.1550-7408.1969.tb02304.x; Kumar S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-357; Kutisova K, 2005, PARASITOLOGY, V131, P309, DOI 10.1017/S0031182005008000; Le SQ, 2008, PHILOS T R SOC B, V363, P3965, DOI 10.1098/rstb.2008.0180; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; LEE JJ, 1962, J PROTOZOOL, V9, P445, DOI 10.1111/j.1550-7408.1962.tb02651.x; Levy MG, 2003, J PARASITOL, V89, P99, DOI 10.1645/0022-3395(2003)089[0099:TFANPH]2.0.CO;2; LOCKE LN, 1962, J PARASITOL, V48, P497, DOI 10.2307/3275231; Lopes FR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-330; Maass A, 2006, EUR J PROTISTOL, V42, P125, DOI 10.1016/j.ejop.2006.03.001; MADDISON WP, 2006, MACCLADE 4 08; Makiuchi T, 2007, GENE, V394, P78, DOI 10.1016/j.gene.2007.02.009; Malik SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002879; Mantini C, 2009, J CLIN MICROBIOL, V47, P2336, DOI 10.1128/JCM.00353-09; Maslov DA, 1999, PROTIST, V150, P33, DOI 10.1016/S1434-4610(99)70007-6; MATTERN CFT, 1972, J PROTOZOOL, V19, P265, DOI 10.1111/j.1550-7408.1972.tb03456.x; MATTERN CFT, 1969, J PROTOZOOL, V16, P668, DOI 10.1111/j.1550-7408.1969.tb02326.x; Mcdougald L.R., 2008, DIS POULTRY, P1095; Miller M. A., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Miller M. A., 2010, CIPRES PORTALS; Moreira D, 2007, MOL PHYLOGENET EVOL, V44, P255, DOI 10.1016/j.ympev.2006.11.001; Noda S, 2009, MOL PHYLOGENET EVOL, V52, P217, DOI 10.1016/j.ympev.2009.03.011; O'Kelly CJ, 1999, J EUKARYOT MICROBIOL, V46, P522, DOI 10.1111/j.1550-7408.1999.tb06070.x; Ohkuma M, 2009, P ROY SOC B-BIOL SCI, V276, P239, DOI 10.1098/rspb.2008.1094; Ohkuma M, 2007, MOL PHYLOGENET EVOL, V42, P847, DOI 10.1016/j.ympev.2006.09.016; Oud L, 2009, SOUTH MED J, V102, P330, DOI 10.1097/SMJ.0b013e318182f392; Parfrey LW, 2010, SYST BIOL, V59, P518, DOI 10.1093/sysbio/syq037; PATTERSON DJ, 1990, J MAR BIOL ASSOC UK, V70, P381, DOI 10.1017/S0025315400035487; Pritham EJ, 2007, GENE, V390, P3, DOI 10.1016/j.gene.2006.08.008; Quon DVK, 1996, J MOL EVOL, V43, P253, DOI 10.1007/PL00006084; ROGALSKI TM, 1990, GENETICS, V126, P889; ROGALSKI TM, 1988, GENETICS, V120, P409; Rogers MB, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-89; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; SANDHU GS, 1989, BIOTECHNIQUES, V7, P689; Silva JC, 2005, MOL BIOL EVOL, V22, P126, DOI 10.1093/molbev/msh260; Simpson AGB, 2001, J EUKARYOT MICROBIOL, V48, P480, DOI 10.1111/j.1550-7408.2001.tb00183.x; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Simpson AGB, 2008, MOL PHYLOGENET EVOL, V47, P366, DOI 10.1016/j.ympev.2007.11.035; STABLER RM, 1954, EXP PARASITOL, V3, P368, DOI 10.1016/0014-4894(54)90035-1; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stark D, 2010, EUR J CLIN MICROBIOL, V29, P411, DOI 10.1007/s10096-010-0876-4; Stark D, 2010, AM J TROP MED HYG, V82, P614, DOI 10.4269/ajtmh.2010.09-0478; Stechmann A, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-101; Swofford DL, 2005, PAUP PHYLOGENETIC AN; TAI JH, 1993, EXP PARASITOL, V76, P278, DOI 10.1006/expr.1993.1033; Tyzzer E. E., 1920, Journal of Parasitology Urbana, V6, DOI 10.2307/3271065; Vanacova S, 2001, MOL BIOCHEM PARASIT, V115, P239, DOI 10.1016/S0166-6851(01)00294-8; Viscogliosi E, 1998, J MOL EVOL, V47, P190, DOI 10.1007/PL00006376; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wu G, 1999, P NATL ACAD SCI USA, V96, P6285, DOI 10.1073/pnas.96.11.6285; Yubuki N, 2010, J EUKARYOT MICROBIOL, V57, P554, DOI 10.1111/j.1550-7408.2010.00509.x; ZUBACOVA Z, 2010, MOL BIOCH PARASITOL; Zubacova Z, 2008, MOL BIOCHEM PARASIT, V161, P49, DOI 10.1016/j.molbiopara.2008.06.004	111	35	39	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20774	10.1371/journal.pone.0020774	http://dx.doi.org/10.1371/journal.pone.0020774			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695260	gold, Green Submitted, Green Published			2022-12-25	WOS:000291612900024
J	Tvermoes, BE; Bird, GS; Freedman, JH				Tvermoes, Brooke E.; Bird, Gary S.; Freedman, Jonathan H.			Cadmium Induces Transcription Independently of Intracellular Calcium Mobilization	PLOS ONE			English	Article							GENE-EXPRESSION; HEPG2 CELLS; METAL CARCINOGENESIS; MICROARRAY ANALYSIS; EPITHELIAL-CELLS; RAT HEPATOCYTES; MESANGIAL CELLS; C-FOS; APOPTOSIS; MECHANISMS	Background: Exposure to cadmium is associated with human pathologies and altered gene expression. The molecular mechanisms by which cadmium affects transcription remain unclear. It has been proposed that cadmium activates transcription by altering intracellular calcium concentration ([Ca(2+)](i)) and disrupting calcium-mediated intracellular signaling processes. This hypothesis is based on several studies that may be technically problematic; including the use of BAPTA chelators, BAPTA-based fluorescent sensors, and cytotoxic concentrations of metal. Methodology/Principal Finding: In the present report, the effects of cadmium on [Ca(2+)] i under non-cytotoxic and cytotoxic conditions was monitored using the protein-based calcium sensor yellow cameleon (YC3.60), which was stably expressed in HEK293 cells. In HEK293 constitutively expressing YC3.60, this calcium sensor was found to be insensitive to cadmium. Exposing HEK293::YC3.60 cells to non-cytotoxic cadmium concentrations was sufficient to induce transcription of cadmium-responsive genes but did not affect [Ca(2+)] i mobilization or increase steady-state mRNA levels of calcium-responsive genes. In contrast, exposure to cytotoxic concentrations of cadmium significantly reduced intracellular calcium stores and altered calcium-responsive gene expression. Conclusions/Significance: These data indicate that at low levels, cadmium induces transcription independently of intracellular calcium mobilization. The results also support a model whereby cytotoxic levels of cadmium activate calcium-responsive transcription as a general response to metal-induced intracellular damage and not via a specific mechanism. Thus, the modulation of intracellular calcium may not be a primary mechanism by which cadmium regulates transcription.	[Tvermoes, Brooke E.; Freedman, Jonathan H.] NIEHS, Lab Toxicol & Pharmacol, NIH, Res Triangle Pk, NC 27709 USA; [Bird, Gary S.] NIEHS, Lab Signal Transduct, NIH, Res Triangle Pk, NC 27709 USA; [Tvermoes, Brooke E.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Duke University	Tvermoes, BE (corresponding author), NIEHS, Lab Toxicol & Pharmacol, NIH, POB 12233, Res Triangle Pk, NC 27709 USA.	freedma1@niehs.nih.gov	Bird, Gary/AAI-8186-2021	Bird, Gary/0000-0003-1389-8748	NIH; NIEHS [Z01ES102045]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102045] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by the Intramural Research Program of the NIH, and NIEHS (Z01ES102045). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Adams TK, 2002, ENVIRON HEALTH PERSP, V110, P813, DOI 10.1289/ehp.02110s5813; Akesson AA, 2005, ENVIRON HEALTH PERSP, V113, P1627, DOI 10.1289/ehp.8033; Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504; Beyersmann D, 1997, TOXICOL APPL PHARM, V144, P247, DOI 10.1006/taap.1997.8125; Biagioli M, 2008, CELL CALCIUM, V43, P184, DOI 10.1016/j.ceca.2007.05.003; Bird GS, 2008, METHODS, V46, P204, DOI 10.1016/j.ymeth.2008.09.009; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Chuang SM, 2000, CARCINOGENESIS, V21, P1423, DOI 10.1093/carcin/21.7.1423; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; Engstrom A, 2009, ENVIRON RES, V109, P188, DOI 10.1016/j.envres.2008.10.008; Friberg L, 1992, ENV HLTH CRITERIA 13; HINKLE PM, 1992, J BIOL CHEM, V267, P25553; Hogervorst J, 2007, ENVIRON RES, V103, P30, DOI 10.1016/j.envres.2006.05.009; Hsiao CJJ, 2009, BIOCHIMIE, V91, P329, DOI 10.1016/j.biochi.2008.10.006; Hsiao CJJ, 2004, J BIOCHEM MOL TOXIC, V18, P133, DOI 10.1002/jbt.20018; IARC Working Group on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, 1993, BER CADM MERC EXP GL; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Jin YH, 2003, NAT GENET, V34, P326, DOI 10.1038/ng1172; Jones BF, 2008, HEPATOLOGY, V48, P1273, DOI 10.1002/hep.22461; Joseph P, 2001, TOXICOL SCI, V61, P295, DOI 10.1093/toxsci/61.2.295; Kawata K, 2009, ENVIRON MOL MUTAGEN, V50, P46, DOI 10.1002/em.20438; Kim J, 2004, TOXICOL SCI, V81, P518, DOI 10.1093/toxsci/kfh221; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; Lee MJ, 2002, TOXICOLOGY, V174, P109, DOI 10.1016/S0300-483X(02)00045-8; Lemarie A, 2004, FREE RADICAL BIO MED, V36, P1517, DOI 10.1016/j.freeradbiomed.2004.03.020; Li M, 2000, J BIOL CHEM, V275, P39702, DOI 10.1074/jbc.M007369200; Liu F, 2006, ENVIRON HEALTH PERSP, V114, P859, DOI 10.1289/ehp.8920; Liu Y, 2007, FEBS LETT, V581, P1481, DOI 10.1016/j.febslet.2007.03.003; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattie MD, 2001, BIOCHEM BIOPH RES CO, V285, P921, DOI 10.1006/bbrc.2001.5259; McElwee MK, 2009, J MOL BIOL, V393, P1013, DOI 10.1016/j.jmb.2009.08.077; Menke A, 2009, ENVIRON HEALTH PERSP, V117, P190, DOI 10.1289/ehp.11236; MERALI Z, 1975, CAN J PHYSIOL PHARM, V53, P174, DOI 10.1139/y75-024; Misra UK, 2002, CELL SIGNAL, V14, P327, DOI 10.1016/S0898-6568(01)00268-6; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; MORTON KA, 1992, J BIOL CHEM, V267, P2880; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Paniagua-Castro N, 2008, TOXICOL IN VITRO, V22, P75, DOI 10.1016/j.tiv.2007.08.005; Pourahmad J, 2000, TOXICOLOGY, V143, P263, DOI 10.1016/S0300-483X(99)00178-X; Putney J W Jr, 2001, Mol Interv, V1, P84; Safran M, 2002, BIOINFORMATICS, V18, P1542, DOI 10.1093/bioinformatics/18.11.1542; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schutte R, 2008, ENVIRON HEALTH PERSP, V116, P777, DOI 10.1289/ehp.11167; Shih YL, 2005, ANN NY ACAD SCI, V1042, P497, DOI 10.1196/annals.1338.043; Song MO, 2009, PHYSIOL GENOMICS, V38, P386, DOI 10.1152/physiolgenomics.00083.2009; Song MO, 2005, MOL CELL BIOCHEM, V279, P141, DOI 10.1007/s11010-005-8286-0; Templeton DM, 1998, TOXICOL LETT, V95, P1, DOI 10.1016/S0378-4274(98)00015-0; THASTRUP O, 1994, AGENTS ACTIONS, V43, P187, DOI 10.1007/BF01986687; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Tsangaris GT, 2002, TOXICOLOGY, V178, P135, DOI 10.1016/S0300-483X(02)00236-6; WAALKES MP, 1992, CRIT REV TOXICOL, V22, P175, DOI 10.3109/10408449209145323; Waisberg M, 2003, TOXICOLOGY, V192, P95, DOI 10.1016/S0300-483X(03)00305-6; Wang SH, 2008, CELL MOL LIFE SCI, V65, P3640, DOI 10.1007/s00018-008-8383-9; Watkin RD, 2003, TOXICOLOGY, V184, P157, DOI 10.1016/S0300-483X(02)00577-2; Xu J, 2003, J BIOCHEM MOL TOXIC, V17, P67, DOI 10.1002/jbt.10062; Yamada H, 2002, IND HEALTH, V40, P159, DOI 10.2486/indhealth.40.159; Zhou T, 2004, TOXICOL LETT, V154, P191, DOI 10.1016/j.toxlet.2004.07.015	59	10	10	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20542	10.1371/journal.pone.0020542	http://dx.doi.org/10.1371/journal.pone.0020542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694771	gold, Green Submitted, Green Published			2022-12-25	WOS:000291612900014
J	Helal, M; Kong, FR; Chen, SCA; Bain, M; Christen, R; Sintchenko, V				Helal, Manal; Kong, Fanrong; Chen, Sharon C. A.; Bain, Michael; Christen, Richard; Sintchenko, Vitali			Defining Reference Sequences for Nocardia Species by Similarity and Clustering Analyses of 16S rRNA Gene Sequence Data	PLOS ONE			English	Article							HIDDEN MARKOV-MODELS; IDENTIFICATION; PROTEIN; PHYLOGENY; PATHOGENS; SOFTWARE; DYNAMICS; STRAINS; SYSTEM	Background: The intra-and inter-species genetic diversity of bacteria and the absence of 'reference', or the most representative, sequences of individual species present a significant challenge for sequence-based identification. The aims of this study were to determine the utility, and compare the performance of several clustering and classification algorithms to identify the species of 364 sequences of 16S rRNA gene with a defined species in GenBank, and 110 sequences of 16S rRNA gene with no defined species, all within the genus Nocardia. Methods: A total of 364 16S rRNA gene sequences of Nocardia species were studied. In addition, 110 16S rRNA gene sequences assigned only to the Nocardia genus level at the time of submission to GenBank were used for machine learning classification experiments. Different clustering algorithms were compared with a novel algorithm or the linear mapping (LM) of the distance matrix. Principal Components Analysis was used for the dimensionality reduction and visualization. Results: The LM algorithm achieved the highest performance and classified the set of 364 16S rRNA sequences into 80 clusters, the majority of which (83.52%) corresponded with the original species. The most representative 16S rRNA sequences for individual Nocardia species have been identified as 'centroids' in respective clusters from which the distances to all other sequences were minimized; 110 16S rRNA gene sequences with identifications recorded only at the genus level were classified using machine learning methods. Simple kNN machine learning demonstrated the highest performance and classified Nocardia species sequences with an accuracy of 92.7% and a mean frequency of 0.578. Conclusion: The identification of centroids of 16S rRNA gene sequence clusters using novel distance matrix clustering enables the identification of the most representative sequences for each individual species of Nocardia and allows the quantitation of inter- and intra-species variability.	[Helal, Manal; Chen, Sharon C. A.; Sintchenko, Vitali] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Helal, Manal; Kong, Fanrong; Chen, Sharon C. A.; Sintchenko, Vitali] Westmead Hosp, Ctr Infect Dis & Microbiol, Sydney W Area Hlth Serv, Sydney, NSW, Australia; [Bain, Michael] Univ New S Wales, Sch Comp Sci & Engn, Sydney, NSW, Australia; [Christen, Richard] Univ Nice Sophia Antipolis, Nice, France; [Christen, Richard] CNRS, Ctr Biochim, UMR6543, F-06034 Nice, France	University of Sydney; University of Sydney; University of New South Wales Sydney; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Helal, M (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	vitali.sintchenko@swahs.health.nsw.gov.au		Christen, Richard/0000-0002-3396-4362; Sintchenko, Vitali/0000-0002-9261-3650; Helal, Manal/0000-0002-7515-2071	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the Australian National Health and Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius P, 2007, IEEE ACM T COMPUT BI, V4, P693, DOI 10.1109/TCBB.2007.1053; BALDI P, 1994, P NATL ACAD SCI USA, V91, P1059, DOI 10.1073/pnas.91.3.1059; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Christen R, 2008, CURR OPIN BIOTECH, V19, P266, DOI 10.1016/j.copbio.2008.04.003; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Conville PS, 2008, J CLIN MICROBIOL, V46, P1178, DOI 10.1128/JCM.02011-07; Conville PS, 2007, J CLIN MICROBIOL, V45, P1146, DOI 10.1128/JCM.02482-06; Conville PS, 2010, J CLIN MICROBIOL, V48, P2995, DOI 10.1128/JCM.00681-10; Davidsen T, 2010, NUCLEIC ACIDS RES, V38, pD340, DOI 10.1093/nar/gkp912; Dehal PS, 2010, NUCLEIC ACIDS RES, V38, pD396, DOI 10.1093/nar/gkp919; Doolittle WF, 2009, GENOME RES, V19, P744, DOI 10.1101/gr.086645.108; Dutilh BE, 2008, NUCLEIC ACIDS RES, V36, pW470, DOI 10.1093/nar/gkn277; EDGAR R, 2010, BIG ALIGNMENTS THEY; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Euzeby JP, 1997, INT J SYST BACTERIOL, V47, P590, DOI 10.1099/00207713-47-2-590; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fielding AH, 2007, CLUSTER AND CLASSIFICATION TECHNIQUES FOR THE BIOSCIENCES, P1, DOI 10.2277/ 0521618002; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; HELAL M, 2008, P 19 INT C GEN INF G; Hofle MG, 2005, ENVIRON MICROBIOL, V7, P670, DOI 10.1111/j.1462-2920.2005.00738.x; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Kong Fanrong, 2009, Open Microbiol J, V3, P97, DOI 10.2174/1874285800903010097; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Lancashire L, 2005, BIOINFORMATICS, V21, P2191, DOI 10.1093/bioinformatics/bti368; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; MANAL H, 2011, LINEAR NORMALI UNPUB; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; McTaggart LR, 2010, J CLIN MICROBIOL, V48, P4525, DOI 10.1128/JCM.00883-10; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nelson DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010785; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Roth A, 2003, J CLIN MICROBIOL, V41, P851, DOI 10.1128/JCM.41.2.851-856.2003; Saubolle MA, 2003, J CLIN MICROBIOL, V41, P4497, DOI 10.1128/JCM.41.10.4497-4501.2003; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Sgourakis NG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-104; Sintchenko V, 2007, NAT REV MICROBIOL, V5, P464, DOI 10.1038/nrmicro1656; Steinke D, 2005, PHILOS T R SOC B, V360, P1975, DOI 10.1098/rstb.2005.1729; Todd Mays, 2004, GROUNDWATER HYDROLOG, V3rd; Witten I. H., 2005, DATA MINING PRACTICA; Xiao M, 2010, J CLIN MICROBIOL, V48, P503, DOI 10.1128/JCM.01761-09; Yeung KY, 2001, BIOINFORMATICS, V17, P763, DOI 10.1093/bioinformatics/17.9.763; ZHAO Y, 2002, C INF KNOWL MAN NOV	47	7	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e19517	10.1371/journal.pone.0019517	http://dx.doi.org/10.1371/journal.pone.0019517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687706	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500001
J	Baranger, K; Zani, ML; Labas, V; Dallet-Choisy, S; Moreau, T				Baranger, Kevin; Zani, Marie-Louise; Labas, Valerie; Dallet-Choisy, Sandrine; Moreau, Thierry			Secretory Leukocyte Protease Inhibitor (SLPI) Is, like Its Homologue Trappin-2 (Pre-Elafin), a Transglutaminase Substrate	PLOS ONE			English	Article							CROSS-LINKING; PROTEINASE-INHIBITOR; EPIDERMAL-KERATINOCYTES; TISSUE TRANSGLUTAMINASE; ELASTASE INHIBITOR; FACTOR-XIIIA; IN-VITRO; SEQUENCE; SKIN; IDENTIFICATION	Human lungs contain secretory leukocyte protease inhibitor (SLPI), elafin and its biologically active precursor trappin-2 (pre-elafin). These important low-molecular weight inhibitors are involved in controlling the potentially deleterious proteolytic activities of neutrophil serine proteases including elastase, proteinase 3 and cathepsin G. We have shown previously that trappin-2, and to a lesser extent, elafin can be linked covalently to various extracellular matrix proteins by tissue transglutaminases and remain potent protease inhibitors. SLPI is composed of two distinct domains, each of which is about 40% identical to elafin, but it lacks consensus transglutaminase sequence(s), unlike trappin-2 and elafin. We investigated the actions of type 2 tissue transglutaminase and plasma transglutaminase activated factor XIII on SLPI. It was readily covalently bound to fibronectin or elastin by both transglutaminases but did not compete with trappin-2 cross-linking. Cross-linked SLPI still inhibited its target proteases, elastase and cathepsin G. We have also identified the transglutamination sites within SLPI, elafin and trappin-2 by mass spectrometry analysis of tryptic digests of inhibitors cross-linked to mono-dansyl cadaverin or to a fibronectin-derived glutamine-rich peptide. Most of the reactive lysine and glutamine residues in SLPI are located in its first N-terminal elafin-like domain, while in trappin-2, they are located in both the N-terminal cementoin domain and the elafin moiety. We have also demonstrated that the transglutamination substrate status of the cementoin domain of trappin-2 can be transferred from one protein to another, suggesting that it may provide transglutaminase-dependent attachment properties for engineered proteins. We have thus added to the corpus of knowledge on the biology of these potential therapeutic inhibitors of airway proteases.	[Baranger, Kevin; Zani, Marie-Louise; Dallet-Choisy, Sandrine; Moreau, Thierry] Univ Tours, IFR Imagerie Fonct 135, INSERM, Proteases & Vectorisat Pulm U618, Tours, France; [Labas, Valerie] INRA, Lab Spectrometrie Masse Plateau Anal Integrat Bio, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; INRAE	Baranger, K (corresponding author), Univ Mediterrannee Aix Marseille II, Fac Med Nord, NICN, CNRS,UMR6184, Marseille, France.	moreaut@univ-tours.fr		Dallet-Choisy, Sandrine/0000-0002-6530-4107	INSERM; Region Centre; European Union; Agence Nationale de la Recherche; INSERM-Region Centre	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Centre(Region Centre-Val de Loire); European Union(European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); INSERM-Region Centre(Institut National de la Sante et de la Recherche Medicale (Inserm)Region Centre-Val de Loire)	The study has received financial support from INSERM, from Region Centre (INFINHI project), from European Union (Fonds Europeen de Developpement Regional) and from Agence Nationale de la Recherche (NSP&COPD project). KB was the recipient of a joint INSERM-Region Centre doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Csosz E, 2008, J MOL BIOL, V383, P390, DOI 10.1016/j.jmb.2008.08.026; EISENBERG SP, 1990, J BIOL CHEM, V265, P7976; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; FESUS L, 1986, EUR J BIOCHEM, V154, P371, DOI 10.1111/j.1432-1033.1986.tb09407.x; Guyot N, 2005, BIOCHEMISTRY-US, V44, P15610, DOI 10.1021/bi051418i; Guyot N, 2005, BIOL CHEM, V386, P391, DOI 10.1515/BC.2005.047; Hevessy Z, 2000, THROMB RES, V99, P399, DOI 10.1016/S0049-3848(00)00261-9; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; KAMPS JA, 1989, AM REV RESPIR DIS, V140, P471; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; KRAMPS JA, 1990, BIOCHIM BIOPHYS ACTA, V1038, P178, DOI 10.1016/0167-4838(90)90202-Q; LORAND L, 1991, P NATL ACAD SCI USA, V88, P82, DOI 10.1073/pnas.88.1.82; MOLHUIZEN HOF, 1993, J BIOL CHEM, V268, P12028; Moreau T, 2008, BIOCHIMIE, V90, P284, DOI 10.1016/j.biochi.2007.09.007; MORTENSEN SB, 1981, FEBS LETT, V129, P314, DOI 10.1016/0014-5793(81)80191-3; Murthy SNP, 2009, BIOCHEMISTRY-US, V48, P2654, DOI 10.1021/bi802323z; Muto J, 2007, J INVEST DERMATOL, V127, P1358, DOI 10.1038/sj.jid.5700647; NARA K, 1994, J BIOCHEM, V115, P441, DOI 10.1093/oxfordjournals.jbchem.a124357; PARAMESWARAN KN, 1990, P NATL ACAD SCI USA, V87, P8472, DOI 10.1073/pnas.87.21.8472; Ritchie H, 2000, J BIOL CHEM, V275, P24915, DOI 10.1074/jbc.M002901200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schalkwijk J, 1999, BIOCHEM J, V340, P569, DOI 10.1042/0264-6021:3400569; Schmidt S, 2008, FEBS LETT, V582, P3132, DOI 10.1016/j.febslet.2008.07.049; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Sugimura Y, 2006, J BIOL CHEM, V281, P17699, DOI 10.1074/jbc.M513538200; TAKAHASHI M, 1992, FEBS LETT, V308, P79, DOI 10.1016/0014-5793(92)81055-Q; von Horsten HH, 2007, J BIOL CHEM, V282, P32912, DOI 10.1074/jbc.M703956200; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Wingens M, 1998, J INVEST DERMATOL, V111, P996, DOI 10.1046/j.1523-1747.1998.00425.x; Zani ML, 2009, PROTEIN SCI, V18, P579, DOI 10.1002/pro.64; Zani ML, 2004, EUR J BIOCHEM, V271, P2370, DOI 10.1111/j.1432-1033.2004.04156.x; Zeeuwen PLJM, 2001, J INVEST DERMATOL, V116, P693, DOI 10.1046/j.1523-1747.2001.01309.x	32	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20976	10.1371/journal.pone.0020976	http://dx.doi.org/10.1371/journal.pone.0020976			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687692	Green Published, gold, Green Submitted			2022-12-25	WOS:000291607000033
J	Koutmos, M; Gherasim, C; Smith, JL; Banerjee, R				Koutmos, Markos; Gherasim, Carmen; Smith, Janet L.; Banerjee, Ruma			Structural Basis of Multifunctionality in a Vitamin B-12-processing Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE TRANSFERASES; METHYLMALONIC ACIDURIA; IDENTIFICATION; PROTEINS; LIGAND	An early step in the intracellular processing of vitamin B-12 involves CblC, which exhibits dual reactivity, catalyzing the reductive decyanation of cyanocobalamin (vitamin B-12), and the dealkylation of alkylcobalamins (e.g. methylcobalamin; MeCbl). Insights into how the CblC scaffold supports this chemical dichotomy have been unavailable despite it being the most common locus of patient mutations associated with inherited cobalamin disorders that manifest in both severe homocystinuria and methylmalonic aciduria. Herein, we report structures of human CblC, with and without bound MeCbl, which provide novel biochemical insights into its mechanism of action. Our results reveal that CblC is the most divergent member of the NADPH-dependent flavin reductase family and can use FMN or FAD as a prosthetic group to catalyze reductive decyanation. Further-more, CblC is the first example of an enzyme with glutathione transferase activity that has a sequence and structure unrelated to the GST superfamily. CblC thus represents an example of evolutionary adaptation of a common structural platform to perform diverse chemistries. The CblC structure allows us to rationalize the biochemical basis of a number of pathological mutations associated with severe clinical phenotypes.	[Banerjee, Ruma] Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48106 USA; Univ Michigan, Med Ctr, Inst Life Sci, Ann Arbor, MI 48106 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Med Ctr, Dept Biol Chem, Ann Arbor, MI 48106 USA.	rbanerje@umich.edu		Koutmos, Markos/0000-0003-0933-6312	National Institutes of Health [DK45776, GM024908]; National Institute of General Medical Sciences [Y1-GM-1104]; National Cancer Institute [Y1-CO-1020]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK045776, R01DK045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM024908, R01GM024908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK45776 (to R. B.) and GM024908 (to Rowena G. Matthews).; We thank Rowena G. Matthews for critical discussions and for input on the manuscript. We acknowledge the General Medicine and Cancer Collaborative Access Team, supported by the National Institute of General Medical Sciences (Y1-GM-1104) and the National Cancer Institute (Y1-CO-1020), for beam time and assistance at the Advanced Photon Source. We thank W. C. Brown and J. Delproposto (Life Sciences Institute, University of Michigan, Ann Arbor, MI) for cloning CblC in one of the expression plasmids (construct 3).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Banerjee R, 2009, CURR OPIN CHEM BIOL, V13, P484, DOI 10.1016/j.cbpa.2009.07.007; BROWN KL, 1984, J AM CHEM SOC, V106, P7894, DOI 10.1021/ja00337a043; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froese DS, 2009, MOL GENET METAB, V98, P338, DOI 10.1016/j.ymgme.2009.07.014; Hannibal L, 2009, MOL GENET METAB, V97, P260, DOI 10.1016/j.ymgme.2009.04.005; Kim J, 2008, P NATL ACAD SCI USA, V105, P14551, DOI 10.1073/pnas.0805989105; Kim J, 2009, J BIOL CHEM, V284, P33418, DOI 10.1074/jbc.M109.057877; Kim P, 2005, NUCLEIC ACIDS RES, V33, pD75, DOI 10.1093/nar/gki118; Lerner-Ellis JP, 2009, HUM MUTAT, V30, P1072, DOI 10.1002/humu.21001; Lerner-Ellis JP, 2006, NAT GENET, V38, P93, DOI 10.1038/ng1683; LEXA D, 1983, ACCOUNTS CHEM RES, V16, P235, DOI 10.1021/ar00091a001; MASSEY V, 1977, J BIOL CHEM, V252, P5612; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oakley AJ, 2005, CURR OPIN STRUC BIOL, V15, P716, DOI 10.1016/j.sbi.2005.10.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEZACKA EH, 1993, BIOCHIM BIOPHYS ACTA, V1157, P167, DOI 10.1016/0304-4165(93)90061-C; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Taga ME, 2007, NATURE, V446, P449, DOI 10.1038/nature05611; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Thomas SR, 2009, J BIOL CHEM, V284, P19659, DOI 10.1074/jbc.M109.013458	26	60	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29780	29787		10.1074/jbc.M111.261370	http://dx.doi.org/10.1074/jbc.M111.261370			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21697092	Green Published, hybrid			2022-12-25	WOS:000294046600037
J	Liu, JP; Zhang, JH; Gong, QG; Xiong, P; Huang, HD; Wu, B; Lu, GW; Wu, JH; Shi, YY				Liu, Jianping; Zhang, Jiahai; Gong, Qingguo; Xiong, Peng; Huang, Hongda; Wu, Bo; Lu, Guowei; Wu, Jihui; Shi, Yunyu			Solution Structure of Tandem SH2 Domains from Spt6 Protein and Their Binding to the Phosphorylated RNA Polymerase II C-terminal Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR SPT6; SRC HOMOLOGY-2 DOMAIN; TRANSCRIPTION ELONGATION; TYROSINE PHOSPHORYLATION; CRYSTAL-STRUCTURES; NMR; SEQUENCE; SPECIFICITY; ROLES; IICTD	Spt6 is a highly conserved transcription elongation factor and histone chaperone. It binds directly to the RNA polymerase II C-terminal domain (RNAPII CTD) through its C-terminal region that recognizes RNAPII CTD phosphorylation. In this study, we determined the solution structure of the C-terminal region of Saccharomyces cerevisiae Spt6, and we discovered that Spt6 has two SH2 domains in tandem. Structural and phylogenetic analysis revealed that the second SH2 domain was evolutionarily distant from canonical SH2 domains and represented a novel SH2 subfamily with a novel binding site for phosphoserine. In addition, NMR chemical shift perturbation experiments demonstrated that the tandem SH2 domains recognized Tyr(1), Ser(2), Ser(5), and Ser(7) phosphorylation of RNAPII CTD with millimolar binding affinities. The structural basis for the binding of the tandem SH2 domains to different forms of phosphorylated RNAPII CTD and its physiological relevance are discussed. Our results also suggest that Spt6 may use the tandem SH2 domain module to sense the phosphorylation level of RNAPII CTD.	[Wu, Jihui; Shi, Yunyu] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wu, JH (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China.	wujihui@ustc.edu.cn; yyshi@ustc.edu.cn	Huang, Hongda/G-8962-2015; Shi, Yunyu/B-3240-2009	Shi, Yunyu/0000-0002-1348-4759; Wu, Bo/0000-0003-4556-0477	Chinese National Natural Science Foundation [30830031]; National Basic Research Program of China [2011CB966302, 2011CB911104]; Chinese National High Technology RD Program [2006AA02A315]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese National High Technology RD Program	This work is supported by grants from the Chinese National Natural Science Foundation (Grant 30830031), the National Basic Research Program of China (Grants 2011CB966302 and 2011CB911104), and the Chinese National High Technology R&D Program (Grant 2006AA02A315).	Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Akhtar MS, 2009, MOL CELL, V34, P387, DOI 10.1016/j.molcel.2009.04.016; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Baskaran R, 1997, J BIOL CHEM, V272, P18905, DOI 10.1074/jbc.272.30.18905; Belotserkovskaya R, 2004, CURR OPIN GENET DEV, V14, P139, DOI 10.1016/j.gde.2004.02.004; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Close D, 2011, J MOL BIOL, V408, P697, DOI 10.1016/j.jmb.2011.03.002; Corden JL, 2007, SCIENCE, V318, P1735, DOI 10.1126/science.1152624; Dahmus ME, 1996, J BIOL CHEM, V271, P19009, DOI 10.1074/jbc.271.32.19009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S10822-016-9944-X; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; DUYSTER J, 1995, P NATL ACAD SCI USA, V92, P1555, DOI 10.1073/pnas.92.5.1555; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; Egloff S, 2007, SCIENCE, V318, P1777, DOI 10.1126/science.1145989; Endoh M, 2004, MOL CELL BIOL, V24, P3324, DOI 10.1128/MCB.24.8.3324-3336.2004; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Gan WX, 2009, PROTEINS, V74, P996, DOI 10.1002/prot.22209; GODDARD TD, 2008, SPARKY 3 VERSION 3 1; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kim M, 2009, J BIOL CHEM, V284, P26421, DOI 10.1074/jbc.M109.028993; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Liao YC, 2007, J CELL BIOL, V176, P43, DOI 10.1083/jcb.200608015; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu BA, 2006, MOL CELL, V22, P851, DOI 10.1016/j.molcel.2006.06.001; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Pawson T, 2001, TRENDS CELL BIOL, V11, P504, DOI 10.1016/S0962-8924(01)02154-7; Poy F, 1999, MOL CELL, V4, P555, DOI 10.1016/S1097-2765(00)80206-3; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Sun M, 2010, J BIOL CHEM, V285, P41597, DOI 10.1074/jbc.M110.144568; Svejstrup JQ, 2003, SCIENCE, V301, P1053, DOI 10.1126/science.1088901; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; WAKSMAN G, 1993, TEST, V72, P779; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08	47	26	26	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29218	29226		10.1074/jbc.M111.252130	http://dx.doi.org/10.1074/jbc.M111.252130			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21676864	Green Published, hybrid			2022-12-25	WOS:000293837000057
J	Ranganathan, P; Vasquez-Del Carpio, R; Kaplan, FM; Wang, H; Gupta, A; VanWye, JD; Capobianco, AJ				Ranganathan, Prathibha; Vasquez-Del Carpio, Rodrigo; Kaplan, Fred M.; Wang, Hong; Gupta, Ashu; VanWye, Jeffrey D.; Capobianco, Anthony J.			Hierarchical Phosphorylation within the Ankyrin Repeat Domain Defines a Phosphoregulatory Loop That Regulates Notch Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; SULFATE-POLYACRYLAMIDE-GEL; MAMMARY EPITHELIAL-CELLS; SPLIT COMPLEX GENES; NF-KAPPA-B; INTRACELLULAR DOMAIN; MAMMALIAN NOTCH; IN-VITRO; NEOPLASTIC TRANSFORMATION; NUCLEAR-LOCALIZATION	The Notch signal transduction pathway mediates important cellular functions through direct cell-to-cell contact. Deregulation of Notch activity can lead to an altered cell proliferation and has been linked to many human cancers. Casein kinase 2 (CK2), a ubiquitous kinase, regulates several cellular processes by phosphorylating proteins involved in signal transduction, gene expression, and protein synthesis. In this report we identify Notch(ICD) as a novel target of phosphorylation by CK2. Using mapping and mutational studies, we identified serine 1901, located in the ankyrin domain of Notch, as the target amino acid. Interestingly, phosphorylation of serine 1901 by CK2 appears to generate a second phosphorylation site at threonine 1898. Furthermore, threonine 1898 phosphorylation only occurs when Notch forms a complex with Mastermind and CSL. Phosphorylation of both threonine 1898 and serine 1901 resulted in decreased binding of the Notch-Mastermind-CSL ternary complex to DNA and consequently lower transcriptional activity. These data indicate that the phosphorylation of serine 1901 and threonine 1898 negatively regulates Notch function by dissociating the complex from DNA. This study identifies a new component involved in regulation of Notch(ICD) transcriptional activity, reinforcing the notion that a precise and tight regulation is required for this essential signaling pathway.	[Ranganathan, Prathibha; Vasquez-Del Carpio, Rodrigo; Kaplan, Fred M.; Wang, Hong; Gupta, Ashu; VanWye, Jeffrey D.; Capobianco, Anthony J.] Univ Miami, Mol Oncol Program, Div Surg Oncol,Miller Sch Med, Dewitt Daughtry Family Surg & Sylvester Comprehen, Miami, FL 33136 USA	University of Miami	Capobianco, AJ (corresponding author), 1600 NW 10th Ave,104, Miami, FL 33136 USA.	TCapobianco@med.miami.edu		Capobianco, Anthony/0000-0002-3706-6797	National Institutes of Health (NCI) [ROI CA 83736, 125044-04]; Samuel Waxman Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [R01CA083736] Funding Source: NIH RePORTER	National Institutes of Health (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Samuel Waxman Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants ROI CA 83736 and 125044-04 (NCI; to A. J. C.). This work was also supported by the Samuel Waxman Foundation for Cancer Research (to A. J. C.).	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Aster JC, 1997, J BIOL CHEM, V272, P11336; Aster JC, 2000, MOL CELL BIOL, V20, P7505, DOI 10.1128/MCB.20.20.7505-7515.2000; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Brown MS, 2010, CLIN CANCER RES, V16, P2295, DOI 10.1158/1078-0432.CCR-09-3200; Capobianco AJ, 1997, MOL CELL BIOL, V17, P6265, DOI 10.1128/MCB.17.11.6265; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Ehebauer MT, 2005, BIOCHEM J, V392, P13, DOI 10.1042/BJ20050515; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Espinosa L, 2003, J BIOL CHEM, V278, P32227, DOI 10.1074/jbc.M304001200; Fernandez-Martinez J, 2009, J CELL SCI, V122, P1574, DOI 10.1242/jcs.044354; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Foltz DR, 2001, BIOCHEM BIOPH RES CO, V286, P484, DOI 10.1006/bbrc.2001.5421; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; GALLAHAN D, 1987, J VIROL, V61, P218, DOI 10.1128/JVI.61.1.218-220.1987; Giusiano S, 2011, EUR J CANCER, V47, P792, DOI 10.1016/j.ejca.2010.11.028; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; Hsieh JJD, 1997, J VIROL, V71, P1938, DOI 10.1128/JVI.71.3.1938-1945.1997; Ingles-Esteve J, 2001, J BIOL CHEM, V276, P44873, DOI 10.1074/jbc.M104703200; Ishitani T, 2010, NAT CELL BIOL, V12, P278, DOI 10.1038/ncb2028; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jeffries S, 2002, MOL CELL BIOL, V22, P3927, DOI 10.1128/MCB.22.11.3927-3941.2002; Jeffries S, 2000, MOL CELL BIOL, V20, P3928, DOI 10.1128/MCB.20.11.3928-3941.2000; JENNINGS B, 1994, DEVELOPMENT, V120, P3537; KAMESHITA I, 1989, ANAL BIOCHEM, V183, P139, DOI 10.1016/0003-2697(89)90181-4; Kelliher MA, 1996, EMBO J, V15, P5160, DOI 10.1002/j.1460-2075.1996.tb00900.x; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kurooka H, 1998, NUCLEIC ACIDS RES, V26, P5448, DOI 10.1093/nar/26.23.5448; LARDELLI M, 1994, MECH DEVELOP, V46, P123, DOI 10.1016/0925-4773(94)90081-7; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; LUO KX, 1991, METHOD ENZYMOL, V201, P149; Mumm JS, 2000, MOL CELL, V5, P197, DOI 10.1016/S1097-2765(00)80416-5; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Redmond L, 2000, NAT NEUROSCI, V3, P30, DOI 10.1038/71104; ROBBINS J, 1992, J VIROL, V66, P2594, DOI 10.1128/JVI.66.4.2594-2599.1992; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Ronchini C, 2000, ONCOGENE, V19, P3914, DOI 10.1038/sj.onc.1203719; Rustighi A, 2009, NAT CELL BIOL, V11, P133, DOI 10.1038/ncb1822; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shimizu K, 2000, MOL CELL BIOL, V20, P6913, DOI 10.1128/MCB.20.18.6913-6922.2000; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; Soriano JV, 2000, INT J CANCER, V86, P652; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Tawfic S, 2001, HISTOL HISTOPATHOL, V16, P573, DOI 10.14670/HH-16.573; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Vasquez-Del Carpio R, 2011, MOL CELL BIOL, V31, P1396, DOI 10.1128/MCB.00360-10; WEINMASTER G, 1991, DEVELOPMENT, V113, P199; WEINMASTER G, 1992, DEVELOPMENT, V116, P931; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wettstein DA, 1997, DEVELOPMENT, V124, P693; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Zhou SF, 2000, MOL CELL BIOL, V20, P2400, DOI 10.1128/MCB.20.7.2400-2410.2000	71	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28844	28857		10.1074/jbc.M111.243600	http://dx.doi.org/10.1074/jbc.M111.243600			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21685388	Green Published, hybrid			2022-12-25	WOS:000293837000022
J	Noyer, C; Thomas, OP; Becerro, MA				Noyer, Charlotte; Thomas, Olivier P.; Becerro, Mikel A.			Patterns of Chemical Diversity in the Mediterranean Sponge Spongia lamella	PLOS ONE			English	Article							CRAMBE-CRAMBE PORIFERA; MARINE SPONGES; BIOGEOGRAPHIC COMPARISONS; GEOGRAPHIC-VARIATION; COMMERCIAL SPONGES; ECOLOGY; ALGA; VARIABILITY; DEFENSES; COMMUNITIES	The intra-specific diversity in secondary metabolites can provide crucial information for understanding species ecology and evolution but has received limited attention in marine chemical ecology. The complex nature of diversity is partially responsible for the lack of studies, which often target a narrow number of major compounds. Here, we investigated the intra-specific chemical diversity of the Mediterranean sponge Spongia lamella. The chemical profiles of seven populations spreading over 1200 km in the Western Mediterranean were obtained by a straightforward SPE-HPLC-DAD-ELSD process whereas the identity of compounds was assessed by comparison between HPLC-MS spectra and literature data. Chemical diversity calculated by richness and Shannon indexes differed significantly between sponge populations but not at a larger regional scale. We used factor analysis, analysis of variance, and regression analysis to examine the chemical variability of this sponge at local and regional scales, to establish general patterns of variation in chemical diversity. The abundance of some metabolites varied significantly between sponge populations. Despite these significant differences between populations, we found a clear pattern of increasing chemical dissimilarity with increasing geographic distance. Additional large spatial scale studies on the chemical diversity of marine organisms will validate the universality or exclusivity of this pattern.	[Noyer, Charlotte; Becerro, Mikel A.] CSIC, Ctr Adv Studies Blanes, CEAB, Blanes, Spain; [Thomas, Olivier P.] Univ Nice Sophia Antipolis, Lab Chim Mol Bioact & Aromes, CNRS, LCMBA,UMR 6001, F-06034 Nice, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Noyer, C (corresponding author), CSIC, Ctr Adv Studies Blanes, CEAB, Blanes, Spain.	mikel@ceab.csic.es	Becerro, Mikel/ABC-9478-2021; Becerro, Mikel/A-5325-2008	Becerro, Mikel/0000-0002-6047-350X; THOMAS, Olivier/0000-0002-5708-1409	French Agence Nationale de la Recherche on Biodiversity [ANR-06-BDIV-001]; Spanish Ministry of Science and Technology [CTM2010-17755]; Benthomics program [CTM2010-22218-C02-01]; European Union [MRTN-CT-2004-512301]	French Agence Nationale de la Recherche on Biodiversity(French National Research Agency (ANR)); Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Benthomics program; European Union(European Commission)	This project was supported by the French Agence Nationale de la Recherche on Biodiversity (ECIMAR program ANR-06-BDIV-001; http://www.ecimar.org/cms/), the Spanish Ministry of Science and Technology (SOLID program CTM2010-17755, and Benthomics program CTM2010-22218-C02-01), and the European Union (BIOCAPITAL UE grant MRTN-CT-2004-512301; http://www.biocapital.de/welcome.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.`	Abdo DA, 2007, J CHEM ECOL, V33, P1635, DOI 10.1007/s10886-007-9326-x; Agrawal AA, 2006, Q REV BIOL, V81, P349, DOI 10.1086/511529; AIELLO A, 1988, J NAT PROD, V51, P999, DOI 10.1021/np50059a036; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BAKUS GJ, 1974, SCIENCE, V185, P951, DOI 10.1126/science.185.4155.951; Becerro MA, 2003, OECOLOGIA, V135, P91, DOI 10.1007/s00442-002-1138-7; Becerro MA, 1997, HYDROBIOLOGIA, V355, P77, DOI 10.1023/A:1003019221354; Becerro MA, 1997, J CHEM ECOL, V23, P1527, DOI 10.1023/B:JOEC.0000006420.04002.2e; BECERRO MA, 2008, MAR ECOL, V9, P167; Becerro Mikel A., 2001, Recent Research Developments in Ecology, V1, P81; Blunt JW, 2010, NAT PROD REP, V27, P165, DOI 10.1039/b906091j; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; Castritsi-Catharios J, 2007, J MAR BIOL ASSOC UK, V87, P1765, DOI 10.1017/S0025315407056986; CIMINO G, 1977, J CHEM SOC PERK T 1, P1587, DOI 10.1039/p19770001587; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Connolly SR, 1999, ECOL MONOGR, V69, P277, DOI 10.1890/0012-9615(1999)069[0277:TOMCCP]2.0.CO;2; Cronin G, 1996, ECOLOGY, V77, P1531, DOI 10.2307/2265549; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Fahey SJ, 2002, J CHEM ECOL, V28, P1773, DOI 10.1023/A:1020509117545; FATTORUSSO E, 1971, TETRAHEDRON, V27, P3909, DOI 10.1016/S0040-4020(01)98252-3; Feral JP, 2002, J EXP MAR BIOL ECOL, V268, P121, DOI 10.1016/S0022-0981(01)00382-3; Ferretti C, 2009, MAR ECOL-EVOL PERSP, V30, P327, DOI 10.1111/j.1439-0485.2008.00278.x; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; FIELMAN KT, 1995, MAR ECOL PROG SER, V116, P125, DOI 10.3354/meps116125; FONTANA A, 1995, COMP BIOCHEM PHYS B, V111, P283, DOI 10.1016/0305-0491(94)00250-X; Fontana A, 1996, J NAT PROD, V59, P869, DOI 10.1021/np9600964; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Gaston K. J., 2004, BIODIVERSITY INTRO; Harper MK, 2001, CRC MAR SCI, P3; Hay ME, 1996, J EXP MAR BIOL ECOL, V200, P103, DOI 10.1016/S0022-0981(96)02659-7; Hay ME., 1996, OCEANOGRAPHY, V9, P10, DOI [10.5670/oceanog.1996.21, DOI 10.5670/OCEANOG.1996.21]; Hemmi A, 2004, MAR BIOL, V145, P759, DOI 10.1007/s00227-004-1360-4; Ianora A, 2006, ESTUAR COAST, V29, P531, DOI 10.1007/BF02784281; Ivanisevic J, 2011, METABOLOMICS, V7, P289, DOI 10.1007/s11306-010-0239-2; Jumaryatno P, 2007, J NAT PROD, V70, P1725, DOI 10.1021/np070156d; Karban R, 1997, ECOLOGY, V78, P1351; Laport MS, 2009, CURR PHARM BIOTECHNO, V10, P86, DOI 10.2174/138920109787048625; LEE DI, 1999, NAT PROD SCI, V5, P93; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Marti R, 2005, SCI MAR, V69, P485; Marti R, 2004, MAR ECOL PROG SER, V282, P73, DOI 10.3354/meps282073; Matlock DB, 1999, HYDROBIOLOGIA, V399, P267; McGarigal K., 2000, MULTIVARIATE STAT WI; Noyer C., 2010, THESIS U BARCELONA; Noyer C, 2010, SYMBIOSIS, V51, P239, DOI 10.1007/s13199-010-0082-2; Noyer C, 2009, CONSERV GENET, V10, P1895, DOI 10.1007/s10592-009-9848-6; Nunez CV, 2008, BIOCHEM SYST ECOL, V36, P283, DOI 10.1016/j.bse.2007.09.008; Page M, 2005, J CHEM ECOL, V31, P1161, DOI 10.1007/s10886-005-4254-0; Paul VJ, 2006, NAT PROD REP, V23, P153, DOI 10.1039/b404735b; PAUL VJ, 1992, J EXP MAR BIOL ECOL, V160, P191, DOI 10.1016/0022-0981(92)90237-5; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Pronzato R, 1999, AQUAT CONSERV, V9, P485, DOI 10.1002/(SICI)1099-0755(199909/10)9:5<485::AID-AQC362>3.3.CO;2-E; Pronzato R, 2008, MAR ECOL-EVOL PERSP, V29, P146, DOI 10.1111/j.1439-0485.2008.00235.x; Puglisi MP, 2000, MAR ECOL PROG SER, V207, P263, DOI 10.3354/meps207263; Raveendran TV, 2009, CURR SCI INDIA, V97, P508; Rueda A, 1998, J NAT PROD, V61, P258, DOI 10.1021/np970390b; SACRISTANSORIAN.O, 2010, APPL ENV MICROBIOL; Sala E, 2006, ANNU REV ENV RESOUR, V31, P93, DOI 10.1146/annurev.energy.31.020105.100235; Sara M., 1973, TRAITE ZOOLOGIE ANAT, P462; Sipkema D, 2005, MAR BIOTECHNOL, V7, P142, DOI 10.1007/s10126-004-0405-5; Siska EL, 2002, ECOLOGY, V83, P3369, DOI 10.1890/0012-9658(2002)083[3369:LVIPOS]2.0.CO;2; TARGETT NM, 1992, OECOLOGIA, V89, P464, DOI 10.1007/BF00317150; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; TEEYAPANT R, 1993, Z NATURFORSCH C, V48, P939; Templado J., 2004, GUIA INVERTEBRADOS P, P214; THOMPSON JE, 1987, BIOCHEM SYST ECOL, V15, P595, DOI 10.1016/0305-1978(87)90111-6; Thoms C, 2008, J CHEM ECOL, V34, P1242, DOI 10.1007/s10886-008-9518-z; Turon X, 1996, OIKOS, V75, P33, DOI 10.2307/3546318; Turon X, 2009, SCI MAR, V73, P387, DOI 10.3989/scimar.2009.73n2387; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; WAHL M, 1989, MAR ECOL PROG SER, V58, P175, DOI 10.3354/meps058175; Webster NS, 2007, ENVIRON MICROBIOL, V9, P1363, DOI 10.1111/j.1462-2920.2007.01303.x; WHITTAKER RH, 1972, EVOLUTION MEASUREMEN, P231; Wilson, 1988, BIODIVERSITY, P170; Wittstock U, 2002, CURR OPIN PLANT BIOL, V5, P300, DOI 10.1016/S1369-5266(02)00264-9; Wright JT, 2000, MAR BIOL, V136, P439, DOI 10.1007/s002270050703; Wright JT, 2004, ECOLOGY, V85, P2946, DOI 10.1890/03-4041; Wright JT, 2000, MAR ECOL PROG SER, V207, P227, DOI 10.3354/meps207227; Yuan JP, 2007, FOOD CHEM, V105, P1755, DOI 10.1016/j.foodchem.2007.04.070	79	27	28	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20844	10.1371/journal.pone.0020844	http://dx.doi.org/10.1371/journal.pone.0020844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698108	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600021
J	Tang, XJ; Dong, WB; Griffith, J; Nilsen, R; Matthes, A; Cheng, KB; Reeves, J; Schuttler, HB; Case, ME; Arnold, J; Logan, DA				Tang, Xiaojia; Dong, Wubei; Griffith, James; Nilsen, Roger; Matthes, Allison; Cheng, Kevin B.; Reeves, Jaxk; Schuttler, H. -Bernd; Case, Mary E.; Arnold, Jonathan; Logan, David A.			Systems Biology of the qa Gene Cluster in Neurospora crassa	PLOS ONE			English	Article							SHIKIMATE CATABOLIC PATHWAY; FILAMENTOUS FUNGUS; GENOME SEQUENCE; HIGH-THROUGHPUT; QA-1F GENE; EXPRESSION; ORGANIZATION; NETWORKS; REVEALS; TRANSCRIPTION	An ensemble of genetic networks that describe how the model fungal system, Neurospora crassa, utilizes quinic acid (QA) as a sole carbon source has been identified previously. A genetic network for QA metabolism involves the genes, qa-1F and qa-1S, that encode a transcriptional activator and repressor, respectively and structural genes, qa-2, qa-3, qa-4, qa-x, and qa-y. By a series of 4 separate and independent, model-guided, microarray experiments a total of 50 genes are identified as QA-responsive and hypothesized to be under QA-1F control and/or the control of a second QA-responsive transcription factor (NCU03643) both in the fungal binuclear Zn(II)2Cys6 cluster family. QA-1F regulation is not sufficient to explain the quantitative variation in expression profiles of the 50 QA-responsive genes. QA-responsive genes include genes with products in 8 mutually connected metabolic pathways with 7 of them one step removed from the tricarboxylic (TCA) Cycle and with 7 of them one step removed from glycolysis: (1) starch and sucrose metabolism; (2) glycolysis/glucanogenesis; (3) TCA Cycle; (4) butanoate metabolism; (5) pyruvate metabolism; (6) aromatic amino acid and QA metabolism; (7) valine, leucine, and isoleucine degradation; and (8) transport of sugars and amino acids. Gene products both in aromatic amino acid and QA metabolism and transport show an immediate response to shift to QA, while genes with products in the remaining 7 metabolic modules generally show a delayed response to shift to QA. The additional QA-responsive cutinase transcription factor-1 beta (NCU03643) is found to have a delayed response to shift to QA. The series of microarray experiments are used to expand the previously identified genetic network describing the qa gene cluster to include all 50 QA-responsive genes including the second transcription factor (NCU03643). These studies illustrate new methodologies from systems biology to guide model-driven discoveries about a core metabolic network involving carbon and amino acid metabolism in N. crassa.	[Tang, Xiaojia; Schuttler, H. -Bernd] Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA; [Dong, Wubei; Griffith, James; Nilsen, Roger; Matthes, Allison; Cheng, Kevin B.; Case, Mary E.; Arnold, Jonathan] Univ Georgia, Dept Genet, Athens, GA 30602 USA; [Griffith, James] Univ Georgia, Coll Agr & Environm Sci, Athens, GA 30602 USA; [Tang, Xiaojia; Reeves, Jaxk] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Logan, David A.] Clark Atlanta Univ, Dept Biol Sci, Atlanta, GA 30314 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Clark Atlanta University	Tang, XJ (corresponding author), Univ Georgia, Dept Phys & Astron, Athens, GA 30602 USA.	arnold@uga.edu	Schuttler, Heinz-Bernd/AFT-0395-2022	Tang, Xiaojia/0000-0003-2457-9953; arnold, jonathan/0000-0001-5845-1048; Dong, Wubei/0000-0001-8513-8751	NSF [DBI-06463155, MCB-0542915, BES-0425762, DBI-01041715, MRI-0821263]; University of Minnesota Supercomputer Center; University of Georgia College of Agricultural and Environmental Sciences; University of Georgia Research Computing Center; SUN Grid [12021957]	NSF(National Science Foundation (NSF)); University of Minnesota Supercomputer Center; University of Georgia College of Agricultural and Environmental Sciences; University of Georgia Research Computing Center; SUN Grid	NSF DBI-06463155, MCB-0542915, BES-0425762, DBI-01041715, MRI-0821263, SUN Grid Grant 12021957, The University of Minnesota Supercomputer Center, The University of Georgia College of Agricultural and Environmental Sciences, and the University of Georgia Research Computing Center supported this work. The funders had no role in study design, data collection, and analysis, decision to publish, or prepration of the manuscript.	Aleman-Meza B, 2009, COMPUT MATH APPL, V57, P420, DOI 10.1016/j.camwa.2008.10.086; Arnett DR, 2009, FUNGAL GENET BIOL, V46, P377, DOI 10.1016/j.fgb.2009.02.003; ARNOLD J, 2005, HDB IND MYCOLOGY, P763; Battogtokh D, 2002, P NATL ACAD SCI USA, V99, P16904, DOI 10.1073/pnas.262658899; Benjamini Y, 2001, ANN STAT, V29, P1165; Bordel S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000859; Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004; Brown KS, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021904; Campbell J. W., 1994, FUNGAL GENET NEWSL, V41, P20; CASE ME, 1958, COLD SPRING HARB SYM, V23, P119, DOI 10.1101/SQB.1958.023.01.016; CASE ME, 1972, GENETICS, V71, P337; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHALEFF RS, 1974, J GEN MICROBIOL, V81, P337, DOI 10.1099/00221287-81-2-337; CHALEFF RS, 1974, J GEN MICROBIOL, V81, P357, DOI 10.1099/00221287-81-2-357; Chen CH, 2009, EMBO J, V28, P1029, DOI 10.1038/emboj.2009.54; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456; Covert MW, 2003, BIOTECHNOL BIOENG, V84, P763, DOI 10.1002/bit.10849; Covert MW, 2001, J THEOR BIOL, V213, P73, DOI 10.1006/jtbi.2001.2405; DANIEL C, 1976, APPL STAT IND EXPT, P294; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dong WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003105; Dunn O. J., 1974, Applied statistics: analysis of variance and regression; Endy D, 2000, P NATL ACAD SCI USA, V97, P5375, DOI 10.1073/pnas.090101397; FLAVELL RB, 1968, J BACTERIOL, V95, P1063, DOI 10.1128/JB.95.3.1063-1068.1968; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GILES NH, 1967, P NATL ACAD SCI USA, V58, P1930, DOI 10.1073/pnas.58.5.1930; GILES NH, 1991, J HERED, V82, P1; GILES NH, 1985, MICROBIOL REV, V49, P338, DOI 10.1128/MMBR.49.3.338-358.1985; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Hood L, 2003, MECH AGEING DEV, V124, P9, DOI 10.1016/S0047-6374(02)00164-1; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jayawardhana B, 2008, BIOINFORMATICS, V24, P1191, DOI 10.1093/bioinformatics/btn103; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kasuga T, 2005, NUCLEIC ACIDS RES, V33, P6469, DOI 10.1093/nar/gki953; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Logan DA, 2007, BIOINFORMATION, V1, P390, DOI 10.6026/97320630001390; Mannhaupt G, 2003, NUCLEIC ACIDS RES, V31, P1944, DOI 10.1093/nar/gkg293; Marx CJ, 2005, PLOS BIOL, V3, P244, DOI 10.1371/journal.pbio.0030016; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; Okuda S, 2008, NUCLEIC ACIDS RES, V36, pW423, DOI 10.1093/nar/gkn282; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; PATEL VB, 1985, MOL CELL BIOL, V5, P3593, DOI 10.1128/MCB.5.12.3593; PERKINS DD, 2000, NEUROSPORA COMPENDIU, P325; Pihur V, 2007, BIOINFORMATICS, V23, P1607, DOI 10.1093/bioinformatics/btm158; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; RINES H, 1969, THESIS YALE U; ROUSSEEUW PJ, 1984, J AM STAT ASSOC, V79, P871, DOI 10.2307/2288718; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saldanha AJ, 2004, MOL BIOL CELL, V15, P4089, DOI 10.1091/mbc.e04-04-0306; Skovran E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014091; Teusink B, 2000, EUR J BIOCHEM, V267, P5313, DOI 10.1046/j.1432-1327.2000.01527.x; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Townsend JP, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-54; TYLER BM, 1984, CELL, V36, P493, DOI 10.1016/0092-8674(84)90242-3; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Xie X, 2004, FUNGAL GENET BIOL, V41, P1104, DOI 10.1016/j.fgb.2004.08.009; Yu YH, 2007, P NATL ACAD SCI USA, V104, P2809, DOI 10.1073/pnas.0611005104; Zhang Z, 2010, FUNGAL GENET BIOL, V47, P199, DOI 10.1016/j.fgb.2009.12.001	68	13	13	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20671	10.1371/journal.pone.0020671	http://dx.doi.org/10.1371/journal.pone.0020671			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695121	Green Submitted, gold, Green Published			2022-12-25	WOS:000291682300008
J	Gonugunta, VK; Nair, BC; Rajhans, R; Sareddy, GR; Nair, SS; Vadlamudi, RK				Gonugunta, Vijay K.; Nair, Binoj C.; Rajhans, Rajib; Sareddy, Gangadhara R.; Nair, Sujit S.; Vadlamudi, Ratna K.			Regulation of rDNA Transcription by Proto-Oncogene PELP1	PLOS ONE			English	Article							RNA-POLYMERASE-I; BREAST-CANCER CELLS; NUCLEOLAR PROTEOME; ESTROGEN-RECEPTOR; RIBOSOMAL DNA; PATHWAY	Background: Proline-, glutamic acid-, and leucine-rich protein (PELP1) is a novel nuclear receptor coregulator with a multitude of functions. PELP1 serves as a scaffolding protein that couples various signaling complexes with nuclear receptors and participates as a transcriptional coregulator. Recent data suggest that PELP1 expression is deregulated in hormonal cancers, and that PELP1 functions as a proto-oncogene; however, the mechanism by which PELP1 promotes oncogenesis remains elusive. Methodology/Principal Findings: Using pharmacological inhibitors, confocal microscopy and biochemical assays, we demonstrated that PELP1 is localized in the nucleolus and that PELP1 is associated with the active ribosomal RNA transcription. Cell synchronization studies showed that PELP1 nucleolar localization varies and the greatest amount of nucleolar localization was observed during S and G2 phases. Using pharmacological compounds and CDK site mutants of PELP1, we found that CDK's activity plays an important role on PELP1 nucleolar localization. Depletion of PELP1 by siRNA decreased the expression of pre-rRNA. Reporter gene assays using ribosomal DNA (pHrD) luc-reporter revealed that PELP1WT but not PELP1MT enhanced the expression of reporter. Deletion of nucleolar domains abolished PELP1-mediated activation of the pHrD reporter. ChIP analysis revealed that PELP1 is recruited to the promoter regions of rDNA and is needed for optimal transcription of ribosomal RNA. Conclusions/Significance: Collectively, our results suggest that proto-oncogene PELP1 plays a vital role in rDNA transcription. PELP1 modulation of rRNA transcription, a key step in ribosomal biogenesis may have implications in PELP1-mediated oncogenic functions.	[Gonugunta, Vijay K.; Nair, Binoj C.; Rajhans, Rajib; Sareddy, Gangadhara R.; Nair, Sujit S.; Vadlamudi, Ratna K.] Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA; [Gonugunta, Vijay K.; Nair, Binoj C.; Rajhans, Rajib; Sareddy, Gangadhara R.; Nair, Sujit S.; Vadlamudi, Ratna K.] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Nair, Binoj C.] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Gonugunta, VK (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Obstet & Gynecol, San Antonio, TX 78229 USA.	vadlamudi@uthscsa.edu	Nair, Binoj/A-1936-2012		National Institutes of Health [CA0095681]; Department of Defense [W81XWH-09-1-0010]; NATIONAL CANCER INSTITUTE [R01CA095681] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the grants National Institutes of Health-CA0095681 (RKV) and Department of Defense pre-doctoral grant W81XWH-09-1-0010 (BCN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Balasenthil S, 2003, J BIOL CHEM, V278, P22119, DOI 10.1074/jbc.M212822200; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Chakravarty D, 2010, IUBMB LIFE, V62, P163, DOI 10.1002/iub.287; Choi YB, 2004, J BIOL CHEM, V279, P50930, DOI 10.1074/jbc.M406831200; Cos S, 1996, LIFE SCI, V58, P2447, DOI 10.1016/0024-3205(96)00249-4; Coute Y, 2006, MASS SPECTROM REV, V25, P215, DOI 10.1002/mas.20067; Deisenroth C, 2010, ONCOGENE, V29, P4253, DOI 10.1038/onc.2010.189; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Finkbeiner E, 2011, EMBO J, V30, P1067, DOI 10.1038/emboj.2011.33; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Habashy H.O., 2009, BREAST CANC RES TREA; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; LI LL, 1992, EXP CELL RES, V199, P262, DOI 10.1016/0014-4827(92)90433-9; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Meraner J, 2008, CELL BIOL INT, V32, P1073, DOI 10.1016/j.cellbi.2008.04.018; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nagpal JK, 2008, MOL CANCER RES, V6, P851, DOI 10.1158/1541-7786.MCR-07-2030; Nair BC, 2010, CANCER RES, V70, P7166, DOI 10.1158/0008-5472.CAN-10-0628; Nair SS, 2004, CANCER RES, V64, P6416, DOI 10.1158/0008-5472.CAN-04-1786; Nair SS, 2010, EMBO REP, V11, P438, DOI 10.1038/embor.2010.62; Padmakumar VC, 2009, MOL CELL BIOL, V29, P2582, DOI 10.1128/MCB.00952-08; Rajhans R, 2007, CANCER RES, V67, P5505, DOI 10.1158/0008-5472.CAN-06-3647; Sirri V, 2002, J CELL BIOL, V156, P969, DOI 10.1083/jcb.200201024; Staub E, 2004, BIOESSAYS, V26, P567, DOI 10.1002/bies.20032; Vadlamudi Ratna K, 2007, Nucl Recept Signal, V5, pe004; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; VAN RJ, 2010, NAT REV CANCER, V10, P301; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Wu CH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000090; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200	36	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e21095	10.1371/journal.pone.0021095	http://dx.doi.org/10.1371/journal.pone.0021095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695158	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300040
J	Kim, MP; Fleming, JB; Wang, HM; Abbruzzese, JL; Choi, W; Kopetz, S; McConkey, DJ; Evans, DB; Gallick, GE				Kim, Michael P.; Fleming, Jason B.; Wang, Huamin; Abbruzzese, James L.; Choi, Woonyoung; Kopetz, Scott; McConkey, David J.; Evans, Douglas B.; Gallick, Gary E.			ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma	PLOS ONE			English	Article							CANCER STEM-CELLS; ALDEHYDE DEHYDROGENASE-ACTIVITY; BRAIN-TUMORS; IDENTIFICATION; GROWTH; MARKER	Background: Multiple studies in recent years have identified highly tumorigenic populations of cells that drive tumor formation. These cancer stem cells (CSCs), or tumor-initiating cells (TICs), exhibit properties of normal stem cells and are associated with resistance to current therapies. As pancreatic adenocarcinoma is among the most resistant human cancers to chemo-radiation therapy, we sought to evaluate the presence of cell populations with tumor-initiating capacities in human pancreatic tumors. Understanding which pancreatic cancer cell populations possess tumor-initiating capabilities is critical to characterizing and understanding the biology of pancreatic CSCs towards therapeutic ends. Methodology/Principal Findings: We have isolated populations of cells with high ALDH activity (ALDH high) and/or CD133 cell surface expression from human xenograft tumors established from multiple patient tumors with pancreatic adenocarcinoma (direct xenograft tumors) and from the pancreatic cancer cell line L3.6pl. Through fluorescent activated cell sorting (FACs)-mediated enrichment and depletion of selected pancreatic cancer cell populations, we sought to discriminate the relative tumorigenicity of cell populations that express the pancreatic CSC markers CD133 and aldehyde dehydrogenase (ALDH). ALDH high and ALDH low cell populations were further examined for co-expression of CD44 and/or CD24. We demonstrate that unlike cell populations demonstrating low ALDH activity, as few as 100 cells enriched for high ALDH activity were capable of tumor formation, irrespective of CD133 expression. In direct xenograft tumors, the proportions of total tumor cells expressing ALDH and/or CD133 in xenograft tumors were unchanged through a minimum of two passages. We further demonstrate that ALDH expression among patients with pancreatic adenocarcinoma is heterogeneous, but the expression is constant in serial generations of individual direct xenograft tumors established from bulk human pancreatic tumors in NOD/SCID mice. Conclusions/Significance: We conclude that, in contrast to some previous studies, cell populations enriched for high ALDH activity alone are sufficient for efficient tumor-initiation with enhanced tumorigenic potential relative to CD133(+) and ALDH low cell populations in some direct xenograft tumors. Although cell populations enriched for CD133 expression may alone possess tumorigenic potential, they are significantly less tumorigenic than ALDH(high) cell populations. ALDH(high)/CD44(+)/CD24(+) or ALDH(low)/CD44(+)/CD24(+) phenotypes do not appear to significantly contribute to tumor formation at low numbers of inoculated tumor cells. ALDH expression broadly varies among patients with pancreatic adenocarcinoma and the apparent expression is recapitulated in serial generations of direct xenograft tumors in NOD/SCID. We have thus identified a distinct population of TICs that should lead to identification of novel targets for pancreatic cancer therapy.	[Kim, Michael P.; Fleming, Jason B.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Wang, Huamin] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Abbruzzese, James L.; Kopetz, Scott] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA; [Choi, Woonyoung; McConkey, David J.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA; [Evans, Douglas B.] Med Coll Wisconsin, Dept Surg, Milwaukee, WI 53226 USA; [Gallick, Gary E.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Medical College of Wisconsin; University of Texas System; UTMD Anderson Cancer Center	Kim, MP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA.	ggallick@mdanderson.org	Kopetz, Scott/AAC-1387-2019	Kopetz, Scott/0000-0001-9647-3416	MD Anderson Cancer Center; Gillson Longenbaugh Foundation; National Institutes of Health (NIH) [5P20 CA101936, T-32 09599]; NCI [P30CA16672]; NATIONAL CANCER INSTITUTE [P20CA101936, P30CA016672] Funding Source: NIH RePORTER	MD Anderson Cancer Center; Gillson Longenbaugh Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the Various Donor Fund for Pancreatic Cancer Research, MD Anderson Cancer Center (JBF); Gillson Longenbaugh Foundation (GEG); National Institutes of Health (NIH) 5P20 CA101936 (JLA, DM, and GEG); NIH T-32 09599 (MPK); and Core Grant NCI#P30CA16672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Curley MD, 2009, STEM CELLS, V27, P2875, DOI 10.1002/stem.236; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Eyler CE, 2008, J CLIN ONCOL, V26, P2839, DOI 10.1200/JCO.2007.15.1829; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hess DA, 2006, BLOOD, V107, P2162, DOI 10.1182/blood-2005-06-2284; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Ishizawa K, 2010, CELL STEM CELL, V7, P279, DOI 10.1016/j.stem.2010.08.009; Kim MP, 2009, NAT PROTOC, V4, P1670, DOI 10.1038/nprot.2009.171; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li DH, 2004, LANCET, V363, P1049, DOI 10.1016/S0140-6736(04)15841-8; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Storms RW, 2005, BLOOD, V106, P95, DOI 10.1182/blood-2004-09-3652; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001	28	203	215	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20636	10.1371/journal.pone.0020636	http://dx.doi.org/10.1371/journal.pone.0020636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695188	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300008
J	Crother, TR; Schroder, NWJ; Karlin, J; Chen, S; Shimada, K; Slepenkin, A; Alsabeh, R; Peterson, E; Arditi, M				Crother, Timothy R.; Schroeder, Nicolas W. J.; Karlin, Justin; Chen, Shuang; Shimada, Kenichi; Slepenkin, Anatoly; Alsabeh, Randa; Peterson, Ellena; Arditi, Moshe			Chlamydia pneumoniae Infection Induced Allergic Airway Sensitization Is Controlled by Regulatory T-Cells and Plasmacytoid Dendritic Cells	PLOS ONE			English	Article							MOUSE MODEL; ASTHMA; RESPONSES; IMMUNITY; INFLAMMATION; ACTIVATION; INDUCTION; EXPANSION; SURVIVAL; TLR4	Chlamydia pneumoniae (CP) is associated with induction and exacerbation of asthma. CP infection can induce allergic airway sensitization in mice in a dose-and time-dependent manner. Allergen exposure 5 days after a low dose (mild-moderate), but not a high dose (severe) CP infection induces antigen sensitization in mice. Innate immune signals play a critical role in controlling CP infection induced allergic airway sensitization, however these mechanisms have not been fully elucidated. Wild-type, TLR2-/-, and TLR4-/- mice were infected intranasally (i.n.) with a low dose of CP, followed by i.n. exposure to human serum albumin (HSA) and challenged with HSA 2 weeks later. Airway inflammation, immunoglobulins, eosinophils, and goblet cells were measured. Low dose CP infection induced allergic sensitization in TLR2-/- mice, but not in TLR4-/- mice, due to differential Treg responses in these genotypes. TLR2-/- mice had reduced numbers of Tregs in the lung during CP infection while TLR4-/- mice had increased numbers. High dose CP infection resulted in an increase in Tregs and pDCs in lungs, which prevented antigen sensitization in WT mice. Depletion of Tregs or pDCs resulted in allergic airway sensitization. We conclude that Tregs and pDCs are critical determinants regulating CP infection-induced allergic sensitization. Furthermore, TLR2 and TLR4 signaling during CP infection may play a regulatory role through the modulation of Tregs.	[Crother, Timothy R.; Alsabeh, Randa] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA; [Slepenkin, Anatoly; Peterson, Ellena] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA	Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Irvine	Crother, TR (corresponding author), Univ Calif Los Angeles, Cedars Sinai Med Ctr, Dept Pathol & Lab Med, Los Angeles, CA 90048 USA.	moshe.arditi@cshs.org	Crother, Timothy R/E-2879-2010	Crother, Timothy R/0000-0001-8465-6127	National Institutes of Health [HL-66436, AI-067995]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants HL-66436 and AI-067995 (to MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639; Baru AM, 2010, EUR J IMMUNOL, V40, P2259, DOI 10.1002/eji.200939972; Belkaid Y, 2008, CELL HOST MICROBE, V3, P341, DOI 10.1016/j.chom.2008.05.011; Blasi F, 2007, INT J ANTIMICROB AG, V29, P485, DOI 10.1016/j.ijantimicag.2006.11.029; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Card JW, 2010, INFECT IMMUN, V78, P2488, DOI 10.1128/IAI.01270-09; Chen Q, 2009, J IMMUNOL, V183, P4458, DOI 10.4049/jimmunol.0901465; Dahl ME, 2004, NAT IMMUNOL, V5, P337, DOI 10.1038/ni1041; de Heer HJ, 2004, J EXP MED, V200, P89, DOI 10.1084/jem.20040035; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Horvat JC, 2010, J ALLERGY CLIN IMMUN, V125, P617, DOI 10.1016/j.jaci.2009.10.018; HORVAT JC, 2010, J IMMUNOLOGY BALTIMO; Johnston SL, 2005, AM J RESP CRIT CARE, V172, P1078, DOI 10.1164/rccm.200412-1743PP; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kool M, 2009, J IMMUNOL, V183, P1074, DOI 10.4049/jimmunol.0900471; Korsgren M, 1997, J EXP MED, V185, P885, DOI 10.1084/jem.185.5.885; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Liu HY, 2006, P NATL ACAD SCI USA, V103, P7048, DOI 10.1073/pnas.0601554103; Locksley RM, 2010, CELL, V140, P777, DOI 10.1016/j.cell.2010.03.004; Loures FV, 2010, INFECT IMMUN, V78, P1078, DOI 10.1128/IAI.01198-09; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Marsland BJ, 2004, CLIN EXP ALLERGY, V34, P1299, DOI 10.1111/j.1365-2222.2004.02021.x; Moore WC, 2010, AM J RESP CRIT CARE, V181, P315, DOI 10.1164/rccm.200906-0896OC; Naiki Y, 2005, J BIOL CHEM, V280, P29242, DOI 10.1074/jbc.M503225200; Netea MG, 2004, J IMMUNOL, V172, P3712, DOI 10.4049/jimmunol.172.6.3712; Prebeck S, 2001, J IMMUNOL, V167, P3316, DOI 10.4049/jimmunol.167.6.3316; Preston JA, 2011, EUR RESPIR J, V37, P53, DOI 10.1183/09031936.00049510; Redecke V, 2004, J IMMUNOL, V172, P2739, DOI 10.4049/jimmunol.172.5.2739; Rodriguez N, 2006, EUR J IMMUNOL, V36, P1145, DOI 10.1002/eji.200535152; Schroeder NWJ, 2008, J ALLERGY CLIN IMMUN, V122, P595, DOI 10.1016/j.jaci.2008.06.038; SHARMA M, 2009, BLOOD; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; SLY PD, 2010, J ALLERGY CLIN IMMUN; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Strickland DH, 2006, J EXP MED, V203, P2649, DOI 10.1084/jem.20060155; Sutherland ER, 2007, CHEST, V132, P1962, DOI 10.1378/chest.06-2415; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Zhang N, 2010, IMMUNOL LETT, V127, P119, DOI 10.1016/j.imlet.2009.10.004	40	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20784	10.1371/journal.pone.0020784	http://dx.doi.org/10.1371/journal.pone.0020784			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695198	gold, Green Published			2022-12-25	WOS:000291612600023
J	Xu, J; Huang, W; Zhong, CR; Luo, DJ; Li, SF; Zhu, ZY; Hu, W				Xu, Jing; Huang, Wei; Zhong, Chengrong; Luo, Daji; Li, Shuangfei; Zhu, Zuoyan; Hu, Wei			Defining Global Gene Expression Changes of the Hypothalamic-Pituitary-Gonadal Axis in Female sGnRH-Antisense Transgenic Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; COMPLEMENTARY-DNA SUBTRACTION; GOLDFISH CARASSIUS-AURATUS; C-TYPE LECTIN; OVARIAN-FUNCTION; GROWTH-HORMONE; 3 FORMS; IDENTIFICATION; CLONING; GNRH	Background: The hypothalamic-pituitary-gonadal (HPG) axis is critical in the development and regulation of reproduction in fish. The inhibition of neuropeptide gonadotropin-releasing hormone (GnRH) expression may diminish or severely hamper gonadal development due to it being the key regulator of the axis, and then provide a model for the comprehensive study of the expression patterns of genes with respect to the fish reproductive system. Methodology/Principal Findings: In a previous study we injected 342 fertilized eggs from the common carp (Cyprinus carpio) with a gene construct that expressed antisense sGnRH. Four years later, we found a total of 38 transgenic fish with abnormal or missing gonads. From this group we selected the 12 sterile females with abnormal ovaries in which we combined suppression subtractive hybridization (SSH) and cDNA microarray analysis to define changes in gene expression of the HPG axis in the present study. As a result, nine, 28, and 212 genes were separately identified as being differentially expressed in hypothalamus, pituitary, and ovary, of which 87 genes were novel. The number of down-and up-regulated genes was five and four (hypothalamus), 16 and 12 (pituitary), 119 and 93 (ovary), respectively. Functional analyses showed that these genes involved in several biological processes, such as biosynthesis, organogenesis, metabolism pathways, immune systems, transport links, and apoptosis. Within these categories, significant genes for neuropeptides, gonadotropins, metabolic, oogenesis and inflammatory factors were identified. Conclusions/Significance: This study indicated the progressive scaling-up effect of hypothalamic sGnRH antisense on the pituitary and ovary receptors of female carp and provided comprehensive data with respect to global changes in gene expression throughout the HPG signaling pathway, contributing towards improving our understanding of the molecular mechanisms and regulative pathways in the reproductive system of teleost fish.	[Xu, Jing; Huang, Wei; Zhong, Chengrong; Luo, Daji; Li, Shuangfei; Zhu, Zuoyan; Hu, Wei] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China; [Xu, Jing] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xu, J (corresponding author), Chinese Acad Sci, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	huwei@ihb.ac.cn	Luo, Daji/AAQ-3065-2021		Development Plan of the state Key Fundamental Research of China [2007CB109206]; National Natural Science Foundation [30930069]; Hubei Provincial Foundation for Distinguished Youth Scholar [2008ABB010]	Development Plan of the state Key Fundamental Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hubei Provincial Foundation for Distinguished Youth Scholar	This work was supported by the Development Plan of the state Key Fundamental Research of China (Grant No. 2007CB109206), National Natural Science Foundation (Grant No. 30930069) and Hubei Provincial Foundation for Distinguished Youth Scholar (Grant No. 2008ABB010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMLUCKENBACH J, 2008, CYBIUM, V32, P142; Amano M, 2009, PEPTIDES, V30, P1979, DOI 10.1016/j.peptides.2009.05.022; Amiya N, 2008, GEN COMP ENDOCR, V155, P88, DOI 10.1016/j.ygcen.2007.03.007; Barb CR, 2008, REPROD DOMEST ANIM, V43, P324, DOI 10.1111/j.1439-0531.2008.01173.x; Blazquez M, 1998, ENDOCRINOLOGY, V139, P4870, DOI 10.1210/en.139.12.4870; Bobe J, 2009, COMP BIOCHEM PHYS A, V153, P63, DOI 10.1016/j.cbpa.2008.10.021; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Callaghan TR, 2010, MAR BIOTECHNOL, V12, P664, DOI 10.1007/s10126-009-9254-6; Campbell B, 2006, BIOL REPROD, V75, P34, DOI 10.1095/biolreprod.105.049494; Carnevali O, 2006, GEN COMP ENDOCR, V146, P195, DOI 10.1016/j.ygcen.2005.12.007; Chiocchio SR, 2001, BIOL REPROD, V64, P1466, DOI 10.1095/biolreprod64.5.1466; Clelland E, 2009, MOL CELL ENDOCRINOL, V312, P42, DOI 10.1016/j.mce.2009.04.009; Coffman MA, 2000, BIOL REPROD, V62, P928, DOI 10.1095/biolreprod62.4.928; Darias MJ, 2008, MAR BIOTECHNOL, V10, P416, DOI 10.1007/s10126-007-9078-1; Degani G, 2003, GEN COMP ENDOCR, V134, P88, DOI 10.1016/S0016-6480(03)00238-7; Ding NZ, 2002, ZYGOTE, V10, P239, DOI 10.1017/S0967199402002319; Dong CH, 2004, DEV BIOL, V265, P341, DOI 10.1016/j.ydbio.2003.08.028; Douglas AJ, 2007, PHYSIOL BEHAV, V91, P352, DOI 10.1016/j.physbeh.2007.04.012; Fujiki K, 2001, FISH SHELLFISH IMMUN, V11, P275, DOI 10.1006/fsim.2000.0331; Gill JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011911; Guilgur LG, 2006, COMP BIOCHEM PHYS A, V144, P272, DOI 10.1016/j.cbpa.2006.02.016; Hellqvist A, 2006, GEN COMP ENDOCR, V145, P263, DOI 10.1016/j.ygcen.2005.09.012; Hu W, 2007, AQUACULTURE, V271, P498, DOI 10.1016/j.aquaculture.2007.04.075; Huang W, 2009, MOL CELL ENDOCRINOL, V307, P224, DOI 10.1016/j.mce.2009.04.003; Kitahashi T, 2009, ENDOCRINOLOGY, V150, P821, DOI 10.1210/en.2008-0940; Lake J, 2010, COMP BIOCHEM PHYS D, V5, P24, DOI 10.1016/j.cbd.2009.09.002; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Li SF, 2004, SCI CHINA SER C, V47, P349, DOI 10.1360/03yc0117; Li Shuang-Fei, 2004, Acta Genetica Sinica, V31, P1072; Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007244; Liu DL, 2002, CHINESE SCI BULL, V47, P1145, DOI 10.1007/BF02907597; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckenbach JA, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-2; Luo DJ, 2009, BIOL REPROD, V80, P674, DOI 10.1095/biolreprod.108.074203; Maclean N, 2002, GENE, V295, P265, DOI 10.1016/S0378-1119(02)00735-7; Maclean N, 2003, INFORM SYST BIOTECHN, V12, P3; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Marlatt VL, 2008, MOL CELL ENDOCRINOL, V283, P38, DOI 10.1016/j.mce.2007.10.013; Martyniuk CJ, 2006, PHYSIOL GENOMICS, V27, P328, DOI 10.1152/physiolgenomics.00090.2006; Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934; Munakata A, 2010, GEN COMP ENDOCR, V165, P456, DOI 10.1016/j.ygcen.2009.04.011; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Poisa-Beiro L, 2009, J IMMUNOL, V183, P6600, DOI 10.4049/jimmunol.0801726; Popesku JT, 2008, MOL CELL ENDOCRINOL, V293, P43, DOI 10.1016/j.mce.2008.06.017; Popesku JT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012338; Praveen B, 2005, BIOINFORMATION, V1, P14, DOI 10.6026/97320630001014; Robker RL, 2000, P NATL ACAD SCI USA, V97, P4689, DOI 10.1073/pnas.080073497; Sower SA, 2009, GEN COMP ENDOCR, V161, P20, DOI 10.1016/j.ygcen.2008.11.023; Tanaka M, 2009, J ENDOCRINOL, V203, P389, DOI 10.1677/JOE-09-0330; Tingaud-Sequeira A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-434; Uzbekova S, 2000, J MOL ENDOCRINOL, V25, P337, DOI 10.1677/jme.0.0250337; Vallee M, 2005, BIOL REPROD, V73, P63, DOI 10.1095/biolreprod.104.037069; Vickers ED, 2004, BIOL REPROD, V70, P1136, DOI 10.1095/biolreprod.103.023846; Villaret DB, 2000, LARYNGOSCOPE, V110, P374, DOI 10.1097/00005537-200003000-00008; von Schalburg KR, 2005, BIOL REPROD, V72, P687, DOI 10.1095/biolreprod.104.034967; Walsh JG, 2007, FISH SHELLFISH IMMUN, V22, P308, DOI 10.1016/j.fsi.2006.04.007; Wong AC, 2004, ZEBRAFISH, V1, P203, DOI 10.1089/zeb.2004.1.203; Wong TT, 2004, BIOL REPROD, V71, P1026, DOI 10.1095/biolreprod.104.028019; Wu ZD, 2008, FUNCT INTEGR GENOMIC, V8, P165, DOI 10.1007/s10142-007-0064-5; Xu ZW, 2010, GEN COMP ENDOCR, V167, P373, DOI 10.1016/j.ygcen.2009.10.005; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yaron Z, 2003, INT REV CYTOL, V225, P131, DOI 10.1016/S0074-7696(05)25004-0; Zohar Y, 2010, GEN COMP ENDOCR, V165, P438, DOI 10.1016/j.ygcen.2009.04.017	64	33	39	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21057	10.1371/journal.pone.0021057	http://dx.doi.org/10.1371/journal.pone.0021057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695218	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600044
J	Abdul-Hay, SO; Kang, D; McBride, M; Li, LL; Zhao, J; Leissring, MA				Abdul-Hay, Samer O.; Kang, Dongcheul; McBride, Melinda; Li, Lilin; Zhao, Ji; Leissring, Malcolm A.			Deletion of Insulin-Degrading Enzyme Elicits Antipodal, Age-Dependent Effects on Glucose and Insulin Tolerance	PLOS ONE			English	Article							DEGRADATION; RESISTANCE; MECHANISMS; MICE; INHIBITOR; PRODUCTS	Background: Insulin-degrading enzyme (IDE) is widely recognized as the principal protease responsible for the clearance and inactivation of insulin, but its role in glycemic control in vivo is poorly understood. We present here the first longitudinal characterization, to our knowledge, of glucose regulation in mice with pancellular deletion of the IDE gene (IDE-KO mice). Methodology: IDE-KO mice and wild-type (WT) littermates were characterized at 2, 4, and 6 months of age in terms of body weight, basal glucose and insulin levels, and insulin and glucose tolerance. Consistent with a functional role for IDE in insulin clearance, fasting serum insulin levels in IDE-KO mice were found to be similar to 3-fold higher than those in wild-type (WT) controls at all ages examined. In agreement with previous observations, 6-mo-old IDE-KO mice exhibited a severe diabetic phenotype characterized by increased body weight and pronounced glucose and insulin intolerance. In marked contrast, 2-mo-old IDE-KO mice exhibited multiple signs of improved glycemic control, including lower fasting glucose levels, lower body mass, and modestly enhanced insulin and glucose tolerance relative to WT controls. Biochemically, the emergence of the diabetic phenotype in IDE-KO mice correlated with age-dependent reductions in insulin receptor (IR) levels in muscle, adipose, and liver tissue. Primary adipocytes harvested from 6-mo-old IDE-KO mice also showed functional impairments in insulin-stimulated glucose uptake. Conclusions: Our results indicate that the diabetic phenotype in IDE-KO mice is not a primary consequence of IDE deficiency, but is instead an emergent compensatory response to chronic hyperinsulinemia resulting from complete deletion of IDE in all tissues throughout life. Significantly, our findings provide new evidence to support the idea that partial and/or transient inhibition of IDE may constitute a valid approach to the treatment of diabetes.	[Abdul-Hay, Samer O.; Kang, Dongcheul; McBride, Melinda; Leissring, Malcolm A.] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA; [Li, Lilin; Zhao, Ji; Leissring, Malcolm A.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL USA	Mayo Clinic; Scripps Research Institute	Abdul-Hay, SO (corresponding author), Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA.	Leissring@mayo.edu	LEISSRING, MALCOLM/AAW-5361-2021	LEISSRING, MALCOLM/0000-0001-7185-4255	National Institutes of Health [AG030718]; NATIONAL INSTITUTE ON AGING [R21AG030718] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work supported by National Institutes of Health grant AG030718 and a generous donation from The Unforgettable Fund (www.theunforgettablefund.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authier F, 1996, CLIN INVEST MED, V19, P149; Bennett RG, 2000, J BIOL CHEM, V275, P36621, DOI 10.1074/jbc.M006170200; DUCKWORTH WC, 1976, BIOCHIM BIOPHYS ACTA, V437, P531, DOI 10.1016/0304-4165(76)90021-0; DUCKWORTH WC, 1988, J BIOL CHEM, V263, P1826; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319, DOI 10.1210/edrv-9-3-319; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Fakhrai-Rad H, 2000, HUM MOL GENET, V9, P2149, DOI 10.1093/hmg/9.14.2149; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Farris W, 2004, AM J PATHOL, V164, P1425, DOI 10.1016/S0002-9440(10)63229-4; Giugliano D, 2009, ACTA DIABETOL, V46, P173, DOI 10.1007/s00592-009-0134-3; GOTO Y, 1976, TOHOKU J EXP MED, V119, P85, DOI 10.1620/tjem.119.85; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Leissring MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010504; MARBAN SL, 1989, DEV GENET, V10, P356, DOI 10.1002/dvg.1020100503; MARTIN C, 1983, CAN J PHYSIOL PHARM, V61, P802, DOI 10.1139/y83-123; Miles PDG, 1998, J CLIN INVEST, V101, P202, DOI 10.1172/JCI1256; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; MIRSKY IA, 1955, P SOC EXP BIOL MED, V88, P76; MIRSKY IA, 1955, SCIENCE, V122, P559, DOI 10.1126/science.122.3169.559; MIRSKY IA, 1957, RECENT PROG HORM RES, V13, P429; MIRSKY IA, 1957, ANN NY ACAD SCI, V71, P103, DOI 10.1111/j.1749-6632.1957.tb54580.x; RIZZA R, 1990, ADV SEC MESS PHOSPH, V24, P511; Wiedmer T, 2004, P NATL ACAD SCI USA, V101, P13296, DOI 10.1073/pnas.0405354101	23	80	85	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20818	10.1371/journal.pone.0020818	http://dx.doi.org/10.1371/journal.pone.0020818			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695259	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612900029
J	Cohen, ME; Xiao, YH; Eisenberg, RJ; Cohen, GH; Isaacs, SN				Cohen, Matthew E.; Xiao, Yuhong; Eisenberg, Roselyn J.; Cohen, Gary H.; Isaacs, Stuart N.			Antibody against Extracellular Vaccinia Virus (EV) Protects Mice through Complement and Fc Receptors	PLOS ONE			English	Article							SECONDARY POXVIRUS INFECTION; OUTER-MEMBRANE PROTEINS; SMALLPOX VACCINE; ENVELOPED VIRUS; CPG OLIGODEOXYNUCLEOTIDES; RESPIRATORY CHALLENGE; NEUTRALIZING ANTIBODY; MONOCLONAL-ANTIBODIES; NONHUMAN-PRIMATES; IMMUNE-RESPONSES	Protein-based subunit smallpox vaccines have shown their potential as effective alternatives to live virus vaccines in animal model challenge studies. We vaccinated mice with combinations of three different vaccinia virus (VACV) proteins (A33, B5, L1) and examined how the combined antibody responses to these proteins cooperate to effectively neutralize the extracellular virus (EV) infectious form of VACV. Antibodies against these targets were generated in the presence or absence of CpG adjuvant so that Th1-biased antibody responses could be compared to Th2-biased responses to the proteins with aluminum hydroxide alone, specifically with interest in looking at the ability of anti-B5 and anti-A33 polyclonal antibodies (pAb) to utilize complement-mediated neutralization in vitro. We found that neutralization of EV by anti-A33 or anti-B5 pAb can be enhanced in the presence of complement if Th1-biased antibody (IgG2a) is generated. Mechanistic differences found for complement-mediated neutralization showed that anti-A33 antibodies likely result in virolysis, while anti-B5 antibodies with complement can neutralize by opsonization (coating). In vivo studies found that mice lacking the C3 protein of complement were less protected than wild-type mice after passive transfer of anti-B5 pAb or vaccination with B5. Passive transfer of anti-B5 pAb or monoclonal antibody into mice lacking Fc receptors (FcRs) found that FcRs were also important in mediating protection. These results demonstrate that both complement and FcRs are important effector mechanisms for antibody-mediated protection from VACV challenge in mice.	[Cohen, Matthew E.; Xiao, Yuhong; Isaacs, Stuart N.] Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Eisenberg, Roselyn J.] Univ Penn, Sch Vet Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Eisenberg, Roselyn J.; Cohen, Gary H.] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Cohen, ME (corresponding author), Univ Penn, Sch Med, Dept Med, Div Infect Dis, Philadelphia, PA 19104 USA.	isaacs@upenn.edu	Isaacs, Stuart/HGA-3405-2022	Tripp, Ralph/0000-0002-2924-9956	Public Health Service Grant [U01 AI-077913]; Middle Atlantic Regional Center of Excellence in Biodefense and Emerging Infectious Diseases [U54 AI-057168]; University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI077913, U54AI057168] Funding Source: NIH RePORTER	Public Health Service Grant(United States Department of Health & Human ServicesUnited States Public Health Service); Middle Atlantic Regional Center of Excellence in Biodefense and Emerging Infectious Diseases; University of Pennsylvania; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service Grant U01 AI-077913 and the Middle Atlantic Regional Center of Excellence in Biodefense and Emerging Infectious Diseases (U54 AI-057168). Some authors were also supported by the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaz-Carroll L, 2005, J VIROL, V79, P6260, DOI 10.1128/JVI.79.10.6260-6271.2005; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; AZEREDO DS, 2002, J EXP MED, V195, P665; Beachkofsky TM, 2010, ARCH DERMATOL, V146, P656, DOI 10.1001/archdermatol.2010.46; Bell E, 2004, VIROLOGY, V325, P425, DOI 10.1016/j.virol.2004.05.004; Belyakov IM, 2003, P NATL ACAD SCI USA, V100, P9458, DOI 10.1073/pnas.1233578100; Bengali Z, 2009, VIROLOGY, V389, P132, DOI 10.1016/j.virol.2009.04.012; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; Benhnia MREI, 2009, J VIROL, V83, P12355, DOI 10.1128/JVI.01593-09; Benhnia MREI, 2009, J VIROL, V83, P1201, DOI 10.1128/JVI.01797-08; Bradbury J, 2001, Lancet Infect Dis, V1, P290, DOI 10.1016/S1473-3099(01)00132-3; Buchman GW, 2010, VACCINE, V28, P6627, DOI 10.1016/j.vaccine.2010.07.030; CARTER RH, 1992, SCIENCE, V256, P105, DOI 10.1126/science.1373518; CHARREAU B, 1994, TRANSPLANTATION, V58, P1222, DOI 10.1097/00007890-199412150-00015; Chen ZC, 2006, P NATL ACAD SCI USA, V103, P1882, DOI 10.1073/pnas.0510598103; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; COHEN ME, 2009, IMPROVED SMALLPOX VA, P838; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Da Costa XJ, 1999, P NATL ACAD SCI USA, V96, P12708, DOI 10.1073/pnas.96.22.12708; Delaney KN, 2010, VIRAL IMMUNOL, V23, P201, DOI 10.1089/vim.2009.0107; Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261; Ellis RW, 2010, HUM VACCINES, V6, P367, DOI 10.4161/hv.6.5.12210; EY PL, 1980, MOL IMMUNOL, V17, P699, DOI 10.1016/0161-5890(80)90139-X; Fang M, 2006, VIROLOGY, V345, P231, DOI 10.1016/j.virol.2005.09.056; Fischer MB, 1998, SCIENCE, V280, P582, DOI 10.1126/science.280.5363.582; Fogg C, 2004, J VIROL, V78, P10230, DOI 10.1128/JVI.78.19.10230-10237.2004; Fogg CN, 2007, VACCINE, V25, P2787, DOI 10.1016/j.vaccine.2006.12.037; Fulginiti VA, 2003, CLIN INFECT DIS, V37, P251, DOI 10.1086/375825; Galmiche MC, 1999, VIROLOGY, V254, P71, DOI 10.1006/viro.1998.9516; Golovkin M, 2007, P NATL ACAD SCI USA, V104, P6864, DOI 10.1073/pnas.0701451104; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Heraud JM, 2006, J IMMUNOL, V177, P2552, DOI 10.4049/jimmunol.177.4.2552; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hooper JW, 2004, J VIROL, V78, P4433, DOI 10.1128/JVI.78.9.4433-4443.2004; Hooper JW, 2000, VIROLOGY, V266, P329, DOI 10.1006/viro.1999.0096; ICHIHASHI Y, 1994, VIROLOGY, V202, P834, DOI 10.1006/viro.1994.1405; Jezek Z, 1988, HUMAN MONKEYPOX; JOUVINMARCHE E, 1989, IMMUNOGENETICS, V29, P92, DOI 10.1007/BF00395856; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; Kennedy RB, 2009, VACCINE, V27, pD73, DOI 10.1016/j.vaccine.2009.07.103; Klinman DM, 2006, INT REV IMMUNOL, V25, P135, DOI 10.1080/08830180600743057; Klinman DM, 2009, ADV DRUG DELIVER REV, V61, P248, DOI 10.1016/j.addr.2008.12.012; Law M, 2001, VIROLOGY, V280, P132, DOI 10.1006/viro.2000.0750; Lustig S, 2005, J VIROL, V79, P13454, DOI 10.1128/JVI.79.21.13454-13462.2005; Lustig S, 2004, VIROLOGY, V328, P30, DOI 10.1016/j.virol.2004.07.024; Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5; Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005; Millan CLB, 1998, P NATL ACAD SCI USA, V95, P15553, DOI 10.1073/pnas.95.26.15553; Moore ZS, 2006, LANCET, V367, P425, DOI 10.1016/S0140-6736(06)68143-9; Moyron-Quiroz JE, 2009, VACCINE, V28, P140, DOI 10.1016/j.vaccine.2009.09.086; Nalca A, 2010, DRUG DES DEV THER, V4, P71; NEUBERGER MS, 1981, EUR J IMMUNOL, V11, P1012, DOI 10.1002/eji.1830111212; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Ochsenbein AF, 1999, J EXP MED, V190, P1165, DOI 10.1084/jem.190.8.1165; Panchanathan V, 2005, P NATL ACAD SCI USA, V102, P12921, DOI 10.1073/pnas.0505180102; Panchanathan V, 2006, J VIROL, V80, P6333, DOI 10.1128/JVI.00115-06; Panchanathan V, 2010, IMMUNOL CELL BIOL, V88, P461, DOI 10.1038/icb.2009.110; Paran N, 2009, HUM VACCINES, V5, P824, DOI 10.4161/hv.10295; PAYNE LG, 1985, J GEN VIROL, V66, P643, DOI 10.1099/0022-1317-66-3-643; PAYNE LG, 1980, J GEN VIROL, V50, P89, DOI 10.1099/0022-1317-50-1-89; Poland GA, 2005, VACCINE, V23, P2078, DOI 10.1016/j.vaccine.2005.01.012; Pozdnyakova O, 2003, J IMMUNOL, V170, P84, DOI 10.4049/jimmunol.170.1.84; Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; Vanderplasschen A, 1997, J GEN VIROL, V78, P2041, DOI 10.1099/0022-1317-78-8-2041; Vanderplasschen A, 1998, P NATL ACAD SCI USA, V95, P7544, DOI 10.1073/pnas.95.13.7544; Viner KM, 2005, MICROBES INFECT, V7, P579, DOI 10.1016/j.micinf.2005.02.004; VOGEL CW, 1984, J IMMUNOL METHODS, V73, P203, DOI 10.1016/0022-1759(84)90045-0; Wang SY, 2009, BLOOD, V114, P5322, DOI 10.1182/blood-2009-01-200469; Weeratna RD, 2001, FEMS IMMUNOL MED MIC, V32, P65, DOI 10.1016/S0928-8244(01)00267-X; WOLFFE EJ, 1995, VIROLOGY, V211, P53, DOI 10.1006/viro.1995.1378; Xiao YH, 2007, VACCINE, V25, P1214, DOI 10.1016/j.vaccine.2006.10.009; Zimmermann S, 1998, J IMMUNOL, V160, P3627; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	75	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20597	10.1371/journal.pone.0020597	http://dx.doi.org/10.1371/journal.pone.0020597			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687676	gold, Green Published, Green Submitted			2022-12-25	WOS:000291611500034
J	Liu, LZ; Jiang, Y; Carpenter, RL; Jing, Y; Peiper, SC; Jiang, BH				Liu, Ling-Zhi; Jiang, Yue; Carpenter, Richard L.; Jing, Yi; Peiper, Stephen C.; Jiang, Bing-Hua			Role and Mechanism of Arsenic in Regulating Angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OBSTRUCTIVE PULMONARY-DISEASE; PROSTATE-CANCER CELLS; HIF-1-ALPHA EXPRESSION; HUMAN KERATINOCYTES; TUMOR ANGIOGENESIS; LUNG-DISEASE; DNA-DAMAGE; IN-VIVO; ACTIVATION	Arsenic is a wide spread carcinogen associated with several kinds of cancers including skin, lung, bladder, and liver cancers. Lung is one of the major targets of arsenic exposure. Angiogenesis is the pivotal process during carcinogenesis and chronic pulmonary diseases, but the role and mechanism of arsenic in regulating angiogenesis remain to be elucidated. In this study we show that short time exposure of arsenic induces angiogenesis in both human immortalized lung epithelial cells BEAS-2B and adenocarcinoma cells A549. To study the molecular mechanism of arsenic-inducing angiogenesis, we find that arsenic induces reactive oxygen species (ROS) generation, which activates AKT and ERK1/2 signaling pathways and increases the expression of hypoxia-inducible factor 1 (HIF-1) and vascular endothelial growth factor (VEGF). Inhibition of ROS production suppresses angiogenesis by decreasing AKT and ERK activation and HIF-1 expression. Inhibition of ROS, AKT and ERK1/2 signaling pathways is sufficient to attenuate arsenic-inducing angiogenesis. HIF-1 and VEGF are downstream effectors of AKT and ERK1/2 that are required for arsenic-inducing angiogenesis. These results shed light on the mechanism of arsenic in regulating angiogenesis, and are helpful to develop mechanism-based intervention to prevent arsenic-induced carcinogenesis and angiogenesis in the future.	[Liu, Ling-Zhi; Jiang, Yue; Carpenter, Richard L.; Jing, Yi; Peiper, Stephen C.; Jiang, Bing-Hua] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Jefferson University	Liu, LZ (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	bhjiang@jefferson.edu		Liu, Ling-Zhi/0000-0001-9234-457X; Hartl, Carla/0000-0001-9769-7462; Jiang, Bing-Hua/0000-0003-4526-2031; Carpenter, Richard/0000-0001-9986-6493	National Institute of Environmental Health Sciences, National Institutes of Health [R21ES017237]; National Cancer Institute, National Institutes of Health [R01CA109460]; National Heart, Lung and Blood Institute, National Institutes of Health [R01HL091456]; NATIONAL CANCER INSTITUTE [R01CA109460] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017237] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors acknowledge financial support from the National Institute of Environmental Health Sciences, National Institutes of Health R21ES017237 grant; the National Cancer Institute, National Institutes of Health R01CA109460 grant; and National Heart, Lung and Blood Institute, National Institutes of Health R01HL091456 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROWN LM, 1984, ENVIRON RES, V34, P250, DOI 10.1016/0013-9351(84)90093-8; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chowdhury R, 2010, TOXICOL LETT, V198, P263, DOI 10.1016/j.toxlet.2010.07.006; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Cooper KL, 2009, FREE RADICAL BIO MED, V47, P381, DOI 10.1016/j.freeradbiomed.2009.04.034; Davey JC, 2007, TOXICOL SCI, V98, P75, DOI 10.1093/toxsci/kfm013; Ding W, 2005, MOL CELL BIOCHEM, V279, P105, DOI 10.1007/s11010-005-8227-y; DONG JT, 1993, MUTAT RES, V302, P97, DOI 10.1016/0165-7992(93)90010-S; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Gao N, 2004, MOL CELL BIOCHEM, V255, P33, DOI 10.1023/B:MCBI.0000007259.65742.16; Hasaneen NA, 2007, AM J PHYSIOL-LUNG C, V293, pL1059, DOI 10.1152/ajplung.00480.2006; Huang CS, 2004, MOL CELL BIOCHEM, V255, P57, DOI 10.1023/B:MCBI.0000007261.04684.78; Jatta K, 2009, J CLIN PATHOL, V62, P70, DOI 10.1136/jcp.2008.057190; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Kamat CD, 2005, TOXICOL SCI, V86, P248, DOI 10.1093/toxsci/kfi190; Kiersniewska-Stepien D, 2006, EUR CYTOKINE NETW, V17, P75; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; Knobeloch LM, 2006, J HEALTH POPUL NUTR, V24, P206; Lee L, 2005, ENVIRON HEALTH PERSP, V113, P207, DOI 10.1289/ehp.7200; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LI G, 2011, J CELL PHYSL; Liu LZ, 2006, FREE RADICAL BIO MED, V41, P1521, DOI 10.1016/j.freeradbiomed.2006.08.003; Mazumder DNG, 2007, J ENVIRON SCI HEAL A, V42, P1859, DOI 10.1080/10934520701566926; Meng D, 2010, TOXICOL APPL PHARM, V244, P291, DOI 10.1016/j.taap.2010.01.004; Mottet D, 2003, J CELL PHYSIOL, V194, P30, DOI 10.1002/jcp.10176; Mousa SA, 2007, CARCINOGENESIS, V28, P962, DOI 10.1093/carcin/bgl229; Neuberger John S, 2003, Rev Environ Health, V18, P251; Pi JB, 2005, INT J CANCER, V116, P20, DOI 10.1002/ijc.20990; Reichard JF, 2007, BIOCHEM BIOPH RES CO, V352, P188, DOI 10.1016/j.bbrc.2006.11.001; Sampayo-Reyes A, 2010, TOXICOL SCI, V117, P63, DOI 10.1093/toxsci/kfq173; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shi HL, 2004, CHEM RES TOXICOL, V17, P871, DOI 10.1021/tx049939e; Skinner HD, 2004, MOL CELL BIOCHEM, V255, P19, DOI 10.1023/B:MCBI.0000007257.67733.3b; STOHRER G, 1991, ARCH TOXICOL, V65, P525; Straub AC, 2009, AM J PATHOL, V174, P1949, DOI 10.2353/ajpath.2009.081016; Voelkel NF, 2007, CHEST, V131, P874, DOI 10.1378/chest.06-2453; Waalkes MP, 2004, CARCINOGENESIS, V25, P133, DOI 10.1093/carcin/bgg181; Walters EH, 2008, PHARMACOL THERAPEUT, V118, P128, DOI 10.1016/j.pharmthera.2008.01.007; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Yang Q, 2008, CURR DRUG METAB, V9, P661, DOI 10.2174/138920008785821684; Ying SM, 2009, NUCLEIC ACIDS RES, V37, P5105, DOI 10.1093/nar/gkp538; Zhong H, 2000, CANCER RES, V60, P1541; Zhou Q, 2007, CARCINOGENESIS, V28, P28, DOI 10.1093/carcin/bgl085	45	58	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20858	10.1371/journal.pone.0020858	http://dx.doi.org/10.1371/journal.pone.0020858			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687637	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500049
J	Yin, JH; Shen, YJ; Yuan, ZY; Lu, WY; Xu, YX; Cao, JP				Yin, Jianhai; Shen, Yujuan; Yuan, Zhongying; Lu, Weiyuan; Xu, Yuxin; Cao, Jianping			Prevalence of the Cryptosporidium Pig Genotype II in Pigs from the Yangtze River Delta, China	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; PHYLOGENETIC ANALYSIS; GIARDIA	Background: Cryptosporidium spp. is prevalent globally, pigs are an important Cryptosporidium reservoir. In China, little data regarding rates of Cryptosporidium infections in pigs are available. The present study was therefore aimed at characterizing the distribution of Cryptosporidium species in pigs from two different cities, Shaoxing and Shanghai, from the Yangtze River delta. Methodology/Principal Findings: Nested PCR to amplify the 18S rRNA locus on DNA extracted from fecal samples (n = 94) revealed the positive rate of Cryptosporidium in pigs from two cities was approximately 17.0%. The positive rates in Shanghai and Shaoxing were 14.3% and 25.0% respectively. Amplified sequences were verified by sequencing. The identified strain belonged to the C. pig genotype II using BLAST analysis in the NCBI database. Conclusion/Significance: Our finding of Cryptosporidium pig genotype II in pigs in the Yangtze River delta area suggests that pig farms in this region must be considered a public health threat and proper control measures be introduced.	[Yin, Jianhai; Shen, Yujuan; Yuan, Zhongying; Lu, Weiyuan; Xu, Yuxin; Cao, Jianping] WHO Collaborating Ctr Malaria, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Parasitic Diseases, Chinese Center for Disease Control & Prevention	Yin, JH (corresponding author), WHO Collaborating Ctr Malaria, Natl Inst Parasit Dis, Chinese Ctr Dis Control & Prevent, Key Lab Parasite & Vector Biol,Minist Hlth, Shanghai, Peoples R China.	caojp@yahoo.com	Yin, Jianhai/AAF-5820-2020; Cao, Jianping/AFL-5468-2022; Yin, Jianhai/GRS-2880-2022	Cao, Jianping/0000-0002-1974-0047; Yin, Jianhai/0000-0003-1333-8732	Chinese Special Program for Scientific Research of Public Health [200802012]; Chinese National Key Program for Infectious Diseases [2008ZX10004-002, 2009ZX10004-201]	Chinese Special Program for Scientific Research of Public Health; Chinese National Key Program for Infectious Diseases	Y.S. was supported by grants from the Chinese Special Program for Scientific Research of Public Health No. 200802012 and the Chinese National Key Program for Infectious Diseases No. 2008ZX10004-002. J.C. was supported by grant from the Chinese National Key Program for Infectious Diseases No. 2009ZX10004-201. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalmers RM, 2009, EMERG INFECT DIS, V15, P829, DOI 10.3201/eid1505.081419; Chen F, 2007, ZOONOSES PUBLIC HLTH, V54, P393, DOI 10.1111/j.1863-2378.2007.01078.x; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Jiang JL, 2005, APPL ENVIRON MICROB, V71, P4446, DOI 10.1128/AEM.71.8.4446-4454.2005; Johnson J, 2008, EXP PARASITOL, V119, P418, DOI 10.1016/j.exppara.2008.04.009; Kvac M, 2009, PARASITOL RES, V104, P425, DOI 10.1007/s00436-008-1215-x; Kvac M, 2009, EMERG INFECT DIS, V15, P982, DOI [10.3201/eid1506.07621, 10.3201/eid1506.071621]; Kvac M, 2009, VET PARASITOL, V160, P319, DOI 10.1016/j.vetpar.2008.11.007; Langkjaer RB, 2007, PARASITOLOGY, V134, P339, DOI 10.1017/S0031182006001533; Plutzer J, 2009, VET PARASITOL, V165, P187, DOI 10.1016/j.vetpar.2009.07.003; Xiao LH, 2006, APPL ENVIRON MICROB, V72, P4461, DOI 10.1128/AEM.00370-06; Xiao LH, 1999, APPL ENVIRON MICROB, V65, P1578; Xiao LH, 2000, APPL ENVIRON MICROB, V66, P5492, DOI 10.1128/AEM.66.12.5492-5498.2000; Xiao LH, 2004, CLIN MICROBIOL REV, V17, P72, DOI 10.1128/CMR.17.1.72-97.2004; Xiao Lihua, 2007, P119; Xiao LH, 2008, INT J PARASITOL, V38, P1239, DOI 10.1016/j.ijpara.2008.03.006; ZHAOCHANGCHENG, 2005, ANIMAL HUSBANDRY VET, V37, P18; ZHOURONGQIONG, 2007, J SW CHINA NORMAL U, V32, P82	18	19	21	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20738	10.1371/journal.pone.0020738	http://dx.doi.org/10.1371/journal.pone.0020738			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677776	Green Submitted, gold, Green Published			2022-12-25	WOS:000291355500040
J	Gui, SY; Wooderchak, WL; Daly, MP; Porter, PJ; Johnson, SJ; Hevel, JM				Gui, Shanying; Wooderchak, Whitney L.; Daly, Michael P.; Porter, Paula J.; Johnson, Sean J.; Hevel, Joan M.			Investigation of the Molecular Origins of Protein-arginine Methyltransferase I (PRMT1) Product Specificity Reveals a Role for Two Conserved Methionine Residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; LYSINE METHYLTRANSFERASES; HISTONE METHYLATION; STRUCTURAL BASIS; PHE/TYR SWITCH; DOMAIN; VIVO; MECHANISM; SOFTWARE; BINDING	Protein-arginine methyltransferases aid in the regulation of many biological processes by methylating specific arginyl groups within targeted proteins. The varied nature of the response to methylation is due in part to the diverse product specificity displayed by the protein-arginine methyltransferases. In addition to site location within a protein, biological response is also determined by the degree (mono-/dimethylation) and type of arginine dimethylation (asymmetric/symmetric). Here, we have identified two strictly conserved methionine residues in the PRMT1 active site that are not only important for activity but also control substrate specificity. Mutation of Met-155 or Met-48 results in a loss in activity and a change in distribution of mono-and dimethylated products. The altered substrate specificity of M155A and M48L mutants is also evidenced by automethylation. Investigation into the mechanistic basis of altered substrate recognition led us to consider each methyl transfer step separately. Single turnover experiments reveal that the rate of transfer of the second methyl group is much slower than transfer of the first methyl group in M48L, especially for arginine residues located in the center of the peptide substrate where turnover of the monomethylated species is negligible. Thus, altered product specificity in M48L originates from the differential effect of the mutation on the two rates. Characterization of the two active-site methionines provides the first insight into how the PRMT1 active site is engineered to control product specificity.	[Gui, Shanying; Wooderchak, Whitney L.; Porter, Paula J.; Johnson, Sean J.; Hevel, Joan M.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA; [Daly, Michael P.] Waters Corp, Beverly, MA 01915 USA	Utah System of Higher Education; Utah State University; Waters Corporation	Hevel, JM (corresponding author), Utah State Univ, Dept Chem & Biochem, 0300 Old Main Hill, Logan, UT 84322 USA.	Joanie.Hevel@usu.edu	Gui, Shanying/AAM-8633-2021; Johnson, Sean/G-8191-2012	Johnson, Sean/0000-0001-7992-2494; Hevel, Joan/0000-0002-9559-4635	Herman Frasch Foundation [657-HF07]; National Science Foundation [0920776]; American Recovery and Reinvestment Act; American Heart Association; Div Of Molecular and Cellular Bioscience [0920776] Funding Source: National Science Foundation	Herman Frasch Foundation; National Science Foundation(National Science Foundation (NSF)); American Recovery and Reinvestment Act; American Heart Association(American Heart Association); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by Herman Frasch Foundation Award 657-HF07 (to J. M. H.), National Science Foundation Award 0920776 (to J. M. H.) funded through the American Recovery and Reinvestment Act, and an American Heart Association undergraduate research fellowship (to P. J. P.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balakrishnan L, 2010, CRIT REV BIOCHEM MOL, V45, P440, DOI 10.3109/10409238.2010.504700; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Collins RE, 2005, J BIOL CHEM, V280, P5563, DOI 10.1074/jbc.M410483200; Cornell KA, 1996, BIOCHEM BIOPH RES CO, V228, P724, DOI 10.1006/bbrc.1996.1723; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Coward J. K., 1977, BIOCH ADENOSYLMETHIO, P127; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Dorgan KM, 2006, ANAL BIOCHEM, V350, P249, DOI 10.1016/j.ab.2006.01.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Huang SM, 2005, GENE DEV, V19, P1885, DOI 10.1101/gad.1333905; Jansson M, 2008, NAT CELL BIOL, V10, P1431, DOI 10.1038/ncb1802; Kirmizis A, 2009, NAT STRUCT MOL BIOL, V16, P449, DOI 10.1038/nsmb.1569; Lakowski TM, 2010, ACS CHEM BIOL, V5, P1053, DOI 10.1021/cb100161u; LEHRER SS, 1971, BIOCHEMISTRY-US, V10, P3254, DOI 10.1021/bi00793a015; Levine T.B., 2006, METABOLIC SYNDROME C; Markowski P, 2007, ANAL CHIM ACTA, V605, P205, DOI 10.1016/j.aca.2007.10.033; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Olsen J, 1979, TRANSMETHYLATION; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 2006, J BIOL CHEM, V281, P11115, DOI 10.1074/jbc.M513053200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; REICH NO, 1991, BIOCHEMISTRY-US, V30, P2933, DOI 10.1021/bi00225a029; *RIG CORP, 2006, CRYSTALCLEAR INT PRO; Rust HL, 2011, BIOCHEMISTRY-US, V50, P3332, DOI 10.1021/bi102022e; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Segel IH, 1975, ENZYME KINETICS BEHA; Suh-Lailam BB, 2010, ANAL BIOCHEM, V398, P218, DOI 10.1016/j.ab.2009.09.005; Takahashi YH, 2009, MOL CELL BIOL, V29, P3478, DOI 10.1128/MCB.00013-09; Tang J, 2000, J BIOL CHEM, V275, P7723, DOI 10.1074/jbc.275.11.7723; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; ZAPPIA V, 1980, J CHROMATOGR, V189, P399, DOI 10.1016/S0021-9673(00)80319-2; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhang X, 2008, P NATL ACAD SCI USA, V105, P5728, DOI 10.1073/pnas.0801788105; Zubieta C, 2003, PLANT CELL, V15, P1704, DOI 10.1105/tpc.014548; Zubieta C, 2002, PLANT CELL, V14, P1265, DOI 10.1105/tpc.001412; Zubieta C, 2001, NAT STRUCT BIOL, V8, P271, DOI 10.1038/85029	45	24	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29118	29126		10.1074/jbc.M111.224097	http://dx.doi.org/10.1074/jbc.M111.224097			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697082	hybrid, Green Published			2022-12-25	WOS:000293837000048
J	Nakano, C; Horinouchi, S; Ohnishi, Y				Nakano, Chiaki; Horinouchi, Sueharu; Ohnishi, Yasuo			Characterization of a Novel Sesquiterpene Cyclase Involved in (+)-Caryolan-1-ol Biosynthesis in Streptomyces griseus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESSENTIAL OIL COMPOSITION; FACTOR REGULATORY CASCADE; A-FACTOR; MORPHOLOGICAL DEVELOPMENT; SECONDARY METABOLISM; MOLECULAR-CLONING; GERMACRADIENOL SYNTHASE; GEOSMIN BIOSYNTHESIS; BIOLOGICAL-ACTIVITY; GENE	Most terpenoids have been isolated from plants and fungi and only a few from bacteria. However, an increasing number of genome sequences indicate that bacteria possess a variety of terpenoid cyclase genes. We characterized a sesquiterpene cyclase gene (SGR2079, named gcoA) found in Streptomyces griseus. When expressed in Streptomyces lividans, gcoA directed production of a sesquiterpene, isolated and determined to be (+)-caryolan-1-ol using spectroscopic analyses. (+)-Caryolan-1-ol was also detected in the crude cell lysate of wild-type S. griseus but not in a gcoA knockout mutant, indicating that GcoA is a genuine (+)-caryolan-1-ol synthase. Enzymatic properties were characterized using N-terminally histidine-tagged GcoA, produced in Escherichia coli. As expected, incubation of the recombinant GcoA protein with farnesyl diphosphate yielded (+)-caryolan-1-ol. However, a small amount of another sesquiterpene was also detected. This was identified as the bicyclic sesquiterpene hydrocarbon (+)-beta-caryophyllene by comparison with an authentic sample using GC-MS. Incorporation of a deuterium atom into the C-9 methylene of (+)-caryolan-1-ol in an in vitro GcoA reaction in deuterium oxide indicated that (+)-caryolan-1-ol was synthesized by a proton attack on the C-8/C-9 double bond of (+)-beta-caryophyllene. Several beta-caryophyllene synthases have been identified from plants, but these cannot synthesize caryolan-1-ol. Although caryolan-1-ol has been isolated previously from several plants, the enzyme responsible for its biosynthesis has not been identified previously. GcoA is thus the first known caryolan-1-ol synthase. Isolation of caryolan-1-ol from microorganisms is unprecedented.	[Nakano, Chiaki; Horinouchi, Sueharu; Ohnishi, Yasuo] Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138567, Japan	University of Tokyo	Ohnishi, Y (corresponding author), Univ Tokyo, Dept Biotechnol, Grad Sch Agr & Life Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138567, Japan.	ayasuo@mail.ecc.u-tokyo.ac.jp		Ohnishi, Yasuo/0000-0001-7633-9236	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan	This work was supported in part by the Targeted Proteins Research Program (TPRP) of the Ministry of Education, Culture, Sports, Science, and Technology of Japan and a Funding Program for Next Generation World-Leading Researchers from the Bureau of Science, Technology, and Innovation Policy, Cabinet Office, Government of Japan.	Abel C, 2009, PLANTA, V230, P1, DOI 10.1007/s00425-009-0921-7; Agger SA, 2008, J BACTERIOL, V190, P6084, DOI 10.1128/JB.00759-08; Akanuma G, 2009, MOL MICROBIOL, V73, P898, DOI 10.1111/j.1365-2958.2009.06814.x; BARTON DHR, 1952, J CHEM SOC, P2210, DOI 10.1039/jr9520002210; BECK E, 1982, GENE, V19, P327, DOI 10.1016/0378-1119(82)90023-3; Cane DE, 2006, J ANTIBIOT, V59, P471, DOI 10.1038/ja.2006.66; Cane DE, 2003, P NATL ACAD SCI USA, V100, P1547, DOI 10.1073/pnas.0337625100; CANE DE, 1994, BIOCHEMISTRY-US, V33, P5846, DOI 10.1021/bi00185a024; Chen F, 2003, PLANT CELL, V15, P481, DOI 10.1105/tpc.007989; Chou WKW, 2010, J AM CHEM SOC, V132, P8850, DOI 10.1021/ja103087w; Christianson DW, 2006, CHEM REV, V106, P3412, DOI 10.1021/cr050286w; Rocha KAD, 2010, APPL CATAL A-GEN, V374, P87, DOI 10.1016/j.apcata.2009.11.032; Degenhardt J, 2009, PHYTOCHEMISTRY, V70, P1621, DOI 10.1016/j.phytochem.2009.07.030; Dickschat JS, 2005, CHEM BIODIVERS, V2, P318, DOI 10.1002/cbdv.200590014; FITJER L, 1995, J AM CHEM SOC, V117, P9180, DOI 10.1021/ja00141a009; FRICKE C, 1995, PHYTOCHEMISTRY, V39, P1119, DOI 10.1016/0031-9422(95)00184-9; Ghimire GP, 2008, J MICROBIOL BIOTECHN, V18, P1216; Giglio S, 2008, ENVIRON SCI TECHNOL, V42, P8027, DOI 10.1021/es801465w; Hara H, 2009, MICROBIOL-SGM, V155, P2197, DOI 10.1099/mic.0.027862-0; Horinouchi S, 2007, P JPN ACAD B-PHYS, V83, P277, DOI [10.2183/pjab.83.277, 10.2183/pjab/83.277]; Hu YF, 2011, CHEM BIOL, V18, P32, DOI 10.1016/j.chembiol.2010.11.008; Jayaprakasha GK, 2003, J AGR FOOD CHEM, V51, P4344, DOI 10.1021/jf034169i; Kamatou GPP, 2008, S AFR J BOT, V74, P230, DOI 10.1016/j.sajb.2007.08.002; Kato JY, 2007, P NATL ACAD SCI USA, V104, P2378, DOI 10.1073/pnas.0607472104; Keszei A, 2010, PHYTOCHEMISTRY, V71, P844, DOI 10.1016/j.phytochem.2010.03.013; Kopke D, 2008, PLANTA, V228, P427, DOI 10.1007/s00425-008-0747-8; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; Konig WA, 1996, PHYTOCHEMISTRY, V43, P629, DOI 10.1016/0031-9422(96)00354-8; Lin X, 2006, J AM CHEM SOC, V128, P6022, DOI 10.1021/ja061292s; Lourens ACU, 2004, J ETHNOPHARMACOL, V95, P253, DOI 10.1016/j.jep.2004.07.027; Meekijjaroenroj A, 2007, FLAVOUR FRAG J, V22, P300, DOI 10.1002/ffj.1797; MISRA R, 1979, TETRAHEDRON, V35, P2301, DOI 10.1016/0040-4020(79)80125-8; Mockute D, 2001, PHYTOCHEMISTRY, V57, P65, DOI 10.1016/S0031-9422(00)00474-X; Ohnishi Y, 2005, BIOSCI BIOTECH BIOCH, V69, P431, DOI 10.1271/bbb.69.431; Ohnishi Y, 1999, MOL MICROBIOL, V34, P102, DOI 10.1046/j.1365-2958.1999.01579.x; Ohnishi Y, 2008, J BACTERIOL, V190, P4050, DOI 10.1128/JB.00204-08; Orav A, 2004, J AGR FOOD CHEM, V52, P2582, DOI 10.1021/jf030635s; Schilmiller AL, 2010, PLANT PHYSIOL, V153, P1212, DOI 10.1104/pp.110.157214; Takamatsu S, 2011, MICROB BIOTECHNOL, V4, P184, DOI 10.1111/j.1751-7915.2010.00209.x; Tetzlaff CN, 2006, BIOCHEMISTRY-US, V45, P6179, DOI 10.1021/bi060419n; TRESSL R, 1983, J AGR FOOD CHEM, V31, P892, DOI 10.1021/jf00118a056	41	49	53	1	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27980	27987		10.1074/jbc.M111.265652	http://dx.doi.org/10.1074/jbc.M111.265652			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21693706	hybrid, Green Published			2022-12-25	WOS:000293557800016
J	de Oliveira, JMPF; van Passel, MWJ; Schaap, PJ; de Graaff, LH				de Oliveira, Jose Miguel P. Ferreira; van Passel, Mark W. J.; Schaap, Peter J.; de Graaff, Leo H.			Proteomic Analysis of the Secretory Response of Aspergillus niger to D-Maltose and D-Xylose	PLOS ONE			English	Article							SHOTGUN PROTEOMICS; TRANSCRIPTIONAL ACTIVATOR; ENDOPLASMIC-RETICULUM; EXPRESSION; GENE; STRESS; REGULATOR; REVEALS; BINDING; FUNGI	Fungi utilize polysaccharide substrates through extracellular digestion catalyzed by secreted enzymes. Thus far, protein secretion by the filamentous fungus Aspergillus niger has mainly been studied at the level of individual proteins and by genome and transcriptome analyses. To extend these studies, a complementary proteomics approach was applied with the aim to investigate the changes in secretome and microsomal protein composition resulting from a shift to a high level secretion condition. During growth of A. niger on D-sorbitol, small amounts of D-maltose or D-xylose were used as inducers of the extracellular amylolytic and xylanolytic enzymes. Upon induction, protein compositions in the extracellular broth as well as in enriched secretory organelle (microsomal) fractions were analyzed using a shotgun proteomics approach. In total 102 secreted proteins and 1,126 microsomal proteins were identified in this study. Induction by D-maltose or D-xylose resulted in the increase in specific extracellular enzymes, such as glucoamylase A on D-maltose and b-xylosidase D on D-xylose, as well as of microsomal proteins. This reflects the differential expression of selected genes coding for dedicated extracellular enzymes. As expected, the addition of extra D-sorbitol had no effect on the expression of carbohydrate-active enzymes, compared to addition of D-xylose or D-maltose. Furthermore, D-maltose induction caused an increase in microsomal proteins related to translation (e.g., Rpl15) and vesicular transport (e. g., the endosomal-cargo receptor Erv14). Millimolar amounts of the inducers D-maltose and D-xylose are sufficient to cause a direct response in specific protein expression levels. Also, after induction by D-maltose or D-xylose, the induced enzymes were found in microsomes and extracellular. In agreement with our previous findings for D-xylose induction, D-maltose induction leads to recruitment of proteins involved in proteasome-mediated degradation.	[de Oliveira, Jose Miguel P. Ferreira; van Passel, Mark W. J.; Schaap, Peter J.; de Graaff, Leo H.] Wageningen Univ, Lab Syst & Synthet Biol, Wageningen, Netherlands	Wageningen University & Research	de Oliveira, JMPF (corresponding author), Wageningen Univ, Lab Syst & Synthet Biol, Wageningen, Netherlands.	leo.degraaff@wur.nl	Ferreira de Oliveira, José Miguel P./AFM-8368-2022; de Oliveira, Jose Miguel Ferreira/AAU-8778-2020; van Passel, Mark WJ/K-5698-2012; Ferreira de Oliveira, Jose Miguel P/F-6250-2011	Ferreira de Oliveira, José Miguel P./0000-0002-3883-0806; de Oliveira, Jose Miguel Ferreira/0000-0002-3883-0806; Ferreira de Oliveira, Jose Miguel P/0000-0002-3883-0806; Schaap, Peter/0000-0002-4346-6084	Netherlands Organization for Scientific Research (NWO) via a VENI	Netherlands Organization for Scientific Research (NWO) via a VENI(Netherlands Organization for Scientific Research (NWO))	MWJvP is funded by the Netherlands Organization for Scientific Research (NWO) via a VENI grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sheikh H, 2004, MOL MICROBIOL, V53, P1731, DOI 10.1111/j.1365-2958.2004.04236.x; Archer DB, 2008, ADV BIOCHEM ENG BIOT, V111, P99, DOI 10.1007/10_2007_094; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Braaksma M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-584; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Oliveira JMPF, 2010, APPL ENVIRON MICROB, V76, P4421, DOI 10.1128/AEM.00482-10; de Vries RP, 1999, APPL ENVIRON MICROB, V65, P2453; DELAMOTTE RS, 1987, BIOCHEMISTRY-US, V26, P7363, DOI 10.1021/bi00397a025; DOWZER CEA, 1991, MOL CELL BIOL, V11, P5701, DOI 10.1128/MCB.11.11.5701; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Geysens S, 2009, FUNGAL GENET BIOL, V46, pS121, DOI 10.1016/j.fgb.2008.07.016; Guillemette T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-158; Han Y, 2007, J BIOL CHEM, V282, P9581, DOI 10.1074/jbc.M608961200; Jacobs DI, 2009, FUNGAL GENET BIOL, V46, pS141, DOI 10.1016/j.fgb.2008.08.012; Kellner H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010971; Lee DG, 1999, BIOCHEM BIOPH RES CO, V263, P646, DOI 10.1006/bbrc.1999.1428; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lu X, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-23; McCann MC, 2008, CURR OPIN PLANT BIOL, V11, P314, DOI 10.1016/j.pbi.2008.04.001; Noguchi Y, 2009, APPL MICROBIOL BIOT, V85, P141, DOI 10.1007/s00253-009-2236-9; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Oliveira JM, 2008, APPL MICROBIOL BIOT, V80, P917, DOI 10.1007/s00253-008-1640-x; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; Petersen KL, 1999, MOL GEN GENET, V262, P668, DOI 10.1007/s004380051129; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Roiz L, 2006, CANCER-AM CANCER SOC, V106, P2295, DOI 10.1002/cncr.21878; Ruijter GJG, 1999, MICROBIOL-SGM, V145, P2569, DOI 10.1099/00221287-145-9-2569; Shimokawa T, 2009, BIORESOURCE TECHNOL, V100, P6651, DOI 10.1016/j.biortech.2009.06.100; Sokal R.R., 1994, BIOMETRY PRINCIPLES; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; van der Veen D, 2009, APPL ENVIRON MICROB, V75, P2414, DOI 10.1128/AEM.02270-08; van Esse HP, 2008, PLANT CELL, V20, P1948, DOI 10.1105/tpc.108.059394; van Peij NNME, 1998, MOL MICROBIOL, V27, P131, DOI 10.1046/j.1365-2958.1998.00666.x; Vizcaino JA, 2010, NUCLEIC ACIDS RES, V38, pD736, DOI 10.1093/nar/gkp964; Vodisch M, 2009, PROTEOMICS, V9, P1407, DOI 10.1002/pmic.200800394; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	38	35	68	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20865	10.1371/journal.pone.0020865	http://dx.doi.org/10.1371/journal.pone.0020865			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698107	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600022
J	Hunt, KM; Foster, JA; Forney, LJ; Schutte, UME; Beck, DL; Abdo, Z; Fox, LK; Williams, JE; McGuire, MK; McGuire, MA				Hunt, Katherine M.; Foster, James A.; Forney, Larry J.; Schuette, Ursel M. E.; Beck, Daniel L.; Abdo, Zaid; Fox, Lawrence K.; Williams, Janet E.; McGuire, Michelle K.; McGuire, Mark A.			Characterization of the Diversity and Temporal Stability of Bacterial Communities in Human Milk	PLOS ONE			English	Article							BREAST-MILK; FLORA; INFECTION; WOMEN; RISK	Recent investigations have demonstrated that human milk contains a variety of bacterial genera; however, as of yet very little work has been done to characterize the full diversity of these milk bacterial communities and their relative stability over time. To more thoroughly investigate the human milk microbiome, we utilized microbial identification techniques based on pyrosequencing of the 16S ribosomal RNA gene. Specifically, we characterized the bacterial communities present in milk samples collected from 16 women at three time-points over four weeks. Results indicated that milk bacterial communities were generally complex; several genera represented greater than 5% of the relative community abundance, and the community was often, yet not always, stable over time within an individual. These results support the conclusion that human milk, which is recommended as the optimal nutrition source for almost all healthy infants, contains a collection of bacteria more diverse than previously reported. This finding begs the question as to what role this community plays in colonization of the infant gastrointestinal tract and maintaining mammary health.	[Hunt, Katherine M.; McGuire, Mark A.] Univ Idaho, Dept Anim & Vet Sci, Moscow, ID 83843 USA; [Foster, James A.; Forney, Larry J.; Schuette, Ursel M. E.; Beck, Daniel L.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Abdo, Zaid] Univ Idaho, Dept Math, Dept Stat, Moscow, ID 83843 USA; [Fox, Lawrence K.] Washington State Univ, Dept Vet Clin Sci, Pullman, WA 99164 USA; [McGuire, Michelle K.] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Hunt, Katherine M.; Foster, James A.; Forney, Larry J.; Beck, Daniel L.; Abdo, Zaid; McGuire, Mark A.] Univ Idaho, Initiat Bioinformat & Evolutionary Studies IBEST, Moscow, ID 83843 USA	Idaho; University of Idaho; Idaho; University of Idaho; Idaho; University of Idaho; Washington State University; Washington State University; Idaho; University of Idaho	Hunt, KM (corresponding author), Univ Idaho, Dept Anim & Vet Sci, Moscow, ID 83843 USA.	mmcguire@uidaho.edu	McGuire, Michelle/AAA-4272-2022; Abdo, Zaid/E-5176-2017	McGuire, Michelle/0000-0001-8214-2229; Abdo, Zaid/0000-0002-8272-7734; Foster, James/0000-0002-6770-6521	United Dairymen of Idaho; National Institutes of Health [P20 RR15587, P20 RR016454]; Idaho Agricultural Experimental Station; Initiative for Bioinformatics and Evolutionary Studies (IBEST) at the University of Idaho; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015587, P20RR016454] Funding Source: NIH RePORTER	United Dairymen of Idaho; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Idaho Agricultural Experimental Station; Initiative for Bioinformatics and Evolutionary Studies (IBEST) at the University of Idaho; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the United Dairymen of Idaho, the National Institutes of Health Grants P20 RR15587 and P20 RR016454, the Idaho Agricultural Experimental Station, and the Initiative for Bioinformatics and Evolutionary Studies (IBEST) at the University of Idaho. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Barbosa-Cesnik C, 2003, JAMA-J AM MED ASSOC, V289, P1609, DOI 10.1001/jama.289.13.1609; Beck D, 2011, BIOINFORMATICS, V27, P1700, DOI 10.1093/bioinformatics/btr196; BROWN KH, 1989, PEDIATRICS, V83, P31; Collado MC, 2009, LETT APPL MICROBIOL, V48, P523, DOI 10.1111/j.1472-765X.2009.02567.x; Colombo APV, 2009, J PERIODONTOL, V80, P1421, DOI 10.1902/jop.2009.090185; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DOHOO IR, 1991, PREV VET MED, V10, P225, DOI 10.1016/0167-5877(91)90006-N; Fetherston C, 2001, Breastfeed Rev, V9, P5; Foxman B, 2002, AM J EPIDEMIOL, V155, P103, DOI 10.1093/aje/155.2.103; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; Gillman MW, 2001, JAMA-J AM MED ASSOC, V285, P2461, DOI 10.1001/jama.285.19.2461; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Gueimonde M, 2007, NEONATOLOGY, V92, P64, DOI 10.1159/000100088; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Heikkila MP, 2003, J APPL MICROBIOL, V95, P471, DOI 10.1046/j.1365-2672.2003.02002.x; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Jensen RG, 1995, HDB MILK COMPOSITION; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; LopezAlarcon M, 1997, J NUTR, V127, P436, DOI 10.1093/jn/127.3.436; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin R, 2007, RES MICROBIOL, V158, P31, DOI 10.1016/j.resmic.2006.11.004; Martin R, 2009, APPL ENVIRON MICROB, V75, P965, DOI 10.1128/AEM.02063-08; Nasidze I, 2009, GENOME RES, V19, P636, DOI 10.1101/gr.084616.108; National Mastitis Council, 1987, LAB FIELD HDB BOV MA; NEWBURG DS, 2001, BIOACTIVE COMPONENTS; Osterman K L, 2000, J Hum Lact, V16, P297, DOI 10.1177/089033440001600405; Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403; Perez PF, 2007, PEDIATRICS, V119, pE724, DOI 10.1542/peds.2006-1649; Ramsay DT, 2004, PEDIATRICS, V113, P361, DOI 10.1542/peds.113.2.361; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schwebke JR, 2005, J INFECT DIS, V192, P1315, DOI 10.1086/462430; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; von Kries R, 1999, BRIT MED J, V319, P147, DOI 10.1136/bmj.319.7203.147; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; YOSHIOKA H, 1983, PEDIATRICS, V72, P317; Zhou X, 2007, ISME J, V1, P121, DOI 10.1038/ismej.2007.12	40	462	483	2	126	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21313	10.1371/journal.pone.0021313	http://dx.doi.org/10.1371/journal.pone.0021313			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695057	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600058
J	Sanchez, S; Bakas, L; Gratton, E; Herlax, V				Sanchez, Susana; Bakas, Laura; Gratton, Enrico; Herlax, Vanesa			Alpha Hemolysin Induces an Increase of Erythrocytes Calcium: A FLIM 2-Photon Phasor Analysis Approach	PLOS ONE			English	Article							ESCHERICHIA-COLI HEMOLYSIN; PHOSPHOLIPID SCRAMBLASE; MODULATION FLUOROMETRY; MULTIFREQUENCY PHASE; MEMBRANES; PROTEIN; REPRESENTATION; TOXIN; PHOSPHATIDYLSERINE; ACTIVATION	alpha-hemolysin (HlyA) from Escherichia coli is considered as the prototype of a family of toxins called RTX (repeat in toxin), a group of proteins that share genetic and structural features. HlyA is an important virulence factor in E. coli extraintestinal infections, such as meningitis, septicemia and urinary infections. High concentrations of the toxin cause the lysis of several cells such as erythrocytes, granulocytes, monocytes, endothelial and renal epithelial cells of different species. At low concentrations it induces the production of cytokines and apoptosis. Since many of the subcytolytic effects in other cells have been reported to be triggered by the increase of intracellular calcium, we followed the calcium concentration inside the erythrocytes while incubating with sublytic concentrations of HlyA. Calcium concentration was monitored using the calcium indicator Green 1, 2-photon excitation, and fluorescence lifetime imaging microscopy (FLIM). Data were analyzed using the phasor representation. In this report, we present evidence that, at sublytic concentrations, HlyA induces an increase of calcium concentration in rabbit erythrocytes in the first 10 s. Results are discussed in relation to the difficulties of measuring calcium concentrations in erythrocytes where hemoglobin is present, the contribution of the background and the heterogeneity of the response observed in individual cells.	[Sanchez, Susana; Gratton, Enrico] Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92717 USA; [Sanchez, Susana] Ctr Nacl Invest Cardiovasc, Fdn CNIC Carlos III, Microscopy Unit, Madrid, Spain; [Bakas, Laura; Herlax, Vanesa] Univ Nacl La Plata, Fac Ciencias Med, CONICET, CCT La Plata,Inst Invest Bioquim La Plata INIBIOL, Buenos Aires, DF, Argentina; [Bakas, Laura] Univ Nacl La Plata, Fac Ciencias Exactas, Dept Ciencias Biol, Buenos Aires, DF, Argentina	University of California System; University of California Irvine; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata; National University of La Plata	Sanchez, S (corresponding author), Univ Calif Irvine, Fluorescence Dynam Lab, Irvine, CA 92717 USA.	vherlax@aetos.med.unlp.edu.ar	Sánchez, Susana/HII-3113-2022	Herlax, Vanesa/0000-0003-4218-8702	CONICET-NSF; Agencia Nacional de Promocion Cientifica y Tecnologica [647]; National Center for Research Resources of the National Institutes of Health [PHS 5 P41-RR003155]; UCI; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003155] Funding Source: NIH RePORTER	CONICET-NSF(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); National Center for Research Resources of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); UCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by grants for International Cooperation between CONICET-NSF (www.conicet.gov.ar) and Agencia Nacional de Promocion Cientifica y Tecnologica (PICT No647). SS and EG thank the National Center for Research Resources of the National Institutes of Health (PHS 5 P41-RR003155) and UCI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakas L, 2006, BIOPHYS J, V91, P3748, DOI 10.1529/biophysj.106.090019; Barreiro O, 2008, J CELL BIOL, V183, P527, DOI 10.1083/jcb.200805076; Bhadki S., 1996, ARCH MICROBIOL, V165, P73; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BITBOL M, 1987, BIOCHIM BIOPHYS ACTA, V904, P268, DOI 10.1016/0005-2736(87)90376-2; Celli A, 2010, BIOPHYS J, V98, P911, DOI 10.1016/j.bpj.2009.10.055; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Foller M, 2007, CELL PHYSIOL BIOCHEM, V20, P1051, DOI 10.1159/000110715; Garcia-Marcos A, 2008, BIOPHYS J, V94, P2884, DOI 10.1529/biophysj.107.121822; GRIMMINGER F, 1991, J CLIN INVEST, V88, P1531, DOI 10.1172/JCI115463; Grimminger F, 1997, J IMMUNOL, V159, P1909; Hanson KM, 2002, BIOPHYS J, V83, P1682, DOI 10.1016/S0006-3495(02)73936-2; Herlax V, 2009, J BIOL CHEM, V284, P25199, DOI 10.1074/jbc.M109.009365; HERRMANN A, 1990, BIOCHIM BIOPHYS ACTA, V1027, P41, DOI 10.1016/0005-2736(90)90045-P; James NG, 2011, ANAL BIOCHEM, V410, P70, DOI 10.1016/j.ab.2010.11.011; JAMESON DM, 1984, BIOPHYS J, V45, P795, DOI 10.1016/S0006-3495(84)84224-1; JAMESON DM, 1984, APPL SPECTROSC REV, V20, P55, DOI 10.1080/05704928408081716; Kaestner L, 2006, CELL CALCIUM, V39, P13, DOI 10.1016/j.ceca.2005.09.004; Kaestner L, 2004, PHOTOCH PHOTOBIO SCI, V3, P981, DOI 10.1039/b403127j; Koschinski A., 2006, FASEB J, pE80; Kuypers F A, 1998, Curr Opin Hematol, V5, P122; Laestadius A, 2002, KIDNEY INT, V62, P2035, DOI 10.1046/j.1523-1755.2002.00661.x; Moayeri M, 1997, INFECT IMMUN, V65, P2233, DOI 10.1128/IAI.65.6.2233-2239.1997; MOAYERI M, 1994, INFECT IMMUN, V62, P4124, DOI 10.1128/IAI.62.10.4124-4134.1994; Noomnarm U, 2009, PHOTOSYNTH RES, V101, P181, DOI 10.1007/s11120-009-9457-8; OSTOLAZA H, 1995, FEBS LETT, V371, P303, DOI 10.1016/0014-5793(95)00927-2; Redford GI, 2005, J FLUORESC, V15, P805, DOI 10.1007/s10895-005-2990-8; Schindel C, 2001, EUR J BIOCHEM, V268, P800, DOI 10.1046/j.1432-1327.2001.01937.x; Skals M, 2010, J BIOL CHEM, V285, P15557, DOI 10.1074/jbc.M109.082578; Skalsa M, 2009, P NATL ACAD SCI USA, V106, P4030, DOI 10.1073/pnas.0807044106; SNYDER IS, 1969, J GEN MICROBIOL, V5, P133; Soloaga A, 1998, BIOCHEMISTRY-US, V37, P6387, DOI 10.1021/bi9730994; Soupene E, 2006, BRIT J HAEMATOL, V133, P436, DOI 10.1111/j.1365-2141.2006.06051.x; Stefl M, 2011, ANAL BIOCHEM, V410, P62, DOI 10.1016/j.ab.2010.11.010; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Tiffert T., 2003, CALCIUM HOMEOSTASIS, P373; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Woon LA, 1999, CELL CALCIUM, V25, P313, DOI 10.1054/ceca.1999.0029; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhou QS, 1997, J BIOL CHEM, V272, P18240, DOI 10.1074/jbc.272.29.18240	41	12	13	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21127	10.1371/journal.pone.0021127	http://dx.doi.org/10.1371/journal.pone.0021127			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698153	gold, Green Published			2022-12-25	WOS:000291734100058
J	Yang, JJ; Cho, LY; Ma, SH; Ko, KP; Shin, A; Choi, BY; Han, DS; Song, KS; Kim, YS; Chang, SH; Shin, HR; Kang, D; Yoo, KY; Park, SK				Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Ko, Kwang-Pil; Shin, Aesun; Choi, Bo Youl; Han, Dong Soo; Song, Kyu Sang; Kim, Yong Sung; Chang, Soung-Hoon; Shin, Hai-Rim; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.			Oncogenic CagA Promotes Gastric Cancer Risk via Activating ERK Signaling Pathways: A Nested Case-Control Study	PLOS ONE			English	Article							HELICOBACTER-PYLORI CAGA; VIRULENCE FACTORS; EPITHELIAL-CELLS; PROTEIN; CRK; INFECTION; C3G; CARCINOGENESIS; ADHESION; DOCK180	Background: CagA cellular interaction via activation of the ERK signaling pathway may be a starting point in the development of gastric cancer. This study aimed to evaluate whether genes involved in ERK downstream signaling pathways activated by CagA are susceptible genetic markers for gastric cancer. Methods: In the discovery phase, a total of 580 SNPs within +/-5 kbp of 30 candidate genes were genotyped to examine an association with gastric cancer risk in the Korean Multi-center Cancer Cohort (100 incident gastric cancer case-control sets). The most significant SNPs (raw or permutated p value<0.02) identified in the discovery analysis were re-evaluated in the extension phase using unconditional logistic regression model (400 gastric cancer case-control sets). Combined analyses including pooled-and meta-analysis were conducted to summarize all the results. Results: 24 SNPs in eight genes (ERK, Dock180, C3G, Rap1, Src, CrkL, Mek and Crk) were significantly associated with gastric cancer risk in the individual SNP analyses in the discovery phase (p<0.05). In the extension analyses, ERK rs5999749, Dock180 rs4635002 and C3G rs7853122 showed marginally significant gene-dose effects for gastric cancer. Consistently, final combined analysis presented the SNPs as significantly associated with gastric cancer risk (OR = 1.56, [95% CI: 1.19-2.06], OR = 0.61, [95% CI: 0.43-0.87], OR = 0.59, [95% CI: 0.54-0.76], respectively). Conclusions: Our findings suggest that ERK rs5999749, Dock180 rs4635002 and C3G rs7853122 are genetic determinants in gastric carcinogenesis.	[Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Ko, Kwang-Pil] Gachon Univ Med & Sci, Dept Prevent Med, Inchon, South Korea; [Shin, Aesun; Shin, Hai-Rim] Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea; [Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Han, Dong Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Coll Med, Dept Pathol, Taejon, South Korea; [Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Chang, Soung-Hoon] Konkuk Univ, Dept Prevent Med, Chungju, South Korea; [Shin, Hai-Rim] Western Pacific Reg Off, World Hlth Org, Manila, Philippines; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Yang, Jae Jeong; Cho, Lisa Y.; Ma, Seung Hyun; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Gachon University; National Cancer Center - Korea (NCC); Hanyang University; Hanyang University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Konkuk University; Konkuk University Medical Center; World Health Organization; Seoul National University (SNU); Seoul National University (SNU)	Yang, JJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	suepark@snu.ac.kr	Yoo, Keun-Young/J-5548-2012; Shin, Aesun/E-9145-2014; Han, Dong Soo/P-1753-2015; Han, Dong Soo/AHD-6285-2022; Kang, Dae Hee/E-8631-2012; Park, Sue Kyung/J-2757-2012	Shin, Aesun/0000-0002-6426-1969; Han, Dong Soo/0000-0001-7103-3318; Kang, Daehee/0000-0003-4031-5878	Ministry of Education, Science and Technology [KRF-2007-313-E00175, NRF-2009-0066258]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology [KRF-2007-313-E00175] and [NRF-2009-0066258]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLASER MJ, 1995, CANCER RES, V55, P2111; Fischer W, 2001, MOL MICROBIOL, V42, P1337, DOI 10.1046/j.1365-2958.2001.02714.x; Handa O, 2007, BIOCHEM PHARMACOL, V73, P1697, DOI 10.1016/j.bcp.2006.10.022; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Hatakeyama M, 2003, MICROBES INFECT, V5, P143, DOI 10.1016/S1286-4579(02)00085-0; Hatakeyama M, 2006, INT J HEMATOL, V84, P301, DOI 10.1532/IJH97.06166; Hirata T, 2004, J HUM GENET, V49, P290, DOI 10.1007/s10038-004-0148-1; Keates S, 1999, J IMMUNOL, V163, P5552; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Lin Charles H., 2009, V496, P129, DOI 10.1007/978-1-59745-553-4_10; Mochizuki N, 2000, J BIOL CHEM, V275, P12667, DOI 10.1074/jbc.275.17.12667; *NCBI OMIM, NCBI OMIM DEDICATOR; Ohba Y, 2001, EMBO J, V20, P3333, DOI 10.1093/emboj/20.13.3333; Park CY, 2002, J CLIN MICROBIOL, V40, P4753, DOI 10.1128/JCM.40.12.4753-4756.2002; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Parsonnet J, 1997, GUT, V40, P297, DOI 10.1136/gut.40.3.297; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rohde M, 2003, MOL MICROBIOL, V49, P219, DOI 10.1046/j.1365-2958.2003.03549.x; Samuelsson J, 2011, INT J ONCOL, V38, P1575, DOI 10.3892/ijo.2011.972; Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Wang H, 2010, TUMOR BIOL, V31, P59, DOI 10.1007/s13277-009-0009-9; Wen SC, 2009, CANCER LETT, V282, P1, DOI 10.1016/j.canlet.2008.11.016; Wu CB, 2001, J NEUROSCI, V21, P5406, DOI 10.1523/JNEUROSCI.21-15-05406.2001; Wu YC, 1998, NATURE, V392, P501, DOI 10.1038/33163; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhu YL, 2005, ONCOGENE, V24, P3886, DOI 10.1038/sj.onc.1208551	31	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21155	10.1371/journal.pone.0021155	http://dx.doi.org/10.1371/journal.pone.0021155			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698158	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100062
J	Chang, JG; Yang, DM; Chang, WH; Chow, LP; Chan, WL; Lin, HH; Huang, HD; Chang, YS; Hung, CH; Yang, WK				Chang, Jan-Gowth; Yang, Den-Mei; Chang, Wen-Hsin; Chow, Lu-Ping; Chan, Wen-Ling; Lin, Hui-Hua; Huang, Hsien-Da; Chang, Ya-Sian; Hung, Cheng-Hao; Yang, Wen-Kuang			Small Molecule Amiloride Modulates Oncogenic RNA Alternative Splicing to Devitalize Human Cancer Cells	PLOS ONE			English	Article							PRE-MESSENGER-RNA; SR PROTEIN; MEDIATED APOPTOSIS; CARCINOMA-CELLS; PHOSPHORYLATION; EXPRESSION; MECHANISMS; LINES; DEPHOSPHORYLATION; PHOSPHATASE-1	Alternative splicing involves differential exon selection of a gene transcript to generate mRNA and protein isoforms with structural and functional diversity. Abnormal alternative splicing has been shown to be associated with malignant phenotypes of cancer cells, such as chemo-resistance and invasive activity. Screening small molecules and drugs for modulating RNA splicing in human hepatocellular carcinoma cell line Huh-7, we discovered that amiloride, distinct from four pH-affecting amiloride analogues, could "normalize" the splicing of BCL-X, HIPK3 and RON/MISTR1 transcripts. Our proteomic analyses of amiloride-treated cells detected hypo-phosphorylation of splicing factor SF2/ASF, and decreased levels of SRp20 and two un-identified SR proteins. We further observed decreased phosphorylation of AKT, ERK1/2 and PP1, and increased phosphorylation of p38 and JNK, suggesting that amiloride treatment down-regulates kinases and up-regulates phosphatases in the signal pathways known to affect splicing factor protein phosphorylation. These amiloride effects of "normalized" oncogenic RNA splicing and splicing factor hypo-phosphorylation were both abrogated by pretreatment with a PP1 inhibitor. Global exon array of amiloride-treated Huh-7 cells detected splicing pattern changes involving 584 exons in 551 gene transcripts, many of which encode proteins playing key roles in ion transport, cellular matrix formation, cytoskeleton remodeling, and genome maintenance. Cellular functional analyses revealed subsequent invasion and migration defects, cell cycle disruption, cytokinesis impairment, and lethal DNA degradation in amiloride-treated Huh-7 cells. Other human solid tumor and leukemic cells, but not a few normal cells, showed similar amiloride-altered RNA splicing with devitalized consequence. This study thus provides mechanistic underpinnings for exploiting small molecule modulation of RNA splicing for cancer therapeutics.	[Chang, Jan-Gowth; Lin, Hui-Hua; Chang, Ya-Sian] Kaohsiung Med Univ, Univ Hosp, Dept Med Res, Kaohsiung, Taiwan; [Chang, Jan-Gowth; Lin, Hui-Hua] Kaohsiung Med Univ, Grad Inst Clin Med, Kaohsiung, Taiwan; [Chang, Jan-Gowth; Chang, Wen-Hsin] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Yang, Den-Mei; Hung, Cheng-Hao; Yang, Wen-Kuang] China Med Univ Hosp, Dept Med Res, Cell Gene Therapy Res Lab, Taichung, Taiwan; [Chow, Lu-Ping] Natl Taiwan Univ, Coll Med, Grad Inst Biochem & Mol Biol, Taipei 10764, Taiwan; [Chan, Wen-Ling; Huang, Hsien-Da] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Chan, Wen-Ling; Huang, Hsien-Da] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Yang, Wen-Kuang] China Med Univ, Dept Biochem, Taichung, Taiwan; [Yang, Wen-Kuang] China Med Univ, Dept Med, Taichung, Taiwan; [Chang, Jan-Gowth] Kaohsiung Med Univ Hosp, Ctr Canc, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Taiwan; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Chang, JG (corresponding author), Kaohsiung Med Univ, Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.	jgchang@ms.kmuh.org.tw; wkyang@mail.cmu.edu.tw	Huang, Hsien-Da/AAA-7376-2019	CHOW, LU-PING/0000-0002-4420-211X	National Science Council of Taiwan [NSC-95-2320-B-037-049, NSC 95-2311-B-009-004-MY3, NSC 97-2627-B-009-007]; Department of Health of Taiwan [DOH95-B-11-TM007, DOH96-TD-I-111-TM003]	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Department of Health of Taiwan	This work was supported by Research grants NSC-95-2320-B-037-049 (JGC), NSC 95-2311-B-009-004-MY3 (HDH) and NSC 97-2627-B-009-007 (HDH) from the National Science Council of Taiwan and by DOH95-B-11-TM007 (WKY) and DOH96-TD-I-111-TM003 (WKY) from the Department of Health of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BULL MB, 1968, CIRCULATION, V37, P45, DOI 10.1161/01.CIR.37.1.45; Caceres JF, 2002, TRENDS GENET, V18, P186, DOI 10.1016/S0168-9525(01)02626-9; Cao WH, 1997, RNA, V3, P1456; CARDINALI B, 1994, FEBS LETT, V352, P276, DOI 10.1016/0014-5793(94)00973-2; Chan CH, 2006, MOL CELL PROTEOMICS, V5, P702, DOI 10.1074/mcp.M500029-MCP200; CHANG WH, CANC RES, V71, P383; Chen QY, 1997, HEPATOLOGY, V26, P59; Chen WS, 2001, INT J CANCER, V91, P894, DOI 10.1002/1097-0215(200102)9999:9999<894::AID-IJC1146>3.3.CO;2-R; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curtin JF, 2004, J BIOL CHEM, V279, P17090, DOI 10.1074/jbc.M307629200; DAVIS RJ, 1985, J BIOL CHEM, V260, P2543; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; FUXD, 1995, RNA, V1, P663; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; GUI JF, 1994, NATURE, V369, P678, DOI 10.1038/369678a0; HARN HJ, 1994, BIOCHEM MOL BIOL INT, V33, P743; Hertel KJ, 2005, TRENDS BIOCHEM SCI, V30, P115, DOI 10.1016/j.tibs.2005.01.002; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Hung SC, 2004, INT J CANCER, V110, P313, DOI 10.1002/ijc.20126; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Juang SH, 2004, J INTERF CYTOK RES, V24, P231, DOI 10.1089/107999004323034105; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kim KM, 2005, ONCOGENE, V24, P355, DOI 10.1038/sj.onc.1208213; Koizumi J, 1999, J BIOL CHEM, V274, P11125, DOI 10.1074/jbc.274.16.11125; Lozzio B B, 1977, Int J Cancer, V19, P136, DOI 10.1002/ijc.2910190119; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Medhurst AL, 2006, BLOOD, V108, P2072, DOI 10.1182/blood-2005-11-008151; Misteli T, 1996, MOL BIOL CELL, V7, P1559, DOI 10.1091/mbc.7.10.1559; Ngo JCK, 2008, MOL CELL, V29, P563, DOI 10.1016/j.molcel.2007.12.017; Pajares MJ, 2007, LANCET ONCOL, V8, P349, DOI 10.1016/S1470-2045(07)70104-3; Patel NA, 2005, J BIOL CHEM, V280, P14302, DOI 10.1074/jbc.M411485200; Pelisch F, 2005, J BIOL CHEM, V280, P25461, DOI 10.1074/jbc.M412007200; Pozzoli U, 2005, CELL MOL LIFE SCI, V62, P1579, DOI 10.1007/s00018-005-5030-6; Prasad J, 1999, MOL CELL BIOL, V19, P6991; Schwerk C, 2005, MOL CELL, V19, P1, DOI 10.1016/j.molcel.2005.05.026; Skop AR, 2004, SCIENCE, V305, P61, DOI 10.1126/science.1097931; Srebrow A, 2006, J CELL SCI, V119, P2635, DOI 10.1242/jcs.03053; Srinivasan K, 2005, METHODS, V37, P345, DOI 10.1016/j.ymeth.2005.09.007; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stetefeld J, 2005, TRENDS BIOCHEM SCI, V30, P515, DOI 10.1016/j.tibs.2005.07.001; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Swift Pauline A, 2004, Am J Pharmacogenomics, V4, P161, DOI 10.2165/00129785-200404030-00003; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Xiao SH, 1997, GENE DEV, V11, P334, DOI 10.1101/gad.11.3.334; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; Yuo CY, 2008, ANN NEUROL, V63, P26, DOI 10.1002/ana.21241	55	47	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e18643	10.1371/journal.pone.0018643	http://dx.doi.org/10.1371/journal.pone.0018643			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694768	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900002
J	Tanwar, PS; Zhang, LH; Kaneko-Tarui, T; Curley, MD; Taketo, MM; Rani, P; Roberts, DJ; Teixeira, JM				Tanwar, Pradeep S.; Zhang, LiHua; Kaneko-Tarui, Tomoko; Curley, Michael D.; Taketo, Makoto M.; Rani, Poonam; Roberts, Drucilla J.; Teixeira, Jose M.			Mammalian Target of Rapamycin Is a Therapeutic Target for Murine Ovarian Endometrioid Adenocarcinomas with Dysregulated Wnt/beta-Catenin and PTEN	PLOS ONE			English	Article							MULLERIAN-INHIBITING SUBSTANCE; TRANSGENIC MOUSE MODEL; CELL TUMOR-DEVELOPMENT; BETA-CATENIN; SURFACE EPITHELIUM; FOLLICULAR DEVELOPMENT; REPRODUCTIVE-TRACT; GRANULOSA-CELLS; BREAST-CANCER; EXPRESSION	Despite the fact that epithelial ovarian cancers are the leading cause of death from gynecological cancer, very little is known about the pathophysiology of the disease. Mutations in the WNT and PI3K pathways are frequently observed in the human ovarian endometrioid adenocarcinomas (OEAs). However, the role of WNT/beta-catenin and PTEN/AKT signaling in the etiology and/or progression of this disease is currently unclear. In this report we show that mice with a gain-of-function mutation in beta-catenin that leads to dysregulated nuclear accumulation of beta-catenin expression in the ovarian surface epithelium (OSE) cells develop indolent, undifferentiated tumors with both mesenchymal and epithelial characteristics. Combining dysregulated beta-catenin with homozygous deletion of PTEN in the OSE resulted in development of significantly more aggressive tumors, which was correlated with inhibition of p53 expression and cellular senescence. Induced expression of both mTOR kinase, a master regulator of proliferation, and phosphorylation of its downstream target, S6Kinase was also observed in both the indolent and aggressive mouse tumors, as well as in human OEA with nuclear beta-catenin accumulation. Ectopic allotransplants of the mouse ovarian tumor cells with a gain-of-function mutation in beta-catenin and PTEN deletion developed into tumors with OEA histology, the growth of which were significantly inhibited by oral rapamycin treatment. These studies demonstrate that rapamycin might be an effective therapeutic for human ovarian endometrioid patients with dysregulated Wnt/beta-catenin and Pten/PI3K signaling.	[Tanwar, Pradeep S.; Zhang, LiHua; Kaneko-Tarui, Tomoko; Curley, Michael D.; Rani, Poonam; Teixeira, Jose M.] Massachusetts Gen Hosp, Dept Obstet Gynecol & Reprod Biol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Tanwar, Pradeep S.; Zhang, LiHua; Kaneko-Tarui, Tomoko; Curley, Michael D.; Rani, Poonam; Roberts, Drucilla J.; Teixeira, Jose M.] Harvard Univ, Sch Med, Boston, MA USA; [Taketo, Makoto M.] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Roberts, Drucilla J.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Kyoto University; Harvard University; Massachusetts General Hospital	Teixeira, JM (corresponding author), Massachusetts Gen Hosp, Dept Obstet Gynecol & Reprod Biol, Vincent Ctr Reprod Biol, Boston, MA 02114 USA.	teixeira@helix.mgh.harvard.edu	Tanwar, Pradeep/AAU-6831-2020; Roberts, Drucilla/AAB-6379-2022; Kaneko-Tarui, Tomoko/E-3319-2010; Teixeira, Jose/P-2542-2014	Kaneko-Tarui, Tomoko/0000-0001-5463-1551; Teixeira, Jose/0000-0002-6438-5064	NIH [HD052701]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052701] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported in part by an NIH grant to JMT (HD052701) and by Vincent Memorial Research Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Ahmad I, 2011, ONCOGENE, V30, P178, DOI 10.1038/onc.2010.399; Arango NA, 2005, DEV BIOL, V288, P276, DOI 10.1016/j.ydbio.2005.09.045; Arango NA, 2008, MOL REPROD DEV, V75, P1154, DOI 10.1002/mrd.20858; Auersperg N, 2001, ENDOCR REV, V22, P255, DOI 10.1210/er.22.2.255; Ball BA, 2008, THERIOGENOLOGY, V70, P968, DOI 10.1016/j.theriogenology.2008.05.059; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; Brabletz T, 2001, P NATL ACAD SCI USA, V98, P10356, DOI 10.1073/pnas.171610498; Chang HL, 2009, GYNECOL ONCOL, V114, P57, DOI 10.1016/j.ygyno.2009.02.023; Cheng WJ, 2005, NAT MED, V11, P531, DOI 10.1038/nm1230; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Connolly DC, 2003, CANCER RES, V63, P1389; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Diegel CR, 2010, CANCER RES, V70, P9143, DOI 10.1158/0008-5472.CAN-10-1758; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dubeau L, 1999, GYNECOL ONCOL, V72, P437, DOI 10.1006/gyno.1998.5275; Fan HY, 2008, MOL ENDOCRINOL, V22, P2128, DOI 10.1210/me.2008-0095; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Fan HY, 2009, CANCER RES, V69, P6463, DOI 10.1158/0008-5472.CAN-08-3363; Freeman DJ, 2003, CANCER CELL, V3, P117, DOI 10.1016/S1535-6108(03)00021-7; Fujishita T, 2008, P NATL ACAD SCI USA, V105, P13544, DOI 10.1073/pnas.0800041105; Gatcliffe TA, 2008, INT J GYNECOL CANCER, V18, P954, DOI 10.1111/j.1525-1438.2007.01127.x; Halberg RB, 2000, P NATL ACAD SCI USA, V97, P3461, DOI 10.1073/pnas.050585597; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Harada N, 2002, CANCER RES, V62, P1971; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Jamin SP, 2002, NAT GENET, V32, P408, DOI 10.1038/ng1003; Jung A, 2001, AM J PATHOL, V159, P1613, DOI 10.1016/S0002-9440(10)63007-6; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kobayashi A, 2003, NAT REV GENET, V4, P969, DOI 10.1038/nrg1225; Kurrey NK, 2009, STEM CELLS, V27, P2059, DOI 10.1002/stem.154; Lague MN, 2008, CARCINOGENESIS, V29, P2062, DOI 10.1093/carcin/bgn186; Lesche R, 2002, GENESIS, V32, P148, DOI 10.1002/gene.10036; Liang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004295; Liu M, 2005, CANCER RES, V65, P5325, DOI 10.1158/0008-5472.CAN-04-4589; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Mabuchi S, 2009, CLIN CANCER RES, V15, P5404, DOI 10.1158/1078-0432.CCR-09-0365; MIDDLEBROOK BS, 2009, ENDOCRINOLOGY; Orsulic S, 2002, CANCER CELL, V1, P53, DOI 10.1016/S1535-6108(01)00002-2; Renlund N, 2008, ENDOCRINOLOGY, V149, P108, DOI 10.1210/en.2007-0529; Rosen DG, 2009, FRONT BIOSCI-LANDMRK, V14, P2089, DOI 10.2741/3364; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sawyer HR, 2002, BIOL REPROD, V66, P1134, DOI 10.1095/biolreprod66.4.1134; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; Szotek PP, 2007, STEM CELLS, V25, P1317, DOI 10.1634/stemcells.2006-0204; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tanwar PS, 2009, BIOL REPROD, V81, P545, DOI 10.1095/biolreprod.108.075648; Teixeira J, 2001, ENDOCR REV, V22, P657, DOI 10.1210/er.22.5.657; Trazzi S, 2011, HUM MOL GENET, V20, P1560, DOI 10.1093/hmg/ddr033; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Wright K, 1999, INT J CANCER, V82, P625, DOI 10.1002/(SICI)1097-0215(19990827)82:5<625::AID-IJC1>3.0.CO;2-2; Wu R, 2001, CANCER RES, V61, P8247; Wu R, 2007, CANCER CELL, V11, P321, DOI 10.1016/j.ccr.2007.02.016; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	56	42	44	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20715	10.1371/journal.pone.0020715	http://dx.doi.org/10.1371/journal.pone.0020715			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695255	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900021
J	Shimamura, T; Imoto, S; Shimada, Y; Hosono, Y; Niida, A; Nagasaki, M; Yamaguchi, R; Takahashi, T; Miyano, S				Shimamura, Teppei; Imoto, Seiya; Shimada, Yukako; Hosono, Yasuyuki; Niida, Atsushi; Nagasaki, Masao; Yamaguchi, Rui; Takahashi, Takashi; Miyano, Satoru			A Novel Network Profiling Analysis Reveals System Changes in Epithelial-Mesenchymal Transition	PLOS ONE			English	Article							NEGATIVE FEEDBACK LOOP; E-CADHERIN EXPRESSION; BREAST-CANCER CELLS; GENE NETWORKS; IN-VIVO; TRANSCRIPTIONAL REPRESSOR; TUMOR-METASTASIS; MIGRATION; INVASION; GROWTH	Patient-specific analysis of molecular networks is a promising strategy for making individual risk predictions and treatment decisions in cancer therapy. Although systems biology allows the gene network of a cell to be reconstructed from clinical gene expression data, traditional methods, such as Bayesian networks, only provide an averaged network for all samples. Therefore, these methods cannot reveal patient-specific differences in molecular networks during cancer progression. In this study, we developed a novel statistical method called NetworkProfiler, which infers patient-specific gene regulatory networks for a specific clinical characteristic, such as cancer progression, from gene expression data of cancer patients. We applied NetworkProfiler to microarray gene expression data from 762 cancer cell lines and extracted the system changes that were related to the epithelial-mesenchymal transition (EMT). Out of 1732 possible regulators of E-cadherin, a cell adhesion molecule that modulates the EMT, NetworkProfiler, identified 25 candidate regulators, of which about half have been experimentally verified in the literature. In addition, we used NetworkProfiler to predict EMT-dependent master regulators that enhanced cell adhesion, migration, invasion, and metastasis. In order to further evaluate the performance of NetworkProfiler, we selected Krueppel-like factor 5 (KLF5) from a list of the remaining candidate regulators of E-cadherin and conducted in vitro validation experiments. As a result, we found that knockdown of KLF5 by siRNA significantly decreased E-cadherin expression and induced morphological changes characteristic of EMT. In addition, in vitro experiments of a novel candidate EMT-related microRNA, miR-100, confirmed the involvement of miR-100 in several EMT-related aspects, which was consistent with the predictions obtained by NetworkProfiler.	[Shimamura, Teppei; Imoto, Seiya; Niida, Atsushi; Nagasaki, Masao; Yamaguchi, Rui; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan; [Shimada, Yukako; Hosono, Yasuyuki; Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Showa Ku, Nagoya, Aichi 4648601, Japan	University of Tokyo; Nagoya University	Shimamura, T (corresponding author), Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan.	shima@ims.u-tokyo.ac.jp	Hosono, Yasuyuki/GOP-1342-2022; Takahashi, Takashi/I-7262-2014; Hosono, Yasuyuki/J-4295-2019	Takahashi, Takashi/0000-0003-0615-7001; Nagasaki, Masao/0000-0002-4292-8785; Shimamura, Teppei/0000-0003-2994-872X; Miyano, Satoru/0000-0002-1753-6616	MEXT, Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by "Research and Development of the Next-Generation Integrated Simulation of Living Matter" (a part of the Development and Use of the Next-Generation Supercomputer Project of MEXT) and "Integrative Systems Understanding of Cancer for Advanced Diagnosis, Therapy and Prevention" (Grant-in-Aid for Scientific Research on Innovative Areas from MEXT, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiseshaiah P, 2007, CANCER RES, V67, P6204, DOI 10.1158/0008-5472.CAN-06-4687; Almeida MS, 2005, MECH DEVELOP, V122, P1282, DOI 10.1016/j.mod.2005.08.004; AUNG CS, 2010, EUR J CELL BIOL 0821; Bansal M, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100120; Bauer K, 2000, BLOOD, V96, P4236; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Buchwalter G, 2005, MOL CELL BIOL, V25, P10853, DOI 10.1128/MCB.25.24.10853-10862.2005; Cai CM, 2007, MOL ENDOCRINOL, V21, P1835, DOI 10.1210/me.2006-0480; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chen HM, 2009, CANCER RES, V69, P9228, DOI 10.1158/0008-5472.CAN-09-1950; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Dahl KDC, 2005, MOL BIOL CELL, V16, P1901; Eger A, 2005, ONCOGENE, V24, P2375, DOI 10.1038/sj.onc.1208429; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Hajra KM, 2002, CANCER RES, V62, P1613; Hartung J., 2008, STAT METAANALYSIS AP; Hayes SA, 2003, ONCOGENE, V22, P4841, DOI 10.1038/sj.onc.1206730; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI [DOI 10.2307/1267351, DOI 10.1080/00401706.1970.10488634]; Hong IK, 2006, J BIOL CHEM, V281, P24279, DOI 10.1074/jbc.M601209200; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Hurst DR, 2009, CANCER RES, V69, P1279, DOI 10.1158/0008-5472.CAN-08-3559; Imtiyaz HZ, 2010, J CLIN INVEST, V120, P2699, DOI 10.1172/JCI39506; Janulis M, 1999, J BIOL CHEM, V274, P801, DOI 10.1074/jbc.274.2.801; Jean C, 2009, CANCER RES, V69, P3291, DOI 10.1158/0008-5472.CAN-08-1909; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kim KS, 2006, CANCER RES, V66, P7983, DOI 10.1158/0008-5472.CAN-05-4381; Kozaki K, 2000, CANCER RES, V60, P2535; Lu X, 2010, CANCER RES, V70, P3905, DOI 10.1158/0008-5472.CAN-09-3739; Malin D, 2007, MOL CELL BIOL, V27, P2486, DOI 10.1128/MCB.01736-06; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Gonzalez-Angulo AM, 2010, J CLIN ONCOL, V28, P2777, DOI 10.1200/JCO.2009.27.0777; Marlowe JL, 2005, J CELL BIOCHEM, V96, P1174, DOI 10.1002/jcb.20656; Matsuya M, 1998, J BIOL CHEM, V273, P1003, DOI 10.1074/jbc.273.2.1003; Matsuzaki K, 2009, CANCER RES, V69, P5321, DOI 10.1158/0008-5472.CAN-08-4203; Minami T, 2006, J BIOL CHEM, V281, P20503, DOI 10.1074/jbc.M513112200; Mori-Akiyama Y, 2003, P NATL ACAD SCI USA, V100, P9360, DOI 10.1073/pnas.1631288100; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Niida A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-71; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Panda DK, 2001, J BIOL CHEM, V276, P41229, DOI 10.1074/jbc.M104231200; Perez-Moreno MA, 2001, J BIOL CHEM, V276, P27424, DOI 10.1074/jbc.M100827200; Perry C, 2002, ONCOGENE, V21, P8428, DOI 10.1038/sj.onc.1205945; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Schedin PJ, 2004, ONCOGENE, V23, P1766, DOI 10.1038/sj.onc.1207391; Schilsky RL, 2010, NAT REV DRUG DISCOV, V9, P363, DOI 10.1038/nrd3181; Schymeinsky J, 2006, BLOOD, V108, P3919, DOI 10.1182/blood-2005-12-030387; Sekimoto G, 2007, CANCER RES, V67, P5090, DOI 10.1158/0008-5472.CAN-06-4629; Shair KHY, 2008, CANCER RES, V68, P6997, DOI 10.1158/0008-5472.CAN-08-1178; Shimamura T, 2010, BIOINFORMATICS, V26, P1064, DOI 10.1093/bioinformatics/btq080; Shimamura T, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-41; Sobrado VR, 2009, J CELL SCI, V122, P1014, DOI 10.1242/jcs.028241; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taguchi A, 2008, CANCER RES, V68, P5540, DOI 10.1158/0008-5472.CAN-07-6460; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Tomioka N, 2000, J NEUROSCI, V20, P5802, DOI 10.1523/JNEUROSCI.20-15-05802.2000; Wang B, 2010, DIABETES, V59, P1794, DOI 10.2337/db09-1736; Wang E, 2010, CH CRC MATH COMP BIO, P1, DOI 10.1201/9781439811863-f; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang YZ, 2008, J BIOL CHEM, V283, P18812, DOI 10.1074/jbc.M801384200; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yori JL, 2010, J BIOL CHEM, V285, P16854, DOI 10.1074/jbc.M110.114546; Zent CS, 1996, P NATL ACAD SCI USA, V93, P1044, DOI 10.1073/pnas.93.3.1044; Zhang XM, 2009, CANCER RES, V69, P6033, DOI 10.1158/0008-5472.CAN-08-4592; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	74	29	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20804	10.1371/journal.pone.0020804	http://dx.doi.org/10.1371/journal.pone.0020804			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687740	Green Published, Green Submitted, gold			2022-12-25	WOS:000291607000023
J	Bai, XG; Yang, LM; Tian, MH; Chen, JH; Shi, JS; Yang, YP; Hu, XY				Bai, Xuegui; Yang, Liming; Tian, Meihua; Chen, Jinhui; Shi, Jisen; Yang, Yongping; Hu, Xiangyang			Nitric Oxide Enhances Desiccation Tolerance of Recalcitrant Antiaris toxicaria Seeds via Protein S-Nitrosylation and Carbonylation	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; ABSCISIC-ACID; HYDROXYL RADICALS; STOMATAL CLOSURE; OXIDATIVE BURST; ARABIDOPSIS; ASCORBATE; DORMANCY; MAIZE; DEHYDROASCORBATE	The viability of recalcitrant seeds is lost following stress from either drying or freezing. Reactive oxygen species (ROS) resulting from uncontrolled metabolic activity are likely responsible for seed sensitivity to drying. Nitric oxide (NO) and the ascorbate-glutathione cycle can be used for the detoxification of ROS, but their roles in the seed response to desiccation remain poorly understood. Here, we report that desiccation induces rapid accumulation of H2O2, which blocks recalcitrant Antiaris toxicaria seed germination; however, pretreatment with NO increases the activity of antioxidant ascorbate-glutathione pathway enzymes and metabolites, diminishes H2O2 production and assuages the inhibitory effects of desiccation on seed germination. Desiccation increases the protein carbonylation levels and reduces protein S-nitrosylation of these antioxidant enzymes; these effects can be reversed with NO treatment. Antioxidant protein S-nitrosylation levels can be further increased by the application of S-nitrosoglutathione reductase inhibitors, which further enhances NO-induced seed germination rates after desiccation and reduces desiccation-induced H2O2 accumulation. These findings suggest that NO reinforces recalcitrant seed desiccation tolerance by regulating antioxidant enzyme activities to stabilize H2O2 accumulation at an appropriate concentration. During this process, protein carbonylation and S-nitrosylation patterns are used as a specific molecular switch to control antioxidant enzyme activities.	[Bai, Xuegui; Tian, Meihua; Yang, Yongping; Hu, Xiangyang] Chinese Acad Sci, Inst Tibet Plateau Res Kunming, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China; [Chen, Jinhui; Shi, Jisen] Nanjing Forestry Univ, Minist Educ, Key Lab Forest Genet & Biotechnol, Nanjing, Peoples R China; [Yang, Liming] Huaiyin Normal Univ, Sch Life Sci, Huaian, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Nanjing Forestry University; Huaiyin Normal University	Bai, XG (corresponding author), Chinese Acad Sci, Inst Tibet Plateau Res Kunming, Kunming Inst Bot, Key Lab Biodivers & Biogeog, Kunming, Peoples R China.	huxiangyang@mail.kib.ac.cn	Hu, Xiangyang/AAQ-3313-2021		CAS; National Science Foundation [30871704, 30971452, 30900871]	CAS(Chinese Academy of Sciences); National Science Foundation(National Science Foundation (NSF))	This work was supported by 100 Talents Program of CAS and National Science Foundation grant of China (No. 30871704, No. 30971452 and No. 30900871). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailly C, 2004, SEED SCI RES, V14, P93, DOI 10.1079/SSR2004159; Beligni MV, 2002, PLANT PHYSIOL, V129, P1642, DOI 10.1104/pp.002337; Bethke PC, 2007, PLANT PHYSIOL, V143, P1173, DOI 10.1104/pp.106.093435; Bethke PC, 2006, J EXP BOT, V57, P517, DOI 10.1093/jxb/erj060; Bethke PC, 2006, PLANTA, V223, P805, DOI 10.1007/s00425-005-0116-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bright J, 2006, PLANT J, V45, P113, DOI 10.1111/j.1365-313X.2005.02615.x; Cheng HY, 2008, J INTEGR PLANT BIOL, V50, P1549, DOI 10.1111/j.1744-7909.2008.00723.x; Corpas FJ, 2008, PLANT SIGNAL BEHAV, V3, P301, DOI 10.4161/psb.3.5.5277; De Tullio MC, 1998, PLANT PHYSIOL BIOCH, V36, P433, DOI 10.1016/S0981-9428(98)80207-6; Desikan R, 2002, P NATL ACAD SCI USA, V99, P16314, DOI 10.1073/pnas.252461999; Freschi L, 2010, PLANT PHYSIOL, V152, P1971, DOI 10.1104/pp.109.151613; Fry SC, 2001, BIOCHEM J, V357, P729, DOI 10.1042/0264-6021:3570729; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Grennan AK, 2007, PLANT PHYSIOL, V144, P1237, DOI 10.1104/pp.104.900228; He YK, 2004, SCIENCE, V305, P1968, DOI 10.1126/science.1098837; Hu XY, 2005, PLANT PHYSIOL, V137, P663, DOI 10.1104/pp.104.054494; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Koller A, 2002, P NATL ACAD SCI USA, V99, P11969, DOI 10.1073/pnas.172183199; Komatsu S, 2009, J PROTEOME RES, V8, P4766, DOI 10.1021/pr900460x; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Leprince O., 1993, Seed Science Research, V3, P231, DOI 10.1017/S0960258500001859; Lindermayr C, 2005, PLANT PHYSIOL, V137, P921, DOI 10.1104/pp.104.058719; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561; Neill SJ, 2002, J EXP BOT, V53, P1237, DOI 10.1093/jexbot/53.372.1237; Neill S, 2008, J EXP BOT, V59, P25, DOI 10.1093/jxb/erm218; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Oracz K, 2007, PLANT J, V50, P452, DOI 10.1111/j.1365-313X.2007.03063.x; Orozco-Cardenas ML, 2001, PLANT CELL, V13, P179, DOI 10.1105/tpc.13.1.179; Pammenter NW, 1999, SEED SCI RES, V9, P13, DOI 10.1017/S0960258599000033; Pukacka S, 2006, J PLANT PHYSIOL, V163, P1259, DOI 10.1016/j.jplph.2005.10.003; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Roach T, 2008, PHYSIOL PLANTARUM, V133, P131, DOI 10.1111/j.1399-3054.2007.00986.x; Roach T, 2010, PLANT CELL ENVIRON, V33, P59, DOI 10.1111/j.1365-3040.2009.02053.x; SANGHANI PC, 2009, J BIOCH, P24354; Sarath G, 2006, PLANTA, V223, P1154, DOI 10.1007/s00425-005-0162-3; Sarath G, 2007, PLANTA, V226, P697, DOI 10.1007/s00425-007-0517-z; Schweikert C, 2002, PHYTOCHEMISTRY, V61, P31, DOI 10.1016/S0031-9422(02)00183-8; Sen S., 2010, American Journal of Plant Physiology, V5, P122; SMITH IK, 1985, PLANT PHYSIOL, V79, P1044, DOI 10.1104/pp.79.4.1044; Song SQ, 2009, J INTEGR PLANT BIOL, V51, P646, DOI 10.1111/j.1744-7909.2009.00836.x; Sun BT, 2007, J PLANT PHYSIOL, V164, P536, DOI 10.1016/j.jplph.2006.02.011; Tanou G, 2010, J PROTEOME RES, V9, P5994, DOI 10.1021/pr100782h; Tanou G, 2009, PLANT J, V60, P795, DOI 10.1111/j.1365-313X.2009.04000.x; Zhang AY, 2007, NEW PHYTOL, V175, P36, DOI 10.1111/j.1469-8137.2007.02071.x; Zheng CF, 2009, ENVIRON EXP BOT, V67, P222, DOI 10.1016/j.envexpbot.2009.05.002	47	114	116	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20714	10.1371/journal.pone.0020714	http://dx.doi.org/10.1371/journal.pone.0020714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674063	Green Published, gold, Green Submitted			2022-12-25	WOS:000291310600027
J	Allsopp, RC; El Ajouz, S; Schmid, R; Evans, RJ				Allsopp, Rebecca C.; El Ajouz, Sam; Schmid, Ralf; Evans, Richard J.			Cysteine Scanning Mutagenesis (Residues Glu(52)-Gly(96)) of the Human P2X1 Receptor for ATP MAPPING AGONIST BINDING AND CHANNEL GATING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN P2X(1) RECEPTORS; SUBSTITUTION MUTANTS; AMINO-ACIDS; ION-CHANNEL; IDENTIFICATION; SITE; RECOGNITION; ANTAGONIST; LIGAND; ERRORS	P2X receptors are ATP-gated cation channels. The x-ray structure of a P2X4 receptor provided a major advance in understanding the molecular basis of receptor properties. However, how agonists are coordinated, the extent of the binding site, and the contribution of the vestibules in the extracellular domain to ionic permeation have not been addressed. We have used cysteine-scanning mutagenesis to determine the contribution of residues Glu(52)-Gly(96) to human P2X1 receptor properties. ATP potency was reduced for the mutants K68C, K70C, and F92C. The efficacy of the partial agonist BzATP was also reduced for several mutants forming the back of the proposed agonist binding site. Molecular docking in silico of both ATP and BzATP provided models of the agonist binding site consistent with these data. Individual cysteine mutants had no effect or slightly increased antagonism by suramin or pyridoxal-phosphate-6-azophenyl-2',4'-disulfonate. Mutants at the entrance to and lining the upper vestibule were unaffected by cysteine-reactive methanethiosulfonate (MTS) reagents, suggesting that it does not contribute to ionic permeation. Mutants that were sensitive to modification by MTS reagents were predominantly found either around the proposed ATP binding pocket or on the strands connecting the binding pocket to the transmembrane region and lining the central vestibule. In particular, ATP sensitivity and currents were increased by a positively charged MTS reagent at the G60C mutant at the interface between the central and extracellular vestibule. This suggests that dilation of the base of the central vestibule contributes to gating of the receptor.	[Allsopp, Rebecca C.; El Ajouz, Sam; Evans, Richard J.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Schmid, Ralf] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester	Evans, RJ (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	rje6@le.ac.uk	Schmid, Ralf/ABE-1065-2020; Schmid, Ralf/E-6722-2011	Schmid, Ralf/0000-0002-0203-4023; Schmid, Ralf/0000-0002-0203-4023	Wellcome Trust; British Heart Foundation	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation)	This work was supported by the Wellcome Trust and the British Heart Foundation.	Adriouch S, 2008, FASEB J, V22, P861, DOI 10.1096/fj.07-9294com; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; Bodnar M, 2011, J BIOL CHEM, V286, P2739, DOI 10.1074/jbc.M110.167437; Burnstock G, 2006, PHARMACOL REV, V58, P58, DOI 10.1124/pr.58.1.5; Digby HR, 2005, J NEUROCHEM, V95, P1746, DOI 10.1111/j.1471-4159.2005.03494.x; DUNN PM, 1988, BRIT J PHARMACOL, V93, P243, DOI 10.1111/j.1476-5381.1988.tb11427.x; Ennion S, 2000, J BIOL CHEM, V275, P29361, DOI 10.1074/jbc.M003637200; Evans RJ, 2010, BRIT J PHARMACOL, V161, P961, DOI 10.1111/j.1476-5381.2010.00728.x; EVANS RJ, 1995, MOL PHARMACOL, V48, P178; GarciaGuzman M, 1997, MOL PHARMACOL, V51, P109, DOI 10.1124/mol.51.1.109; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Jiang RT, 2011, P NATL ACAD SCI USA, V108, P9066, DOI 10.1073/pnas.1102170108; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; LAMBRECHT G, 1992, EUR J PHARMACOL, V217, P217, DOI 10.1016/0014-2999(92)90877-7; Lape R, 2008, NATURE, V454, P722, DOI 10.1038/nature07139; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; Marquez-Klaka B, 2009, EUR BIOPHYS J BIOPHY, V38, P329, DOI 10.1007/s00249-008-0325-9; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; RALEVIC V, 1995, J PHYSIOL-LONDON, V483, P703, DOI 10.1113/jphysiol.1995.sp020615; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; Roberts JA, 2004, J BIOL CHEM, V279, P9043, DOI 10.1074/jbc.M308964200; Roberts JA, 2008, J BIOL CHEM, V283, P20126, DOI 10.1074/jbc.M800294200; Roberts JA, 2007, J NEUROSCI, V27, P4072, DOI 10.1523/JNEUROSCI.2310-06.2007; Roberts JA, 2006, PFLUG ARCH EUR J PHY, V452, P486, DOI 10.1007/s00424-006-0073-6; Roberts JA, 2009, J NEUROCHEM, V109, P1042, DOI 10.1111/j.1471-4159.2009.06035.x; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wolf C, 2011, MOL PHARMACOL, V79, P649, DOI 10.1124/mol.110.068700; Zemkova H, 2007, J NEUROCHEM, V102, P1139, DOI 10.1111/j.1471-4159.2007.04616.x	37	39	39	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29207	29217		10.1074/jbc.M111.260364	http://dx.doi.org/10.1074/jbc.M111.260364			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21690089	hybrid, Green Published			2022-12-25	WOS:000293837000056
J	Pan, CG; Cai, LF; Lu, H; Lu, L; Jiang, SB				Pan, Chungen; Cai, Lifeng; Lu, Hong; Lu, Lu; Jiang, Shibo			A Novel Chimeric Protein-based HIV-1 Fusion Inhibitor Targeting gp41 Glycoprotein with High Potency and Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							6-HELIX BUNDLE FORMATION; ENVELOPE GLYCOPROTEIN; ENTRY INHIBITORS; MEMBRANE-FUSION; COILED-COIL; TYPE-1 GP41; INFECTION; PEPTIDE; ENFUVIRTIDE; DOMAIN	T20 (enfuvirtide, Fuzeon) is the first generation HIV-1 fusion inhibitor approved for salvage therapy of HIV-1-infected patients refractory to current antiretroviral drugs. However, its application is limited by the high cost of peptide synthesis, rapid proteolysis, and poor efficacy against emerging drug-resistant strains. Here we reported the design of a novel chimera protein-based fusion inhibitor targeting gp41, TLT35, that uses a flexible 35-mer linker to couple T20 and T1144, the first and next generation HIV-1 fusion inhibitors, respectively. TLT35, which was expressed in Escherichia coli with good yield, showed low nM activity against HIV-1-mediated cell-cell fusion and infection by laboratory-adapted HIV-1 strains (X4 or R5), including T20-resistant variants and primary HIV-1 isolates of clades A to G and group O (R5 or X4R5). TLT35 was stable in human sera and in peripheral blood mononuclear cell culture and was more resistant to proteolysis than either T20 or T1144 alone. Circular dichroism spectra showed that TLT35 folded into a thermally stable conformation with high alpha-helical content and T-m value in aqueous solution. It formed a highly stable complex with gp41 N-terminal heptad repeat peptide and blocked formation of the gp41 six-helix-bundle core. These merits combined with an anticipated low production cost for expression of TLT35 in E. coli make this novel protein-based fusion inhibitor a promising candidate for further development as an anti-HIV-1 microbicide or therapeutic for the prevention and treatment of HIV-1 infection.	[Pan, Chungen; Cai, Lifeng; Lu, Hong; Lu, Lu; Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Key Lab Med Mol Virol, Minist Hlth,Minist Educ, Shanghai 200032, Peoples R China; [Lu, Lu; Jiang, Shibo] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Pan, Chungen] Sun Yat Sen Univ, Zhongshan Sch Med, Key Lab Trop Dis Control, Inst Human Virol,Minist Educ, Guangzhou 510080, Guangdong, Peoples R China; [Cai, Lifeng] Beijing Inst Pharmacol & Toxicol, Beijing 100850, Peoples R China	New York Blood Center; Fudan University; Fudan University; Sun Yat Sen University; Academy of Military Medical Sciences - China	Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.	sjiang@nybloodcenter.org	lu, lu/HII-7530-2022; Lu, Lu/K-7070-2014; Jiang, Shibo/L-4500-2014; lu, lu/HGA-0894-2022	Lu, Lu/0000-0002-2255-0391; Jiang, Shibo/0000-0001-8283-7135; Pan, Chungen/0000-0003-0359-533X	National Institutes of Health [AI046221]; Guangdong Recruitment Program of Creative Research Groups; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046221, R21AI046221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Guangdong Recruitment Program of Creative Research Groups; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI046221 (to S. J.). This work was also supported by the Guangdong Recruitment Program of Creative Research Groups (to C. P.).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Ashkenazi A, 2011, EUR BIOPHYS J BIOPHY, V40, P349, DOI 10.1007/s00249-010-0666-z; Bellamy-Mclntyre AK, 2007, J BIOL CHEM, V282, P23104, DOI 10.1074/jbc.M703485200; Cai LF, 2010, CHEMMEDCHEM, V5, P1813, DOI 10.1002/cmdc.201000289; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Chan DC, 1998, P NATL ACAD SCI USA, V95, P15613, DOI 10.1073/pnas.95.26.15613; Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0; DELMEDICO M, 2006, 13 C RETR OPP INF FE; Dervillez X, 2006, CHEMMEDCHEM, V1, P330, DOI 10.1002/cmdc.200500062; Dimitrov AS, 2001, J BIOL CHEM, V276, P30335, DOI 10.1074/jbc.M103788200; Dimitrov DS, 1997, CELL, V91, P721, DOI 10.1016/S0092-8674(00)80460-2; Dwyer JJ, 2003, BIOCHEMISTRY-US, V42, P4945, DOI 10.1021/bi027283n; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; He YX, 2008, P NATL ACAD SCI USA, V105, P16332, DOI 10.1073/pnas.0807335105; Hong LA, 2003, J VIROL METHODS, V107, P155, DOI 10.1016/S0166-0934(02)00213-6; Ji H, 1999, J VIROL, V73, P8578, DOI 10.1128/JVI.73.10.8578-8586.1999; JIANG S, 2004, DRUG DISCOV TODAY, V1, P497; JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0; Jiang SB, 2004, ANTIMICROB AGENTS CH, V48, P4349, DOI 10.1128/AAC.48.11.4349-4359.2004; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Liu SW, 2007, J BIOL CHEM, V282, P9612, DOI 10.1074/jbc.M609148200; Liu SW, 2007, CURR PHARM DESIGN, V13, P143, DOI 10.2174/138161207779313722; Liu SW, 2005, J BIOL CHEM, V280, P11259, DOI 10.1074/jbc.M411141200; Lu H, 2006, AIDS RES HUM RETROV, V22, P411, DOI 10.1089/aid.2006.22.411; LU M, 1995, NAT STRUCT BIOL, V2, P1075, DOI 10.1038/nsb1295-1075; Melby T, 2007, AIDS RES HUM RETROV, V23, P1366, DOI 10.1089/aid.2006.0277; MOORE JP, 1993, VIRAL FUSION MECHANI, P233; Ni L, 2005, BIOCHEM BIOPH RES CO, V332, P831, DOI 10.1016/j.bbrc.2005.05.037; Otaka A, 2002, ANGEW CHEM INT EDIT, V41, P2938, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Pang W, 2008, VIROLOGY, V377, P80, DOI 10.1016/j.virol.2008.04.013; Reeves JD, 2004, J VIROL, V78, P5476, DOI 10.1128/JVI.78.10.5476-5485.2004; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Wexler-Cohen Y, 2007, FASEB J, V21, P3677, DOI 10.1096/fj.07-8582com; WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770	35	16	16	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28425	28434		10.1074/jbc.M111.241992	http://dx.doi.org/10.1074/jbc.M111.241992			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21690094	Green Published, hybrid			2022-12-25	WOS:000293557800058
J	Ma, ZH; Swede, H; Cassarino, D; Fleming, E; Fire, A; Dadras, SS				Ma, Zhihai; Swede, Helen; Cassarino, David; Fleming, Elizabeth; Fire, Andrew; Dadras, Soheil S.			Up-Regulated Dicer Expression in Patients with Cutaneous Melanoma	PLOS ONE			English	Article							MALIGNANT-MELANOMA; CELL-PROLIFERATION; REDUCED EXPRESSION; CANCER-PATIENTS; MICRORNAS; CARCINOMA; SURVIVAL; PROFILES; OVEREXPRESSION; ADENOCARCINOMA	Background: MicroRNAs (miRNAs) are small non-coding RNAs (18-24 nucleotides) that have recently been shown to regulate gene expression during cancer progression. Dicer, a central enzyme in the multi-component miRNA biogenesis pathway, is involved in cutting precursor miRNAs to functionally mature forms. Emerging evidence shows that Dicer expression is deregulated in some human malignancies and it correlates with tumor progression, yet this role has not yet been investigated in skin cancers. Methods and Findings: Using an anti-human monoclonal antibody against Dicer and immunohistochemistry, we compared the expression of Dicer protein among 404 clinically annotated controls and skin tumors consisting of melanocytic nevi (n = 71), a variety of melanomas (n = 223), carcinomas (n = 73) and sarcomas (n = 12). Results showed a cell-specific up-regulated Dicer in 81% of cutaneous, 80% of acrolentiginous and 96% of metastatic melanoma specimens compared to carcinoma or sarcoma specimens (P<0.0001). The expression of Dicer was significantly higher in melanomas compared to benign melanocytic nevi (P<0.0001). In patients with cutaneous melanomas, Dicer up-regulation was found to be significantly associated with an increased tumor mitotic index (P = 0.04), Breslow's depth of invasion (P = 0.03), nodal metastasis (P = 0.04) and a higher American Joint Committee on Caner (AJCC) clinical stage (P = 0.009). Using western blot analysis, we confirmed the cell-specific up-regulation of Dicer protein in vitro. A pooled-analysis on mRNA profiling in cutaneous tumors showed up-regulation of Dicer at the RNA level in cutaneous melanoma, also showing deregulation of other enzymes that participate in the biogenesis and maturation of canonical miRNAs. Conclusions: Increased Dicer expression may be a clinically useful biomarker for patients with cutaneous melanoma. Understanding deregulation of Dicer and its influence on miRNA maturation is needed to predict the susceptibility of melanoma patients to miRNA-based therapy in the future.	[Ma, Zhihai; Fire, Andrew] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA; [Swede, Helen] Univ Connecticut, Ctr Hlth, Dept Community Med & Hlth Care, Farmington, CT USA; [Cassarino, David] So Calif Permanente Med Grp, Dept Pathol, Los Angeles, CA 90027 USA; [Fleming, Elizabeth; Dadras, Soheil S.] Univ Connecticut, Ctr Hlth, Dept Genet Dev Biol, Farmington, CT USA; [Dadras, Soheil S.] Univ Connecticut, Ctr Hlth, Dept Dermatol, Farmington, CT USA	Stanford University; University of Connecticut; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; University of Connecticut; University of Connecticut	Ma, ZH (corresponding author), Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA.	dadras@uchc.edu	Ma, Zhihai/E-7130-2015	Fire, Andrew/0000-0001-6217-8312; Cassarino, David/0000-0001-8875-0858	Melanoma Research Foundation; Stanford University Cancer Center; department of Pathology, Stanford University	Melanoma Research Foundation; Stanford University Cancer Center; department of Pathology, Stanford University(Stanford University)	This work was supported by 2008 Melanoma Research Foundation Career Development Award (SSD), Seed Grant from Stanford University Cancer Center (SSD) and research funds from the department of Pathology, Stanford University (SSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Caramuta S, 2010, J INVEST DERMATOL, V130, P2062, DOI 10.1038/jid.2010.63; Chiosea SI, 2008, VIRCHOWS ARCH, V452, P629, DOI 10.1007/s00428-007-0574-5; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Dadras SS, 2003, AM J PATHOL, V162, P1951, DOI 10.1016/S0002-9440(10)64328-3; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Ihara Y, 2002, CANCER GENET CYTOGEN, V135, P177, DOI 10.1016/S0165-4608(01)00654-9; Jakymiw A, 2010, GENE CHROMOSOME CANC, V49, P549, DOI 10.1002/gcc.20765; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Levy C, 2010, CELL, V141, P994, DOI 10.1016/j.cell.2010.05.004; Ma ZH, 2009, J MOL DIAGN, V11, P420, DOI 10.2353/jmoldx.2009.090041; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mueller DW, 2009, J INVEST DERMATOL, V129, P1740, DOI 10.1038/jid.2008.452; Muralidhar B, 2007, J PATHOL, V212, P368, DOI 10.1002/path.2179; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Sand M, 2011, EUR J DERMATOL, V21, P18, DOI [10.1684/ejd.2011.1210, 10.1684/ejd.2010.1210]; Scatolini M, 2010, INT J CANCER, V126, P1869, DOI 10.1002/ijc.24899; Segura MF, 2010, CLIN CANCER RES, V16, P1577, DOI 10.1158/1078-0432.CCR-09-2721; Shao JY, 2002, CHINESE MED J-PEKING, V115, P571; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187; Tzai TS, 2003, UROLOGY, V62, P378, DOI 10.1016/S0090-4295(03)00344-3; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103	35	48	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20494	10.1371/journal.pone.0020494	http://dx.doi.org/10.1371/journal.pone.0020494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698147	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600008
J	Schuler, MS; Cooper, BS; Storm, JJ; Sears, MW; Angilletta, MJ				Schuler, Matthew S.; Cooper, Brandon S.; Storm, Jonathan J.; Sears, Michael W.; Angilletta, Michael J., Jr.			Isopods Failed to Acclimate Their Thermal Sensitivity of Locomotor Performance during Predictable or Stochastic Cooling	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; SWIMMING PERFORMANCE; HEAT TOLERANCE; TEMPERATURE; STRESS; COLD; COMPENSATION; ADAPTATION; PHYSIOLOGY; EVOLUTION	Most organisms experience environments that vary continuously over time, yet researchers generally study phenotypic responses to abrupt and sustained changes in environmental conditions. Gradual environmental changes, whether predictable or stochastic, might affect organisms differently than do abrupt changes. To explore this possibility, we exposed terrestrial isopods (Porcellio scaber) collected from a highly seasonal environment to four thermal treatments: (1) a constant 20 degrees C; (2) a constant 10 degrees C; (3) a steady decline from 20 degrees to 10 degrees C; and (4) a stochastic decline from 20 degrees to 10 degrees C that mimicked natural conditions during autumn. After 45 days, we measured thermal sensitivities of running speed and thermal tolerances (critical thermal maximum and chill-coma recovery time). Contrary to our expectation, thermal treatments did not affect the thermal sensitivity of locomotion; isopods from all treatments ran fastest at 33 degrees to 34 degrees C and achieved more than 80% of their maximal speed over a range of 10 degrees to 11 degrees C. Isopods exposed to a stochastic decline in temperature tolerated cold the best, and isopods exposed to a constant temperature of 20 degrees C tolerated cold the worst. No significant variation in heat tolerance was observed among groups. Therefore, thermal sensitivity and heat tolerance failed to acclimate to any type of thermal change, whereas cold tolerance acclimated more during stochastic change than it did during abrupt change.	[Schuler, Matthew S.; Cooper, Brandon S.; Storm, Jonathan J.; Angilletta, Michael J., Jr.] Indiana State Univ, Dept Biol, Terre Haute, IN 47809 USA; [Sears, Michael W.] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA	Indiana State University; Bryn Mawr College	Schuler, MS (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	matt.s.schuler@gmail.com			National Science Foundation [IOS 0616344]; College of Graduate Studies at Indiana State University	National Science Foundation(National Science Foundation (NSF)); College of Graduate Studies at Indiana State University	This research was supported by the National Science Foundation (IOS 0616344) and by the College of Graduate Studies at Indiana State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2008, FUNCT ECOL, V22, P78, DOI 10.1111/j.1365-2435.2007.01348.x; Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; Angilletta MJ, 2003, TRENDS ECOL EVOL, V18, P234, DOI 10.1016/S0169-5347(03)00087-9; Bailey DM, 2005, POLAR BIOL, V28, P464, DOI 10.1007/s00300-004-0699-9; Botkin DB, 2007, BIOSCIENCE, V57, P227, DOI 10.1641/B570306; Bradshaw WE, 2003, AM NAT, V161, P735, DOI 10.1086/374344; BROYDEN CG, 1970, MATH COMPUT, V24, P365, DOI 10.1090/S0025-5718-1970-0279993-0; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cooper BS, 2008, J THERM BIOL, V33, P320, DOI 10.1016/j.jtherbio.2008.04.001; CRAWLEY MJ, 2007, R BOOK WILEY; Cunningham SC, 2003, NEW PHYTOL, V157, P55, DOI 10.1046/j.1469-8137.2003.00652.x; Day N, 2005, J EXP BIOL, V208, P2683, DOI 10.1242/jeb.01669; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Folguera G, 2009, COMP BIOCHEM PHYS A, V154, P389, DOI 10.1016/j.cbpa.2009.07.008; Gabriel W, 2005, J EVOLUTION BIOL, V18, P873, DOI 10.1111/j.1420-9101.2005.00959.x; Gabriel W, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P286; Gabriel W, 2006, ARCH HYDROBIOL, V167, P1, DOI 10.1127/0003-9136/2006/0167-0001; Geister TL, 2007, BEHAV ECOL, V18, P658, DOI 10.1093/beheco/arm024; Gibert P, 2001, PHYSIOL BIOCHEM ZOOL, V74, P429, DOI 10.1086/320429; Glanville EJ, 2006, J EXP BIOL, V209, P4869, DOI 10.1242/jeb.02585; Hoffmann AA, 2003, J EVOLUTION BIOL, V16, P614, DOI 10.1046/j.1420-9101.2003.00561.x; Hoffmann AA, 2003, SCIENCE, V301, P100, DOI 10.1126/science.1084296; HUEY RB, 1979, AM ZOOL, V19, P357; Huey RB, 1999, AM ZOOL, V39, P323; JOHNSON TP, 1995, J EXP BIOL, V198, P2165; Kalberer SR, 2006, PLANT SCI, V171, P3, DOI 10.1016/j.plantsci.2006.02.013; Kimura MT, 2004, OECOLOGIA, V140, P442, DOI 10.1007/s00442-004-1605-4; Lagerspetz KYH, 2006, J THERM BIOL, V31, P332, DOI 10.1016/j.jtherbio.2006.01.003; Li XC, 2005, J THERM BIOL, V30, P588, DOI 10.1016/j.jtherbio.2005.09.002; Martin N, 2009, COMP BIOCHEM PHYS A, V152, P599, DOI 10.1016/j.cbpa.2009.01.010; Matsukura K, 2009, MALACOLOGIA, V51, P263, DOI 10.4002/040.051.0203; Nunney L, 1997, EVOLUTION, V51, P1529, DOI [10.2307/2411205, 10.1111/j.1558-5646.1997.tb01476.x]; O'Steen S, 2003, PHYSIOL BIOCHEM ZOOL, V76, P484, DOI 10.1086/376421; Payton ME, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.34; Peck LS, 2008, MAR ECOL PROG SER, V358, P181, DOI 10.3354/meps07336; Peck LS, 2009, POLAR BIOL, V32, P399, DOI 10.1007/s00300-008-0532-y; Peck LS, 2004, FUNCT ECOL, V18, P625, DOI 10.1111/j.0269-8463.2004.00903.x; Prosser C. L., 1991, ENV METABOLIC ANIMAL; Ragland GJ, 2007, J EVOLUTION BIOL, V20, P2144, DOI 10.1111/j.1420-9101.2007.01428.x; Ruel JJ, 1999, TRENDS ECOL EVOL, V14, P361, DOI 10.1016/S0169-5347(99)01664-X; Schaefer J, 2006, J FISH BIOL, V69, P722, DOI 10.1111/j.1095-8649.2006.01145.x; Seebacher F, 2005, BIOL LETTERS, V1, P151, DOI 10.1098/rsbl.2004.0280; Shih Hsi-Te, 2000, Acta Zoologica Taiwanica, V11, P47; SMITH E M, 1974, Arctic and Alpine Research, V6, P13, DOI 10.2307/1550366; Sorensen JG, 2002, ECOL LETT, V5, P16, DOI 10.1046/j.1461-0248.2002.00296.x; Team RDC, 2019, R LANG ENV STAT COMP; Wilson RS, 2005, ANIM BEHAV, V70, P1387, DOI 10.1016/j.anbehav.2004.12.024; WILSON RS, 2007, PHILOS T RO IN PRESS	49	25	25	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20905	10.1371/journal.pone.0020905	http://dx.doi.org/10.1371/journal.pone.0020905			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698113	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600030
J	Alvarez-Rueda, N; Fleury, A; Morio, F; Pagniez, F; Gastinel, L; Le Pape, P				Alvarez-Rueda, Nidia; Fleury, Audrey; Morio, Florent; Pagniez, Fabrice; Gastinel, Louis; Le Pape, Patrice			Amino Acid Substitutions at the Major Insertion Loop of Candida albicans Sterol 14alpha-Demethylase Are Involved in Fluconazole Resistance	PLOS ONE			English	Article							LANOSTEROL 14-ALPHA-DEMETHYLASE; AZOLE RESISTANCE; ASPERGILLUS-FUMIGATUS; MOLECULAR-MECHANISMS; 3-DIMENSIONAL MODEL; ANTIFUNGAL AGENTS; DRUG-RESISTANCE; PICHIA-PASTORIS; RISK-FACTORS; DEMETHYLASE	Background: In the fungal pathogen Candida albicans, amino acid substitutions of 14alpha-demethylase (CaErg11p, CaCYP51) are associated with azole antifungals resistance. This is an area of research which is very dynamic, since the stakes concern the screening of new antifungals which circumvent resistance. The impact of amino acid substitutions on azole interaction has been postulated by homology modeling in comparison to the crystal structure of Mycobacterium tuberculosis (MT-CYP51). Modeling of amino acid residues situated between positions 428 to 459 remains difficult to explain to date, because they are in a major insertion loop specifically present in fungal species. Methodology/Principal Finding: Fluconazole resistance of clinical isolates displaying Y447H and V456I novel CaErg11p substitutions confirmed in vivo in a murine model of disseminated candidiasis. Y447H and V456I implication into fluconazole resistance was then studied by site-directed mutagenesis of wild-type CaErg11p and by heterogeneously expression into the Pichia pastoris model. CLSI modified tests showed that V447H and V456I are responsible for an 8-fold increase in fluconazole MICs of P. pastoris mutants compared to the wild-type controls. Moreover, mutants showed a sustained capacity for producing ergosterol, even in the presence of fluconazole. Based on these biological results, we are the first to propose a hybrid homology structure-function model of Ca-CYP51 using 3 different homology modeling programs. The variable position of the protein insertion loop, using different liganded or non-liganded templates of recently solved CYP51 structures, suggests its inherent flexibility. Mapping of recognized azole-resistant substitutions indicated that the flexibility of this region is probably enhanced by the relatively high glycine content of the consensus. Conclusions/Significance: The results highlight the potential role of the insertion loop in azole resistance in the human pathogen C. albicans. This new data should be taken into consideration for future studies aimed at designing new antifungal agents, which circumvent azole resistance.	[Alvarez-Rueda, Nidia; Fleury, Audrey; Morio, Florent; Pagniez, Fabrice; Le Pape, Patrice] Univ Nantes, Nantes Atlantique Univ, Fac Pharm Nantes, Dept Parasitol & Mycol Med,IICiMed EA1155, Nantes, France; [Morio, Florent; Le Pape, Patrice] CHU Nantes, Lab Parasitol Mycol, F-44035 Nantes 01, France; [Gastinel, Louis] Univ Limoges, INSERM UMR 850, Lab Pharmacol Immunosuppresseurs Transplantat, Limoges, France	Nantes Universite; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges	Alvarez-Rueda, N (corresponding author), Univ Nantes, Nantes Atlantique Univ, Fac Pharm Nantes, Dept Parasitol & Mycol Med,IICiMed EA1155, Nantes, France.	nidia.alvarez-rueda@univ-nantes.fr; patrice.le-pape@univ-nantes.fr	Le Pape, Patrice/AAY-3632-2021; Morio, Florent/B-6159-2008; Le Pape, Patrice/W-1472-2019	Morio, Florent/0000-0002-5859-6105; Le Pape, Patrice/0000-0001-5059-6402; ALVAREZ RUEDA, Nidia/0000-0002-5629-1930; pagniez, fabrice/0000-0002-1759-5106; Saraswathi, N.T./0000-0002-9061-1571				Chau AS, 2004, ANTIMICROB AGENTS CH, V48, P2124, DOI 10.1128/AAC.48.6.2124-2131.2004; CHEN CK, PLOS NEGL TROP DIS, V4, pE651; Coste A, 2007, EUKARYOT CELL, V6, P1889, DOI 10.1128/EC.00151-07; Cregg JM, 2000, MOL BIOTECHNOL, V16, P23, DOI 10.1385/MB:16:1:23; Daly R, 2005, J MOL RECOGNIT, V18, P119, DOI 10.1002/jmr.687; Enoch DA, 2006, J MED MICROBIOL, V55, P809, DOI 10.1099/jmm.0.46548-0; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P419, DOI 10.1007/s10096-006-0159-2; Fernandez L, 2006, PROTEIN EXPRES PURIF, V49, P256, DOI 10.1016/j.pep.2006.06.015; Franz R, 1998, ANTIMICROB AGENTS CH, V42, P3065, DOI 10.1128/AAC.42.12.3065; Garnacho-Montero J, 2010, ANTIMICROB AGENTS CH, V54, P3149, DOI 10.1128/AAC.00479-10; Ghannoum MA, 1996, J CLIN MICROBIOL, V34, P489, DOI 10.1128/JCM.34.3.489-495.1996; Goldman GH, 2004, DIAGN MICR INFEC DIS, V50, P25, DOI 10.1016/j.diagmicrobio.2004.04.009; Howard SJ, 2009, EMERG INFECT DIS, V15, P1068, DOI 10.3201/eid1507.090043; Ikeda F, 2000, ANTIMICROB AGENTS CH, V44, P614, DOI 10.1128/AAC.44.3.614-618.2000; Ji HT, 2000, J MED CHEM, V43, P2493, DOI 10.1021/jm990589g; Johnson MD, 2010, CURR FUNGAL INFECT R, V4, P87, DOI 10.1007/s12281-010-0018-6; Kakeya H, 2000, ANTIMICROB AGENTS CH, V44, P2985, DOI 10.1128/AAC.44.11.2985-2990.2000; KALB VF, 1987, DNA-J MOLEC CELL BIO, V6, P529, DOI 10.1089/dna.1987.6.529; Kelly SL, 1999, FEMS MICROBIOL LETT, V180, P171, DOI 10.1111/j.1574-6968.1999.tb08792.x; Krieger E, 2002, BIOINFORMATICS, V18, P315, DOI 10.1093/bioinformatics/18.2.315; Labelle AJ, 2008, CRIT CARE MED, V36, P2967, DOI 10.1097/CCM.0b013e31818b3477; LAI MH, 1989, NUCLEIC ACIDS RES, V17, P804, DOI 10.1093/nar/17.2.804; Lamb DC, 2000, CHEM-BIOL INTERACT, V125, P165, DOI 10.1016/S0009-2797(99)00169-6; Lamb DC, 1997, J BIOL CHEM, V272, P5682, DOI 10.1074/jbc.272.9.5682; Lee MK, 2004, J ANTIMICROB CHEMOTH, V53, P217, DOI 10.1093/jac/dkh040; Loffler J, 1997, FEMS MICROBIOL LETT, V151, P263, DOI 10.1016/S0378-1097(97)00172-9; Macauley-Patrick S, 2005, YEAST, V22, P249, DOI 10.1002/yea.1208; Maebashi K, 2002, MICROBIOL IMMUNOL, V46, P317, DOI 10.1111/j.1348-0421.2002.tb02702.x; Marichal P, 1999, MICROBIOL-SGM, V145, P2701, DOI 10.1099/00221287-145-10-2701; Morio F, 2010, DIAGN MICR INFEC DIS, V66, P373, DOI 10.1016/j.diagmicrobio.2009.11.006; OSTROSKYZEICHNE.L, 2010, MED MYCOL; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Parker JE, 2008, ANTIMICROB AGENTS CH, V52, P3597, DOI 10.1128/AAC.00517-08; Parkins MD, 2007, J ANTIMICROB CHEMOTH, V60, P613, DOI 10.1093/jac/dkm212; Perea S, 2001, ANTIMICROB AGENTS CH, V45, P2676, DOI 10.1128/AAC.45.10.2676-2684.2001; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 1995, CLIN INFECT DIS, V21, P1507, DOI 10.1093/clinids/21.6.1507; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; REX JH, 1995, ANTIMICROB AGENTS CH, V39, P906, DOI 10.1128/AAC.39.4.906; Sanglard D, 1998, ANTIMICROB AGENTS CH, V42, P241, DOI 10.1093/jac/42.2.241; Sanglard D, 1996, ANTIMICROB AGENTS CH, V40, P2300, DOI 10.1128/AAC.40.10.2300; Sanglard D, 2002, ENFERM INFEC MICR CL, V20, P462, DOI 10.1016/S0213-005X(02)72842-5; Sheng CQ, 2009, ANTIMICROB AGENTS CH, V53, P3487, DOI 10.1128/AAC.01630-08; Sheng CQ, 2004, J BIOMOL STRUCT DYN, V22, P91, DOI 10.1080/07391102.2004.10506984; SNCCLS, 2002, M27A2 NCCLS; Strushkevich N, 2010, J MOL BIOL, V397, P1067, DOI 10.1016/j.jmb.2010.01.075; Trabocchi A, 2010, J MED CHEM, V53, P2502, DOI 10.1021/jm901734u; VANDENBOSSCHE H, 1990, BIOCHEM SOC T, V18, P56; Venkateswarlu K, 1996, ANTIMICROB AGENTS CH, V40, P1382, DOI 10.1128/AAC.40.6.1382; Venkateswarlu K, 1996, ANTIMICROB AGENTS CH, V40, P2443, DOI 10.1128/AAC.40.11.2443; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4235, DOI 10.1128/AAC.00587-10; White T C, 1997, Oral Dis, V3 Suppl 1, pS102; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1488, DOI 10.1128/AAC.41.7.1488; White TC, 2002, ANTIMICROB AGENTS CH, V46, P1704, DOI 10.1128/AAC.46.6.1704-1713.2002; White TC, 1997, ANTIMICROB AGENTS CH, V41, P1482, DOI 10.1128/AAC.41.7.1482; Xiao L, 2004, ANTIMICROB AGENTS CH, V48, P568, DOI 10.1128/AAC.48.2.568-574.2004	56	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21239	10.1371/journal.pone.0021239	http://dx.doi.org/10.1371/journal.pone.0021239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698128	Green Published, Green Submitted, gold			2022-12-25	WOS:000291734100072
J	Oikonomou, C; Cross, FR				Oikonomou, Catherine; Cross, Frederick R.			Rising Cyclin-CDK Levels Order Cell Cycle Events	PLOS ONE			English	Article							BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; ANAPHASE TRANSITION; DNA-REPLICATION; S-PHASE; MITOSIS; CDC28; PHOSPHORYLATION; ENTRY; KINASE	Background: Diverse mitotic events can be triggered in the correct order and time by a single cyclin-CDK. A single regulator could confer order and timing on multiple events if later events require higher cyclin-CDK than earlier events, so that gradually rising cyclin-CDK levels can sequentially trigger responsive events: the "quantitative model" of ordering. Methodology/Principal Findings: This 'quantitative model' makes predictions for the effect of locking cyclin at fixed levels for a protracted period: at low cyclin levels, early events should occur rapidly, while late events should be slow, defective, or highly variable (depending on threshold mechanism). We titrated the budding yeast mitotic cyclin Clb2 within its endogenous expression range to a stable, fixed level and measured time to occurrence of three mitotic events: growth depolarization, spindle formation, and spindle elongation, as a function of fixed Clb2 level. These events require increasingly more Clb2 according to their normal order of occurrence. Events occur efficiently and with low variability at fixed Clb2 levels similar to those observed when the events normally occur. A second prediction of the model is that increasing the rate of cyclin accumulation should globally advance timing of all events. Moderate (<2-fold) overexpression of Clb2 accelerates all events of mitosis, resulting in consistently rapid sequential cell cycles. However, this moderate overexpression also causes a significant frequency of premature mitoses leading to inviability, suggesting that Clb2 expression level is optimized to balance the fitness costs of variability and catastrophe. Conclusions/Significance: We conclude that mitotic events are regulated by discrete cyclin-CDK thresholds. These thresholds are sequentially triggered as cyclin increases, yielding reliable order and timing. In many biological processes a graded input must be translated into discrete outputs. In such systems, expression of the central regulator is likely to be tuned to an optimum level, as we observe here for Clb2.	[Oikonomou, Catherine; Cross, Frederick R.] Rockefeller Univ, Lab Cell Cycle Genet, New York, NY 10021 USA	Rockefeller University	Oikonomou, C (corresponding author), Rockefeller Univ, Lab Cell Cycle Genet, 1230 York Ave, New York, NY 10021 USA.	fcross@rockefeller.edu		Oikonomou, Catherine/0000-0003-2312-4746	NIH [GM47238]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078153, R01GM047238] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	C.O. and F. C. were supported by NIH grant GM47238. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMON A, 1992, NATURE, V355, P368, DOI 10.1038/355368a0; AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Anderson VE, 2007, MOL BIOL CELL, V18, P2047, DOI 10.1091/mbc.E06-10-0918; Archambault V, 2005, CELL CYCLE, V4, P125, DOI 10.4161/cc.4.1.1402; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Chee MK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000935; Chen KC, 2004, MOL BIOL CELL, V15, P3841, DOI 10.1091/mbc.E03-11-0794; Coudreuse D, 2010, NATURE, V468, P1074, DOI 10.1038/nature09543; Crasta K, 2006, EMBO J, V25, P2551, DOI 10.1038/sj.emboj.7601136; CROSS FR, 1995, CURR OPIN CELL BIOL, V7, P790, DOI 10.1016/0955-0674(95)80062-X; Cross FR, 2002, MOL BIOL CELL, V13, P52, DOI 10.1091/mbc.01-05-0265; Deibler RW, 2010, MOL CELL, V37, P753, DOI 10.1016/j.molcel.2010.02.023; Drapkin BJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.78; FITCH I, 1992, MOL BIOL CELL, V3, P805, DOI 10.1091/mbc.3.7.805; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Haase SB, 1999, NATURE, V401, P394, DOI 10.1038/43930; Haase SB, 2001, NAT CELL BIOL, V3, P38, DOI 10.1038/35050543; HARTWELL LH, 1971, J MOL BIOL, V59, P183, DOI 10.1016/0022-2836(71)90420-7; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; Harvey SL, 2003, CURR BIOL, V13, P264, DOI 10.1016/S0960-9822(03)00049-6; Hood JK, 2001, J CELL SCI, V114, P589; Jorgensen P, 2007, MOL BIOL CELL, V18, P3523, DOI 10.1091/mbc.E06-10-0973; KATZ WS, 1995, CELL, V82, P297, DOI 10.1016/0092-8674(95)90317-8; Keaton MA, 2006, CURR OPIN MICROBIOL, V9, P540, DOI 10.1016/j.mib.2006.10.004; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Levine K, 1996, MOL CELL BIOL, V16, P6794; LEW DJ, 1993, J CELL BIOL, V120, P1305, DOI 10.1083/jcb.120.6.1305; Li S, 2006, J CELL BIOL, V173, P867, DOI 10.1083/jcb.200603153; Loog M, 2005, NATURE, V434, P104, DOI 10.1038/nature03329; Lu Y, 2010, CELL, V141, P268, DOI 10.1016/j.cell.2010.03.021; McNulty JJ, 2005, CURR BIOL, V15, P2190, DOI 10.1016/j.cub.2005.11.039; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Picard D, 1999, NUCL RECEPTORS PRACT, P261; PRINGLE JR, 1981, MOL BIOL YEAST SACCH, P97; Rahal R, 2008, GENE DEV, V22, P1534, DOI 10.1101/gad.1638308; RICHARDSON H, 1992, GENE DEV, V6, P2021, DOI 10.1101/gad.6.11.2021; Rudner AD, 2000, J CELL BIOL, V149, P1361, DOI 10.1083/jcb.149.7.1361; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; SCHWOB E, 1994, CELL, V79, P233, DOI 10.1016/0092-8674(94)90193-7; SNYDER M, 1989, J CELL BIOL, V108, P1419, DOI 10.1083/jcb.108.4.1419; Stern B, 1996, TRENDS GENET, V12, P345; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; SURANA U, 1991, CELL, V65, P145, DOI 10.1016/0092-8674(91)90416-V; SURANA U, 1993, EMBO J, V12, P1969, DOI 10.1002/j.1460-2075.1993.tb05846.x; Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455; WEINERT TA, 1994, GENE DEV, V8, P652, DOI 10.1101/gad.8.6.652; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467	50	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20788	10.1371/journal.pone.0020788	http://dx.doi.org/10.1371/journal.pone.0020788			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695202	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612600025
J	Dixit, AR; Dhankher, OP				Dixit, Anirudha R.; Dhankher, Om Parkash			A Novel Stress-Associated Protein 'AtSAP10' from Arabidopsis thaliana Confers Tolerance to Nickel, Manganese, Zinc, and High Temperature Stress	PLOS ONE			English	Article							KAPPA-B ACTIVATION; SAP GENE FAMILY; TRANSGENIC TOBACCO; EXPRESSION ANALYSIS; SIGNALING PATHWAYS; FUSION PROTEINS; FINGER PROTEIN; COLD STRESS; IN-VIVO; PLANTS	We describe here the functional characterization of a novel AtSAP10, a member of the Stress Associated Protein (SAP) gene family, from Arabidopsis thaliana ecotype Columbia. AtSAP10 contains an A20 and AN1 zinc-finger domain at the N- and C-terminal, respectively. Arabidopsis SAP10 showed differential regulation by various abiotic stresses such as heavy metals and metalloids (Ni, Cd, Mn, Zn, and As), high and low temperatures, cold, and ABA. Overexpression of AtSAP10 in Arabidopsis conferred strong tolerance to heavy metals such as Ni, Mn, and Zn and to high temperature stress. AtSAP10 transgenic plants under these stress conditions grew green and healthy, attained several-fold more biomass, and had longer roots as compared to wild type plants. Further, while these transgenic plants accumulated significantly greater amounts of Ni and Mn in both shoots and root tissues, there was no significant difference in the accumulation of Zn. AtSAP10 promoter-GUS fusion studies revealed a root and floral organ-specific expression of AtSAP10. Overexpression of AtSAP10-GFP fusion protein showed the localization in both nucleus and cytoplasm. Taken together, these results showed that AtSAP10 is a potentially useful candidate gene for engineering tolerance to heavy metals and to abiotic stress in cultivated plants.	[Dixit, Anirudha R.] Univ Massachusetts, Dept Plant Soil & Insect Sci, Amherst, MA 01003 USA; Univ Massachusetts, Plant Biol Grad Program, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Dixit, AR (corresponding author), Univ Massachusetts, Dept Plant Soil & Insect Sci, Amherst, MA 01003 USA.	parkash@psis.umass.edu	Dhankher, Om Parkash P/P-1880-2016; Dixit, Anirudha R/O-5597-2016	Dixit, Anirudha R/0000-0001-9595-5624; Dhankher, Om Parkash/0000-0003-0737-6783	Plant Biology Graduate Program; Department of Plant, Soil, and Insect Sciences	Plant Biology Graduate Program; Department of Plant, Soil, and Insect Sciences	This work was supported by partial funding from the Plant Biology Graduate Program and from the Department of Plant, Soil, and Insect Sciences to ARD as teaching assistant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bechtold N, 1998, METH MOL B, V82, P259; Ben Saad R, 2010, PLANT MOL BIOL, V72, P171, DOI 10.1007/s11103-009-9560-4; BOYER JS, 1982, SCIENCE, V218, P443, DOI 10.1126/science.218.4571.443; Dhankher OP, 2002, NAT BIOTECHNOL, V20, P1140, DOI 10.1038/nbt747; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Duan W, 2000, GENE, V256, P113, DOI 10.1016/S0378-1119(00)00365-6; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Escobar MA, 2003, MOL PLANT PATHOL, V4, P57, DOI 10.1046/j.1364-3703.2003.00148.x; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Haralampidis K, 2002, PLANT PHYSIOL, V129, P1138, DOI 10.1104/pp.004044; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hishiya A, 2006, EMBO J, V25, P554, DOI 10.1038/sj.emboj.7600945; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Huang J, 2004, J BIOL CHEM, V279, P16847, DOI 10.1074/jbc.M309491200; Huang J, 2008, GENE, V420, P135, DOI 10.1016/j.gene.2008.05.019; JEFFERSON RA, 1987, EMBO J, V6, P3901; Jin Y, 2007, GENOMICS, V90, P265, DOI 10.1016/j.ygeno.2007.03.019; Kang MY, 2011, PLANT MOL BIOL, V75, P451, DOI 10.1007/s11103-011-9748-2; Kanneganti V, 2008, PLANT MOL BIOL, V66, P445, DOI 10.1007/s11103-007-9284-2; Kilian J, 2007, PLANT J, V50, P347, DOI 10.1111/j.1365-313X.2007.03052.x; Kohler RH, 1998, TRENDS PLANT SCI, V3, P317, DOI 10.1016/S1360-1385(98)01276-X; Larkindale J, 2005, PLANT PHYSIOL, V138, P882, DOI 10.1104/pp.105.062257; LINNEN JM, 1993, GENE, V128, P181, DOI 10.1016/0378-1119(93)90561-G; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; Mukhopadhyay A, 2004, P NATL ACAD SCI USA, V101, P6309, DOI 10.1073/pnas.0401572101; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; NAGY JI, 1976, Z PFLANZENPHYSIOL, V78, P453, DOI 10.1016/S0044-328X(76)80093-1; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; RIEPING M, 1992, MOL GEN GENET, V231, P226, DOI 10.1007/BF00279795; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Siemianowski O, 2011, PLANT BIOTECHNOL J, V9, P64, DOI 10.1111/j.1467-7652.2010.00531.x; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Stroher E, 2009, MOL PLANT, V2, P357, DOI 10.1093/mp/ssn084; Vij S, 2008, FUNCT INTEGR GENOMIC, V8, P301, DOI 10.1007/s10142-008-0078-7; Vij S, 2006, MOL GENET GENOMICS, V276, P565, DOI 10.1007/s00438-006-0165-1; von Arnim AG, 1998, GENE, V221, P35, DOI 10.1016/S0378-1119(98)00433-8; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Yu DQ, 2001, PLANT CELL, V13, P1527, DOI 10.1105/tpc.13.7.1527	43	54	62	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20921	10.1371/journal.pone.0020921	http://dx.doi.org/10.1371/journal.pone.0020921			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695274	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612900038
J	Eifler, J; Martinelli, E; Santonico, M; Capuano, R; Schild, D; Di Natale, C				Eifler, Jakob; Martinelli, Eugenio; Santonico, Marco; Capuano, Rosamaria; Schild, Detlev; Di Natale, Corrado			Differential Detection of Potentially Hazardous Fusarium Species in Wheat Grains by an Electronic Nose	PLOS ONE			English	Article							FUNGAL VOLATILES; DEOXYNIVALENOL; MYCOTOXINS; TRICHOTHECENES; TRICHODIENE; FUMONISINS; VOMITOXIN; CEREALS; TOXINS; BLIGHT	Fungal infestation on wheat is an increasingly grave nutritional problem in many countries worldwide. Fusarium species are especially harmful pathogens due to their toxic metabolites. In this work we studied volatile compounds released by F. cerealis, F. graminearum, F. culmorum and F. redolens using SPME-GC/MS. By using an electronic nose we were able to differentiate between infected and non-infected wheat grains in the post-harvest chain. Our electronic nose was capable of distinguishing between four wheat Fusaria species with an accuracy higher than 80%.	[Eifler, Jakob] Univ Gottingen, Dept Crop Sci, Gottingen, Germany; [Eifler, Jakob; Schild, Detlev] Univ Gottingen, Dept Neurophysiol & Cellular Biophys, Gottingen, Germany; [Martinelli, Eugenio; Santonico, Marco; Capuano, Rosamaria; Di Natale, Corrado] Univ Rome, Dept Elect Engn, Rome, Italy	University of Gottingen; University of Gottingen; Sapienza University Rome	Eifler, J (corresponding author), Univ Gottingen, Dept Crop Sci, Gottingen, Germany.	dschild@gwdg.de	Santonico, Marco/K-4465-2016; Capuano, Rosamaria/K-9258-2016; Capuano, Rosamaria/U-6111-2019; Di Natale, Corrado/M-8701-2014; Martinelli, Eugenio/AAA-9105-2019	Santonico, Marco/0000-0002-3755-6198; Di Natale, Corrado/0000-0002-0543-4348; Martinelli, Eugenio/0000-0002-6673-2066; Capuano, Rosamaria/0000-0002-7811-0862	German Ministry of Education and Research, BMBF; Bernstein Forum of Neurotechnology [01GQ0810]	German Ministry of Education and Research, BMBF(Federal Ministry of Education & Research (BMBF)); Bernstein Forum of Neurotechnology	This work was supported by the German Ministry of Education and Research, BMBF, Focus Neurotechnology (grant to Dr. Detlev Schild). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by the Bernstein Forum of Neurotechnology (01GQ0810).	ABOUZIED MM, 1991, APPL ENVIRON MICROB, V57, P672, DOI 10.1128/AEM.57.3.672-677.1991; Atkins Simon D., 2004, Journal of Applied Genetics, V45, P3; Ballantine D.S., 1997, ACOUSTIC WAVE SENSOR; BORJESSON T, 1989, CEREAL CHEM, V66, P300; Bottalico A, 2002, EUR J PLANT PATHOL, V108, P611, DOI 10.1023/A:1020635214971; BRANDFASS C, 2006, THESIS U GOTTINGEN; D'Amico A, 2010, LUNG CANCER, V68, P170, DOI 10.1016/j.lungcan.2009.11.003; Di Natale C, 2007, SENSOR ACTUAT B-CHEM, V121, P238, DOI 10.1016/j.snb.2006.09.038; Dowell FE, 1999, CEREAL CHEM, V76, P573, DOI 10.1094/CCHEM.1999.76.4.573; Falasconi M, 2005, SENSOR ACTUAT B-CHEM, V108, P250, DOI 10.1016/j.snb.2004.09.046; Iyer MS, 2003, J FOOD PROTECT, V66, P451, DOI 10.4315/0362-028X-66.3.451; Jelen H, 1997, J MICROBIOL METH, V31, P45, DOI 10.1016/S0167-7012(97)00088-2; Jonsson A, 1997, INT J FOOD MICROBIOL, V35, P187, DOI 10.1016/S0168-1605(96)01218-4; Keshri G, 2000, J APPL MICROBIOL, V89, P825, DOI 10.1046/j.1365-2672.2000.01185.x; KORPI A, 2006, ARB HALSA, V13; Korsching S, 2002, CURR OPIN NEUROBIOL, V12, P387, DOI 10.1016/S0959-4388(02)00348-3; Magan N, 2000, J STORED PROD RES, V36, P319, DOI 10.1016/S0022-474X(99)00057-0; Maragos CM, 2002, J AGR FOOD CHEM, V50, P1827, DOI 10.1021/jf011487d; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Miyazawa M, 2008, J OLEO SCI, V57, P585, DOI 10.5650/jos.57.585; NAGLE TC, 2003, HDB MACHINE OLFACTIO; Olsson J, 2002, INT J FOOD MICROBIOL, V72, P203, DOI 10.1016/S0168-1605(01)00685-7; PAOLESSE R, 2004, ENCY NANOSCIENCE NAN, V9, P21; Paolesse R, 2006, SENSOR ACTUAT B-CHEM, V119, P425, DOI 10.1016/j.snb.2005.12.047; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pasanen AL, 1996, ANALYST, V121, P1949, DOI 10.1039/an9962101949; Peraica M, 1999, B WORLD HEALTH ORGAN, V77, P754; Perkowski J, 2008, INT J FOOD MICROBIOL, V126, P127, DOI 10.1016/j.ijfoodmicro.2008.05.028; Plattner RD, 1999, NAT TOXINS, V7, P365, DOI 10.1002/1522-7189(199911/12)7:6<365::AID-NT85>3.0.CO;2-0; RACCA P, 2007, DLG PUBLIKATIONEN, V4, P60; Razzazi-Fazeli E, 1999, J CHROMATOGR A, V854, P45, DOI 10.1016/S0021-9673(99)00616-0; Rock F, 2008, CHEM REV, V108, P705, DOI 10.1021/cr068121q; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Santonico M, 2010, FOOD CHEM, V121, P789, DOI 10.1016/j.foodchem.2009.12.086; Schaafsma AW, 1998, MYCOPATHOLOGIA, V142, P107, DOI 10.1023/A:1006937720711; Schaafsma AW, 2001, CAN J PLANT PATHOL, V23, P279, DOI 10.1080/07060660109506941; Schnurer J, 1999, FUNGAL GENET BIOL, V27, P209, DOI 10.1006/fgbi.1999.1139; Schollenberger M, 1999, MYCOPATHOLOGIA, V147, P49, DOI 10.1023/A:1007088502400; VANEGMOND HP, 2004, FAO FOOD NUTR PAP, V81; *WHO, 2001, WHO TECH REP SER, V906; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Yazar S, 2008, INT J MOL SCI, V9, P2062, DOI 10.3390/ijms9112062	42	45	48	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e21026	10.1371/journal.pone.0021026	http://dx.doi.org/10.1371/journal.pone.0021026			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695232	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900046
J	Malavige, GN; Rostron, T; Rohanachandra, LT; Jayaratne, SD; Fernando, N; De Silva, AD; Liyanage, M; Ogg, G				Malavige, Gathsaurie Neelika; Rostron, Tim; Rohanachandra, Lochana T.; Jayaratne, S. D.; Fernando, Neluka; De Silva, Aruna Dharshan; Liyanage, Malaka; Ogg, Graham			HLA Class I and Class II Associations in Dengue Viral Infections in a Sri Lankan Population	PLOS ONE			English	Article							T-CELL RESPONSES; HEMORRHAGIC-FEVER; VIRUS-INFECTION; DISEASE; PATHOGENESIS; FREQUENCIES	Background: HLA class I and class II alleles have been shown to be associated with the development of dengue hemorrhagic fever (DHF)/dengue shock syndrome (DSS) in different populations. However, the majority of studies have been based on limited numbers of patients. In this study we aimed to investigate the HLA-class I and class II alleles that are positively and negatively associated with the development of DSS in a cohort of patients with DHF and also the alleles associated with development of DHF during primary dengue infections in a Sri Lankan population. Methodology/Principal Findings: The allele frequencies of HLA class I and class II alleles were compared in 110 patients with DHF and 119 individuals from the population who had never reported a symptomatic dengue infection at the time of recruitment. We found that HLA-A*31 (corrected P = 0.01) and DRB1*08 (corrected P = 0.009) were associated with susceptibility to DSS when infected with the dengue virus, during secondary dengue infection. The frequency of DRB1*08 allele was 28.7 times higher than in the normal population in patients with DSS. HLA-A*31 allele was increased 16.6 fold in DHF who developed shock when compared to those who did not develop shock. A*24 (corrected P = 0.03) and DRB1*12 (corrected P = 0.041) were strongly associated with the development of DHF during primary dengue infection. Conclusions/Significance: These data suggest that certain HLA alleles confer susceptibility/protection to severe dengue infections. As T cell epitope recognition depend on the HLA type of an individual, it would be now important to investigate how epitope specific T cells associate with primary and secondary dengue infections and in severe dengue infections.	[Malavige, Gathsaurie Neelika; Rohanachandra, Lochana T.; Fernando, Neluka; Liyanage, Malaka] Univ Sri Jayawardanapura, Dept Microbiol, Nugegoda, Sri Lanka; [Jayaratne, S. D.] Univ Sri Jayawardanapura, Dept Med, Nugegoda, Sri Lanka; [Malavige, Gathsaurie Neelika; Rostron, Tim; Ogg, Graham] Univ Oxford, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford, England; [De Silva, Aruna Dharshan] Genetech Res Inst, Colombo, Sri Lanka; [Ogg, Graham] Churchill Hosp, Dept Dermatol, Oxford OX3 7LJ, England	University Sri Jayewardenepura; University Sri Jayewardenepura; University of Oxford; University of Oxford	Malavige, GN (corresponding author), Univ Sri Jayawardanapura, Dept Microbiol, Nugegoda, Sri Lanka.	graham.ogg@ndm.ox.ac.uk	Malavige, Gathsaurie/J-5483-2015	Malavige, Gathsaurie/0000-0001-9201-0449; De Silva, Aruna/0000-0001-5291-9543; Ogg, Graham/0000-0002-3097-045X	MRC; MRC [G0701693, MC_U137881017] Funding Source: UKRI; Medical Research Council [G1000800h, G0701693, MC_U137881017] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding was provided by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Falcon-Lezama JA, 2009, ACTA TROP, V112, P193, DOI 10.1016/j.actatropica.2009.07.025; Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Callaway E, 2007, NATURE, V448, P734, DOI 10.1038/448734a; Chau Tran Nguyen Bich, 2008, J Infect Dis, V198, P516, DOI 10.1086/590117; Chen RF, 2009, CLIN IMMUNOL, V131, P404, DOI 10.1016/j.clim.2009.01.015; Dong T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001192; LaFleur C, 2002, HUM IMMUNOL, V63, P1039, DOI 10.1016/S0198-8859(02)00682-1; Lan NTP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000304; Loke H, 2002, AM J TROP MED HYG, V67, P102, DOI 10.4269/ajtmh.2002.67.102; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Malavige GN, 2007, INT J IMMUNOGENET, V34, P313, DOI 10.1111/j.1744-313X.2007.00698.x; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Sierra B, 2007, HUM IMMUNOL, V68, P531, DOI 10.1016/j.humimm.2007.03.001; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Stephens HAF, 2002, TISSUE ANTIGENS, V60, P309, DOI 10.1034/j.1399-0039.2002.600405.x; Tissera HA, 2010, PROCEDIA VACCINOL, V2, P109, DOI 10.1016/j.provac.2010.03.020; Vaughn DW, 1999, AM J TROP MED HYG, V60, P693, DOI 10.4269/ajtmh.1999.60.693; Waduge R, 2006, J CLIN VIROL, V37, P27, DOI 10.1016/j.jcv.2006.06.002; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; *WHO, 2009, DENG GUILD DIAGN PRE	24	43	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20581	10.1371/journal.pone.0020581	http://dx.doi.org/10.1371/journal.pone.0020581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694773	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900015
J	Schulz, C; Paus, M; Frey, K; Schmid, R; Kohl, Z; Mennerich, D; Winkler, J; Gillardon, F				Schulz, Cathrin; Paus, Marie; Frey, Katharina; Schmid, Ramona; Kohl, Zacharias; Mennerich, Detlev; Winkler, Juergen; Gillardon, Frank			Leucine-Rich Repeat Kinase 2 Modulates Retinoic Acid-Induced Neuronal Differentiation of Murine Embryonic Stem Cells	PLOS ONE			English	Article							PARKINSONS-DISEASE; ADULT HIPPOCAMPAL; PROBE LEVEL; IN-VITRO; LRRK2; MICE; NEUROGENESIS; EXPRESSION; BRAIN; PHOSPHORYLATION	Background: Dominant mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most prevalent cause of Parkinson's disease, however, little is known about the biological function of LRRK2 protein. LRRK2 is expressed in neural precursor cells suggesting a role in neurodevelopment. Methodology/Principal Findings: In the present study, differential gene expression profiling revealed a faster silencing of pluripotency-associated genes, like Nanog, Oct4, and Lin28, during retinoic acid-induced neuronal differentiation of LRRK2-deficient mouse embryonic stem cells compared to wildtype cultures. By contrast, expression of neurotransmitter receptors and neurotransmitter release was increased in LRRK2+/- cultures indicating that LRRK2 promotes neuronal differentiation. Consistently, the number of neural progenitor cells was higher in the hippocampal dentate gyrus of adult LRRK2-deficient mice. Alterations in phosphorylation of the putative LRRK2 substrates, translation initiation factor 4E binding protein 1 and moesin, do not appear to be involved in altered differentiation, rather there is indirect evidence that a regulatory signaling network comprising retinoic acid receptors, let-7 miRNA and downstream target genes/mRNAs may be affected in LRRK2-deficient stem cells in culture. Conclusion/Significance: Parkinson's disease-linked LRRK2 mutations that associated with enhanced kinase activity may affect retinoic acid receptor signaling during neurodevelopment and/or neuronal maintenance as has been shown in other mouse models of chronic neurodegenerative diseases.	[Schulz, Cathrin; Frey, Katharina; Schmid, Ramona; Mennerich, Detlev; Gillardon, Frank] Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Biberach, Germany; [Paus, Marie; Kohl, Zacharias; Winkler, Juergen] Univ Hosp Erlangen, Div Mol Neurol, Erlangen, Germany	Boehringer Ingelheim; University of Erlangen Nuremberg	Schulz, C (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, CNS Res, Biberach, Germany.	Frank.Gillardon@boehringer-ingelheim.com		Winkler, Jurgen/0000-0003-0630-9204	Boehringer Ingelheim Pharma GmbH Co KG	Boehringer Ingelheim Pharma GmbH Co KG(Boehringer Ingelheim)	The authors are employees of Boehringer Ingelheim Pharma GmbH & Co KG. The company funded the study. The funder has approved submission of the manuscript. The funder did play a role in study design, data collection and analysis, decision to publish, and presentation of the manuscript.	Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Andres-Mateos E, 2009, J NEUROSCI, V29, P15846, DOI 10.1523/JNEUROSCI.4357-09.2009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Bour G, 2007, TRENDS CELL BIOL, V17, P302, DOI 10.1016/j.tcb.2007.04.003; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Crews L, 2008, J NEUROSCI, V28, P4250, DOI 10.1523/JNEUROSCI.0066-08.2008; DACHSEL JC, 2010, PARKINSONISM RELAT D; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gehrke S, 2010, NATURE, V466, P637, DOI 10.1038/nature09191; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Jechlinger M, 2003, ONCOGENE, V22, P7155, DOI 10.1038/sj.onc.1206887; Kohl Z, 2007, BRAIN RES, V1155, P24, DOI 10.1016/j.brainres.2007.04.039; Krezel W, 1998, SCIENCE, V279, P863, DOI 10.1126/science.279.5352.863; Kronenberg G, 2010, J NEUROSCI, V30, P3419, DOI 10.1523/JNEUROSCI.4231-09.2010; Krzyzosiak A, 2010, NEURON, V66, P908, DOI 10.1016/j.neuron.2010.05.004; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Mata IF, 2006, TRENDS NEUROSCI, V29, P286, DOI 10.1016/j.tins.2006.03.006; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Melrose H, 2008, FUTUR NEUROL, V3, P669, DOI 10.2217/14796708.3.6.669; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Nakamura F, 1999, MOL BIOL CELL, V10, P2669, DOI 10.1091/mbc.10.8.2669; Owens DF, 2002, NEURON, V36, P989, DOI 10.1016/S0896-6273(02)01136-4; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; PARKINSON H, 2010, NUCL ACIDS RES; Schrenk-Siemens K, 2008, STEM CELLS, V26, P2153, DOI 10.1634/stemcells.2008-0010; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Serra HG, 2006, CELL, V127, P697, DOI 10.1016/j.cell.2006.09.036; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Zechel S, 2010, INT J DEV NEUROSCI, V28, P391, DOI 10.1016/j.ijdevneu.2010.04.002	45	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20820	10.1371/journal.pone.0020820	http://dx.doi.org/10.1371/journal.pone.0020820			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695257	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900030
J	Tsang, A; Seidle, H; Jawaid, S; Zhou, WD; Smith, C; Couch, RD				Tsang, Arthur; Seidle, Heather; Jawaid, Safdar; Zhou, Weidong; Smith, Clint; Couch, Robin D.			Francisella tularensis 2-C-Methyl-D-Erythritol 4-Phosphate Cytidylyltransferase: Kinetic Characterization and Phosphoregulation	PLOS ONE			English	Article							ISOPRENOID BIOSYNTHESIS; ESCHERICHIA-COLI; NONMEVALONATE PATHWAY; 4-(CYTIDINE 5'-DIPHOSPHO)-2-C-METHYL-D-ERYTHRITOL; PROTEIN; LYTB; SYNTHASE; GCPE; IDENTIFICATION; PYROPHOSPHATE	Deliberate and natural outbreaks of infectious disease, the prevalence of antibiotic resistant strains, and the ease by which antibiotic resistant bacteria can be intentionally engineered all underscore the necessity of effective vaccines and continued development of novel antimicrobial/antiviral therapeutics. Isoprenes, a group of molecules fundamentally involved in a variety of crucial biological functions, are derived from either the mevalonic acid (MVA) or methylerythritol phosphate (MEP) pathway. While mammals utilize the MVA pathway, many bacteria utilize the MEP pathway, highlighting the latter as an attractive target for antibiotic development. In this report we describe the cloning and characterization of Francisella tularensis MEP cytidylyltransferase, a MEP pathway enzyme and potential target for antibiotic development. Size exclusion chromatography indicates the protein exists as a dimer in solution. Enzyme assays produced an apparent K-M(MEP) = 178 mu M, K-M(CTP) = 73 mu M, k(cat)(MEP) = 1 s(-1), k(cat)(CTP) = 0.8 s(-1), and a k(cat)(MEP)/K-M(MEP) = 3.4 x 10(5) M-1 min(-1). The enzyme exhibits a strict preference for Mg+2 as a divalent cation and CTP as the nucleotide. Titanium dioxide chromatography-tandem mass spectrometry identified Thr141 as a site of phosphorylation. T141D and T141E site-directed mutants are catalytically inactive, suggesting a mechanism for post-translational control of metabolic flux through the F. tularensis MEP pathway. Overall, our study suggests that MEP cytidylyltransferase is an excellent target for the development of novel antibiotics against F. tularensis.	[Tsang, Arthur; Seidle, Heather; Jawaid, Safdar; Couch, Robin D.] George Mason Univ, Dept Chem & Biochem, Manassas, VA 20110 USA; [Tsang, Arthur; Seidle, Heather; Jawaid, Safdar; Couch, Robin D.] George Mason Univ, Natl Ctr Biodef & Infect Dis, Manassas, VA USA; [Zhou, Weidong] George Mason Univ, Dept Mol & Microbiol, Manassas, VA USA; [Zhou, Weidong] George Mason Univ, Ctr Appl Prote & Mol Med, Manassas, VA USA; [Smith, Clint] USA, Geospatial Res & Engn Div, Engn Res & Dev Ctr, Alexandria, VA USA	George Mason University; George Mason University; George Mason University; George Mason University; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC)	Tsang, A (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA 20110 USA.	rcouch@gmu.edu	JAWAID, SAFDAR/C-1444-2013		George Mason University	George Mason University	This work was supported by startup funds provided by George Mason University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2002, P NATL ACAD SCI USA, V99, P12108, DOI 10.1073/pnas.182412599; AGRANOFF BW, 1959, J AM CHEM SOC, V81, P1254, DOI 10.1021/ja01514a059; Altincicek B, 2002, FEBS LETT, V532, P437, DOI 10.1016/S0014-5793(02)03726-2; Altincicek B, 2001, FEBS LETT, V499, P37, DOI 10.1016/S0014-5793(01)02516-9; Altincicek B, 2001, J BACTERIOL, V183, P2411, DOI 10.1128/JB.183.8.2411-2416.2001; AMDUR BH, 1957, J AM CHEM SOC, V79, P2646, DOI 10.1021/ja01567a077; Bernal C, 2005, ANAL BIOCHEM, V337, P55, DOI 10.1016/j.ab.2004.10.011; BLOCH K, 1959, J BIOL CHEM, V234, P2595; Campos N, 2001, FEBS LETT, V488, P170, DOI 10.1016/S0014-5793(00)02420-0; CLARKE PR, 1990, EMBO J, V9, P2439, DOI 10.1002/j.1460-2075.1990.tb07420.x; Cunningham FX, 2000, J BACTERIOL, V182, P5841, DOI 10.1128/JB.182.20.5841-5848.2000; DHEPAGANON S, 1994, BIOCHEMISTRY-US, V33, P13355, DOI 10.1021/bi00249a023; Eoh H, 2007, J BACTERIOL, V189, P8922, DOI 10.1128/JB.00925-07; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Giersiefen H, 2003, EXS, V93, P1; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hecht S, 2001, P NATL ACAD SCI USA, V98, P14837, DOI 10.1073/pnas.201399298; Herz S, 2000, P NATL ACAD SCI USA, V97, P2486, DOI 10.1073/pnas.040554697; Hill RE, 1996, J BIOL CHEM, V271, P30426, DOI 10.1074/jbc.271.48.30426; HILL RE, 1989, J AM CHEM SOC, V111, P1916, DOI 10.1021/ja00187a076; Jawaid S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008288; JORDAN PM, 1983, BIOCHEM J, V213, P153, DOI 10.1042/bj2130153; JULLIARD JH, 1991, P NATL ACAD SCI USA, V88, P2042, DOI 10.1073/pnas.88.6.2042; JULLIARD JH, 1992, CR ACAD SCI III-VIE, V314, P285; Kollas AK, 2002, FEBS LETT, V532, P432, DOI 10.1016/S0014-5793(02)03725-0; Koppisch AT, 2002, BIOCHEMISTRY-US, V41, P236, DOI 10.1021/bi0118207; Kuzuyama T, 2000, TETRAHEDRON LETT, V41, P2925, DOI 10.1016/S0040-4039(00)00295-1; Kuzuyama T, 2000, TETRAHEDRON LETT, V41, P703, DOI 10.1016/S0040-4039(99)02143-7; Lange BM, 1998, P NATL ACAD SCI USA, V95, P2100, DOI 10.1073/pnas.95.5.2100; Luchini A, 2008, NANO LETT, V8, P350, DOI 10.1021/nl072174l; Luttgen H, 2000, P NATL ACAD SCI USA, V97, P1062, DOI 10.1073/pnas.97.3.1062; McAteer S, 2001, J BACTERIOL, V183, P7403, DOI 10.1128/JB.183.24.7403-7407.2001; MIZIORKO HM, 1977, J BIOL CHEM, V252, P1414; Richard SB, 2004, BIOCHEMISTRY-US, V43, P12189, DOI 10.1021/bi0487241; Richard SB, 2001, NAT STRUCT BIOL, V8, P641, DOI 10.1038/89691; Rodriguez-Concepcion Manuel, 2006, Phytochemistry Reviews, V5, P1, DOI 10.1007/s11101-005-3130-4; Rohdich F, 2005, BIOCHEM SOC T, V33, P785, DOI 10.1042/BST0330785; Rohdich F, 2003, P NATL ACAD SCI USA, V100, P1586, DOI 10.1073/pnas.0337742100; Rohdich F, 2002, P NATL ACAD SCI USA, V99, P1158, DOI 10.1073/pnas.032658999; Rohdich F, 1999, P NATL ACAD SCI USA, V96, P11758, DOI 10.1073/pnas.96.21.11758; Rohmer M, 2008, LIPIDS, V43, P1095, DOI 10.1007/s11745-008-3261-7; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shi WJ, 2007, J BIOCHEM MOL BIOL, V40, P911; Singh N, 2007, CURR PHARM DESIGN, V13, P1161, DOI 10.2174/138161207780618939; Tang CM, 2001, ANNU REV GENOM HUM G, V2, P259, DOI 10.1146/annurev.genom.2.1.259; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	47	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20884	10.1371/journal.pone.0020884	http://dx.doi.org/10.1371/journal.pone.0020884			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694781	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900034
J	Antonio, JDS; Schweitzer, MH; Jensen, ST; Kalluri, R; Buckley, M; Orgel, JPRO				Antonio, James D. San; Schweitzer, Mary H.; Jensen, Shane T.; Kalluri, Raghu; Buckley, Michael; Orgel, Joseph P. R. O.			Dinosaur Peptides Suggest Mechanisms of Protein Survival	PLOS ONE			English	Article							COLLAGEN FIBRILS; SOFT-TISSUE; CELLULAR PRESERVATION; ORGANIC-MATTER; CROSS-LINKS; I COLLAGEN; BONE; MATRIX; SEQUENCES; MASTODON	Eleven collagen peptide sequences recovered from chemical extracts of dinosaur bones were mapped onto molecular models of the vertebrate collagen fibril derived from extant taxa. The dinosaur peptides localized to fibril regions protected by the close packing of collagen molecules, and contained few acidic amino acids. Four peptides mapped to collagen regions crucial for cell-collagen interactions and tissue development. Dinosaur peptides were not represented in more exposed parts of the collagen fibril or regions mediating intermolecular cross-linking. Thus functionally significant regions of collagen fibrils that are physically shielded within the fibril may be preferentially preserved in fossils. These results show empirically that structure-function relationships at the molecular level could contribute to selective preservation in fossilized vertebrate remains across geological time, suggest a 'preservation motif', and bolster current concepts linking collagen structure to biological function. This non-random distribution supports the hypothesis that the peptides are produced by the extinct organisms and suggests a chemical mechanism for survival.	[Antonio, James D. San] Orthovita Inc, Operat, Malvern, PA USA; [Schweitzer, Mary H.] N Carolina State Univ, Dept Marine Earth & Atmospher Sci, Raleigh, NC 27695 USA; [Schweitzer, Mary H.] N Carolina Museum Nat Sci, Raleigh, NC USA; [Schweitzer, Mary H.] Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA; [Jensen, Shane T.] Univ Penn, Wharton Sch, Dept Stat, Philadelphia, PA 19104 USA; [Kalluri, Raghu] Beth Israel Deaconess Med Ctr, Dept Med, Div Matrix Biol, Boston, MA 02215 USA; [Kalluri, Raghu] Harvard Univ, Sch Med, Boston, MA USA; [Kalluri, Raghu] Harvard Massachusetts Inst Technol, Dept Biol Chem & Mol Pharmacol, Div Hlth Sci & Technol, Boston, MA USA; [Buckley, Michael] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England; [Buckley, Michael] Univ York, Dept Archaeol, York YO10 5DD, N Yorkshire, England; [Orgel, Joseph P. R. O.] IIT, Dept Biol, Pritzker Inst Biomed Sci & Engn, Chicago, IL 60616 USA	University of North Carolina; North Carolina State University; Montana State University System; Montana State University Bozeman; University of Pennsylvania; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; University of Manchester; University of York - UK; Illinois Institute of Technology	Antonio, JDS (corresponding author), Orthovita Inc, Operat, Malvern, PA USA.	jsanantonio@orthovita.com; orgel@iit.edu	Schweitzer, Mary/V-8143-2019; schweitzer, mary h/A-6756-2010; Kalluri, Raghu/E-2677-2015	schweitzer, mary h/0000-0002-0427-3829; Buckley, Michael/0000-0002-4166-8213; Kalluri, Raghu/0000-0002-2190-547X	NIH [RR 08630, DK 55001]; NSF [0644015]; David and Lucile Packard Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055001] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded by NIH RR 08630 and an NSF Career Award 0644015 to JPROO; NIH DK 55001 grant to RK; and grants from NSF and The David and Lucile Packard Foundation to MHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asara JM, 2007, SCIENCE, V317, P1324, DOI 10.1126/science.317.5843.1324; Asara JM, 2007, SCIENCE, V316, P280, DOI 10.1126/science.1137614; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Bern M, 2009, J PROTEOME RES; Buckley M, 2011, GEOCHIM COSMOCHIM AC, V75, P2007, DOI 10.1016/j.gca.2011.01.022; Buckley M, 2009, RAPID COMMUN MASS SP, V23, P3843, DOI 10.1002/rcm.4316; Buckley M, 2008, SCIENCE, V319, DOI 10.1126/science.1147046; CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099; Collins MJ, 2000, GEOLOGY, V28, P1139, DOI 10.1130/0091-7613(2000)28<1139:SRODOO>2.0.CO;2; Collins MJ, 2002, ARCHAEOMETRY, V44, P383, DOI 10.1111/1475-4754.t01-1-00071; COLLINS MJ, 1995, J ARCHAEOL SCI, V22, P175, DOI 10.1006/jasc.1995.0019; Hanson DA, 1996, J BIOL CHEM, V271, P26508, DOI 10.1074/jbc.271.43.26508; Hoss M, 2000, NATURE, V404, P453, DOI 10.1038/35006551; Hu XW, 1997, BBA-GEN SUBJECTS, V1334, P327, DOI 10.1016/S0304-4165(96)00112-2; Kaye TG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002808; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Lindqvist C, 2010, P NATL ACAD SCI USA, V107; Miles CA, 2001, MICRON, V32, P325, DOI 10.1016/S0968-4328(00)00034-2; Miles CA, 1999, BIOPHYS J, V76, P3243, DOI 10.1016/S0006-3495(99)77476-X; Miller EJ, 1984, EXTRACELLULAR MATRIX; NEMETHY G, 1986, BIOCHEMISTRY-US, V25, P3184, DOI 10.1021/bi00359a016; Nielsen-Marsh C., 2002, BIOCHEMISTRY-US, V24, P12, DOI [10.1042/BIO02403012, DOI 10.1042/BIO02403012]; NOTBOHM H, 1992, J PROTEIN CHEM, V11, P635, DOI 10.1007/BF01024964; Organ CL, 2008, SCIENCE, V320, P499, DOI 10.1126/science.1154284; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Orgel JP, 2000, STRUCT FOLD DES, V8, P137, DOI 10.1016/S0969-2126(00)00089-7; Ostrom PH, 2006, GEOCHIM COSMOCHIM AC, V70, P2034, DOI 10.1016/j.gca.2006.01.004; Perumal S, 2008, P NATL ACAD SCI USA, V105, P2824, DOI 10.1073/pnas.0710588105; Pevzner PA, 2008, SCIENCE, V321, DOI 10.1126/science.1155006; QIAN YR, 1993, GEOCHIM COSMOCHIM AC, V57, P3281, DOI 10.1016/0016-7037(93)90540-D; Salamon M, 2005, P NATL ACAD SCI USA, V102, P13783, DOI 10.1073/pnas.0503718102; Salmon V, 2000, ORG GEOCHEM, V31, P463, DOI 10.1016/S0146-6380(00)00013-9; Schmidt-Schultz TH, 2004, AM J PHYS ANTHROPOL, V123, P30, DOI 10.1002/ajpa.10308; Schweitzer MH, 2009, SCIENCE, V324, P626, DOI 10.1126/science.1165069; Schweitzer MH, 2007, SCIENCE, V316, P277, DOI 10.1126/science.1138709; Schweitzer MH, 2007, P ROY SOC B-BIOL SCI, V274, P183, DOI 10.1098/rspb.2006.3705; Schweitzer MH, 2005, SCIENCE, V307, P1952, DOI 10.1126/science.1108397; Sweeney SM, 2008, J BIOL CHEM, V283, P21187, DOI 10.1074/jbc.M709319200; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; Trueman CN, 2002, ARCHAEOMETRY, V44, P371, DOI 10.1111/1475-4754.t01-1-00070; Tuross N, 2002, ARCHAEOMETRY, V44, P427, DOI 10.1111/1475-4754.00075; Tuross N., 1989, Applied Geochemistry, V4, P255, DOI 10.1016/0883-2927(89)90026-7; VANDERREST M, 1991, FASEB J, V5, P2814, DOI 10.1096/fasebj.5.13.1916105; Weiner S, 1999, J STRUCT BIOL, V126, P241, DOI 10.1006/jsbi.1999.4107; Wojtowicz A, 1999, CALCIFIED TISSUE INT, V64, P370, DOI 10.1007/PL00005816; 1996, COMPUTATIONAL CHEM, V20, P339	46	14	14	7	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20381	10.1371/journal.pone.0020381	http://dx.doi.org/10.1371/journal.pone.0020381			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687667	Green Published, gold			2022-12-25	WOS:000291611500019
J	Kevei, Z; Baloban, M; Da Ines, O; Tiricz, H; Kroll, A; Regulski, K; Mergaert, P; Kondorosi, E				Kevei, Zoltan; Baloban, Mikhail; Da Ines, Olivier; Tiricz, Hilda; Kroll, Alexandra; Regulski, Krzysztof; Mergaert, Peter; Kondorosi, Eva			Conserved CDC20 Cell Cycle Functions Are Carried out by Two of the Five Isoforms in Arabidopsis thaliana	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; SPINDLE-ASSEMBLY CHECKPOINT; GENE-EXPRESSION; S-PHASE; APC/C; PROTEIN; ACTIVATORS; DISTINCT; MITOSIS; BOX	Background: The CDC20 and Cdh1/CCS52 proteins are substrate determinants and activators of the Anaphase Promoting Complex/Cyclosome (APC/C) E3 ubiquitin ligase and as such they control the mitotic cell cycle by targeting the degradation of various cell cycle regulators. In yeasts and animals the main CDC20 function is the destruction of securin and mitotic cyclins. Plants have multiple CDC20 gene copies whose functions have not been explored yet. In Arabidopsis thaliana there are five CDC20 isoforms and here we aimed at defining their contribution to cell cycle regulation, substrate selectivity and plant development. Methodology/Principal Findings: Studying the gene structure and phylogeny of plant CDC20s, the expression of the five AtCDC20 gene copies and their interactions with the APC/C subunit APC10, the CCS52 proteins, components of the mitotic checkpoint complex (MCC) and mitotic cyclin substrates, conserved CDC20 functions could be assigned for AtCDC20.1 and AtCDC20.2. The other three intron-less genes were silent and specific for Arabidopsis. We show that AtCDC20.1 and AtCDC20.2 are components of the MCC and interact with mitotic cyclins with unexpected specificity. AtCDC20.1 and AtCDC20.2 are expressed in meristems, organ primordia and AtCDC20.1 also in pollen grains and developing seeds. Knocking down both genes simultaneously by RNAi resulted in severe delay in plant development and male sterility. In these lines, the meristem size was reduced while the cell size and ploidy levels were unaffected indicating that the lower cell number and likely slowdown of the cell cycle are the cause of reduced plant growth. Conclusions/Significance: The intron-containing CDC20 gene copies provide conserved and redundant functions for cell cycle progression in plants and are required for meristem maintenance, plant growth and male gametophyte formation. The Arabidopsis-specific intron-less genes are possibly "retrogenes" and have hitherto undefined functions or are pseudogenes.	[Kevei, Zoltan; Baloban, Mikhail; Da Ines, Olivier; Kroll, Alexandra; Regulski, Krzysztof; Mergaert, Peter; Kondorosi, Eva] Ctr Natl Rech Sci, Inst Sci Vegetal, Unite Propre Rech 2355, Gif Sur Yvette, France; [Kevei, Zoltan; Tiricz, Hilda; Kondorosi, Eva] Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, Szeged, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Kevei, Z (corresponding author), Ctr Natl Rech Sci, Inst Sci Vegetal, Unite Propre Rech 2355, Gif Sur Yvette, France.	Eva.Kondorosi@isv.cnrs-gif.fr	DA INES, Olivier/J-6901-2015; Kevei, Zoltan/AAF-5054-2021; Kroll, Alexandra/F-6974-2012; Mergaert, Peter/M-1265-2019	DA INES, Olivier/0000-0002-1868-3781; Kevei, Zoltan/0000-0002-3065-3198; Mergaert, Peter/0000-0002-5919-7317; Kondorosi, Eva/0000-0002-4065-8515; Baloban, Mikhail/0000-0003-3919-1222	Marie Curie Intra European Fellowship [025304]; Marie Curie Early Stage Training Network "ADOPT" [MEST-CT-2004-504066]; Agence National de la Recherche Grant "Aracyclosome" [ANR-05-BLAN-0072-01]; Hungarian Office for Research and Technology [OMFB-00441/2007]; Conseil General de l'Essonne, for assistance with microscopy	Marie Curie Intra European Fellowship(European Commission); Marie Curie Early Stage Training Network "ADOPT"(European Commission); Agence National de la Recherche Grant "Aracyclosome"(French National Research Agency (ANR)); Hungarian Office for Research and Technology; Conseil General de l'Essonne, for assistance with microscopy	Z.K. was a recipient of a Marie Curie Intra European Fellowship #025304. The study was supported by the Marie Curie Early Stage Training Network "ADOPT"-Grant MEST-CT-2004-504066, by the Agence National de la Recherche Grant "Aracyclosome" ANR-05-BLAN-0072-01 and by the Hungarian Office for Research and Technology, Grant OMFB-00441/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to Samuel Mondy for help with statistical analysis with the R software, to Adam Kondorosi for his constant support and Attila Kereszt for his help in the expression studies. Arabidopsis insertion lines were obtained from the Nottingham Stock Center (Loughborough, United Kingdom). We thank the Imagif Cell Biology Unit (Gif-sur-Yvette, France), which is supported by the Conseil General de l'Essonne, for assistance with microscopy.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Baker DJ, 2007, CELL MOL LIFE SCI, V64, P589, DOI 10.1007/s00018-007-6443-1; Barow M, 2003, PLANT CELL ENVIRON, V26, P571, DOI 10.1046/j.1365-3040.2003.00988.x; Caillaud MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006757; Capron A, 2003, TRENDS PLANT SCI, V8, P83, DOI 10.1016/S1360-1385(02)00028-6; Cebolla A, 1999, EMBO J, V18, P4476, DOI 10.1093/emboj/18.16.4476; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clarke DJ, 2003, NAT CELL BIOL, V5, P928, DOI 10.1038/ncb1046; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Diaz-Martinez LA, 2009, CELL CYCLE, V8, P2733, DOI 10.4161/cc.8.17.9403; Fulop K, 2005, CELL CYCLE, V4, P1084; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Jin F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001147; Kaessmann H, 2009, NAT REV GENET, V10, P19, DOI 10.1038/nrg2487; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; Kasili R, 2010, GENETICS, V185, P257, DOI 10.1534/genetics.109.113274; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; Kwee HS, 2003, PLANT J, V36, P853, DOI 10.1046/j.1365-313X.2003.01925.x; Lima MD, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-254; Liu Z, 2006, PLANT CELL, V18, P1213, DOI 10.1105/tpc.105.036913; Lopez-Juez E, 2008, PLANT CELL, V20, P947, DOI 10.1105/tpc.107.057075; Manchado E, 2010, BIOCHEM SOC T, V38, P65, DOI 10.1042/BST0380065; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Marrocco K, 2009, DEVELOPMENT, V136, P1475, DOI 10.1242/dev.035535; Mondal G, 2006, BIOCHEM J, V396, P243, DOI 10.1042/BJ20051914; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Perez-Perez JM, 2008, PLANT J, V53, P78, DOI 10.1111/j.1365-313X.2007.03312.x; Pesin JA, 2008, ANNU REV CELL DEV BI, V24, P475, DOI 10.1146/annurev.cellbio.041408.115949; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pfleger CM, 2000, GENE DEV, V14, P655; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Prinz S, 1998, CURR BIOL, V8, P750, DOI 10.1016/S0960-9822(98)70298-2; Proost S, 2009, PLANT CELL, V21, P3718, DOI 10.1105/tpc.109.071506; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Roudier F, 2000, PLANT J, V23, P73, DOI 10.1046/j.1365-313x.2000.00794.x; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Sigrist SJ, 1997, CELL, V90, P671, DOI 10.1016/S0092-8674(00)80528-0; Stemmann O, 2006, CELL CYCLE, V5, P11, DOI 10.4161/cc.5.1.2296; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tarayre S, 2004, PLANT CELL, V16, P422, DOI 10.1105/tpc.018952; TOPFER R, 1987, NUCLEIC ACIDS RES, V15, P5890, DOI 10.1093/nar/15.14.5890; van Zon W, 2010, J CELL BIOL, V190, P587, DOI 10.1083/jcb.200912084; Vanstraelen M, 2009, P NATL ACAD SCI USA, V106, P11806, DOI 10.1073/pnas.0901193106; Vinardell JM, 2003, PLANT CELL, V15, P2093, DOI 10.1105/tpc.014373; Weingartner M, 2004, PLANT CELL, V16, P643, DOI 10.1105/tpc.020057; Yang Y, 2010, CURR OPIN NEUROBIOL, V20, P92, DOI 10.1016/j.conb.2009.12.004; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu H, 2007, MOL CELL, V27, P3, DOI 10.1016/j.molcel.2007.06.009; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	55	52	69	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20618	10.1371/journal.pone.0020618	http://dx.doi.org/10.1371/journal.pone.0020618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687678	Green Submitted, gold, Green Published			2022-12-25	WOS:000291611500035
J	Maia, S; Pelletier, M; Ding, JX; Hsu, YM; Sallan, SE; Rao, SP; Nadler, LM; Cardoso, AA				Maia, Sara; Pelletier, Marc; Ding, Jixin; Hsu, Yen-Ming; Sallan, Stephen E.; Rao, Sambasiva P.; Nadler, Lee M.; Cardoso, Angelo A.			Aberrant Expression of Functional BAFF-System Receptors by Malignant B-Cell Precursors Impacts Leukemia Cell Survival	PLOS ONE			English	Article							NECROSIS-FACTOR FAMILY; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW MICROENVIRONMENT; NF-KAPPA-B; MYELOMA CELLS; LYMPHOCYTE STIMULATOR; AUTOIMMUNE-DISEASE; MATURATION ANTIGEN; TNF RECEPTOR; T-CELLS	Despite exhibiting oncogenic events, patient's leukemia cells are responsive and dependent on signals from their malignant bone marrow (BM) microenvironment, which modulate their survival, cell cycle progression, trafficking and resistance to chemotherapy. Identification of the signaling pathways mediating this leukemia/microenvironment interplay is critical for the development of novel molecular targeted therapies. We observed that primary leukemia B-cell precursors aberrantly express receptors of the BAFF-system, BAFF-R, BCMA, and TACI. These receptors are functional as their ligation triggers activation of NF-kappa B, MAPK/JNK, and Akt signaling. Leukemia cells express surface BAFF and APRIL ligands, and soluble BAFF is significantly higher in leukemia patients in comparison to age-matched controls. Interestingly, leukemia cells also express surface APRIL, which seems to be encoded by APRIL-delta, a novel isoform that lacks the furin convertase domain. Importantly, we observed BM microenvironmental cells express the ligands BAFF and APRIL, including surface and secreted BAFF by BM endothelial cells. Functional studies showed that signals through BAFF-system receptors impact the survival and basal proliferation of leukemia B-cell precursors, and support the involvement of both homotypic and heterotypic mechanisms. This study shows an unforeseen role for the BAFF-system in the biology of precursor B-cell leukemia, and suggests that the target disruption of BAFF signals may constitute a valid strategy for the treatment of this cancer.	[Maia, Sara; Nadler, Lee M.; Cardoso, Angelo A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Sallan, Stephen E.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Ding, Jixin; Cardoso, Angelo A.] Indiana Univ Sch Med, Div Hematol Oncol, Indianapolis, IN USA; [Pelletier, Marc; Hsu, Yen-Ming] Biogen Idec Inc, Dept Prot Engn, Cambridge, MA USA; [Rao, Sambasiva P.] Biogen Idec Inc, Dept Immunobiol Autoimmun, Cambridge, MA USA; [Maia, Sara; Cardoso, Angelo A.] Inst Mol Med, Lisbon, Portugal	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Indiana University System; Indiana University Bloomington; Biogen; Biogen; Universidade de Lisboa	Maia, S (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	aacardos@iupui.edu	Maia, Sara/B-2513-2013	Maia, Sara/0000-0001-8638-0566	National Institutes of Health [P01-CA68484]; Fundacao Ciencia e Tecnologia (FCT-Portugal); NATIONAL CANCER INSTITUTE [P01CA068484] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao Ciencia e Tecnologia (FCT-Portugal)(Portuguese Foundation for Science and Technology); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work was supported by National Institutes of Health (P01-CA68484), Fundacao Ciencia e Tecnologia (FCT-Portugal); SM was supported by a FCT-Portugal scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barata JT, 2001, BLOOD, V98, P1524, DOI 10.1182/blood.V98.5.1524; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; BRADSTOCK KF, 1995, LEUKEMIA LYMPHOMA, V18, P1, DOI 10.3109/10428199509064917; Campana D, 1996, Hum Cell, V9, P317; Cardoso AA, 1997, BLOOD, V90, P549, DOI 10.1182/blood.V90.2.549.549_549_561; Cardoso AA, 1996, BLOOD, V88, P41; Corthals SL, 2006, BRIT J HAEMATOL, V132, P452, DOI 10.1111/j.1365-2141.2005.05893.x; Costa LF, 2006, BLOOD, V107, P285, DOI 10.1182/blood-2005-06-2208; Craxton A, 2003, BLOOD, V101, P4464, DOI 10.1182/blood-2002-10-3123; Darce JR, 2007, J IMMUNOL, V179, P7276, DOI 10.4049/jimmunol.179.11.7276; Day ES, 2005, BIOCHEMISTRY-US, V44, P1919, DOI 10.1021/bi048227k; Gross JA, 2000, NATURE, V404, P995, DOI 10.1038/35010115; Hahne M, 1998, J EXP MED, V188, P1185, DOI 10.1084/jem.188.6.1185; He B, 2004, J IMMUNOL, V172, P3268, DOI 10.4049/jimmunol.172.5.3268; Karpusas M, 2002, J MOL BIOL, V315, P1145, DOI 10.1006/jmbi.2001.5296; Khare SD, 2000, P NATL ACAD SCI USA, V97, P3370, DOI 10.1073/pnas.050580697; Kimberley FC, 2009, J CELL PHYSIOL, V218, P1, DOI 10.1002/jcp.21561; LAABI Y, 1994, NUCLEIC ACIDS RES, V22, P1147, DOI 10.1093/nar/22.7.1147; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Lopez-Fraga M, 2001, EMBO REP, V2, P945, DOI 10.1093/embo-reports/kve198; Mackay F, 1999, J EXP MED, V190, P1697, DOI 10.1084/jem.190.11.1697; Mackay F, 2003, ANNU REV IMMUNOL, V21, P231, DOI 10.1146/annurev.immunol.21.120601.141152; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Marsters SA, 2000, CURR BIOL, V10, P785, DOI 10.1016/S0960-9822(00)00566-2; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Moreaux J, 2005, BLOOD, V106, P1021, DOI 10.1182/blood-2004-11-4512; Moreaux J, 2004, BLOOD, V103, P3148, DOI 10.1182/blood-2003-06-1984; Mudry RE, 2000, BLOOD, V96, P1926, DOI 10.1182/blood.V96.5.1926.h8001926_1926_1932; Nishio M, 2005, BLOOD, V106, P1012, DOI 10.1182/blood-2004-03-0889; Parameswaran R, 2010, CANCER RES, V70, P4346, DOI 10.1158/0008-5472.CAN-10-0300; Reid GSD, 2005, BLOOD, V105, P3641, DOI 10.1182/blood-2004-06-2468; Rennert P, 2000, J EXP MED, V192, P1677, DOI 10.1084/jem.192.11.1677; Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5; Schiemann B, 2001, SCIENCE, V293, P2111, DOI 10.1126/science.1061964; Schneider P, 1999, J EXP MED, V189, P1747, DOI 10.1084/jem.189.11.1747; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Smith SH, 2003, J IMMUNOL, V170, P5820, DOI 10.4049/jimmunol.170.12.5820; Tai YT, 2006, CANCER RES, V66, P6675, DOI 10.1158/0008-5472.CAN-06-0190; Tangye SG, 2006, SEMIN IMMUNOL, V18, P305, DOI 10.1016/j.smim.2006.04.004; Thompson JS, 2000, J EXP MED, V192, P129, DOI 10.1084/jem.192.1.129; Thompson JS, 2001, SCIENCE, V293, P2108, DOI 10.1126/science.1061965; Treml LS, 2007, J IMMUNOL, V178, P7531, DOI 10.4049/jimmunol.178.12.7531; Veiga JP, 2006, EXP HEMATOL, V34, P610, DOI 10.1016/j.exphem.2006.01.013; von Bulow GU, 2001, IMMUNITY, V14, P573, DOI 10.1016/S1074-7613(01)00130-3; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; Xia XZ, 2000, J EXP MED, V192, P137, DOI 10.1084/jem.192.1.137; Xu LG, 2002, J IMMUNOL, V169, P6883, DOI 10.4049/jimmunol.169.12.6883; Xu SL, 2001, MOL CELL BIOL, V21, P4067, DOI 10.1128/MCB.21.12.4067-4074.2001; Yan MH, 2000, NAT IMMUNOL, V1, P37, DOI 10.1038/76889; Yan MH, 2001, CURR BIOL, V11, P1547, DOI 10.1016/S0960-9822(01)00481-X; Yan MH, 2001, NAT IMMUNOL, V2, P638, DOI 10.1038/89790	52	32	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20787	10.1371/journal.pone.0020787	http://dx.doi.org/10.1371/journal.pone.0020787			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687682	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500044
J	Jones, CL; Minati, L; Harrison, NA; Ward, J; Critchley, HD				Jones, Catherine L.; Minati, Ludovico; Harrison, Neil A.; Ward, Jamie; Critchley, Hugo D.			Under Pressure: Response Urgency Modulates Striatal and Insula Activity during Decision-Making under Risk	PLOS ONE			English	Article							PREFRONTAL CORTEX; CHOICE BEHAVIOR; NEURAL ACTIVITY; PROSPECT-THEORY; TIME PRESSURE; BASAL GANGLIA; UNCERTAINTY; BRAIN; REPRESENTATION; EMOTION	When deciding whether to bet in situations that involve potential monetary loss or gain (mixed gambles), a subjective sense of pressure can influence the evaluation of the expected utility associated with each choice option. Here, we explored how gambling decisions, their psychophysiological and neural counterparts are modulated by an induced sense of urgency to respond. Urgency influenced decision times and evoked heart rate responses, interacting with the expected value of each gamble. Using functional MRI, we observed that this interaction was associated with changes in the activity of the striatum, a critical region for both reward and choice selection, and within the insula, a region implicated as the substrate of affective feelings arising from interoceptive signals which influence motivational behavior. Our findings bridge current psychophysiological and neurobiological models of value representation and action-programming, identifying the striatum and insular cortex as the key substrates of decision-making under risk and urgency.	[Jones, Catherine L.; Minati, Ludovico; Harrison, Neil A.; Critchley, Hugo D.] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Dept Psychiat, Falmer, England; [Jones, Catherine L.; Ward, Jamie] Univ Sussex, Dept Psychol, Falmer, England; [Minati, Ludovico] Fdn IRCCS Ist Neurol Carlo Besta, Dept Sci, Milan, Italy; [Harrison, Neil A.; Critchley, Hugo D.] Sussex Partnership NHS Fdn Trust, Brighton, E Sussex, England; [Ward, Jamie; Critchley, Hugo D.] Univ Sussex, Sackler Ctr Consciousness Sci, Falmer, England	University of Brighton; University of Sussex; University of Sussex; IRCCS Istituto Neurologico Besta; Italfarmaco; University of Sussex	Jones, CL (corresponding author), Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Dept Psychiat, Falmer, England.	catljones@googlemail.com; lminati@ieee.org	Ward, Jamie/F-3609-2011; critchley, hugo d/G-9267-2011; Minati, Ludovico/R-1076-2017	Ward, Jamie/0000-0001-7007-1902; critchley, hugo d/0000-0002-2445-9284; Minati, Ludovico/0000-0002-2532-1674; Lauwereyns, Jan/0000-0003-0551-2550; Harrison, Neil/0000-0002-9584-3769	Medical Research Council UK [RD13]; Wellcome Trust [074333]	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission)	CLJ received doctoral funding from Medical Research Council UK (RD13). LM, NAH and HDC were supported by a programme grant awarded by the Wellcome Trust to HDC (074333). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BENZUR H, 1981, ACTA PSYCHOL, V47, P89, DOI 10.1016/0001-6918(81)90001-9; Bernoulli D, 1954, ECONOMETRICA, V22, P23, DOI 10.2307/1909829; Bogacz R, 2007, NEURAL COMPUT, V19, P442, DOI 10.1162/neco.2007.19.2.442; Botvinick MM, 2007, COGN AFFECT BEHAV NE, V7, P356, DOI 10.3758/CABN.7.4.356; Bradley MM, 2009, PSYCHOPHYSIOLOGY, V46, P1, DOI 10.1111/j.1469-8986.2008.00702.x; BRADLEY MM, 2007, ANDBOOK PSYCHOPHYSIO; Braver TS, 2001, CEREB CORTEX, V11, P825, DOI 10.1093/cercor/11.9.825; BUSEMEYER JR, 1985, J EXP PSYCHOL LEARN, V11, P538, DOI 10.1037/0278-7393.11.3.538; Carter S, 2004, COGNITION EMOTION, V18, P901, DOI 10.1080/02699930341000338; Clark L, 2008, BRAIN, V131, P1311, DOI 10.1093/brain/awn066; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2000, J NEUROSCI, V20, P3033; Critchley HD, 2001, NEURON, V29, P537, DOI 10.1016/S0896-6273(01)00225-2; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Crone EA, 2004, PSYCHOPHYSIOLOGY, V41, P531, DOI 10.1111/j.1469-8986.2004.00197.x; Damasio A.R., 1994, DESCARTES ERROR EMOT; Damasio H, 2002, NAT NEUROSCI, V5, P1104, DOI 10.1038/nn1102-1104; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; FENTONOCREEVY M, 2010, J ORG BEHAV IN PRESS; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Forstmann BU, 2008, P NATL ACAD SCI USA, V105, P17538, DOI 10.1073/pnas.0805903105; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Huettel SA, 2005, J NEUROSCI, V25, P3304, DOI 10.1523/JNEUROSCI.5070-04.2005; Kahneman D., 1982, JUDGEMENT UNCERTAINT; Knutson B, 2005, J NEUROSCI, V25, P4806, DOI 10.1523/JNEUROSCI.0642-05.2005; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; LEDOUX J, 1999, EMOTION COGNITIVE NE; LIBBY WL, 1973, PSYCHOPHYSIOLOGY, V10, P270, DOI 10.1111/j.1469-8986.1973.tb00526.x; Livesey AC, 2007, NEUROPSYCHOLOGIA, V45, P321, DOI 10.1016/j.neuropsychologia.2006.06.033; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Preuschoff K, 2008, J NEUROSCI, V28, P2745, DOI 10.1523/JNEUROSCI.4286-07.2008; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Redgrave P, 1999, NEUROSCIENCE, V89, P1009, DOI 10.1016/S0306-4522(98)00319-4; Sakagami M, 2007, ANN NY ACAD SCI, V1104, P89, DOI 10.1196/annals.1390.010; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Trepel C, 2005, COGNITIVE BRAIN RES, V23, P34, DOI 10.1016/j.cogbrainres.2005.01.016; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Volz KG, 2003, NEUROIMAGE, V19, P271, DOI 10.1016/S1053-8119(03)00122-8; Weller JA, 2009, SOC NEUROSCI-UK, V4, P347, DOI 10.1080/17470910902934400; Wittmann Marc, 2010, J Neurosci Psychol Econ, V3, P15; WRIGHT P, 1974, J APPL PSYCHOL, V59, P555, DOI 10.1037/h0037186; Xue G, 2010, NEUROIMAGE, V50, P709, DOI 10.1016/j.neuroimage.2009.12.097	49	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2011	6	6							e20942	10.1371/journal.pone.0020942	http://dx.doi.org/10.1371/journal.pone.0020942			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	774BN	21677769	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000291356400037
J	Chaves, PB; Alvarenga, CS; Possamai, CD; Dias, LG; Boubli, JP; Strier, KB; Mendes, SL; Fagundes, V				Chaves, Paulo B.; Alvarenga, Clara S.; Possamai, Carla de B.; Dias, Luiz G.; Boubli, Jean P.; Strier, Karen B.; Mendes, Sergio L.; Fagundes, Valeria			Genetic Diversity and Population History of a Critically Endangered Primate, the Northern Muriqui (Brachyteles hypoxanthus)	PLOS ONE			English	Article							WOOLLY SPIDER MONKEY; MITOCHONDRIAL-DNA; ATLANTIC FOREST; CONSERVATION UNITS; STATISTICAL TESTS; NEUTRALITY TESTS; CONTROL REGION; PHYLOGEOGRAPHY; SOUTH; SIZE	Social, ecological, and historical processes affect the genetic structure of primate populations, and therefore have key implications for the conservation of endangered species. The northern muriqui (Brachyteles hypoxanthus) is a critically endangered New World monkey and a flagship species for the conservation of the Atlantic Forest hotspot. Yet, like other neotropical primates, little is known about its population history and the genetic structure of remnant populations. We analyzed the mitochondrial DNA control region of 152 northern muriquis, or 17.6% of the 864 northern muriquis from 8 of the 12 known extant populations and found no evidence of phylogeographic partitions or past population shrinkage/expansion. Bayesian and classic analyses show that this finding may be attributed to the joint contribution of female-biased dispersal, demographic stability, and a relatively large historic population size. Past population stability is consistent with a central Atlantic Forest Pleistocene refuge. In addition, the best scenario supported by an Approximate Bayesian Computation analysis, significant fixation indices (Phi(ST) = 0.49, Phi(CT) = 0.24), and population-specific haplotypes, coupled with the extirpation of intermediate populations, are indicative of a recent geographic structuring of genetic diversity during the Holocene. Genetic diversity is higher in populations living in larger areas (>2,000 hectares), but it is remarkably low in the species overall (theta = 0.018). Three populations occurring in protected reserves and one fragmented population inhabiting private lands harbor 22 out of 23 haplotypes, most of which are population-exclusive, and therefore represent patchy repositories of the species' genetic diversity. We suggest that these populations be treated as discrete units for conservation management purposes.	[Chaves, Paulo B.; Alvarenga, Clara S.; Possamai, Carla de B.; Mendes, Sergio L.; Fagundes, Valeria] Univ Fed Espirito Santo, Dept Ciencias Biol, Vitoria, Espirito Santo, Brazil; [Dias, Luiz G.] Inst Biotropicos Pesquisa Vida Silvestre, Diamantina, MG, Brazil; [Boubli, Jean P.] Wildlife Conservat Soc, Rio De Janeiro, Brazil; [Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53706 USA	Universidade Federal do Espirito Santo; University of Wisconsin System; University of Wisconsin Madison	Chaves, PB (corresponding author), NYU, Dept Anthropol, New York, NY 10003 USA.	vfagunde@pq.cnpq.br	Chaves, Paulo B./G-6013-2010; Strier, Karen B./AAJ-3482-2020; Fagundes, Valeria/E-6107-2014	Chaves, Paulo B./0000-0003-1491-1449; boubli, Jean/0000-0002-5833-9264; Strier, Karen/0000-0003-2520-9110	NSF [BNS 8305322, BCS 8619442, BCS 8958298, BCS 9414129, BCS 0621788, BCS 0921013]; National Geographic Society; Liz Claiborne and Art Ortenberg Foundation; Fulbright Foundation; Sigma Xi; NAS [213]; WWF; L.S.B. Leakey Foundation; Chicago Zoological Society; Lincoln Park Zoo; Margot Marsh Biodiversity Foundation; Conservation International; Graduate School of the University of Wisconsin-Madison; Microsoft Corporation	NSF(National Science Foundation (NSF)); National Geographic Society(National Geographic Society); Liz Claiborne and Art Ortenberg Foundation; Fulbright Foundation; Sigma Xi; NAS; WWF; L.S.B. Leakey Foundation; Chicago Zoological Society; Lincoln Park Zoo; Margot Marsh Biodiversity Foundation; Conservation International; Graduate School of the University of Wisconsin-Madison; Microsoft Corporation(Microsoft)	KBS has supported the long-term demographic and behavioral studies at RPPN-FMA with funds from NSF (www.nsf.org, BNS 8305322, BCS 8619442, BCS 8958298, BCS 9414129, BCS 0621788, BCS 0921013), the National Geographic Society (www.nationalgeographic.com), the Liz Claiborne and Art Ortenberg Foundation (www.lcaof.org), Fulbright Foundation (www.fulbright.org), Sigma Xi Grants-in-Aid (www.sigmaxi.org), Grant #213 from the Joseph Henry Fund of the NAS (www.nationalacademies.org), WWF (www.wwf.org), L.S.B. Leakey Foundation (www.leakeyfoundation.org), Chicago Zoological Society (www.brookfieldzoo.org), Lincoln Park Zoo Neotropic Fund (www.lpzoo.org), Margot Marsh Biodiversity Foundation, Conservation International (www.conservation.org), and the Graduate School of the University of Wisconsin-Madison (www.grad.wisc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank A. Burrell, D. Brito, J. Hodgson, L. Pozzi, L. Costa, and two anonymous reviewers for critically commenting on previous versions of this manuscript, and H. Carreco Jr. for kindly helping produce Figure 1. T. Disotell and A. Di Fiore provided valuable access to computers at New York University and unpublished sequence data, respectively. We are indebted to A. Perrone and M. Paes for assisting in laboratory work. This research was possible because of several field workers who collected the samples: A. Santos, A. Araujo, C. Mendes, D. Guedes, E. Barbosa, F. Ferreira, F. Paim, F. Tabacow, G. Picoretti, G. Schulz, H. Dazilio, J. Oliveira, K. Souza, L. Dias, L. Carmo, L. Moreira, M. Tokuda, M. Iurck, R. Santos, V. Souza, and W. Silva. Instituto de Pesquisas da Mata Atlantica, Fundacao Biodiversitas, and Instituto Driades were responsible for administrative support. We extend our thanks to Sociedade Preserve Muriqui for providing permission to conduct studies at the RPPN-FMA and Instituto Brasileiro do Meio Ambiente e dos Recursos Naturais Renovaveis for issuing the collecting license (363/2001). Part of the genetic analyses was carried out in the Computational Biology Service Unit from Cornell University, which is partially funded by Microsoft Corporation.	AGUIRRE AC, 1971, AN ACAD BRAS CIENC, V1, P1; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ascunce MS, 2007, MOL PHYLOGENET EVOL, V43, P202, DOI 10.1016/j.ympev.2006.10.004; AVISE JC, 1999, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 2004, MOL ECOL, V13, P827, DOI 10.1111/j.1365-294X.2004.02101.x; Beerli P., 2008, MIGRATE VERSION 3 0; Behling H, 2002, PALAEOGEOGR PALAEOCL, V177, P19, DOI 10.1016/S0031-0182(01)00349-2; Brito D, 2008, BIODIVERS CONSERV, V17, P3255, DOI 10.1007/s10531-008-9427-z; Brito D, 2006, BIODIVERS CONSERV, V15, P4197, DOI 10.1007/s10531-005-3575-1; Brown Keith S. Jr, 2005, P166; Carnaval AC, 2008, J BIOGEOGR, V35, P1187, DOI 10.1111/j.1365-2699.2007.01870.x; Carnaval AC, 2009, SCIENCE, V323, P785, DOI 10.1126/science.1166955; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; CHESSER RK, 1991, GENETICS, V129, P573; Collins AC, 2000, INT J PRIMATOL, V21, P421, DOI 10.1023/A:1005487802312; Collins AC, 2000, INT J PRIMATOL, V21, P381, DOI 10.1023/A:1005435718241; Colwell RK, 2013, ESTIMATES STAT ESTIM; Cornuet JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-401; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Costa LP, 2000, BIOTROPICA, V32, P872; Cowlishaw G., 2000, PRIMATE CONSERVATION; Deinard AS, 2000, AM J PHYS ANTHROPOL, V111, P25, DOI 10.1002/(SICI)1096-8644(200001)111:1<25::AID-AJPA3>3.0.CO;2-R; DESA RML, 1993, AM J PRIMATOL, V29, P145, DOI 10.1002/ajp.1350290206; Di Fiore A, 2003, YEARB PHYS ANTHROPOL, V46, P62, DOI 10.1002/ajpa.10382; Di Fiore Anthony, 2009, P211, DOI 10.1007/978-0-387-78705-3_9; Dietz JM, 2000, CONSERV BIOL SER, V4, P203; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fagundes V, 2008, GENET MOL BIOL, V31, P166, DOI 10.1590/S1415-47572008000100028; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Frankham R, 1996, CONSERV BIOL, V10, P1500, DOI 10.1046/j.1523-1739.1996.10061500.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; GALINDOLEAL C, 2003, ATLANTIC FOREST S AM, P360; Galtier N, 2009, MOL ECOL, V18, P4541, DOI 10.1111/j.1365-294X.2009.04380.x; Galtier N, 2009, BIOL LETTERS, V5, P413, DOI 10.1098/rsbl.2008.0662; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Groves CP, 2005, MAMMAL SPECIES WORLD, P111; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hodgson JA, 2009, P NATL ACAD SCI USA, V106, P5534, DOI 10.1073/pnas.0810346106; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jalil MF, 2008, MOL ECOL, V17, P2898, DOI 10.1111/j.1365-294X.2008.03793.x; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; Ledru MP, 2005, QUATERNARY RES, V64, P444, DOI 10.1016/j.yqres.2005.08.006; Lessios HA, 2008, ANNU REV ECOL EVOL S, V39, P63, DOI 10.1146/annurev.ecolsys.38.091206.095815; Liu Z, 2007, MOL ECOL, V16, P3334, DOI 10.1111/j.1365-294X.2007.03383.x; MANTEL N, 1967, CANCER RES, V27, P209; MELNICK DJ, 1992, INT J PRIMATOL, V13, P379, DOI 10.1007/BF02547824; Melo Fabiano R., 2005, Neotropical Primates, V13, P19; Mendes Sergio L., 2005, Neotropical Primates, V13, P7; MENDES SL, 2008, 2008 IUCN RED LIST T; Moritz C, 1999, HEREDITAS, V130, P217, DOI 10.1111/j.1601-5223.1999.00217.x; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nei M., 1987, MOL EVOLUTIONARY GEN; Nishimura A, 2003, INT J PRIMATOL, V24, P707, DOI 10.1023/A:1024681703616; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Peters JL, 2008, EVOLUTION, V62, P1469, DOI 10.1111/j.1558-5646.2008.00372.x; Pope Theresa R., 1996, P119; Pope TR, 1998, J MAMMAL, V79, P692, DOI 10.2307/1383081; POPE TR, 1992, EVOLUTION, V46, P1112, DOI 10.1111/j.1558-5646.1992.tb00623.x; Pope TR, 1998, INT J PRIMATOL, V19, P95, DOI 10.1023/A:1020311111401; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Rambaut A., 2007, TRACER V1 4; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; ROGERS AR, 1988, AM J PHYS ANTHROPOL, V77, P435, DOI 10.1002/ajpa.1330770405; Rooney AP, 2001, EVOLUTION, V55, P1678; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schrago CG, 2003, MOL BIOL EVOL, V20, P1620, DOI 10.1093/molbev/msg172; Scott JM, 2010, CONSERV LETT, V3, P91, DOI 10.1111/j.1755-263X.2010.00096.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; Storz JF, 1999, J MAMMAL, V80, P553, DOI 10.2307/1383301; Storz JF, 2002, EVOLUTION, V56, P817; Strier KB, 2008, ANNU REV ANTHROPOL, V37, P21, DOI 10.1146/annurev.anthro.37.081407.085218; Strier KB, 2006, AM J PHYS ANTHROPOL, V130, P227, DOI 10.1002/ajpa.20366; Strier Karen B., 1999, P109; Strier KB, 2000, BIOTROPICA, V32, P903; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; TAKAHATA N, 1985, GENETICS, V109, P441; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tchaicka L, 2007, MOL ECOL, V16, P819, DOI 10.1111/j.1365-294X.2006.03185.x; Thome MTC, 2010, MOL PHYLOGENET EVOL, V55, P1018, DOI 10.1016/j.ympev.2010.02.003; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; VALLE CMC, 1984, PRIMATOLOGIA BRASIL, P271; Vieira C. C., 1944, Papeis Avulsos do Departamento de Zoologia Sao Paulo, V4, P1; Vigilant L, 2004, AM J PRIMATOL, V64, P161, DOI 10.1002/ajp.20070; Vigilant L, 2009, PRIMATES, V50, P105, DOI 10.1007/s10329-008-0124-z; Wegmann D, 2010, MOL BIOL EVOL, V27, P1425, DOI 10.1093/molbev/msq028; Zhang BC, 2016, J BASIC MICROB, V56, P670, DOI 10.1002/jobm.201500751	97	22	22	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20722	10.1371/journal.pone.0020722	http://dx.doi.org/10.1371/journal.pone.0020722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21694757	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000291355500038
J	Oka, T; Schmitt, AP; Sudol, M				Oka, T.; Schmitt, A. P.; Sudol, M.			Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP	ONCOGENE			English	Article						angiomotin family; WW domains; PDZ domains; YAP as scaffold; cell detachment; apoptosis	YES-ASSOCIATED PROTEIN; HIPPO SIGNALING PATHWAY; NUCLEAR-LOCALIZATION; TUMOR-SUPPRESSOR; JUNCTIONS; COMPONENT; FAMILY; MST2	YAP (Yes-associated protein) oncogene has been found to form a stable complex with members of the Angiomotin (Amot) family of proteins, which bind WW domains of YAP and sequester the protein in the cytoplasm and junctional complexes. The Amot-mediated retention of YAP in the cytoplasm results in the inhibition of its proliferative function. Using apoptotic 'read-out' of YAP in HEK293 cells, we confirmed the molecular mode by which Amot regulates YAP. We showed that a representative member of the Amot family, AmotL1 (Angiomotin-like-1), uses its PPxY motifs to bind WW domains of YAP and inhibit YAP's nuclear translocation and pro-apoptotic function. Recently we also showed that YAP uses its PDZ-binding motif to interact with zona occludens-2 (ZO-2) protein, which promotes YAP's translocation to the nucleus. We also asked if AmotL1, YAP and ZO-2 signal together. We report here that AmotL1 and ZO-2 form a tripartite complex with YAP and regulate its function in HEK293 cells in opposite directions. AmotL1 inhibits proapoptotic function of YAP, whereas ZO-2 enhances it. As YAP is a potent oncogene, the identification and characterization of its regulators is important. AmotL1 and ZO-2 are two candidates that could be harnessed to control the oncogenic function of YAP. Oncogene (2012) 31, 128-134; doi: 10.1038/onc.2011.216; published online 20 June 2011	[Oka, T.; Sudol, M.] Geisinger Med Clin, Weis Ctr Res, Lab Signal Transduct & Prote Profiling, Danville, PA 17822 USA; [Schmitt, A. P.] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA; [Sudol, M.] Mt Sinai Sch Med, Dept Med, New York, NY USA	Geisinger Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Icahn School of Medicine at Mount Sinai	Sudol, M (corresponding author), Geisinger Med Clin, Weis Ctr Res, Lab Signal Transduct & Prote Profiling, 100 N Acad Ave, Danville, PA 17822 USA.	msudol1@geisinger.edu		Schmitt, Anthony/0000-0001-9272-058X	PA Breast Cancer Coalition grants [60707, 9200903]; Geisinger Clinic	PA Breast Cancer Coalition grants; Geisinger Clinic	This research was supported by PA Breast Cancer Coalition grants(#60707 and #9200903) and by Geisinger Clinic.	Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bratt A, 2005, J BIOL CHEM, V280, P34859, DOI 10.1074/jbc.M503915200; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Chan SW, 2011, J BIOL CHEM, V286, P7018, DOI 10.1074/jbc.C110.212621; Ehsanian R, 2010, ONCOGENE, V29, P6160, DOI 10.1038/onc.2010.339; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matsuda T, 2007, P NATL ACAD SCI USA, V104, P1027, DOI 10.1073/pnas.0610155104; Nishimura M, 2002, J BIOL CHEM, V277, P5583, DOI 10.1074/jbc.M110154200; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; Oka T, 2009, GENES CELLS, V14, P607, DOI 10.1111/j.1365-2443.2009.01292.x; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Pei ZF, 2010, VIROLOGY, V397, P155, DOI 10.1016/j.virol.2009.11.002; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Sudol Marius, 2010, Genes Cancer, V1, P1115, DOI 10.1177/1947601911401911; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	23	90	92	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	1					128	134		10.1038/onc.2011.216	http://dx.doi.org/10.1038/onc.2011.216			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	877JT	21685940				2022-12-25	WOS:000299176200012
J	Swaminathan, G; Cartwright, CA				Swaminathan, G.; Cartwright, C. A.			Rack1 promotes epithelial cell-cell adhesion by regulating E-cadherin endocytosis	ONCOGENE			English	Article						RACK1; Src; E-cadherin; adhesion; endocytosis; invasion	PROTEIN-TYROSINE-PHOSPHATASE; COLON-CANCER CELLS; SRC FAMILY KINASES; PTP-MU; MESENCHYMAL TRANSITION; CARCINOMA-CELLS; SIGNAL-TRANSDUCTION; MEDIATED ADHESION; CATENIN COMPLEX; DOWN-REGULATION	E-cadherin and its cytoplasmic partners, catenins, mediate epithelial cell-cell adhesion. Disruption of this adhesion allows cancer cells to invade and metastasize. Aberrant activation of the Src tyrosine kinase disrupts cell-cell contacts through an E-cadherin/catenin-dependent mechanism. Previously we showed that Rack1 regulates the growth of colon cells by suppressing Src activity at G(1) and mitotic checkpoints, and in the intrinsic apoptotic and Akt cell survival pathways. Here we show that Rack1, partly by inhibiting Src, promotes cell-cell adhesion and reduces the invasive potential of colon cancer cells. Rack1 stabilizes E-cadherin and catenins at cell-cell contacts by inhibiting the Src phosphorylation of E-cadherin, the ubiquitination of E-cadherin by the E3 ligase Hakai and the endocytosis of E-cadherin. Upon depletion and restoration of extracellular calcium, Rack1 facilitates the re-assembly of E-cadherin-containing cell-cell contacts. Rack1 also blocks HGF-induced endocytosis of E-cadherin, disruption of cell-cell contacts and cell scatter. Our results uncover a novel function of Rack1 in maintaining the junctional homeostasis of intestinal epithelial cells by regulation of the Src- and growth factor-induced endocytosis of E-cadherin. Oncogene (2012) 31, 376-389; doi:10.1038/onc.2011.242; published online 20 June 2011	[Swaminathan, G.; Cartwright, C. A.] Stanford Univ, Dept Med, Stanford, CA 94305 USA	Stanford University	Cartwright, CA (corresponding author), Stanford Univ, Dept Med, M211 Alway Bldg,MC 5187,300 Pasteur Dr, Stanford, CA 94305 USA.	chris.cartwright@stanford.edu			NIH [DK43743]; NIH Digestive Disease Center [DK56339]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK043743, P30DK056339, R01DK043743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Digestive Disease Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Toufan Parman for performing initial preliminary experiments. We are grateful to Jenny Cheng, James Nelson, Anson Lowe and Manuel Amieva for helpful discussions and reagents. We thank James Nelson for the gift of MDCK cells and the members of the Lipsick laboratory for help with confocal imaging. We thank Jenny Cheng for critical review of the data and the manuscript. This work was supported by the NIH Grant DK43743 (CAC) and the NIH Digestive Disease Center Grant DK56339.	Avizienyte E, 2004, MOL BIOL CELL, V15, P2794, DOI 10.1091/mbc.E03-12-0879; Avizienyte E, 2005, CURR OPIN CELL BIOL, V17, P542, DOI 10.1016/j.ceb.2005.08.007; Avizienyte E, 2002, NAT CELL BIOL, V4, P632, DOI 10.1038/ncb829; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Bertotti A, 2010, CLIN CANCER RES, V16, P3933, DOI 10.1158/1078-0432.CCR-10-0106; Berx G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003129; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Chang BY, 1998, MOL CELL BIOL, V18, P3245, DOI 10.1128/MCB.18.6.3245; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chang BY, 2001, J BIOL CHEM, V276, P20346, DOI 10.1074/jbc.M101375200; Chattopadhyay N, 2003, J CELL BIOL, V163, P1351, DOI 10.1083/jcb.200306067; Cox EA, 2003, MOL BIOL CELL, V14, P658, DOI 10.1091/mbc.E02-03-0142; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Doan AT, 2007, EXP CELL RES, V313, P2667, DOI 10.1016/j.yexcr.2007.05.013; Emaduddin M, 2008, P NATL ACAD SCI USA, V105, P2358, DOI 10.1073/pnas.0712176105; Fan SJ, 2009, J BIOL CHEM, V284, P7561, DOI 10.1074/jbc.M807497200; Fomenkov A, 2004, CELL CYCLE, V3, P1285, DOI 10.4161/cc.3.10.1155; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Hellberg CB, 2002, J BIOL CHEM, V277, P11165, DOI 10.1074/jbc.M112157200; Herynk MH, 2007, J EXP THER ONCOL, V6, P205; Irby RB, 2002, CANCER RES, V62, P2669; Janda E, 2006, ONCOGENE, V25, P7117, DOI 10.1038/sj.onc.1209701; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kiely PA, 2005, J BIOL CHEM, V280, P7624, DOI 10.1074/jbc.M412889200; Kim JB, 2000, J CELL BIOL, V151, P1193, DOI 10.1083/jcb.151.6.1193; Kowalczyk AP, 2004, CURR OPIN CELL BIOL, V16, P522, DOI 10.1016/j.ceb.2004.07.001; Lai AZ, 2009, TRENDS CELL BIOL, V19, P542, DOI 10.1016/j.tcb.2009.07.002; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Li YC, 2009, MOL CELL BIOL, V29, P3953, DOI 10.1128/MCB.00449-09; LIPSICH LA, 1983, J VIROL, V48, P352, DOI 10.1128/JVI.48.2.352-360.1983; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mamidipudi V, 2007, ONCOGENE, V26, P2914, DOI 10.1038/sj.onc.1210091; Mamidipudi V, 2004, MOL CELL BIOL, V24, P6788, DOI 10.1128/MCB.24.15.6788-6798.2004; Mamidipudi V, 2009, ONCOGENE, V28, P4421, DOI 10.1038/onc.2009.293; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mourton T, 2001, J BIOL CHEM, V276, P14896, DOI 10.1074/jbc.M010823200; Ohgaki R, 2008, J BIOL CHEM, V283, P4417, DOI 10.1074/jbc.M705146200; Orlichenko L, 2009, MOL BIOL CELL, V20, P4140, DOI 10.1091/mbc.E08-10-1043; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Parent A, 2008, TRAFFIC, V9, P394, DOI 10.1111/j.1600-0854.2007.00692.x; Rengifo-Cam W, 2004, ONCOGENE, V23, P289, DOI 10.1038/sj.onc.1207041; Saitoh M, 2009, BIOCHEM BIOPH RES CO, V381, P560, DOI 10.1016/j.bbrc.2009.02.098; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Schill NJ, 2009, BIOCHEM J, V418, P247, DOI 10.1042/BJ20081844; Serrels B, 2010, CURR BIOL, V20, P1086, DOI 10.1016/j.cub.2010.04.042; Shen Y, 2008, J BIOL CHEM, V283, P5127, DOI 10.1074/jbc.M703300200; Skoudy A, 1996, BIOCHEM J, V317, P279, DOI 10.1042/bj3170279; Varghese B, 2008, MOL CELL BIOL, V28, P5275, DOI 10.1128/MCB.00350-08; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Wadhawan A, 2011, CANCER TREAT REV, V37, P234, DOI 10.1016/j.ctrv.2010.08.003; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	61	32	34	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	3					376	389		10.1038/onc.2011.242	http://dx.doi.org/10.1038/onc.2011.242			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21685945	Bronze			2022-12-25	WOS:000299542100010
J	Yao, R; Natsume, Y; Saiki, Y; Shioya, H; Takeuchi, K; Yamori, T; Toki, H; Aoki, I; Saga, T; Noda, T				Yao, R.; Natsume, Y.; Saiki, Y.; Shioya, H.; Takeuchi, K.; Yamori, T.; Toki, H.; Aoki, I.; Saga, T.; Noda, T.			Disruption of Tacc3 function leads to in vivo tumor regression	ONCOGENE			English	Article						TACC3; mitosis; spindle; p53; tumor regression	SUPPRESSOR GENE; BREAST-CANCER; COILED-COIL; ZYG-9 FORM; PROTEIN; P53; EXPRESSION; MUTATIONS; CELLS; TAC-1	The formation of the bipolar spindle is responsible for accurate chromosomal segregation during mitosis. The dynamic instability of microtubules has an important role in this process, and has been shown to be an effective target for cancer chemotherapy. Several agents that target non-microtubule mitotic proteins, including the motor protein Eg5, Aurora kinases and Polo-like kinases, are currently being developed as chemotherapeutic drugs. However, because the efficacies of these drugs remain elusive, new molecular targets that have essential roles in tumor cells are desired. Here, we provide in vivo evidence that transforming acidic coiled-coil-3 (Tacc3) is a potential target for cancer chemotherapy. Using MRI, we showed that Tacc3 loss led to the regression of mouse thymic lymphoma in vivo, which was accompanied by massive apoptosis. By contrast, normal tissues, including the thymus, showed no overt abnormalities, despite high Tacc3 expression. in vitro analysis indicated that Tacc3 depletion induced multi-polar spindle formation, which led to mitotic arrest, followed by apoptosis. Similar responses have been observed in Burkitt's lymphoma and T-ALL. These results show that Tacc3 is a vulnerable component of the spindle assembly in lymphoma cells and is a promising cancer chemotherapy target. Oncogene (2012) 31, 135-148; doi:10.1038/onc.2011.235; published online 20 June 2011	[Yao, R.] Japanese Fdn Canc Res, Dept Cell Biol, Inst Canc, Koto Ku, Tokyo 1358550, Japan; [Takeuchi, K.] Japanese Fdn Canc Res, Dept Pathol, Inst Canc, Tokyo 1358550, Japan; [Yamori, T.] Japanese Fdn Canc Res, Div Mol Pharmacol, Ctr Canc Chemotherapy, Tokyo 1358550, Japan; [Toki, H.; Noda, T.] RIKEN, Bioresource Ctr, Team Adv Dev & Evaluat Human Dis Models, Ibaraki, Japan; [Aoki, I.; Saga, T.] Natl Inst Radiol Sci, Diagnost Imaging Program, Mol Imaging Ctr, Chiba 260, Japan	Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; Japanese Foundation for Cancer Research; RIKEN; National Institutes for Quantum Science & Technology	Yao, R (corresponding author), Japanese Fdn Canc Res, Dept Cell Biol, Inst Canc, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan.	ryao@jfcr.or.jp	Aoki, Ichio/ABF-7336-2020; Aoki, Ichio/G-2529-2011; Noda, Tetsuo/B-1667-2016; Takeuchi, Kengo/C-3614-2008	Aoki, Ichio/0000-0002-4429-5053; Takeuchi, Kengo/0000-0002-1599-5800	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank T Jacks for providing the R26CreERT2 mice; S Shibata, T Nakahara T Shimomura, S Saito and F Yamagishi for MRI imaging; S Hasegawa for helpful discussions; and Y Terui for the donation of human lymphoma cells. We also thank Y Inoue and T Hirota for critically reading the manuscript. This work was supported by a Grant-in-Aid for cancer research from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barr AR, 2008, MOL CELL BIOL, V28, P7199, DOI 10.1128/MCB.01040-08; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; CHARRASSE S, 1995, EUR J BIOCHEM, V234, P406, DOI 10.1111/j.1432-1033.1995.406_b.x; CHENG J, 1990, MOL CELL BIOL, V10, P5502, DOI 10.1128/MCB.10.10.5502; CHOW VTK, 1993, CANCER LETT, V73, P141, DOI 10.1016/0304-3835(93)90256-9; Cinti C, 2000, ONCOGENE, V19, P5098, DOI 10.1038/sj.onc.1203848; Cullen CF, 2001, NAT CELL BIOL, V3, P637, DOI 10.1038/35083025; D'Assoro AB, 2002, ONCOGENE, V21, P6146, DOI 10.1038/sj.onc.1205772; FARRELL PJ, 1991, EMBO J, V10, P2879, DOI 10.1002/j.1460-2075.1991.tb07837.x; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; GAIDANO G, 1991, P NATL ACAD SCI USA, V88, P5413, DOI 10.1073/pnas.88.12.5413; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2000, EMBO J, V19, P241, DOI 10.1093/emboj/19.2.241; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Harrison Michael R, 2009, Clin Adv Hematol Oncol, V7, P54; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jacquemier J, 2005, CANCER RES, V65, P767; Janssen K, 2007, BLOOD, V110, P3662, DOI 10.1182/blood-2007-02-073213; Jung CK, 2006, PATHOL INT, V56, P503, DOI 10.1111/j.1440-1827.2006.01998.x; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Lee MJ, 2001, NAT CELL BIOL, V3, P643, DOI 10.1038/35083033; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Oliferenko S, 2002, NAT CELL BIOL, V4, P816, DOI 10.1038/ncb861; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Schmidt S, 2010, ONCOGENE, V29, P6184, DOI 10.1038/onc.2010.354; Schneider L, 2008, ONCOGENE, V27, P116, DOI 10.1038/sj.onc.1210628; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Schuendeln MM, 2004, MOL CELL BIOL, V24, P6403, DOI 10.1128/MCB.24.14.6403-6409.2004; Shamma A, 2009, CANCER CELL, V15, P255, DOI 10.1016/j.ccr.2009.03.001; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sudakin V, 2007, BIODRUGS, V21, P225, DOI 10.2165/00063030-200721040-00003; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Yao R, 2007, CANCER SCI, V98, P555, DOI 10.1111/j.1349-7006.2007.00433.x	45	32	32	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	2					135	148		10.1038/onc.2011.235	http://dx.doi.org/10.1038/onc.2011.235			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21685933				2022-12-25	WOS:000299307400001
J	Shin, HJ; Park, YH; Kim, SU; Moon, HB; Park, DS; Han, YH; Lee, CH; Lee, DS; Song, IS; Lee, DH; Kim, M; Kim, NS; Kim, DG; Kim, JM; Kim, SK; Kim, YN; Kim, SS; Choi, CS; Kim, YB; Yu, DY				Shin, Hye-Jun; Park, Young-Ho; Kim, Sun-Uk; Moon, Hyung-Bae; Park, Do Sim; Han, Ying-Hao; Lee, Chul-Ho; Lee, Dong-Seok; Song, In-Sung; Lee, Dae Ho; Kim, Minhye; Kim, Nam-Soon; Kim, Dae-Ghon; Kim, Jin-Man; Kim, Sang-Keun; Kim, Yo Na; Kim, Su Sung; Choi, Cheol Soo; Kim, Young-Bum; Yu, Dae-Yeul			Hepatitis B Virus X Protein Regulates Hepatic Glucose Homeostasis via Activation of Inducible Nitric Oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-SECRETION; KAPPA-B; LIVER; GENE; TRANSCRIPTION; EXPRESSION; GLUCONEOGENESIS; PROMOTER; CANCER; RISK	Dysregulation of liver functions leads to insulin resistance causing type 2 diabetes mellitus and is often found in chronic liver diseases. However, the mechanisms of hepatic dysfunction leading to hepatic metabolic disorder are still poorly understood in chronic liver diseases. The current work investigated the role of hepatitis B virus X protein (HBx) in regulating glucose metabolism. We studied HBx-overexpressing (HBxTg) mice and HBxTg mice lacking inducible nitric oxide synthase (iNOS). Here we show that gene expressions of the key gluconeogenic enzymes were significantly increased in HepG2 cells expressing HBx (HepG2-HBx) and in non-tumor liver tissues of hepatitis B virus patients with high levels of HBx expression. In the liver of HBxTg mice, the expressions of gluconeogenic genes were also elevated, leading to hyperglycemia by increasing hepatic glucose production. However, this effect was insufficient to cause systemic insulin resistance. Importantly, the actions of HBx on hepatic glucose metabolism are thought to be mediated via iNOS signaling, as evidenced by the fact that deficiency of iNOS restored HBx-induced hyperglycemia by suppressing the gene expression of gluconeogenic enzymes. Treatment of HepG2-HBx cells with nitric oxide (NO) caused a significant increase in the expression of gluconeogenic genes, but JNK1 inhibition was completely normalized. Furthermore, hyperactivation of JNK1 in the liver of HBxTg mice was also suppressed in the absence of iNOS, indicating the critical role for JNK in the mutual regulation of HBx- and iNOS-mediated glucose metabolism. These findings establish a novel mechanism of HBx-driven hepatic metabolic disorder that is modulated by iNOS-mediated activation of JNK.	[Shin, Hye-Jun; Park, Young-Ho; Kim, Sun-Uk; Han, Ying-Hao; Lee, Chul-Ho; Lee, Dong-Seok; Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, Dis Model Res Lab, Aging Res Ctr, Taejon 305806, South Korea; [Shin, Hye-Jun; Park, Young-Ho; Kim, Sun-Uk; Han, Ying-Hao; Lee, Chul-Ho; Lee, Dong-Seok; Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, World Class Inst, Taejon 305806, South Korea; [Shin, Hye-Jun; Kim, Sang-Keun] Chungnam Natl Univ, Coll Vet Med, Taejon 305764, South Korea; [Park, Young-Ho; Yu, Dae-Yeul] Univ Sci & Technol, Dept Funct Genom, Taejon 305333, South Korea; [Moon, Hyung-Bae; Park, Do Sim] Wonkwang Univ Coll Med, Dept Pathol, Iksan 570749, South Korea; [Moon, Hyung-Bae; Park, Do Sim] Wonkwang Univ Coll Med, Inst Med Sci, Iksan 570749, South Korea; [Lee, Dong-Seok] Kyungpook Natl Univ, Coll Nat Sci, Taegu 702701, South Korea; [Song, In-Sung; Kim, Nam-Soon] Korea Res Inst Biosci & Biotechnol, Genome Res Ctr, Taejon 305806, South Korea; [Lee, Dae Ho; Kim, Minhye; Kim, Young-Bum] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Kim, Dae-Ghon] Chonbuk Natl Univ Med Sch & Hosp, Dept Internal Med, Jeonju 561756, South Korea; [Kim, Jin-Man] Chungnam Natl Univ, Coll Med, Taejon 305764, South Korea; [Kim, Yo Na; Kim, Su Sung; Choi, Cheol Soo] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea; [Choi, Cheol Soo] Gachon Univ Med & Sci, Div Endocrinol, Gil Med Ctr, Inchon 406840, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Research Institute of Bioscience & Biotechnology (KRIBB); Chungnam National University; Wonkwang University; Wonkwang University; Kyungpook National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Jeonbuk National University; Jeonbuk National University Hospital; Chungnam National University; Gachon University; Gachon University	Kim, YB (corresponding author), 330 Brookline Ave,CLS-736, Boston, MA USA.	ykim2@bidmc.harvard.edu; dyyu10@kribb.re.kr	Park, Do-Sim/B-6594-2013; Park, Do-Sim/P-1529-2019	Park, Do-Sim/0000-0002-6001-4223; Park, Do-Sim/0000-0002-6001-4223; Lee, Dong Seok/0000-0001-6348-8937; KIM, JIN MAN/0000-0003-0905-9730	21st Century Frontier Program in the Functional Human Genome Project [HGM0200934]; International Collaboration Program of Science and Technology [FGM0600914]; Ministry of Education, Science and Technology of Korea (MEST); Ministry for Health and Welfare [BCM0061011]; KRIBB Research Initiative [KGM3320911]; Ministry for Health, Welfare and Family Affairs, Korea [A084651]; National Institutes of Health [R01DK083567]; American Diabetes Association [1-09-RA-87]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083567] Funding Source: NIH RePORTER	21st Century Frontier Program in the Functional Human Genome Project; International Collaboration Program of Science and Technology; Ministry of Education, Science and Technology of Korea (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry for Health and Welfare; KRIBB Research Initiative; Ministry for Health, Welfare and Family Affairs, Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the 21st Century Frontier Program in the Functional Human Genome Project (Grant HGM0200934), by the International Collaboration Program of Science and Technology (Grant FGM0600914), by the World Class Institute (WCI) Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology of Korea (MEST), by a grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare (Grant BCM0061011), by the KRIBB Research Initiative Program Grant (Grant KGM3320911), by a grant of the Korea Healthcare technology R&D Project, Ministry for Health, Welfare and Family Affairs, Korea (Grant A084651) (to C. S. C.), and by National Institutes of Health Grant R01DK083567 (to Y. B. K.) and American Diabetes Association Grant 1-09-RA-87) (to Y. B. K.).	Cheng AYS, 2006, DIABETOLOGIA, V49, P1777, DOI 10.1007/s00125-006-0294-4; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; Custro N, 2001, DIABETES METAB, V27, P476; Garcia-Compean D, 2009, ANN HEPATOL, V8, P13, DOI 10.1016/S1665-2681(19)31805-8; Gavin JR, 1999, DIABETES CARE, V22, pS5; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Kapur S, 1997, DIABETES, V46, P1691, DOI 10.2337/diabetes.46.11.1691; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim KH, 2007, GASTROENTEROLOGY, V132, P1955, DOI 10.1053/j.gastro.2007.03.039; KRUSZYNSKA YT, 1991, HEPATOLOGY, V14, P103, DOI 10.1002/hep.1840140117; Lara-Pezzi E, 1998, HEPATOLOGY, V28, P1013, DOI 10.1002/hep.510280416; LaVecchia C, 1997, INT J CANCER, V73, P204, DOI 10.1002/(SICI)1097-0215(19971009)73:2<204::AID-IJC7>3.0.CO;2-#; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Majano P, 2001, HEPATOLOGY, V34, P1218, DOI 10.1053/jhep.2001.29626; Majano PL, 1998, J CLIN INVEST, V101, P1343, DOI 10.1172/JCI774; McGowder D, 1999, NITRIC OXIDE-BIOL CH, V3, P481, DOI 10.1006/niox.1999.0254; Nakashima Y, 2008, METABOLISM, V57, P1350, DOI 10.1016/j.metabol.2008.05.001; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Nguyen Mindie H, 2003, Rev Gastroenterol Disord, V3, P125; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Pollack H., 2006, Morbidity and Mortality Weekly Report, V55, P505; Sprangers F, 1998, BIOCHEM J, V330, P1045, DOI 10.1042/bj3301045; Su F, 2001, J VIROL, V75, P215, DOI 10.1128/JVI.75.1.215-225.2001; Wang YY, 2010, METABOLISM, V59, P486, DOI 10.1016/j.metabol.2009.07.038; Watanabe S, 2008, J GASTROENTEROL, V43, P509, DOI 10.1007/s00535-008-2193-6; XIE QW, 1992, SCIENCE, V256, P225, DOI 10.1126/science.1373522; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Yu DY, 1999, J HEPATOL, V31, P123, DOI 10.1016/S0168-8278(99)80172-X; Zhang JD, 2001, P NATL ACAD SCI USA, V98, P3756, DOI 10.1073/pnas.071054598	34	36	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29872	29881		10.1074/jbc.M111.259978	http://dx.doi.org/10.1074/jbc.M111.259978			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21690090	Green Published, hybrid			2022-12-25	WOS:000294046600046
J	Havrylenko, S; Legouis, R; Negrutskii, B; Mirande, M				Havrylenko, Svitlana; Legouis, Renaud; Negrutskii, Boris; Mirande, Marc			Caenorhabditis elegans Evolves a New Architecture for the Multi-aminoacyl-tRNA Synthetase Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGINYL-TRANSFER-RNA; ELONGATION-FACTOR; MACROMOLECULAR COMPLEXES; MULTISYNTHETASE COMPLEX; MULTIENZYME COMPLEX; PURIFICATION; PROTEIN; COMPONENT; SUBUNIT; ORGANIZATION	MARS is an evolutionary conserved supramolecular assembly of aminoacyl-tRNA synthetases found in eukaryotes. This complex was thought to be ubiquitous in the deuterostome and protostome clades of bilaterians because similar complexes were isolated from arthropods and vertebrates. However, several features of the component enzymes suggested that in the nematode Caenorhabditis elegans, a species grouped with arthropods in modern phylogeny, this complex might not exist, or should display a significantly different structural organization. C. elegans was also taken as a model system to study in a multicellular organism amenable to experimental approaches, the reason for existence of these supramolecular entities. Here, using a proteomic approach, we have characterized the components of MARS in C. elegans. We show that this organism evolved a specific structural organization of this complex, which contains several bona fide components of the MARS complexes known so far, but also displays significant variations. These data highlight molecular evolution events that took place after radiation of bilaterians. Remarkably, it shows that expansion of MARS assembly in metazoans is not linear, but is the result of additions but also of subtractions along evolution. We then undertook an experimental approach, using inactivation of the endogenous copy of methionyl-tRNA synthetase by RNAi and expression of transgenic variants, to understand the role in complex assembly and the in vivo functionality, of the eukaryotic-specific domains appended to aminoacyl-tRNA synthetases. We show that rescue of the worms and assembly of transgenic variants into MARS rest on the presence of these appended domains.	[Havrylenko, Svitlana; Mirande, Marc] CNRS, LEBS, F-91190 Gif Sur Yvette, France; [Legouis, Renaud] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [Havrylenko, Svitlana; Negrutskii, Boris] Natl Acad Sci Ukraine, Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU	Mirande, M (corresponding author), CNRS, LEBS, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	mirande@lebs.cnrs-gif.fr	Legouis, Renaud/S-1250-2017; Legouis, Renaud/G-9088-2014; Negrutskii, Boris/G-6439-2016	Legouis, Renaud/0000-0002-2699-2584; Negrutskii, Boris/0000-0001-5974-1629	Association pour la Recherche sur le Cancer; CNRS; Bourse du Gouvernement Francais; Fondation pour la Recherche Medicale; NIH National Center for Research Resources (NCRR)	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); CNRS(Centre National de la Recherche Scientifique (CNRS)); Bourse du Gouvernement Francais; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by grants from the "Association pour la Recherche sur le Cancer" and Projet International de Cooperation Scientifique-CNRS.; Recipient of a "Bourse du Gouvernement Francais" and of a fellowship from "Fondation pour la Recherche Medicale."; We thank Jerome Reboul (Laboratoire de Genomique Fonctionnelle, Marseille, France) for the gift of the pSB_GW::TAG vector, and Y. Kohara (National Institute of Genetics, Mishima, Japan) for the gift of the cDNA clone yk1416a08. Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). We also thank David Cornu and Manuela Argentini from the SICaPS facility of the CNRS campus of Gif-sur-Yvette for performing LC-MS/MS analyses.	Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; BEC G, 1994, J BIOL CHEM, V269, P2086; BEC G, 1989, J BIOL CHEM, V264, P21131; Berthonneau E, 2000, FEBS LETT, V470, P300, DOI 10.1016/S0014-5793(00)01343-0; BRANDSMA M, 1995, EUR J BIOCHEM, V233, P277, DOI 10.1111/j.1432-1033.1995.277_1.x; BRENNER S, 1974, GENETICS, V77, P71; Cerini C, 1997, EUR J BIOCHEM, V244, P176, DOI 10.1111/j.1432-1033.1997.00176.x; CERINI C, 1991, EMBO J, V10, P4267, DOI 10.1002/j.1460-2075.1991.tb05005.x; CIRAKOGLU B, 1985, BIOCHIM BIOPHYS ACTA, V829, P173, DOI 10.1016/0167-4838(85)90186-4; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Francklyn CS, 2010, FEBS LETT, V584, P366, DOI 10.1016/j.febslet.2009.11.045; Frechin M, 2010, FEBS LETT, V584, P427, DOI 10.1016/j.febslet.2009.11.037; Golinelli-Cohen MP, 2007, MOL CELL BIOCHEM, V300, P47, DOI 10.1007/s11010-006-9367-4; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Hausmann CD, 2008, FEBS LETT, V582, P2178, DOI 10.1016/j.febslet.2008.05.043; Havrylenko S, 2010, PROTEIN SCI, V19, P2475, DOI 10.1002/pro.529; Hunt-Newbury R, 2007, PLOS BIOL, V5, P1981, DOI 10.1371/journal.pbio.0050237; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jiang SL, 2005, FEBS LETT, V579, P6049, DOI 10.1016/j.febslet.2005.09.062; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2009, J BIOL CHEM, V284, P13746, DOI 10.1074/jbc.M900480200; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; KAO J, 1994, J BIOL CHEM, V269, P9774; Karanasios E, 2010, FEBS LETT, V584, P3842, DOI 10.1016/j.febslet.2010.08.023; KELLERMANN O, 1979, EUR J BIOCHEM, V99, P541, DOI 10.1111/j.1432-1033.1979.tb13286.x; KELLERMANN O, 1982, J BIOL CHEM, V257, P1041; KERJAN P, 1994, BBA-GEN SUBJECTS, V1199, P293, DOI 10.1016/0304-4165(94)90009-4; KERJAN P, 1992, BIOCHIMIE, V74, P195, DOI 10.1016/0300-9084(92)90046-H; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; LAZARD M, 1993, GENE, V132, P237, DOI 10.1016/0378-1119(93)90201-D; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; MIRANDE M, 1983, EUR J BIOCHEM, V131, P163, DOI 10.1111/j.1432-1033.1983.tb07244.x; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; Mirande M, 2010, FEBS LETT, V584, P443, DOI 10.1016/j.febslet.2009.11.027; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; Polanowska J, 2004, BIOTECHNIQUES, V36, P778, DOI 10.2144/04365BM05; Praitis V, 2001, GENETICS, V157, P1217; Quevillon S, 1999, J MOL BIOL, V285, P183, DOI 10.1006/jmbi.1998.2316; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Ray PS, 2011, MOL BIOL EVOL, V28, P437, DOI 10.1093/molbev/msq246; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Schaffer AA, 2001, NUCLEIC ACIDS RES, V29, P2994, DOI 10.1093/nar/29.14.2994; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Zheng YG, 2006, BIOCHEMISTRY-US, V45, P1338, DOI 10.1021/bi051675n	52	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28476	28487		10.1074/jbc.M111.254037	http://dx.doi.org/10.1074/jbc.M111.254037			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685384	hybrid, Green Published			2022-12-25	WOS:000293557800063
J	Kim, EH; Vicci, VR; Han, SJ; Alvarez, TL				Kim, Eun H.; Vicci, Vincent R.; Han, Sang J.; Alvarez, Tara L.			Sustained Fixation Induced Changes in Phoria and Convergence Peak Velocity	PLOS ONE			English	Article							VERGENCE EYE-MOVEMENTS; CEREBELLAR DORSAL VERMIS; NEURAL CONTROL; DISPARITY; DYNAMICS; ADAPTATION; MODEL; INSUFFICIENCY; NEURONS; SYSTEM	Purpose: This study sought to investigate the influence of phoria adaptation on convergence peak velocity from responses located at different initial vergence positions. Methods: Symmetrical 4 degrees convergence step responses and near dissociated phoria (measured at 40 cm from the subject's midline) were recorded from six subjects with normal binocular vision using an infrared limbus tracking system with a haploscope. Two different sustained fixations (1 degrees and 16 degrees convergent rotation along the subject's midline) were used to study whether phoria had an influence on the peak velocity of convergence responses located at two initial vergence positions (1 degrees or 'far' steps and 12 degrees or 'near' steps). Results: Phoria was significantly adapted after a sustained fixation task at near (16 degrees) and far (1 degrees) (p<0.002). A repeated measures ANOVA showed that convergence far steps were significantly faster than the near steps (p<0.03). When comparing convergence steps with the same initial vergence position, steps measured after near phoria adaptation were faster than responses after far adaptation (p<0.02). A regression analysis demonstrated that the change in phoria and the change in convergence peak velocity were significantly correlated for the far convergence steps (r = 0.97, p = 0.001). A weaker correlation was observed for the near convergence steps (r = 0.59, p = 0.20). Conclusion: As a result of sustained fixation, phoria was adapted and the peak velocity of the near and far convergence steps was modified. This study has clinical considerations since prisms, which evoke phoria adaptation, can be prescribed to help alleviate visual discomfort. Future investigations should include a systematic study of how prisms may influence convergence and divergence eye movements for those prescribed with prisms within their spectacles.	[Kim, Eun H.; Han, Sang J.; Alvarez, Tara L.] New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA; [Vicci, Vincent R.] Dept Vis, Westfield, NJ USA; Kessler Inst, Dept Vis Rehabil, W Orange, NJ USA	New Jersey Institute of Technology; Kessler Institute for Rehabilitation	Kim, EH (corresponding author), New Jersey Inst Technol, Dept Biomed Engn, Newark, NJ 07102 USA.	tara.l.alvarez@njit.edu		Alvarez, Tara/0000-0002-8797-1613	National Science Foundation [BES-0447713]	National Science Foundation(National Science Foundation (NSF))	This work was supported in part by a CAREER award from the National Science Foundation (BES-0447713). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez TL, 2007, COMPUT BIOL MED, V37, P903, DOI 10.1016/j.compbiomed.2006.03.009; Alvarez TL, 2010, OPTOMETRY VISION SCI, V87, P985, DOI 10.1097/OPX.0b013e3181fef1aa; Alvarez TL, 2005, J VISION, V5, P640, DOI 10.1167/5.7.4; Alvarez TL, 2005, VISION RES, V45, P1847, DOI 10.1016/j.visres.2005.01.017; Alvarez TL, 2002, CAH PSYCHOL COGN, V21, P243; BAHILL AT, 1982, BIOL CYBERN, V45, P1, DOI 10.1007/BF00387207; BIRNBAUM MH, 1985, AM J OPTOM PHYS OPT, V62, P732; Brautaset RL, 2005, OPHTHAL PHYSL OPT, V25, P215, DOI 10.1111/j.1475-1313.2005.00276.x; Brautaset RL, 2006, INVEST OPHTH VIS SCI, V47, P2876, DOI 10.1167/iovs.04-1372; Chumerin N, 2010, INT J NEURAL SYST, V20, P267, DOI 10.1142/S0129065710002425; Durand JB, 2007, CEREB CORTEX, V17, P1260, DOI 10.1093/cercor/bhl050; Han SJ, 2010, OPHTHAL PHYSL OPT, V30, P95, DOI 10.1111/j.1475-1313.2009.00681.x; Horng JL, 1998, VISION RES, V38, P2761, DOI 10.1016/S0042-6989(97)00453-7; Howarth PA, 2000, OPTOMETRY VISION SCI, V77, P616, DOI 10.1097/00006324-200011000-00013; HUNG GK, 1992, OPHTHAL PHYSL OPT, V12, P319, DOI 10.1111/j.1475-1313.1992.tb00404.x; HUNG GK, 1983, INVEST OPHTH VIS SCI, V24, P772; HUNG GK, 1986, IEEE T BIO-MED ENG, V33, P1021, DOI 10.1109/TBME.1986.325868; Hung GK, 1997, VISION RES, V37, P1197, DOI 10.1016/S0042-6989(97)00271-X; Jaschinski W, 2008, VISION RES, V48, P253, DOI 10.1016/j.visres.2007.11.004; Kim EH, 2010, INVEST OPHTH VIS SCI, V51, P4017, DOI 10.1167/iovs.09-4560; KRISHNAN VV, 1977, IEEE T BIO-MED ENG, V24, P44, DOI 10.1109/TBME.1977.326207; Lavrich JB, 2010, CURR OPIN OPHTHALMOL, V21, P356, DOI 10.1097/ICU.0b013e32833cf03a; Lee YY, 2008, J VISION, V8, DOI 10.1167/8.12.5; Lee YY, 2009, VISION RES, V49, P2960, DOI 10.1016/j.visres.2009.09.013; Leigh RJ, 2006, NEUROLOGY EYE MOVEME, P763; LEVINSON M M, 1986, Journal of Heart Transplantation, V5, P236; MAYS LE, 1984, J NEUROPHYSIOL, V51, P1091, DOI 10.1152/jn.1984.51.5.1091; MAYS LE, 1986, J NEUROPHYSIOL, V56, P1007, DOI 10.1152/jn.1986.56.4.1007; MORLEY JW, 1992, J NEUROPHYSIOL, V67, P1475, DOI 10.1152/jn.1992.67.6.1475; Nitta T, 2008, CEREB CORTEX, V18, P1042, DOI 10.1093/cercor/bhm143; Nitta T, 2008, PROG BRAIN RES, V171, P173, DOI 10.1016/S0079-6123(08)00623-7; NORTH RV, 1982, AM J OPTOM PHYS OPT, V59, P983; Patel SS, 1999, OPTOMETRY VISION SCI, V76, P656, DOI 10.1097/00006324-199909000-00024; Patel SS, 2001, NEURAL COMPUT, V13, P1495, DOI 10.1162/089976601750264983; Patel SS, 1997, VISION RES, V37, P1383, DOI 10.1016/S0042-6989(96)00279-9; POBUDA M, 1993, BIOL CYBERN, V68, P221, DOI 10.1007/BF00224855; POGGIO GF, 1977, J NEUROPHYSIOL, V40, P1392, DOI 10.1152/jn.1977.40.6.1392; RASHBASS C, 1961, J PHYSIOL-LONDON, V159, P339, DOI 10.1113/jphysiol.1961.sp006812; SALADIN JJ, 1986, AM J OPTOM PHYS OPT, V63, P645; Sander T, 2009, BRAIN, V132, P103, DOI 10.1093/brain/awn306; Satgunam P, 2009, VISION RES, V49, P1795, DOI 10.1016/j.visres.2009.04.015; SCHOR CM, 1979, VISION RES, V19, P1359, DOI 10.1016/0042-6989(79)90208-6; Schor CM, 2002, ANN NY ACAD SCI, V956, P297, DOI 10.1111/j.1749-6632.2002.tb02828.x; SEMMLOW JL, 1986, INVEST OPHTH VIS SCI, V27, P558; Takagi M, 2003, PROG BRAIN RES, V142, P19; TROTTER Y, 1992, SCIENCE, V257, P1279, DOI 10.1126/science.1519066; van Leeuwen AF, 1999, VISION RES, V39, P3095, DOI 10.1016/S0042-6989(99)00066-8; Yang Q, 2009, INVEST OPHTH VIS SCI, V50, P1145, DOI 10.1167/iovs.08-2474; Ying SH, 2006, EXP BRAIN RES, V171, P297, DOI 10.1007/s00221-005-0267-8; Yuan WH, 2000, VISION RES, V40, P3089, DOI 10.1016/S0042-6989(00)00162-0	50	19	20	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20883	10.1371/journal.pone.0020883	http://dx.doi.org/10.1371/journal.pone.0020883			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698110	Green Submitted, Green Published, gold			2022-12-25	WOS:000291737600027
J	Lomonosov, M; Meziane, EK; Ye, HT; Nelson, DE; Randle, SJ; Laman, H				Lomonosov, Mikhail; Meziane, El Kahina; Ye, Hongtao; Nelson, David E.; Randle, Suzanne J.; Laman, Heike			Expression of Fbxo7 in Haematopoietic Progenitor Cells Cooperates with p53 Loss to Promote Lymphomagenesis	PLOS ONE			English	Article							NF-KAPPA-B; DEPENDENT KINASE 6; F-BOX; SUPPRESSOR-CELLS; DIFFERENTIATION; CYCLE; CDK6; PROLIFERATION; INFLAMMATION; METHYLATION	Fbxo7 is an unusual F box protein that augments D-type cyclin complex formation with Cdk6, but not Cdk4 or Cdk2, and its over-expression has been demonstrated to transform immortalised fibroblasts in a Cdk6-dependent manner. Here we present new evidence in vitro and in vivo on the oncogenic potential of this regulatory protein in primary haematopoietic stem and progenitor cells (HSPCs). Increasing Fbxo7 expression in HSPCs suppressed their colony forming ability in vitro, specifically decreasing CD11b (Mac1) expression, and these effects were dependent on an intact p53 pathway. Furthermore, increased Fbxo7 levels enhanced the proliferative capacity of p53 null HSPCs when they were grown in reduced concentrations of stem cell factor. Finally, irradiated mice reconstituted with p53 null, but not wild-type, HSPCs expressing Fbxo7 showed a statistically significant increase in the incidence of T cell lymphoma in vivo. These data argue that Fbxo7 negatively regulates the proliferation and differentiation of HSPCs in a p53-dependent manner, and that in the absence of p53, Fbxo7 expression can promote T cell lymphomagenesis.	[Lomonosov, Mikhail; Meziane, El Kahina; Ye, Hongtao; Nelson, David E.; Randle, Suzanne J.; Laman, Heike] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Lomonosov, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	hl316@cam.ac.uk	Nelson, David/AAX-5648-2021	Nelson, David/0000-0002-5034-0885; Kostenko, Anna/0000-0002-6372-778X; Laman, Heike/0000-0002-6089-171X	Cancer Research UK; Association for International Cancer Research; Leukemia and Lymphoma Research; Biotechnology and Biological Sciences Research Council; BBSRC [BB/F012764/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F012764/1] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Association for International Cancer Research; Leukemia and Lymphoma Research; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from the Cancer Research UK, the Association for International Cancer Research, Leukemia and Lymphoma Research, and the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang XLL, 2005, ONCOGENE, V24, P2860, DOI 10.1038/sj.onc.1208614; Brown G, 2003, EXP CELL RES, V291, P282, DOI 10.1016/S0014-4827(03)00393-8; Card GL, 2000, EMBO J, V19, P2877, DOI 10.1093/emboj/19.12.2877; Cenciarelli C, 1999, CURR BIOL, V9, P1177, DOI 10.1016/S0960-9822(00)80020-2; Chang YF, 2006, BIOCHEM BIOPH RES CO, V342, P1022, DOI 10.1016/j.bbrc.2006.02.061; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corcoran MM, 1999, ONCOGENE, V18, P6271, DOI 10.1038/sj.onc.1203033; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fujimoto T, 2007, EMBO J, V26, P2361, DOI 10.1038/sj.emboj.7601675; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Grossel MJ, 2006, CELL CYCLE, V5, P266, DOI 10.4161/cc.5.3.2385; Grossel MJ, 2006, J CELL BIOCHEM, V97, P485, DOI 10.1002/jcb.20712; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; HAWLEY RG, 1994, GENE THER, V1, P136; Hayette S, 2003, BLOOD, V102, P1549, DOI 10.1182/blood-2003-04-1220; Hermand D, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-30; Hershko A, 1997, CURR OPIN CELL BIOL, V9, P788, DOI 10.1016/S0955-0674(97)80079-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HEYWORTH CM, 1992, BLOOD, V80, P2230; Ho MS, 2008, CELL MOL LIFE SCI, V65, P1977, DOI 10.1007/s00018-008-7592-6; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Hu MG, 2009, CANCER RES, V69, P810, DOI 10.1158/0008-5472.CAN-08-2473; Ilyin GP, 2000, GENOMICS, V67, P40, DOI 10.1006/geno.2000.6211; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Laman H, 2006, CELL CYCLE, V5, P279, DOI 10.4161/cc.5.3.2403; Laman H, 2005, EMBO J, V24, P3104, DOI 10.1038/sj.emboj.7600775; Liu XG, 2009, JPN J CLIN ONCOL, V39, P418, DOI 10.1093/jjco/hyp037; Lorincz MC, 2002, MOL CELL BIOL, V22, P7572, DOI 10.1128/MCB.22.21.7572-7580.2002; Lorincz MC, 2000, MOL CELL BIOL, V20, P842, DOI 10.1128/MCB.20.3.842-850.2000; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066, DOI 10.1128/MCB.14.3.2066; Matushansky I, 2003, ONCOGENE, V22, P4143, DOI 10.1038/sj.onc.1206484; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; Nagaraj S, 2010, CANCER J, V16, P348, DOI 10.1097/PPO.0b013e3181eb3358; Osborne CS, 1999, J VIROL, V73, P5490, DOI 10.1128/JVI.73.7.5490-5496.1999; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; RIBECHINI E, 2010, MED MICROBIOL IMMUNO; Schneider G, 2011, BBA-REV CANCER, V1815, P90, DOI 10.1016/j.bbcan.2010.10.003; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Varfolomeev E, 2008, CELL CYCLE, V7, P1511, DOI 10.4161/cc.7.11.5959; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4	43	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21165	10.1371/journal.pone.0021165	http://dx.doi.org/10.1371/journal.pone.0021165			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695055	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600050
J	Paul, C; Pohnert, G				Paul, Carsten; Pohnert, Georg			Interactions of the Algicidal Bacterium Kordia algicida with Diatoms: Regulated Protease Excretion for Specific Algal Lysis	PLOS ONE			English	Article							TOXIC DINOFLAGELLATE; HAHELLA-CHEJUENSIS; MARINE-BACTERIA; ORGANIC-MATTER; PHYTOPLANKTON; COMMUNICATION; BAY; VIRULENCE; DYNAMICS; PLANKTON	Interactions of planktonic bacteria with primary producers such as diatoms have great impact on plankton population dynamics. Several studies described the detrimental effect of certain bacteria on diatoms but the biochemical nature and the regulation mechanism involved in the production of the active compounds remained often elusive. Here, we investigated the interactions of the algicidal bacterium Kordia algicida with the marine diatoms Skeletonema costatum, Thalassiosira weissflogii, Phaeodactylum tricornutum, and Chaetoceros didymus. Algicidal activity was only observed towards the first three of the tested diatom species while C. didymus proved to be not susceptible. The cell free filtrate and the >30 kDa fraction of stationary K. algicida cultures is fully active, suggesting a secreted algicidal principle. The active supernatant from bacterial cultures exhibited high protease activity and inhibition experiments proved that these enzymes are involved in the observed algicidal action of the bacteria. Protease mediated interactions are not controlled by the presence of the alga but dependent on the cell density of the K. algicida culture. We show that protease release is triggered by cell free bacterial filtrates suggesting a quorum sensing dependent excretion mechanism of the algicidal protein. The K. algicida / algae interactions in the plankton are thus host specific and under the control of previously unidentified factors.	[Paul, Carsten; Pohnert, Georg] Univ Jena, Inst Inorgan & Analyt Chem, Dept Bioorgan Analyt, Jena, Germany	Friedrich Schiller University of Jena	Paul, C (corresponding author), Univ Jena, Inst Inorgan & Analyt Chem, Dept Bioorgan Analyt, Jena, Germany.	Georg.Pohnert@uni-jena.de	Pohnert, Georg/D-3721-2013	Pohnert, Georg/0000-0003-2351-6336	Volkswagen Foundation; Jena School for Microbial Communication	Volkswagen Foundation(Volkswagen); Jena School for Microbial Communication	The study was funded by the Volkswagen Foundation in the framework of a Lichtenberg Professorship (http://www.volkswagen-stiftung.de/) and the Jena School for Microbial Communication (http://www.jsmc.uni-jena.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; AZAM F, 1992, PROG OCEANOGR, V30, P151, DOI 10.1016/0079-6611(92)90011-N; Bassler BL, 1999, CURR OPIN MICROBIOL, V2, P582, DOI 10.1016/S1369-5274(99)00025-9; COLE JJ, 1982, ANNU REV ECOL SYST, V13, P291, DOI 10.1146/annurev.es.13.110182.001451; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Doucette GJ, 1999, J PHYCOL, V35, P1447, DOI 10.1046/j.1529-8817.1999.3561447.x; FENCHEL T, 1988, ANNU REV ECOL SYST, V19, P19, DOI 10.1146/annurev.es.19.110188.000315; Ferrier M, 2002, J APPL MICROBIOL, V92, P706, DOI 10.1046/j.1365-2672.2002.01576.x; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Grossart HP, 2007, AQUAT MICROB ECOL, V47, P163, DOI 10.3354/ame047163; Grossart HP, 1999, AQUAT MICROB ECOL, V19, P1, DOI 10.3354/ame019001; IMAI I, 1995, FISHERIES SCI, V61, P628, DOI 10.2331/fishsci.61.628; Imai I, 2008, HARMFUL ALGAE, V7, P360, DOI 10.1016/j.hal.2007.12.010; Jeong H, 2005, NUCLEIC ACIDS RES, V33, P7066, DOI 10.1093/nar/gki1016; Jones LJ, 1997, ANAL BIOCHEM, V251, P144, DOI 10.1006/abio.1997.2259; JONES S, 1993, EMBO J, V12, P2477, DOI 10.1002/j.1460-2075.1993.tb05902.x; Jung SW, 2008, J APPL MICROBIOL, V105, P186, DOI 10.1111/j.1365-2672.2008.03733.x; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Kwon SK, 2010, APPL ENVIRON MICROB, V76, P1661, DOI 10.1128/AEM.01468-09; Lee SO, 2000, APPL ENVIRON MICROB, V66, P4334, DOI 10.1128/AEM.66.10.4334-4339.2000; Leflaive J, 2009, NEW PHYTOL, V184, P794, DOI 10.1111/j.1469-8137.2009.03033.x; Legrand C, 2003, PHYCOLOGIA, V42, P406, DOI 10.2216/i0031-8884-42-4-406.1; MAIER I, 1994, BOT ACTA, V107, P451, DOI 10.1111/j.1438-8677.1994.tb00820.x; Mayali X, 2004, J EUKARYOT MICROBIOL, V51, P139, DOI 10.1111/j.1550-7408.2004.tb00538.x; Mayali X, 2008, J PHYCOL, V44, P923, DOI 10.1111/j.1529-8817.2008.00549.x; Mayali X, 2008, APPL ENVIRON MICROB, V74, P2595, DOI 10.1128/AEM.02191-07; Mayali X, 2002, HARMFUL ALGAE, V1, P277, DOI 10.1016/S1568-9883(02)00032-X; Mitsutani A, 2001, PHYCOLOGIA, V40, P286, DOI 10.2216/i0031-8884-40-3-286.1; Morin D, 2003, J CHROMATOGR A, V1002, P79, DOI 10.1016/S0021-9673(03)00730-1; Nakashima T, 2006, AQUAT MICROB ECOL, V45, P255, DOI 10.3354/ame045255; Nakashima T, 2006, APPL MICROBIOL BIOT, V73, P684, DOI 10.1007/s00253-006-0507-2; OPPENHEIMER CH, 1952, J MAR RES, V11, P10; Pohnert G, 2005, CHEMBIOCHEM, V6, P946, DOI 10.1002/cbic.200400348; Rooney-Varga JN, 2005, MICROB ECOL, V49, P163, DOI 10.1007/s00248-003-1057-0; Roth PB, 2008, HARMFUL ALGAE, V7, P682, DOI 10.1016/j.hal.2008.02.002; Skerratt JH, 2002, MAR ECOL PROG SER, V244, P1, DOI 10.3354/meps244001; Sohn JH, 2004, INT J SYST EVOL MICR, V54, P675, DOI 10.1099/ijs.0.02689-0; Su RQ, 2007, HARMFUL ALGAE, V6, P799, DOI 10.1016/j.hal.2007.04.004; Tilman D., 1982, Monographs in Population Biology, pi; Valade E, 2004, J BACTERIOL, V186, P2288, DOI 10.1128/JB.186.8.2288-2294.2004; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Wang XL, 2005, HARMFUL ALGAE, V4, P433, DOI 10.1016/j.hal.2004.06.001; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams P, 2007, PHILOS T R SOC B, V362, P1119, DOI 10.1098/rstb.2007.2039; Yoshinaga I, 1997, FISHERIES SCI, V63, P94, DOI 10.2331/fishsci.63.94	45	122	135	6	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21032	10.1371/journal.pone.0021032	http://dx.doi.org/10.1371/journal.pone.0021032			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695044	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600040
J	Pantos, O; Hoegh-Guldberg, O				Pantos, Olga; Hoegh-Guldberg, Ove			Shared Skeletal Support in a Coral-Hydroid Symbiosis	PLOS ONE			English	Article							CALICOBLASTIC EPITHELIUM; DESMOCYTE DEVELOPMENT; CNIDARIA; GROWTH; ATTACHMENT; FRAGMENTS; CELLS; SEA	Hydroids form symbiotic relationships with a range of invertebrate hosts. Where they live with colonial invertebrates such as corals or bryozoans the hydroids may benefit from the physical support and protection of their host's hard exoskeleton, but how they interact with them is unknown. Electron microscopy was used to investigate the physical interactions between the colonial hydroid Zanclea margaritae and its reef-building coral host Acropora muricata. The hydroid tissues extend below the coral tissue surface sitting in direct contact with the host's skeleton. Although this arrangement provides the hydroid with protective support, it also presents problems of potential interference with the coral's growth processes and exposes the hydroid to overgrowth and smothering. Desmocytes located within the epidermal layer of the hydroid's perisarc-free hydrorhizae fasten it to the coral skeleton. The large apical surface area of the desmocyte and high bifurcation of the distal end within the mesoglea, as well as the clustering of desmocytes suggests that a very strong attachment between the hydroid and the coral skeleton. This is the first study to provide a detailed description of how symbiotic hydroids attach to their host's skeleton, utilising it for physical support. Results suggest that the loss of perisarc, a characteristic commonly associated with symbiosis, allows the hydroid to utilise desmocytes for attachment. The use of these anchoring structures provides a dynamic method of attachment, facilitating detachment from the coral skeleton during extension, thereby avoiding overgrowth and smothering enabling the hydroid to remain within the host colony for prolonged periods of time.	[Pantos, Olga; Hoegh-Guldberg, Ove] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Pantos, Olga; Hoegh-Guldberg, Ove] Univ Queensland, Global Change Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Pantos, O (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	o.pantos@uq.edu.au	Hoegh-Guldberg, Ove/ABA-5420-2020; Hoegh-Guldberg, Ove/H-6169-2011	Hoegh-Guldberg, Ove/0000-0001-7510-6713; Hoegh-Guldberg, Ove/0000-0001-7510-6713	Queensland Smart State Fellowship award, Australia; Natural Environment Research Council, UK	Queensland Smart State Fellowship award, Australia; Natural Environment Research Council, UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by funding from the Queensland Smart State Fellowship award, Australia and the Natural Environment Research Council, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch-Gottlib L, 2005, MAT SCI ENG C-BIO S, V25, P81, DOI 10.1016/j.msec.2004.09.006; Barneah O, 2002, INVERTEBR BIOL, V121, P81; BARNES DJ, 1980, LIMNOL OCEANOGR, V25, P1113, DOI 10.4319/lo.1980.25.6.1113; Boero F, 2000, ITAL J ZOOL, V67, P93, DOI 10.1080/11250000009356301; BOUILLON J, 1971, Z ZELLFORSCH MIK ANA, V121, P218, DOI 10.1007/BF00340673; Bouillon J., 2006, INTRO HYDROZOA; BOURNE GC, 1899, Q J MICR SCI XLI, P499; Brahmi C, 2010, CORAL REEFS, V29, P175, DOI 10.1007/s00338-009-0557-x; CHAPMAN D M, 1969, Tissue and Cell, V1, P619, DOI 10.1016/S0040-8166(69)80036-4; Gili JM, 2006, POLAR BIOL, V29, P624, DOI 10.1007/s00300-005-0098-x; GLADFELTER EH, 1978, B MAR SCI, V28, P728; Goldberg WM, 2001, TISSUE CELL, V33, P376, DOI 10.1054/tice.2001.0191; Goldberg WM, 2001, TISSUE CELL, V33, P388, DOI 10.1054/tice.2001.0192; HOFMANN DK, 1990, MAR BIOL, V105, P509, DOI 10.1007/BF01316322; KINGSLEY RJ, 1987, J EXP ZOOL, V241, P171, DOI 10.1002/jez.1402410203; Lirman D, 2000, J EXP MAR BIOL ECOL, V251, P41, DOI 10.1016/S0022-0981(00)00205-7; MARCUM BA, 1978, TISSUE CELL, V10, P113, DOI 10.1016/0040-8166(78)90010-1; McKinney F, 2009, ICHNOS, V16, P193, DOI 10.1080/10420940802686160; Millard N.A.H., 1973, Annales Mus r Afr cent (Ser 8 Sci zool), VNo.206, P1; Millard NAH, 1975, ANN S AFR MUS, V68, P1; Muscatine L, 1997, CORAL REEFS, V16, P205, DOI 10.1007/s003380050075; OSMAN RW, 1981, SCIENCE, V211, P846, DOI 10.1126/science.211.4484.846; Pantos O, 2010, CORAL REEFS, V29, P761, DOI 10.1007/s00338-010-0622-5; PIRAINO S, 1994, MAR BIOL, V118, P695, DOI 10.1007/BF00347518; Piraino Stefano, 1992, Scientia Marina, V56, P141; Puce S, 2007, SYMBIOSIS, V44, P137; Puce S, 2008, J MAR BIOL ASSOC UK, V88, P1643, DOI 10.1017/S0025315408001094; REES WJ, 1967, MALACOL SOC LONDON P, V37, P213; RISTEDT H, 1985, Marine Ecology, V6, P167, DOI 10.1111/j.1439-0485.1985.tb00136.x; SHINN E. A., 1966, J PALEONTOL, V40, P233; Tambutte E, 2007, CORAL REEFS, V26, P517, DOI 10.1007/s00338-007-0263-5; TIDBALL JG, 1982, TISSUE CELL, V14, P85, DOI 10.1016/0040-8166(82)90009-X	32	13	13	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20946	10.1371/journal.pone.0020946	http://dx.doi.org/10.1371/journal.pone.0020946			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695083	Green Published, Green Submitted, gold			2022-12-25	WOS:000291682300022
J	Schultz, SW; Nilsson, KPR; Westermark, GT				Schultz, Sebastian Wolfgang; Nilsson, K. Peter R.; Westermark, Gunilla Torstensdotter			Drosophila Melanogaster as a Model System for Studies of Islet Amyloid Polypeptide Aggregation	PLOS ONE			English	Article							GENE RELATED PEPTIDE; BETA-CELL APOPTOSIS; ALZHEIMERS-DISEASE; DIABETES-MELLITUS; TRANSGENIC MICE; HUMAN CALCITONIN; FIBRIL PROTEIN; FAT-BODY; EXPRESSION; TYPE-2	Background: Recent research supports that aggregation of islet amyloid polypeptide (IAPP) leads to cell death and this makes islet amyloid a plausible cause for the reduction of beta cell mass, demonstrated in patients with type 2 diabetes. IAPP is produced by the beta cells as a prohormone, and proIAPP is processed into IAPP by the prohormone convertases PC1/3 and PC2 in the secretory granules. Little is known about the pathogenesis for islet amyloid and which intracellular mechanisms are involved in amyloidogenesis and induction of cell death. Methodology/Principal Findings: We have established expression of human proIAPP (hproIAPP), human IAPP (hIAPP) and the non-amyloidogenic mouse IAPP (mIAPP) in Drosophila melanogaster, and compared survival of flies with the expression driven to different cell populations. Only flies expressing hproIAPP in neurons driven by the Gal4 driver elavC(155,Gal4) showed a reduction in lifespan whereas neither expression of hIAPP or mIAPP influenced survival. Both hIAPP and hproIAPP expression caused formation of aggregates in CNS and fat body region, and these aggregates were both stained by the dyes Congo red and pFTAA, both known to detect amyloid. Also, the morphology of the highly organized protein granules that developed in the fat body of the head in hIAPP and hproIAPP expressing flies was characterized, and determined to consist of 15.8 nm thick pentagonal rod-like structures. Conclusions/Significance: These findings point to a potential for Drosophila melanogaster to serve as a model system for studies of hproIAPP and hIAPP expression with subsequent aggregation and developed pathology.	[Schultz, Sebastian Wolfgang] Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden; [Nilsson, K. Peter R.] Linkoping Univ, IFM Dept Chem, Linkoping, Sweden; [Westermark, Gunilla Torstensdotter] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden	Linkoping University; Linkoping University; Uppsala University	Schultz, SW (corresponding author), Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.	gunilla.westermark@mcb.uu.se			Swedish Research Council; European Union; Swedish Diabetes Association; Family Ernfors Fund; European Research Council (ERC); Knut and Alice Wallenberg Foundation; Swedish Foundation for Strategic Research	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission); Swedish Diabetes Association; Family Ernfors Fund; European Research Council (ERC)(European Research Council (ERC)European Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research)	The work has been funded by the Swedish Research Council (GTW), the European Union FP6 (EURAMY) (GTW), Swedish Diabetes Association (GTW), Family Ernfors Fund (GTW), the European Research Council (ERC, Project MUMID) (KPRN), the Knut and Alice Wallenberg Foundation (KPRN), and the Swedish Foundation for Strategic Research (KPRN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2008, EXP DIABETES RES, DOI 10.1155/2008/562985; Aslund A, 2009, ACS CHEM BIOL, V4, P673, DOI 10.1021/cb900112v; Berg I, 2010, NAT PROTOC, V5, P935, DOI 10.1038/nprot.2010.41; Berg I, 2009, NEURODEGENER DIS, V6, P127, DOI 10.1159/000213761; BRAND AH, 1993, DEVELOPMENT, V118, P401; BYFIELD PGH, 1969, BIOCHEM J, V111, pP13, DOI 10.1042/bj1110013P; Clark A, 1996, APMIS, V104, P12, DOI 10.1111/j.1699-0463.1996.tb00680.x; COHEN E, 1993, ARCH INSECT BIOCHEM, V22, P245, DOI 10.1002/arch.940220118; Crowther DC, 2006, METHOD ENZYMOL, V412, P234, DOI 10.1016/S0076-6879(06)12015-7; Crowther DC, 2005, NEUROSCIENCE, V132, P123, DOI 10.1016/j.neuroscience.2004.12.025; FREEMAN M, 1997, COMMUNICATION; Gavin BA, 2006, J NEUROSCI, V26, P12408, DOI 10.1523/JNEUROSCI.3372-06.2006; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Guardado-Mendoza R, 2009, P NATL ACAD SCI USA, V106, P13992, DOI 10.1073/pnas.0906471106; Gurlo T, 2010, AM J PATHOL, V176, P861, DOI 10.2353/ajpath.2010.090532; Hammarstrom P, 2010, BIOCHEMISTRY-US, V49, P6838, DOI 10.1021/bi100922r; HOWARD CF, 1978, DIABETES, V27, P357, DOI 10.2337/diabetes.27.4.357; Huang CJ, 2007, DIABETES, V56, P2016, DOI 10.2337/db07-0197; Hubbard GB, 2002, J MED PRIMATOL, V31, P84, DOI 10.1034/j.1600-0684.2002.01020.x; Janson J, 1996, P NATL ACAD SCI USA, V93, P7283, DOI 10.1073/pnas.93.14.7283; KANATSUKA A, 1989, FEBS LETT, V259, P199, DOI 10.1016/0014-5793(89)81527-3; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V194, P720, DOI 10.1006/bbrc.1993.1881; Kramer Jamie M, 2003, Genet Mol Res, V2, P43; Krampert M, 2000, CHEM BIOL, V7, P855, DOI 10.1016/S1074-5521(00)00034-X; Lee SC, 2001, CLIN ENDOCRINOL, V54, P541, DOI 10.1046/j.1365-2265.2001.01244.x; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; LOCKE M, 1968, J CELL BIOL, V36, P453, DOI 10.1083/jcb.36.3.453; LUKINIUS A, 1989, DIABETOLOGIA, V32, P240, DOI 10.1007/BF00285291; MALOY AL, 1981, HUM PATHOL, V12, P917, DOI 10.1016/S0046-8177(81)80197-9; Moreau-Fauvarque C, 1998, MECH DEVELOP, V78, P47, DOI 10.1016/S0925-4773(98)00147-6; NELKIN BD, 1984, BIOCHEM BIOPH RES CO, V123, P648, DOI 10.1016/0006-291X(84)90278-X; Nilsson KPR, 2010, AM J PATHOL, V176, P563, DOI 10.2353/ajpath.2010.080797; Paulsson JF, 2006, DIABETOLOGIA, V49, P1237, DOI 10.1007/s00125-006-0206-7; Paulsson JF, 2005, DIABETES, V54, P2117, DOI 10.2337/diabetes.54.7.2117; Pokrzywa M, 2007, EUR J NEUROSCI, V26, P913, DOI 10.1111/j.1460-9568.2007.05728.x; Pokrzywa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014343; PUCHTLER H, 1965, J HISTOCHEM CYTOCHEM, V13, P693, DOI 10.1177/13.8.693; Rezaval C, 2007, EUR J NEUROSCI, V25, P683, DOI 10.1111/j.1460-9568.2007.05317.x; Sakagashira S, 1996, DIABETES, V45, P1279, DOI 10.2337/diabetes.45.9.1279; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sepp KJ, 2001, DEV BIOL, V238, P47, DOI 10.1006/dbio.2001.0411; Sipe JD, 2010, AMYLOID, V17, P101, DOI 10.3109/13506129.2010.526812; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; Takei Y, 2004, FEBS LETT, V556, P53, DOI 10.1016/S0014-5793(03)01368-1; TOJO S, 1978, J CELL BIOL, V78, P823, DOI 10.1083/jcb.78.3.823; Verchere CB, 1996, P NATL ACAD SCI USA, V93, P3492, DOI 10.1073/pnas.93.8.3492; Wang J, 2001, DIABETES, V50, P534, DOI 10.2337/diabetes.50.3.534; Westermark GT, 2000, UPSALA J MED SCI, V105, P97, DOI 10.1517/03009734000000057; WESTERMARK P, 1987, AM J PATHOL, V127, P414; WESTERMARK P, 1972, UPSALA J MED SCI, V77, P91, DOI 10.1517/03009734000000014; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; WESTERMARK P, 1986, BIOCHEM BIOPH RES CO, V140, P827, DOI 10.1016/0006-291X(86)90708-4; YANO BL, 1981, VET PATHOL, V18, P181, DOI 10.1177/030098588101800205; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036; Zhu TH, 2011, DIABETES-METAB RES, V27, P28, DOI 10.1002/dmrr.1140	55	19	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20221	10.1371/journal.pone.0020221	http://dx.doi.org/10.1371/journal.pone.0020221			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695120	Green Published, Green Submitted, gold			2022-12-25	WOS:000291682300005
J	Flisikowska, T; Thorey, IS; Offner, S; Ros, F; Lifke, V; Zeitler, B; Rottmann, O; Vincent, A; Zhang, L; Jenkins, S; Niersbach, H; Kind, AJ; Gregory, PD; Schnieke, AE; Platzer, J				Flisikowska, Tatiana; Thorey, Irmgard S.; Offner, Sonja; Ros, Francesca; Lifke, Valeria; Zeitler, Bryan; Rottmann, Oswald; Vincent, Anna; Zhang, Lei; Jenkins, Shirin; Niersbach, Helmut; Kind, Alexander J.; Gregory, Philip D.; Schnieke, Angelika E.; Platzer, Josef			Efficient Immunoglobulin Gene Disruption and Targeted Replacement in Rabbit Using Zinc Finger Nucleases	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; TRANSGENIC MICE; PRION PROTEIN; KNOCKOUT RATS; GENOME; MOUSE; PIGS; GENERATION; CELLS; MODEL	Rabbits are widely used in biomedical research, yet techniques for their precise genetic modification are lacking. We demonstrate that zinc finger nucleases (ZFNs) introduced into fertilized oocytes can inactivate a chosen gene by mutagenesis and also mediate precise homologous recombination with a DNA gene-targeting vector to achieve the first gene knockout and targeted sequence replacement in rabbits. Two ZFN pairs were designed that target the rabbit immunoglobulin M (IgM) locus within exons 1 and 2. ZFN mRNAs were microinjected into pronuclear stage fertilized oocytes. Founder animals carrying distinct mutated IgM alleles were identified and bred to produce offspring. Functional knockout of the immunoglobulin heavy chain locus was confirmed by serum IgM and IgG deficiency and lack of IgM(+) and IgG(+) B lymphocytes. We then tested whether ZFN expression would enable efficient targeted sequence replacement in rabbit oocytes. ZFN mRNA was co-injected with a linear DNA vector designed to replace exon 1 of the IgM locus with similar to 1.9 kb of novel sequence. Double strand break induced targeted replacement occurred in up to 17% of embryos and in 18% of fetuses analyzed. Two major goals have been achieved. First, inactivation of the endogenous IgM locus, which is an essential step for the production of therapeutic human polyclonal antibodies in the rabbit. Second, establishing efficient targeted gene manipulation and homologous recombination in a refractory animal species. ZFN mediated genetic engineering in the rabbit and other mammals opens new avenues of experimentation in immunology and many other research fields.	[Flisikowska, Tatiana; Rottmann, Oswald; Kind, Alexander J.; Schnieke, Angelika E.] Tech Univ Munich, Chair Livestock Biotechnol, D-8050 Freising Weihenstephan, Germany; [Thorey, Irmgard S.; Offner, Sonja; Ros, Francesca; Lifke, Valeria; Niersbach, Helmut; Platzer, Josef] Roche Diagnost GmbH, Pharma Res & Early Dev, Penzberg, Germany; [Zeitler, Bryan; Vincent, Anna; Zhang, Lei; Jenkins, Shirin; Gregory, Philip D.] Sangamo BioSci Inc, Richmond, CA USA	Technical University of Munich; Roche Holding; Sangamo Therapeutics, Inc.	Flisikowska, T (corresponding author), Tech Univ Munich, Chair Livestock Biotechnol, D-8050 Freising Weihenstephan, Germany.	schnieke@wzw.tum.de	Flisikowska, Tatiana/I-9043-2014	Flisikowska, Tatiana/0000-0003-0481-117X; Gregory, Philip/0000-0001-9249-2468; Schnieke, Angelika/0000-0002-5761-9635	F. Hoffmann-LaRoche Ltd.	F. Hoffmann-LaRoche Ltd.(Hoffmann-La Roche)	The work was funded by F. Hoffmann-LaRoche Ltd. The funders set the overall goal of the project but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The manuscript was approved in its final form by the funders.	BESENFELDER U, 1993, J REPROD FERTIL, V99, P53, DOI 10.1530/jrf.0.0990053; Bibikova M, 2003, SCIENCE, V300, P764, DOI 10.1126/science.1079512; BRINSTER RL, 1989, P NATL ACAD SCI USA, V86, P7087, DOI 10.1073/pnas.86.18.7087; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Carbery ID, 2010, GENETICS, V186, P451, DOI 10.1534/genetics.110.117002; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Chentoufi AA, 2010, J IMMUNOL, V184, P2561, DOI 10.4049/jimmunol.0902322; Cui XX, 2011, NAT BIOTECHNOL, V29, P64, DOI 10.1038/nbt.1731; Dai YF, 2002, NAT BIOTECHNOL, V20, P251, DOI 10.1038/nbt0302-251; Davis WC, 2008, J VET SCI, V9, P51, DOI 10.4142/jvs.2008.9.1.51; Denning C, 2001, NAT BIOTECHNOL, V19, P559, DOI 10.1038/89313; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; Green LL, 1999, J IMMUNOL METHODS, V231, P11, DOI 10.1016/S0022-1759(99)00137-4; Groves DJ, 2000, HYBRIDOMA, V19, P201, DOI 10.1089/02724570050109602; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Ishida Isao, 2002, Cloning and Stem Cells, V4, P91, DOI 10.1089/153623002753632084; Jasper PJ, 2003, J IMMUNOL, V171, P6372, DOI 10.4049/jimmunol.171.12.6372; Kamihira M, 2009, J BIOTECHNOL, V141, P18, DOI 10.1016/j.jbiotec.2009.02.022; KNIGHT KL, 1990, CELL, V60, P963, DOI 10.1016/0092-8674(90)90344-E; Koike T, 2009, ARTERIOSCL THROM VAS, V29, P2047, DOI 10.1161/ATVBAHA.109.190264; Kondo M, 2009, INVEST OPHTH VIS SCI, V50, P1371, DOI 10.1167/iovs.08-2863; Kuroiwa Y, 2004, NAT GENET, V36, P775, DOI 10.1038/ng1373; Kuroiwa Y, 2009, NAT BIOTECHNOL, V27, P173, DOI 10.1038/nbt.1521; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; LAMOYI E, 1985, J EXP MED, V162, P1149, DOI 10.1084/jem.162.4.1149; LO D, 1991, EUR J IMMUNOL, V21, P1001, DOI 10.1002/eji.1830210421; Lombardi R, 2009, CIRCULATION, V119, P1398, DOI 10.1161/CIRCULATIONAHA.108.790501; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; LONBERG N, 1994, NATURE, V368, P856, DOI 10.1038/368856a0; Marian AJ, 2005, CIRCULATION, V111, P2276, DOI 10.1161/01.CIR.0000167559.13502.9A; Mashimo T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008870; McCreath KJ, 2000, NATURE, V405, P1066, DOI 10.1038/35016604; Mendez MJ, 1997, NAT GENET, V15, P146, DOI 10.1038/ng0297-146; MENDICINO M, 2010, TRANSGENIC RES  0916; Meng XD, 2008, NAT BIOTECHNOL, V26, P695, DOI 10.1038/nbt1398; Meyer M, 2010, P NATL ACAD SCI USA, V107, P15022, DOI 10.1073/pnas.1009424107; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nicholson IC, 1999, J IMMUNOL, V163, P6898; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Popkov M, 2003, J MOL BIOL, V325, P325, DOI 10.1016/S0022-2836(02)01232-9; RAMSOONDAR J, 2010, TRANSGENIC RES  0926; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Shiomi M, 2009, ATHEROSCLEROSIS, V207, P1, DOI 10.1016/j.atherosclerosis.2009.03.024; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; WAGNER SD, 1994, NUCLEIC ACIDS RES, V22, P1389, DOI 10.1093/nar/22.8.1389; WEIDLE UH, 1991, GENE, V98, P185, DOI 10.1016/0378-1119(91)90172-8; Yu GH, 2006, J GEN VIROL, V87, P1019, DOI 10.1099/vir.0.81384-0; Zakhartchenko V, 2011, BIOL REPROD, V84, P229, DOI 10.1095/biolreprod.110.087098	51	105	127	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e21045	10.1371/journal.pone.0021045	http://dx.doi.org/10.1371/journal.pone.0021045			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695153	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300036
J	Lu, SY; Chang, FY; Cheng, CC; Lee, KD; Huang, YC				Lu, Sheng-Yun; Chang, Fang-Yu; Cheng, Ching-Chung; Lee, Keong-Diong; Huang, Yhu-Chering			Methicillin-Resistant Staphylococcus aureus Nasal Colonization among Adult Patients Visiting Emergency Department in a Medical Center in Taiwan	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; RISK-FACTORS; MUPIROCIN OINTMENT; INFECTIONS; PREVALENCE; CARRIAGE; CHILDREN	Background: Within the past 10 years, methicillin-resistant Staphylococcus aureus (MRSA) has not only been a hospital pathogen but also a community pathogen. To understand the carriage rate of methicillin-resistant Staphylococcus aureus (MRSA) among the adult patients visiting emergency department (ED), we conducted this study. Methodology/Principal Findings: From May 21 to August 12, 2009, a total of 502 adult patients visiting emergency department (ED) of a tertiary care hospital in northern Taiwan were recruited in this study and surveyed for nasal carriage of MRSA. A questionnaire regarding the risk factors for MRSA acquisition was also obtained. The overall prevalence of MRSA nasal carriage among the patients was 3.8%. The carriage rate was significantly higher in patients with risk factors for MRSA acquisition (5.94%) than those without risk factors (2.12%). Patients with urinary complaints, diabetes mellitus, chronic kidney disease and current percutaneous tube usage were significantly associated with MRSA colonization. By multiple logistic regression analysis, only current usage of catheters or tubes was the independent predictor for MRSA nasal colonization. Of the 19 MRSA, most isolates belonged to one of two linages, characterized as sequence type (ST) 239 (32%) and ST 59 (58%). The latter linage, accounting for 83% of 6 isolates from patients without risk factors, is a community-associated (CA) clone in Taiwan, while the former linage is among healthcare-associated clones. Conclusion/Significance: A substantial proportion of patients visiting ED, particularly with current usage of percutaneous catheter or tubes, in northern Taiwan carried MRSA, mostly community strains, in nares.	[Lu, Sheng-Yun; Chang, Fang-Yu; Cheng, Ching-Chung; Huang, Yhu-Chering] Chang Gung Univ, Coll Med, Tao Yuan, Taiwan; [Lee, Keong-Diong] Chang Gung Mem Hosp Linko, Dept Emergency Med, Tao Yuan, Taiwan; [Huang, Yhu-Chering] Chang Gung Mem Hosp Linko, Dept Pediat, Tao Yuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lu, SY (corresponding author), Chang Gung Univ, Coll Med, Tao Yuan, Taiwan.	ychuang@adm.cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG 460112]; Medical Foundation	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Medical Foundation	This work was supported by a grant from Chang Gung Memorial Hospital (CMRPG 460112) and Medical Foundation in Memory of Dr. Deh-Lin Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOELAERT JR, 1993, NEPHROL DIAL TRANSPL, V8, P235; Chen CB, 2010, J HOSP INFECT, V74, P238, DOI 10.1016/j.jhin.2009.10.026; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; Chen CJ, 2009, DIAGN MICR INFEC DIS, V65, P199, DOI 10.1016/j.diagmicrobio.2009.05.020; Clinical and Laboratory Standards Institute, 2006, M100S16 CLIN LAB STA; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DeLeo FR, 2010, LANCET, V375, P1557, DOI 10.1016/S0140-6736(09)61999-1; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Donnio PY, 2004, J ANTIMICROB CHEMOTH, V53, P808, DOI 10.1093/jac/dkh185; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Fluit AC, 2001, J CLIN MICROBIOL, V39, P3727, DOI 10.1128/JCM.39.10.3727-3732.2001; Fridkin SK, 2005, NEW ENGL J MED, V352, P1436, DOI 10.1056/NEJMoa043252; Goering RV, 2008, J CLIN MICROBIOL, V46, P2842, DOI 10.1128/JCM.00521-08; Gorwitz RJ, 2008, J INFECT DIS, V197, P1; Halablab MAm Hijazi SM, 2009, EPIDEMIOL INFECT, V27, P1; Hsueh PR, 2002, EMERG INFECT DIS, V8, P132; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YC, 2007, J CLIN MICROBIOL, V45, P3992, DOI 10.1128/JCM.01202-07; Huang YC, 2006, J CLIN MICROBIOL, V44, P2268, DOI 10.1128/JCM.00776-06; Jernigan JA, 2008, ANN EMERG MED, V52, P534, DOI 10.1016/j.annemergmed.2008.09.001; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lu PL, 2005, J CLIN MICROBIOL, V43, P132, DOI 10.1128/JCM.43.1.132-139.2005; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Naimi TS, 2003, JAMA-J AM MED ASSOC, V290, P2976, DOI 10.1001/jama.290.22.2976; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Patel M, 2009, DRUGS, V69, P693, DOI 10.2165/00003495-200969060-00004; Safdar N, 2008, AM J MED, V121, P310, DOI 10.1016/j.amjmed.2007.07.034; Thodis E, 1998, PERITON DIALYSIS INT, V18, P261; Unzeitigova Martina, 2006, Klin Mikrobiol Infekc Lek, V12, P19; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026	33	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e18620	10.1371/journal.pone.0018620	http://dx.doi.org/10.1371/journal.pone.0018620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695178	Green Submitted, gold, Green Published			2022-12-25	WOS:000291663300001
J	Butler, D; Hwang, J; Estick, C; Nishiyama, A; Kumar, SS; Baveghems, C; Young-Oxendine, HB; Wisniewski, ML; Charalambides, A; Bahr, BA				Butler, David; Hwang, Jeannie; Estick, Candice; Nishiyama, Akiko; Kumar, Saranya Santhosh; Baveghems, Clive; Young-Oxendine, Hollie B.; Wisniewski, Meagan L.; Charalambides, Ana; Bahr, Ben A.			Protective Effects of Positive Lysosomal Modulation in Alzheimer's Disease Transgenic Mouse Models	PLOS ONE			English	Article							AMYLOID-BETA-PROTEIN; A-BETA; PRECURSOR PROTEIN; CATHEPSIN-D; NATURAL OLIGOMERS; MEMORY DEFICITS; CA1 NEURONS; IN-VIVO; BRAIN; MICE	Alzheimer's disease (AD) is an age-related neurodegenerative pathology in which defects in proteolytic clearance of amyloid beta peptide (A beta) likely contribute to the progressive nature of the disorder. Lysosomal proteases of the cathepsin family exhibit up-regulation in response to accumulating proteins including A beta(1-42). Here, the lysosomal modulator Z-Phe-Ala-diazomethylketone (PADK) was used to test whether proteolytic activity can be enhanced to reduce the accumulation events in AD mouse models expressing different levels of Ab pathology. Systemic PADK injections in APP(SwInd) and APPswe/PS1 Delta E9 mice caused 3-to 8-fold increases in cathepsin B protein levels and 3- to 10-fold increases in the enzyme's activity in lysosomal fractions, while neprilysin and insulin-degrading enzyme remained unchanged. Biochemical analyses indicated the modulation predominantly targeted the active mature forms of cathepsin B and markedly changed Rab proteins but not LAMP1, suggesting the involvement of enhanced trafficking. The modulated lysosomal system led to reductions in both A beta immunostaining as well as A beta(x-42) sandwich ELISA measures in APP(SwInd) mice of 10-11 months. More extensive A beta deposition in 20-22-month APPswe/PS1 Delta E9 mice was also reduced by PADK. Selective ELISAs found that a corresponding production of the less pathogenic A beta(1-38) occurs as A beta(1-42) levels decrease in the mouse models, indicating that PADK treatment leads to A beta truncation. Associated with A beta clearance was the elimination of behavioral and synaptic protein deficits evident in the two transgenic models. These findings indicate that pharmacologically-controlled lysosomal modulation reduces A beta(1-42) accumulation, possibly through intracellular truncation that also influences extracellular deposition, and in turn offsets the defects in synaptic composition and cognitive functions. The selective modulation promotes clearance at different levels of A beta pathology and provides proof-of-principle for small molecule therapeutic development for AD and possibly other protein accumulation disorders.	[Butler, David; Hwang, Jeannie; Estick, Candice; Bahr, Ben A.] Univ Connecticut, Neurosci Program, Storrs, CT USA; [Butler, David; Hwang, Jeannie; Baveghems, Clive; Charalambides, Ana; Bahr, Ben A.] Univ Connecticut, Dept Pharmaceut Sci, Storrs, CT USA; [Estick, Candice; Nishiyama, Akiko; Kumar, Saranya Santhosh; Bahr, Ben A.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT USA; [Kumar, Saranya Santhosh; Bahr, Ben A.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT USA; [Hwang, Jeannie; Young-Oxendine, Hollie B.; Wisniewski, Meagan L.; Charalambides, Ana; Bahr, Ben A.] Univ N Carolina Pembroke, William C Friday Lab, Biotechnol Res & Training Ctr, Pembroke, NC USA	University of Connecticut; University of Connecticut; University of Connecticut; University of Connecticut; University of North Carolina	Butler, D (corresponding author), Harvard Inst Med, Ctr Neurol Dis, Boston, MA USA.	Bahr@uncp.edu	Baveghems, Clive/G-6648-2015	Baveghems, Clive/0000-0002-4396-8738	National Institutes of Health [R25 GM077634]; North Carolina Biotechnology Center (Research Triangle Park, North Carolina); Institute for the Study of Aging; University of Connecticut School of Pharmacy and Center for Students with Disabilities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM077634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); North Carolina Biotechnology Center (Research Triangle Park, North Carolina); Institute for the Study of Aging; University of Connecticut School of Pharmacy and Center for Students with Disabilities; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grant R25 GM077634, the Oliver Smithies Grant from the North Carolina Biotechnology Center (Research Triangle Park, North Carolina), the Institute for the Study of Aging, and the University of Connecticut School of Pharmacy and Center for Students with Disabilities. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr BA, 1998, J COMP NEUROL, V397, P139; BAHR BA, 1995, J NEUROSCI RES, V42, P294, DOI 10.1002/jnr.490420303; BAHR BA, 1994, EXP NEUROL, V129, P81, DOI 10.1006/exnr.1994.1149; BANAYSCHWARTZ M, 1992, J NEUROCHEM, V58, P2207, DOI 10.1111/j.1471-4159.1992.tb10965.x; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Bayer TA, 2008, NEURODEGENER DIS, V5, P140, DOI 10.1159/000113684; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Bendiske J, 2002, J NEUROPATH EXP NEUR, V61, P640, DOI 10.1093/jnen/61.7.640; Bi X, 2000, NEUROSCIENCE, V97, P395, DOI 10.1016/S0306-4522(00)00021-X; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Burdick D, 1997, BRAIN RES, V746, P275, DOI 10.1016/S0006-8993(96)01262-0; Butler D, 2005, REJUV RES, V8, P227, DOI 10.1089/rej.2005.8.227; Butler D, 2006, AUTOPHAGY, V2, P234, DOI 10.4161/auto.2729; Callahan LM, 1999, J NEUROPATH EXP NEUR, V58, P275, DOI 10.1097/00005072-199903000-00007; CATALDO AM, 1995, NEURON, V14, P671, DOI 10.1016/0896-6273(95)90324-0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Eckman EA, 2005, BIOCHEM SOC T, V33, P1101, DOI 10.1042/BST0331101; Esposito L, 2006, J NEUROSCI, V26, P5167, DOI 10.1523/JNEUROSCI.0482-06.2006; Fuentealba RA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011884; Ginsberg SD, 2000, ANN NEUROL, V48, P77, DOI 10.1002/1531-8249(200007)48:1<77::AID-ANA12>3.3.CO;2-1; Ginsberg SD, 2010, BIOL PSYCHIAT, V68, P885, DOI 10.1016/j.biopsych.2010.05.030; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; HAJIMOHAMMADREZA I, 1994, BRAIN RES, V640, P25, DOI 10.1016/0006-8993(94)91853-8; Hama E, 2004, J BIOL CHEM, V279, P30259, DOI 10.1074/jbc.M401891200; Higuchi M, 2005, BBA-PROTEINS PROTEOM, V1751, P60, DOI 10.1016/j.bbapap.2005.02.013; Hook G, 2007, BIOL CHEM, V388, P979, DOI 10.1515/BC.2007.117; Hu XY, 2009, P NATL ACAD SCI USA, V106, P20324, DOI 10.1073/pnas.0911281106; Kanju PM, 2007, J NEUROPATH EXP NEUR, V66, P779, DOI 10.1097/nen.0b013e3181461ae7; Khurana V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001026; Klein DM, 2009, J PHARMACOL EXP THER, V328, P813, DOI 10.1124/jpet.108.147082; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lee HJ, 2004, J NEUROSCI, V24, P1888, DOI 10.1523/JNEUROSCI.3809-03.2004; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li M, 2007, PROG NEUROBIOL, V83, P131, DOI 10.1016/j.pneurobio.2007.08.002; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Mielke JG, 1997, NEUROSCI LETT, V227, P169, DOI 10.1016/S0304-3940(97)00340-6; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; Nixon RA, 2001, J ALZHEIMERS DIS, V3, P97, DOI 10.3233/JAD-2001-3114; O'Nuallain B, 2010, J NEUROSCI, V30, P14411, DOI 10.1523/JNEUROSCI.3537-10.2010; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Ryzhikov S, 2008, J MOL NEUROSCI, V34, P131, DOI 10.1007/s12031-007-9009-7; SALMINEN A, 1984, AM J PATHOL, V117, P64; SALMINEN A, 1990, BIOCHEM J, V272, P39, DOI 10.1042/bj2720039; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; Scullion GA, 2011, NEUROPHARMACOLOGY, V60, P223, DOI 10.1016/j.neuropharm.2010.09.002; Selkoe DJ, 2001, NEURON, V32, P177, DOI 10.1016/S0896-6273(01)00475-5; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; SUTHERLAND JHR, 1983, BIOCHEM BIOPH RES CO, V110, P332, DOI 10.1016/0006-291X(83)91300-1; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; TANAKA K, 1984, J BIOL CHEM, V259, P5937; vanderStappen JWJ, 1996, INT J CANCER, V67, P547, DOI 10.1002/(SICI)1097-0215(19960807)67:4<547::AID-IJC14>3.0.CO;2-4; Verheijen JH, 2006, CLIN CHEM, V52, P1168, DOI 10.1373/clinchem.2006.066720; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wang SQ, 2010, J NEUROCHEM, V115, P47, DOI 10.1111/j.1471-4159.2010.06899.x; Yan P, 2009, J NEUROSCI, V29, P10706, DOI 10.1523/JNEUROSCI.2637-09.2009; Yang CN, 2011, NEUROBIOL DIS, V42, P221, DOI 10.1016/j.nbd.2011.01.005; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341	67	70	71	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20501	10.1371/journal.pone.0020501	http://dx.doi.org/10.1371/journal.pone.0020501			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695208	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600013
J	Johnson, RA; McFadden, GI; Goodman, CD				Johnson, Russell A.; McFadden, Geoffrey I.; Goodman, Christopher D.			Characterization of Two Malaria Parasite Organelle Translation Elongation Factor G Proteins: The Likely Targets of the Anti-Malarial Fusidic Acid	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; RESISTANCE; APICOPLAST; TRANSFECTION; PROTEOME; COMPLEX	Malaria parasites harbour two organelles with bacteria-like metabolic processes that are the targets of many anti-bacterial drugs. One such drug is fusidic acid, which inhibits the translation component elongation factor G. The response of P. falciparum to fusidic acid was characterised using extended SYBR-Green based drug trials. This revealed that fusidic acid kills in vitro cultured P. falciparum parasites by immediately blocking parasite development. Two bacterial-type protein translation elongation factor G genes are identified as likely targets of fusidic acid. Sequence analysis suggests that these proteins function in the mitochondria and apicoplast and both should be sensitive to fusidic acid. Microscopic examination of protein-reporter fusions confirm the prediction that one elongation factor G is a component of parasite mitochondria whereas the second is a component of the relict plastid or apicoplast. The presence of two putative targets for a single inhibitory compound emphasizes the potential of elongation factor G as a drug target in malaria.	[Johnson, Russell A.; McFadden, Geoffrey I.; Goodman, Christopher D.] Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3052, Australia	University of Melbourne	Johnson, RA (corresponding author), Univ Melbourne, Sch Bot, Plant Cell Biol Res Ctr, Parkville, Vic 3052, Australia.	deang@unimelb.edu.au	McFadden, Geoffrey McFadden I/F-7667-2014	McFadden, Geoffrey McFadden I/0000-0002-5351-1627; Goodman, Christopher/0000-0002-8923-7594	National Health and Medical Research Council [637406]; Australian Research Council [FF0668705]; Fulbright Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Fulbright Fellowship	This work was supported by National Health and Medical Research Council (www.nhmrc.gov.au) Grant #637406, the Australian Research Council (www.arc.gov.au) Grant #FF0668705. RAJ was supported by a Fulbright Fellowship (fulbright.state.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Karadaghi S, 1996, STRUCTURE, V4, P555, DOI 10.1016/S0969-2126(96)00061-5; Albrecht V, 2006, PLANT MOL BIOL, V60, P507, DOI 10.1007/s11103-005-4921-0; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Atkinson GC, 2011, MOL BIOL EVOL, V28, P1281, DOI 10.1093/molbev/msq316; Bender A, 2003, MOL BIOCHEM PARASIT, V132, P59, DOI 10.1016/j.molbiopara.2003.07.001; Besier S, 2003, MOL MICROBIOL, V47, P463, DOI 10.1046/j.1365-2958.2003.03307.x; BLACK FT, 1985, LANCET, V1, P578; Bradley D J, 2001, Commun Dis Public Health, V4, P84; Chaubey S, 2005, MOL MICROBIOL, V56, P81, DOI 10.1111/j.1365-2958.2005.04538.x; Crabb BS, 1996, P NATL ACAD SCI USA, V93, P7289, DOI 10.1073/pnas.93.14.7289; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; FEAGIN JE, 1992, NUCLEIC ACIDS RES, V20, P879, DOI 10.1093/nar/20.4.879; FICHERA ME, 1995, ANTIMICROB AGENTS CH, V39, P1530, DOI 10.1128/AAC.39.7.1530; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; GODTFREDSEN WO, 1962, NATURE, V193, P987, DOI 10.1038/193987a0; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Gray MW, 1999, SCIENCE, V283, P1476, DOI 10.1126/science.283.5407.1476; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; He CY, 2001, EMBO J, V20, P330, DOI 10.1093/emboj/20.3.330; Huang S, 2009, PLANT PHYSIOL, V149, P719, DOI 10.1104/pp.108.131300; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; Lannergard J, 2009, ANTIMICROB AGENTS CH, V53, P2059, DOI 10.1128/AAC.00871-08; McFadden GI, 1996, NATURE, V381, P482, DOI 10.1038/381482a0; Millar AH, 2001, PLANT PHYSIOL, V127, P1711, DOI 10.1104/pp.010387; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Mullin KA, 2006, P NATL ACAD SCI USA, V103, P9572, DOI 10.1073/pnas.0602293103; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Painter HJ, 2007, NATURE, V446, P88, DOI 10.1038/nature05572; Sidhu ABS, 2007, J BIOL CHEM, V282, P2494, DOI 10.1074/jbc.M608615200; Smilkstein M, 2004, ANTIMICROB AGENTS CH, V48, P1803, DOI 10.1128/AAC.48.5.1803-1806.2004; Thompson JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0203S00; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; van Dooren GG, 2005, MOL MICROBIOL, V57, P405, DOI 10.1111/j.1365-2958.2005.04699.x; van Dooren GG, 2006, FEMS MICROBIOL REV, V30, P596, DOI 10.1111/j.1574-6976.2006.00027.x; von Zychlinski A, 2005, MOL CELL PROTEOMICS, V4, P1072, DOI 10.1074/mcp.M500018-MCP200; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; Waller RF, 1998, P NATL ACAD SCI USA, V95, P12352, DOI 10.1073/pnas.95.21.12352; WHO, 2010, GUID TREATM MAL, V2nd	41	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20633	10.1371/journal.pone.0020633	http://dx.doi.org/10.1371/journal.pone.0020633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695207	Green Published, gold			2022-12-25	WOS:000291612600016
J	Kardakaris, R; Gareus, R; Xanthoulea, S; Pasparakis, M				Kardakaris, Rozina; Gareus, Ralph; Xanthoulea, Sofia; Pasparakis, Manolis			Endothelial and Macrophage-Specific Deficiency of P38 alpha MAPK Does Not Affect the Pathogenesis of Atherosclerosis in ApoE(-/-) Mice	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; FOAM CELL-FORMATION; GENE-EXPRESSION; P38; INFLAMMATION; INHIBITION; IMMUNE; RECOMBINATION; MIGRATION; DISEASES	Background: The p38 alpha Mitogen-Activated Protein Kinase (MAPK) regulates stress-and inflammation-induced cellular responses. Factors implicated in the development of atherosclerosis including modified low-density lipoprotein (LDL), cytokines and even shear stress induce p38 activation in endothelial cells and macrophages, which may be important for plaque formation. This study investigates the effects of endothelial-and macrophage-specific deficiency of p38 alpha in atherosclerosis development, in Apolipoprotein E deficient (ApoE(-/-)) mice. Methodology/Principal Findings: ApoE(-/-) mice with macrophage or endothelial cell-specific p38 alpha deficiency were fed a high cholesterol diet (HCD) for 10 weeks and atherosclerosis development was assessed by histological and molecular methods. Surprisingly, although p38 alpha-deficiency strongly attenuated oxidized LDL-induced expression of molecules responsible for monocyte recruitment in endothelial cell cultures in vitro, endothelial-specific p38 alpha ablation in vivo did not affect atherosclerosis development. Similarly, macrophage specific deletion of p38 alpha did not affect atherosclerotic plaque development in ApoE(-/-) mice. Conclusions: Although previous studies implicated p38 alpha signaling in atherosclerosis, our in vivo experiments suggest that p38 alpha function in endothelial cells and macrophages does not play an important role in atherosclerotic plaque formation in ApoE deficient mice.	[Kardakaris, Rozina; Gareus, Ralph; Xanthoulea, Sofia; Pasparakis, Manolis] Univ Cologne, Inst Genet, Ctr Mol Med, D-5000 Cologne, Germany	University of Cologne	Kardakaris, R (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	pasparakis@uni-koeln.de	Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017	Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; xanthoulea, sofia/0000-0003-4700-3404	Cologne Excellence Cluster in Cellular Stress Responses in Aging Associated Diseases (CECAD); European Union [MRTN-CT-2004-005632]	Cologne Excellence Cluster in Cellular Stress Responses in Aging Associated Diseases (CECAD); European Union(European Commission)	This work was supported by grants from the Cologne Excellence Cluster in Cellular Stress Responses in Aging Associated Diseases (CECAD) and the European Union (IMDEMI, MRTN-CT-2004-005632) to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashwell JD, 2006, NAT REV IMMUNOL, V6, P532, DOI 10.1038/nri1865; Beardmore VA, 2005, MOL CELL BIOL, V25, P10454, DOI 10.1128/MCB.25.23.10454-10464.2005; Borbiev T, 2004, AM J PHYSIOL-LUNG C, V287, pL911, DOI 10.1152/ajplung.00372.2003; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Denes L, 2002, BRIT J PHARMACOL, V136, P597, DOI 10.1038/sj.bjp.0704738; Forde A, 2002, GENESIS, V33, P191, DOI 10.1002/gene.10117; Galkina E, 2009, ANNU REV IMMUNOL, V27, P165, DOI 10.1146/annurev.immunol.021908.132620; Gareus R, 2008, CELL METAB, V8, P372, DOI 10.1016/j.cmet.2008.08.016; Gratton JP, 2001, J BIOL CHEM, V276, P30359, DOI 10.1074/jbc.M009698200; Hansson GK, 2006, NAT REV IMMUNOL, V6, P508, DOI 10.1038/nri1882; Heinrichsdorff J, 2008, EMBO REP, V9, P1048, DOI 10.1038/embor.2008.149; Jagavelu K, 2007, CIRC RES, V101, P1104, DOI 10.1161/CIRCRESAHA.107.156075; Kanters E, 2003, J CLIN INVEST, V112, P1176, DOI 10.1172/JCI18580; Kiermayer C, 2007, GENESIS, V45, P11, DOI 10.1002/dvg.20244; Kim C, 2008, NAT IMMUNOL, V9, P1019, DOI 10.1038/ni.1640; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lei ZB, 2002, CARDIOVASC RES, V53, P524, DOI 10.1016/S0008-6363(01)00491-6; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; McMullen ME, 2005, J BIOL CHEM, V280, P20995, DOI 10.1074/jbc.M407060200; Nolden L, 2006, NAT METHODS, V3, P461, DOI 10.1038/NMETH884; Ricci R, 2004, SCIENCE, V306, P1558, DOI 10.1126/science.1101909; Schieven GL, 2005, CURR TOP MED CHEM, V5, P921, DOI 10.2174/1568026054985902; Seimon T, 2009, J LIPID RES, V50, pS382, DOI 10.1194/jlr.R800032-JLR200; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Smith SJ, 2006, BRIT J PHARMACOL, V149, P393, DOI 10.1038/sj.bjp.0706885; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Westra J, 2004, ARTHRITIS RES THER, V6, pR384, DOI 10.1186/ar1204; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhao M, 2002, APMIS, V110, P458, DOI 10.1034/j.1600-0463.2002.100604.x	31	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e21055	10.1371/journal.pone.0021055	http://dx.doi.org/10.1371/journal.pone.0021055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695272	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900050
J	Mir, RA; Chauhan, SS				Mir, Riyaz A.; Chauhan, Shyam S.			Down Regulation of a Matrix Degrading Cysteine Protease Cathepsin L, by Acetaldehyde: Role of C/EBP alpha	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; FAT-STORING CELLS; GENE-EXPRESSION; HUMAN LIVER; LIPID-PEROXIDATION; RAT HEPATOCYTES; ALCOHOL; ETHANOL; FIBROSIS; BINDING	Background: The imbalance between extra cellular matrix (ECM) synthesis and degradation is critical aspect of various hepatic pathologies including alcohol induced liver fibrosis. This study was carried out to investigate the effect of acetaldehyde on expression of an extra cellular matrix degrading protease cathepsin L (CTSL) in HepG2 cells. Methodology and Results: We measured the enzymatic activity, protein and, mRNA levels of CTSL in acetaldehyde treated and untreated cells. The binding of CAAT enhancer binding protein alpha (C/EBP alpha) to CTSL promoter and its key role in the transcription from this promoter and conferring responsiveness to acetaldehyde was established by site directed mutagenesis, electrophoretic mobility shift assay (EMSA), chromatin immunoprecipitation (ChIP) assays and siRNA technology. Acetaldehyde treatment significantly decreased CTSL activity and protein levels in HepG2 cells. A similar decrease in the mRNA levels and promoter activity was also observed. This decrease by acetaldehyde was attributed to the fall in the liver enriched transcription factor C/EBP alpha levels and it's binding to the CTSL promoter. Mutagenesis of C/EBP alpha binding motifs revealed the key role of this factor in CTSL transcription as well as conferring responsiveness to acetaldehyde. The siRNA mediated silencing of the C/EBP alpha expression mimicked the effect of acetaldehyde on CTSL levels and its promoter activity. It also abolished the responsiveness of this promoter to acetaldehyde. Conclusion: Acetaldehyde down regulates the C/EBP alpha mediated CTSL expression in hepatic cell lines. The decreased expression of CTSL may at least in part contribute to ECM deposition in liver which is a hallmark of alcoholic liver fibrosis.	[Mir, Riyaz A.; Chauhan, Shyam S.] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Mir, RA (corresponding author), All India Inst Med Sci, Dept Biochem, New Delhi 110029, India.	s_s_chauhan@hotmail.com			JRF & SRF from Indian Council of Medical Research (ICMR), New Delhi; Department of Science and Technology, Government of India, New Delhi	JRF & SRF from Indian Council of Medical Research (ICMR), New Delhi(Indian Council of Medical Research (ICMR)); Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India))	Riyaz A. Mir was a recipient of JRF & SRF from Indian Council of Medical Research (ICMR), New Delhi. This work was supported by a research grant from Department of Science and Technology, Government of India, New Delhi. The funders has no role in study design, data collection and analysis, decision to publish, or in the preparation of this manuscript.	Arora S, 2002, GENE, V293, P123, DOI 10.1016/S0378-1119(02)00700-X; ARTHUR MJP, 1995, J HEPATOL, V22, P43; ARTHUR MJP, 1992, BIOCHEM J, V287, P701, DOI 10.1042/bj2870701; Attard FA, 2001, DNA CELL BIOL, V20, P455, DOI 10.1089/104454901316976082; Bakhshi R, 2001, GENE, V275, P93, DOI 10.1016/S0378-1119(01)00650-3; CARTER EA, 1988, ALCOHOL CLIN EXP RES, V12, P555, DOI 10.1111/j.1530-0277.1988.tb00241.x; CASINI A, 1994, BIOCHEM BIOPH RES CO, V199, P1019, DOI 10.1006/bbrc.1994.1331; CASINI A, 1994, LIFE SCI, V55, P1311, DOI 10.1016/0024-3205(94)00763-2; CHAUHAN SS, 1991, CANCER RES, V51, P1478; Chauhan SS, 1998, BIOCHEMISTRY-US, V37, P8584, DOI 10.1021/bi972251z; Chen AP, 2000, MOL CELL BIOL, V20, P2818, DOI 10.1128/MCB.20.8.2818-2826.2000; Dehrmann FM, 1995, ARCH BIOCHEM BIOPHYS, V324, P93, DOI 10.1006/abbi.1995.9924; Farkas D, 2005, CHEM RES TOXICOL, V18, P1132, DOI 10.1021/tx0500225; Felbor U, 2000, EMBO J, V19, P1187, DOI 10.1093/emboj/19.6.1187; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Fernandez-Checa JC, 1998, SEMIN LIVER DIS, V18, P389, DOI 10.1055/s-2007-1007172; Fibbi G, 1999, HEPATOLOGY, V29, P868, DOI 10.1002/hep.510290343; GARCIARUIZ C, 1994, J CLIN INVEST, V94, P193, DOI 10.1172/JCI117306; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Hsiang CY, 2007, TOXICOL LETT, V171, P78, DOI 10.1016/j.toxlet.2007.04.009; II K, 1985, J HISTOCHEM CYTOCHEM, V33, P1173, DOI 10.1177/33.11.4056381; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; ISHAK KG, 1991, ALCOHOL CLIN EXP RES, V15, P45, DOI 10.1111/j.1530-0277.1991.tb00518.x; Ishidoh K, 1998, BIOL CHEM, V379, P131; Jonsson IM, 2007, P NATL ACAD SCI USA, V104, P258, DOI 10.1073/pnas.0608620104; Kane S E, 1990, Semin Cancer Biol, V1, P127; Keerthivasan S, 2007, GENE, V399, P129, DOI 10.1016/j.gene.2007.05.002; Kirschke H, 1995, PROTEIN PROFILE, V2, P1587; LIEBER CS, 1994, GASTROENTEROLOGY, V106, P1085, DOI 10.1016/0016-5085(94)90772-2; Mantle D, 1999, CLIN CHIM ACTA, V281, P101, DOI 10.1016/S0009-8981(98)00211-3; Mello T, 2008, MOL ASPECTS MED, V29, P17, DOI 10.1016/j.mam.2007.10.001; MILANI S, 1994, AM J PATHOL, V144, P528; NIEMELA O, 1991, J CLIN INVEST, V87, P1367, DOI 10.1172/JCI115141; NIEMELA O, 1995, HEPATOLOGY, V22, P1208, DOI 10.1016/0270-9139(95)90630-4; Perez-Liza G, 2005, PHARMACOLOGY, V73, P23, DOI 10.1159/000081071; Rodriguez-Antona C, 2003, MOL PHARMACOL, V63, P1180, DOI 10.1124/mol.63.5.1180; Rojkind M, 1999, ALCOHOL CLIN EXP RES, V23, P934, DOI 10.1097/00000374-199905000-00026; Rousselet N, 2004, CANCER RES, V64, P146, DOI 10.1158/0008-5472.CAN-03-1717; Ryvnyak VV, 2004, B EXP BIOL MED+, V137, P90, DOI 10.1023/B:BEBM.0000024396.17895.77; Schedel J, 2004, GENE THER, V11, P1040, DOI 10.1038/sj.gt.3302265; SCHUPPAN D, 1990, SEMIN LIVER DIS, V10, P1, DOI 10.1055/s-2008-1040452; SHAW S, 1981, J LAB CLIN MED, V98, P417; Xia Dong, 2006, Hepatobiliary Pancreat Dis Int, V5, P409	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20768	10.1371/journal.pone.0020768	http://dx.doi.org/10.1371/journal.pone.0020768			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687683	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500042
J	Zhang, HX; Ding, LN; Fang, XM; Shi, ZM; Zhang, YT; Chen, HB; Yan, XZ; Dai, JY				Zhang, Hongxia; Ding, Lina; Fang, Xuemei; Shi, Zhimin; Zhang, Yating; Chen, Hebing; Yan, Xianzhong; Dai, Jiayin			Biological Responses to Perfluorododecanoic Acid Exposure in Rat Kidneys as Determined by Integrated Proteomic and Metabonomic Studies	PLOS ONE			English	Article							PERFLUOROOCTANOIC ACID; MESSENGER-RNA; PERMEABILITY TRANSITION; PERFLUORINATED ACIDS; PATTERN-RECOGNITION; RENAL REABSORPTION; LIVER; TOXICITY; PROTEIN; METABOLISM	Background: Perfluorododecanoic acid (PFDoA) is a perfluorinated carboxylic chemical (PFC) that has broad applications and distribution in the environment. While many studies have focused on hepatotoxicity, immunotoxicity, and reproductive toxicity of PFCAs, few have investigated renal toxicity. Methodology/Principal Findings: Here, we used comparative proteomic and metabonomic technologies to provide a global perspective on renal response to PFDoA. Male rats were exposed to 0, 0.05, 0.2, and 0.5 mg/kg/day of PFDoA for 110 days. After 2-D DIGE and MALDI TOF/TOF analysis, 79 differentially expressed proteins between the control and the PFDoA treated rats (0.2 and 0.5 mg-dosed groups) were successfully identified. These proteins were mainly involved in amino acid metabolism, the tricarboxylic acid cycle, gluconeogenesis, glycolysis, electron transport, and stress response. Nuclear magnetic resonance-based metabonomic analysis showed an increase in pyruvate, lactate, acetate, choline, and a variety of amino acids in the highest dose group. Furthermore, the profiles of free amino acids in the PFDoA treated groups were investigated quantitatively by high-coverage quantitative iTRAQ-LC MS/MS, which showed levels of sarcosine, asparagine, histidine, 1-methylhistidine, Ile, Leu, Val, Trp, Tyr, Phe, Cys, and Met increased markedly in the 0.5 mg dosed group, while homocitrulline, alpha-aminoadipic acid, beta-alanine, and cystathionine decreased. Conclusion/Significance: These observations provide evidence that disorders in glucose and amino acid metabolism may contribute to PFDoA nephrotoxicity. Additionally, alpha(2u) globulin may play an important role in protecting the kidneys from PFDoA toxicity.	[Zhang, Hongxia; Ding, Lina; Fang, Xuemei; Shi, Zhimin; Zhang, Yating; Dai, Jiayin] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China; [Chen, Hebing; Yan, Xianzhong] Natl Ctr Biomed Anal, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Zhang, HX (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing, Peoples R China.	yanxz@nic.bmi.ac.cn; daijy@ioz.ac.cn	shi, zhimin/F-5416-2012; Dai, Jiayin/C-6654-2012	Dai, Jiayin/0000-0003-4908-5597	National Natural Science Foundation of China [20837004, C31025006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China (Grant # 20837004 and C31025006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alvares K, 1996, CARCINOGENESIS, V17, P311, DOI 10.1093/carcin/17.2.311; Andersen ME, 2006, TOXICOLOGY, V227, P156, DOI 10.1016/j.tox.2006.08.004; Apelberg BJ, 2007, ENVIRON SCI TECHNOL, V41, P3891, DOI 10.1021/es0700911; Bera S, 2008, FEBS J, V275, P5899, DOI 10.1111/j.1742-4658.2008.06718.x; CHAN KM, 1978, BIOCHIM BIOPHYS ACTA, V521, P333, DOI 10.1016/0005-2787(78)90275-7; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coen M, 2003, CHEM RES TOXICOL, V16, P295, DOI 10.1021/tx0256127; Cooper AJL, 2004, NEUROCHEM INT, V44, P557, DOI 10.1016/j.neuint.2003.12.002; Cui L, 2009, ARCH ENVIRON CON TOX, V56, P338, DOI 10.1007/s00244-008-9194-6; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Ding LN, 2009, J PROTEOME RES, V8, P2882, DOI 10.1021/pr9000256; *EPA OOPPATRAD, 2002, AR2261136 US EPA OOP; EXTON JH, 1972, METABOLISM, V21, P945, DOI 10.1016/0026-0495(72)90028-5; Feng JH, 2002, ANAL BIOCHEM, V301, P1, DOI 10.1006/abio.2001.5471; Fusaro G, 2002, ONCOGENE, V21, P4539, DOI 10.1038/sj.onc.1205551; Garibotto G, 2002, J RENAL NUTR, V12, P8, DOI 10.1053/jren.2002.29600; Giesy JP, 2001, ENVIRON SCI TECHNOL, V35, P1339, DOI 10.1021/es001834k; Griffin JL, 2004, CURR DRUG METAB, V5, P389, DOI 10.2174/1389200043335432; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Han X, 2005, DRUG CHEM TOXICOL, V28, P197, DOI 10.1081/DCT-200052547; Han X, 2004, DRUG CHEM TOXICOL, V27, P341, DOI 10.1081/DCT-200039725; HANHIJARVI H, 1982, P SOC EXP BIOL MED, V171, P50; Harford J. B., 1997, POSTTRANSCRIPTIONAL; He LH, 2003, J BIOL CHEM, V278, P16755, DOI 10.1074/jbc.M300153200; HOLMES E, 1994, ANAL BIOCHEM, V220, P284, DOI 10.1006/abio.1994.1339; Hundley SG, 2006, DRUG CHEM TOXICOL, V29, P137, DOI 10.1080/01480540600561361; IKEDA Y, 1983, J BIOL CHEM, V258, P9477; Jullig M, 2007, PROTEOM CLIN APPL, V1, P565, DOI 10.1002/prca.200600831; Kannan K, 2002, ENVIRON SCI TECHNOL, V36, P3210, DOI 10.1021/es020519q; Kannan K, 2002, CHEMOSPHERE, V49, P225, DOI 10.1016/S0045-6535(02)00304-1; KAWASHIMA Y, 1991, BIOCHEM PHARMACOL, V42, P1921, DOI 10.1016/0006-2952(91)90590-2; Kennedy GL, 2004, CRIT REV TOXICOL, V34, P351, DOI 10.1080/10408440490464705; Kudo N, 2002, CHEM-BIOL INTERACT, V139, P301, DOI 10.1016/S0009-2797(02)00006-6; Lau C, 2007, TOXICOL SCI, V99, P366, DOI 10.1093/toxsci/kfm128; Li CY, 2009, UROL RES, V37, P211, DOI 10.1007/s00240-009-0197-1; Mao YY, 2008, TRANSPL IMMUNOL, V19, P74, DOI 10.1016/j.trim.2008.01.006; Martin FPJ, 2007, J PROTEOME RES, V6, P1471, DOI 10.1021/pr060596a; Martin JW, 2004, ENVIRON SCI TECHNOL, V38, P373, DOI 10.1021/es034727+; Moody CA, 2002, ENVIRON SCI TECHNOL, V36, P545, DOI 10.1021/es011001+; NAGAHARA N, 1995, J BIOL CHEM, V270, P16230, DOI 10.1074/jbc.270.27.16230; Nesatyy VJ, 2007, ENVIRON SCI TECHNOL, V41, P6891, DOI 10.1021/es070561r; NEUHAUS OW, 1986, P SOC EXP BIOL MED, V182, P531; NEUHAUS OW, 1979, KIDNEY INT, V16, P409, DOI 10.1038/ki.1979.144; Nie L, 2006, BIOCHEM BIOPH RES CO, V339, P603, DOI 10.1016/j.bbrc.2005.11.055; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; ROY AK, 1976, FEBS LETT, V70, P137, DOI 10.1016/0014-5793(76)80743-0; Schaffer S, 2003, ADV EXP MED BIOL, V526, P307; Seacat AM, 2003, TOXICOLOGY, V183, P117, DOI 10.1016/S0300-483X(02)00511-5; Seacat AM, 2002, TOXICOL SCI, V68, P249, DOI 10.1093/toxsci/68.1.249; Senthilkumar K, 2007, B ENVIRON CONTAM TOX, V79, P427, DOI 10.1007/s00128-007-9243-2; Shipley JM, 2004, TOXICOL SCI, V80, P151, DOI 10.1093/toxsci/kfh130; Smithwick M, 2006, ENVIRON SCI TECHNOL, V40, P1139, DOI 10.1021/es051750h; Son HY, 2008, ARCH TOXICOL, V82, P239, DOI 10.1007/s00204-007-0246-x; Thompson WE, 2001, ENDOCRINOLOGY, V142, P4076, DOI 10.1210/en.142.9.4076; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Waters NJ, 2002, BIOCHEM PHARMACOL, V64, P67, DOI 10.1016/S0006-2952(02)01016-X; Willker W, 1998, MAGN RESON CHEM, V36, pS79, DOI 10.1002/(SICI)1097-458X(199806)36:13<S79::AID-OMR294>3.3.CO;2-Q; Witzmann FA, 1996, FUND APPL TOXICOL, V31, P124, DOI 10.1006/faat.1996.0083; Zamzami N, 2005, CELL DEATH DIFFER, V12, P1478, DOI 10.1038/sj.cdd.4401682; Zhang H, 2008, TOXICOL APPL PHARM, V227, P16, DOI 10.1016/j.taap.2007.09.026	62	28	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20862	10.1371/journal.pone.0020862	http://dx.doi.org/10.1371/journal.pone.0020862			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677784	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500047
J	Ermak, G; Pritchard, MA; Dronjak, S; Niu, B; Davies, KJA				Ermak, Gennady; Pritchard, Melanie A.; Dronjak, Sladjana; Niu, Brenda; Davies, Kelvin J. A.			Do RCAN1 proteins link chronic stress with neurodegeneration?	FASEB JOURNAL			English	Article						glucocorticoids; tau	AMYOTROPHIC-LATERAL-SCLEROSIS; SYNDROME CRITICAL REGION-1; ALZHEIMERS-DISEASE; DOWN-SYNDROME; OXIDATIVE STRESS; RAT-BRAIN; DSCR1 ADAPT78; TAU-PROTEIN; CALCINEURIN; EXPRESSION	It has long been suspected that chronic stress can exacerbate, or even cause, disease. We now propose that the RCAN1 gene, which can generate several RCAN1 protein isoforms, may be at least partially responsible for this phenomenon. We review data showing that RCAN1 proteins can be induced by multiple stresses, and present new data also implicating psychosocial/emotional stress in RCAN1 induction. We further show that transgenic mice overexpressing the RCAN1-1L protein exhibit accumulation of hyperphosphorylated tau protein (AT8 antibody), an early precursor to the formation of neurofibrillary tangles and neurodegeneration of the kind seen in Alzheimer disease. We propose that, although transient induction of the RCAN1 gene might protect cells against acute stress, persistent stress may cause chronic RCAN1 overexpression, resulting in serious side effects. Chronically elevated levels of RCAN1 proteins may promote or exacerbate various diseases, including tauopathies such as Alzheimer disease. We propose that the mechanism by which stress can lead to these diseases involves the inhibition of calcineurin and the induction of GSK-3 beta by RCAN1 proteins. Both inhibition of calcineurin and induction of GSK-3 beta contribute to accumulation of phosphorylated tau, formation of neurofibrillary tangles, and eventual neurodegeneration.-Ermak, G., Pritchard, M. A., Dronjak, S., Niu, B., Davies, K. J. A. Do RCAN1 proteins link chronic stress with neurodegeneration? FASEB J. 25, 3306-3311 (2011). www.fasebj.org	[Ermak, Gennady; Niu, Brenda; Davies, Kelvin J. A.] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Davis Sch Gerontol, Los Angeles, CA 90089 USA; [Ermak, Gennady; Niu, Brenda; Davies, Kelvin J. A.] Univ So Calif, Div Mol & Computat Biol, Dornsife Coll Letters Arts & Sci, Los Angeles, CA 90089 USA; [Pritchard, Melanie A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Dronjak, Sladjana] Inst Nucl Sci Vinca, Lab Mol Biol & Endocrinol, Belgrade, Serbia	University of Southern California; University of Southern California; Monash University; University of Belgrade	Davies, KJA (corresponding author), Univ So Calif, Andrus Gerontol Ctr, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	kelvin@usc.edu		Davies, Kelvin/0000-0001-7790-3003; Dronjak Cucakovic, Sladjana/0000-0002-4334-8002	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES003598, R01ES003598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG016256] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG016256] Funding Source: Medline; NIEHS NIH HHS [R56 ES003598, R01 ES003598] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Chang KT, 2005, NAT NEUROSCI, V8, P1577, DOI 10.1038/nn1564; Chang KT, 2003, P NATL ACAD SCI USA, V100, P15794, DOI 10.1073/pnas.2536696100; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Cho YJ, 2005, ARCH BIOCHEM BIOPHYS, V439, P121, DOI 10.1016/j.abb.2005.05.002; Clausen H, 2005, BRIT J SPORT MED, V39, P661, DOI 10.1136/bjsm.2004.017046; Cook CN, 2005, J ALZHEIMERS DIS, V8, P63; Crawford DR, 1997, ARCH BIOCHEM BIOPHYS, V342, P6, DOI 10.1006/abbi.1997.0109; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2006, FEBS J, V273, P2100, DOI 10.1111/j.1742-4658.2006.05217.x; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; FUENTES JJ, 1995, HUM MOL GENET, V4, P1935, DOI 10.1093/hmg/4.10.1935; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Garver TD, 1999, MOL PHARMACOL, V55, P632; Gavrilovic L, 2010, NEUROIMMUNOMODULAT, V17, P265, DOI 10.1159/000290042; GOLDKUHL R, EUR SURG RES, V44, P117; GOTO S, 1986, BRAIN RES, V397, P161, DOI 10.1016/0006-8993(86)91381-8; GRAVES AB, 1990, AM J EPIDEMIOL, V131, P491, DOI 10.1093/oxfordjournals.aje.a115523; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Harris CD, 2007, FEBS J, V274, P1715, DOI 10.1111/j.1742-4658.2007.05717.x; Hirakawa Yasuko, 2009, J Mol Signal, V4, P6, DOI 10.1186/1750-2187-4-6; Iqbal K, 2008, J CELL MOL MED, V12, P38, DOI 10.1111/j.1582-4934.2008.00225.x; Jeong YH, 2006, FASEB J, V20, P729, DOI 10.1096/fj.05-4265fje; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Kayyali US, 1997, J NEUROCHEM, V68, P1668; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; KORNEYEV A, 1995, NEUROSCI LETT, V191, P19, DOI 10.1016/0304-3940(95)11546-3; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Ladner CJ, 1996, J NEUROPATH EXP NEUR, V55, P924, DOI 10.1097/00005072-199608000-00008; Martinez A, 2008, J ALZHEIMERS DIS, V15, P181; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; Michtalik HJ, 2004, FREE RADICAL BIO MED, V37, P454, DOI 10.1016/j.freeradbiomed.2004.05.014; Morsch R, 1999, J NEUROPATH EXP NEUR, V58, P188, DOI 10.1097/00005072-199902000-00008; Papasozomenos SC, 1996, J NEUROCHEM, V66, P1140; Piazza O, 2004, CURR MED RES OPIN, V20, P505, DOI 10.1185/030079904125003296; Poppek D, 2006, BIOCHEM J, V400, P511, DOI 10.1042/BJ20060463; Porta S, 2007, HUM MOL GENET, V16, P1039, DOI 10.1093/hmg/ddm049; U M, 2004, LEUKEMIA, V18, P1850, DOI 10.1038/sj.leu.2403516; Wang YL, 2002, AM J PHYSIOL-HEART C, V283, pH533, DOI 10.1152/ajpheart.00002.2002; Wilson RS, 2005, NEUROLOGY, V64, P380, DOI 10.1212/01.WNL.0000149525.53525.E7; WOON FL, PROG NEUROPSYCHOPHAR, V34, P1181; Xie HQ, 1998, J NEUROSCI RES, V53, P153, DOI 10.1002/(SICI)1097-4547(19980715)53:2<153::AID-JNR4>3.3.CO;2-5; Yanagisawa M, 1999, FEBS LETT, V461, P329, DOI 10.1016/S0014-5793(99)01480-5	44	35	35	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3306	3311		10.1096/fj.11-185728	http://dx.doi.org/10.1096/fj.11-185728			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21680892	Green Published, Green Submitted			2022-12-25	WOS:000295356400003
J	Chinthalapudi, K; Taft, MH; Martin, R; Heissler, SM; Preller, M; Hartmann, FK; Brandstaetter, H; Kendrick-Jones, J; Tsiavaliaris, G; Gutzeit, HO; Fedorov, R; Buss, F; Knolker, HJ; Coluccio, LM; Manstein, DJ				Chinthalapudi, Krishna; Taft, Manuel H.; Martin, Rene; Heissler, Sarah M.; Preller, Matthias; Hartmann, Falk K.; Brandstaetter, Hemma; Kendrick-Jones, John; Tsiavaliaris, Georgios; Gutzeit, Herwig O.; Fedorov, Roman; Buss, Folma; Knoelker, Hans-Joachim; Coluccio, Lynne M.; Manstein, Dietmar J.			Mechanism and Specificity of Pentachloropseudilin-mediated Inhibition of Myosin Motor Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; DICTYOSTELIUM; AFFINITY; DOMAIN	Here, we report that the natural compound pentachloropseudilin (PClP) acts as a reversible and allosteric inhibitor of myosin ATPase and motor activity. IC50 values are in the range from 1 to 5 mu M for mammalian class-1 myosins and greater than 90 mu M for class-2 and class-5 myosins, and no inhibition was observed with class-6 and class-7 myosins. We show that in mammalian cells, PClP selectively inhibits myosin-1c function. To elucidate the structural basis for PClP-induced allosteric coupling and isoform-specific differences in the inhibitory potency of the compound, we used a multifaceted approach combining direct functional, crystallographic, and in silico modeling studies. Our results indicate that allosteric inhibition by PClP is mediated by the combined effects of global changes in protein dynamics and direct communication between the catalytic and allosteric sites via a cascade of small conformational changes along a conserved communication pathway.	[Chinthalapudi, Krishna; Preller, Matthias; Fedorov, Roman; Manstein, Dietmar J.] Hannover Med Sch, Res Ctr Struct Anal, OE8830, D-30623 Hannover, Germany; [Taft, Manuel H.; Heissler, Sarah M.; Hartmann, Falk K.; Tsiavaliaris, Georgios; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE4350, D-30623 Hannover, Germany; [Martin, Rene; Knoelker, Hans-Joachim] Tech Univ Dresden, Dept Chem, D-01069 Dresden, Germany; [Brandstaetter, Hemma; Buss, Folma] Univ Cambridge, Cambridge Inst Med Res, Dept Clin Biochem, Wellcome Trust Med Res Council MRC, Cambridge CB2 0XY, England; [Kendrick-Jones, John] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Gutzeit, Herwig O.] Tech Univ Dresden, Dept Biol, D-01217 Dresden, Germany; [Coluccio, Lynne M.] Boston Biomed Res Inst, Watertown, MA 02472 USA	Hannover Medical School; Hannover Medical School; Technische Universitat Dresden; University of Cambridge; MRC Laboratory Molecular Biology; Technische Universitat Dresden; Boston Biomedical Research Institute	Manstein, DJ (corresponding author), Hannover Med Sch, Inst Biophys Chem, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manstein.dietmar@mh-hannover.de	Taft, Manuel/O-1396-2019; Manstein, Dietmar J./AAG-2640-2019; Manstein, Dietmar J. J/M-1034-2013; Preller, Matthias/P-1176-2016; Taft, Manuel H/T-2508-2017; Knölker, Hans-Joachim/I-4954-2019; Chinthalapudi, Krishna/B-4550-2018	Taft, Manuel/0000-0001-5853-8629; Manstein, Dietmar J./0000-0003-0763-0147; Manstein, Dietmar J. J/0000-0003-0763-0147; Preller, Matthias/0000-0002-7784-4012; Taft, Manuel H/0000-0001-5853-8629; Knölker, Hans-Joachim/0000-0002-9631-5239; Buss, Folma/0000-0003-4457-3479; Chinthalapudi, Krishna/0000-0003-3669-561X; Fedorov, Roman/0000-0002-5240-4205	Deutsche Forschungsgemeinschaft (DFG) [MA 1081/16-1]; Cluster of Excellence "Rebirth"; Fonds der Chemischen Industrie; Wellcome Trust; National Institutes of Health [DC008793]; Medical Research Council; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC008793, R01DC008793] Funding Source: NIH RePORTER; MRC [MC_U105184323] Funding Source: UKRI; Medical Research Council [MC_U105184323] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cluster of Excellence "Rebirth"; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Wellcome Trust(Wellcome Trust); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant MA 1081/16-1 and the Cluster of Excellence "Rebirth" (to D. J. M.), Fonds der Chemischen Industrie (to D. J. M. and H.-J. K.), a Wellcome Trust University Award (to F. B.), a Wellcome Trust Studentship (to H. B.), National Institutes of Health Grant DC008793 (to L. M. C.), and the Medical Research Council (J. K.-J.).	Adamek N, 2008, P NATL ACAD SCI USA, V105, P5710, DOI 10.1073/pnas.0710520105; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheung A, 2002, NAT CELL BIOL, V4, P83, DOI 10.1038/ncb734; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Fedorov R, 2009, NAT STRUCT MOL BIOL, V16, P80, DOI 10.1038/nsmb.1542; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Gulick AM, 2000, J BIOL CHEM, V275, P398, DOI 10.1074/jbc.275.1.398; Gulick AM, 1997, BIOCHEMISTRY-US, V36, P11619, DOI 10.1021/bi9712596; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; MANSTEIN DJ, 1995, J MUSCLE RES CELL M, V16, P325, DOI 10.1007/BF00121141; Martin R, 2009, ANGEW CHEM INT EDIT, V48, P8042, DOI 10.1002/anie.200903743; Perreault-Micale C, 2000, J BIOL CHEM, V275, P21618, DOI 10.1074/jbc.M000363200; Poupon V, 2003, MOL BIOL CELL, V14, P4015, DOI 10.1091/mbc.E03-01-0040; Preller M, 2011, J MED CHEM, V54, P3675, DOI 10.1021/jm200259f; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; Walsh DP, 2006, CHEM REV, V106, P2476, DOI 10.1021/cr0404141	25	48	49	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29700	29708		10.1074/jbc.M111.239210	http://dx.doi.org/10.1074/jbc.M111.239210			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21680745	Green Published, hybrid			2022-12-25	WOS:000294046600029
J	Wolf-Ringwall, AL; Winter, PW; Liu, JJ; Van Orden, AK; Roess, DA; Barisas, G				Wolf-Ringwall, Amber L.; Winter, Peter W.; Liu, Jingjing; Van Orden, Alan K.; Roess, Deborah A.; Barisas, George			Restricted Lateral Diffusion of Luteinizing Hormone Receptors in Membrane Microdomains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; HUMAN CHORIONIC-GONADOTROPIN; RESONANCE ENERGY-TRANSFER; SINGLE-PARTICLE TRACKING; PHOTON-COUNTING HISTOGRAM; HUMAN LUTROPIN RECEPTOR; CELL PLASMA-MEMBRANE; LH RECEPTORS; CYTOCHALASIN-D; LUTEAL CELLS	Single particle tracking was used to evaluate lateral motions of individual FLAG-tagged human luteinizing hormone (LH) receptors expressed on CHO cells and native LH receptors on both KGN human granulosa-derived tumor cells and M17 human neuroblastoma cells before and after exposure to human chorionic gonadotropin (hCG). Compared with LH receptors on untreated cells, LH receptors on cells treated with 100 nM hCG exhibit restricted lateral diffusion and are confined in small, nanometer-scale, membrane compartments. Similar to LH receptors labeled with Au-hCG, LH receptors labeled with gold-deglycosylated hCG, an hCG antagonist, also exhibit restricted lateral diffusion and are confined in nanoscale membrane compartments on KGN cells treated with 100 nM hCG. LH receptor point mutants lacking potential palmitoylation sites remain in large compartments despite treatment with 100 nM hCG as do LH receptors on cells treated with cytochalasin D. Finally, both polarization homotransfer fluorescence resonance energy transfer imaging and photon counting histogram analysis indicate that treatment with hCG induces aggregation of YFP-coupled LH receptors stably expressed on CHO cells. Taken together, our results demonstrate that binding of hCG induces aggregation of LH receptors within nanoscale, cell surface membrane compartments, that hCG binding also affects the lateral motions of antagonist binding LH receptors, and that receptor surface densities must be considered in evaluating the extent of hormone-dependent receptor aggregation.	[Van Orden, Alan K.; Barisas, George] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Wolf-Ringwall, Amber L.; Roess, Deborah A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Winter, Peter W.; Roess, Deborah A.; Barisas, George] Colorado State Univ, Cell & Mol Biol Program, Ft Collins, CO 80523 USA; [Liu, Jingjing] Tufts Med Ctr, Boston, MA 02111 USA	Colorado State University; Colorado State University; Colorado State University; Tufts Medical Center	Barisas, G (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.	barisas@lamar.colostate.edu	Van Orden, Alan K/N-4219-2015		National Institutes of Health [HD41980]; U.S. Department of Agriculture Animal Health and Disease at Colorado State University; National Science Foundation [MCB-1024669, CHE-0628260]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD041980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Agriculture Animal Health and Disease at Colorado State University; National Science Foundation(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by National Institutes of Health Grant HD41980 (to D. A. R.), the U.S. Department of Agriculture Animal Health and Disease Program at Colorado State University (to D. A. R.), and National Science Foundation Grants MCB-1024669 (to B. G. B.) and CHE-0628260.	AMSTERDAM A, 1980, P NATL ACAD SCI-BIOL, V77, P3440, DOI 10.1073/pnas.77.6.3440; Bader AN, 2011, CHEMPHYSCHEM, V12, P475, DOI 10.1002/cphc.201000801; Barisas BG, 2007, BIOPHYS CHEM, V126, P209, DOI 10.1016/j.bpc.2006.05.026; Barron AM, 2010, ENDOCRINOLOGY, V151, P5380, DOI 10.1210/en.2009-1168; Bowen RL, 2004, J BIOL CHEM, V279, P20539, DOI 10.1074/jbc.M311993200; Brameshuber M, 2010, J BIOL CHEM, V285, P41765, DOI 10.1074/jbc.M110.182121; CASELLA JF, 1981, NATURE, V293, P302, DOI 10.1038/293302a0; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chen Y, 2009, CHEM-EUR J, V15, P5327, DOI 10.1002/chem.200802305; Chu YW, 1999, CYTOMETRY, V36, P333, DOI 10.1002/(SICI)1097-0320(19990801)36:4<333::AID-CYTO8>3.0.CO;2-F; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Dacres H, 2010, ANAL CHEM, V82, P432, DOI 10.1021/ac9022956; Daumas F, 2003, BIOPHYS J, V84, P356, DOI 10.1016/S0006-3495(03)74856-5; Day CA, 2009, BBA-BIOMEMBRANES, V1788, P245, DOI 10.1016/j.bbamem.2008.10.024; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; DRAGSTEN P, 1979, P NATL ACAD SCI USA, V76, P5163, DOI 10.1073/pnas.76.10.5163; DUNKEL L, 1993, ENDOCRINOLOGY, V132, P763, DOI 10.1210/en.132.2.763; Ganguly S, 2011, BIOPHYS J, V100, P361, DOI 10.1016/j.bpj.2010.12.3692; Guan RB, 2009, J BIOL CHEM, V284, P7483, DOI 10.1074/jbc.M809150200; Horvat RD, 2001, MOL ENDOCRINOL, V15, P534, DOI 10.1210/me.15.4.534; Horvat RD, 1999, BIOCHEM BIOPH RES CO, V255, P382, DOI 10.1006/bbrc.1999.0185; Hunzicker-Dunn M, 2003, J BIOL CHEM, V278, P42744, DOI 10.1074/jbc.M306133200; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; Ji IH, 2002, MOL ENDOCRINOL, V16, P1299, DOI 10.1210/me.16.6.1299; Jin H, 1997, EUR J PHARMACOL, V324, P109, DOI 10.1016/S0014-2999(97)00059-9; Jung JY, 2006, J AM CHEM SOC, V128, P1240, DOI 10.1021/ja0560736; KAWATE N, 1994, J BIOL CHEM, V269, P30651; Kusumi A, 2010, FEBS LETT, V584, P1814, DOI 10.1016/j.febslet.2010.02.047; Lei Y, 2005, BIOCHEM BIOPH RES CO, V337, P430, DOI 10.1016/j.bbrc.2005.09.066; Lei Y, 2007, MOL CELL ENDOCRINOL, V260, P65, DOI 10.1016/j.mce.2005.11.046; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; LUBORSKY JL, 1984, ENDOCRINOLOGY, V115, P2217, DOI 10.1210/endo-115-6-2217; LUBORSKY JL, 1979, MOL CELL ENDOCRINOL, V15, P61, DOI 10.1016/0303-7207(79)90008-X; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; NISWENDER GD, 1985, ENDOCRINOLOGY, V116, P164, DOI 10.1210/endo-116-1-164; Perroud TD, 2003, CHEMPHYSCHEM, V4, P1121, DOI 10.1002/cphc.200300824; Ponimaskin EG, 2002, J BIOL CHEM, V277, P2534, DOI 10.1074/jbc.M106529200; Puett D, 1996, MOL CELL ENDOCRINOL, V125, P55, DOI 10.1016/S0303-7207(96)03954-8; Rao M, 2005, BBA-MOL CELL RES, V1746, P221, DOI 10.1016/j.bbamcr.2005.08.002; Ries J, 2008, PHYS CHEM CHEM PHYS, V10, P3487, DOI 10.1039/b718132a; Ritchie K, 2003, MOL MEMBR BIOL, V20, P13, DOI 10.1080/0968768021000055698; ROESS DA, 1988, ENDOCRINOLOGY, V122, P261, DOI 10.1210/endo-122-1-261; Roess DA, 2003, BIOL REPROD, V69, P1765, DOI 10.1095/biolreprod.103.018846; ROESS DA, 1992, BIOCHIM BIOPHYS ACTA, V1137, P309, DOI 10.1016/0167-4889(92)90151-Z; Roess DA, 1997, BBA-MOL CELL RES, V1357, P98, DOI 10.1016/S0167-4889(97)00019-0; Roess DA, 2000, BBA-BIOMEMBRANES, V1464, P242, DOI 10.1016/S0005-2736(00)00159-0; Roess DA, 2000, ENDOCRINOLOGY, V141, P4518, DOI 10.1210/en.141.12.4518; Ruan QQ, 2002, BIOPHYS J, V83, P3177, DOI 10.1016/S0006-3495(02)75320-4; SAIRAM MR, 1983, J BIOL CHEM, V258, P445; SAKO Y, 1994, J CELL BIOL, V125, P1251, DOI 10.1083/jcb.125.6.1251; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Saxton MJ, 1997, BIOPHYS J, V72, P1744, DOI 10.1016/S0006-3495(97)78820-9; Schulze C, 2009, CELL MOTIL CYTOSKEL, V66, P193, DOI 10.1002/cm.20341; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Smith SML, 2006, ENDOCRINOLOGY, V147, P1789, DOI 10.1210/en.2005-1046; Szidonya L, 2008, J ENDOCRINOL, V196, P435, DOI 10.1677/JOE-07-0573; Tao YX, 2004, J BIOL CHEM, V279, P5904, DOI 10.1074/jbc.M311162200; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Zeng HW, 2001, J BIOL CHEM, V276, P3451, DOI 10.1074/jbc.M007488200	61	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29818	29827		10.1074/jbc.M111.250969	http://dx.doi.org/10.1074/jbc.M111.250969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21690095	Green Published, hybrid			2022-12-25	WOS:000294046600041
J	Ferreira, JS; Rooyakkers, A; She, K; Ribeiro, L; Carvalho, AL; Craig, AM				Ferreira, Joana S.; Rooyakkers, Amanda; She, Kevin; Ribeiro, Luis; Carvalho, Ana Luisa; Craig, Ann Marie			Activity and Protein Kinase C Regulate Synaptic Accumulation of N-Methyl-D-aspartate (NMDA) Receptors Independently of GluN1 Splice Variant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CULTURED HIPPOCAMPAL-NEURONS; ER RETENTION SIGNAL; NR1 SUBUNIT; SURFACE EXPRESSION; TERMINAL DOMAIN; MESSENGER-RNA; RAT-BRAIN; TRAFFICKING; PHOSPHORYLATION; SYNAPSES	NMDA receptors are calcium-permeable ionotropic receptors that detect coincident glutamate binding and membrane depolarization and are essential for many forms of synaptic plasticity in the mammalian brain. The obligatory GluN1 subunit of NMDA receptors is alternatively spliced at multiple sites, generating forms that vary in N-terminal N1 and C-terminal C1, C2, and C2' cassettes. Based on expression of GluN1 constructs in heterologous cells and in wild type neurons, the prevalent view is that the C-terminal cassettes regulate synaptic accumulation and its modulation by homeostatic activity blockade and by protein kinase C (PKC). Here, we tested the role of GluN1 splicing in regulated synaptic accumulation of NMDA receptors by lentiviral expression of individual GluN1 splice variants in hippocampal neurons cultured from GluN1 (-/-) mice. High efficiency transduction of GluN1 at levels similar to endogenous was achieved. Under control conditions, the C2' cassette mediated enhanced synaptic accumulation relative to the alternate C2 cassette, whereas the presence or absence of N1 or C1 had no effect. Surprisingly all GluN1 splice variants showed > 2-fold increased synaptic accumulation with chronic blockade of NMDA receptor activity. Furthermore, in this neuronal rescue system, all GluN1 splice variants were equally rapidly dispersed upon activation of PKC. These results indicate that the major mechanisms mediating homeostatic synaptic accumulation and PKC dispersal of NMDA receptors occur independently of GluN1 splice isoform.	[Ferreira, Joana S.; Ribeiro, Luis; Carvalho, Ana Luisa] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Ferreira, Joana S.; Ribeiro, Luis; Carvalho, Ana Luisa] Univ Coimbra, Dept Life Sci, P-3004517 Coimbra, Portugal; [Rooyakkers, Amanda; She, Kevin; Craig, Ann Marie] Univ British Columbia, Brain Res Ctr, Vancouver, BC V6T 2B5, Canada; [Rooyakkers, Amanda; She, Kevin; Craig, Ann Marie] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 2B5, Canada	Universidade de Coimbra; Universidade de Coimbra; University of British Columbia; University of British Columbia	Carvalho, AL (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.	alc@cnc.uc.pt; amcraig@interchange.ubc.ca	Craig, Ann Marie/M-2054-2014; Ferreira, Joana/AAY-8702-2020; Carvalho, Ana Luisa/K-6367-2013; Ribeiro, Luís Filipe/U-3826-2017; Ferreira, Joana/I-9447-2014	Ferreira, Joana/0000-0002-1049-8063; Carvalho, Ana Luisa/0000-0001-8368-6666; Ribeiro, Luís Filipe/0000-0003-1790-6848; Ferreira, Joana/0000-0002-1049-8063	Canadian Institutes of Health Research (CIHR) [MOP-69096]; Portuguese Foundation for Science and Technology (FCT) [PTDC/BIA-BCM/71789/2006, PTDC/SAU-NEU/099440/2008]; Canada Research Chair; Michael Smith Foundation; FCT [(SFRH/BD/37522/2007, SFRH/BD/47879/2008]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Michael Smith Foundation(Michael Smith Foundation for Health Research); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by the Canadian Institutes of Health Research (CIHR) MOP-69096 (to A. M. C.), by the Portuguese Foundation for Science and Technology (FCT) PTDC/BIA-BCM/71789/2006 and PTDC/SAU-NEU/099440/2008 (to A. L. C.), and by salary awards CIHR Frederick Banting and Charles Best Canada Graduate Scholarship (to K. S.), Canada Research Chair and Michael Smith Foundation for Health Research Senior Scholarship (to A. M. C.), and FCT Graduate Scholarships (SFRH/BD/37522/2007, to J. S. F. and SFRH/BD/47879/2008, to L. R.).	Al-Hallaq RA, 2001, J NEUROCHEM, V77, P110, DOI 10.1046/j.1471-4159.2001.t01-1-00210.x; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Blahos J, 1996, J BIOL CHEM, V271, P15669, DOI 10.1074/jbc.271.26.15669; Bradley J, 2006, J NEUROSCI, V26, P1065, DOI 10.1523/JNEUROSCI.3347-05.2006; Caldeira MV, 2007, MOL CELL NEUROSCI, V35, P208, DOI 10.1016/j.mcn.2007.02.019; Chung HJ, 2004, J NEUROSCI, V24, P10248, DOI 10.1523/JNEUROSCI.0546-04.2004; Crump FT, 2001, J NEUROSCI, V21, P5079, DOI 10.1523/JNEUROSCI.21-14-05079.2001; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; DURAND GM, 1992, P NATL ACAD SCI USA, V89, P9359, DOI 10.1073/pnas.89.19.9359; Ehlers MD, 1998, J NEUROSCI, V18, P720; EHLERS MD, 1995, SCIENCE, V269, P1734, DOI 10.1126/science.7569904; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Fong DK, 2002, J NEUROSCI, V22, P2153, DOI 10.1523/JNEUROSCI.22-06-02153.2002; FORREST D, 1994, NEURON, V13, P325, DOI 10.1016/0896-6273(94)90350-6; Gomes AR, 2008, MOL CELL NEUROSCI, V37, P323, DOI 10.1016/j.mcn.2007.10.008; Goslin K., 1998, CULTURING NERVE CELL, P339; Hall RA, 1997, J BIOL CHEM, V272, P4135, DOI 10.1074/jbc.272.7.4135; Hawkins LM, 2004, J BIOL CHEM, V279, P28903, DOI 10.1074/jbc.M402599200; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lau CG, 2010, J NEUROSCI, V30, P242, DOI 10.1523/JNEUROSCI.4933-08.2010; LAURIE DJ, 1994, J NEUROSCI, V14, P3180; Leonard AS, 1997, J BIOL CHEM, V272, P12107, DOI 10.1074/jbc.272.18.12107; Liao DZ, 2001, J NEUROSCI, V21, P6008, DOI 10.1523/JNEUROSCI.21-16-06008.2001; Manadas B, 2009, J PROTEOME RES, V8, P4536, DOI 10.1021/pr900366x; MCBAIN CJ, 1994, PHYSIOL REV, V74, P723, DOI 10.1152/physrev.1994.74.3.723; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MORIYOSHI K, 1991, NATURE, V354, P31, DOI 10.1038/354031a0; Mu YY, 2003, NEURON, V40, P581, DOI 10.1016/S0896-6273(03)00676-7; Okabe S, 1999, J NEUROSCI, V19, P7781; Perez-Otano I, 2005, TRENDS NEUROSCI, V28, P229, DOI 10.1016/j.tins.2005.03.004; Petralia RS, 2010, NEUROSCIENCE, V167, P68, DOI 10.1016/j.neuroscience.2010.01.022; Rao A, 1998, J NEUROSCI, V18, P1217; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Scott DB, 2001, J NEUROSCI, V21, P3063, DOI 10.1523/JNEUROSCI.21-09-03063.2001; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Standley S, 2000, NEURON, V28, P887, DOI 10.1016/S0896-6273(00)00161-6; Stephenson FA, 2008, MOL MEMBR BIOL, V25, P311, DOI 10.1080/09687680801971367; TINGLEY WG, 1993, NATURE, V364, P70, DOI 10.1038/364070a0; Tingley WG, 1997, J BIOL CHEM, V272, P5157, DOI 10.1074/jbc.272.8.5157; Traynelis SF, 1998, J NEUROSCI, V18, P6163; TRAYNELIS SF, 1995, SCIENCE, V268, P873, DOI 10.1126/science.7754371; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; Westphal RS, 1999, SCIENCE, V285, P93, DOI 10.1126/science.285.5424.93; Xie JY, 2001, NATURE, V410, P936, DOI 10.1038/35073593; Zhang J, 2009, J NEUROSCI, V29, P4274, DOI 10.1523/JNEUROSCI.5602-08.2009; ZUKIN RS, 1995, TRENDS NEUROSCI, V18, P306, DOI 10.1016/0166-2236(95)93920-S	53	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28331	28342		10.1074/jbc.M111.222539	http://dx.doi.org/10.1074/jbc.M111.222539			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676872	Green Published, hybrid			2022-12-25	WOS:000293557800050
J	Murakami, M; Giampietro, C; Giannotta, M; Corada, M; Torselli, I; Orsenigo, F; Cocito, A; d'Ario, G; Mazzarol, G; Confalonieri, S; Di Fiore, PP; Dejana, E				Murakami, Masato; Giampietro, Costanza; Giannotta, Monica; Corada, Monica; Torselli, Ilaria; Orsenigo, Fabrizio; Cocito, Andrea; d'Ario, Giovanni; Mazzarol, Giovanni; Confalonieri, Stefano; Di Fiore, Pier Paolo; Dejana, Elisabetta			Abrogation of Junctional Adhesion Molecule-A Expression Induces Cell Apoptosis and Reduces Breast Cancer Progression	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VE-CADHERIN; INFLAMMATION; HOMEOSTASIS; CARCINOMA; MOTILITY; DISEASE; TUMORS	Intercellular junctions promote homotypic cell to cell adhesion and transfer intracellular signals which control cell growth and apoptosis. Junctional adhesion molecule-A (JAM-A) is a transmembrane immunoglobulin located at tight junctions of normal epithelial cells of mammary ducts and glands. In the present paper we show that JAM-A acts as a survival factor for mammary carcinoma cells. JAM-A null mice expressing Polyoma Middle T under MMTV promoter develop significantly smaller mammary tumors than JAM-A positive mice. Angiogenesis and inflammatory or immune infiltrate were not statistically modified in absence of JAM-A but tumor cell apoptosis was significantly increased. Tumor cells isolated from JAM-A null mice or 4T1 cells incubated with JAM-A blocking antibodies showed reduced growth and increased apoptosis which paralleled altered junctional architecture and adhesive function. In a breast cancer clinical data set, tissue microarray data show that JAM-A expression correlates with poor prognosis. Gene expression analysis of mouse tumor samples showed a correlation between genes enriched in human G3 tumors and genes over expressed in JAM-A +/+ mammary tumors. Conversely, genes enriched in G1 human tumors correlate with genes overexpressed in JAM-A-/- tumors. We conclude that down regulation of JAM-A reduces tumor aggressive behavior by increasing cell susceptibility to apoptosis. JAM-A may be considered a negative prognostic factor and a potential therapeutic target.	[Murakami, Masato; Giampietro, Costanza; Giannotta, Monica; Corada, Monica; Torselli, Ilaria; Orsenigo, Fabrizio; Cocito, Andrea; d'Ario, Giovanni; Mazzarol, Giovanni; Confalonieri, Stefano; Di Fiore, Pier Paolo; Dejana, Elisabetta] Fdn FIRC Inst Mol Oncol, IFOM, Milan, Italy; [Dejana, Elisabetta] Univ Milan, Dept Biomol Sci & Biotechnol, Sch Sci, Milan, Italy; [Di Fiore, Pier Paolo] Univ Milan, Dept Med Surg & Odontoiatr, Sch Med, Milan, Italy; [Di Fiore, Pier Paolo] European Inst Oncol, Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Milan; IRCCS European Institute of Oncology (IEO)	Murakami, M (corresponding author), Fdn FIRC Inst Mol Oncol, IFOM, Milan, Italy.	elisabetta.dejana@ifom-ieo-campus.it	Giampietro, Costanza/D-4643-2016; Dejana, Elisabetta/A-6274-2016; Confalonieri, Stefano/AAQ-6786-2020; Di Fiore, Pier Paolo/K-2130-2012	Giampietro, Costanza/0000-0001-5229-3835; Confalonieri, Stefano/0000-0001-6886-9851; Di Fiore, Pier Paolo/0000-0002-2252-0950; DEJANA, ELISABETTA/0000-0002-0007-0426; Orsenigo, Fabrizio/0000-0001-9135-8478; Corada, Monica/0000-0001-8220-0871	Associazione Italiana per la Ricerca sul Cancro; Association for International Cancer Research; European Community [202213, 223098, NMP3-LA-2008-214402]; European Research Council; Italian Ministries of Education-University-Research (MIUR) of Health; Cariplo Foundation; Fondation Leducq Transatlantic Network of Excellence; Ferrari Foundation; Monzino Foundation	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Association for International Cancer Research; European Community(European Commission); European Research Council(European Research Council (ERC)European Commission); Italian Ministries of Education-University-Research (MIUR) of Health(Ministry of Education, Universities and Research (MIUR)); Cariplo Foundation(Fondazione Cariplo); Fondation Leducq Transatlantic Network of Excellence(Leducq Foundation); Ferrari Foundation; Monzino Foundation	Associazione Italiana per la Ricerca sul Cancro, Association for International Cancer Research, European Community (EUSTROKE contract202213, OPTISTEM contract223098, ANGIOSCAFF NMP3-LA-2008-214402, ENDOSTEM and JUSTBRAIN), European Research Council, Italian Ministries of Education-University-Research (MIUR) and of Health, Cariplo Foundation, Fondation Leducq Transatlantic Network of Excellence, Ferrari Foundation, Monzino Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzoni G, 2005, J CELL SCI, V118, P623, DOI 10.1242/jcs.01661; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Cera MR, 2009, J CELL SCI, V122, P268, DOI 10.1242/jcs.037127; Cera MR, 2004, J CLIN INVEST, V114, P729, DOI 10.1172/JCI200421231; Confalonieri S, 2009, ONCOGENE, V28, P2959, DOI 10.1038/onc.2009.156; Corada M, 2005, P NATL ACAD SCI USA, V102, P10634, DOI 10.1073/pnas.0500147102; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Gutwein P, 2009, BIOCHEM BIOPH RES CO, V380, P387, DOI 10.1016/j.bbrc.2009.01.100; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Iurlaro M, 2004, AM J PATHOL, V165, P181, DOI 10.1016/S0002-9440(10)63287-7; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Laukoetter MG, 2007, J EXP MED, V204, P3067, DOI 10.1084/jem.20071416; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu Y, 2000, J CELL SCI, V113, P2363; Mandell KJ, 2005, J BIOL CHEM, V280, P11665, DOI 10.1074/jbc.M412650200; McSherry EA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2853; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Murakami M, 2006, BLOOD, V108, P1849, DOI 10.1182/blood-2006-04-016030; Murakami M, 2010, CANCER RES, V70, P1759, DOI 10.1158/0008-5472.CAN-09-1703; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Qian BZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006562; Severson EA, 2009, CURR OPIN CELL BIOL, V21, P701, DOI 10.1016/j.ceb.2009.06.005; Spagnuolo R, 2004, BLOOD, V103, P3005, DOI 10.1182/blood-2003-07-2459; Vestweber D, 2007, IMMUNOL REV, V218, P178, DOI 10.1111/j.1600-065X.2007.00533.x; Vetrano S, 2008, GASTROENTEROLOGY, V135, P173, DOI 10.1053/j.gastro.2008.04.002; Weber C, 2007, NAT REV IMMUNOL, V7, P467, DOI 10.1038/nri2096	29	43	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21242	10.1371/journal.pone.0021242	http://dx.doi.org/10.1371/journal.pone.0021242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695058	gold, Green Published			2022-12-25	WOS:000291737600055
J	Sorokina, EA; Muheisen, S; Mlodik, N; Semina, EV				Sorokina, Elena A.; Muheisen, Sanaa; Mlodik, Nevin; Semina, Elena V.			MIP/Aquaporin 0 Represents a Direct Transcriptional Target of PITX3 in the Developing Lens	PLOS ONE			English	Article							MAJOR INTRINSIC PROTEIN; AUTOSOMAL-DOMINANT CATARACT; MIP GENE; CONGENITAL CATARACT; RIEGER-SYNDROME; CHINESE FAMILY; HOMEOBOX GENE; OCULAR LENS; ZEBRAFISH PITX3; BETA-CATENIN	The PITX3 bicoid-type homeodomain transcription factor plays an important role in lens development in vertebrates. PITX3 deficiency results in a spectrum of phenotypes from isolated cataracts to microphthalmia in humans, and lens degeneration in mice and zebrafish. While identification of downstream targets of PITX3 is vital for understanding the mechanisms of normal ocular development and human disease, these targets remain largely unknown. To isolate genes that are directly regulated by PITX3, we performed a search for genomic sequences that contain evolutionarily conserved bicoid/PITX3 binding sites and are located in the proximity of known genes. Two bicoid sites that are conserved from zebrafish to human were identified within the human promoter of the major intrinsic protein of lens fiber, MIP/AQP0. MIP/AQP0 deficiency was previously shown to be associated with lens defects in humans and mice. We demonstrate by both chromatin immunoprecipitation and electrophoretic mobility shift assay that PITX3 binds to MIP/AQP0 promoter region in vivo and is able to interact with both bicoid sites in vitro. In addition, we show that wild-type PITX3 is able to activate the MIP/AQP0 promoter via interaction with the proximal bicoid site in cotransfection experiments and that the introduction of mutations disrupting binding to this site abolishes this activation. Furthermore, mutant forms of PITX3 fail to produce the same levels of transactivation as wild-type when cotransfected with the MIP/AQP0 reporter. Finally, knockdown of pitx3 in zebrafish affects formation of a DNA-protein complex associated with mip1 promoter sequences; and examination of expression in pitx3 morphant and control zebrafish revealed a delay in and reduction of mip1 expression in pitx3-deficient embryos. Therefore, our data suggest that PITX3 is involved in direct regulation of MIP/AQP0 expression and that the alteration of MIP/AQP0 expression is likely to contribute to the lens phenotype in cataract patients with PITX3 mutations.	[Sorokina, Elena A.; Muheisen, Sanaa; Mlodik, Nevin; Semina, Elena V.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Sorokina, Elena A.; Muheisen, Sanaa; Mlodik, Nevin; Semina, Elena V.] Med Coll Wisconsin, Childrens Res Inst, Milwaukee, WI 53226 USA; [Sorokina, Elena A.; Muheisen, Sanaa; Mlodik, Nevin; Semina, Elena V.] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Semina, Elena V.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Medical College of Wisconsin	Sorokina, EA (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	esemina@mcw.edu			National Eye Institute [EY013606]; Children's Research Institute Foundation at Children's Hospital of Wisconsin; NATIONAL EYE INSTITUTE [R01EY013606] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Children's Research Institute Foundation at Children's Hospital of Wisconsin; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding was provided by grant EY013606 from the National Eye Institute and by support from the Children's Research Institute Foundation at Children's Hospital of Wisconsin to EVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amen M, 2007, MOL CELL BIOL, V27, P7560, DOI 10.1128/MCB.00315-07; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Berry V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.020289; Berry V, 2000, NAT GENET, V25, P15, DOI 10.1038/75538; Bidinost C, 2006, INVEST OPHTH VIS SCI, V47, P1274, DOI 10.1167/iovs.05-1095; Burdon KP, 2006, MOL VIS, V12, P367; Chepelinsky Ana B, 2009, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-540-79885-9_14; Dunia I, 1998, J CELL SCI, V111, P2109; Dutta S, 2005, DEVELOPMENT, V132, P1579, DOI 10.1242/dev.01723; Elgar G, 2008, TRENDS GENET, V24, P344, DOI 10.1016/j.tig.2008.04.005; Finzi Simone, 2005, Ophthalmic Genet, V26, P125, DOI 10.1080/13816810500229124; Francis P, 2000, BRIT J OPHTHALMOL, V84, P1376, DOI 10.1136/bjo.84.12.1376; Francis P, 2000, HUM MOL GENET, V9, P2329, DOI 10.1093/oxfordjournals.hmg.a018925; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Geyer DD, 2006, AM J OPHTHALMOL, V141, P761, DOI 10.1016/j.ajo.2005.11.008; Golestaneh N, 2004, J BIOL CHEM, V279, P31813, DOI 10.1074/jbc.M403473200; Gu F, 2007, MOL VIS, V13, P1651; Gurnett CA, 2008, AM J HUM GENET, V83, P616, DOI 10.1016/j.ajhg.2008.10.004; Hjalt TA, 2001, J CELL BIOL, V152, P545, DOI 10.1083/jcb.152.3.545; Ho HY, 2009, MECH DEVELOP, V126, P18, DOI 10.1016/j.mod.2008.10.007; Island ML, 2002, MOL CELL BIOL, V22, P7120, DOI 10.1128/MCB.22.20.7120-7133.2002; Jiang J, 2009, MOL VIS, V15, P38; Khosrowshahian F, 2005, DEV DYNAM, V234, P577, DOI 10.1002/dvdy.20540; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; L'Honore A, 2007, DEV BIOL, V307, P421, DOI 10.1016/j.ydbio.2007.04.034; Lamba P, 2008, ENDOCRINOLOGY, V149, P3095, DOI 10.1210/en.2007-0425; Lebel M, 2001, J NEUROCHEM, V77, P558, DOI 10.1046/j.1471-4159.2001.00257.x; Lin H, 2007, MOL VIS, V13, P1822; MALININA N A, 1981, Ontogenez, V12, P589; Medina-Martinez O, 2009, DEV DYNAM, V238, P2193, DOI 10.1002/dvdy.21924; MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010; Ohtaka-Maruyama C, 1998, NUCLEIC ACIDS RES, V26, P407, DOI 10.1093/nar/26.2.407; PISANO MM, 1991, GENOMICS, V11, P981; Pommereit D, 2001, MECH DEVELOP, V102, P255, DOI 10.1016/S0925-4773(01)00305-7; Qiu HY, 2008, GENESIS, V46, P324, DOI 10.1002/dvg.20399; Quentien MH, 2002, J BIOL CHEM, V277, P44408, DOI 10.1074/jbc.M207824200; Quirk CC, 2001, MOL ENDOCRINOL, V15, P734, DOI 10.1210/me.15.5.734; Rieger DK, 2001, GENOMICS, V72, P61, DOI 10.1006/geno.2000.6464; Sakazume S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-84; Semina EV, 2000, HUM MOL GENET, V9, P1575, DOI 10.1093/hmg/9.11.1575; Semina EV, 1997, HUM MOL GENET, V6, P2109, DOI 10.1093/hmg/6.12.2109; Semina EV, 1998, NAT GENET, V19, P167, DOI 10.1038/527; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shi XH, 2005, MECH DEVELOP, V122, P513, DOI 10.1016/j.mod.2004.11.012; Shi XH, 2006, MECH DEVELOP, V123, P761, DOI 10.1016/j.mod.2006.07.004; Shiels A, 1996, NAT GENET, V12, P212, DOI 10.1038/ng0296-212; Shiels A, 2001, PHYSIOL GENOMICS, V7, P179, DOI 10.1152/physiolgenomics.00078.2001; Sidjanin DJ, 2001, GENOMICS, V74, P313, DOI 10.1006/geno.2001.6509; Summers KM, 2008, MOL VIS, V14, P2010; Suszko MI, 2003, MOL ENDOCRINOL, V17, P318, DOI 10.1210/me.2002-0081; Vadlamudi U, 2005, J CELL SCI, V118, P1129, DOI 10.1242/jcs.01706; Varadaraj K, 2007, DEV DYNAM, V236, P1319, DOI 10.1002/dvdy.21125; Vihtelic TS, 2005, MOL VIS, V11, P1083; Wang KJ, 2011, MOL VIS, V17, P70; Wang W, 2010, MOL VIS, V16, P534; Wang XY, 1995, GENE, V167, P321, DOI 10.1016/0378-1119(95)00637-0; WEBSTER EH, 1986, J EMBRYOL EXP MORPH, V92, P85; West-Mays JA, 1999, DEV BIOL, V206, P46, DOI 10.1006/dbio.1998.9132; West-Mays JA, 2002, DEV BIOL, V245, P13, DOI 10.1006/dbio.2002.0624; Woolfe A, 2008, ADV GENET, V61, P307, DOI 10.1016/S0065-2660(07)00012-0; Zhou L, 2002, MOL VIS, V8, P143; Zilinski CA, 2005, GENESIS, V41, P33, DOI 10.1002/gene.20094; Zinkevich NS, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-13; ZWAAN J, 1975, DEV BIOL, V44, P306, DOI 10.1016/0012-1606(75)90401-7	65	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21122	10.1371/journal.pone.0021122	http://dx.doi.org/10.1371/journal.pone.0021122			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698120	gold, Green Submitted, Green Published			2022-12-25	WOS:000291737600042
J	Karl, S; Gurarie, D; Zimmerman, PA; King, CH; St Pierre, TG; Davis, TME				Karl, Stephan; Gurarie, David; Zimmerman, Peter A.; King, Charles H.; St Pierre, Tim G.; Davis, Timothy M. E.			A Sub-Microscopic Gametocyte Reservoir Can Sustain Malaria Transmission	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM GAMETOCYTES; TROPHOZOITE-INDUCED INFECTIONS; ANOPHELES-PUNCTULATUS COMPLEX; INSECTICIDE-TREATED NETS; RETROSPECTIVE EXAMINATION; SULFADOXINE-PYRIMETHAMINE; CLINICAL IMMUNITY; SPOROZOITE RATES; COMBINATION; THERAPY	Background: Novel diagnostic tools, including PCR and high field gradient magnetic fractionation (HFGMF), have improved detection of asexual Plasmodium falciparum parasites and especially infectious gametocytes in human blood. These techniques indicate a significant number of people carry gametocyte densities that fall below the conventional threshold of detection achieved by standard light microscopy (LM). Methodology/Principal Findings: To determine how low-level gametocytemia may affect transmission in present large-scale efforts for P. falciparum control in endemic areas, we developed a refinement of the classical Ross-Macdonald model of malaria transmission by introducing multiple infective compartments to model the potential impact of highly prevalent, low gametocytaemic reservoirs in the population. Models were calibrated using field-based data and several numerical experiments were conducted to assess the effect of high and low gametocytemia on P. falciparum transmission and control. Special consideration was given to the impact of long-lasting insecticide-treated bed nets (LLIN), presently considered the most efficient way to prevent transmission, and particularly LLIN coverage similar to goals targeted by the Roll Back Malaria and Global Fund malaria control campaigns. Our analyses indicate that models which include only moderate-to-high gametocytemia (detectable by LM) predict finite eradication times after LLIN introduction. Models that include a low gametocytemia reservoir (requiring PCR or HFGMF detection) predict much more stable, persistent transmission. Our modeled outcomes result in significantly different estimates for the level and duration of control needed to achieve malaria elimination if submicroscopic gametocytes are included. Conclusions/Significance: It will be very important to complement current methods of surveillance with enhanced diagnostic techniques to detect asexual parasites and gametocytes to more accurately plan, monitor and guide malaria control programs aimed at eliminating malaria.	[Karl, Stephan; St Pierre, Tim G.] Univ Western Australia, Sch Phys, Crawley, WA, Australia; [Gurarie, David] Case Western Reserve Univ, Dept Math, Cleveland, OH 44106 USA; [Zimmerman, Peter A.; King, Charles H.] Case Western Reserve Univ, Ctr Global Hlth & Dis, Cleveland, OH 44106 USA; [Karl, Stephan; Davis, Timothy M. E.] Univ Western Australia, Fremantle Hosp, Sch Med & Pharmacol, Crawley, WA, Australia	University of Western Australia; Case Western Reserve University; Case Western Reserve University; University of Western Australia	Karl, S (corresponding author), Univ Western Australia, Sch Phys, Crawley, WA, Australia.	stephan.karl@physics.uwa.edu.au	Gurarie, David/AAA-2096-2021; St Pierre, Timothy G/A-5509-2008; Davis, Timothy ME/M-5144-2014; Karl, Stephan/A-2365-2012	St Pierre, Timothy G/0000-0003-4682-4972; King, Charles/0000-0001-8349-9270; Davis, Timothy/0000-0003-0749-7411; Zimmerman, Peter/0000-0002-5349-4513; Gurarie, David/0000-0002-5314-7888	Fogarty International Center [R01TW008067, R01TW007872]; National Health and Medical Research Council; FOGARTY INTERNATIONAL CENTER [R01TW008067, R01TW007872] Funding Source: NIH RePORTER	Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by National Institutes of Health Research Grants R01TW008067 (CHK) and R01TW007872 (PAZ), funded by the Ecology of Infectious Diseases Program of the Fogarty International Center. TD was supported by a National Health and Medical Research Council Practitioner Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; ANDERSON RM, 1989, PARASITOLOGY, V99, pS59, DOI 10.1017/S0031182000083426; Aron J.L., 1982, P139; Atkinson JA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-119; Bailey N. T. J., 1982, BIOMATHEMATICS MALAR; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; Beavogui AH, 2010, INT J PARASITOL, V40, P1213, DOI 10.1016/j.ijpara.2010.04.010; Bejon P, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-104; Bhattarai A, 2007, PLOS MED, V4, P1784, DOI 10.1371/journal.pmed.0040309; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; Bousema JT, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-18; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; BURKOT TR, 1989, AM J TROP MED HYG, V40, P229, DOI 10.4269/ajtmh.1989.40.229; BURKOT TR, 1988, AM J TROP MED HYG, V39, P135, DOI 10.4269/ajtmh.1988.39.135; Canyon DV, 1999, J MED ENTOMOL, V36, P301, DOI 10.1093/jmedent/36.3.301; CATTANI JA, 1986, PAPUA NEW GUINEA MED, V29, P11; CHAMBERS RG, 2009, UN SECRETARY GEN SPE; Collins WE, 1999, AM J TROP MED HYG, V61, P44, DOI 10.4269/tropmed.1999.61-044; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Collins WE, 1999, AM J TROP MED HYG, V61, P20, DOI 10.4269/tropmed.1999.61-020; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; Curtis Chris F, 2002, Biomedica, V22, P455; DIETZ K, 1974, B WORLD HEALTH ORGAN, V50, P347; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Drakeley CJ, 1999, TROP MED INT HEALTH, V4, P131, DOI 10.1046/j.1365-3156.1999.00361.x; Feachem RGA, 2009, SHRINKING MALARIA MA; FILIPE JAN, 2007, PLOS COMPUTATIONAL B, V3; GRAVES PM, 1988, PARASITOLOGY, V96, P251, DOI 10.1017/S003118200005825X; Hommel M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S1; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Karl S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-98; Karl S, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-66; KOELLA JC, 1991, ACTA TROP, V49, P1, DOI 10.1016/0001-706X(91)90026-G; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Kone A, 2010, INT J PARASITOL, V40, P1221, DOI 10.1016/j.ijpara.2010.05.004; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; MACCORMACK CP, 1986, J TROP MED HYG, V89, P295; MACDONALD G, 1952, Trop Dis Bull, V49, P813; Molineaux L, 1980, THE GARKI PROJECT; MURPHY JR, 1989, J CLIN MICROBIOL, V27, P1434, DOI 10.1128/JCM.27.7.1434-1437.1989; Mwerinde O, 2005, ACTA TROP, V95, pS183; Nyarango PM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-33; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; Okrah J, 2002, TROP MED INT HEALTH, V7, P240, DOI 10.1046/j.1365-3156.2002.00856.x; Otten M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-14; Owusu-Agyei S, 2002, TROP MED INT HEALTH, V7, P599, DOI 10.1046/j.1365-3156.2002.00902.x; Owusu-Agyei S, 2001, AM J TROP MED HYG, V65, P197, DOI 10.4269/ajtmh.2001.65.197; PAGANOTTI G, 2004, AM J TROPICAL MED HY, V71; PAGANOTTI G, 2006, PARASITOLOGY; Romi R, 2002, AM J TROP MED HYG, V66, P2, DOI 10.4269/ajtmh.2002.66.2; Ross R., 1911, PREVENTION MALARIA, DOI [10.1007/978-0-85729-115-8-12, DOI 10.1007/978-0-85729-115-8-12]; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; SHARMA VP, 1986, SOC SCI MED, V22, P835, DOI 10.1016/0277-9536(86)90238-8; SHEKALAGHE S, 2007, TROPICAL MED INT HLT, V12; Smith DL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-87; Talman AM, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-24; Tangpukdee N, 2008, KOREAN J PARASITOL, V46, P65, DOI 10.3347/kjp.2008.46.2.65; TARLOV AR, 1962, ARCH INTERN MED, V109, P209, DOI 10.1001/archinte.1962.03620140081013; Toe LP, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-175	60	58	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20805	10.1371/journal.pone.0020805	http://dx.doi.org/10.1371/journal.pone.0020805			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695129	Green Published, Green Submitted, gold			2022-12-25	WOS:000291682300012
J	Bradshaw, L; Davies, E; Devine, M; Flanagan, P; Kelly, P; O'Connor, K; Drobniewski, F; Nikolayevskyy, V; Abubakar, I				Bradshaw, Louise; Davies, Elizabeth; Devine, Michael; Flanagan, Peter; Kelly, Paul; O'Connor, Kevin; Drobniewski, Francis; Nikolayevskyy, Vladislav; Abubakar, Ibrahim			The Role of the Interferon Gamma Release Assay in Assessing Recent Tuberculosis Transmission in a Hospital Incident	PLOS ONE			English	Article							LATENT TUBERCULOSIS; INFECTION	In 2007, an extensive contact screening investigation into onward transmission of tuberculosis was instigated at a hospital in Northern Ireland following diagnosis of pulmonary multi-drug resistant TB in a healthcare worker. Interferon gamma release assays (IGRAs) were used to test 333 patients and 98 staff. We investigated for evidence of onward transmission and recent infection based on analysis of clinical, demographic and IGRA data. We also described within-patient variability of IGRA results. Among patients and staff, increasing age of patients was the only factor associated with IGRA positivity. Greatest within-subject variability of IU/mL in serially-tested patients/staff was seen in those with a positive IGRA test and this did not correlate with increased exposure to the index case. IGRA positivity being largely explained by increasing age in patients and previous TB contact in staff lends weight to the conclusion that IGRA positivity reflected previous infection rather than recent transmission.	[Bradshaw, Louise; Abubakar, Ibrahim] Hlth Protect Agcy Ctr Infect, TB Sect, Dept Resp Dis, London, England; [Davies, Elizabeth; Devine, Michael; Flanagan, Peter; Kelly, Paul; O'Connor, Kevin] No Hlth & Social Care Trust Headquarters, No Hlth & Social Care Trust, Ballymena, Antrim, North Ireland; [Drobniewski, Francis; Nikolayevskyy, Vladislav] Hlth Protect Agcy Natl Mycobacterium Reference La, London, England	Health Protection Agency	Bradshaw, L (corresponding author), Hlth Protect Agcy Ctr Infect, TB Sect, Dept Resp Dis, London, England.	louise.bradshaw@hpa.org.uk	Nikolayevskyy, Vladyslav/HFZ-7738-2022	Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Abubakar, Ibrahim/0000-0002-0370-1430				[Anonymous], 2009, TUB UK ANN REP TUB S; CHEESEMAN E A, 1956, Br J Prev Soc Med, V10, P115; Communicable Disease Surveillance Centre (Northern Ireland), EP TUB NO IR ANN SUR; Fraser A Paul M Attamna A Leibovici L, 2006, COCHRANE DATABASE SY; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Hinks TSC, 2009, INFECT IMMUNITY; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; *NAT COLL CTR CHRO, 2006, TUB CLIN DIAGN MAN T; Pai M, 2010, LANCET INFECT DIS, P761; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Pai M, 2007, PLOS MED, V4, P980, DOI 10.1371/journal.pmed.0040208; Pai M, 2010, NAT REV MICROBIOL, V8, P242, DOI 10.1038/nrmicro2236-c1; Swindells JE, 2009, J HOSP INFECT, P1; van Zyl-Smit RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008517; Zwerling A, 2011, THORAX	15	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20770	10.1371/journal.pone.0020770	http://dx.doi.org/10.1371/journal.pone.0020770			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695149	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000291663300019
J	Esberg, A; Moqtaderi, Z; Fan, XC; Lu, J; Struhl, K; Bystrom, A				Esberg, Anders; Moqtaderi, Zarmik; Fan, Xiaochun; Lu, Jian; Struhl, Kevin; Bystrom, Anders			Iwr1 Protein Is Important for Preinitiation Complex Formation by All Three Nuclear RNA Polymerases in Saccharomyces cerevisiae	PLOS ONE			English	Article							INITIATOR TRANSFER-RNA; TRANSCRIPTION MACHINERY; HISTONE EVICTION; IN-VIVO; YEAST; DISCRIMINATION; ELONGATION; BINDING; GENES; DISSECTION	Background: Iwr1, a protein conserved throughout eukaryotes, was originally identified by its physical interaction with RNA polymerase (Pol) II. Principal Findings: Here, we identify Iwr1 in a genetic screen designed to uncover proteins involved in Pol III transcription in S. cerevisiae. Iwr1 is important for Pol III transcription, because an iwr1 mutant strain shows reduced association of TBP and Pol III at Pol III promoters, a decreased rate of Pol III transcription, and lower steady-state levels of Pol III transcripts. Interestingly, an iwr1 mutant strain also displays reduced association of TBP to Pol I-transcribed genes and of both TBP and Pol II to Pol II-transcribed promoters. Despite this, rRNA and mRNA levels are virtually unaffected, suggesting a post-transcriptional mechanism compensating for the occupancy defect. Conclusions: Thus, Iwr1 plays an important role in preinitiation complex formation by all three nuclear RNA polymerases.	[Esberg, Anders; Lu, Jian; Bystrom, Anders] Umea Univ, Dept Mol Biol, Umea, Sweden; [Moqtaderi, Zarmik; Fan, Xiaochun; Struhl, Kevin] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Umea University; Harvard University; Harvard Medical School	Esberg, A (corresponding author), Umea Univ, Labs Chem Biol Umea, Umea, Sweden.	kevin@hms.harvard.edu; anders.bystrom@molbiol.umu.se	Lu, Jian/G-8391-2011	Lu, Jian/0000-0001-6522-8485; Bystrom, Anders/0000-0003-1281-3888	Swedish Cancer Foundation [3516-B05-12XAB]; Swedish Research Council [621-2006-4269]; Margareta Dannbergs Foundation [223-302-06]; Wenner-Gren Foundations; National Institutes of Health [GM 30186]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030186, R01GM030186] Funding Source: NIH RePORTER	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Margareta Dannbergs Foundation; Wenner-Gren Foundations; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the Swedish Cancer Foundation (Project 3516-B05-12XAB), Swedish Research Council (Project 621-2006-4269), and Margareta Dannbergs Foundation (Project 223-302-06) to AB, the Wenner-Gren Foundations to AE, and National Institutes of Health (GM 30186) to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astrom SU, 1999, MOL GEN GENET, V261, P967; ASTROM SU, 1994, CELL, V79, P535, DOI 10.1016/0092-8674(94)90262-3; BENDER A, 1991, MOL CELL BIOL, V11, P1295, DOI 10.1128/MCB.11.3.1295; BJORK GR, 1995, PROG NUCLEIC ACID RE, V50, P263, DOI 10.1016/S0079-6603(08)60817-X; CAMIER S, 1985, EMBO J, V4, P491, DOI 10.1002/j.1460-2075.1985.tb03655.x; CARLES C, 1991, J BIOL CHEM, V266, P24092; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; CORMACK BP, 1992, CELL, V69, P685, DOI 10.1016/0092-8674(92)90232-2; Czeko E, 2011, MOL CELL, V42, P261, DOI 10.1016/j.molcel.2011.02.033; FORSTER C, 1993, NUCLEIC ACIDS RES, V21, P5679; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Geiduschek EP, 2001, J MOL BIOL, V310, P1, DOI 10.1006/jmbi.2001.4732; GOODRICH LA, 1994, CURR OPIN CELL BIOL, V6, P403, DOI 10.1016/0955-0674(94)90033-7; Hahn S, 2004, NAT STRUCT MOL BIOL, V11, P394, DOI 10.1038/nsmb763; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KEITH G, 1990, NUCLEIC ACIDS RES, V18, P5989, DOI 10.1093/nar/18.20.5989; KIESEWETTER S, 1990, NUCLEIC ACIDS RES, V18, P4677, DOI 10.1093/nar/18.16.4677; KRANZ JE, 1990, P NATL ACAD SCI USA, V87, P6629, DOI 10.1073/pnas.87.17.6629; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Peiro-Chova L, 2009, J BIOL CHEM, V284, P28958, DOI 10.1074/jbc.M109.012153; Roberts DN, 2003, P NATL ACAD SCI USA, V100, P14695, DOI 10.1073/pnas.2435566100; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Schramm L, 2002, GENE DEV, V16, P2593, DOI 10.1101/gad.1018902; Schwabish MA, 2007, MOL CELL BIOL, V27, P6987, DOI 10.1128/MCB.00717-07; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Struhl K, 1999, CELL, V98, P1, DOI 10.1016/S0092-8674(00)80599-1; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Willis IM, 2007, TRENDS BIOCHEM SCI, V32, P51, DOI 10.1016/j.tibs.2006.12.001	32	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20829	10.1371/journal.pone.0020829	http://dx.doi.org/10.1371/journal.pone.0020829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695216	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600032
J	Johnson, JA; West, J; Maynard, KB; Hemnes, AR				Johnson, Jennifer A.; West, James; Maynard, Karen B.; Hemnes, Anna R.			ACE2 Improves Right Ventricular Function in a Pressure Overload Model	PLOS ONE			English	Article							CONVERTING ENZYME 2; HEART IN-VIVO; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; MOUSE HEART; CHYMASE; ANGIOTENSIN-(1-7); PREVENTION; ECHOCARDIOGRAPHY; PHOSPHORYLATION	Background: Right ventricular (RV) dysfunction is a complication of pulmonary hypertension and portends a poor prognosis. Pharmacological therapies targeting RV function in pulmonary hypertension may reduce symptoms, improve hemodynamics, and potentially increase survival. We hypothesize that recombinant human angiotensin-converting enzyme 2 (rhACE2) will improve RV function in a pressure overload model. Results: rhACE2 administered at 1.8 mg/kg/day improved RV systolic and diastolic function in pulmonary artery banded mice as measured by in vivo hemodynamics. Specifically, rhACE2 increased RV ejection fraction and decreased RV end diastolic pressure and diastolic time constant (p < 0.05). In addition, rhACE2 decreased RV hypertrophy as measured by RV/LV+S ratio (p < 0.05). There were no significant negative effects of rhACE2 administration on LV function. rhACE2 had no significant effect on fibrosis as measured by trichrome staining and collagen1 alpha 1 expression. In pulmonary artery banded mice, rhACE2 increased Mas receptor expression and normalized connexin 37 expression. Conclusion: In a mouse RV load-stress model of early heart failure, rhACE2 diminished RV hypertrophy and improved RV systolic and diastolic function in association with a marker of intercellular communication. rhACE2 may be a novel treatment for RV failure.	[Johnson, Jennifer A.; West, James; Maynard, Karen B.; Hemnes, Anna R.] Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37203 USA	Vanderbilt University	Johnson, JA (corresponding author), Vanderbilt Univ, Med Ctr, Div Allergy Pulm & Crit Care Med, Nashville, TN 37203 USA.	jennifer.johnson.2@vanderbilt.edu	West, James/E-2960-2010	West, James/0000-0002-6004-0202	National Institutes of Health [KO8 HL093363, T32 HL094296]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093363, T32HL094296, R01HL095797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr. Hemnes is funded by National Institutes of Health KO8 HL093363. Dr. Johnson is funded by National Institutes of Health T32 HL094296. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcells E, 1997, AM J PHYSIOL-HEART C, V273, pH1769, DOI 10.1152/ajpheart.1997.273.4.H1769; Batlle M, 2006, J HEART LUNG TRANSPL, V25, P1117, DOI 10.1016/j.healun.2006.04.012; Collins KA, 2003, PHYSIOL GENOMICS, V13, P227, DOI 10.1152/physiolgenomics.00005.2003; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; DALONZO GE, 1991, ANN INTERN MED, V115, P343, DOI 10.7326/0003-4819-115-5-343; De Mello WC, 2007, J RENIN-ANGIO-ALDO S, V8, P74, DOI 10.3317/jraas.2007.015; Dias-Peixoto MF, 2008, HYPERTENSION, V52, P542, DOI 10.1161/HYPERTENSIONAHA.108.114280; Doggrell SA, 2004, CARDIOVASC RES, V61, P653, DOI 10.1016/j.cardiores.2003.11.029; Donoghue M, 2003, J MOL CELL CARDIOL, V35, P1043, DOI 10.1016/S0022-2828(03)00177-9; Dyer LA, 2009, DEV BIOL, V336, P137, DOI 10.1016/j.ydbio.2009.10.009; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Ferreira AJ, 2009, AM J RESP CRIT CARE, V179, P1048, DOI 10.1164/rccm.200811-1678OC; Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008; Giani JF, 2008, EXP PHYSIOL, V93, P570, DOI 10.1113/expphysiol.2007.014269; Giani JF, 2007, AM J PHYSIOL-HEART C, V293, pH1154, DOI 10.1152/ajpheart.01395.2006; Grobe JL, 2007, CLIN SCI, V113, P357, DOI 10.1042/CS20070160; Grobe JL, 2007, AM J PHYSIOL-HEART C, V292, pH736, DOI 10.1152/ajpheart.00937.2006; Haefliger JA, 2000, DEV DYNAM, V218, P331, DOI 10.1002/(SICI)1097-0177(200006)218:2<331::AID-DVDY7>3.0.CO;2-4; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Hemnes AR, 2008, INT J CLIN PRACT, V62, P11, DOI 10.1111/j.1742-1241.2008.01812.x; Jin DN, 2001, JPN J PHARMACOL, V86, P203, DOI 10.1254/jjp.86.203; KAARTINEN M, 1994, ARTERIOSCLER THROMB, V14, P966, DOI 10.1161/01.ATV.14.6.966; Kassiri Z, 2009, CIRC-HEART FAIL, V2, P446, DOI 10.1161/CIRCHEARTFAILURE.108.840124; Kelly RG, 2001, DEV CELL, V1, P435, DOI 10.1016/S1534-5807(01)00040-5; Lovren F, 2008, AM J PHYSIOL-HEART C, V295, pH1377, DOI 10.1152/ajpheart.00331.2008; Mercure C, 2008, CIRC RES, V103, P1319, DOI 10.1161/CIRCRESAHA.108.184911; Miyazaki M, 2006, PHARMACOL THERAPEUT, V112, P668, DOI 10.1016/j.pharmthera.2006.05.008; Mjaatvedt CH, 2001, DEV BIOL, V238, P97, DOI 10.1006/dbio.2001.0409; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; POLAK JF, 1983, J AM COLL CARDIOL, V2, P217, DOI 10.1016/S0735-1097(83)80156-9; Reesink HJ, 2007, J THORAC CARDIOV SUR, V133, P58, DOI 10.1016/j.jtcvs.2006.09.032; RITCHIE M, 1993, J AM COLL CARDIOL, V22, P1170, DOI 10.1016/0735-1097(93)90433-2; Santos RAS, 2007, CURR OPIN NEPHROL HY, V16, P122, DOI 10.1097/MNH.0b013e328031f362; Sarkissian SD, 2008, HYPERTENSION, V51, P712, DOI 10.1161/HYPERTENSIONAHA.107.100693; Schmieder RE, 1996, JAMA-J AM MED ASSOC, V275, P1507, DOI 10.1001/jama.275.19.1507; Shenoy A, 2010, AM J RESP CRIT CARE, V181; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2013.10.029, 10.1016/j.jacc.2009.04.012]; Syed F, 2005, J AM SOC ECHOCARDIOG, V18, P982, DOI 10.1016/j.echo.2005.05.001; Takai S, 2003, J PHARMACOL EXP THER, V305, P17, DOI 10.1124/jpet.102.045179; Waldo KL, 2001, DEVELOPMENT, V128, P3179; Winter MM, 2009, HEART, V95, P960, DOI 10.1136/hrt.2008.156265; Yamazato Y, 2009, HYPERTENSION, V54, P365, DOI 10.1161/HYPERTENSIONAHA.108.125468; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369	45	50	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20828	10.1371/journal.pone.0020828	http://dx.doi.org/10.1371/journal.pone.0020828			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695173	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612600031
J	Katsura, Y; Satta, Y				Katsura, Yukako; Satta, Yoko			Evolutionary History of the Cancer Immunity Antigen MAGE Gene Family	PLOS ONE			English	Article							T-CELL EPITOPES; TUMOR-ANTIGENS; MELANOMA; IDENTIFICATION; PEPTIDES; EXPRESSION; BINDING; PROTEIN; ORIGIN; DNA	The evolutionary mode of a multi-gene family can change over time, depending on the functional differentiation and local genomic environment of family members. In this study, we demonstrate such a change in the melanoma antigen (MAGE) gene family on the mammalian X chromosome. The MAGE gene family is composed of ten subfamilies that can be categorized into two types. Type I genes are of relatively recent origin, and they encode epitopes for human leukocyte antigen (HLA) in cancer cells. Type II genes are relatively ancient and some of their products are known to be involved in apoptosis or cell proliferation. The evolutionary history of the MAGE gene family can be divided into four phases. In phase I, a single-copy state of an ancestral gene and the evolutionarily conserved mode had lasted until the emergence of eutherian mammals. In phase II, eight subfamily ancestors, with the exception for MAGE-C and MAGE-D subfamilies, were formed via retrotransposition independently. This would coincide with a transposition burst of LINE elements at the eutherian radiation. However, MAGE-C was generated by gene duplication of MAGE-A. Phase III is characterized by extensive gene duplication within each subfamily and in particular the formation of palindromes in the MAGE-A subfamily, which occurred in an ancestor of the Catarrhini. Phase IV is characterized by the decay of a palindrome in most Catarrhini, with the exception of humans. Although the palindrome is truncated by frequent deletions in apes and Old World monkeys, it is retained in humans. Here, we argue that this human-specific retention stems from negative selection acting on MAGE-A genes encoding epitopes of cancer cells, which preserves their ability to bind to highly divergent HLA molecules. These findings are interpreted with consideration of the biological factors shaping recent human MAGE-A genes.	[Katsura, Yukako; Satta, Yoko] Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Kanagawa, Japan	Graduate University for Advanced Studies - Japan	Katsura, Y (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Studies Biosyst, Kanagawa, Japan.	satta@soken.ac.jp		Satta, Yoko/0000-0002-5305-493X	 [17018032]		This work was supported by a Grant-in Aid for Scientific Research on Priority Areas (17018032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artamonova II, 2004, J MOL EVOL, V59, P620, DOI 10.1007/s00239-004-2654-3; Bertrand M, 2004, DEV DYNAM, V230, P325, DOI 10.1002/dvdy.20026; Bhowmick BK, 2007, GENOME RES, V17, P441, DOI 10.1101/gr.5734907; Bischof JM, 2003, DEV DYNAM, V228, P475, DOI 10.1002/dvdy.10398; Bredenbeck A, 2005, J IMMUNOL, V174, P6716, DOI 10.4049/jimmunol.174.11.6716; Brunet M, 2002, NATURE, V418, P145, DOI 10.1038/nature00879; Caballero OL, 2009, CANCER SCI, V100, P2014, DOI 10.1111/j.1349-7006.2009.01303.x; Castelli C, 2000, J CELL PHYSIOL, V182, P323, DOI 10.1002/(SICI)1097-4652(200003)182:3<323::AID-JCP2>3.0.CO;2-#; CELIS E, 1994, P NATL ACAD SCI USA, V91, P2105, DOI 10.1073/pnas.91.6.2105; Chianese-Bullock KA, 2005, J IMMUNOL, V174, P3080, DOI 10.4049/jimmunol.174.5.3080; Chomez P, 2001, CANCER RES, V61, P5544; Crotzer VL, 2009, J IMMUNOL, V182, P3335, DOI 10.4049/jimmunol.0803458; CZELUSNIAK J, 1982, NATURE, V298, P297, DOI 10.1038/298297a0; Delbridge ML, 2009, GENOME RES, V19, P1350, DOI 10.1101/gr.088625.108; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Elango N, 2009, BIOL LETTERS, V5, P405, DOI 10.1098/rsbl.2008.0712; Escudier B, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-10; FEDOROFF NV, 1979, CELL, V16, P697, DOI 10.1016/0092-8674(79)90086-2; FRITSCH EF, 1980, CELL, V19, P959, DOI 10.1016/0092-8674(80)90087-2; Gotoh M, 2002, INT J CANCER, V100, P565, DOI 10.1002/ijc.10509; Graff-Dubois S, 2002, J IMMUNOL, V169, P575, DOI 10.4049/jimmunol.169.1.575; Groeper C, 2007, INT J CANCER, V120, P337, DOI 10.1002/ijc.22309; Han MV, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P114; Hasegawa M, 2003, GENES GENET SYST, V78, P267, DOI 10.1266/ggs.78.267; Heinemeyer T, 1998, NUCLEIC ACIDS RES, V26, P362, DOI 10.1093/nar/26.1.362; Hillig RC, 2001, J MOL BIOL, V310, P1167, DOI 10.1006/jmbi.2001.4816; Kim TM, 2004, J KOREAN MED SCI, V19, P177, DOI 10.3346/jkms.2004.19.2.177; Kirkin AF, 1998, EXP CLIN IMMUNOGENET, V15, P19, DOI 10.1159/000019050; Klein J, 1997, IMMUNOLOGY; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lin CZ, 2002, GENE, V285, P269, DOI 10.1016/S0378-1119(02)00395-5; Lopez-Sanchez N, 2007, PHYSIOL GENOMICS, V30, P156, DOI 10.1152/physiolgenomics.00249.2006; Lucas S, 1998, CANCER RES, V58, P743; Luescher IF, 1996, J BIOL CHEM, V271, P12463, DOI 10.1074/jbc.271.21.12463; Lund O, 2004, IMMUNOGENETICS, V55, P797, DOI 10.1007/s00251-004-0647-4; Lurquin C, 1997, GENOMICS, V46, P397, DOI 10.1006/geno.1997.5052; Marsman M, 2005, ADV CANCER RES, V93, P129, DOI 10.1016/S0065-230X(05)93004-2; Marturano J, 2008, CANCER IMMUNOL IMMUN, V57, P207, DOI 10.1007/s00262-007-0364-6; Miyahara Y, 2005, CLIN CANCER RES, V11, P5581, DOI 10.1158/1078-0432.CCR-04-2585; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Nishimura I, 2008, NEUROSCIENCE, V154, P572, DOI 10.1016/j.neuroscience.2008.03.075; Novellino L, 2005, CANCER IMMUNOL IMMUN, V54, P187, DOI 10.1007/s00262-004-0560-6; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Pold M, 2000, DEV COMP IMMUNOL, V24, P719, DOI 10.1016/S0145-305X(00)00027-6; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; RONQUIST F, 2005, MRBAYES 3 1 MRBAYES; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Satta Y, 2004, J MOL EVOL, V59, P478, DOI 10.1007/s00239-004-2639-2; Sawai H, 2004, GENETICS, V166, P1897, DOI 10.1534/genetics.166.4.1897; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Smit AFA, 1996, CURR OPIN GENET DEV, V6, P743, DOI 10.1016/S0959-437X(96)80030-X; SONNHAMMER ELL, 1995, GENE-COMBIS, V167, P1; Stamatakis A, 2005, BIOINFORMATICS, V21, P456, DOI 10.1093/bioinformatics/bti191; Sugihara K, 2007, P NATL ACAD SCI USA, V104, P3799, DOI 10.1073/pnas.0611516104; TAKAHATA N, HUMANITY AFRICAN NAI, P299; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatsumi T, 2003, CLIN CANCER RES, V9, P947; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsunoda T, 1999, BIOINFORMATICS, V15, P622, DOI 10.1093/bioinformatics/15.7.622; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vujanovic L, 2007, CLIN CANCER RES, V13, P6796, DOI 10.1158/1078-0432.CCR-07-1909; Wang XF, 2007, CANCER IMMUNOL IMMUN, V56, P807, DOI 10.1007/s00262-006-0230-y; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; YU CL, 1995, SCIENCE, V269, P81, DOI 10.1126/science.7541555	67	30	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20365	10.1371/journal.pone.0020365	http://dx.doi.org/10.1371/journal.pone.0020365			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695252	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612600009
J	Murata, M; Fujimoto, H; Nishimura, K; Charoensuk, K; Nagamitsu, H; Raina, S; Kosaka, T; Oshima, T; Ogasawara, N; Yamada, M				Murata, Masayuki; Fujimoto, Hiroko; Nishimura, Kaori; Charoensuk, Kannikar; Nagamitsu, Hiroshi; Raina, Satish; Kosaka, Tomoyuki; Oshima, Taku; Ogasawara, Naotake; Yamada, Mamoru			Molecular Strategy for Survival at a Critical High Temperature in Eschierichia coli	PLOS ONE			English	Article							ESCHERICHIA-COLI; STATIONARY-PHASE; DNA-REPLICATION; GENE-EXPRESSION; RNA-POLYMERASE; SIGMA-FACTOR; CELL-LYSIS; RPOE GENE; PROTEIN; IDENTIFICATION	The molecular mechanism supporting survival at a critical high temperature (CHT) in Escherichia coli was investigated. Genome-wide screening with a single-gene knockout library provided a list of genes indispensable for growth at 47 degrees C, called thermotolerant genes. Genes for which expression was affected by exposure to CHT were identified by DNA chip analysis. Unexpectedly, the former contents did not overlap with the latter except for dnaJ and dnaK, indicating that a specific set of non- heat shock genes is required for the organism to survive under such a severe condition. More than half of the mutants of the thermotolerant genes were found to be sensitive to H2O2 at 30 degrees C, suggesting that the mechanism of thermotolerance partially overlaps with that of oxidative stress resistance. Their encoded enzymes or proteins are related to outer membrane organization, DNA double-strand break repair, tRNA modification, protein quality control, translation control or cell division. DNA chip analyses of essential genes suggest that many of the genes encoding ribosomal proteins are down-regulated at CHT. Bioinformatics analysis and comparison with the genomic information of other microbes suggest that E. coli possesses several systems for survival at CHT. This analysis allows us to speculate that a lipopolysaccharide biosynthesis system for outer membrane organization and a sulfur-relay system for tRNA modification have been acquired by horizontal gene transfer.	[Murata, Masayuki; Fujimoto, Hiroko; Nishimura, Kaori; Charoensuk, Kannikar; Nagamitsu, Hiroshi; Yamada, Mamoru] Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan; [Raina, Satish] Res Ctr Borstel, Div Med & Biochem Microbiol, Borstel, Germany; [Kosaka, Tomoyuki; Yamada, Mamoru] Yamaguchi Univ, Fac Agr, Dept Biol Chem, Yamaguchi 753, Japan; [Oshima, Taku; Ogasawara, Naotake] Nara Inst Sci & Technol, Grad Sch Informat Sci, Nara, Japan	Yamaguchi University; Forschungszentrum Borstel; Yamaguchi University; Nara Institute of Science & Technology	Murata, M (corresponding author), Yamaguchi Univ, Grad Sch Med, Ube, Yamaguchi 755, Japan.	m-yamada@yamaguchi-u.ac.jp	Raina, Satish/AAU-9550-2021; Ogasawara, Naotake/B-7971-2011	Raina, Satish/0000-0003-3175-4932; Yamada, Mamoru/0000-0003-4354-7324; Kosaka, Tomoyuki/0000-0002-8181-9127	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science (JSPS); National Research Council of Thailand (NRCT)	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT))	This work was supported by the Program for Promotion of Basic Research Activities for Innovative Biosciences and the Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science and Technology. This work was performed as collaborative research in the Asian Core Program between Yamaguchi University and Khon Kaen University, which was supported by the Scientific Cooperation Program agreed to by the Japan Society for the Promotion of Science (JSPS) and the National Research Council of Thailand (NRCT). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DE, 1996, J MOL BIOL, V263, P582, DOI 10.1006/jmbi.1996.0600; AIBA H, 1981, J BIOL CHEM, V256, P1905; Al Refaii A, 2009, MOL MICROBIOL, V71, P748, DOI 10.1111/j.1365-2958.2008.06561.x; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; AlDeib AA, 1996, J BACTERIOL, V178, P6782, DOI 10.1128/jb.178.23.6782-6789.1996; Arends SJR, 2010, J BACTERIOL, V192, P242, DOI 10.1128/JB.01244-09; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barak R, 1998, J BACTERIOL, V180, P985, DOI 10.1128/JB.180.4.985-988.1998; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Bennett RJ, 1996, P NATL ACAD SCI USA, V93, P12217, DOI 10.1073/pnas.93.22.12217; Bloor AE, 2006, APPL ENVIRON MICROB, V72, P2520, DOI 10.1128/AEM.72.4.2520-2525.2006; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Britton RA, 1997, GENETICS, V145, P867; CASSEY B, 1988, FEMS MICROBIOL LETT, V1159, P325; Dahl C, 2008, J MOL BIOL, V384, P1287, DOI 10.1016/j.jmb.2008.10.016; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davidson JF, 1996, P NATL ACAD SCI USA, V93, P5116, DOI 10.1073/pnas.93.10.5116; ERICKSON JW, 1989, GENE DEV, V3, P1462, DOI 10.1101/gad.3.9.1462; Fijalkowska IJ, 1997, J BACTERIOL, V179, P7435, DOI 10.1128/jb.179.23.7435-7445.1997; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Gerding MA, 2009, J BACTERIOL, V191, P7383, DOI 10.1128/JB.00811-09; Gunasekera TS, 2008, J BACTERIOL, V190, P3712, DOI 10.1128/JB.01990-07; GUPTA RS, 1995, MOL MICROBIOL, V15, P1, DOI 10.1111/j.1365-2958.1995.tb02216.x; HAYDON DJ, 1993, FEBS LETT, V336, P43, DOI 10.1016/0014-5793(93)81605-Y; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; Ikegami A, 2005, BIOSCI BIOTECH BIOCH, V69, P1595, DOI 10.1271/bbb.69.1595; Ikeuchi Y, 2006, MOL CELL, V21, P97, DOI 10.1016/j.molcel.2005.11.001; Kabir MS, 2005, MICROBIOL-SGM, V151, P2721, DOI 10.1099/mic.0.28004-0; KAMPFENKEL K, 1993, J BACTERIOL, V175, P4485, DOI 10.1128/JB.175.14.4485-4491.1993; KANG PJ, 1990, J BACTERIOL, V172, P2055, DOI 10.1128/jb.172.4.2055-2064.1990; Klein G, 2003, MOL MICROBIOL, V48, P269, DOI 10.1046/j.1365-2958.2003.03449.x; Klein G, 2009, J BIOL CHEM, V284, P15369, DOI 10.1074/jbc.M900490200; Kneidinger B, 2002, J BACTERIOL, V184, P363, DOI 10.1128/JB.184.2.363-369.2002; Lauhon CT, 2002, J BACTERIOL, V184, P6820, DOI 10.1128/JB.184.24.6820-6829.2002; LAUHON CT, 2000, J BIOL CHEM, V280, P26760; LEHNINGER AL, 1993, PROTEIN METABOLISM P, P892; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; LYNGSTADAAS A, 1995, MOL GEN GENET, V247, P546, DOI 10.1007/BF00290345; Mihara H, 2002, APPL MICROBIOL BIOT, V60, P12, DOI 10.1007/s00253-002-1107-4; Mogi T, 2006, BBA-BIOENERGETICS, V1757, P860, DOI 10.1016/j.bbabio.2006.05.043; MORIMOTO RI, 1996, TRANSCRIPTIONAL REGU, P139; Morita M, 1999, J BACTERIOL, V181, P401, DOI 10.1128/JB.181.2.401-410.1999; Motamedi MR, 1999, GENE DEV, V13, P2889, DOI 10.1101/gad.13.21.2889; Narberhaus F, 1998, MOL MICROBIOL, V28, P315, DOI 10.1046/j.1365-2958.1998.00794.x; Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nitta T, 2000, J BACTERIOL, V182, P5231, DOI 10.1128/JB.182.18.5231-5237.2000; Noor R, 2009, J MOL MICROB BIOTECH, V17, P177, DOI 10.1159/000236029; Ohara M, 1999, J BACTERIOL, V181, P4318, DOI 10.1128/JB.181.14.4318-4325.1999; Perron K, 2005, MOL MICROBIOL, V56, P1087, DOI 10.1111/j.1365-2958.2005.04597.x; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; RAINA S, 1991, NUCLEIC ACIDS RES, V19, P3811, DOI 10.1093/nar/19.14.3811; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; Rene O, 2011, NUCLEIC ACIDS RES, V39, P1855, DOI 10.1093/nar/gkq1049; Rojas DM, 2005, RES MICROBIOL, V156, P465, DOI 10.1016/j.resmic.2004.12.010; RONCERO C, 1992, J BACTERIOL, V174, P3250, DOI 10.1128/jb.174.10.3250-3260.1992; Rudolph B, 2010, J BIOL CHEM, V285, P19029, DOI 10.1074/jbc.M110.103374; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; Taylor SV, 1998, J BIOL CHEM, V273, P16555, DOI 10.1074/jbc.273.26.16555; Tehranchi AK, 2010, CELL, V141, P595, DOI 10.1016/j.cell.2010.03.036; Tomoyasu T, 1998, MOL MICROBIOL, V30, P567, DOI 10.1046/j.1365-2958.1998.01090.x; Tsunedomi R, 2003, J BACTERIOL, V185, P1783, DOI 10.1128/JB.185.6.1783-1795.2003; Uehara T, 2010, EMBO J, V29, P1412, DOI 10.1038/emboj.2010.36; Valentin-Hansen P, 2007, CURR OPIN MICROBIOL, V10, P152, DOI 10.1016/j.mib.2007.03.001; WALL D, 1992, J BACTERIOL, V174, P6554, DOI 10.1128/JB.174.20.6554-6562.1992; Watts T, 2009, J MOL BIOL, V391, P275, DOI 10.1016/j.jmb.2009.06.037; XIAO H, 1993, J BIOL CHEM, V268, P11779; Yamamoto N, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.92; Yura T, 2000, BACTERIAL STRESS RESPONSES, P3	70	54	56	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20063	10.1371/journal.pone.0020063	http://dx.doi.org/10.1371/journal.pone.0020063			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695201	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600005
J	Otalora-Luna, F; Dickens, JC				Otalora-Luna, Fernando; Dickens, Joseph C.			Multimodal Stimulation of Colorado Potato Beetle Reveals Modulation of Pheromone Response by Yellow Light	PLOS ONE			English	Article							LEPTINOTARSA-DECEMLINEATA SAY; AGGREGATION PHEROMONE; VISUAL ORIENTATION; COLEOPTERA; CHRYSOMELIDAE; HOST; SERVOSPHERE; INSECTS; FLIGHT; (S)-3,7-DIMETHYL-2-OXO-6-OCTENE-1,3-DIOL	Orientation of insects to host plants and conspecifics is the result of detection and integration of chemical and physical cues present in the environment. Sensory organs have evolved to be sensitive to important signals, providing neural input for higher order multimodal processing and behavioral output. Here we report experiments to determine decisions made by Colorado potato beetle (CPB), Leptinotarsa decemlineata, in response to isolated stimuli and multimodal combinations of signals on a locomotion compensator. Our results show that in complete darkness and in the absence of other stimuli, pheromonal stimulation increases attraction behavior of CPB as measured in oriented displacement and walking speed. However, orientation to the pheromone is abolished when presented with the alternative stimulation of a low intensity yellow light in a dark environment. The ability of the pheromone to stimulate these diurnal beetles in the dark in the absence of other stimuli is an unexpected but interesting observation. The predominance of the phototactic response over that to pheromone when low intensity lights were offered as choices seems to confirm the diurnal nature of the insect. The biological significance of the response to pheromone in the dark is unclear. The phototactic response will play a key role in elucidating multimodal stimulation in the host-finding process of CPB, and perhaps other insects. Such information might be exploited in the design of applications to attract and trap CPB for survey or control purposes and other insect pests using similar orientation mechanisms.	[Otalora-Luna, Fernando] Ctr Estudios Interdisciplinario Fis CEIF, Inst Venezolano Invest Cient IVIC, Lab Ecol Sensorial, Parroquia Jaji, Estado MeRIda, Venezuela; [Dickens, Joseph C.] ARS, Invas Insect Biocontrol & Behav Lab, Inst Plant Sci, Henry A Wallace Beltsville Agr Res Ctr,USDA, Beltsville, MD USA	United States Department of Agriculture (USDA)	Otalora-Luna, F (corresponding author), Ctr Estudios Interdisciplinario Fis CEIF, Inst Venezolano Invest Cient IVIC, Lab Ecol Sensorial, Parroquia Jaji, Estado MeRIda, Venezuela.	fotalora@ivic.gob.ve	Dickens, Dick/AGY-7295-2022; Luna, Fernando Otálora/R-9992-2019	Luna, Fernando Otálora/0000-0002-5313-2184	USDA; ARS; Potato Research Program; LOCTI contribution fund	USDA(United States Department of Agriculture (USDA)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Potato Research Program; LOCTI contribution fund	This work was partially supported by a grant provided to JCD from the USDA, ARS, Potato Research Program, and by a grant provided to FOL from the LOCTI contribution fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A., 2009, FRUIT VEG CEREAL SCI, V3, P10; Alyokhin AV, 1999, ENVIRON ENTOMOL, V28, P425, DOI 10.1093/ee/28.3.425; [Anonymous], 2010, R LANG ENV STAT COMP; Babu BN, 2009, TETRAHEDRON LETT, V50, P66, DOI 10.1016/j.tetlet.2008.10.092; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; Batschelet E, 1981, CIRCULAR STAT BIOL; Bell WJ, 1991, SEARCHING BEHAV BEHA, DOI DOI 10.1371/journal.pone.0086271; Boiteau G, 2005, ENVIRON ENTOMOL, V34, P1150, DOI 10.1603/0046-225X(2005)034[1150:VOONAP]2.0.CO;2; Chu CC, 2000, J ECON ENTOMOL, V93, P1329, DOI 10.1603/0022-0493-93.4.1329; Dickens Joseph C., 2000, Agricultural and Forest Entomology, V2, P167, DOI 10.1046/j.1461-9563.2000.00065.x; Doring TF, 2007, ENTOMOL GEN, V29, P81; Dusenbery D.B., 1992, SENSORY ECOLOGY ORGA; Edwards MA, 1997, CAN ENTOMOL, V129, P667, DOI 10.4039/Ent129667-4; ENDLER JA, 1990, BIOL J LINN SOC, V41, P315, DOI 10.1111/j.1095-8312.1990.tb00839.x; Fenk LM, 2010, J COMP PHYSIOL A, V196, P957, DOI 10.1007/s00359-010-0575-8; GRAHAM K, 1959, NATURE, V184, P283, DOI 10.1038/184283b0; Hammock JA, 2007, ARTHROPOD-PLANT INTE, V1, P27, DOI 10.1007/s11829-007-9005-4; Hausmann C, 2004, ENVIRON ENTOMOL, V33, P1410, DOI 10.1603/0046-225X-33.5.1410; JERMY T, 1988, ENTOMOL EXP APPL, V49, P83, DOI 10.1007/BF00188242; KITCHING RL, 1982, RES POPUL ECOL, V24, P224, DOI 10.1007/BF02515573; KRAMER E, 1976, PHYSIOL ENTOMOL, V1, P27, DOI 10.1111/j.1365-3032.1976.tb00883.x; Kuhar TP, 2006, AGR FOREST ENTOMOL, V8, P77, DOI 10.1111/j.1461-9555.2006.00286.x; Kulahci IG, 2008, P R SOC B, V275, P797, DOI 10.1098/rspb.2007.1176; LONNENDONKER U, 1993, J COMP PHYSIOL A, V172, P741, DOI 10.1007/BF00195399; MISCHKE U, 1981, Zoologische Beitraege, V27, P319; Oliver JE, 2002, TETRAHEDRON LETT, V43, P2641, DOI 10.1016/S0040-4039(02)00349-0; Omura H, 2005, OECOLOGIA, V142, P588, DOI 10.1007/s00442-004-1761-6; Otalora-Luna F, 2004, J COMP PHYSIOL A, V190, P847, DOI 10.1007/s00359-004-0540-5; Otalora-Luna F, 2011, ENTOMOL EXP APPL, V138, P93, DOI 10.1111/j.1570-7458.2010.01081.x; PROKOPY RJ, 1983, ANNU REV ENTOMOL, V28, P337, DOI 10.1146/annurev.en.28.010183.002005; Raguso RA, 2002, ANIM BEHAV, V64, P685, DOI 10.1006/anbe.2002.4010; Roderick GK, 2003, ANN ENTOMOL SOC AM, V96, P631, DOI 10.1603/0013-8746(2003)096[0631:SPICPB]2.0.CO;2; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; SHOREY H. H., 1965, ANN ENTOMOL SOC AMER, V58, P833, DOI 10.1093/aesa/58.6.833; Szentesi A, 2002, ENTOMOL EXP APPL, V105, P141, DOI 10.1023/A:1022194408297; Teder T, 2005, OIKOS, V108, P321, DOI 10.1111/j.0030-1299.2005.13609.x; VISSER JH, 1977, ENTOMOL EXP APPL, V21, P14, DOI 10.1007/BF00300336; ZEHNDER G, 1987, ENVIRON ENTOMOL, V16, P1199, DOI 10.1093/ee/16.5.1199; [No title captured]; [No title captured]; [No title captured]; [No title captured]	42	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20990	10.1371/journal.pone.0020990	http://dx.doi.org/10.1371/journal.pone.0020990			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695167	gold, Green Submitted, Green Published			2022-12-25	WOS:000291612600039
J	Robinson, P; Etheridge, S; Song, L; Shah, R; Fitzgerald, EM; Jones, OT				Robinson, Philip; Etheridge, Sarah; Song, Lele; Shah, Riddhi; Fitzgerald, Elizabeth M.; Jones, Owen T.			Targeting of Voltage-Gated Calcium Channel alpha(2)delta-1 Subunit to Lipid Rafts Is Independent from a GPI-Anchoring Motif	PLOS ONE			English	Article							PLASMA-MEMBRANE VESICLES; CA2+ CHANNELS; CELL-SURFACE; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHOR; QUANTITATIVE PROTEOMICS; ION CHANNELS; PROTEINS; DOMAIN; SECRETION; LOCALIZATION	Voltage-gated calcium channels (Ca-v) exist as heteromultimers comprising a pore-forming alpha(1) with accessory beta and alpha(2)delta subunits which modify channel trafficking and function. We previously showed that alpha(2)delta-1 (and likely the other mammalian alpha(2)delta isoforms - alpha(2)delta-2, 3 and 4) is required for targeting Ca(v)s to lipid rafts, although the mechanism remains unclear. Whilst originally understood to have a classical type I transmembrane (TM) topology, recent evidence suggests the alpha(2)delta subunit contains a glycosylphosphatidylinositol (GPI)-anchor that mediates its association with lipid rafts. To test this notion, we have used a strategy based on the expression of chimera, where the reported GPI-anchoring sequences in the gabapentinoid-sensitive alpha(2)delta-1 subunit have been substituted with those of a functionally inert Type I TM-spanning protein - PIN-G. Using imaging, electrophysiology and biochemistry, we find that lipid raft association of PIN-alpha(2)delta is unaffected by substitution of the GPI motif with the TM domain of PIN-G. Moreover, the presence of the GPI motif alone is not sufficient for raft localisation, suggesting that upstream residues are required. GPI-anchoring is susceptible to phosphatidylinositol-phospholipase C (PI-PLC) cleavage. However, whilst raft localisation of PIN-alpha(2)delta is disrupted by PI-PLC treatment, this is assay-dependent and non-specific effects of PI-PLC are observed on the distribution of the endogenous raft marker, caveolin, but not flotillin. Taken together, these data are most consistent with a model where alpha(2)delta-1 retains its type I transmembrane topology and its targeting to lipid rafts is governed by sequences upstream of the putative GPI anchor, that promote protein-protein, rather than lipid-lipid interactions.	[Robinson, Philip; Etheridge, Sarah; Song, Lele; Shah, Riddhi; Fitzgerald, Elizabeth M.; Jones, Owen T.] Univ Manchester, Fac Life Sci, Core Technol Facil, Manchester, Lancs, England	University of Manchester	Robinson, P (corresponding author), Univ Manchester, Fac Life Sci, Core Technol Facil, Manchester, Lancs, England.	Elizabeth.m.fitzgerald@manchester.ac.uk; Owen.t.jones@manchester.ac.uk			Medical Research Council, UK [81568]; MRC [G0700381] Funding Source: UKRI; Medical Research Council [G0700381] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by funds from the Medical Research Council, UK (Project Grant I.D. 81568 to EF and OJ). www.mrc.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balijepalli RC, 2006, P NATL ACAD SCI USA, V103, P7500, DOI 10.1073/pnas.0503465103; Bauer CS, 2010, CURR OPIN NEUROBIOL, V20, P563, DOI 10.1016/j.conb.2010.05.007; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bernstein GM, 2007, CELL CALCIUM, V41, P27, DOI 10.1016/j.ceca.2006.04.010; Bernstein GM, 1999, NEUROSCIENCE, V94, P1083, DOI 10.1016/S0306-4522(99)00371-1; Browman DT, 2007, TRENDS CELL BIOL, V17, P394, DOI 10.1016/j.tcb.2007.06.005; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chen Y, 2009, J CELL SCI, V122, P3966, DOI 10.1242/jcs.049346; Chichili GR, 2007, J BIOL CHEM, V282, P36682, DOI 10.1074/jbc.M702959200; Dai SP, 2009, PHYSIOL REV, V89, P411, DOI 10.1152/physrev.00029.2007; Dart C, 2010, J PHYSIOL-LONDON, V588, P3169, DOI 10.1113/jphysiol.2010.191585; Davies A, 2007, TRENDS PHARMACOL SCI, V28, P220, DOI 10.1016/j.tips.2007.03.005; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; Douglass AD, 2005, CELL, V121, P937, DOI 10.1016/j.cell.2005.04.009; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; ELLIOTT EM, 1995, J NEUROSCI, V15, P6433; Elortza F, 2003, MOL CELL PROTEOMICS, V2, P1261, DOI 10.1074/mcp.M300079-MCP200; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Felix R, 1997, J NEUROSCI, V17, P6884; FERGUSON MAJ, 1985, J BIOL CHEM, V260, P4547; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Ge MT, 2003, BIOPHYS J, V85, P1278, DOI 10.1016/S0006-3495(03)74563-9; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gurnett CA, 1997, J BIOL CHEM, V272, P18508, DOI 10.1074/jbc.272.29.18508; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Ibarguren M, 2011, J LIPID RES, V52, P635, DOI 10.1194/jlr.M012591; Incardona JP, 1996, MOL BIOL CELL, V7, P613, DOI 10.1091/mbc.7.4.613; Jacobo SMP, 2009, J PHARMACOL EXP THER, V330, P283, DOI 10.1124/jpet.109.150672; JAY SD, 1991, J BIOL CHEM, V266, P3287; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lundbaek JA, 2003, BIOPHYS J, V84, P2080, DOI 10.1016/S0006-3495(03)75015-2; MAYOR S, 1995, MOL BIOL CELL, V6, P929, DOI 10.1091/mbc.6.7.929; McKeown L, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-15; Muller CS, 2010, P NATL ACAD SCI USA, V107, P14950, DOI 10.1073/pnas.1005940107; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nikolaus J, 2010, BIOPHYS J, V99, P489, DOI 10.1016/j.bpj.2010.04.027; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; Poisson Guylaine, 2007, Genomics Proteomics & Bioinformatics, V5, P121, DOI 10.1016/S1672-0229(07)60022-9; Quinn PJ, 2010, PROG LIPID RES, V49, P390, DOI 10.1016/j.plipres.2010.05.002; Robinson P, 2010, CELL CALCIUM, V48, P183, DOI 10.1016/j.ceca.2010.08.006; Sandoval A, 2004, FEBS LETT, V576, P21, DOI 10.1016/j.febslet.2004.08.054; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Stetzkowski-Marden F, 2006, J LIPID RES, V47, P2121, DOI 10.1194/jlr.M600182-JLR200; Striessnig J, 2008, CHANNELS, V2, P233, DOI 10.4161/chan.2.4.5847; Stuermer CAO, 2011, BBA-MOL BASIS DIS, V1812, P415, DOI 10.1016/j.bbadis.2010.12.004; SU B, 1989, MOL CELL BIOL, V9, P3369, DOI 10.1128/MCB.9.8.3369; Toselli M, 2005, BIOPHYS J, V89, P2443, DOI 10.1529/biophysj.105.065623; Vacher H, 2008, PHYSIOL REV, V88, P1407, DOI 10.1152/physrev.00002.2008; Verghese GM, 2006, AM J PHYSIOL-CELL PH, V291, pC1258, DOI 10.1152/ajpcell.00637.2005; Wang JY, 1999, J MOL BIOL, V286, P1303, DOI 10.1006/jmbi.1999.2584; Watanabe K, 2008, BBA-BIOMEMBRANES, V1778, P2671, DOI 10.1016/j.bbamem.2008.09.011; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiser O, 1996, FEBS LETT, V379, P15, DOI 10.1016/0014-5793(95)01475-6; Woodman SE, 2002, J BIOL CHEM, V277, P38988, DOI 10.1074/jbc.M205511200; Xia FZ, 2007, ENDOCRINOLOGY, V148, P2157, DOI 10.1210/en.2006-1296; Zacks MA, 2006, MOL MEMBR BIOL, V23, P209, DOI 10.1080/09687860600601494	72	37	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e19802	10.1371/journal.pone.0019802	http://dx.doi.org/10.1371/journal.pone.0019802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695204	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600003
J	McGee, KC; Harte, AL; da Silva, NF; Al-Daghri, N; Creely, SJ; Kusminski, CM; Tripathi, G; Levick, PL; Khanolkar, M; Evans, M; Chittari, MV; Patel, V; Kumar, S; McTernan, PG				McGee, Kirsty C.; Harte, Alison L.; da Silva, Nancy F.; Al-Daghri, Nasser; Creely, Steven J.; Kusminski, Christine M.; Tripathi, Gyanendra; Levick, Paul L.; Khanolkar, Manish; Evans, Marc; Chittari, Madhu V.; Patel, Vinod; Kumar, Sudhesh; McTernan, Philip G.			Visfatin Is Regulated by Rosiglitazone in Type 2 Diabetes Mellitus and Influenced by NF kappa B and JNK in Human Abdominal Subcutaneous Adipocytes	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; ACTIVATED RECEPTOR-GAMMA; HUMAN ADIPOSE-TISSUE; PLASMA VISFATIN; INSULIN-RESISTANCE; GENE-EXPRESSION; VISCERAL FAT; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; ASIAN INDIANS	Visfatin has been proposed as an insulin-mimicking adipocytokine, predominantly secreted from adipose tissue and correlated with obesity. However, recent studies suggest visfatin may act as a proinflammatory cytokine. Our studies sought to determine the significance of this adipocytokine and its potential role in the pathogenesis of T2DM. Firstly, we examined the effects of diabetic status on circulating visfatin levels, and several other adipocytokines, demonstrating that diabetic status increased visfatin*, TNF-alpha*** and IL-6*** compared with non-diabetic subjects (*p<0.05, **p<0.01, ***p<0.001, respectively). We then assessed the effects of an insulin sensitizer, rosiglitazone (RSG), in treatment naive T2DM subjects, on circulating visfatin levels. Our findings showed that visfatin was reduced post-RSG treatment [vs. pre-treatment (*p<0.05)] accompanied by a reduction in HOMA-IR**, thus implicating a role for insulin in visfatin regulation. Further studies addressed the intracellular mechanisms by which visfatin may be regulated, and may exert pro-inflammatory effects, in human abdominal subcutaneous (Abd Sc) adipocytes. Following insulin (Ins) and RSG treatment, our in vitro findings highlighted that insulin (100 nM), alone, upregulated visfatin protein expression whereas, in combination with RSG (10 nM), it reduced visfatin*, IKK beta** and p-JNK1/2*. Furthermore, inhibition of JNK protein exacted a significant reduction in visfatin expression (**p<0.01), whilst NF-kappa B blockade increased visfatin (*p<0.05), thus identifying JNK as the more influential factor in visfatin regulation. Additional in vitro analysis on adipokines regulating visfatin showed that only Abd Sc adipocytes treated with recombinant human (rh)IL-6 increased visfatin protein (*p<0.05), whilst rh visfatin treatment, itself, had no influence on TNF-alpha, IL-6 or resistin secretion from Sc adipocytes. These data highlight visfatin's regulation by insulin and RSG, potentially acting through NF-kappa B and JNK mechanisms, with only rh IL-6 modestly affecting visfatin regulation. Taken together, these findings suggest that visfatin may represent a pro-inflammatory cytokine that is influenced by insulin/insulin sensitivity via the NF-kappa B and JNK pathways.	[McGee, Kirsty C.; Harte, Alison L.; da Silva, Nancy F.; Creely, Steven J.; Kusminski, Christine M.; Tripathi, Gyanendra; Chittari, Madhu V.; Kumar, Sudhesh; McTernan, Philip G.] UHCW Trust, Clin Sci Res Inst, Unit Diabet & Metab, Coventry, W Midlands, England; [Al-Daghri, Nasser] King Saud Univ, Coll Sci, Dept Biochem, Biomarkers Res Program, Riyadh 11451, Saudi Arabia; [Levick, Paul L.] Priory Hosp, BMI, Birmingham, W Midlands, England; [Khanolkar, Manish; Evans, Marc] Cardiff Univ, Heart Res Inst, Cardiff, S Glam, Wales; [Patel, Vinod] George Eliot Hosp NHS Trust, Ctr Diabet, Nuneaton, Warwick, England	University of Warwick; King Saud University; Cardiff University	McGee, KC (corresponding author), UHCW Trust, Clin Sci Res Inst, Unit Diabet & Metab, Coventry, W Midlands, England.	p.g.mcternan@warwick.ac.uk	Tripathi, Gyanendra/C-8832-2011; Al-Daghri, Nasser/G-7736-2011; Al-Daghri, Nasser/A-8360-2011; kumar, sudhesh/D-6945-2013	Al-Daghri, Nasser/0000-0001-5472-1725; Al-Daghri, Nasser/0000-0001-5472-1725; McTernan, Philip/0000-0001-9023-0261; Tripathi, Gyanendra/0000-0001-6889-706X; kumar, sudhesh/0000-0003-4326-5941	Birmingham Science City; The Department of Health; The British Heart Foundation	Birmingham Science City; The Department of Health; The British Heart Foundation(British Heart Foundation)	Birmingham Science City funded equipment that supported this research. The Department of Health provided a Department of Health studentship, which funded Kirsty McGee. The British Heart Foundation funded Dr. Alison Harte's BHF Intermediate Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aller R, 2009, DIGEST DIS SCI, V54, P1772, DOI 10.1007/s10620-008-0539-9; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang YC, 2010, METABOLISM, V59, P93, DOI 10.1016/j.metabol.2009.07.011; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Chen WP, 2010, CLIN CHEM LAB MED, V48, P1141, DOI 10.1515/CCLM.2010.230; Choi KC, 2005, BIOCHEM BIOPH RES CO, V336, P747, DOI 10.1016/j.bbrc.2005.08.203; Curat CA, 2006, DIABETOLOGIA, V49, P744, DOI 10.1007/s00125-006-0173-z; Dogru T, 2007, DIABETES RES CLIN PR, V76, P24, DOI 10.1016/j.diabres.2006.07.031; Filippatos TD, 2007, J ENDOCRINOL INVEST, V30, P323, DOI 10.1007/BF03346300; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Garten A, 2010, BIOCHEM BIOPH RES CO, V391, P376, DOI 10.1016/j.bbrc.2009.11.066; Haider DG, 2006, DIABETOLOGIA, V49, P1909, DOI 10.1007/s00125-006-0303-7; Haider DG, 2006, AM J PHYSIOL-ENDOC M, V291, pE885, DOI 10.1152/ajpendo.00109.2006; Hammarstedt A, 2006, J CLIN ENDOCR METAB, V91, P1181, DOI 10.1210/jc.2005-1395; Harte A, 2005, CIRCULATION, V111, P1954, DOI 10.1161/01.CIR.0000161954.17870.5D; Harte AL, 2003, DIABETES OBES METAB, V5, P302, DOI 10.1046/j.1463-1326.2003.00276.x; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Kendal CE, 2007, PLACENTA, V28, P305, DOI 10.1016/j.placenta.2006.03.011; Kim SR, 2008, BBA-MOL CELL RES, V1783, P886, DOI 10.1016/j.bbamcr.2008.01.004; Kloting N, 2005, BIOCHEM BIOPH RES CO, V332, P1070, DOI 10.1016/j.bbrc.2005.05.058; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Kralisch S, 2005, AM J PHYSIOL-ENDOC M, V289, pE586, DOI 10.1152/ajpendo.00090.2005; Liu SW, 2009, CLIN ENDOCRINOL, V71, P202, DOI 10.1111/j.1365-2265.2008.03453.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mayi TH, 2010, FEBS J, V277, P3308, DOI 10.1111/j.1742-4658.2010.07729.x; McTernan PG, 2003, J CLIN ENDOCR METAB, V88, P6098, DOI 10.1210/jc.2003-030898; McTernan PG, 2002, DIABETES, V51, P1493, DOI 10.2337/diabetes.51.5.1493; McTernan PG, 2000, INT J OBESITY, V24, P875, DOI 10.1038/sj.ijo.0801254; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; Ognjanovic S, 2001, J MOL ENDOCRINOL, V26, P107, DOI 10.1677/jme.0.0260107; Oki K, 2007, CLIN ENDOCRINOL, V67, P796, DOI 10.1111/j.1365-2265.2007.02966.x; Pagano C, 2006, J CLIN ENDOCR METAB, V91, P3165, DOI 10.1210/jc.2006-0361; Pfutzner A, 2007, HORM METAB RES, V39, P764, DOI 10.1055/s-2007-985867; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sandeep S, 2007, METABOLISM, V56, P565, DOI 10.1016/j.metabol.2006.12.005; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; SEO JA, 2007, PLASMA VISFATIN LEVE; Skop V, 2010, PHYSIOL RES, V59, P615, DOI 10.33549/physiolres.931845; Smith J, 2006, CLIN ENDOCRINOL, V65, P667, DOI 10.1111/j.1365-2265.2006.02647.x; Takebayashi K, 2007, METABOLISM, V56, P451, DOI 10.1016/j.metabol.2006.12.001; Varma V, 2007, J CLIN ENDOCR METAB, V92, P666, DOI 10.1210/jc.2006-1303; Xie H, 2007, CALCIFIED TISSUE INT, V80, P201, DOI 10.1007/s00223-006-0155-7; Zahorska-Markiewicz B, 2007, METABOLISM, V56, P1131, DOI 10.1016/j.metabol.2007.04.007; ZHU J, 2008, HORM METAB RES	46	29	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20287	10.1371/journal.pone.0020287	http://dx.doi.org/10.1371/journal.pone.0020287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694775	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900008
J	Shetty, A; Chen, SC; Tocheva, EI; Jensen, GJ; Hickey, WJ				Shetty, Ameesha; Chen, Shicheng; Tocheva, Elitza I.; Jensen, Grant J.; Hickey, William J.			Nanopods: A New Bacterial Structure and Mechanism for Deployment of Outer Membrane Vesicles	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; STATISTICAL-MODEL; VIRULENCE; PROTEIN	Background: Bacterial outer membrane vesicles (OMV) are packets of periplasmic material that, via the proteins and other molecules they contain, project metabolic function into the environment. While OMV production is widespread in proteobacteria, they have been extensively studied only in pathogens, which inhabit fully hydrated environments. However, many (arguably most) bacterial habitats, such as soil, are only partially hydrated. In the latter, water is characteristically distributed as films on soil particles that are, on average thinner, than are typical OMV (ca.<= 10 nm water film vs. 20 to > 200 nm OMV;). Methodology/Principal Findings: We have identified a new bacterial surface structure, termed a "nanopod'', that is a conduit for projecting OMV significant distances (e.g., >= 6 mu m) from the cell. Electron cryotomography was used to determine nanopod three-dimensional structure, which revealed chains of vesicles within an undulating, tubular element. By using immunoelectron microscopy, proteomics, heterologous expression and mutagenesis, the tubes were determined to be an assembly of a surface layer protein (NpdA), and the interior structures identified as OMV. Specific metabolic function(s) for nanopods produced by Delftia sp. Cs1-4 are not yet known. However, a connection with phenanthrene degradation is a possibility since nanopod formation was induced by growth on phenanthrene. Orthologs of NpdA were identified in three other genera of the Comamonadaceae family, and all were experimentally verified to form nanopods. Conclusions/Significance: Nanopods are new bacterial organelles, and establish a new paradigm in the mechanisms by which bacteria effect long-distance interactions with their environment. Specifically, they create a pathway through which cells can effectively deploy OMV, and the biological activity these transmit, in a diffusion-independent manner. Nanopods would thus allow environmental bacteria to expand their metabolic sphere of influence in a manner previously unknown for these organisms.	[Shetty, Ameesha; Hickey, William J.] Univ Wisconsin, Mol & Environm Toxicol Program, Madison, WI 53706 USA; [Chen, Shicheng; Hickey, William J.] Univ Wisconsin, Dept Soil Sci, ON Allen Lab Soil Microbiol, Madison, WI 53706 USA; [Tocheva, Elitza I.; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jensen, Grant J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Shetty, A (corresponding author), Univ Wisconsin, Mol & Environm Toxicol Program, Madison, WI 53706 USA.	wjhickey@wisc.edu	Chen, Shicheng/S-9340-2019; Hickey, William/HGC-5490-2022	Chen, Shicheng/0000-0001-6094-5514	NSF [MCB0920664]; NIH [R01 AI067548]; Natural Sciences and Engineering Research Council of Canada; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Direct For Biological Sciences [0920664] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067548] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by grants to WJH (NSF MCB0920664) and to GJJ (NIH R01 AI067548); EIT was supported by a Natural Sciences and Engineering Research Council of Canada Postdoctorate Fellowship. Sequencing and annotation of the Delftia sp. Cs1-4 genome was done by the U. S. Department of Energy Joint Genome Institute, through the Community Sequencing Project (CSP795673 to WJH). The work conducted by the U. S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U.S. Department of Energy under contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKITA EM, 1992, J FOOD SCI, V57, P629, DOI 10.1111/j.1365-2621.1992.tb08058.x; Bomberger JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000382; Camilli A, 2006, SCIENCE, V311, P1113, DOI 10.1126/science.1121357; Deatherage BL, 2009, MOL MICROBIOL, V72, P1395, DOI 10.1111/j.1365-2958.2009.06731.x; Dechesne A, 2010, P NATL ACAD SCI USA, V107, P14369, DOI 10.1073/pnas.1008392107; Dudler R, 2006, CURR OPIN BIOTECH, V17, P268, DOI 10.1016/j.copbio.2006.04.004; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; ENGELHARDT H, 1990, J STRUCT BIOL, V105, P92, DOI 10.1016/1047-8477(90)90103-J; Frias A, 2010, MICROB ECOL, V59, P476, DOI 10.1007/s00248-009-9622-9; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; HICKEY WJ, 1990, APPL ENVIRON MICROB, V56, P3842, DOI 10.1128/AEM.56.12.3842-3850.1990; Iancu CV, 2005, J STRUCT BIOL, V151, P288, DOI 10.1016/j.jsb.2005.07.004; KADURUGAMUWA JL, 1995, J BACTERIOL, V177, P3998, DOI 10.1128/jb.177.14.3998-4008.1995; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; LEMAIRE M, 1995, J BACTERIOL, V177, P2451, DOI 10.1128/jb.177.9.2451-2459.1995; Mashburn LM, 2005, NATURE, V437, P422, DOI 10.1038/nature03925; Mashburn-Warren L, 2008, GEOBIOLOGY, V6, P214, DOI 10.1111/j.1472-4669.2008.00157.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nieuwland R, 2010, THROMB RES, V125, pS49, DOI 10.1016/j.thromres.2010.01.037; Or D, 2007, ADV WATER RESOUR, V30, P1505, DOI 10.1016/j.advwatres.2006.05.025; Pinel N, 2008, INT J SYST EVOL MICR, V58, P2147, DOI 10.1099/ijs.0.65174-0; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06; Schwartzbach SD, 2010, METHODS MOL BIOL, V657, P1, DOI 10.1007/978-1-60761-783-9; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; Tashiro Y, 2010, APPL ENVIRON MICROB, V76, P3732, DOI 10.1128/AEM.02794-09; Vacca DJ, 2005, APPL ENVIRON MICROB, V71, P3797, DOI 10.1128/AEM.71.7.3797-3805.2005; Yaron S, 2000, APPL ENVIRON MICROB, V66, P4414, DOI 10.1128/AEM.66.10.4414-4420.2000; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	30	46	46	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20725	10.1371/journal.pone.0020725	http://dx.doi.org/10.1371/journal.pone.0020725			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687732	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000291607000020
J	Schulz, P; Fischer, C; Detjen, KM; Rieke, S; Hilfenhaus, G; von Marschall, Z; Bohmig, M; Koch, I; Kehrberger, J; Hauff, P; Thierauch, KH; Alves, F; Wiedenmann, B; Scholz, A				Schulz, Petra; Fischer, Christian; Detjen, Katharina M.; Rieke, Svenja; Hilfenhaus, Georg; von Marschall, Zofia; Boehmig, Michael; Koch, Inga; Kehrberger, Jenny; Hauff, Peter; Thierauch, Karl Heinz; Alves, Frauke; Wiedenmann, Bertram; Scholz, Arne			Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer	FASEB JOURNAL			English	Article						lymphangiogenesis; animal model; orthotopic	PHASE-III TRIAL; TUMOR ANGIOGENESIS; DIFFERENTIAL EXPRESSION; SERUM ANGIOPOIETIN-2; DISEASE PROGRESSION; ENDOTHELIAL-CELLS; IN-VIVO; GROWTH; RECEPTOR; COMBINATION	Lymphatic metastasis constitutes a critical route of disease dissemination, which limits the prognosis of patients with pancreatic ductal adenocarcinoma (PDAC). As lymphangiogenesis has been implicated in stimulation of lymphatic metastasis by vascular endothelial growth factor-C (VEGF-C) and VEGF-D, we studied the effect of the angioregulatory growth factor angiopoietin-2 (Ang-2) on PDAC progression. Ang-2 was found to be expressed in transformed cells of human PDAC specimens, with corresponding Tie-2 receptors present on blood and lymphatic endothelium. In vitro in PDAC cells, Ang-2 was subject to autocrine/paracrine TGF-beta stimulation (2-fold induction, P=0.0106) acting on the -61- to +476-bp element of the human Ang-2 promoter. In turn, Ang-2 regulated the expression of genes involved in cell motility and tumor suppression. Orthotopic PDAC xenografts with forced expression of Ang-2, but not Ang-1, displayed increased blood and lymphatic vessel density, and an enhanced rate of lymphatic metastasis (6.7- to 9.1-fold, P<0.01), which was prevented by sequestration of Ang-2 via coexpression of soluble Tie-2. Notably, elevated circulating Ang-2 in patients with PDAC correlated with the extent of lymphatic metastasis. Furthermore, median survival was reduced from 28.4 to 7.7 mo in patients with circulating Ang-2 >= 75th percentile (P=0.0005). These findings indicate that Ang-2 participates in the control of lymphatic metastasis, constitutes a noninvasive prognostic biomarker, and may provide an accessible therapeutic target in PDAC.-Schulz, P., Fischer, C., Detjen, K. M., Rieke, S., Hilfenhaus, G., von Marschall, Z., Bohmig, M., Koch, I., Kehrberger, J., Hauff, P., Thierauch, K.-H., Alves, F., Wiedenmann, B., Scholz, A. Angiopoietin-2 drives lymphatic metastasis of pancreatic cancer. FASEB J. 25, 3325-3335 (2011). www.fasebj.org	[Schulz, Petra; Fischer, Christian; Detjen, Katharina M.; Rieke, Svenja; Hilfenhaus, Georg; von Marschall, Zofia; Boehmig, Michael; Koch, Inga; Kehrberger, Jenny; Wiedenmann, Bertram; Scholz, Arne] Charite, Campus Virchow Klinikum, Med Klin Schwerpunkt Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Fischer, Christian; Detjen, Katharina M.; Hilfenhaus, Georg] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Hauff, Peter; Thierauch, Karl Heinz] Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany; [Alves, Frauke] Univ Gottingen, Klin Hamatol & Onkol, Gottingen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bayer AG; Bayer Healthcare Pharmaceuticals; University of Gottingen	Detjen, KM (corresponding author), Charite, Campus Virchow Klinikum, Med Klin Schwerpunkt Hepatol & Gastroenterol, Augustenburger Pl 1, D-13353 Berlin, Germany.	katharina.detjen@charite.de		Wiedenmann, Bertram/0000-0002-7890-2552; Hilfenhaus, Georg/0000-0001-8764-077X	Deutsche Forschungsgemeinschaft (DFG); Experimental and Clinical Research Center (Charite-Universitatsmedizin, Berlin, Germany); Speidel scholarship; Sonnenfeld Stiftung; Muggenburg Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Experimental and Clinical Research Center (Charite-Universitatsmedizin, Berlin, Germany); Speidel scholarship; Sonnenfeld Stiftung; Muggenburg Stiftung	A.S. was supported by a grant from Deutsche Forschungsgemeinschaft (DFG), P.S. was supported by a DFG scholarship, C.F. was supported by a grant from the Experimental and Clinical Research Center (Charite-Universitatsmedizin, Berlin, Germany), G.H. was supported by a Speidel scholarship, and K.M.D. and B.W. were supported by Sonnenfeld Stiftung and Muggenburg Stiftung. The authors thank Annett Rexin, Nicole Thiele, and Martina Welzel for expert technical support. This work was designed and initiated by Prof. Stefan Rosewicz (August 13, 1960 to May 20, 2004).	Ahmad SA, 2001, CANCER RES, V61, P1255; Audero E, 2001, ARTERIOSCL THROM VAS, V21, P536, DOI 10.1161/01.ATV.21.4.536; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Brown JL, 2010, MOL CANCER THER, V9, P145, DOI 10.1158/1535-7163.MCT-09-0554; Carlson TR, 2001, J BIOL CHEM, V276, P26516, DOI 10.1074/jbc.M100282200; Chen XY, 2009, NEUROSCI RES, V64, P348, DOI 10.1016/j.neures.2009.04.007; Detjen KM, 2010, CLIN CANCER RES, V16, P420, DOI 10.1158/1078-0432.CCR-09-1924; Durkin AJ, 2004, J AM COLL SURGEONS, V199, P724, DOI 10.1016/j.jamcollsurg.2004.07.021; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Fischer C, 2005, J BIOL CHEM, V280, P37266, DOI 10.1074/jbc.M411580200; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Ghaneh P, 2007, GUT, V56, P1134, DOI 10.1136/gut.2006.103333; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Hegen A, 2004, ARTERIOSCL THROM VAS, V24, P1803, DOI 10.1161/01.ATV.0000140819.81839.0e; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Hu B, 2006, CANCER RES, V66, P775, DOI 10.1158/0008-5472.CAN-05-1149; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Jo MJ, 2009, ANN SURG ONCOL, V16, P2052, DOI 10.1245/s10434-009-0474-9; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Karlan BY, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.5000; Kindler HL, 2010, J CLIN ONCOL, V28, P3617, DOI 10.1200/JCO.2010.28.1386; Koch M, 2009, J PATHOL, V219, P356, DOI 10.1002/path.2605; Kumpers P, 2008, BLOOD, V112, P2139, DOI 10.1182/blood-2007-12-130021; Kurahara H, 2004, CLIN CANCER RES, V10, P8413, DOI 10.1158/1078-0432.CCR-04-0379; Lee OH, 2006, NEOPLASIA, V8, P419, DOI 10.1593/neo.06109; Lewis CE, 2007, CANCER RES, V67, P8429, DOI 10.1158/0008-5472.CAN-07-1684; Mehlen P, 2004, J CLIN ONCOL, V22, P3420, DOI 10.1200/JCO.2004.02.019; Mita AC, 2010, CLIN CANCER RES, V16, P3044, DOI 10.1158/1078-0432.CCR-09-3368; Morrissey C, 2008, CLIN EXP METASTAS, V25, P377, DOI 10.1007/s10585-007-9116-4; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Park JH, 2007, CHEST, V132, P200, DOI 10.1378/chest.06-2915; Reiss Y, 2009, J PATHOL, V217, P571, DOI 10.1002/path.2484; Sarraf-Yazdi S, 2008, J SURG RES, V146, P16, DOI 10.1016/j.jss.2007.04.028; Schulz P, 2008, BRIT J CANCER, V99, P110, DOI 10.1038/sj.bjc.6604457; Seraj MJ, 2000, CANCER RES, V60, P2764; Sfiligoi C, 2003, INT J CANCER, V103, P466, DOI 10.1002/ijc.10851; Shim WSN, 2007, MOL CANCER RES, V5, P655, DOI 10.1158/1541-7786.MCR-07-0072; Simon MP, 2008, J CELL PHYSIOL, V217, P809, DOI 10.1002/jcp.21558; Smith RA, 2008, DIGEST SURG, V25, P226, DOI 10.1159/000140961; Sotgia F, 2006, AM J PATHOL, V168, P292, DOI 10.2353/ajpath.2006.050429; Stoeltzing O, 2003, CANCER RES, V63, P3370; Stoeltzing O, 2002, BRIT J CANCER, V87, P1182, DOI 10.1038/sj.bjc.6600598; Stratmann A, 2001, INT J CANCER, V91, P273, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1054>3.0.CO;2-Q; Tian S, 2002, BRIT J CANCER, V86, P645, DOI 10.1038/sj.bjc.6600082; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Villeneuve J, 2008, BRAIN PATHOL, V18, P401, DOI 10.1111/j.1750-3639.2008.00139.x; Von Marschall Z, 2005, INT J ONCOL, V27, P669; Wang J, 2005, BIOCHEM BIOPH RES CO, V337, P386, DOI 10.1016/j.bbrc.2005.09.051; Yoshiji H, 2005, GUT, V54, P1768, DOI 10.1136/gut.2005.067900; Yuan HT, 2009, MOL CELL BIOL, V29, P2011, DOI 10.1128/MCB.01472-08	53	49	52	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3325	3335		10.1096/fj.11-182287	http://dx.doi.org/10.1096/fj.11-182287			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21685330				2022-12-25	WOS:000295356400005
J	Rosell, FI; Kuo, HH; Mauk, AG				Rosell, Federico I.; Kuo, Hsin H.; Mauk, A. Grant			NADH Oxidase Activity of Indoleamine 2,3-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDES; NATURAL CIRCULAR-DICHROISM; L-TRYPTOPHAN; AUTOMATED DOCKING; DIFFERENT PEROXIDASES; MOLECULAR SIMULATION; HYDROGEN-PEROXIDE; SUBSTRATE-BINDING; SUPEROXIDE ANION; HUMAN-HEMOGLOBIN	The heme enzyme indoleamine 2,3-dioxygenase (IDO) was found to oxidize NADH under aerobic conditions in the absence of other enzymes or reactants. This reaction led to the formation of the dioxygen adduct of IDO and supported the oxidation of Trp to N-formylkynurenine. Formation of the dioxygen adduct and oxidation of Trp were accelerated by the addition of small amounts of hydrogen peroxide, and both processes were inhibited in the presence of either superoxide dismutase or catalase. Anaerobic reaction of IDO with NADH proceeded only in the presence of a mediator ( e. g. methylene blue) and resulted in formation of the ferrous form of the enzyme. We propose that trace amounts of peroxide previously proposed to occur in NADH solutions as well as solid NADH activate IDO and lead to aerobic formation of superoxide and the reactive dioxygen adduct of the enzyme.	[Mauk, A. Grant] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Ctr Blood Res, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Mauk, AG (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mauk@interchange.ubc.ca			Canadian Cancer Society; University of British Columbia; Canadian Foundation for Innovation; Centre for Blood Research	Canadian Cancer Society(Canadian Cancer Society (CCS)); University of British Columbia; Canadian Foundation for Innovation(Canada Foundation for Innovation); Centre for Blood Research	This work was supported in part by a grant from the Canadian Cancer Society.; Supported in part by a University of British Columbia university graduate fellowship.; Recipient of a Canada research chair. To whom correspondence should be addressed. Tel.: 604-822-3719; Fax: 604-822-6860; E-mail: mauk@interchange.ubc.ca.; We thank Dr. Marcia R. Mauk for developing the original IDO purification protocol, Dr. David S. Waugh for providing the polyHis-tagged TEV protease expression system, Drs. Susanne Ludwiczek and Tomoko Misono for expressing and purifying the TEV protease used, and Dr. Wei Chen for analysis of recombinant IDO by electrospray mass spectrometry. The Cary spectrophotometers and Applied Biosystems Q-Star mass spectrometers were obtained through grants from the Canadian Foundation for Innovation to the University of British Columbia Laboratory of Molecular Biophysics and the Centre for Blood Research.	Bellamacina CR, 1996, FASEB J, V10, P1257, DOI 10.1096/fasebj.10.11.8836039; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; BERNOFSKY C, 1982, J BIOL CHEM, V257, P6809; BERNOFSKY C, 1987, PYRIDINE NUCLEOTID B, P105; Brasen JC, 2004, ARCH BIOCHEM BIOPHYS, V431, P55, DOI 10.1016/j.abb.2004.07.019; BROWN WD, 1969, J BIOL CHEM, V244, P6702; Capece L, 2010, J BIOL INORG CHEM, V15, P811, DOI 10.1007/s00775-010-0646-x; CASHON R, 1986, J BIOL CHEM, V261, P2700; Chauhan N, 2008, BIOCHEMISTRY-US, V47, P4761, DOI 10.1021/bi702405a; Chung LW, 2008, J AM CHEM SOC, V130, P12299, DOI 10.1021/ja803107w; DOLIN MI, 1962, BIOCHIM BIOPHYS ACTA, V63, P219, DOI 10.1016/0006-3002(62)90361-X; EDGELL CJ, 1983, P NATL ACAD SCI-BIOL, V80, P3734, DOI 10.1073/pnas.80.12.3734; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; ESWAR N, 2006, CURRENT PROTOCOLS BI, V15; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; HALLIWELL B, 1978, PHOTOCHEM PHOTOBIOL, V28, P757, DOI 10.1111/j.1751-1097.1978.tb07013.x; HAYAISHI O, 1977, J BIOL CHEM, V252, P3548; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIRATA F, 1977, J BIOL CHEM, V252, P4637; Hull RV, 2001, BIOPHYS CHEM, V90, P9, DOI 10.1016/S0301-4622(00)00239-8; Hultquist D E, 1981, Prog Clin Biol Res, V55, P291; HULTQUIST DE, 1971, NATURE-NEW BIOL, V229, P252, DOI 10.1038/newbio229252a0; Irimia A, 2004, EMBO J, V23, P1234, DOI 10.1038/sj.emboj.7600147; ISHIMURA Y, 1970, J BIOL CHEM, V245, P3593; JACOBSEN MP, 1995, BBA-PROTEIN STRUCT M, V1246, P17, DOI 10.1016/0167-4838(94)00174-F; KAJITA A, 1970, BIOCHEM BIOPH RES CO, V39, P1199, DOI 10.1016/0006-291X(70)90688-1; Kirkor ES, 2000, ANAL CHEM, V72, P1381, DOI 10.1021/ac990957o; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; KOSOWER EM, 1978, J AM CHEM SOC, V100, P5185, DOI 10.1021/ja00484a047; KREHL WA, 1945, SCIENCE, V101, P489, DOI 10.1126/science.101.2628.489; Kummer U, 1996, BBA-GEN SUBJECTS, V1289, P397, DOI 10.1016/0304-4165(95)00176-X; LAND EJ, 1971, BIOCHIM BIOPHYS ACTA, V234, P34, DOI 10.1016/0005-2728(71)90126-5; Lewis-Ballester A, 2009, P NATL ACAD SCI USA, V106, P17371, DOI 10.1073/pnas.0906655106; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; LIVINGSTON DJ, 1985, J BIOL CHEM, V260, P5699; Lu CY, 2011, J BIOL CHEM, V286, P21220, DOI 10.1074/jbc.M111.221507; Lu CY, 2010, BIOCHEMISTRY-US, V49, P5028, DOI 10.1021/bi1005078; Lu CY, 2009, J AM CHEM SOC, V131, P12866, DOI 10.1021/ja9029768; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; MacKenzie CR, 2007, CURR DRUG METAB, V8, P237, DOI 10.2174/138920007780362518; Maghzal GJ, 2008, J BIOL CHEM, V283, P12014, DOI 10.1074/jbc.M710266200; MARMORSTEIN RQ, 1987, J BIOL CHEM, V262, P4922; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; MCCOMB RB, 1976, CLIN CHEM, V22, P141; MCDONALD G, 1972, BIOCHEMISTRY-US, V11, P1920, DOI 10.1021/bi00760a029; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; NAKAMURA S, 1969, NATURE, V222, P794, DOI 10.1038/222794a0; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; NISHIZUKA Y, 1963, J BIOL CHEM, V238, pP483; OGO S, 1989, J BIOL CHEM, V264, P11302; Olek RA, 2002, CLIN CHIM ACTA, V324, P129, DOI 10.1016/S0009-8981(02)00242-5; Oshima R, 2004, J MOL BIOL, V342, P207, DOI 10.1016/j.jmb.2004.07.009; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; PEARSON JT, BIOCHEMISTRY, V49, P2647; Poljak A, 2006, ARCH BIOCHEM BIOPHYS, V450, P9, DOI 10.1016/j.abb.2006.03.003; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SANNES LJ, 1979, BIOCHEM BIOPH RES CO, V91, P1309, DOI 10.1016/0006-291X(79)91209-9; SARMA RH, 1970, BIOCHEMISTRY-US, V9, P539, DOI 10.1021/bi00805a013; Scheeline A, 1997, CHEM REV, V97, P739, DOI 10.1021/cr960081a; Schenkman JB, 1999, DRUG METAB REV, V31, P351, DOI 10.1081/DMR-100101923; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; SONO M, 1986, BIOCHEMISTRY-US, V25, P6089, DOI 10.1021/bi00368a038; SONO M, 1984, BIOCHIM BIOPHYS ACTA, V789, P170, DOI 10.1016/0167-4838(84)90202-4; STELLWAGEN E, 1977, ACCOUNTS CHEM RES, V10, P92, DOI 10.1021/ar50111a004; STELLWAGEN E, 1990, METHOD ENZYMOL, V182, P343; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; SUTTON HC, 1976, BIOCHEM J, V155, P503, DOI 10.1042/bj1550503; SUZUKI T, 1992, J MOL BIOL, V228, P698, DOI 10.1016/0022-2836(92)90854-D; Suzuki T, 1996, BBA-GENE STRUCT EXPR, V1308, P41, DOI 10.1016/0167-4781(96)00059-0; Suzuki T, 2003, GENE, V308, P89, DOI 10.1016/S0378-1119(03)00467-0; Suzuki T, 1998, COMP BIOCHEM PHYS B, V121, P117, DOI 10.1016/S0305-0491(98)10086-X; SUZUKI T, 1994, J PROTEIN CHEM, V13, P9, DOI 10.1007/BF01891987; TANIGUCHI T, 1979, J BIOL CHEM, V254, P3288; UCHIDA K, 1983, J BIOL CHEM, V258, P2519; Valeur KR, 1996, BBA-GEN SUBJECTS, V1289, P377, DOI 10.1016/0304-4165(95)00174-3; van den Heuvel RHH, 2004, J BIOL CHEM, V279, P12860, DOI 10.1074/jbc.M313765200; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VELICK SF, 1961, S LIGHT LIFE, P108; Vlasits J, 2007, FEBS LETT, V581, P320, DOI 10.1016/j.febslet.2006.12.037; Vottero E, 2006, FEBS LETT, V580, P2265, DOI 10.1016/j.febslet.2006.03.034; VOTTERO ER, 2007, THESIS U BRIT COLUMB; WEBER G, 1957, NATURE, V180, P1409, DOI 10.1038/1801409a0; YAMAMOTO S, 1967, J BIOL CHEM, V242, P5260; YAMAZAKI I, 1967, BIOCHIM BIOPHYS ACTA, V132, P310, DOI 10.1016/0005-2744(67)90150-7; YAMAZAKI I, 1965, BIOCHEM BIOPH RES CO, V19, P249, DOI 10.1016/0006-291X(65)90513-9; Yanagisawa S, 2011, FARADAY DISCUSS, V148, P239, DOI 10.1039/c004552g; YOKOTA K, 1965, BIOCHIM BIOPHYS ACTA, V105, P301, DOI 10.1016/S0926-6593(65)80154-0	93	16	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29273	29283		10.1074/jbc.M111.262139	http://dx.doi.org/10.1074/jbc.M111.262139			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21690092	Green Published, hybrid			2022-12-25	WOS:000293837000062
J	Lavra, L; Rinaldo, C; Ulivieri, A; Luciani, E; Fidanza, P; Giacomelli, L; Bellotti, C; Ricci, A; Trovato, M; Soddu, S; Bartolazzi, A; Sciacchitano, S				Lavra, Luca; Rinaldo, Cinzia; Ulivieri, Alessandra; Luciani, Emidio; Fidanza, Paolo; Giacomelli, Laura; Bellotti, Carlo; Ricci, Alberto; Trovato, Maria; Soddu, Silvia; Bartolazzi, Armando; Sciacchitano, Salvatore			The Loss of the p53 Activator HIPK2 Is Responsible for Galectin-3 Overexpression in Well Differentiated Thyroid Carcinomas	PLOS ONE			English	Article							INTERACTING PROTEIN KINASE-2; CLINICOPATHOLOGICAL SIGNIFICANCE; ANTIAPOPTOTIC MOLECULE; GASTRIC-CANCER; DNA-DAMAGE; EXPRESSION; GENE; MUTATIONS; TRANSCRIPTION; APOPTOSIS	Background: Galectin-3 (Gal-3) is an anti-apoptotic molecule involved in thyroid cells transformation. It is specifically overexpressed in thyroid tumour cells and is currently used as a preoperative diagnostic marker of thyroid malignancy. Gal-3 expression is downregulated by wt-p53 at the transcriptional level. In well-differentiated thyroid carcinomas (WDTCs) there is an unexplained paradoxical concomitant expression of Gal-3 and wt-p53. HIPK2 is a co-regulator of different transcription factors, and modulates basic cellular processes mainly through the activation of wt-p53. Since we demonstrated that HIPK2 is involved in p53-mediated Gal-3 downregulation, we asked whether HIPK2 deficiency might be responsible for such paradoxical Gal-3 overexpression in WDTC. Methodology/Principal Findings: We analyzed HIPK2 protein and mRNA levels, as well as loss of heterozygosity (LOH) at the HIPK2 locus (7q32-34), in thyroid tissue samples. HIPK2 protein levels were high in all follicular hyperplasias (FHs) analyzed. Conversely, HIPK2 was undetectable in 91.7% of papillary thyroid carcinomas (PTCs) and in 60.0% of follicular thyroid carcinomas (FTCs). HIPK2 mRNA levels were upregulated in FH compared to normal thyroid tissue (NTT), while PTC showed mean HIPK2 mRNA levels lower than FH and, in 61.5% of cases, also lower than NTT. We found LOH at HIPK-2 gene locus in 37.5% of PTCs, 14.3% of FTCs and 18.2% of follicular adenomas. To causally link these data with Gal-3 upregulation, we performed in vitro experiments, using the PTC-derived K1 cells, in which HIPK2 expression was manipulated by RNA interference (RNAi) or plasmid-mediated overexpression. HIPK2 RNAi was associated with Gal-3 upregulation, while HIPK2 overexpression with Gal-3 downregulation. Conclusions/Significance: Our results indicate that HIPK2 expression and function are impaired in WDTCs, in particular in PTCs, and that this event explains Gal-3 overexpression typically observed in these types of tumours. Therefore, HIPK2 can be considered as a new tumour suppressor gene for thyroid cancers.	[Lavra, Luca; Ulivieri, Alessandra; Fidanza, Paolo; Sciacchitano, Salvatore] St Pietro Fatebenefratelli Hosp, Res Ctr, Rome, Italy; [Rinaldo, Cinzia; Soddu, Silvia] Regina Elena Inst Canc Res, Dept Expt Oncol, Mol Oncogenesis Lab, Rome, Italy; [Luciani, Emidio; Bartolazzi, Armando] St Andrea Univ Hosp, Dept Pathol, Rome, Italy; [Giacomelli, Laura] Univ Roma La Sapienza, Dept Surg Sci, Rome, Italy; [Bellotti, Carlo] Univ Roma La Sapienza, Chair Surg, St Andrea Hosp, Rome, Italy; [Ricci, Alberto; Sciacchitano, Salvatore] Univ Roma La Sapienza, Dept Clin & Mol Med, Rome, Italy; [Trovato, Maria] Univ Messina, Dept Human Pathol, Policlin G Martino Univ Hosp, Messina, Italy; [Bartolazzi, Armando] Karolinska Hosp, Cellular & Mol Tumour Pathol Lab, Canc Ctr Karolinska, S-10401 Stockholm, Sweden	IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; University of Messina; Karolinska Institutet; Karolinska University Hospital	Lavra, L (corresponding author), St Pietro Fatebenefratelli Hosp, Res Ctr, Rome, Italy.	soddu@ifo.it; Armando.Bartolazzi@cck.ki.se; salvatore.sciacchitano@uniroma1.it	Rinaldo, Cinzia/A-4252-2015; Soddu, Silvia/ABH-6774-2020; Sciacchitano, Salvatore/AAM-5895-2020; Giacomelli, Laura/K-2697-2018; Soddu, Silvia/K-2467-2018; Bartolazzi, Armando/K-9708-2016	Rinaldo, Cinzia/0000-0001-6124-762X; Soddu, Silvia/0000-0001-8526-0044; Sciacchitano, Salvatore/0000-0003-1492-5365; Soddu, Silvia/0000-0001-8526-0044; Trovato, Maria/0000-0001-8518-4918; Bartolazzi, Armando/0000-0001-7820-5127; GIACOMELLI, Laura/0000-0003-3598-7522; Ricci, Alberto/0000-0002-1718-1587	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C); Ministero della Salute-Bando Giovani Ricercatori	Associazione Italiana per la Ricerca sul Cancro (A.I.R.C)(Fondazione AIRC per la ricerca sul cancro); Ministero della Salute-Bando Giovani Ricercatori	L.L. is a recipient of a fellowships from Associazione Italiana per la Ricerca sul Cancro (A.I.R.C). This work was also supported by Ministero della Salute-Bando Giovani Ricercatori funded to C.R. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahani S, 1997, CANCER RES, V57, P5272; BARTEK J, 1993, J PATHOL, V169, P27, DOI 10.1002/path.1711690106; Bartolazzi A, 2001, LANCET, V357, P1644, DOI 10.1016/S0140-6736(00)04817-0; Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; Calzado MA, 2007, CELL CYCLE, V6, P139, DOI 10.4161/cc.6.2.3788; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; DONGHI R, 1993, J CLIN INVEST, V91, P1753, DOI 10.1172/JCI116385; FAGIN JA, 1993, J CLIN INVEST, V91, P179, DOI 10.1172/JCI116168; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Han SY, 2003, GENOMICS, V81, P105, DOI 10.1016/S0888-7543(02)00029-0; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Huang HJ, 1999, GENE CHROMOSOME CANC, V24, P48, DOI 10.1002/(SICI)1098-2264(199901)24:1<48::AID-GCC7>3.0.CO;2-V; Iacovelli S, 2009, CELL PROLIFERAT, V42, P373, DOI 10.1111/j.1365-2184.2009.00601.x; Kawachi K, 2000, HUM PATHOL, V31, P428, DOI 10.1053/hp.2000.6534; Kitamura Y, 2001, J CLIN ENDOCR METAB, V86, P4268, DOI 10.1210/jc.86.9.4268; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lavra L, 2009, J PATHOL, V218, P66, DOI 10.1002/path.2510; Lazzereschi D, 1998, INT J CANCER, V76, P806, DOI 10.1002/(SICI)1097-0215(19980610)76:6<806::AID-IJC7>3.0.CO;2-1; Li XL, 2007, ONCOGENE, V26, P7231, DOI 10.1038/sj.onc.1210523; Lin CL, 2009, MOL CANCER RES, V7, P1655, DOI 10.1158/1541-7786.MCR-09-0274; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Nikiforov YE, 2010, CANCER-AM CANCER SOC, V116, P1626, DOI 10.1002/cncr.24889; Okada K, 2006, ANTICANCER RES, V26, P1369; Piantelli M, 2002, J CLIN ONCOL, V20, P3850, DOI 10.1200/JCO.2002.01.078; Pierantoni GM, 2007, J CLIN INVEST, V117, P693, DOI 10.1172/JCI29852; Pierantoni GM, 2002, BIOCHEM BIOPH RES CO, V290, P942, DOI 10.1006/bbrc.2001.6310; Pierantoni GM, 2001, ONCOGENE, V20, P6132, DOI 10.1038/sj.onc.1204635; Rinaldo C, 2008, BBA-MOL CELL RES, V1783, P2124, DOI 10.1016/j.bbamcr.2008.06.006; Rinaldo C, 2007, BIOCHEM CELL BIOL, V85, P411, DOI 10.1139/O07-071; Robbins J, 2000, Rev Endocr Metab Disord, V1, P197, DOI 10.1023/A:1010031115233; Schneider AB, 2005, NAT CLIN PRACT ENDOC, V1, P82, DOI 10.1038/ncpendmet0022; Shimamura T, 2002, CLIN CANCER RES, V8, P2570; Trovato M, 2004, ENDOCR-RELAT CANCER, V11, P365, DOI 10.1677/erc.0.0110365; Ulivieri A, 2008, J PATHOL, V215, P87, DOI 10.1002/path.2331; Volante M, 2007, AM J SURG PATHOL, V31, P1256, DOI 10.1097/PAS.0b013e3180309e6a; VOLSI VAL, 2004, WHO CLASSIFICATION T, P49; Yoshii T, 2001, INT J ONCOL, V18, P787; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; Zenklusen JC, 2000, ONCOGENE, V19, P1729, DOI 10.1038/sj.onc.1203488; Zhang JS, 1998, ONCOGENE, V17, P789, DOI 10.1038/sj.onc.1201996	43	44	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20665	10.1371/journal.pone.0020665	http://dx.doi.org/10.1371/journal.pone.0020665			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698151	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600013
J	Bauer-Mehren, A; Bundschus, M; Rautschka, M; Mayer, MA; Sanz, F; Furlong, LI				Bauer-Mehren, Anna; Bundschus, Markus; Rautschka, Michael; Mayer, Miguel A.; Sanz, Ferran; Furlong, Laura I.			Gene-Disease Network Analysis Reveals Functional Modules in Mendelian, Complex and Environmental Diseases	PLOS ONE			English	Article							ARSENIC EXPOSURE; CANCER; DISORDERS; KNOWLEDGE; PATHWAYS; RISK	Background: Scientists have been trying to understand the molecular mechanisms of diseases to design preventive and therapeutic strategies for a long time. For some diseases, it has become evident that it is not enough to obtain a catalogue of the disease-related genes but to uncover how disruptions of molecular networks in the cell give rise to disease phenotypes. Moreover, with the unprecedented wealth of information available, even obtaining such catalogue is extremely difficult. Principal Findings: We developed a comprehensive gene-disease association database by integrating associations from several sources that cover different biomedical aspects of diseases. In particular, we focus on the current knowledge of human genetic diseases including mendelian, complex and environmental diseases. To assess the concept of modularity of human diseases, we performed a systematic study of the emergent properties of human gene-disease networks by means of network topology and functional annotation analysis. The results indicate a highly shared genetic origin of human diseases and show that for most diseases, including mendelian, complex and environmental diseases, functional modules exist. Moreover, a core set of biological pathways is found to be associated with most human diseases. We obtained similar results when studying clusters of diseases, suggesting that related diseases might arise due to dysfunction of common biological processes in the cell. Conclusions: For the first time, we include mendelian, complex and environmental diseases in an integrated gene-disease association database and show that the concept of modularity applies for all of them. We furthermore provide a functional analysis of disease-related modules providing important new biological insights, which might not be discovered when considering each of the gene-disease association repositories independently. Hence, we present a suitable framework for the study of how genetic and environmental factors, such as drugs, contribute to diseases. Availability: The gene-disease networks used in this study and part of the analysis are available at http://ibi.imim.es/DisGeNET/DisGeNETweb.html#Download.	[Bauer-Mehren, Anna; Rautschka, Michael; Mayer, Miguel A.; Sanz, Ferran; Furlong, Laura I.] Univ Pompeu Fabra, Hosp del Mar Res Inst, IMIM, Res Programme Biomed Informat GRIB, Barcelona, Spain; [Bundschus, Markus] Univ Munich, Inst Comp Sci, Munich, Germany	Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Pompeu Fabra University; University of Munich	Bauer-Mehren, A (corresponding author), Univ Pompeu Fabra, Hosp del Mar Res Inst, IMIM, Res Programme Biomed Informat GRIB, Barcelona, Spain.	lfurlong@imim.es	Mayer, Miguel Angel/K-5255-2014; Mayer, Miguel Angel/AAL-2810-2021; Gasull, Martina/J-4076-2019; Sanz, Ferran/B-3852-2009; Furlong, Laura I./AAX-1376-2020	Mayer, Miguel Angel/0000-0003-0362-6298; Mayer, Miguel Angel/0000-0003-0362-6298; Sanz, Ferran/0000-0002-7534-7661; Furlong, Laura I./0000-0002-9383-528X	European Commission [EU-ADR] [ICT-215847]; Innovative Medicines Initiative [eTOX] [115002]; AGAUR; Instituto de Salud Carlos III FEDER [CP10/00524]	European Commission [EU-ADR]; Innovative Medicines Initiative [eTOX]; AGAUR(Agencia de Gestio D'Ajuts Universitaris de Recerca Agaur (AGAUR)); Instituto de Salud Carlos III FEDER(Instituto de Salud Carlos III)	This work was supported by the European Commission [EU-ADR, ICT-215847], Innovative Medicines Initiative [eTOX, 115002], the AGAUR [to A.B.M.] and Instituto de Salud Carlos III FEDER (CP10/00524) grants. The Research Unit on Biomedical Informatics (GRIB) is a node of the Spanish National Institute of Bioinformatics (INB) and a member of the COMBIOMED network. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD NN, 1991, P NATL ACAD SCI USA, V88, P6624, DOI 10.1073/pnas.88.15.6624; Altman RB, 2007, NAT GENET, V39, P426, DOI 10.1038/ng0407-426; Ananiadou S, 2010, TRENDS BIOTECHNOL, V28, P381, DOI 10.1016/j.tibtech.2010.04.005; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Argos M, 2006, CANCER EPIDEM BIOMAR, V15, P1367, DOI 10.1158/1055-9965.EPI-06-0106; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Bau DT, 2002, ENVIRON HEALTH PERSP, V110, P753, DOI 10.1289/ehp.02110s5753; Bauer-Mehren A, 2010, BIOINFORMATICS, V26, P2924, DOI 10.1093/bioinformatics/btq538; Bauer-Mehren A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S6; Bauer-Mehren A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.47; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bundschus M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-207; Butts CT, 2009, SCIENCE, V325, P414, DOI 10.1126/science.1171022; Carreira S, 2006, GENE DEV, V20, P3426, DOI 10.1101/gad.406406; Celik I, 2008, ENVIRON RES, V108, P48, DOI 10.1016/j.envres.2008.04.001; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chavali S, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-78; CHIOU HY, 1995, CANCER RES, V55, P1296; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; De Luca L, 2008, EUR J HEART FAIL, V10, P201, DOI 10.1016/j.ejheart.2008.01.002; Dipple KM, 2000, MOL GENET METAB, V71, P43, DOI 10.1006/mgme.2000.3052; Duerr RH, 2003, J CLIN GASTROENTEROL, V37, P358, DOI 10.1097/00004836-200311000-00003; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Fernandez A, 2009, TRENDS PHARMACOL SCI, V30, P403, DOI 10.1016/j.tips.2009.06.001; Freudenberg J, 2002, BIOINFORMATICS, V18, pS110, DOI 10.1093/bioinformatics/18.suppl_2.S110; GABOR C, 2006, IGRAPH SOFTWARE PACK; De Lomana ALG, 2010, J COMPUT BIOL, V17, P869, DOI 10.1089/cmb.2008.0240; Garraway LA, 2006, CANCER RES, V66, P2506, DOI 10.1158/0008-5472.CAN-05-4604; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kann MG, 2010, BRIEF BIOINFORM, V11, P96, DOI 10.1093/bib/bbp048; Kennedy JA, 2000, J CARDIOVASC PHARM, V36, P794, DOI 10.1097/00005344-200012000-00016; Klein T. E., 2001, Pharmacogenomics Journal, V1, P167; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lima-Mendez G, 2009, MOL BIOSYST, V5, P1482, DOI 10.1039/b908681a; Lu ZY, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P269; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Mattingly CJ, 2006, TOXICOL SCI, V92, P587, DOI 10.1093/toxsci/kfl008; Melkoniemi M, 2000, AM J HUM GENET, V66, P368, DOI 10.1086/302750; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Park S, 2008, ASIAN PAC J CANCER P, V9, P371; Przulj N, 2004, BIOINFORMATICS, V20, P340, DOI 10.1093/bioinformatics/btg415; Radosavljevic V, 2008, J ENVIRON HEALTH, V71, P40; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; REEUWIJK J, 2005, CLIN GENET, V67, P281; Rubinstein R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-12; Sankaranarayanan R, 2010, ANN ONCOL; Scaldaferri F, 2007, J DIGEST DIS, V8, P171, DOI 10.1111/j.1751-2980.2007.00310.x; Scriver CR, 1999, TRENDS GENET, V15, P267, DOI 10.1016/S0168-9525(99)01761-8; Sharan R, 2007, MOL SYST BIOL, V3, P88; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Snead MP, 1999, J MED GENET, V36, P353; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Thun MJ, 2010, CARCINOGENESIS, V31, P100, DOI 10.1093/carcin/bgp263; TSUDA T, 1995, AM J EPIDEMIOL, V141, P198, DOI 10.1093/oxfordjournals.aje.a117421; Van Dongen S. M., 2000, GRAPH CLUSTERING FLO; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Yang CY, 2008, J TOXICOL ENV HEAL A, V71, P1559, DOI 10.1080/15287390802392065; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zaghloul NA, 2010, TRENDS GENET, V26, P168, DOI 10.1016/j.tig.2010.01.006	71	112	119	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20284	10.1371/journal.pone.0020284	http://dx.doi.org/10.1371/journal.pone.0020284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695124	Green Published, gold, Green Submitted			2022-12-25	WOS:000291682300006
J	Ochala, J; Ahlbeck, K; Radell, PJ; Eriksson, LI; Larsson, L				Ochala, Julien; Ahlbeck, Karsten; Radell, Peter J.; Eriksson, Lars I.; Larsson, Lars			Factors Underlying the Early Limb Muscle Weakness in Acute Quadriplegic Myopathy Using an Experimental ICU Porcine Model	PLOS ONE			English	Article							CRITICAL ILLNESS MYOPATHY; SKELETAL-MUSCLE; SARCOMERE-LENGTH; ANIMAL-MODEL; MECHANISMS; FIBERS; VELOCITY; MYOSIN; EXCITABILITY; INACTIVATION	The basic mechanisms underlying acquired generalized muscle weakness and paralysis in critically ill patients remain poorly understood and may be related to prolonged mechanical ventilation/immobilization (MV) or to other triggering factors such as sepsis, systemic corticosteroid (CS) treatment and administration of neuromuscular blocking agents (NMBA). The present study aims at exploring the relative importance of these factors by using a unique porcine model. Piglets were all exposed to MV together with different combinations of endotoxin-induced sepsis, CS and NMBA for five days. Peroneal motor nerve conduction velocity and amplitude of the compound muscle action potential (CMAP) as well as biceps femoris muscle biopsy specimens were obtained immediately after anesthesia on the first day and at the end of the 5-day experimental period. Results showed that peroneal nerve motor conduction velocity is unaffected whereas the size of the CMAP decreases independently of the type of intervention, in all groups after 5 days. Otherwise, despite a preserved size, muscle fibre specific force (maximum force normalized to cross-sectional area) decreased dramatically for animals exposed to MV in combination with CS or/and sepsis. These results suggest that the rapid declines in CMAP amplitude and in force generation capacity are triggered by independent mechanisms with significant clinical and therapeutic implications.	[Ochala, Julien; Larsson, Lars] Uppsala Univ, Dept Neurosci, Uppsala, Sweden; [Ahlbeck, Karsten; Radell, Peter J.; Eriksson, Lars I.] Karolinska Inst, Sect Anesthesiol & Intens Care Med, Stockholm, Sweden; [Larsson, Lars] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA	Uppsala University; Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Ochala, J (corresponding author), Uppsala Univ, Dept Neurosci, Uppsala, Sweden.	julien.ochala@neuro.uu.se	Larsson, Lars/AAY-1347-2021; Ochala, Julien/K-4120-2017	Ochala, Julien/0000-0002-6358-2920; Larsson, Lars/0000-0003-3722-035X	Swedish Research Council; Swedish Institute; Association Francaise contre les Myopathies; Stockholm County Council (ALF); KI Foundations; Swedish Research Council [8651]; King Gustaf V and Queen Victoria's Foundation; European Commission [EC Fp7CT, 223756, COST CM1001]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute; Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Stockholm County Council (ALF)(Stockholm County Council); KI Foundations; Swedish Research Council(Swedish Research CouncilEuropean Commission); King Gustaf V and Queen Victoria's Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was supported by grants from the Swedish Research Council, Swedish Institute and Association Francaise contre les Myopathies to JO, Stockholm County Council (ALF), and KI Foundations to PR, LIE, and from the Swedish Research Council (8651), Association Francaise contre les Myopathies, King Gustaf V and Queen Victoria's Foundation, and European Commission (MyoAge, EC Fp7CT&-223756, COST CM1001) to LL. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BANDUSEELA VC, 2009, PHYSL GENOMICS; Bolton CF, 1996, INTENS CARE MED, V22, P841; EDMAN KAP, 1979, J PHYSIOL-LONDON, V291, P143, DOI 10.1113/jphysiol.1979.sp012804; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Fitts RH, 2007, AM J PHYSIOL-CELL PH, V293, pC313, DOI 10.1152/ajpcell.00573.2006; Friedrich O, 2004, J NEUROL, V251, P53, DOI 10.1007/s00415-004-0272-z; Friedrich O, 2005, J NUTR, V135, p1813S, DOI 10.1093/jn/135.7.1813S; Friedrich O, 2006, CURR OPIN CLIN NUTR, V9, P403, DOI 10.1097/01.mco.0000232900.59168.a0; Frontera WR, 1997, MUSCLE NERVE, V20, P948, DOI 10.1002/(SICI)1097-4598(199708)20:8<948::AID-MUS3>3.0.CO;2-6; GOLDBERG AL, 1980, FED PROC, V39, P31; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Hudson LD, 2003, NEW ENGL J MED, V348, P745, DOI 10.1056/NEJMe020180; Khan J, 2008, CRIT CARE CLIN, V24, P165, DOI 10.1016/j.ccc.2007.10.004; LARSSON L, 1993, J PHYSIOL-LONDON, V472, P595, DOI 10.1113/jphysiol.1993.sp019964; Larsson L, 2000, CRIT CARE MED, V28, P34, DOI 10.1097/00003246-200001000-00006; Larsson L, 2007, CRIT CARE MED, V35, pS484, DOI 10.1097/01.CCM.0000278055.40121.54; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; MOSS RL, 1979, J PHYSIOL-LONDON, V292, P177, DOI 10.1113/jphysiol.1979.sp012845; MOSS RL, 1986, J PHYSIOL-LONDON, V377, P487, DOI 10.1113/jphysiol.1986.sp016199; Norman H, 2006, ACTA ANAESTH SCAND, V50, P1058, DOI 10.1111/j.1399-6576.2006.01105.x; Ochala J, 2008, EXP PHYSIOL, V93, P486, DOI 10.1113/expphysiol.2007.041798; Radell PJ, 2002, INTENS CARE MED, V28, P358, DOI 10.1007/s00134-002-1207-8; Reid MB, 2001, MED SCI SPORT EXER, V33, P371, DOI 10.1097/00005768-200103000-00006; Rich MM, 2003, J PHYSIOL-LONDON, V547, P555, DOI 10.1113/jphysiol.2002.035188; Rich MM, 1997, MUSCLE NERVE, V20, P665; Rich MM, 2001, ANN NEUROL, V50, P26, DOI 10.1002/ana.1016; Rich MM, 1998, ANN NEUROL, V43, P171, DOI 10.1002/ana.410430207; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; Schakman O, 2009, HORM RES, V72, P36, DOI 10.1159/000229762	29	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20876	10.1371/journal.pone.0020876	http://dx.doi.org/10.1371/journal.pone.0020876			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695079	Green Submitted, Green Published, gold			2022-12-25	WOS:000291682300017
J	Fulvini, AA; Ramanunninair, M; Le, JH; Pokorny, BA; Arroyo, JM; Silverman, J; Devis, R; Bucher, D				Fulvini, Andrew A.; Ramanunninair, Manojkumar; Le, Jianhua; Pokorny, Barbara A.; Arroyo, Jennifer Minieri; Silverman, Jeanmarie; Devis, Rene; Bucher, Doris			Gene Constellation of Influenza A Virus Reassortants with High Growth Phenotype Prepared as Seed Candidates for Vaccine Production	PLOS ONE			English	Article							AMINO-ACID CHANGE; REVERSE GENETICS; RT-PCR; GENERATION; HEMAGGLUTININ; RECOMBINANTS; SYSTEM; YIELD; IDENTIFICATION; ANTIGENICITY	Background: Influenza A virus vaccines undergo yearly reformulations due to the antigenic variability of the virus caused by antigenic drift and shift. It is critical to the vaccine manufacturing process to obtain influenza A seed virus that is antigenically identical to circulating wild type (wt) virus and grows to high titers in embryonated chicken eggs. Inactivated influenza A seasonal vaccines are generated by classical reassortment. The classical method takes advantage of the ability of the influenza virus to reassort based on the segmented nature of its genome. In ovo co-inoculation of a high growth or yield (hy) donor virus and a low yield wt virus with antibody selection against the donor surface antigens results in progeny viruses that grow to high titers in ovo with wt origin hemagglutinin (HA) and neuraminidase (NA) glycoproteins. In this report we determined the parental origin of the remaining six genes encoding the internal proteins that contribute to the hy phenotype in ovo. Methodology: The genetic analysis was conducted using reverse transcription-polymerase chain reaction (RT-PCR) and restriction fragment length polymorphism (RFLP). The characterization was conducted to determine the parental origin of the gene segments (hy donor virus or wt virus), gene segment ratios and constellations. Fold increase in growth of reassortant viruses compared to respective parent wt viruses was determined by hemagglutination assay titers. Significance: In this study fifty-seven influenza A vaccine candidate reassortants were analyzed for the presence or absence of correlations between specific gene segment ratios, gene constellations and hy reassortant phenotype. We found two gene ratios, 6:2 and 5:3, to be the most prevalent among the hy reassortants analyzed, although other gene ratios also conferred hy in certain reassortants.	[Fulvini, Andrew A.; Ramanunninair, Manojkumar; Le, Jianhua; Pokorny, Barbara A.; Arroyo, Jennifer Minieri; Silverman, Jeanmarie; Devis, Rene; Bucher, Doris] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA	New York Medical College	Fulvini, AA (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.	doris_bucher@nymc.edu			International Federation of Pharmaceutical Manufacturers and Associations-Influenza Vaccine Supply Task Force (IFPMA-IVS)	International Federation of Pharmaceutical Manufacturers and Associations-Influenza Vaccine Supply Task Force (IFPMA-IVS)	Research support for preparation of NYMC reassortants was provided by the International Federation of Pharmaceutical Manufacturers and Associations-Influenza Vaccine Supply Task Force (IFPMA-IVS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAEZ M, 1980, J INFECT DIS, V141, P362, DOI 10.1093/infdis/141.3.362; BOTH GW, 1983, P NATL ACAD SCI-BIOL, V80, P6996, DOI 10.1073/pnas.80.22.6996; Brett I, 2002, J VIROL METHODS, V100, P133, DOI 10.1016/S0166-0934(01)00412-8; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; FRANCIS T, 1945, AM J HYG, V42, P1; FRANCIS T, 1944, JAMA-J AM MED ASSOC, V124, P982; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; JOHANSSON BE, 1989, VIROLOGY, V171, P634, DOI 10.1016/0042-6822(89)90638-7; KILBOURN.ED, 1971, J INFECT DIS, V124, P449, DOI 10.1093/infdis/124.5.449; KILBOURN.ED, 1969, B WORLD HEALTH ORGAN, V41, P643; KILBOURNE ED, 1978, P NATL ACAD SCI USA, V75, P6258, DOI 10.1073/pnas.75.12.6258; KILBOURNE ED, 1960, J EXP MED, V111, P387, DOI 10.1084/jem.111.3.387; KILBOURNE ED, 1988, P NATL ACAD SCI USA, V85, P7782, DOI 10.1073/pnas.85.20.7782; KLIMOV A, 1983, ACTA VIROL, V27, P434; LEIBOVIT.A, 1971, J INFECT DIS, V124, P481, DOI 10.1093/infdis/124.5.481; Liu T, 2002, VIROLOGY, V304, P89, DOI 10.1006/viro.2002.1669; MCCAHON D, 1972, J GEN VIROL, V15, P73, DOI 10.1099/0022-1317-15-1-73; Neumann G, 2005, P NATL ACAD SCI USA, V102, P16825, DOI 10.1073/pnas.0505587102; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Offringa DP, 2000, J VIROL METHODS, V88, P15, DOI 10.1016/S0166-0934(00)00180-4; Osterhaus ADME, 2008, VACCINE, V26, pD1, DOI 10.1016/j.vaccine.2008.07.073; OXFORD JS, 1978, NATURE, V273, P778, DOI 10.1038/273778a0; Palese P., 2007, FIELDS VIROLOGY, P1647; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Robertson JS, 2011, VACCINE, V29, P1836, DOI 10.1016/j.vaccine.2010.12.044; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Rudneva IA, 2007, ARCH VIROL, V152, P1139, DOI 10.1007/s00705-006-0931-8; Sakamoto S, 1996, J VIROL METHODS, V56, P161, DOI 10.1016/0166-0934(95)01909-X; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; World Health Organization Department of Communicable Disease Surveillance and Response, 2002, WORLD HLTH REP 2002, P32	32	42	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20823	10.1371/journal.pone.0020823	http://dx.doi.org/10.1371/journal.pone.0020823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695145	gold, Green Submitted, Green Published			2022-12-25	WOS:000291663300022
J	Sample, SJ; Hao, ZL; Wilson, AP; Muir, P				Sample, Susannah J.; Hao, Zhengling; Wilson, Aliya P.; Muir, Peter			Role of Calcitonin Gene-Related Peptide in Bone Repair after Cyclic Fatigue Loading	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; FUNCTIONAL ADAPTATION; NERVOUS-SYSTEM; MATRIX MICRODAMAGE; SENSORY FIBERS; SUBSTANCE-P; MOUSE FEMUR; CGRP; RAT; CELLS	Background: Calcitonin gene related peptide (CGRP) is a neuropeptide that is abundant in the sensory neurons which innervate bone. The effects of CGRP on isolated bone cells have been widely studied, and CGRP is currently considered to be an osteoanabolic peptide that has effects on both osteoclasts and osteoblasts. However, relatively little is known about the physiological role of CGRP in-vivo in the skeletal responses to bone loading, particularly fatigue loading. Methodology/Principal Findings: We used the rat ulna end-loading model to induce fatigue damage in the ulna unilaterally during cyclic loading. We postulated that CGRP would influence skeletal responses to cyclic fatigue loading. Rats were fatigue loaded and groups of rats were infused systemically with 0.9% saline, CGRP, or the receptor antagonist, CGRP(8-37), for a 10 day study period. Ten days after fatigue loading, bone and serum CGRP concentrations, serum tartrate-resistant acid phosphatase 5b (TRAP5b) concentrations, and fatigue-induced skeletal responses were quantified. We found that cyclic fatigue loading led to increased CGRP concentrations in both loaded and contralateral ulnae. Administration of CGRP(8-37) was associated with increased targeted remodeling in the fatigue-loaded ulna. Administration of CGRP or CGRP(8-37) both increased reparative bone formation over the study period. Plasma concentration of TRAP5b was not significantly influenced by either CGRP or CGRP(8-37) administration. Conclusions: CGRP signaling modulates targeted remodeling of microdamage and reparative new bone formation after bone fatigue, and may be part of a neuronal signaling pathway which has regulatory effects on load-induced repair responses within the skeleton.	[Sample, Susannah J.; Hao, Zhengling; Wilson, Aliya P.; Muir, Peter] Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sample, SJ (corresponding author), Univ Wisconsin, Sch Vet Med, Comparat Orthopaed Res Lab, Madison, WI 53706 USA.	muirp@vetmed.wisc.edu	Muir, Peter/AAH-8057-2021	Muir, Peter/0000-0003-0028-6005	AO Foundation Switzerland [S-06-9M]; National Institutes of Health [T32 RR17503, T32 RR023916]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR023916, T32RR017503] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD010423] Funding Source: NIH RePORTER	AO Foundation Switzerland; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by a grant from the AO Research Fund of the AO Foundation Switzerland (Project S-06-9M). Susannah J. Sample also received support from National Institutes of Health (T32 RR17503 and T32 RR023916). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARA SG, 1985, SCIENCE, V229, P1094, DOI 10.1126/science.2994212; Ballica R, 1999, J BONE MINER RES, V14, P1067, DOI 10.1359/jbmr.1999.14.7.1067; Bergula AP, 1999, BONE, V24, P171, DOI 10.1016/S8756-3282(98)00165-3; BERNARD GW, 1990, PEPTIDES, V11, P625, DOI 10.1016/0196-9781(90)90171-Z; Boyce BF, 2008, ARCH BIOCHEM BIOPHYS, V473, P139, DOI 10.1016/j.abb.2008.03.018; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Burr DB, 1997, J BONE MINER RES, V12, P6, DOI 10.1359/jbmr.1997.12.1.6; Burr DB, 2002, BONE, V30, P2, DOI 10.1016/S8756-3282(01)00619-6; Chenu C., 2004, Journal of Musculoskeletal & Neuronal Interactions, V4, P132; Cornish J, 1999, J BONE MINER RES, V14, P1302, DOI 10.1359/jbmr.1999.14.8.1302; de Souza RL, 2005, J BONE MINER RES, V20, P2159, DOI 10.1359/JBMR.050812; Drissi H, 1997, J BONE MINER RES, V12, P1805, DOI 10.1359/jbmr.1997.12.11.1805; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; Frost HM, 2001, ANAT RECORD, V262, P398, DOI 10.1002/ar.1049; Gangula PRR, 2002, BIOL REPROD, V67, P1881, DOI 10.1095/biolreprod.102.007682; Gangula PRR, 2000, HYPERTENSION, V35, P470, DOI 10.1161/01.HYP.35.1.470; GREENBERG B, 1987, BRIT J PHARMACOL, V92, P789, DOI 10.1111/j.1476-5381.1987.tb11382.x; Gross TS, 1999, J APPL PHYSIOL, V86, P230, DOI 10.1152/jappl.1999.86.1.230; HAEGERSTRAND A, 1990, P NATL ACAD SCI USA, V87, P3299, DOI 10.1073/pnas.87.9.3299; HAN SP, 1990, J PHARMACOL EXP THER, V255, P423; Hay DL, 2007, CLIN EXP PHARMACOL P, V34, P963, DOI 10.1111/j.1440-1681.2007.04703.x; Hay DL, 2005, MOL PHARMACOL, V67, P1655, DOI 10.1124/mol.104.008615; Henriksen K, 2007, OSTEOPOROSIS INT, V18, P681, DOI 10.1007/s00198-006-0286-8; HILL EL, 1991, CELL TISSUE RES, V264, P469, DOI 10.1007/BF00319037; Hirt D, 1997, PEPTIDES, V18, P1461, DOI 10.1016/S0196-9781(97)00199-X; HOHMANN EL, 1986, SCIENCE, V232, P868, DOI 10.1126/science.3518059; HUKKANEN M, 1992, J RHEUMATOL, V19, P1252; Imai S, 1997, J BONE MINER RES, V12, P1018, DOI 10.1359/jbmr.1997.12.7.1018; Irie K, 2002, MICROSC RES TECHNIQ, V58, P85, DOI 10.1002/jemt.10122; Ishizuka K, 2005, NEUROSCI LETT, V379, P47, DOI 10.1016/j.neulet.2004.12.046; Ivanusic JJ, 2009, J COMP NEUROL, V517, P276, DOI 10.1002/cne.22160; KELLY PJ, 1990, MICROVASC RES, V39, P364, DOI 10.1016/0026-2862(90)90049-W; Konttinen YT, 1996, ACTA ORTHOP SCAND, V67, P632, DOI 10.3109/17453679608997772; Kotha SP, 2004, J BIOMECH, V37, P541, DOI 10.1016/j.jbiomech.2003.08.009; KUBOTA M, 1985, BIOCHEM BIOPH RES CO, V132, P88, DOI 10.1016/0006-291X(85)90992-1; Lerner U. H., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P440; Lerner U. H., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P154; Li L, 2007, J ORTHOP RES, V25, P1204, DOI 10.1002/jor.20406; Mach DB, 2002, NEUROSCIENCE, V113, P155, DOI 10.1016/S0306-4522(02)00165-3; Martin CD, 2007, NEUROSCI LETT, V427, P148, DOI 10.1016/j.neulet.2007.08.055; Mrak E, 2010, J CELL PHYSIOL, V225, P701, DOI 10.1002/jcp.22266; Muir P, 2006, BONE, V38, P342, DOI 10.1016/j.bone.2005.08.020; Muir P, 1999, BONE, V25, P571, DOI 10.1016/S8756-3282(99)00205-7; Muir P, 2007, BONE, V40, P948, DOI 10.1016/j.bone.2006.11.012; Naot D, 2008, BONE, V43, P813, DOI 10.1016/j.bone.2008.07.003; OWAN I, 1994, BONE MINER, V24, P151, DOI 10.1016/S0169-6009(08)80152-3; Reinshagen M, 1998, J PHARMACOL EXP THER, V286, P657; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Sample SJ, 2008, J BONE MINER RES, V23, P1372, DOI [10.1359/jbmr.080407, 10.1359/JBMR.080407]; Sample SJ, 2010, J BONE MINER RES, V25, P2016, DOI 10.1002/jbmr.101; Schinke T, 2004, J BONE MINER RES, V19, P2049, DOI 10.1359/JBMR.040915; Spencer GJ, 2004, FEBS LETT, V559, P6, DOI 10.1016/S0014-5793(04)00053-5; Tabarowski Z, 1996, ACTA HISTOCHEM, V98, P453, DOI 10.1016/S0065-1281(96)80013-4; Tilakaratne N, 2000, J PHARMACOL EXP THER, V294, P61; Uzan B, 2008, J CELL PHYSIOL, V215, P122, DOI 10.1002/jcp.21294; Valentijn K, 1997, BONE, V21, P269, DOI 10.1016/S8756-3282(97)00142-7; Villa I, 2003, AM J PHYSIOL-ENDOC M, V284, pE627, DOI 10.1152/ajpendo.00307.2002; Wang LP, 2010, BONE, V46, P1369, DOI 10.1016/j.bone.2009.11.029; Wimalawansa SJ, 1996, ENDOCR REV, V17, P533, DOI 10.1210/er.17.5.533; Wu Q, 2009, NEUROSCI LETT, V463, P254, DOI 10.1016/j.neulet.2009.07.078; Yoneda T, 2011, BONE, V48, P100, DOI 10.1016/j.bone.2010.07.009; Yu LC, 2009, NEUROSCI BIOBEHAV R, V33, P1185, DOI 10.1016/j.neubiorev.2009.03.009; ZAIDI M, 1987, J ENDOCRINOL, V115, P511, DOI 10.1677/joe.0.1150511	63	32	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20386	10.1371/journal.pone.0020386	http://dx.doi.org/10.1371/journal.pone.0020386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694766	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900009
J	Cheng, S; Kirton, LG; Panandam, JM; Siraj, SS; Ng, KKS; Tan, SG				Cheng, Shawn; Kirton, Laurence G.; Panandam, Jothi M.; Siraj, Siti S.; Ng, Kevin Kit-Siong; Tan, Soon-Guan			Evidence for a Higher Number of Species of Odontotermes (Isoptera) than Currently Known from Peninsular Malaysia from Mitochondrial DNA Phylogenies	PLOS ONE			English	Article							FUNGUS-GROWING TERMITES; MACROTERMITINAE; EVOLUTION; MORPHOLOGY; GENE	Termites of the genus Odontotermes are important decomposers in the Old World tropics and are sometimes important pests of crops, timber and trees. The species within the genus often have overlapping size ranges and are difficult to differentiate based on morphology. As a result, the taxonomy of Odontotermes in Peninsular Malaysia has not been adequately worked out. In this study, we examined the phylogeny of 40 samples of Odontotermes from Peninsular Malaysia using two mitochondrial DNA regions, that is, the 16S ribosomal RNA and cytochrome oxidase subunit I genes, to aid in elucidating the number of species in the peninsula. Phylogenies were reconstructed from the individual gene and combined gene data sets using parsimony and likelihood criteria. The phylogenies supported the presence of up to eleven species in Peninsular Malaysia, which were identified as O. escherichi, O. hainanensis, O. javanicus, O. longignathus, O. malaccensis, O. oblongatus, O. paraoblongatus, O. sarawakensis, and three possibly new species. Additionally, some of our taxa are thought to comprise a complex of two or more species. The number of species found in this study using DNA methods was more than the initial nine species thought to occur in Peninsular Malaysia. The support values for the clades and morphology of the soldiers provided further evidence for the existence of eleven or more species. Higher resolution genetic markers such as microsatellites would be required to confirm the presence of cryptic species in some taxa.	[Cheng, Shawn; Kirton, Laurence G.; Ng, Kevin Kit-Siong] Forest Res Inst Malaysia, Trop Forest Biodivers Ctr, Kepong, Selangor, Malaysia; [Panandam, Jothi M.; Siraj, Siti S.] Univ Putra Malaysia, Fac Agr, Serdang, Malaysia; [Cheng, Shawn; Tan, Soon-Guan] Univ Putra Malaysia, Fac Biotechnol & Biomol Sci, Serdang, Selangor, Malaysia	Institute Penyelidikan Perhutanan Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Cheng, S (corresponding author), Forest Res Inst Malaysia, Trop Forest Biodivers Ctr, Kepong, Selangor, Malaysia.	shawn@frim.gov.my; sgtan_98@yahoo.com	Tan, Soon Guan/V-1782-2019; Cheng, Shawn/ABC-3064-2021; Ng, Kevin/F-9489-2012; Tan, S G/B-2448-2010	Tan, Soon Guan/0000-0001-9960-4493; Tan, S G/0000-0001-9960-4493; Ng, Kevin Kit Siong/0000-0002-7810-7575	Ministry of Natural Resources and Environment, Malaysia	Ministry of Natural Resources and Environment, Malaysia	The work was funded by the Ministry of Natural Resources and Environment, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; AHMAD M., 1958, BIOLOGIA [PAKISTAN], V4, P33; AHMAD MUZAFFER, 1965, BULL AMER MUS NATUR HIST, V131, P1; Bignell DE, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P363; Chhotani O. B., 1997, FAUNA INDIA ISOPTERA, V2; Darlington JPEC, 2008, INSECT SOC, V55, P256, DOI 10.1007/s00040-008-1012-7; Darlington JPEC, 1997, INSECT SOC, V44, P393, DOI 10.1007/s000400050060; Davison D, 2001, INSECT SOC, V48, P138, DOI 10.1007/PL00001756; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Holmgren N, 1913, KUNGLIGA SVENSKA VET, V50, P1; Kambhampati S, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P1; Kirton LG, 2007, J TROP FOR SCI, V19, P67; Liu H, 1992, MOL PHYLOGENET EVOL, V1, P41, DOI 10.1016/1055-7903(92)90034-E; Mitchell JD, 2002, SOCIOBIOLOGY, V40, P47; Posada D, 2006, COLLAPSE DESCRIBING; Roonwal ML, 1986, ZOOL ANZ, V178, P236; Rouland-Lefevre C, 2000, TERMITES: EVOLUTION, SOCIALITY, SYMBIOSES, ECOLOGY, P289; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; THO YP, 1991, MALAYAN FOREST RECOR, V36	21	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20992	10.1371/journal.pone.0020992	http://dx.doi.org/10.1371/journal.pone.0020992			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687629	gold, Green Published, Green Submitted			2022-12-25	WOS:000291611500057
J	Fridley, BL; Iversen, E; Tsai, YY; Jenkins, GD; Goode, EL; Sellers, TA				Fridley, Brooke L.; Iversen, Ed; Tsai, Ya-Yu; Jenkins, Gregory D.; Goode, Ellen L.; Sellers, Thomas A.			A Latent Model for Prioritization of SNPs for Functional Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POPULATION; SCAN	One difficult question facing researchers is how to prioritize SNPs detected from genetic association studies for functional studies. Often a list of the top M SNPs is determined based on solely the p-value from an association analysis, where M is determined by financial/time constraints. For many studies of complex diseases, multiple analyses have been completed and integrating these multiple sets of results may be difficult. One may also wish to incorporate biological knowledge, such as whether the SNP is in the exon of a gene or a regulatory region, into the selection of markers to follow-up. In this manuscript, we propose a Bayesian latent variable model (BLVM) for incorporating "features" about a SNP to estimate a latent "quality score", with SNPs prioritized based on the posterior probability distribution of the rankings of these quality scores. We illustrate the method using data from an ovarian cancer genome-wide association study (GWAS). In addition to the application of the BLVM to the ovarian GWAS, we applied the BLVM to simulated data which mimics the setting involving the prioritization of markers across multiple GWAS for related diseases/traits. The top ranked SNP by BLVM for the ovarian GWAS, ranked 2(nd) and 7(th) based on p-values from analyses of all invasive and invasive serous cases. The top SNP based on serous case analysis p-value (which ranked 197(th) for invasive case analysis), was ranked 8(th) based on the posterior probability of being in the top 5 markers (0.13). In summary, the application of the BLVM allows for the systematic integration of multiple SNP "features" for the prioritization of loci for fine-mapping or functional studies, taking into account the uncertainty in ranking.	[Fridley, Brooke L.; Jenkins, Gregory D.; Goode, Ellen L.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Iversen, Ed] Duke Univ, Dept Stat Sci, Durham, NC USA; [Tsai, Ya-Yu; Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Epidemiol & Genet, Tampa, FL USA	Mayo Clinic; Duke University; H Lee Moffitt Cancer Center & Research Institute	Fridley, BL (corresponding author), Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN 55905 USA.	fridley.brooke@mayo.edu	Fridley, Brooke L/D-8315-2015	Fridley, Brooke L/0000-0001-7739-7956	Minnesota Partnership for Biotechnology and Medical Genomics [R01 CA114343, R21 CA140879]; Mayo Foundation; NATIONAL CANCER INSTITUTE [R21CA140879, R01CA114343, R01CA122443] Funding Source: NIH RePORTER	Minnesota Partnership for Biotechnology and Medical Genomics; Mayo Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported by R01 CA114343, R21 CA140879, Minnesota Partnership for Biotechnology and Medical Genomics grant and the Mayo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERT JH, 1993, J AM STAT ASSOC, V88, P669, DOI 10.2307/2290350; Chen GK, 2007, AM J HUM GENET, V81, P397, DOI 10.1086/519794; Cheng KF, 2005, GENET EPIDEMIOL, V28, P183, DOI 10.1002/gepi.20044; Congdon P., 2007, BAYESIAN STAT MODELL, V704; Conti DV, 2003, AM J HUM GENET, V72, P351, DOI 10.1086/346117; Everitt B., 1984, INTRO LATENT VARIABL; Gamazon ER, 2010, BIOINFORMATICS, V26, P259, DOI 10.1093/bioinformatics/btp644; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Ghosh M, 2000, J STAT PLAN INFER, V88, P99, DOI 10.1016/S0378-3758(99)00201-3; Goldstein H, 1996, J ROY STAT SOC A STA, V159, P385, DOI 10.2307/2983325; Guarino C., 2005, HIGHER ED EUROPE, V30, P147, DOI [10.1080/03797720500260033, DOI 10.1080/03797720500260033]; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Ioannidis JPA, 2009, NAT REV GENET, V10, P318, DOI 10.1038/nrg2544; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; LAIRD NM, 1989, J EDUC STAT, V14, P29, DOI 10.2307/1164724; Lee S.-Y., 2007, STRUCTURAL EQUATION; Lewinger JP, 2007, GENET EPIDEMIOL, V31, P871, DOI 10.1002/gepi.20248; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lund, 2004, WINBUGS VERSION 2 0; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; McCulloch CE, 1997, J AM STAT ASSOC, V92, P162, DOI 10.2307/2291460; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rasch G, 1990, PROBABILISTIC MODELS; Rizopoulos D, 2006, J STAT SOFTW, V17; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Snijders T, 1999, MULTILEVEL ANAL; Thomas A, 2004, BRUGS USER MANUAL VE; Witte JS, 1997, GENET EPIDEMIOL, V14, P1137, DOI 10.1002/(SICI)1098-2272(1997)14:6<1137::AID-GEPI96>3.0.CO;2-H; Zaykin DV, 2005, GENETICS, V171, P813, DOI 10.1534/genetics.105.044206; Zhong H, 2010, AM J HUM GENET, V86, P581, DOI 10.1016/j.ajhg.2010.02.020	31	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20764	10.1371/journal.pone.0020764	http://dx.doi.org/10.1371/journal.pone.0020764			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687685	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500041
J	Puertolas, E; Canudo, JI; Cruzado-Caballero, P				Puertolas, Eduardo; Canudo, Jose I.; Cruzado-Caballero, Penelope			A New Crocodylian from the Late Maastrichtian of Spain: Implications for the Initial Radiation of Crocodyloids	PLOS ONE			English	Article							SOUTHERN FRANCE; IBERIAN PENINSULA; PALEOBIOGEOGRAPHICAL IMPLICATIONS; ALLODAPOSUCHUS-PRECEDENS; EUROPE; PYRENEES; EUSUCHIA; DINOSAUR; REASSESSMENT; MORPHOLOGY	Background: The earliest crocodylians are known primarily from the Late Cretaceous of North America and Europe. The representatives of Gavialoidea and Alligatoroidea are known in the Late Cretaceous of both continents, yet the biogeographic origins of Crocodyloidea are poorly understood. Up to now, only one representative of this clade has been known from the Late Cretaceous, the basal crocodyloid Prodiplocynodon from the Maastrichtian of North America. Methodology/Principal Findings: The fossil studied is a skull collected from sandstones in the lower part of the Tremp Formation, in Chron C30n, dated at -67.6 to 65.5 Ma (late Maastrichtian), in Aren (Huesca, Spain). It is located in a continuous section that contains the K/P boundary, in which the dinosaur faunas closest to the K/P boundary in Europe have been described, including Arenysaurus ardevoli and Blasisaurus canudoi. Phylogenetic analysis places the new taxon, Arenysuchus gascabadiolorum, at the base of Crocodyloidea. Conclusions/Significance: The new taxon is the oldest crocodyloid representative in Eurasia. Crocodyloidea had previously only been known from the Palaeogene onwards in this part of Laurasia. Phylogenetically, Arenysuchus gascabadiolorum is situated at the base of the first radiation of crocodyloids that occurred in the late Maastrichtian, shedding light on this part of the cladogram. The presence of basal crocodyloids at the end of the Cretaceous both in North America and Europe provides new evidence of the faunal exchange via the Thulean Land Bridge during the Maastrichtian.	[Puertolas, Eduardo; Canudo, Jose I.; Cruzado-Caballero, Penelope] Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain	University of Zaragoza	Puertolas, E (corresponding author), Univ Zaragoza, Fac Ciencias, Grp Aragosaurus IUCA, E-50009 Zaragoza, Spain.	puertola@unizar.es	Cruzado-Caballero, Penélope/AAF-8250-2020; Pascual, Eduardo Puértolas/A-3309-2012	Cruzado-Caballero, Penélope/0000-0002-5819-8254; Pascual, Eduardo Puértolas/0000-0003-0759-7105; Canudo Sanagustin, Jose Ignacio/0000-0003-1732-9155	Ministry of Science and Innovation [CGL2007-62469, CGL2010-16447]; European Regional Development Fund; Government of Aragon	Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission); Government of Aragon(Gobierno de Aragon)	This paper forms part of the projects CGL2007-62469 and CGL2010-16447, subsidized by the Ministry of Science and Innovation, the European Regional Development Fund, the Government of Aragon ("Grupos Consolidados" and "Direccion General de Patrimonio Cultural"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald JD, 2004, DINOSAURIA, 2ND EDITION, P672; Ardevol L, 2000, AAPG BULL, V84, P566; Barroso-Barcenilla F, 2009, CRETACEOUS RES, V30, P1268, DOI 10.1016/j.cretres.2009.07.010; Benton M.J., 1988, PHYLOGENY CLASSIFICA, V35A, P295, DOI DOI 10.1017/S0016756800006476; Benton MJ, 2010, PALAEOGEOGR PALAEOCL, V293, P438, DOI 10.1016/j.palaeo.2010.01.026; BERG D, 1966, ABH HESS LANDESAMT B, V52, P105; Blain HA, 2010, CRETACEOUS RES, V31, P433, DOI 10.1016/j.cretres.2010.06.001; Brochu CA, 1997, SYST BIOL, V46, P479, DOI 10.2307/2413693; Brochu CA, 1999, J VERTEBR PALEONTOL, V19, P9, DOI 10.1080/02724634.1999.10011201; BROCHU CA, 2011, ZOOLOGICAL IN PRESS; BUFFETAUT E, 1980, MESOZOIC VERTEBRATE, V1, P5; Buffetaut Eric, 1997, Geology Today, V13, P60, DOI 10.1046/j.1365-2451.1997.d01-729.x; Buscalioni A.D., 1986, Journal of Vertebrate Paleontology, V6, P209; Buscalioni A.D., 1992, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V187, P1; Buscalioni AD, 2001, J VERTEBR PALEONTOL, V21, P74, DOI 10.1671/0272-4634(2001)021[0074:AROTCA]2.0.CO;2; Buscalioni AD, 2004, CRETACEOUS RES, V25, P267, DOI 10.1016/j.cretres.2003.12.004; Buscalioni AD, 1997, CR ACAD SCI II A, V325, P525, DOI 10.1016/S1251-8050(97)89872-2; BUSCALIONI AD, 1990, SCI TERRE, V60, P129; Buscalioni Angela D., 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P77; Buscalioni Angela D., 1999, Estudios del Museo de Ciencias Naturales de Alava, V14, P213; Canudo JI, 2003, DINOSAURIOS OTROS RE, V26, P251; Casanovas ML, 1999, GEOL MIJNBOUW-N J G, V78, P345, DOI 10.1023/A:1003859501941; Casanovas ML, 1999, GEOL MAG, V136, P205, DOI 10.1017/S0016756899002319; Company J, 2009, AMEGHINIANA, V46, P391; Cruzado-Caballero P, 2010, CAN J EARTH SCI, V47, P1507, DOI 10.1139/E10-081; Cruzado-Caballero P, 2010, AMEGHINIANA, V47, P153, DOI 10.5710/AMGH.v47i2.6; Csiki Z, 2010, PALAEOGEOGR PALAEOCL, V293, P265, DOI 10.1016/j.palaeo.2010.05.032; Cuevas J.L., 1992, ACTA GEOLOGICA HISPA, V27, P95; Delfino M, 2008, PALAEONTOLOGY, V51, P1091, DOI 10.1111/j.1475-4983.2008.00800.x; Delfino M, 2008, J VERTEBR PALEONTOL, V28, P111, DOI 10.1671/0272-4634(2008)28[111:ACSOAP]2.0.CO;2; Delfino M, 2009, ZOOL J LINN SOC-LOND, V156, P140, DOI 10.1111/j.1096-3642.2008.00478.x; Fastovsky D.E., 2005, GEOLOGICAL SOC AM TO, V15, P4; Fitzinger L.J.F.J., 1826, NEUE CLASSIFICATION, DOI [10.5962/bhl.title.4683, DOI 10.5962/BHL.TITLE.4683]; Fonnesu F., 1984, THESIS U AUTONOMA BA; GAETE R, 2007, 55 S VERT PAL COMP A; Ginsburg Leonard, 1997, Geodiversitas, V19, P107; Gmelin JF, 1789, LEIPZIG, V1, P1033; Godefroit P, 2009, NATURWISSENSCHAFTEN, V96, P495, DOI 10.1007/s00114-008-0499-0; Goloboff P.A., 2003, TREE ANAL USING NEW; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Huxley T.H., 1875, Q J GEOLOGICAL SOC, V41, P423, DOI DOI 10.1144/GSL.JGS.1875.031.01-04.29; Iordansky N.N., 1973, P201; Laurent Y, 1999, CR ACAD SCI II A, V328, P781, DOI 10.1016/S1251-8050(99)80171-2; Laurent Yves, 2000, Oryctos, V3, P19; Le Loeuff J., 1998, 1 INT M DIN PAL LISB, P49; LELOEUFF J, 1995, CR ACAD SCI II A, V321, P693; LELOEUFF J, 1991, CRETACEOUS RES, V12, P93, DOI 10.1016/S0195-6671(05)80019-9; LELOUEFF J, 1994, GEOL MAG, V131, P625, DOI 10.1017/S0016756800012413; Lopez- ~Martinez N., 2000, 1 INT S DIN EGGS BAB, P95; Lopez-Martinez N, 2001, CRETACEOUS RES, V22, P41, DOI 10.1006/cres.2000.0236; Lopez-Martinez N, 1999, GEOBIOS-LYON, V32, P617, DOI 10.1016/S0016-6995(99)80011-4; Martin James E., 2005, Journal of Mammalian Evolution, V12, P495, DOI 10.1007/s10914-005-7330-x; Martin JE, 2008, ZOOL J LINN SOC-LOND, V152, P567, DOI 10.1111/j.1096-3642.2007.00358.x; Martin JE, 2007, J VERTEBR PALEONTOL, V27, P362, DOI 10.1671/0272-4634(2007)27[362:NMOTLC]2.0.CO;2; Martin JE, 2010, PALAEOGEOGR PALAEOCL, V293, P406, DOI 10.1016/j.palaeo.2009.10.021; Martin JE, 2010, J VERTEBR PALEONTOL, V30, P756, DOI 10.1080/02724631003758318; Martin Jeremy Emiland, 2005, Kaupia Darmstaedter Beitraege zur Naturgeschichte, V14, P33; McKenna M.C., 1983, STRUCTURE DEV GREENL, P351, DOI [10.1007/978-1-4613-3485-9_19, DOI 10.1007/978-1-4613-3485-9_19]; Mey P.H.W., 1968, LEIDSE GEOL MEDED, V41, P221; Mook C. C., 1940, American Museum Novitates, VNo. 1097, P1; MOOK CHARLES C., 1941, AMER MUS NOVITATES, V1128, P1; Norell Mark A., 1994, American Museum Novitates, V3116, P1; NOVACEK MJ, 1991, B AM MUS NAT HIST, V208, P1; Oms O., 2004, GEOTEMAS, V6, P51; Ortega F.J., 1992, P59; Pereda-Suberbiola X, 1999, ZUBIA, V17, P259; Pereda-Suberbiola X, 2009, CR PALEVOL, V8, P559, DOI 10.1016/j.crpv.2009.05.002; Pereda-Suberbiola X, 2009, J VERTEBR PALEONTOL, V29, P946, DOI 10.1671/039.029.0317; Pereda-Suberbiola X, 2009, B SOC GEOL FR, V180, P57, DOI 10.2113/gssgfbull.180.1.57; Prieto-Marquez A, 2009, CRETACEOUS RES, V30, P1238, DOI 10.1016/j.cretres.2009.06.005; Riera V, 2009, PALAEOGEOGR PALAEOCL, V283, P160, DOI 10.1016/j.palaeo.2009.09.018; Rosell J., 2001, REV SOC GEOLOGICA ES, V14, P47; RUSSELL DA, 1993, CAN J EARTH SCI, V30, P2002, DOI 10.1139/e93-176; Salisbury SW, 2006, P ROY SOC B-BIOL SCI, V273, P2439, DOI 10.1098/rspb.2006.3613; Salisbury SW, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P85; Sanmartin I, 2001, BIOL J LINN SOC, V73, P345, DOI 10.1006/bijl.2001.0542; Souquet P., 1967, THESIS U TOULOUSE; Sues HD, 2009, P R SOC B, V276, P2549, DOI 10.1098/rspb.2009.0229; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TORCIDA F, ACTA PALEON IN PRESS; VASSE D, 1992, GEOBIOS-LYON, V25, P293, DOI 10.1016/S0016-6995(06)80407-9; VASSE D, 1993, THESIS U PARIS 6; Vasse Denis, 1998, Oryctos, V1, P65; Vignaud P, 1996, CR ACAD SCI II A, V322, P595; Weishampel DB, 2010, PALAEOGEOGR PALAEOCL, V293, P419, DOI 10.1016/j.palaeo.2010.03.024; Wu XC, 2001, CAN J EARTH SCI, V38, P1689, DOI 10.1139/e01-052; Wu XC, 2001, CAN J EARTH SCI, V38, P1665, DOI 10.1139/e01-059; YOUNG CC, 1964, VERTEBRAT PALASIATIC, V5, P189	89	55	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20011	10.1371/journal.pone.0020011	http://dx.doi.org/10.1371/journal.pone.0020011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687705	gold, Green Published, Green Submitted			2022-12-25	WOS:000291611500006
J	Du, ZY; Ma, T; Lock, EJ; Hao, Q; Kristiansen, K; Froyland, L; Madsen, L				Du, Zhen-Yu; Ma, Tao; Lock, Erik-Jan; Hao, Qin; Kristiansen, Karsten; Froyland, Livar; Madsen, Lise			Depot-Dependent Effects of Adipose Tissue Explants on Co-Cultured Hepatocytes	PLOS ONE			English	Article							INSULIN-RESISTANCE; RAT-LIVER; OBESITY; CELLS; INFLAMMATION; ADIPOCYTES; FAT; PREADIPOCYTES; INTERLEUKIN-6; ADIPOKINES	We have developed an in vitro hepatocyte-adipose tissue explant (ATE) co-culture model enabling examination of the effect of visceral and subcutaneous adipose tissues on primary rat hepatocytes. Initial analyses of inflammatory marker genes were performed in fractionated epididymal or inguinal adipose tissues. Expressions of inflammation related genes (IL-6, TNF-alpha, COX-2) were higher in the inguinal than the epididymal ATE. Similarly, expressions of marker genes of macrophage and monocyte (MPEG-1, CD68, F4/80, CD64) were higher in the stromal vascular fraction (SVF) isolated from inguinal ATE than that from epididymal ATE. However, expressions of lipolysis related genes (ATGL, HSL, perilipin-1) were higher in the epididymal adipocytes than inguinal adipocytes. Moreover, secretion of IL-6 and PGE2 was higher from inguinal ATEs than from epididymal ATEs. There was a trend that the total levels of IL-6, TNF-alpha and PGE2 in the media from inguinal ATEs co-cultured with primary rat hepatocytes were higher than that in the media from epididymal ATEs co-cultured with hepatocytes, although the significant difference was only seen in PGE2. Lipolysis, measured as glycerol release, was similar in the ATEs isolated from inguinal and epididymal adipose tissues when cultured alone, but the glycerol release was higher in the ATEs isolated from epididymal than from inguinal adipose tissue when co-cultured with hepatocytes. Compared to epididymal ATEs, the ATEs from inguinal adipose tissue elicited a stronger cytotoxic response and higher level of insulin resistance in the co-cultured hepatocytes. In conclusion, our results reveal depot-dependent effects of ATEs on co-cultured primary hepatocytes, which in part may be related to a more pronounced infiltration of stromal vascular cells (SVCs), particularly macrophages, in inguinal adipose tissue resulting in stronger responses in terms of hepatotoxicity and insulin-resistance.	[Du, Zhen-Yu; Lock, Erik-Jan; Froyland, Livar; Madsen, Lise] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Ma, Tao; Hao, Qin; Kristiansen, Karsten; Madsen, Lise] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Du, ZY (corresponding author), Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway.	zdu@nifes.no	Lock, Erik-Jan/AAM-9766-2020; Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014; Lock, Erik-Jan/B-7523-2012; Lock, Erik-Jan/F-3115-2012	Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Hao, Qin/0000-0002-6775-2181; Du, Zhen-Yu/0000-0001-6581-5313; Lock, Erik-Jan/0000-0002-8157-5249	Norwegian Research Council [173534/I30]; Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation	Norwegian Research Council(Research Council of NorwayEuropean Commission); Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation)	This work was supported by grants from the Norwegian Research Council (SIP project number 173534/I30) and also partly supported by the Danish Natural Science Research Council, the Novo Nordisk Foundation and the Carlsberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boden G, 2002, EUR J CLIN INVEST, V32, P14, DOI 10.1046/j.1365-2362.32.s3.3.x; Cancello R, 2006, BJOG-INT J OBSTET GY, V113, P1141, DOI 10.1111/j.1471-0528.2006.01004.x; Chatterjee TK, 2009, CIRC RES, V104, P541, DOI 10.1161/CIRCRESAHA.108.182998; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Degrace P, 2007, J BIOL CHEM, V282, P20816, DOI 10.1074/jbc.M611391200; Dietze D, 2002, DIABETES, V51, P2369, DOI 10.2337/diabetes.51.8.2369; Du ZY, 2010, BBA-MOL CELL BIOL L, V1801, P526, DOI 10.1016/j.bbalip.2010.01.002; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-4; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gesta S, 2003, HORM METAB RES, V35, P158, DOI 10.1055/s-2003-39070; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Harkins JM, 2004, J NUTR, V134, P2673, DOI 10.1093/jn/134.10.2673; Hauner H, 2005, P NUTR SOC, V64, P163, DOI 10.1079/PNS2005428; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kelley DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE941, DOI 10.1152/ajpendo.2000.278.5.E941; Klein HH, 2002, J HEPATOL, V37, P432, DOI 10.1016/S0168-8278(02)00217-9; LOTZ M, 1989, ANN NY ACAD SCI, V557, P509; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Miles JM, 2005, DIABETES CARE, V28, P2326, DOI 10.2337/diacare.28.9.2326; Misra A, 1997, OBES RES, V5, P93, DOI 10.1002/j.1550-8528.1997.tb00648.x; NESBITT JE, 1992, J BIOL CHEM, V267, P5739; Nicklas BJ, 2006, J AM GERIATR SOC, V54, P413, DOI 10.1111/j.1532-5415.2005.00624.x; Nielsen S, 2004, J CLIN INVEST, V113, P1582, DOI [10.1172/JCI200421047, 10.1172/JCI21047]; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Pelleymounter MA, 1998, AM J PHYSIOL-REG I, V275, pR950, DOI 10.1152/ajpregu.1998.275.4.R950; SEGLEN PO, 1973, EXP CELL RES, V82, P391, DOI 10.1016/0014-4827(73)90357-1; SMEDSROD B, 1985, J LEUKOCYTE BIOL, V38, P213, DOI 10.1002/jlb.38.2.213; Suganami T, 2010, J LEUKOCYTE BIOL, V88, P33, DOI 10.1189/jlb.0210072; Tanko LB, 2003, CIRCULATION, V107, P1626, DOI 10.1161/01.CIR.0000057974.74060.68; Thorne A, 2002, INT J OBESITY, V26, P193, DOI 10.1038/sj.ijo.0801871; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Turtzo LC, 2001, P NATL ACAD SCI USA, V98, P12385, DOI 10.1073/pnas.231478898; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Villena JA, 2001, INT J OBESITY, V25, P1275, DOI 10.1038/sj.ijo.0801680; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wang ZC, 2006, BIOCHEM BIOPH RES CO, V345, P976, DOI 10.1016/j.bbrc.2006.04.173; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007	40	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20917	10.1371/journal.pone.0020917	http://dx.doi.org/10.1371/journal.pone.0020917			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687689	Green Published, gold, Green Submitted			2022-12-25	WOS:000291607000028
J	Fernandez, C; Farias, L; Ulloa, O				Fernandez, Camila; Farias, Laura; Ulloa, Osvaldo			Nitrogen Fixation in Denitrified Marine Waters	PLOS ONE			English	Article							ANAEROBIC AMMONIUM OXIDATION; NORTH PACIFIC; PHYLOGENETIC ANALYSIS; DEFICIENT WATERS; N-2 FIXATION; NIFH GENES; DIVERSITY; CYANOBACTERIA; ORGANIZATION; DIAZOTROPH	Nitrogen fixation is an essential process that biologically transforms atmospheric dinitrogen gas to ammonia, therefore compensating for nitrogen losses occurring via denitrification and anammox. Currently, inputs and losses of nitrogen to the ocean resulting from these processes are thought to be spatially separated: nitrogen fixation takes place primarily in open ocean environments (mainly through diazotrophic cyanobacteria), whereas nitrogen losses occur in oxygen-depleted intermediate waters and sediments (mostly via denitrifying and anammox bacteria). Here we report on rates of nitrogen fixation obtained during two oceanographic cruises in 2005 and 2007 in the eastern tropical South Pacific (ETSP), a region characterized by the presence of coastal upwelling and a major permanent oxygen minimum zone (OMZ). Our results show significant rates of nitrogen fixation in the water column; however, integrated rates from the surface down to 120 mvaried by similar to 30 fold between cruises (7.5+/-4.6 versus 190+/-82.3 mu mol m(-2)d(-1)). Moreover, rates were measured down to 400 m depth in 2007, indicating that the contribution to the integrated rates of the subsurface oxygen-deficient layer was similar to 5 times higher (574+/-294 mu mol m(-2) d(-1)) than the oxic euphotic layer (48+/-68 mu mol m(-2) d(-1)). Concurrent molecular measurements detected the dinitrogenase reductase gene nifH in surface and subsurface waters. Phylogenetic analysis of the nifH sequences showed the presence of a diverse diazotrophic community at the time of the highest measured nitrogen fixation rates. Our results thus demonstrate the occurrence of nitrogen fixation in nutrient-rich coastal upwelling systems and, importantly, within the underlying OMZ. They also suggest that nitrogen fixation is a widespread process that can sporadically provide a supplementary source of fixed nitrogen in these regions.	[Fernandez, Camila; Farias, Laura; Ulloa, Osvaldo] Univ Concepcion, Dept Oceanog, Concepcion, Chile; [Fernandez, Camila; Farias, Laura; Ulloa, Osvaldo] Univ Concepcion, Ctr Invest Oceanog Pacifico Sur Oriental COPAS, Concepcion, Chile; [Fernandez, Camila] UPMC, Banyuls Sur Mer, France; [Fernandez, Camila] Observ Oceanol, CNRS, LOMIC, UMR 7621, Banyuls Sur Mer, France	Universidad de Concepcion; Universidad de Concepcion; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Fernandez, C (corresponding author), Univ Concepcion, Dept Oceanog, Concepcion, Chile.	fernandez@obs-banyuls.fr	Ulloa, Osvaldo/E-1821-2011	Ulloa, Osvaldo/0000-0002-9501-5576; Farias, Laura/0000-0002-9479-1557; /0000-0002-8492-5881	Chilean National Commission for Scientific and Technological Research [11060297, 1501007]; Fundacion Andes; COPAS Centre, Chile; Agouron Institute [AI-MO3_06_1]	Chilean National Commission for Scientific and Technological Research; Fundacion Andes; COPAS Centre, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Agouron Institute(Pfizer)	This study was supported by the Chilean National Commission for Scientific and Technological Research through FONDECYT grant 11060297 (CF) and FONDAP grant 1501007 (OU, LF). CF was supported by a postdoctoral fellowship from the Fundacion Andes and the COPAS Centre, Chile. Additional funding was provided by the Agouron Institute grant AI-MO3_06_1 to OU. Part of the present work was carried out under the auspices of the Danish Expedition Foundation (Dansk Ekspeditionsfond). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUMAN A, 2001, APPL ENV MICROB, V67; Berman-Frank I, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1537, DOI 10.1016/B978-0-12-372522-6.00035-9; Blaha D, 2005, FEMS MICROBIOL LETT, V244, P157, DOI 10.1016/j.femsle.2005.01.034; Bonnet S, 2008, BIOGEOSCIENCES, V5, P215, DOI 10.5194/bg-5-215-2008; Brandes JA, 1998, LIMNOL OCEANOGR, V43, P1680, DOI 10.4319/lo.1998.43.7.1680; CAPONE DG, 2005, GLOBAL BIOGEOCHEMICA, V19, DOI DOI 10.1029/2004CB002331; Chang BX, 2010, DEEP-SEA RES PT I, V57, P1092, DOI 10.1016/j.dsr.2010.05.009; Chien YT, 1996, J BACTERIOL, V178, P143, DOI 10.1128/jb.178.1.143-148.1996; Choo QC, 2003, APPL ENVIRON MICROB, V69, P3658, DOI 10.1128/AEM.69.6.3658-3662.2003; Codispoti LA, 2007, BIOGEOSCIENCES, V4, P233, DOI 10.5194/bg-4-233-2007; CODISPOTI LA, 1980, J MAR RES, V38, P453; COPINMONTEGUT C, 1994, DEEP-SEA RES PT I, V41, P439, DOI 10.1016/0967-0637(94)90090-6; Dalsgaard T, 2003, NATURE, V422, P606, DOI 10.1038/nature01526; De Pol-Holz R, 2009, DEEP-SEA RES PT II, V56, P1100, DOI 10.1016/j.dsr2.2008.09.014; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Dore JE, 2002, LIMNOL OCEANOGR, V47, P1595, DOI 10.4319/lo.2002.47.6.1595; Dore JE, 2008, PROG OCEANOGR, V76, P2, DOI 10.1016/j.pocean.2007.10.002; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Falcon LI, 2004, APPL ENVIRON MICROB, V70, P765, DOI 10.1128/AEM.70.2.765-770.2004; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Farias L, 2007, DEEP-SEA RES PT I, V54, P164, DOI 10.1016/j.dsr.2006.11.003; Fulweiler RW, 2007, NATURE, V448, P180, DOI 10.1038/nature05963; Goto M, 2005, FEMS MICROBIOL LETT, V246, P33, DOI 10.1016/j.femsle.2005.03.042; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halm H, 2009, ENVIRON MICROBIOL, V11, P1945, DOI 10.1111/j.1462-2920.2009.01917.x; Hamersley MR, 2007, LIMNOL OCEANOGR, V52, P923, DOI 10.4319/lo.2007.52.3.0923; Hansen JW, 2000, MAR ECOL PROG SER, V208, P273, DOI 10.3354/meps208273; Holmes RM, 1999, CAN J FISH AQUAT SCI, V56, P1801, DOI 10.1139/cjfas-56-10-1801; Jetten MSM, 2001, CURR OPIN BIOTECH, V12, P283, DOI 10.1016/S0958-1669(00)00211-1; Kopke M, 2010, P NATL ACAD SCI USA, V107, P13087, DOI 10.1073/pnas.1004716107; Kuypers MMM, 2003, NATURE, V422, P608, DOI 10.1038/nature01472; Kuypers MMM, 2005, P NATL ACAD SCI USA, V102, P6478, DOI 10.1073/pnas.0502088102; MCPHADEN MJ, 2008, ADV GEOSCI, V14, P219, DOI DOI 10.5194/ADGE0-14-219-2008; Mehta MP, 2003, APPL ENVIRON MICROB, V69, P960, DOI 10.1128/AEM.69.2.960-970.2003; Mohr W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012583; Montoya JP, 2007, BIOGEOSCIENCES, V4, P369, DOI 10.5194/bg-4-369-2007; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Montoya JP, 1996, APPL ENVIRON MICROB, V62, P986, DOI 10.1128/AEM.62.3.986-993.1996; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Noar JD, 2009, INT J SYST EVOL MICR, V59, P1941, DOI 10.1099/ijs.0.003368-0; Nzoue A, 2009, SYST APPL MICROBIOL, V32, P400, DOI 10.1016/j.syapm.2009.06.002; Paerl HW, 2000, MICROBIAL ECOLOGY OC, P387; Parsons T.R., 1984, MANUAL BIOL CHEM MET; Pinto-Tomas AA, 2009, SCIENCE, V326, P1120, DOI 10.1126/science.1173036; Raimbault P, 2008, BIOGEOSCIENCES, V5, P323, DOI 10.5194/bg-5-323-2008; Ramirez-Flandes S, 2008, BIOINFORMATICS, V24, P2539, DOI 10.1093/bioinformatics/btn466; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Riemann L, 2010, AQUAT MICROB ECOL, V61, P225, DOI 10.3354/ame01431; Sigman DM, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002458; Steward GF, 2004, APPL ENVIRON MICROB, V70, P1455, DOI 10.1128/AEM.70.3.1455-1465.2004; Thamdrup B, 2002, APPL ENVIRON MICROB, V68, P1312, DOI 10.1128/AEM.68.3.1312-1318.2002; Thamdrup B, 2006, LIMNOL OCEANOGR, V51, P2145, DOI 10.4319/lo.2006.51.5.2145; Ward BB, 2009, NATURE, V461, P78, DOI 10.1038/nature08276; Welsh DT, 2000, ECOL LETT, V3, P58, DOI 10.1046/j.1461-0248.2000.00111.x; Yang JC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006085; Zani S, 2000, APPL ENVIRON MICROB, V66, P3119, DOI 10.1128/AEM.66.7.3119-3124.2000; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169; Zehr JP, 2006, NATO SCI S SS IV EAR, V64, P337; Zehr JP, 2003, BIOTECHNIQUES, V35, P996, DOI 10.2144/03355st08; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; ZEHR JP, 1989, APPL ENVIRON MICROB, V55, P2522, DOI 10.1128/AEM.55.10.2522-2526.1989; Zehr JP, 2001, METHOD MICROBIOL, V30, P271, DOI 10.1016/S0580-9517(01)30049-1; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	64	124	127	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20539	10.1371/journal.pone.0020539	http://dx.doi.org/10.1371/journal.pone.0020539			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687726	Green Published, gold, Green Submitted			2022-12-25	WOS:000291607000011
J	Malik, WQ; Schummers, J; Sur, M; Brown, EN				Malik, Wasim Q.; Schummers, James; Sur, Mriganka; Brown, Emery N.			Denoising Two-Photon Calcium Imaging Data	PLOS ONE			English	Article							IN-VIVO; VISUAL-CORTEX; COLORED NOISE; FIRING RATE; RESPONSES; SIGNALS; MODEL; ORIENTATION; INFERENCE; PATTERNS	Two-photon calcium imaging is now an important tool for in vivo imaging of biological systems. By enabling neuronal population imaging with subcellular resolution, this modality offers an approach for gaining a fundamental understanding of brain anatomy and physiology. Proper analysis of calcium imaging data requires denoising, that is separating the signal from complex physiological noise. To analyze two-photon brain imaging data, we present a signal plus colored noise model in which the signal is represented as harmonic regression and the correlated noise is represented as an order p autoregressive process. We provide an efficient cyclic descent algorithm to compute approximate maximum likelihood parameter estimates by combing a weighted least-squares procedure with the Burg algorithm. We use Akaike information criterion to guide selection of the harmonic regression and the autoregressive model orders. Our flexible yet parsimonious modeling approach reliably separates stimulus-evoked fluorescence response from background activity and noise, assesses goodness of fit, and estimates confidence intervals and signal-to-noise ratio. This refined separation leads to appreciably enhanced image contrast for individual cells including clear delineation of subcellular details and network activity. The application of our approach to in vivo imaging data recorded in the ferret primary visual cortex demonstrates that our method yields substantially denoised signal estimates. We also provide a general Volterra series framework for deriving this and other signal plus correlated noise models for imaging. This approach to analyzing two-photon calcium imaging data may be readily adapted to other computational biology problems which apply correlated noise models.	[Malik, Wasim Q.; Brown, Emery N.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA; [Malik, Wasim Q.; Schummers, James; Sur, Mriganka; Brown, Emery N.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Schummers, James; Sur, Mriganka] MIT, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Brown, Emery N.] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts Institute of Technology (MIT)	Malik, WQ (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02115 USA.	wqm@mit.edu		Schummers, James/0000-0002-1030-824X	U.S. National Institutes of Health [DP1 OD003646-01, R01 EB006385-01, EY07023, EY017098]; NATIONAL EYE INSTITUTE [R01EY017098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB006385] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003646] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by U.S. National Institutes of Health DP1 OD003646-01, R01 EB006385-01, EY07023 and EY017098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barretto RPJ, 2009, NAT METHODS, V6, P511, DOI 10.1038/nmeth.1339; Basole A, 2003, NATURE, V423, P986, DOI 10.1038/nature01721; Box GEP, 2008, TIME SERIES ANAL FOR, DOI DOI 10.1002/9781118619193; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brown EN, 2000, AM J PHYSIOL-ENDOC M, V279, pE669, DOI 10.1152/ajpendo.2000.279.3.E669; Brunel N, 2003, NEURAL COMPUT, V15, P2281, DOI 10.1162/089976603322362365; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Chen YZ, 2008, J NEUROPHYSIOL, V99, P1366, DOI 10.1152/jn.00698.2007; CORRADI C, 1979, J ECONOMETRICS, V11, P303; Denk W, 1997, NEURON, V18, P351, DOI 10.1016/S0896-6273(00)81237-4; Destexhe A, 2001, NEUROSCIENCE, V107, P13, DOI 10.1016/S0306-4522(01)00344-X; Effern A, 2000, PHYSICA D, V140, P257, DOI 10.1016/S1386-9477(00)00111-9; Everson RM, 1998, P NATL ACAD SCI USA, V95, P8334, DOI 10.1073/pnas.95.14.8334; Fisher NI, 1995, STAT ANAL CIRCULAR D; Friston KJ, 1998, MAGNET RESON MED, V39, P41, DOI 10.1002/mrm.1910390109; Gabbay M, 2000, NEUROIMAGE, V11, P313, DOI 10.1006/nimg.2000.0547; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; GIBSON JD, 1991, IEEE T SIGNAL PROCES, V39, P1732, DOI 10.1109/78.91144; Gobel W, 2007, NAT METHODS, V4, P73, DOI 10.1038/NMETH989; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Helmchen F, 2005, NAT METHODS, V2, P932, DOI 10.1038/NMETH818; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HOMMA R, 2009, DYNAMIC BRAIN IMAGIN; Huang MC, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3385468; Kalatsky VA, 2003, NEURON, V38, P529, DOI 10.1016/S0896-6273(03)00286-1; KANTZ H, 1993, PHYS REV E, V48, P1529, DOI 10.1103/PhysRevE.48.1529; Kantz H., 2004, NONLINEAR TIME SERIE; Kay S., 1999, MODERN SPECTRAL ESTI; Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Majewska A, 2000, PFLUG ARCH EUR J PHY, V441, P398, DOI 10.1007/s004240000435; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Marhl M, 2010, BIOPHYS CHEM, V148, P42, DOI 10.1016/j.bpc.2010.02.006; Martinez LM, 2002, J PHYSIOL-LONDON, V540, P321, DOI 10.1113/jphysiol.2001.012776; Mironov SL, 2008, J PHYSIOL-LONDON, V586, P2277, DOI 10.1113/jphysiol.2007.149021; Mrsic-Flogel T, 2003, CURR BIOL, V13, pR778, DOI 10.1016/j.cub.2003.09.022; Mukamel EA, 2009, NEURON, V63, P747, DOI 10.1016/j.neuron.2009.08.009; MYERS RH, 2002, GEN LINEAR MODELS; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Ozden I, 2008, J NEUROPHYSIOL, V100, P495, DOI 10.1152/jn.01310.2007; Perc M, 2008, BIOPHYS CHEM, V132, P33, DOI 10.1016/j.bpc.2007.10.002; Perc M, 2009, CHAOS, V19, DOI 10.1063/1.3160017; Purdon PL, 2001, NEUROIMAGE, V14, P912, DOI 10.1006/nimg.2001.0870; Sakai Y, 1999, NEURAL NETWORKS, V12, P1181, DOI 10.1016/S0893-6080(99)00053-2; Schetzen M., 2006, VOLTERRA WIENER THEO; SCHREIBER T, 1991, PHYS LETT A, V160, P411, DOI 10.1016/0375-9601(91)90237-3; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Shenderov AD, 1997, BIOPHYS J, V72, P2382, DOI 10.1016/S0006-3495(97)78883-0; Sjulson L, 2007, PHYSIOLOGY, V22, P47, DOI 10.1152/physiol.00036.2006; Sornborger A, 2003, NEUROIMAGE, V18, P610, DOI 10.1016/S1053-8119(02)00045-9; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Wilt BA, 2009, ANNU REV NEUROSCI, V32, P435, DOI 10.1146/annurev.neuro.051508.135540; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	54	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20490	10.1371/journal.pone.0020490	http://dx.doi.org/10.1371/journal.pone.0020490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687727	gold, Green Published			2022-12-25	WOS:000291607000008
J	Runckel, C; Flenniken, ML; Engel, JC; Ruby, JG; Ganem, D; Andino, R; DeRisi, JL				Runckel, Charles; Flenniken, Michelle L.; Engel, Juan C.; Ruby, J. Graham; Ganem, Donald; Andino, Raul; DeRisi, Joseph L.			Temporal Analysis of the Honey Bee Microbiome Reveals Four Novel Viruses and Seasonal Prevalence of Known Viruses, Nosema, and Crithidia	PLOS ONE			English	Article							DEFORMED WING VIRUS; COLONY COLLAPSE DISORDER; ACUTE PARALYSIS VIRUS; COMPLETE GENOME SEQUENCE; APIS-MELLIFERA L.; MOLECULAR DIAGNOSIS; NUCLEOTIDE-SEQUENCE; GENETIC-ANALYSIS; SACBROOD VIRUS; CERANAE	Honey bees (Apis mellifera) play a critical role in global food production as pollinators of numerous crops. Recently, honey bee populations in the United States, Canada, and Europe have suffered an unexplained increase in annual losses due to a phenomenon known as Colony Collapse Disorder (CCD). Epidemiological analysis of CCD is confounded by a relative dearth of bee pathogen field studies. To identify what constitutes an abnormal pathophysiological condition in a honey bee colony, it is critical to have characterized the spectrum of exogenous infectious agents in healthy hives over time. We conducted a prospective study of a large scale migratory bee keeping operation using high-frequency sampling paired with comprehensive molecular detection methods, including a custom microarray, qPCR, and ultra deep sequencing. We established seasonal incidence and abundance of known viruses, Nosema sp., Crithidia mellificae, and bacteria. Ultra deep sequence analysis further identified four novel RNA viruses, two of which were the most abundant observed components of the honey bee microbiome (similar to 10(11) viruses per honey bee). Our results demonstrate episodic viral incidence and distinct pathogen patterns between summer and winter time-points. Peak infection of common honey bee viruses and Nosema occurred in the summer, whereas levels of the trypanosomatid Crithidia mellificae and Lake Sinai virus 2, a novel virus, peaked in January.	[Runckel, Charles; Ruby, J. Graham; Ganem, Donald; DeRisi, Joseph L.] Howard Hughes Med Inst, Bethesda, MD 20817 USA; [Runckel, Charles; Ruby, J. Graham; Ganem, Donald; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Runckel, Charles; Ruby, J. Graham; Ganem, Donald; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Runckel, Charles; Ruby, J. Graham; Ganem, Donald; DeRisi, Joseph L.] Univ Calif San Francisco, Dept Microbiol, San Francisco, CA USA; [Flenniken, Michelle L.; Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Engel, Juan C.] Univ Calif San Francisco, Sandler Ctr Drug Discovery, San Francisco, CA 94143 USA; [Engel, Juan C.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Runckel, C (corresponding author), Howard Hughes Med Inst, Bethesda, MD 20817 USA.	joe@derisilab.ucsf.edu			Howard Hughes Medical Institute; Genentech Graduate Student Fellowship; A.P. Giannini Foundation; UC-Davis's Haagen Dazs	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Genentech Graduate Student Fellowship; A.P. Giannini Foundation; UC-Davis's Haagen Dazs	This work was supported by a research grant from Project Apis m. (www.projectapism.org) awarded to J.D.R. J.D.R. is supported by the Howard Hughes Medical Institute. C. R. is supported by at the Genentech Graduate Student Fellowship. M. L. F. is supported by an A.P. Giannini Foundation Medical Research Fellowship and research funds from UC-Davis's Haagen Dazs Postdoctoral Fellowship in Honey Bee Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; BAILEY L, 1974, J GEN VIROL, V25, P175, DOI 10.1099/0022-1317-25-2-175; BAILEY L, 1980, J GEN VIROL, V51, P405, DOI 10.1099/0022-1317-51-2-405; BAILEY L, 1981, ANN APPL BIOL, V97, P109, DOI 10.1111/j.1744-7348.1981.tb02999.x; Baker A, 2008, J INVERTEBR PATHOL, V98, P239, DOI 10.1016/j.jip.2008.02.010; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Boncristiani HF, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-221; Bourgeois AL, 2010, J INVERTEBR PATHOL, V103, P53, DOI 10.1016/j.jip.2009.10.009; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Bromenshenk JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013181; BROWN BV, 1993, SYST ENTOMOL, V18, P191, DOI 10.1111/j.1365-3113.1993.tb00662.x; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Buchen-Osmond C, 2003, COMPUT SCI ENG, V5, P16, DOI 10.1109/MCISE.2003.1196303; Cameron S. A., 2011, P NATL ACAD SCI US; Chen YP, 2007, ADV VIRUS RES, V70, P33, DOI 10.1016/S0065-3527(07)70002-7; Chen Y, 2008, J INVERTEBR PATHOL, V97, P186, DOI 10.1016/j.jip.2007.07.010; Chen YP, 2007, AM BEE J, V147, P1027; Chen YP, 2006, APPL ENVIRON MICROB, V72, P606, DOI 10.1128/AEM.72.1.606-611.2006; Chen YP, 2005, APPL ENVIRON MICROB, V71, P436, DOI 10.1128/AEM.71.1.436-441.2005; Chen YP, 2004, APIDOLOGIE, V35, P441, DOI 10.1051/apido:2004031; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chiu CY, 2007, J CLIN MICROBIOL, V45, P2340, DOI 10.1128/JCM.00364-07; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; CLARK TB, 1985, INT J SYST BACTERIOL, V35, P296, DOI 10.1099/00207713-35-3-296; CORE A, 2011, EMERGING THREAT HONE; Cornman RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000466; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Craggs JK, 2001, J VIROL METHODS, V94, P111, DOI 10.1016/S0166-0934(01)00281-6; de Graaf DC, 2006, LETT APPL MICROBIOL, V43, P583, DOI 10.1111/j.1472-765X.2006.02057.x; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; de Miranda JR, 2004, J GEN VIROL, V85, P2263, DOI 10.1099/vir.0.79990-0; DeGrandi-Hoffman G, 2010, J INSECT PHYSIOL, V56, P1184, DOI 10.1016/j.jinsphys.2010.03.017; Delaney DA, 2009, ANN ENTOMOL SOC AM, V102, P666, DOI 10.1603/008.102.0411; Drummond A, 2010, GENEIOUS V5 1; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; ENGEL JC, 1985, J BIOL CHEM, V260, P105; Forsgren E, 2005, MICROB ECOL, V50, P369, DOI 10.1007/s00248-004-0188-2; Forsgren E, 2010, J INVERTEBR PATHOL, V103, pS5, DOI 10.1016/j.jip.2009.06.016; Foster LJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006387; Fries I, 2010, J INVERTEBR PATHOL, V103, pS73, DOI 10.1016/j.jip.2009.06.017; Gauthier L, 2007, APIDOLOGIE, V38, P426, DOI 10.1051/apido:2007026; Genersch E, 2010, APIDOLOGIE, V41, P332, DOI 10.1051/apido/2010014; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; Ghosh RC, 1999, J GEN VIROL, V80, P1541, DOI 10.1099/0022-1317-80-6-1541; Gisder S, 2010, APPL ENVIRON MICROB, V76, P3032, DOI 10.1128/AEM.03097-09; Govan VA, 2000, VIROLOGY, V277, P457, DOI 10.1006/viro.2000.0616; HAMIDUZZAMAN MM, 2010, J INVERTEBR PATHOL; Hamilton PB, 2004, INT J PARASITOL, V34, P1393, DOI 10.1016/j.ijpara.2004.08.011; Harrap K A, 1979, Adv Virus Res, V25, P273, DOI 10.1016/S0065-3527(08)60572-2; Higes M, 2008, ENVIRON MICROBIOL, V10, P2659, DOI 10.1111/j.1462-2920.2008.01687.x; Higes M, 2007, J INVERTEBR PATHOL, V94, P211, DOI 10.1016/j.jip.2006.11.001; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Johnson R, 2010, HONEY BEE COLONY COL; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Kistler A, 2007, J INFECT DIS, V196, P817, DOI 10.1086/520816; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Klee J, 2007, J INVERTEBR PATHOL, V96, P1, DOI 10.1016/j.jip.2007.02.014; KNUDSEN G, 2011, PLOS ONE UNPUB; Langridge D. F., 1967, Journal of Protozoology, V14, P485; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Leat N, 2000, J GEN VIROL, V81, P2111, DOI 10.1099/0022-1317-81-8-2111; Liang T, 2010, LETT APPL MICROBIOL, V51, P532, DOI 10.1111/j.1472-765X.2010.02927.x; LOMMEL SA, 1985, INTERVIROLOGY, V23, P199, DOI 10.1159/000149606; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Maori E, 2007, J GEN VIROL, V88, P3428, DOI 10.1099/vir.0.83284-0; Martin-Hernandez R, 2007, APPL ENVIRON MICROB, V73, P6331, DOI 10.1128/AEM.00270-07; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; MORSE RA, 2000, VALUE HONEY BEES POL, P1; MOUCHES C, 1983, ANN INST PASTEUR MIC, VA134, P383, DOI 10.1016/S0769-2609(83)80063-5; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Otterstatter MC, 2002, ECOL ENTOMOL, V27, P229, DOI 10.1046/j.1365-2311.2002.00403.x; Palacios G, 2008, J VIROL, V82, P6209, DOI 10.1128/JVI.00251-08; Paxton RJ, 2007, APIDOLOGIE, V38, P558, DOI 10.1051/apido:2007037; Pennisi E, 2006, SCIENCE, V314, P578, DOI 10.1126/science.314.5799.578; Plaskon NE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007468; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Ribiere M, 2002, APIDOLOGIE, V33, P339, DOI 10.1051/apido:2002020; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sammataro D, 2000, ANNU REV ENTOMOL, V45, P519, DOI 10.1146/annurev.ento.45.1.519; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Shen MQ, 2005, J GEN VIROL, V86, P2281, DOI 10.1099/vir.0.80824-0; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stoltz D, 1995, J APICULT RES, V34, P153, DOI 10.1080/00218839.1995.11100900; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; Urisman A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r78; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; VANENGELSDORP D, 2010, PRELIMINARY RESULTS; Vanengelsdorp D, 2007, AM BEE J, V147, P599; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Wang D, 2002, P NATL ACAD SCI USA, V99, P15687, DOI 10.1073/pnas.242579699; Wang D, 2003, PLOS BIOL, V1, P257, DOI 10.1371/journal.pbio.0000002; Welch A, 2009, APPL ENVIRON MICROB, V75, P7862, DOI 10.1128/AEM.01319-09; Williams GR, 2008, J INVERTEBR PATHOL, V99, P342, DOI 10.1016/j.jip.2008.04.005; Winston M., 1987, The biology of the honey bee.; Yourth CP, 2008, INSECT SOC, V55, P86, DOI 10.1007/s00040-007-0974-1; USDA ARS QUESTIONS A	102	288	300	1	156	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20656	10.1371/journal.pone.0020656	http://dx.doi.org/10.1371/journal.pone.0020656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687739	Green Published, gold, Green Submitted			2022-12-25	WOS:000291607000017
J	Sar, P; Peter, R; Rath, B; Das Mohapatra, A; Mishra, SK				Sar, Pranati; Peter, Rosalima; Rath, Bandita; Das Mohapatra, Alok; Mishra, Sandip K.			3, 3 ' 5 Triiodo L Thyronine Induces Apoptosis in Human Breast Cancer MCF-7cells, Repressing SMP30 Expression through Negative Thyroid Response Elements	PLOS ONE			English	Article							NUCLEAR RECEPTOR COREPRESSORS; MAMMARY EPITHELIAL-CELLS; MARKER PROTEIN-30 SMP30; HEP G2 CELLS; HORMONE RECEPTOR; HISTONE DEACETYLASE; ESTROGEN-RECEPTOR; IN-VIVO; KNOCKOUT MICE; TARGET GENE	Background: Thyroid hormones regulate cell proliferation, differentiation as well as apoptosis. However molecular mechanism underlying apoptosis as a result of thyroid hormone signaling is poorly understood. The antiapoptotic role of Senescence Marker Protein-30 (SMP30) has been characterized in response to varieties of stimuli as well as in knock out model. Our earlier data suggest that thyroid hormone 3, 395 Triiodo L Thyronine (T-3), represses SMP30 in rat liver. Methodology/Principal Findings: In highly metastatic MCF-7, human breast cancer cell line T3 treatment repressed SMP30 expression leading to enhanced apoptosis. Analysis by flow cytometry and other techniques revealed that overexpression and silencing of SMP30 in MCF-7 resulted in decelerated and accelerated apoptosis respectively. In order to identify the cis-acting elements involved in this regulation, we have analyzed hormone responsiveness of transiently transfected hSMP30 promoter deletion reporter vectors in MCF-7 cells. As opposed to the expected epigenetic outcome, thyroid hormone down regulated hSMP30 promoter activity despite enhanced recruitment of acetylated H3 on thyroid response elements (TREs). From the stand point of established epigenetic concept we have categorised these two TREs as negative response elements. Our attempt of siRNA mediated silencing of TR beta, reduced the fold of repression of SMP30 gene expression. In presence of thyroid hormone, Trichostatin-A (TSA), which is a Histone deacetylase (HDAC) inhibitor further inhibited SMP30 promoter activity. The above findings are in support of categorisation of both the thyroid response element as negative response elements as usually TSA should have reversed the repressions. Conclusion: This is the first report of novel mechanistic insights into the remarkable downregulation of SMP30 gene expression by thyroid hormone which in turn induces apoptosis in MCF-7 human breast cancer cells. We believe that our study represents a good ground for future effort to develop new therapeutic approaches to challenge the progression of breast cancer.	[Sar, Pranati; Peter, Rosalima; Rath, Bandita; Mishra, Sandip K.] Inst Life Sci, Dept Gene Funct & Regulat, Canc Biol Lab, Bhubaneswar, Orissa, India; [Das Mohapatra, Alok] Inst Life Sci, Dept Infect Dis Biol, Vector Born Dis Lab, Bhubaneswar, Orissa, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS)	Sar, P (corresponding author), Inst Life Sci, Dept Gene Funct & Regulat, Canc Biol Lab, Bhubaneswar, Orissa, India.	sandipkmishra@hotmail.com	Sar, Pranati/AAE-5045-2022	Mishra, Sandip/0000-0002-0776-6581	Department of Biotechnology, Goverment of India; University Grant Commission, Goverment of India, New Delhi	Department of Biotechnology, Goverment of India; University Grant Commission, Goverment of India, New Delhi(University Grants Commission, India)	This study was supported by funds from the Department of Biotechnology, Goverment of India. PS is supported by a research fellowship from University Grant Commission, Goverment of India, New Delhi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2011, CANCER LETT, V300, P1, DOI 10.1016/j.canlet.2010.09.008; Alonso M, 2009, ENDOCRINOLOGY, V150, P3927, DOI 10.1210/en.2009-0093; ALVARADOPISANI AR, 1986, ANTICANCER RES, V6, P1347; Berghagen H, 2002, J BIOL CHEM, V277, P49517, DOI 10.1074/jbc.M209546200; BURKE RE, 1978, CANCER RES, V38, P3769; Cestari SH, 2009, ARQ BRAS ENDOCRINOL, V53, P859, DOI 10.1590/S0004-27302009000700010; Chimenti F, 2009, J MED CHEM, V52, P530, DOI 10.1021/jm800885d; CHOU CW, 2011, PLOS ONE, V6, P1; Conde I, 2006, ANN ONCOL, V17, P60, DOI 10.1093/annonc/mdj040; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; Diaz-Cruz ES, 2010, CANCER RES, V70, P3965, DOI 10.1158/0008-5472.CAN-09-3450; Duan H, 2005, MOL CELL BIOL, V25, P1608, DOI 10.1128/MCB.25.5.1608-1619.2005; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; FEI ZL, 1992, ENDOCRINOLOGY, V130, P1145; FUJITA T, 1992, BIOCHIM BIOPHYS ACTA, V1116, P122, DOI 10.1016/0304-4165(92)90108-7; Fujita T, 1998, BIOCHEM BIOPH RES CO, V250, P374, DOI 10.1006/bbrc.1998.9327; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gonzalez-Sancho JM, 2002, MOL CARCINOGEN, V34, P25, DOI 10.1002/mc.10046; GUIGON CJ, 2011, ONCOGENE, P1; Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645; Hara M, 2000, THYROID, V10, P1023, DOI 10.1089/thy.2000.10.1023; Ishigami A, 2002, AM J PATHOL, V161, P1273, DOI 10.1016/S0002-9440(10)64404-5; Ishii S, 2004, MOL ENDOCRINOL, V18, P1708, DOI 10.1210/me.2004-0067; Jeong DH, 2008, J RADIAT RES, V49, P653, DOI 10.1269/jrr.08042; KATZ RW, 1993, J BIOL CHEM, V268, P19392; Kim JJ, 2010, SEMIN REPROD MED, V28, P81, DOI 10.1055/s-0029-1242998; Kim SW, 2005, J BIOL CHEM, V280, P14545, DOI 10.1074/jbc.M411517200; Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Liu Y, 2006, MOL ENDOCRINOL, V20, P483, DOI 10.1210/me.2005-0101; LOPEZBARAHONA M, 1995, EMBO J, V14, P1145, DOI 10.1002/j.1460-2075.1995.tb07098.x; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Martinez MB, 2000, CANCER CHEMOTH PHARM, V45, P93, DOI 10.1007/s002800050016; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mihara S, 1999, J CLIN ENDOCR METAB, V84, P1378, DOI 10.1210/jc.84.4.1378; Mishra SK, 2004, ONCOGENE, V23, P4422, DOI 10.1038/sj.onc.1207569; Mishra SK, 2003, J BIOL CHEM, V278, P19209, DOI 10.1074/jbc.M301968200; NARAYANAN CH, 1986, EXP BRAIN RES, V62, P61; Nicholson RI, 2005, BREAST CANCER RES TR, V93, pS3, DOI 10.1007/s10549-005-9036-4; Nygard M, 2006, J MOL ENDOCRINOL, V36, P517, DOI 10.1677/jme.1.01874; Ortiga-Carvalho TM, 2005, J CLIN INVEST, V115, P2517, DOI 10.1172/JCI24109; Park SW, 2005, MOL CELL, V19, P643, DOI 10.1016/j.molcel.2005.08.008; Porter P, 2008, NEW ENGL J MED, V358, P213, DOI 10.1056/NEJMp0708307; Rath B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-43; SAATCIOGLU F, 1993, CELL, V75, P1095, DOI 10.1016/0092-8674(93)90319-L; Santos GM, 2006, MOL PHARMACOL, V70, P793, DOI 10.1124/mol.106.025627; Sar P, 2007, MOL CELL BIOCHEM, V303, P239, DOI 10.1007/s11010-007-9462-1; Sasaki S, 1999, EMBO J, V18, P5389, DOI 10.1093/emboj/18.19.5389; Shibusawa N, 2003, J CLIN INVEST, V112, P588, DOI 10.1172/JCI200318377; Shibusawa N, 2003, J BIOL CHEM, V278, P732, DOI 10.1074/jbc.M207264200; Silva JM, 2002, ONCOGENE, V21, P4307, DOI 10.1038/sj.onc.1205534; SMALLRIDGE RC, 1980, CLIN RES, V28, pA421; Smyth PPA, 1997, ANN MED, V29, P189, DOI 10.3109/07853899708999335; Tagami T, 1997, MOL CELL BIOL, V17, P2642, DOI 10.1128/MCB.17.5.2642; Tagami T, 1999, J BIOL CHEM, V274, P22345, DOI 10.1074/jbc.274.32.22345; Tagami T, 1998, MOL ENDOCRINOL, V12, P1888, DOI 10.1210/me.12.12.1888; Tfayli A., 2010, J ONCOL, P1; Turken O, 2003, BREAST CANCER RES, V5, pR110, DOI 10.1186/bcr609; VONDERHAAR BK, 1979, ENDOCRINOLOGY, V104, P409, DOI 10.1210/endo-104-2-409; WANG D, 2010, PLOS ONE, V5, P1; Wang DQ, 2009, MOL ENDOCRINOL, V23, P600, DOI 10.1210/me.2008-0389; WILLIAMS GR, BASIC CONCEPTS CLIN, P217; Wilson MA, 2002, J BIOL CHEM, V277, P15171, DOI 10.1074/jbc.M200349200; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; Yen PM, 2003, EMBO REP, V4, P581, DOI 10.1038/sj.embor.embor862; Yokoe T, 1997, ANTICANCER RES, V17, P695; LANCET, V374, P1567	67	30	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20861	10.1371/journal.pone.0020861	http://dx.doi.org/10.1371/journal.pone.0020861			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687737	gold, Green Published, Green Submitted			2022-12-25	WOS:000291607000024
J	Kim, EY; Chen, L; Ma, YL; Yu, W; Chang, J; Moskowitz, IP; Wang, J				Kim, Eun Young; Chen, Li; Ma, Yanlin; Yu, Wei; Chang, Jiang; Moskowitz, Ivan P.; Wang, Jun			Expression of Sumoylation Deficient Nkx2.5 Mutant in Nkx2.5 Haploinsufficient Mice Leads to Congenital Heart Defects	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; CARDIOMYOCYTE PROLIFERATION; GENE ACTIVITY; IN-VITRO; CSX/NKX2.5 HOMEOPROTEIN; MUSCLE DIFFERENTIATION; SUMO-1 MODIFICATION; CARDIAC DEVELOPMENT; TINMAN HOMOLOG; CONDUCTION	Nkx2.5 is a cardiac specific homeobox gene critical for normal heart development. We previously identified Nkx2.5 as a target of sumoylation, a posttranslational modification implicated in a variety of cellular activities. Sumoylation enhanced Nkx2.5 activity via covalent attachment to the lysine residue 51, the primary SUMO acceptor site. However, how sumoylation regulates the activity of Nkx2.5 in vivo remains unknown. We generated transgenic mice overexpressing sumoylation deficient mutant K51R (conversion of lysine 51 to arginine) specifically in mouse hearts under the control of cardiac a-myosin heavy chain (alpha-MHC) promoter (K51R-Tg). Expression of the Nkx2.5 mutant transgene in the wild type murine hearts did not result in any overt cardiac phenotype. However, in the presence of Nkx2.5 haploinsufficiency, cardiomyocyte-specific expression of the Nkx2.5 K51R mutant led to congenital heart diseases (CHDs), accompanied with decreased cardiomyocyte proliferation. Also, a number of human CHDs-associated Nkx2.5 mutants exhibited aberrant sumoylation. Our work demonstrates that altered sumoylation status may underlie the development of human CHDs associated with Nkx2.5 mutants.	[Kim, Eun Young] Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA; [Chen, Li; Wang, Jun] Texas Heart Inst, Dept Basic Res Labs, Houston, TX 77025 USA; [Ma, Yanlin; Chang, Jiang] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Houston, TX USA; [Yu, Wei] Univ Houston, Dept Biochem & Mol Biol, Houston, TX USA; [Moskowitz, Ivan P.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Moskowitz, Ivan P.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Texas System; University of Texas Health Science Center Houston; Texas Heart Institute; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Houston System; University of Houston; University of Chicago; University of Chicago	Kim, EY (corresponding author), Univ Texas Hlth Sci Ctr Houston, Program Genes & Dev, Houston, TX USA.	junwang@heart.thi.tmc.edu		Chang, Jiang/0000-0003-3707-7557; Moskowitz, Ivan/0000-0003-0014-4963	Texas Higher Education Coordinating Board (THECB); American Heart Association; National Institutes of Health [P30]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102314, K02HL098956, R01HL092153, R21HL094844] Funding Source: NIH RePORTER	Texas Higher Education Coordinating Board (THECB); American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants from the Texas Higher Education Coordinating Board (THECB) and the American Heart Association to JW, and American Heart Association Grant-in-Aid National Institutes of Health grants to JC. JW is also supported by a P30 grant from the NIH as a Newly Independent Investigator (NII). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Andreou AM, 2007, AM J HUM GENET, V81, P700, DOI 10.1086/521033; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Chen CY, 1997, MOL ENDOCRINOL, V11, P812, DOI 10.1210/me.11.6.812; Chen CY, 1996, DEV GENET, V19, P119, DOI 10.1002/(SICI)1520-6408(1996)19:2<119::AID-DVG3>3.0.CO;2-C; Davies TC, 1996, DEV GENET, V18, P234, DOI 10.1002/(SICI)1520-6408(1996)18:3&lt;234::AID-DVG4&gt;3.0.CO;2-A; Feng QP, 2002, CIRCULATION, V106, P873, DOI 10.1161/01.CIR.0000024114.82981.EA; GREPIN C, 1995, MOL CELL BIOL, V15, P4095; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Hiroi Y, 2001, NAT GENET, V28, P276, DOI 10.1038/90123; Kasahara H, 2001, J CLIN INVEST, V108, P189, DOI 10.1172/JCI200112694; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; Kasahara H, 2003, J MOL CELL CARDIOL, V35, P243, DOI 10.1016/S0022-2828(03)00002-6; KOMATSU T, 2004, MOL ENDOCRINOL; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Makino S, 1999, J CLIN INVEST, V103, P697, DOI 10.1172/JCI5298; Manabe I, 2001, CIRC RES, V88, P1127, DOI 10.1161/hh1101.091339; Matsuzaki K, 2003, BIOCHEM BIOPH RES CO, V306, P32, DOI 10.1016/S0006-291X(03)00910-0; Moses Kelvin A., 2001, Genesis The Journal of Genetics and Development, V31, P176, DOI 10.1002/gene.10022; Moskowitz IPG, 2007, CELL, V129, P1365, DOI 10.1016/j.cell.2007.04.036; Qi X, 2007, DEV BIOL, V311, P136, DOI 10.1016/j.ydbio.2007.08.022; Rauch R, 2010, J MED GENET, V47, P321, DOI 10.1136/jmg.2009.070391; Reamon-Buettner S. M., 2010, HUM MUTAT; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004; Schoenfeld JR, 1998, J MOL CELL CARDIOL, V30, P2269, DOI 10.1006/jmcc.1998.0787; Sepulveda JL, 2002, J BIOL CHEM, V277, P25775, DOI 10.1074/jbc.M203122200; Shinbo Y, 2006, CELL DEATH DIFFER, V13, P96, DOI 10.1038/sj.cdd.4401704; Song LY, 2007, CIRC RES, V101, P277, DOI 10.1161/CIRCRESAHA.107.155630; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Takeda M, 2009, LAB INVEST, V89, P983, DOI 10.1038/labinvest.2009.59; Tamamori-Adachi M, 2008, CARDIOVASC RES, V80, P181, DOI 10.1093/cvr/cvn183; Tanaka M, 1999, DEVELOPMENT, V126, P1269; Toko H, 2002, J BIOL CHEM, V277, P24735, DOI 10.1074/jbc.M107669200; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2011, WIRES SYST BIOL MED, V3, P446, DOI 10.1002/wsbm.130; Wang J, 2011, BIRTH DEFECTS RES A, V91, P468, DOI 10.1002/bdra.20816; Wang J, 2010, CIRC RES, V107, P19, DOI 10.1161/CIRCRESAHA.110.220491; Winston JB, 2010, CIRCULATION, V121, P1313, DOI 10.1161/CIRCULATIONAHA.109.887687; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559; Zhang YQ, 2008, J CELL BIOL, V182, P35, DOI 10.1083/jcb.200712124; Zhang YZ, 2010, GENE DEV, V24, P1746, DOI 10.1101/gad.1929210	47	29	33	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20803	10.1371/journal.pone.0020803	http://dx.doi.org/10.1371/journal.pone.0020803			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677783	Green Submitted, Green Published, gold			2022-12-25	WOS:000291355500044
J	Andreotti, V; Ciribilli, Y; Monti, P; Bisio, A; Lion, M; Jordan, J; Fronza, G; Menichini, P; Resnick, MA; Inga, A				Andreotti, Virginia; Ciribilli, Yari; Monti, Paola; Bisio, Alessandra; Lion, Mattia; Jordan, Jennifer; Fronza, Gilberto; Menichini, Paola; Resnick, Michael A.; Inga, Alberto			p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening System	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; MUTANT P53; TUMOR-SUPPRESSOR; IN-VIVO; CANCER-CELLS; DNA-DAMAGE; WILD-TYPE; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; THERAPEUTIC TARGET	Background: The p53 tumor suppressor, which is altered in most cancers, is a sequence-specific transcription factor that is able to modulate the expression of many target genes and influence a variety of cellular pathways. Inactivation of the p53 pathway in cancer frequently occurs through the expression of mutant p53 protein. In tumors that retain wild type p53, the pathway can be altered by upstream modulators, particularly the p53 negative regulators MDM2 and MDM4. Methodology/Principal Findings: Given the many factors that might influence p53 function, including expression levels, mutations, cofactor proteins and small molecules, we expanded our previously described yeast-based system to provide the opportunity for efficient investigation of their individual and combined impacts in a miniaturized format. The system integrates i) variable expression of p53 proteins under the finely tunable GAL1,10 promoter, ii) single copy, chromosomally located p53-responsive and control luminescence reporters, iii) enhanced chemical uptake using modified ABC-transporters, iv) small-volume formats for treatment and dual-luciferase assays, and v) opportunities to co-express p53 with other cofactor proteins. This robust system can distinguish different levels of expression of WT and mutant p53 as well as interactions with MDM2 or 53BP1. Conclusions/Significance: We found that the small molecules Nutlin and RITA could both relieve the MDM2-dependent inhibition of WT p53 transactivation function, while only RITA could impact p53/53BP1 functional interactions. PRIMA-1 was ineffective in modifying the transactivation capacity of WT p53 and missense p53 mutations. This dual-luciferase assay can, therefore, provide a high-throughput assessment tool for investigating a matrix of factors that can influence the p53 network, including the effectiveness of newly developed small molecules, on WT and tumor-associated p53 mutants as well as interacting proteins.	[Andreotti, Virginia; Monti, Paola; Fronza, Gilberto; Menichini, Paola] IST, Natl Inst Canc Res, Unit Mol Mutagenesis, Genoa, Italy; [Ciribilli, Yari; Bisio, Alessandra; Lion, Mattia; Jordan, Jennifer; Inga, Alberto] CIBIO, Ctr Integrat Biol, Lab Transcript Networks, Trento, Italy; [Resnick, Michael A.] Natl Inst Environm Hlth Sci, Chromosome Stabil Grp, Mol Genet Lab, Durham, NC USA	University of Genoa; IRCCS AOU San Martino IST	Andreotti, V (corresponding author), Univ Genoa, Dept Oncol Biol & Genet, Genoa, Italy.	Resnick@niehs.nih.gov; inga@science.unitn.it	Fronza, Gilberto/AAG-8735-2019; Inga, Alberto/AAC-3815-2022; resnick, Michael/F-1668-2019; Menichini, Paola/K-9422-2016; Andreotti, Virginia/AAB-5169-2022; Andreotti, Virginia/K-4506-2016; Bisio, Alessandra/C-8214-2011; Ciribilli, Yari/K-2751-2018; Monti, Paola/Y-1118-2019	Fronza, Gilberto/0000-0003-3722-553X; Inga, Alberto/0000-0002-8767-1637; resnick, Michael/0000-0002-8473-7506; Andreotti, Virginia/0000-0002-2569-0832; Andreotti, Virginia/0000-0002-2569-0832; Ciribilli, Yari/0000-0001-9231-379X; Monti, Paola/0000-0002-1978-4998; Menichini, Paola/0000-0003-0057-6184; BISIO, Alessandra/0000-0002-3326-1923	NIEHS [Z01-ES065079]; Italian Association for Cancer Research (AIRC) [9086, 5506]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES065079, ZIAES065079] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by intramural research funds from NIEHS to MAR, project Z01-ES065079, and by the Italian Association for Cancer Research (AIRC IG#9086 to AI and AIRC IG#5506 to GF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alarcon-Vargas D, 2002, CARCINOGENESIS, V23, P541, DOI 10.1093/carcin/23.4.541; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Blagosklonny MV, 1996, INT J CANCER, V67, P386, DOI 10.1002/(SICI)1097-0215(19960729)67:3<386::AID-IJC13>3.0.CO;2-6; Bullock AN, 1997, P NATL ACAD SCI USA, V94, P14338, DOI 10.1073/pnas.94.26.14338; Bykov VJN, 2002, CARCINOGENESIS, V23, P2011, DOI 10.1093/carcin/23.12.2011; Bykov VJN, 2002, NAT MED, V8, P282, DOI 10.1038/nm0302-282; Cao L, 2009, MOL CELL, V35, P534, DOI 10.1016/j.molcel.2009.06.037; Chao C, 2000, P NATL ACAD SCI USA, V97, P11936, DOI 10.1073/pnas.220252297; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Coutinho I, 2011, EXP CELL RES; Coutinho I, 2009, FEBS LETT, V583, P3582, DOI 10.1016/j.febslet.2009.10.030; Derbyshire DJ, 2002, EMBO J, V21, P3863, DOI 10.1093/emboj/cdf383; Di Ventura B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001507; Dumaz N, 1999, EMBO J, V18, P7002, DOI 10.1093/emboj/18.24.7002; Eischen CM, 2009, CANCER CELL, V15, P161, DOI 10.1016/j.ccr.2009.02.004; Farnebo M, 2010, BIOCHEM BIOPH RES CO, V396, P85, DOI 10.1016/j.bbrc.2010.02.152; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; FLAMAN JM, 1995, P NATL ACAD SCI USA, V92, P3963, DOI 10.1073/pnas.92.9.3963; Foster BA, 1999, SCIENCE, V286, P2507, DOI 10.1126/science.286.5449.2507; Freedman DA, 1999, CELL MOL LIFE SCI, V55, P96, DOI 10.1007/s000180050273; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200; Gottlieb E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001040; Grinkevich VV, 2009, CANCER CELL, V15, P441, DOI 10.1016/j.ccr.2009.03.021; Han X, 2007, MODERN PATHOL, V20, P54, DOI 10.1038/modpathol.3800727; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Inga A, 2001, ONCOGENE, V20, P3409, DOI 10.1038/sj.onc.1204457; Inga A, 2001, ONCOGENE, V20, P501, DOI 10.1038/sj.onc.1204116; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; IWABUCHI K, 1994, P NATL ACAD SCI USA, V91, P6098, DOI 10.1073/pnas.91.13.6098; Jegga AG, 2008, P NATL ACAD SCI USA, V105, P944, DOI 10.1073/pnas.0704694105; Jordan JJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000104; Kachirskaia I, 2008, J BIOL CHEM, V283, P34660, DOI 10.1074/jbc.M806020200; Kastan MB, 2007, CELL, V128, P837, DOI 10.1016/j.cell.2007.02.022; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kaustov L, 2007, J BIOL CHEM, V282, P11300, DOI 10.1074/jbc.M611297200; Kitayner M, 2006, MOL CELL, V22, P741, DOI 10.1016/j.molcel.2006.05.015; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; KOLODKIN AL, 1986, CELL, V46, P733, DOI 10.1016/0092-8674(86)90349-1; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lane D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000893; LaRusch GA, 2007, CANCER RES, V67, P450, DOI 10.1158/0008-5472.CAN-06-2710; LUNA RMD, 1995, NATURE, V378, P203; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MEYERS S, 1992, CURR GENET, V21, P431, DOI 10.1007/BF00351651; Michael D, 2002, CURR OPIN GENET DEV, V12, P53, DOI 10.1016/S0959-437X(01)00264-7; Mitterbauer R, 2003, APPL ENVIRON MICROB, V69, P805, DOI 10.1128/AEM.69.2.805-811.2003; Olivier M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001008; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Popowicz GM, 2008, CELL CYCLE, V7, P2441, DOI 10.4161/cc.6365; Poyurovsky MV, 2010, NAT STRUCT MOL BIOL, V17, P982, DOI 10.1038/nsmb.1872; Reamon-Buettner SM, 2009, HUM MOL GENET, V18, P3567, DOI 10.1093/hmg/ddp305; Rehman A, 2005, BREAST CANCER RES, V7, pR765, DOI 10.1186/bcr1290; Resnick MA, 2003, P NATL ACAD SCI USA, V100, P9934, DOI 10.1073/pnas.1633803100; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Roy S, 2010, J MOL BIOL, V398, P489, DOI 10.1016/j.jmb.2010.03.024; Russo D, 2010, BIOCHEM BIOPH RES CO, V402, P345, DOI 10.1016/j.bbrc.2010.10.031; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Selivanova G, 2010, SEMIN CANCER BIOL, V20, P46, DOI 10.1016/j.semcancer.2010.02.006; Shakked Z, 2007, P NATL ACAD SCI USA, V104, P12231, DOI 10.1073/pnas.0705319104; Shangary S, 2008, MOL CANCER THER, V7, P1533, DOI 10.1158/1535-7163.MCT-08-0140; Shibata A, 2010, MOL CELL BIOL, V30, P3371, DOI 10.1128/MCB.01644-09; Stepanov A, 2008, MOL PHARMACOL, V74, P423, DOI 10.1124/mol.107.044651; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, METHOD ENZYMOL, V409, P329, DOI 10.1016/S0076-6879(05)09019-1; Sun SH, 2008, CANCER BIOL THER, V7, P845, DOI 10.4161/cbt.7.6.5841; Toledo F, 2007, INT J BIOCHEM CELL B, V39, P1476, DOI 10.1016/j.biocel.2007.03.022; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Tomso DJ, 2005, P NATL ACAD SCI USA, V102, P6431, DOI 10.1073/pnas.0501721102; Tran HT, 1997, MOL CELL BIOL, V17, P2859, DOI 10.1128/MCB.17.5.2859; Valentin-Vega YA, 2007, HUM PATHOL, V38, P1553, DOI 10.1016/j.humpath.2007.03.005; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Wang T, 2001, EMBO J, V20, P6404, DOI 10.1093/emboj/20.22.6404; Ward IM, 2003, MOL CELL BIOL, V23, P2556, DOI 10.1128/MCB.23.7.2556-2563.2003; Wiman KG, 2010, ONCOGENE, V29, P4245, DOI 10.1038/onc.2010.188; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675	83	38	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20643	10.1371/journal.pone.0020643	http://dx.doi.org/10.1371/journal.pone.0020643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674059	Green Published, Green Submitted, gold			2022-12-25	WOS:000291310600022
J	Huang, SH; Long, M; Wu, CH; Kwon-Chung, KJ; Chang, YC; Chi, F; Lee, S; Jong, A				Huang, Sheng-He; Long, Min; Wu, Chun-Hua; Kwon-Chung, Kyung J.; Chang, Yun C.; Chi, Feng; Lee, Susan; Jong, Ambrose			Invasion of Cryptococcus neoformans into Human Brain Microvascular Endothelial Cells Is Mediated through the Lipid Rafts-Endocytic Pathway via the Dual Specificity Tyrosine Phosphorylation-regulated Kinase 3 (DYRK3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTORS; INTRACELLULAR TRAFFICKING; DEPENDENT ENDOCYTOSIS; CHOLERA-TOXIN; CYTOSKELETON; ACTIVATION; CAVEOLAE; PROTEIN; MEMBRANE; SURVIVAL	Cryptococcus neoformans is a neurotropic fungal pathogen, which provokes the onset of devastating meningoencephalitis. Weused human brain microvascular endothelial cells (HBMEC) as the in vitro model to investigate how C. neoformans traverses across the blood-brain barrier. In this study, we present several lines of evidence indicating that C. neoformans invasion is mediated through the endocytic pathway via lipid rafts. Human CD44 molecules from lipid rafts can directly interact with hyaluronic acid, the C. neoformans ligand. Bikunin, which perturbs CD44 function in the lipid raft, can block C. neoformans adhesion and invasion of HBMEC. The lipid raft marker, ganglioside GM1, co-localizes with CD44 on the plasma membrane, and C. neoformans cells can adhere to the host cell in areas where GM1 is enriched. These findings suggest that C. neoformans entry takes place on the lipid rafts. Upon C. neoformans engagement, GM1 is internalized through vesicular structures to the nuclear membrane. This endocytic redistribution process is abolished by cytochalasin D, nocodazole, or anti-DYRK3 (dual specificity tyrosine-phosphorylation-regulated kinase 3) siRNA. Concomitantly, the knockdown of DYRK3 significantly reduces C. neoformans invasion across the HBMEC monolayer in vitro. Our data demonstrate that the lipid raft-dependent endocytosis process mediates C. neoformans internalization into HBMEC and that the CD44 protein of the hosts, cytoskeleton, and intracellular kinase-DYRK3 are involved in this process.	[Huang, Sheng-He; Long, Min; Wu, Chun-Hua; Chi, Feng; Jong, Ambrose] Univ So Calif, Saban Res Inst, Childrens Hosp Los Angeles, Dept Pediat, Los Angeles, CA 90027 USA; [Lee, Susan] Univ So Calif, Dept Pathol, Keck Sch Med, Los Angeles, CA 90027 USA; [Kwon-Chung, Kyung J.; Chang, Yun C.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA	Children's Hospital Los Angeles; University of Southern California; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jong, A (corresponding author), Childrens Hosp, Div Hematol Oncol, Mailstop 57,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	ajong@chla.usc.edu	Chi, Feng/H-5895-2012		National Institutes of Health from USPHS [R01-NS047599, R01-AI40635]; National Institutes of Health from NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000057, R01AI040635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047599] Funding Source: NIH RePORTER	National Institutes of Health from USPHS; National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-NS047599 (to A.J.) and R01-AI40635 from USPHS (to S.H.H.).; Supported by National Institutes of Health grants from the intramural program of NIAID.	Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Berndsen CE, 2008, NAT STRUCT MOL BIOL, V15, P948, DOI 10.1038/nsmb.1459; Bogacheva O, 2008, J BIOL CHEM, V283, P36665, DOI 10.1074/jbc.M807844200; Casadevall A, 2001, J INFECT DIS, V184, P337, DOI 10.1086/322044; Chang YC, 2006, INFECT IMMUN, V74, P3930, DOI 10.1128/IAI.00089-06; Chang YC, 2004, INFECT IMMUN, V72, P4985, DOI 10.1128/IAI.72.9.4985-4995.2004; Chen SHM, 2003, J MED MICROBIOL, V52, P961, DOI 10.1099/jmm.0.05230-0; Chinnapen DJF, 2007, FEMS MICROBIOL LETT, V266, P129, DOI 10.1111/j.1574-6968.2006.00545.x; Cho EY, 2007, MOL ENDOCRINOL, V21, P2242, DOI 10.1210/me.2007-0202; Fiori JL, 2009, ENDOCRINOLOGY, V150, P2551, DOI 10.1210/en.2008-1344; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Ivanov Andrei I., 2008, V440, P15, DOI 10.1007/978-1-59745-178-9_2; Jong A, 2008, CELL MICROBIOL, V10, P1854, DOI 10.1111/j.1462-5822.2008.01172.x; Jong A, 2008, CELL MICROBIOL, V10, P1313, DOI 10.1111/j.1462-5822.2008.01128.x; Jong A, 2007, EUKARYOT CELL, V6, P1486, DOI 10.1128/EC.00120-07; Kusumi A, 2005, BBA-MOL CELL RES, V1746, P234, DOI 10.1016/j.bbamcr.2005.10.001; KWONCHUNG KJ, 1978, AM J EPIDEMIOL, V108, P337, DOI 10.1093/oxfordjournals.aje.a112628; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Li K, 2002, J BIOL CHEM, V277, P47052, DOI 10.1074/jbc.M205374200; Lord KA, 2000, BLOOD, V95, P2838, DOI 10.1182/blood.V95.9.2838.009k29_2838_2846; Moyrand F, 2007, MOL MICROBIOL, V64, P771, DOI 10.1111/j.1365-2958.2007.05695.x; Mundy DI, 2002, J CELL SCI, V115, P4327, DOI 10.1242/jcs.00117; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pelkmans L, 2005, CURR OPIN MICROBIOL, V8, P331, DOI 10.1016/j.mib.2005.02.018; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Sadygov RG, 2004, NAT METHODS, V1, P195, DOI 10.1038/NMETH725; Seck T, 2003, J BIOL CHEM, V278, P10408, DOI 10.1074/jbc.M209655200; Seveau S, 2004, J CELL BIOL, V166, P743, DOI 10.1083/jcb.200406078; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sverdlov M, 2009, MOL BIOL CELL, V20, P4531, DOI 10.1091/mbc.E08-10-0997; Wakahara K, 2005, J CELL BIOCHEM, V94, P995, DOI 10.1002/jcb.20364; Wojchowski DM, 2006, BLOOD CELL MOL DIS, V36, P232, DOI 10.1016/j.bcmd.2006.01.007; Yavlovich A, 2004, FEMS MICROBIOL LETT, V233, P241, DOI 10.1016/j.femsle.2004.02.016; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0; Zhang DY, 2005, GENOMICS, V85, P117, DOI 10.1016/j.ygeno.2004.08.021	47	49	57	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2011	286	40					34761	34769		10.1074/jbc.M111.219378	http://dx.doi.org/10.1074/jbc.M111.219378			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	827DD	21693704	Green Published, hybrid			2022-12-25	WOS:000295406300030
J	Chen, CJ; Rayment, I; Gilbert, SP				Chen, Chun Ju; Rayment, Ivan; Gilbert, Susan P.			Kinesin Kar3Cik1 ATPase Pathway for Microtubule Cross-linking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MITOTIC SPINDLE; MOTOR DOMAIN; CRYOELECTRON MICROSCOPY; CRYSTAL-STRUCTURE; BINDING-SITES; PLUS ENDS; NCD TAIL; IN-VIVO; PROTEIN	Kar3Cik1 is a Saccharomyces cerevisiae kinesin-14 that functions to shorten cytoplasmic microtubules (MTs) during yeast mating yet maintains mitotic spindle stability by cross-linking anti-parallel interpolar MTs. Kar3 contains both an ATP-and a MT-binding site, yet there is no evidence of a nucleotide-binding site in Cik1. Presteady-state and steady-state kinetic experiments were pursued to define the regulation of Kar3Cik1 interactions with the MT lattice expected during interpolar MT cross-linking. The results reveal that association of Kar3Cik1 with the MT occurs at 4.9 mu M-1 s(-1), followed by a 5-s(-1) structural transition that limits ADP release from the Kar3 head. Mant-ATP binding occurred at 2.1 mu M-1 s(-1), and the pulsechase experiments revealed an ATP-promoted isomerization at 69 s(-1). ATPhydrolysis was observed as a rapid step at 26 s(-1) and was required for the Kar3Cik1 motor to detach from MT. The conformational change at 5 s(-1) that occurred after Kar3Cik1 MTassociation and prior toADPrelease was hypothesized to be the rate-limiting step for steady-state ATP turnover. We propose a model in which Kar3Cik1 interacts with the MT lattice through an alternating cycle of Cik1 MT collision followed by Kar3 MT binding with head-head communication between Kar3 and Cik1 modulated by the Kar3 nucleotide state and intramolecular strain.	[Chen, Chun Ju; Gilbert, Susan P.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Chen, Chun Ju; Gilbert, Susan P.] Rensselaer Polytech Inst, Dept Biol, Troy, NY 12180 USA; [Rayment, Ivan] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA	Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; University of Wisconsin System; University of Wisconsin Madison	Gilbert, SP (corresponding author), Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, BT 2237,110 8th St, Troy, NY 12180 USA.	sgilbert@rpi.edu	rayment, ivan/A-2720-2008	rayment, ivan/0000-0001-9279-7835	National Institutes of Health [GM54141, K02-AR47841, GM086351]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K02AR047841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054141, R01GM086351, R37GM054141] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54141, Career Development Award K02-AR47841 (to S. P. G.), and Grant GM086351 (to I. R.).	Allingham JS, 2007, CELL, V128, P1161, DOI 10.1016/j.cell.2006.12.046; Barrett JG, 2000, MOL BIOL CELL, V11, P2373, DOI 10.1091/mbc.11.7.2373; Benanti JA, 2009, MOL CELL, V33, P581, DOI 10.1016/j.molcel.2009.01.032; Braun M, 2009, NAT CELL BIOL, V11, P724, DOI 10.1038/ncb1878; Chu HMA, 2005, EMBO J, V24, P3214, DOI 10.1038/sj.emboj.7600790; Cottingham FR, 1999, J CELL BIOL, V147, P335, DOI 10.1083/jcb.147.2.335; Crevel IMTC, 1996, J MOL BIOL, V257, P66, DOI 10.1006/jmbi.1996.0147; deCastro MJ, 2000, NAT CELL BIOL, V2, P724, DOI 10.1038/35036357; ENDOW SA, 1990, NATURE, V345, P81, DOI 10.1038/345081a0; Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320; Farrell CM, 2002, J BIOL CHEM, V277, P17079, DOI 10.1074/jbc.M108793200; Fink G, 2009, NAT CELL BIOL, V11, P717, DOI 10.1038/ncb1877; Foster KA, 1998, J BIOL CHEM, V273, P35307, DOI 10.1074/jbc.273.52.35307; Foster KA, 2000, BIOCHEMISTRY-US, V39, P1784, DOI 10.1021/bi991500b; Foster KA, 2001, J BIOL CHEM, V276, P19259, DOI 10.1074/jbc.M008347200; Fridman V, 2009, EMBO REP, V10, P387, DOI 10.1038/embor.2009.7; Gardner MK, 2008, J CELL BIOL, V180, P91, DOI 10.1083/jcb.200710164; GILBERT SP, 1995, NATURE, V373, P671, DOI 10.1038/373671a0; Gilbert SP, 2000, METHODS, V22, P337, DOI 10.1006/meth.2000.1086; Gulick AM, 1998, BIOCHEMISTRY-US, V37, P1769, DOI 10.1021/bi972504o; HACKNEY DD, 1988, P NATL ACAD SCI USA, V85, P6314, DOI 10.1073/pnas.85.17.6314; Hildebrandt ER, 2006, J BIOL CHEM, V281, P26004, DOI 10.1074/jbc.M604817200; Hildebrandt ER, 2000, BBA-MOL CELL RES, V1496, P99, DOI 10.1016/S0167-4889(00)00012-4; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; Hirose K, 2006, MOL CELL, V23, P913, DOI 10.1016/j.molcel.2006.07.020; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Karabay A, 1999, BIOCHEMISTRY-US, V38, P1838, DOI 10.1021/bi981850i; Klumpp LM, 2003, J BIOL CHEM, V278, P39059, DOI 10.1074/jbc.M304250200; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Kocik E, 2009, J BIOL CHEM, V284, P35735, DOI 10.1074/jbc.M109.024240; Krzysiak TC, 2006, J BIOL CHEM, V281, P39444, DOI 10.1074/jbc.M608056200; Mackey AT, 2003, J BIOL CHEM, V278, P3527, DOI 10.1074/jbc.M206219200; Maddox PS, 2003, CURR BIOL, V13, P1423, DOI 10.1016/S0960-9822(03)00547-5; Manning BD, 1999, J CELL BIOL, V144, P1219, DOI 10.1083/jcb.144.6.1219; MCDONALD HB, 1990, CELL, V63, P1159, DOI 10.1016/0092-8674(90)90412-8; MCDONALD HB, 1990, CELL, V61, P991, DOI 10.1016/0092-8674(90)90064-L; MELUH PB, 1990, CELL, V60, P1029, DOI 10.1016/0092-8674(90)90351-E; Molk JN, 2006, J CELL BIOL, V172, P27, DOI 10.1083/jcb.200510032; Oladipo A, 2007, MOL BIOL CELL, V18, P3601, DOI 10.1091/mbc.e06-12-1085; PAGE BD, 1992, GENE DEV, V6, P1414, DOI 10.1101/gad.6.8.1414; PAGE BD, 1994, J CELL BIOL, V124, P507, DOI 10.1083/jcb.124.4.507; Pechatnikova E, 1999, BIOPHYS J, V77, P1003, DOI 10.1016/S0006-3495(99)76951-1; ROMBERG L, 1993, NATURE, V361, P168, DOI 10.1038/361168a0; ROOF DM, 1992, J CELL BIOL, V118, P95, DOI 10.1083/jcb.118.1.95; Saunders W, 1997, MOL BIOL CELL, V8, P1025, DOI 10.1091/mbc.8.6.1025; SAUNDERS WS, 1992, CELL, V70, P451, DOI 10.1016/0092-8674(92)90169-D; Song H, 1996, BIOCHEMISTRY-US, V35, P11203, DOI 10.1021/bi960997b; Sosa H, 1997, CELL, V90, P217, DOI 10.1016/S0092-8674(00)80330-X; Sproul LR, 2005, CURR BIOL, V15, P1420, DOI 10.1016/j.cub.2005.06.066; WALKER RA, 1990, NATURE, V347, P780, DOI 10.1038/347780a0; Wendt T, 2003, J MOL BIOL, V333, P541, DOI 10.1016/j.jmb.2003.08.051; Wendt TG, 2002, EMBO J, V21, P5969, DOI 10.1093/emboj/cdf622; Yun M, 2003, EMBO J, V22, P5382, DOI 10.1093/emboj/cdg531	53	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29261	29272		10.1074/jbc.M111.255554	http://dx.doi.org/10.1074/jbc.M111.255554			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21680740	Green Published, hybrid			2022-12-25	WOS:000293837000061
J	Lira, A; Kulczycki, J; Slack, R; Anisman, H; Park, DS				Lira, Arman; Kulczycki, Jerzy; Slack, Ruth; Anisman, Hymie; Park, David S.			Involvement of the Fc gamma Receptor in a Chronic N-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Mouse Model of Dopaminergic Loss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; MICROGLIAL ACTIVATION; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; NITRIC-OXIDE; REACTIVE MICROGLIA; OXIDATIVE STRESS; NEURODEGENERATION; NEURONS; DEGENERATION	Although there is growing evidence for a role of the innate immune response in Parkinson's disease, the nature of any humoral response in dopaminergic degeneration is uncertain. Here we report on a protracted N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of dopaminergic death that potentially allows a more full adaptive humoral response to develop. Rag2 mutant mice that lack the full adaptive response (deficient in both T and B cells) are resistant to dopaminergic death and behavioral deficiencies in this model. These mice are resensitized after reconstitution with WT splenocytes. To more directly provide evidence for humoral/IgG involvement, we show that deficiency of Fc gamma receptors, which are critical for activation of macrophages/microglia by binding to IgGs, is also protective in this protracted model. Fc gamma R-deficient mice display improved behavior and impaired microglial activation. Interestingly, however, Rag2 mutant but not Fc gamma R-deficient mice are resistant to a more standard N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine paradigm where death is more rapid. Taken together, these data indicate that, provided sufficient time, the humoral arm of the adaptive immune system can play a critical functional role in modulating the microglial response to dopaminergic degeneration and suggest that this humoral component may participate in degeneration in Parkinson's disease.	[Lira, Arman; Slack, Ruth; Park, David S.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada; [Kulczycki, Jerzy; Anisman, Hymie] Carleton Univ, Inst Neurosci, Ottawa, ON K1S 5B6, Canada; [Park, David S.] Pusan Natl Univ, Dept Cogno Mechatron Engn, Pusan, South Korea	University of Ottawa; Carleton University; Pusan National University	Park, DS (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	dpark@uottawa.ca		Park, David/0000-0002-4490-3784; Slack, Ruth/0000-0002-1552-2835	Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation of Ontario (HSFO); Parkinson's Disease Foundation (PDF); Parkinson's Society of Canada (PSC); Michael J. Fox Foundation; Neuroscience Canada; Centre for Stroke Recovery (CSR) Canadian Stroke Network; Ministry of Education, Science and Technology, South Korea [R31-2008-000-20004-0]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario (HSFO)(Heart & Stroke Foundation of Ontario); Parkinson's Disease Foundation (PDF); Parkinson's Society of Canada (PSC); Michael J. Fox Foundation; Neuroscience Canada; Centre for Stroke Recovery (CSR) Canadian Stroke Network; Ministry of Education, Science and Technology, South Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Canadian Institutes of Health Research (CIHR), the Heart and Stroke Foundation of Ontario (HSFO), the Parkinson's Disease Foundation (PDF), the Parkinson's Society of Canada (PSC), Michael J. Fox Foundation, Neuroscience Canada, the Centre for Stroke Recovery (CSR) Canadian Stroke Network, and World Class University program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology, South Korea Grant R31-2008-000-20004-0.	Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Appel SH, 2010, TRENDS IMMUNOL, V31, P7, DOI 10.1016/j.it.2009.09.003; Arai H, 2004, J BIOL CHEM, V279, P51647, DOI 10.1074/jbc.M407328200; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Benner EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001376; Brochard V, 2009, J CLIN INVEST, V119, P182, DOI 10.1172/JCI36470; Cao SW, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-42; CARVEY PM, 1991, NEUROLOGY, V41, P53, DOI 10.1212/WNL.41.5_Suppl_2.53; Crocker SJ, 2003, J NEUROSCI, V23, P4081; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dawson TM, 2010, NEURON, V66, P646, DOI 10.1016/j.neuron.2010.04.034; De Pablos RM, 2004, FASEB J, V18, P407, DOI 10.1096/fj.04-2153fje; Doucet JP, 1996, EUR J NEUROSCI, V8, P365, DOI 10.1111/j.1460-9568.1996.tb01220.x; DRAGUNOW M, 1995, MOL BRAIN RES, V30, P393, DOI 10.1016/0169-328X(95)00037-S; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Fasano S., 2002, Current Molecular Medicine (Hilversum), V2, P649, DOI 10.2174/1566524023362005; Fiszer U, 1996, J NEUROL SCI, V139, P66, DOI 10.1016/S0022-510X(96)00002-0; Gao HM, 2002, J NEUROSCI, V22, P782, DOI 10.1523/JNEUROSCI.22-03-00782.2002; He Y, 2002, EXP NEUROL, V176, P322, DOI 10.1006/exnr.2002.7946; Hunot S, 1999, J NEUROSCI, V19, P3440; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; Kim WG, 2000, J NEUROSCI, V20, P6309, DOI 10.1523/JNEUROSCI.20-16-06309.2000; Kurkowska-Jastrzebska I, 1999, ACTA NEUROBIOL EXP, V59, P1; Kurkowska-Jastrzebska I, 1999, EXP NEUROL, V156, P50, DOI 10.1006/exnr.1998.6993; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Liberatore GT, 1999, NAT MED, V5, P1403; McCormack AL, 2008, J NEUROPATH EXP NEUR, V67, P793, DOI 10.1097/NEN.0b013e318180f0bd; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Neff F, 2008, AUTOIMMUN REV, V7, P501, DOI 10.1016/j.autrev.2008.04.010; Orr CF, 2005, BRAIN, V128, P2665, DOI 10.1093/brain/awh625; Petiniot LK, 2000, P NATL ACAD SCI USA, V97, P6664, DOI 10.1073/pnas.97.12.6664; Schatz David G., 2004, Cell, VS116, pS103, DOI 10.1016/S0092-8674(04)00042-X; Serra Pier Andrea, 2008, Parkinsonism Relat Disord, V14 Suppl 2, pS189, DOI 10.1016/j.parkreldis.2008.04.029; Stone DK, 2009, ANTIOXID REDOX SIGN, V11, P2151, DOI [10.1089/ars.2009.2460, 10.1089/ARS.2009.2460]; Storch A, 2004, J NEURAL TRANSM, V111, P1267, DOI 10.1007/s00702-004-0203-2; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Theodore S, 2008, J NEUROPATH EXP NEUR, V67, P1149, DOI 10.1097/NEN.0b013e31818e5e99; ULVESTAD E, 1994, J NEUROL SCI, V121, P125, DOI 10.1016/0022-510X(94)90340-9; ULVESTAD E, 1994, J NEUROPATH EXP NEUR, V53, P27, DOI 10.1097/00005072-199401000-00004; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yokoyama H, 2008, NEUROL SCI, V29, P293, DOI 10.1007/s10072-008-0986-2; Zeng HY, 2005, INVEST OPHTH VIS SCI, V46, P2992, DOI 10.1167/iovs.05-0118	43	10	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28783	28793		10.1074/jbc.M111.244830	http://dx.doi.org/10.1074/jbc.M111.244830			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21693708	hybrid, Green Published			2022-12-25	WOS:000293837000016
J	Bah, A; Gilson, E; Wellinger, RJ				Bah, Amadou; Gilson, Eric; Wellinger, Raymund J.			Telomerase Is Required to Protect Chromosomes with Vertebrate-type T(2)AG(3) 3 ' Ends in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TELOMERES; MAMMALIAN TELOMERES; LENGTH REGULATION; BUDDING YEAST; G-TAILS; REPLICATION; MAINTENANCE; ELONGATION; SENESCENCE; RAP1	Telomeres containing vertebrate-type DNA repeats can be stably maintained in Saccharomyces cerevisiae cells. We show here that telomerase is required for growth of yeast cells containing these vertebrate-type telomeres. When present at the chromosome termini, these heterologous repeats elicit a DNA damage response and a certain deprotection of telomeres. The data also show that these phenotypes are due only to the terminal localization of the vertebrate repeats because if they are sandwiched between native yeast repeats, no phenotype is observed. Indeed and quite surprisingly, in this latter situation, telomeres are of virtually normal lengths, despite the presence of up to 50% of heterologous repeats. Furthermore, the presence of the distal vertebrate-type repeats can cause increased problems of the replication fork. These results show that in budding yeast the integrity of the 3' overhang is required for proper termination of telomere replication as well as protection.	[Bah, Amadou; Wellinger, Raymund J.] Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Grp ARN,RNA Grp, Sherbrooke, PQ J1H 5N4, Canada; [Bah, Amadou; Gilson, Eric] Univ Lyon, CNRS UMR 5239, Ecole Normale Super Lyon, Lab Biol Mol Cellule, F-69364 Lyon, France; [Gilson, Eric] Univ Nice Sophia Antipolis, CNRS UMR 6267, Inst Natl Sante & Rech Med U998, Lab Biol & Pathol Genomes, F-06107 Nice, France; [Gilson, Eric] Ctr Hosp Univ Nice, Dept Med Genet, F-06202 Nice, France	University of Sherbrooke; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice	Gilson, E (corresponding author), Univ Sherbrooke, Fac Med & Sci Sante, Dept Microbiol & Infectiol, Grp ARN,RNA Grp, 3001 12E Ave Nord, Sherbrooke, PQ J1H 5N4, Canada.	Eric.Gilson@unice.fr; Raymund.Wellinger@USherbrooke.ca	Wellinger, Raymund/K-3207-2019	Wellinger, Raymund/0000-0001-6670-2759	Canadian Institutes of Health Research (CIHR) [MOP-110982]; Association de la Recherche contre le Cancer (ARC); Institut National du Cancer; Agence Nationale de la Recherche (ANR); European Community [F2-2007-200950]; French Ministry of Foreign Affairs	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Association de la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); European Community(European Commission); French Ministry of Foreign Affairs	This work was supported Canadian Institutes of Health Research (CIHR) Grant MOP-110982) (to R. J. W.) and by grants from the Association de la Recherche contre le Cancer (ARC), from the Institut National du Cancer (Program TELOFUN), from the Agence Nationale de la Recherche (ANR) (Program TELOREP and INNATELO), and from the European Community (TELOMARKER Health Grant F2-2007-200950) (to E. G.). This work was also supported by the Lavoisier Grant from the French Ministry of Foreign Affairs (to A. B.).	Abdallah P, 2009, NAT CELL BIOL, V11, P988, DOI 10.1038/ncb1911; Alexander MK, 2003, EMBO J, V22, P1688, DOI 10.1093/emboj/cdg154; Arneric M, 2007, EMBO REP, V8, P1080, DOI 10.1038/sj.embor.7401082; Bah A, 2004, NUCLEIC ACIDS RES, V32, P1917, DOI 10.1093/nar/gkh511; Belli G, 1998, YEAST, V14, P1127, DOI 10.1002/(SICI)1097-0061(19980915)14:12<1127::AID-YEA300>3.0.CO;2-#; Berthiau AS, 2006, EMBO J, V25, P846, DOI 10.1038/sj.emboj.7600975; Brachmann CB, 1998, YEAST, V14, P115; Brevet V, 2003, EMBO J, V22, P1697, DOI 10.1093/emboj/cdg155; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A; Dehe PM, 2010, FEBS LETT, V584, P3725, DOI 10.1016/j.febslet.2010.07.045; di Domenico EG, 2009, DNA REPAIR, V8, P209, DOI 10.1016/j.dnarep.2008.10.005; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Giraud-Panis MJ, 2010, FEBS LETT, V584, P3785, DOI 10.1016/j.febslet.2010.08.004; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; Henning KA, 1998, P NATL ACAD SCI USA, V95, P5667, DOI 10.1073/pnas.95.10.5667; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; LeBel C, 2005, J CELL SCI, V118, P2785, DOI 10.1242/jcs.02394; LeBel Catherine, 2006, Methods Mol Biol, V313, P265; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Lundblad V, 2002, ONCOGENE, V21, P522, DOI 10.1038/sj.onc.1205079; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Makovets S, 2004, MOL CELL BIOL, V24, P4019, DOI 10.1128/MCB.24.9.4019-4031.2004; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; McElligott R, 1997, EMBO J, V16, P3705, DOI 10.1093/emboj/16.12.3705; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Paciotti V, 2000, GENE DEV, V14, P2046; Paeschke K, 2010, FEBS LETT, V584, P3760, DOI 10.1016/j.febslet.2010.07.007; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pardo B, 2005, EMBO J, V24, P3117, DOI 10.1038/sj.emboj.7600778; Pike BL, 2003, J BIOL CHEM, V278, P30421, DOI 10.1074/jbc.C300227200; Ray A, 1999, MOL CELL BIOL, V19, P31; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; ROSENBERG M, 1990, MICROBIAL CELL SURFA, P1; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; Shore D, 2009, EMBO J, V28, P2309, DOI 10.1038/emboj.2009.195; Teng SC, 1999, MOL CELL BIOL, V19, P8083; Tourriere H, 2005, MOL CELL, V19, P699, DOI 10.1016/j.molcel.2005.07.028; Vega LR, 2007, PLOS GENET, V3, P1065, DOI 10.1371/journal.pgen.0030105; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Ye J, 2010, CELL, V142, P230, DOI 10.1016/j.cell.2010.05.032	48	11	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27132	27138		10.1074/jbc.M111.220186	http://dx.doi.org/10.1074/jbc.M111.220186			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676873	hybrid, Green Published			2022-12-25	WOS:000293268700008
J	Xie, T; He, Y; Korkeamaki, H; Zhang, YB; Imhoff, R; Lohi, O; Radhakrishnan, I				Xie, Tao; He, Yuan; Korkeamaki, Hanna; Zhang, Yongbo; Imhoff, Rebecca; Lohi, Olli; Radhakrishnan, Ishwar			Structure of the 30-kDa Sin3-associated Protein (SAP30) in Complex with the Mammalian Sin3A Corepressor and Its Role in Nucleic Acid Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE COMPLEX; CHROMATIN-MODIFYING COMPLEX; AUTOMATED NOE ASSIGNMENT; DNA-BINDING; NMR-SPECTROSCOPY; TRANSCRIPTIONAL COREPRESSOR; SACCHAROMYCES-CEREVISIAE; MACROMOLECULAR STRUCTURE; GENE-EXPRESSION; FAMILY PROTEINS	The similar to 2-megadalton evolutionarily conserved histone deacetylase-associated Rpd3L/Sin3L complex plays critical roles in altering the histone code and repressing transcription of a broad range of genes involved in many aspects of cellular physiology. Targeting of this complex to specific regions of the genome is presumed to rely on interactions involving one or more of at least 10 distinct subunits in the complex. Here we describe the solution structure of the complex formed by the interacting domains of two constitutively associated subunits, mSin3A and SAP30. The mSin3A paired amphipathic helix 3 (PAH3) domain in the complex adopts the left-handed four-helix bundle structure characteristic of PAH domains. The SAP30 Sin3 interaction domain (SID) binds to PAH3 via a tripartite structural motif, including a C-terminal helix that targets the canonical PAH hydrophobic cleft while two other helices and an N-terminal extension target a discrete surface formed largely by the PAH3 alpha 2, alpha 3, and alpha 3' helices. The protein-protein interface is extensive (similar to 1400 angstrom(2)), accounting for the high affinity of the interaction and the constitutive association of the SAP30 subunit with the Rpd3L/Sin3L complex. We further show using NMR that the mSin3A PAH3-SAP30 SID complex can bind to nucleic acids, hinting at a role for a nucleolar localization sequence in the SID alpha A helix in targeting the Rpd3L/Sin3L complex for silencing ribosomal RNA genes.	[Korkeamaki, Hanna; Lohi, Olli] Univ Tampere, Sch Med, Pediat Res Ctr, Tampere 33520, Finland; [Korkeamaki, Hanna; Lohi, Olli] Tampere Univ Hosp, Tampere 33520, Finland; [Xie, Tao; He, Yuan; Zhang, Yongbo; Imhoff, Rebecca; Radhakrishnan, Ishwar] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Tampere University; Tampere University; Tampere University Hospital; Northwestern University	Lohi, O (corresponding author), Univ Tampere, Sch Med, Pediat Res Ctr, Tampere 33520, Finland.	olli.lohi@uta.fi; i-radhakrishnan@northwestern.edu	Radhakrishnan, Ishwar/AHA-7392-2022; Radhakrishnan, Ishwar/R-8442-2018; Lohi, Olli/AAW-6157-2021; He, Yuan/GVT-7268-2022; He, Yuan/C-7341-2015	Radhakrishnan, Ishwar/0000-0002-0195-9710; Radhakrishnan, Ishwar/0000-0002-0195-9710; Lohi, Olli/0000-0001-9195-0797; He, Yuan/0000-0002-1455-3963; He, Yuan/0000-0002-1455-3963	National Institutes of Health [R01 GM064715]; Foundation for Pediatric Research in Finland; Finnish Medical Foundation; Tampere University Hospital [9K073]; Nona and Kullervo Vare Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern University [P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR019071] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064715] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Foundation for Pediatric Research in Finland; Finnish Medical Foundation; Tampere University Hospital; Nona and Kullervo Vare Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM064715 (to I. R.). This work was also supported by the Foundation for Pediatric Research in Finland, the Finnish Medical Foundation, the Competitive Research Funding of Tampere University Hospital (Grant 9K073), and the Nona and Kullervo Vare Foundation (to O. L.) and by Grant P30 CA060553 from the Robert H. Lurie Comprehensive Cancer Center at Northwestern University.	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Binda O, 2006, MOL CELL BIOL, V26, P1917, DOI 10.1128/MCB.26.5.1917-1931.2006; Brubaker K, 2000, CELL, V103, P655, DOI 10.1016/S0092-8674(00)00168-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chen Jie, 2010, Virologica Sinica, V25, P417, DOI 10.1007/s12250-010-3147-8; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Cunliffe VT, 2008, CURR OPIN GENET DEV, V18, P404, DOI 10.1016/j.gde.2008.10.001; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589; Fleischer TC, 2003, MOL CELL BIOL, V23, P3456, DOI 10.1128/MCB.23.10.3456-3467.2003; Gardner KE, 2011, J MOL BIOL, V409, P36, DOI 10.1016/j.jmb.2011.01.040; Gohring F, 1997, EMBO J, V16, P7361, DOI 10.1093/emboj/16.24.7361; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; He Y, 2009, NUCLEIC ACIDS RES, V37, P2142, DOI 10.1093/nar/gkp051; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hsieh JJD, 1999, P NATL ACAD SCI USA, V96, P23, DOI 10.1073/pnas.96.1.23; Huang NE, 2003, BIOCHEM BIOPH RES CO, V306, P267, DOI 10.1016/S0006-291X(03)00966-5; Jelinic P, 2011, MOL CELL BIOL, V31, P54, DOI 10.1128/MCB.00840-10; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kipp M, 2000, MOL CELL BIOL, V20, P7480, DOI 10.1128/MCB.20.20.7480-7489.2000; Kumar GS, 2011, J MOL BIOL, V408, P987, DOI 10.1016/j.jmb.2011.03.043; Kuzmichev A, 2002, MOL CELL BIOL, V22, P835, DOI 10.1128/MCB.22.3.835-848.2002; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Le May N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040013; LeBoeuf M, 2010, DEV CELL, V19, P807, DOI 10.1016/j.devcel.2010.10.015; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Linge JP, 2004, J MAGN RESON, V167, P334, DOI 10.1016/j.jmr.2004.01.010; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Loewith R, 2001, J BIOL CHEM, V276, P24068, DOI 10.1074/jbc.M102176200; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Nomura M, 2005, J MOL BIOL, V354, P903, DOI 10.1016/j.jmb.2005.10.008; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; OTTING G, 1990, Q REV BIOPHYS, V23, P39, DOI 10.1017/S0033583500005412; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Sahu SC, 2008, J MOL BIOL, V375, P1444, DOI 10.1016/j.jmb.2007.11.079; Salerno WJ, 2004, NUCLEIC ACIDS RES, V32, pW566, DOI 10.1093/nar/gkh434; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Sichtig N, 2007, ARCH BIOCHEM BIOPHYS, V467, P67, DOI 10.1016/j.abb.2007.08.015; Sif S, 2001, GENE DEV, V15, P603, DOI 10.1101/gad.872801; Silverstein RA, 2005, CURR GENET, V47, P1, DOI 10.1007/s00294-004-0541-5; Spronk CAEM, 2000, NAT STRUCT BIOL, V7, P1100; Sun ZW, 1999, GENETICS, V152, P921; Suzuki R, 2009, PROTEINS, V75, P336, DOI 10.1002/prot.22243; Swanson KA, 2004, NAT STRUCT MOL BIOL, V11, P738, DOI 10.1038/nsmb798; van Ingen H, 2004, BIOCHEMISTRY-US, V43, P46, DOI 10.1021/bi0355645; Viiri KM, 2006, NUCLEIC ACIDS RES, V34, P3288, DOI 10.1093/nar/gkl401; Viiri KM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-149; Viiri KM, 2009, MOL CELL BIOL, V29, P342, DOI 10.1128/MCB.01213-08; Wilting RH, 2010, EMBO J, V29, P2586, DOI 10.1038/emboj.2010.136; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0; Zhang Y, 1998, MOL CELL, V1, P1021, DOI 10.1016/S1097-2765(00)80102-1; Zhou YG, 2002, EMBO J, V21, P4632, DOI 10.1093/emboj/cdf460; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	67	21	21	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27814	27824		10.1074/jbc.M111.252494	http://dx.doi.org/10.1074/jbc.M111.252494			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676866	Green Published, hybrid			2022-12-25	WOS:000293268700073
J	Cardoso, J; Lima, CD; Leal, T; Gradia, DF; Fragoso, SP; Goldenberg, S; De Sa, RG; Krieger, MA				Cardoso, Josiane; Lima, Carla De Paula; Leal, Tiago; Gradia, Daniela F.; Fragoso, Stenio P.; Goldenberg, Samuel; De Sa, Renata Guerra; Krieger, Marco A.			Analysis of Proteasomal Proteolysis during the In Vitro Metacyclogenesis of Trypanosoma cruzi	PLOS ONE			English	Article							OXIDATIVE STRESS; SELECTIVE DEGRADATION; PROTEIN-DEGRADATION; PROTOZOAN PARASITE; OXIDIZED PROTEINS; MAMMALIAN-CELLS; 26S PROTEASOME; UBIQUITIN; DIFFERENTIATION; REPLICATION	Proteasomes are large protein complexes, whose main function is to degrade unnecessary or damaged proteins. The inhibition of proteasome activity in Trypanosoma cruzi blocks parasite replication and cellular differentiation. We demonstrate that proteasome-dependent proteolysis occurs during the cellular differentiation of T. cruzi from replicative non-infectious epimastigotes to non-replicative and infectious trypomastigotes (metacyclogenesis). No peaks of ubiquitin-mediated degradation were observed and the profile of ubiquitinated conjugates was similar at all stages of differentiation. However, an analysis of carbonylated proteins showed significant variation in oxidized protein levels at the various stages of differentiation and the proteasome inhibition also increased oxidized protein levels. Our data suggest that different proteasome complexes coexist during metacyclogenesis. The 20S proteasome may be free or linked to regulatory particles (PA700, PA26 and PA200), at specific cell sites and the coordinated action of these complexes would make it possible for proteolysis of ubiquitin-tagged proteins and oxidized proteins, to coexist in the cell.	[Cardoso, Josiane; Lima, Carla De Paula; Gradia, Daniela F.; Fragoso, Stenio P.; Goldenberg, Samuel; Krieger, Marco A.] Inst Carlos Chagas FIOCRUZ, Curitiba, Parana, Brazil; [Leal, Tiago; De Sa, Renata Guerra] Univ Fed Ouro Preto, Ouro Preto, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Ouro Preto	Cardoso, J (corresponding author), Inst Carlos Chagas FIOCRUZ, Curitiba, Parana, Brazil.	mkrieger@tecpar.br	Krieger, Marco/AAE-8611-2020; P, CM/B-1358-2013; Goldenberg, Samuel/ABD-8908-2022; Publica, Inct Saude/J-9544-2013; GOLDENBERG, SAMUEL/B-4116-2009; Gradia, Daniela Fiori/I-8068-2012; Fragoso, Stenio/AAB-4703-2019	GOLDENBERG, SAMUEL/0000-0002-4892-163X; Gradia, Daniela Fiori/0000-0002-1452-5807; Fragoso, Stenio/0000-0002-0909-7940; Krieger, Marco Aurelio/0000-0003-0030-3952	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CAPES; FIOCRUZ; National Institutes of Health (NIH) [5R01AI050196-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050196] Funding Source: NIH RePORTER	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FIOCRUZ; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This investigation received financial support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), CAPES, FIOCRUZ, and a National Institutes of Health (NIH) grant 5R01AI050196-02. SG and MAK hold CNPq research fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Baker SP, 2005, CELL, V123, P361, DOI 10.1016/j.cell.2005.10.013; BAROJEK M, 2004, CELL MOL LIFE SCI, V61, P1579; Baugh JM, 2009, J MOL BIOL, V386, P814, DOI 10.1016/j.jmb.2008.12.081; Bonifacino JS, 1998, ANNU REV CELL DEV BI, V14, P19, DOI 10.1146/annurev.cellbio.14.1.19; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Cadenas E, 2000, FREE RADICAL BIO MED, V29, P222, DOI 10.1016/S0891-5849(00)00317-8; CAMARGO EP, 1964, REV INST MED TROP SP, V93, P93; Cardoso J, 2008, PARASITOL RES, V103, P941, DOI 10.1007/s00436-008-1081-6; CHEN M, 2005, ANN NY ACAD SCI, V1051, P1; CIECHANOVER A, 2006, HEMATOLOGY AM SOC HE, V505, P1; CONTRERAS V T, 1988, Memorias do Instituto Oswaldo Cruz, V83, P123, DOI 10.1590/S0074-02761988000100016; de Diego JL, 2001, BIOCHEMISTRY-US, V40, P1053, DOI 10.1021/bi001659k; DeMartino GN, 1999, J BIOL CHEM, V274, P22123, DOI 10.1074/jbc.274.32.22123; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; Figueiredo RCBQ, 2000, J PARASITOL, V86, P1213, DOI 10.1645/0022-3395(2000)086[1213:DOTCEM]2.0.CO;2; Gantt SM, 1998, ANTIMICROB AGENTS CH, V42, P2731, DOI 10.1128/AAC.42.10.2731; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Goldberg AL, 2007, BIOCHEM SOC T, V35, P12, DOI 10.1042/BST0350012; GOLDENBERG S, 1987, MOL STRATEGIES PARAS, P203; Gonzalez J, 1996, J EXP MED, V184, P1909, DOI 10.1084/jem.184.5.1909; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; GRUNE T, 1995, J BIOL CHEM, V270, P2344, DOI 10.1074/jbc.270.5.2344; Grune T, 1996, J BIOL CHEM, V271, P15504, DOI 10.1074/jbc.271.26.15504; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Grune T, 1997, FASEB J, V11, P526, DOI 10.1096/fasebj.11.7.9212076; Guerra-Sa R, 2005, EXP PARASITOL, V109, P228, DOI 10.1016/j.exppara.2005.01.002; Gutierrez B, 2009, PARASITOL INT, V58, P367, DOI 10.1016/j.parint.2009.07.012; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Jariel-Encontre I, 2008, BBA-REV CANCER, V1786, P153, DOI 10.1016/j.bbcan.2008.05.004; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; Mendez J, 2002, MOL CELL, V9, P481, DOI 10.1016/S1097-2765(02)00467-7; Pahl HL, 1996, CURR OPIN CELL BIOL, V8, P340, DOI 10.1016/S0955-0674(96)80007-X; Parodi-Talice A, 2007, J MASS SPECTROM, V42, P1422, DOI 10.1002/jms.1267; Paugam A, 2003, TRENDS PARASITOL, V19, P55, DOI 10.1016/S1471-4922(02)00064-8; Preckel T, 1999, SCIENCE, V286, P2162, DOI 10.1126/science.286.5447.2162; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Reinheckel T, 2000, ARCH BIOCHEM BIOPHYS, V377, P65, DOI 10.1006/abbi.2000.1717; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; RUBIN DM, 1995, CURR BIOL, V5, P854, DOI 10.1016/S0960-9822(95)00172-2; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shaw MK, 2000, PARASITOLOGY, V121, P35, DOI 10.1017/S0031182099006071; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; SOUSA MA, 1983, MEM I OSWALDO CRUZ, V78, P317; Tanaka K, 1998, J BIOCHEM-TOKYO, V123, P195; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Wainszelbaum MJ, 2003, BIOCHEM J, V375, P705, DOI 10.1042/BJ20021907; Yao Y, 1999, J BIOL CHEM, V274, P33921, DOI 10.1074/jbc.274.48.33921	50	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21027	10.1371/journal.pone.0021027	http://dx.doi.org/10.1371/journal.pone.0021027			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698116	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600039
J	Russo, L; Stehouwer, R; Heberling, JM; Shea, K				Russo, Laura; Stehouwer, Rachel; Heberling, Jacob Mason; Shea, Katriona			The Composite Insect Trap: An Innovative Combination Trap for Biologically Diverse Sampling	PLOS ONE			English	Article							MALAISE; BIODIVERSITY; HYMENOPTERA; ABUNDANCE; COLOR	Documentation of insect diversity is an important component of the study of biodiversity, community dynamics, and global change. Accurate identification of insects usually requires catching individuals for close inspection. However, because insects are so diverse, most trapping methods are specifically tailored to a particular taxonomic group. For scientists interested in the broadest possible spectrum of insect taxa, whether for long term monitoring of an ecosystem or for a species inventory, the use of several different trapping methods is usually necessary. We describe a novel composite method for capturing a diverse spectrum of insect taxa. The Composite Insect Trap incorporates elements from four different existing trapping methods: the cone trap, malaise trap, pan trap, and flight intercept trap. It is affordable, resistant, easy to assemble and disassemble, and collects a wide variety of insect taxa. Here we describe the design, construction, and effectiveness of the Composite Insect Trap tested during a study of insect diversity. The trap catches a broad array of insects and can eliminate the need to use multiple trap types in biodiversity studies. We propose that the Composite Insect Trap is a useful addition to the trapping methods currently available to ecologists and will be extremely effective for monitoring community level dynamics, biodiversity assessment, and conservation and restoration work. In addition, the Composite Insect Trap will be of use to other insect specialists, such as taxonomists, that are interested in describing the insect taxa in a given area.	[Russo, Laura; Shea, Katriona] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Stehouwer, Rachel] Univ Michigan, Dept Landscape Architecture, Ann Arbor, MI 48109 USA; [Heberling, Jacob Mason] Syracuse Univ, Dept Biol, Syracuse, NY 13244 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Michigan System; University of Michigan; Syracuse University	Russo, L (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	lar322@psu.edu	Shea, Katriona/B-7954-2008; Heberling, Mason/I-4506-2019	Shea, Katriona/0000-0002-7607-8248; Heberling, Mason/0000-0003-0756-5090	Pennsylvania State University; National Science Foundation (NSF) [DEB-0815373]; Direct For Biological Sciences [0815373] Funding Source: National Science Foundation	Pennsylvania State University; National Science Foundation (NSF)(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Pennsylvania State University, the National Science Foundation (NSF) REU Program, and NSF grant #DEB-0815373 to KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar AP, 2010, J INSECT CONSERV, V14, P199, DOI 10.1007/s10841-009-9246-x; Campbell JW, 2007, J INSECT CONSERV, V11, P399, DOI 10.1007/s10841-006-9055-4; DISNEY R H L, 1982, Field Studies, V5, P607; Duelli P, 1999, AGR ECOSYST ENVIRON, V74, P33, DOI 10.1016/S0167-8809(99)00029-8; Finlay BJ, 2006, P ROY SOC B-BIOL SCI, V273, P1935, DOI 10.1098/rspb.2006.3525; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; HARSTACK AW, 1979, J ECON ENTOMOL, V72, P519; Hoback WW, 1999, ENTOMOL EXP APPL, V91, P393, DOI 10.1023/A:1003667427454; HOSKING G P, 1979, New Zealand Entomologist, V7, P87; Johnson N.F., 2004, BORROR DELONGS INTRO; JUILLET JA, 1963, ZOOLOGY, V41, P219; KIM KC, 1993, BIODIVERS CONSERV, V2, P191, DOI 10.1007/BF00056668; Kim KC, 2006, ECOL RES, V21, P794, DOI 10.1007/s11284-006-0035-7; Leong JM, 1999, ECOL ENTOMOL, V24, P329, DOI 10.1046/j.1365-2311.1999.00196.x; Longcore T, 2003, RESTOR ECOL, V11, P397, DOI 10.1046/j.1526-100X.2003.rec0221.x; LOPEZ JD, 1994, J ECON ENTOMOL, V87, P793, DOI 10.1093/jee/87.3.793; MARTIN JEH, 1977, COLLECTING PREPARING; MATTHEWS RW, 1970, J NEW YORK ENTOMOL S, V78, P52; MAY RM, 2010, ECOLOGY, V329, P41; Missa O, 2009, J INSECT CONSERV, V13, P103, DOI 10.1007/s10841-007-9130-5; MOERICKE V, 1955, Z ANGEW ENTOMOL, V37, P22; NOYES JS, 1989, J NAT HIST, V23, P285, DOI 10.1080/00222938900770181; PECK S B, 1980, Coleopterists Bulletin, V34, P237; Southwood T.R.E., 1978, ECOLOGICAL METHODS, V2nd ed., DOI 10.1007/978-94-015-7291-0; Su JC, 2001, ENVIRON ENTOMOL, V30, P400, DOI 10.1603/0046-225X-30.2.400; TOWNES H, 1972, Entomological News, V83, P239	26	24	27	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21079	10.1371/journal.pone.0021079	http://dx.doi.org/10.1371/journal.pone.0021079			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698160	gold, Green Submitted, Green Published			2022-12-25	WOS:000291734100051
J	Khare, S; Linster, CL; Clarke, SG				Khare, Shilpi; Linster, Carole L.; Clarke, Steven G.			The Interplay between Protein L-Isoaspartyl Methyltransferase Activity and Insulin-Like Signaling to Extend Lifespan in Caenorhabditis elegans	PLOS ONE			English	Article							O-METHYLTRANSFERASE; REPAIR; LONGEVITY; DAF-16; GENE; TRANSCRIPTION; SURVIVAL; PATHWAY; GROWTH; DAUER	The protein L-isoaspartyl-O-methyltransferase functions to initiate the repair of isomerized aspartyl and asparaginyl residues that spontaneously accumulate with age in a variety of organisms. Caenorhabditis elegans nematodes lacking the pcm-1 gene encoding this enzyme display a normal lifespan and phenotype under standard laboratory growth conditions. However, significant defects in development, egg laying, dauer survival, and autophagy have been observed in pcm-1 mutant nematodes when deprived of food and when exposed to oxidative stress. Interestingly, overexpression of this repair enzyme in both Drosophila and C. elegans extends adult lifespan under thermal stress. In this work, we show the involvement of the insulin/insulin-like growth factor-1 signaling (IIS) pathway in PCM-1-dependent lifespan extension in C. elegans. We demonstrate that reducing the levels of the DAF-16 downstream transcriptional effector of the IIS pathway by RNA interference reduces the lifespan extension resulting from PCM-1 overexpression. Using quantitative real-time PCR analysis, we show the up-regulation of DAF-16-dependent stress response genes in the PCM-1 overexpressor animals compared to wild-type and pcm-1 mutant nematodes under mild thermal stress conditions. Additionally, similar to other long-lived C. elegans mutants in the IIS pathway, including daf-2 and age-1 mutants, PCM-1 overexpressor adult animals display increased resistance to severe thermal stress, whereas pcm-1 mutant animals survive less long under these conditions. Although we observe a higher accumulation of damaged proteins in pcm-1 mutant nematodes, the basal level of isoaspartyl residues detected in wild-type animals was not reduced by PCM-1 overexpression. Our results support a signaling role for the protein L-isoaspartyl methyltransferase in lifespan extension that involves the IIS pathway, but that may be independent of its function in overall protein repair.	[Khare, Shilpi; Linster, Carole L.; Clarke, Steven G.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA; [Clarke, Steven G.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Linster, Carole L.] Catholic Univ Louvain, Physiol Chem Lab, B-1200 Brussels, Belgium; [Linster, Carole L.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universite Catholique Louvain; Universite Catholique Louvain	Khare, S (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	skhare@chem.ucla.edu; carole.linster@uclouvain.be; clarke@mbi.ucla.edu		Linster, Carole/0000-0001-7143-0719	NIH [GM026020, AG032303]; Ellison Medical Foundation; Fonds de le Recherche Scientifique (FNRS); European Union [FP7/2007-2013, 276814]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM026020, R01GM026020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032303] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Fonds de le Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Union(European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH Grant GM026020 and AG032303 and an Ellison Medical Foundation Senior Scholar in Aging Award. CLL is supported by the Fonds de le Recherche Scientifique (FNRS) and by the European Union Seventh Framework Programme (FP7/2007-2013) under grant agreement 276814. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LN, 2011, J BIOL CHEM IN PRESS, V286; Alper S, 2010, J BIOL CHEM, V285, P1822, DOI 10.1074/jbc.M109.057323; Ayyadevara S, 2008, AGING CELL, V7, P13, DOI 10.1111/j.1474-9726.2007.00348.x; Banfield KL, 2008, J GERONTOL A-BIOL, V63, P798, DOI 10.1093/gerona/63.8.798; Chavous DA, 2001, P NATL ACAD SCI USA, V98, P14814, DOI 10.1073/pnas.251446498; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Cournoyer P, 2009, NEUROPHARMACOLOGY, V56, P839, DOI 10.1016/j.neuropharm.2009.01.008; DORMAN JB, 1995, GENETICS, V141, P1399; Doyle HA, 2003, J IMMUNOL, V171, P2840, DOI 10.4049/jimmunol.171.6.2840; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Farrar C, 2005, AGING CELL, V4, P1, DOI 10.1111/j.1474-9728.2004.00136.x; FRIEDMAN DB, 1988, GENETICS, V118, P75; Furuchi T, 2010, CHEM BIODIVERS, V7, P1337, DOI 10.1002/cbdv.200900273; Gomez TA, 2008, MECH AGEING DEV, V129, P752, DOI 10.1016/j.mad.2008.09.019; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Iser WB, 2007, DEV BIOL, V303, P434, DOI 10.1016/j.ydbio.2006.04.467; KAGAN RM, 1995, BIOCHEMISTRY-US, V34, P10794, DOI 10.1021/bi00034a012; Kagan RM, 1997, ARCH BIOCHEM BIOPHYS, V348, P320, DOI 10.1006/abbi.1997.0362; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kawli T, 2010, P NATL ACAD SCI USA, V107, P13788, DOI 10.1073/pnas.0914715107; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khare S, 2009, MECH AGEING DEV, V130, P670, DOI 10.1016/j.mad.2009.08.002; Kim E, 1997, P NATL ACAD SCI USA, V94, P6132, DOI 10.1073/pnas.94.12.6132; Kindrachuk J, 2003, J BIOL CHEM, V278, P50880, DOI 10.1074/jbc.M308423200; Kosugi S, 2008, BIOCHEM BIOPH RES CO, V371, P22, DOI 10.1016/j.bbrc.2008.03.109; Lamarre M, 2008, NEUROPHARMACOLOGY, V55, P669, DOI 10.1016/j.neuropharm.2008.05.033; Li J, 2008, PLOS BIOL, V6, P1870, DOI 10.1371/journal.pbio.0060233; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Oge L, 2008, PLANT CELL, V20, P3022, DOI 10.1105/tpc.108.058479; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Panowski SH, 2009, TRENDS ENDOCRIN MET, V20, P259, DOI 10.1016/j.tem.2009.03.006; Raices M, 2005, PLOS GENET, V1, P295, DOI 10.1371/journal.pgen.0010030; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Shaw WM, 2007, CURR BIOL, V17, P1635, DOI 10.1016/j.cub.2007.08.058; Sulston J., 1988, NEMATODE CAENORHABDI, P587; Sutphin George L, 2009, J Vis Exp, DOI 10.3791/1152; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tullet JMA, 2008, CELL, V132, P1025, DOI 10.1016/j.cell.2008.01.030; Verma P, 2010, PLANTA, V231, P329, DOI 10.1007/s00425-009-1050-z; Visick JE, 1998, J BACTERIOL, V180, P2623, DOI 10.1128/JB.180.10.2623-2629.1998; Wang JL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001048; Yamawaki TM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000468; Zhang LZ, 2009, FREE RADICAL BIO MED, V46, P414, DOI 10.1016/j.freeradbiomed.2008.10.041	53	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20850	10.1371/journal.pone.0020850	http://dx.doi.org/10.1371/journal.pone.0020850			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695191	Green Published, gold, Green Submitted			2022-12-25	WOS:000291663300026
J	Lopez-Coviella, I; Mellott, TJ; Schnitzler, AC; Blusztajn, JK				Lopez-Coviella, Ignacio; Mellott, Tiffany J.; Schnitzler, Aletta C.; Blusztajn, Jan K.			BMP9 Protects Septal Neurons from Axotomy-Evoked Loss of Cholinergic Phenotype	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; BASAL FOREBRAIN; HIPPOCAMPAL-FORMATION; SEPTOHIPPOCAMPAL PATHWAY; ACETYLTRANSFERASE ACTIVITY; DENTATE GYRUS; ADULT-RATS; LESIONS; EXPRESSION; DIFFERENTIATION	Background: Cholinergic projection from the septum to the hippocampus is crucial for normal cognitive function and degeneration of cells and nerve fibers within the septohippocampal pathway contributes to the pathophysiology of Alzheimer's disease. Bone morphogenetic protein (BMP) 9 is a cholinergic differentiating factor during development both in vivo and in vitro. Methodology/Principal Findings: To determine whether BMP9 could protect the adult cholinergic septohippocampal pathway from axotomy-evoked loss of the cholinergic phenotype, we performed unilateral fimbria-fornix transection in mice and treated them with a continuous intracerebroventricular infusion of BMP9 for six days. The number of choline acetyltransferase (CHAT)-positive cells was reduced by 50% in the medial septal nucleus ipsilateral to the lesion as compared to the intact, contralateral side, and BMP9 infusion prevented this loss in a dose-dependent manner. Moreover, BMP9 prevented most of the decline of hippocampal acetylcholine levels ipsilateral to the lesion, and markedly increased CHAT, choline transporter CHT, NGF receptors p75 (NGFR-p75) and TrkA (NTRK1), and NGF protein content in both the lesioned and unlesioned hippocampi. In addition, BMP9 infusion reduced bilaterally hippocampal levels of basic FGF (FGF2) protein. Conclusions/Significance: These data indicate that BMP9 administration can prevent lesion-evoked impairment of the cholinergic septohippocampal neurons in adult mice and, by inducing NGF, establishes a trophic environment for these cells.	[Lopez-Coviella, Ignacio; Blusztajn, Jan K.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Mellott, Tiffany J.; Schnitzler, Aletta C.; Blusztajn, Jan K.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Boston University; Boston University	Lopez-Coviella, I (corresponding author), Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA.	jbluszta@bu.edu		Mellott, Tiffany/0000-0003-3287-9374; /0000-0001-8438-3122	NIH [AG032709, AG009525]; NATIONAL INSTITUTE ON AGING [P01AG009525, R01AG032709] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH grants AG032709 and AG009525. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazalakova MH, 2006, HANDB EXP PHARM, V175, P525; Brandon EP, 2004, J NEUROSCI, V24, P5459, DOI 10.1523/JNEUROSCI.1106-04.2004; BRITO GNO, 1990, BEHAV BRAIN RES, V36, P127, DOI 10.1016/0166-4328(90)90167-D; Canossa M, 1996, EMBO J, V15, P3369, DOI 10.1002/j.1460-2075.1996.tb00702.x; Caronia G, 2010, J NEUROSCI, V30, P6291, DOI 10.1523/JNEUROSCI.0550-10.2010; CLARKE DJ, 1985, BRAIN RES, V360, P349, DOI 10.1016/0006-8993(85)91253-3; Dickinson-Anson H, 1998, NEUROSCIENCE, V84, P771, DOI 10.1016/S0306-4522(97)00543-5; DUNNETT SB, 1982, BRAIN RES, V251, P335, DOI 10.1016/0006-8993(82)90751-X; Ericson J, 1998, DEVELOPMENT, V125, P1005; GAGE FH, 1984, NEUROSCI LETT, V44, P211, DOI 10.1016/0304-3940(84)90083-1; GAGE FH, 1983, BRAIN RES, V268, P39, DOI 10.1016/0006-8993(83)90388-8; GAYKEMA RPA, 1990, J COMP NEUROL, V293, P103, DOI 10.1002/cne.902930109; Gilmor ML, 1998, J NEUROCHEM, V71, P2411; HARTIKKA J, 1988, J NEUROSCI RES, V21, P352, DOI 10.1002/jnr.490210227; HEFTI F, 1984, BRAIN RES, V293, P305, DOI 10.1016/0006-8993(84)91237-X; HIGGINS GA, 1989, NEURON, V3, P247, DOI 10.1016/0896-6273(89)90038-X; JUNARD EO, 1990, EXP NEUROL, V110, P25, DOI 10.1016/0014-4886(90)90048-W; KOLIATSOS VE, 1991, EXP NEUROL, V112, P161, DOI 10.1016/0014-4886(91)90066-L; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; LAPCHAK PA, 1991, NEUROSCIENCE, V42, P639, DOI 10.1016/0306-4522(91)90033-K; Lazo OM, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-5; LEWIS PR, 1967, BRAIN, V90, P521, DOI 10.1093/brain/90.3.521; LI YW, 1995, J NEUROSCI, V15, P2888; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Lopez-Coviella I, 2005, P NATL ACAD SCI USA, V102, P6984, DOI 10.1073/pnas.0502097102; Mehler Mark F, 2002, Results Probl Cell Differ, V39, P27; Mellott TJ, 2007, BRAIN RES, V1151, P1, DOI 10.1016/j.brainres.2007.03.004; MILNER TA, 1984, EXP BRAIN RES, V55, P579; Misawa H, 2001, NEUROSCIENCE, V105, P87, DOI 10.1016/S0306-4522(01)00147-6; MOBLEY WC, 1986, MOL BRAIN RES, V1, P53, DOI 10.1016/0169-328X(86)90020-3; MONTERO CN, 1988, J NEUROSCI, V8, P2986; Mufson Elliott J, 2008, Expert Rev Neurother, V8, P1703, DOI 10.1586/14737175.8.11.1703; Naumann T, 2002, J NEUROSCI, V22, P2409, DOI 10.1523/JNEUROSCI.22-07-02409.2002; Niewiadomska G, 2011, BEHAV BRAIN RES, V221, P515, DOI 10.1016/j.bbr.2010.02.024; Ota M, 2006, DEV DYNAM, V235, P646, DOI 10.1002/dvdy.20673; Panni MK, 1999, NEUROSCIENCE, V89, P1113, DOI 10.1016/S0306-4522(98)00385-6; POTTER PE, 1983, J NEUROCHEM, V41, P188, DOI 10.1111/j.1471-4159.1983.tb13668.x; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; Sarter M, 2000, NEUROSCIENCE, V95, P933; Schnitzler AC, 2010, J NEUROSCI, V30, P8221, DOI 10.1523/JNEUROSCI.5611-09.2010; Shanks M, 2009, CURR MED RES OPIN, V25, P2439, DOI 10.1185/03007990903209332; SHUTE CCD, 1966, Z ZELLFORSCH MIK ANA, V69, P334, DOI 10.1007/BF00406286; SOFRONIEW MV, 1990, SCIENCE, V247, P338, DOI 10.1126/science.1688664; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239	44	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e21166	10.1371/journal.pone.0021166	http://dx.doi.org/10.1371/journal.pone.0021166			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695154	Green Published, gold, Green Submitted			2022-12-25	WOS:000291663300042
J	Wang, W; Li, YF; Zhang, Y; Yuan, XH; Xu, DZ; Guan, YX; Feng, XY; Chen, YB; Sun, XW; Li, W; Zhan, YQ; Zhou, ZW				Wang, Wei; Li, Yuanfang; Zhang, Yu; Yuan, Xiuhong; Xu, Dazhi; Guan, Yuanxiang; Feng, Xingyu; Chen, Yingbo; Sun, Xiaowei; Li, Wei; Zhan, Youqing; Zhou, Zhiwei			Incorporation of Extranodal Metastasis of Gastric Carcinoma into the 7th Edition UICC TNM Staging System	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR DEPOSITS; CANCER; PROGNOSIS	Background: To assess the clinical significance and prognostic impact of extranodal metastasis (EM) in gastric carcinoma and establish an optimal classification in the staging system. Methodology/Principal Findings: A total of 1343 patients with gastric carcinoma who underwent surgical resection were recruited to determine the frequency and prognostic significance of EMs. EMs were divided into two groups (EM1 and EM2) and then incorporated into the 7(th) edition UICC TNM staging system. EMs was detected in 179 (13.3%) of 1343 patients who underwent radical resection. Multivariate analysis identified EMs as an independent prognostic factor (HR = 1.412, 95%CI = 1.151-1.731, P<0.001). After curative operation, the overall survival rate were worse in patients with >= 3 cases of EM (EM2) than those with the number of 1 and 2 cases (EM1) (P<0.001). Survival of patients with EM1 was found almost comparable to that of N3 stage (P = 0.437). Survival of patients with EM2 showed similar to that of stage IV patients (P = 0.896). By using the linear trend X-2, likelihood ratio X-2, and Akaike information criterion (AIC) test, EM1 treated as N3 stage and EM2 treated as M1 stage performed higher linear trend X-2 scores, likelihood ratio X-2 scores, and lower AIC value than the 7(th) edition UICC TNM staging system, which represented the optimum prognostic stratification, together with better homogeneity, discriminatory ability, and monotonicity of gradients. Conclusions/Significance: EMs might be classified based on their number and prognostic information and should incorporate into the TNM staging system.	[Wang, Wei; Li, Yuanfang; Zhang, Yu; Yuan, Xiuhong; Xu, Dazhi; Guan, Yuanxiang; Feng, Xingyu; Chen, Yingbo; Sun, Xiaowei; Li, Wei; Zhan, Youqing; Zhou, Zhiwei] Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wei; Li, Yuanfang; Yuan, Xiuhong; Xu, Dazhi; Guan, Yuanxiang; Feng, Xingyu; Chen, Yingbo; Sun, Xiaowei; Li, Wei; Zhan, Youqing; Zhou, Zhiwei] Sun Yat Sen Univ, Dept Gastr & Pancreat Surg, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yu] Sun Yat Sen Univ, Dept Pathol, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Wang, W (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol S China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	zhouzhw@sysucc.org.cn	Li, Yuan/GXV-1310-2022		Science and Technology Projects of Guangdong Province [2008B030301103, 2009B080701006]	Science and Technology Projects of Guangdong Province	This work was supported by Science and Technology Projects of Guangdong Province [Grant number 2008B030301103 and 2009B080701006]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; Cho YK, 2008, CANCER-AM CANCER SOC, V112, P352, DOI 10.1002/cncr.23185; Etoh T, 2006, BRIT J SURG, V93, P369, DOI 10.1002/bjs.5240; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hsu PK, 2010, ANN THORAC SURG, V89, P1024, DOI 10.1016/j.athoracsur.2010.01.017; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Kee KM, 2007, INT J CANCER, V120, P2650, DOI 10.1002/ijc.22616; Puppa G, 2007, MODERN PATHOL, V20, P843, DOI 10.1038/modpathol.3800791; Puppa G, 2009, MODERN PATHOL, V22, P410, DOI 10.1038/modpathol.2008.198; Sobin, 2009, UICC TNM CLASSIFICAT; Sobin LH., 2010, TNM CLASSIFICATION M; Tanaka T, 2000, J SURG ONCOL, V75, P165, DOI 10.1002/1096-9098(200011)75:3<165::AID-JSO3>3.0.CO;2-5; Ueno S, 2001, HEPATOLOGY, V34, P529, DOI 10.1053/jhep.2001.27219; UICC, 2017, TNM CLASSIFICATION M; Wang W, 2010, ANN SURG ONCOL; Wunsch K, 2010, AM J CLIN PATHOL, V133, P388, DOI 10.1309/AJCPAWOLX7ADZQ2K; Wunder JS, 2000, CANCER, V88, P2721, DOI 10.1002/1097-0142(20000615)88:12<2721::AID-CNCR10>3.0.CO;2-D	18	17	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e19557	10.1371/journal.pone.0019557	http://dx.doi.org/10.1371/journal.pone.0019557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695186	Green Submitted, gold, Green Published			2022-12-25	WOS:000291663300003
J	Balabanova, Y; Nikolayevskyy, V; Ignatyeva, O; Kontsevaya, I; Rutterford, CM; Shakhmistova, A; Malomanova, N; Chinkova, Y; Mironova, S; Fedorin, I; Drobniewski, FA				Balabanova, Yanina; Nikolayevskyy, Vladyslav; Ignatyeva, Olga; Kontsevaya, Irina; Rutterford, Clare M.; Shakhmistova, Anastasiya; Malomanova, Nadezhda; Chinkova, Yulia; Mironova, Svetlana; Fedorin, Ivan; Drobniewski, Francis A.			Survival of Civilian and Prisoner Drug-Sensitive, Multi- and Extensive Drug- Resistant Tuberculosis Cohorts Prospectively Followed in Russia	PLOS ONE			English	Article							XDR-TB; HIV; STRAINS; DIFFERENTIATION; EPIDEMIOLOGY; OUTCOMES; FAMILY	Objective and Methods: A long-term observational study was conducted in Samara, Russia to assess the survival and risk factors for death of a cohort of non-multidrug resistant tuberculosis (non-MDRTB) and multidrug resistant tuberculosis (MDRTB) civilian and prison patients and a civilian extensive drug-resistant tuberculosis (XDRTB) cohort. Results: MDRTB and XDRTB rates of 54.8% and 11.1% were identified in the region. Half (50%) of MDRTB patients and the majority of non-MDRTB patients (71%) were still alive at 5 years. Over half (58%) of the patients died within two years of establishing a diagnosis of XDRTB. In the multivariate analysis, retreatment (HR = 1.61, 95% CI 1.04, 2.49) and MDRTB (HR = 1.67, 95% CI 1.17, 2.39) were significantly associated with death within the non-MDR/MDRTB cohort. The effect of age on survival was relatively small (HR = 1.01, 95% CI 1.00, 1.02). No specific factor affected survival of XDRTB patients although median survival time for HIV-infected versus HIV-negative patients from this group was shorter (185 versus 496 days). The majority of MDRTB and XDRTB strains (84% and 92% respectively) strains belonged to the Beijing family. Mutations in the rpoB (codon 531 in 81/92; 88.8%), katG (mutation S315T in 91/92, 98.9%) and inhA genes accounted for most rifampin and isoniazid resistance respectively, mutations in the QRDR region of gyrA for most fluroquinolone resistance (68/92; 73.5%). Conclusions: Alarmingly high rates of XDRTB exist. Previous TB treatment cycles and MDR were significant risk factors for mortality. XDRTB patients' survival is short especially for HIV-infected patients. Beijing family strains comprise the majority of drug-resistant strains.	[Balabanova, Yanina; Nikolayevskyy, Vladyslav; Rutterford, Clare M.; Drobniewski, Francis A.] Univ London, Barts & London Sch Med, Queen Mary Coll, London, England; [Balabanova, Yanina; Ignatyeva, Olga; Kontsevaya, Irina; Shakhmistova, Anastasiya; Malomanova, Nadezhda; Chinkova, Yulia; Mironova, Svetlana; Fedorin, Ivan] Samara Oblast TB Dispensary, Samara, Russia	University of London; Queen Mary University London	Balabanova, Y (corresponding author), Univ London, Barts & London Sch Med, Queen Mary Coll, London, England.	y.balabanova@qmul.ac.uk	Kontsevaya, Irina/AAJ-8173-2020; Nikolayevskyy, Vladyslav/HFZ-7738-2022	Nikolayevskyy, Vladyslav/0000-0002-9502-0332; Robinson, Clare/0000-0002-2673-2205; Kontsevaya, Irina/0000-0003-3421-7550	EU; Foundation for Innovative Novel Diagnostics, Switzerland; UK Department for International Development	EU(European Commission); Foundation for Innovative Novel Diagnostics, Switzerland; UK Department for International Development	The study was partially funded by an EU FP7 Programme ("TB-EURO-GEN") grant, the Foundation for Innovative Novel Diagnostics, Switzerland, and the UK Department for International Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atun RA, 2005, EUR J PUBLIC HEALTH, V15, P350, DOI 10.1093/eurpub/cki018; Balabanova Y, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-44; Balabanova Y, 2005, EUR J CLIN MICROBIOL, V24, P136, DOI 10.1007/s10096-004-1268-4; Balabanova Y, 2004, J ANTIMICROB CHEMOTH, V54, P673, DOI 10.1093/jac/dkh383; BENDAYAN D, 2010, EUR J CLIN MICROBIOL; Brown TJ, 2006, J MICROBIOL METH, V65, P294, DOI 10.1016/j.mimet.2005.08.002; Dheda K, 2010, INFECT DIS CLIN N AM, V24, P705, DOI 10.1016/j.idc.2010.05.001; DROBNIEWSKI F, 1995, LANCET, V346, P948, DOI 10.1016/S0140-6736(95)91562-1; Drobniewski F, 2005, JAMA-J AM MED ASSOC, V293, P2726, DOI 10.1001/jama.293.22.2726; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; GANDHI NR, 2009, AM J RESP CRIT CAR; Gopaul KK, 2006, J CLIN MICROBIOL, V44, P2492, DOI 10.1128/JCM.01428-05; He GX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010799; Jeon DS, 2009, INT J TUBERC LUNG D, V13, P594; Kim DH, 2008, AM J RESP CRIT CARE, V178, P1075, DOI 10.1164/rccm.200801-132OC; Koenig R, 2008, SCIENCE, V319, P894, DOI 10.1126/science.319.5865.894; Kruuner A, 2006, J CLIN MICROBIOL, V44, P811, DOI 10.1128/JCM.44.3.811-818.2006; Kwara A, 2003, J CLIN MICROBIOL, V41, P2683, DOI 10.1128/JCM.41.6.2683-2685.2003; Leimane V, 2010, EUR RESPIR J, V36, P584, DOI 10.1183/09031936.00003710; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Migliori GB, 2009, EUR RESPIR J, V34, P778, DOI 10.1183/09031936.00059409; Migliori GB, 2008, CLIN INFECT DIS, V46, P958, DOI 10.1086/528875; Migliori GB, 2010, CURR OPIN PULM MED, V16, P171, DOI 10.1097/MCP.0b013e328337573e; *MIN HLTH RUSS FED, 2003, IMPR TB CONTR ACT RU; Mitnick CD, 2008, NEW ENGL J MED, V359, P563, DOI 10.1056/NEJMoa0800106; Murray J, 1999, AM J RESP CRIT CARE, V159, P733, DOI 10.1164/ajrccm.159.3.9804147; Nikolayevskyy VV, 2007, CLIN MICROBIOL INFEC, V13, P129, DOI 10.1111/j.1469-0691.2006.01583.x; Nikolayevskyy V, 2006, EMERG INFECT DIS, V12, P1406, DOI 10.3201/eid1209.041623; Podlekareva DN, 2009, AIDS, V23, P2485, DOI 10.1097/QAD.0b013e3283326879; Ruddy M, 2005, THORAX, V60, P130, DOI 10.1136/thx.2004.026922; *SAM OBL TUB DISP, 2009, ANN REP TB CONTR SAM; Shah NS, 2008, JAMA-J AM MED ASSOC, V300, P2153, DOI 10.1001/jama.300.18.2153; SIDDIQI S, 2007, MGIT PROCEDURE MANUA; Velji P, 2009, EMERG INFECT DIS, V15, P1609, DOI 10.3201/eid1510.090463; Wells CD, 2007, J INFECT DIS, V196, pS86, DOI 10.1086/518665; WHO, 2008, GLOBAL TUBERCULOSIS; World Health Organization, 2008, WHOHTMTB2008392; Wright A, 2009, LANCET, V373, P1861, DOI 10.1016/S0140-6736(09)60331-7	38	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20531	10.1371/journal.pone.0020531	http://dx.doi.org/10.1371/journal.pone.0020531			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695213	Green Published, gold			2022-12-25	WOS:000291612600014
J	Moreno, MD; Sanchez-Porro, C; Piubeli, F; Frias, L; Garcia, MT; Mellado, E				de Lourdes Moreno, Maria; Sanchez-Porro, Cristina; Piubeli, Francine; Frias, Luciana; Teresa Garcia, Maria; Mellado, Encarnacion			Cloning, Characterization and Analysis of cat and ben Genes from the Phenol Degrading Halophilic Bacterium Halomonas organivorans	PLOS ONE			English	Article							CATECHOL 1,2-DIOXYGENASE; DEGRADATION; BIODEGRADATION; STRAIN; CATABOLISM; PATHWAYS; BIOLOGY; CARBON	Background: Extensive use of phenolic compounds in industry has resulted in the generation of saline wastewaters that produce significant environmental contamination; however, little information is available on the degradation of phenolic compounds in saline conditions. Halomonas organivorans G-16.1 (CECT 5995(T)) is a moderately halophilic bacterium that we isolated in a previous work from saline environments of South Spain by enrichment for growth in different pollutants, including phenolic compounds. PCR amplification with degenerate primers revealed the presence of genes encoding ring-cleaving enzymes of the beta-ketoadipate pathway for aromatic catabolism in H. organivorans. Findings: The gene cluster catRBCA, involved in catechol degradation, was isolated from H. organivorans. The genes catA, catB, catC and the divergently transcribed catR code for catechol 1,2-dioxygenase (1,2-CTD), cis, cis-muconate cycloisomerase, muconolactone delta-isomerase and a LysR-type transcriptional regulator, respectively. The benzoate catabolic genes (benA and benB) are located flanking the cat genes. The expression of cat and ben genes by phenol and benzoic acid was shown by RT-PCR analysis. The induction of catA gene by phenol and benzoic acid was also probed by the measurement of 1,2-CTD activity in H. organivorans growth in presence of these inducers. 16S rRNA and catA gene-based phylogenies were established among different degrading bacteria showing no phylogenetic correlation between both genes. Conclusions/Significance: In this work, we isolated and determined the sequence of a gene cluster from a moderately halophilic bacterium encoding ortho-pathway genes involved in the catabolic metabolism of phenol and analyzed the gene organization, constituting the first report characterizing catabolic genes involved in the degradation of phenol in moderate halophiles, providing an ideal model system to investigate the potential use of this group of extremophiles in the decontamination of saline environments.	[de Lourdes Moreno, Maria; Sanchez-Porro, Cristina; Teresa Garcia, Maria; Mellado, Encarnacion] Univ Seville, Dept Microbiol & Parasitol, Seville, Spain; [Piubeli, Francine; Frias, Luciana] Univ Estadual Campinas, Dept Food Sci, Sao Paulo, Brazil	University of Sevilla; Universidade Estadual de Campinas	Moreno, MD (corresponding author), Univ Seville, Dept Microbiol & Parasitol, Seville, Spain.	emellado@us.es	de Lourdes Moreno Amador, María/H-5836-2012; Sanchez, Cristina/K-8027-2017; MELLADO, ENCARNACIÓN/K-8665-2014; GARCÍA GUTIÉRREZ, MARIA TERESA/K-6515-2014; Piubeli, Francine/H-1991-2015	de Lourdes Moreno Amador, María/0000-0002-7490-2037; Sanchez, Cristina/0000-0002-1834-1239; MELLADO, ENCARNACIÓN/0000-0002-7135-1428; GARCÍA GUTIÉRREZ, MARIA TERESA/0000-0002-0916-6256; Piubeli, Francine/0000-0002-5065-5297	Spanish Ministry of Science and Education [CTM2006-03310, BIO2006-06927]; Junta de Andalucia [P08-RNM-3515]	Spanish Ministry of Science and Education(Spanish Government); Junta de Andalucia(Junta de Andalucia)	This work was supported by grants from the Spanish Ministry of Science and Education (CTM2006-03310 and BIO2006-06927) and Junta de Andalucia (P08-RNM-3515). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abd-El-Haleem D, 2002, MICROB ECOL, V43, P217, DOI 10.1007/s00248-002-2003-2; Alva VA, 2003, ENVIRON SCI TECHNOL, V37, P4397, DOI 10.1021/es0341844; Basha K.M., 2010, ASIAN J EXP BIOL SCI, V1, P219; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brusa T, 2001, MICROBIOL RES, V156, P49, DOI 10.1078/0944-5013-00075; Camara B, 2007, J BACTERIOL, V189, P1664, DOI 10.1128/JB.01192-06; Cowles CE, 2000, J BACTERIOL, V182, P6339, DOI 10.1128/JB.182.22.6339-6346.2000; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Duffner FM, 2000, GENE, V256, P215, DOI 10.1016/S0378-1119(00)00352-8; Earhart CA, 2005, BIOCHEM BIOPH RES CO, V338, P198, DOI 10.1016/j.bbrc.2005.08.221; El Azhari N, 2010, J HAZARD MATER, V177, P593, DOI 10.1016/j.jhazmat.2009.12.074; Eulberg D, 1998, ANTON LEEUW INT J G, V74, P71, DOI 10.1023/A:1001755928637; Garcia MT, 2005, FEMS MICROBIOL ECOL, V54, P97, DOI 10.1016/j.femsec.2005.03.009; Garcia MT, 2004, INT J SYST EVOL MICR, V54, P1723, DOI 10.1099/ijs.0.63114-0; Gayathri K. V., 2010, Journal of Bioremediation and Biodegradation, V1, P1000104, DOI 10.4172/2155-6199.1000104; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Heinaru E, 2000, FEMS MICROBIOL ECOL, V31, P195, DOI 10.1111/j.1574-6941.2000.tb00684.x; Hinteregger C, 1997, BIOTECHNOL LETT, V19, P1099, DOI 10.1023/A:1018488410102; Jimenez JI, 2002, ENVIRON MICROBIOL, V4, P824, DOI 10.1046/j.1462-2920.2002.00370.x; Kim D, 2008, FEMS MICROBIOL LETT, V280, P235, DOI 10.1111/j.1574-6968.2008.01067.x; KUKOR JJ, 1988, J BACTERIOL, V170, P4458, DOI 10.1128/jb.170.10.4458-4465.1988; Le Borgne S, 2008, J MOL MICROB BIOTECH, V15, P74, DOI 10.1159/000121323; Li Y, 2006, ENVIRON TECHNOL, V27, P511, DOI 10.1080/09593332808618662; Margesin R, 2001, APPL MICROBIOL BIOT, V56, P650, DOI 10.1007/s002530100701; Maskow T, 2004, EXTREMOPHILES, V8, P133, DOI 10.1007/s00792-003-0372-1; Mellado E., 2003, MICROORGANISMS HLTH, P233; Munoz JA, 2001, FOLIA MICROBIOL, V46, P297, DOI 10.1007/BF02815617; NGAI KL, 1990, METHOD ENZYMOL, V188, P122; NIETO JJ, 1989, APPL ENVIRON MICROB, V55, P2385, DOI 10.1128/AEM.55.9.2385-2390.1989; Oren A, 2002, J IND MICROBIOL BIOT, V28, P56, DOI 10.1038/sj.jim.7000176; Peyton BM, 2002, WATER RES, V36, P4811, DOI 10.1016/S0043-1354(02)00200-2; Pieper DH, 2000, CURR OPIN BIOTECH, V11, P262, DOI 10.1016/S0958-1669(00)00094-X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrook J, 2001, MOL CLONING LAB MANU; Sandhu A, 2009, MICROB ECOL, V57, P276, DOI 10.1007/s00248-008-9473-9; Shen FT, 2009, SYST APPL MICROBIOL, V32, P291, DOI 10.1016/j.syapm.2009.04.002; Tancsics A, 2008, J APPL MICROBIOL, V105, P1026, DOI 10.1111/j.1365-2672.2008.03832.x; Top EM, 2003, CURR OPIN BIOTECH, V14, P262, DOI 10.1016/S0958-1669(03)00066-1; Valley MP, 2005, BIOCHEMISTRY-US, V44, P11024, DOI 10.1021/bi050902i; Ventosa A, 1998, MICROBIOL MOL BIOL R, V62, P504, DOI 10.1128/MMBR.62.2.504-544.1998; Vesely M, 2007, APPL MICROBIOL BIOT, V76, P159, DOI 10.1007/s00253-007-0997-6; Vetting MW, 2000, STRUCTURE, V8, P429, DOI 10.1016/S0969-2126(00)00122-2; Wang CH, 2007, INORG CHIM ACTA, V360, P2944, DOI 10.1016/j.ica.2007.02.034	43	23	23	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21049	10.1371/journal.pone.0021049	http://dx.doi.org/10.1371/journal.pone.0021049			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695219	gold, Green Submitted, Green Published			2022-12-25	WOS:000291612600043
J	Bourguignon, LYW; Earle, C; Wong, G; Spevak, CC; Krueger, K				Bourguignon, L. Y. W.; Earle, C.; Wong, G.; Spevak, C. C.; Krueger, K.			Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells	ONCOGENE			English	Article						nanog; Stat-3; miR-21; hyaluronan; CD44; head & neck cancer	NF-KAPPA-B; CANCER STATISTICS; GENE-EXPRESSION; TUMOR-CELLS; RHO-KINASE; HYALURONAN; BREAST; PROGRESSION; ACTIVATION; TRANSCRIPTION	MicroRNAs are often associated with the pathogenesis of many cancers, including head and neck squamous cell carcinoma (HNSCC). In particular, microRNA-21 (miR-21) appears to have a critical role in tumor cell survival, chemoresistance and HNSCC progression. In this study, we investigated matrix hyaluronan (HA)-induced CD44 (a primary HA receptor) interaction with the stem cell markers, Nanog and Stat-3, in HNSCC cells (HSC-3 cells). Our results indicate that HA binding to CD44 promotes Nanog-Stat-3 (also tyrosine phosphorylated Stat-3) complex formation, nuclear translocation and transcriptional activation. Further analyses reveal that miR-21 is controlled by an upstream promoter containing Stat-3 binding site(s), while chromatin immunoprecipitation assays demonstrate that stimulation of miR-21 expression by HA/CD44 signaling is Nanog/Stat-3-dependent in HNSCC cells. This process results in a decrease of a tumor suppressor protein (PDCD4), and an upregulation of i nhibitors of the apoptosis family of proteins (IAPs) as well as chemoresistance in HSC-3 cells. Treatment of HSC-3 cells with Nanog- and/or Stat-3-specific small interfering RNAs effectively blocks HA-mediated Nanog-Stat-3 signaling events, abrogates miR-21 production and increases PDCD4 expression. Subsequently, this Nanog-Stat-3 signaling inhibition causes downregulation of survival protein (IAP) expression and enhancement of chemosensitivity. To further evaluate the role of miR-21 in tumor cell-specific functions, HSC-3 cells were also transfected with a specific anti-miR-21 inhibitor in order to silence miR-21 expression and block its target functions. Our results demonstrate that anti-miR-21 inhibitor not only upregulates PDCD4 expression but also decreases IAP expression and enhances chemosensitivity in HA-treated HNSCC cells. Together, these findings indicate that the HA-induced CD44 interaction with Nanog and Stat-3 has a pivotal role in miR-21 production leading to PDCD4 reduction, IAP upregulation and chemoresistance in HNSCC cells. This novel Nanog/Stat-3 signaling pathway-specific mechanism involved in miR-21 production is significant for the formation of future intervention strategies in the treatment of HA/CD44-activated HNSCC. Oncogene (2012) 31, 149-160; doi:10.1038/onc.2011.222; published online 20 June 2011	[Bourguignon, L. Y. W.] Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, San Francisco, CA 94121 USA; San Francisco VA Med Ctr, San Francisco, CA USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Bourguignon, LYW (corresponding author), Univ Calif San Francisco, Dept Med, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	lilly.bourguignon@ucsf.edu			Veterans Affairs (VA) Merit Review grant; United States Public Health grants [R01 CA66163, R01 CA78633, P01 AR39448]; NATIONAL CANCER INSTITUTE [R01CA066163, R01CA078633] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448, R01AR050023] Funding Source: NIH RePORTER	Veterans Affairs (VA) Merit Review grant; United States Public Health grants; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We gratefully acknowledge the assistance of Drs Gerard J Bourguignon and Walter M Holleran in the preparation and review of this manuscript. We are grateful for Ms Christina Camacho for her assistance in preparing graphs and illustrations. We would also like to thank for Dr Shaomeng Wang from the University of Michigan for providing us an IAP inhibitor, SM164. This work was supported by Veterans Affairs (VA) Merit Review grant and United States Public Health grants (R01 CA66163, R01 CA78633 and P01 AR39448). LYWB is a VA Senior Research Career Scientist.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Bourguignon LYW, 2010, J BIOL CHEM, V285, P36721, DOI 10.1074/jbc.M110.162305; Bourguignon LYW, 2009, J BIOL CHEM, V284, P26533, DOI 10.1074/jbc.M109.027466; Bourguignon LYW, 2009, J BIOL CHEM, V284, P2657, DOI 10.1074/jbc.M806708200; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chiou SH, 2008, CLIN CANCER RES, V14, P4085, DOI 10.1158/1078-0432.CCR-07-4404; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Ezeh UI, 2005, CANCER-AM CANCER SOC, V104, P2255, DOI 10.1002/cncr.21432; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Hunter AM, 2007, APOPTOSIS, V12, P1543, DOI 10.1007/s10495-007-0087-3; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kashyap V, 2009, STEM CELLS DEV, V18, P1093, DOI 10.1089/scd.2009.0113; Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nakamura M, 2005, ONCOL REP, V14, P1281; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Song JI, 2000, ONCOGENE, V19, P2489, DOI 10.1038/sj.onc.1203483; Toole BP, 2002, AM J PATHOL, V161, P745, DOI 10.1016/S0002-9440(10)64232-0; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Torre C, 2010, ARCH OTOLARYNGOL, V136, P493, DOI 10.1001/archoto.2010.25; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang SJ, 2011, AM J PATHOL, V178, P956, DOI 10.1016/j.ajpath.2010.11.077; Wang SJ, 2009, LARYNGOSCOPE, V119, P1518, DOI 10.1002/lary.20506; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9	30	174	182	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	2					149	160		10.1038/onc.2011.222	http://dx.doi.org/10.1038/onc.2011.222			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21685938	Green Accepted, Green Submitted			2022-12-25	WOS:000299307400002
J	Banerjee, A; Lang, JY; Hung, MC; Sengupta, K; Banerjee, SK; Baksi, K; Banerjee, DK				Banerjee, Aditi; Lang, Jing-Yu; Hung, Mien-Chie; Sengupta, Krishanu; Banerjee, Sushanta K.; Baksi, Krishna; Banerjee, Dipak K.			Unfolded Protein Response Is Required in nu/nu Mice Microvasculature for Treating Breast Tumor with Tunicamycin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL-CELL PROLIFERATION; CANCER GROWTH; IN-VITRO; ANGIOGENESIS; GLYCOSYLATION; EXPRESSION; INHIBITORS; SILIBININ; SYNTHASE; CAMP	Up-regulation of the dolichol pathway, a "hallmark" of asparagine-linked protein glycosylation, enhances angiogenesis in vitro. The dynamic relationship between these two processes is now evaluated with tunicamycin. Capillary endothelial cells treated with tunicamycin were growth inhibited and could not be reversed with exogenous VEGF(165). Inhibition of angiogenesis is supported by down-regulation of (i) phosphorylated VEGFR1 and VEGFR2 receptors; (ii) VEGF(165)-specific phosphotyrosine kinase activity; and (iii) Matrigel (TM) invasion and chemotaxis. In vivo, tunicamycin prevented the vessel development in Matrigel (TM) implants in athymic Balb/c (nu/nu) mice. Immunohistochemical analysis of CD34 (p < 0.001) and CD144 (p < 0.001) exhibited reduced vascularization. A 3.8-fold increased expression of TSP-1, an endogenous angiogenesis inhibitor in Matrigel (TM) implants correlated with that in tunicamycin (32 h)-treated capillary endothelial cells. Intravenous injection of tunicamycin (0.5 mg/kg to 1.0 mg/kg) per week slowed down a double negative (MDA-MB-435) grade III breast adenocarcinoma growth by similar to 50-60% in 3 weeks. Histopathological analysis of the paraffin sections indicated significant reduction in vessel size, the microvascular density and tumor mitotic index. Ki-67 and VEGF expression in tumor tissue were also reduced. A significant reduction of N-glycan expression in tumor microvessel was also observed. High expression of GRP-78 in CD144-positive cells supported unfolded protein response-mediated ER stress in tumor microvasculature. similar to 65% reduction of a triple negative (MDA-MB-231) breast tumor xenograft in 1 week with tunicamycin (0.25 mg/kg) given orally and the absence of systemic and/or organ failure strongly supported tunicamycin's potential for a powerful glycotherapeutic treatment of breast cancer in the clinic.	[Banerjee, Aditi; Banerjee, Dipak K.] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Lang, Jing-Yu; Hung, Mien-Chie] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Hung, Mien-Chie] China Med Univ, Ctr Mol Med, Taichung 404, Taiwan; [Hung, Mien-Chie] China Med Univ, Grad Inst Canc Biol, Taichung 404, Taiwan; [Sengupta, Krishanu; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Vet Affairs Med Ctr, Canc Res Unit, Kansas City, KS 66160 USA; [Sengupta, Krishanu; Banerjee, Sushanta K.] Univ Kansas, Med Ctr, Div Hematol & Oncol, Dept Med, Kansas City, KS 66160 USA; [Baksi, Krishna] Univ Cent Caribe, Sch Med, Dept Anat & Cell Biol, Bayamon, PR 00960 USA; [Banerjee, Dipak K.] Univ Puerto Rico, Inst Funct Nanomat, San Juan, PR 00931 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan; University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Kansas; University of Kansas Medical Center; University of Puerto Rico	Banerjee, DK (corresponding author), Univ Puerto Rico, Sch Med, Dept Biochem, Med Sci Campus, San Juan, PR 00936 USA.	dipak.banerjee@upr.edu	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740; Sengupta, Krishanu/0000-0001-6600-2621	National Institutes of Health (NIH) [U54-CA096297]; Susan G. Komen for the Cure [BCTR0600582]; VA Merit Grant; NIH/NCRR/RCMI [G12-RR03035]; NATIONAL CANCER INSTITUTE [U54CA096297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); VA Merit Grant; NIH/NCRR/RCMI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by Grant U54-CA096297 from the National Institutes of Health (NIH) and Susan G. Komen for the Cure BCTR0600582 (to D. K. B.), a VA Merit Grant (to S. K. B.), and NIH/NCRR/RCMI Grant G12-RR03035 (to K. B.).	Baksi K, 2008, CURR DRUG TARGETS, V9, P262, DOI 10.2174/138945008783954916; Banerjee DK, 2011, ADV EXP MED BIOL, V705, P453, DOI 10.1007/978-1-4419-7877-6_24; Banerjee DK, 2005, J BIOL CHEM, V280, P4174, DOI 10.1074/jbc.M406962200; BANERJEE DK, 1993, INDIAN J BIOCHEM BIO, V30, P389; BANERJEE DK, 1985, P NATL ACAD SCI USA, V82, P4702, DOI 10.1073/pnas.82.14.4702; BANERJEE DK, 2008, ANGIOGENESIS BASIC S, P287; BORNSTEIN P, 1995, J CELL BIOL, V130, P503, DOI 10.1083/jcb.130.3.503; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; BROOKS PC, 1995, J CLIN INVEST, V96, P1815, DOI 10.1172/JCI118227; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Contessa JN, 2008, CANCER RES, V68, P3803, DOI 10.1158/0008-5472.CAN-07-6389; DAS SK, 1994, MOL CELL BIOCHEM, V140, P49, DOI 10.1007/BF00928365; Dass CR, 2007, J DENT RES, V86, P927, DOI 10.1177/154405910708601005; Erlichman C, 2001, ANN ONCOL, V12, P389, DOI 10.1023/A:1011183905848; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; FOLKMAN J, 1994, J CLIN ONCOL, V12, P441, DOI 10.1200/JCO.1994.12.3.441; FOTSIS T, 1994, NATURE, V368, P237, DOI 10.1038/368237a0; Grossfeld GD, 1997, J NATL CANCER I, V89, P219, DOI 10.1093/jnci/89.3.219; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hidalgo M, 2001, JNCI-J NATL CANCER I, V93, P178, DOI 10.1093/jnci/93.3.178; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; KIM KJ, 1993, NATURE, V362, P841, DOI 10.1038/362841a0; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Martinez JA, 1999, CELL MOL BIOL, V45, P137; Martinez JA, 2006, GLYCOCONJUGATE J, V23, P209, DOI 10.1007/s10719-006-7926-2; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Munoz R, 2005, BREAST, V14, P466, DOI 10.1016/j.breast.2005.08.026; NGUYEN M, 1992, J BIOL CHEM, V267, P26157; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; OLIVEIRA CM, 1990, J CELL PHYSIOL, V144, P467, DOI 10.1002/jcp.1041440314; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; PILI R, 1995, CANCER RES, V55, P2920; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Schneider BP, 2005, J CLIN ONCOL, V23, P1782, DOI 10.1200/JCO.2005.12.017; Sellappan S, 2004, CANCER RES, V64, P3479, DOI 10.1158/0008-5472.CAN-3299-2; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Singh RP, 2008, CANCER RES, V68, P2043, DOI 10.1158/0008-5472.CAN-07-6247; Singh RP, 2006, J NATL CANCER I, V98, P846, DOI 10.1093/jnci/djj231; TIGANIS T, 1992, EXP CELL RES, V198, P191, DOI 10.1016/0014-4827(92)90371-E; VARTANIAN RK, 1994, AM J PATHOL, V144, P1188; Weidner Noel, 1996, P167; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200; Zhang ZB, 2010, BIOCATAL BIOTRANSFOR, V28, P90, DOI 10.3109/10242420903411629; Zwick E, 2001, ENDOCR-RELAT CANCER, V8, P161, DOI 10.1677/erc.0.0080161	45	67	67	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29127	29138		10.1074/jbc.M110.169771	http://dx.doi.org/10.1074/jbc.M110.169771			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21676868	Green Published, hybrid			2022-12-25	WOS:000293837000049
J	Orru, R; Dudek, HM; Martinoli, C; Pazmino, DET; Royant, A; Weik, M; Fraaije, MW; Mattevi, A				Orru, Roberto; Dudek, Hanna M.; Martinoli, Christian; Pazmino, Daniel E. Torres; Royant, Antoine; Weik, Martin; Fraaije, Marco W.; Mattevi, Andrea			Snapshots of Enzymatic Baeyer-Villiger Catalysis OXYGEN ACTIVATION AND INTERMEDIATE STABILIZATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENYLACETONE-MONOOXYGENASE; CYCLOHEXANONE MONOOXYGENASE; SPECIFICITY; MECHANISM; CRYSTALS; OXIDASE; REVEAL	Baeyer-Villiger monooxygenases catalyze the oxidation of carbonylic substrates to ester or lactone products using NADPH as electron donor and molecular oxygen as oxidative reactant. Using protein engineering, kinetics, microspectrophotometry, crystallography, and intermediate analogs, we have captured several snapshots along the catalytic cycle which highlight key features in enzyme catalysis. After acting as electron donor, the enzyme-bound NADP(H) forms an H-bond with the flavin cofactor. This interaction is critical for stabilizing the oxygen-activating flavin-peroxide intermediate that results from the reaction of the reduced cofactor with oxygen. An essential active-site arginine acts as anchoring element for proper binding of the ketone substrate. Its positively charged guanidinium group can enhance the propensity of the substrate to undergo a nucleophilic attack by the flavin-peroxide intermediate. Furthermore, the arginine side chain, together with the NADP(+) ribose group, forms the niche that hosts the negatively charged Criegee intermediate that is generated upon reaction of the substrate with the flavin-peroxide. The fascinating ability of Baeyer-Villiger monooxygenases to catalyze a complex multistep catalytic reaction originates from concerted action of this Arg-NADP(H) pair and the flavin subsequently to promote flavin reduction, oxygen activation, tetrahedral intermediate formation, and product synthesis and release. The emerging picture is that these enzymes are mainly oxygen-activating and "Criegee-stabilizing" catalysts that act on any chemically suitable substrate that can diffuse into the active site, emphasizing their potential value as toolboxes for biocatalytic applications.	[Dudek, Hanna M.; Pazmino, Daniel E. Torres; Fraaije, Marco W.] Univ Groningen, Lab Biochem, Groningen Biomol Sci & Biotechnol Inst, NL-9747 AG Groningen, Netherlands; [Orru, Roberto; Martinoli, Christian; Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy; [Royant, Antoine; Weik, Martin] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, CNRS Commissariat Energie Atom, F-38027 Grenoble, France; [Royant, Antoine; Weik, Martin] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University of Groningen; University of Pavia; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); European Synchrotron Radiation Facility (ESRF)	Fraaije, MW (corresponding author), Univ Groningen, Lab Biochem, Groningen Biomol Sci & Biotechnol Inst, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	m.w.fraaije@rug.nl; andrea.mattevi@unipv.it	Royant, Antoine/G-3684-2012; Weik, Martin/M-2770-2017; Fraaije, Marco/E-8421-2014; Mattevi, Andrea/R-4469-2019; Orru, Roberto/E-9779-2013; mattevi, andrea/K-5464-2012	Royant, Antoine/0000-0002-1919-8649; Weik, Martin/0000-0001-9297-642X; Mattevi, Andrea/0000-0002-9523-7128; mattevi, andrea/0000-0002-9523-7128; Fraaije, Marco/0000-0001-6346-5014	European Union Project Oxygreen [212281]; Fondazione Cariplo Grant [2008.3148]	European Union Project Oxygreen; Fondazione Cariplo Grant(Fondazione Cariplo)	This work was supported by European Union Project Oxygreen 212281 and Fondazione Cariplo Grant 2008.3148.	Alfieri A, 2008, P NATL ACAD SCI USA, V105, P6572, DOI 10.1073/pnas.0800859105; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CRIEGEE R, 1948, LIEBIGS ANN CHEM, V560, P127; de Gonzalo G, 2006, J MOL CATAL B-ENZYM, V39, P91, DOI 10.1016/j.molcatb.2006.01.010; de Gonzalo G, 2005, TETRAHEDRON-ASYMMETR, V16, P3077, DOI 10.1016/j.tetasy.2005.08.004; de Gonzalo G, 2010, CHEMBIOCHEM, V11, P2208, DOI 10.1002/cbic.201000395; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Dudek HM, 2010, APPL MICROBIOL BIOT, V88, P1135, DOI 10.1007/s00253-010-2769-y; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Flot D, 2010, J SYNCHROTRON RADIAT, V17, P107, DOI 10.1107/S0909049509041168; Fraaije MW, 2005, APPL MICROBIOL BIOT, V66, P393, DOI 10.1007/s00253-004-1749-5; GHISLA S, 2009, FLAVIN COENZYMES; JONES KC, 1986, J BIOL CHEM, V261, P2553; Malito E, 2004, P NATL ACAD SCI USA, V101, P13157, DOI 10.1073/pnas.0404538101; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Mattevi A, 2006, TRENDS BIOCHEM SCI, V31, P276, DOI 10.1016/j.tibs.2006.03.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGeehan J, 2009, J SYNCHROTRON RADIAT, V16, P163, DOI 10.1107/S0909049509001629; Mihovilovic MD, 2002, EUR J ORG CHEM, V2002, P3711; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Pazmino DET, 2010, J BIOTECHNOL, V146, P9, DOI 10.1016/j.jbiotec.2010.01.021; Pazmino DET, 2008, BIOCHEMISTRY-US, V47, P4082, DOI 10.1021/bi702296k; Pazmino DET, 2008, ANGEW CHEM INT EDIT, V47, P2275, DOI 10.1002/anie.200704630; Pazmino DET, 2010, CURR OPIN CHEM BIOL, V14, P138, DOI 10.1016/j.cbpa.2009.11.017; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Reetz MT, 2009, J AM CHEM SOC, V131, P15424, DOI 10.1021/ja906212k; Rohr AK, 2010, ANGEW CHEM INT EDIT, V49, P2324, DOI 10.1002/anie.200907143; Royant A, 2007, J APPL CRYSTALLOGR, V40, P1105, DOI 10.1107/S0021889807044196; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Schlichting I, 2000, SCIENCE, V287, P1615, DOI 10.1126/science.287.5458.1615; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Sucharitakul J, 2011, J BIOL CHEM, V286, P16900, DOI 10.1074/jbc.M111.222976; Pazmino DET, 2007, ADV SYNTH CATAL, V349, P1361, DOI 10.1002/adsc.200700045; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van den Heuvel RHH, 2005, J BIOL CHEM, V280, P32115, DOI 10.1074/jbc.M503758200; Weik M, 2010, ACTA CRYSTALLOGR D, V66, P437, DOI 10.1107/S0907444910002702; Wu S, 2010, P NATL ACAD SCI USA, V107, P2775, DOI 10.1073/pnas.0911656107	40	110	111	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29284	29291		10.1074/jbc.M111.255075	http://dx.doi.org/10.1074/jbc.M111.255075			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697090	Green Published, hybrid			2022-12-25	WOS:000293837000084
J	Lott, K; Bhardwaj, A; Sims, PJ; Cingolani, G				Lott, Kaylen; Bhardwaj, Anshul; Sims, Peter J.; Cingolani, Gino			A Minimal Nuclear Localization Signal (NLS) in Human Phospholipid Scramblase 4 That Binds Only the Minor NLS-binding Site of Importin alpha 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN IMPORT; CRYSTALLOGRAPHIC ANALYSIS; STRUCTURAL BASIS; RECOGNITION; BETA; PHOSPHORYLATION; IDENTIFICATION; PALMITOYLATION; MONOPARTITE; MECHANISM	Importin alpha 1 can bind classical nuclear localization signals (NLSs) in two NLS-binding sites, known as "major" and "minor." The major site is located between ARM repeats 2-4, whereas the minor site spans ARM 7-8. In this study, we have characterized the cellular localization of human phospholipid scramblase 4 (hPLSCR4), a member of the phospholipid scramblase protein family. We identified a minimal NLS in hPLSCR4 ((273)GSIIRKWN(280)) that contains only two basic amino acids. This NLS is both necessary for nuclear localization of hPLSCR4 in transfected HeLa cells and sufficient for nuclear import of a non-diffusible cargo in permeabilized cells. Mutation of only one of the two basic residues, Arg(277), correlates with loss of nuclear localization, suggesting this amino acid plays a key role in nuclear transport. Crystallographic analysis of mammalian importin alpha 1 in complex with the hPLSCR4-NLS reveals this minimal NLS binds specifically and exclusively to the minor binding site of importin alpha. These data provide the first structural and functional evidence of a novel NLS-binding mode in importin alpha 1 that uses only the minor groove as the exclusive site for nuclear import of nonclassical cargos.	[Lott, Kaylen; Bhardwaj, Anshul; Cingolani, Gino] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA; [Lott, Kaylen] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Sims, Peter J.] Univ Rochester, Med Ctr, Dept Pathol & Lab Med, Rochester, NY 14642 USA	Jefferson University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Rochester	Cingolani, G (corresponding author), 233 S 10th St, Philadelphia, PA 19107 USA.	gino.cingolani@jefferson.edu		Bhardwaj, Anshul/0000-0002-0897-979X	National Institutes of Health [5R01GM074846, 5R01HL063819]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 5R01GM074846 (to G. C.) and 5R01HL063819 (to P. J. S.).	ADAM SA, 1990, J CELL BIOL, V111, P807, DOI 10.1083/jcb.111.3.807; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bateman A, 2009, BIOINFORMATICS, V25, P159, DOI 10.1093/bioinformatics/btn595; Ben-Efraim I, 2004, BIOCHEMISTRY-US, V43, P3518, DOI 10.1021/bi0356911; Bevers EM, 2010, FEBS LETT, V584, P2724, DOI 10.1016/j.febslet.2010.03.020; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; Chen CW, 2011, J LEUKOCYTE BIOL, V90, P221, DOI 10.1189/jlb.0111006; Chen MH, 2005, J BIOL CHEM, V280, P10599, DOI 10.1074/jbc.M413194200; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; COLLEDGE WH, 1986, MOL CELL BIOL, V6, P4136, DOI 10.1128/MCB.6.11.4136; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cook A, 2007, ANNU REV BIOCHEM, V76, P647, DOI 10.1146/annurev.biochem.76.052705.161529; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Ilmarinen T, 2006, FEBS J, V273, P315, DOI 10.1111/j.1742-4658.2005.05065.x; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kitamura R, 2006, J VIROL, V80, P1979, DOI 10.1128/JVI.80.4.1979-1991.2006; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kutay U, 1997, EMBO J, V16, P1153, DOI 10.1093/emboj/16.6.1153; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Lott K, 2010, J BIOL CHEM, V285, P13769, DOI 10.1074/jbc.M109.095760; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Nardozzi JD, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-32; Sahu SK, 2007, ARCH BIOCHEM BIOPHYS, V462, P103, DOI 10.1016/j.abb.2007.04.002; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun J, 2002, BIOCHEMISTRY-US, V41, P6338, DOI 10.1021/bi025610l; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Weis K, 1996, EMBO J, V15, P7120, DOI 10.1002/j.1460-2075.1996.tb01103.x; Wiedmer T, 2000, BBA-BIOMEMBRANES, V1467, P244, DOI 10.1016/S0005-2736(00)00236-4; Wiedmer T, 2004, P NATL ACAD SCI USA, V101, P13296, DOI 10.1073/pnas.0405354101; Wiedmer T, 2003, BIOCHEMISTRY-US, V42, P1227, DOI 10.1021/bi026679w; Wyles JP, 2007, NUCLEIC ACIDS RES, V35, P4076, DOI 10.1093/nar/gkm434; Zhao J, 1998, J BIOL CHEM, V273, P6603, DOI 10.1074/jbc.273.12.6603; Zhao J, 1998, BIOCHEMISTRY-US, V37, P6361, DOI 10.1021/bi980218m; Zhou QS, 2000, BLOOD, V95, P2593, DOI 10.1182/blood.V95.8.2593.008k32_2593_2599; Zhou QS, 2002, BLOOD, V99, P4030, DOI 10.1182/blood-2001-12-0271	53	52	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28160	28169		10.1074/jbc.M111.228007	http://dx.doi.org/10.1074/jbc.M111.228007			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21690087	Green Published, hybrid			2022-12-25	WOS:000293557800034
J	Zou, CB; Ellis, BM; Smith, RM; Chen, BB; Zhao, YT; Mallampalli, RK				Zou, Chunbin; Ellis, Bryon M.; Smith, Rebecca M.; Chen, Bill B.; Zhao, Yutong; Mallampalli, Rama K.			Acyl-CoA:Lysophosphatidylcholine Acyltransferase I (Lpcat1) Catalyzes Histone Protein O-Palmitoylation to Regulate mRNA Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLCHOLINE SYNTHESIS; CHROMATIN-STRUCTURE; PHOSPHORYLATION; MAINTENANCE; DROSOPHILA; STABILITY; HORMONE; YEAST; COA	The enzyme acyl-CoA:lysophosphatidylcholine acyltransferase (Lpcat1) is a critical cytosolic enzyme needed for lung surfactant synthesis that catalyzes an acyltransferase reaction by adding a palmitate to the sn-2 position of lysophospholipids. Here we report that histone H4 protein is subject to palmitoylation catalyzed by Lpcat1 in a calcium-regulated manner. Cytosolic Lpcat1 was observed to shift into the nucleus in lung epithelia in response to exogenous Ca2+. Nuclear Lpcat1 colocalizes with and binds to histone H4, where it catalyzes histone H4 palmitoylation. Mutagenesis studies demonstrated that Ser(47) within histone H4 serves as a putative acceptor site, indicative of Lpcat1-mediated O-palmitoylation. Lpcat1 knockdown or expression of a histone H4 Ser(47A) mutant protein in cells decreased cellular mRNA synthesis. These findings provide the first evidence of a protein substrate for Lpcat1 and reveal that histone lipidation may occur through its O-palmitoylation as a novel post-translational modification. This epigenetic modification regulates global gene transcriptional activity.	[Zou, Chunbin] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Acute Lung Injury Ctr Excellence, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Univ Pittsburgh, Dept Cell Biol & Physiol, Pittsburgh, PA 15213 USA; [Mallampalli, Rama K.] Vet Affairs Pittsburgh Healthcare Syst, Med Specialty Serv Line, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Zou, CB (corresponding author), Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Acute Lung Injury Ctr Excellence, BST E1 103,200 Lathrop St, Pittsburgh, PA 15213 USA.	zouc@upmc.edu	Zou, Chunbin/L-7488-2019	Zou, Chunbin/0000-0003-1355-4726	National Institutes of Health [R01 HL096376, HL097376, HL098174]; United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development; United States Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098174, R01HL096376, R01HL097376, R01HL091916] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development(US Department of Veterans Affairs); United States Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL096376, HL097376, and HL098174 (to R. K. M.). This material is based upon work supported, in part, by the United States Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. This work was also supported by a Merit Review Award from the United States Department of Veterans Affairs.	Agassandian M, 2010, FASEB J, V24, P1271, DOI 10.1096/fj.09-136044; Brown E M, 1984, Prog Clin Biol Res, V168, P139; Chamoun Z, 2001, SCIENCE, V293, P2080, DOI 10.1126/science.1064437; Chen BB, 2011, MOL CELL BIOL, V31, P1905, DOI 10.1128/MCB.00723-10; Cheng L, 2009, AM J PHYSIOL-ENDOC M, V297, pE1276, DOI 10.1152/ajpendo.00475.2009; Cooley J, 2008, J LEUKOCYTE BIOL, V83, P946, DOI 10.1189/jlb.1007684; Favale NO, 2010, BBA-MOL CELL BIOL L, V1801, P1184, DOI 10.1016/j.bbalip.2010.07.003; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Hemsley PA, 2008, TRENDS PLANT SCI, V13, P295, DOI 10.1016/j.tplants.2008.04.006; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kotova E, 2011, P NATL ACAD SCI USA, V108, P6205, DOI 10.1073/pnas.1019644108; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mansilla F, 2009, J MOL MED, V87, P85, DOI 10.1007/s00109-008-0409-0; Matsuda S, 2008, GENES CELLS, V13, P879, DOI 10.1111/j.1365-2443.2008.01212.x; Mazzarelli P, 2007, CANCER BIOL THER, V6, P1606, DOI 10.4161/cbt.6.10.4742; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Pszczolkowski MA, 1999, MOL CELL ENDOCRINOL, V158, P163, DOI 10.1016/S0303-7207(99)00167-7; Robzyk K, 2000, SCIENCE, V287, P501, DOI 10.1126/science.287.5452.501; Ryan AJ, 2008, J BIOL CHEM, V283, P24628, DOI 10.1074/jbc.M801167200; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Shin JA, 2005, MOL CELL, V19, P817, DOI 10.1016/j.molcel.2005.08.021; Sorek N, 2009, CURR OPIN PLANT BIOL, V12, P714, DOI 10.1016/j.pbi.2009.09.003; Soupene E, 2008, P NATL ACAD SCI USA, V105, P88, DOI 10.1073/pnas.0709737104; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Wang YM, 2001, CELL, V105, P433, DOI 10.1016/S0092-8674(01)00325-7; Wilson J. P., 2011, MOL CELL PR IN PRESS; Yang J, 2008, CELL, V132, P387, DOI 10.1016/j.cell.2008.01.017; Zempleni J, 2008, NUTR REV, V66, pS46, DOI 10.1111/j.1753-4887.2008.00073.x; Zou CB, 2011, J BIOL CHEM, V286, P2719, DOI 10.1074/jbc.M110.192377	30	57	59	4	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28019	28025		10.1074/jbc.M111.253385	http://dx.doi.org/10.1074/jbc.M111.253385			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685381	hybrid, Green Published			2022-12-25	WOS:000293557800020
J	Qin, W; Sundaram, M; Wang, YW; Zhou, H; Zhong, SM; Chang, CC; Manhas, S; Yao, EF; Parks, RJ; McFie, PJ; Stone, SJ; Jiang, ZHG; Wang, CR; Figeys, D; Jia, WP; Yao, ZM				Qin, Wen; Sundaram, Meenakshi; Wang, Yuwei; Zhou, Hu; Zhong, Shumei; Chang, Chia-Ching; Manhas, Sanjay; Yao, Erik F.; Parks, Robin J.; McFie, Pamela J.; Stone, Scot J.; Jiang, Zhenghui G.; Wang, Congrong; Figeys, Daniel; Jia, Weiping; Yao, Zemin			Missense Mutation in APOC3 within the C-terminal Lipid Binding Domain of Human ApoC-III Results in Impaired Assembly and Secretion of Triacylglycerol-rich Very Low Density Lipoproteins EVIDENCE THAT ApoC-III PLAYS A MAJOR ROLE IN THE FORMATION OF LIPID PRECURSORS WITHIN THE MICROSOMAL LUMEN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; FATTY LIVER-DISEASE; APOLIPOPROTEIN-C; HEPATIC VLDL; INHIBITION; METABOLISM; CELLS; DEFICIENCY; MICROSOMES; FRAGMENTS	Hepatic assembly of triacylglycerol (TAG)-rich very low density lipoproteins (VLDL) is achieved through recruitment of bulk TAG (presumably in the form of lipid droplets within the microsomal lumen) into VLDL precursor containing apolipoprotein (apo) B-100. We determined protein/lipid components of lumenal lipid droplets (LLD) in cells expressing recombinant human apoC-III (C3wt) or a mutant form (K58E, C3KE) initially identified in humans that displayed hypotriglyceridemia. Although expression of C3wt markedly stimulated secretion of TAGand apoB-100 as VLDL1, the K58E mutation (located at the C-terminal lipid binding domain) abolished the effect in transfected McA-RH7777 cells and in apoc3-null mice. Metabolic labeling studies revealed that accumulation of TAG in LLD was decreased (by 50%) in cells expressing C3KE. A Fat Western lipid protein overlay assay showed drastically reduced lipid binding of the mutant protein. Substituting Lys(58) with Arg demonstrated that the positive charge at position 58 is crucial for apoC-III binding to lipid and for promoting TAG secretion. On the other hand, substituting both Lys(58) and Lys(60) with Glu resulted in almost entire elimination of lipid binding and loss of function in promoting TAG secretion. Thus, the lipid binding domain of apoC-III plays a key role in the formation of LLD for hepatic VLDL assembly and secretion.	[Sundaram, Meenakshi; Wang, Yuwei; Zhou, Hu; Zhong, Shumei; Manhas, Sanjay; Yao, Erik F.; Figeys, Daniel; Yao, Zemin] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, Ottawa, ON K1H 8M5, Canada; [Qin, Wen; Wang, Congrong; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai Clin Ctr Diabet,Shanghai Diabet Inst, Shanghai 200233, Peoples R China; [Parks, Robin J.] Ottawa Hosp Res Inst, Ottawa, ON K1H 8L6, Canada; [McFie, Pamela J.; Stone, Scot J.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada; [Chang, Chia-Ching] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan; [Chang, Chia-Ching] Acad Sinica, Inst Phys, Taipei 11529, Taiwan; [Jiang, Zhenghui G.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	University of Ottawa; Shanghai Jiao Tong University; University of Ottawa; Ottawa Hospital Research Institute; University of Saskatchewan; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Boston University	Yao, ZM (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa Inst Syst Biol, 451 Smyth Rd, Ottawa, ON K1H 8M5, Canada.	zyao@uottawa.ca	Jiang, Z. Gordon/U-5256-2017; Chang, Chia-Ching/F-1247-2011; 王, 从容/HDM-0959-2022	Jiang, Z. Gordon/0000-0003-0495-9940; Chang, Chia-Ching/0000-0002-3444-0894; 王, 从容/0000-0002-8645-1114; Figeys, Daniel/0000-0002-5373-7546	Heart and Stroke Foundation of Ontario [NA-7026]; China-Canada Health Research Initiative [CCI 92211, 30811120437]; J.-Louis Levesque Foundation; Shanghai Jiao Tong University	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); China-Canada Health Research Initiative; J.-Louis Levesque Foundation; Shanghai Jiao Tong University	This work was supported by the Heart and Stroke Foundation of Ontario (NA-7026 (to Z. Y.), China-Canada Health Research Initiative Grants CCI 92211 (to Z. Y.), and 30811120437 (to W. J.), and by the J.-Louis Levesque Foundation (to D. F.).; Recipient of Special Funding for Visiting Doctoral Students Program from Shanghai Jiao Tong University.	Athar H, 2004, J LIPID RES, V45, P764, DOI 10.1194/jlr.D300026-JLR200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; CHANG TY, 1981, ANAL BIOCHEM, V116, P298, DOI 10.1016/0003-2697(81)90360-2; DOWLER S, 2002, SCI STKE, P16, DOI DOI 10.1126/STKE.2002.129; Gangabadage CS, 2008, J BIOL CHEM, V283, P17416, DOI 10.1074/jbc.M800756200; GINSBERG HN, 1986, J CLIN INVEST, V78, P1287, DOI 10.1172/JCI112713; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Khalil MB, 2009, J LIPID RES, V50, P47, DOI 10.1194/jlr.M800204-JLR200; Kulinski A, 2002, J BIOL CHEM, V277, P31516, DOI 10.1074/jbc.M202015200; Liu HQ, 2000, BIOCHEMISTRY-US, V39, P9201, DOI 10.1021/bi0009441; McLeod RS, 1996, J BIOL CHEM, V271, P18445, DOI 10.1074/jbc.271.31.18445; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; Pollin TI, 2008, SCIENCE, V322, P1702, DOI 10.1126/science.1161524; Raabe M, 1999, J CLIN INVEST, V103, P1287, DOI 10.1172/JCI6576; Rogers L, 2008, CARDIOVASC RES, V78, P167, DOI 10.1093/cvr/cvn005; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; SEHAYEK E, 1991, J BIOL CHEM, V266, P18259; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SPARROW JT, 1973, P NATL ACAD SCI USA, V70, P2124, DOI 10.1073/pnas.70.7.2124; SPARROW JT, 1977, BIOCHEMISTRY-US, V16, P5427, DOI 10.1021/bi00644a004; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Sundaram M, 2010, J LIPID RES, V51, P150, DOI [10.1194/jlr.M900346-JLR200, 10.1194/M900346-JLR200]; Sundaram M, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-35; Sundaram M, 2010, J LIPID RES, V51, P1524, DOI 10.1194/jlr.M005108; Talmud PJ, 2002, HUM MOL GENET, V11, P3039, DOI 10.1093/hmg/11.24.3039; VANCE DE, 1984, BIOCHIM BIOPHYS ACTA, V792, P39, DOI 10.1016/0005-2760(84)90280-7; VONECKARDSTEIN A, 1991, J CLIN INVEST, V87, P1724, DOI 10.1172/JCI115190; Wang H, 2007, J BIOL CHEM, V282, P33218, DOI 10.1074/jbc.M706841200; Wang YW, 1999, J BIOL CHEM, V274, P27793, DOI 10.1074/jbc.274.39.27793; Zheng CY, 2008, AM J CLIN NUTR, V88, P272, DOI 10.1093/ajcn/88.2.272; Zheng CY, 2007, J LIPID RES, V48, P1190, DOI 10.1194/jlr.P600011-JLR200; Zhong SM, 2010, J BIOL CHEM, V285, P6453, DOI 10.1074/jbc.M109.060467	34	82	85	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27769	27780		10.1074/jbc.M110.203679	http://dx.doi.org/10.1074/jbc.M110.203679			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676879	Green Published, hybrid			2022-12-25	WOS:000293268700069
J	Cai, J; Wu, L; Qi, XP; Calzi, SL; Caballero, S; Shaw, L; Ruan, Q; Grant, MB; Boulton, ME				Cai, Jun; Wu, Lin; Qi, Xiaoping; Calzi, Sergio Li; Caballero, Sergio; Shaw, Lynn; Ruan, Qing; Grant, Maria B.; Boulton, Michael E.			PEDF Regulates Vascular Permeability by a gamma-Secretase-Mediated Pathway	PLOS ONE			English	Article							EPITHELIUM-DERIVED-FACTOR; ENDOTHELIAL-GROWTH-FACTOR; BLOOD-RETINAL BARRIER; INTRAVITREAL BEVACIZUMAB AVASTIN; HYPOXIC-ISCHEMIC CONDITIONS; DIABETIC MACULAR EDEMA; ADHERENS JUNCTIONS; TIGHT JUNCTIONS; VE-CADHERIN; EYE DISEASE	Increased vascular permeability is an inciting event in many vascular complications including diabetic retinopathy. We have previously reported that pigment epithelium-derived factor (PEDF) is able to inhibit vascular endothelial growth factor (VEGF)-induced angiogenesis through a novel gamma-secretase-dependent pathway. In this study, we asked whether inhibition of VEGF-induced permeability by PEDF is also gamma-secretase-mediated and to dissect the potential mechanisms involved. Vascular permeability was assessed in vitro by measuring transendothelial resistance and paracellular permeability to dextran and in vivo by following leakage of intravenous FITC-labelled albumin into the retina in the presence or absence of VEGF and PEDF in varying combinations. Experiments were undertaken in the presence or absence of a gamma-secretase inhibitor. To assess junctional integrity immunohistochemistry for the adherens junction (AJ) proteins, VE-cadherin and beta-catenin, and the tight junction (TJ) protein, claudin-5 was undertaken using cultured cells and flat mount retinas. Protein expression and the association between AJ proteins, VEGF receptors (VEGFRs) and c-secretase constituents were determined by immunoprecipitation and Western Blot analysis. In selected experiments the effect of hypoxia on junctional integrity was also assessed. PEDF inhibition of VEGF-induced permeability, both in cultured microvascular endothelial cell monolayers and in vivo in the mouse retinal vasculature, is mediated by c-secretase. PEDF acted by a) preventing dissociation of AJ and TJ proteins and b) regulating both the association of VEGF receptors with AJ proteins and the subsequent phosphorylation of the AJ proteins, VE-cadherin and b-catenin. Association of c-secretase with AJ proteins appears to be critical in the regulation of vascular permeability. Although hypoxia increased VEGFR expression there was a significant dissociation of VEGFR from AJ proteins. In conclusion, PEDF regulates VEGF-induced vascular permeability via a novel c-secretase dependent pathway and targeting downstream effectors of PEDF action may represent a promising therapeutic strategy for preventing or ameliorating increased vascular permeability.	[Cai, Jun; Wu, Lin; Qi, Xiaoping; Ruan, Qing; Boulton, Michael E.] Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA; [Calzi, Sergio Li; Caballero, Sergio; Shaw, Lynn; Grant, Maria B.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Cai, J (corresponding author), Univ Florida, Dept Anat & Cell Biol, Gainesville, FL 32611 USA.	meboulton@ufl.edu		WU, LIN/0000-0001-9642-223X	National Institutes of Health [EY018358, EY012601, EY007739]; NATIONAL EYE INSTITUTE [R01EY012601, R01EY007739, P30EY021721, R01EY018358, R29EY007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090730] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants EY018358 (Boulton) and EY012601, EY007739 (Grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablonczy Z, 2009, J BIOL CHEM, V284, P30177, DOI 10.1074/jbc.M109.032391; Aiello LP, 1997, DIABETES, V46, P1473, DOI 10.2337/diabetes.46.9.1473; Antonetti D A, 1999, Semin Ophthalmol, V14, P240, DOI 10.3109/08820539909069543; Avery RL, 2006, OPHTHALMOLOGY, V113, P1695, DOI 10.1016/j.ophtha.2006.05.064; Banumathi E, 2010, EXP EYE RES, V90, P89, DOI 10.1016/j.exer.2009.09.014; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; BOULTON M, 1994, EXP EYE RES, V59, P243, DOI 10.1006/exer.1994.1104; Boulton ME, 2008, J CELL MOL MED, V12, P781, DOI 10.1111/j.1582-4934.2008.00274.x; Cai J, 2006, MICROVASC RES, V71, P20, DOI 10.1016/j.mvr.2005.10.004; Cai J, 2006, J BIOL CHEM, V281, P3604, DOI 10.1074/jbc.M507401200; Cai J, 2002, EYE, V16, P242, DOI 10.1038/sj.eye.6700133; Cai J, 2006, CLIN CANCER RES, V12, P3510, DOI 10.1158/1078-0432.CCR-06-0094; Cai J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018076; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Fanning AS, 2009, ANN NY ACAD SCI, V1165, P113, DOI 10.1111/j.1749-6632.2009.04440.x; Ferrara N, 2005, ROLE VEGF REGULATION, P209; Funatsu H, 2006, OPHTHALMOLOGY, V113, P294, DOI 10.1016/j.ophtha.2005.10.030; Gavard J, 2009, FEBS LETT, V583, P1, DOI 10.1016/j.febslet.2008.11.032; Grant MB, 2004, EXPERT OPIN INV DRUG, V13, P1275, DOI 10.1517/13543784.13.10.1275; Haritoglou C, 2006, RETINA-J RET VIT DIS, V26, P999, DOI 10.1097/01.iae.0000247165.38655.bf; Ideno J, 2007, INT J MOL MED, V19, P75; Ishida S, 2003, INVEST OPHTH VIS SCI, V44, P2155, DOI 10.1167/iovs.02-0807; Jorge R, 2006, RETINA-J RET VIT DIS, V26, P1006, DOI 10.1097/01.iae.0000246884.76018.63; Kaur C, 2008, CURR NEUROVASC RES, V5, P71, DOI 10.2174/156720208783565645; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kawaguchi T, 2010, CURR MOL MED, V10, P302, DOI 10.2174/156652410791065255; Koyanagi S, 2003, CANCER RES, V63, P7277; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; Marambaud P, 2002, EMBO J, V21, P1948, DOI 10.1093/emboj/21.8.1948; Monaghan-Benson E, 2009, J BIOL CHEM, V284, P25602, DOI 10.1074/jbc.M109.009894; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Navaratna D, 2007, DIABETES, V56, P2380, DOI 10.2337/db06-1694; Parisiadou L, 2004, NEURODEGENER DIS, V1, P184, DOI 10.1159/000080984; Park K, 2011, AM J PATHOL, V178, P688, DOI 10.1016/j.ajpath.2010.10.014; Patel JI, 2006, EXP EYE RES, V82, P798, DOI 10.1016/j.exer.2005.10.002; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Qaum T, 2001, INVEST OPHTH VIS SCI, V42, P2408; Rahimi N, 2006, FRONT BIOSCI-LANDMRK, V11, P818; Raisler BJ, 2002, P NATL ACAD SCI USA, V99, P8909, DOI 10.1073/pnas.122247299; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Sheikpranbabu S, 2010, BIOCHIMIE, V92, P1040, DOI 10.1016/j.biochi.2010.05.004; Sheikpranbabu S, 2010, VASC PHARMACOL, V52, P84, DOI 10.1016/j.vph.2009.12.002; Skondra D, 2008, INVEST OPHTH VIS SCI, V49, P726, DOI 10.1167/iovs.07-0405; Spranger J, 2001, DIABETES, V50, P2641, DOI 10.2337/diabetes.50.12.2641; Starita Carla, 2007, Dev Ophthalmol, V39, P122, DOI 10.1159/000098504; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; Tombran-Tink J, 2010, CURR MOL MED, V10, P267, DOI 10.2174/156652410791065336; Ueda S, 2010, CURR MOL MED, V10, P279, DOI 10.2174/156652410791065291; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Weis SM, 2008, CURR OPIN HEMATOL, V15, P243, DOI 10.1097/MOH.0b013e3282f97d86; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Witmer AN, 2003, PROG RETIN EYE RES, V22, P1, DOI 10.1016/S1350-9462(02)00043-5; Yamagishi S, 2007, J INT MED RES, V35, P896, DOI 10.1177/147323000703500619; Yamagishi S, 2006, J BIOL CHEM, V281, P20213, DOI 10.1074/jbc.M602110200; Yang JL, 2010, INVEST OPHTH VIS SCI, V51, P3273, DOI 10.1167/iovs.08-2878; Zhang SX, 2006, J MOL ENDOCRINOL, V37, P1, DOI 10.1677/jme.1.02008; Zhang SX, 2006, FASEB J, V20, P323, DOI 10.1096/fj.05-4313fje	65	55	58	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21164	10.1371/journal.pone.0021164	http://dx.doi.org/10.1371/journal.pone.0021164			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695048	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600049
J	Duttagupta, R; Jiang, R; Gollub, J; Getts, RC; Jones, KW				Duttagupta, Radha; Jiang, Rong; Gollub, Jeremy; Getts, Robert C.; Jones, Keith W.			Impact of Cellular miRNAs on Circulating miRNA Biomarker Signatures	PLOS ONE			English	Article							MICRORNA EXPRESSION; CANCER; PATTERNS; SERUM; DIAGNOSIS; MIRBASE; RNAS	Effective diagnosis and surveillance of complex multi-factorial disorders such as cancer can be improved by screening of easily accessible biomarkers. Highly stable cell free Circulating Nucleic Acids (CNA) present as both RNA and DNA species have been discovered in the blood and plasma of humans. Correlations between tumor-associated genomic/epigenetic/ transcriptional changes and alterations in CNA levels are strong predictors of the utility of this biomarker class as promising clinical indicators. Towards this goal microRNAs (miRNAs) representing a class of naturally occurring small non-coding RNAs of 19-25 nt in length have emerged as an important set of markers that can associate their specific expression profiles with cancer development. In this study we investigate some of the pre-analytic considerations for isolating plasma fractions for the study of miRNA biomarkers. We find that measurement of circulating miRNA levels are frequently confounded by varying levels of cellular miRNAs of different hematopoietic origins. In order to assess the relative proportions of this cell-derived class, we have fractionated whole blood into plasma and its ensuing sub-fractions. Cellular miRNA signatures in cohorts of normal individuals are catalogued and the abundance and gender specific expression of bona fide circulating markers explored after calibrating the signal for this interfering class. A map of differentially expressed profiles is presented and the intrinsic variability of circulating miRNA species investigated in subsets of healthy males and females.	[Duttagupta, Radha; Jiang, Rong; Gollub, Jeremy; Jones, Keith W.] Affymetrix Inc, Appl Res, Santa Clara, CA USA; [Getts, Robert C.] Genisphere LLC, Res & Dev, Hatfield, PA USA	Affymetrix	Duttagupta, R (corresponding author), Affymetrix Inc, Appl Res, Santa Clara, CA USA.	Keith_Jones@affymetrix.com			Affymetrix Inc	Affymetrix Inc	Support for this work was provided by Affymetrix Inc which employs all authors (with the exception of RCG who is an employee of Genisphere LLC). Genisphere LLC contributed the resources for the generation of the Leukocytic dataset. Affymetrix contributed all other resources necessary for the development of the presented methods and conclusions and played a role in study design, data collection, analysis and decision to publish.	Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chiu RWK, 2001, CLIN CHEM, V47, P1607; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hsu SD, 2008, NUCLEIC ACIDS RES, V36, pD165, DOI 10.1093/nar/gkm1012; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Jima DD, 2010, BLOOD, V116, pE118, DOI 10.1182/blood-2010-05-285403; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lawrie CH, 2008, BRIT J HAEMATOL, V141, P672, DOI 10.1111/j.1365-2141.2008.07077.x; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SC, 2010, ORAL ONCOL, V46, P204, DOI 10.1016/j.oraloncology.2009.12.005; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Reid G., 2010, CRIT REV ONCOL HEMAT, DOI 10,1016/j.critrevonc.,2010.11.004; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van der Vaart M, 2007, CLIN CHEM, V53, P2215, DOI 10.1373/clinchem.2007.092734; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Willingham AT, 2006, CELL, V125, P1215, DOI 10.1016/j.cell.2006.06.009; Zhang Wei, 2009, In Silico Biology, V9, P55, DOI 10.3233/ISB-2009-0387	32	242	258	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20769	10.1371/journal.pone.0020769	http://dx.doi.org/10.1371/journal.pone.0020769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698099	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600016
J	Li, X; Li, CQ; Shang, DS; Li, J; Han, JW; Miao, YB; Wang, Y; Wang, QH; Li, W; Wu, C; Zhang, YP; Li, X; Yao, QL				Li, Xia; Li, Chunquan; Shang, Desi; Li, Jing; Han, Junwei; Miao, Yingbo; Wang, Yan; Wang, Qianghu; Li, Wei; Wu, Chao; Zhang, Yunpeng; Li, Xiang; Yao, Qianlan			The Implications of Relationships between Human Diseases and Metabolic Subpathways	PLOS ONE			English	Article							TOPOLOGICAL FEATURES; HOUSEKEEPING GENES; NETWORK BIOLOGY; EXPRESSION; DATABASE; MODULARITY; PATHWAYS; PROTEINS; GENOMICS; TARGET	One of the challenging problems in the etiology of diseases is to explore the relationships between initiation and progression of diseases and abnormalities in local regions of metabolic pathways. To gain insight into such relationships, we applied the "k-clique" subpathway identification method to all disease-related gene sets. For each disease, the disease risk regions of metabolic pathways were then identified and considered as subpathways associated with the disease. We finally built a disease-metabolic subpathway network (DMSPN). Through analyses based on network biology, we found that a few subpathways, such as that of cytochrome P450, were highly connected with many diseases, and most belonged to fundamental metabolisms, suggesting that abnormalities of fundamental metabolic processes tend to cause more types of diseases. According to the categories of diseases and subpathways, we tested the clustering phenomenon of diseases and metabolic subpathways in the DMSPN. The results showed that both disease nodes and subpathway nodes displayed slight clustering phenomenon. We also tested correlations between network topology and genes within disease-related metabolic subpathways, and found that within a disease-related subpathway in the DMSPN, the ratio of disease genes and the ratio of tissue-specific genes significantly increased as the number of diseases caused by the subpathway increased. Surprisingly, the ratio of essential genes significantly decreased and the ratio of housekeeping genes remained relatively unchanged. Furthermore, the coexpression levels between disease genes and other types of genes were calculated for each subpathway in the DMSPN. The results indicated that those genes intensely influenced by disease genes, including essential genes and tissue-specific genes, might be significantly associated with the disease diversity of subpathways, suggesting that different kinds of genes within a disease-related subpathway may play significantly differential roles on the diversity of diseases caused by the corresponding subpathway.	[Li, Xia; Li, Chunquan; Shang, Desi; Li, Jing; Han, Junwei; Wang, Yan; Wang, Qianghu; Li, Wei; Wu, Chao; Zhang, Yunpeng; Li, Xiang; Yao, Qianlan] Harbin Med Univ, Biopharmaceut Key Lab Heilongjiang Prov, Harbin, Peoples R China; [Li, Xia; Li, Chunquan; Shang, Desi; Li, Jing; Han, Junwei; Wang, Yan; Wang, Qianghu; Li, Wei; Wu, Chao; Zhang, Yunpeng; Li, Xiang; Yao, Qianlan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Miao, Yingbo] Nankai Univ, Coll Pharm, Tianjin 300071, Peoples R China	Harbin Medical University; Harbin Medical University; Nankai University	Li, X (corresponding author), Harbin Med Univ, Biopharmaceut Key Lab Heilongjiang Prov, Harbin, Peoples R China.	lixia@hrbmu.edu.cn	Li, Chunquan/AAI-1072-2020; Han, Junwei/T-9849-2018; li, xia/HHZ-7468-2022	Li, Chunquan/0000-0002-4700-5496; Han, Junwei/0000-0002-3276-0819; qianlan, yao/0000-0003-0737-4147	National Natural Science Foundation of China [30871394, 61073136, 91029717]; National Science Foundation of Heilongjiang Province [ZJG0501, 1055HG009, GB03C602-4, BMFH060044]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20102307120027, 20102307110022]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Heilongjiang Province; Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported in part by the National Natural Science Foundation of China (Grant Nos. 30871394, 61073136 and 91029717), the National Science Foundation of Heilongjiang Province (Grant Nos. ZJG0501, 1055HG009, GB03C602-4, and BMFH060044), and the Specialized Research Fund for the Doctoral Program of Higher Education of China (Grant Nos. 20102307120027, and 20102307110022). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2004, BIOINFORMATICS, V20, P578, DOI 10.1093/bioinformatics/btg455; Antonov AV, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r179; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Beloqui A, 2009, SCIENCE, V326, P252, DOI 10.1126/science.1174094; Binetti R, 2001, Epidemiol Prev, V25, P31; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Braun P, 2008, P NATL ACAD SCI USA, V105, P9849, DOI 10.1073/pnas.0805644105; Cicero AFG, 2007, CLIN INTERV AGING, V2, P73, DOI 10.2147/ciia.2007.2.1.73; Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9; Das UN, 2008, LIPIDS HEALTH DIS, V7, DOI 10.1186/1476-511X-7-37; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Ge XJ, 2005, GENOMICS, V86, P127, DOI 10.1016/j.ygeno.2005.04.008; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gohlke JM, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-46; Guengerich F Peter, 2003, Mol Interv, V3, P194, DOI 10.1124/mi.3.4.194; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Han JDJ, 2008, CELL RES, V18, P224, DOI 10.1038/cr.2008.16; Hatzimanikatis V, 2004, CURR OPIN STRUC BIOL, V14, P300, DOI 10.1016/j.sbi.2004.04.004; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jiang XP, 2008, FEBS LETT, V582, P2549, DOI 10.1016/j.febslet.2008.06.023; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Khatri P, 2005, NUCLEIC ACIDS RES, V33, pW762, DOI 10.1093/nar/gki472; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Li CQ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp667; Li X, 2004, NUCLEIC ACIDS RES, V32, P2685, DOI 10.1093/nar/gkh563; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Liu X, 2009, CURR CANCER DRUG TAR, V9, P938, DOI 10.2174/156800909790192374; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Oti M, 2007, CLIN GENET, V71, P1, DOI 10.1111/j.1399-0004.2006.00708.x; Papin JA, 2004, TRENDS BIOCHEM SCI, V29, P641, DOI 10.1016/j.tibs.2004.10.001; Park JY, 2007, P NATL ACAD SCI USA, V104, P17916, DOI 10.1073/pnas.0705081104; Renfrow MB, 2007, ANAL BIOANAL CHEM, V389, P1397, DOI 10.1007/s00216-007-1500-z; Russo S, 2003, PSYCHOSOM MED, V65, P665, DOI 10.1097/01.PSY.0000078188.74020.CC; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; She XW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-269; Steinman Lawrence, 2006, Proc Am Thorac Soc, V3, P484, DOI 10.1513/pats.200603-061MS; Ten S, 2001, J CLIN ENDOCR METAB, V86, P2909, DOI 10.1210/jc.86.7.2909; Tiffin N, 2009, GENOME MED, V1, DOI 10.1186/gm77; Tu ZD, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-31; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004	53	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21131	10.1371/journal.pone.0021131	http://dx.doi.org/10.1371/journal.pone.0021131			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695054	gold, Green Published, Green Submitted			2022-12-25	WOS:000291737600046
J	Ma, XC; Jiang, D; Jiang, WH; Wang, F; Jia, M; Wu, J; Hashimoto, K; Dang, YH; Gao, CG				Ma, Xian-cang; Jiang, Dong; Jiang, Wen-hui; Wang, Fen; Jia, Min; Wu, Jin; Hashimoto, Kenji; Dang, Yong-hui; Gao, Cheng-ge			Social Isolation-Induced Aggression Potentiates Anxiety and Depressive-Like Behavior in Male Mice Subjected to Unpredictable Chronic Mild Stress	PLOS ONE			English	Article							TAIL-SUSPENSION TEST; NATIONAL-COMORBIDITY-SURVEY; MOLECULAR CLOCK GENES; MOOD DISORDERS; NEUROTROPHIC FACTOR; ANTIDEPRESSANT-LIKE; ANIMAL-MODELS; LIFE EVENTS; CIRCADIAN ABNORMALITIES; INDUCED ANHEDONIA	Background: Accumulating epidemiological evidence shows that life event stressors are major vulnerability factors for psychiatric diseases such as major depression. It is also well known that social isolation in male mice results in aggressive behavior. However, it is not known how social isolation-induced aggression affects anxiety and depressive-like behavior in isolated male mice subjected to unpredictable chronic mild stress (CMS), an animal model of depression. Methodology/Principal Findings: C57/B6 male mice were divided into 3 groups; non-stressed controls, in Group I; isolated mice subjected to the CMS protocol in Group II and aggression by physical contact in socially isolated mice subjected to the CMS protocol in Group III. In the sucrose intake test, ingestion of a 1% sucrose solution by mice in Groups II and III was significantly lower than in Group I. Furthermore, intake of this solution in Group III mice was significantly lower than in Group II mice. In the open field test, mice in Group III, showed reduced locomotor activity and reduced entry and retention time in the central zone, compared to Groups I and II mice. Moreover, the distances moved in 1 hour by Group III mice did not differ between night and morning. In the light/black box test, Groups II and III animals spent significantly less time in the light box compared to Group I animals. In the tail suspension test (TST) and forced swimming test (FST), the immobility times of Group II and Group III mice were significantly longer than in Group I mice. In addition, immobility times in the FST were significantly longer in Group III than in Group II mice. Conclusions/Significance: These findings show that social isolation-induced aggression could potentiate anxiety and depressive -like behaviors in isolated male mice subjected to CMS.	[Ma, Xian-cang; Jiang, Dong; Jiang, Wen-hui; Wang, Fen; Jia, Min; Hashimoto, Kenji; Gao, Cheng-ge] Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Psychiat, Xian 710049, Peoples R China; [Wu, Jin; Hashimoto, Kenji] Chiba Univ, Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan; [Dang, Yong-hui] Xi An Jiao Tong Univ, Key Lab Hlth Minist Forens Med, Key Lab Environm & Genes Related Dis, Educ Minist,Sch Med,Dept Forens Med, Xian 710049, Peoples R China	Xi'an Jiaotong University; Chiba University; Xi'an Jiaotong University	Gao, CG (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Coll Med, Dept Psychiat, Xian 710049, Peoples R China.	psydyh@mail.xjtu.edu.cn; yaogaow@163.com	jiang, wen/GYI-9662-2022; Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	National Natural Science Foundation of China [30700261, 30870887]; Ministry of Science and Technology of China [2009DFA31080]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	The project was supported by the National Natural Science Foundation of China (No. 30700261 and No. 30870887) and the Ministry of Science and Technology of China (No. 2009DFA31080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai F, 2001, PHARMACOL BIOCHEM BE, V70, P187, DOI 10.1016/S0091-3057(01)00599-8; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bibancos T, 2007, GENES BRAIN BEHAV, V6, P529, DOI 10.1111/j.1601-183X.2006.00280.x; BRUCE ML, 1992, AM J PSYCHIAT, V149, P914; Bunney JN, 2008, BRIT MED BULL, V86, P23, DOI 10.1093/bmb/ldn019; Bunney WE, 2000, NEUROPSYCHOPHARMACOL, V22, P335, DOI 10.1016/S0893-133X(99)00145-1; CRUSIO WE, 1987, BEHAV BRAIN RES, V26, P153, DOI 10.1016/0166-4328(87)90163-X; Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825; Cryan JF, 2005, NEUROSCI BIOBEHAV R, V29, P571, DOI 10.1016/j.neubiorev.2005.03.009; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; EICHELMAN BS, 1990, ANNU REV MED, V41, P149; FAWCETT J, 1983, ARCH GEN PSYCHIAT, V40, P79; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Gotlib IH, 2008, BIOL PSYCHIAT, V63, P847, DOI 10.1016/j.biopsych.2007.10.008; Hashimoto K, 2004, BRAIN RES REV, V45, P104, DOI 10.1016/j.brainresrev.2004.02.003; Hashimoto K, 2011, EXPERT REV NEUROTHER, V11, P33, DOI 10.1586/ERN.10.176; Hashimoto K, 2010, PSYCHIAT CLIN NEUROS, V64, P341, DOI 10.1111/j.1440-1819.2010.02113.x; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Hatzinger M, 2000, World J Biol Psychiatry, V1, P105, DOI 10.3109/15622970009150573; Holsboer F, 2001, J AFFECT DISORDERS, V62, P77, DOI 10.1016/S0165-0327(00)00352-9; KATZ RJ, 1982, PHARMACOL BIOCHEM BE, V16, P965, DOI 10.1016/0091-3057(82)90053-3; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P231, DOI 10.1016/0149-7634(81)90004-X; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kessler RC, 1997, ANNU REV PSYCHOL, V48, P191, DOI 10.1146/annurev.psych.48.1.191; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; KLEIN DF, 1974, ARCH GEN PSYCHIAT, V31, P447; Koizumi H, 2006, EUR J NEUROSCI, V24, P2335, DOI 10.1111/j.1460-9568.2006.05094.x; Li NX, 2011, BIOL PSYCHIAT, V69, P754, DOI 10.1016/j.biopsych.2010.12.015; Liu XQ, 2001, BIOL PSYCHIAT, V49, P575, DOI 10.1016/S0006-3223(00)01028-3; Malick J B, 1979, Curr Dev Psychopharmacol, V5, P1; MONLEON S, 1995, PSYCHOPHARMACOLOGY, V117, P453, DOI 10.1007/BF02246218; Mormede C, 2002, NEUROIMMUNOMODULAT, V10, P359, DOI 10.1159/000071477; Nemeroff Charles B, 2007, Expert Rev Neurother, V7, pS11, DOI 10.1586/14737175.7.11s.S11; Nestler EJ, 2002, NEURON, V34, P13, DOI 10.1016/S0896-6273(02)00653-0; Nestler EJ, 2002, BIOL PSYCHIAT, V52, P503, DOI 10.1016/S0006-3223(02)01405-1; Paykel ES, 2003, ACTA PSYCHIAT SCAND, V108, P61, DOI 10.1034/j.1600-0447.108.s418.13.x; PEARLIN LI, 1977, AM SOCIOL REV, V42, P704, DOI 10.2307/2094860; Peng WH, 2007, LIFE SCI, V81, P933, DOI 10.1016/j.lfs.2007.08.003; Phillips AG, 1997, PSYCHOPHARMACOLOGY, V134, P361, DOI 10.1007/s002130050469; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Ripoll N, 2003, BEHAV BRAIN RES, V143, P193, DOI 10.1016/S0166-4328(03)00034-2; Sanchez C, 1997, PSYCHOPHARMACOLOGY, V129, P197, DOI 10.1007/s002130050181; SANCHEZ C, 1993, PSYCHOPHARMACOLOGY, V110, P53, DOI 10.1007/BF02246950; Skolnick P, 2009, TRENDS PHARMACOL SCI, V30, P563, DOI 10.1016/j.tips.2009.09.002; Strekalova T, 2006, BEHAV PHARMACOL, V17, P271, DOI 10.1097/00008877-200605000-00008; TOKITA K, 2011, PHARM BIOCH IN PRESS; VALZELLI L, 1985, METHOD FIND EXP CLIN, V4, P189; WILLNER P, 1984, PSYCHOPHARMACOLOGY, V83, P1, DOI 10.1007/BF00427414; Willner P, 2005, NEUROPSYCHOBIOLOGY, V52, P90, DOI 10.1159/000087097; Willner P, 1997, PSYCHOPHARMACOLOGY, V134, P319, DOI 10.1007/s002130050456; WILLNER P, 1992, NEUROSCI BIOBEHAV R, V16, P525, DOI 10.1016/S0149-7634(05)80194-0; YOSHIKAWA T, 2000, GENEME RES, V357, P357; Zarate C, 2010, HARVARD REV PSYCHIAT, V18, P293, DOI 10.3109/10673229.2010.511059; Zomkowski ADE, 2006, PROG NEURO-PSYCHOPH, V30, P1419, DOI 10.1016/j.pnpbp.2006.05.016	56	80	90	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20955	10.1371/journal.pone.0020955	http://dx.doi.org/10.1371/journal.pone.0020955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698062	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600034
J	Carrol, ED; Mankhambo, LA; Guiver, M; Banda, DL; Denis, B; Dove, W; Jeffers, G; Molyneux, EM; Molyneux, ME; Hart, CA; Graham, SM				Carrol, Enitan D.; Mankhambo, Limangeni A.; Guiver, Malcolm; Banda, Daniel L.; Denis, Brigitte; Dove, Winifred; Jeffers, Graham; Molyneux, Elizabeth M.; Molyneux, Malcolm E.; Hart, C. Anthony; Graham, Stephen M.		IPD Study Grp	PCR Improves Diagnostic Yield from Lung Aspiration in Malawian Children with Radiologically Confirmed Pneumonia	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; COMMUNITY-ACQUIRED PNEUMONIA; TRANSTHORACIC NEEDLE ASPIRATION; INVASIVE PNEUMOCOCCAL DISEASE; SEQUENTIAL MULTIPLEX PCR; REAL-TIME PCR; HUMAN BOCAVIRUS; CHILDHOOD PNEUMONIA; SYNCYTIAL-VIRUS; HUMAN METAPNEUMOVIRUS	Background: Accurate data on childhood pneumonia aetiology are essential especially from regions where mortality is high, in order to inform case-management guidelines and the potential of prevention strategies such as bacterial conjugate vaccines. Yield from blood culture is low, but lung aspirate culture provides a higher diagnostic yield. We aimed to determine if diagnostic yield could be increased further by polymerase chain reaction (PCR) detection of bacteria (Streptococcus pneumoniae and Haemophilus influenzae b) and viruses in lung aspirate fluid. Methods: A total of 95 children with radiological focal, lobar or segmental consolidation had lung aspirate performed and sent for bacterial culture and for PCR for detection of bacteria, viruses and Pneumocystis jirovecii. In children with a pneumococcal aetiology, pneumococcal bacterial loads were calculated in blood and lung aspirate fluid. Results: Blood culture identified a bacterial pathogen in only 8 patients (8%). With the addition of PCR on lung aspirate samples, causative pathogens (bacterial, viral, pneumocystis) were identified singly or as co-infections in 59 children (62%). The commonest bacterial organism was S. pneumoniae (41%), followed by H. influenzae b (6%), and the commonest virus identified was adenovirus (16%), followed by human bocavirus (HBoV) (4%), either as single or co-infection. Conclusions: In a select group of African children, lung aspirate PCR significantly improves diagnostic yield. Our study confirms a major role of S. pneumoniae and viruses in the aetiology of childhood pneumonia in Africa.	[Carrol, Enitan D.; Jeffers, Graham] Univ Liverpool, Inst Child Hlth, Alder Hey Childrens NHS Fdn Trust, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England; [Carrol, Enitan D.; Mankhambo, Limangeni A.; Banda, Daniel L.; Denis, Brigitte; Molyneux, Malcolm E.; Graham, Stephen M.; IPD Study Grp] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Programm, Blantyre, Malawi; [Mankhambo, Limangeni A.; Molyneux, Elizabeth M.] Univ Malawi, Coll Med, Dept Paediat, Blantyre, Malawi; [Guiver, Malcolm] Hlth Protect Agcy, Hlth Protect Agcy NW, Manchester, Lancs, England; [Dove, Winifred; Hart, C. Anthony] Univ Liverpool, Dept Clin Infect Microbiol & Immunol, Liverpool L69 3BX, Merseyside, England; [Graham, Stephen M.] Univ Melbourne, Dept Paediat, Ctr Int Child Hlth, Melbourne, Vic, Australia; [Graham, Stephen M.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Vic, Australia	Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Malawi; University of Malawi; Health Protection Agency; University of Liverpool; University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne	Carrol, ED (corresponding author), Univ Liverpool, Inst Child Hlth, Alder Hey Childrens NHS Fdn Trust, Dept Womens & Childrens Hlth, Liverpool L69 3BX, Merseyside, England.	edcarrol@liv.ac.uk		Carrol, Enitan/0000-0001-8357-7726; Graham, Stephen/0000-0003-3525-2294	Wellcome Trust [068026, 074124/Z/04/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Career Development Fellowship (Grant No. 068026) to EDC. SMG and MEM were recipients of Wellcome Trust funding (core grant 074124/Z/04/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2000, ANN TROP MED PARASIT, V94, P197, DOI 10.1080/00034980050006366; Allander T, 2007, CLIN INFECT DIS, V44, P904, DOI 10.1086/512196; Berkley JA, 2010, JAMA-J AM MED ASSOC, V303, P2051, DOI 10.1001/jama.2010.675; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Cane PA, 2003, BONE MARROW TRANSPL, V31, P309, DOI 10.1038/sj.bmt.1703849; Carrol ED, 2007, PEDIATR INFECT DIS J, V26, P416, DOI 10.1097/01.inf.0000260253.22994.61; Carrol ED, 2007, JAIDS-J ACQ IMM DEF, V44, P443, DOI 10.1097/QAI.0b013e31802f8390; Carrol ED, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006621; Choi EH, 2006, CLIN INFECT DIS, V43, P585, DOI 10.1086/506350; Corless CE, 2001, J CLIN MICROBIOL, V39, P1553, DOI 10.1128/JCM.39.4.1553-1558.2001; Couroucli XI, 2000, PEDIATR RES, V47, P225, DOI 10.1203/00006450-200002000-00013; Don M, 2010, PEDIATR PULM, V45, P120, DOI 10.1002/ppul.21151; Findlow H, 2009, CLIN VACCINE IMMUNOL, V16, P222, DOI 10.1128/CVI.00292-08; Fry AM, 2007, J INFECT DIS, V195, P1038, DOI 10.1086/512163; Garcia A, 1999, J CLIN MICROBIOL, V37, P709; Graham SM, 2008, B WORLD HEALTH ORGAN, V86, P349, DOI 10.2471/BLT.07.048512; Graham SM, 2011, PEDIATR INFECT DIS J, V30, P33, DOI 10.1097/INF.0b013e3181fcabe4; Greensill J, 2003, EMERG INFECT DIS, V9, P372, DOI 10.3201/eid0903.020289; Guiver M, 2001, TRANSPLANTATION, V71, P1609, DOI 10.1097/00007890-200106150-00021; Kaplan NM, 2008, J MED VIROL, V80, P168, DOI 10.1002/jmv.21067; Kaplan NM, 2006, EMERG INFECT DIS, V12, P1418, DOI 10.3201/eid1209.060417; Lahti E, 2009, THORAX, V64, P252, DOI 10.1136/thx.2008.099051; Madhi SA, 2000, J PEDIATR-US, V137, P78, DOI 10.1067/mpd.2000.105350; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; Morais L, 2007, J MED MICROBIOL, V56, P1181, DOI 10.1099/jmm.0.47346-0; Naghipour M, 2007, J MED VIROL, V79, P539, DOI 10.1002/jmv.20815; OCALLAGHANGORDO C, 2011, PEDIAT INFE IN PRESS; Payton A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-28; Saha SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003576; Schildgen O, 2008, CLIN MICROBIOL REV, V21, P291, DOI 10.1128/CMR.00030-07; Schuchat Anne, 2004, Semin Pediatr Infect Dis, V15, P181, DOI 10.1053/j.spid.2004.05.010; Scott JAG, 1999, CHEST, V116, P1716, DOI 10.1378/chest.116.6.1716; SIVIT CJ, 1995, PEDIATR RADIOL, V25, P389, DOI 10.1007/BF02021718; Stein RT, 2007, PEDIATR PULM, V42, P1095, DOI 10.1002/ppul.20652; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024; Volz S, 2007, J CLIN VIROL, V40, P229, DOI 10.1016/j.jcv.2007.07.017; Vuori-Holopainen E, 2002, CLIN INFECT DIS, V34, P583, DOI 10.1086/338642; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Yomo A, 1997, ANN TROP PAEDIATR, V17, P239, DOI 10.1080/02724936.1997.11747894	40	34	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21042	10.1371/journal.pone.0021042	http://dx.doi.org/10.1371/journal.pone.0021042			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695128	Green Published, gold			2022-12-25	WOS:000291682300027
J	Gigley, JP; Khan, IA				Gigley, Jason P.; Khan, Imtiaz A.			Plasmacytoid DC from Aged Mice Down-Regulate CD8 T Cell Responses by Inhibiting cDC Maturation after Encephalitozoon cuniculi Infection	PLOS ONE			English	Article							DENDRITIC CELLS; TOXOPLASMA-GONDII; LYMPH-NODES; IN-VIVO; IMMUNITY; VIRUS; MICROSPORIDIOSIS; PHENOTYPE; PATHWAY; ANTIGEN	Age associated impairment of immune function results in inefficient vaccination, tumor surveillance and increased severity of infections. Several alterations in adaptive immunity have been observed and recent studies report age related declines in innate immune responses to opportunistic pathogens including Encephalitozoon cuniculi. We previously demonstrated that conventional dendritic cells (cDC) from 9-month-old animals exhibit sub-optimal response to E. cuniculi infection, suggesting that age associated immune senescence begins earlier than expected. We focused this study on how age affects plasmacytoid DC (pDC) function. More specifically how aged pDC affect cDC function as we observed that the latter are the predominant activators of CD8 T cells during this infection. Our present study demonstrates that pDC from middle-aged mice (12 months) suppress young (8 week old) cDC driven CD8 T cell priming against E. cuniculi infection. The suppressive effect of pDC from older mice decreased maturation of young cDC via cell contact. Aged mouse pDC exhibited higher expression of PD-L1 and blockade of their interaction with cDC via this molecule restored cDC maturation and T cell priming. Furthermore, the PD-L1 dependent suppression of cDC T cell priming was restricted to effector function of antigen-specific CD8 T cells not their expansion. To the best of our knowledge, the data presented here is the first report highlighting a cell contact dependent, PD-L1 regulated, age associated defect in a DC subpopulation that results in a suboptimal immune response against E. cuniculi infection. These results have broad implications for design of immunotherapeutic approaches to enhance immunity for aging populations.	[Gigley, Jason P.; Khan, Imtiaz A.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA	George Washington University	Gigley, JP (corresponding author), George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.	mtmixk@gwumc.edu			National Institutes of Health [AI071778]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071778] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grant AI071778 awarded to I. A. K. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2008, J CLIN IMMUNOL, V28, P14, DOI 10.1007/s10875-007-9127-6; Agrawal A, 2007, EXP GERONTOL, V42, P421, DOI 10.1016/j.exger.2006.11.007; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Benedict CA, 2008, J IMMUNOL, V180, P4836, DOI 10.4049/jimmunol.180.7.4836; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222; Castellaneta A, 2009, J IMMUNOL, V183, P6922, DOI 10.4049/jimmunol.0900582; Cella M, 2000, NAT IMMUNOL, V1, P305, DOI 10.1038/79747; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Contractor N, 2007, J IMMUNOL, V179, P2690, DOI 10.4049/jimmunol.179.5.2690; Decman V, 2010, J IMMUNOL, V184, P5151, DOI 10.4049/jimmunol.0902063; Didier ES, 2005, ACTA TROP, V94, P61, DOI 10.1016/j.actatropica.2005.01.010; Didier ES, 2004, VET PARASITOL, V126, P145, DOI 10.1016/j.vetpar.2004.09.006; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Eaton SM, 2008, J IMMUNOL, V181, P4825, DOI 10.4049/jimmunol.181.7.4825; Fischer J, 2008, INFECT IMMUN, V76, P4737, DOI 10.1128/IAI.00733-08; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grolleau-Julius A, 2009, CANCER IMMUNOL IMMUN, V58, P1935, DOI 10.1007/s00262-008-0636-9; Guan HB, 2007, J IMMUNOL, V179, P590, DOI 10.4049/jimmunol.179.1.590; Hadeiba H, 2008, NAT IMMUNOL, V9, P1253, DOI 10.1038/ni.1658; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Kapasi ZF, 2002, EUR J IMMUNOL, V32, P1567, DOI 10.1002/1521-4141(200206)32:6<1567::AID-IMMU1567>3.0.CO;2-P; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Khan IA, 1999, J IMMUNOL, V162, P6086; Kovacs EJ, 2009, TRENDS IMMUNOL, V30, P319, DOI 10.1016/j.it.2009.03.012; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; LAWLOR EM, 2010, INFECT IMMUN; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Lores B, 2002, CLIN INFECT DIS, V34, P918, DOI 10.1086/339205; Maue AC, 2009, TRENDS IMMUNOL, V30, P301, DOI 10.1016/j.it.2009.04.007; MIRZA N, 2010, J IMMUNOL; Moretto M, 2004, J IMMUNOL, V172, P4402, DOI 10.4049/jimmunol.172.7.4402; Moretto MM, 2008, J IMMUNOL, V181, P7977, DOI 10.4049/jimmunol.181.11.7977; Munn DH, 2004, J CLIN INVEST, V114, P280, DOI 10.1172/JCI200421583; Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339; O'Keeffe M, 2002, J EXP MED, V196, P1307, DOI 10.1084/jem.20021031; Pepper M, 2008, J IMMUNOL, V180, P6229, DOI 10.4049/jimmunol.180.9.6229; Reizis B, 2010, CURR OPIN IMMUNOL, V22, P206, DOI 10.1016/j.coi.2010.01.005; Remer KA, 2007, EUR J IMMUNOL, V37, P2463, DOI 10.1002/eji.200636780; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Shodell M, 2002, SCAND J IMMUNOL, V56, P518, DOI 10.1046/j.1365-3083.2002.01148.x; Shreedhar V, 1999, IMMUNITY, V11, P625, DOI 10.1016/S1074-7613(00)80137-5; Smit JJ, 2006, J EXP MED, V203, P1153, DOI 10.1084/jem.20052359; Stout-Delgado HW, 2008, J IMMUNOL, V181, P6747, DOI 10.4049/jimmunol.181.10.6747; Talay O, 2009, P NATL ACAD SCI USA, V106, P2741, DOI 10.1073/pnas.0813367106; Tsukamoto H, 2009, P NATL ACAD SCI USA, V106, P18333, DOI 10.1073/pnas.0910139106; Wang L, 2008, P NATL ACAD SCI USA, V105, P9331, DOI 10.1073/pnas.0710441105; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wong CP, 2010, EXP GERONTOL, V45, P163, DOI 10.1016/j.exger.2009.11.005; Yao S, 2009, BLOOD, V113, P5811, DOI 10.1182/blood-2009-02-203141; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Yoneyama H, 2004, INT IMMUNOL, V16, P915, DOI 10.1093/intimm/dxh093; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zhang XH, 2002, J EXP MED, V195, P283, DOI 10.1084/jem.20011267	56	24	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20838	10.1371/journal.pone.0020838	http://dx.doi.org/10.1371/journal.pone.0020838			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695169	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612600033
J	Hayasaka, S; Hugenschmidt, CE; Laurienti, PJ				Hayasaka, Satoru; Hugenschmidt, Christina E.; Laurienti, Paul J.			A Network of Genes, Genetic Disorders, and Brain Areas	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DISEASE GENES; INTERMEDIATE PHENOTYPES; EXTENDED PEDIGREE; IDENTIFICATION; HERITABILITY; SUSCEPTIBILITY; MECHANISMS; RISK; TASK	The network-based approach has been used to describe the relationship among genes and various phenotypes, producing a network describing complex biological relationships. Such networks can be constructed by aggregating previously reported associations in the literature from various databases. In this work, we applied the network-based approach to investigate how different brain areas are associated to genetic disorders and genes. In particular, a tripartite network with genes, genetic diseases, and brain areas was constructed based on the associations among them reported in the literature through text mining. In the resulting network, a disproportionately large number of gene-disease and disease-brain associations were attributed to a small subset of genes, diseases, and brain areas. Furthermore, a small number of brain areas were found to be associated with a large number of the same genes and diseases. These core brain regions encompassed the areas identified by the previous genome-wide association studies, and suggest potential areas of focus in the future imaging genetics research. The approach outlined in this work demonstrates the utility of the network-based approach in studying genetic effects on the brain.	[Hayasaka, Satoru] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27106 USA; [Hayasaka, Satoru; Laurienti, Paul J.] Wake Forest Univ, Bowman Gray Sch Med, Dept Radiol, Winston Salem, NC USA; [Hugenschmidt, Christina E.] Wake Forest Univ, Bowman Gray Sch Med, Ctr Genom & Personalized Med Res, Winston Salem, NC USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Hayasaka, S (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27106 USA.	shayasak@wfubmc.edu			Translational Science Institute of Wake Forest University [TSI-K12]; National Institute of Neurological Disorders and Stroke [NS058700, NS070917]; National Institute of Diabetes and Digestive and Kidney Diseases [F32 DK083214]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK083214] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070917, R01NS058700] Funding Source: NIH RePORTER	Translational Science Institute of Wake Forest University; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the Translational Science Institute of Wake Forest University (TSI-K12), the National Institute of Neurological Disorders and Stroke (NS058700, NS070917), and the National Institute of Diabetes and Digestive and Kidney Diseases (F32 DK083214). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ANDERSON TW, 1954, J AM STAT ASSOC, V49, P765, DOI 10.2307/2281537; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bilder Robert M, 2009, Cogn Neuropsychiatry, V14, P419, DOI 10.1080/13546800902787180; Blokland GAM, 2008, BIOL PSYCHOL, V79, P70, DOI 10.1016/j.biopsycho.2008.03.006; Brun CC, 2009, NEUROIMAGE, V48, P37, DOI 10.1016/j.neuroimage.2009.05.022; Callicott JH, 2005, P NATL ACAD SCI USA, V102, P8627, DOI 10.1073/pnas.0500515102; Glahn DC, 2010, P NATL ACAD SCI USA, V107, P1223, DOI 10.1073/pnas.0909969107; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Johnson N.L., 1995, CONTINUOUS UNIVARIAT, VVolumes 1 and 2; Karlsgodt KH, 2010, J NEUROSCI, V30, P8197, DOI 10.1523/JNEUROSCI.0359-10.2010; Kochunov P, 2010, NEUROIMAGE, V53, P1126, DOI 10.1016/j.neuroimage.2009.12.045; Kochunov P, 2010, NEUROIMAGE, V53, P1109, DOI 10.1016/j.neuroimage.2010.01.078; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; Mehan MR, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S62; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Meyer-Lindenberg A, 2006, MOL PSYCHIATR, V11, P867, DOI 10.1038/sj.mp.4001860; Meyer-Lindenberg A, 2006, NAT REV NEUROSCI, V7, P818, DOI 10.1038/nrn1993; Meyer-Lindenberg A, 2009, HUM BRAIN MAPP, V30, P1938, DOI 10.1002/hbm.20639; Miozzi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002439; Mossa S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.138701; Ozgur A, 2008, BIOINFORMATICS, V24, pI277, DOI 10.1093/bioinformatics/btn182; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Potkin SG, 2009, MOL PSYCHIATR, V14, P416, DOI 10.1038/mp.2008.127; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Rogers J, 2007, HUM BRAIN MAPP, V28, P576, DOI 10.1002/hbm.20407; Sambataro F, 2009, BIOL PSYCHIAT, V66, P540, DOI 10.1016/j.biopsych.2009.04.014; Schmitt JE, 2008, CEREB CORTEX, V18, P1737, DOI 10.1093/cercor/bhm211; Seshadri S, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-S1-S15; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Stein JL, 2010, NEUROIMAGE, V53, P1160, DOI 10.1016/j.neuroimage.2010.02.032; Stein JL, 2010, NEUROIMAGE, V51, P542, DOI 10.1016/j.neuroimage.2010.02.068; Stumpf MPH, 2005, LECT NOTES COMPUT SC, V3737, P65; Tan HY, 2008, MOL PSYCHIATR, V13, P233, DOI 10.1038/sj.mp.4002145; Tan HY, 2007, P NATL ACAD SCI USA, V104, P12536, DOI 10.1073/pnas.0610125104; Thompson P, 2002, ANN MED, V34, P523, DOI 10.1080/078538902321117733; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vandewalle G, 2009, J NEUROSCI, V29, P7948, DOI 10.1523/JNEUROSCI.0229-09.2009; Wang JG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000521; Winkler AM, 2010, NEUROIMAGE, V53, P1135, DOI 10.1016/j.neuroimage.2009.12.028; Wu XB, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.27; Xu GF, 2009, BRAIN, V132, P383, DOI 10.1093/brain/awn254; Xu M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S1-S12	44	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20907	10.1371/journal.pone.0020907	http://dx.doi.org/10.1371/journal.pone.0020907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695164	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600035
J	Mak, M; Reinhart-King, CA; Erickson, D				Mak, Michael; Reinhart-King, Cynthia A.; Erickson, David			Microfabricated Physical Spatial Gradients for Investigating Cell Migration and Invasion Dynamics	PLOS ONE			English	Article							CANCER STEM-CELLS; SUBSTRATE STIFFNESS; HETEROGENEITY; ADHESION; IDENTIFICATION; MECHANICS; SIGNALS; GROWTH	We devise a novel assay that introduces micro-architectures into highly confining microchannels to probe the decision making processes of migrating cells. The conditions are meant to mimic the tight spaces in the physiological environment that cancer cells encounter during metastasis within the matrix dense stroma and during intravasation and extravasation through the vascular wall. In this study we use the assay to investigate the relative probabilities of a cell 1) permeating and 2) repolarizing (turning around) when it migrates into a spatially confining region. We observe the existence of both states even within a single cell line, indicating phenotypic heterogeneity in cell migration invasiveness and persistence. We also show that varying the spatial gradient of the taper can induce behavioral changes in cells, and different cell types respond differently to spatial changes. Particularly, for bovine aortic endothelial cells (BAECs), higher spatial gradients induce more cells to permeate (60%) than lower gradients (12%). Furthermore, highly metastatic breast cancer cells (MDA-MB-231) demonstrate a more invasive and permeative nature (87%) than non-metastatic breast epithelial cells (MCF-10A) (25%). We examine the migration dynamics of cells in the tapered region and derive characteristic constants that quantify this transition process. Our data indicate that cell response to physical spatial gradients is both cell-type specific and heterogeneous within a cell population, analogous to the behaviors reported to occur during tumor progression. Incorporation of micro-architectures in confined channels enables the probing of migration behaviors specific to defined geometries that mimic in vivo microenvironments.	[Mak, Michael; Reinhart-King, Cynthia A.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA; [Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Cornell University; Cornell University	Mak, M (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14850 USA.	de54@cornell.edu	Reinhart-King, Cynthia A./A-9264-2016; Erickson, David/A-3319-2009	Reinhart-King, Cynthia A./0000-0001-6959-3914; Erickson, David/0000-0002-1624-9711	Cornell Center on the Microenvironment and Metastasis, National Cancer Institute [U54CA143876]; National Science Foundation [ECS-0335765]; NATIONAL CANCER INSTITUTE [U54CA143876] Funding Source: NIH RePORTER	Cornell Center on the Microenvironment and Metastasis, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work described was supported by the Cornell Center on the Microenvironment and Metastasis through Award Number U54CA143876 from the National Cancer Institute. This work was performed in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Network, which is supported by the National Science Foundation (Grant ECS-0335765). Michael Mak is a NSF Graduate Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Bao G, 2003, NAT MATER, V2, P715, DOI 10.1038/nmat1001; BARAK LS, 1980, P NATL ACAD SCI-BIOL, V77, P980, DOI 10.1073/pnas.77.2.980; Bloom RJ, 2008, BIOPHYS J, V95, P4077, DOI 10.1529/biophysj.108.132738; Brandman O, 2008, SCIENCE, V322, P390, DOI 10.1126/science.1160617; Brown XQ, 2005, BIOMATERIALS, V26, P3123, DOI 10.1016/j.biomaterials.2004.08.009; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Dieterich P, 2008, P NATL ACAD SCI USA, V105, P459, DOI 10.1073/pnas.0707603105; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; FELLER W, 1945, B AM MATH SOC, V51, P800, DOI 10.1090/S0002-9904-1945-08448-1; FIDLER IJ, 1978, CANCER RES, V38, P2651; Fraley SI, 2010, NAT CELL BIOL, V12, P598, DOI 10.1038/ncb2062; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; Hawkins RJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058103; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Jiang XY, 2005, P NATL ACAD SCI USA, V102, P975, DOI 10.1073/pnas.0408954102; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kraning-Rush CM, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/1/015009; Kumar G, 2007, ADV MATER, V19, P1084, DOI 10.1002/adma.200601629; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Mahmud G, 2009, NAT PHYS, V5, P606, DOI 10.1038/NPHYS1306; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Pathak A, 2011, INTEGR BIOL-UK, V3, P267, DOI 10.1039/c0ib00095g; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rolli CG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008726; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shields JD, 2007, CANCER CELL, V11, P526, DOI 10.1016/j.ccr.2007.04.020; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Suresh S, 2007, ACTA MATER, V55, P3989, DOI 10.1016/j.actamat.2007.04.022; THERIOT JA, 1991, NATURE, V352, P126, DOI 10.1038/352126a0; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wakatsuki T, 2000, BIOPHYS J, V79, P2353, DOI 10.1016/S0006-3495(00)76481-2; Wolf K, 2009, CLIN EXP METASTAS, V26, P289, DOI 10.1007/s10585-008-9190-2; Yamauchi K, 2008, CANCER RES, V68, P516, DOI 10.1158/0008-5472.CAN-07-3063; Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041; Zaman MH, 2006, P NATL ACAD SCI USA, V103, P10889, DOI 10.1073/pnas.0604460103	47	54	55	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20825	10.1371/journal.pone.0020825	http://dx.doi.org/10.1371/journal.pone.0020825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695222	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612600029
J	Chen, CC; Huang, B; Anderson, JT; Bystrom, AS				Chen, Changchun; Huang, Bo; Anderson, James T.; Bystrom, Anders S.			Unexpected Accumulation of ncm(5)U and ncm(5)s(2)U in a trm9 Mutant Suggests an Additional Step in the Synthesis of mcm(5)U and mcm(5)s(2)U	PLOS ONE			English	Article							KLUYVEROMYCES-LACTIS ZYMOCIN; POLYMERASE-II HOLOENZYME; RNA WOBBLE POSITIONS; SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; ELONGATOR COMPLEX; YEAST; URIDINE; METHYLTRANSFERASE; REQUIRES	Background: Transfer RNAs are synthesized as a primary transcript that is processed to produce a mature tRNA. As part of the maturation process, a subset of the nucleosides are modified. Modifications in the anticodon region often modulate the decoding ability of the tRNA. At position 34, the majority of yeast cytosolic tRNA species that have a uridine are modified to 5-carbamoylmethyluridine (ncm(5)U), 5-carbamoylmethyl-2'-O-methyluridine (ncm(5)Um), 5-methoxycarbonylmethyl-uridine (mcm(5)U) or 5-methoxycarbonylmethyl-2-thiouridine (mcm(5)s(2)U). The formation of mcm(5) and ncm(5) side chains involves a complex pathway, where the last step in formation of mcm(5) is a methyl esterification of cm(5) dependent on the Trm9 and Trm112 proteins. Methodology and Principal Findings: Both Trm9 and Trm112 are required for the last step in formation of mcm(5) side chains at wobble uridines. By co-expressing a histidine-tagged Trm9p together with a native Trm112p in E. coli, these two proteins purified as a complex. The presence of Trm112p dramatically improves the methyltransferase activity of Trm9p in vitro. Single tRNA species that normally contain mcm(5)U or mcm(5)s(2)U nucleosides were isolated from trm9 Delta or trm112 Delta mutants and the presence of modified nucleosides was analyzed by HPLC. In both mutants, mcm(5)U and mcm(5)s(2)U nucleosides are absent in tRNAs and the major intermediates accumulating were ncm(5)U and ncm(5)s(2)U, not the expected cm(5)U and cm(5)s(2)U. Conclusions: Trm9p and Trm112p function together at the final step in formation of mcm(5)U in tRNA by using the intermediate cm(5)U as a substrate. In tRNA isolated from trm9 Delta and trm112 Delta strains, ncm(5)U and ncm(5)s(2)U nucleosides accumulate, questioning the order of nucleoside intermediate formation of the mcm(5) side chain. We propose two alternative explanations for this observation. One is that the intermediate cm(5)U is generated from ncm(5)U by a yet unknown mechanism and the other is that cm(5)U is formed before ncm(5)U and mcm(5)U.	[Chen, Changchun; Huang, Bo; Bystrom, Anders S.] Umea Univ, Dept Mol Biol, Umea, Sweden; [Huang, Bo] Vanderbilt Univ, Sch Med, Dept Med & Publ Hlth, Div Epidemiol, Nashville, TN 37212 USA; [Anderson, James T.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Umea University; Vanderbilt University; Marquette University	Chen, CC (corresponding author), Umea Univ, Dept Mol Biol, Umea, Sweden.	james.anderson@mu.edu; anders.bystrom@molbiol.umu.se		Chen, Changchun/0000-0003-2233-8996; Bystrom, Anders/0000-0003-1281-3888	Swedish Cancer Foundation [CAN 2007/890]; Swedish Science Research Council [2009-4761]; Insamlingstiftelsen [223-27-10]; National Institutes of Health, United States of America [R01GM069949]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069949] Funding Source: NIH RePORTER	Swedish Cancer Foundation; Swedish Science Research Council; Insamlingstiftelsen; National Institutes of Health, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Swedish Cancer Foundation (CAN 2007/890 to A. S. B.), the Swedish Science Research Council (2009-4761 to A. S. B.), Insamlingstiftelsen (223-27-10 to A. S. B.) and R01GM069949 from the National Institutes of Health, United States of America, to J.T.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar C, 2008, MOL MICROBIOL, V69, P1221, DOI 10.1111/j.1365-2958.2008.06350.x; Bjork GR, 2007, RNA, V13, P1245, DOI 10.1261/rna.558707; Bjork GR, 2001, EMBO J, V20, P231, DOI 10.1093/emboj/20.1.231; BJORK GR, 1995, BIOSYNTHESIS FUNCTIO, P165; Bujnicki JM, 2004, RNA, V10, P1236, DOI 10.1261/rna.7470904; Burke D., 2000, METHODS YEAST GENETI; Fichtner L, 2003, MOL MICROBIOL, V49, P1297, DOI 10.1046/j.1365-2958.2003.03632.x; Fichtner L, 2002, MOL MICROBIOL, V43, P783, DOI 10.1046/j.1365-2958.2002.02794.x; Fiorentini P, 1997, MOL CELL BIOL, V17, P2764, DOI 10.1128/MCB.17.5.2764; Frohloff F, 2003, J BIOL CHEM, V278, P956, DOI 10.1074/jbc.M210060200; Frohloff F, 2001, EMBO J, V20, P1993, DOI 10.1093/emboj/20.8.1993; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Greenwood C, 2009, J BIOL CHEM, V284, P141, DOI 10.1074/jbc.M805312200; HAGERVALL TG, 1987, J BIOL CHEM, V262, P8488; Heurgue-Hamard V, 2006, J BIOL CHEM, V281, P36140, DOI 10.1074/jbc.M608571200; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Huang B, 2005, RNA, V11, P424, DOI 10.1261/rna.7247705; Huang B, 2008, RNA, V14, P2183, DOI 10.1261/rna.1184108; Jablonowski D, 2004, MOL BIOL CELL, V15, P1459, DOI 10.1091/mbc.E03-10-0750; Jablonowski D, 2001, GENETICS, V159, P1479; Jablonowski D, 2009, EUKARYOT CELL, V8, P1637, DOI 10.1128/EC.00205-09; Johansson MJO, 2008, MOL CELL BIOL, V28, P3301, DOI 10.1128/MCB.01542-07; Johansson MJO, 2005, FINE TUNING RNA FUNC; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kalhor HR, 2003, MOL CELL BIOL, V23, P9283, DOI 10.1128/MCB.23.24.9283-9292.2003; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2001, MOL CELL BIOL, V21, P8203, DOI 10.1128/MCB.21.23.8203-8212.2001; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu J, 2005, RNA, V11, P1648, DOI 10.1261/rna.2172105; Mazauric MH, 2010, J BIOL CHEM, V285, P18505, DOI 10.1074/jbc.M110.113100; Mehlgarten C, 2003, MOL GENET GENOMICS, V269, P188, DOI 10.1007/s00438-003-0807-5; Mehlgarten C, 2009, MOL MICROBIOL, V73, P869, DOI 10.1111/j.1365-2958.2009.06811.x; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Nakai Y, 2008, J BIOL CHEM, V283, P27469, DOI 10.1074/jbc.M804043200; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Petrakis TG, 2005, J BIOL CHEM, V280, P19454, DOI 10.1074/jbc.M413373200; Purushothaman SK, 2005, MOL CELL BIOL, V25, P4359, DOI 10.1128/MCB.25.11.4359-4370.2005; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; TUMAITIS T D, 1970, Biochimica et Biophysica Acta, V224, P391, DOI 10.1016/0005-2787(70)90572-1; van den Born E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1173; Winkler GS, 2001, J BIOL CHEM, V276, P32743, DOI 10.1074/jbc.M105303200; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	49	39	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20783	10.1371/journal.pone.0020783	http://dx.doi.org/10.1371/journal.pone.0020783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687733	Green Published, Green Submitted, gold			2022-12-25	WOS:000291607000021
J	Hu, J; Xu, T; Zhu, T; Lou, Q; Wang, XQ; Wu, Y; Huang, RZ; Liu, JR; Liu, HY; Yu, FY; Ding, BX; Huang, YL; Tong, WY; Qu, D				Hu, Jian; Xu, Tao; Zhu, Tao; Lou, Qiang; Wang, Xueqin; Wu, Yang; Huang, Renzheng; Liu, Jingran; Liu, Huayong; Yu, Fangyou; Ding, Baixing; Huang, Yalin; Tong, Wenyan; Qu, Di			Monoclonal Antibodies against Accumulation-Associated Protein Affect EPS Biosynthesis and Enhance Bacterial Accumulation of Staphylococcus epidermidis	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; COAGULASE-NEGATIVE STAPHYLOCOCCI; BIOFILM FORMATION; EXTRACELLULAR DNA; ICA LOCUS; AUREUS; INFECTIONS; EXPRESSION; ADHERENCE; RELEASE	Because there is no effective antibiotic to eradicate Staphylococcus epidermidis biofilm infections that lead to the failure of medical device implantations, the development of anti-biofilmvaccines is necessary. Biofilmformation by S. epidermidis requires accumulation-associated protein (Aap) that contains sequence repeats known as G5 domains, which are responsible for the Zn2+-dependent dimerization of Aap to mediate intercellular adhesion. Antibodies against Aap have been reported to inhibit biofilm accumulation. In the present study, three monoclonal antibodies (MAbs) against the Aap C-terminal single B-repeat construct followed by the 79-aa half repeat (AapBrpt1.5) were generated. MAb18B6 inhibited biofilm formation by S. epidermidis RP62A to 60% of the maximum, while MAb25C11 and MAb20B9 enhanced biofilm accumulation. All three MAbs aggregated the planktonic bacteria to form visible cell clusters. Epitope mapping revealed that the epitope of MAb18B6, which recognizes an identical area within AapBrpt constructs from S. epidermidis RP62A, was not shared by MAb25C11 and MAb20B9. Furthermore, all three MAbs were found to affect both Aap expression and extracellular polymeric substance (EPS, including extracellular DNA and PIA) biosynthesis in S. epidermidis and enhance the cell accumulation. These findings contribute to a better understanding of staphylococcal biofilm formation and will help to develop epitope-peptide vaccines against staphylococcal infections.	[Hu, Jian; Xu, Tao; Zhu, Tao; Lou, Qiang; Wang, Xueqin; Wu, Yang; Huang, Renzheng; Liu, Jingran; Liu, Huayong; Yu, Fangyou; Tong, Wenyan; Qu, Di] Fudan Univ, Inst Med Microbiol, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China; [Hu, Jian; Xu, Tao; Zhu, Tao; Lou, Qiang; Wang, Xueqin; Wu, Yang; Huang, Renzheng; Liu, Jingran; Liu, Huayong; Yu, Fangyou; Tong, Wenyan; Qu, Di] Fudan Univ, Inst Med Microbiol, Key Lab Med Mol Virol, Minist Hlth, Shanghai 200433, Peoples R China; [Hu, Jian; Xu, Tao; Zhu, Tao; Lou, Qiang; Wang, Xueqin; Wu, Yang; Huang, Renzheng; Liu, Jingran; Liu, Huayong; Yu, Fangyou; Huang, Yalin; Tong, Wenyan; Qu, Di] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China; [Ding, Baixing] Wenzhou Med Coll, Affiliated Hosp 1, Dept Intens Care Unit, Wenzhou, Peoples R China; [Huang, Yalin] Fudan Univ, Inst Stem Cell Res & Regenerat Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Wenzhou Medical University; Fudan University	Hu, J (corresponding author), Fudan Univ, Inst Med Microbiol, Key Lab Med Mol Virol, Minist Educ, Shanghai 200433, Peoples R China.	wytong@fudan.edu.cn; dqu@fudan.edu.cn	Qu, Di/AAO-4590-2020		High-Tech Research and Development Program of China [2006AA02A253]; Ministry of Science and Technology of China [2009ZX09303-005, 2008ZX10003-016, 2010DFA32100]; National Natural Science Foundation of China [30800036]; Scientific Technology Development Foundation of Shanghai [08JC1401600, 10410700600]	High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Technology Development Foundation of Shanghai	This work was supported by the High-Tech Research and Development Program of China (2006AA02A253; http://www.863.gov.cn), the Program of Ministry of Science and Technology of China (2009ZX09303-005, 2008ZX10003-016, 2010DFA32100; http://www.nmp.gov.cn), the National Natural Science Foundation of China (30800036; http://www.nsfc.gov.cn/Portal0/default106.htm) and the Scientific Technology Development Foundation of Shanghai (08JC1401600, 10410700600; http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Laham N, 2007, J BACTERIOL, V189, P4494, DOI 10.1128/JB.00160-07; Bao WJ, 2006, PROTEIN EXPRES PURIF, V47, P599, DOI 10.1016/j.pep.2005.11.021; Bayles KW, 2007, NAT REV MICROBIOL, V5, P721, DOI 10.1038/nrmicro1743; Broekhuizen CAN, 2009, BIOMATERIALS, V30, P6444, DOI 10.1016/j.biomaterials.2009.08.018; Brunskill EW, 1996, J BACTERIOL, V178, P611, DOI 10.1128/jb.178.3.611-618.1996; Cheng Y, 2004, BIOCHEM BIOPH RES CO, V317, P401, DOI 10.1016/j.bbrc.2004.03.068; CHRISTENSEN GD, 1985, J CLIN MICROBIOL, V22, P996, DOI 10.1128/JCM.22.6.996-1006.1985; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Das T, 2010, APPL ENVIRON MICROB, V76, P3405, DOI 10.1128/AEM.03119-09; Fluckiger U, 2005, INFECT IMMUN, V73, P1811, DOI 10.1128/IAI.73.3.1811-1819.2005; Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; GRONENBORN AM, 1991, SCIENCE, V253, P657, DOI 10.1126/science.1871600; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; KOWALSKI JJ, 1971, INFECT IMMUN, V4, P205, DOI 10.1128/IAI.4.3.205-211.1971; Macintosh RL, 2009, J BACTERIOL, V191, P7007, DOI 10.1128/JB.00764-09; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; Mack D, 1999, J HOSP INFECT, V43, pS113, DOI 10.1016/S0195-6701(99)90074-9; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; McKenney D, 1998, INFECT IMMUN, V66, P4711, DOI 10.1128/IAI.66.10.4711-4720.1998; MEYERBLOCH JC, 1980, ARCH DERMATOL RES, V268, P1, DOI 10.1007/BF00403880; Moscoso M, 2006, J BACTERIOL, V188, P7785, DOI 10.1128/JB.00673-06; O'Gara JP, 2001, J MED MICROBIOL, V50, P582, DOI 10.1099/0022-1317-50-7-582; Otto M, 2008, CURR TOP MICROBIOL, V322, P207; Qin ZQ, 2007, MICROBIOL-SGM, V153, P2083, DOI 10.1099/mic.0.2007/006031-0; Qin ZQ, 2007, J MED MICROBIOL, V56, P83, DOI 10.1099/jmm.0.46799-0; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Rupp ME, 1994, CLIN INFECT DIS, V19, P44; Sun DQ, 2005, CLIN DIAGN LAB IMMUN, V12, P93, DOI 10.1128/CDLI.12.1.93-100.2005; Visai L, 2007, INT J ARTIF ORGANS, V30, P813, DOI 10.1177/039139880703000911; von Eiff C, 2002, LANCET INFECT DIS, V2, P677, DOI 10.1016/S1473-3099(02)00438-3; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Whitchurch CB, 2002, SCIENCE, V295, P1487, DOI 10.1126/science.295.5559.1487; Ziebuhr W, 1997, INFECT IMMUN, V65, P890, DOI 10.1128/IAI.65.3.890-896.1997	41	26	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20918	10.1371/journal.pone.0020918	http://dx.doi.org/10.1371/journal.pone.0020918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687690	Green Published, gold, Green Submitted			2022-12-25	WOS:000291607000029
J	Terry, T; Chen, ZQ; Dixon, RAF; Vanderslice, P; Zoldhelyi, P; Willerson, JT; Liu, Q				Terry, Toya; Chen, Zhiqiang; Dixon, Richard A. F.; Vanderslice, Peter; Zoldhelyi, Pierre; Willerson, James T.; Liu, Qi			CD34(+)/M-cadherin(+) Bone Marrow Progenitor Cells Promote Arteriogenesis in Ischemic Hindlimbs of ApoE(-/-) Mice	PLOS ONE			English	Article							CRITICAL LIMB ISCHEMIA; PERIPHERAL ARTERIAL-DISEASE; SKELETAL-MUSCLE CELLS; THERAPEUTIC ANGIOGENESIS; M-CADHERIN; POSTNATAL NEOVASCULARIZATION; AUTOLOGOUS TRANSPLANTATION; MONONUCLEAR-CELLS; VASCULAR-DISEASE; APOLIPOPROTEIN-E	Background: Cell-based therapy shows promise in treating peripheral arterial disease (PAD); however, the optimal cell type and long-term efficacy are unknown. In this study, we identified a novel subpopulation of adult progenitor cells positive for CD34 and M-cadherin (CD34(+)/M-cad(+) BMCs) in mouse and human bone marrow. We also examined the long-lasting therapeutic efficacy of mouse CD34(+)/M-cad(+) BMCs in restoring blood flow and promoting vascularization in an atherosclerotic mouse model of PAD. Methods and Findings: Colony-forming cell assays and flow cytometry analysis showed that CD34(+)/M-cad(+) BMCs have hematopoietic progenitor properties. When delivered intra-arterially into the ischemic hindlimbs of ApoE(-/-) mice, CD34(+)/M-cad(+) BMCs alleviated ischemia and significantly improved blood flow compared with CD34(+)/M-cad(-) BMCs, CD34(-)/M-cad(+) BMCs, or unselected BMCs. Significantly more arterioles were seen in CD34(+)/M-cad(+) cell-treated limbs than in any other treatment group 60 days after cell therapy. Furthermore, histologic assessment and morphometric analyses of hindlimbs treated with GFP(+) CD34(+)/M-cad(+) cells showed that injected cells incorporated into solid tissue structures at 21 days. Confocal microscopic examination of GFP(+) CD34(+)/M-cad(+) cell-treated ischemic legs followed by immunostaining indicated the vascular differentiation of CD34(+)/M-cad(+) progenitor cells. A cytokine antibody array revealed that CD34(+)/M-cad(+) cell-conditioned medium contained higher levels of cytokines in a unique pattern, including bFGF, CRG-2, EGF, Flt-3 ligand, IGF-1, SDF-1, and VEGFR-3, than did CD34(+)/M-cad(-) cell-conditioned medium. The proangiogenic cytokines secreted by CD34(+)/M-cad(+) cells induced oxygen-and nutrient-depleted endothelial cell sprouting significantly better than CD34(+)/M-cad(-) cells during hypoxia. Conclusion: CD34(+)/M-cad(+) BMCs represent a new progenitor cell type that effectively alleviates hindlimb ischemia in ApoE(-/-) mice by consistently improving blood flow and promoting arteriogenesis. Additionally, CD34(+)/M-cad(+) BMCs contribute to microvascular remodeling by differentiating into vascular cells and releasing proangiogenic cytokines and growth factors.	[Terry, Toya; Dixon, Richard A. F.; Vanderslice, Peter; Zoldhelyi, Pierre; Willerson, James T.; Liu, Qi] St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA; [Chen, Zhiqiang; Willerson, James T.] Univ Texas Hlth Sci Ctr, Houston, TX USA	Saint Lukes Episcopal Hospital; Texas Heart Institute; University of Texas System; University of Texas Health Science Center Houston	Terry, T (corresponding author), St Lukes Episcopal Hosp, Texas Heart Inst, Houston, TX 77030 USA.	qliu@heart.thi.tmc.edu			MacDonald General Research Fund [09RDM001]; American Heart Association [10SDG4260005]	MacDonald General Research Fund; American Heart Association(American Heart Association)	The study was funded by the following two grants: the MacDonald General Research Fund (09RDM001) and the American Heart Association (10SDG4260005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguren XL, 2009, J MOL MED, V87, P3, DOI 10.1007/s00109-008-0394-3; ARANGUREN XL, 2010, CELL TRANSPLANT; Aronow H, 2008, AM J CARDIOVASC DRUG, V8, P353, DOI 10.2165/0129784-200808060-00002; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Breslow JL, 1996, SCIENCE, V272, P685, DOI 10.1126/science.272.5262.685; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Charrasse S, 2004, ONCOGENE, V23, P2420, DOI 10.1038/sj.onc.1207382; Corti S, 2002, EXP CELL RES, V277, P74, DOI 10.1006/excr.2002.5543; Criqui MH, 2008, CIRCULATION, V118, P2830, DOI 10.1161/CIRCULATIONAHA.108.191172; De Falco E, 2004, BLOOD, V104, P3472, DOI 10.1182/blood-2003-12-4423; DONALIES M, 1991, P NATL ACAD SCI USA, V88, P8024, DOI 10.1073/pnas.88.18.8024; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; He YL, 2004, BBA-REV CANCER, V1654, P3, DOI 10.1016/j.bbcan.2003.07.003; Heszele MFC, 2004, ENDOCRINOLOGY, V145, P4803, DOI 10.1210/en.2004-1037; Higashi Y, 2004, CIRCULATION, V109, P1215, DOI 10.1161/01.CIR.0000121427.53291.78; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kajiguchi M, 2007, CIRC J, V71, P196, DOI 10.1253/circj.71.196; KALWITZ G, 2009, CONNECT TISSUE RES; Kamata Y, 2007, RHEUMATOLOGY, V46, P882, DOI 10.1093/rheumatology/kel436; Kawamoto Atsuhiko, 2002, Cardiovasc Radiat Med, V3, P221, DOI 10.1016/S1522-1865(03)00082-9; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Kolvenbach R, 2007, J CARDIOVASC SURG, V48, P39; Kudo FA, 2003, INT ANGIOL, V22, P344; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Liu Q, 2009, VASC ENDOVASC SURG, V43, P433, DOI 10.1177/1538574409335158; Losordo DW, 2004, CIRCULATION, V109, P2692, DOI 10.1161/01.CIR.0000128596.49339.05; Maier A, 2004, AM J PHYSIOL-CELL PH, V286, pC708, DOI 10.1152/ajpcell.00369.2003; Makinen T, 2001, NAT MED, V7, P199, DOI 10.1038/84651; Meir KS, 2004, ARTERIOSCL THROM VAS, V24, P1006, DOI 10.1161/01.ATV.0000128849.12617.f4; Minar E, 2009, HAMOSTASEOLOGIE, V29, P102; Musaro A, 2004, P NATL ACAD SCI USA, V101, P1206, DOI 10.1073/pnas.0303792101; REDDICK RL, 1994, ARTERIOSCLER THROMB, V14, P141, DOI 10.1161/01.ATV.14.1.141; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Saigawa T, 2004, CIRC J, V68, P1189, DOI 10.1253/circj.68.1189; Sekiguchi H, 2009, J CELL PHYSIOL, V219, P235, DOI 10.1002/jcp.21672; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Slovut DP, 2008, VASC MED, V13, P281, DOI 10.1177/1358863X08091485; STRONG JP, 1992, ARCH PATHOL LAB MED, V116, P1268; Tateishi-Yuyama E, 2002, LANCET, V360, P427, DOI 10.1016/S0140-6736(02)09670-8; Wang H, 2005, CELL BIOL INT, V29, P654, DOI 10.1016/j.cellbi.2005.03.019; Wouters K, 2005, CLIN CHEM LAB MED, V43, P470, DOI 10.1515/CCLM.2005.085; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22; Yamamoto K, 2004, ARTERIOSCL THROM VAS, V24, pE192, DOI 10.1161/01.ATV.0000147730.78953.60; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; ZESCHNIGK M, 1995, J CELL SCI, V108, P2973; Zhang S, 2004, CIRCULATION, V110, P3803, DOI 10.1161/01.CIR.0000150796.18473.8E; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhang S, 2007, CIRC RES, V100, P693, DOI 10.1161/01.RES.0000260803.98329.1c	52	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20673	10.1371/journal.pone.0020673	http://dx.doi.org/10.1371/journal.pone.0020673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677770	Green Submitted, Green Published, gold			2022-12-25	WOS:000291355500031
J	Tong, ZT; Cai, MY; Wang, XG; Kong, LL; Mai, SJ; Liu, YH; Zhang, HB; Liao, YJ; Zheng, F; Zhu, W; Liu, TH; Bian, XW; Guan, XY; Lin, MC; Zeng, MS; Zeng, YX; Kung, HF; Xie, D				Tong, Z-T; Cai, M-Y; Wang, X-G; Kong, L-L; Mai, S-J; Liu, Y-H; Zhang, H-B; Liao, Y-J; Zheng, F.; Zhu, W.; Liu, T-H; Bian, X-W; Guan, X-Y; Lin, M. C.; Zeng, M-S; Zeng, Y-X; Kung, H-F; Xie, D.			EZH2 supports nasopharyngeal carcinoma cell aggressiveness by forming a co-repressor complex with HDAC1/HDAC2 and Snail to inhibit E-cadherin	ONCOGENE			English	Article						nasopharyngeal carcinoma; EZH2; E-cadherin; HDAC; Snail	TRANSCRIPTION FACTOR SNAIL; EMBRYONIC STEM-CELLS; GROUP PROTEIN EZH2; ZESTE HOMOLOG-2; DEVELOPMENTAL REGULATORS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; POOR-PROGNOSIS; GASTRIC-CANCER; POLYCOMB	The enhancer of zeste homolog 2 (EZH2) is upregulated and has an oncogenic role in several types of human cancer. However, the abnormalities of EZH2 and its underlying mechanisms in the pathogenesis of nasopharyngeal carcinoma (NPC) remain unknown. In this study, we found that high expression of EZH2 in NPC was associated closely with an aggressive and/or poor prognostic phenotype (P<0.05). In NPC cell lines, knockdown of EZH2 by short hairpin RNA was sufficient to inhibit cell invasiveness/metastasis both in vitro and in vivo, whereas ectopic overexpression of EZH2 supported NPC cell invasive capacity with a decreased expression of E-cadherin. In addition, ablation of endogenous Snail in NPC cells virtually totally prevented the repressive activity of EZH2 to E-cadherin, indicating that Snail might be a predominant mediator of EZH2 to suppress E-cadherin. Furthermore, co-immunoprecipitation (IP), chromatin IP and luciferase reporter assays demonstrated that in NPC cells, (1) EZH2 interacted with HDAC1/HDAC2 and Snail to form a repressive complex; (2) these components interact in a linear fashion, not in a triangular fashion, that is, HDAC1 or HDAC2 bridge the interaction between EZH2 and Snail; and (3) the EZH2/HDAC1/2/Snail complex could closely bind to the E-cadherin promoter by Snail, but not YY1, to repress E-cadherin. The data provided in this report suggest a critical role of EZH2 in the control of cell invasion and/or metastasis by forming a co-repressor complex with HDAC1/HDAC2/Snail to repress E-cadherin, an activity that might be responsible, at least in part, for the development and/or progression of human NPCs. Oncogene (2012) 31, 583-594; doi:10.1038/onc.2011.254; published online 20 June 2011	[Tong, Z-T; Cai, M-Y; Mai, S-J; Liao, Y-J; Zheng, F.; Zhu, W.; Liu, T-H; Guan, X-Y; Zeng, M-S; Zeng, Y-X; Kung, H-F; Xie, D.] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510060, Guangdong, Peoples R China; [Tong, Z-T; Mai, S-J; Liao, Y-J; Zheng, F.; Zhu, W.; Liu, T-H; Guan, X-Y; Zeng, M-S; Zeng, Y-X; Xie, D.] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510060, Guangdong, Peoples R China; [Tong, Z-T; Kong, L-L] An Hui Med Univ, Affiliated Hosp 1, Dept Radiotherapy, Hefei, Peoples R China; [Wang, X-G] Sun Yat Sen Univ, Zhong Shan Sch Med, Dept Pharmacol, Guangzhou 510060, Guangdong, Peoples R China; [Liu, Y-H] Guangdong Prov Peoples Hosp, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Zhang, H-B] Guangdong Prov Peoples Hosp, Dept Otolaryngol, Guangzhou, Guangdong, Peoples R China; [Bian, X-W] Third Mil Med Univ, SW Hosp, Inst Pathol, Chongqing, Peoples R China; [Bian, X-W] Third Mil Med Univ, SW Hosp, SW Canc Ctr, Chongqing, Peoples R China; [Lin, M. C.; Kung, H-F] Chinese Univ Hong Kong, State Key Lab Oncol S China, Hong Kong, Hong Kong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Anhui Medical University; Sun Yat Sen University; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Army Medical University; Army Medical University; Chinese University of Hong Kong	Xie, D (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, 651 Dongfeng Rd E,Room 634, Guangzhou 510060, Guangdong, Peoples R China.	xied@mail.sysu.edu.cn	mai, sj/HGE-8908-2022; LIAO, YIJI/Z-4902-2019; Bian, Xiu-Wu/D-4736-2017; Guan, Xin-Yuan/A-3639-2009; /A-3639-2009	LIAO, YIJI/0000-0002-0849-4573; Bian, Xiu-Wu/0000-0003-4383-0197; Zhu, Wei-Guo/0000-0001-8385-6581; Guan, Xin-Yuan/0000-0002-4485-6017; /0000-0003-1874-9805; zeng, musheng/0000-0003-3509-5591	Foundation of Guangzhou Science and Technology Bureau, China [2005Z1-E0131]; 973 Project of China [2010CB912802, 2010CB529400]	Foundation of Guangzhou Science and Technology Bureau, China; 973 Project of China(National Basic Research Program of China)	We thank Dr Clifford W Welsch (Michigan State University) for his valuable comments and extensive edit for the paper. This work was supported by the Foundation of Guangzhou Science and Technology Bureau, China (2005Z1-E0131 to DX and HFK) and the 973 Project of China (2010CB912802 to HFK and 2010CB529400 to XWB and MCL).	Bachmann IM, 2006, J CLIN ONCOL, V24, P268, DOI 10.1200/JCO.2005.01.5180; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cai MY, 2011, GUT, V60, P967, DOI 10.1136/gut.2010.231993; Camp RL, 2004, CLIN CANCER RES, V10, P7252, DOI 10.1158/1078-0432.CCR-04-0713; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Cao Q, 2008, ONCOGENE, V27, P7274, DOI 10.1038/onc.2008.333; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen YC, 2007, HEPATOLOGY, V46, P200, DOI 10.1002/hep.21668; Collett K, 2006, CLIN CANCER RES, V12, P1168, DOI 10.1158/1078-0432.CCR-05-1533; FANDI A, 1994, SEMIN ONCOL, V21, P382; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Fujii S, 2008, CANCER SCI, V99, P738, DOI 10.1111/j.1349-7006.2008.00743.x; He LR, 2010, INT J CANCER, V127, P138, DOI 10.1002/ijc.25031; Herranz N, 2008, MOL CELL BIOL, V28, P4772, DOI 10.1128/MCB.00323-08; Kidani K, 2009, ORAL ONCOL, V45, P39, DOI 10.1016/j.oraloncology.2008.03.016; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lo KW, 2004, CANCER CELL, V5, P423, DOI 10.1016/S1535-6108(04)00119-9; Matsukawa Y, 2006, CANCER SCI, V97, P484, DOI 10.1111/j.1349-7006.2006.00203.x; Mimori K, 2005, EJSO-EUR J SURG ONC, V31, P376, DOI 10.1016/j.ejso.2004.11.001; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Raman JD, 2005, CLIN CANCER RES, V11, P8570, DOI 10.1158/1078-0432.CCR-05-1047; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Satijn DPE, 2001, MOL CELL BIOL, V21, P1360, DOI 10.1128/MCB.21.4.1360-1369.2001; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simon JA, 2008, MUTAT RES-FUND MOL M, V647, P21, DOI 10.1016/j.mrfmmm.2008.07.010; Song LB, 2009, J CLIN INVEST, V119, P3626, DOI 10.1172/JCI39374; Sudo T, 2005, BRIT J CANCER, V92, P1754, DOI 10.1038/sj.bjc.6602531; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; van der Vlag J, 1999, NAT GENET, V23, P474, DOI 10.1038/70602; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wei William I, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P99, DOI 10.1097/MOO.0b013e3280148a06; Wilkinson F, 2010, J CELL BIOCHEM, V109, P478, DOI 10.1002/jcb.22424; Xie D, 2003, INT J CANCER, V107, P896, DOI 10.1002/ijc.11514	40	157	175	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	FEB	2012	31	5					583	594		10.1038/onc.2011.254	http://dx.doi.org/10.1038/onc.2011.254			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	891MS	21685935				2022-12-25	WOS:000300221800005
J	Rego, MA; Harney, JA; Mauro, M; Shen, M; Howlett, NG				Rego, M. A.; Harney, J. A.; Mauro, M.; Shen, M.; Howlett, N. G.			Regulation of the activation of the Fanconi anemia pathway by the p21 cyclin-dependent kinase inhibitor	ONCOGENE			English	Article						Fanconi anemia; ubiquitination; deubiquitination; genome stability; DNA repair	P53-MEDIATED G(1) ARREST; FRAGILE-SITE STABILITY; CELL NUCLEAR ANTIGEN; DNA-DAMAGE RESPONSE; CROSS-LINK REPAIR; MONOUBIQUITINATED FANCD2; UBIQUITIN LIGASE; COMPLEX; PROTEIN; GENE	Fanconi anemia (FA) is a rare disease characterized by congenital defects, progressive bone marrow failure and heightened cancer susceptibility. The FA proteins, BRCA1 and FANCD1/BRCA2 function cooperatively in the FA-BRCA pathway to repair damaged DNA. Activation of the FA-BRCA pathway occurs via the monoubiquitination of the FANCD2 and FANCI proteins, targeting these proteins to discrete nuclear foci where they function in DNA repair. The cellular regulation of FANCD2/I monoubiquitination, however, remains poorly understood. In this study, we have examined the roles of the p53 tumor suppressor protein, as well as its downstream target, the p21(Cip1/Waf1) cyclin-dependent kinase inhibitor, in the regulation of the activation of the FA-BRCA pathway. We demonstrate that, in contrast to p53, p21 has a major role in the regulation of the activation of the FA-BRCA pathway: p21 promotes S-phase and DNA damage-inducible FANCD2/I monoubiquitination and nuclear foci formation. Several lines of evidence establish that this effect is not a consequence of a defective G1-S checkpoint or altered cell-cycle progression in the absence of p21. Instead, we demonstrate that p21 is required for the transcriptional repression of the USP1 deubiquitinating enzyme upon exposure to DNA-damaging agents. In the absence of p21, persistent USP1 expression precludes the DNA damage-inducible accumulation of monoubiquitinated FANCD2 and FANCI. Consequently, p21(-/-) cells exhibit increased levels of mitomycin C-inducible complex chromosomal aberrations and elevated gamma H2AX nuclear foci formation. Our results demonstrate that p21 has a critical role in the regulation of the activation of the FA-BRCA pathway and suggest a broader role for p21 in the orchestration of DNA repair processes following exposure to DNA crosslinking agents. Oncogene (2012) 31, 366-375; doi:10.1038/onc.2011.237; published online 20 June 2011	[Howlett, N. G.] Univ Rhode Isl, Ctr Biotechnol & Life Sci 379, Dept Cell & Mol Biol, Kingston, RI 02881 USA	University of Rhode Island	Howlett, NG (corresponding author), Univ Rhode Isl, Ctr Biotechnol & Life Sci 379, Dept Cell & Mol Biol, 120 Flagg Rd, Kingston, RI 02881 USA.	nhowlett@mail.uri.edu		Mauro, Maurizio/0000-0002-5452-0795	Leukemia Research Foundation; RI-INBRE from the National Center for Research Resources [P20RR016457-09]; National Institutes of Health/National Heart, Lung and Blood Institute [R21HL095991-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016457] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101977, R21HL095991] Funding Source: NIH RePORTER	Leukemia Research Foundation; RI-INBRE from the National Center for Research Resources; National Institutes of Health/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the members of the Howlett laboratory, Paul R Andreassen, Matthew Stoner and Patrick Sung for helpful discussions. We thank Tony T Huang and Patrick Sung for the anti-USP1 and anti-FANCI antibodies, respectively. We thank Bert Vogelstein for cells. This work was supported by a Leukemia Research Foundation New Investigator grant (NGH), RI-INBRE Grant P20RR016457-09 from the National Center for Research Resources (NGH) and National Institutes of Health/National Heart, Lung and Blood Institute Grant R21HL095991-01 (NGH).	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Abukhdeir Abde M., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000744; Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Alpi A, 2007, MOL CELL BIOL, V27, P8421, DOI 10.1128/MCB.00504-07; Andreassen PR, 2004, GENE DEV, V18, P1958, DOI 10.1101/gad.1196104; Arlt MF, 2004, MOL CELL BIOL, V24, P6701, DOI 10.1128/mcb.24.15.6701-6709.2004; AUERBACH AD, 1993, EXP HEMATOL, V21, P731; Avkin S, 2006, MOL CELL, V22, P407, DOI 10.1016/j.molcel.2006.03.022; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Chen JJ, 1996, P NATL ACAD SCI USA, V93, P11597, DOI 10.1073/pnas.93.21.11597; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Collis SJ, 2007, NAT CELL BIOL, V9, P391, DOI 10.1038/ncb1555; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; ELDEIRY WS, 1994, CANCER RES, V54, P1169; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Harney JA, 2008, PEDIAT HLTH, V2, P175; Hoskins EE, 2008, ONCOGENE, V27, P4798, DOI 10.1038/onc.2008.121; Howlett NG, 2005, HUM MOL GENET, V14, P693, DOI 10.1093/hmg/ddi065; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Howlett NG, 2009, J BIOL CHEM, V284, P28935, DOI 10.1074/jbc.M109.016352; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Kee Y, 2010, GENE DEV, V24, P1680, DOI 10.1101/gad.1955310; Kim Y, 2011, NAT GENET, V43, P142, DOI 10.1038/ng.750; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; Kratz K, 2010, CELL, V142, P77, DOI 10.1016/j.cell.2010.06.022; Liu T, 2010, SCIENCE, V329, P693, DOI 10.1126/science.1192656; Machida YJ, 2006, MOL CELL, V23, P589, DOI 10.1016/j.molcel.2006.06.024; MacKay C, 2010, CELL, V142, P65, DOI 10.1016/j.cell.2010.06.021; Mathew CG, 2006, ONCOGENE, V25, P5875, DOI 10.1038/sj.onc.1209878; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; PODUST VN, 1995, BIOCHEMISTRY-US, V34, P8869, DOI 10.1021/bi00027a039; Prives C, 2008, CELL CYCLE, V7, P3840, DOI 10.4161/cc.7.24.7243; Rego MA, 2009, MUTAT RES-FUND MOL M, V668, P27, DOI 10.1016/j.mrfmmm.2008.11.018; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Smogorzewska A, 2010, MOL CELL, V39, P36, DOI 10.1016/j.molcel.2010.06.023; Stoepker C, 2011, NAT GENET, V43, P138, DOI 10.1038/ng.751; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Vaz F, 2010, NAT GENET, V42, P406, DOI 10.1038/ng.570; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang XZ, 2007, MOL CELL BIOL, V27, P3098, DOI 10.1128/MCB.02357-06; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Yamamoto K, 2005, MOL CELL BIOL, V25, P34, DOI 10.1128/MCB.25.1.34-43.2005; Yamazoe M, 2004, DNA REPAIR, V3, P1175, DOI 10.1016/j.dnarep.2004.03.039	54	25	26	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	JAN	2012	31	3					366	375		10.1038/onc.2011.237	http://dx.doi.org/10.1038/onc.2011.237			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21685936	Green Accepted			2022-12-25	WOS:000299542100009
J	Crooks, RO; Rao, T; Mason, JM				Crooks, Richard O.; Rao, Tara; Mason, Jody M.			Truncation, Randomization, and Selection GENERATION OF A REDUCED LENGTH c-Jun ANTAGONIST THAT RETAINS HIGH INTERACTION STABILITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL COILED-COILS; OLIGOMERIZATION DOMAIN; EMPIRICAL PARAMETERS; PROTEIN-INTERACTION; FOLDING PROBLEM; ALPHA-HELICES; CHAIN-LENGTH; DNA-BINDING; IN-VIVO; PEPTIDES	The DNA binding activity of the transcriptional regulator activator protein-1 shows considerable promise as a target in cancer therapy. A number of different strategies have been employed to inhibit the function of this protein with promise having been demonstrated both in vitro and in vivo. Peptidebased therapeutics have received renewed interest in the last few years, and a number of 37-amino acid peptides capable of binding to the coiled coil dimerization domain of Jun and Fos have been derived. Here, we demonstrate how truncation and semirational library design, followed by protein-fragment complementation, can be used to produce a leucine zipper binding peptide by iterative means. To this end, we have implemented this strategy on the FosW peptide to produce 4hFosW. This peptide is truncated by four residues with comparably favorable binding properties and demonstrates the possibility to design progressively shorter peptides to serve as leucine zipper antagonists while retaining many of the key features of the parent peptide. Whether or not the necessity for low molecular weight antagonists is required from the perspective of druggability and efficacy is subject to debate. However, antagonists of reduced length are worthy of perusal from the point of view of synthetic cost as well as identifying the smallest functional unit that is required for binding.	[Crooks, Richard O.; Rao, Tara; Mason, Jody M.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Essex	Mason, JM (corresponding author), Univ Essex, Dept Biol Sci, Wivenhoe Pk, Colchester CO4 3SQ, Essex, England.	jmason@essex.ac.uk	Mason, Jody/W-8204-2019; Mason, Jody/A-9329-2011	Mason, Jody/0000-0002-4118-1958; Mason, Jody/0000-0002-4118-1958	Wellcome Trust [WT090184MA]; Department of Biological Sciences, University of Essex, RCIF; Cancer Research UK [11738] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Department of Biological Sciences, University of Essex, RCIF; Cancer Research UK(Cancer Research UK)	This work was supported in part by Wellcome Trust Grant WT090184MA.; We thank the Department of Biological Sciences, University of Essex, RCIF funding for the purchase of an Isothermal Titration Calorimeter. We thank Dr. Miao Yu for technical assistance.	Acharya A, 2006, BIOCHEMISTRY-US, V45, P11324, DOI 10.1021/bi060822u; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Bird GH, 2010, P NATL ACAD SCI USA, V107, P14093, DOI 10.1073/pnas.1002713107; Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; Dixon JM, 2005, PHOTOCHEM PHOTOBIOL, V81, P212, DOI 10.1562/2004-11-06-TSN-361.1; ELWELL ML, 1977, BIOCHIM BIOPHYS ACTA, V494, P367, DOI 10.1016/0005-2795(77)90166-0; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x; Harrison RS, 2010, P NATL ACAD SCI USA, V107, P11686, DOI 10.1073/pnas.1002498107; Jochum W, 2001, ONCOGENE, V20, P2401, DOI 10.1038/sj.onc.1204389; KRYLOV D, 1994, EMBO J, V13, P2849, DOI 10.1002/j.1460-2075.1994.tb06579.x; Krylov D, 1998, J MOL BIOL, V279, P959, DOI 10.1006/jmbi.1998.1762; Kwok SC, 2004, BIOPOLYMERS, V76, P378, DOI 10.1002/bip.20141; Kwok SC, 2004, J BIOL CHEM, V279, P21576, DOI 10.1074/jbc.M401074200; Ladbury JE, 2010, NAT REV DRUG DISCOV, V9, P23, DOI 10.1038/nrd3054; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; LAU SYM, 1984, J BIOL CHEM, V259, P3253; MAKI Y, 1987, P NATL ACAD SCI USA, V84, P2848, DOI 10.1073/pnas.84.9.2848; Mason JM, 2007, J BIOL CHEM, V282, P23015, DOI 10.1074/jbc.M701828200; Mason JM, 2007, BIOCHEMISTRY-US, V46, P4804, DOI 10.1021/bi602506p; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Mason JM, 2010, FUTURE MED CHEM, V2, P1813, DOI [10.4155/fmc.10.259, 10.4155/FMC.10.259]; Mason JM, 2009, FEBS J, V276, P7305, DOI 10.1111/j.1742-4658.2009.07440.x; Mason JM, 2009, BIOCHEMISTRY-US, V48, P10380, DOI 10.1021/bi901401e; Mason JM, 2008, BIOCHEM SOC T, V36, P1442, DOI 10.1042/BST0361442; Matthews CP, 2007, CURR CANCER DRUG TAR, V7, P317, DOI 10.2174/156800907780809723; Moitra J, 1997, BIOCHEMISTRY-US, V36, P12567, DOI 10.1021/bi971424h; MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024; MUNOZ V, 1995, J MOL BIOL, V245, P275, DOI 10.1006/jmbi.1994.0023; Olive M, 1997, J BIOL CHEM, V272, P18586, DOI 10.1074/jbc.272.30.18586; OSHEA EK, 1993, CURR BIOL, V3, P658, DOI 10.1016/0960-9822(93)90063-T; OSHEA EK, 1992, CELL, V68, P699, DOI 10.1016/0092-8674(92)90145-3; Otvos Laszlo Jr., 2008, V494, P1, DOI 10.1007/978-1-59745-419-3_1; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Pelletier JN, 1999, NAT BIOTECHNOL, V17, P683, DOI 10.1038/10897; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Seldeen KL, 2008, ARCH BIOCHEM BIOPHYS, V473, P48, DOI 10.1016/j.abb.2008.02.024; Shepherd NE, 2005, J AM CHEM SOC, V127, P2974, DOI 10.1021/ja0456003; Taylor M, 2010, BIOCHEMISTRY-US, V49, P3261, DOI 10.1021/bi100144m; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; WILLIAMS RW, 1987, BIOCHIM BIOPHYS ACTA, V916, P200, DOI 10.1016/0167-4838(87)90109-9; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Worrall JAR, 2011, FEBS J, V278, P663, DOI 10.1111/j.1742-4658.2010.07988.x	49	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29470	29479		10.1074/jbc.M111.221267	http://dx.doi.org/10.1074/jbc.M111.221267			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21697091	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000294046600004
J	Kaufmann, M; Prosser, DE; Jones, G				Kaufmann, Martin; Prosser, David E.; Jones, Glenville			Bioengineering Anabolic Vitamin D-25-Hydroxylase Activity into the Human Vitamin D Catabolic Enzyme, Cytochrome P450 CYP24A1, by a V391L Mutation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; 25-HYDROXYVITAMIN D-3; SUBSTRATE-BINDING; CALCITROIC ACID; METABOLISM; PATHWAY; ACTIVATION; KIDNEY; RAT; 1,25-DIHYDROXYVITAMIN-D3	CYP24A1 is a mitochondrial cytochrome P450 (CYP) that catabolizes 1 alpha,25-dihydroxyvitamin D-3 (1 alpha,25-(OH)(2)D-3) to different products: calcitroic acid or 1 alpha,25-(OH)(2)D-3-26,23-lactone via multistep pathways commencing with C24 and C23 hydroxylation, respectively. Despite the ability of CYP24A1 to catabolize a wide range of 25-hydroxylated analogs including 25-hydroxyvitamin D-3, the enzyme is unable to metabolize the synthetic prodrug, 1 alpha-hydroxyvitamin D-3 (1 alpha-OH-D-3), pre-sumably because it lacks a C25-hydroxyl. In the current study we show that a single V391L amino acid substitution in the beta 3a-strand of human CYP24A1 converts this enzyme from a catabolic 1 alpha,25-(OH)(2)D-3-24-hydroxylase into an anabolic 1 alpha-OH-D-3-25-hydroxylase, thereby forming the hormone, 1 alpha,25-(OH)(2)D-3. Furthermore, because the mutant enzyme retains its basal ability to catabolize 1 alpha,25-(OH)(2)D-3 via C24 hydroxylation, it can also make calcitroic acid. Previous work has shown that an A326G mutation is responsible for the regioselectivity differences observed between human (primarily C24-hydroxylating) and opossum (C23-hydroxylating) CYP24A1. When the V391L and A326G mutations were combined (V391L/A326G), the mutant enzyme continued to form 1 alpha,25-(OH)(2)D-3 from 1 alpha-OH-D-3, but this initial product was diverted via the C23 hydroxylation pathway into the 26,23-lactone. The relative position of Val-391 in the beta 3a-strand of a homology model and the crystal structure of rat CYP24A1 is consistent with hydrophobic contact of Val-391 and the substrate side chain near C21. We interpret that the substrate specificity of V391L-modified human CYP24A1 toward 1 alpha-OH-D-3 is enabled by an altered contact with the substrate side chain that optimally positions C25 of the 1 alpha-OH-D-3 above the heme for hydroxylation.	[Kaufmann, Martin; Prosser, David E.; Jones, Glenville] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [Jones, Glenville] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada	Queens University - Canada; Queens University - Canada	Jones, G (corresponding author), Queens Univ, Dept Biochem, Botterell Hall Rm 650, Kingston, ON K7L 3N6, Canada.	gj1@queensu.ca			Canadian Institutes of Health Research [MA-9475, MMA-38116, MMA-69106]; Cytochroma Inc.	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Cytochroma Inc.	This study was supported by Canadian Institutes of Health Research Grants MA-9475, MMA-38116, and MMA-69106 and a research grant from Cytochroma Inc.	AKIYOSHISHIBATA M, 1994, EUR J BIOCHEM, V224, P335, DOI 10.1111/j.1432-1033.1994.00335.x; Annalora A, 2004, ARCH BIOCHEM BIOPHYS, V425, P133, DOI 10.1016/j.abb.2004.01.025; Annalora AJ, 2007, ARCH BIOCHEM BIOPHYS, V460, P262, DOI 10.1016/j.abb.2006.11.018; Annalora AJ, 2010, J MOL BIOL, V396, P441, DOI 10.1016/j.jmb.2009.11.057; Astecker N, 2004, ARCH BIOCHEM BIOPHYS, V431, P261, DOI 10.1016/j.abb.2004.08.023; Beckman MJ, 1996, BIOCHEMISTRY-US, V35, P8465, DOI 10.1021/bi960658i; Bottner B, 1996, J BIOL CHEM, V271, P8028; Cheng JB, 2003, J BIOL CHEM, V278, P38084, DOI 10.1074/jbc.M307028200; Cojocaru V, 2007, BBA-GEN SUBJECTS, V1770, P390, DOI 10.1016/j.bbagen.2006.07.005; DELUCA HF, 1974, FED PROC, V33, P2211; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; GAMBHIR V, 2011, IMMUNOBIOLO IN PRESS; GUO YD, 1993, P NATL ACAD SCI USA, V90, P8668, DOI 10.1073/pnas.90.18.8668; Gupta RP, 2005, J CLIN ENDOCR METAB, V90, P1210, DOI 10.1210/jc.2004-0966; Hamamoto H, 2006, MOL PHARMACOL, V70, P120, DOI 10.1124/mol.106.023275; Haussler MR, 1998, J BONE MINER RES, V13, P325, DOI 10.1359/jbmr.1998.13.3.325; Hewison M, 2005, VITAMIN D: VOLS 1 AND 2, 2ND EDITION, P1379; HOLICK MF, 1976, J BIOL CHEM, V251, P1020; HORIUCHI N, 1995, HORM METAB RES, V27, P83, DOI 10.1055/s-2007-979914; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; MAKIN G, 1989, BIOCHEM J, V262, P173, DOI 10.1042/bj2620173; Masuda S, 2006, BBA-MOL CELL BIOL L, V1761, P221, DOI 10.1016/j.bbalip.2006.01.004; Masuda S, 2007, ARCH BIOCHEM BIOPHYS, V460, P177, DOI 10.1016/j.abb.2006.11.030; OGORMAN S, 1991, SCIENCE, V251, P1351, DOI 10.1126/science.1900642; PEDERSEN JI, 1988, BIOCHEM J, V250, P527, DOI 10.1042/bj2500527; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Prosser DE, 2004, TRENDS BIOCHEM SCI, V29, P664, DOI 10.1016/j.tibs.2004.10.005; QAW F, 1993, J BIOL CHEM, V268, P282; REDDY GS, 1989, BIOCHEMISTRY-US, V28, P1763, DOI 10.1021/bi00430a051; Sakaki T, 2000, EUR J BIOCHEM, V267, P6158, DOI 10.1046/j.1432-1327.2000.01680.x; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; Strushkevich N, 2008, J MOL BIOL, V380, P95, DOI 10.1016/j.jmb.2008.03.065; Swart AC, 2010, J STEROID BIOCHEM, V119, P112, DOI 10.1016/j.jsbmb.2009.12.014; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Yamada S, 1998, J MED CHEM, V41, P1467, DOI 10.1021/jm970761l	35	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28729	28737		10.1074/jbc.M111.236679	http://dx.doi.org/10.1074/jbc.M111.236679			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697097	Green Published, hybrid			2022-12-25	WOS:000293837000011
J	Murga-Zamalloa, CA; Ghosh, AK; Patil, SB; Reed, NA; Chan, LS; Davuluri, S; Peranen, J; Hurd, TW; Rachel, RA; Khanna, H				Murga-Zamalloa, Carlos A.; Ghosh, Amiya K.; Patil, Suresh B.; Reed, Nathan A.; Chan, Lan Sze; Davuluri, Supriya; Peranen, Johan; Hurd, Toby W.; Rachel, Rivka A.; Khanna, Hemant			Accumulation of the Raf-1 Kinase Inhibitory Protein (Rkip) Is Associated with Cep290-mediated Photoreceptor Degeneration in Ciliopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMINANT RETINITIS-PIGMENTOSA; BARDET-BIEDL-SYNDROME; RETINAL DEGENERATION; VERTEBRATE PHOTORECEPTOR; INTRAFLAGELLAR TRANSPORT; OUTER SEGMENTS; PRIMARY CILIA; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; SENSORY CILIUM	Primary cilia regulate polarized protein trafficking in photo-receptors, which are dynamic and highly compartmentalized sensory neurons of retina. The ciliary protein Cep290 modulates cilia formation and is frequently mutated in syndromic and non-syndromic photoreceptor degeneration. However, the underlying mechanism of associated retinopathy is unclear. Using the Cep290 mutant mouse rd16 (retinal degeneration 16), we show that Cep290-mediated photoreceptor degeneration is associated with aberrant accumulation of its novel interacting partner Rkip (Raf-1 kinase inhibitory protein). This effect is phenocopied by morpholino-mediated depletion of cep290 in zebrafish. We further demonstrate that ectopic accumulation of Rkip leads to defective cilia formation in zebrafish and cultured cells, an effect mediated by its interaction with the ciliary GTPase Rab8A. Our data suggest that Rkip prevents cilia formation and is associated with Cep290-mediated photoreceptor degeneration. Furthermore, our results indicate that preventing accumulation of Rkip could potentially ameliorate such degeneration.	[Murga-Zamalloa, Carlos A.; Ghosh, Amiya K.; Patil, Suresh B.; Reed, Nathan A.; Chan, Lan Sze; Davuluri, Supriya; Khanna, Hemant] Univ Michigan, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48105 USA; [Hurd, Toby W.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48105 USA; [Patil, Suresh B.; Davuluri, Supriya; Khanna, Hemant] Univ Massachusetts, Sch Med, Dept Ophthalmol, Worcester, MA 01605 USA; [Peranen, Johan] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Rachel, Rivka A.] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Massachusetts System; University of Massachusetts Worcester; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Khanna, H (corresponding author), 381 Plantat St,Biotech 5,Suite 250, Worcester, MA 01605 USA.	hemant.khanna@umassmed.edu	Murga-Zamalloa, Carlos/AAX-9387-2021	Murga-Zamalloa, Carlos/0000-0002-2238-5066	National Institutes of Health [EY007961, 5P60 DK20572]; Michigan Diabetes Research and Training Center; Foundation for Fighting Blindness; Midwest Eye Banks and Transplantation Center; Vision Core Facilities [EY07003]; NATIONAL EYE INSTITUTE [P30EY007003, R29EY007961, F31EY007003, R01EY007961] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan Diabetes Research and Training Center; Foundation for Fighting Blindness; Midwest Eye Banks and Transplantation Center; Vision Core Facilities; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY007961 and 5P60 DK20572 to the Michigan Diabetes Research and Training Center, the Foundation for Fighting Blindness, and Midwest Eye Banks and Transplantation Center, and Vision Core Facilities Grant EY07003.	Adams NA, 2007, OPHTHALMIC GENET, V28, P113, DOI 10.1080/13816810701537424; ARSHAVSKY VY, 2003, SCI STKE, pPE43; Besharse J.C., 1986, RETINA MODEL CELL BI; BESHARSE JC, 1977, J CELL BIOL, V75, P507, DOI 10.1083/jcb.75.2.507; Besharse JC, 2003, ADV EXP MED BIOL, V533, P157; BESHARSE JC, 1977, SCIENCE, V196, P536, DOI 10.1126/science.300504; BESHARSE JC, 1976, J EXP ZOOL, V198, P287, DOI 10.1002/jez.1401980302; Calvert PD, 2010, J GEN PHYSIOL, V135, P173, DOI 10.1085/jgp.200910322; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DERETIC D, 1995, J CELL SCI, V108, P215; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Ghosh AK, 2010, HUM MOL GENET, V19, P90, DOI 10.1093/hmg/ddp469; Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Khanna H, 2005, J BIOL CHEM, V280, P33580, DOI 10.1074/jbc.M505827200; Khanna H, 2009, NAT GENET, V41, P739, DOI 10.1038/ng.366; Kim J, 2008, HUM MOL GENET, V17, P3796, DOI 10.1093/hmg/ddn277; Klysik J, 2008, CELL SIGNAL, V20, P1, DOI 10.1016/j.cellsig.2007.07.003; LAVAIL MM, 1973, J CELL BIOL, V58, P650, DOI 10.1083/jcb.58.3.650; Leitch CC, 2008, NAT GENET, V40, P443, DOI 10.1038/ng.97; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Maerker T, 2008, HUM MOL GENET, V17, P71, DOI 10.1093/hmg/ddm285; Marszalek JR, 2000, CELL, V102, P175, DOI 10.1016/S0092-8674(00)00023-4; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; Murga-Zamalloa CA, 2010, HUM MOL GENET, V19, P3591, DOI 10.1093/hmg/ddq275; Murga-Zamalloa CA, 2009, J GENET, V88, P399, DOI 10.1007/s12041-009-0061-7; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Noorwez SM, 2009, J BIOL CHEM, V284, P33333, DOI 10.1074/jbc.M109.043364; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Peranen J, 1996, J CELL BIOL, V135, P153, DOI 10.1083/jcb.135.1.153; PETERS KR, 1983, J CELL BIOL, V96, P265, DOI 10.1083/jcb.96.1.265; Rosenbaum JL, 1999, J CELL BIOL, V144, P385, DOI 10.1083/jcb.144.3.385; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Simister PC, 2002, ACTA CRYSTALLOGR D, V58, P1077, DOI 10.1107/S090744490200522X; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; SOROKIN S, 1962, J CELL BIOL, V15, P363, DOI 10.1083/jcb.15.2.363; Strissel KJ, 2005, J BIOL CHEM, V280, P29250, DOI 10.1074/jbc.M501789200; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Theroux S, 2007, BRAIN RES BULL, V71, P559, DOI 10.1016/j.brainresbull.2006.11.010; Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; Williams DS, 2002, VISION RES, V42, P455, DOI 10.1016/S0042-6989(01)00228-0; Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011; Yang J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000955; Yoder BK, 2006, DEV CELL, V10, P541, DOI 10.1016/j.devcel.2006.04.010; YOUNG RW, 1968, J ULTRA MOL STRUCT R, V23, P462, DOI 10.1016/S0022-5320(68)80111-X; Zeng LC, 2008, EXPERT OPIN THER TAR, V12, P1275, DOI [10.1517/14728222.12.10.1275, 10.1517/14728222.12.10.1275 ]	60	36	36	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28276	28286		10.1074/jbc.M111.237560	http://dx.doi.org/10.1074/jbc.M111.237560			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685394	Green Published, hybrid			2022-12-25	WOS:000293557800045
J	Wang, CC; Borchert, A; Ugun-Klusek, A; Tang, LY; Lui, WT; Chu, CY; Billett, E; Kuhn, H; Ufer, C				Wang, Chi Chiu; Borchert, Astrid; Ugun-Klusek, Aslihan; Tang, Ling Yin; Lui, Wai Ting; Chu, Ching Yan; Billett, Ellen; Kuhn, Hartmut; Ufer, Christoph			Monoamine Oxidase A Expression Is Vital for Embryonic Brain Development by Modulating Developmental Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-DEFICIENT MICE; KNOCK-OUT MICE; CELL-DEATH; C-MYC; MAO-A; PATHWAY; MOUSE; DIFFERENTIATION; INHIBITORS; DISORDERS	Monoamine oxidases (MAO-A, MAO-B) metabolize biogenic amines and have been implicated in neuronal apoptosis. Although apoptosis is an important process in embryo development, the role of MAO isoenzymes has not been investigated in detail. We found that expression of MAO-A and MAO-B can be detected early on during embryo development. Expression levels remained constant until around midgestation but then dropped to almost undetectable levels toward birth. Similar expression kinetics were observed in the brain. Isoform-specific expression silencing of MAO-A mediated by siRNA during in vitro embryogenesis induced developmental defects, as indicated by a reduction of the crown rump length and impaired cerebral development. These alterations were paralleled by elevated serotonin levels. Similar abnormalities were observed when embryos were cultured in the presence of the MAO-A inhibitor clorgyline or when the transcriptional inhibitor of MAO-A expression R1 was overexpressed. In contrast, no such alterations were detected when expression of MAO-B was knocked down. To explore the underlying mechanisms for the developmental abnormalities in MAO-A knockdown embryos, we quantified the degree of developmental apoptosis in the developing brain. MAO-A knockdown reduced the number of apoptotic cells in the neuroepithelium, which coincided with impaired activation of caspases 3 and 9. Moreover, we observed reduced cyclin D1 levels as an indicator of impaired cell proliferation in MAO-A knockdown embryos. This data highlights	[Borchert, Astrid; Kuhn, Hartmut; Ufer, Christoph] Univ Med Berlin Charite, Inst Biochem, D-13347 Berlin, Germany; [Wang, Chi Chiu; Tang, Ling Yin; Lui, Wai Ting; Chu, Ching Yan] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Wang, Chi Chiu] Chinese Univ Hong Kong, Inst Biomed Sci, Shatin, Hong Kong, Peoples R China; [Ugun-Klusek, Aslihan; Billett, Ellen; Ufer, Christoph] Nottingham Trent Univ, Sch Sci & Technol, Nottingham NG11 8NS, England	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Nottingham Trent University	Kuhn, H (corresponding author), Univ Med Berlin Charite, Inst Biochem, Oudenarder Str 16, D-13347 Berlin, Germany.	hartmut.kuehn@charite.de	Wang, Ronald/C-6541-2014	Wang, Ronald/0000-0002-3928-7278; Billett, Ellen/0000-0001-8245-6519; Ugun Klusek, Aslihan/0000-0002-0199-0275; Borchert, Astrid/0000-0003-3551-5592	European Commission [LSHM-CT-2004-0050333]; Li Ka Shing Institute of Health Sciences [6901988]; Leverhulme Trust;  [2008.1.052]	European Commission(European CommissionEuropean Commission Joint Research Centre); Li Ka Shing Institute of Health Sciences; Leverhulme Trust(Leverhulme Trust); 	This work was supported in part by European Commission Grants FP6 and LSHM-CT-2004-0050333 (to H. K.), by Direct Grant 2008.1.052 and Special Equipment Grant for High-performance Microscopic Platform for Live Genetics in 2008 and for Micromanipulation System for Transgenics in 2004 and Li Ka Shing Institute of Health Sciences 6901988 (to C. C. W.), and by a Leverhulme Trust grant (to E. E. B. and C. U.).	Alwan S, 2009, CNS DRUGS, V23, P493, DOI 10.2165/00023210-200923060-00004; BACH AWJ, 1988, P NATL ACAD SCI USA, V85, P4934, DOI 10.1073/pnas.85.13.4934; Beglopoulos V, 2004, NEUROMOL MED, V6, P13, DOI 10.1385/NMM:6:1:013; Billett EE, 2004, NEUROTOXICOLOGY, V25, P139, DOI 10.1016/S0161-813X(03)00094-9; Bortner CD, 2002, ANNU REV PHARMACOL, V42, P259, DOI 10.1146/annurev.pharmtox.42.083101.143836; Borue X, 2007, INT J DEV NEUROSCI, V25, P341, DOI 10.1016/j.ijdevneu.2007.06.003; Burnet H, 2001, J NEUROSCI, V21, P5212, DOI 10.1523/JNEUROSCI.21-14-05212.2001; CASES O, 1995, SCIENCE, V268, P833; Cecconi F, 2008, CELL DEATH DIFFER, V15, P1170, DOI 10.1038/cdd.2008.64; Chen K, 2004, J BIOL CHEM, V279, P39645, DOI 10.1074/jbc.M405550200; Chen K, 2005, J BIOL CHEM, V280, P11552, DOI 10.1074/jbc.M410033200; Chen K, 2004, NEUROTOXICOLOGY, V25, P31, DOI 10.1016/S0161-813X(03)00113-X; Chen K, 2007, J BIOL CHEM, V282, P115, DOI 10.1074/jbc.M609830200; Cheng AW, 2010, J NEUROSCI, V30, P10752, DOI 10.1523/JNEUROSCI.2037-10.2010; Chiou SH, 2006, BRIT J PHARMACOL, V148, P587, DOI 10.1038/sj.bjp.0706766; Cohen G, 1997, P NATL ACAD SCI USA, V94, P4890, DOI 10.1073/pnas.94.10.4890; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Copp AJ, 2005, J ANAT, V207, P623, DOI 10.1111/j.1469-7580.2005.00476.x; Fitzgerald JC, 2007, J NEUROCHEM, V103, P2189, DOI 10.1111/j.1471-4159.2007.04921.x; Geha RM, 2001, J BIOL CHEM, V276, P9877, DOI 10.1074/jbc.M006972200; Grimsby J, 1997, NAT GENET, V17, P206, DOI 10.1038/ng1097-206; Guo Y, 2005, ONCOGENE, V24, P2599, DOI 10.1038/sj.onc.1208326; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Jahng JW, 1997, SYNAPSE, V25, P30; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Luo XY, 2003, DEV NEUROSCI-BASEL, V25, P173, DOI 10.1159/000072266; Mateyak MK, 1999, MOL CELL BIOL, V19, P4672; McClellan KA, 2007, CELL CYCLE, V6, P2917, DOI 10.4161/cc.6.23.4997; Naoi M, 2009, J NEURAL TRANSM, V116, P1371, DOI 10.1007/s00702-009-0309-7; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Popova NK, 2006, PSYCHONEUROENDOCRINO, V31, P179, DOI 10.1016/j.psyneuen.2005.06.005; Santoni-Rugiu E, 1998, CANCER RES, V58, P123; Scott AL, 2008, NEUROREPORT, V19, P739, DOI 10.1097/WNR.0b013e3282fd6e88; Scrutton NS, 2004, NAT PROD REP, V21, P722, DOI 10.1039/b306788m; Senechal Y, 2006, NEURODEGENER DIS, V3, P134, DOI 10.1159/000094772; Shih JC, 2007, NEUROCHEM RES, V32, P1757, DOI 10.1007/s11064-007-9384-z; Stankovski L, 2007, J NEUROSCI, V27, P1315, DOI 10.1523/JNEUROSCI.4395-06.2007; Suarez-Merino B, 2001, Hum Mutat, V17, P523, DOI 10.1002/humu.1140; Syagailo YV, 2001, AM J MED GENET, V105, P168, DOI 10.1002/ajmg.1193; Ufer C, 2010, ANTIOXID REDOX SIGNA; Ufer C, 2008, GENE DEV, V22, P1838, DOI 10.1101/gad.466308; Upton AL, 1999, J NEUROSCI, V19, P7007, DOI 10.1523/JNEUROSCI.19-16-07007.1999; VANMAELEFABRY G, 1990, TOXICOL IN VITRO, V4, P149, DOI 10.1016/0887-2333(90)90037-T; Vitalis T, 2002, J COMP NEUROL, V442, P331, DOI 10.1002/cne.10093; WANG CC, 2005, NEUROEMBRYOL AGING, V3, P78; Youdim MBH, 2006, NAT REV NEUROSCI, V7, P295, DOI 10.1038/nrn1883	46	27	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28322	28330		10.1074/jbc.M111.241422	http://dx.doi.org/10.1074/jbc.M111.241422			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21697081	hybrid, Green Published			2022-12-25	WOS:000293557800049
J	Lu, CY; Tilan, JU; Everhart, L; Czarnecka, M; Soldin, SJ; Mendu, DR; Jeha, D; Hanafy, J; Lee, CK; Sun, JF; Izycka-Swieszewska, E; Toretsky, JA; Kitlinska, J				Lu, Congyi; Tilan, Jason U.; Everhart, Lindsay; Czarnecka, Magdalena; Soldin, Steven J.; Mendu, Damodara R.; Jeha, Dima; Hanafy, Jailan; Lee, Christina K.; Sun, Junfeng; Izycka-Swieszewska, Ewa; Toretsky, Jeffrey A.; Kitlinska, Joanna			Dipeptidyl Peptidases as Survival Factors in Ewing Sarcoma Family of Tumors IMPLICATIONS FOR TUMOR BIOLOGY AND THERAPY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBROBLAST ACTIVATION PROTEIN; APOPTOSIS-INDUCING FACTOR; NEUROPEPTIDE-Y; SUBSTRATE-SPECIFICITY; POTENTIAL TARGETS; CELL-LINES; IV; EXPRESSION; CANCER; RECEPTOR	Ewing sarcoma family of tumors (ESFT) is a group of aggressive pediatric malignancies driven by the EWS-FLI1 fusion protein, an aberrant transcription factor up-regulating specific target genes, such as neuropeptide Y (NPY) and its Y1 and Y5 receptors (Y5Rs). Previously, we have shown that both exogenous NPY and endogenous NPY stimulate ESFT cell death via its Y1 and Y5Rs. Here, we demonstrate that this effect is prevented by dipeptidyl peptidases (DPPs), which cleave NPY to its shorter form, NPY3-36, not active at Y1Rs. We have shown that NPY-induced cell death can be abolished by overexpression of DPPs and enhanced by their down-regulation. Both NPY treatment and DPP blockade activated the same cell death pathway mediated by poly(ADP-ribose) polymerase (PARP-1) and apoptosis-inducing factor (AIF). Moreover, the decrease in cell survival induced by DPP inhibition was blocked by Y1 and Y5R antagonists, confirming its dependence on endogenous NPY. Interestingly, similar levels of NPY-driven cell death were achieved by blocking membrane DPPIV and cytosolic DPP8 and DPP9. Thus, this is the first evidence of these intracellular DPPs cleaving releasable peptides, such as NPY, in live cells. In contrast, another membrane DPP, fibroblast activation protein (FAP), did not affect NPY actions. In conclusion, DPPs act as survival factors for ESFT cells and protect them from cell death induced by endogenous NPY. This is the first demonstration that intracellular DPPs are involved in regulation of ESFT growth and may become potential therapeutic targets for these tumors.	[Jeha, Dima; Hanafy, Jailan; Lee, Christina K.; Kitlinska, Joanna] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC 20057 USA; [Soldin, Steven J.] Georgetown Univ, Dept Pharmacol, Washington, DC 20057 USA; [Mendu, Damodara R.] Georgetown Univ, Georgetown Howard Univ Ctr Clin & Translat Sci, Washington, DC 20057 USA; [Toretsky, Jeffrey A.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Sun, Junfeng] NIH, Dept Crit Care Med, Bethesda, MD 20892 USA; [Izycka-Swieszewska, Ewa] Med Univ Gdansk, Dept Pathomorphol, PL-80211 Gdansk, Poland	Georgetown University; Georgetown University; Georgetown University; Georgetown University; National Institutes of Health (NIH) - USA; Fahrenheit Universities; Medical University Gdansk	Kitlinska, J (corresponding author), 3900 Reservoir Rd NW,Basic Sci Bldg,Rm 231A, Washington, DC 20057 USA.	jbk4@georgetown.edu	Lu, Congyi/G-3984-2013; Izycka-Swieszewska, Ewa/AAX-5191-2020	izycka-swieszewska, ewa/0000-0001-7550-1326	National Institutes of Health [1RO1CA123211-01]; Children's Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA138212, R01CA123211, R01CA133662] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1CA123211-01 (to J. K.) and funding from the Children's Cancer Foundation (to J. K.).	Adams S, 2004, CANCER RES, V64, P5471, DOI 10.1158/0008-5472.CAN-04-0447; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Ajami K, 2008, FEBS LETT, V582, P819, DOI 10.1016/j.febslet.2008.02.005; Bjelke JR, 2006, BIOCHEM J, V396, P391, DOI 10.1042/BJ20060079; Boonacker E, 2003, EUR J CELL BIOL, V82, P53, DOI 10.1078/0171-9335-00302; Boujrad H, 2007, CELL CYCLE, V6, P2612, DOI 10.4161/cc.6.21.4842; Busek P, 2004, INT J BIOCHEM CELL B, V36, P408, DOI 10.1016/S1357-2725(03)00262-0; Cunningham CC, 2007, EXPERT OPIN INV DRUG, V16, P1459, DOI 10.1517/13543784.16.9.1459; Dolznig Helmut, 2005, Cancer Immun, V5, P10; Edosada CY, 2006, J BIOL CHEM, V281, P7437, DOI 10.1074/jbc.M511112200; Frerker N, 2007, PEPTIDES, V28, P257, DOI 10.1016/j.peptides.2006.09.027; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Hansel DE, 2001, NATURE, V410, P940, DOI 10.1038/35073601; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; HONG WJ, 1988, J BIOL CHEM, V263, P16892; Jacques D, 2003, CAN J PHYSIOL PHARM, V81, P288, DOI 10.1139/Y02-165; Kaipio K, 2005, BIOCHEM BIOPH RES CO, V337, P633, DOI 10.1016/j.bbrc.2005.09.093; Kelly T, 2005, DRUG RESIST UPDATE, V8, P51, DOI 10.1016/j.drup.2005.03.002; Kitlinska J, 2005, CANCER RES, V65, P1719, DOI 10.1158/0008-5472.CAN-04-2192; Kitlinska J, 2006, ADV EXP MED BIOL, V575, P223; Korner M, 2008, CLIN CANCER RES, V14, P5043, DOI 10.1158/1078-0432.CCR-07-4551; Lambeir AM, 2008, BIOCHEM PHARMACOL, V76, P1637, DOI 10.1016/j.bcp.2008.07.029; Lee EW, 2003, J CLIN INVEST, V111, P1853, DOI 10.1172/JCI200316929; Lu C, 2010, ONCOGENE, V29, P5630, DOI 10.1038/onc.2010.301; Ludwig JA, 2008, CURR OPIN ONCOL, V20, P412, DOI 10.1097/CCO.0b013e328303ba1d; Maes MB, 2007, J LEUKOCYTE BIOL, V81, P1252, DOI 10.1189/jlb.0906546; MENTLEIN R, 1993, REGUL PEPTIDES, V49, P133, DOI 10.1016/0167-0115(93)90435-B; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; Narra K, 2007, CANCER BIOL THER, V6, P1691, DOI 10.4161/cbt.6.11.4874; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Pitman MR, 2009, FRONT BIOSCI-LANDMRK, V14, P3619, DOI 10.2741/3476; Pons J, 2003, CAN J PHYSIOL PHARM, V81, P177, DOI 10.1139/Y02-166; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Sheriff' S, 1998, REGUL PEPTIDES, V75-6, P309, DOI 10.1016/S0167-0115(98)00083-4; Sheriff S, 2002, PEPTIDES, V23, P87, DOI 10.1016/S0196-9781(01)00583-6; Silva AP, 2005, BIOL CELL, V97, P457, DOI 10.1042/BC20040102; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Son MY, 2011, J CELL MOL MED, V15, P152, DOI 10.1111/j.1582-4934.2009.00956.x; Uren A, 2003, ONCOGENE, V22, P2334, DOI 10.1038/sj.onc.1206330; Van der Veken P, 2007, J MED CHEM, V50, P5568, DOI 10.1021/jm701005a; VANVALEN F, 1992, J CANCER RES CLIN, V118, P529, DOI 10.1007/BF01225268; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wassberg E, 1999, UPSALA J MED SCI, V104, P1; Wilson MJ, 2000, J ANDROL, V21, P220; Yu DMT, 2010, FEBS J, V277, P1126, DOI 10.1111/j.1742-4658.2009.07526.x; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zukowska-Grojec Z, 1998, CIRC RES, V83, P187, DOI 10.1161/01.RES.83.2.187	49	45	47	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27494	27505		10.1074/jbc.M111.224089	http://dx.doi.org/10.1074/jbc.M111.224089			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21680731	hybrid, Green Published			2022-12-25	WOS:000293268700044
J	Antri, M; Mellen, N; Cazalets, JR				Antri, Myriam; Mellen, Nicholas; Cazalets, Jean-Rene			Functional Organization of Locomotor Interneurons in the Ventral Lumbar Spinal Cord of the Newborn Rat	PLOS ONE			English	Article							LEFT-RIGHT COORDINATION; RHYTHM GENERATION; V2A INTERNEURONS; NEURONS; NETWORKS; PATTERN; WALKING; IDENTIFICATION; LOCALIZATION; OSCILLATIONS	Although the mammalian locomotor CPG has been localized to the lumbar spinal cord, the functional-anatomical organization of flexor and extensor interneurons has not been characterized. Here, we tested the hypothesis that flexor and extensor interneuronal networks for walking are physically segregated in the lumbar spinal cord. For this purpose, we performed optical recordings and lesion experiments from a horizontally sectioned lumbar spinal cord isolated from neonate rats. This ventral hemi spinal cord preparation produces well-organized fictive locomotion when superfused with 5-HT/NMDA. The dorsal surface of the preparation was visualized using the Ca(2+) indicator fluo-4 AM, while simultaneously monitoring motor output at ventral roots L2 and L5. Using calcium imaging, we provided a general mapping view of the interneurons that maintained a stable phase relationship with motor output. We showed that the dorsal surface of L1 segment contains a higher density of locomotor rhythmic cells than the other segments. Moreover, L1 segment lesioning induced the most important changes in the locomotor activity in comparison with lesions at the T13 or L2 segments. However, no lesions led to selective disruption of either flexor or extensor output. In addition, this study found no evidence of functional parcellation of locomotor interneurons into flexor and extensor pools at the dorsal-ventral midline of the lumbar spinal cord of the rat.	[Antri, Myriam; Cazalets, Jean-Rene] Univ Bordeaux, CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, Bordeaux, France; [Mellen, Nicholas] Univ Louisville, Kosair Childrens Hosp Res Inst, Louisville, KY 40292 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; University of Louisville	Antri, M (corresponding author), Univ Bordeaux, CNRS, Inst Neurosci Cognit & Integrat Aquitaine, UMR 5287, Bordeaux, France.	myriam.antri@gmail.com	Cazalets, Jean-René/D-7851-2014; ANTRI, Myriam/AAC-7314-2022	Cazalets, Jean-René/0000-0001-9047-3933; ANTRI, Myriam/0000-0002-5303-0997	Association Francaise contre les Myopathies; Institut pour la Recherche sur les Paraplegies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Institut pour la Recherche sur les Paraplegies	This work was supported by the Association Francaise contre les Myopathies (www.afm-telethon.fr) and the Institut pour la Recherche sur les Paraplegies (www.irp.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Bonnot AS, 2005, J NEUROPHYSIOL, V93, P1793, DOI 10.1152/jn.00923.2004; Bonnot AS, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-03-j0001.2002; Brown TG, 1911, P R SOC LOND B-CONTA, V84, P308, DOI 10.1098/rspb.1911.0077; Butt SJB, 2002, BRAIN RES REV, V40, P107, DOI 10.1016/S0165-0173(02)00194-7; Butt SJB, 2002, J NEUROSCI, V22, P9961; Calabrese RL, 1998, CURR OPIN NEUROBIOL, V8, P710, DOI 10.1016/S0959-4388(98)80112-8; Cheng JG, 1998, J NEUROSCI, V18, P4295; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Dougherty KJ, 2010, J NEUROSCI, V30, P24, DOI 10.1523/JNEUROSCI.4821-09.2010; Dyck J, 2009, J NEUROPHYSIOL, V102, P590, DOI 10.1152/jn.00212.2009; Gahtan E, 2002, J NEUROPHYSIOL, V87, P608, DOI 10.1152/jn.00596.2001; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; Grossmann KS, 2010, PROG BRAIN RES, V187, P19, DOI [10.1016/S0079-6123(10)87002-5, 10.1016/B978-0-444-53613-6.00002-2]; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P565, DOI 10.1152/jn.1994.72.2.565; Kiehn O, 1996, NEUROSCIENCE, V75, P263, DOI 10.1016/0306-4522(96)00250-3; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Krause KL, 2009, J APPL PHYSIOL, V106, P605, DOI 10.1152/japplphysiol.90966.2008; Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641; Kwan AC, 2009, J NEUROSCI, V29, P11601, DOI 10.1523/JNEUROSCI.1612-09.2009; Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1; Lashley Karl S., 1950, SOC EXP BIOL S 4 PSY, V4, P454; MACLEAN JN, 1995, NEUROSCI LETT, V197, P9, DOI 10.1016/0304-3940(95)11882-W; Manzini I, 2008, J NEUROSCI METH, V167, P140, DOI 10.1016/j.jneumeth.2007.07.018; McCrea DA, 2008, BRAIN RES REV, V57, P134, DOI 10.1016/j.brainresrev.2007.08.006; Mellen NM, 2010, RESP PHYSIOL NEUROBI, V172, P1, DOI 10.1016/j.resp.2010.04.013; Mellen NM, 2009, NEUROIMAGE, V47, P1331, DOI 10.1016/j.neuroimage.2009.04.016; Mellen NM, 2003, NEURON, V37, P821, DOI 10.1016/S0896-6273(03)00092-8; Nakayama K, 2002, J NEUROSCI, V22, P10388; Parri HR, 2001, NAT NEUROSCI, V4, P803, DOI 10.1038/90507; Raastad M, 1996, NEURON, V17, P729, DOI 10.1016/S0896-6273(00)80204-4; SPECK DF, 1982, J NEUROSCI, V2, P744; Stepien AE, 2008, NEURON, V60, P1, DOI 10.1016/j.neuron.2008.09.030; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhong GS, 2010, J NEUROSCI, V30, P170, DOI 10.1523/JNEUROSCI.4849-09.2010	37	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20529	10.1371/journal.pone.0020529	http://dx.doi.org/10.1371/journal.pone.0020529			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698092	Green Submitted, Green Published, gold			2022-12-25	WOS:000291737600009
J	Sfanos, KS; Aloia, AL; Hicks, JL; Esopi, DM; Steranka, JP; Shao, W; Sanchez-Martinez, S; Yegnasubramanian, S; Burns, KH; Rein, A; De Marzo, AM				Sfanos, Karen Sandell; Aloia, Amanda L.; Hicks, Jessica L.; Esopi, David M.; Steranka, Jared P.; Shao, Wei; Sanchez-Martinez, Silvia; Yegnasubramanian, Srinivasan; Burns, Kathleen H.; Rein, Alan; De Marzo, Angelo M.			Identification of Replication Competent Murine Gammaretroviruses in Commonly Used Prostate Cancer Cell Lines	PLOS ONE			English	Article							HUMAN RETROVIRUS XMRV; VIRUS	A newly discovered gammaretrovirus, termed XMRV, was recently reported to be present in the prostate cancer cell line CWR22Rv1. Using a combination of both immunohistochemistry with broadly-reactive murine leukemia virus (MLV) antisera and PCR, we determined if additional prostate cancer or other cell lines contain XMRV or MLV-related viruses. Our study included a total of 72 cell lines, which included 58 of the 60 human cancer cell lines used in anticancer drug screens and maintained at the NCI-Frederick (NCI-60). We have identified gammaretroviruses in two additional prostate cancer cell lines: LAPC4 and VCaP, and show that these viruses are replication competent. Viral genome sequencing identified the virus in LAPC4 and VCaP as nearly identical to another known xenotropic MLV, Bxv-1. We also identified a gammaretrovirus in the non-small-cell lung carcinoma cell line EKVX. Prostate cancer cell lines appear to have a propensity for infection with murine gammaretroviruses, and we propose that this may be in part due to cell line establishment by xenograft passage in immunocompromised mice. It is unclear if infection with these viruses is necessary for cell line establishment, or what confounding role they may play in experiments performed with these commonly used lines. Importantly, our results suggest a need for regular screening of cancer cell lines for retroviral "contamination", much like routine mycoplasma testing.	[Sfanos, Karen Sandell; Hicks, Jessica L.; Burns, Kathleen H.; De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Aloia, Amanda L.; Sanchez-Martinez, Silvia; Rein, Alan] NCI, HIV Drug Resistance Program, Frederick, MD 21701 USA; [Esopi, David M.; Yegnasubramanian, Srinivasan; De Marzo, Angelo M.] Sidney Kimmel Comprehens Canc Ctr, Dept Oncol, Baltimore, MD USA; [Steranka, Jared P.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21205 USA; [Shao, Wei] Sci Applicat Int Corp, Adv Biomed Comp Ctr, Frederick, MD USA; [De Marzo, Angelo M.] Johns Hopkins Univ, Sch Med, Dept Urol, Brady Urol Res Inst, Baltimore, MD 21205 USA	Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Science Applications International Corporation (SAIC); Johns Hopkins University	Sfanos, KS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.	ksfanos@jhmi.edu		Burns, Kathleen/0000-0003-1620-3761	Prevent Cancer Foundation; NIH, National Cancer Institute, Center for Cancer Research; NCI-SPORE [P50CA58236]; NATIONAL CANCER INSTITUTE [P50CA058236, ZIABC011325] Funding Source: NIH RePORTER	Prevent Cancer Foundation; NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI-SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	K.S.S. was supported by a postdoctoral fellowship award from the Prevent Cancer Foundation. This research was supported in part by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. IHC studies were supported by NCI-SPORE in prostate cancer P50CA58236. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloia AL, 2010, CANCER RES, V70, P10028, DOI 10.1158/0008-5472.CAN-10-2837; BOVEN E, 1992, CANCER RES, V52, P5940; CAVALLO R, 1994, MICROBIOLOGICA, V17, P195; Cohen J, 2011, SCIENCE, V331, P1253, DOI 10.1126/science.331.6022.1253; FRANKEL WN, 1990, GENETICS, V124, P221; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Hue S, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-111; Jern P, 2007, PLOS GENET, V3, P2014, DOI 10.1371/journal.pgen.0030183; Klein KA, 1997, NAT MED, V3, P402, DOI 10.1038/nm0497-402; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Korenchuk S, 2001, IN VIVO, V15, P163; Kozak CA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-101; LUSSO P, 1990, SCIENCE, V247, P848, DOI 10.1126/science.2305256; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Raisch KP, 2003, VIROLOGY, V308, P83, DOI 10.1016/S0042-6822(02)00074-0; Robinson MJ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-108; Silverman RH, 2010, NAT REV UROL, V7, P392, DOI 10.1038/nrurol.2010.77; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TODARO GJ, 1973, P NATL ACAD SCI USA, V70, P859, DOI 10.1073/pnas.70.3.859; TRAVERSARI C, 1989, J IMMUNOL, V142, P2887; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; Voisset C, 2008, MICROBIOL MOL BIOL R, V72, P157, DOI 10.1128/MMBR.00033-07; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413	25	41	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20874	10.1371/journal.pone.0020874	http://dx.doi.org/10.1371/journal.pone.0020874			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698104	Green Submitted, Green Published, gold			2022-12-25	WOS:000291737600025
J	Srivastava, A; Cai, LM; Mrazek, J; Malmberg, RL				Srivastava, Anuj; Cai, Liming; Mrazek, Jan; Malmberg, Russell L.			Mutational Patterns in RNA Secondary Structure Evolution Examined in Three RNA Families	PLOS ONE			English	Article							RIBOSOMAL-RNA; TELOMERASE RNA; PHYLOGENETIC ANALYSIS; COMPARATIVE SEQUENCE; DATABASE; TMRNA; INFERENCE; MODEL; RECONSTRUCTION; INFORMATION	The goal of this work was to study mutational patterns in the evolution of RNA secondary structure. We analyzed bacterial tmRNA, RNaseP and eukaryotic telomerase RNA secondary structures, mapping structural variability onto phylogenetic trees constructed primarily from rRNA sequences. We found that secondary structures evolve both by whole stem insertion/deletion, and by mutations that create or disrupt stem base pairing. We analyzed the evolution of stem lengths and constructed substitution matrices describing the changes responsible for the variation in the RNA stem length. In addition, we used principal component analysis of the stem length data to determine the most variable stems in different families of RNA. This data provides new insights into the evolution of RNA secondary structures and patterns of variation in the lengths of double helical regions of RNA molecules. Our findings will facilitate design of improved mutational models for RNA structure evolution.	[Srivastava, Anuj; Cai, Liming; Mrazek, Jan; Malmberg, Russell L.] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Cai, Liming] Univ Georgia, Dept Comp Sci, Athens, GA 30602 USA; [Mrazek, Jan] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Malmberg, Russell L.] Univ Georgia, Dept Plant Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Srivastava, A (corresponding author), Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA.	anuj@uga.edu	Srivastava, Anuj/L-4705-2019	Malmberg, Russell/0000-0002-7448-5034	National Science Foundation [IIS 0916250]; National Institutes of Health [R01GM072080-01A1]; University of Georgia Franklin College of Arts and Science's; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072080] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Franklin College of Arts and Science's; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in part by the National Science Foundation (IIS 0916250), National Institutes of Health (R01GM072080-01A1) and from the University of Georgia Franklin College of Arts and Science's research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley RK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000483; Brown JW, 1999, NUCLEIC ACIDS RES, V27, P314, DOI 10.1093/nar/27.1.314; BROWN JW, 1990, 2 INT M STRUCT MECH; Cannone JJ, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-2; Chen JL, 2000, CELL, V100, P503, DOI 10.1016/S0092-8674(00)80687-X; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins LJ, 2000, J MOL EVOL, V51, P194, DOI 10.1007/s002390010081; Dandjinou AT, 2004, CURR BIOL, V14, P1148, DOI 10.1016/j.cub.2004.05.054; de Novoa PG, 2004, NUCLEIC ACIDS RES, V32, pD104, DOI 10.1093/nar/gkh102; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FOX GE, 1975, J MOL EVOL, V6, P61, DOI 10.1007/BF01732674; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; GUTELL RR, 1994, MICROBIOL REV, V58, P10, DOI 10.1128/MMBR.58.1.10-26.1994; GUTELL RR, 1996, STRUCTURE EVOLUTION, P15; Haas ES, 1996, NUCLEIC ACIDS RES, V24, P4775, DOI 10.1093/nar/24.23.4775; Haas ES, 1998, NUCLEIC ACIDS RES, V26, P4093, DOI 10.1093/nar/26.18.4093; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Holmes I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-166; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Klein RJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-44; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Krishnan NM, 2004, MOL BIOL EVOL, V21, P1871, DOI 10.1093/molbev/msh198; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; LINGNER J, 1994, GENE DEV, V8, P1984, DOI 10.1101/gad.8.16.1984; Ly H, 2003, MOL CELL BIOL, V23, P6849, DOI 10.1128/MCB.23.19.6849-6856.2003; Maddison, 2019, MESQUITE MODULAR SYS; MADDISON DR, 2007, TREE LIFE WEB PROJEC, P19; MALMBERG R, 2010, J BIOINFORM IN PRESS; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; MCCORMICKGRAHAM M, 1995, NUCLEIC ACIDS RES, V23, P1091, DOI 10.1093/nar/23.7.1091; Podlevsky JD, 2008, NUCLEIC ACIDS RES, V36, pD339, DOI 10.1093/nar/gkm700; Rivas E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000172; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Savill NJ, 2001, GENETICS, V157, P399; Smit S, 2007, NUCLEIC ACIDS RES, V35, P3339, DOI 10.1093/nar/gkm101; Sun FJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-153; THORNE JL, 1992, J MOL EVOL, V34, P3, DOI 10.1007/BF00163848; THORNE JL, 1991, J MOL EVOL, V33, P114, DOI 10.1007/BF02193625; Williams KP, 1996, RNA, V2, P1306; Williams PD, 2006, PLOS COMPUT BIOL, V2, P598, DOI 10.1371/journal.pcbi.0020069; WOESE CR, 1993, RNA WORLD, P91; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zwieb C, 1999, NUCLEIC ACIDS RES, V27, P2063, DOI 10.1093/nar/27.10.2063; Zwieb C, 2003, NUCLEIC ACIDS RES, V31, P446, DOI 10.1093/nar/gkg019	46	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20484	10.1371/journal.pone.0020484	http://dx.doi.org/10.1371/journal.pone.0020484			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698102	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600007
J	Sanghera, DK; Been, LF; Ralhan, S; Wander, GS; Mehra, NK; Singh, JR; Ferrell, RE; Kamboh, MI; Aston, CE				Sanghera, Dharambir K.; Been, Latonya F.; Ralhan, Sarju; Wander, Gurpreet S.; Mehra, Narinder K.; Singh, Jai Rup; Ferrell, Robert E.; Kamboh, Mohammed I.; Aston, Christopher E.			Genome-Wide Linkage Scan to Identify Loci Associated with Type 2 Diabetes and Blood Lipid Phenotypes in the Sikh Diabetes Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; SOUTH ASIANS; MYOCARDIAL-INFARCTION; GLUCOSE-INTOLERANCE; GENETIC-LINKAGE; RISK; POLYMORPHISMS; CHOLESTEROL; PREVALENCE; STATISTICS	In this investigation, we have carried out an autosomal genome-wide linkage analysis to map genes associated with type 2 diabetes (T2D) and five quantitative traits of blood lipids including total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, very low-density lipoprotein (VLDL) cholesterol, and triglycerides in a unique family-based cohort from the Sikh Diabetes Study (SDS). A total of 870 individuals (526 male/344 female) from 321 families were successfully genotyped using 398 polymorphic microsatellite markers with an average spacing of 9.26 cM on the autosomes. Results of non-parametric multipoint linkage analysis using Sall statistics (implemented in Merlin) did not reveal any chromosomal region to be significantly associated with T2D in this Sikh cohort. However, linkage analysis for lipid traits using QTL-ALL analysis revealed promising linkage signals with p <= 0.005 for total cholesterol, LDL cholesterol, and HDL cholesterol at chromosomes 5p15, 9q21, 10p11, 10q21, and 22q13. The most significant signal (p = 0.0011) occurred at 10q21.2 for HDL cholesterol. We also observed linkage signals for total cholesterol at 22q13.32 (p = 0.0016) and 5p15.33 (p = 0.0031) and for LDL cholesterol at 10p11.23 (p = 0.0045). Interestingly, some of linkage regions identified in this Sikh population coincide with plausible candidate genes reported in recent genome-wide association and meta-analysis studies for lipid traits. Our study provides the first evidence of linkage for loci associated with quantitative lipid traits at four chromosomal regions in this Asian Indian population from Punjab. More detailed examination of these regions with more informative genotyping, sequencing, and functional studies should lead to rapid detection of novel targets of therapeutic importance.	[Sanghera, Dharambir K.; Been, Latonya F.; Aston, Christopher E.] Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Coll Med, Oklahoma City, OK 73190 USA; [Ralhan, Sarju; Wander, Gurpreet S.] Hero DMC Heart Inst, Cardiol Sect, Ludhiana, Punjab, India; [Mehra, Narinder K.] All India Inst Med Sci & Res, Dept Transplant Immunol & Immunogenet, New Delhi, India; [Singh, Jai Rup] Cent Univ, Bathinda, Punjab, India; [Ferrell, Robert E.; Kamboh, Mohammed I.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Dayanand Medical College & Hospital; All India Institute of Medical Sciences (AIIMS) New Delhi; Central University of Punjab; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Sanghera, DK (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Pediat, Coll Med, Oklahoma City, OK 73190 USA.	Dharambir-sanghera@ouhsc.edu		Kamboh, M. Ilyas/0000-0002-3453-1438; Sanghera, Dharambir/0000-0001-7203-8655	Fogarty International Center (FIC) [K01TW006087, R01DK082766]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of Oklahoma Health Sciences Center, Oklahoma City, OK; Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA; National Heart Lung and Blood Institute (NHLBI)'s Mammalian Genotyping Service [HV48141]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV048141] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [K01TW006087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082766] Funding Source: NIH RePORTER	Fogarty International Center (FIC)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Oklahoma Health Sciences Center, Oklahoma City, OK; Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA(University of Pittsburgh); National Heart Lung and Blood Institute (NHLBI)'s Mammalian Genotyping Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was supported by NIH grants (K01TW006087 and R01DK082766) funded by the Fogarty International Center (FIC) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and a seed grant from University of Oklahoma Health Sciences Center, Oklahoma City, OK and also in part by the Department of Human Genetics, University of Pittsburgh, Pittsburgh, PA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study would not have been possible without the generous support of the families who participated in this study and the non-governmental, social, and religious organizations who assisted in the recruitment and ascertainment of the SDS families. Authors are also thankful to Mr. Jagtar S. Sanghera for his repeated help in subject recruitment and providing guidance and support in logistical and ethical issues. We are thankful to National Heart Lung and Blood Institute (NHLBI)'s Mammalian Genotyping Service (Contract Number HV48141), for genotyping our study population.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Diabetes Association, 2004, Diabetes Care, V27 Suppl 1, pS5, DOI 10.2337/diacare.27.2007.S5; BALARAJAN R, 1991, BMJ-BRIT MED J, V302, P560, DOI 10.1136/bmj.302.6776.560; BANERJI MA, 1995, DIABETES, V44, P141, DOI 10.2337/diabetes.44.2.141; Basnyat B, 2004, BMJ-BRIT MED J, V328, P781, DOI 10.1136/bmj.328.7443.781; Been LF, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-18; Bhattacharjee S, 2008, AM J HUM GENET, V82, P567, DOI 10.1016/j.ajhg.2007.11.012; Boehnke M, 1997, AM J HUM GENET, V61, P423, DOI 10.1086/514862; Bosse Y, 2004, J LIPID RES, V45, P2174, DOI 10.1194/jlr.R400008-JLR200; Bourgain C, 2007, EUR J HUM GENET, V15, P260, DOI 10.1038/sj.ejhg.5201753; Broeckel U, 2002, NAT GENET, V30, P210, DOI 10.1038/ng827; Coon H, 2002, HUM GENET, V111, P263, DOI 10.1007/s00439-002-0773-8; Coon H, 2001, ARTERIOSCL THROM VAS, V21, P1969, DOI 10.1161/hq1201.100228; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Davis S., 1996, American Journal of Human Genetics, V59, pA216; Epstein MP, 2000, AM J HUM GENET, V67, P1219, DOI 10.1016/S0002-9297(07)62952-8; Erdmann J, 2011, EUR HEART J, V32, P158, DOI 10.1093/eurheartj/ehq405; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; Hegele RA, 2009, NAT REV GENET, V10, P109, DOI 10.1038/nrg2481; Heijmans BT, 2005, EUR J HUM GENET, V13, P1143, DOI 10.1038/sj.ejhg.5201466; Huertas-Vazquez A, 2010, HUM GENET, V127, P83, DOI 10.1007/s00439-009-0749-z; Hunt SC, 2000, ARTERIOSCL THROM VAS, V20, P1089, DOI 10.1161/01.ATV.20.4.1089; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lacquemant C, 2000, DIABETES METAB, V26, P393; Lilja HE, 2004, J LIPID RES, V45, P1876, DOI 10.1194/jlr.M400141-JLR200; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; MATHER HM, 1985, BRIT MED J, V291, P1081, DOI 10.1136/bmj.291.6502.1081; MCKEIGUE PM, 1992, DIABETOLOGIA, V35, P785; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1988, BRIT HEART J, V60, P390; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mukhopadhyay N, 2005, BIOINFORMATICS, V21, P2556, DOI 10.1093/bioinformatics/bti364; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Nakagami T, 2003, DIABETOLOGIA, V46, P1063, DOI 10.1007/s00125-003-1158-9; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; OTT J, 1989, P NATL ACAD SCI USA, V86, P4175, DOI 10.1073/pnas.86.11.4175; Pollin TI, 2004, ATHEROSCLEROSIS, V173, P89, DOI 10.1016/j.atherosclerosis.2003.11.012; RAMACHANDRAN A, 1988, BRIT MED J, V297, P587, DOI 10.1136/bmj.297.6648.587; RAMACHANDRAN A, 2003, INT DIABETES MONITOR, V15, P1; Sanghera DK, 2008, ANN HUM GENET, V72, P499, DOI 10.1111/j.1469-1809.2008.00443.x; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Sanghera DK, 2006, HUM BIOL, V78, P43, DOI 10.1353/hub.2006.0027; Sanghera DK, 2010, METABOLISM, V59, P492, DOI 10.1016/j.metabol.2009.07.043; Sengul H, 2001, AM J HUM GENET, V69, P179, DOI 10.1086/321264; Snehalatha C, 1999, DIABETIC MED, V16, P408, DOI 10.1046/j.1464-5491.1999.00084.x; Staels B, 1998, CIRCULATION, V98, P2088, DOI 10.1161/01.CIR.98.19.2088; Tulloch-Reid MK, 2003, DIABETES CARE, V26, P2556, DOI 10.2337/diacare.26.9.2556; VOTEY SR, 2004, EMEDICINE J; WEEKS DE, 1990, AM J HUM GENET, V47, P592; WHITTEMORE AS, 1994, BIOMETRICS, V50, P118, DOI 10.2307/2533202; Wigginton JE, 2005, BIOINFORMATICS, V21, P3445, DOI 10.1093/bioinformatics/bti529; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yamada Y, 2009, ATHEROSCLEROSIS, V207, P144, DOI 10.1016/j.atherosclerosis.2009.03.038; Zeggini E, 2007, DIABETIC MED, V24, P1181, DOI 10.1111/j.1464-5491.2007.02274.x	59	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21188	10.1371/journal.pone.0021188	http://dx.doi.org/10.1371/journal.pone.0021188			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698157	gold, Green Published, Green Accepted			2022-12-25	WOS:000291734100066
J	Cao, DD; Li, H; Yi, JY; Zhang, JJ; Che, HL; Cao, JK; Yang, L; Zhu, CQ; Jiang, WB				Cao, Dongdong; Li, He; Yi, Jianyong; Zhang, Jingjing; Che, Huilian; Cao, Jiankang; Yang, Liu; Zhu, Chunqiu; Jiang, Weibo			Antioxidant Properties of the Mung Bean Flavonoids on Alleviating Heat Stress	PLOS ONE			English	Article							NITRIC-OXIDE; RED WINE; ISOVITEXIN; EXTRACT; DISEASE; ABILITY; VITEXIN; DAMAGE; ASSAY; SHOCK	Background: It is a widespread belief in Asian countries that mung bean soup (MBS) may afford a protective effect against heat stress. Lack of evidence supports MBS conferring a benefit in addition to water. Results: Here we show that vitexin and isovitexin are the major antioxidant components in mungbean (more than 96% of them existing in the bean seed coat), and both of them could be absorbed via gavage into rat plasma. In the plasma of rats fed with mungbean coat extract before or after exposure to heat stress, the levels of malonaldehyde and activities of lactate dehydrogenase and nitric oxide synthase were remarkably reduced; the levels of total antioxidant capacity and glutathione (a quantitative assessment of oxidative stress) were significantly enhanced. Conclusions: Our results demonstrate that MBS can play additional roles to prevent heat stress injury. Characterization of the mechanisms underlying mungbean beneficial effects should help in the design of diet therapy strategies to alleviate heat stress, as well as provide reference for searching natural medicines against oxidative stress induced diseases.	[Cao, Dongdong; Li, He; Yi, Jianyong; Zhang, Jingjing; Che, Huilian; Cao, Jiankang; Yang, Liu; Zhu, Chunqiu; Jiang, Weibo] China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100094, Peoples R China	China Agricultural University	Cao, DD (corresponding author), China Agr Univ, Coll Food Sci & Nutr Engn, Beijing 100094, Peoples R China.	jwb@cau.edu.cn		Yi, Jian Yong/0000-0003-3820-0270; Che, Huilian/0000-0002-1632-5729	Natural Science Foundation of China [30871763, 81072305]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of China (No. 30871763 and No 81072305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agouni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005557; Ahmet I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005954; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Corder R, 2001, NATURE, V414, P863, DOI 10.1038/414863a; Fu YJ, 2007, J CHROMATOGR A, V1139, P206, DOI 10.1016/j.chroma.2006.11.015; Gupta V, 2010, FOOD CHEM TOXICOL, V48, P1019, DOI 10.1016/j.fct.2010.01.012; HANASAKI Y, 1994, FREE RADICAL BIO MED, V16, P845, DOI 10.1016/0891-5849(94)90202-X; Hayashi T, 2008, PHARMACOL THERAPEUT, V120, P333, DOI 10.1016/j.pharmthera.2008.09.002; Howe AS, 2007, AM J SPORT MED, V35, P1384, DOI 10.1177/0363546507305013; Joshipura KJ, 1999, JAMA-J AM MED ASSOC, V282, P1233, DOI 10.1001/jama.282.13.1233; Lord-Fontaine S, 2002, FREE RADICAL BIO MED, V32, P752, DOI 10.1016/S0891-5849(02)00769-4; Masella R, 2005, J NUTR BIOCHEM, V16, P577, DOI 10.1016/j.jnutbio.2005.05.013; Middleton E, 2000, PHARMACOL REV, V52, P673; Morillas-Ruiz JM, 2006, CLIN NUTR, V25, P444, DOI 10.1016/j.clnu.2005.11.007; Peng XF, 2008, FOOD CHEM, V106, P475, DOI 10.1016/j.foodchem.2007.06.016; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Serafini M, 2003, NATURE, V424, P1013, DOI 10.1038/4241013a; Sobotkova A, 2009, FREE RADICAL BIO MED, V47, P1707, DOI 10.1016/j.freeradbiomed.2009.09.015; Trott A, 2008, MOL BIOL CELL, V19, P1104, DOI 10.1091/mbc.E07-10-1004; Villano D, 2007, TALANTA, V71, P230, DOI 10.1016/j.talanta.2006.03.050; XU Y, 1992, CANCER RES, V52, P3875; Zhang Y, 2005, J CHROMATOGR A, V1065, P177, DOI 10.1016/j.chroma.2004.12.086	24	66	74	3	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21071	10.1371/journal.pone.0021071	http://dx.doi.org/10.1371/journal.pone.0021071			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695166	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600045
J	Ruzagira, E; Wandiembe, S; Abaasa, A; Levin, J; Bwanika, A; Bahemuka, U; Price, MA; Kamali, A				Ruzagira, Eugene; Wandiembe, Symon; Abaasa, Andrew; Levin, Jonathan; Bwanika, Agnes; Bahemuka, Ubaldo; Price, Matthew A.; Kamali, Anatoli			Prevalence and Incidence of HIV in a Rural Community-Based HIV Vaccine Preparedness Cohort in Masaka, Uganda	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TRANSMISSION; INFECTION; INTERVENTIONS; MANAGEMENT	Background: Local HIV epidemiology data are critical in determining the suitability of a population for HIV vaccine efficacy trials. The objective of this study was to estimate the prevalence and incidence of, and determine risk factors for HIV transmission in a rural community-based HIV vaccine preparedness cohort in Masaka, Uganda. Methods: Between February and July 2004, we conducted a house-to-house HIV sero-prevalence survey among consenting individuals aged 18-60 years. Participants were interviewed, counseled and asked to provide blood for HIV testing. We then enrolled the HIV uninfected participants in a 2-year HIV sero-incidence study. Medical evaluations, HIV counseling and testing, and sample collection for laboratory analysis were done quarterly. Sexual risk behaviour data was collected every 6 months. Results: The HIV point prevalence was 11.2%, and was higher among women than men (12.9% vs. 8.6%, P = 0.007). Risk factors associated with prevalent HIV infection for men were age <25 years (aOR = 0.05, 95% CI 0.01-0.35) and reported genital ulcer disease in the past year (aOR = 2.17, 95% CI 1.23-3.83). Among women, being unmarried (aOR = 2.59, 95% CI 1.75-3.83) and reported genital ulcer disease in the past year (aOR = 2.40, 95% CI 1.64-3.51) were associated with prevalent HIV infection. Twenty-one seroconversions were recorded over 2025.8 person-years, an annual HIV incidence of 1.04% (95% CI: 0.68-1.59). The only significant risk factor for incident HIV infection was being unmarried (aRR = 3.44, 95% CI 1.43-8.28). Cohort retention after 2 years was 87%. Conclusions: We found a high prevalence but low incidence of HIV in this cohort. HIV vaccine efficacy trials in this population may not be feasible due to the large sample sizes that would be required. HIV vaccine preparatory efforts in this setting should include identification of higher risk populations.	[Ruzagira, Eugene; Wandiembe, Symon; Abaasa, Andrew; Levin, Jonathan; Bwanika, Agnes; Bahemuka, Ubaldo; Kamali, Anatoli] Uganda Res Unit AIDS, Med Res Council MRC, Uganda Virus Res Inst UVRI, Entebbe, Uganda; [Price, Matthew A.] Int AIDS Vaccine Initiat IAVI, New York, NY USA	International AIDS Vaccine Initiative	Ruzagira, E (corresponding author), Uganda Res Unit AIDS, Med Res Council MRC, Uganda Virus Res Inst UVRI, Entebbe, Uganda.	eugene.ruzagira@mrcuganda.org	Price, Matt/AAK-6881-2021	Price, Matt/0000-0002-2918-1373; Ruzagira, Eugene/0000-0002-7291-1693; Bwanika Naggirinya, Agnes/0000-0001-6795-3138	International AIDS Vaccine Initiative (IAVI); Medical Research Council [MC_U950080930] Funding Source: researchfish; MRC [MC_U950080930] Funding Source: UKRI	International AIDS Vaccine Initiative (IAVI); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was sponsored by the International AIDS Vaccine Initiative (IAVI). IAVI contributed to the study design, decision to publish, and preparation of the manuscript. In addition, this work was made possible in part by the generous support of the American people through the United States Agency for International Development (USAID). The contents are the responsibility of the study authors and do not necessarily reflect the views of USAID or the United States Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; [Anonymous], [No title captured]; Auvert B, 2001, AIDS, V15, pS15, DOI 10.1097/00002030-200108004-00003; Biraro S, 2009, SEX TRANSM INFECT, V85, pI3, DOI 10.1136/sti.2008.033928; Carpenter LM, 1999, AIDS, V13, P1083, DOI 10.1097/00002030-199906180-00012; Dickerson MC, 1996, SEX TRANSM DIS, V23, P429, DOI 10.1097/00007435-199609000-00015; Esparza J, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200100005-00008; Esparza J, 2001, B WORLD HEALTH ORGAN, V79, P1133; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Kamali A, 2003, LANCET, V361, P645, DOI 10.1016/S0140-6736(03)12598-6; Kamali A, 2002, TROP MED INT HEALTH, V7, P1053, DOI 10.1046/j.1365-3156.2002.00963.x; NUNN AJ, 1995, AIDS, V9, P503, DOI 10.1097/00002030-199509050-00013; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; RUZAGIRA E, 2009, TROP MED INT HEALTH, V14, P1; Sateren WB, 2006, JAIDS-J ACQ IMM DEF, V43, P102, DOI 10.1097/01.qai.0000226795.61957.40; STOVER J, 2002, 2811 WORLD BANK; Vardas E, 2005, MICROBES INFECT, V7, P1436, DOI 10.1016/j.micinf.2005.07.021; Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224	18	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20684	10.1371/journal.pone.0020684	http://dx.doi.org/10.1371/journal.pone.0020684			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677779	Green Published, gold, Green Submitted			2022-12-25	WOS:000291355500034
J	Lv, MY; Wang, JW; Wang, XD; Zuo, T; Zhu, YZ; Kong, W; Yu, XH				Lv, Mingyu; Wang, Jiawen; Wang, Xiaodan; Zuo, Tao; Zhu, Yingzi; Kong, Wei; Yu, Xianghui			Polarity Changes in the Transmembrane Domain Core of HIV-1 Vpu Inhibits Its Anti-Tetherin Activity	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; MEMBRANE-PROTEIN VPU; VIRUS TYPE-1 HIV-1; FULL-LENGTH VPU; CYTOPLASMIC DOMAIN; PARTICLE RELEASE; CELL-SURFACE; BETA-TRCP; RESTRICTION; DEGRADATION	Tetherin (BST-2/CD317) is an interferon-inducible antiviral protein that restricts the release of enveloped viruses from infected cells. The HIV-1 accessory protein Vpu can efficiently antagonize this restriction. In this study, we analyzed mutations of the transmembrane (TM) domain of Vpu, including deletions and substitutions, to delineate amino acids important for HIV-1 viral particle release and in interactions with tetherin. The mutants had similar subcellular localization patterns with that of wild-type Vpu and were functional with respect to CD4 downregulation. We showed that the hydrophobic binding surface for tetherin lies in the core of the Vpu TM domain. Three consecutive hydrophobic isoleucine residues in the middle region of the Vpu TM domain, I15, I16 and I17, were important for stabilizing the tetherin binding interface and determining its sensitivity to tetherin. Changing the polarity of the amino acids at these positions resulted in severe impairment of Vpu-induced tetherin targeting and antagonism. Taken together, these data reveal a model of specific hydrophobic interactions between Vpu and tetherin, which can be potentially targeted in the development of novel anti-HIV-1 drugs.	[Lv, Mingyu; Wang, Jiawen; Wang, Xiaodan; Zuo, Tao; Zhu, Yingzi; Kong, Wei; Yu, Xianghui] Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin Province, Peoples R China	Jilin University	Lv, MY (corresponding author), Jilin Univ, Coll Life Sci, Natl Engn Lab AIDS Vaccine, Changchun 130023, Jilin Province, Peoples R China.	weikong@jlu.edu.cn; xianghui@jlu.edu.cn		Tripp, Ralph/0000-0002-2924-9956	National Natural Science Foundation of China [30570363, 20972009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 30570363) and (No. 20972009) http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew AJ, 2011, J VIROL, V85, P2611, DOI 10.1128/JVI.02080-10; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Becker CFW, 2004, J BIOL CHEM, V279, P17483, DOI 10.1074/jbc.M313212200; BOUR S, 1995, J VIROL, V69, P1510, DOI 10.1128/JVI.69.3.1510-1520.1995; COHEN EA, 1988, NATURE, V334, P532, DOI 10.1038/334532a0; Douglas JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000913; Douglas JL, 2009, J VIROL, V83, P7931, DOI 10.1128/JVI.00242-09; Dube M, 2009, J VIROL, V83, P4574, DOI 10.1128/JVI.01800-08; Ewart GD, 1996, J VIROL, V70, P7108, DOI 10.1128/JVI.70.10.7108-7115.1996; Fischer WB, 2003, FEBS LETT, V552, P39, DOI 10.1016/S0014-5793(03)00782-8; Fischer WB, 2009, INT REV CEL MOL BIO, V275, P35, DOI 10.1016/S1937-6448(09)75002-6; Goff SP, 2007, NAT REV MICROBIOL, V5, P253, DOI 10.1038/nrmicro1541; Goffinet C, 2010, J VIROL, V84, P4089, DOI 10.1128/JVI.01549-09; Goffinet C, 2009, CELL HOST MICROBE, V5, P285, DOI 10.1016/j.chom.2009.01.009; GOTTLINGER HG, 1993, P NATL ACAD SCI USA, V90, P7381, DOI 10.1073/pnas.90.15.7381; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Iwabu Y, 2009, J BIOL CHEM, V284, P35060, DOI 10.1074/jbc.M109.058305; Jouvenet N, 2009, J VIROL, V83, P1837, DOI 10.1128/JVI.02211-08; Kaletsky RL, 2009, P NATL ACAD SCI USA, V106, P2886, DOI 10.1073/pnas.0811014106; Kochendoerfer GG, 2004, J AM CHEM SOC, V126, P2439, DOI 10.1021/ja038985i; Kruger J, 2010, EUR BIOPHYS J BIOPHY, V39, P1069, DOI 10.1007/s00249-009-0487-0; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Lemaitre V, 2006, J BIOMOL STRUCT DYN, V23, P485, DOI 10.1080/07391102.2006.10507074; Lemaitre V, 2004, FEBS LETT, V563, P75, DOI 10.1016/S0014-5793(04)00251-0; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; Magadan JG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000869; MALDARELLI F, 1993, J VIROL, V67, P5056, DOI 10.1128/JVI.67.8.5056-5061.1993; Mangeat B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000574; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; Margottin F, 1996, VIROLOGY, V223, P381, DOI 10.1006/viro.1996.0491; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Mehnert T, 2007, J BIOMOL STRUCT DYN, V24, P589, DOI 10.1080/07391102.2007.10507148; Mitchell RS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000450; Miyagi E, 2009, P NATL ACAD SCI USA, V106, P2868, DOI 10.1073/pnas.0813223106; Montal M, 2003, FEBS LETT, V552, P1, DOI 10.1016/S0014-5793(03)00848-2; Montal M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000246; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nguyen KL, 2004, VIROLOGY, V319, P163, DOI 10.1016/j.virol.2003.11.021; Pacyniak E, 2005, AIDS RES HUM RETROV, V21, P379, DOI 10.1089/aid.2005.21.379; Park SH, 2003, J MOL BIOL, V333, P409, DOI 10.1016/j.jmb.2003.08.048; Patargias G, 2009, J BIOMOL STRUCT DYN, V27, P1; Paul M, 1998, J VIROL, V72, P1270, DOI 10.1128/JVI.72.2.1270-1279.1998; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Ruiz A, 2010, VIROLOGY, V408, P89, DOI 10.1016/j.virol.2010.08.031; Sakuma T, 2009, J VIROL, V83, P2382, DOI 10.1128/JVI.01607-08; SCHUBERT U, 1992, EUR J BIOCHEM, V204, P875, DOI 10.1111/j.1432-1033.1992.tb16707.x; Schubert U, 1996, FEBS LETT, V398, P12, DOI 10.1016/S0014-5793(96)01146-5; Schubert U, 1996, J VIROL, V70, P809, DOI 10.1128/JVI.70.2.809-819.1996; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Skasko M, 2011, VIROLOGY, V411, P65, DOI 10.1016/j.virol.2010.12.038; STREBEL K, 1988, SCIENCE, V241, P1221, DOI 10.1126/science.3261888; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; SUBBRAMANIAN RA, 1994, J VIROL, V68, P6831, DOI 10.1128/JVI.68.11.6831-6835.1994; Tervo HM, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-9; TERWILLIGER EF, 1989, P NATL ACAD SCI USA, V86, P5163, DOI 10.1073/pnas.86.13.5163; Tiganos E, 1998, VIROLOGY, V251, P96, DOI 10.1006/viro.1998.9368; Tokarev AA, 2011, J VIROL, V85, P51, DOI 10.1128/JVI.01795-10; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Varthakavi V, 2006, TRAFFIC, V7, P298, DOI 10.1111/j.1600-0854.2005.00380.x; Varthakavi V, 2003, P NATL ACAD SCI USA, V100, P15154, DOI 10.1073/pnas.2433165100; Vigan R, 2010, J VIROL, V84, P12958, DOI 10.1128/JVI.01699-10; Waheed AA, 2008, J VIROL, V82, P9776, DOI 10.1128/JVI.00917-08; WILLEY RL, 1992, J VIROL, V66, P7193, DOI 10.1128/JVI.66.12.7193-7200.1992; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591	67	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20890	10.1371/journal.pone.0020890	http://dx.doi.org/10.1371/journal.pone.0020890			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674066	Green Submitted, gold, Green Published			2022-12-25	WOS:000291310600035
J	Creighton, J; Jian, MY; Sayner, S; Alexeyev, M; Insel, PA				Creighton, Judy; Jian, MingYuan; Sayner, Sarah; Alexeyev, Mikhail; Insel, Paul A.			Adenosine monophosphate-activated kinase alpha 1 promotes endothelial barrier repair	FASEB JOURNAL			English	Article						cadherins; calcium; capillary; caveolin; microdomains	PROTEIN-COUPLED-RECEPTORS; CELL-CELL CONTACTS; LIPID RAFTS; METABOLIC-DISORDERS; HEART-DISEASE; GAP FORMATION; CA2+ ENTRY; MIGRATION; LUNG; CAVEOLAE	The vascular endothelium responds to damage through activation of multiple signaling events that restore cell-cell adhesion and vascular integrity. However, the molecular mechanisms that integrate these events are not clearly defined. Herein, we identify a previously unexpected role for adenosine monophosphate-activated protein kinase (AMPK) in pulmonary microvascular endothelial cell (PMVEC) repair. PMVECs selectively express the AMPK alpha 1 catalytic subunit, pharmacological and short hairpin RNA-mediated inhibition of which attenuates Ca(2+) entry in these cells induced by the inflammatory Ca(2+)-signaling mimetic thapsigargin. We find that AMPK alpha 1 activity is required for the formation of PMVEC cell-cell networks in a prorepair environment and for monolayer resealing after wounding. Decreasing AMPK alpha 1 expression reduces barrier resistance in PMVEC monolayers, results consistent with a role for AMPK alpha 1 in cell-cell adhesion. AMPK alpha 1 colocalizes and coimmunoprecipitates with the adherens junction protein N-cadherin and cofractionates with proteins selectively expressed in caveolar membranes. Assessment of permeability, by measuring the filtration coefficient (K(f)) in isolated perfused lungs, confirmed that AMPK activation contributes to barrier repair in vivo. Our findings thus provide novel evidence for AMPK alpha 1 in Ca(2+) influx-mediated signaling and wound repair in the endothelium.-Creighton, J., Jian, M., Sayner, S., Alexeyev, M., Insel, P. A. Adenosine monophosphate-activated kinase alpha 1 promotes endothelial barrier repair. FASEB J. 25, 3356-3365 (2011). www.fasebj.org	[Insel, Paul A.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Creighton, Judy; Jian, MingYuan] Univ Alabama, Dept Anesthesiol, Birmingham, AL USA; [Sayner, Sarah; Alexeyev, Mikhail] Univ S Alabama, Ctr Lung Biol, Mobile, AL 36688 USA; [Sayner, Sarah; Alexeyev, Mikhail] Univ S Alabama, Dept Cell Biol & Neurosci, Mobile, AL 36688 USA; [Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA	University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; University of South Alabama; University of South Alabama; University of California System; University of California San Diego	Insel, PA (corresponding author), Univ Calif San Diego, Dept Pharmacol, Mail Code 0636 UCSD,9500 Gilman Dr, La Jolla, CA 92093 USA.	pinsel@ucsd.edu			U.S. National Institutes of Health [HL102296, RR031286, HL007261]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR031286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL091651, R01HL102296, T32HL007261, P01HL066299, R03HL110803] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Troy Stevens (University of South Alabama College of Medicine, Mobile, AL, USA) for providing cells. This work was supported by U.S. National Institutes of Health grants HL102296 (to J.C.), RR031286 (to M.A.), and HL007261 (to P.A.I.).	Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Anderson RGW, 2008, NAT BIOTECHNOL, V26, P380, DOI 10.1038/nbt0408-380; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; Causeret M, 2005, MOL BIOL CELL, V16, P2168, DOI 10.1091/mbc.E04-09-0829; Chen ZH, 2010, P NATL ACAD SCI US; Cioffi DL, 2002, J CELL BIOL, V157, P1267, DOI 10.1083/jcb.200204022; Cioffi DL, 2006, MICROCIRCULATION, V13, P709, DOI 10.1080/10739680600930354; Colombo SL, 2009, BIOCHEM J, V421, P163, DOI 10.1042/BJ20090613; Creighton JR, 2003, AM J PHYSIOL-LUNG C, V284, pL100, DOI 10.1152/ajplung.00083.2002; Creighton J, 2008, J CELL SCI, V121, P110, DOI 10.1242/jcs.011692; Crossthwaite AJ, 2005, J BIOL CHEM, V280, P6380, DOI 10.1074/jbc.M411987200; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; Fisslthaler B, 2009, CIRC RES, V105, P114, DOI 10.1161/CIRCRESAHA.109.201590; Fuhs SR, 2011, J BIOL CHEM, V286, P14830, DOI 10.1074/jbc.M110.214270; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Hardie DG, 2008, FEBS LETT, V582, P81, DOI 10.1016/j.febslet.2007.11.018; Hardie DG, 2011, BIOCHEM SOC T, V39, P1, DOI 10.1042/BST0390001; Hutchinson DS, 2008, PHARMACOL THERAPEUT, V119, P291, DOI 10.1016/j.pharmthera.2008.05.008; Insel PA, 2005, BIOCHEM SOC T, V33, P1131, DOI 10.1042/BST0331131; Insel PA, 2009, CURR OPIN NEPHROL HY, V18, P50, DOI 10.1097/MNH.0b013e3283186f82; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Ko KS, 2001, J CELL SCI, V114, P1155; Liao YY, 2009, P NATL ACAD SCI USA, V106, P3202, DOI 10.1073/pnas.0813346106; Louis M, 2008, J CELL SCI, V121, P3951, DOI 10.1242/jcs.037218; Marrs GS, 2009, MOL CELL NEUROSCI, V40, P390, DOI 10.1016/j.mcn.2008.12.007; Martini A, 2010, ACTA PHYSIOL, V198, P449, DOI 10.1111/j.1748-1716.2009.02070.x; Meoli DF, 2009, AM J PHYSIOL-LUNG C, V297, pL706, DOI 10.1152/ajplung.90598.2008; Nakao S, 2008, J CELL BIOL, V182, P395, DOI 10.1083/jcb.200802069; Ofori-Acquah SF, 2008, MICROVASC RES, V75, P391, DOI 10.1016/j.mvr.2007.10.006; Pani B, 2009, CELL CALCIUM, V45, P625, DOI 10.1016/j.ceca.2009.02.009; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stevens T, 1999, AM J PHYSIOL-LUNG C, V277, pL119, DOI 10.1152/ajplung.1999.277.1.L119; Taulet N, 2009, J BIOL CHEM, V284, P23137, DOI 10.1074/jbc.M109.017665; Townsley MI, 2006, MICROCIRCULATION, V13, P725, DOI 10.1080/10739680600930362; Viollet B, 2007, DIABETES METAB, V33, P395, DOI 10.1016/j.diabet.2007.10.004; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Wu SW, 2009, AM J PHYSIOL-LUNG C, V297, pL650, DOI 10.1152/ajplung.00015.2009; Yarrow JC, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-21; Zhang L, 2011, J BIOL CHEM, V286, P16879, DOI 10.1074/jbc.M110.186932; Zheng B, 2007, P NATL ACAD SCI USA, V104, P819, DOI 10.1073/pnas.0610157104; Zhou C, 2007, AM J PHYSIOL-LUNG C, V292, pL833, DOI 10.1152/ajplung.00377.2006; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x	45	32	33	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	OCT	2011	25	10					3356	3365		10.1096/fj.10-179218	http://dx.doi.org/10.1096/fj.10-179218			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21680893	Green Published			2022-12-25	WOS:000295356400008
J	Bloemink, MJ; Melkani, GC; Dambacher, CM; Bernstein, SI; Geeves, MA				Bloemink, Marieke J.; Melkani, Girish C.; Dambacher, Corey M.; Bernstein, Sanford I.; Geeves, Michael A.			Two Drosophila Myosin Transducer Mutants with Distinct Cardiomyopathies Have Divergent ADP and Actin Affinities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTATIONS DIFFERENTIALLY AFFECT; DILATED CARDIOMYOPATHY; MUSCLE MYOSIN; HYPERTROPHIC CARDIOMYOPATHY; MICROGRAM QUANTITIES; ALPHA-TROPOMYOSIN; CARDIAC MYOSIN; THIN-FILAMENTS; MOTOR FUNCTION; SWISS-MODEL	Two Drosophila myosin II point mutations (D45 and Mhc(5)) generate Drosophila cardiac phenotypes that are similar to dilated or restrictive human cardiomyopathies. Our homology models suggest that the mutations (A261T in D45, G200D in Mhc(5)) could stabilize (D45) or destabilize (Mhc(5)) loop 1 of myosin, a region known to influence ADP release. To gain insight into the molecular mechanism that causes the cardiomyopathic phenotypes to develop, we determined whether the kinetic properties of the mutant molecules have been altered. We used myosin subfragment 1 (S1) carrying either of the two mutations (S1(A261T) and S1(G200D)) from the indirect flight muscles of Drosophila. The kinetic data show that the two point mutations have an opposite effect on the enzymatic activity of S1. S1(A261T) is less active (reduced ATPase, higher ADP affinity for S1 and actomyosin subfragment 1 (actin.S1), and reduced ATP-induced dissociation of actin.S1), whereas S1(G200D) shows increased enzymatic activity (enhanced ATPase, reduced ADP affinity for both S1 and actin.S1). The opposite changes in the myosin properties are consistent with the induced cardiac phenotypes for S1(A261T) (dilated) and S1(G200D) (restrictive). Our results provide novel insights into the molecular mechanisms that cause different cardiomyopathy phenotypes for these mutants. In addition, we report that S1(A261T) weakens the affinity of S1.ADP for actin, whereas S1(G200D) increases it. This may account for the suppression (A261T) or enhancement (G200D) of the skeletal muscle hypercontraction phenotype induced by the troponin I held-up(2) mutation in Drosophila.	[Melkani, Girish C.; Dambacher, Corey M.; Bernstein, Sanford I.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Melkani, Girish C.; Dambacher, Corey M.; Bernstein, Sanford I.] San Diego State Univ, Inst Mol Biol, San Diego, CA 92182 USA; [Bloemink, Marieke J.; Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	California State University System; San Diego State University; California State University System; San Diego State University; University of Kent	Bernstein, SI (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	sbernst@sciences.sdsu.edu; m.a.geeves@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Melkani, Girish/0000-0003-0353-4633; Bloemink, Marieke Johanna/0000-0001-9441-2783; Bernstein, Sanford/0000-0001-7094-5390	National Institutes of Health [GM32443]; Wellcome Trust [085309]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032443, R37GM032443] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM32443 (to G. C. M., C. M. D., and S. I. B.). This work was also supported by Wellcome Trust Program Grant 085309 (to M. A. G. and M. J. B.).	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Baker JE, 2002, BIOPHYS J, V82, P2134, DOI 10.1016/S0006-3495(02)75560-4; Bloemink MJ, 2009, J MOL BIOL, V389, P707, DOI 10.1016/j.jmb.2009.04.036; Cammarato A, 2008, MOL BIOL CELL, V19, P553, DOI 10.1091/mbc.E07-09-0890; Cammarato A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018497; Clark RJ, 2003, J MUSCLE RES CELL M, V24, P315; Coureux PD, 2004, EMBO J, V23, P4527, DOI 10.1038/sj.emboj.7600458; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Dweck D, 2008, J BIOL CHEM, V283, P33119, DOI 10.1074/jbc.M804070200; Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Kronert WA, 1999, J CELL BIOL, V144, P989, DOI 10.1083/jcb.144.5.989; Lakdawala NK, 2010, J AM COLL CARDIOL, V55, P320, DOI 10.1016/j.jacc.2009.11.017; Lin N, 2011, CIRC RES, V108, P1306, DOI 10.1161/CIRCRESAHA.110.238105; Marston SB, 2011, J CARDIOVASC TRANSL, V4, P245, DOI 10.1007/s12265-011-9266-2; Miller BM, 2007, J MOL BIOL, V368, P1051, DOI 10.1016/j.jmb.2007.02.042; Miller BM, 2003, J BIOL CHEM, V278, P50293, DOI 10.1074/jbc.M308318200; Nanni L, 2003, BIOCHEM BIOPH RES CO, V309, P391, DOI 10.1016/j.bbrc.2003.08.014; Nyitrai M, 2006, J MOL BIOL, V355, P432, DOI 10.1016/j.jmb.2005.10.063; O'Connell CB, 2007, BBA-MOL CELL RES, V1773, P615, DOI 10.1016/j.bbamcr.2006.06.012; Ocorr KA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000601; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Palmer BM, 2004, AM J PHYSIOL-HEART C, V287, pH91, DOI 10.1152/ajpheart.01015.2003; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; Swank DM, 2003, J BIOL CHEM, V278, P17475, DOI 10.1074/jbc.M212727200; Swank DM, 2006, P NATL ACAD SCI USA, V103, P17543, DOI 10.1073/pnas.0604972103; Sweeney HL, 1998, J BIOL CHEM, V273, P6262, DOI 10.1074/jbc.273.11.6262; Vikhorev PG, 2010, J MUSCLE RES CELL M, V31, P171, DOI 10.1007/s10974-010-9221-x; Webb MR, 2004, BIOCHEMISTRY-US, V43, P14463, DOI 10.1021/bi0486334; Webb MR, 2001, BIOPHYS J, V81, P1562, DOI 10.1016/S0006-3495(01)75810-9; Weiss S, 2000, J MUSCLE RES CELL M, V21, P423, DOI 10.1023/A:1005690106951; Wolf MJ, 2006, P NATL ACAD SCI USA, V103, P1394, DOI 10.1073/pnas.0507359103	36	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28435	28443		10.1074/jbc.M111.258228	http://dx.doi.org/10.1074/jbc.M111.258228			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680742	hybrid, Green Published			2022-12-25	WOS:000293557800059
J	Boucher, JM; Peterson, SM; Urs, S; Zhang, CX; Liaw, L				Boucher, Joshua M.; Peterson, Sarah M.; Urs, Sumithra; Zhang, Chunxiang; Liaw, Lucy			The miR-143/145 Cluster Is a Novel Transcriptional Target of Jagged-1/Notch Signaling in Vascular Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH LIGAND; ALPHA-ACTIN; MICRORNAS; EXPRESSION; DIFFERENTIATION; MODULATION; ACTIVATION; PHENOTYPE; DISEASES; PATHWAY	Activation of Notch signaling by Jagged-1 (Jag-1) in vascular smooth muscle cells (VSMC) promotes a differentiated phenotype characterized by increased expression of contractile proteins. Recent studies show that microRNAs (miR)-143/145 regulates VSMC phenotype. The serum response factor (SRF)/myocardin complex binds to CArG sequences to activate miR-143/145 transcription, but no other regulators are known in VSMC. Using miR arrays, we found miR-143/145 induced following expression of a constitutively active Notch1 intracellular domain (N1ICD). We hypothesized that miR-143/145 is required for Jag-1/Notch-induced VSMC differentiation. Activation of Notch receptors by Jag-1 caused CBF1-dependent up-regulation of miR-143/145, increased differentiation, and decreased proliferation. Conversely, inhibiting basal Notch signaling decreased steady state levels of miR-143/145. Using SRF knockdown, we found that Jag-1/Notch induction of miR-143/145 is SRF independent, although full acquisition of contractile markers requires SRF. Using miR-143/145 promoter reporter constructs we show Jag-1/Notch increases promoter activity, and this is dependent on intact CBF1 consensus sites within the promoter. Chromatin immunoprecipitation (ChIP) assays revealed that N1ICD-containing complexes bind to CBF1 sites in the miR-143/145 promoter. We also identified N1ICD complex binding to CBF1 sites within the endogenous human miR-143/145 promoter. Using miR-143/145-interfering oligonucleotides, we demonstrate that Jag-1/Notch signaling requires induction of both miR-143 and miR-145 to promote the VSMC contractile phenotype. Thus, miR-143/145 is a novel transcriptional target of Jag-1/Notch signaling in VSMC. We propose miR-143/145 as activated independently by Jag-1/Notch and SRF in parallel pathways. Multiple pathways converging on miR-143/145 provides potential for fine-tuning or amplification of VSMC differentiation signals.	[Boucher, Joshua M.; Peterson, Sarah M.; Urs, Sumithra; Liaw, Lucy] Maine Med Ctr, Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Boucher, Joshua M.; Peterson, Sarah M.; Liaw, Lucy] Univ Maine, Grad Sch Biomed Sci, Orono, ME 04473 USA; [Zhang, Chunxiang] Univ Med & Dent New Jersey, Dept Anesthesiol, Newark, NJ 07101 USA	Maine Medical Center; University of Maine System; University of Maine Orono; Rutgers State University New Brunswick; Rutgers State University Medical Center	Liaw, L (corresponding author), Maine Med Ctr, Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	liawl@mmc.org	zhang, xiang chun/HCH-7063-2022	zhang, xiang chun/0000-0001-8303-6495	National Institutes of Health [R01 HL070865]; National Center for Research Resources [P20RR15555]; Graduate School of Biomedical Sciences at the University of Maine, Orono; American Heart Association [10PRE3680003]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555, P20RR018789] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070865] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Graduate School of Biomedical Sciences at the University of Maine, Orono; American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HL070865 (to L. L.) and P20RR15555 from the National Center for Research Resources (to R. E. Friesel and L. L.).; Supported by fellowships from the Graduate School of Biomedical Sciences at the University of Maine, Orono, and a predoctoral fellowship from the Founders Affiliate of the American Heart Association (10PRE3680003).; Supported by fellowships from the Graduate School of Biomedical Sciences at the University of Maine, Orono.	Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Doi H, 2006, J BIOL CHEM, V281, P28555, DOI 10.1074/jbc.M602749200; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; GRIDLEY T, 2007, DEVELOPMENT; Havrda MC, 2006, THROMB HAEMOSTASIS, V96, P361, DOI 10.1160/TH06-04-0224; High FA, 2008, P NATL ACAD SCI USA, V105, P1955, DOI 10.1073/pnas.0709663105; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Ii M, 2010, CIRCULATION, V121, P1104, DOI 10.1161/CIRCULATIONAHA.105.553917; Iio A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-136; Kartha RV, 2010, J CARDIOVASC TRANSL, V3, P256, DOI 10.1007/s12265-010-9172-z; King-Briggs KE, 2000, DIFFERENTIATION, V66, P43, DOI 10.1046/j.1432-0436.2000.066001043.x; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Li YX, 2009, CIRCULATION, V119, P2686, DOI 10.1161/CIRCULATIONAHA.108.790485; Lindner V, 2001, AM J PATHOL, V159, P875, DOI 10.1016/S0002-9440(10)61763-4; Liu H, 2009, CIRC RES, V104, P466, DOI 10.1161/CIRCRESAHA.108.184846; Liu N, 2010, DEV CELL, V18, P510, DOI 10.1016/j.devcel.2010.03.010; Liu Y, 2010, ACTA PHARMACOL SIN, V31, P10, DOI 10.1038/aps.2009.185; Louvi A, 2006, DEV NEUROSCI-BASEL, V28, P5, DOI 10.1159/000090748; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Montgomery RL, 2010, CURR DRUG TARGETS, V11, P936; Morrow D, 2008, CIRC RES, V103, P1370, DOI 10.1161/CIRCRESAHA.108.187534; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Parmacek MS, 2009, J CLIN INVEST, V119, P2526, DOI 10.1172/JCI40503; Proweller A, 2005, J BIOL CHEM, V280, P8994, DOI 10.1074/jbc.M413316200; Proweller A, 2007, P NATL ACAD SCI USA, V104, P16275, DOI 10.1073/pnas.0707950104; Quillard T, 2008, ARTERIOSCL THROM VAS, V28, P2258, DOI 10.1161/ATVBAHA.108.174995; Rozen S, 2000, Methods Mol Biol, V132, P365; Sainson RCA, 2008, ANGIOGENESIS, V11, P41, DOI 10.1007/s10456-008-9098-0; Small EM, 2010, CIRCULATION, V121, P1022, DOI 10.1161/CIRCULATIONAHA.109.889048; Song ZF, 2010, J CARDIOVASC TRANSL, V3, P246, DOI 10.1007/s12265-010-9163-0; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Tang Sung-Chun, 2009, Acta Neurol Taiwan, V18, P81; Tang YF, 2008, CIRC RES, V102, P661, DOI 10.1161/CIRCRESAHA.107.165134; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Thyberg J, 1998, HISTOL HISTOPATHOL, V13, P871, DOI 10.14670/HH-13.871; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Varnum-Finney B, 2000, J CELL SCI, V113, P4313; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Zhang CX, 2009, CELL CYCLE, V8, P3469, DOI 10.4161/cc.8.21.9837	44	109	114	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28312	28321		10.1074/jbc.M111.221945	http://dx.doi.org/10.1074/jbc.M111.221945			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21685392	Green Published, hybrid			2022-12-25	WOS:000293557800048
J	Thotsaporn, K; Chenprakhon, P; Sucharitakul, J; Mattevi, A; Chaiyen, P				Thotsaporn, Kittisak; Chenprakhon, Pirom; Sucharitakul, Jeerus; Mattevi, Andrea; Chaiyen, Pimchai			Stabilization of C4a-Hydroperoxyflavin in a Two-component Flavin-dependent Monooxygenase Is Achieved through Interactions at Flavin N5 and C4a Atoms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-HYDROXYPHENYLACETATE 3-HYDROXYLASE; 4-HYDROXYPHENYLACETATE 3-MONOOXYGENASE; CRYSTAL-STRUCTURES; CYCLOHEXANONE MONOOXYGENASE; ACINETOBACTER-BAUMANNII; OXYGENASE COMPONENT; MECHANISM; REDUCTASE; BIOSYNTHESIS; HYDROXYLASE	p-Hydroxyphenylacetate (HPA) 3-hydroxylase is a two-component flavin-dependent monooxygenase. Based on the crystal structure of the oxygenase component (C-2), His-396 is 4.5 angstrom from the flavin C4a locus, whereas Ser-171 is 2.9 angstrom from the flavin N5 locus. We investigated the roles of these two residues in the stability of the C4a-hydroperoxy-FMN intermediate. The results indicated that the rate constant for C4a-hydroperoxy-FMN formation decreased similar to 30-fold in H396N, 100-fold in H396A, and 300-fold in the H396V mutant, compared with the wild-type enzyme. Lesser effects of the mutations were found for the subsequent step of H2O2 elimination. Studies on pH dependence showed that the rate constant of H2O2 eliminationinH396N and H396V increased when pH increased with pK(a)> 9.6 and > 9.7, respectively, similar to the wild-type enzyme (pK(a) > 9.4). These data indicated that His-396 is important for the formation of the C4a-hydroperoxy-FMN intermediate but is not involved in H2O2 elimination. Transient kinetics of the Ser-171 mutants with oxygen showed that the rate constants for the H2O2 elimination in S171A and S171T were similar to 1400-fold and 8-fold greater than the wild type, respectively. Studies on the pH dependence of S171A with oxygen showed that the rate constant of H2O2 elimination increased with pH rise and exhibited an approximate pK(a) of 8.0. These results indicated that the interaction of the hydroxyl group side chain of Ser-171 and flavin N5 is required for the stabilization of C4a-hydroperoxy-FMN. The double mutant S171A/H396V reacted with oxygen to directly form the oxidized flavin without stabilizing the C4a-hydroperoxy-FMN intermediate, which confirmed the findings based on the single mutation that His-396 was important for formation and Ser-171 for stabilization of the C4a-hydroperoxy FMN intermediate in C-2.	[Thotsaporn, Kittisak; Chenprakhon, Pirom; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Dept Biochem, Bangkok 10400, Thailand; [Thotsaporn, Kittisak; Chenprakhon, Pirom; Chaiyen, Pimchai] Mahidol Univ, Fac Sci, Ctr Excellence Prot Struct & Funct, Bangkok 10400, Thailand; [Sucharitakul, Jeerus] Chulalongkorn Univ, Fac Dent, Dept Biochem, Bangkok 10330, Thailand; [Mattevi, Andrea] Univ Pavia, Dept Genet & Microbiol, I-27100 Pavia, Italy	Mahidol University; Mahidol University; Chulalongkorn University; University of Pavia	Chaiyen, P (corresponding author), Mahidol Univ, Fac Sci, Dept Biochem, Rama 6 Rd, Bangkok 10400, Thailand.	scpcy@mahidol.ac.th	Mattevi, Andrea/R-4469-2019; mattevi, andrea/K-5464-2012; Chaiyen, Pimchai/R-5052-2019	Mattevi, Andrea/0000-0002-9523-7128; mattevi, andrea/0000-0002-9523-7128; Chaiyen, Pimchai/0000-0002-8533-1604; Chenprakhon, Pirom/0000-0002-5927-6920	Thailand Research Fund [BRG5480001, MRG5380240]; Faculty of Science, Mahidol University; Royal Golden Jubilee Ph. D. Program [PHD/0008/2549]; Institute for the Promotion of Teaching Science and Technology	Thailand Research Fund(Thailand Research Fund (TRF)); Faculty of Science, Mahidol University; Royal Golden Jubilee Ph. D. Program(Thailand Research Fund (TRF)); Institute for the Promotion of Teaching Science and Technology	This work was supported by the Thailand Research Fund Grant BRG5480001 and a grant from the Faculty of Science, Mahidol University (to P. C.).; Supported by the Royal Golden Jubilee Ph. D. Program Grant PHD/0008/2549.; Supported by the Institute for the Promotion of Teaching Science and Technology.; Supported by the Thailand Research Fund Grant MRG5380240.	Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Ballou DP, 2005, BIOCHEM BIOPH RES CO, V338, P590, DOI 10.1016/j.bbrc.2005.09.081; Bitto E, 2008, PROTEINS, V70, P289, DOI 10.1002/prot.21627; Bruender NA, 2010, BIOCHEMISTRY-US, V49, P3517, DOI 10.1021/bi100318v; BRUICE TC, 1984, ISRAEL J CHEM, V24, P54; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P13856, DOI 10.1021/bi9715122; Chaiyen P, 1997, BIOCHEMISTRY-US, V36, P8060, DOI 10.1021/bi970089u; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chaiyen P, 2010, ARCH BIOCHEM BIOPHYS, V493, P62, DOI 10.1016/j.abb.2009.08.021; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Dresen C, 2010, J BIOL CHEM, V285, P22264, DOI 10.1074/jbc.M109.099028; Ellis HR, 2010, ARCH BIOCHEM BIOPHYS, V497, P1, DOI 10.1016/j.abb.2010.02.007; Entsch B, 2005, ARCH BIOCHEM BIOPHYS, V433, P297, DOI 10.1016/j.abb.2004.09.029; Fagan RL, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P37; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; Heemstra JR, 2008, J AM CHEM SOC, V130, P14024, DOI 10.1021/ja806467a; Hu Y, 2008, J AM CHEM SOC, V130, P15756, DOI 10.1021/ja8051415; Kim SH, 2008, PROTEINS, V70, P718, DOI 10.1002/prot.21534; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Koskiniemi H, 2007, J MOL BIOL, V372, P633, DOI 10.1016/j.jmb.2007.06.087; Li L, 2008, J MOL BIOL, V376, P453, DOI 10.1016/j.jmb.2007.11.069; Lin SJ, 2008, J AM CHEM SOC, V130, P6616, DOI 10.1021/ja710601d; MASSEY V, 1971, FLAVINS FLAVOPROTEIN, P349; Mirza IA, 2009, J AM CHEM SOC, V131, P8848, DOI 10.1021/ja9010578; Okai M, 2006, BIOCHEMISTRY-US, V45, P5103, DOI 10.1021/bi052313i; Orru R, 2010, J BIOL CHEM, V285, P35021, DOI 10.1074/jbc.M110.161372; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Pitsawong W, 2010, J BIOL CHEM, V285, P9697, DOI 10.1074/jbc.M109.073247; Ruangchan N, 2011, J BIOL CHEM, V286, P223, DOI 10.1074/jbc.M110.163881; Sheng DW, 2001, BIOCHEMISTRY-US, V40, P11156, DOI 10.1021/bi011153h; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2005, BIOCHEMISTRY-US, V44, P10434, DOI 10.1021/bi050615e; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Sucharitakul J, 2011, J BIOL CHEM, V286, P16900, DOI 10.1074/jbc.M111.222976; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Ukaegbu UE, 2010, BIOCHEMISTRY-US, V49, P1678, DOI 10.1021/bi901693u; Valton J, 2008, J BIOL CHEM, V283, P10287, DOI 10.1074/jbc.M709730200; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; VENKATARAM UV, 1984, J CHEM SOC CHEM COMM, P899, DOI 10.1039/c39840000899; Vey JL, 2010, BIOCHEMISTRY-US, V49, P9306, DOI 10.1021/bi101336u; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Yeh E, 2007, BIOCHEMISTRY-US, V46, P1284, DOI 10.1021/bi0621213; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhang H, 2007, J AM CHEM SOC, V129, P14670, DOI 10.1021/ja0744854	48	54	56	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28170	28180		10.1074/jbc.M111.241836	http://dx.doi.org/10.1074/jbc.M111.241836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680741	Green Published, hybrid			2022-12-25	WOS:000293557800035
J	Parkkinen, T; Boer, H; Janis, J; Andberg, M; Penttila, M; Koivula, A; Rouvinen, J				Parkkinen, Tarja; Boer, Harry; Janis, Janne; Andberg, Martina; Penttila, Merja; Koivula, Anu; Rouvinen, Juha			Crystal Structure of Uronate Dehydrogenase from Agrobacterium tumefaciens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID	Uronate dehydrogenase from Agrobacterium tumefaciens (AtUdh) belongs to the short-chain dehydrogenase/reductase superfamily and catalyzes the oxidation of D-galacturonic acid and D-glucuronic acid with NAD(+) as a cofactor. We have determined the crystal structures of an apo-form of AtUdh, a ternary form in complex with NADH and product (substrate-soaked structure), and an inactive Y136A mutant in complex with NAD(+). The crystal structures suggest AtUdh to be a homohexamer, which has also been observed to be the major form in solution. The monomer contains a Rossmann fold, essential for nucleotide binding and a common feature of the short-chain dehydrogenase/reductase family enzymes. The ternary complex structure reveals a product, D-galactaro-1,5-lactone, which is bound above the nicotinamide ring. This product rearranges in solution to D-galactaro-1,4-lactone as verified by mass spectrometry analysis, which agrees with our previous NMR study. The crystal structure of the mutant with the catalytic residue Tyr-136 substituted with alanine shows changes in the position of Ile-74 and Ser-75. This probably altered the binding of the nicotinamide end of NAD(+), which was not visible in the electron density map. The structures presented provide novel insights into cofactor and substrate binding and the reaction mechanism of AtUdh. This information can be applied to the design of efficient microbial conversion of D-galacturonic acid-based waste materials.	[Parkkinen, Tarja; Janis, Janne; Rouvinen, Juha] Univ Eastern Finland, Dept Chem, FI-80101 Joensuu, Finland; [Boer, Harry; Andberg, Martina; Penttila, Merja; Koivula, Anu] VTT Tech Res Ctr Finland, FI-02044 Espoo, Finland	University of Eastern Finland; VTT Technical Research Center Finland	Rouvinen, J (corresponding author), Univ Eastern Finland, Dept Chem, POB 111, FIN-80101 Joensuu, Finland.	juha.rouvinen@uef.fi	Penttilä, Merja E/A-4710-2013; Jänis, Janne/B-7326-2014	Boer, Harry/0000-0002-1685-2270; Rouvinen, Juha/0000-0003-1843-5718; Koivula, Anu/0000-0002-7600-5700; Parkkinen, Tarja/0000-0002-2348-0508; Blomster Andberg, Martina/0000-0002-8021-9947; Penttila, Merja/0000-0002-6929-1032	Academy of Finland through the Finnish Centre of Excellence in White Biotechnology-Green Chemistry [118573]	Academy of Finland through the Finnish Centre of Excellence in White Biotechnology-Green Chemistry(Academy of Finland)	This work was supported by the Academy of Finland through the Finnish Centre of Excellence in White Biotechnology-Green Chemistry (Decision 118573).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allard STM, 2004, J BIOL CHEM, V279, P2211, DOI 10.1074/jbc.M310134200; Boer H, 2010, APPL MICROBIOL BIOT, V86, P901, DOI 10.1007/s00253-009-2333-9; CHANG YF, 1970, J BACTERIOL, V102, P85, DOI 10.1128/JB.102.1.85-96.1970; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; JORNVALL H, 1995, BIOCHEMISTRY-US, V34, P6003, DOI 10.1021/bi00018a001; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; KILGORE WW, 1959, NATURE, V183, P1412, DOI 10.1038/1831412a0; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Pasanen S, 2007, INT J MASS SPECTROM, V263, P22, DOI 10.1016/j.ijms.2006.12.002; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Richard P, 2009, APPL MICROBIOL BIOT, V82, P597, DOI 10.1007/s00253-009-1870-6; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; UEBERSCH.KH, 1974, EUR J BIOCHEM, V48, P389, DOI 10.1111/j.1432-1033.1974.tb03780.x; WAGNER G, 1976, EUR J BIOCHEM, V61, P589, DOI 10.1111/j.1432-1033.1976.tb10054.x; Yasutake Y, 2007, J MOL BIOL, V367, P1034, DOI 10.1016/j.jmb.2007.01.029; Yoon SH, 2009, J BACTERIOL, V191, P1565, DOI 10.1128/JB.00586-08; ZAJIC JE, 1959, J BACTERIOL, V78, P734, DOI 10.1128/JB.78.5.734-735.1959	23	23	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27294	27300		10.1074/jbc.M111.254854	http://dx.doi.org/10.1074/jbc.M111.254854			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21676870	hybrid, Green Published			2022-12-25	WOS:000293268700025
J	Varum, S; Rodrigues, AS; Moura, MB; Momcilovic, O; Easley, CA; Ramalho-Santos, J; Van Houten, B; Schatten, G				Varum, Sandra; Rodrigues, Ana S.; Moura, Michelle B.; Momcilovic, Olga; Easley, Charles A.; Ramalho-Santos, Joao; Van Houten, Bennett; Schatten, Gerald			Energy Metabolism in Human Pluripotent Stem Cells and Their Differentiated Counterparts	PLOS ONE			English	Article							GLUCOSE; HEXOKINASE; MITOCHONDRIA; EXPRESSION; PYRUVATE; TISSUE; GENES; MYC; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; METHYLATION	Background: Human pluripotent stem cells have the ability to generate all cell types present in the adult organism, therefore harboring great potential for the in vitro study of differentiation and for the development of cell-based therapies. Nonetheless their use may prove challenging as incomplete differentiation of these cells might lead to tumoregenicity. Interestingly, many cancer types have been reported to display metabolic modifications with features that might be similar to stem cells. Understanding the metabolic properties of human pluripotent stem cells when compared to their differentiated counterparts can thus be of crucial importance. Furthermore recent data has stressed distinct features of different human pluripotent cells lines, namely when comparing embryo-derived human embryonic stem cells (hESCs) and induced pluripotent stem cells (IPSCs) reprogrammed from somatic cells. Methodology/Principal Findings: We compared the energy metabolism of hESCs, IPSCs, and their somatic counterparts. Focusing on mitochondria, we tracked organelle localization and morphology. Furthermore we performed gene expression analysis of several pathways related to the glucose metabolism, including glycolysis, the pentose phosphate pathway and the tricarboxylic acid (TCA) cycle. In addition we determined oxygen consumption rates (OCR) using a metabolic extracellular flux analyzer, as well as total intracellular ATP levels by high performance liquid chromatography (HPLC). Finally we explored the expression of key proteins involved in the regulation of glucose metabolism. Conclusions/Findings: Our results demonstrate that, although the metabolic signature of IPSCs is not identical to that of hESCs, nonetheless they cluster with hESCs rather than with their somatic counterparts. ATP levels, lactate production and OCR revealed that human pluripotent cells rely mostly on glycolysis to meet their energy demands. Furthermore, our work points to some of the strategies which human pluripotent stem cells may use to maintain high glycolytic rates, such as high levels of hexokinase II and inactive pyruvate dehydrogenase (PDH).	[Varum, Sandra; Rodrigues, Ana S.; Momcilovic, Olga; Easley, Charles A.; Schatten, Gerald] Magee Womens Res Inst, Pittsburgh Dev Ctr, Pittsburgh, PA USA; [Rodrigues, Ana S.] Univ Coimbra, Ctr Neurosci & Cell Biol, PhD Programme Expt Biol & Biomed PDBEB, Coimbra, Portugal; [Varum, Sandra; Rodrigues, Ana S.; Ramalho-Santos, Joao] Univ Coimbra, Dept Life Sci, Coimbra, Portugal; [Moura, Michelle B.; Van Houten, Bennett] Univ Pittsburgh Sch Med, Univ Pittsburgh Canc Inst, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Schatten, Gerald] Univ Pittsburgh Sch Med, Dept Obstet Gynecol & Reprod Sci & Cell Biol Phys, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Universidade de Coimbra; Universidade de Coimbra; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Varum, S (corresponding author), Magee Womens Res Inst, Pittsburgh Dev Ctr, Pittsburgh, PA USA.	schattengp@upmc.edu	Santos, João/HHZ-5595-2022; Van Houten, Bennett/K-2284-2019; Ramalho-Santos, João/F-8641-2012; Rodrigues, Ana Sofia/ABA-9042-2020; Schatten, Gerald/B-3253-2009	Ramalho-Santos, João/0000-0002-1172-4018; Rodrigues, Ana Sofia/0000-0001-7060-879X; Schatten, Gerald/0000-0001-5206-7782	National Institute of Health and Development [1P01HD047675, 1R01ES019566]; Fundacao para a Ciencia e Tecnologia Portugal (FCT) [PTDC/EBB-EBI/101114/2008, SFRH/BD/33463/2008]; PA CURE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD047675] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES019566] Funding Source: NIH RePORTER	National Institute of Health and Development; Fundacao para a Ciencia e Tecnologia Portugal (FCT)(Portuguese Foundation for Science and Technology); PA CURE; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by grants from the National Institute of Health and Development, 1P01HD047675(GS), 1R01ES019566 (BVH), Fundacao para a Ciencia e Tecnologia Portugal (FCT), PTDC/EBB-EBI/101114/2008 (JRS) and PA CURE (BVH). ASR is a recipient of a fellowship from FCT SFRH/BD/33463/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS FH, 1971, J PEDIATR-US, V78, P837, DOI 10.1016/S0022-3476(71)80356-6; ARORA KK, 1988, J BIOL CHEM, V263, P17422; Berridge MV, 2010, MITOCHONDRION, V10, P584, DOI 10.1016/j.mito.2010.08.002; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Boros LG, 2000, CANCER RES, V60, P1183; BUSTAMANTE E, 1981, J BIOL CHEM, V256, P8699; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; Cascante M, 2000, NUTR CANCER, V36, P150, DOI 10.1207/S15327914NC3602_2; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; Cinelli P, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-57; Coussens M, 2010, P NATL ACAD SCI USA, V107, P13842, DOI 10.1073/pnas.0913834107; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Ferreira LMR, 2010, EXP MOL PATHOL, V89, P372, DOI 10.1016/j.yexmp.2010.08.006; FISCHER B, 1993, J REPROD FERTIL, V99, P673, DOI 10.1530/jrf.0.0990673; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; GolshaniHebroni SG, 1997, J BIOENERG BIOMEMBR, V29, P331, DOI 10.1023/A:1022442629543; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Heikkinen S, 1999, J BIOL CHEM, V274, P22517, DOI 10.1074/jbc.274.32.22517; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Houghton FD, 2006, DIFFERENTIATION, V74, P11, DOI 10.1111/j.1432-0436.2006.00052.x; Hussein SM, 2011, NATURE, V471, P58, DOI 10.1038/nature09871; JOSE C, 2010, BIOCHIM BIOPHYS ACTA; Kim JW, 2004, MOL CELL BIOL, V24, P5923, DOI 10.1128/MCB.24.13.5923-5936.2004; KLETZIEN RF, 1994, FASEB J, V8, P174, DOI 10.1096/fasebj.8.2.8119488; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; LEESE HJ, 1984, J REPROD FERTIL, V72, P9, DOI 10.1530/jrf.0.0720009; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Loiseau D, 2009, MOL CARCINOGEN, V48, P733, DOI 10.1002/mc.20539; Madhok BM, 2010, BRIT J CANCER, V102, P1746, DOI 10.1038/sj.bjc.6605701; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Majewski N, 2004, MOL CELL BIOL, V24, P730, DOI 10.1128/MCB.24.2.730-740.2004; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Qian W, 2010, METHODS, V51, P452, DOI 10.1016/j.ymeth.2010.03.006; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; St John JC, 2005, CLONING STEM CELLS, V7, P141, DOI 10.1089/clo.2005.7.141; STERN S, 1971, J EXP ZOOL, V176, P179, DOI 10.1002/jez.1401760206; Suhr ST, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0008124, 10.1371/journal.pone.0014095]; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tian WN, 1998, J BIOL CHEM, V273, P10609, DOI 10.1074/jbc.273.17.10609; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Wamelink MMC, 2005, J CHROMATOGR B, V823, P18, DOI 10.1016/j.jchromb.2005.01.001; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Wu KJ, 1999, SCIENCE, V283, P676, DOI 10.1126/science.283.5402.676; Yeung TM, 2011, P NATL ACAD SCI USA, V108, P4382, DOI 10.1073/pnas.1014519107; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; ZHAO T, 2011, NATURE	57	484	494	5	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20914	10.1371/journal.pone.0020914	http://dx.doi.org/10.1371/journal.pone.0020914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698063	Green Published, Green Accepted, gold			2022-12-25	WOS:000291737600032
J	Xu, Y; Liu, LF; Qiu, XS; Jiang, LL; Huang, B; Li, HY; Li, ZX; Luo, WT; Wang, EH				Xu, Ying; Liu, Lifeng; Qiu, Xueshan; Jiang, Lili; Huang, Bo; Li, Haiying; Li, Zixuan; Luo, Wenting; Wang, Enhua			CCL21/CCR7 Promotes G(2)/M Phase Progression via the ERK Pathway in Human Non-Small Cell Lung Cancer Cells	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; CC-CHEMOKINE RECEPTOR-7; MATURE DENDRITIC CELLS; N-TERMINAL KINASE; MAMMALIAN FIBROBLASTS; CYCLIN-A; PROTEIN-KINASES; DOWN-REGULATION; MELANOMA-CELLS; T-LYMPHOCYTES	C-C chemokine receptor 7 (CCR7) contributes to the survival of certain cancer cell lines, but its role in the proliferation of human non-small cell lung cancer (NSCLC) cells remains vague. Proliferation assays performed on A549 and H460 NSCLC cells using Cell Counting Kit-8 indicated that activation of CCR7 by its specific ligand, exogenous chemokine ligand 21 (CCL21), was associated with a significant linear increase in cell proliferation with duration of exposure to CCL21. The CCL21/CCR7 interaction significantly increased the fraction of cells in the G(2)/M phase of the cell cycle as measured by flow cytometry. In contrast, CCL21/CCR7 had no significant influence on the G(0)/G(1) and S phases. Western blot and real-time PCR indicated that CCL21/CCR7 significantly upregulated expression of cyclin A, cyclin B1, and cyclin-dependent kinase 1 (CDK1), which are related to the G(2)/M phase transition. The expression of cyclin D1 and cyclin E, which are related to the G(0)/G(1) and G(1)/S transitions, was not altered. The CCL21/CCR7 interaction significantly enhanced phosphorylation of extracellular signal-regulated kinase (P-ERK) but not Akt, as measured by Western blot. LY294002, a selective inhibitor of PI3K that prevents activation of the downstream Akt, did not weaken the effect of CCL21/CCR7 on P-ERK. Coimmunoprecipitation further confirmed that there was an interaction between P-ERK and cyclin A, cyclin B1, or CDK1, particularly in the presence of CCL21. CCR7 small interfering RNA or PD98059, a selective inhibitor of MEK that disrupts the activation of downstream ERK, significantly abolished the effects of exogenous CCL21. These results suggest that CCL21/CCR7 contributes to the time-dependent proliferation of human NSCLC cells by upregulating cyclin A, cyclin B1, and CDK1 potentially via the ERK pathway.	[Xu, Ying; Qiu, Xueshan; Jiang, Lili; Huang, Bo; Li, Haiying; Li, Zixuan; Luo, Wenting; Wang, Enhua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Liaoning, Peoples R China; [Xu, Ying; Qiu, Xueshan; Jiang, Lili; Huang, Bo; Li, Haiying; Li, Zixuan; Luo, Wenting; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China; [Xu, Ying; Qiu, Xueshan; Jiang, Lili; Huang, Bo; Li, Haiying; Li, Zixuan; Luo, Wenting; Wang, Enhua] China Med Univ, Inst Pathol & Pathophysiol, Shenyang, Liaoning, Peoples R China; [Liu, Lifeng] China Med Univ, Affiliated Hosp 1, Dept Orthopaed, Shenyang, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Qiu, XS (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Liaoning, Peoples R China.	xueshan-qiu@hotmail.com			National Natural Science Foundation of China [30972967]; Research Fund for the Doctoral Program of the Higher Education of China [20092104110018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of the Higher Education of China	This work was supported by grants from National Natural Science Foundation of China (No. 30972967) and Research Fund for the Doctoral Program of the Higher Education of China (No. 20092104110018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arenberg DA, 2001, CANCER IMMUNOL IMMUN, V49, P587, DOI 10.1007/s002620000147; Badr G, 2005, INT IMMUNOL, V17, P459, DOI 10.1093/intimm/dxh227; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Banas B, 2004, KIDNEY INT, V66, P2256, DOI 10.1111/j.1523-1755.2004.66037.x; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Curnock AP, 2002, IMMUNOLOGY, V105, P125, DOI 10.1046/j.1365-2567.2002.01345.x; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Dieu MC, 1998, J EXP MED, V188, P373, DOI 10.1084/jem.188.2.373; Ding YZ, 2003, CLIN CANCER RES, V9, P3406; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Escribano C, 2009, J IMMUNOL, V183, P6282, DOI 10.4049/jimmunol.0804093; GIRARD F, 1991, CELL, V67, P1169, DOI 10.1016/0092-8674(91)90293-8; Gollmer K, 2009, BLOOD, V114, P580, DOI 10.1182/blood-2009-01-200923; Hayne C, 2000, J BIOL CHEM, V275, P31876, DOI 10.1074/jbc.M002766200; Hirao M, 2000, CANCER RES, V60, P2209; Iijima N, 2005, INT IMMUNOL, V17, P1201, DOI 10.1093/intimm/dxh297; Ishigami S, 2007, HEPATO-GASTROENTEROL, V54, P1025; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; Jenh CH, 1999, J IMMUNOL, V162, P3765; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; KauffmanZeh A, 1997, NATURE, V385, P544, DOI 10.1038/385544a0; Kim JW, 2005, CLIN CANCER RES, V11, P7901, DOI 10.1158/1078-0432.CCR-05-1346; KING RW, 1994, CELL, V79, P563, DOI 10.1016/0092-8674(94)90542-8; KNOBLICH JA, 1993, EMBO J, V12, P65, DOI 10.1002/j.1460-2075.1993.tb05632.x; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kodama J, 2007, ANN ONCOL, V18, P70, DOI 10.1093/annonc/mdl342; Kulik G, 1997, MOL CELL BIOL, V17, P1595, DOI 10.1128/MCB.17.3.1595; Lee SJ, 2010, PHYTOTHER RES, V24, P1870, DOI 10.1002/ptr.3214; Li Y, 2009, CANCER BIOL THER, V8, P322, DOI 10.4161/cbt.8.4.7332; Li Z, 2008, CELL BIOL TOXICOL, V24, P401, DOI 10.1007/s10565-008-9054-1; Liu FY, 2010, BRIT J ORAL MAX SURG, V48, P291, DOI 10.1016/j.bjoms.2009.06.007; Liu LF, 2011, J PINEAL RES, V50, P222, DOI 10.1111/j.1600-079X.2010.00832.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Minden A, 1997, BBA-REV CANCER, V1333, pF85, DOI 10.1016/S0304-419X(97)00018-8; Mori T, 2005, CANCER RES, V65, P1800, DOI 10.1158/0008-5472.CAN-04-3531; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Pizarro JG, 2008, J PINEAL RES, V45, P8, DOI 10.1111/j.1600-079X.2007.00548.x; Riol-Blanco L, 2005, J IMMUNOL, V174, P4070, DOI 10.4049/jimmunol.174.7.4070; Roulston A, 1998, J BIOL CHEM, V273, P10232, DOI 10.1074/jbc.273.17.10232; Rudd BD, 2005, J VIROL, V79, P3350, DOI 10.1128/JVI.79.6.3350-3357.2005; Sanchez-Sanchez N, 2004, BLOOD, V104, P619, DOI 10.1182/blood-2003-11-3943; Shannon LA, 2010, J BIOL CHEM, V285, P38781, DOI 10.1074/jbc.M110.152173; Sozzani S, 1998, J IMMUNOL, V161, P1083; Takanami I, 2003, INT J CANCER, V105, P186, DOI 10.1002/ijc.11063; Takeuchi H, 2004, CLIN CANCER RES, V10, P2351, DOI 10.1158/1078-0432.CCR-03-0195; Wang J, 2005, ONCOGENE, V24, P5897, DOI 10.1038/sj.onc.1208740; Wang J, 2004, CANCER RES, V64, P1861, DOI 10.1158/0008-5472.CAN-03-2968; Wegiel B, 2008, INT J CANCER, V122, P1521, DOI 10.1002/ijc.23261; Wiley HE, 2001, J NATL CANCER I, V93, P1638, DOI 10.1093/jnci/93.21.1638; Wornle Markus, 2004, BMC Nephrol, V5, P8, DOI 10.1186/1471-2369-5-8; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Wu YM, 2009, J NEUROCHEM, V109, P1157, DOI 10.1111/j.1471-4159.2009.06043.x; Yu SY, 2008, CANCER BIOL THER, V7, P1037; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	58	33	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21119	10.1371/journal.pone.0021119	http://dx.doi.org/10.1371/journal.pone.0021119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698152	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100057
J	Greenwood, M; Clarke, C; Lee, CC; Gunsalam, A; Clarke, RH				Greenwood, Melinda; Clarke, Charles; Lee, Ch'ien C.; Gunsalam, Ansou; Clarke, Rohan H.			A Unique Resource Mutualism between the Giant Bornean Pitcher Plant, Nepenthes rajah, and Members of a Small Mammal Community	PLOS ONE			English	Article								The carnivorous pitcher plant genus Nepenthes grows in nutrient-deficient substrates and produce jug-shaped leaf organs (pitchers) that trap arthropods as a source of N and P. A number of Bornean Nepenthes demonstrate novel nutrient acquisition strategies. Notably, three giant montane species are engaged in a mutualistic association with the mountain treeshrew, Tupaia montana, in which the treeshrew defecates into the pitchers while visiting them to feed on nectar secretions on the pitchers' lids. Although the basis of this resource mutualism has been elucidated, many aspects are yet to be investigated. We sought to provide insights into the value of the mutualism to each participant. During initial observations we discovered that the summit rat, R. baluensis, also feeds on sugary exudates of N. rajah pitchers and defecates into them, and that this behavior appears to be habitual. The scope of the study was therefore expanded to assess to what degree N. rajah interacts with the small mammal community. We found that both T. montana and R. baluensis are engaged in a mutualistic interaction with N. rajah. T. montana visit pitchers more frequently than R. baluensis, but daily scat deposition rates within pitchers do not differ, suggesting that the mutualistic relationships are of a similar strength. This study is the first to demonstrate that a mutualism exists between a carnivorous plant species and multiple members of a small mammal community. Further, the newly discovered mutualism between R. baluensis and N. rajah represents only the second ever example of a multidirectional resource-based mutualism between a mammal and a carnivorous plant.	[Greenwood, Melinda; Clarke, Rohan H.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia; [Clarke, Charles] Monash Univ, Sch Sci, Bandar Sunway, Selangor, Malaysia; [Gunsalam, Ansou] Sabah Pk, Kota Kinabalu, Sabah, Malaysia	Monash University; Monash University; Monash University Sunway	Greenwood, M (corresponding author), Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.	rohan.clarke@monash.edu	Clarke, Rohan/A-9462-2013		Monash University Sunway Campus	Monash University Sunway Campus(Monash University)	The research was funded by an internal research grant from Monash University Sunway Campus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker HG, 1998, BIOTROPICA, V30, P559, DOI 10.1111/j.1744-7429.1998.tb00097.x; Chin LJ, 2010, NEW PHYTOL, V186, P461, DOI 10.1111/j.1469-8137.2009.03166.x; Clarke C, 2006, NEPENTHES BORNEO; CLARKE C, 2010, PLANT SIGNA IN PRESS, V5; Clarke CM, 2009, BIOL LETTERS, V5, P632, DOI 10.1098/rsbl.2009.0311; CLARKE MC, 2001, NEPENTHES SUMATRA PE; Emmons L.H., 2000, TUPAI FIELD STUDY BO; *GEOSC AUSTR, 2010, GEOD GPS ASTR INF; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; GRAFE TU, 2011, BIOL LETT IN PRESS; Jebb M, 1997, BLUMEA, V42, P1; Juniper B.E., 1989, CARNIVOROUS PLANTS; Moran JA, 2003, INT J PLANT SCI, V164, P635, DOI 10.1086/375422; PAYNE J, 2005, FIELD GUIDE MAMMALS	14	26	26	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e21114	10.1371/journal.pone.0021114	http://dx.doi.org/10.1371/journal.pone.0021114			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695073	Green Published, gold, Green Submitted			2022-12-25	WOS:000291682300030
J	Zardi, GI; Nicastro, KR; Canovas, F; Costa, JF; Serrao, EA; Pearson, GA				Zardi, Gerardo I.; Nicastro, Katy R.; Canovas, Fernando; Costa, Joana Ferreira; Serrao, Ester A.; Pearson, Gareth A.			Adaptive Traits Are Maintained on Steep Selective Gradients despite Gene Flow and Hybridization in the Intertidal Zone	PLOS ONE			English	Article							FUCUS-SPIRALIS; LITTORINA-SAXATILIS; MATING SYSTEM; FUCOID ALGAE; REPRODUCTIVE ISOLATION; ECOLOGICAL DIVERGENCE; VESICULOSUS FUCACEAE; ASCOPHYLLUM-NODOSUM; MICROSATELLITE LOCI; SEQUENCE ALIGNMENT	Gene flow among hybridizing species with incomplete reproductive barriers blurs species boundaries, while selection under heterogeneous local ecological conditions or along strong gradients may counteract this tendency. Congeneric, externally-fertilizing fucoid brown algae occur as distinct morphotypes along intertidal exposure gradients despite gene flow. Combining analyses of genetic and phenotypic traits, we investigate the potential for physiological resilience to emersion stressors to act as an isolating mechanism in the face of gene flow. Along vertical exposure gradients in the intertidal zone of Northern Portugal and Northwest France, the mid-low shore species Fucus vesiculosus, the upper shore species Fucus spiralis, and an intermediate distinctive morphotype of F. spiralis var. platycarpus were morphologically characterized. Two diagnostic microsatellite loci recovered 3 genetic clusters consistent with prior morphological assignment. Phylogenetic analysis based on single nucleotide polymorphisms in 14 protein coding regions unambiguously resolved 3 clades; sympatric F. vesiculosus, F. spiralis, and the allopatric (in southern Iberia) population of F. spiralis var. platycarpus. In contrast, the sympatric F. spiralis var. platycarpus (from Northern Portugal) was distributed across the 3 clades, strongly suggesting hybridization/introgression with both other entities. Common garden experiments showed that physiological resilience following exposure to desiccation/heat stress differed significantly between the 3 sympatric genetic taxa; consistent with their respective vertical distribution on steep environmental clines in exposure time. Phylogenetic analyses indicate that F. spiralis var. platycarpus is a distinct entity in allopatry, but that extensive gene flow occurs with both higher and lower shore species in sympatry. Experimental results suggest that strong selection on physiological traits across steep intertidal exposure gradients acts to maintain the 3 distinct genetic and morphological taxa within their preferred vertical distribution ranges. On the strength of distributional, genetic, physiological and morphological differences, we propose elevation of F. spiralis var. platycarpus from variety to species level, as F. guiryi.	[Zardi, Gerardo I.; Nicastro, Katy R.; Canovas, Fernando; Costa, Joana Ferreira; Serrao, Ester A.; Pearson, Gareth A.] Univ Algarve, CCMAR CIMAR Lab Associado, Faro, Portugal	Universidade do Algarve	Zardi, GI (corresponding author), Univ Algarve, CCMAR CIMAR Lab Associado, Faro, Portugal.	katynicastro@yahoo.it	Zardi, Gerardo/M-4026-2013; Costa, Joana/A-6994-2014; Nicastro, Katy R/ABI-1531-2020; Pearson, Gareth/J-3911-2013; Serrao, Ester A/C-6686-2012; Nicastro, Katy/AAY-3692-2021; Cánovas, Fernando/M-3457-2013; Nicastro, Katy/D-2259-2012	Zardi, Gerardo/0000-0001-8798-5794; Costa, Joana/0000-0002-3482-840X; Nicastro, Katy R/0000-0002-7071-141X; Pearson, Gareth/0000-0002-0768-464X; Serrao, Ester A/0000-0003-1316-658X; Cánovas, Fernando/0000-0002-8837-1927; Nicastro, Katy/0000-0002-7071-141X	FCT, Portugal; ESF; FCT; FEDER [ADAPT POCTI (PPCDT)/MAR/61105/2004]	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); ESF(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FEDER(European Commission)	This research was supported by post-doctoral fellowships from FCT, Portugal and ESF (to GIZ, KRN and FC) and funded by projects from FCT (http://www.fct.pt) and FEDER (http://ec.europa.eu/regional_policy/funds/feder/index_pt.htm; ADAPT POCTI (PPCDT)/MAR/61105/2004) to GAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, PHILOS T R SOC B, V358, P1123, DOI 10.1098/rstb.2003.1289; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Batters E.A.L., 1902, CATALOGUE BRIT MARIN; BELL EC, 1995, J EXP MAR BIOL ECOL, V191, P29, DOI 10.1016/0022-0981(95)00037-R; Billard E, 2005, EUR J PHYCOL, V40, P397, DOI 10.1080/09670260500334354; Billard E, 2010, MAR ECOL PROG SER, V405, P163, DOI 10.3354/meps08517; BOERGESEN F, 1909, BOT J LINN SOC, V39, P105; Boller ML, 2007, J EXP BIOL, V210, P1874, DOI 10.1242/jeb.02775; Borge T, 2005, J EVOLUTION BIOL, V18, P1416, DOI 10.1111/j.1420-9101.2005.00964.x; Bradshaw AD, 1984, PERSPECTIVES PLANT P, P213; Broyles SB, 2002, EVOLUTION, V56, P1943, DOI 10.1111/j.0014-3820.2002.tb00120.x; BUTLER WL, 1978, ANNU REV PLANT PHYS, V29, P345, DOI 10.1146/annurev.pp.29.060178.002021; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; CHAPMAN ARO, 1990, HYDROBIOLOGIA, V192, P77, DOI 10.1007/BF00006228; CHAPMAN ARO, 1995, PHYCOLOGIA, V34, P1, DOI 10.2216/i0031-8884-34-1-1.1; CHAPMAN ARO, 1990, HYDROBIOLOGIA, V204, P205, DOI 10.1007/BF00040235; CHARLESWORTH D, 1995, GENETICS, V140, P415; Collado-Vides L, 1999, J PHYCOL, V35, P325, DOI 10.1046/j.1529-8817.1999.3520325.x; Connell J.H., 1972, Annual Rev Ecol Syst, V3, P169, DOI 10.1146/annurev.es.03.110172.001125; COSTICH DE, 1992, J EVOLUTION BIOL, V5, P589, DOI 10.1046/j.1420-9101.1992.5040589.x; Coyer JA, 2006, MOL PHYLOGENET EVOL, V39, P209, DOI 10.1016/j.ympev.2006.01.019; Coyer JA, 2002, MOL ECOL NOTES, V2, P35, DOI 10.1046/j.1471-8278 .2001.00138.x; COYER JA, 2010, MOL PHYLOGE IN PRESS; Coyer JA, 2006, BIOL LETT-UK, V2, P405, DOI 10.1098/rsbl.2006.0489; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Davison IR, 1996, J PHYCOL, V32, P197, DOI 10.1111/j.0022-3646.1996.00197.x; DEPAULA EJ, 1982, PHYCOLOGIA, V21, P145, DOI 10.2216/i0031-8884-21-2-145.1; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; DRING MJ, 1982, MAR ECOL PROG SER, V8, P301, DOI 10.3354/meps008301; DROMGOOLE FI, 1980, BOT MAR, V23, P149, DOI 10.1515/botm.1980.23.3.149; DRUEHL LD, 1982, CAN J BOT, V60, P1409, DOI 10.1139/b82-179; Dudgeon S, 2001, FUNCT ECOL, V15, P595, DOI 10.1046/j.0269-8463.2001.00559.x; ENDLER JA, 1973, SCIENCE, V179, P243, DOI 10.1126/science.179.4070.243; Engel CR, 2005, MOL ECOL, V14, P2033, DOI 10.1111/j.1365-294X.2005.02558.x; Engel CR, 2003, MOL ECOL NOTES, V3, P180, DOI 10.1046/j.1471-8286.2003.00390.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fitzpatrick BM, 2008, J EVOLUTION BIOL, V21, P1452, DOI 10.1111/j.1420-9101.2008.01611.x; Galindo J, 2009, MOL ECOL, V18, P919, DOI 10.1111/j.1365-294X.2008.04076.x; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gao H, 2007, GENETICS; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; GUIRY MD, 2009, ALGAEBASE WORLD WIDE; Hamrick JL, 1997, CROP SCI, V37, P26, DOI 10.2135/cropsci1997.0011183X003700010004x; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HAWKINS SJ, 1985, MAR ECOL PROG SER, V20, P265, DOI 10.3354/meps020265; Hay ME, 1986, EC PLANT FORM FUNCTI, P635; Hays CG, 2007, ECOLOGY, V88, P149, DOI 10.1890/0012-9658(2007)88[149:APDATI]2.0.CO;2; Hey J, 2006, CURR OPIN GENET DEV, V16, P592, DOI 10.1016/j.gde.2006.10.005; Hoekstra HE, 2004, EVOLUTION, V58, P1329; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hunt LJH, 2008, J PHYCOL, V44, P1164, DOI 10.1111/j.1529-8817.2008.00578.x; Johannesson K, 1995, EVOLUTION, V49, P1180, DOI 10.1111/j.1558-5646.1995.tb04445.x; Johannesson K, 2009, EVOL ECOL, V23, P5, DOI 10.1007/s10682-007-9225-1; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirkpatrick M, 2001, P ROY SOC B-BIOL SCI, V268, P1259, DOI 10.1098/rspb.2000.1427; Ladah LB, 2008, MAR BIOL, V155, P583, DOI 10.1007/s00227-008-1054-4; Lenormand T, 2002, TRENDS ECOL EVOL, V17, P183, DOI 10.1016/S0169-5347(02)02497-7; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; MAY RM, 1975, AM NAT, V109, P659, DOI 10.1086/283036; Mayr E., 1963, ANIMAL SPECIES EVOLU, P797; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McCracken KG, 2009, MOL BIOL EVOL, V26, P815, DOI 10.1093/molbev/msp007; McNeill J., 2006, V146, P1; MCQUAID CD, 1988, BEHAV ADAPTATION INT, P213; Neiva J, 2010, MOL ECOL, V19, P4812, DOI 10.1111/j.1365-294X.2010.04853.x; Nicastro KR, 2008, MAR ECOL PROG SER, V368, P189, DOI 10.3354/meps07607; Palumbi SR, 2003, SCIENCE, V299, P51, DOI 10.1126/science.1080775; PARKE M, 1953, J MAR BIOL ASSOC UK, V32, P497, DOI 10.1017/S0025315400014685; Pearson G, 2006, EUR J PHYCOL, V41, P97, DOI 10.1080/09670260500505011; PEARSON G, 2009, MAR BIOTECHNOL, P1436; Pearson GA, 2006, INTEGR COMP BIOL, V46, P587, DOI 10.1093/icb/icl030; Pearson GA, 2009, J ECOL, V97, P450, DOI 10.1111/j.1365-2745.2009.01481.x; PEREZRUZAFA IM, 2001, FLORA PHYCOLOGIA IBE, P33; Perrin C, 2007, EUR J PHYCOL, V42, P219, DOI 10.1080/09670260701336554; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Postma E, 2005, NATURE, V433, P65, DOI 10.1038/nature03083; Pritchard JK, 2000, GENETICS, V155, P945; Quesada H, 2007, EVOLUTION, V61, P1600, DOI 10.1111/j.1558-5646.2007.00135.x; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; Rolan-Alvarez E, 1997, EVOLUTION, V51, P1838, DOI 10.1111/j.1558-5646.1997.tb05107.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schiel DR, 2006, ANNU REV ECOL EVOL S, V37, P343, DOI 10.1146/annurev.ecolsys.37.091305.110251; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Scott GW, 2001, EUR J PHYCOL, V36, P43, DOI 10.1017/S0967026201003055; Serrao EA, 1996, P NATL ACAD SCI USA, V93, P5286, DOI 10.1073/pnas.93.11.5286; Serrao EA, 1999, J PHYCOL, V35, P382, DOI 10.1046/j.1529-8817.1999.3520382.x; SERRAO EA, 1997, PHYCOLOGIA S, V36, P101; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Sokolova IM, 2003, J EXP BIOL, V206, P195, DOI 10.1242/jeb.00054; Sokolova IM, 2000, MAR BIOL, V137, P297, DOI 10.1007/s002270000343; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Sweigart AL, 2003, EVOLUTION, V57, P2490, DOI 10.1111/j.0014-3820.2003.tb01494.x; Swindell WR, 2006, CONSERV GENET, V7, P79, DOI 10.1007/s10592-005-8223-5; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; TING CS, 1993, PLANT PHYSIOL, V101, P1323, DOI 10.1104/pp.101.4.1323; Tomanek L, 2000, PHYSIOL BIOCHEM ZOOL, V73, P249, DOI 10.1086/316740; Wallace AL, 2004, J PHYCOL, V40, P1013, DOI 10.1111/j.1529-8817.2004.04085.x; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x	108	74	75	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e19402	10.1371/journal.pone.0019402	http://dx.doi.org/10.1371/journal.pone.0019402			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695117	Green Published, gold, Green Submitted			2022-12-25	WOS:000291682300001
J	Alama, A; Bruzzo, C; Cavalieri, Z; Forlani, A; Utkin, Y; Casciano, I; Romani, M				Alama, Angela; Bruzzo, Cristina; Cavalieri, Zita; Forlani, Alessandra; Utkin, Yuri; Casciano, Ida; Romani, Massimo			Inhibition of the Nicotinic Acetylcholine Receptors by Cobra Venom alpha-Neurotoxins: Is There a Perspective in Lung Cancer Treatment?	PLOS ONE			English	Article							NONNEURONAL ALPHA-7-NICOTINIC RECEPTOR; CHOLINERGIC SYSTEM; SUBUNIT GENES; MUSCLE-TYPE; EXPRESSION; CELLS; NEUROBLASTOMA; APOPTOSIS; TOXIN; SNAKE	Nicotine exerts its oncogenic effects through the binding to nicotinic acetylcholine receptors (nAChRs) and the activation of downstream pathways that block apoptosis and promote neo-angiogenesis. The nAChRs of the alpha 7 subtype are present on a wide variety of cancer cells and their inhibition by cobra venom neurotoxins has been proposed in several articles and reviews as a potential innovative lung cancer therapy. However, since part of the published results was recently retracted, we believe that the antitumoral activity of cobra venom neurotoxins needs to be independently re-evaluated. We determined the activity of alpha-neurotoxins from Naja atra (short-chain neurotoxin, alpha-cobrotoxin) and Naja kaouthia (long-chain neurotoxin, alpha-cobratoxin) in vitro by cytotoxicity measurements in 5 lung cancer cell lines, by colony formation assay with alpha 7nAChRs expressing and non-expressing cell lines and in vivo by assessing tumor growth in an orthotopic Non-Obese Diabetic/Severe Combined Immunodeficient (NOD/SCID) mouse model system utilizing different treatment schedules and dosages. No statistically significant reduction in tumor growth was observed in the treatment arms in comparison to the control for both toxins. Paradoxically alpha-cobrotoxin from Naja atra showed the tendency to enhance tumor growth although, even in this case, the statistical significance was not reached. In conclusion our results show that, in contrast with other reports, the nAChR inhibitors alpha-cobratoxin from N. kaouthia and alpha-cobrotoxin from N. atra neither suppressed tumor growth nor prolonged the survival of the treated animals.	[Alama, Angela; Bruzzo, Cristina; Cavalieri, Zita] IST, Lung Canc Unit, Ist Nazl Ric Cancro, Genoa, Italy; [Forlani, Alessandra; Casciano, Ida; Romani, Massimo] IST, Lab Tumor Genet & Epigenet, Ist Nazl Ric Cancro, Genoa, Italy; [Utkin, Yuri] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia	University of Genoa; IRCCS AOU San Martino IST; University of Genoa; IRCCS AOU San Martino IST; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Alama, A (corresponding author), IST, Lung Canc Unit, Ist Nazl Ric Cancro, Genoa, Italy.	massimo.romani@istge.it	Utkin, Yuri/L-2952-2019; Utkin, Yuri N./F-1958-2014; Alama, Angela/AAE-7203-2019	Utkin, Yuri/0000-0002-4609-970X; Utkin, Yuri N./0000-0002-4609-970X; Alama, Angela/0000-0002-9726-201X; casciano, ida/0000-0003-1776-670X	Italian Ministry of Health; Fondazione Compagnia di San Paolo, Torino	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Compagnia di San Paolo, Torino(Compagnia di San Paolo)	Funding was provided by the Italian Ministry of Health (www.salute.gov.it/) and Fondazione Compagnia di San Paolo, Torino (www.compagniadisanpaolo.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri F, 2001, CHEM-BIOL INTERACT, V134, P27, DOI 10.1016/S0009-2797(00)00249-0; Carlisle DL, 2007, PULM PHARMACOL THER, V20, P629, DOI 10.1016/j.pupt.2006.07.001; Casciano I, 2002, CELL DEATH DIFFER, V9, P246, DOI 10.1038/sj.cdd.4400993; Catassi A, 2008, EUR J CANCER, V44, P2296, DOI 10.1016/j.ejca.2008.06.045; Davis R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007524; De Ambrosis A, 2007, INT J CANCER, V120, P39, DOI 10.1002/ijc.22173; de Totero D, 2003, HAEMATOLOGICA, V88, P148; Egleton RD, 2008, TRENDS PHARMACOL SCI, V29, P151, DOI 10.1016/j.tips.2007.12.006; Egleton RD, 2009, PHARMACOL THERAPEUT, V121, P205, DOI 10.1016/j.pharmthera.2008.10.007; Feng Y, 2004, AM J HUM GENET, V75, P112, DOI 10.1086/422194; Feofanov AV, 2005, BIOCHEM J, V390, P11, DOI 10.1042/BJ20041892; Fruchart-Gaillard C, 2002, P NATL ACAD SCI USA, V99, P3216, DOI 10.1073/pnas.042699899; Grozio A, 2008, INT J CANCER, V122, P1911, DOI 10.1002/ijc.23298; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; IWAGUCHI T, 1985, BIOCHEM INT, V10, P343; Kukhtina VV, 2000, BIOORG KHIM+, V26, P803; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Li MD, 2005, HUM MOL GENET, V14, P1211, DOI 10.1093/hmg/ddi132; MANECKJEE R, 1994, CELL GROWTH DIFFER, V5, P1033; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Nirthanan S, 2004, J PHARMACOL SCI, V94, P1, DOI 10.1254/jphs.94.1; Osipov AV, 2008, J BIOL CHEM, V283, P14571, DOI 10.1074/jbc.M802085200; Paleari L, 2008, CELL PROLIFERAT, V41, P936, DOI 10.1111/j.1365-2184.2008.00566.x; Paleari L, 2008, SEMIN CANCER BIOL, V18, P211, DOI 10.1016/j.semcancer.2007.12.009; Paleari L, 2006, INT J ONCOL, V29, P1381; Paleari L, 2009, DRUG DISCOV TODAY, V14, P822, DOI 10.1016/j.drudis.2009.06.016; Paleari L, 2009, AM J RESP CRIT CARE, V179, P1141, DOI 10.1164/rccm.200806-908OC; Paleari L, 2009, INT J CANCER, V125, P199, DOI 10.1002/ijc.24299; Plummer HK, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-29; Romani M, 1999, INT J CANCER, V84, P365, DOI 10.1002/(SICI)1097-0215(19990820)84:4<365::AID-IJC6>3.0.CO;2-X; Russo P, 2006, CURR MED CHEM, V13, P3493, DOI 10.2174/092986706779026192; Schuller HM, 2008, ANTI-CANCER DRUG, V19, P655, DOI 10.1097/CAD.0b013e3283025b58; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 2000, EUR J PHARMACOL, V393, P265, DOI 10.1016/S0014-2999(00)00094-7; Schuller HM, 1998, BIOCHEM PHARMACOL, V55, P1377, DOI 10.1016/S0006-2952(97)00651-5; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Spindel ER, 2009, AM J RESP CRIT CARE, V179, P1081, DOI 10.1164/rccm.200901-0013ED; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tsetlin VI, 2004, FEBS LETT, V557, P9, DOI 10.1016/S0014-5793(03)01454-6; Utkin YN, 2001, J BIOL CHEM, V276, P15810, DOI 10.1074/jbc.M100788200; Wessler I, 1998, PHARMACOL THERAPEUT, V77, P59, DOI 10.1016/S0163-7258(97)00085-5; Witkop B, 1999, P AM PHILOS SOC, V143, P540	43	29	30	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20695	10.1371/journal.pone.0020695	http://dx.doi.org/10.1371/journal.pone.0020695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695184	gold, Green Published, Green Submitted			2022-12-25	WOS:000291663300011
J	Weinstein, SJ; Yu, K; Horst, RL; Parisi, D; Virtamo, J; Albanes, D				Weinstein, Stephanie J.; Yu, Kai; Horst, Ronald L.; Parisi, Dominick; Virtamo, Jarmo; Albanes, Demetrius			Serum 25-Hydroxyvitamin D and Risk of Lung Cancer in Male Smokers: A Nested Case-Control Study	PLOS ONE			English	Article							VITAMIN-D STATUS; SEASONAL VARIABILITY; SURVIVAL; COHORT; POLYMORPHISMS; MORTALITY; PROSTATE	Background: A role for vitamin D in cancer risk reduction has been hypothesized, but few data exist for lung cancer. We investigated the relationship between vitamin D status, using circulating 25-hydroxyvitamin D [25(OH) D], and lung cancer risk in a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study of Finnish male smokers. Methods: Lung cancer cases (n = 500) were randomly selected based on month of blood collection, and 500 controls were matched to them based on age and blood collection date. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using multivariate-adjusted conditional logistic regression. To account for seasonal variation in 25(OH) D concentrations, season-specific and season-standardized quintiles of 25(OH) D were examined, and models were also stratified on season of blood collection (darker season = November-April and sunnier season = May-October). Predetermined, clinically-defined cutpoints for 25(OH) D and 25(OH) D as a continuous measure were also examined. Results: Overall, 25(OH) D was not associated with lung cancer. Risks were 1.08 (95% CI 0.67-1.75) and 0.83 (95% CI 0.53-1.31) in the highest vs. lowest season-specific and season-standardized quintiles of 25(OH) D, respectively, and 0.91 (95% CI 0.48-1.72) for the >= 75 vs. <25 nmol/L clinical categories. Inverse associations were, however, suggested for subjects with blood collections from November-April, with ORs of 0.77 (95% CI 0.41-1.45, p-trend = 0.05) and 0.65 (95% CI 0.37-1.14, p-trend = 0.07) in the highest vs. lowest season-specific and season-standardized quintiles of 25(OH) D, respectively, and 0.61 (95% CI 0.24-1.52, p-trend = 0.01) for >= 75 vs. <25 nmol/L. We also found 11% lower risk for a 10 nmol/L increase in 25(OH) D in the darker season based on the continuous measure (OR = 0.89, 95% CI 0.81-0.98, p = 0.02). Conclusion: In this prospective study of male smokers, circulating 25(OH) D was not associated with lung cancer risk overall, although inverse associations were suggested among those whose blood was drawn during darker months.	[Weinstein, Stephanie J.; Yu, Kai; Albanes, Demetrius] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Horst, Ronald L.] Heartland Assays Inc, Ames, IA USA; [Parisi, Dominick] Informat Management Serv Inc, Silver Spring, MD USA; [Virtamo, Jarmo] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Information Management Services, Inc.; Finland National Institute for Health & Welfare	Weinstein, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	weinstes@mail.nih.gov	Weinstein, Stephanie J/P-1627-2017; Albanes, Demetrius/B-9749-2015	Weinstein, Stephanie J/0000-0002-3834-1535; 	National Institutes of Health; National Cancer Institute; National Cancer Institute, Department of Health and Human Services [N01-CN-45165, N01-RC-45035, N01-RC-37004]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIACP010195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the National Institutes of Health and the National Cancer Institute. Additionally, this research was supported by Public Health Service contracts N01-CN-45165, N01-RC-45035, and N01-RC-37004 from the National Cancer Institute, Department of Health and Human Services. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ronald L. Horst is an employee of Heartland Assays, Inc., and Dominick Parisi is an employee of Information Management Services, Inc. These authors played a role in performing the experiments and analysis of the data.	Abnet CC, 2010, AM J EPIDEMIOL, V172, P94, DOI 10.1093/aje/kwq121; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Bikle DD, 2009, CLIN REV BONE MINER, V7, P114, DOI 10.1007/s12018-009-9033-y; Chung M., 2009, AHRQ PUBLICATION; Fears TR, 2000, CANCER EPIDEM BIOMAR, V9, P403; Freedman DM, 2007, JNCI-J NATL CANCER I, V99, P1594, DOI 10.1093/jnci/djm204; Freedman DM, 2010, CANCER RES, V70, P8587, DOI 10.1158/0008-5472.CAN-10-1420; Gallicchio L, 2010, AM J EPIDEMIOL, V172, P47, DOI 10.1093/aje/kwq115; Gallicchio L, 2010, AM J EPIDEMIOL, V172, P10, DOI 10.1093/aje/kwq116; Grant WB, 2009, ANN EPIDEMIOL, V19, P446, DOI 10.1016/j.annepidem.2008.12.014; Heist RS, 2008, J CLIN ONCOL, V26, P5596, DOI 10.1200/JCO.2008.18.0406; Hofmann JN, 2010, CANCER EPIDEM BIOMAR, V19, P927, DOI 10.1158/1055-9965.EPI-09-1121; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; *IARC, 2009, VIT D CANC; IOM, 2011, DIET REF INT CALC VI; Jenab M, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5500; Jones G, 1999, ENDOCRINOLOGY, V140, P3303, DOI 10.1210/en.140.7.3303; Jorde R, 2010, AM J EPIDEMIOL, V171, P903, DOI 10.1093/aje/kwq005; Karohl C, 2010, AM J CLIN NUTR, V92, P1393, DOI 10.3945/ajcn.2010.30176; Kilkkinen A, 2008, CANCER EPIDEM BIOMAR, V17, P3274, DOI 10.1158/1055-9965.EPI-08-0199; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Lim HS, 2006, INT J CANCER, V119, P1530, DOI 10.1002/ijc.22052; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Looker AC, 2008, AM J CLIN NUTR, V88, P1519, DOI 10.3945/ajcn.2008.26182; Mondul AM, 2010, CANCER RES, V70, P9218, DOI 10.1158/0008-5472.CAN-10-0985; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Porojnicu AC, 2007, LUNG CANCER, V55, P263, DOI 10.1016/j.lungcan.2006.11.013; Purdue MP, 2010, AM J EPIDEMIOL, V172, P58, DOI 10.1093/aje/kwq117; Stolzenberg-Solomon RZ, 2010, AM J EPIDEMIOL, V172, P81, DOI 10.1093/aje/kwq120; VANDERRHEE H, 2009, EUR J CANC PREV; Vieth R, 2009, ANTICANCER RES, V29, P3675; Wagner D, 2009, CLIN BIOCHEM, V42, P1549, DOI 10.1016/j.clinbiochem.2009.07.013; Wang YT, 2009, AM J EPIDEMIOL, V170, P88, DOI 10.1093/aje/kwp086; Weinstein SJ, 2011, AM J EPIDEMIOL, V173, P499, DOI 10.1093/aje/kwq398; Zeleniuch-Jacquotte A, 2010, AM J EPIDEMIOL, V172, P36, DOI 10.1093/aje/kwq114; Zheng W, 2010, AM J EPIDEMIOL, V172, P70, DOI 10.1093/aje/kwq118; Zhou W, 2005, CANCER EPIDEM BIOMAR, V14, P2303, DOI 10.1158/1055-9965.EPI-05-0335; Zhou W, 2007, J CLIN ONCOL, V25, P479, DOI 10.1200/JCO.2006.07.5358; Zhou W, 2006, CANCER EPIDEM BIOMAR, V15, P2239, DOI 10.1158/1055-9965.EPI-06-0023	40	39	40	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20796	10.1371/journal.pone.0020796	http://dx.doi.org/10.1371/journal.pone.0020796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695165	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600028
J	Neyrinck, AM; Possemiers, S; Druart, C; van de Wiele, T; De Backer, F; Cani, PD; Larondelle, Y; Delzenne, NM				Neyrinck, Audrey M.; Possemiers, Sam; Druart, Celine; van de Wiele, Tom; De Backer, Fabienne; Cani, Patrice D.; Larondelle, Yvan; Delzenne, Nathalie M.			Prebiotic Effects of Wheat Arabinoxylan Related to the Increase in Bifidobacteria, Roseburia and Bacteroides/Prevotella in Diet-Induced Obese Mice	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL COMMUNITY; LIPID-METABOLISM; LINOLEIC-ACID; IN-VITRO; GLUCOSE; MECHANISM; INSULIN; PLASMA; LIVER	Background: Alterations in the composition of gut microbiota - known as dysbiosis - has been proposed to contribute to the development of obesity, thereby supporting the potential interest of nutrients targeting the gut with beneficial effect for host adiposity. We test the ability of a specific concentrate of water-extractable high molecular weight arabinoxylans (AX) from wheat to modulate both the gut microbiota and lipid metabolism in high-fat (HF) diet-induced obese mice. Methodology/Principal Findings: Mice were fed either a control diet (CT) or a HF diet, or a HF diet supplemented with AX (10% w/w) during 4 weeks. AX supplementation restored the number of bacteria that were decreased upon HF feeding, i.e. Bacteroides-Prevotella spp. and Roseburia spp. Importantly, AX treatment markedly increased caecal bifidobacteria content, in particular Bifidobacterium animalis lactis. This effect was accompanied by improvement of gut barrier function and by a lower circulating inflammatory marker. Interestingly, rumenic acid (C18:2 c9,t11) was increased in white adipose tissue due to AX treatment, suggesting the influence of gut bacterial metabolism on host tissue. In parallel, AX treatment decreased adipocyte size and HF diet-induced expression of genes mediating differentiation, fatty acid uptake, fatty acid oxidation and inflammation, and decreased a key lipogenic enzyme activity in the subcutaneous adipose tissue. Furthermore, AX treatment significantly decreased HF-induced adiposity, body weight gain, serum and hepatic cholesterol accumulation and insulin resistance. Correlation analysis reveals that Roseburia spp. and Bacteroides/Prevotella levels inversely correlate with these host metabolic parameters. Conclusions/Significance: Supplementation of a concentrate of water-extractable high molecular weight AX in the diet counteracted HF-induced gut dysbiosis together with an improvement of obesity and lipid-lowering effects. We postulate that hypocholesterolemic, anti-inflammatory and anti-obesity effects are related to changes in gut microbiota. These data support a role for wheat AX as interesting nutrients with prebiotic properties related to obesity prevention.	[Neyrinck, Audrey M.; Druart, Celine; De Backer, Fabienne; Cani, Patrice D.; Delzenne, Nathalie M.] Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium; [Possemiers, Sam; van de Wiele, Tom] Univ Ghent, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium; [Larondelle, Yvan] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium	Universite Catholique Louvain; Ghent University; Universite Catholique Louvain	Neyrinck, AM (corresponding author), Catholic Univ Louvain, Louvain Drug Res Inst, Metab & Nutr Res Grp, B-1200 Brussels, Belgium.	nathalie.delzenne@uclouvain.be	Neyrinck, Audrey/AAE-7929-2019; Delzenne, Nathalie/AAC-4628-2019; D., Cani Patrice/M-8055-2016; Van de Wiele, Tom/C-8638-2011	Neyrinck, Audrey/0000-0002-9435-3338; Delzenne, Nathalie/0000-0003-2115-6082; D., Cani Patrice/0000-0003-2040-2448; Van de Wiele, Tom/0000-0001-6854-5689; Possemiers, Sam/0000-0002-6893-5780; Druart, Celine/0000-0002-7786-9172	Walloon Region [D31-1107]; Danone Institute	Walloon Region; Danone Institute(Danone Nutricia)	This work supported by a grant from the Walloon Region (General Directory of Agriculture, convention D31-1107, http://agriculture.wallonie.be). PDC is a Research Associate from the Fonds de la Recherche Scientifique (FRS-FNRS) Belgium (http://www.frs-fnrs.be/). SP and TVDW are Postdoctoral Researchers from the Research Foundation - Flanders (Fonds voor Wetenschappelijk Onderzoek [FWO] - Vlaanderen, http://www.fwo.be/). CD benefits from a Danone Institute grant (http://www.danoneinstitute.be/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani MA, 2007, DIABETES CARE, V30, P89, DOI 10.2337/dc06-1519; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Aronsson L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013087; AWAD AB, 1981, J NUTR, V111, P34, DOI 10.1093/jn/111.1.34; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2010, BBA-MOL CELL BIOL L, V1801, P240, DOI 10.1016/j.bbalip.2009.09.009; Benjamin S, 2009, NUTR METAB, V6, DOI 10.1186/1743-7075-6-36; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Delzenne NM, 2010, INT DAIRY J, V20, P277, DOI 10.1016/j.idairyj.2009.11.006; Delzenne NM, 2002, BRIT J NUTR, V87, pS255, DOI 10.1079/BJN/2002545; Delzenne NM, 2002, CURR OPIN LIPIDOL, V13, P61, DOI 10.1097/00041433-200202000-00009; Delzenne NM, 2001, AM J CLIN NUTR, V73, p456S, DOI 10.1093/ajcn/73.2.456s; Devillard E, 2009, MICROBIOL-SGM, V155, P513, DOI 10.1099/mic.0.023416-0; Devillard E, 2007, J BACTERIOL, V189, P2566, DOI 10.1128/JB.01359-06; DEWULF EM, 2010, J NUTR BIOC IN PRESS; Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Garcia AL, 2007, EUR J CLIN NUTR, V61, P334, DOI 10.1038/sj.ejcn.1602525; Grootaert C, 2007, TRENDS FOOD SCI TECH, V18, P64, DOI 10.1016/j.tifs.2006.08.004; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hughes SA, 2007, J AGR FOOD CHEM, V55, P4589, DOI 10.1021/jf070293g; Kok N, 1996, METABOLISM, V45, P1547, DOI 10.1016/S0026-0495(96)90186-9; LAIRON D, 1985, AM J CLIN NUTR, V42, P629, DOI 10.1093/ajcn/42.4.629; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; LINN TC, 1981, ARCH BIOCHEM BIOPHYS, V209, P613, DOI 10.1016/0003-9861(81)90320-9; Lopez HW, 1999, J NUTR BIOCHEM, V10, P500, DOI 10.1016/S0955-2863(99)00036-4; Lu ZX, 2004, EUR J CLIN NUTR, V58, P621, DOI 10.1038/sj.ejcn.1601857; Lu ZX, 2000, AM J CLIN NUTR, V71, P1123; Maes C, 2002, J CEREAL SCI, V35, P315, DOI 10.1006/jcrs.2001.0439; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Martinez I, 2009, APPL ENVIRON MICROB, V75, P4175, DOI 10.1128/AEM.00380-09; Marzorati M, 2009, AGRO FOOD IND HI TEC, V20, P50; McIntosh FM, 2009, MICROBIOL-SGM, V155, P285, DOI 10.1099/mic.0.022921-0; Monobe M, 2008, J JPN SOC FOOD SCI, V55, P245, DOI 10.3136/nskkk.55.245; Nakano R, 2006, BIOCHEM PHARMACOL, V72, P42, DOI 10.1016/j.bcp.2006.03.023; NEYRINCK AM, 2011, J NUTR BIOC IN PRESS; Neyrinck AM, 2010, CURR OPIN CLIN NUTR, V13, P722, DOI 10.1097/MCO.0b013e32833ec3fb; Neyrinck AM, 2009, INT IMMUNOPHARMACOL, V9, P767, DOI 10.1016/j.intimp.2009.02.015; Possemiers S, 2004, FEMS MICROBIOL ECOL, V49, P495, DOI 10.1016/j.femsec.2004.05.002; Possemiers S, 2006, J NUTR, V136, P1862, DOI 10.1093/jn/136.7.1862; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; STIENSTRA R, 2006, PPAR RES, V2007, P95974; Suzuki S, 2008, NUTR RES, V28, P258, DOI 10.1016/j.nutres.2008.02.007; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Van de Wiele T, 2004, FEMS MICROBIOL ECOL, V51, P143, DOI 10.1016/j.femsec.2004.07.014; Van den Abbeele P, 2010, DIETARY FIBRE: NEW FRONTIERS FOR FOOD AND HEALTH, P233; Vardakou M, 2008, INT J FOOD MICROBIOL, V123, P166, DOI 10.1016/j.ijfoodmicro.2007.11.007; Ventura M, 2001, APPL ENVIRON MICROB, V67, P2760, DOI 10.1128/AEM.67.6.2760-2765.2001; Wall R, 2009, AM J CLIN NUTR, V89, P1393, DOI 10.3945/ajcn.2008.27023; Wydro P, 2007, BIOMACROMOLECULES, V8, P2611, DOI 10.1021/bm700453x	57	318	344	4	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20944	10.1371/journal.pone.0020944	http://dx.doi.org/10.1371/journal.pone.0020944			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695273	Green Published, gold			2022-12-25	WOS:000291612900042
J	Zhang, RR; Edwards, JR; Ko, SY; Dong, SS; Liu, HB; Oyajobi, BO; Papasian, C; Deng, HW; Zhao, M				Zhang, Rongrong; Edwards, James R.; Ko, Seon-Yle; Dong, Shanshan; Liu, Hongbin; Oyajobi, Babatunde O.; Papasian, Christopher; Deng, Hong-Wen; Zhao, Ming			Transcriptional Regulation of BMP2 Expression by the PTH-CREB Signaling Pathway in Osteoblasts	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; BONE MORPHOGENETIC PROTEIN-2; CAMP-RESPONSE ELEMENT; PARATHYROID-HORMONE REQUIRES; CYSTINE KNOT PROTEIN; KINASE-A; GENE-EXPRESSION; OVARIECTOMIZED RATS; ANABOLIC ACTIONS; STRUCTURAL BASIS	Intermittent application of parathyroid hormone (PTH) has well established anabolic effects on bone mass in rodents and humans. Although transcriptional mechanisms responsible for these effects are not fully understood, it is recognized that transcriptional factor cAMP response element binding protein (CREB) mediates PTH signaling in osteoblasts, and that there is a communication between the PTH-CREB pathway and the BMP2 signaling pathway, which is important for osteoblast differentiation and bone formations. These findings, in conjunction with putative cAMP response elements (CREs) in the BMP2 promoter, led us to hypothesize that the PTH-CREB pathway could be a positive regulator of BMP2 transcription in osteoblasts. To test this hypothesis, we first demonstrated that PTH signaling activated CREB by phosphorylation in osteoblasts, and that both PTH and CREB were capable of promoting osteoblastic differentiation of primary mouse osteoblast cells and multiple rodent osteoblast cell lines. Importantly, we found that the PTH-CREB signaling pathway functioned as an effective activator of BMP2 expression, as pharmacologic and genetic modulation of PTH-CREB activity significantly affected BMP2 expression levels in these cells. Lastly, through multiple promoter assays, including promoter reporter deletion, mutation, chromatin immunoprecipitation (ChIP), and electrophoretic mobility shift assay (EMSA), we identified a specific CRE in the BMP2 promoter which is responsible for CREB transactivation of the BMP2 gene in osteoblasts. Together, these results demonstrate that the anabolic function of PTH signaling in bone is mediated, at least in part, by CREB transactivation of BMP2 expression in osteoblasts.	[Zhang, Rongrong; Dong, Shanshan; Liu, Hongbin; Deng, Hong-Wen; Zhao, Ming] Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA; [Edwards, James R.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Ko, Seon-Yle] Dankook Univ, Sch Dent, Cheonan, Choongnam, South Korea; [Oyajobi, Babatunde O.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Papasian, Christopher] Univ Missouri, Dept Basic Med Sci, Kansas City, MO 64110 USA; [Zhao, Ming] Tulane Univ, Dept Cellular & Mol Biol, New Orleans, LA 70118 USA	Tulane University; Vanderbilt University; Dankook University; University of Texas System; University of Texas Health San Antonio; University of Missouri System; University of Missouri Kansas City; Tulane University	Zhang, RR (corresponding author), Tulane Univ, Dept Biostat & Bioinformat, New Orleans, LA 70118 USA.	mzhao1@tulane.edu	zhang, rongrong/G-1775-2016	Oyajobi, Babatunde/0000-0002-1064-3072; Deng, Hong-Wen/0000-0002-0387-8818	NIAMS NIH HHS [R01 AR057049] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR057049] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blois JT, 2004, J BIOL CHEM, V279, P30123, DOI 10.1074/jbc.M402793200; Cardinaux JR, 2000, MOL CELL BIOL, V20, P1546, DOI 10.1128/MCB.20.5.1546-1552.2000; Chandhoke TK, 2008, BONE, V43, P101, DOI 10.1016/j.bone.2008.03.012; Cosman Felicia, 2006, Curr Rheumatol Rep, V8, P63, DOI 10.1007/s11926-006-0028-0; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Detry C, 2008, BONE, V42, P422, DOI 10.1016/j.bone.2007.10.016; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Ghayor C, 2009, BIOCHEM BIOPH RES CO, V381, P247, DOI 10.1016/j.bbrc.2009.02.032; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; Groppe J, 2003, J BONE JOINT SURG AM, V85A, P52, DOI 10.2106/00004623-200300003-00010; Groppe J, 2002, NATURE, V420, P636, DOI 10.1038/nature01245; Han CYE, 2009, BIOORG MED CHEM LETT, V19, P1442, DOI 10.1016/j.bmcl.2009.01.025; Hodsman AB, 2005, ENDOCR REV, V26, P688, DOI 10.1210/er.2004-0006; Horiuchi H, 2002, BONE, V30, P589, DOI 10.1016/S8756-3282(02)00681-6; Horiuchi H, 2001, BONE, V28, P290, DOI 10.1016/S8756-3282(00)00450-6; Huang WC, 2005, CANCER RES, V65, P2303, DOI 10.1158/0008-5472.CAN-04-3448; Iida-Klein A, 2002, J BONE MINER RES, V17, P808, DOI 10.1359/jbmr.2002.17.5.808; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Ionescu AM, 2004, J CELL PHYSIOL, V198, P428, DOI 10.1002/jcp.10421; Kinoshita T, 2000, BONE, V27, P811, DOI 10.1016/S8756-3282(00)00395-1; Lee YS, 1997, J CELL PHYSIOL, V170, P153, DOI 10.1002/(SICI)1097-4652(199702)170:2<153::AID-JCP7>3.0.CO;2-N; LIU H, 2010, ASBMR 2010 ANN M TOR; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Matsuo N, 2006, J BIOL CHEM, V281, P5445, DOI 10.1074/jbc.M509923200; Mosekilde L, 2000, BONE, V26, P643, DOI 10.1016/S8756-3282(00)00276-3; Nakao Y, 2009, BONE, V44, P872, DOI 10.1016/j.bone.2009.01.370; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Pekkinen M, 2008, BONE, V43, P84, DOI 10.1016/j.bone.2008.02.021; Persengiev SP, 2003, APOPTOSIS, V8, P225, DOI 10.1023/A:1023633704132; QI H, 1995, J BONE MINER RES, V10, P948; Qin L, 2005, J CELL BIOCHEM, V96, P632, DOI 10.1002/jcb.20550; ROSEN V, 1994, J BONE MINER RES, V9, P1759; Schnoke M, 2007, J ORTHOP RES, V25, P933, DOI 10.1002/jor.20373; Solomou EE, 2001, J IMMUNOL, V166, P5665, DOI 10.4049/jimmunol.166.9.5665; Su JL, 2007, J BIOL CHEM, V282, P19385, DOI 10.1074/jbc.M702452200; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Swarthout JT, 2002, J BONE MINER RES, V17, P1401, DOI 10.1359/jbmr.2002.17.8.1401; Takai H, 2007, J CELL BIOCHEM, V102, P240, DOI 10.1002/jcb.21297; Thomas T, 2006, JOINT BONE SPINE, V73, P262, DOI 10.1016/j.jbspin.2005.11.007; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yadav VK, 2008, CELL, V135, P825, DOI 10.1016/j.cell.2008.09.059; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yin TT, 2000, CIRCULATION, V102, P2636, DOI 10.1161/01.cir.102.21.2636; Yu SB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007583; Zhao L, 2009, J BONE MINER RES, V24, P826, DOI [10.1359/JBMR.081236, 10.1359/jbmr.081236]; Zhao M, 2005, BONE, V36, pS142; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zhao M, 2009, BONE, V44, pS27, DOI 10.1016/j.bone.2009.01.062; Zhao M, 2006, MOL CELL BIOL, V26, P6197, DOI 10.1128/MCB.02214-05; Zhao M, 2009, MOL CELL BIOL, V29, P1291, DOI 10.1128/MCB.01566-08; Zhou H, 2003, BONE, V32, P513, DOI 10.1016/S8756-3282(03)00057-7	55	57	60	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20780	10.1371/journal.pone.0020780	http://dx.doi.org/10.1371/journal.pone.0020780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695256	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900026
J	Leger, A; Le Guiner, C; Nickerson, ML; Im, KM; Ferry, N; Moullier, P; Snyder, RO; Penaud-Budloo, M				Leger, Adrien; Le Guiner, Caroline; Nickerson, Michael L.; Im, Kate Mcgee; Ferry, Nicolas; Moullier, Philippe; Snyder, Richard O.; Penaud-Budloo, Magalie			Adeno-Associated Viral Vector-Mediated Transgene Expression Is Independent of DNA Methylation in Primate Liver and Skeletal Muscle	PLOS ONE			English	Article							LONG TERMINAL REPEAT; VIRUS-DERIVED VECTORS; GENE-THERAPY VECTORS; INTRAMUSCULAR INJECTION; AVIAN-SARCOMA; CHROMATIN; PROMOTER; PATTERNS; DELIVERY; GENOMES	Recombinant adeno-associated viral (rAAV) vectors can support long-term transgene expression in quiescent tissues. Intramuscular (IM) administration of a single-stranded AAV vector (ssAAV) in the nonhuman primate (NHP) results in a peak protein level at 2-3 months, followed by a decrease over several months before reaching a steady-state. To investigate transgene expression and vector genome persistence, we previously demonstrated that rAAV vector genomes associate with histones and form a chromatin structure in NHP skeletal muscle more than one year after injection. In the mammalian nucleus, chromatin remodeling via epigenetic modifications plays key role in transcriptional regulation. Among those, CpG hyper-methylation of promoters is a known hallmark of gene silencing. To assess the involvement of DNA methylation on the transgene expression, we injected NHP via the IM or the intravenous (IV) route with a recombinant ssAAV2/1 vector. The expression cassette contains the transgene under the transcriptional control of the constitutive Rous Sarcoma Virus promoter (RSVp). Total DNA isolated from NHP muscle and liver biopsies from 1 to 37 months post-injection was treated with sodium bisulfite and subsequently analyzed by pyrosequencing. No significant CpG methylation of the RSVp was found in rAAV virions or in vector DNA isolated from NHP transduced tissues. Direct de novo DNA methylation appears not to be involved in repressing transgene expression in NHP after gene transfer mediated by ssAAV vectors. The study presented here examines host/vector interactions and the impact on transgene expression in a clinically relevant model.	[Leger, Adrien; Le Guiner, Caroline; Moullier, Philippe; Snyder, Richard O.; Penaud-Budloo, Magalie] INSERM, UMR649, Nantes, France; [Le Guiner, Caroline; Moullier, Philippe] Genethon, Evry, France; [Nickerson, Michael L.; Im, Kate Mcgee] NCI, NIH, Frederick, MD 21701 USA; [Ferry, Nicolas] INSERM, UMR948, Nantes, France; [Moullier, Philippe; Snyder, Richard O.] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA; [Snyder, Richard O.] Univ Florida, Ctr Excellence Regenerat Hlth Biotechnol, Alachua, FL USA	Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Institut National de la Sante et de la Recherche Medicale (Inserm); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Leger, A (corresponding author), INSERM, UMR649, Nantes, France.	magalie.penaud-budloo@univ-nantes.fr	Magalie, PENAUD-BUDLOO/E-7009-2019	Magalie, PENAUD-BUDLOO/0000-0002-4944-2753; Leger, Adrien/0000-0001-8772-6776	INSERM; University of Nantes; Association Francaise contre les Myopathies (AFM); National Institutes of Health at the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIABC011300] Funding Source: NIH RePORTER	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Nantes; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); National Institutes of Health at the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support was received from the INSERM, the University of Nantes and the Association Francaise contre les Myopathies (AFM). This research was also supported in part by the Intramural Research Program of the National Institutes of Health at the National Cancer Institute. No additional external funding was received for this study. This work was performed under a Cooperative Agreement between INSERM, AFM, l'Etablissement Francais du Sang (EFS) and the University of Florida Center of Excellence for Regenerative Health Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-78; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen ZY, 2008, MOL THER, V16, P548, DOI 10.1038/sj.mt.6300399; CULLEN BR, 1985, MOL CELL BIOL, V5, P438, DOI 10.1128/MCB.5.3.438; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Ellis J, 2005, HUM GENE THER, V16, P1241, DOI 10.1089/hum.2005.16.1241; Favre D, 2002, J VIROL, V76, P11605, DOI 10.1128/JVI.76.22.11605-11611.2002; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; Hejnar J, 2001, P NATL ACAD SCI USA, V98, P565, DOI 10.1073/pnas.98.2.565; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; Hodges BL, 2004, MOL THER, V10, P269, DOI 10.1016/j.ymthe.2004.04.018; Hoelzer K, 2008, NUCLEIC ACIDS RES, V36, P2825, DOI 10.1093/nar/gkn121; Hong K, 2001, BIOMOL ENG, V18, P185, DOI 10.1016/S1389-0344(01)00100-9; Hsieh CL, 1997, MOL CELL BIOL, V17, P5897, DOI 10.1128/MCB.17.10.5897; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Huang XP, 2009, HUM GENE THER, V20, P293, DOI 10.1089/hum.2008.141; Ishida T, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-69; KATZ RA, 1983, J GEN VIROL, V64, P429, DOI 10.1099/0022-1317-64-2-429; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lieberman PM, 2006, TRENDS MICROBIOL, V14, P132, DOI 10.1016/j.tim.2006.01.001; Lizee G, 2003, HUM GENE THER, V14, P497, DOI 10.1089/104303403764539387; Lorincz MC, 2000, MOL CELL BIOL, V20, P842, DOI 10.1128/MCB.20.3.842-850.2000; Lu YQ, 2006, J GENE MED, V8, P730, DOI 10.1002/jgm.896; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Meissner A, 2010, NAT BIOTECHNOL, V28, P1079, DOI 10.1038/nbt.1684; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Mobley CM, 1998, J VIROL, V72, P6592, DOI 10.1128/JVI.72.8.6592-6601.1998; Nishimura M, 2007, DRUG METAB PHARMACOK, V22, P178, DOI 10.2133/dmpk.22.178; Okitsu CY, 2007, MOL CELL BIOL, V27, P2746, DOI 10.1128/MCB.02291-06; Paulus C, 2010, REV MED VIROL, V20, P34, DOI 10.1002/rmv.632; Penaud-Budloo M, 2008, J VIROL, V82, P7875, DOI 10.1128/JVI.00649-08; Potapova A, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-6; Reed K, 2010, ANAL BIOCHEM, V397, P96, DOI 10.1016/j.ab.2009.10.021; Riu ER, 2007, MOL THER, V15, P1348, DOI 10.1038/sj.mt.6300177; Rivera VM, 2005, BLOOD, V105, P1424, DOI 10.1182/blood-2004-06-2501; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Salva MZ, 2007, MOL THER, V15, P320, DOI 10.1038/sj.mt.6300027; Salvetti A, 1998, HUM GENE THER, V9, P695, DOI 10.1089/hum.1998.9.5-695; Schnepp BC, 2003, J VIROL, V77, P3495, DOI 10.1128/JVI.77.6.3495-3504.2003; Schuttrumpf J, 2011, HUM GENE THER, V22, P101, DOI 10.1089/hum.2009.212; Senigl F, 2008, J VIROL, V82, P7818, DOI 10.1128/JVI.00419-08; Sun X, 2010, HUM GENE THER, V21, P750, DOI 10.1089/hum.2009.214; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Takai Daiya, 2003, In Silico Biology, V3, P235; Toromanoff A, 2008, MOL THER, V16, P1291, DOI 10.1038/mt.2008.87; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Zhu JG, 2009, J CLIN INVEST, V119, P2388, DOI 10.1172/JCI37607	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20881	10.1371/journal.pone.0020881	http://dx.doi.org/10.1371/journal.pone.0020881			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687632	Green Submitted, gold, Green Published			2022-12-25	WOS:000291611500051
J	Katsurano, M; Niwa, T; Yasui, Y; Shigematsu, Y; Yamashita, S; Takeshima, H; Lee, MS; Kim, YJ; Tanaka, T; Ushijima, T				Katsurano, M.; Niwa, T.; Yasui, Y.; Shigematsu, Y.; Yamashita, S.; Takeshima, H.; Lee, M. S.; Kim, Y-J; Tanaka, T.; Ushijima, T.			Early-stage formation of an epigenetic field defect in a mouse colitis model, and non-essential roles of T- and B-cells in DNA methylation induction	ONCOGENE			English	Article						epigenetics; DNA methylation; inflammation; colon cancer; mouse	INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; INTESTINAL EPITHELIAL-CELLS; PROMOTER HYPERMETHYLATION; HELICOBACTER-PYLORI; ULCERATIVE-COLITIS; GASTRIC MUCOSAE; CANCER; MICE; GENE	Epigenetic fields for cancerization are involved in development of human cancers, especially those associated with inflammation and multiple occurrences. However, it is still unclear when such field defects are formed and what component of inflammation is involved in induction of aberrant DNA methylation. Here, in a mouse colitis model induced by dextran sulfate sodium (DSS), we identified three CpG islands specifically methylated in colonic epithelial cells exposed to colitis. Their methylation levels started to increase as early as 8 weeks after DSS treatment and continued to increase until colon cancers developed at 15 weeks. In contrast to the temporal profile of DNA methylation levels, infiltration of inflammatory cells spiked immediately after the DSS treatment and then gradually decreased. Exposure of cultured colonic epithelial cells to DSS did not induce DNA methylation and it was indicated that inflammation triggered by the DSS treatment was responsible for methylation induction. To clarify components of inflammation involved, severe combined immunodeficiency (SCID) mice that lack functional T- and B-cells were similarly treated. Even in SCID mice, DNA methylation, along with colon tumors, were induced at the same levels as in their background strain of mice (C.B17). Comparative analysis of inflammation-related genes showed that Ifng, Il1b and Nos2 had expression concordant with methylation induction whereas Il2, Il6, Il10, Tnf did not. These results showed that an epigenetic field defect is formed at early stages of colitis-associated carcinogenesis and that functional T and B cells are non-essential for the formation. Oncogene (2012) 31, 342-351; doi:10.1038/onc.2011.241; published online 20 June 2011	[Ushijima, T.] Natl Canc Ctr, Res Inst, Div Epigen, Chuo Ku, Tokyo 1040045, Japan; [Yasui, Y.; Tanaka, T.] Kanazawa Med Univ, Dept Oncol Pathol, Kanazawa, Ishikawa, Japan; [Lee, M. S.; Kim, Y-J] Yonsei Univ, Genome Regulat Ctr, Dept Biochem, Seoul 120749, South Korea	National Cancer Center - Japan; Kanazawa Medical University; Yonsei University	Ushijima, T (corresponding author), Natl Canc Ctr, Res Inst, Div Epigen, Chuo Ku, Tokyo 1040045, Japan.	tushijim@ncc.go.jp	Ushijima, Toshikazu/AAP-5742-2021	Ushijima, Toshikazu/0000-0003-3405-7817; Takeshima, Hideyuki/0000-0002-8552-2427	Ministry of Health, Labour and Welfare, Japan; Korea Foundation for International Cooperation of Science Technology; Foundation for Promotion of Cancer Research	Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Korea Foundation for International Cooperation of Science Technology; Foundation for Promotion of Cancer Research	We thank Dr H Fukamachi for his kind provision of the LIF-16 cell line. This study was supported by the Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour and Welfare, Japan; and by the Global Research Laboratory Program from Korea Foundation for International Cooperation of Science & Technology. MK and YS are recipients of Research Resident Fellowships from the Foundation for Promotion of Cancer Research. This study was supported by the Third-term Comprehensive Cancer Control Strategy from the Ministry of Health, Labour and Welfare, Japan (TU), and by the Global Research Laboratory Program from Korea Foundation for International Cooperation of Science & Technology (Y-JK and TU).	Araki Y, 2006, ONCOL REP, V16, P1357; Autschbach F, 2002, VIRCHOWS ARCH, V441, P500, DOI 10.1007/s00428-002-0684-z; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Braakhuis BJM, 2003, CANCER RES, V63, P1727; CAPPELLO M, 1992, GUT, V33, P1214, DOI 10.1136/gut.33.9.1214; CHENG H, 1984, GASTROENTEROLOGY, V86, P78; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Fraga MF, 2004, CANCER RES, V64, P5527, DOI 10.1158/0008-5472.CAN-03-4061; Garrity-Park MM, 2010, AM J GASTROENTEROL; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Hahn MA, 2008, CANCER RES, V68, P10280, DOI 10.1158/0008-5472.CAN-08-1957; Hanada T, 2006, J EXP MED, V203, P1391, DOI 10.1084/jem.20060436; Hmadcha A, 1999, J EXP MED, V190, P1595, DOI 10.1084/jem.190.11.1595; Hodge DR, 2001, J BIOL CHEM, V276, P39508, DOI 10.1074/jbc.C100343200; Hsieh CJ, 1998, CANCER RES, V58, P3942; Hur K, 2011, CARCINOGENESIS, V32, P35, DOI 10.1093/carcin/bgq219; Issa JPJ, 2001, CANCER RES, V61, P3573; Ito R, 2006, CLIN EXP IMMUNOL, V146, P330, DOI 10.1111/j.1365-2249.2006.03214.x; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kass DH, 1997, GENETICA, V99, P1, DOI 10.1023/A:1018350810791; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kim YH, 2011, ANN SURG ONCOL, V18, P2338, DOI 10.1245/s10434-011-1573-y; Kondo Y, 2000, HEPATOLOGY, V32, P970, DOI 10.1053/jhep.2000.19797; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Li Y, 2010, GUT, V59, P227, DOI 10.1136/gut.2009.184176; LIGUMSKY M, 1990, GUT, V31, P686, DOI 10.1136/gut.31.6.686; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; McLaughlan JM, 1997, J PATHOL, V181, P87; Nagao M, 2001, MUTAT RES-FUND MOL M, V477, P119, DOI 10.1016/S0027-5107(01)00113-0; Nakajima T, 2006, CANCER EPIDEM BIOMAR, V15, P2317, DOI 10.1158/1055-9965.EPI-06-0436; Ni J, 1996, GUT, V39, P234, DOI 10.1136/gut.39.2.234; Niwa T, 2005, CANCER SCI, V96, P409, DOI 10.1111/j.1349-7006.2005.00068.x; Niwa T, 2010, CANCER RES, V70, P1430, DOI 10.1158/0008-5472.CAN-09-2755; Popivanova BK, 2008, J CLIN INVEST, V118, P560, DOI [10.1172/JC132453, 10.1172/JCI32453]; Qian XM, 2008, CANCER LETT, V263, P107, DOI 10.1016/j.canlet.2007.12.023; Riggs AD, 2004, P NATL ACAD SCI USA, V101, P4, DOI 10.1073/pnas.0307781100; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Schulmann K, 2005, ONCOGENE, V24, P4138, DOI 10.1038/sj.onc.1208598; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Taniwaki K, 2007, CANCER RES, V67, P4311, DOI 10.1158/0008-5472.CAN-06-4761; Ushijima T, 2005, CANCER SCI, V96, P206, DOI 10.1111/j.1349-7006.2005.00035.x; Ushijima T, 2005, NAT REV CANCER, V5, P223, DOI 10.1038/nrc1571; Ushijima T, 2007, J BIOCHEM MOL BIOL, V40, P142; Vuillemenot BR, 2004, CARCINOGENESIS, V25, P623, DOI 10.1093/carcin/bgh038; Wang D, 2010, ONCOGENE, V29, P781, DOI 10.1038/onc.2009.421; Yamashita S, 2008, CANCER RES, V68, P2112, DOI 10.1158/0008-5472.CAN-07-5282; Yamashita S, 2009, DNA RES, V16, P275, DOI 10.1093/dnares/dsp017; Yu L, 2005, NAT GENET, V37, P265, DOI 10.1038/ng1521	51	57	59	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	3					342	351		10.1038/onc.2011.241	http://dx.doi.org/10.1038/onc.2011.241			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21685942				2022-12-25	WOS:000299542100007
J	Pla, AF; Ong, HL; Cheng, KT; Brossa, A; Bussolati, B; Lockwich, T; Paria, B; Munaron, L; Ambudkar, IS				Pla, A. Fiorio; Ong, H. L.; Cheng, K. T.; Brossa, A.; Bussolati, B.; Lockwich, T.; Paria, B.; Munaron, L.; Ambudkar, I. S.			TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling	ONCOGENE			English	Article						Ca2+ signals; TRP channels; endothelial cells; cell migration; actin remodeling; tumor angiogenesis	PROTEIN-KINASE; ION CHANNELS; CA2+ ENTRY; ANGIOGENESIS; GROWTH; TRANSLOCATION; EXPRESSION; CALCIUM; PROLIFERATION; CONTRIBUTES	Changes in intracellular calcium [Ca2+](i) levels control critical cytosolic and nuclear events that are involved in the initiation and progression of tumor angiogenesis in endothelial cells (ECs). Therefore, the mechanism(s) involved in agonist-induced Ca-i(2+) signaling is a potentially important molecular target for controlling angiogenesis and tumor growth. Several studies have shown that blood vessels in tumors differ from normal vessels in their morphology, blood flow and permeability. We had previously reported a key role for arachidonic acid (AA)-mediated Ca2+ entry in the initial stages of tumor angiogenesis in vitro. In this study we assessed the mechanism involved in AA-induced EC migration. We report that TRPV4, an AA-activated channel, is differentially expressed in EC derived from human breast carcinomas (BTEC) as compared with 'normal' EC (HMVEC). BTEC display a significant increase in TRPV4 expression, which was correlated with greater Ca2+ entry, induced by AA or 4 alpha PDD (a selective TRPV4 agonist) in the tumor-derived ECs. Wound-healing assays revealed a key role of TRPV4 in regulating cell migration of BTEC but not HMVEC. Knockdown of TRPV4 expression completely abolished AA-induced BTEC migration, suggesting that TRPV4 mediates the pro-angiogenic effects promoted by AA. Furthermore, pre-incubation of BTEC with AA induced actin remodeling and a subsequent increase in the surface expression of TRPV4. This was consistent with the increased plasma membrane localization of TRPV4 and higher AA-stimulated Ca2+ entry in the migrating cells. Together, the data presented herein demonstrate that: (1) TRPV4 is differentially expressed in tumor-derived versus 'normal' EC; (2) TRPV4 has a critical role in the migration of tumor-derived but not 'normal' EC migration; and (3) AA induces actin remodeling in BTEC, resulting in a corresponding increase of TRPV4 expression in the plasma membrane. We suggest that the latter is critical for migration of EC and thus in promoting angiogenesis and tumor growth. Oncogene (2012) 31, 200-212; doi:10.1038/onc.2011.231; published online 20 June 2011	[Pla, A. Fiorio; Brossa, A.; Munaron, L.] Univ Turin, Dept Anim & Human Biol, I-10123 Turin, Italy; [Pla, A. Fiorio; Munaron, L.] Ctr Complex Syst Mol Biol & Med SysBioM, Turin, Italy; [Pla, A. Fiorio; Munaron, L.] Nanostruct Interfaces & Surfaces Ctr Excellence, Turin, Italy; [Ong, H. L.; Cheng, K. T.; Lockwich, T.; Paria, B.; Ambudkar, I. S.] NIDCR, Secretory Physiol Sect, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA; [Brossa, A.; Bussolati, B.] Univ Turin, Ctr Mol Biotechnol, Dept Internal Med, Turin, Italy	University of Turin; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Turin	Pla, AF (corresponding author), Univ Turin, Dept Anim & Human Biol, V Accademia Albertina 13, I-10123 Turin, Italy.	alessandra.fiorio@unito.it	Bussolati, Benedetta/AAA-9058-2022; Fiorio Pla, Alessandra/B-6646-2012	Bussolati, Benedetta/0000-0002-3663-5134; Fiorio Pla, Alessandra/0000-0003-4576-1594; Ong, Hwei Ling/0000-0002-7551-6883; munaron, luca/0000-0001-9247-4446; Brossa, Alessia/0000-0002-5973-5007	University of Torino; Regione Piemonte (Ricerca Scientifica Applicata Sanita'); National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000438] Funding Source: NIH RePORTER	University of Torino; Regione Piemonte (Ricerca Scientifica Applicata Sanita')(Regione Piemonte); National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the University of Torino, Regione Piemonte (Ricerca Scientifica Applicata Sanita') and the National Institute of Dental and Craniofacial Research (Intramural Research). We thank Dr Kenneth Yamada (NIDCR, NIH, Bethesda, MD, USA) for the beta-actin-mCherry and Dr Michael X. Zhu (Department of Physiology and Cell Biology, Ohio State University, OH, USA) for the TRPV4-GFP construct.	Antoniotti S, 2003, J CELL PHYSIOL, V197, P370, DOI 10.1002/jcp.10359; Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Becker D, 2009, EUR J CELL BIOL, V88, P141, DOI 10.1016/j.ejcb.2008.10.002; Bhati R, 2008, AM J PATHOL, V172, P1381, DOI 10.2353/ajpath.2008.070988; Birnbaumer L, 2009, ANNU REV PHARMACOL, V49, P395, DOI 10.1146/annurev.pharmtox.48.113006.094928; Boels K, 2001, J CELL SCI, V114, P3599; Bussolati B, 2006, EXP CELL RES, V312, P913, DOI 10.1016/j.yexcr.2005.12.004; Bussolati B, 2003, FASEB J, V17, P1159, DOI 10.1096/fj.02-0557fje; Bussolati B, 2011, FASEB J; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Collino F, 2008, AM J PHYSIOL-RENAL, V294, pF1185, DOI 10.1152/ajprenal.00442.2007; Everaerts W, 2010, PROG BIOPHYS MOL BIO, V103, P2, DOI 10.1016/j.pbiomolbio.2009.10.002; Folkman J, 2003, CURR MOL MED, V3, P643, DOI 10.2174/1566524033479465; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Goswami C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011654; Grange C, 2006, ONCOL REP, V15, P381; Hamdollah Zadeh MA, 2008, MICROCIRCULATION, V15, P605, DOI 10.1080/10739680802220323; Hartmannsgruber V, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000827; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hyde CAC, 2009, INT IMMUNOPHARMACOL, V9, P701, DOI 10.1016/j.intimp.2009.02.003; Kwan HY, 2007, BBA-MOL BASIS DIS, V1772, P907, DOI 10.1016/j.bbadis.2007.02.013; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liu XB, 2006, J BIOL CHEM, V281, P15485, DOI 10.1074/jbc.M600549200; Ma X, 2010, ARTERIOSCL THROM VAS, V30, P2249, DOI 10.1161/ATVBAHA.110.212084; Meves H, 2008, BRIT J PHARMACOL, V155, P4, DOI 10.1038/bjp.2008.216; Moes M, 2010, CELL MOL LIFE SCI, V67, P1547, DOI 10.1007/s00018-010-0267-0; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Munaron L, 2009, CURR MED CHEM, V16, P4691, DOI 10.2174/092986709789878210; Mutai H, 2005, NEUROSCIENCE, V132, P1115, DOI 10.1016/j.neuroscience.2005.01.046; Nie D, 2002, CELL MOL LIFE SCI, V59, P799, DOI 10.1007/s00018-002-8468-9; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Patton AM, 2003, CURR PHARM DESIGN, V9, P543, DOI 10.2174/1381612033391559; PEPPELENBOSCH MP, 1995, CELL, V81, P849, DOI 10.1016/0092-8674(95)90005-5; PEPPELENBOSCH MP, 1995, J NEUROSCI METH, V58, P49, DOI 10.1016/0165-0270(94)00158-D; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Pla AF, 2001, CELL CALCIUM, V30, P235, DOI 10.1054/ceca.2001.0234; Pla AF, 2008, MOL CANCER RES, V6, P535, DOI 10.1158/1541-7786.MCR-07-0271; Pla AF, 2010, MOL CANCER RES, V8, P1466, DOI 10.1158/1541-7786.MCR-10-0002; Pocock TM, 2004, AM J PHYSIOL-HEART C, V286, pH1015, DOI 10.1152/ajpheart.00826.2003; Prevarskaya N, 2010, TRENDS MOL MED, V16, P107, DOI 10.1016/j.molmed.2010.01.005; Roberts LA, 2003, J CELL PHYSIOL, V196, P196, DOI 10.1002/jcp.10303; Shin EA, 1999, FEBS LETT, V452, P355, DOI 10.1016/S0014-5793(99)00657-2; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; St Croix B, 2000, SCIENCE, V289, P1197; Suzuki M, 2003, J BIOL CHEM, V278, P51448, DOI 10.1074/jbc.M308212200; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Troidl C, 2009, J CELL MOL MED, V13, P2613, DOI 10.1111/j.1582-4934.2008.00579.x; TSAI MH, 1989, MOL CELL BIOL, V9, P5260, DOI 10.1128/MCB.9.11.5260; Van Buren JJ, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-17; Waning J, 2007, CELL CALCIUM, V42, P17, DOI 10.1016/j.ceca.2006.11.005; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Yu PC, 2010, CIRC RES, V106, P1221, DOI 10.1161/CIRCRESAHA.109.207670	53	132	136	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	2					200	212		10.1038/onc.2011.231	http://dx.doi.org/10.1038/onc.2011.231			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	879CN	21685934	Green Accepted			2022-12-25	WOS:000299307400006
J	Shenoy, SK; Han, S; Zhao, YL; Hara, MR; Oliver, T; Cao, Y; Dewhirst, MW				Shenoy, S. K.; Han, S.; Zhao, Y. L.; Hara, M. R.; Oliver, T.; Cao, Y.; Dewhirst, M. W.			beta-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression	ONCOGENE			English	Article						arrestin; HIF-1; VEGF; hypoxia	NUCLEAR EXPORT SIGNAL; INDUCIBLE FACTOR-I; BETA-ARRESTIN; ENDOTHELIAL-CELLS; IMATINIB MESYLATE; PROSTATE-CANCER; GENE-EXPRESSION; RECEPTOR; HYPOXIA; ANGIOGENESIS	beta-Arrestins 1 and 2 are multifunctional adaptor proteins originally discovered for their role in desensitizing seven-transmembrane receptor signaling via the heterotrimeric guanine nucleotide-binding proteins. Recently identified roles of beta-arrestins include regulation of cancer cell chemotaxis and proliferation. Herein, we report that beta-arrestin1 expression regulates breast tumor colonization in nude mice and cancer cell viability during hypoxia. beta-Arrestin1 robustly interacts with nuclear hypoxia-induced factor-1 alpha (HIF-1 alpha) that is stabilized during hypoxia and potentiates HIF-1-dependent transcription of the angiogenic factor vascular endothelial growth factor-A (VEGF-A). Increased expression of beta-arrestin1 in human breast cancer (infiltrating ductal carcinoma or IDC and metastatic IDC) correlates with increased levels of VEGF-A. While the anti-angiogenic drug thalidomide inhibits HIF-1-dependent VEGF transcription in breast carcinoma cells, it does not prevent HIF-1 alpha stabilization, but leads to aberrant localization of HIF-1 alpha to the perinuclear compartments and surprisingly stimulates nuclear export of beta-arrestin1. Additionally, imatinib mesylate that inhibits release of VEGF induces nuclear export of beta-arrestin1-HIF-1 alpha complexes. Our findings suggest that beta-arrestin1 regulates nuclear signaling during hypoxia to promote survival of breast cancer cells via VEGF signaling and that drugs that induce its translocation from the nucleus to the cytoplasm could be useful in anti-angiogenic and breast cancer therapies. Oncogene (2012) 31, 282-292; doi:10.1038/onc.2011.238; published online 20 June 2011	[Shenoy, S. K.; Han, S.; Hara, M. R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Shenoy, S. K.; Oliver, T.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Zhao, Y. L.; Cao, Y.; Dewhirst, M. W.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Shenoy, SK (corresponding author), Duke Univ, Med Ctr, Dept Med, Room 412,SANDS Bldg,POB 103204, Durham, NC 27710 USA.	sudha@receptor-biol.duke.edu	Dewhirst, Mark/Q-1302-2019; Shenoy, Sudha/AAN-4075-2021	Dewhirst, Mark/0000-0003-3459-6546; Shenoy, Sudha/0000-0002-2565-4663	NIH [HL080525, CA40355]; NATIONAL CANCER INSTITUTE [R01CA040355] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080525] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We are grateful to Dr Lefkowitz for his insightful comments. We thank Ms Vidya Venkat for technical support. We acknowledge grant support from the NIH (HL080525 to SKS and CA40355 to MWD).	Alvarez CJP, 2009, ENDOCR-RELAT CANCER, V16, P599, DOI 10.1677/ERC-08-0192; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Beppu K, 2004, JNCI-J NATL CANCER I, V96, P46, DOI 10.1093/jnci/djh004; Buchanan FG, 2006, P NATL ACAD SCI USA, V103, P1492, DOI 10.1073/pnas.0510562103; Chuaqui RF, 1997, AM J PATHOL, V150, P297; DAAKA Y, 2004, SCI STKE, pRE2; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Dasgupta P, 2006, J CLIN INVEST, V116, P3083, DOI 10.1172/JCI28164C1; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dredge K, 2002, BRIT J CANCER, V87, P1166, DOI 10.1038/sj.bjc.6600607; Ebos JML, 2002, MOL CANCER RES, V1, P89; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Figg WD, 2006, CLIN PHARMACOL THER, V79, P1, DOI 10.1016/j.clpt.2005.09.006; FOLKMAN J, 1971, J EXP MED, V133, P275, DOI 10.1084/jem.133.2.275; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Ge L, 2004, J BIOL CHEM, V279, P55419, DOI 10.1074/jbc.M410312200; Girnita L, 2007, J BIOL CHEM, V282, P11329, DOI 10.1074/jbc.M611526200; Holaday JW, 2009, MOL INTERV, V9, P157, DOI 10.1124/mi.9.4.2; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kelly P, 2006, P NATL ACAD SCI USA, V103, P8173, DOI 10.1073/pnas.0510254103; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; KVIETIKOVA I, 1995, NUCLEIC ACIDS RES, V23, P4542, DOI 10.1093/nar/23.22.4542; Lakshmikanthan V, 2009, P NATL ACAD SCI USA, V106, P9379, DOI 10.1073/pnas.0900258106; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Letessier A, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-245; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Li TT, 2009, MOL CANCER RES, V7, P1064, DOI 10.1158/1541-7786.MCR-08-0578; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Ma XJ, 2003, P NATL ACAD SCI USA, V100, P5974, DOI 10.1073/pnas.0931261100; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mythreye K, 2009, P NATL ACAD SCI USA, V106, P8221, DOI 10.1073/pnas.0812879106; Niida A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-71; Raghuwanshi SK, 2008, J IMMUNOL, V180, P5699, DOI 10.4049/jimmunol.180.8.5699; Rosano L, 2009, P NATL ACAD SCI USA, V106, P2806, DOI 10.1073/pnas.0807158106; Scott MGH, 2002, J BIOL CHEM, V277, P37693, DOI 10.1074/jbc.M207552200; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Vacca A, 2005, J CLIN ONCOL, V23, P5334, DOI 10.1200/JCO.2005.03.723; Vlahovic G, 2006, BRIT J CANCER, V95, P1013, DOI 10.1038/sj.bjc.6603366; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang P, 2003, J BIOL CHEM, V278, P11648, DOI 10.1074/jbc.M208109200; Zou L, 2008, FASEB J, V22, P355, DOI 10.1096/fj.07-9046com	48	54	54	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN	2012	31	3					282	292		10.1038/onc.2011.238	http://dx.doi.org/10.1038/onc.2011.238			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	882DQ	21685944	Green Accepted			2022-12-25	WOS:000299542100002
J	He, Y; Galant, A; Pang, QY; Strul, JM; Balogun, SF; Jez, JM; Chen, SX				He, Yan; Galant, Ashley; Pang, Qiuying; Strul, Johanna M.; Balogun, Sherifat F.; Jez, Joseph M.; Chen, Sixue			Structural and Functional Evolution of Isopropylmalate Dehydrogenases in the Leucine and Glucosinolate Pathways of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID; 3-ISOPROPYLMALATE DEHYDROGENASE; CHAIN-ELONGATION; METHYLTHIOALKYLMALATE SYNTHASE; BIOSYNTHESIS; METABOLISM; RESOLUTION; GENE	The methionine chain-elongation pathway is required for aliphatic glucosinolate biosynthesis in plants and evolved from leucine biosynthesis. In Arabidopsis thaliana, three 3-isopropylmalate dehydrogenases (AtIPMDHs) play key roles in methionine chain-elongation for the synthesis of aliphatic glucosinolates (e. g. AtIPMDH1) and leucine (e. g. AtIPMDH2 and AtIPMDH3). Here we elucidate the molecular basis underlying the metabolic specialization of these enzymes. The 2.25 angstrom resolution crystal structure of AtIPMDH2 was solved to provide the first detailed molecular architecture of a plant IPMDH. Modeling of 3-isopropylmalate binding in the AtIPMDH2 active site and sequence comparisons of prokaryotic and eukaryotic IPMDH suggest that substitution of one active site residue may lead to altered substrate specificity and metabolic function. Site-directed mutagenesis of Phe-137 to a leucine in AtIPMDH1 (AtIPMDH1-F137L) reduced activity toward 3-(2'-methylthio)ethylmalate by 200-fold, but enhanced catalytic efficiency with 3-isopropylmalate to levels observed with AtIPMDH2 and AtIPMDH3. Conversely, the AtIPMDH2-L134F and AtIPMDH3-L133F mutants enhanced catalytic efficiency with 3-(2'-methylthio) ethylmalate similar to 100-fold and reduced activity for 3-isopropylmalate. Furthermore, the altered in vivo glucosinolate profile of an Arabidopsis ipmdh1 T-DNA knock-out mutant could be restored to wild-type levels by constructs expressing AtIPMDH1, AtIPMDH2-L134F, or AtIPMDH3-L133F, but not by AtIPMDH1-F137L. These results indicate that a single amino acid substitution results in functional divergence of IPMDH in planta to affect substrate specificity and contributes to the evolution of specialized glucosinolate biosynthesis from the ancestral leucine pathway.	[He, Yan; Pang, Qiuying; Strul, Johanna M.; Chen, Sixue] Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL 32610 USA; [Galant, Ashley; Balogun, Sherifat F.; Jez, Joseph M.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	State University System of Florida; University of Florida; Washington University (WUSTL)	Chen, SX (corresponding author), Univ Florida, Dept Biol, Genet Inst, Plant Mol & Cellular Biol Program, Gainesville, FL 32610 USA.	schen@ufl.edu	CHEN, SI/GZL-4800-2022		National Science Foundation [MCB-0845162, MCB-0904215]; Dept. of Energy Office of Biological and Environmental Research [DE-AC02-06CH11357]; American Society of Plant Biologists; National Institutes of Health-MARC uSTAR	National Science Foundation(National Science Foundation (NSF)); Dept. of Energy Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); American Society of Plant Biologists; National Institutes of Health-MARC uSTAR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation (Grants MCB-0845162 (to S. C.) and MCB-0904215, to (J. M. J.)). Portions of this research were carried out at the Argonne National Laboratory Structural Biology Center at the Advanced Photon Source, a national user facility operated by the University of Chicago for the Dept. of Energy Office of Biological and Environmental Research (DE-AC02-06CH11357).; Supported by an American Society of Plant Biologists Pioneer Hi-Bred Graduate Research Fellowship.; Recipient of an National Institutes of Health-MARC uSTAR Undergraduate Fellowship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aktas DF, 2009, BIOCHEMISTRY-US, V48, P3565, DOI 10.1021/bi8022976; Bak S, 1998, PLANT MOL BIOL, V38, P725, DOI 10.1023/A:1006064202774; Bak Soren, 2006, Phytochemistry Reviews, V5, P309, DOI 10.1007/s11101-006-9033-1; Binder S, 2007, PHYSIOL PLANTARUM, V129, P68, DOI 10.1111/j.1399-3054.2006.00800.x; Chen S, 2001, PLANT PHYSIOL BIOCH, V39, P743, DOI 10.1016/S0981-9428(01)01301-8; Chen SX, 2003, PLANT J, V33, P923, DOI 10.1046/j.1365-313X.2003.01679.x; de Kraker JW, 2011, PLANT CELL, V23, P38, DOI 10.1105/tpc.110.079269; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Field B, 2004, PLANT PHYSIOL, V135, P828, DOI 10.1104/pp.104.039347; Galant A, 2009, PLANT CELL, V21, P3450, DOI 10.1105/tpc.109.071183; He Y, 2011, NEW PHYTOL, V189, P160, DOI 10.1111/j.1469-8137.2010.03460.x; He Y, 2010, PLANT CELL PHYSIOL, V51, P1480, DOI 10.1093/pcp/pcq113; He Y, 2009, PLANT J, V60, P679, DOI 10.1111/j.1365-313X.2009.03990.x; Hopkins RJ, 2009, ANNU REV ENTOMOL, V54, P57, DOI 10.1146/annurev.ento.54.110807.090623; Imada K, 1998, STRUCTURE, V6, P971, DOI 10.1016/S0969-2126(98)00099-9; KADONO S, 1995, J BIOCHEM-TOKYO, V118, P745, DOI 10.1093/oxfordjournals.jbchem.a124975; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Knill T, 2008, PLANT PHYSIOL, V146, P1028, DOI 10.1104/pp.107.111609; Knill T, 2009, PLANT MOL BIOL, V71, P227, DOI 10.1007/s11103-009-9519-5; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Newton E, 2010, OECOLOGIA, V164, P689, DOI 10.1007/s00442-010-1702-5; Nozawa A, 2005, BIOSCI BIOTECH BIOCH, V69, P806, DOI 10.1271/bbb.69.806; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sankoff D, 2001, CURR OPIN GENET DEV, V11, P681, DOI 10.1016/S0959-437X(00)00253-7; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P1181, DOI 10.1093/pcp/pcp079; Schuster J, 2006, PLANT CELL, V18, P2664, DOI 10.1105/tpc.105.039339; Singh RK, 2005, J MOL BIOL, V346, P1, DOI 10.1016/j.jmb.2004.11.059; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Wallon G, 1997, J MOL BIOL, V266, P1016, DOI 10.1006/jmbi.1996.0797; Yan XF, 2007, PLANTA, V226, P1343, DOI 10.1007/s00425-007-0627-7	33	28	28	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28794	28801		10.1074/jbc.M111.262519	http://dx.doi.org/10.1074/jbc.M111.262519			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697089	hybrid, Green Published			2022-12-25	WOS:000293837000017
J	Chew, SL; Or, MY; Chang, CXL; Gehring, AJ; Bertoletti, A; Grotenbreg, GM				Chew, Shi Ling; Or, Ming Yan; Chang, Cynthia Xin Lei; Gehring, Adam J.; Bertoletti, Antonio; Grotenbreg, Gijsbert M.			Stability Screening of Arrays of Major Histocompatibility Complexes on Combinatorially Encoded Flow Cytometry Beads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL EPITOPE; CLASS-I MOLECULES; PEPTIDE-BINDING; MURINE; HLA; SPECIFICITY; COMPETITION; DISCOVERY; H-2D(B); LIGANDS	The binding and stabilization capacity of potential T cell epitopes to class I MHC molecules form the basis for their immunogenicity and provide fundamental insight into factors that dictate cellular immune responses. We have developed a versatile high throughput cell-free method to measure MHC stability by capturing a variety of MHC products on the surface of streptavidin-coated particles followed by flow cytometry analysis. Arrays of peptide-MHC combinations, generated by exchanging conditional ligand-loaded MHC, could be probed in a single experiment, thus combining the molecular precision of biochemically purified MHCs with high content multiparametric flow cytometry-based assays. Semiquantitative determination of the peptide affinity for the restriction element could also be accomplished through competition experiments using this bead-based assay. Furthermore, the generated peptide-MHC reagents could directly be applied to antigen-specific CD8(+) T lymphocyte analysis. The combinatorial labeling of beads allowed straightforward identification by their unique fluorescent signatures and provided a convenient means for extended assay multiplexing.	[Grotenbreg, Gijsbert M.] Natl Univ Singapore, Inst Life Sci, Immunol Programme, Ctr Life Sci 03 05, Singapore 117456, Singapore; [Chew, Shi Ling; Or, Ming Yan; Chang, Cynthia Xin Lei; Grotenbreg, Gijsbert M.] Natl Univ Singapore, Dept Biol Sci, Dept Microbiol, Singapore 117456, Singapore; [Chang, Cynthia Xin Lei; Grotenbreg, Gijsbert M.] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Inst Life Sci, Singapore 117456, Singapore; [Gehring, Adam J.; Bertoletti, Antonio] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Brenner Ctr Mol Med, Singapore 117609, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Grotenbreg, GM (corresponding author), Natl Univ Singapore, Inst Life Sci, Immunol Programme, Ctr Life Sci 03 05, 28 Med Dr, Singapore 117456, Singapore.	grotenbreg@nus.edu.sg	Bertoletti, Antonio/AAD-4830-2022	Bertoletti, Antonio/0000-0002-2942-0485; Gehring, Adam/0000-0003-1150-5840	Singapore National Research Foundation [NRF2007NRF-RF001-226]; National University of Singapore Graduate School for Integrative Science and Engineering	Singapore National Research Foundation(National Research Foundation, Singapore); National University of Singapore Graduate School for Integrative Science and Engineering(National University of Singapore)	This work was supported by Singapore National Research Foundation Research Fellowship NRF2007NRF-RF001-226.; Recipient of a National University of Singapore Graduate School for Integrative Science and Engineering graduate scholarship.	Achour A, 2006, J MOL BIOL, V356, P382, DOI 10.1016/j.jmb.2005.11.068; Bakker AH, 2008, P NATL ACAD SCI USA, V105, P3825, DOI 10.1073/pnas.0709717105; BERTOLETTI A, 1993, J VIROL, V67, P2376, DOI 10.1128/JVI.67.4.2376-2380.1993; BERTOLETTI A, 1994, NATURE, V369, P407, DOI 10.1038/369407a0; Bertoletti A, 1997, HEPATOLOGY, V26, P1027, DOI 10.1002/hep.510260435; Chang CXL, 2011, FRONT BIOSCI-LANDMRK, V16, P3014, DOI 10.2741/3895; Frickel EM, 2008, J INFECT DIS, V198, P1625, DOI 10.1086/593019; GARBOCZI DN, 1992, P NATL ACAD SCI USA, V89, P3429, DOI 10.1073/pnas.89.8.3429; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Glithero A, 2006, J BIOL CHEM, V281, P12699, DOI 10.1074/jbc.M511683200; Gredmark-Russ S, 2008, J VIROL, V82, P12205, DOI 10.1128/JVI.01463-08; Grotenbreg GM, 2008, P NATL ACAD SCI USA, V105, P3831, DOI 10.1073/pnas.0711504105; Grotenbreg GM, 2007, J BIOL CHEM, V282, P21425, DOI 10.1074/jbc.M702844200; Hadrup SR, 2009, METHODS MOL BIOL, V524, P383, DOI 10.1007/978-1-59745-450-6_28; Hadrup SR, 2009, NAT METHODS, V6, P520, DOI 10.1038/nmeth.1345; HOSKEN NA, 1990, SCIENCE, V248, P367, DOI 10.1126/science.2326647; Kessler JH, 2003, HUM IMMUNOL, V64, P245, DOI 10.1016/S0198-8859(02)00787-5; Klug F, 2009, CURR PHARM DESIGN, V15, P3221, DOI 10.2174/138161209789105180; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; Newell EW, 2009, NAT METHODS, V6, P497, DOI 10.1038/nmeth.1344; PARKER KC, 1992, J IMMUNOL, V149, P1896; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; Pira GL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/325720; Provenzano M, 2006, TRENDS MOL MED, V12, P465, DOI 10.1016/j.molmed.2006.08.008; Rodenko B, 2006, NAT PROTOC, V1, P1120, DOI 10.1038/nprot.2006.121; Rodenko B, 2009, J AM CHEM SOC, V131, P12305, DOI 10.1021/ja9037565; Shields MJ, 1998, MOL IMMUNOL, V35, P919, DOI 10.1016/S0161-5890(98)00083-2; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; vanderBurg SH, 1995, HUM IMMUNOL, V44, P189, DOI 10.1016/0198-8859(95)00105-0; Wilson DC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000815	32	7	7	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28466	28475		10.1074/jbc.M111.262691	http://dx.doi.org/10.1074/jbc.M111.262691			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680737	hybrid, Green Published			2022-12-25	WOS:000293557800062
J	Hillmann, F; Argentini, M; Buddelmeijer, N				Hillmann, Falk; Argentini, Manuela; Buddelmeijer, Nienke			Kinetics and Phospholipid Specificity of Apolipoprotein N-Acyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LECITHIN-RETINOL ACYLTRANSFERASE; PROLIPOPROTEIN SIGNAL PEPTIDASE; OUTER-MEMBRANE LIPOPROTEIN; ESCHERICHIA-COLI; BACTERIAL PROLIPOPROTEIN; ENZYME INTERMEDIATE; SDS-PAGE; PROTEIN; IDENTIFICATION; TRANSLOCATION	The enzyme apolipoprotein N-acyltransferase (Lnt) is an integral membrane protein that catalyzes the last step in the post-translational modification of bacterial lipoproteins. Lnt undergoes covalent modification in the presence of phospholipids resulting in a thioester acyl-enzyme intermediate. It then transfers the acyl chain to the alpha-amino group of the N-terminal diacylglyceryl-modified cysteine of apolipoprotein, leading to the formation of mature triacylated lipoprotein. To gain insight into the catalytic mechanism of this two-step reaction, we overproduced and purified the enzyme of Escherichia coli and studied its N-acyltransferase activity using a novel in vitro assay. The purified enzyme was fully active, as judged by its ability to form a stable thioester acyl-enzyme intermediate and N-acylate the apo-form of the murein lipoprotein Lpp in vitro. Incorporation of [H-3] palmitate and mass spectrometry analysis demonstrated that Lnt recognized the synthetic diacylglyceryl-modified lipopeptide FSL-1 as a substrate in a mixed micelle assay. Kinetics of Lnt using phosphatidylethanolamine as an acyl donor and FSL-1 as a substrate were consistent with a ping-pong type mechanism, demonstrating slow acyl-enzyme intermediate formation and rapid N-acyl transfer to the apolipopeptide in vitro. In contrast to earlier in vitro observations, the N-acyltransferase activity was strongly affected by the phospholipid headgroup and acyl chain composition.	[Hillmann, Falk; Buddelmeijer, Nienke] Inst Pasteur, Mol Genet Unit, CNRS URA 2172, F-75724 Paris 15, France; [Argentini, Manuela] CNRS, Inst Chim Subst Nat, Ctr Rech GIF, F-91198 Gif Sur Yvette, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Buddelmeijer, N (corresponding author), Inst Pasteur, Mol Genet Unit, CNRS URA 2172, 25 Rue Docteur Roux, F-75724 Paris 15, France.	niebud@pasteur.fr	Buddelmeijer, Nienke/AAM-3312-2021	Hillmann, Falk/0000-0002-5493-930X	German Academic Exchange Service (DAAD)	German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	Supported by a postdoctoral fellowship of the German Academic Exchange Service (DAAD). Present address: Dept. of Molecular and Applied Microbiology, Leibniz Inst. for Natural Product Research and Infection Biology, Hans-Knoll-Institut, Beutenbergstr. 11a, D-07745 Jena, Germany.	Adu-Bobie J, 2004, INFECT IMMUN, V72, P1914, DOI 10.1128/IAI.72.4.1914-1919.2004; Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; Asanuma M, 2011, FEBS J, V278, P716, DOI 10.1111/j.1742-4658.2010.07990.x; Bartling CM, 2008, BIOCHEMISTRY-US, V47, P5290, DOI 10.1021/bi800240r; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; Bok D, 2003, BIOCHEMISTRY-US, V42, P6090, DOI 10.1021/bi0342416; BRAUN V, 1969, EUR J BIOCHEM, V10, P426, DOI 10.1111/j.1432-1033.1969.tb00707.x; Brown JS, 2001, MOL MICROBIOL, V40, P572, DOI 10.1046/j.1365-2958.2001.02414.x; Buddelmeijer N, 2010, BIOCHEMISTRY-US, V49, P341, DOI 10.1021/bi9020346; COOPER CL, 1989, J BIOL CHEM, V264, P7384; DENFERT C, 1989, J BACTERIOL, V171, P3673, DOI 10.1128/jb.171.7.3673-3679.1989; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; FRAIPONT C, 1994, BIOCHEM J, V298, P189, DOI 10.1042/bj2980189; Fukuda A, 2002, J BIOL CHEM, V277, P43512, DOI 10.1074/jbc.M206816200; Gimenez MI, 2007, MOL MICROBIOL, V66, P1597, DOI 10.1111/j.1365-2958.2007.06034.x; Golczak M, 2010, J BIOL CHEM, V285, P29217, DOI 10.1074/jbc.M110.152314; GUPTA SD, 1993, J BIOL CHEM, V268, P16551; GUPTA SD, 1991, FEMS MICROBIOL LETT, V78, P37; GUPTA SD, 1991, J BIOL CHEM, V266, P9983; Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x; Harvat EM, 2005, J BIOL CHEM, V280, P12028, DOI 10.1074/jbc.M414368200; JACKOWSKI S, 1986, J BIOL CHEM, V261, P1328; Jin XH, 2007, J BIOL CHEM, V282, P3614, DOI 10.1074/jbc.M606369200; Kadner R. J., 1996, ESCHERICHIA COLI SAL, V2nd; KONTINEN VP, 1993, MOL MICROBIOL, V8, P727, DOI 10.1111/j.1365-2958.1993.tb01616.x; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kurokawa K, 2009, J BIOL CHEM, V284, P8406, DOI 10.1074/jbc.M809618200; Lewenza S, 2005, GENOME RES, V15, P321, DOI 10.1101/gr.3257305; MUNOA FJ, 1991, J BIOL CHEM, V266, P17667; Nakamura J, 2002, MICROBIOL IMMUNOL, V46, P151, DOI 10.1111/j.1348-0421.2002.tb02680.x; Narita S, 2010, METHODS MOL BIOL, V619, P117, DOI 10.1007/978-1-60327-412-8_7; Okusawa T, 2004, INFECT IMMUN, V72, P1657, DOI 10.1128/IAI.72.3.1657-1665.2004; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; Rando RR, 2002, BIOCHEM BIOPH RES CO, V292, P1243, DOI 10.1006/bbrc.2001.2021; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200; SANKARAN K, 1995, METHOD ENZYMOL, V250, P683; SANKARAN K, 1995, METHOD ENZYMOL, V248, P169; SANKARAN K, 1994, J BIOL CHEM, V269, P19701; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; TOKUNAGA M, 1982, J BIOL CHEM, V257, P9922; Tschumi A, 2009, J BIOL CHEM, V284, P27146, DOI 10.1074/jbc.M109.022715; Valente FMA, 2007, FEBS LETT, V581, P3341, DOI 10.1016/j.febslet.2007.06.020; Vidal-Ingigliardi D, 2007, J BACTERIOL, V189, P4456, DOI 10.1128/JB.00099-07; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; WILLIAMS MG, 1989, J BACTERIOL, V171, P565, DOI 10.1128/jb.171.1.565-568.1989	49	40	41	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27936	27946		10.1074/jbc.M111.243519	http://dx.doi.org/10.1074/jbc.M111.243519			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21676878	Green Published, hybrid			2022-12-25	WOS:000293557800012
J	Liaset, B; Hao, Q; Jorgensen, H; Hallenborg, P; Du, ZY; Ma, T; Marschall, HU; Kruhoffer, M; Li, RQ; Li, QB; Yde, CC; Criales, G; Bertram, HC; Mellgren, G; Ofjord, ES; Lock, EJ; Espe, M; Froyland, L; Madsen, L; Kristiansen, K				Liaset, Bjorn; Hao, Qin; Jorgensen, Henry; Hallenborg, Philip; Du, Zhen-Yu; Ma, Tao; Marschall, Hanns-Ulrich; Kruhoffer, Mogens; Li, Ruiqiang; Li, Qibin; Yde, Christian Clement; Criales, Gabriel; Bertram, Hanne C.; Mellgren, Gunnar; Ofjord, Erik Snorre; Lock, Erik-Jan; Espe, Marit; Froyland, Livar; Madsen, Lise; Kristiansen, Karsten			Nutritional Regulation of Bile Acid Metabolism Is Associated with Improved Pathological Characteristics of the Metabolic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FARNESOID-X-RECEPTOR; LOW-DENSITY LIPOPROTEIN; NUCLEAR RECEPTOR; GENE-EXPRESSION; BROWN ADIPOCYTES; DIETARY TAURINE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ENZYMATIC-HYDROLYSIS; TARGETED DISRUPTION	Bile acids (BAs) are powerful regulators of metabolism, and mice treated orally with cholic acid are protected from diet-induced obesity, hepatic lipid accumulation, and increased plasma triacylglycerol (TAG) and glucose levels. Here, we show that plasma BA concentration in rats was elevated by exchanging the dietary protein source from casein to salmon protein hydrolysate (SPH). Importantly, the SPH-treated rats were resistant to diet-induced obesity. SPH-treated rats had reduced fed state plasma glucose and TAG levels and lower TAG in liver. The elevated plasma BA concentration was associated with induction of genes involved in energy metabolism and uncoupling, Dio2, Pgc-1 alpha, and Ucp1, in interscapular brown adipose tissue. Interestingly, the same transcriptional pattern was found in white adipose tissue depots of both abdominal and subcutaneous origin. Accordingly, rats fed SPH-based diet exhibited increased whole body energy expenditure and heat dissipation. In skeletal muscle, expressions of the peroxisome proliferator-activated receptor beta/delta target genes (Cpt-1b, Angptl4, Adrp, and Ucp3) were induced. Pharmacological removal of BAs by inclusion of 0.5 weight % cholestyramine to the high fat SPH diet attenuated the reduction in abdominal obesity, the reduction in liver TAG, and the decrease in nonfasted plasma TAG and glucose levels. Induction of Ucp3 gene expression in muscle by SPH treatment was completely abolished by cholestyramine inclusion. Taken together, our data provide evidence that bile acid metabolism can be modulated by diet and that such modulation may prevent/ameliorate the characteristic features of the metabolic syndrome.	[Liaset, Bjorn; Du, Zhen-Yu; Criales, Gabriel; Lock, Erik-Jan; Espe, Marit; Froyland, Livar; Madsen, Lise] Natl Inst Nutr & Seafood Res, N-5817 Bergen, Norway; [Hao, Qin; Ma, Tao; Madsen, Lise; Kristiansen, Karsten] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Jorgensen, Henry; Yde, Christian Clement] Aarhus Univ, Dept Anim Hlth Welf & Nutr, DK-8830 Tjele, Denmark; [Hallenborg, Philip] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Acad, Inst Med, S-40530 Gothenburg, Sweden; [Kruhoffer, Mogens] AROS Appl Biotechnol, DK-8200 Aarhus, Denmark; [Li, Ruiqiang; Li, Qibin] Beijing Genom Inst, Shenzhen 518083, Peoples R China; [Bertram, Hanne C.] Aarhus Univ, Dept Food Sci, DK-5792 Aarslev, Denmark; [Mellgren, Gunnar] Univ Bergen, Inst Med, N-5021 Bergen, Norway; [Mellgren, Gunnar] Haukeland Hosp, Hormone Lab, N-5021 Bergen, Norway; [Ofjord, Erik Snorre] Ctr Clin Trials, N-5094 Bergen, Norway	University of Copenhagen; Aarhus University; University of Southern Denmark; University of Gothenburg; Beijing Genomics Institute (BGI); Aarhus University; University of Bergen; University of Bergen; Haukeland University Hospital	Liaset, B (corresponding author), Natl Inst Nutr & Seafood Res, POB 2029 Nordnes, N-5817 Bergen, Norway.	bli@nifes.no; kk@bio.ku.dk	Marschall, Hanns-Ulrich/K-8842-2017; Mellgren, Gunnar/AAG-6573-2020; Lock, Erik-Jan/AAM-9766-2020; Madsen, Lise/C-6246-2012; Kristiansen, Karsten/J-5148-2014; Lock, Erik-Jan/B-7523-2012; Bertram, Hanne Christine/I-8439-2019; Lock, Erik-Jan/F-3115-2012	Marschall, Hanns-Ulrich/0000-0001-7347-3085; Mellgren, Gunnar/0000-0001-6282-4986; Madsen, Lise/0000-0003-4468-1947; Kristiansen, Karsten/0000-0002-6024-0917; Bertram, Hanne Christine/0000-0002-1882-5321; Hao, Qin/0000-0002-6775-2181; Lock, Erik-Jan/0000-0002-8157-5249; Du, Zhen-Yu/0000-0001-6581-5313; Liaset, Bjorn/0000-0002-8652-7801	Danish Natural Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation [2101-06-0005]; University of Bergen; Program Committee on Nutrition; Eckbo Foundation; Norwegian Research Council [200515-I30]; Innovation Norway; RUBIN; Danish Council for Strategic Research [2101-06-0005]	Danish Natural Science Research Council(Danish Natural Science Research Council); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); University of Bergen; Program Committee on Nutrition; Eckbo Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); Innovation Norway; RUBIN; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF))	This work was supported by the Danish Natural Science Research Council, The Novo Nordisk Foundation, The Carlsberg Foundation (performed as part of the research program of the Danish Obesity Research Centre supported by the Danish Council for Strategic Research Grant 2101-06-0005), University of Bergen, Program Committee on Nutrition, The Eckbo Foundation, and Norwegian Research Council Grant 200515-I30. This work was carried out as a part of the "DOCMAR" research program funded by Innovation Norway and RUBIN and supported by the Danish Council for Strategic Research Grant 2101-06-0005.	Akiyama TE, 2004, J BIOL CHEM, V279, P20874, DOI 10.1074/jbc.M312802200; BALLATORI N, 1992, AM J PHYSIOL, V263, pG617, DOI 10.1152/ajpgi.1992.263.5.G617; Bar A, 1999, REGUL TOXICOL PHARM, V29, pS11, DOI 10.1006/rtph.1998.1266; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; BAS S, 1983, ARCH BIOCHEM BIOPHYS, V222, P416, DOI 10.1016/0003-9861(83)90539-8; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; Bouckenooghe T, 2006, CURR OPIN CLIN NUTR, V9, P728, DOI 10.1097/01.mco.0000247469.26414.55; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; De Fabiani E, 2003, J BIOL CHEM, V278, P39124, DOI 10.1074/jbc.M305079200; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Enochsson L, 2010, NUTRITION, V26, P405, DOI 10.1016/j.nut.2009.05.005; Esteller A, 2008, WORLD J GASTROENTERO, V14, P5641, DOI 10.3748/wjg.14.5641; Evans MJ, 2009, AM J PHYSIOL-GASTR L, V296, pG543, DOI 10.1152/ajpgi.90585.2008; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7; Glicksman C, 2010, ANN CLIN BIOCHEM, V47, P482, DOI 10.1258/acb.2010.010040; Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101; HARDISON WGM, 1978, GASTROENTEROLOGY, V75, P71; Hirokane H, 2004, J BIOL CHEM, V279, P45685, DOI 10.1074/jbc.M404255200; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Ikemoto S, 1997, AM J PHYSIOL-ENDOC M, V273, pE37, DOI 10.1152/ajpendo.1997.273.1.E37; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kast HR, 2001, MOL ENDOCRINOL, V15, P1720, DOI 10.1210/me.15.10.1720; Katsuma S, 2005, BIOCHEM BIOPH RES CO, V329, P386, DOI 10.1016/j.bbrc.2005.01.139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Kleiner S, 2009, J BIOL CHEM, V284, P18624, DOI 10.1074/jbc.M109.008797; Lambert G, 2003, J BIOL CHEM, V278, P2563, DOI 10.1074/jbc.M209525200; LARUSSO NF, 1978, AM J DIG DIS, V23, P385, DOI 10.1007/BF01072919; Lauridsen C, 2008, J SCI FOOD AGR, V88, P720, DOI 10.1002/jsfa.3142; Lee CH, 2006, P NATL ACAD SCI USA, V103, P3444, DOI 10.1073/pnas.0511253103; Liaset B, 2003, PROCESS BIOCHEM, V38, P1747, DOI 10.1016/S0032-9592(02)00251-0; Liaset B, 2008, PROCESS BIOCHEM, V43, P42, DOI 10.1016/j.procbio.2007.10.007; Liaset B, 2009, BBA-MOL CELL BIOL L, V1791, P254, DOI 10.1016/j.bbalip.2009.01.016; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Madsen L, 1999, LIPIDS, V34, P447, DOI 10.1007/s11745-999-0384-6; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; Madsen L, 2008, J BIOL CHEM, V283, P7196, DOI 10.1074/jbc.M707775200; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Marschall HU, 2006, J LIPID RES, V47, P582, DOI 10.1194/jlr.M500427-JLR200; Martens H, 2000, FOOD QUAL PREFER, V11, P5, DOI 10.1016/S0950-3293(99)00039-7; Martens HA, 1998, CHEMOMETR INTELL LAB, V44, P99, DOI 10.1016/S0169-7439(98)00167-1; Martin IV, 2010, BIOL CHEM, V391, P1441, DOI 10.1515/BC.2010.141; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; Maruyama T, 2006, J ENDOCRINOL, V191, P197, DOI 10.1677/joe.1.06546; Muhfeld A, 2003, ARCH BIOCHEM BIOPHYS, V413, P32, DOI 10.1016/S0003-9861(03)00098-5; Nakatani H, 2009, METABOLISM, V58, P1400, DOI 10.1016/j.metabol.2009.05.006; Park T, 1999, NUTR RES, V19, P1777, DOI 10.1016/S0271-5317(99)00118-9; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Patti ME, 2009, OBESITY, V17, P1671, DOI 10.1038/oby.2009.102; Pauli-Magnus C, 2005, J HEPATOL, V43, P342, DOI 10.1016/j.jhep.2005.03.017; Pizarro M, 2004, GUT, V53, P1837, DOI 10.1136/gut.2003.037689; Sanderson LM, 2010, PHYSIOL GENOMICS, V41, P42, DOI 10.1152/physiolgenomics.00127.2009; Sato H, 2008, J MED CHEM, V51, P1831, DOI 10.1021/jm7015864; Shonsey EM, 2005, METHOD ENZYMOL, V400, P374, DOI 10.1016/S0076-6879(05)00022-4; Simoncic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-96; Sinal CJ, 2001, J BIOL CHEM, V276, P47154, DOI 10.1074/jbc.M107000200; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Sirvent A, 2004, FEBS LETT, V566, P173, DOI 10.1016/j.febslet.2004.04.026; SUCKLING KE, 1991, ATHEROSCLEROSIS, V89, P183, DOI 10.1016/0021-9150(91)90059-C; SUGIYAMA K, 1989, AGR BIOL CHEM TOKYO, V53, P1647, DOI 10.1080/00021369.1989.10869537; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Thomas C, 2009, CELL METAB, V10, P167, DOI 10.1016/j.cmet.2009.08.001; Torra IP, 2003, MOL ENDOCRINOL, V17, P259, DOI 10.1210/me.2002-0120; VESSEY DA, 1983, BIOCHEM J, V214, P923, DOI 10.1042/bj2140923; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watanabe M, 2006, NATURE, V439, P484, DOI 10.1038/nature04330; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yokogoshi H, 1999, J NUTR, V129, P1705, DOI 10.1093/jn/129.9.1705; ZHANG RW, 1992, AM J PHYSIOL, V262, pG351, DOI 10.1152/ajpgi.1992.262.2.G351; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103	82	49	54	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28382	28395		10.1074/jbc.M111.234732	http://dx.doi.org/10.1074/jbc.M111.234732			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680746	Green Published, hybrid			2022-12-25	WOS:000293557800054
J	Hagedorn, M; Carter, VL				Hagedorn, Mary; Carter, Virginia L.			Zebrafish Reproduction: Revisiting In Vitro Fertilization to Increase Sperm Cryopreservation Success	PLOS ONE			English	Article							SWORDTAIL XIPHOPHORUS-HELLERI; REFRIGERATED STORAGE; HIGH-THROUGHPUT; DANIO-RERIO; FISH; SPERMATOZOA; DILUTION; OOCYTES; EGGS; DRUM	Although conventional cryopreservation is a proven method for long-term, safe storage of genetic material, protocols used by the zebrafish community are not standardized and yield inconsistent results, thereby putting the security of many genotypes in individual laboratories and stock centers at risk. An important challenge for a successful zebrafish sperm cryopreservation program is the large variability in the post-thaw in vitro fertilization success (0 to 80%). But how much of this variability was due to the reproductive traits of the in vitro fertilization process, and not due to the cryopreservation process? These experiments only assessed the in vitro process with fresh sperm, but yielded the basic metrics needed for successful in vitro fertilization using cryopreserved sperm, as well. We analyzed the reproductive traits for zebrafish males with a strict body condition range. It did not correlate with sperm volume, or motility (P > 0.05), but it did correlate with sperm concentration. Younger males produced more concentrated sperm (P < 0.05). To minimize the wastage of sperm during the in vitro fertilization process, 10 6 cells/ml was the minimum sperm concentration needed to achieve an in vitro fertilization success of >= 70%. During the in vitro process, pooling sperm did not reduce fertilization success (P > 0.05), but pooling eggs reduced it by approximately 30 to 50% (P < 0.05). This reduction in fertilization success was due not to the pooling of the females' eggs, but to the type of tools used to handle the eggs. Recommendations to enhance the in vitro process for zebrafish include: 1) using males of a body condition closer to 1.5 for maximal sperm concentration; 2) minimizing sperm wastage by using a working sperm concentration of 10(6) motile cells/ml for in vitro fertilization; and 3) never using metal or sharp-edged tools to handle eggs prior to fertilization.	[Hagedorn, Mary; Carter, Virginia L.] Smithsonian Conservat Biol Inst, Washington, DC USA; [Hagedorn, Mary; Carter, Virginia L.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI USA	Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Hawaii System	Hagedorn, M (corresponding author), Smithsonian Conservat Biol Inst, Smithsonian Natl Zool Pk, Washington, DC USA.	hagedornm@si.edu			National Institutes of Health, National Center for Research Resources [5R24RR023998]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR023998] Funding Source: NIH RePORTER	National Institutes of Health, National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health, National Center for Research Resources (Grant # 5R24RR023998). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Coffman MA, 1998, BIOL REPROD, V59, P497, DOI 10.1095/biolreprod59.3.497; CorleySmith GE, 1996, GENETICS, V142, P1265; Draper BW, 2004, METHOD CELL BIOL, V77, P91; HARVEY B, 1982, CAN J ZOOL, V60, P1867, DOI 10.1139/z82-242; HSU SY, 1993, CAN J FISH AQUAT SCI, V50, P932, DOI 10.1139/f93-107; Huang CJ, 2004, CRYOBIOLOGY, V48, P295, DOI 10.1016/j.crybiol.2004.02.004; Huang CJ, 2004, THERIOGENOLOGY, V62, P179, DOI 10.1016/j.theriogenology.2003.09.019; Jing RY, 2009, AQUACULTURE, V290, P165, DOI 10.1016/j.aquaculture.2009.02.027; Knight J, 2002, NATURE, V417, P785, DOI 10.1038/417785a; Morris JP, 2003, BIOTECHNIQUES, V35, P956; Paniagua-Chavez CG, 1998, J SHELLFISH RES, V17, P231; RANA KJ, 1989, AQUACULTURE, V76, P335, DOI 10.1016/0044-8486(89)90085-9; Ratzan SC., 2000, NATL LIB MED CURRENT, V1; Rizzo E, 2003, THERIOGENOLOGY, V60, P1059, DOI 10.1016/S0093-691X(03)00108-0; Sakai N, 1997, MOL MAR BIOL BIOTECH, V6, P84; Seki S, 2008, REPRODUCTION, V135, P285, DOI 10.1530/REP-07-0416; Sood R, 2006, METHODS, V39, P220, DOI 10.1016/j.ymeth.2006.04.012; Tiersch TR, 2001, MAR BIOTECHNOL, V3, pS212, DOI 10.1007/s10126001-0044-z; Wayman William R., 1996, Gulf Research Reports, V9, P183; Wayman WR, 1997, THERIOGENOLOGY, V47, P1519, DOI 10.1016/S0093-691X(97)00158-1; Wayman WR, 1998, AQUAC RES, V29, P267, DOI 10.1046/j.1365-2109.1998.00198.x; Westerfield M., 2005, ZEBRAFISH BOOK GUIDE; WILLIAMS JE, 2000, MANUAL FISHERIES SUR, V2, P25; Yang HP, 2007, THERIOGENOLOGY, V68, P128, DOI 10.1016/j.theriogenology.2007.02.015; Yang HP, 2009, COMP BIOCHEM PHYS C, V149, P224, DOI 10.1016/j.cbpc.2008.07.005	25	21	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21059	10.1371/journal.pone.0021059	http://dx.doi.org/10.1371/journal.pone.0021059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698162	Green Published, gold, Green Submitted			2022-12-25	WOS:000291734100048
J	Idelevich, A; Kerschnitzki, M; Shahar, R; Monsonego-Ornan, E				Idelevich, Anna; Kerschnitzki, Michael; Shahar, Ron; Monsonego-Ornan, Efrat			1,25(OH)(2)D-3 Alters Growth Plate Maturation and Bone Architecture in Young Rats with Normal Renal Function	PLOS ONE			English	Article							VITAMIN-D-RECEPTOR; INTERMITTENT CALCITRIOL THERAPY; MINERAL ION HOMEOSTASIS; CHRONIC KIDNEY-DISEASE; SECONDARY HYPERPARATHYROIDISM; 1,25-DIHYDROXYVITAMIN D-3; VASCULAR CALCIFICATION; BIOMECHANICAL ANALYSES; NULL MICE; CHONDROCYTES	Whereas detrimental effects of vitamin D deficiency are known over century, the effects of vitamin D receptor activation by 1,25(OH)(2)D-3, the principal hormonal form of vitamin D, on the growing bone and its growth plate are less clear. Currently, 1,25(OH)(2)D-3 is used in pediatric patients with chronic kidney disease and mineral and bone disorder (CKD-MBD) and is strongly associated with growth retardation. Here, we investigate the effect of 1,25(OH)(2)D-3 treatment on bone development in normal young rats, unrelated to renal insufficiency. Young rats received daily i.p. injections of 1 mu g/kg 1,25(OH)(2)D-3 for one week, or intermittent 3 mu g/kg 1,25(OH)(2)D-3 for one month. Histological analysis revealed narrower tibial growth plates, predominantly in the hypertrophic zone of 1,25(OH)(2)D-3-treated animals in both experimental protocols. This phenotype was supported by narrower distribution of aggrecan, collagens II and X mRNA, shown by in situ hybridization. Concomitant with altered chondrocyte maturation, 1,25(OH)(2)D-3 increased chondrocyte proliferation and apoptosis in terminal hypertrophic cells. In vitro treatment of the chondrocytic cell line ATDC5 with 1,25(OH)(2)D-3 lowered differentiation and increased proliferation dose and time-dependently. Micro-CT analysis of femurs from 1-week 1,25(OH)(2)D-3-treated group revealed reduced cortical thickness, elevated cortical porosity, and higher trabecular number and thickness. 1-month administration resulted in a similar cortical phenotype but without effect on trabecular bone. Evaluation of fluorochrome binding with confocal microscopy revealed inhibiting effects of 1,25(OH)(2)D-3 on intracortical bone formation. This study shows negative effects of 1,25(OH)(2)D-3 on growth plate and bone which may contribute to the exacerbation of MBD in the CKD pediatric patients.	[Idelevich, Anna; Monsonego-Ornan, Efrat] Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel; [Shahar, Ron] Hebrew Univ Jerusalem, Koret Sch Vet Med, Robert H Smith Fac Agr Food & Environm, IL-76100 Rehovot, Israel; [Kerschnitzki, Michael] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Max Planck Society	Idelevich, A (corresponding author), Hebrew Univ Jerusalem, Inst Biochem Food Sci & Nutr, IL-76100 Rehovot, Israel.	ornanme@agri.huji.ac.il			Israel Science Foundation [292/07]; Bundesministerium fur Bildung und Forschung (BMBF) [01 EC 1006C, 9133]; DFG through the Berlin-Brandenburg School for Regenerative Therapies (BSRT) [GSC 203]	Israel Science Foundation(Israel Science Foundation); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG through the Berlin-Brandenburg School for Regenerative Therapies (BSRT)	This research was supported by The Israel Science Foundation (grant no. 292/07). M.K. is funded by Bundesministerium fur Bildung und Forschung (BMBF, Grant-number: 01 EC 1006C, project 9133) and by DFG funding through the Berlin-Brandenburg School for Regenerative Therapies (BSRT) GSC 203. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Anderson PH, 2008, MOL ASPECTS MED, V29, P397, DOI 10.1016/j.mam.2008.05.003; Ben-Zvi T, 2006, J CELL SCI, V119, P380, DOI 10.1242/jcs.02740; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Challa TD, 2010, MOL CELL ENDOCRINOL, V323, P282, DOI 10.1016/j.mce.2010.03.025; Dardenne O, 2003, J BONE MINER RES, V18, P637, DOI 10.1359/jbmr.2003.18.4.637; Dardenne O, 2003, BONE, V32, P332, DOI 10.1016/S8756-3282(03)00023-1; Donohue MM, 2002, ENDOCRINOLOGY, V143, P3691, DOI 10.1210/en.2002-220454; Dusso AS, 2005, AM J PHYSIOL-RENAL, V289, pF8, DOI 10.1152/ajprenal.00336.2004; Erben RG, 1997, ENDOCRINOLOGY, V138, P4629, DOI 10.1210/en.138.11.4629; Finch JL, 2010, AM J PHYSIOL-RENAL, V298, pF1315, DOI 10.1152/ajprenal.00552.2009; GOODMAN WG, 1994, KIDNEY INT, V46, P1160, DOI 10.1038/ki.1994.380; HIGH WB, 1981, AM J PATHOL, V104, P41; Hopper TAJ, 2007, J COMPUT ASSIST TOMO, V31, P320, DOI 10.1097/01.rct.0000238007.19258.3d; Karsenty G, 2009, ANNU REV CELL DEV BI, V25, P629, DOI 10.1146/annurev.cellbio.042308.113308; Kuizon BD, 1998, KIDNEY INT, V53, P205, DOI 10.1046/j.1523-1755.1998.00724.x; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; London GM, 2008, J AM SOC NEPHROL, V19, P1827, DOI 10.1681/ASN.2007050622; Masuyama R, 2006, J CLIN INVEST, V116, P3150, DOI 10.1172/JCI29463; Mizobuchi M, 2007, KIDNEY INT, V72, P709, DOI 10.1038/sj.ki.5002406; Naja RP, 2009, ENDOCRINOLOGY, V150, P4024, DOI 10.1210/en.2008-1410; Nilsson O, 2005, HORM RES, V64, P157, DOI 10.1159/000088791; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; QUERFELD U, 2010, PEDIAT NEPHROL; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reich A, 2005, J APPL PHYSIOL, V98, P2381, DOI 10.1152/japplphysiol.01073.2004; Reich A, 2008, BONE, V43, P766, DOI 10.1016/j.bone.2008.06.004; Reich A, 2010, J APPL PHYSIOL, V108, P172, DOI 10.1152/japplphysiol.00821.2009; Salusky IB, 1998, KIDNEY INT, V54, P907, DOI 10.1046/j.1523-1755.1998.00045.x; Sanchez CP, 2007, KIDNEY INT, V72, P582, DOI 10.1038/sj.ki.5002375; Sanchez CP, 2008, REV ENDOCR METAB DIS, V9, P131, DOI 10.1007/s11154-007-9071-z; Sanchez CP, 2010, PEDIATR NEPHROL, V25, P643, DOI 10.1007/s00467-009-1307-6; Sanchez CP, 2003, J AM SOC NEPHROL, V14, P148, DOI 10.1097/01.ASN.0000039565.56011.BE; SANDELL LJ, 1994, J ORTHOP RES, V12, P1, DOI 10.1002/jor.1100120102; Schoenau E, 2004, HORM RES, V61, P257, DOI 10.1159/000076635; Shapiro F, 2008, EUR CELLS MATER, V15, P53, DOI 10.22203/eCM.v015a05; Simsa S, 2007, J ANIM SCI, V85, P1393, DOI 10.2527/jas.2006-711; Simsa S, 2007, AM J PHYSIOL-REG I, V292, pR2216, DOI 10.1152/ajpregu.00864.2006; Suda T, 2003, J CELL BIOCHEM, V88, P259, DOI 10.1002/jcb.10331; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Tanaka H, 2004, J STEROID BIOCHEM, V89-90, P343, DOI 10.1016/j.jsbmb.2004.03.021; Wesseling K, 2008, PEDIATR NEPHROL, V23, P195, DOI 10.1007/s00467-007-0671-3; WRONSKI TJ, 1986, ENDOCRINOLOGY, V119, P2580, DOI 10.1210/endo-119-6-2580; Xue YB, 2006, ENDOCRINOLOGY, V147, P4801, DOI 10.1210/en.2006-0403; Zittermann A, 2008, MOL ASPECTS MED, V29, P423, DOI 10.1016/j.mam.2008.04.002	45	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20772	10.1371/journal.pone.0020772	http://dx.doi.org/10.1371/journal.pone.0020772			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695192	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300020
J	Coulibaly-N'Golo, D; Allali, B; Kouassi, SK; Fichet-Calvet, E; Becker-Ziaja, B; Rieger, T; Olschlager, S; Dosso, H; Denys, C; ter Meulen, J; Akoua-Koffi, C; Gunther, S				Coulibaly-N'Golo, David; Allali, Bernard; Kouassi, Stephane K.; Fichet-Calvet, Elisabeth; Becker-Ziaja, Beate; Rieger, Toni; Oelschlaeger, Stephan; Dosso, Hernri; Denys, Christiane; ter Meulen, Jan; Akoua-Koffi, Chantal; Guenther, Stephan			Novel Arenavirus Sequences in Hylomyscus sp. and Mus (Nannomys) setulosus from Cote d'Ivoire: Implications for Evolution of Arenaviruses in Africa	PLOS ONE			English	Article							LASSA-VIRUS; MASTOMYS-NATALENSIS; PYGMY MICE; PHYLOGENY; RODENTIA; MURINAE; FEVER; RNA; MITOCHONDRIAL; BIOGEOGRAPHY	This study aimed to identify new arenaviruses and gather insights in the evolution of arenaviruses in Africa. During 2003 through 2005, 1,228 small mammals representing 14 different genera were trapped in 9 villages in south, east, and middle west of Cote d'Ivoire. Specimens were screened by pan-Old World arenavirus RT-PCRs targeting S and L RNA segments as well as immunofluorescence assay. Sequences of two novel tentative species of the family Arenaviridae, Menekre and Gbagroube virus, were detected in Hylomyscus sp. and Mus (Nannomys) setulosus, respectively. Arenavirus infection of Mus (Nannomys) setulosus was also demonstrated by serological testing. Lassa virus was not found, although 60% of the captured animals were Mastomys natalensis. Complete S RNA and partial L RNA sequences of the novel viruses were recovered from the rodent specimens and subjected to phylogenetic analysis. Gbagroube virus is a closely related sister taxon of Lassa virus, while Menekre virus clusters with the Ippy/Mobala/Mopeia virus complex. Reconstruction of possible virus-host co-phylogeny scenarios suggests that, within the African continent, signatures of co-evolution might have been obliterated by multiple host-switching events.	[Coulibaly-N'Golo, David; Allali, Bernard; Kouassi, Stephane K.; Akoua-Koffi, Chantal] Inst Pasteur Cote Ivoire, Lab Arbovirus Enterovirus, Abidjan, Cote Ivoire; [Coulibaly-N'Golo, David; Becker-Ziaja, Beate; Rieger, Toni; Oelschlaeger, Stephan; Guenther, Stephan] Bernhard Nocht Inst Trop Med, Dept Virol, Hamburg, Germany; [Fichet-Calvet, Elisabeth; Denys, Christiane] Museum Natl Hist Nat, Dept Systemat & Evolut, F-75231 Paris, France; [Dosso, Hernri] Univ dAbobo Adjame, Ctr Rech Ecol, Abidjan, Cote Ivoire; [ter Meulen, Jan] Univ Marburg, Inst Virol, D-3550 Marburg, Germany; [ter Meulen, Jan] Merck Res Labs, West Point, PA USA	Bernhard Nocht Institut fur Tropenmedizin; Museum National d'Histoire Naturelle (MNHN); Philipps University Marburg; Merck & Company	Coulibaly-N'Golo, D (corresponding author), Inst Pasteur Cote Ivoire, Lab Arbovirus Enterovirus, Abidjan, Cote Ivoire.	guenther@bni.uni-hamburg.de	Denys, Christiane/K-8144-2019	Denys, Christiane/0000-0002-1519-1546; Rieger, Toni/0000-0002-7863-1916; Gunther, Stephan/0000-0002-6562-0230; AKOUA KOFFI, Chantal/0000-0003-0975-6632	European Community [INCO-DEV ICA4-CT2002-10050, 228292, PIEF-GA-2009-235164]; German Research Foundation (DFG) [GU 883/1-1]	European Community(European Commission); German Research Foundation (DFG)(German Research Foundation (DFG))	The study was supported by grants INCO-DEV ICA4-CT2002-10050, 228292 (European Virus Archive), and Marie-Curie PIEF-GA-2009-235164 from the European Community (http://ec.europa.eu/research/fp6/index_en.cfm; http://ec.europa.eu/research/fp7/), and grant GU 883/1-1 from the German Research Foundation (DFG) (http://www.dfg.de/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Department of Virology of the Bernhard-Nocht-Institute is a WHO Collaborating Centre for Arbovirus and Haemorrhagic Fever Reference and Research (DEU-000115).	Akoua-Koffi C, 2006, Med Trop (Mars), V66, P465; ARMSTRONG CHARLES, 1939, PUBL HEALTH REPTS, V54, P673, DOI 10.2307/4582864; Atkin S, 2009, EUROSURVEILLANCE, V14; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Bowen MD, 1997, MOL PHYLOGENET EVOL, V8, P301, DOI 10.1006/mpev.1997.0436; Bowen MD, 2000, J VIROL, V74, P6992, DOI 10.1128/JVI.74.15.6992-7004.2000; Briese T, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000455; de Bellocq JG, 2010, EMERG INFECT DIS, V16, P692, DOI 10.3201/eid1604.091721; DIGOUTTE JP, 1978, AM J TROP MED HYG, V27, P389; Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Fichet-Calvet E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000388; GONZALEZ JP, 1983, INTERVIROLOGY, V19, P105, DOI 10.1159/000149344; Gunther S, 2009, EMERG INFECT DIS, V15, P2008, DOI 10.3201/eid1512.090864; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Holmes EC, 2008, ANNU REV MICROBIOL, V62, P307, DOI 10.1146/annurev.micro.62.081307.162912; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; HUFERT FT, 1989, ARCH VIROL, V106, P201, DOI 10.1007/BF01313953; Hughes AL, 2000, MOL BIOL EVOL, V17, P1558, DOI 10.1093/oxfordjournals.molbev.a026254; Hugot JP, 2001, INFECT GENET EVOL, V1, P13, DOI 10.1016/S1567-1348(01)00003-X; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Kouassi SK, 2008, MAMMALIA, V72, P237, DOI 10.1515/MAMM.2008.035; Lecompte E, 2007, VIROLOGY, V364, P178, DOI 10.1016/j.virol.2007.02.008; Lecompte E, 2006, EMERG INFECT DIS, V12, P1971; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Ledesma J, 2009, EMERG INFECT DIS, V15, P1677, DOI 10.3201/eid1510.090563; MAREE S, 2002, THESIS U PRETORIA PR; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Merkle D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S60; Nicolas V, 2006, MOL PHYLOGENET EVOL, V38, P779, DOI 10.1016/j.ympev.2005.11.024; Olschlager S, 2010, J CLIN MICROBIOL, V48, P2009, DOI 10.1128/JCM.02351-09; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Palacios G, 2010, J GEN VIROL, V91, P1315, DOI 10.1099/vir.0.017798-0; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; Ramsden C, 2009, MOL BIOL EVOL, V26, P143, DOI 10.1093/molbev/msn234; Ramsden C, 2008, MOL BIOL EVOL, V25, P1488, DOI 10.1093/molbev/msn093; Safronetz D, 2010, EMERG INFECT DIS, V16, P1123, DOI 10.3201/eid1607.100146; Steppan SJ, 2005, MOL PHYLOGENET EVOL, V37, P370, DOI 10.1016/j.ympev.2005.04.016; Steppan SJ, 2004, SYST BIOL, V53, P533, DOI 10.1080/10635150490468701; Taylor DJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-193; Taylor PJ, 2004, ZOOL SCR, V33, P389, DOI 10.1111/j.0300-3256.2004.00157.x; Veyrunes F, 2005, MOL PHYLOGENET EVOL, V36, P358, DOI 10.1016/j.ympev.2005.02.011; Vieth S, 2007, T ROY SOC TROP MED H, V101, P1253, DOI 10.1016/j.trstmh.2005.03.018; WILSON SM, 1991, VIROLOGY, V180, P543, DOI 10.1016/0042-6822(91)90068-M; WULFF H, 1977, B WORLD HEALTH ORGAN, V55, P441	49	61	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20893	10.1371/journal.pone.0020893	http://dx.doi.org/10.1371/journal.pone.0020893			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695269	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900035
J	Lucena, F; Barros, AK; Principe, JC; Ohnishi, N				Lucena, Fausto; Barros, Allan Kardec; Principe, Jose C.; Ohnishi, Noboru			Statistical Coding and Decoding of Heartbeat Intervals	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; RESPIRATORY SINUS ARRHYTHMIA; SYMPATHOVAGAL BALANCE; AUTONOMIC REGULATION; RATE-VARIABILITY; NATURAL IMAGES; NOISE; ORGANIZATION; MECHANISMS; EFFICIENCY	The heart integrates neuroregulatory messages into specific bands of frequency, such that the overall amplitude spectrum of the cardiac output reflects the variations of the autonomic nervous system. This modulatory mechanism seems to be well adjusted to the unpredictability of the cardiac demand, maintaining a proper cardiac regulation. A longstanding theory holds that biological organisms facing an ever-changing environment are likely to evolve adaptive mechanisms to extract essential features in order to adjust their behavior. The key question, however, has been to understand how the neural circuitry self-organizes these feature detectors to select behaviorally relevant information. Previous studies in computational perception suggest that a neural population enhances information that is important for survival by minimizing the statistical redundancy of the stimuli. Herein we investigate whether the cardiac system makes use of a redundancy reduction strategy to regulate the cardiac rhythm. Based on a network of neural filters optimized to code heartbeat intervals, we learn a population code that maximizes the information across the neural ensemble. The emerging population code displays filter tuning proprieties whose characteristics explain diverse aspects of the autonomic cardiac regulation, such as the compromise between fast and slow cardiac responses. We show that the filters yield responses that are quantitatively similar to observed heart rate responses during direct sympathetic or parasympathetic nerve stimulation. Our findings suggest that the heart decodes autonomic stimuli according to information theory principles analogous to how perceptual cues are encoded by sensory systems.	[Lucena, Fausto; Ohnishi, Noboru] Nagoya Univ, Biol Informat Engn Lab, Nagoya, Aichi 4648601, Japan; [Lucena, Fausto; Barros, Allan Kardec] Univ Fed Maranhao, Lab Proc Informacao Biol, Sao Luis, Maranhao, Brazil; [Barros, Allan Kardec] Natl Agcy Petr Gas & Biofuels, Rio De Janeiro, Brazil; [Principe, Jose C.] Univ Florida, Dept Elect & Comp Engn, Gainesville, FL USA	Nagoya University; Universidade Federal do Maranhao; State University System of Florida; University of Florida	Lucena, F (corresponding author), Nagoya Univ, Biol Informat Engn Lab, Nagoya, Aichi 4648601, Japan.	lucena@ohnishi.nagoya-u.ac.jp	Lucena, Fausto Lucena/F-6711-2012; Barros, Allan Kardec/ABD-5032-2021; principe, jose/N-8099-2014	Barros, Allan Kardec/0000-0002-1654-0955; 	Ministry of Education, Culture, Sports, Science and Technology of Japan; Nagoya University; ONR [N00014-07-1-0698]; NSF [ECCS-0856441]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Nagoya University; ONR(Office of Naval Research); NSF(National Science Foundation (NSF))	This work is sponsored by the Ministry of Education, Culture, Sports, Science and Technology of Japan and Nagoya University. The third author acknowledges funding from ONR N00014-07-1-0698 and NSF ECCS-0856441. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; ALEXANDER B, 1999, NATURE, V2, P974; ASHMORE JF, 1983, NATURE, V304, P536, DOI 10.1038/304536a0; Atick JJ, 1990, NEURAL COMPUT, V2, P308, DOI 10.1162/neco.1990.2.3.308; ATTNEAVE F, 1954, PSYCHOL REV, V61, P183, DOI 10.1037/h0054663; Barbieri R, 2005, AM J PHYSIOL-HEART C, V288, pH424, DOI 10.1152/ajpheart.00482.2003; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bell AJ, 1996, NETWORK-COMP NEURAL, V7, P261, DOI 10.1088/0954-898X/7/2/005; Bell AJ, 1997, VISION RES, V37, P3327, DOI 10.1016/S0042-6989(97)00121-1; BERGER RD, 1989, AM J PHYSIOL, V256, pH142, DOI 10.1152/ajpheart.1989.256.1.H142; BERNARDI L, 1989, J APPL PHYSIOL, V67, P1447, DOI 10.1152/jappl.1989.67.4.1447; Berntson G. G., 1999, CARDIAC ELECTROPHYSI, V3, P279, DOI [10.1023/A:1009920002142, DOI 10.1023/A:1009920002142]; BERNTSON GG, 1993, PSYCHOPHYSIOLOGY, V30, P183, DOI 10.1111/j.1469-8986.1993.tb01731.x; Boyett MR, 2000, CARDIOVASC RES, V47, P658, DOI 10.1016/S0008-6363(00)00135-8; Camm AJ, 1996, EUR HEART J, V17, P354; Chakravarthy SV, 1997, BIOL CYBERN, V76, P207, DOI 10.1007/s004220050333; Chen Z, 2010, IEEE T BIO-MED ENG, V57, P1335, DOI 10.1109/TBME.2010.2041002; Chorvat D, 2008, BIOSYSTEMS, V92, P49, DOI 10.1016/j.biosystems.2007.11.003; COMON P, 1994, SIGNAL PROCESS, V36, P287, DOI 10.1016/0165-1684(94)90029-9; Cover TM, 1991, ELEMENTS INFORM THEO; CRAWFORD AC, 1981, J PHYSIOL-LONDON, V312, P377, DOI 10.1113/jphysiol.1981.sp013634; Davies ME, 2007, SIGNAL PROCESS, V87, P1819, DOI 10.1016/j.sigpro.2007.01.011; Durka PJ, 2001, IEEE T SIGNAL PROCES, V49, P507, DOI 10.1109/78.905866; Faes L, 2009, IEEE T BIO-MED ENG, V56, P205, DOI 10.1109/TBME.2008.2008726; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; FIELD DJ, 1987, J OPT SOC AM A, V4, P2379, DOI 10.1364/JOSAA.4.002379; FIELD DJ, 1998, HDB BRAIN THEORY NEU; FURTH PM, 1995, IEEE T CIRCUITS-I, V42, P966, DOI 10.1109/81.477209; FURTH PM, 1995, THESIS J HOPKINS U B; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Haag J, 1998, J NEUROSCI, V18, P7972; Hidaka I, 2001, J NEUROPHYSIOL, V86, P559, DOI 10.1152/jn.2001.86.2.559; Hidaka I, 2000, PHYS REV LETT, V85, P3740, DOI 10.1103/PhysRevLett.85.3740; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Ivanov PC, 1996, NATURE, V383, P323, DOI 10.1038/383323a0; Jackson JC, 2009, P NATL ACAD SCI USA, V106, P10177, DOI 10.1073/pnas.0901727106; Jacobs RA, 1991, NEURAL COMPUT, V3, P79, DOI 10.1162/neco.1991.3.1.79; JALIFE J, 1984, J PHYSIOL-LONDON, V356, P221, DOI 10.1113/jphysiol.1984.sp015461; Kawada T, 1996, AM J PHYSIOL-HEART C, V271, pH288, DOI 10.1152/ajpheart.1996.271.1.H288; Kawada T, 1997, AM J PHYSIOL-HEART C, V272, pH2180, DOI 10.1152/ajpheart.1997.272.5.H2180; Kawada T, 1999, AM J PHYSIOL-REG I, V276, pR782, DOI 10.1152/ajpregu.1999.276.3.R782; KOBAYASHI M, 1982, IEEE T BIO-MED ENG, V29, P456, DOI 10.1109/TBME.1982.324972; Koldovsky Z, 2006, IEEE T NEURAL NETWOR, V17, P1265, DOI 10.1109/TNN.2006.875991; Kostal L, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000053; LAUGHLIN S, 1981, Z NATURFORSCH C, V36, P910; Laughlin SB, 1998, NAT NEUROSCI, V1, P36, DOI 10.1038/236; Laurent G, 1999, SCIENCE, V286, P723, DOI 10.1126/science.286.5440.723; Lesica NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001655; LEVY MN, 1971, CIRC RES, V29, P437, DOI 10.1161/01.RES.29.5.437; Lewicki MS, 2002, NAT NEUROSCI, V5, P356, DOI 10.1038/nn831; LINSKER R, 1990, ANNU REV NEUROSCI, V13, P257, DOI 10.1146/annurev.neuro.13.1.257; Machens CK, 2005, NEURON, V47, P447, DOI 10.1016/j.neuron.2005.06.015; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Malliani A, 1998, CIRCULATION, V98, P2640; Malliani A, 1999, NEWS PHYSIOL SCI, V14, P111, DOI 10.1152/physiologyonline.1999.14.3.111; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Massimini M, 2000, J PHYSIOL-LONDON, V526, P387, DOI 10.1111/j.1469-7793.2000.t01-1-00387.x; Mokrane A, 1995, AM J PHYSIOL-HEART C, V269, pH1931, DOI 10.1152/ajpheart.1995.269.6.H1931; Montano N, 2001, ANN NY ACAD SCI, V940, P299; O'Neill JC, 1999, IEEE T SIGNAL PROCES, V47, P133, DOI 10.1109/78.738246; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rao S, 2009, PATTERN RECOGN LETT, V30, P222, DOI 10.1016/j.patrec.2008.09.011; Rieke F, 1995, P ROY SOC B-BIOL SCI, V262, P259, DOI 10.1098/rspb.1995.0204; Schultz SR., 2007, SCHOLARPEDIA, V2, P2046, DOI 10.4249/scholarpedia.2046; Schwartz O, 2001, NAT NEUROSCI, V4, P819, DOI 10.1038/90526; Simoncelli EP, 2001, ANNU REV NEUROSCI, V24, P1193, DOI 10.1146/annurev.neuro.24.1.1193; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; SRINIVASAN MV, 1982, PROC R SOC SER B-BIO, V216, P427, DOI 10.1098/rspb.1982.0085; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; VANHATEREN JH, 1992, BIOL CYBERN, V68, P23, DOI 10.1007/BF00203134; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Wessel N., 2000, HERZSCHRITTMACHERTHE, V11, P159, DOI [10.1007/s003990070035, DOI 10.1007/S003990070035]; Yu YG, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.108103	76	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20227	10.1371/journal.pone.0020227	http://dx.doi.org/10.1371/journal.pone.0020227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694763	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900007
J	Seaman, ME; Peirce, SM; Kelly, K				Seaman, Marc E.; Peirce, Shayn M.; Kelly, Kimberly			Rapid Analysis of Vessel Elements (RAVE): A Tool for Studying Physiologic, Pathologic and Tumor Angiogenesis	PLOS ONE			English	Article							FRACTAL DIMENSION; IMAGE-ANALYSIS; GROWTH-FACTOR; ARCHITECTURE; CANCER; NEOVASCULARIZATION; QUANTIFICATION; STIMULATION; INHIBITION; DISEASES	Quantification of microvascular network structure is important in a myriad of emerging research fields including microvessel remodeling in response to ischemia and drug therapy, tumor angiogenesis, and retinopathy. To mitigate analyst-specific variation in measurements and to ensure that measurements represent actual changes in vessel network structure and morphology, a reliable and automatic tool for quantifying microvascular network architecture is needed. Moreover, an analysis tool capable of acquiring and processing large data sets will facilitate advanced computational analysis and simulation of microvascular growth and remodeling processes and enable more high throughput discovery. To this end, we have produced an automatic and rapid vessel detection and quantification system using a MATLAB graphical user interface (GUI) that vastly reduces time spent on analysis and greatly increases repeatability. Analysis yields numerical measures of vessel volume fraction, vessel length density, fractal dimension (a measure of tortuosity), and radii of murine vascular networks. Because our GUI is open sourced to all, it can be easily modified to measure parameters such as percent coverage of non-endothelial cells, number of loops in a vascular bed, amount of perfusion and two-dimensional branch angle. Importantly, the GUI is compatible with standard fluorescent staining and imaging protocols, but also has utility analyzing brightfield vascular images, obtained, for example, in dorsal skinfold chambers. A manually measured image can be typically completed in 20 minutes to 1 hour. In stark comparison, using our GUI, image analysis time is reduced to around 1 minute. This drastic reduction in analysis time coupled with increased repeatability makes this tool valuable for all vessel research especially those requiring rapid and reproducible results, such as anti-angiogenic drug screening.	[Seaman, Marc E.; Peirce, Shayn M.; Kelly, Kimberly] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22904 USA; [Seaman, Marc E.; Peirce, Shayn M.; Kelly, Kimberly] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA	University of Virginia; University of Virginia	Seaman, ME (corresponding author), Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22904 USA.	kak3x@virginia.edu		Peirce, Shayn/0000-0001-5857-5606	National Institutes of Health (NIH) [RO1 CA137071]; National Heart, Lung, and Blood Institute (NHLBI) [HL082838-02]; NATIONAL CANCER INSTITUTE [R01CA137071] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082838] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	KK and MS are funded by the National Institutes of Health (NIH) RO1 CA137071. SP is funded by the National Heart, Lung, and Blood Institute (NHLBI) HL082838-02. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alvarez Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007867; Aronin CEP, 2010, TISSUE ENG PT A, V16, P1801, DOI [10.1089/ten.tea.2009.0539, 10.1089/ten.TEA.2009.0539]; Bearden SE, 2004, J PHYSIOL-LONDON, V561, P535, DOI 10.1113/jphysiol.2004.068262; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; BUNTROCK P, 1982, EXP PATHOL-JENA, V21, P62, DOI 10.1016/S0232-1513(82)80054-6; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Doukas CN, 2008, IEEE T INF TECHNOL B, V12, P650, DOI 10.1109/TITB.2008.926463; Ferraro B, 2010, GENE THER, V17, P763, DOI 10.1038/gt.2010.43; Gazit Y, 1997, MICROCIRCULATION-LON, V4, P395, DOI 10.3109/10739689709146803; Goutzanis LP, 2009, HEAD NECK-J SCI SPEC, V31, P298, DOI 10.1002/hed.20959; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Jude EB, 2010, DIABETIC MED, V27, P4, DOI 10.1111/j.1464-5491.2009.02866.x; Kim C, 2007, ANN THORAC SURG, V83, P640, DOI 10.1016/j.athoracsur.2006.09.044; Kumar I, 2009, BRIT J SURG, V96, P1484, DOI 10.1002/bjs.6778; LEUNIG M, 1992, CANCER RES, V52, P6553; Li J, 2010, MICROVASC RES, V80, P10, DOI 10.1016/j.mvr.2009.12.002; Silva RLE, 2010, J CELL PHYSIOL, V225, P855, DOI 10.1002/jcp.22296; Lin KY, 2008, TRANSL ONCOL, V1, P84, DOI 10.1593/tlo.08118; Liu S, 2010, TISSUE ENG A; Matoba S, 2009, CURR PHARM DESIGN, V15, P2769, DOI 10.2174/138161209788923840; Niemisto A, 2005, IEEE T MED IMAGING, V24, P549, DOI 10.1109/TMI.2004.837339; Parsons-Wingerter P, 1998, MICROVASC RES, V55, P201, DOI 10.1006/mvre.1998.2073; Pourgholami MH, 2010, BIOCHEM BIOPH RES CO, V397, P729, DOI 10.1016/j.bbrc.2010.06.019; Taylor AC, 2010, MICROVASC RES, V79, P93, DOI 10.1016/j.mvr.2010.01.006; Wang L, 2010, BIOMATERIALS, V31, P9452, DOI 10.1016/j.biomaterials.2010.08.036; WEISSTEIN EW, MINKOWSKIBOULIGAND D	26	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20807	10.1371/journal.pone.0020807	http://dx.doi.org/10.1371/journal.pone.0020807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694777	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900028
J	McLeish, NJ; Simmonds, P; Robertson, C; Handel, I; McGilchrist, M; Singh, BK; Kerr, S; Chase-Topping, ME; Sinka, K; Bronsvoort, M; Porteous, DJ; Carman, W; McMenamin, J; Leigh-Brown, A; Woolhouse, MEJ				McLeish, Nigel J.; Simmonds, Peter; Robertson, Chris; Handel, Ian; McGilchrist, Mark; Singh, Brajendra K.; Kerr, Shona; Chase-Topping, Margo E.; Sinka, Katy; Bronsvoort, Mark; Porteous, David J.; Carman, William; McMenamin, James; Leigh-Brown, Andrew; Woolhouse, Mark E. J.			Sero-Prevalence and Incidence of A/H1N1 2009 Influenza Infection in Scotland in Winter 2009-2010	PLOS ONE			English	Article								Background: Sero-prevalence is a valuable indicator of prevalence and incidence of A/H1N1 2009 infection. However, raw sero-prevalence data must be corrected for background levels of cross-reactivity (i.e. imperfect test specificity) and the effects of immunisation programmes. Methods and Findings: We obtained serum samples from a representative sample of 1563 adults resident in Scotland between late October 2009 and April 2010. Based on a microneutralisation assay, we estimate that 44% (95% confidence intervals (CIs): 40-47%) of the adult population of Scotland were sero-positive for A/H1N1 2009 influenza by 1 March 2010. Correcting for background cross-reactivity and for recorded vaccination rates by time and age group, we estimated that 34% (27-42%) were naturally infected with A/H1N1 2009 by 1 March 2010. The central estimate increases to >40% if we allow for imperfect test sensitivity. Over half of these infections are estimated to have occurred during the study period and the incidence of infection in late October 2009 was estimated at 4.3 new infections per 1000 people per day (1.2 to 7.2), falling close to zero by April 2010. The central estimate increases to over 5.0 per 1000 if we allow for imperfect test specificity. The rate of infection was higher for younger adults than older adults. Raw sero-prevalences were significantly higher in more deprived areas (likelihood ratio trend statistic = 4.92,1 df, P = 0.03) but there was no evidence of any difference in vaccination rates. Conclusions: We estimate that almost half the adult population of Scotland were sero-positive for A/H1N1 2009 influenza by early 2010 and that the majority of these individuals (except in the oldest age classes) sero-converted as a result of natural infection with A/H1N1 2009. Public health planning should consider the possibility of higher rates of infection with A/H1N1 2009 influenza in more deprived areas.	[McLeish, Nigel J.; Simmonds, Peter; Singh, Brajendra K.; Woolhouse, Mark E. J.] Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Robertson, Chris] Univ Strathclyde, Dept Math & Stat, Glasgow, Lanark, Scotland; [Robertson, Chris; Sinka, Katy; McMenamin, James] Hlth Protect Scotland, Glasgow, Lanark, Scotland; [Handel, Ian; Bronsvoort, Mark] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Handel, Ian; Bronsvoort, Mark] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh, Midlothian, Scotland; [McGilchrist, Mark] Univ Dundee, Hlth Informat Ctr, Dundee, Scotland; [Kerr, Shona; Porteous, David J.] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Edinburgh, Midlothian, Scotland; [Chase-Topping, Margo E.] Univ Edinburgh, Ctr Immun, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Chase-Topping, Margo E.] Univ Edinburgh, Ctr Infect & Evolut, Ashworth Labs, Edinburgh, Midlothian, Scotland; [Carman, William] Gartnavel Royal Hosp, W Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland; [Leigh-Brown, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Strathclyde; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Dundee; University of Edinburgh; University of Edinburgh; University of Edinburgh; Gartnavel Royal Hospital; University of Edinburgh	McLeish, NJ (corresponding author), Univ Edinburgh, Ctr Infect Dis, Ashworth Labs, Edinburgh, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk	Porteous, David/AAA-3446-2021; Porteous, David J/C-7289-2013; Singh, Brajendra Kumar/C-3787-2012; Brown, Andrew Leigh/ABF-8269-2020; Leigh Brown, Andrew/F-3802-2010	Porteous, David/0000-0003-1249-6106; Porteous, David J/0000-0003-1249-6106; Singh, Brajendra Kumar/0000-0001-5847-8750; Brown, Andrew Leigh/0000-0002-5700-3128; Leigh Brown, Andrew/0000-0002-5700-3128; Simmonds, Peter/0000-0002-7964-4700; Bronsvoort, Mark/0000-0002-3271-8485; Kerr, Shona/0000-0002-4137-1495	Scotland's Chief Scientist Office [CZH/4/616, GS09033]; University of Edinburgh Interdisciplinary Centre for Human and Avian Influenza Research; Wellcome Trust; BBSRC; Chief Scientist Office [CZH/4/616, CZD/16/6/2] Funding Source: researchfish	Scotland's Chief Scientist Office; University of Edinburgh Interdisciplinary Centre for Human and Avian Influenza Research; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Chief Scientist Office	This work was supported by Scotland's Chief Scientist Office (ref. no. CZH/4/616) and the University of Edinburgh Interdisciplinary Centre for Human and Avian Influenza Research. Sera collection was facilitated by the Generation Scotland Scottish Family Health Study, supported by Scotland's Chief Scientist Office (ref. no. GS09033). We are grateful to all the individuals and general practitioners taking part, the Scottish School of Primary Care, and the whole Generation Scotland team. The Chief Scientist Office of the Scottish Government and the Scottish Funding Council provide core support for Generation Scotland. MECT is supported by the Wellcome Trust. IH and MB are supported by Institute Strategic Grant funding from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson WE, 2010, EUROSURVEILLANCE, V15; Baguelin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017074; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chen MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012474; Gilbert GL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012562; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Kissling E, 2009, EURO SURVEILL, V14; Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Nicholson KG, 2001, LANCET, V357, P1937, DOI 10.1016/S0140-6736(00)05066-2; Papenburg J, 2011, CLIN VACCINE IMMUNOL, V18, P520, DOI 10.1128/CVI.00449-10; Plummer M, 2003, PROC 3 INT WORK DIST, V3, P1; SCOTLAND HP, 2010, PANDEMIC INFLUENZA H; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Smith BH, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-74; TEAM RDC, 2007, R LANGUAGE ENV STAT; Van Kerkhove MD, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000275; *WHO, 2010, SER STUD PAND INFL H, P229; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601; [No title captured]	21	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20358	10.1371/journal.pone.0020358	http://dx.doi.org/10.1371/journal.pone.0020358			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687661	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500018
J	Zhu, WJ; Jiao, YM; Lei, RY; Hua, W; Wang, R; Ji, YX; Liu, ZY; Wei, FL; Zhang, T; Shi, XL; Wu, H; Zhang, LQ				Zhu, Weijun; Jiao, Yanmei; Lei, Rongyue; Hua, Wei; Wang, Rui; Ji, Yunxia; Liu, Zhiying; Wei, Feili; Zhang, Tong; Shi, Xuanlin; Wu, Hao; Zhang, Linqi			Rapid Turnover of 2-LTR HIV-1 DNA during Early Stage of Highly Active Antiretroviral Therapy	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TERMINAL REPEAT CIRCLES; BLOOD MONONUCLEAR-CELLS; CD4(+) T-CELLS; TIME PCR ASSAY; IN-VIVO; COMBINATION THERAPY; PLASMA VIREMIA; MICROBIAL TRANSLOCATION; LIFELONG PERSISTENCE	Background: Despite prolonged treatment with highly active antiretroviral therapy (HAART), the infectious HIV-1 continues to replicate and resides latently in the resting memory CD4+ T lymphocytes, which blocks the eradication of HIV-1. The viral persistence of HIV-1 is mainly caused by its proviral DNA being either linear nonintegrated, circular nonintegrated, or integrated. Previous reports have largely focused on the dynamics of HIV-1 DNA from the samples collected with relatively long time intervals during the process of disease and HAART treatment, which may have missed the intricate changes during the intervals in early treatment. Methodology/Principal Findings: In this study, we investigated the dynamics of HIV-1 DNA in patients during the early phase of HARRT treatment. Using optimized real time PCR, we observed significant changes in 2-LTR during the first 12-week of treatment, while total and integrated HIV-1 DNA remained stable. The doubling time and half-life of 2-LTR were not correlated with the baseline and the rate of changes in plasma viral load and various CD4+ T-cell populations. Longitudinal analyses on 2-LTR sequences and plasma lipopolysaccharide (LPS) levels did not reveal any significant changes in the same treatment period. Conclusions/Significance: Our study revealed the rapid changes in 2-LTR concentration in a relatively large number of patients during the early HAART treatment. The rapid changes indicate the rapid infusion and clearance of cells bearing 2-LTR in the peripheral blood. Those changes are not expected to be caused by the blocking of viral integration, as our study did not include the integrase inhibitor raltegravir. Our study helps better understand the dynamics of HIV-DNA and its potential role as a biomarker for the diseases and for the treatment efficacy of HAART.	[Zhu, Weijun; Lei, Rongyue; Zhang, Linqi] Chinese Acad Med Sci, AIDS Res Ctr, Inst Pathogen Biol, Beijing 100730, Peoples R China; [Zhu, Weijun; Lei, Rongyue; Zhang, Linqi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Jiao, Yanmei; Hua, Wei; Wang, Rui; Ji, Yunxia; Liu, Zhiying; Wei, Feili; Zhang, Tong; Wu, Hao] Capital Med Univ, Ctr Infect Dis, Beijing You An Hosp, Beijing, Peoples R China; [Shi, Xuanlin; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Beijing 100084, Peoples R China; [Shi, Xuanlin; Zhang, Linqi] Tsinghua Univ, Res Ctr Publ Hlth, Sch Med, Beijing 100084, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Tsinghua University; Tsinghua University	Zhu, WJ (corresponding author), Chinese Acad Med Sci, AIDS Res Ctr, Inst Pathogen Biol, Beijing 100730, Peoples R China.	wuhd@public.bta.net.cn; zhanglinqi@tsinghua.edu.cn	Zhang, Tong/HGC-1090-2022; ZHANG, LIN/GYD-9123-2022	Zhu, Weijun/0000-0002-6060-133X	Natural Science Foundation of China [30800980, 30825035]; Chinese 973 program [2006CB504202]; National 11th 5-year project [2008ZX10001-006, 2008ZX10001-011]; IPB, CAMS [2007IPB009, 2007IPB12]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 973 program(National Basic Research Program of China); National 11th 5-year project; IPB, CAMS	This study was supported by the Natural Science Foundation of China (grant 30800980 to W.Z and grant 30825035 to L.Z), the Chinese 973 program (grant 2006CB504202 to L.Z.), the National 11th 5-year project 2008ZX10001-006 and 2008ZX10001-011 and grants from IPB, CAMS (2007IPB009 to W.Z and 2007IPB12 to L.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Andreoni A, 2000, AIDS, V14, P23, DOI 10.1097/00002030-200001070-00003; Bart PA, 2000, AIDS, V14, P1887, DOI 10.1097/00002030-200009080-00002; Beloukas A, 2009, J CLIN MICROBIOL, V47, P2194, DOI 10.1128/JCM.01264-08; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brussel A, 2003, J VIROL, V77, P10119, DOI 10.1128/JVI.77.18.10119-10124.2003; Brussel A, 2003, AIDS, V17, P645, DOI 10.1097/00002030-200303280-00001; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Cavert W, 1997, SCIENCE, V276, P960, DOI 10.1126/science.276.5314.960; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; CHUN TW, 1995, NAT MED, V1, P1284, DOI 10.1038/nm1295-1284; Chun TW, 1999, NATURE, V401, P874, DOI 10.1038/44755; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Delaugerre C, 2010, AIDS, V24, P2391, DOI 10.1097/QAD.0b013e32833d214c; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer M, 2003, ANTIVIR THER, V8, P97; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; Gillim-Ross L, 2005, VIRAL IMMUNOL, V18, P190, DOI 10.1089/vim.2005.18.190; Gunthard HF, 1999, J VIROL, V73, P9404; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Ibanez A, 1999, AIDS, V13, P1045, DOI 10.1097/00002030-199906180-00007; Koelsch KK, 2008, J INFECT DIS, V197, P411, DOI 10.1086/525283; Lai JP, 2003, CLIN DIAGN LAB IMMUN, V10, P1123, DOI 10.1128/CDLI.10.6.1123-1128.2003; Martinez-Picado J, 2002, J VIROL, V76, P12344, DOI 10.1128/JVI.76.23.12344-12348.2002; Ngo-Giang-Huong N, 2001, AIDS, V15, P665, DOI 10.1097/00002030-200104130-00001; Pakker NG, 1998, NAT MED, V4, P208, DOI 10.1038/nm0298-208; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pierson TC, 2002, J VIROL, V76, P4138, DOI 10.1128/JVI.76.8.4138-4144.2002; Reigadas S, 2010, J ANTIMICROB CHEMOTH, V65, P434, DOI 10.1093/jac/dkp473; Sachsenberg N, 1998, J EXP MED, V187, P1295, DOI 10.1084/jem.187.8.1295; Sharkey M, 2005, J VIROL, V79, P5203, DOI 10.1128/JVI.79.8.5203-5210.2005; Sharkey M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001303; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; Sum SSM, 2004, J CLIN MICROBIOL, V42, P3438, DOI 10.1128/JCM.42.8.3438-3440.2004; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Viard JP, 2004, AIDS, V18, P45, DOI 10.1097/00002030-200401020-00005; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; Wong JK, 1997, P NATL ACAD SCI USA, V94, P12574, DOI 10.1073/pnas.94.23.12574; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yerly S, 2000, AIDS, V14, P2805, DOI 10.1097/00002030-200012220-00001; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zanchetta M, 2006, J INFECT DIS, V193, P1718, DOI 10.1086/504264; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101	54	24	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e21081	10.1371/journal.pone.0021081	http://dx.doi.org/10.1371/journal.pone.0021081			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687638	Green Published, Green Submitted, gold			2022-12-25	WOS:000291611500059
J	Shaman, J; Jeon, CY; Giovannucci, E; Lipsitch, M				Shaman, Jeffrey; Jeon, Christie Y.; Giovannucci, Edward; Lipsitch, Marc			Shortcomings of Vitamin D-Based Model Simulations of Seasonal Influenza	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; RESPIRATORY-TRACT INFECTION; 3RD NATIONAL-HEALTH; TRANSMISSION; ASSOCIATION; MORTALITY; CLOSURE; IMPACT; TRIAL; MEN	Seasonal variation in serum concentration of the vitamin D metabolite 25(OH) vitamin D [25(OH) D], which contributes to host immune function, has been hypothesized to be the underlying source of observed influenza seasonality in temperate regions. The objective of this study was to determine whether observed 25(OH) D levels could be used to simulate observed influenza infection rates. Data of mean and variance in 25(OH) D serum levels by month were obtained from the Health Professionals Follow-up Study and used to parameterize an individual-based model of influenza transmission dynamics in two regions of the United States. Simulations were compared with observed daily influenza excess mortality data. Best-fitting simulations could reproduce the observed seasonal cycle of influenza; however, these best-fit simulations were shown to be highly sensitive to stochastic processes within the model and were unable consistently to reproduce observed seasonal patterns. In this respect the simulations with the vitamin D forced model were inferior to similar modeling efforts using absolute humidity and the school calendar as seasonal forcing variables. These model results indicate it is unlikely that seasonal variations in vitamin D levels principally determine the seasonality of influenza in temperate regions.	[Shaman, Jeffrey] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Jeon, Christie Y.] Columbia Univ, Ctr Infect Dis Epidemiol Res, Dept Int Ctr AIDS Care & Treatment Programs, Mailman Sch Publ Hlth, New York, NY USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Giovannucci, Edward] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Epidemiol & Immunol, Boston, MA 02115 USA; [Lipsitch, Marc] Harvard Univ, Sch Publ Hlth, Ctr Communicable Dis Dynam, Dept Infect Dis, Boston, MA 02115 USA	Columbia University; Columbia University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health	Shaman, J (corresponding author), Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.	jls106@columbia.edu		Lipsitch, Marc/0000-0003-1504-9213	United States National Institutes of Health [1U54GM088558]; Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche(Roche Holding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the United States National Institutes of Health Models of Infectious Disease Agent Study program through cooperative agreement 1U54GM088558. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Co-author Marc Lipsitch discloses consulting or honorarium income from the Avian/Pandemic Flu Registry (Outcome Sciences, funded in part by Roche) and from Pfizer and Novartis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cannell JJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-29; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Giovannucci E, 2006, JNCI-J NATL CANCER I, V98, P451, DOI 10.1093/jnci/djj101; Holmes AD, 1932, IND ENG CHEM, V24, P1058, DOI 10.1021/ie50273a021; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Lips P, 2001, J CLIN ENDOCR METAB, V86, P1212, DOI 10.1210/jc.86.3.1212; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martins D, 2007, ARCH INTERN MED, V167, P1159, DOI 10.1001/archinte.167.11.1159; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Simonsen L, 2005, ARCH INTERN MED, V165, P265, DOI 10.1001/archinte.165.3.265; Urashima M, 2010, AM J CLIN NUTR, V91, P1255, DOI 10.3945/ajcn.2009.29094; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Yamshchikov AV, 2009, ENDOCR PRACT, V15, P438, DOI 10.4158/EP09101.ORR; YOUNG GA, 1949, P SOC EXP BIOL MED, V72, P695, DOI 10.3181/00379727-72-17545	22	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20743	10.1371/journal.pone.0020743	http://dx.doi.org/10.1371/journal.pone.0020743			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677774	Green Published, gold, Green Submitted			2022-12-25	WOS:000291355500041
J	Leitao, BB; Jones, MC; Brosens, JJ				Leitao, Beatriz B.; Jones, Marius C.; Brosens, Jan J.			The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death	FASEB JOURNAL			English	Article						endometrium; apoptosis; c-Jun	ENDOMETRIAL STROMAL CELLS; C-JUN; TRANSCRIPTIONAL REPRESSION; PROTEIN INHIBITOR; CROSS-TALK; KINASE; SUMOYLATION; PATHWAY; STAT1; APOPTOSIS	Human endometrial stromal cells (HESCs) exposed to reactive oxygen species (ROS) mount a hypersumoylation response in a c-Jun N-terminal kinase (JNK)-dependent manner. The mechanism that couples JNK signaling to the small ubiquitin-related modifier (SUMO) pathway and its functional consequences are not understood. We show that ROS-dependent JNK activation converges on the SUMO pathway via PIAS1 (protein inhibitor of activated STAT1). Unexpectedly, PIAS1 knockdown not only prevented ROS-dependent hypersumoylation but also enhanced JNK signaling in HESCs. Conversely, PIAS overexpression increased sumoylation of various substrates, including c-Jun, yet inhibited basal and ROS-dependent JNK activity independently of its SUMO ligase function. Expression profiling demonstrated that PIAS1 knockdown enhances and profoundly modifies the transcriptional response to oxidative stress signals. Using a cutoff of 2-fold change or more, a total of 250 ROS-sensitive genes were identified, 97 of which were not dependent on PIAS1. PIAS1 knockdown abolished the regulation of 43 genes but also sensitized 110 other genes to ROS. Importantly, PIAS1 silencing was obligatory for the induction of several cellular defense genes in response to oxidative stress. In agreement, PIAS1 knockdown attenuated ROS-dependent caspase-3/7 activation and subsequent apoptosis. Thus, PIAS1 determines the level of JNK activity in HESCs, couples ROS signaling to the SUMO pathway, and promotes oxidative cell death.-Leitao, B. B., Jones, M. C., Brosens, J. J. The SUMO E3-ligase PIAS1 couples reactive oxygen species-dependent JNK activation to oxidative cell death. FASEB J. 25, 3416-3425 (2011). www.fasebj.org	[Leitao, Beatriz B.; Jones, Marius C.; Brosens, Jan J.] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England	Imperial College London	Brosens, JJ (corresponding author), Univ Warwick, Clin Sci Res Inst, Div Reprod Hlth, Coventry CV2 2DX, W Midlands, England.	j.j.brosens@warwick.ac.uk		Brosens, Jan/0000-0003-0116-9329	Wellcome Trust [084336]; Genesis Trust; UK National Institute for Health Research Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); Genesis Trust; UK National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR))	The authors are indebted to all the women and clinicians who participated in this study. This work was supported by the Wellcome Trust (084336), the Genesis Trust, and the UK National Institute for Health Research Biomedical Research Centre funding scheme. The authors declare no conflicts of interest.	ANGEL P, 1988, CELL, V55, P875, DOI 10.1016/0092-8674(88)90143-2; Bin L, 2008, TRENDS PHARMACOL SCI, V29, P505, DOI 10.1016/j.tips.2008.07.008; Bossis G, 2005, MOL CELL BIOL, V25, P6964, DOI 10.1128/MCB.25.16.6964-6979.2005; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Brosens JJ, 2006, J MOL ENDOCRINOL, V36, P389, DOI 10.1677/jme.1.02060; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; Cheng JK, 2005, J BIOL CHEM, V280, P14492, DOI 10.1074/jbc.M412185200; Christian M, 2002, MOL ENDOCRINOL, V16, P141, DOI 10.1210/me.16.1.141; Cloke B, 2008, ENDOCRINOLOGY, V149, P4462, DOI 10.1210/en.2008-0356; Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Jones MC, 2006, P NATL ACAD SCI USA, V103, P16272, DOI 10.1073/pnas.0603002103; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kotaja N, 2002, MOL CELL BIOL, V22, P5222, DOI 10.1128/MCB.22.14.5222-5234.2002; Kurihara I, 2005, J BIOL CHEM, V280, P6721, DOI 10.1074/jbc.M411820200; Lee JH, 2009, MOL CELL, V35, P806, DOI 10.1016/j.molcel.2009.07.021; Leitao B, 2010, FASEB J, V24, P1541, DOI 10.1096/fj.09-149153; Liu B, 2001, J BIOL CHEM, V276, P36624, DOI 10.1074/jbc.M101085200; Liu B, 2007, CELL, V129, P903, DOI 10.1016/j.cell.2007.03.056; Liu B, 2010, SCIENCE, V330, P521, DOI 10.1126/science.1193787; Molton SA, 2003, ONCOGENE, V22, P4690, DOI 10.1038/sj.onc.1206692; Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321; Rui HL, 2002, J BIOL CHEM, V277, P42981, DOI 10.1074/jbc.M208099200; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Takano M, 2007, MOL ENDOCRINOL, V21, P2334, DOI 10.1210/me.2007-0058; Wang Y, 2008, PHYTOMEDICINE, V15, P923, DOI 10.1016/j.phymed.2008.09.003; Weber S, 2009, GENE DEV, V23, P118, DOI 10.1101/gad.489409; Xu Z, 2008, FASEB J, V22, P127, DOI 10.1096/fj.06-7871com; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Yang SH, 2003, CELL CYCLE, V2, P528, DOI 10.4161/cc.2.6.597	38	46	50	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2011	25	10					3416	3425		10.1096/fj.11-186346	http://dx.doi.org/10.1096/fj.11-186346			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	826LU	21676946	Green Published			2022-12-25	WOS:000295356400013
J	Horejs, C; Ristl, R; Tscheliessnig, R; Sleytr, UB; Pum, D				Horejs, Christine; Ristl, Robin; Tscheliessnig, Rupert; Sleytr, Uwe B.; Pum, Dietmar			Single-molecule Force Spectroscopy Reveals the Individual Mechanical Unfolding Pathways of a Surface Layer Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL POLYMER; N-TERMINAL PART; S-LAYER; STRUCTURAL INSIGHTS; BINDING; STABILITY; TITIN; SBSB; FIBRONECTIN; CONFORMATIONS	Surface layers (S-layers) represent an almost universal feature of archaeal cell envelopes and are probably the most abundant bacterial cell proteins. S-layers are monomolecular crystalline structures of single protein or glycoprotein monomers that completely cover the cell surface during all stages of the cell growth cycle, thereby performing their intrinsic function under a constant intra- and intermolecular mechanical stress. In Gram-positive bacteria, the individual S-layer proteins are anchored by a specific binding mechanism to polysaccharides (secondary cell wall polymers) that are linked to the underlying peptidoglycan layer. In this work, atomic force microscopy-based single-molecule force spectroscopy and a polyprotein approach are used to study the individual mechanical unfolding pathways of an S-layer protein. We uncover complex unfolding pathways involving the consecutive unfolding of structural intermediates, where a mechanical stability of 87 pN is revealed. Different initial extensibilities allow the hypothesis that S-layer proteins adapt highly stable, mechanically resilient conformations that are not extensible under the presence of a pulling force. Interestingly, a change of the unfolding pathway is observed when individual S-layer proteins interact with secondary cell wall polymers, which is a direct signature of a conformational change induced by the ligand. Moreover, the mechanical stability increases up to 110 pN. This work demonstrates that single-molecule force spectroscopy offers a powerful tool to detect subtle changes in the structure of an individual protein upon binding of a ligand and constitutes the first conformational study of surface layer proteins at the single-molecule level.	[Horejs, Christine; Ristl, Robin; Sleytr, Uwe B.; Pum, Dietmar] Univ Nat Resources & Life Sci, Dept Nanobiotechnol, A-1190 Vienna, Austria; [Tscheliessnig, Rupert] Univ Nat Resources & Life Sci, Inst Biotechnol, Austrian Ctr Ind Biotechnol, A-1190 Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; Austrian Centre of Industrial Biotechnology; University of Natural Resources & Life Sciences, Vienna	Pum, D (corresponding author), Muthgasse 11, A-1190 Vienna, Austria.	pum@boku.ac.at		Pum, Dietmar/0000-0002-1895-4940; Ristl, Robin/0000-0002-4163-9236; Horejs, Christine-Maria/0000-0002-8614-7737	Air Force [FA9550-09-1-0342, FA9550-10-1-0223]; Austrian Science Fund [P19047-B12, P21954-B20]; Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry of Traffic, Innovation, and Technology (BMVIT); Styrian Business Promotion Agency; Standortagentur Tirol; Technology Agency of the City of Vienna through the COMET; Austrian Academy of Sciences	Air Force; Austrian Science Fund(Austrian Science Fund (FWF)); Federal Ministry of Economy, Family and Youth (BMWFJ); Federal Ministry of Traffic, Innovation, and Technology (BMVIT); Styrian Business Promotion Agency; Standortagentur Tirol; Technology Agency of the City of Vienna through the COMET; Austrian Academy of Sciences	This work was supported by the Air Force projects FA9550-09-1-0342, and FA9550-10-1-0223, by the Austrian Science Fund Projects P19047-B12 and P21954-B20 (to C. S.), and by the Federal Ministry of Economy, Family and Youth (BMWFJ), the Federal Ministry of Traffic, Innovation, and Technology (BMVIT), the Styrian Business Promotion Agency, the Standortagentur Tirol, and Technology Agency of the City of Vienna through the COMET Funding Program managed by the Austrian Research Promotion Agency FFG.; Holds a DOC-fFORTE fellowship of the Austrian Academy of Sciences.	Ainavarapu RK, 2005, BIOPHYS J, V89, P3337, DOI 10.1529/biophysj.105.062034; Baneyx G, 2001, P NATL ACAD SCI USA, V98, P14464, DOI 10.1073/pnas.251422998; Bertz M, 2008, J MOL BIOL, V378, P447, DOI 10.1016/j.jmb.2008.02.025; BREITWIESER A, 1992, J BACTERIOL, V174, P8008, DOI 10.1128/JB.174.24.8008-8015.1992; Brucale M, 2009, CHEMBIOCHEM, V10, P176, DOI 10.1002/cbic.200800581; BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175; Cao Y, 2008, J MOL BIOL, V378, P1132, DOI 10.1016/j.jmb.2008.03.046; Cao Y, 2007, P NATL ACAD SCI USA, V104, P15677, DOI 10.1073/pnas.0705367104; Cao Y, 2011, BIOPHYS J, V100, P1794, DOI 10.1016/j.bpj.2011.02.030; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P11288, DOI 10.1073/pnas.96.20.11288; Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694; Chung S, 2010, P NATL ACAD SCI USA, V107, P16536, DOI 10.1073/pnas.1008280107; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101; Dougan L, 2009, P NATL ACAD SCI USA, V106, P12605, DOI 10.1073/pnas.0900678106; EGELSEER EM, 2009, S LAYERS MICROBIAL B, P4424; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; FLORIN EL, 1995, BIOSENS BIOELECTRON, V10, P895, DOI 10.1016/0956-5663(95)99227-C; Garcia-Manyes S, 2007, BIOPHYS J, V93, P2436, DOI 10.1529/biophysj.107.104422; Garcia-Manyes S, 2009, P NATL ACAD SCI USA, V106, P10534, DOI 10.1073/pnas.0901213106; Greene DN, 2008, BIOPHYS J, V95, P1360, DOI 10.1529/biophysj.108.130237; Hann E, 2007, BIOPHYS J, V92, pL79, DOI 10.1529/biophysj.106.102475; Hertadi R, 2003, J MOL BIOL, V333, P993, DOI 10.1016/j.jmb.2003.09.010; Horejs C, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2826375; Horejs C, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3565457; Horejs C, 2011, ACS NANO, V5, P2288, DOI 10.1021/nn1035729; Horejs C, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3489682; Howorka S, 2000, J BIOL CHEM, V275, P37876, DOI 10.1074/jbc.M003838200; JAENICKE R, 1985, BIOL CHEM H-S, V366, P663, DOI 10.1515/bchm3.1985.366.2.663; Jarosch M, 2001, MICROBIOL-SGM, V147, P1353, DOI 10.1099/00221287-147-5-1353; Johnson CP, 2007, SCIENCE, V317, P663, DOI 10.1126/science.1139857; Junker JP, 2009, P NATL ACAD SCI USA, V106, P14361, DOI 10.1073/pnas.0904654106; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; Junker JP, 2005, BIOPHYS J, V89, pL46, DOI 10.1529/biophysj.105.072066; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kinns H, 2008, J MOL BIOL, V377, P589, DOI 10.1016/j.jmb.2008.01.019; Kinns H, 2010, J MOL BIOL, V395, P742, DOI 10.1016/j.jmb.2009.10.012; Kuen B, 1997, J BACTERIOL, V179, P1664, DOI 10.1128/jb.179.5.1664-1670.1997; Li LW, 2005, J MOL BIOL, V345, P817, DOI 10.1016/j.jmb.2004.11.021; LUPAS A, 1994, J BACTERIOL, V176, P1224, DOI 10.1128/jb.176.5.1224-1233.1994; Mader C, 2004, J BACTERIOL, V186, P1758, DOI 10.1128/JB.186.6.1758-1768.2004; Messner P, 2010, PROKARYOTIC CELL WALL COMPOUNDS: STRUCTURE AND BIOCHEMISTRY, P53, DOI 10.1007/978-3-642-05062-6_2; Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170; Norville JE, 2007, J STRUCT BIOL, V160, P313, DOI 10.1016/j.jsb.2007.06.002; Oberhauser AF, 2001, P NATL ACAD SCI USA, V98, P468, DOI 10.1073/pnas.021321798; Oberhauser AF, 2002, J MOL BIOL, V319, P433, DOI 10.1016/S0022-2836(02)00306-6; Oberhauser AF, 1998, NATURE, V393, P181, DOI 10.1038/30270; Pavkov T, 2003, ACTA CRYSTALLOGR D, V59, P1466, DOI 10.1107/S0907444903010990; Pavkov T, 2008, STRUCTURE, V16, P1226, DOI 10.1016/j.str.2008.05.012; Peng Q, 2008, P NATL ACAD SCI USA, V105, P1885, DOI 10.1073/pnas.0706775105; Perez-Jimenez R, 2006, J BIOL CHEM, V281, P40010, DOI 10.1074/jbc.M609890200; Petersen BO, 2008, CARBOHYD RES, V343, P1346, DOI 10.1016/j.carres.2008.03.029; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Puchner EM, 2010, ANGEW CHEM INT EDIT, V49, P1147, DOI 10.1002/anie.200905956; Puchner EM, 2009, CURR OPIN STRUC BIOL, V19, P605, DOI 10.1016/j.sbi.2009.09.005; Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109; Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466; Ries W, 1997, J BACTERIOL, V179, P3892, DOI 10.1128/jb.179.12.3892-3898.1997; Runzler D, 2004, J BIOL CHEM, V279, P5207, DOI 10.1074/jbc.M308819200; Sambrook J, 2001, MOL CLONING LAB MANU; Sara M, 1998, J BACTERIOL, V180, P6780; Sara M, 2001, TRENDS MICROBIOL, V9, P47, DOI 10.1016/S0966-842X(00)01905-3; SARA M, 1987, J BACTERIOL, V169, P4092, DOI 10.1128/jb.169.9.4092-4098.1987; Sara M, 1998, J BACTERIOL, V180, P4146; Schaffer C, 2005, MICROBIOL-SGM, V151, P643, DOI 10.1099/mic.0.27749-0; Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x; Shaub A, 1999, NAT CELL BIOL, V1, pE173, DOI 10.1038/15608; Sleytr U. B., 1989, ELECT MICROSCOPY SUB, P13; Sleytr U. B., 2005, SUPRAMOLECULAR POLYM, P583; Sleytr UB, 1999, TRENDS MICROBIOL, V7, P253, DOI 10.1016/S0966-842X(99)01513-9; SLEYTR UB, 1975, J ULTRA MOL STRUCT R, V50, P103, DOI 10.1016/S0022-5320(75)90012-X; SLEYTR UB, 1983, ANNU REV MICROBIOL, V37, P311, DOI 10.1146/annurev.mi.37.100183.001523; Sleytr UB, 1988, CRYSTALLINE BACTERIA; Verbelen C, 2007, ULTRAMICROSCOPY, V107, P1004, DOI 10.1016/j.ultramic.2007.02.040; Vogel V, 2001, TRENDS BIOTECHNOL, V19, P416, DOI 10.1016/S0167-7799(01)01737-1; Vogel V, 2009, CURR OPIN CELL BIOL, V21, P38, DOI 10.1016/j.ceb.2009.01.002; Wang CC, 2011, BIOPHYS J, V100, P1094, DOI 10.1016/j.bpj.2011.01.011; Wegmann S, 2011, J BIOL CHEM, V286, P20512, DOI 10.1074/jbc.M111.237875; Whitelam S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.088102	79	12	13	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27416	27424		10.1074/jbc.M111.251322	http://dx.doi.org/10.1074/jbc.M111.251322			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21690085	hybrid, Green Published			2022-12-25	WOS:000293268700037
J	Lee, SF; Srinivasan, B; Sephton, CF; Dries, DR; Wang, B; Yu, C; Wang, Y; Dewey, CM; Shah, S; Jiang, J; Yu, G				Lee, Sheu-Fen; Srinivasan, Bhooma; Sephton, Chantelle F.; Dries, Daniel R.; Wang, Bing; Yu, Cong; Wang, Yun; Dewey, Colleen M.; Shah, Sanjiv; Jiang, Jin; Yu, Gang			gamma-Secretase-regulated Proteolysis of the Notch Receptor by Mitochondrial Intermediate Peptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRAMEMBRANE PROTEOLYSIS; DROSOPHILA-MELANOGASTER; INTRACELLULAR DOMAIN; PRECURSOR PROTEIN; INDUCED APOPTOSIS; ACTIVATED NOTCH; NUCLEAR ACCESS; IN-VIVO; B-CELLS; PRESENILIN	Notch is a transmembrane receptor that controls a diverse array of cellular processes including cell proliferation, differentiation, survival, and migration. The cellular outcome of Notch signaling is dependent on extracellular and intracellular signals, but the complexities of its regulation are not well understood. Canonical Notch signaling involves ligand association that triggers sequential and regulated proteolysis of Notch at several sites. Ligand-dependent proteolysis at the S2 site removes the bulk of the extracellular domain of Notch. Subsequent gamma-secretase-mediated intramembrane proteolysis of the remaining membrane-tethered Notch fragment at the S3 site produces a nuclear-destined Notch intracellular domain (NICD). Here we show that following gamma-secretase cleavage, Notch is proteolyzed at a novel S5 site. We have identified this S5 site to be eight amino acids downstream of the S3 site. Biochemical fractionation and purification resulted in the identification of the S5 site protease as the mitochondrial intermediate peptidase (MIPEP). Expression of the MIPEP-cleaved NICD (Delta NICD) results in a decrease in cell viability and mitochondria membrane potential. The sequential and regulated proteolysis by gamma-secretase and MIPEP suggests a new means by which Notch function can be modulated.	[Wang, Bing; Jiang, Jin] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Lee, Sheu-Fen; Srinivasan, Bhooma; Sephton, Chantelle F.; Dries, Daniel R.; Yu, Cong; Wang, Yun; Dewey, Colleen M.; Shah, Sanjiv; Yu, Gang] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Shah, Sanjiv] Merck Res Labs, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Merck & Company	Jiang, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Jin.Jiang@UTSouthwestern.edu; Gang.Yu@UTSouthwestern.edu		DRIES, DANIEL/0000-0002-0530-5212	National Institutes of Health [F32AG031625, R01AG023104, R01AG029547, R01GM067045]; Ted Nash Long Life Foundation; Welch Foundation [I-1776, I-1603]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067045, R01GM061269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029547, R01AG023104, F32AG031625] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ted Nash Long Life Foundation; Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants F32AG031625 (to D. R. D.), R01AG023104 and R01AG029547 (to G. Y.), and R01GM067045 (to J. J.). This work was also supported by the Ted Nash Long Life Foundation and by Welch Foundation Grants I-1776 (to G. Y.) and I-1603 (to J. J.).	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Barrick D, 2006, CELL, V124, P883, DOI 10.1016/j.cell.2006.02.028; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brou C, 2000, MOL CELL, V5, P207, DOI 10.1016/S1097-2765(00)80417-7; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; DAUM G, 1982, J BIOL CHEM, V257, P3075; de la Pena P, 2001, NEUROLOGY, V57, P1235, DOI 10.1212/WNL.57.7.1235; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; Dotti MT, 2004, ARCH NEUROL-CHICAGO, V61, P942, DOI 10.1001/archneur.61.6.942; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FORTINI ME, 1994, CELL, V79, P273, DOI 10.1016/0092-8674(94)90196-1; Friedmann DR, 2008, J BIOL CHEM, V283, P14781, DOI 10.1074/jbc.M709501200; Gupta-Rossi N, 2004, J CELL BIOL, V166, P73, DOI 10.1083/jcb.200310098; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Jehn BM, 1999, J IMMUNOL, V162, P635; Lathion S, 2003, CANCER RES, V63, P8687; Le Gall M, 2008, DEV BIOL, V313, P556, DOI 10.1016/j.ydbio.2007.10.030; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Leong KG, 2006, BLOOD, V107, P2223, DOI 10.1182/blood-2005-08-3329; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Miller DT, 1998, DEVELOPMENT, V125, P2327; Morimura T, 2000, J BIOL CHEM, V275, P36523, DOI 10.1074/jbc.M006415200; Mourikis P, 2006, P NATL ACAD SCI USA, V103, P1307, DOI 10.1073/pnas.0510564103; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pavlov PF, 2011, FASEB J, V25, P78, DOI 10.1096/fj.10-157230; Perumalsamy LR, 2010, P NATL ACAD SCI USA, V107, P6882, DOI 10.1073/pnas.0910060107; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Romer S, 2003, CELL DEATH DIFFER, V10, P833, DOI 10.1038/sj.cdd.4401253; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Struhl G, 1998, CELL, V93, P649, DOI 10.1016/S0092-8674(00)81193-9; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; Tagami S, 2008, MOL CELL BIOL, V28, P165, DOI 10.1128/MCB.00863-07; Tammam J, 2009, BRIT J PHARMACOL, V158, P1183, DOI 10.1111/j.1476-5381.2009.00389.x; THORIG GEW, 1981, GENETICS, V99, P65; THORIG GEW, 1981, MOL GEN GENET, V182, P31, DOI 10.1007/BF00422763; Verheyen EM, 1996, GENETICS, V144, P1127; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	57	12	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27447	27453		10.1074/jbc.M111.243154	http://dx.doi.org/10.1074/jbc.M111.243154			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21685396	Green Published			2022-12-25	WOS:000293268700040
J	Zhao, HT; Huang, DZ				Zhao, Hongtao; Huang, Danzhi			Hydrogen Bonding Penalty upon Ligand Binding	PLOS ONE			English	Article							ORBITAL ELECTRONEGATIVITY METHOD; MODIFIED PARTIAL EQUALIZATION; SITE-DIRECTED MUTAGENESIS; TRANSFER-RNA-SYNTHETASE; KINASE INHIBITORS; ENZYME STRUCTURE; DOCKING; MOLECULES; DESIGN; DISCOVERY	Ligand binding involves breakage of hydrogen bonds with water molecules and formation of new hydrogen bonds between protein and ligand. In this work, the change of hydrogen bonding energy in the binding process, namely hydrogen bonding penalty, is evaluated with a new method. The hydrogen bonding penalty can not only be used to filter unrealistic poses in docking, but also improve the accuracy of binding energy calculation. A new model integrated with hydrogen bonding penalty for free energy calculation gives a root mean square error of 0.7 kcal/mol on 74 inhibitors in the training set and of 1.1 kcal/mol on 64 inhibitors in the test set. Moreover, an application of hydrogen bonding penalty into a high throughput docking campaign for EphB4 inhibitors is presented, and remarkably, three novel scaffolds are discovered out of seven tested. The binding affinity and ligand efficiency of the most potent compound is about 300 nM and 0.35 kcal/mol per non-hydrogen atom, respectively.	[Zhao, Hongtao; Huang, Danzhi] Univ Zurich, Dept Biochem, Zurich, Switzerland	University of Zurich	Zhao, HT (corresponding author), Univ Zurich, Dept Biochem, Zurich, Switzerland.	dhuang@bioc.uzh.ch	Zhao, Hongtao/H-1674-2015	Zhao, Hongtao/0000-0002-9318-1052	Swiss National Science Foundation [31003A_122442]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant (31003A_122442) of the Swiss National Science Foundation (www.snf.ch) to D.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941; Bardelle C, 2008, BIOORG MED CHEM LETT, V18, P2776, DOI 10.1016/j.bmcl.2008.04.015; Berger DM, 2009, BIOORG MED CHEM LETT, V19, P6519, DOI 10.1016/j.bmcl.2009.10.049; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Cordero B, 2008, DALTON T, P2832, DOI 10.1039/b801115j; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; FERSHT AR, 1985, NATURE, V314, P235, DOI 10.1038/314235a0; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gibson AE, 2002, J MED CHEM, V45, P3381, DOI 10.1021/jm020056z; GOODSELL DS, 1990, PROTEINS, V8, P195, DOI 10.1002/prot.340080302; Hawkins PCD, 2008, J COMPUT AID MOL DES, V22, P179, DOI 10.1007/s10822-007-9166-3; HINE J, 1972, J AM CHEM SOC, V94, P5766, DOI 10.1021/ja00771a038; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Hunter T, 1998, Harvey Lect, V94, P81; Im W, 1998, COMPUT PHYS COMMUN, V111, P59, DOI 10.1016/S0010-4655(98)00016-2; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Koch P, 2010, J MED CHEM, V53, P1128, DOI 10.1021/jm901392x; Kolb P, 2008, J MED CHEM, V51, P1179, DOI 10.1021/jm070654j; Lafleur K, 2009, J MED CHEM, V52, P6433, DOI 10.1021/jm9009444; Langer T, 2001, CURR PHARM DESIGN, V7, P509, DOI 10.2174/1381612013397861; Miyazaki Y, 2007, BIOORG MED CHEM LETT, V17, P250, DOI 10.1016/j.bmcl.2006.09.050; MOMANY FA, 1992, J COMPUT CHEM, V13, P888, DOI 10.1002/jcc.540130714; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; NO KT, 1990, J PHYS CHEM-US, V94, P4740, DOI 10.1021/j100374a067; NO KT, 1990, J PHYS CHEM-US, V94, P4732, DOI 10.1021/j100374a066; Pennisi A, 2009, BLOOD, V114, P1803, DOI 10.1182/blood-2009-01-201954; STEINER T, 1993, J AM CHEM SOC, V115, P4540, DOI 10.1021/ja00064a016; Stelmach JE, 2003, BIOORG MED CHEM LETT, V13, P277, DOI 10.1016/S0960-894X(02)00752-7; Thilagavathi R, 2010, J CHEM INF MODEL, V50, P415, DOI 10.1021/ci900345h; Wang RX, 2003, J MED CHEM, V46, P2287, DOI 10.1021/jm0203783; WARWICKER J, 1982, J MOL BIOL, V157, P671, DOI 10.1016/0022-2836(82)90505-8; WILKINSON AJ, 1983, BIOCHEMISTRY-US, V22, P3581, DOI 10.1021/bi00284a007; WILKINSON AJ, 1984, NATURE, V307, P187, DOI 10.1038/307187a0; WINTER G, 1982, NATURE, V299, P756, DOI 10.1038/299756a0; Yang CY, 2009, J AM CHEM SOC, V131, P13709, DOI 10.1021/ja9039373; Zhou T, 2010, CHEMMEDCHEM, V5, P1007, DOI 10.1002/cmdc.201000085	42	66	68	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e19923	10.1371/journal.pone.0019923	http://dx.doi.org/10.1371/journal.pone.0019923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698148	gold, Green Submitted, Green Published			2022-12-25	WOS:000291737600001
J	Serino, M; Waget, A; Marsollier, N; Masseboeuf, M; Payros, G; Kabani, C; Denom, J; Lacombe, A; Thiers, JC; Negre-Salvayre, A; Luquet, S; Burcelin, R; Cruciani-Guglielmacci, C; Magnan, C				Serino, Matteo; Waget, Aurelie; Marsollier, Nicolas; Masseboeuf, Myriam; Payros, Gaelle; Kabani, Catherine; Denom, Jessica; Lacombe, Amelie; Thiers, Jean-Claude; Negre-Salvayre, Anne; Luquet, Serge; Burcelin, Remy; Cruciani-Guglielmacci, Celine; Magnan, Christophe			Lipid-Induced Peroxidation in the Intestine Is Involved in Glucose Homeostasis Imbalance in Mice	PLOS ONE			English	Article							INDUCED INSULIN-SECRETION; GLUCAGON-LIKE PEPTIDE-1; HIGH-FAT DIET; GASTROINTESTINAL-TRACT; ENERGY HOMEOSTASIS; ENTERIC NEURONS; OXIDATIVE STRESS; GUT INFLAMMATION; NERVOUS-SYSTEM; FOOD-INTAKE	Background: Daily variations in lipid concentrations in both gut lumen and blood are detected by specific sensors located in the gastrointestinal tract and in specialized central areas. Deregulation of the lipid sensors could be partly involved in the dysfunction of glucose homeostasis. The study aimed at comparing the effect of Medialipid (ML) overload on insulin secretion and sensitivity when administered either through the intestine or the carotid artery in mice. Methodology/Principal Findings: An indwelling intragastric or intracarotid catheter was installed in mice and ML or an isocaloric solution was infused over 24 hours. Glucose and insulin tolerance and vagus nerve activity were assessed. Some mice were treated daily for one week with the anti-lipid peroxidation agent aminoguanidine prior to the infusions and tests. The intestinal but not the intracarotid infusion of ML led to glucose and insulin intolerance when compared with controls. The intestinal ML overload induced lipid accumulation and increased lipid peroxidation as assessed by increased malondialdehyde production within both jejunum and duodenum. These effects were associated with the concomitant deregulation of vagus nerve. Administration of aminoguanidine protected against the effects of lipid overload and normalized glucose homeostasis and vagus nerve activity. Conclusions/Significance: Lipid overload within the intestine led to deregulation of gastrointestinal lipid sensing that in turn impaired glucose homeostasis through changes in autonomic nervous system activity.	[Serino, Matteo; Waget, Aurelie; Masseboeuf, Myriam; Payros, Gaelle; Thiers, Jean-Claude; Negre-Salvayre, Anne; Burcelin, Remy] Fac Med Toulouse, INSERM, U1048, F-31073 Toulouse, France; [Serino, Matteo; Waget, Aurelie; Masseboeuf, Myriam; Payros, Gaelle; Thiers, Jean-Claude; Negre-Salvayre, Anne; Burcelin, Remy] Univ Toulouse, UPS, Inst Malad Metab & Cardiovasc I2MC, Toulouse, France; [Marsollier, Nicolas; Kabani, Catherine; Denom, Jessica; Lacombe, Amelie; Luquet, Serge; Cruciani-Guglielmacci, Celine; Magnan, Christophe] CNRS EAC 4413, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite	Serino, M (corresponding author), Fac Med Toulouse, INSERM, U1048, U317, F-31073 Toulouse, France.	remy.burcelin@inserm.fr	magnan, christophe/AAJ-7622-2021; Serino, Matteo/O-3310-2018; burcelin, remy/M-6013-2014; Luquet, serge/AAT-1809-2021	magnan, christophe/0000-0002-7044-2571; Serino, Matteo/0000-0003-4644-8532; Luquet, serge/0000-0001-8668-6645; Negre-Salvayre, Anne/0000-0003-2136-5706; Cruciani-Guglielmacci, Celine/0000-0002-2562-5360	European Association for the Study of Diabetes (EASD); Amylin; "Agence Nationale de la Recherche" (France) [ANR-07-PHYSIO]	European Association for the Study of Diabetes (EASD); Amylin; "Agence Nationale de la Recherche" (France)(French National Research Agency (ANR))	RB is the recipient of a grant from the European Association for the Study of Diabetes (EASD) and Amylin. CM is the recipient of funding from the "Agence Nationale de la Recherche" (France): ANR-07-PHYSIO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2001, DIABETES, V50, P1030, DOI 10.2337/diabetes.50.5.1030; Bertelsen LS, 2003, DIGEST DIS SCI, V48, P598, DOI 10.1023/A:1022561321533; Bharucha AE, 2008, AM J PHYSIOL-REG I, V295, pR874, DOI 10.1152/ajpregu.00153.2008; BLOUET C, 2009, BEHAV BRAIN RES; Burcelin M, 2002, AM J PHYSIOL-ENDOC M, V282, pE834, DOI 10.1152/ajpendo.00332.2001; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; CHEUNG GW, 2009, CELL MOL LIFE SCI; Clement L, 2002, PFLUG ARCH EUR J PHY, V445, P375, DOI 10.1007/s00424-002-0937-3; Cruciani-Guglielmacci C, 2004, DIABETOLOGIA, V47, P2032, DOI 10.1007/s00125-004-1569-2; Cruciani-Guglielmacci C, 2005, AM J PHYSIOL-ENDOC M, V288, pE148, DOI 10.1152/ajpendo.00225.2004; D'Alessio DA, 2001, J CLIN ENDOCR METAB, V86, P1253, DOI 10.1210/jc.86.3.1253; De Jonge F, 2003, HISTOCHEM CELL BIOL, V119, P477, DOI 10.1007/s00418-003-0532-5; Dockray G J, 2003, J Physiol Pharmacol, V54 Suppl 4, P9; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Gilbert M, 2003, DIABETES, V52, P277, DOI 10.2337/diabetes.52.2.277; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Kellogg AP, 2005, ANTIOXID REDOX SIGN, V7, P1521, DOI 10.1089/ars.2005.7.1521; Kumar Velayudhan Mohan, 1999, Indian Journal of Physiology and Pharmacology, V43, P415; Laerum OD, 2008, AM J GASTROENTEROL, V103, P2350, DOI 10.1111/j.1572-0241.2008.01930.x; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Le Foll C, 2009, AM J PHYSIOL-REG I, V297, pR655, DOI 10.1152/ajpregu.00223.2009; Levin BE, 2006, OBESITY, V14, P192; Levin BE, 2004, DIABETES, V53, P2521, DOI 10.2337/diabetes.53.10.2521; Luquet Serge, 2009, Front Biosci (Schol Ed), V1, P448; Maljaars J, 2007, ALIMENT PHARM THERAP, V26, P241, DOI 10.1111/j.1365-2036.2007.03550.x; Marsollier N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006649; McLaughlin J, 2007, BIOCHEM SOC T, V35, P1199, DOI 10.1042/BST0351199; Migrenne S, 2007, DIABETES METAB, V33, P177, DOI 10.1016/j.diabet.2007.01.006; Murakami M, 2009, J NEUROSCI RES, V87, P2095, DOI 10.1002/jnr.22036; Ogetman Z, 2006, J INVEST SURG, V19, P19, DOI 10.1080/08941930500444396; Petit V, 2007, J LIPID RES, V48, P278, DOI 10.1194/jlr.M600283-JLR200; Raybould HE, 2008, J PHYSIOL BIOCHEM, V64, P349, DOI 10.1007/BF03174091; Rezaie A, 2007, DIGEST DIS SCI, V52, P2015, DOI 10.1007/s10620-006-9622-2; Sayegh AI, 2004, AUTON NEUROSCI-BASIC, V115, P54, DOI 10.1016/j.autneu.2004.08.006; Seidman EG, 2002, NES NUTR WS, V7, P41; Thorens B, 2004, CURR OPIN CLIN NUTR, V7, P471, DOI 10.1097/01.mco.0000134368.91900.84; Vogel U, 2003, FREE RADICAL RES, V37, P947, DOI 10.1080/1071576031000150779; von Boyen GBT, 2002, SCAND J GASTROENTERO, V37, P621, DOI 10.1080/00365520212498; Wang R, 2006, J NEUROPHYSIOL, V95, P1491, DOI 10.1152/jn.00697.2005; Yamamoto H, 2002, J CLIN INVEST, V110, P43, DOI 10.1172/JCI200215595; Yamanaka H, 2005, NEUROSCIENCE, V132, P183, DOI 10.1016/j.neuroscience.2004.12.003; Youssef S, 1999, KIDNEY INT, V55, P907, DOI 10.1046/j.1523-1755.1999.055003907.x	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21184	10.1371/journal.pone.0021184	http://dx.doi.org/10.1371/journal.pone.0021184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698161	Green Published, gold			2022-12-25	WOS:000291734100065
J	Achilli, A; Olivieri, A; Pala, M; Kashani, BH; Carossa, V; Perego, UA; Gandini, F; Santoro, A; Battaglia, V; Grugni, V; Lancioni, H; Sirolla, C; Bonfigli, AR; Cormio, A; Boemi, M; Testa, I; Semino, O; Ceriello, A; Spazzafumo, L; Gadaleta, MN; Marra, M; Testa, R; Franceschi, C; Torroni, A				Achilli, Alessandro; Olivieri, Anna; Pala, Maria; Kashani, Baharak Hooshiar; Carossa, Valeria; Perego, Ugo A.; Gandini, Francesca; Santoro, Aurelia; Battaglia, Vincenza; Grugni, Viola; Lancioni, Hovirag; Sirolla, Cristina; Bonfigli, Anna Rita; Cormio, Antonella; Boemi, Massimo; Testa, Ivano; Semino, Ornella; Ceriello, Antonio; Spazzafumo, Liana; Gadaleta, Maria Nicola; Marra, Maurizio; Testa, Roberto; Franceschi, Claudio; Torroni, Antonio			Mitochondrial DNA Backgrounds Might Modulate Diabetes Complications Rather than T2DM as a Whole	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; CLINICAL EXPRESSION; HAPLOGROUP N9A; NEAR-EASTERN; ASSOCIATION; DISEASE; SUSCEPTIBILITY; RESISTANCE; ORIGIN; RISK	Mitochondrial dysfunction has been implicated in rare and common forms of type 2 diabetes (T2DM). Additionally, rare mitochondrial DNA (mtDNA) mutations have been shown to be causal for T2DM pathogenesis. So far, many studies have investigated the possibility that mtDNA variation might affect the risk of T2DM, however, when found, haplogroup association has been rarely replicated, even in related populations, possibly due to an inadequate level of haplogroup resolution. Effects of mtDNA variation on diabetes complications have also been proposed. However, additional studies evaluating the mitochondrial role on both T2DM and related complications are badly needed. To test the hypothesis of a mitochondrial genome effect on diabetes and its complications, we genotyped the mtDNAs of 466 T2DM patients and 438 controls from a regional population of central Italy (Marche). Based on the most updated mtDNA phylogeny, all 904 samples were classified into 57 different mitochondrial sub-haplogroups, thus reaching an unprecedented level of resolution. We then evaluated whether the susceptibility of developing T2DM or its complications differed among the identified haplogroups, considering also the potential effects of phenotypical and clinical variables. MtDNA backgrounds, even when based on a refined haplogroup classification, do not appear to play a role in developing T2DM despite a possible protective effect for the common European haplogroup H1, which harbors the G3010A transition in the MTRNR2 gene. In contrast, our data indicate that different mitochondrial haplogroups are significantly associated with an increased risk of specific diabetes complications: H (the most frequent European haplogroup) with retinopathy, H3 with neuropathy, U3 with nephropathy, and V with renal failure.	[Achilli, Alessandro; Lancioni, Hovirag] Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy; [Olivieri, Anna; Pala, Maria; Kashani, Baharak Hooshiar; Carossa, Valeria; Perego, Ugo A.; Gandini, Francesca; Battaglia, Vincenza; Grugni, Viola; Semino, Ornella; Torroni, Antonio] Univ Pavia, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Perego, Ugo A.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA; [Santoro, Aurelia; Franceschi, Claudio] Univ Bologna, Dipartimento Patol Sperimentale, I-40126 Bologna, Italy; [Santoro, Aurelia; Franceschi, Claudio] Univ Bologna, CIG Interdept Ctr Biophys & Biocomplex Studies, Bologna, Italy; [Sirolla, Cristina] INRCA Ancona, Dept Gerontol Res, Stat & Biometry Ctr, Ancona, Italy; [Bonfigli, Anna Rita; Boemi, Massimo; Testa, Ivano; Marra, Maurizio; Testa, Roberto] IRCCS, INRCA, Metab & Nutr Res Ctr Diabet, Ancona, Italy; [Cormio, Antonella; Gadaleta, Maria Nicola] Univ Bari, Dipartimento Biochim & Biol Mol E Quagliariello, Bari, Italy; [Semino, Ornella] Univ Pavia, Ctr Interdipartimentale Studi Genere, I-27100 Pavia, Italy; [Ceriello, Antonio] IDIBAPS, Barcelona, Spain; [Ceriello, Antonio] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Barcelona, Spain	University of Perugia; University of Pavia; University of Bologna; University of Bologna; IRCCS INRCA; IRCCS INRCA; Universita degli Studi di Bari Aldo Moro; University of Pavia; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM	Achilli, A (corresponding author), Univ Perugia, Dipartimento Biol Cellulare & Ambientale, I-06100 Perugia, Italy.	antonio.torroni@unipv.it	Bonfigli, Anna Rita R/J-7248-2016; Perego, Ugo/AAG-9327-2019; Testa, Roberto/ABH-7467-2020; Franceschi, Claudio/L-4484-2017; Ceriello, Antonio/J-9575-2016; Lancioni, Hovirag/F-9067-2014; Achilli, Alessandro/I-9236-2012; OLIVIERI, ANNA/I-9235-2012; Battaglia, Vincenza/F-6950-2017; Torroni, Antonio/E-1557-2011; Spazzafumo, Liana/E-5488-2015; Gandini, Francesca/H-8936-2015	Bonfigli, Anna Rita R/0000-0002-9619-0181; Testa, Roberto/0000-0001-8308-7663; Franceschi, Claudio/0000-0001-9841-6386; Lancioni, Hovirag/0000-0001-5514-1853; Achilli, Alessandro/0000-0001-6871-3451; OLIVIERI, ANNA/0000-0002-3941-8098; Torroni, Antonio/0000-0002-4163-4478; Gandini, Francesca/0000-0001-8930-8295; Santoro, Aurelia/0000-0002-7187-1116; Spazzafumo, Liana/0000-0002-9718-1658; SEMINO, Ornella/0000-0002-9675-9403; Pala, Maria/0000-0001-9202-8331; Cormio, Antonella/0000-0002-6029-1722; TESTA, Ivano/0000-0002-7317-4701; Ceriello, Antonio/0000-0001-8122-3203	Fondazione Alma Mater Ticinensis; Roberto and Cornelia Pallotti Legacy for Cancer Research; Italian Ministry of the University [RBNE018AAP]	Fondazione Alma Mater Ticinensis; Roberto and Cornelia Pallotti Legacy for Cancer Research; Italian Ministry of the University(Ministry of Education, Universities and Research (MIUR))	This research received support from Fondazione Alma Mater Ticinensis (to AT and OS), Roberto and Cornelia Pallotti Legacy for Cancer Research (to CF), and the Italian Ministry of the University: Progetti Ricerca Interesse Nazionale 2007 (to AT), FIRB 2001 Protocol RBNE018AAP (to CF and AT), FIRB-Futuro in Ricerca 2008 (to AA and AO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2010, BRAIN, V133, P797, DOI 10.1093/brain/awq015; Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2007, AM J HUM GENET, V80, P759, DOI 10.1086/512822; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cai XY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006423; Carelli V, 2006, AM J HUM GENET, V78, P564, DOI 10.1086/501236; Cerny V, 2011, MOL BIOL EVOL, V28, P71, DOI 10.1093/molbev/msq178; Chinnery PF, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.048876; Cormio A, 2009, BBA-BIOENERGETICS, V1787, P547, DOI 10.1016/j.bbabio.2009.01.008; Crispim D, 2006, ANN HUM GENET, V70, P488, DOI 10.1111/j.1469-1809.2005.00249.x; Dudkina NV, 2005, P NATL ACAD SCI USA, V102, P3225, DOI 10.1073/pnas.0408870102; Feder J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-60; Feder J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-198; Fowler MJ, 2008, CLIN DIABETES, V26, P77, DOI [DOI 10.2337/DIACLIN.26.2.77, 10.2337/diaclin.26.2.77]; Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202; Ha H, 2008, DIABETES RES CLIN PR, V82, pS42, DOI 10.1016/j.diabres.2008.09.017; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Kass GV, 1980, J R STAT SOC C-APPL, P119; Kofler B, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-35; Lenaz G, 2010, ANTIOXID REDOX SIGN, V12, P961, DOI 10.1089/ars.2009.2704; Lenaz G, 2009, INT J BIOCHEM CELL B, V41, P1750, DOI 10.1016/j.biocel.2009.04.003; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maneka N, 2010, CURR OPIN LIPIDOL, V21, P44, DOI 10.1097/MOL.0b013e328334fdb6; Melendez-Ramirez LY, 2010, ENDOCRIN METAB CLIN, V39, P625, DOI 10.1016/j.ecl.2010.05.009; Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4; Ottoni C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013378; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Roostalu U, 2007, MOL BIOL EVOL, V24, P436, DOI 10.1093/molbev/msl173; Samuels DC, 2006, AM J HUM GENET, V78, P713, DOI 10.1086/502682; Saxena R, 2006, AM J HUM GENET, V79, P54, DOI 10.1086/504926; Shriner D, 2007, SCIENCE, V316, P1840; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Tanaka M, 2007, DIABETES, V56, P518, DOI 10.2337/db06-1105; Torroni A, 2006, TRENDS GENET, V22, P339, DOI 10.1016/j.tig.2006.04.001; Underhill PA, 2007, ANNU REV GENET, V41, P539, DOI 10.1146/annurev.genet.41.110306.130407; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586	43	58	58	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e21029	10.1371/journal.pone.0021029	http://dx.doi.org/10.1371/journal.pone.0021029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695278	Green Submitted, gold, Green Accepted, Green Published			2022-12-25	WOS:000291612900047
J	Kembel, SW; Cahill, JF				Kembel, Steven W.; Cahill, James F., Jr.			Independent Evolution of Leaf and Root Traits within and among Temperate Grassland Plant Communities	PLOS ONE			English	Article							ECOLOGICAL STRATEGIES; PHYLOGENETIC SIGNAL; ADAPTIVE RADIATION; FUNCTIONAL TRAITS; FESCUE GRASSLAND; WITHIN-COMMUNITY; CONVERGENCE; ADAPTATION; ASTERACEAE; GRASSES	In this study, we used data from temperate grassland plant communities in Alberta, Canada to test two longstanding hypotheses in ecology: 1) that there has been correlated evolution of the leaves and roots of plants due to selection for an integrated whole-plant resource uptake strategy, and 2) that trait diversity in ecological communities is generated by adaptations to the conditions in different habitats. We tested the first hypothesis using phylogenetic comparative methods to test for evidence of correlated evolution of suites of leaf and root functional traits in these grasslands. There were consistent evolutionary correlations among traits related to plant resource uptake strategies within leaf tissues, and within root tissues. In contrast, there were inconsistent correlations between the traits of leaves and the traits of roots, suggesting different evolutionary pressures on the above and belowground components of plant morphology. To test the second hypothesis, we evaluated the relative importance of two components of trait diversity: within-community variation (species trait values relative to co-occurring species; alpha traits) and among-community variation (the average trait value in communities where species occur; beta traits). Trait diversity was mostly explained by variation among co-occurring species, not among-communities. Additionally, there was a phylogenetic signal in the within-community trait values of species relative to co-occurring taxa, but not in their habitat associations or among-community trait variation. These results suggest that sorting of pre-existing trait variation into local communities can explain the leaf and root trait diversity in these grasslands.	[Kembel, Steven W.; Cahill, James F., Jr.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Kembel, Steven W.] Univ Oregon, Ctr Ecol & Evolutionary Biol, Eugene, OR 97403 USA	University of Alberta; University of Oregon	Kembel, SW (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	skembel@uoregon.edu	Cahill, James F/B-6147-2015	Cahill, James F/0000-0002-4110-1516; Kembel, Steven/0000-0001-5224-0952	National Sciences and Engineering Research Council (NSERC) of Canada; Alberta Conservation Association	National Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Conservation Association	This study was funded by the National Sciences and Engineering Research Council (NSERC) of Canada, and the Alberta Conservation Association 'Challenge Grants in Biodiversity' program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerly DD, 2007, ECOL LETT, V10, P135, DOI 10.1111/j.1461-0248.2006.01006.x; Ackerly DD, 2006, ECOLOGY, V87, pS50, DOI 10.1890/0012-9658(2006)87[50:NEAART]2.0.CO;2; Ackerly DD, 2004, AM NAT, V163, P654, DOI 10.1086/383062; Al-Shehbaz IA, 2006, PLANT SYST EVOL, V259, P89, DOI 10.1007/s00606-006-0415-z; Baldwin BG, 2002, SYST BOT, V27, P161; Beck JB, 2004, TAXON, V53, P691, DOI 10.2307/4135444; BELL G, 1993, OECOLOGIA, V96, P114, DOI 10.1007/BF00318038; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x; Boyce CK, 2002, PALEOBIOLOGY, V28, P70, DOI 10.1666/0094-8373(2002)028&lt;0070:EODPAT&gt;2.0.CO;2; Cahill JF, 1999, ECOLOGY, V80, P466, DOI 10.1890/0012-9658(1999)080[0466:FEOIBA]2.0.CO;2; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Cornelissen JHC, 2003, AUST J BOT, V51, P335, DOI 10.1071/BT02124; COUPLAND RT, 1953, ECOLOGY, V34, P386, DOI 10.2307/1930904; COUPLAND RT, 1950, ECOL MONOGR, V20, P273, DOI 10.2307/1943568; COUPLAND RT, 1961, J ECOL, V49, P135, DOI 10.2307/2257431; Craine J. M., 2001, Oikos, V93, P274, DOI 10.1034/j.1600-0706.2001.930210.x; Craine JM, 2005, ECOLOGY, V86, P12, DOI 10.1890/04-1075; Craine JM, 2003, OECOLOGIA, V134, P471, DOI 10.1007/s00442-002-1155-6; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Diaz S, 2004, J VEG SCI, V15, P295, DOI 10.1111/j.1654-1103.2004.tb02266.x; Eissenstat DM, 1997, ADV ECOL RES, V27, P1, DOI 10.1016/S0065-2504(08)60005-7; Eriksson T, 2003, INT J PLANT SCI, V164, P197, DOI 10.1086/346163; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Givnish TJ, 2004, AM J BOT, V91, P228, DOI 10.3732/ajb.91.2.228; Grime JP, 2006, J VEG SCI, V17, P255, DOI 10.1111/j.1654-1103.2006.tb02444.x; Kembel SW, 2008, ANN BOT-LONDON, V101, P1295, DOI 10.1093/aob/mcn044; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kooyman R, 2010, J ECOL, V98, P517, DOI 10.1111/j.1365-2745.2010.01642.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; LEOPOLD EB, 1987, ANN MO BOT GARD, V74, P841, DOI 10.2307/2399452; Linder HP, 2005, ANNU REV ECOL EVOL S, V36, P107, DOI 10.1146/annurev.ecolsys.36.102403.135635; Messier J, 2010, ECOL LETT, V13, P838, DOI 10.1111/j.1461-0248.2010.01476.x; Moss E.H., 1983, FLORA ALBERTA; MOSS EH, 1947, CAN J RES C, V25, P209, DOI 10.1139/cjr47c-019; Noyes RD, 1999, AM J BOT, V86, P398, DOI 10.2307/2656761; Reich P. B., 2003, International Journal of Plant Sciences, V164, pS143, DOI 10.1086/374368; Reich PB, 1997, P NATL ACAD SCI USA, V94, P13730, DOI 10.1073/pnas.94.25.13730; Reich PB, 1998, FUNCT ECOL, V12, P327, DOI 10.1046/j.1365-2435.1998.00208.x; Ryser P, 2006, PLANT SOIL, V286, P1, DOI 10.1007/s11104-006-9096-1; Salamin N, 2002, SYST BIOL, V51, P136, DOI 10.1080/106351502753475916; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Silvertown J, 2006, ECOLOGY, V87, pS39, DOI 10.1890/0012-9658(2006)87[39:PATHOO]2.0.CO;2; Stromberg CAE, 2005, P NATL ACAD SCI USA, V102, P11980, DOI 10.1073/pnas.0505700102; Tjoelker MG, 2005, NEW PHYTOL, V167, P493, DOI 10.1111/j.1469-8137.2005.01428.x; Wahl S, 2000, NEW PHYTOL, V148, P459, DOI 10.1046/j.1469-8137.2000.00775.x; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; Westoby M, 2006, TRENDS ECOL EVOL, V21, P261, DOI 10.1016/j.tree.2006.02.004; WHITTAKER R H, 1975, P385; WOJCIECHOWSKI MF, ADV LEGUME SYSTEMA 9, P277; Wright IJ, 2004, NATURE, V428, P821, DOI 10.1038/nature02403	55	76	83	11	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e19992	10.1371/journal.pone.0019992	http://dx.doi.org/10.1371/journal.pone.0019992			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687704	Green Submitted, Green Published, gold			2022-12-25	WOS:000291611500005
J	Jain, S; Chodisetti, SB; Agrewala, JN				Jain, Shweta; Chodisetti, Sathi Babu; Agrewala, Javed N.			CD40 Signaling Synergizes with TLR-2 in the BCR Independent Activation of Resting B Cells	PLOS ONE			English	Article							CYTIDINE DEAMINASE AID; TOLL-LIKE RECEPTORS; ANTIBODY-RESPONSES; DISTINCT PATHWAYS; IMMUNE-RESPONSES; LYMPHOCYTES-B; CUTTING EDGE; B-1 CELLS; EXPRESSION; ANTIGEN	Conventionally, signaling through BCR initiates sequence of events necessary for activation and differentiation of B cells. We report an alternative approach, independent of BCR, for stimulating resting B (RB) cells, by involving TLR-2 and CD40 - molecules crucial for innate and adaptive immunity. CD40 triggering of TLR-2 stimulated RB cells significantly augments their activation, proliferation and differentiation. It also substantially ameliorates the calcium flux, antigen uptake capacity and ability of B cells to activate T cells. The survival of RB cells was improved and it increases the number of cells expressing activation induced deaminase (AID), signifying class switch recombination (CSR). Further, we also observed increased activation rate and decreased threshold period required for optimum stimulation of RB cells. These results corroborate well with microarray gene expression data. This study provides novel insights into coordination between the molecules of innate and adaptive immunity in activating B cells, in a BCR independent manner. This strategy can be exploited to design vaccines to bolster B cell activation and antigen presenting efficiency, leading to faster and better immune response.	[Jain, Shweta; Chodisetti, Sathi Babu; Agrewala, Javed N.] CSIR, Inst Microbial Technol, Immunol Lab, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Jain, S (corresponding author), CSIR, Inst Microbial Technol, Immunol Lab, Chandigarh, India.	javed@imtech.res.in	Chodisetti, Sathi Babu/H-3239-2018; Agrewala, Javed Naim/AAS-8449-2021	Chodisetti, Sathi Babu/0000-0001-7473-9420; 	Council of Scientific and Industrial Research (CSIR), India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	This study is supported by Council of Scientific and Industrial Research (CSIR), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHWELL JD, 1984, J EXP MED, V159, P881, DOI 10.1084/jem.159.3.881; ASPINALL R, 1983, IMMUNOLOGY, V48, P309; Barrington RA, 2002, J EXP MED, V196, P1189, DOI 10.1084/jem.20021110; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; Bush TJV, 2008, EUR J IMMUNOL, V38, P400, DOI 10.1002/eji.200737602; DOOLEY S, 1994, HUM GENET, V93, P63; FEARON DT, 1995, ANNU REV IMMUNOL, V13, P127, DOI 10.1146/annurev.immunol.13.1.127; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Greenwald RJ, 2005, ANNU REV IMMUNOL, V23, P515, DOI 10.1146/annurev.immunol.23.021704.115611; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Haas KM, 2002, IMMUNITY, V17, P713, DOI 10.1016/S1074-7613(02)00483-1; He B, 2004, J IMMUNOL, V173, P4479, DOI 10.4049/jimmunol.173.7.4479; Hemmi Hiroaki, 2005, V86, P120, DOI 10.1159/000086657; Hippen KL, 2000, J EXP MED, V191, P883, DOI 10.1084/jem.191.5.883; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Kamioka Y, 2004, J BIOL CHEM, V279, P40091, DOI 10.1074/jbc.M404899200; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kin NW, 2007, J IMMUNOL, V179, P1516, DOI 10.4049/jimmunol.179.3.1516; Kzhyshkowska J, 2006, J CELL MOL MED, V10, P635, DOI 10.1111/j.1582-4934.2006.tb00425.x; Lanzavecchia A, 2007, CURR OPIN IMMUNOL, V19, P268, DOI 10.1016/j.coi.2007.04.002; Lindsley RC, 2007, BLOOD, V109, P2521, DOI 10.1182/blood-2006-04-018085; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; LIU YJ, 1991, EUR J IMMUNOL, V21, P1107, DOI 10.1002/eji.1830210504; Lumsden JM, 2003, J IMMUNOL, V170, P781, DOI 10.4049/jimmunol.170.2.781; Mao CC, 2004, IMMUNITY, V20, P133, DOI 10.1016/S1074-7613(04)00019-6; Massari P, 2002, J IMMUNOL, V168, P1533, DOI 10.4049/jimmunol.168.4.1533; McCoy CE, 2008, FRONT BIOSCI-LANDMRK, V13, P62, DOI 10.2741/2660; Miga A., 2000, Immunological Investigations, V29, P111, DOI 10.3109/08820130009062292; Minguet S, 2008, EUR J IMMUNOL, V38, P2475, DOI 10.1002/eji.200738094; Mizuno T, 2005, J IMMUNOL, V174, P3369, DOI 10.4049/jimmunol.174.6.3369; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Neron S, 2006, INT IMMUNOL, V18, P375, DOI 10.1093/intimm/dxh377; Podojil JR, 2005, TRENDS IMMUNOL, V26, P180, DOI 10.1016/j.it.2005.02.005; Politz O, 2002, BIOCHEM J, V362, P155, DOI 10.1042/0264-6021:3620155; Rau FC, 2009, J IMMUNOL, V183, P7661, DOI 10.4049/jimmunol.0803783; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Sayi A, 2011, J IMMUNOL, V186, P878, DOI 10.4049/jimmunol.1002269; Sun P, 2003, J BIOL CHEM, V278, P4063, DOI 10.1074/jbc.M208699200; Suvas S, 2002, J BIOL CHEM, V277, P7766, DOI 10.1074/jbc.M105902200; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Tsitsikov EN, 1997, P NATL ACAD SCI USA, V94, P10844, DOI 10.1073/pnas.94.20.10844; Vasilevsky S, 2007, J IMMUNOL, V178; Wortis HH, 2001, J IMMUNOL, V166, P2163, DOI 10.4049/jimmunol.166.4.2163; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yi AK, 2003, INT IMMUNOL, V15, P577, DOI 10.1093/intimm/dxg058; YUAN D, 1984, J IMMUNOL, V132, P1561	47	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 2	2011	6	6							e20651	10.1371/journal.pone.0020651	http://dx.doi.org/10.1371/journal.pone.0020651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	773ME	21674065	gold, Green Published, Green Submitted			2022-12-25	WOS:000291310600024
J	Imanishi, Y; Hu, B; Xiao, GT; Yao, XB; Cheng, SY				Imanishi, Yorihisa; Hu, Bo; Xiao, Gutian; Yao, Xuebiao; Cheng, Shi-Yuan			Angiopoietin-2, an Angiogenic Regulator, Promotes Initial Growth and Survival of Breast Cancer Metastases to the Lung through the Integrin-linked Kinase (ILK)-AKT-B Cell Lymphoma 2 (Bcl-2) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; ACTIVATION; AKT1; DISSEMINATION; SUPPRESSION; INHIBITION; EXPRESSION; INVASION; ROLES; ALPHA	The early onsets of breast cancer metastasis involve cell retention, survival, and resistant to apoptosis and subsequent growth at target vascular beds and tissues in distant organs. We previously reported that angiopoietin-2 (Ang2), an angiogenic regulator stimulates MCF-7 breast tumor metastasis from their orthotopic sites to distant organs through the alpha(5)beta(1) integrin/integrin-linked kinase (ILK)/Akt pathway. Here, by using an experimental tumor metastasis model and in vitro studies, we further dissect the underlying mechanism by which Ang2 promotes the initial growth and survival of MCF-7 breast cancer metastasis in the lung of animals. We show that Ang2 increases cell survival and suppresses cell apoptosis through ILK-induced phosphorylation of Akt1, Akt2, and up-regulation of Bcl-2 in breast cancer cells. Inhibition of ILK, Akt1, and Akt2, and their effector Bcl-2 diminishes Ang2-stimulated breast cancer cell survival and Ang2-attenuated apoptosis in vitro, and initial survival and growth of breast cancer metastasis in the lung of animals. Additionally, siRNA knockdown of endogenous Ang2 in three human metastatic breast cancer cell lines also inhibits phosphorylation of Akt, expression of Bcl-2, and tumor cell survival, migration, and increases cell apoptosis. Since increased expression of Ang2 correlates with elevated potential of human breast cancer metastasis in clinic, our data underscore the importance that up-regulated Ang2 not only stimulates breast cancer growth and metastasis at late stages of the process, but is also critical at the initiating stages of metastases onset, thereby suggesting Ang2 as a promising therapeutic target for treating patients with metastatic breast cancer.	[Imanishi, Yorihisa; Hu, Bo; Xiao, Gutian; Yao, Xuebiao; Cheng, Shi-Yuan] Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA; [Imanishi, Yorihisa; Cheng, Shi-Yuan] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA; [Hu, Bo] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Xiao, Gutian] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA 15213 USA; [Imanishi, Yorihisa] Keio Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Yao, Xuebiao] Hefei Natl Lab Phys Sci Nanoscale, Anhui Lab Cellular Dynam & Chem Biol, Hefei 230027, Peoples R China; [Yao, Xuebiao] Morehouse Sch Med, Dept Physiol, Atlanta, GA 30310 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Keio University; Morehouse School of Medicine	Hu, B (corresponding author), Univ Pittsburgh, Sch Med, Inst Canc, Pittsburgh, PA 15213 USA.	hub@upmc.edu; chengs@upmc.edu	Yao, Xuebiao/P-5771-2014; Imanishi, Yorihisa/AAL-3018-2021	Imanishi, Yorihisa/0000-0003-0047-7987	National Institutes of Health [CA130966, CA116616, CA132389]; Pennsylvania Dept. of Health and Innovative Research of Hillman Foundation; American Cancer Society [RSG-06-066-01-MGO]; Chinese Academy of Sciences [KSCX-YW-R65]; Chinese 973 Projects [2007CB914503, 2010CB912103]; NATIONAL CANCER INSTITUTE [R01CA116616, R01CA130966, P20CA132389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Dept. of Health and Innovative Research of Hillman Foundation; American Cancer Society(American Cancer Society); Chinese Academy of Sciences(Chinese Academy of Sciences); Chinese 973 Projects(National Basic Research Program of China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by Grant CA130966 from the National Institutes of Health and the Pennsylvania Dept. of Health and Innovative Research Scholar Awards of the Hillman Foundation (to S. Y. C. and B. H.); National Institutes of Health CA116616, American Cancer Society RSG-06-066-01-MGO (to G. X.), and National Institutes of Health Grant CA132389; Chinese Academy of Sciences KSCX-YW-R65 and Chinese 973 Projects 2007CB914503 and 2010CB912103 (to X. Y.).	Arboleda MJ, 2003, CANCER RES, V63, P196; Arisan ED, 2010, BREAST CANCER RES TR, V119, P271, DOI 10.1007/s10549-009-0343-z; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Brown JL, 2010, MOL CANCER THER, V9, P145, DOI 10.1158/1535-7163.MCT-09-0554; Cascio S, 2008, ONCOGENE, V27, P540, DOI 10.1038/sj.onc.1210660; Chae SS, 2010, CLIN CANCER RES, V16, P3618, DOI 10.1158/1078-0432.CCR-09-3073; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Coxon A, 2010, MOL CANCER THER, V9, P2641, DOI 10.1158/1535-7163.MCT-10-0213; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hashizume H, 2010, CANCER RES, V70, P2213, DOI 10.1158/0008-5472.CAN-09-1977; Helfrich I, 2009, CLIN CANCER RES, V15, P1384, DOI 10.1158/1078-0432.CCR-08-1615; Hu B, 2003, P NATL ACAD SCI USA, V100, P8904, DOI 10.1073/pnas.1533394100; Hu B, 2009, CURR ONCOL REP, V11, P111, DOI 10.1007/s11912-009-0017-3; Huang HH, 2010, NAT REV CANCER, V10, P575, DOI 10.1038/nrc2894; Hutchinson JN, 2004, CANCER RES, V64, P3171, DOI 10.1158/0008-5472.CAN-03-3465; Iliopoulos D, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000356; Imanishi Y, 2007, CANCER RES, V67, P4254, DOI 10.1158/0008-5472.CAN-06-4100; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kirkegaard T, 2010, HISTOPATHOLOGY, V56, P203, DOI 10.1111/j.1365-2559.2009.03467.x; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Nasarre P, 2009, CANCER RES, V69, P1324, DOI 10.1158/0008-5472.CAN-08-3030; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Niu GL, 2007, CANCER RES, V67, P1487, DOI 10.1158/0008-5472.CAN-06-3155; Oliner J, 2004, CANCER CELL, V6, P507, DOI 10.1016/j.ccr.2004.09.030; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Sun M, 2001, CANCER RES, V61, P5985; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Thomas M, 2009, ANGIOGENESIS, V12, P125, DOI 10.1007/s10456-009-9147-3; Wang JH, 2008, CHEM MATER, V20, P20, DOI 10.1021/cm702375e; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670	37	30	33	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29249	29260		10.1074/jbc.M111.235689	http://dx.doi.org/10.1074/jbc.M111.235689			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21680733	Green Published, hybrid			2022-12-25	WOS:000293837000060
J	McFie, PJ; Banman, SL; Kary, S; Stone, SJ				McFie, Pamela J.; Banman, Shanna L.; Kary, Steven; Stone, Scot J.			Murine Diacylglycerol Acyltransferase-2 (DGAT2) Can Catalyze Triacylglycerol Synthesis and Promote Lipid Droplet Formation Independent of Its Localization to the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIATION-RELATED PROTEIN; HEPATITIS-C VIRUS; COA-MONOACYLGLYCEROL ACYLTRANSFERASE; MITOCHONDRIA-ASSOCIATED MEMBRANES; YEAST SACCHAROMYCES-CEREVISIAE; ACYL-COA; TRIGLYCERIDE SYNTHESIS; TRANSMEMBRANE DOMAIN; HYDROPHOBIC-DOMAIN; CORE PROTEIN	Triacylglycerol (TG) is the major form of stored energy in eukaryotic organisms and is synthesized by two distinct acylCoA: diacylglycerol acyltransferase (DGAT) enzymes, DGAT1 and DGAT2. Both DGAT enzymes reside in the endoplasmic reticulum (ER), but DGAT2 also co-localizes with mitochondria and lipid droplets. In this report, we demonstrate that murine DGAT2 is part of a multimeric complex consisting of several DGAT2 subunits. We also identified the region of DGAT2 responsible for its localization to the ER. ADGAT2 mutant lacking both its transmembrane domains, although still associated with membranes, was absent from the ER and instead localized to mitochondria. Unexpectedly, this mutant was still active and capable of interacting with lipid droplets to promote TG storage. Additional experiments indicated that the ER targeting signal was present in the first transmembrane domain (TMD1) of DGAT2. When fused to a fluorescent reporter, TMD1, but not TMD2, was sufficient to target mCherry to the ER. Finally, the interaction of DGAT2 with lipid droplets was dependent on the C terminus of DGAT2. DGAT2 mutants, in which regions of the C terminus were either truncated or specific regions were deleted, failed to co-localize with lipid droplets when cells were oleate loaded to stimulate TG synthesis. Our findings demonstrate that DGAT2 is capable of catalyzing TG synthesis and promote its storage in cytosolic lipid droplets independent of its localization in the ER.	[McFie, Pamela J.; Banman, Shanna L.; Kary, Steven; Stone, Scot J.] Univ Saskatchewan, Dept Biochem, Saskatoon, SK S7N 5E5, Canada	University of Saskatchewan	Stone, SJ (corresponding author), 107 Wiggins Rd, Saskatoon, SK S7N 5E5, Canada.	scot.stone@usask.ca			Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health [FRN 88063]; University of Saskatchewan, Natural Sciences and Engineering Research Council of Canada	Heart and Stroke Foundation of Saskatchewan; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); University of Saskatchewan, Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported in part by a Heart and Stroke Foundation of Saskatchewan Grant-in-aid, Canadian Institutes of Health Research Regional Partnership Program Grant FRN 88063, and the University of Saskatchewan President's Natural Sciences and Engineering Research Council of Canada Fund.	Abell BM, 1997, PLANT CELL, V9, P1481, DOI 10.1105/tpc.9.8.1481; Abell BM, 2004, PLANT J, V37, P461, DOI 10.1111/j.1365-313X.2003.01988.x; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Brasaemle DL, 1997, J LIPID RES, V38, P2249; Buhman KK, 2001, J BIOL CHEM, V276, P40369, DOI 10.1074/jbc.R100050200; Caldas H, 2003, HUM MOL GENET, V12, P2981, DOI 10.1093/hmg/ddg321; Cao JS, 2003, J BIOL CHEM, V278, P25657, DOI 10.1074/jbc.M302835200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Cases S, 2004, DEVELOPMENT, V131, P3047, DOI 10.1242/dev.01158; Cases S, 1998, P NATL ACAD SCI USA, V95, P13018, DOI 10.1073/pnas.95.22.13018; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Cheng D, 2001, BIOCHEM J, V359, P707, DOI 10.1042/0264-6021:3590707; Cheng D, 2003, J BIOL CHEM, V278, P13611, DOI 10.1074/jbc.C300042200; Cinti S, 2001, P NUTR SOC, V60, P319, DOI 10.1079/PNS200192; CUI Z, 1993, J BIOL CHEM, V268, P16655; Farese RV, 2000, CURR OPIN LIPIDOL, V11, P229, DOI 10.1097/00041433-200006000-00002; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; Fujimoto Y, 2004, BBA-MOL CELL RES, V1644, P47, DOI 10.1016/j.bbamcr.2003.10.018; Gidda SK, 2011, TRAFFIC, V12, P452, DOI 10.1111/j.1600-0854.2011.01160.x; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Harris CA, 2011, J LIPID RES, V52, P657, DOI 10.1194/jlr.M013003; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hope RG, 2002, J BIOL CHEM, V277, P4261, DOI 10.1074/jbc.M108798200; Horiguchi Y, 2008, ARCH BIOCHEM BIOPHYS, V479, P121, DOI 10.1016/j.abb.2008.08.020; KENNEDY EP, 1957, ANNU REV BIOCHEM, V26, P119, DOI 10.1146/annurev.bi.26.070157.001003; Kuerschner L, 2008, TRAFFIC, V9, P338, DOI 10.1111/j.1600-0854.2007.00689.x; Lardizabal KD, 2001, J BIOL CHEM, V276, P38862, DOI 10.1074/jbc.M106168200; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Londos C, 1999, SEMIN CELL DEV BIOL, V10, P51, DOI 10.1006/scdb.1998.0275; Man WC, 2006, J LIPID RES, V47, P1928, DOI 10.1194/jlr.M600172-JLR200; McFie PJ, 2010, J BIOL CHEM, V285, P37377, DOI 10.1074/jbc.M110.163691; Mullner H, 2004, BBA-BIOMEMBRANES, V1663, P9, DOI 10.1016/S0005-2736(04)00079-3; Nakamura N, 2003, BIOCHEM BIOPH RES CO, V306, P333, DOI 10.1016/S0006-291X(03)00979-3; Ostermeyer AG, 2004, J CELL BIOL, V164, P69, DOI 10.1083/jcb.200303037; Rayner JC, 1997, EMBO J, V16, P1832, DOI 10.1093/emboj/16.8.1832; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Sato S, 2006, J BIOCHEM, V139, P921, DOI 10.1093/jb/mvj104; Shockey JM, 2006, PLANT CELL, V18, P2294, DOI 10.1105/tpc.106.043695; Simmen T, 2010, BBA-BIOMEMBRANES, V1798, P1465, DOI 10.1016/j.bbamem.2010.04.009; Smith SJ, 2000, NAT GENET, V25, P87, DOI 10.1038/75651; Snapp EL, 2006, P NATL ACAD SCI USA, V103, P6536, DOI 10.1073/pnas.0510657103; Sorger D, 2002, J BACTERIOL, V184, P519, DOI 10.1128/JB.184.2.519-524.2002; STEMBERGER BH, 1984, CELL TISSUE RES, V236, P471, DOI 10.1007/BF00214252; Stone SJ, 2009, J BIOL CHEM, V284, P5352, DOI 10.1074/jbc.M805768200; Stone SJ, 2006, J BIOL CHEM, V281, P40273, DOI 10.1074/jbc.M607986200; Stone SJ, 2000, J BIOL CHEM, V275, P34534, DOI 10.1074/jbc.M002865200; Stone SJ, 2004, J BIOL CHEM, V279, P11767, DOI 10.1074/jbc.M311000200; Subramanian V, 2004, J LIPID RES, V45, P1983, DOI 10.1194/jlr.M400291-JLR200; Targett-Adams P, 2003, J BIOL CHEM, V278, P15998, DOI 10.1074/jbc.M211289200; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Turkish A, 2007, AM J PHYSIOL-GASTR L, V292, pG953, DOI 10.1152/ajpgi.00509.2006; Turro S, 2006, TRAFFIC, V7, P1254, DOI 10.1111/j.1600-0854.2006.00465.x; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wakimoto K, 2003, BIOCHEM BIOPH RES CO, V310, P296, DOI 10.1016/j.bbrc.2003.09.015; Walther TC, 2009, BBA-MOL CELL BIOL L, V1791, P459, DOI 10.1016/j.bbalip.2008.10.009; Wan HC, 2007, FASEB J, V21, P167, DOI 10.1096/fj.06-6711com; Wu CC, 2000, ELECTROPHORESIS, V21, P3470, DOI 10.1002/1522-2683(20001001)21:16<3470::AID-ELPS3470>3.3.CO;2-7; Yang M, 1997, J BIOL CHEM, V272, P1970, DOI 10.1074/jbc.272.3.1970; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Yen CLE, 2002, P NATL ACAD SCI USA, V99, P8512, DOI 10.1073/pnas.132274899; Zehmer JK, 2008, J CELL SCI, V121, P1852, DOI 10.1242/jcs.012013; Zehmer JK, 2009, J CELL SCI, V122, P3694, DOI 10.1242/jcs.054700	68	107	112	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28235	28246		10.1074/jbc.M111.256008	http://dx.doi.org/10.1074/jbc.M111.256008			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680734	Green Published, hybrid			2022-12-25	WOS:000293557800041
J	Dai, JY; Gu, J; Lu, C; Lin, J; Stewart, D; Chang, D; Roth, JA; Wu, XF				Dai, Jingyao; Gu, Jian; Lu, Charles; Lin, Jie; Stewart, David; Chang, David; Roth, Jack A.; Wu, Xifeng			Genetic Variations in the Regulator of G-Protein Signaling Genes Are Associated with Survival in Late-Stage Non-Small Cell Lung Cancer	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RGS PROTEINS; MESSENGER-RNA; PROSTATE-CANCER; HEPATOCELLULAR-CARCINOMA; SUSCEPTIBILITY LOCI; BREAST CANCERS; OVARIAN-CANCER; EXPRESSION; IDENTIFICATION	The regulator of G-protein signaling (RGS) pathway plays an important role in signaling transduction, cellular activities, and carcinogenesis. We hypothesized that genetic variations in RGS gene family may be associated with the response of late-stage non-small cell lung cancer (NSCLC) patients to chemotherapy or chemoradiotherapy. We selected 95 tagging single nucleotide polymorphisms (SNPs) in 17 RGS genes and genotyped them in 598 late-stage NSCLC patients. Thirteen SNPs were significantly associated with overall survival. Among them, rs2749786 of RGS12 was most significant. Stratified analysis by chemotherapy or chemoradiation further identified SNPs that were associated with overall survival in subgroups. Rs2816312 of RGS1 and rs6689169 of RGS7 were most significant in chemotherapy group and chemoradiotherapy group, respectively. A significant cumulative effect was observed when these SNPs were combined. Survival tree analyses identified potential interactions between rs944343, rs2816312, and rs1122794 in affecting survival time in patients treated with chemotherapy, while the genotype of rs6429264 affected survival in chemoradiation-treated patients. To our knowledge, this is the first study to reveal the importance of RGS gene family in the survival of late-stage NSCLC patients.	[Dai, Jingyao; Gu, Jian; Lin, Jie; Chang, David; Wu, Xifeng] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Lu, Charles; Stewart, David] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA; [Roth, Jack A.] Univ Texas MD Anderson Canc Ctr, Dept Thorac & Cardiovasc Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Dai, JY (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.	xwu@mdanderson.org	Gu, Jian/Q-4780-2018	Gu, Jian/0000-0003-3499-0973	National Institutes of Health [R01 CA111646, P50 CA070907, R01 CA055769]; NATIONAL CANCER INSTITUTE [R01CA055769, R01CA111646, P50CA070907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health grants R01 CA111646, P50 CA070907, and R01 CA055769. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Albig AR, 2005, MOL BIOL CELL, V16, P609, DOI 10.1091/mbc.e04-06-0479; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Benzing T, 1999, NAT MED, V5, P913, DOI 10.1038/11354; Berman DM, 2004, CANCER RES, V64, P6820, DOI 10.1158/0008-5472.CAN-04-1916; Berman DM, 1998, J BIOL CHEM, V273, P1269, DOI 10.1074/jbc.273.3.1269; Boss CN, 2007, CLIN CANCER RES, V13, P3347, DOI 10.1158/1078-0432.CCR-06-2156; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Chen X, 2004, MODERN PATHOL, V17, P1198, DOI 10.1038/modpathol.3800167; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Exton JH, 1997, EUR J BIOCHEM, V243, P10, DOI 10.1111/j.1432-1033.1997.t01-1-00010.x; Fournel P, 2005, J CLIN ONCOL, V23, P5910, DOI 10.1200/JCO.2005.03.070; Furuya M, 2004, J PATHOL, V203, P551, DOI 10.1002/path.1543; Grunebach F, 2008, CANCER IMMUNOL IMMUN, V57, P1483, DOI 10.1007/s00262-008-0486-5; Gu J, 2006, CANCER-AM CANCER SOC, V106, P2716, DOI 10.1002/cncr.21944; Gu S, 2009, CLIN SCI, V116, P391, DOI 10.1042/CS20080272; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Han JI, 2006, J LEUKOCYTE BIOL, V79, P1357, DOI 10.1189/jlb.1105693; Hendriks-Balk MC, 2008, EUR J PHARMACOL, V585, P278, DOI 10.1016/j.ejphar.2008.02.088; Hildebrandt MAT, 2009, EXPERT OPIN DRUG MET, V5, P745, DOI 10.1517/17425250902973711; Hollinger S, 2002, PHARMACOL REV, V54, P527, DOI 10.1124/pr.54.3.527; Hurst JH, 2009, BIOCHEM PHARMACOL, V78, P1289, DOI 10.1016/j.bcp.2009.06.028; Hurst JH, 2009, CELL MOL BIOL LETT, V14, P153, DOI 10.2478/s11658-008-0040-7; Ishii M, 2003, LIFE SCI, V74, P163, DOI 10.1016/j.lfs.2003.09.004; Islam TC, 2003, LEUKEMIA, V17, P1880, DOI 10.1038/sj.leu.2403057; Koga H, 2004, CANCER SCI, V95, P411, DOI 10.1111/j.1349-7006.2004.tb03224.x; Manzur M, 2009, CANCER RES, V69, P396, DOI 10.1158/0008-5472.CAN-08-2842; Martinez-Cardus A, 2009, MOL CANCER THER, V8, P194, DOI 10.1158/1535-7163.MCT-08-0659; Nikolova DN, 2008, ONCOL REP, V20, P105; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Ooe A, 2007, BREAST CANCER RES TR, V101, P305, DOI 10.1007/s10549-006-9293-x; Parkin DM, 2001, LANCET ONCOL, V2, P533, DOI 10.1016/S1470-2045(01)00486-7; Penland SK, 2004, SEMIN RADIAT ONCOL, V14, P326, DOI 10.1016/j.semradonc.2004.07.002; Puiffe ML, 2007, NEOPLASIA, V9, P820, DOI 10.1593/neo.07472; Rae FK, 2000, INT J CANCER, V88, P726, DOI 10.1002/1097-0215(20001201)88:5<726::AID-IJC7>3.0.CO;2-H; Rangel J, 2008, AM J SURG PATHOL, V32, P1207, DOI 10.1097/PAS.0b013e31816fd53c; Riddle EL, 2005, CIRC RES, V96, P401, DOI 10.1161/01.RES.0000158287.49872.4e; Sarkar FH, 2004, MUTAT RES-FUND MOL M, V555, P53, DOI 10.1016/j.mrfmmm.2004.04.015; Schwable J, 2005, BLOOD, V105, P2107, DOI 10.1182/blood-2004-03-0940; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Silva APM, 2003, GENE, V310, P49, DOI 10.1016/S0378-1119(03)00501-8; Sliva D, 2004, CURR CANCER DRUG TAR, V4, P327, DOI 10.2174/1568009043332961; Smalley MJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1834; Sood R, 2001, GENOMICS, V73, P211, DOI 10.1006/geno.2001.6500; Stinchcombe TE, 2006, ONCOLOGIST, V11, P809, DOI 10.1634/theoncologist.11-7-809; Takahashi H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-399; Tatenhorst L, 2004, J NEUROPATH EXP NEUR, V63, P210, DOI 10.1093/jnen/63.3.210; Tonjes A, 2004, THYROID, V14, P896, DOI 10.1089/thy.2004.14.896; TRAYNOR J, ANN N Y ACAD SCI, V1187, P341; Tsai CC, 2006, J BIOMED SCI, V13, P241, DOI 10.1007/s11373-005-9062-6; van Meerbeeck J P, 2005, Ned Tijdschr Geneeskd, V149, P72; Wang JM, 2010, CARCINOGENESIS, V31, P1755, DOI 10.1093/carcin/bgq138; Wiechec E, 2008, GENE CHROMOSOME CANC, V47, P766, DOI 10.1002/gcc.20578; Wu XF, 2009, CANCER PREV RES, V2, P617, DOI 10.1158/1940-6207.CAPR-09-0025; Xiao B, 2009, CLIN CHEM LAB MED, V47, P1483, DOI 10.1515/CCLM.2009.344; You M, 2009, CLIN CANCER RES, V15, P2666, DOI 10.1158/1078-0432.CCR-08-2335; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819	56	17	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21120	10.1371/journal.pone.0021120	http://dx.doi.org/10.1371/journal.pone.0021120			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21698121	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600041
J	Demilly, A; Simionato, E; Ohayon, D; Kerner, P; Garces, A; Vervoort, M				Demilly, Adrien; Simionato, Elena; Ohayon, David; Kerner, Pierre; Garces, Alain; Vervoort, Michel			Coe Genes Are Expressed in Differentiating Neurons in the Central Nervous System of Protostomes	PLOS ONE			English	Article							ANNELID PLATYNEREIS-DUMERILII; TRANSCRIPTION FACTOR COLLIER; CELL-TYPE SPECIFICATION; DROSOPHILA CNS; PRIMARY NEUROGENESIS; HOMEODOMAIN PROTEIN; DOPAMINERGIC CELLS; COMMON ORIGIN; SPINAL-CORD; FAMILY	Genes of the coe (collier/olfactory/early B-cell factor) family encode Helix-Loop-Helix transcription factors that are widely conserved in metazoans and involved in many developmental processes, neurogenesis in particular. Whereas their functions during vertebrate neural tube formation have been well documented, very little is known about their expression and role during central nervous system (CNS) development in protostomes. Here we characterized the CNS expression of coe genes in the insect Drosophila melanogaster and the polychaete annelid Platynereis dumerilii, which belong to different subgroups of protostomes and show strikingly different modes of development. In the Drosophila ventral nerve cord, we found that the Collier-expressing cells form a subpopulation of interneurons with diverse molecular identities and neurotransmitter phenotypes. We also demonstrate that collier is required for the proper differentiation of some interneurons belonging to the Eve-Lateral cluster. In Platynereis dumerilii, we cloned a single coe gene, Pdu-coe, and found that it is exclusively expressed in post mitotic neural cells. Using an original technique of in silico 3D registration, we show that Pdu-coe is co-expressed with many different neuronal markers and therefore that, like in Drosophila, its expression defines a heterogeneous population of neurons with diverse molecular identities. Our detailed characterization and comparison of coe gene expression in the CNS of two distantly-related protostomes suggest conserved roles of coe genes in neuronal differentiation in this clade. As similar roles have also been observed in vertebrates, this function was probably already established in the last common ancestor of all bilaterians.	[Demilly, Adrien; Simionato, Elena; Kerner, Pierre; Vervoort, Michel] Univ Paris Diderot, Inst Jacques Monod, UMR CNRS 7592, Paris, France; [Ohayon, David; Garces, Alain] Inst Neurosci Montpellier, INSERM U 1051, Montpellier, France; [Vervoort, Michel] Inst Univ France, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Institut Universitaire de France	Demilly, A (corresponding author), Univ Paris Diderot, Inst Jacques Monod, UMR CNRS 7592, Paris, France.	alain.garces@inserm.fr; vervoort.michel@ijm.univ-paris-diderot.fr	Vervoort, Michel/S-1448-2019	Garces, Alain/0000-0001-6252-9995; Kerner, Pierre/0000-0003-4001-0812; Demilly, Adrien/0000-0002-8165-959X; OHAYON, David/0000-0003-3545-3774	Agence Nationale de la Recherche; CNRS; INSERM; Agence Francaise contre les Myopathies; Institut Universitaire de France	Agence Nationale de la Recherche(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Francaise contre les Myopathies; Institut Universitaire de France	This work was funded by the Agence Nationale de la Recherche, the CNRS, the INSERM, the Agence Francaise contre les Myopathies, and the Institut Universitaire de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan DW, 2003, CELL, V113, P73, DOI 10.1016/S0092-8674(03)00204-6; Bally-Cuif L, 1998, MECH DEVELOP, V77, P85, DOI 10.1016/S0925-4773(98)00144-0; Baumgardt M, 2007, PLOS BIOL, V5, P295, DOI 10.1371/journal.pbio.0050037; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; Broihier HT, 2002, NEURON, V35, P39, DOI 10.1016/S0896-6273(02)00743-2; Callahan CA, 1998, CURR OPIN NEUROBIOL, V8, P582, DOI 10.1016/S0959-4388(98)80084-6; Crozatier M, 1999, DEVELOPMENT, V126, P4385; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Crozatier M, 2002, DEVELOPMENT, V129, P4261; Crozatier M, 1996, CURR BIOL, V6, P707, DOI 10.1016/S0960-9822(09)00452-7; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Crozatier M, 2008, DEV BIOL, V315, P232, DOI 10.1016/j.ydbio.2007.12.030; Daburon V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-131; de Rosa R, 2005, EVOL DEV, V7, P574; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dittrich R, 1997, DEVELOPMENT, V124, P2515; Dorresteijn AWC, 1993, ROUX ARCH DEVEL BIOL, V202, P264; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Dubois L, 1998, CURR BIOL, V8, P199, DOI 10.1016/S0960-9822(98)70084-3; Dubois L, 2007, DEVELOPMENT, V134, P4347, DOI 10.1242/dev.008409; Fischer A, 2004, BIOESSAYS, V26, P314, DOI 10.1002/bies.10409; Fischer AHL, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-31; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Fujioka M, 2003, DEVELOPMENT, V130, P5385, DOI 10.1242/dev.00770; Garces A, 2006, DEVELOPMENT, V133, P1445, DOI 10.1242/dev.02321; Garces A, 2006, EUR J NEUROSCI, V24, P37, DOI 10.1111/j.1460-9568.2006.04887.x; Garcia-Dominguez M, 2003, DEVELOPMENT, V130, P6013, DOI 10.1242/dev.00840; Garel S, 1999, DEVELOPMENT, V126, P5285; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hartenstein V, 2006, BIOESSAYS, V28, P1203, DOI 10.1002/bies.20497; Hattori Y, 2007, GENES CELLS, V12, P1011, DOI 10.1111/j.1365-2443.2007.01107.x; Heanue TA, 1999, GENE DEV, V13, P3231, DOI 10.1101/gad.13.24.3231; Hewes RS, 2003, DEVELOPMENT, V130, P1771, DOI 10.1242/dev.00404; Higashijima S, 1996, DEVELOPMENT, V122, P527; Hinckley CA, 2005, J NEUROPHYSIOL, V93, P1439, DOI 10.1152/jn.00647.2004; Hudson C, 2007, DEVELOPMENT, V134, P3527, DOI 10.1242/dev.002352; Jackson DJ, 2010, DEV GENES EVOL, V220, P221, DOI 10.1007/s00427-010-0343-3; Jekely G, 2007, BIOTECHNIQUES, V42, P751, DOI 10.2144/000112462; Jinushi-Nakao S, 2007, NEURON, V56, P963, DOI 10.1016/j.neuron.2007.10.031; Kerner P, 2009, EVOL DEV, V11, P513, DOI 10.1111/j.1525-142X.2009.00359.x; Kidd S, 1998, GENE DEV, V12, P3728, DOI 10.1101/gad.12.23.3728; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; Kim K, 2005, DEV BIOL, V286, P136, DOI 10.1016/j.ydbio.2005.07.024; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; KUDRYCKI K, 1993, MOL CELL BIOL, V13, P3002, DOI 10.1128/MCB.13.5.3002; Lacin H, 2009, DEVELOPMENT, V136, P3257, DOI 10.1242/dev.037242; Landgraf M, 1999, NEURON, V22, P43, DOI 10.1016/S0896-6273(00)80677-7; Layden MJ, 2006, DEV BIOL, V291, P253, DOI 10.1016/j.ydbio.2005.12.009; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Liberg D, 2002, MOL CELL BIOL, V22, P8389, DOI 10.1128/MCB.22.24.8389-8397.2002; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Mahr A, 2006, GENE EXPR PATTERNS, V6, P299, DOI 10.1016/j.modgep.2005.07.006; Maier H, 2002, SEMIN IMMUNOL, V14, P415, DOI 10.1016/S1044532302000763; Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0; Mazet F, 2004, GENESIS, V38, P58, DOI 10.1002/gene.20006; Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P5837, DOI 10.1242/dev.01447; Miguel-Aliaga I, 2008, PLOS BIOL, V6, P538, DOI 10.1371/journal.pbio.0060058; O'Keefe DD, 1998, DEVELOPMENT, V125, P3915; Odden JP, 2002, J NEUROSCI, V22, P9143; Pang K, 2004, DEV GENES EVOL, V214, P134, DOI 10.1007/s00427-004-0383-7; Panopoulou G, 2005, TRENDS GENET, V21, P559, DOI 10.1016/j.tig.2005.08.004; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; PATEL NH, 1989, DEVELOPMENT, V107, P201; Pozzoli O, 2001, DEV BIOL, V233, P495, DOI 10.1006/dbio.2001.0230; Prasad BC, 1998, DEVELOPMENT, V125, P1561; ROBINOW S, 1988, DEV BIOL, V126, P294, DOI 10.1016/0012-1606(88)90139-X; Rogers JS, 1998, SYST BIOL, V47, P77, DOI 10.1080/106351598261049; Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4; Sato M, 1999, DEVELOPMENT, V126, P1457; Siegler MVS, 1999, NEURON, V22, P265, DOI 10.1016/S0896-6273(00)81088-0; Simionato E, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-33; Simionato E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-170; Skeath JB, 1998, DEVELOPMENT, V125, P1857; Skeath JB, 1999, BIOESSAYS, V21, P922, DOI 10.1002/(SICI)1521-1878(199911)21:11<922::AID-BIES4>3.0.CO;2-T; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; SPANA EP, 1995, DEVELOPMENT, V121, P3489; Stolfi A, 2011, DEVELOPMENT, V138, P995, DOI 10.1242/dev.061507; Stolfi A, 2010, SCIENCE, V329, P565, DOI 10.1126/science.1190181; Tanimoto H, 2000, MOL CELL, V5, P59, DOI 10.1016/S1097-2765(00)80403-7; Tessmar-Raible K, 2005, BIOTECHNIQUES, V39, P460, DOI 10.2144/000112023; Thor S, 1999, NATURE, V397, P76, DOI 10.1038/16275; Thor S, 1997, NEURON, V18, P397, DOI 10.1016/S0896-6273(00)81241-6; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; TRAVIS A, 1993, MOL CELL BIOL, V13, P3392, DOI 10.1128/MCB.13.6.3392; Van Doren M, 2003, DEVELOPMENT, V130, P2355, DOI 10.1242/dev.00454; Vervoort M, 1999, CURR BIOL, V9, P632, DOI 10.1016/S0960-9822(99)80285-1; Wang SS, 1997, J NEUROSCI, V17, P4149; Warren M, 2009, DEV DYNAM, V238, P944, DOI 10.1002/dvdy.21895; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981	93	18	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21213	10.1371/journal.pone.0021213	http://dx.doi.org/10.1371/journal.pone.0021213			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695052	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600053
J	Su, HL; Lin, SH; Wei, JC; Pao, IC; Chiao, SH; Huang, CC; Lin, SZ; Lin, JJ				Su, Hong-Lin; Lin, Siou-Hong; Wei, Jiun-Chiou; Pao, I-Chuan; Chiao, Shu-Her; Huang, Chieh-Chen; Lin, Shinn-Zong; Lin, Jiang-Jen			Novel Nanohybrids of Silver Particles on Clay Platelets for Inhibiting Silver-Resistant Bacteria	PLOS ONE			English	Article							ANTIBACTERIAL PROPERTIES; ESCHERICHIA-COLI; NANOPARTICLES; TOXICITY; MECHANISM	We develop a novel nanohybrid showing a strong antibacterial activity on all of the tested pathogens, including methicillin-resistant Staphylococcus auerus and silver-resistant E. coli. The nanohybrid consists of silver nanoparticles (AgNPs) supported on 1 nm-thick silicate platelets (NSPs). The AgNP/NSP nanohybrid enables to encapsulate bacteria and triggers death signals from the cell membrane. The geographic shape of the NSPs concentrates AgNPs but impedes their penetration into attached cells, mitigating the detrimental effect of silver ion deposition in applied tissues. Moreover, the tightly tethered AgNPs on NSP surface achieve a stronger biocidal effect than silver nitrate, but bypassing Ag+ mechanism, on silver-resistant bacteria. This nanohybrid presents an effective and safe antimicrobial agent in a new perspective.	[Su, Hong-Lin; Lin, Siou-Hong; Pao, I-Chuan; Chiao, Shu-Her; Huang, Chieh-Chen] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Wei, Jiun-Chiou; Lin, Jiang-Jen] Natl Chung Hsing Univ, Dept Mat Sci & Engn, Taichung 40227, Taiwan; [Su, Hong-Lin] China Med Univ, Dept Phys Therapy, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ, Dept Immunol, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ & Hosp, Ctr Neuropsychiat, Taichung, Taiwan; [Lin, Shinn-Zong] China Med Univ Beigang Hosp, Yunlin, Taiwan; [Lin, Jiang-Jen] Natl Taiwan Univ, Inst Polymer Sci & Engn, Taipei 10764, Taiwan	National Chung Hsing University; National Chung Hsing University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Taiwan University	Su, HL (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	suhonglin@gmail.com; jianglin@ntu.edu.tw	Lin, Shinn-Zong/AAX-2379-2020; Huang, Chieh Chen/GMX-4191-2022	Huang, Chieh Chen/0000-0002-3739-6315; LIN, JIANG-JEN/0000-0002-8704-9653	National Science Council [NSC 99-2120-M-002-010]; Taiwan Department of Health Clinical Trial and Research Center of Excellence in Taiwan [DOH100-TD-B-111-004]	National Science Council(Ministry of Science and Technology, Taiwan); Taiwan Department of Health Clinical Trial and Research Center of Excellence in Taiwan	The funding for this project was provided by the National Science Council (NSC 99-2120-M-002-010 to HLS and JJL) and supported in part by Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH100-TD-B-111-004 to SZL) in Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Lail NI, 2003, ENVIRON SCI TECHNOL, V37, P2173, DOI 10.1021/es026159o; Alexandre M, 2000, MAT SCI ENG R, V28, P1, DOI 10.1016/S0927-796X(00)00012-7; Baker C, 2005, J NANOSCI NANOTECHNO, V5, P244, DOI 10.1166/jnn.2005.034; Ben Amor K, 2002, APPL ENVIRON MICROB, V68, P5209, DOI 10.1128/AEM.68.11.5209-5216.2002; Epand RF, 2008, J MOL BIOL, V379, P38, DOI 10.1016/j.jmb.2008.03.047; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Gunawan C, 2009, SMALL, V5, P341, DOI 10.1002/smll.200801202; Gupta A, 1999, NAT MED, V5, P183, DOI 10.1038/5545; Hammer MU, 2010, BIOCHEM J, V427, P477, DOI 10.1042/BJ20091607; Helmy AK, 1999, J COLLOID INTERF SCI, V210, P167, DOI 10.1006/jcis.1998.5930; Hsu SH, 2010, BIOMATERIALS, V31, P6796, DOI 10.1016/j.biomaterials.2010.05.015; Hsu SH, 2009, ACS APPL MATER INTER, V1, P2556, DOI 10.1021/am900479q; Jung WK, 2008, APPL ENVIRON MICROB, V74, P2171, DOI 10.1128/AEM.02001-07; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; KREIBIG U, 1969, Z PHYS, V224, P307, DOI 10.1007/BF01393059; Lee D, 2005, LANGMUIR, V21, P9651, DOI 10.1021/la0513306; Li PR, 2010, ACS APPL MATER INTER, V2, P1608, DOI 10.1021/am1001162; Liu J, 2007, COLLOID SURFACE A, V302, P276, DOI 10.1016/j.colsurfa.2007.02.040; Liu JY, 2010, ACS NANO, V4, P6903, DOI 10.1021/nn102272n; Liu W, 2010, NANOTOXICOLOGY, V4, P319, DOI 10.3109/17435390.2010.483745; Lok CN, 2007, J BIOL INORG CHEM, V12, P527, DOI 10.1007/s00775-007-0208-z; Martinez-Gutierrez F, 2010, NANOMED-NANOTECHNOL, V6, P681, DOI 10.1016/j.nano.2010.02.001; Mironova R, 2001, MOL MICROBIOL, V39, P1061, DOI 10.1046/j.1365-2958.2001.02304.x; Miyoshi H, 2010, J COLLOID INTERF SCI, V345, P433, DOI 10.1016/j.jcis.2010.01.034; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; ROSS D, 1988, PHARMACOL THERAPEUT, V37, P231, DOI 10.1016/0163-7258(88)90027-7; SAMBERG ME, 2010, NANOTOXICOLOGY, DOI DOI 10.3109/17435390.17432010.17525669; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Su HL, 2009, BIOMATERIALS, V30, P5979, DOI 10.1016/j.biomaterials.2009.07.030; Wei LN, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/044103; Wigginton NS, 2010, ENVIRON SCI TECHNOL, V44, P2163, DOI 10.1021/es903187s; Wong MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010394; Woods EJ, 2009, VET MICROBIOL, V138, P325, DOI 10.1016/j.vetmic.2009.03.023	36	60	60	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21125	10.1371/journal.pone.0021125	http://dx.doi.org/10.1371/journal.pone.0021125			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695045	Green Published, Green Submitted, gold			2022-12-25	WOS:000291737600044
J	Crespo, AC; Dominguez, JM; Barreiro, A; Gomez-Gesteira, M; Rogers, BD				Crespo, Alejandro C.; Dominguez, Jose M.; Barreiro, Anxo; Gomez-Gesteira, Moncho; Rogers, Benedict D.			GPUs, a New Tool of Acceleration in CFD: Efficiency and Reliability on Smoothed Particle Hydrodynamics Methods	PLOS ONE			English	Article							FREE-SURFACE FLOWS; WAVE IMPACT; SPH; SIMULATION; MODELS	Smoothed Particle Hydrodynamics (SPH) is a numerical method commonly used in Computational Fluid Dynamics (CFD) to simulate complex free-surface flows. Simulations with this mesh-free particle method far exceed the capacity of a single processor. In this paper, as part of a dual-functioning code for either central processing units (CPUs) or Graphics Processor Units (GPUs), a parallelisation using GPUs is presented. The GPU parallelisation technique uses the Compute Unified Device Architecture (CUDA) of nVidia devices. Simulations with more than one million particles on a single GPU card exhibit speedups of up to two orders of magnitude over using a single-core CPU. It is demonstrated that the code achieves different speedups with different CUDA-enabled GPUs. The numerical behaviour of the SPH code is validated with a standard benchmark test case of dam break flow impacting on an obstacle where good agreement with the experimental results is observed. Both the achieved speed-ups and the quantitative agreement with experiments suggest that CUDA-based GPU programming can be used in SPH methods with efficiency and reliability.	[Crespo, Alejandro C.; Dominguez, Jose M.; Barreiro, Anxo; Gomez-Gesteira, Moncho] Univ Vigo, EPHYSLAB Environm Phys Lab, Orense, Spain; [Rogers, Benedict D.] Univ Manchester, Sch Mech Aerosp & Civil Engn, Manchester, Lancs, England	Universidade de Vigo; University of Manchester	Crespo, AC (corresponding author), Univ Vigo, EPHYSLAB Environm Phys Lab, Orense, Spain.	alexbexe@uvigo.es	Rogers, Benedict D./E-1365-2011; Domínguez, José M./N-2219-2014; C. Crespo, Alejandro J./G-9948-2015; Gesteira, Moncho Gomez/R-9431-2019	Rogers, Benedict D./0000-0002-3269-7979; Domínguez, José M./0000-0002-2586-5081; C. Crespo, Alejandro J./0000-0003-3384-5061; Gesteira, Moncho Gomez/0000-0002-0661-9731; Barreiro, Anxo/0000-0002-8563-9334	Xunta de Galicia; Commission of the European Communities [MTKI-CT-2006-042350]	Xunta de Galicia(Xunta de GaliciaEuropean Commission); Commission of the European Communities(European Commission)	This work was partially supported by Xunta de Galicia under project Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Xunta de Galicia). The authors would also like to acknowledge the ESPHI (A European Smooth Particle Hydrodynamics Initiative) project supported by the Commission of the European Communities (Marie Curie Actions, contract number MTKI-CT-2006-042350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batchelor G.K., 1974, INTRO FLUID DYNAMICS; Belytschko T, 1998, INT J NUMER METH ENG, V43, P785, DOI 10.1002/(SICI)1097-0207(19981115)43:5<785::AID-NME420>3.0.CO;2-9; Gomez-Collado MC, 2010, J INEQUAL APPL, DOI [10.1155/2010/253690, 10.1080/00221686.2010.9641242]; Colagrossi A, 2003, J COMPUT PHYS, V191, P448, DOI 10.1016/S0021-9991(03)00324-3; Crespo AJC, 2008, J WATERW PORT COAST, V134, P313, DOI 10.1061/(ASCE)0733-950X(2008)134:6(313); Crespo AJC, 2008, J MARINE SYST, V72, P135, DOI 10.1016/j.jmarsys.2007.05.018; Crespo AJC, 2007, J HYDRAUL RES, V45, P631, DOI 10.1080/00221686.2007.9521799; Crespo AJC, 2007, CMC-COMPUT MATER CON, V5, P173; Crespo A. J. C., 2010, P 5 INT SPHERIC WORK, P401; Crespo AJC, 2009, P 4 INT SPHERIC WORK, P69; Dalrymple RA, 2006, COAST ENG, V53, P141, DOI 10.1016/j.coastaleng.2005.10.004; Dilts GA, 1999, INT J NUMER METH ENG, V44, P1115, DOI 10.1002/(SICI)1097-0207(19990320)44:8<1115::AID-NME547>3.0.CO;2-L; Dominguez JM, 2011, INT J NUMER METH FL, V67, P2026, DOI 10.1002/fld.2481; GINGOLD RA, 1977, MON NOT R ASTRON SOC, V181, P375, DOI 10.1093/mnras/181.3.375; Gomez-Gesteira M, 2005, OCEAN ENG, V32, P223, DOI 10.1016/j.oceaneng.2004.08.003; Gomez-Gesteira M, 2004, J WATERW PORT COAST, V130, P63, DOI 10.1061/(ASCE)0733-950X(2004)130:2(63); Gomez-Gesteira M, USER GUIDE SPHYSICS; Harada T., 2007, COMPUT GRAPH INT, P63; Herault A, 2009, P 4 INT SPHERIC WORK, P77; Herault A, 2010, J HYDRAUL RES, V48, P74, DOI 10.1080/00221686.2010.9641247; Hughes JP, 2010, J HYDRAUL RES, V48, P105, DOI 10.1080/00221686.2010.9641251; Kleefsman KMT, 2005, J COMPUT PHYS, V206, P363, DOI 10.1016/j.jcp.2004.12.007; Lee ES, 2008, J COMPUT PHYS, V227, P8417, DOI 10.1016/j.jcp.2008.06.005; Lee ES, 2010, J HYDRAUL RES, V48, P50, DOI 10.1080/00221686.2010.9641245; LIBERSKY LD, 1993, J COMPUT PHYS, V109, P67, DOI 10.1006/jcph.1993.1199; Liu GR, 2003, SMOOTHED PARTICLE HY, DOI DOI 10.1142/9789812564405; Lopez D, 2010, J HYDRAUL RES, V48, P142, DOI 10.1080/00221686.2010.9641255; LUCY LB, 1977, ASTRON J, V82, P1013, DOI 10.1086/112164; Maruzewski P, 2010, J HYDRAUL RES, V48, P126, DOI 10.1080/00221686.2010.9641253; Monaghan JJ, 2009, COMPUT PHYS COMMUN, V180, P1811, DOI 10.1016/j.cpc.2009.05.008; MONAGHAN JJ, 1992, ANNU REV ASTRON ASTR, V30, P543, DOI 10.1146/annurev.aa.30.090192.002551; MONAGHAN JJ, 1989, J COMPUT PHYS, V82, P1, DOI 10.1016/0021-9991(89)90032-6; MONAGHAN JJ, 1994, J COMPUT PHYS, V110, P399, DOI 10.1006/jcph.1994.1034; MONAGHAN JJ, 1985, ASTRON ASTROPHYS, V149, P135; Monaghan JJ, 1999, J WATERW PORT C-ASCE, V125, P145, DOI 10.1061/(ASCE)0733-950X(1999)125:3(145); Morris JP, 1997, J COMPUT PHYS, V136, P214, DOI 10.1006/jcph.1997.5776; Moulinec C, 2008, CMES, V1, P11; Randles PW, 1996, COMPUT METHOD APPL M, V139, P375, DOI 10.1016/S0045-7825(96)01090-0; Robinson M, 2009, TURBULENCE VISCOUS M; Rogers BD, 2010, J HYDRAUL RES, V48, P135, DOI 10.1080/00221686.2010.9641254; Rossinelli D, 2010, J COMPUT PHYS, V229, P3316, DOI 10.1016/j.jcp.2010.01.004; Vacondio R, 2011, INT J NUMER IN PRESS; VERLET L, 1967, PHYS REV, V159, P98, DOI 10.1103/PhysRev.159.98; Violeau D, 2007, INT J NUMER METH FL, V53, P277, DOI 10.1002/fld.1292; Wendland H., 1995, Advances in Computational Mathematics, V4, P389, DOI 10.1007/BF02123482; Xu R, 2009, J COMPUT PHYS, V228, P6703, DOI 10.1016/j.jcp.2009.05.032	46	149	156	5	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20685	10.1371/journal.pone.0020685	http://dx.doi.org/10.1371/journal.pone.0020685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695185	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300009
J	Huang, X; Nolte, I; Gao, ZF; Vos, H; Hepkema, B; Poppema, S; van den Berg, A; Diepstra, A				Huang, Xin; Nolte, Ilja; Gao, Zifen; Vos, Hans; Hepkema, Bouke; Poppema, Sibrand; van den Berg, Anke; Diepstra, Arjan			Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; DISEASE; INFECTION; POPULATION; TAIWAN; ADULT; EBV; EXPRESSION; SUBTYPE; BRAZIL	Background: The incidence of classical Hodgkin lymphoma (cHL) and its association with Epstein-Barr virus (EBV) varies significantly with age, sex, ethnicity and geographic location. This is the first report on epidemiological features of cHL patients from Northern regions of China. These features are compared to data from a previously published Dutch cHL population. Methodology/Principal Findings: 157 cHL patients diagnosed between 1997 and 2008 in the North of China were included after histopathological re-evaluation. The Dutch population-based cohort consisted of 515 cHL patients diagnosed between 1987 and 2000. EBV status was determined by in situ hybridization of EBV-encoded small RNAs. In the Chinese population, tumor cells of 39% of the cHL patients were EBV+ and this was significantly associated with male sex, mixed cellularity subtype and young age (<20 y). The median age of the Chinese patients was 9 years younger than that of the Dutch patients (28 y vs. 37 y). In addition, the age distribution between the two populations was strikingly different in both the EBV+ subgroups (p<0.001) and the EBV-subgroups (p = 0.01). The mixed cellularity subtype was almost 3x more frequent amongst the Chinese (p<0.001). Conclusion/Significance: CHL patients from Northern regions of China show a distinctive age distribution pattern with a striking incidence peak of EBV+ mixed cellularity cases among children and adolescents and another high incidence peak of EBV-nodular sclerosis cases in young adults. In comparison to Dutch cHL patients there are pronounced differences in age distribution, subtype and EBV status, presumably caused by complex gene-environmental interactions.	[Huang, Xin; Vos, Hans; Poppema, Sibrand; van den Berg, Anke; Diepstra, Arjan] Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands; [Huang, Xin; Gao, Zifen] Peking Univ, Hlth Sci Ctr, Dept Pathol, Beijing 100871, Peoples R China; [Nolte, Ilja] Univ Groningen, Dept Epidemiol, Univ Med Ctr Groningen, Unit Genet Epidemiol & Bioinformat, Groningen, Netherlands; [Hepkema, Bouke] Univ Groningen, Dept Lab Med, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; Peking University; University of Groningen; University of Groningen	Huang, X (corresponding author), Univ Groningen, Dept Pathol & Med Biol, Univ Med Ctr Groningen, Groningen, Netherlands.	a.diepstra@path.umcg.nl	van den Berg, Anke/H-1718-2011; Poppema, Sibrand/D-1204-2012	van den Berg, Anke/0000-0002-8894-2638; Diepstra, Arjan/0000-0001-9239-1050	Bernoulli bursary; University Medical Center Groningen; Dutch Cancer Society [KWF: RUG 2009-4313]	Bernoulli bursary; University Medical Center Groningen; Dutch Cancer Society(KWF Kankerbestrijding)	This work is supported by a Bernoulli bursary, University Medical Center Groningen and by a grant from the Dutch Cancer Society (KWF: RUG 2009-4313). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Salam S, 2008, LEUKEMIA LYMPHOMA, V49, P1769, DOI 10.1080/10428190802270894; Araujo I, 2006, VIRCHOWS ARCH, V449, P315, DOI 10.1007/s00428-006-0244-z; Armstrong AA, 1998, LEUKEMIA, V12, P1272, DOI 10.1038/sj.leu.2401097; Au WY, 2004, ANN ONCOL, V15, P626, DOI 10.1093/annonc/mdh132; Belgaumi A, 2008, LEUKEMIA LYMPHOMA, V49, P910, DOI 10.1080/10428190801947492; Cartwright RA, 2004, HEMATOL ONCOL, V22, P11, DOI 10.1002/hon.723; CHAN JKC, 1995, HUM PATHOL, V26, P314, DOI 10.1016/0046-8177(95)90064-0; De Matteo E, 2003, ARCH PATHOL LAB MED, V127, P1325; de Oliveira DE, 2002, AM J CLIN PATHOL, V118, P25; Diepstra A, 2009, J CLIN ONCOL, V27, P3815, DOI 10.1200/JCO.2008.20.5138; Flavell KJ, 2000, J CLIN PATHOL-MOL PA, V53, P262, DOI 10.1136/mp.53.5.219; Gandhi MK, 2004, BRIT J HAEMATOL, V125, P267, DOI 10.1111/j.1365-2141.2004.04902.x; Glaser SL, 2002, LEUKEMIA RES, V26, P261, DOI 10.1016/S0145-2126(01)00126-6; GULLEY ML, 1994, BLOOD, V83, P1595; Huang X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010865; Huh J, 1996, CANCER, V77, P949, DOI 10.1002/(SICI)1097-0142(19960301)77:5<949::AID-CNCR22>3.0.CO;2-2; Jarrett AF, 1996, ANN ONCOL, V7, P5; JARRETT RF, 1991, J CLIN PATHOL, V44, P844, DOI 10.1136/jcp.44.10.844; Jarrett RF, 2003, J CLIN PATHOL, V56, P811, DOI 10.1136/jcp.56.11.811; Jarrett RF, 2002, ANN ONCOL, V13, P23, DOI 10.1093/annonc/13.S1.23; Kapatai G, 2007, J CLIN PATHOL, V60, P1342, DOI 10.1136/jcp.2007.050146; Lee MY, 2005, CLIN LAB HAEMATOL, V27, P379, DOI 10.1111/j.1365-2257.2005.00736.x; LIANG R, 1989, HEMATOL ONCOL, V7, P395, DOI 10.1002/hon.2900070602; Liu SM, 1998, CANCER-AM CANCER SOC, V83, P367, DOI 10.1002/(SICI)1097-0142(19980715)83:2<367::AID-CNCR22>3.0.CO;2-Q; MACMAHON B, 1957, CANCER-AM CANCER SOC, V10, P1045, DOI 10.1002/1097-0142(195709/10)10:5<1045::AID-CNCR2820100527>3.0.CO;2-0; Nakatsuka S, 2006, INT J HEMATOL, V83, P391, DOI 10.1532/IJH97.05184; Stein H, 2008, WHO CLASSIFICATION T, V2, P321; Weinreb M, 1996, ARCH DIS CHILD, V74, P27, DOI 10.1136/adc.74.1.27; Wu SJ, 2008, J FORMOS MED ASSOC, V107, P4, DOI 10.1016/S0929-6646(08)60002-9; ZARATEOSORNO A, 1995, CANCER-AM CANCER SOC, V75, P1360, DOI 10.1002/1097-0142(19950315)75:6<1360::AID-CNCR2820750619>3.0.CO;2-U; ZHOU XG, 1993, INT J CANCER, V55, P359, DOI 10.1002/ijc.2910550303	31	18	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21152	10.1371/journal.pone.0021152	http://dx.doi.org/10.1371/journal.pone.0021152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695175	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612600047
J	Wang, OC; Liu, SJ; Zou, JW; Lu, LT; Chen, L; Qiu, SQ; Li, H; Lu, XC				Wang, Ouchen; Liu, Sujun; Zou, Jiawei; Lu, Liting; Chen, Lin; Qiu, Sunquan; Li, He; Lu, Xincheng			Anticancer Activity of 2 alpha, 3 alpha, 19 beta, 23 beta-Tetrahydroxyurs-12-en-28-oic Acid THA), a Novel Triterpenoid Isolated from Sinojackia sarcocarpa	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; STYRAX-JAPONICA; URSOLIC ACID; STEM-BARK; SYNTHETIC TRITERPENOIDS; DRUG DISCOVERY; CYTOCHROME-C; APOPTOSIS; ACTIVATION; BCL-2	Background: Natural products represent an important source for agents of cancer prevention and cancer treatment. More than 60% of conventional anticancer drugs are derived from natural sources, particularly from plant-derived materials. In this study, 2 alpha, 3 alpha, 19 beta, 23 beta-tetrahydroxyurs-12-en-28-oic acid (THA), a novel triterpenoid from the leaves of Sinojackia sarcocarpa, was isolated, and its anticancer activity was investigated both in vitro and in vivo. Principal Findings: THA possessed potent tumor selected toxicity in vitro. It exhibited significantly higher cytotoxicity to the cancer cell lines A2780 and HepG2 than to IOSE144 and QSG7701, two noncancerous cell lines derived from ovary epithelium and liver, respectively. Moreover, THA showed a dose-dependent inhibitory effect on A2780 ovary tumor growth in vivo in nude mice. THA induced a dose-dependent apoptosis and G2/M cell cycle arrest in A2780 and HepG2 cells. The THA-induced cell cycle arrest was accompanied by a downregulation of Cdc2. The apoptosis induced by THA was evident by induction of DNA fragmentation, release of cytoplasmic Cytochrome c from mitochondria, activation of caspases, downregulation of Bcl-2 and upregulation of Bax. Conclusion: The primary data indicated that THA exhibit a high toxicity toward two cancer cells than their respective noncancerous counterparts and has a significant anticancer activity both in vitro and in vivo. Thus, THA and/or its derivatives may have great potential in the prevention and treatment of human ovary tumors and other malignancies.	[Wang, Ouchen; Zou, Jiawei; Lu, Liting; Chen, Lin; Qiu, Sunquan; Lu, Xincheng] Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China; [Wang, Ouchen; Li, He] Wenzhou Med Coll, Affiliated Hosp 1, Wenzhou, Peoples R China; [Liu, Sujun] Leshan Normal Univ, Leshan, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Leshan Normal University	Wang, OC (corresponding author), Wenzhou Med Coll, Inst Genom Med, Wenzhou, Peoples R China.	xinchenglu@yahoo.com			Wenzhou Medical College [A890001]; Leshan Normal University [Z07033]	Wenzhou Medical College; Leshan Normal University	This work was supported by The Initiation Funds for Talent of Wenzhou Medical College (A890001) and the Fellowship for Young Teacher's of Leshan Normal University (Z07033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balunas MJ, 2005, LIFE SCI, V78, P431, DOI 10.1016/j.lfs.2005.09.012; Chen T, 2009, J CELL MOL MED, V13, P1358, DOI 10.1111/j.1582-4934.2008.00360.x; Cragg GM, 2005, J ETHNOPHARMACOL, V100, P72, DOI 10.1016/j.jep.2005.05.011; Glinsky VV, 2009, NEOPLASIA, V11, P901, DOI 10.1593/neo.09594; Harmand PO, 2003, INT J ONCOL, V23, P105; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hyer ML, 2008, CANCER RES, V68, P2927, DOI 10.1158/0008-5472.CAN-07-5759; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Ikeda Y, 2008, MOL NUTR FOOD RES, V52, P26, DOI 10.1002/mnfr.200700389; Itokawa H, 2008, J NAT MED-TOKYO, V62, P263, DOI 10.1007/s11418-008-0246-z; Kassi E, 2007, J CANCER RES CLIN, V133, P493, DOI 10.1007/s00432-007-0193-1; Kassi E, 2009, CANCER INVEST, V27, P723, DOI 10.1080/07357900802672712; Kim MR, 2004, ARCH PHARM RES, V27, P283, DOI 10.1007/BF02980060; Kinghorn AD, 2009, PURE APPL CHEM, V81, P1051, DOI 10.1351/PAC-CON-08-10-16; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; Kwon JH, 2008, PHYTOTHER RES, V22, P1303, DOI 10.1002/ptr.2484; Martin R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005975; Min BS, 2004, PLANTA MED, V70, P1210, DOI 10.1055/s-2004-835853; Min LS, 2004, J NAT PROD, V67, P1980, DOI 10.1021/np040113m; Moon HI, 2005, BIOL PHARM BULL, V28, P2003, DOI 10.1248/bpb.28.2003; Motwani M, 2001, CLIN CANCER RES, V7, P4209; Ovesna Z, 2004, NEOPLASMA, V51, P327; Petronelli A, 2009, ANTI-CANCER DRUG, V20, P880, DOI 10.1097/CAD.0b013e328330fd90; Reyes FJ, 2006, FEBS LETT, V580, P6302, DOI 10.1016/j.febslet.2006.10.038; Saklani A, 2008, DRUG DISCOV TODAY, V13, P161, DOI 10.1016/j.drudis.2007.10.010; Salminen A, 2008, CELL MOL LIFE SCI, V65, P2979, DOI 10.1007/s00018-008-8103-5; Setzer WN, 2003, MINI-REV MED CHEM, V3, P540, DOI 10.2174/1389557033487854; Siripong P, 2009, BIOL PHARM BULL, V32, P1251, DOI 10.1248/bpb.32.1251; Sogno I, 2009, RECENT RESULTS CANC, V181, P209; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Subbaramaiah K, 2000, CANCER RES, V60, P2399; Wang F, 2006, J NAT PROD, V69, P807, DOI 10.1021/np050371z; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yao XH, 2008, ANN BOT-LONDON, V101, P651, DOI 10.1093/aob/mcm332; Yun KJ, 2007, BIOL PHARM BULL, V30, P139, DOI 10.1248/bpb.30.139; Zhang YX, 2010, J CELL BIOCHEM, V109, P764, DOI 10.1002/jcb.22455	36	11	12	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e21130	10.1371/journal.pone.0021130	http://dx.doi.org/10.1371/journal.pone.0021130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695177	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612600046
J	Sypsa, V; Bonovas, S; Tsiodras, S; Baka, A; Efstathiou, P; Malliori, M; Panagiotopoulos, T; Nikolakopoulos, I; Hatzakis, A				Sypsa, Vana; Bonovas, Stefanos; Tsiodras, Sotirios; Baka, Agoritsa; Efstathiou, Panos; Malliori, Meni; Panagiotopoulos, Takis; Nikolakopoulos, Ilias; Hatzakis, Angelos			Estimating the Disease Burden of 2009 Pandemic Influenza A(H1N1) from Surveillance and Household Surveys in Greece	PLOS ONE			English	Article							A H1N1; INFECTION; MORTALITY; SEVERITY; FEATURES; ENGLAND; ILLNESS; VIRUS; AGE	Background: The aim of this study was to assess the disease burden of the 2009 pandemic influenza A(H1N1) in Greece. Methodology/Principal Findings: Data on influenza-like illness (ILI), collected through cross-sectional nationwide telephone surveys of 1,000 households in Greece repeated for 25 consecutive weeks, were combined with data from H1N1 virologic surveillance to estimate the incidence and the clinical attack rate (CAR) of influenza A(H1N1). Alternative definitions of ILI (cough or sore throat and fever>38 degrees C [ILI-38] or fever 37.1-38 degrees C [ILI-37]) were used to estimate the number of symptomatic infections. The infection attack rate (IAR) was approximated using estimates from published studies on the frequency of fever in infected individuals. Data on H1N1 morbidity and mortality were used to estimate ICU admission and case fatality (CFR) rates. The epidemic peaked on week 48/2009 with approximately 750-1,500 new cases/100,000 population per week, depending on ILI-38 or ILI-37 case definition, respectively. By week 6/2010, 7.1%-15.6% of the population in Greece was estimated to be symptomatically infected with H1N1. Children 5-19 years represented the most affected population group (CAR: 27%-54%), whereas individuals older than 64 years were the least affected (CAR:0.6%-2.2%). The IAR (95% CI) of influenza A(H1N1) was estimated to be 19.7% (13.3%, 26.1%). Per 1,000 symptomatic cases, based on ILI-38 case definition, 416 attended health services, 108 visited hospital emergency departments and 15 were admitted to hospitals. ICU admission rate and CFR were 37 and 17.5 per 100,000 symptomatic cases or 13.4 and 6.3 per 100,000 infections, respectively. Conclusions/Significance: Influenza A(H1N1) infected one fifth and caused symptomatic infection in up to 15% of the Greek population. Although individuals older than 65 years were the least affected age group in terms of attack rate, they had 55 and 185 times higher risk of ICU admission and CFR, respectively.	[Sypsa, Vana; Malliori, Meni; Nikolakopoulos, Ilias; Hatzakis, Angelos] Univ Athens, Athens 11528, Greece; [Bonovas, Stefanos; Tsiodras, Sotirios; Panagiotopoulos, Takis] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Baka, Agoritsa; Efstathiou, Panos] Minist Hlth & Social Solidar, Natl Hlth Operat Ctr, Athens, Greece	National & Kapodistrian University of Athens	Sypsa, V (corresponding author), Univ Athens, Athens 11528, Greece.	ahatzak@med.uoa.gr	Bonovas, Stefanos/H-5653-2011; TSIODRAS, SOTIRIOS/AAD-8273-2019; Bonovas, Stefanos/GZG-4609-2022	TSIODRAS, SOTIRIOS/0000-0002-0463-4321; SYPSA, VANA/0000-0002-9430-7614; Bonovas, Stefanos/0000-0001-6102-6579	Hellenic Centre for Diseases Control and Prevention; National and Kapodistrian University of Athens	Hellenic Centre for Diseases Control and Prevention; National and Kapodistrian University of Athens	Work was funded by Hellenic Centre for Diseases Control and Prevention; and National and Kapodistrian University of Athens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera JF, 2003, EUR J EPIDEMIOL, V18, P751, DOI 10.1023/A:1025337616327; Bandaranayake D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013211; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Carrat F, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-301; CDC, 2019, 2009 H1N1 PAND H1N1P; CDC, 2010, CDC EST 2009 H1N1 IN; Collins SD, 1931, PUBLIC HEALTH REP, V46, P1909, DOI 10.2307/4580139; Cutter JL, 2010, ANN ACAD MED SINGAP, V39, P273; D'Ortenzio E, 2010, CLIN MICROBIOL INFEC, V16, P309, DOI 10.1111/j.1469-0691.2010.03171.x; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; Donaldson LJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5213; *ECDC, 2010, ECDC SPEC; Efstathiou P., 2010, Morbidity and Mortality Weekly Report, V59, P682; Ellis J, 2009, EUROSURVEILLANCE, V14; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Hadler JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011677; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; JORDAN WS, 1958, AM J HYG, V68, P190, DOI 10.1093/oxfordjournals.aje.a119962; KLOOSTER T, 2010, EURO SURVEILL, V15; Lau JTF, 2009, BRIT MED J, V338, pb4164, DOI DOI 10.1136/bmj.b4164; Lipsitch M, 2009, LANCET, V374, P1209, DOI 10.1016/S0140-6736(09)61377-5; Malone JL, 2008, EMERG INFECT DIS, V14, P129, DOI 10.3201/eid1401.070265; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; *NEW S WAL PUBL HL, 2009, EURO SURVEILL, V14; Payne L, 2005, Euro Surveill, V10, P241; Pebody RG, 2010, EUROSURVEILLANCE, V15; Presanis AM, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000207; President's Council of Advisors on Science and Technology, 2009, REP PRES US PREP 200; Reed C, 2009, EMERG INFECT DIS, V15, P2004, DOI 10.3201/eid1512.091413; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Sypsa V, 2009, EUROSURVEILLANCE, V14; TSIODRAS S, 2010, EURO SURVEILL, V15; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; VIBOUD C, 2010, PLOS CURR INFLUENZA; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wilson N, 2009, EUROSURVEILLANCE, V14; Wu JT, 2010, CLIN INFECT DIS, V51, P1184, DOI 10.1086/656740	38	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20593	10.1371/journal.pone.0020593	http://dx.doi.org/10.1371/journal.pone.0020593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694769	Green Submitted, Green Published, gold			2022-12-25	WOS:000291612900016
J	Holt, BG; Cote, IM; Emerson, BC				Holt, Ben G.; Cote, Isabelle M.; Emerson, Brent C.			Searching for Speciation Genes: Molecular Evidence for Selection Associated with Colour Morphotypes in the Caribbean Reef Fish Genus Hypoplectrus	PLOS ONE			English	Article							HAMLETS HYPOPLECTRUS; POPULATION-STRUCTURE; MARINE-SPECIATION; SPECIES COMPLEX; GENOME-SCAN; AFLP; DIFFERENTIATION; POLYMORPHISM; DIVERGENCE; SERRANIDAE	Closely related species that show clear phenotypic divergence, but without obvious geographic barriers, can provide opportunities to study how diversification can occur when opportunities for allopatric speciation are limited. We examined genetic divergence in the coral reef fish genus Hypoplectrus (family: Serranidae), which comprises of 10-14 morphotypes that are distinguished solely by their distinct colour patterns, but which show little genetic differentiation. Our goal was to detect loci that show clear disequilibrium between morphotypes and across geographical locations. We conducted Amplified Fragment Length Polymorphism molecular analysis to quantify genetic differentiation among, and selection between, morphotypes. Three loci were consistently divergent beyond neutral expectations in repeated pair-wise morphotype comparisons using two different methods. These loci provide the first evidence for genes that may be associated with colour morphotype in the genus Hypoplectrus.	[Holt, Ben G.] Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark; [Holt, Ben G.; Emerson, Brent C.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [Cote, Isabelle M.] Simon Fraser Univ, Dept Biol Sci, Burnaby, BC V5A 1S6, Canada; [Emerson, Brent C.] IPNA CSIC, Isl Ecol & Evolut Res Grp, Tenerife, Canary Islands, Spain	University of Copenhagen; University of East Anglia; Simon Fraser University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Naturales y Agrobiologia (IPNA)	Holt, BG (corresponding author), Univ Copenhagen, Dept Biol, Ctr Macroecol Evolut & Climate, Copenhagen, Denmark.	bholt@bio.ku.dk	Cote, Isabelle/ABD-5898-2021	Holt, Ben G./0000-0003-0831-9684; Emerson, Brent/0000-0003-4067-9858	National Environment Research Council [S NER/SJ2004/13064, EK76-02/05]; SMGF; Sydney L. Wright Fellowship; NERC [NBAF010001] Funding Source: UKRI; Natural Environment Research Council [NBAF010001] Funding Source: researchfish	National Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); SMGF; Sydney L. Wright Fellowship; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by the National Environment Research Council (studentship S NER/SJ2004/13064 and LSMSF application no. EK76-02/05), with the additional funding by SMGF and the Sydney L. Wright Fellowship (contribution number 1700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2004, J EVOLUTION BIOL, V17, P1238, DOI 10.1111/j.1420-9101.2004.00788.x; Barreto FS, 2008, EVOLUTION, V62, P226, DOI 10.1111/j.1558-5646.2007.00285.x; Beaumont MA, 2004, MOL ECOL, V13, P969, DOI 10.1111/j.1365-294X.2004.02125.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bierne N, 2003, P ROY SOC B-BIOL SCI, V270, P1399, DOI 10.1098/rspb.2003.2404; Coyne JA, 2007, CURR BIOL, V17, pR787, DOI 10.1016/j.cub.2007.06.056; DOMEIER ML, 1994, B MAR SCI, V54, P103; FISCHER EA, 1980, COPEIA, P649, DOI 10.2307/1444441; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Garcia-Machado E, 2004, MAR BIOL, V144, P147, DOI 10.1007/s00227-003-1174-9; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; Holt BG, 2010, GLOBAL ECOL BIOGEOGR, V19, P432, DOI 10.1111/j.1466-8238.2010.00539.x; Holt BG, 2008, MAR ECOL PROG SER, V357, P283, DOI 10.3354/meps07339; Jonsson B, 2001, J FISH BIOL, V58, P605, DOI 10.1006/jfbi.2000.1515; Magurran AE, 2001, GENETICA, V112, P463, DOI 10.1023/A:1013339822246; McCartney MA, 2003, MOL ECOL, V12, P2963, DOI 10.1046/j.1365-294X.2003.01946.x; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; PALUMBI SR, 1992, TRENDS ECOL EVOL, V7, P114, DOI 10.1016/0169-5347(92)90144-Z; Pierotti MER, 2007, J EVOLUTION BIOL, V20, P240, DOI 10.1111/j.1420-9101.2006.01206.x; Puebla O, 2008, MOL ECOL, V17, P1405, DOI 10.1111/j.1365-294X.2007.03654.x; Puebla O, 2007, P ROY SOC B-BIOL SCI, V274, P1265, DOI 10.1098/rspb.2006.0435; Ramon ML, 2003, MOL ECOL, V12, P2975, DOI 10.1046/j.1365-294X.2003.01966.x; Ryan PG, 2007, SCIENCE, V315, P1420, DOI 10.1126/science.1138829; Sambrook J., 2002, MOL CLONING LAB MANU; VEKEMANS X, 2002, AFLP SURV VERSION 1; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Wilding CS, 2001, J EVOLUTION BIOL, V14, P611, DOI 10.1046/j.1420-9101.2001.00304.x; Wood HM, 2008, MOL ECOL, V17, P3123, DOI 10.1111/j.1365-294X.2008.03755.x; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	30	14	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20394	10.1371/journal.pone.0020394	http://dx.doi.org/10.1371/journal.pone.0020394			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687658	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500020
J	Kummu, M; de Moel, H; Ward, PJ; Varis, O				Kummu, Matti; de Moel, Hans; Ward, Philip J.; Varis, Olli			How Close Do We Live to Water? A Global Analysis of Population Distance to Freshwater Bodies	PLOS ONE			English	Article							WORLD; RESOURCES; LEVEL; MAPS	Traditionally, people have inhabited places with ready access to fresh water. Today, over 50% of the global population lives in urban areas, and water can be directed via tens of kilometres of pipelines. Still, however, a large part of the world's population is directly dependent on access to natural freshwater sources. So how are inhabited places related to the location of freshwater bodies today? We present a high-resolution global analysis of how close present-day populations live to surface freshwater. We aim to increase the understanding of the relationship between inhabited places, distance to surface freshwater bodies, and climatic characteristics in different climate zones and administrative regions. Our results show that over 50% of the world's population lives closer than 3 km to a surface freshwater body, and only 10% of the population lives further than 10 km away. There are, however, remarkable differences between administrative regions and climatic zones. Populations in Australia, Asia, and Europe live closest to water. Although populations in arid zones live furthest away from freshwater bodies in absolute terms, relatively speaking they live closest to water considering the limited number of freshwater bodies in those areas. Population distributions in arid zones show statistically significant relationships with a combination of climatic factors and distance to water, whilst in other zones there is no statistically significant relationship with distance to water. Global studies on development and climate adaptation can benefit from an improved understanding of these relationships between human populations and the distance to fresh water.	[Kummu, Matti; Varis, Olli] Aalto Univ, Water & Dev Res Grp, Espoo, Finland; [de Moel, Hans; Ward, Philip J.] Vrije Univ Amsterdam, Inst Environm Studies, Amsterdam, Netherlands	Aalto University; Vrije Universiteit Amsterdam	Kummu, M (corresponding author), Aalto Univ, Water & Dev Res Grp, Espoo, Finland.	matti.kummu@iki.fi	Varis, Olli/G-6506-2011; de Moel, Hans/L-1311-2013; Kummu, Matti/C-4797-2011; Ward, Philip/E-6208-2010	Varis, Olli/0000-0001-9231-4549; Kummu, Matti/0000-0001-5096-0163; de Moel, Hans/0000-0002-6826-1974; Ward, Philip/0000-0001-7702-7859	Maa- ja vesitekniikan tuki ry; Aalto University; Dutch research programme "Climate changes Spatial Planning"; Dutch research programme "Knowledge for Climate."	Maa- ja vesitekniikan tuki ry; Aalto University; Dutch research programme "Climate changes Spatial Planning"; Dutch research programme "Knowledge for Climate."	This work was funded by the following research grants: Maa- ja vesitekniikan tuki ry, postdoctoral funds of Aalto University, Dutch research programme "Climate changes Spatial Planning" and Dutch research programme "Knowledge for Climate." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcamo J, 2007, HYDROLOG SCI J, V52, P247, DOI 10.1623/hysj.52.2.247; [Anonymous], 2008, WORLD POP PROSP 2008; BISWAS AK, 1970, HIST HYDROLOGY, pR12; Cai XM, 2002, WATER INT, V27, P159, DOI 10.1080/02508060208686989; *CIESIN, 2009, GLOB RUR URB MAPP PR; *CIESIN, 2009, GRIDD POP WORLD GPW; de Fraiture C, 2007, WATER RESOUR MANAG, V21, P185, DOI 10.1007/s11269-006-9048-9; Dettinger MD, 2000, J HYDROMETEOROL, V1, P289, DOI 10.1175/1525-7541(2000)001<0289:GCOSFS>2.0.CO;2; GLEICK PH, WORLDS WATER 2008 20; Goldewijk KK, 2010, HOLOCENE, V20, P565, DOI 10.1177/0959683609356587; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Jarvis A., 2008, EOS T AGU, V89, P93, DOI [DOI 10.1029/2008EO100001, 10.1029/2008EO100001]; Kirshen P., 2007, ADAPTATION OPTIONS C; Kummu M, 2011, APPL GEOGR, V31, P495, DOI 10.1016/j.apgeog.2010.10.009; Kummu M, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034006; *LANDSCAN TM, 2007, GLOB POP DAT 2007; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Luck GW, 2007, BIOL REV, V82, P607, DOI 10.1111/j.1469-185X.2007.00028.x; McCool S.F., 2008, WATER PEOPLE CHALLEN; MCCORRISTON J, 1991, AM ANTHROPOL, V93, P46, DOI 10.1525/aa.1991.93.1.02a00030; NIKULA J, 2008, MODERN MYTHS MEKONG, P27; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Parry ML, 2007, CLIMATE CHANGE 2007; Potere D, 2009, INT J REMOTE SENS, V30, P6531, DOI 10.1080/01431160903121134; Rosegrant M. W., 2002, World water and food to 2025: dealing with scarcity; Rosenzweig C., 2008, CLIMATE CHANGE GLOBA; Rubel F, 2010, METEOROL Z, V19, P135, DOI 10.1127/0941-2948/2010/0430; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Shah T, 2007, AGRICULTURE, P395; Siebert S, 2010, HYDROL EARTH SYST SC, V14, P1863, DOI 10.5194/hess-14-1863-2010; Small C, 2003, J COASTAL RES, V19, P584; SMALL C, 2002, ENV HAZARDS, V3, P93; Trabucco A., 2009, GLOBAL ARIDITY INDEX; *UN, 2000, UN WORLD MACR REG CO; United Nations, 2010, WORLD URB PROSP 2009; *USGS, 2001, RIV WORLD PART GLOB; *USGS, 2001, ADM BOUND PART GLOB; Varis O, 2006, INT J WATER RESOUR D, V22, P377, DOI 10.1080/07900620600684550; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Ward PJ, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/4/044011; Ward PJ, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043215; WHO UNICEF, 2010, PROGR SAN DRINK WAT; World Bank, 2009, WORLD DEV REP 2009; *WORLD DAT BANK 2, 1980, GLOB RIV NETW; Zhou Y, 2005, WATER RESOUR RES, V41, DOI 10.1029/2004WR003749	45	146	146	6	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20578	10.1371/journal.pone.0020578	http://dx.doi.org/10.1371/journal.pone.0020578			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687675	gold, Green Published, Green Submitted			2022-12-25	WOS:000291611500032
J	Kamatkar, NG; Shrout, JD				Kamatkar, Nachiket G.; Shrout, Joshua D.			Surface Hardness Impairment of Quorum Sensing and Swarming for Pseudomonas aeruginosa	PLOS ONE			English	Article							RHAMNOLIPID BIOSURFACTANT SYNTHESIS; GENE-EXPRESSION; TRANSCRIPTOME ANALYSIS; MOTILITY; PAO1; BACTERIA; PROTEIN; GROWTH; AGAR; IDENTIFICATION	The importance of rhamnolipid to swarming of the bacterium Pseudomonas aeruginosa is well established. It is frequently, but not exclusively, observed that P. aeruginosa swarms in tendril patterns-formation of these tendrils requires rhamnolipid. We were interested to explain the impact of surface changes on P. aeruginosa swarm tendril development. Here we report that P. aeruginosa quorum sensing and rhamnolipid production is impaired when growing on harder semisolid surfaces. P. aeruginosa wild-type swarms showed huge variation in tendril formation with small deviations to the "standard'' swarm agar concentration of 0.5%. These macroscopic differences correlated with microscopic investigation of cells close to the advancing swarm edge using fluorescent gene reporters. Tendril swarms showed significant rhlA-gfp reporter expression right up to the advancing edge of swarming cells while swarms without tendrils (grown on harder agar) showed no rhlA-gfp reporter expression near the advancing edge. This difference in rhamnolipid gene expression can be explained by the necessity of quorum sensing for rhamnolipid production. We provide evidence that harder surfaces seem to limit induction of quorum sensing genes near the advancing swarm edge and these localized effects were sufficient to explain the lack of tendril formation on hard agar. We were unable to artificially stimulate rhamnolipid tendril formation with added acyl-homoserine lactone signals or increasing the carbon nutrients. This suggests that quorum sensing on surfaces is controlled in a manner that is not solely population dependent.	[Kamatkar, Nachiket G.; Shrout, Joshua D.] Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA; [Shrout, Joshua D.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Shrout, Joshua D.] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame; University of Notre Dame	Kamatkar, NG (corresponding author), Univ Notre Dame, Dept Civil Engn & Geol Sci, Notre Dame, IN 46556 USA.	joshua.shrout@nd.edu	Shrout, Joshua D/C-4743-2012	Shrout, Joshua D/0000-0001-9509-2187	Indiana Clinical and Translational Science Institute (NIH) [UL1RR025761]; Notre Dame Faculty Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025761] Funding Source: NIH RePORTER	Indiana Clinical and Translational Science Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Notre Dame Faculty Research Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the Indiana Clinical and Translational Science Institute (NIH # UL1RR025761) and the Notre Dame Faculty Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240; Beatson SA, 2002, J BACTERIOL, V184, P3598, DOI 10.1128/KB.184.13.3598-3604.2002; BENJACOB E, 1995, NATURE, V373, P566, DOI 10.1038/373566a0; BIBETTE J, 1992, PHYS REV LETT, V69, P2439, DOI 10.1103/PhysRevLett.69.2439; Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0; Caiazza NC, 2005, J BACTERIOL, V187, P7351, DOI 10.1128/JB.187.21.7351-7361.2005; Chen BG, 2007, J BACTERIOL, V189, P8750, DOI 10.1128/JB.01109-07; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Daniels R, 2004, FEMS MICROBIOL REV, V28, P261, DOI 10.1016/j.femsre.2003.09.004; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Doyle TB, 2004, J BACTERIOL, V186, P6341, DOI 10.1128/JB.186.19.6341-6350.2004; Dulla G, 2008, P NATL ACAD SCI USA, V105, P3082, DOI 10.1073/pnas.0711723105; Fuqua C, 2001, ANNU REV GENET, V35, P439, DOI 10.1146/annurev.genet.35.102401.090913; Glick R, 2010, J BACTERIOL, V192, P2973, DOI 10.1128/JB.01601-09; GRASSI C, 1952, ACTA PATHOL MIC SC, V31, P1; Harshey RM, 2003, ANNU REV MICROBIOL, V57, P249, DOI 10.1146/annurev.micro.57.030502.091014; HENRICHSEN J, 1972, BACTERIOL REV, V36, P478, DOI 10.1128/MMBR.36.4.478-503.1972; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; HISATSUKA KI, 1971, AGR BIOL CHEM TOKYO, V35, P686, DOI 10.1080/00021369.1971.10859987; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900; JARVIS FG, 1949, J AM CHEM SOC, V71, P4124, DOI 10.1021/ja01180a073; Kearns DB, 2010, NAT REV MICROBIOL, V8, P634, DOI 10.1038/nrmicro2405; Kohler T, 2000, J BACTERIOL, V182, P5990, DOI 10.1128/JB.182.21.5990-5996.2000; Lequette Y, 2005, J BACTERIOL, V187, P37, DOI 10.1128/JB.187.1.37-44.2005; Marmur A, 2004, LANGMUIR, V20, P3517, DOI 10.1021/la036369u; MATSUYAMA T, 1993, CRIT REV MICROBIOL, V19, P117, DOI 10.3109/10408419309113526; Murray TS, 2006, J BACTERIOL, V188, P6995, DOI 10.1128/JB.00790-06; Nozawa T, 2007, MICROBIOL IMMUNOL, V51, P703, DOI 10.1111/j.1348-0421.2007.tb03959.x; OCHSNER UA, 1994, J BACTERIOL, V176, P2044, DOI 10.1128/jb.176.7.2044-2054.1994; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; Overhage J, 2008, J BACTERIOL, V190, P2671, DOI 10.1128/JB.01659-07; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Passador L, 1996, J BACTERIOL, V178, P5995, DOI 10.1128/jb.178.20.5995-6000.1996; Patrick JE, 2009, J BACTERIOL, V191, P7129, DOI 10.1128/JB.00905-09; PEARSON JP, 1995, P NATL ACAD SCI USA, V92, P1490, DOI 10.1073/pnas.92.5.1490; Rahim R, 2001, MOL MICROBIOL, V40, P708, DOI 10.1046/j.1365-2958.2001.02420.x; Rampioni G, 2007, MOL MICROBIOL, V66, P1557, DOI 10.1111/j.1365-2958.2007.06029.x; Rasband W., 2006, IMAGEJ; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Schuster M, 2003, J BACTERIOL, V185, P2066, DOI 10.1128/JB.185.7.2066-2079.2003; SCRIVEN LE, 1960, NATURE, V187, P186, DOI 10.1038/187186a0; Shrout JD, 2006, MOL MICROBIOL, V62, P1264, DOI 10.1111/j.1365-2958.2006.05421.x; SIEGMUND I, 1991, BIOTECHNOL TECH, V5, P265, DOI 10.1007/BF02438660; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Takahashi C, 2008, FEMS MICROBIOL LETT, V280, P169, DOI 10.1111/j.1574-6968.2007.01057.x; Tremblay J, 2007, ENVIRON MICROBIOL, V9, P2622, DOI 10.1111/j.1462-2920.2007.01396.x; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Tremblay J, 2008, J BASIC MICROB, V48, P509, DOI 10.1002/jobm.200800030; Venturi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009998; Wagner VE, 2003, J BACTERIOL, V185, P2080, DOI 10.1128/JB.185.7.2080-2095.2003; Xavier JB, 2011, MOL MICROBIOL, V79, P166, DOI 10.1111/j.1365-2958.2010.07436.x; Yeung ATY, 2009, J BACTERIOL, V191, P5592, DOI 10.1128/JB.00157-09; Zhu K, 2008, J BACTERIOL, V190, P3147, DOI 10.1128/JB.00080-08	55	25	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20888	10.1371/journal.pone.0020888	http://dx.doi.org/10.1371/journal.pone.0020888			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687741	Green Published, Green Submitted, gold			2022-12-25	WOS:000291607000025
J	Choudhury, K; Cardenas, D; Pullikuth, AK; Catling, AD; Aiyar, A; Kelly, BL				Choudhury, Kohelia; Cardenas, Daviel; Pullikuth, Ashok K.; Catling, Andrew D.; Aiyar, Ashok; Kelly, Ben L.			Trypanosomatid RACK1 Orthologs Show Functional Differences Associated with Translation Despite Similar Roles in Leishmania Pathogenesis	PLOS ONE			English	Article							MAJOR LACK ANTIGEN; PROTEIN-KINASE-C; MAMMALIAN RACK1; SIGNAL-TRANSDUCTION; SCAFFOLD PROTEIN; 80S RIBOSOME; EXPRESSION; GROWTH; ELONGATION; HOMOLOG	RACK1 proteins belong to the eukaryote WD40-repeat protein family and function as spatial regulators of multiple cellular events, including signaling pathways, the cell cycle and translation. For this latter role, structural and genetic studies indicate that RACK1 associates with the ribosome through two conserved positively charged amino acids in its first WD40 domain. Unlike RACK1s, including Trypanosoma brucei RACK1 (TbRACK1), only one of these two positively-charged residues is conserved in the first WD40 domain of the Leishmania major RACK1 ortholog, LACK. We compared virulence-attenuated LACK single copy (LACK/-) L. major, with L. major expressing either two LACK copies (LACK/LACK), or one copy each of LACK and TbRACK1 (LACK/TbRACK1), to evaluate the function of these structurally distinct RACK1 orthologs with respect to translation, viability at host temperatures and pathogenesis. Our results indicate that although the ribosome-binding residues are not fully conserved in LACK, both LACK and TbRACK1 co-sedimented with monosomes and polysomes in LACK/LACK and LACK/TbRACK1 L. major, respectively. LACK/LACK and LACK/TbRACK1 strains differed in their sensitivity to translation inhibitors implying that minor sequence differences between the RACK1 proteins can alter their functional properties. While biochemically distinguishable, both LACK/LACK and LACK/TbRACK1 lines were more tolerant of elevated temperatures, resistant to translation inhibitors, and displayed robust pathogenesis in vivo, contrasting to LACK/-parasites.	[Choudhury, Kohelia; Cardenas, Daviel; Aiyar, Ashok; Kelly, Ben L.] Louisiana State Univ, Dept Microbiol Immunol & Parasitol, Hlth Sci Ctr, New Orleans, LA USA; [Pullikuth, Ashok K.; Catling, Andrew D.] Louisiana State Univ, Dept Pharmacol & Expt Therapeut, Hlth Sci Ctr, New Orleans, LA USA; [Aiyar, Ashok] Louisiana State Univ, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Choudhury, K (corresponding author), Louisiana State Univ, Dept Microbiol Immunol & Parasitol, Hlth Sci Ctr, New Orleans, LA USA.	bkell2@lsuhsc.edu	Pullikuth, Ashok/AAT-2717-2020; Pullikuth, Ashok K/M-3100-2018	Pullikuth, Ashok K/0000-0002-0041-3310	National Institutes of Health [AI055172]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI055172] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded in part by National Institutes of Health Award AI055172 awarded to Ben Kelly and Ashok Aiyar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum S, 2004, BIOCHEM J, V380, P823, DOI 10.1042/BJ20031962; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Buensuceso CS, 2001, J CELL SCI, V114, P1691; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chang BY, 2002, ONCOGENE, V21, P7619, DOI 10.1038/sj.onc.1206002; Chou YC, 1999, BBA-GENE STRUCT EXPR, V1489, P315, DOI 10.1016/S0167-4781(99)00213-4; Coyle SM, 2009, MOL CELL BIOL, V29, P1626, DOI 10.1128/MCB.01718-08; Folgueira C, 2005, J BIOL CHEM, V280, P35172, DOI 10.1074/jbc.M505559200; GALE M, 1994, J CELL SCI, V107, P1825; Gao HX, 2005, P NATL ACAD SCI USA, V102, P10206, DOI 10.1073/pnas.0500926102; GAY DA, 1989, P NATL ACAD SCI USA, V86, P5763, DOI 10.1073/pnas.86.15.5763; Gerbasi VR, 2004, MOL CELL BIOL, V24, P8276, DOI 10.1128/MCB.24.18.8276-8287.2004; Goncalves KA, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-15; Grosso S, 2008, BIOCHEM J, V415, P77, DOI 10.1042/BJ20080463; Grossso S, 2008, BIOCHEM BIOPH RES CO, V376, P65, DOI 10.1016/j.bbrc.2008.08.118; Kelly BL, 2004, INFECT IMMUN, V72, P6924, DOI 10.1128/IAI.72.12.6924-6931.2004; Kelly BL, 2003, J EXP MED, V198, P1689, DOI 10.1084/jem.20031162; Le H, 1998, J BIOL CHEM, V273, P20084, DOI 10.1074/jbc.273.32.20084; Leifso K, 2007, MOL BIOCHEM PARASIT, V152, P35, DOI 10.1016/j.molbiopara.2006.11.009; Liu YV, 2007, J BIOL CHEM, V282, P37064, DOI 10.1074/jbc.M705015200; Mamidipudi V, 2004, FEBS LETT, V567, P321, DOI 10.1016/j.febslet.2004.03.125; Mateyak MK, 2010, J BIOL CHEM, V285, P21209, DOI 10.1074/jbc.R110.113795; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; McLeod M, 2000, MOL CELL BIOL, V20, P4016, DOI 10.1128/MCB.20.11.4016-4027.2000; Mondal S, 2010, EXPERT REV ANTI-INFE, V8, P919, DOI 10.1586/ERI.10.78; MOUGNEAU E, 1995, SCIENCE, V268, P563, DOI 10.1126/science.7725103; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Nunez A, 2009, MOL BIOL CELL, V20, P3996, DOI 10.1091/mbc.E09-05-0388; Regmi S, 2008, MOL MICROBIOL, V70, P724, DOI 10.1111/j.1365-2958.2008.06443.x; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Rothberg KG, 2006, J BIOL CHEM, V281, P9781, DOI 10.1074/jbc.M600133200; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Selvapandiyan A, 2001, J BIOL CHEM, V276, P43253, DOI 10.1074/jbc.M106806200; Sengupta J, 2004, NAT STRUCT MOL BIOL, V11, P957, DOI 10.1038/nsmb822; Shor B, 2003, J BIOL CHEM, V278, P49119, DOI 10.1074/jbc.M303968200; Sondek J, 1996, NATURE, V379, P369, DOI 10.1038/379369a0; Ullah H, 2008, PROTEIN SCI, V17, P1771, DOI 10.1110/ps.035121.108; Valerius O, 2007, MOL CELL PROTEOMICS, V6, P1968, DOI 10.1074/mcp.M700184-MCP200; Van Dyke N, 2009, NUCLEIC ACIDS RES, V37, P6116, DOI 10.1093/nar/gkp645; Vomastek T, 2007, MOL CELL BIOL, V27, P8296, DOI 10.1128/MCB.00598-07; Yoffe Y, 2006, EUKARYOT CELL, V5, P1969, DOI 10.1128/EC.00230-06	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20710	10.1371/journal.pone.0020710	http://dx.doi.org/10.1371/journal.pone.0020710			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677780	Green Published, Green Submitted, gold			2022-12-25	WOS:000291355500037
J	D'Onofrio, M; Paoletti, F; Arisi, I; Brandi, R; Malerba, F; Fasulo, L; Cattaneo, A				D'Onofrio, Mara; Paoletti, Francesca; Arisi, Ivan; Brandi, Rossella; Malerba, Francesca; Fasulo, Luisa; Cattaneo, Antonino			NGF and proNGF Regulate Functionally Distinct mRNAs in PC12 Cells: An Early Gene Expression Profiling	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; PRIMARY RESPONSE GENES; ALZHEIMERS-DISEASE; PHEOCHROMOCYTOMA CELLS; CHOLESTEROL-BIOSYNTHESIS; NEURITE OUTGROWTH; MOLECULAR-CLONING; FACTOR RECEPTORS; LOW-AFFINITY; DEATH	The biological activities of NGF and of its precursor proNGF are quite distinct, due to different receptor binding profiles, but little is known about how proNGF regulates gene expression. Whether proNGF is a purely pro-apoptotic molecule and/or simply a "less potent NGF" is still a matter of debate. We performed experiments to address this question, by verifying whether a proNGF specific transcriptional signature, distinct from that of NGF, could be identified. To this aim, we studied gene expression regulation by proNGF and NGF in PC12 cells incubated for 1 and 4 hours with recombinant NGF and proNGF, in its wild-type or in a furin-cleavage resistant form. mRNA expression profiles were analyzed by whole genome microarrays at early time points, in order to identify specific profiles of NGF and proNGF. Clear differences between the mRNA profiles modulated by the three neurotrophin forms were identified. NGF and proNGF modulate remarkably distinct mRNA expression patterns, with the gene expression profile regulated by NGF being significantly more complex than that by proNGF, both in terms of the total number of differentially expressed mRNAs and of the gene families involved. Moreover, while the total number of genes modulated by NGF increases dramatically with time, that by proNGFs is unchanged or reduced. We identified a subset of regulated genes that could be ascribed to a "pure proNGF" signalling, distinct from the "pure NGF" one. We also conclude that the composition of mixed NGF and proNGF samples, when the two proteins coexist, influences the profile of gene expression. Based on this comparison of the gene expression profiles regulated by NGF and its proNGF precursor, we conclude that the two proteins activate largely distinct transcriptional programs and that the ratio of NGF to proNGF in vivo can profoundly influence the pattern of regulated mRNAs.	[D'Onofrio, Mara; Paoletti, Francesca; Arisi, Ivan; Brandi, Rossella; Malerba, Francesca; Fasulo, Luisa; Cattaneo, Antonino] EBRI European Brain Res Inst, Neurotroph Factors & Neurodegenerat Dis Unit, Rome, Italy; [D'Onofrio, Mara; Arisi, Ivan; Brandi, Rossella] EBRI European Brain Res Inst, Neurogenom IIT Unit, Rome, Italy; [Malerba, Francesca; Cattaneo, Antonino] Scuola Normale Super Pisa, Pisa, Italy	Scuola Normale Superiore di Pisa	D'Onofrio, M (corresponding author), EBRI European Brain Res Inst, Neurotroph Factors & Neurodegenerat Dis Unit, Rome, Italy.	antonino.cattaneo@sns.it	Arisi, Ivan/AAM-1152-2021; Cattaneo, Antonino/K-4471-2016; Cattaneo, Antonino/AAA-7252-2019	Arisi, Ivan/0000-0002-0536-2508; Cattaneo, Antonino/0000-0002-6975-8923; Fasulo, Luisa/0000-0003-3767-9128	Italian Ministry of Higher Education and Scientific Research [PNR RBIP063ANC]; Italian Institute of Technology	Italian Ministry of Higher Education and Scientific Research; Italian Institute of Technology(Istituto Italiano di Tecnologia - IIT)	The work was funded by grant PNR RBIP063ANC from the Italian Ministry of Higher Education and Scientific Research and IIT Grant from the Italian Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althaus HH, 2006, J NEUROCHEM, V98, P506, DOI 10.1111/j.1471-4159.2006.03891.x; ALTIN JG, 1991, J BIOL CHEM, V266, P5401; BARTEL DP, 1989, GENE DEV, V3, P304, DOI 10.1101/gad.3.3.304; BATISTATOU A, 1992, MOL BIOL CELL, V3, P363, DOI 10.1091/mbc.3.3.363; Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Brynczka C, 2008, DIFFERENTIATION, V76, P795, DOI 10.1111/j.1432-0436.2007.00261.x; Capsoni S, 2006, CELL MOL NEUROBIOL, V26, P619, DOI 10.1007/s10571-006-9112-2; Capsoni S, 2010, P NATL ACAD SCI USA, V107, P12299, DOI 10.1073/pnas.1007181107; Casademunt E, 1999, EMBO J, V18, P6050, DOI 10.1093/emboj/18.21.6050; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Chao MV, 2006, CLIN SCI, V110, P167, DOI 10.1042/CS20050163; Chen L, 2008, MOL ENDOCRINOL, V22, P454, DOI 10.1210/me.2007-0384; Chen ZY, 2005, J NEUROSCI, V25, P6156, DOI 10.1523/JNEUROSCI.1017-05.2005; Counts SE, 2005, J NEUROPATH EXP NEUR, V64, P263, DOI 10.1093/jnen/64.4.263; CROSBY SD, 1992, P NATL ACAD SCI USA, V89, P4739, DOI 10.1073/pnas.89.10.4739; CROSBY SD, 1991, MOL CELL BIOL, V11, P3835, DOI 10.1128/MCB.11.8.3835; Dijkmans TF, 2009, BRAIN RES, V1249, P19, DOI 10.1016/j.brainres.2008.10.050; Fahnestock M, 2004, PROG BRAIN RES, V146, P101, DOI 10.1016/S0079-6123(03)46007-X; Fahnestock M, 2004, J NEUROCHEM, V89, P581, DOI 10.1111/j.1471-4159.2004.02360.x; Fahnestock M, 2001, MOL CELL NEUROSCI, V18, P210, DOI 10.1006/mcne.2001.1016; GREENBERG DA, 1985, NEUROSCI LETT, V62, P377, DOI 10.1016/0304-3940(85)90578-6; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hempstead Barbara L., 2006, Current Alzheimer Research, V3, P19, DOI 10.2174/156720506775697061; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HERSCHMAN HR, 1991, ANNU REV BIOCHEM, V60, P281, DOI 10.1146/annurev.biochem.60.1.281; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kichev A, 2009, AM J PATHOL, V175, P2574, DOI 10.2353/ajpath.2009.090018; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Korade Z, 2009, J MOL NEUROSCI, V38, P152, DOI 10.1007/s12031-008-9136-9; KUJUBU DA, 1987, ONCOGENE, V1, P257; LANDRETH GE, 1980, P NATL ACAD SCI-BIOL, V77, P4751, DOI 10.1073/pnas.77.8.4751; Lee KH, 2005, NEUROCHEM RES, V30, P533, DOI 10.1007/s11064-005-2688-y; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; LEVI A, 1985, SCIENCE, V229, P393, DOI 10.1126/science.3839317; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lou H, 2005, NEURON, V45, P245, DOI 10.1016/j.neuron.2004.12.037; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Massa SM, 2006, J NEUROSCI, V26, P5288, DOI 10.1523/JNEUROSCI.3547-05.2006; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Mouri A, 2007, BIOCHEM BIOPH RES CO, V353, P1056, DOI 10.1016/j.bbrc.2006.12.136; Mufson EJ, 2010, NEUROSCI LETT, V471, P129, DOI 10.1016/j.neulet.2010.01.023; NAGATA Y, 1994, BIOCHEM BIOPH RES CO, V199, P1355, DOI 10.1006/bbrc.1994.1380; Nomoto H, 2007, BIOCHEM BIOPH RES CO, V356, P919, DOI 10.1016/j.bbrc.2007.03.059; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Pang PT, 2004, SCIENCE, V306, P487, DOI 10.1126/science.1100135; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; Pedraza CE, 2005, AM J PATHOL, V166, P533, DOI 10.1016/S0002-9440(10)62275-4; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Rattenholl A, 2001, J MOL BIOL, V305, P523, DOI 10.1006/jmbi.2000.4295; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; Shooter EM, 2001, ANNU REV NEUROSCI, V24, P601, DOI 10.1146/annurev.neuro.24.1.601; Sobottka B, 2008, J NEUROCHEM, V107, P1294, DOI 10.1111/j.1471-4159.2008.05690.x; Song WY, 2010, J NEUROSCI, V30, P15608, DOI 10.1523/JNEUROSCI.2581-10.2010; SUTER U, 1991, EMBO J, V10, P2395, DOI 10.1002/j.1460-2075.1991.tb07778.x; TIRONE F, 1989, P NATL ACAD SCI USA, V86, P2088, DOI 10.1073/pnas.86.6.2088; Volosin M, 2006, J NEUROSCI, V26, P7756, DOI 10.1523/JNEUROSCI.1560-06.2006; Wollmer MA, 2010, BBA-MOL CELL BIOL L, V1801, P762, DOI 10.1016/j.bbalip.2010.05.009; Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7; WU BY, 1989, J BIOL CHEM, V264, P9000; Yan CH, 2005, MOL BRAIN RES, V139, P225, DOI 10.1016/j.molbrainres.2005.05.025	63	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20839	10.1371/journal.pone.0020839	http://dx.doi.org/10.1371/journal.pone.0020839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677785	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500046
J	Ye, JQ; Maniatis, T				Ye, Junqiang; Maniatis, Tom			Negative Regulation of Interferon-beta Gene Expression during Acute and Persistent Virus Infections	PLOS ONE			English	Article							NF-KAPPA-B; HEPATITIS-C-VIRUS; ANTIVIRAL SIGNALING PROTEIN; PARAMYXOVIRUS V-PROTEINS; I INTERFERON; SENDAI-VIRUS; RIG-I; IRF-3 ACTIVATION; TRANSCRIPTION FACTORS; IKK-EPSILON	The production of type I interferons (IFNs) in response to viral infections is critical for antiviral immunity. However, IFN production is transient, and continued expression can lead to inflammatory or autoimmune diseases. Thus, understanding the mechanisms underlying the negative regulation of IFN expression could lead to the development of novel therapeutic approaches to the treatment of these diseases. We report that the transcription factor IRF3 plays a central role in the negative regulation of interferon-beta (IFN beta) expression during both acute and persistent (chronic) virus infections. We show that the degradation of IRF3 during acute infections, rather than the activation of transcriptional repressors, leads to the down regulation of IFN beta expression. We also show that the block to IFN beta expression in mouse embryonic fibroblasts that are persistently infected with Sendai virus (SeV) correlates with the absence of transcriptionally active IRF3. Remarkably, ongoing protein synthesis and viral replication are required to maintain repression of the IFN beta gene in persistently infected cells, as the gene can be activated by the protein synthesis inhibitor cycloheximide, or by the antiviral drug ribavirin. Finally, we show that the SeV V protein inhibits IRF3 activity in persistently infected cells. Thus, in conjunction with the known interference with STAT1 by the SeV C protein, both IFN activation and its signaling pathways are blocked in persistently infected cells. We conclude that the transcription factor IRF3 is targeted for turnover and inactivation through distinct mechanisms from both the host cells and virus, leading to the inhibition of IFN beta gene expression during acute and persistent viral infections. These observations show that IRF3 plays a critical role, not only in the activation of the IFN beta gene, but also in the controlling the duration of its expression. (284 words)	[Ye, Junqiang; Maniatis, Tom] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Ye, JQ (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	tm2472@mail.cumc.columbia.edu		Ye, Junqiang/0000-0002-4529-0713	NIH [5R01AI020642]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020642] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work is supported by NIH grant 5R01AI020642 (to T.M.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; BHANDARI BN, 1995, ANNU REV MED, V46, P309; Bibeau-Poirier A, 2006, J IMMUNOL, V177, P5059, DOI 10.4049/jimmunol.177.8.5059; Boasso A, 2008, CLIN IMMUNOL, V126, P235, DOI 10.1016/j.clim.2007.08.015; Bosinger SE, 2009, J CLIN INVEST, V119, P3556, DOI 10.1172/JCI40115; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; CUI J, CELL, V141, P483; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Evans CF, 2002, CURR TOP MICROBIOL, V263, P177; Faisca P, 2007, RES VET SCI, V82, P115, DOI 10.1016/j.rvsc.2006.03.009; FAN CM, 1990, GENE DEV, V4, P29, DOI 10.1101/gad.4.1.29; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Ford E, BIOCH BIOPHYS ACTA, V1799, P328; Forsman A, 2008, TRENDS MICROBIOL, V16, P555, DOI 10.1016/j.tim.2008.09.004; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Fujita T, 2009, IMMUNITY, V31, P4, DOI 10.1016/j.immuni.2009.06.014; GACK MU, J VIROL, V84, P3220; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Garcin D, 2004, J VIROL, V78, P8799, DOI 10.1128/JVI.78.16.8799-8811.2004; Hall JC, NAT REV RHEUMATOL, V6, P40; Herbeuval JP, 2007, CLIN IMMUNOL, V123, P121, DOI 10.1016/j.clim.2006.09.016; Heyninck K, 1999, FEBS LETT, V442, P147, DOI 10.1016/S0014-5793(98)01645-7; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang J, 2005, EMBO J, V24, P4018, DOI 10.1038/sj.emboj.7600863; Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093; KANE M, J VIROL, V84, P4116; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; KELLER AD, 1991, GENE DEV, V5, P868, DOI 10.1101/gad.5.5.868; KIM H, NAT IMMUNOL, V11, P743; Kiyotani K, 2007, VIROLOGY, V359, P82, DOI 10.1016/j.virol.2006.08.053; Komatsu T, 2004, VIROLOGY, V325, P137, DOI 10.1016/j.virol.2004.04.025; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Levy JA, 2009, AIDS, V23, P147, DOI 10.1097/QAD.0b013e3283217f9f; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Lin OS, 2001, ANNU REV MED, V52, P29, DOI 10.1146/annurev.med.52.1.29; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Lin Y, 1997, SCIENCE, V276, P596, DOI 10.1126/science.276.5312.596; Lu LL, 2008, J BIOL CHEM, V283, P14269, DOI 10.1074/jbc.M710089200; Mandl JN, 2008, NAT MED, V14, P1077, DOI 10.1038/nm.1871; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marq JB, 2007, J VIROL, V81, P3187, DOI 10.1128/JVI.02465-06; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mori M, 2004, J BIOL CHEM, V279, P9698, DOI 10.1074/jbc.M310616200; NISTALVILLAN E, J BIOL CHEM, V285, P20252; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okumura A, 2008, VIROLOGY, V373, P85, DOI 10.1016/j.virol.2007.10.042; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Peters K, 2008, J VIROL, V82, P3500, DOI 10.1128/JVI.02536-07; Ren B, 1999, GENE DEV, V13, P125, DOI 10.1101/gad.13.1.125; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Saitoh T, 2006, NAT IMMUNOL, V7, P598, DOI 10.1038/ni1347; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; SUN L, CELL, V140, P436; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; SUN Z, J VIROL, V85, P1036; Takeuchi K, 2001, GENES CELLS, V6, P545, DOI 10.1046/j.1365-2443.2001.00442.x; Tan SL, 2004, CURR OPIN PHARMACOL, V4, P465, DOI 10.1016/j.coph.2004.07.003; Tanaka T, 2007, NAT IMMUNOL, V8, P584, DOI 10.1038/ni1464; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; tenOever BR, 2004, J VIROL, V78, P10636, DOI 10.1128/JVI.78.19.10636-10649.2004; tenOever BR, 2002, J VIROL, V76, P3659, DOI 10.1128/JVI.76.8.3659-3669.2002; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561; Ye JQ, 2011, NAT CHEM BIOL, V7, P25, DOI 10.1038/NCHEMBIO.476; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Yoshida H, 2005, NAT IMMUNOL, V6, P49, DOI 10.1038/ni1146; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	88	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2011	6	6							e20681	10.1371/journal.pone.0020681	http://dx.doi.org/10.1371/journal.pone.0020681			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	774BE	21677781	gold, Green Published, Green Submitted			2022-12-25	WOS:000291355500033
J	Liu, JC; Lengner, CJ; Gaur, T; Lou, Y; Hussain, S; Jones, MD; Borodic, B; Colby, JL; Steinman, HA; van Wijnen, AJ; Stein, JL; Jones, SN; Stein, GS; Lian, JB				Liu, Julie C.; Lengner, Christopher J.; Gaur, Tripti; Lou, Yang; Hussain, Sadiq; Jones, Marci D.; Borodic, Brent; Colby, Jennifer L.; Steinman, Heather A.; van Wijnen, Andre J.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; Lian, Jane B.			Runx2 Protein Expression Utilizes the Runx2 P1 Promoter to Establish Osteoprogenitor Cell Number for Normal Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLAST DIFFERENTIATION; CLEIDOCRANIAL DYSPLASIA; GENE-EXPRESSION; SKELETAL DEVELOPMENT; CHONDROCYTE MATURATION; RUNX/CBFA/AML FACTORS; CBFA1-DEFICIENT MICE; COLLAGEN GENE; CBFA1; RUNX2/CBFA1	The Runt-related transcription factor, Runx2, is essential for osteogenesis and is controlled by both distal (P1) and proximal (P2) promoters. To understand Runx2 function requires determination of the spatiotemporal activity of P1 and P2 to Runx2 protein production. We generated a mouse model in which the P1-derived transcript was replaced with a lacZ reporter allele, resulting in loss of P1-derived protein while simultaneously allowing discrimination between the activities of the two promoters. Loss of P1-driven expression causes developmental defects with cleidocranial dysplasia-like syndromes that persist in the postnatal skeleton. P1 activity is robust in preosteogenic mesenchyme and at the onset of bone formation but decreases as bone matures. Homozygous Runx2-P1(lacZ/lacZ) mice have a normal life span but exhibit severe osteopenia and compromised bone repair in adult mice because of osteoblastic defects and not increased osteoclastic resorption. Gene expression profiles of bone, immunohistochemical studies, and ex vivo differentiation using calvarial osteoblasts and marrow stromal cells identified mechanisms for the skeletal phenotype. The findings indicate that P1 promoter activity is necessary for generating a threshold level of Runx2 protein to commit sufficient osteoprogenitor numbers for normal bone formation. P1 promoter function is not compensated via the P2 promoter. However, the P2 transcript with compensatory mechanisms from bone morphogenetic protein (BMP) and Wnt signaling is adequate for mineralization of the bone tissue that does form. We conclude that selective utilization of the P1 and P2 promoters enables the precise spatiotemporal expression of Runx2 necessary for normal skeletogenesis and the maintenance of bone mass in the adult.	[Liu, Julie C.; Lengner, Christopher J.; Gaur, Tripti; Lou, Yang; Hussain, Sadiq; Borodic, Brent; Colby, Jennifer L.; Steinman, Heather A.; van Wijnen, Andre J.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01655 USA; [Liu, Julie C.; Lengner, Christopher J.; Gaur, Tripti; Lou, Yang; Hussain, Sadiq; Borodic, Brent; Colby, Jennifer L.; Steinman, Heather A.; van Wijnen, Andre J.; Stein, Janet L.; Jones, Stephen N.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA 01655 USA; [Jones, Marci D.] Univ Massachusetts, Sch Med, Dept Orthoped & Phys Rehabil, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lian, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol, 55 Lake Ave N, Worcester, MA 01655 USA.	jane.lian@umassmed.edu	Liu, Julie C/H-7496-2013; van Wijnen, Andre J./AAG-3578-2019	Liu, Julie C/0000-0003-0784-2529; van Wijnen, Andre J./0000-0002-4458-0946; Lengner, Christopher/0000-0002-0574-5189	National Institutes of Health [P01 AR048818, R01 AR039588, R37 DE012528, 1F32AR055030]; NIDDK [DK32520]; NATIONAL CANCER INSTITUTE [R01CA077735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR039588, F32AR055030, P01AR048818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants P01 AR048818 and R01 AR039588 (to G. S. S.), R37 DE012528 (to J. B. L.), and 1F32AR055030 (to J. C. L.).; We thank Douglas J. Adams at the University of Connecticut Health Center for initial microCT studies, Mary Mac-Dougall for helpful discussions, Dana Frederick for technical assistance, Judy Rask for manuscript preparation, and other members of our laboratory for helpful discussions. Core resources supported by National Institutes of Health Diabetes Endocrinology Research Center Grant DK32520 from the NIDDK were used.	Banerjee C, 2001, ENDOCRINOLOGY, V142, P4026, DOI 10.1210/en.142.9.4026; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; BECK KM, 1991, NUCLEIC ACIDS RES, V19, P4975, DOI 10.1093/nar/19.18.4975; Choi JY, 2001, P NATL ACAD SCI USA, V98, P8650, DOI 10.1073/pnas.151236498; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Enomoto H, 2000, J BIOL CHEM, V275, P8695, DOI 10.1074/jbc.275.12.8695; FOCHT RJ, 1984, MOL CELL BIOL, V4, P1843, DOI 10.1128/MCB.4.9.1843; Harada H, 1999, J BIOL CHEM, V274, P6972, DOI 10.1074/jbc.274.11.6972; Inada M, 1999, DEV DYNAM, V214, P279, DOI 10.1002/(SICI)1097-0177(199904)214:4<279::AID-AJA1>3.0.CO;2-W; Javed A, 2001, MOL CELL BIOL, V21, P2891, DOI 10.1128/MCB.21.8.2891-2905.2001; Kitazawa R, 2008, J CELL BIOCHEM, V105, P1289, DOI 10.1002/jcb.21929; Kobayashi I, 2006, BONE, V38, P836, DOI 10.1016/j.bone.2005.10.026; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Leboy PS, 2001, J BONE JOINT SURG AM, V83A, pS15; Lee B, 1997, NAT GENET, V16, P307, DOI 10.1038/ng0797-307; Lengner CJ, 2002, MECH DEVELOP, V114, P167, DOI 10.1016/S0925-4773(02)00050-3; Levanon D, 2003, BLOOD CELL MOL DIS, V30, P161, DOI 10.1016/S1079-9796(03)00023-8; Levanon D, 2001, MECH DEVELOP, V109, P413, DOI 10.1016/S0925-4773(01)00537-8; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Lian JB, 2003, J CELL PHYSIOL, V196, P301, DOI 10.1002/jcp.10316; Lou Y, 2009, HUM MOL GENET, V18, P556, DOI 10.1093/hmg/ddn383; LUFKIN T, 1992, NATURE, V359, P835, DOI 10.1038/359835a0; Maruyama Z, 2007, DEV DYNAM, V236, P1876, DOI 10.1002/dvdy.21187; MCLEAN IW, 1974, J HISTOCHEM CYTOCHEM, V22, P1077, DOI 10.1177/22.12.1077; Mundlos S, 1999, J MED GENET, V36, P177; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Ng CEL, 2007, GENE, V399, P162, DOI 10.1016/j.gene.2007.05.014; OGAWA E, 1993, P NATL ACAD SCI USA, V90, P6859, DOI 10.1073/pnas.90.14.6859; Otto F, 2002, HUM MUTAT, V19, P209, DOI 10.1002/humu.10043; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Park MH, 2001, J BONE MINER RES, V16, P885, DOI 10.1359/jbmr.2001.16.5.885; Pratap J, 2003, CANCER RES, V63, P5357; Smith N, 2005, J CELL PHYSIOL, V203, P133, DOI 10.1002/jcp.20210; Stein GS, 2004, ONCOGENE, V23, P4315, DOI 10.1038/sj.onc.1207676; Stewart M, 1997, P NATL ACAD SCI USA, V94, P8646, DOI 10.1073/pnas.94.16.8646; Sudhakar S, 2001, BIOCHEM BIOPH RES CO, V289, P616, DOI 10.1006/bbrc.2001.6033; Takeda S, 2001, GENE DEV, V15, P467, DOI 10.1101/gad.845101; Terkeltaub R, 1998, ARTHRITIS RHEUM-US, V41, P2152, DOI 10.1002/1529-0131(199812)41:12<2152::AID-ART10>3.3.CO;2-O; Terry A, 2004, GENE, V336, P115, DOI 10.1016/j.gene.2004.04.015; Thompson Z, 2002, J ORTHOPAED RES, V20, P1091, DOI 10.1016/S0736-0266(02)00017-7; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yamashiro T, 2002, MECH DEVELOP, V119, pS107, DOI 10.1016/S0925-4773(03)00101-1; Zaidi SK, 2010, MOL CELL BIOL, V30, P4758, DOI 10.1128/MCB.00646-10; Zelzer E, 2005, CURR TOP DEV BIOL, V65, P169; Zelzer E, 2001, MECH DEVELOP, V106, P97, DOI 10.1016/S0925-4773(01)00428-2; Zhang SQ, 2009, J BONE MINER RES, V24, P1889, DOI [10.1359/JBMR.090502, 10.1359/jbmr.090502]	52	46	49	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					30057	30070		10.1074/jbc.M111.241505	http://dx.doi.org/10.1074/jbc.M111.241505			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21676869	Green Published, hybrid			2022-12-25	WOS:000294046600064
J	Uranga, LA; Balise, VD; Benally, CV; Grey, A; Lusetti, SL				Uranga, Lee A.; Balise, Victoria D.; Benally, Candice V.; Grey, Angelina; Lusetti, Shelley L.			The Escherichia coli DinD Protein Modulates RecA Activity by Inhibiting Postsynaptic RecA Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; NUCLEOPROTEIN FILAMENTS; BINDING-PROTEIN; DUPLEX DNA; GENETIC-RECOMBINATION; RDGC PROTEIN; MECHANISM; EXCHANGE; EXPRESSION; IDENTIFICATION	Escherichia coli dinD is an SOS gene up-regulated in response to DNA damage. We find that the purified DinD protein is a novel inhibitor of RecA-mediated DNA strand exchange activities. Most modulators of RecA protein activity act by controlling the amount of RecA protein bound to single-stranded DNA by affecting either the loading of RecA protein onto DNA or the disassembly of RecA nucleoprotein filaments bound to single-stranded DNA. The DinD protein, however, acts postsynaptically to inhibit RecA during an on-going DNA strand exchange, likely through the disassembly of RecA filaments. DinD protein does not affect RecA single-stranded DNA filaments but efficiently disassembles RecA when bound to two or more DNA strands, effectively halting RecA-mediated branch migration. By utilizing a nonspecific duplex DNA-binding protein, YebG, we show that the DinD effect is not simply due to duplex DNA sequestration. We present a model suggesting that the negative effects of DinD protein are targeted to a specific conformational state of the RecA protein and discuss the potential role of DinD protein in the regulation of recombinational DNA repair.	[Uranga, Lee A.; Balise, Victoria D.; Benally, Candice V.; Grey, Angelina; Lusetti, Shelley L.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Lusetti, SL (corresponding author), POB 30001,MSC 3C, Las Cruces, NM 88003 USA.	slusetti@nmsu.edu		Balise, Victoria/0000-0002-5088-8752	National Institutes of Health, NM-INBRE [P20 RR016480];  [SC2 GM083697];  [R25 GM06122];  [T34 GM07667-34];  [R25 GM048998-13]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM048998, SC2GM083697, T34GM007667, R25GM061222] Funding Source: NIH RePORTER	National Institutes of Health, NM-INBRE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); ; ; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR016480 from the NM-INBRE Program and SC2 GM083697 (to S. L. L.), and R25 GM06122 (to L. A. U. and V. D. B.), T34 GM07667-34 (to C. V. B.), and R25 GM048998-13 (to C. V. B. and A. G.).	ADAMS DE, 1994, P NATL ACAD SCI USA, V91, P9901, DOI 10.1073/pnas.91.21.9901; Briggs GS, 2010, NUCLEIC ACIDS RES, V38, P6433, DOI 10.1093/nar/gkq509; Britt RL, 2010, J BIOL CHEM, V285, P3211, DOI 10.1074/jbc.M109.028951; Bugreev DV, 2011, NAT STRUCT MOL BIOL, V18, P56, DOI 10.1038/nsmb.1946; CHOW SA, 1988, J BIOL CHEM, V263, P3335; CHOW SA, 1986, J BIOL CHEM, V261, P6961; Courcelle J, 2001, GENETICS, V158, P41; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Cox MM, 2003, ANNU REV MICROBIOL, V57, P551, DOI 10.1146/annurev.micro.57.030502.090953; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; Drees JC, 2006, J BIOL CHEM, V281, P4708, DOI 10.1074/jbc.M513592200; Drees JC, 2004, MOL CELL, V15, P789, DOI 10.1016/j.molcel.2004.08.026; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; HOWARDFLANDERS P, 1984, NATURE, V309, P215, DOI 10.1038/309215a0; KENYON CJ, 1980, P NATL ACAD SCI-BIOL, V77, P2819, DOI 10.1073/pnas.77.5.2819; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; KOWALCZYKOWSKI SC, 1995, P NATL ACAD SCI USA, V92, P3478, DOI 10.1073/pnas.92.8.3478; KOWALCZYKOWSKI SC, 1991, ANNU REV BIOPHYS BIO, V20, P539, DOI 10.1146/annurev.bb.20.060191.002543; KRUEGER JH, 1983, J BACTERIOL, V153, P1368, DOI 10.1128/JB.153.3.1368-1378.1983; LAVERY PE, 1992, J BIOL CHEM, V267, P9315; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; LINDSLEY JE, 1990, J BIOL CHEM, V265, P9043; LOHMAN TM, 1985, J BIOL CHEM, V260, P3594; LOHMAN TM, 1986, BIOCHEMISTRY-US, V25, P21, DOI 10.1021/bi00349a004; Lomba MR, 1997, FEMS MICROBIOL LETT, V156, P119, DOI 10.1016/S0378-1097(97)00412-6; Lusetti SL, 2006, MOL CELL, V21, P41, DOI 10.1016/j.molcel.2005.11.011; Lusetti SL, 2002, ANNU REV BIOCHEM, V71, P71, DOI 10.1146/annurev.biochem.71.083101.133940; Lusetti SL, 2004, J BIOL CHEM, V279, P55073, DOI 10.1074/jbc.M410371200; Lusetti SL, 2004, J BIOL CHEM, V279, P30037, DOI 10.1074/jbc.M403064200; Lusetti SL, 2003, J BIOL CHEM, V278, P16381, DOI 10.1074/jbc.M212916200; Lusetti SL, 2003, J BIOL CHEM, V278, P16372, DOI 10.1074/jbc.M212917200; MARRIONE PE, 1995, BIOCHEMISTRY-US, V34, P9809, DOI 10.1021/bi00030a019; MERTENS N, 1995, BIO-TECHNOL, V13, P175, DOI 10.1038/nbt0295-175; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; NEUENDORF SK, 1986, J BIOL CHEM, V261, P8276; O'Reilly EK, 2004, J BACTERIOL, V186, P7149, DOI 10.1128/JB.186.21.7149-7160.2004; Oh TJ, 1999, FEMS MICROBIOL LETT, V177, P271, DOI 10.1111/j.1574-6968.1999.tb13743.x; OHMORI H, 1995, J BACTERIOL, V177, P156, DOI 10.1128/jb.177.1.156-165.1995; Pages V, 2003, DNA REPAIR, V2, P273, DOI 10.1016/S1568-7864(02)00217-3; Park J, 2010, CELL, V142, P544, DOI 10.1016/j.cell.2010.07.016; Petrova V, 2009, MOL CELL, V36, P121, DOI 10.1016/j.molcel.2009.07.026; PUGH BF, 1988, J MOL BIOL, V203, P479, DOI 10.1016/0022-2836(88)90014-9; PUGH BF, 1987, J BIOL CHEM, V262, P1326; PUGH BF, 1987, J BIOL CHEM, V262, P1337; REDDY G, 1995, BIOCHEMISTRY-US, V34, P10194, DOI 10.1021/bi00032a013; Renzette N, 2007, MOL MICROBIOL, V63, P103, DOI 10.1111/j.1365-2958.2006.05496.x; SCHUTTE BC, 1987, BIOCHEMISTRY-US, V26, P5616, DOI 10.1021/bi00392a006; Shan Q, 1997, J MOL BIOL, V265, P519, DOI 10.1006/jmbi.1996.0748; Shan Q, 1997, J BIOL CHEM, V272, P11063; SHIBATA T, 1981, J BIOL CHEM, V256, P7557; ULLSPERGER CJ, 1995, BIOCHEMISTRY-US, V34, P10859, DOI 10.1021/bi00034a019; Veaute X, 2005, EMBO J, V24, P180, DOI 10.1038/sj.emboj.7600485; Webb BL, 1997, CELL, V91, P347, DOI 10.1016/S0092-8674(00)80418-3	55	11	11	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 26	2011	286	34					29480	29491		10.1074/jbc.M111.245373	http://dx.doi.org/10.1074/jbc.M111.245373			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	809IU	21697094	Green Published, hybrid			2022-12-25	WOS:000294046600005
J	Akabayov, B; Kulczyk, AW; Akabayov, SR; Theile, C; McLaughlin, LW; Beauchamp, B; van Oijen, AM; Richardson, CC				Akabayov, Barak; Kulczyk, Arkadiusz W.; Akabayov, Sabine R.; Theile, Christopher; McLaughlin, Larry W.; Beauchamp, Benjamin; van Oijen, Antoine M.; Richardson, Charles C.			Pyrovanadolysis, a Pyrophosphorolysis-like Reaction Mediated by Pyrovanadate, Mn2+, and DNA Polymerase of Bacteriophage T7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI THIOREDOXIN; RAY-ABSORPTION SPECTROSCOPY; EXONUCLEASE ACTIVITY; SEQUENCE ANALYSIS; CRYSTAL-STRUCTURE; TRANSITION-STATE; METAL-IONS; VANADATE; REPLICATION; BINDING	DNA polymerases catalyze the 3'-5'-pyrophosphorolysis of a DNA primer annealed to a DNA template in the presence of pyrophosphate (PPi). In this reversal of the polymerization reaction, deoxynucleotides in DNA are converted to deoxynucleoside 5'-triphosphates. Based on the charge, size, and geometry of the oxygen connecting the two phosphorus atoms of PPi, a variety of compounds was examined for their ability to carry out a reaction similar to pyrophosphorolysis. We describe a manganese-mediated pyrophosphorolysis-like activity using pyrovanadate (VV) catalyzed by the DNA polymerase of bacteriophage T7. We designate this reaction pyrovanadolysis. X-ray absorption spectroscopy reveals a shorter Mn-V distance of the polymerase-VV complex than the Mn-P distance of the polymerase-PPi complex. This structural arrangement at the active site accounts for the enzymatic activation by Mn-VV. We propose that the Mn2+, larger than Mg2+, fits the polymerase active site to mediate binding of VV into the active site of the polymerase. Our results may be the first documentation that vanadium can substitute for phosphorus in biological processes.	[Akabayov, Barak; Kulczyk, Arkadiusz W.; Akabayov, Sabine R.; Theile, Christopher; Beauchamp, Benjamin; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [McLaughlin, Larry W.] Boston Coll, Merkert Chem Ctr, Dept Chem, Chestnut Hill, MA 02467 USA; [van Oijen, Antoine M.] Univ Groningen, Ctr Synthet Biol, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	Harvard University; Harvard Medical School; Boston College; University of Groningen	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave, Boston, MA 02115 USA.	ccr@hms.harvard.edu	Akabayov, Barak/Y-5786-2019; Institute, Zernike/W-7033-2019; Akabayov, Barak/D-1551-2011; van Oijen, Antoine/I-3167-2014	Akabayov, Barak/0000-0002-3882-2742; van Oijen, Antoine/0000-0002-1794-5161	National Institutes of Health [GM54397]; National Institute of Biomedical Imaging and Bioengineering [P30-EB-009998]; National Science Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.) and by Center for Synchrotron Biosciences Grant P30-EB-009998 from the National Institute of Biomedical Imaging and Bioengineering. This work was supported by Grant from the National Science Foundation (to L. W. M.).	Akabayov B, 2005, J SYNCHROTRON RADIAT, V12, P392, DOI 10.1107/S0909049505010150; Akabayov B, 2011, POWDER DIFFR, V26, P159, DOI 10.1154/1.3583156; Akabayov B, 2010, P NATL ACAD SCI USA, V107, P15033, DOI 10.1073/pnas.1010141107; Akabayov B, 2009, BIOCHEMISTRY-US, V48, P1763, DOI 10.1021/bi802123t; Andraos N, 2004, J BIOL CHEM, V279, P50609, DOI 10.1074/jbc.M408428200; Arion D, 1999, DRUG RESIST UPDATE, V2, P91, DOI 10.1054/drup.1999.0076; Borden J, 2006, J PHYS CHEM B, V110, P14988, DOI 10.1021/jp060168s; Brandao TAS, 2009, J AM CHEM SOC, V131, P778, DOI 10.1021/ja807418b; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; CALVO C, 1967, ACTA CRYSTALLOGR, V23, P289, DOI 10.1107/S0365110X67002610; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; DEUTSCHER MP, 1969, J BIOL CHEM, V244, P3019; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Fekry MI, 2011, ACS CHEM BIOL, V6, P127, DOI 10.1021/cb2000023; Gabbara S, 1996, METHOD ENZYMOL, V275, P276; GRESSER MJ, 1986, J AM CHEM SOC, V108, P6229, DOI 10.1021/ja00280a020; GRIENGL H, 1988, J MED CHEM, V31, P1831, DOI 10.1021/jm00117a026; Hamdan SM, 2009, ANNU REV BIOCHEM, V78, P205, DOI 10.1146/annurev.biochem.78.072407.103248; HEINONEN JK, 2001, BIOL ROLE INORGANIC, P10; HOLLOWAY CE, 1986, REV INORG CHEM, V8, P287; JENCKS WP, 1987, CATALYSIS CHEM ENZYM, P111; KORNBERG A, 1992, DNA REPLICATION, P115; KRAUSS M, 1992, J AM CHEM SOC, V114, P3630, DOI 10.1021/ja00036a008; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; LUDWIG J, 1989, J ORG CHEM, V54, P631, DOI 10.1021/jo00264a024; Newville M, 2001, J SYNCHROTRON RADIAT, V8, P322, DOI 10.1107/S0909049500016964; Patel PH, 2001, NAT STRUCT BIOL, V8, P656, DOI 10.1038/90344; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; ROZOVSKAYA TA, 1984, BIOCHEM J, V224, P645, DOI 10.1042/bj2240645; SCOTT RA, 1985, J INORG BIOCHEM, V23, P199, DOI 10.1016/0162-0134(85)85026-1; SIGEL H, 1995, MET IONS BIOL SYST, P153; Solomon A, 2007, P NATL ACAD SCI USA, V104, P4931, DOI 10.1073/pnas.0700066104; STANKIEWICZ PJ, 1987, BIOCHEMISTRY-US, V26, P1264, DOI 10.1021/bi00379a010; Steens N, 2009, CHEM COMMUN, P965, DOI 10.1039/b816785k; Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542; STERN EA, 1993, PHYS REV B, V48, P9825, DOI 10.1103/PhysRevB.48.9825; TABOR S, 1990, J BIOL CHEM, V265, P8322; TABOR S, 1987, J BIOL CHEM, V262, P16212; TABOR S, 1989, P NATL ACAD SCI USA, V86, P4076, DOI 10.1073/pnas.86.11.4076; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TABOR S, 1995, P NATL ACAD SCI USA, V92, P6339, DOI 10.1073/pnas.92.14.6339; TABOR S, 1989, J BIOL CHEM, V264, P6447; TRACEY AS, 1986, P NATL ACAD SCI USA, V83, P609, DOI 10.1073/pnas.83.3.609; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; WESTHEIMER FH, 1987, SCIENCE, V235, P1173, DOI 10.1126/science.2434996; Wolfe-Simon F, 2011, SCIENCE, V332, P1163, DOI 10.1126/science.1197258; YOSHIKAWA M, 1967, TETRAHEDRON LETT, P5065	48	5	6	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					29146	29157		10.1074/jbc.M111.250944	http://dx.doi.org/10.1074/jbc.M111.250944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21697085	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000293837000051
J	Hoffmann, DC; Textoris, C; Oehme, F; Klaassen, T; Goppelt, A; Romer, A; Fugmann, B; Davidson, JM; Werner, S; Krieg, T; Eming, SA				Hoffmann, Daniel C.; Textoris, Christine; Oehme, Felix; Klaassen, Tobias; Goppelt, Andreas; Roemer, Axel; Fugmann, Burkhard; Davidson, Jeffrey M.; Werner, Sabine; Krieg, Thomas; Eming, Sabine A.			Pivotal Role for alpha 1-Antichymotrypsin in Skin Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-LEUKOCYTE ELASTASE; CATHEPSIN-G; WOUND REPAIR; PROTEOLYTIC INACTIVATION; GROWTH-FACTOR; HOST-DEFENSE; LEG ULCERS; INHIBITOR; ALPHA(1)-ANTICHYMOTRYPSIN; DISEASE	alpha 1-Antichymotrypsin (alpha 1-ACT) is a specific inhibitor of leukocyte-derived chymotrypsin-like proteases with largely unknown functions in tissue repair. By examining human and murine skin wounds, we showed that following mechanical injury the physiological repair response is associated with an acute phase response of alpha 1-ACT and the mouse homologue Spi-2, respectively. In both species, attenuated alpha 1-ACT/Spi-2 activity and gene expression at the local wound site was associated with severe wound healing defects. Topical application of recombinant alpha 1-ACT to wounds of diabetic mice rescued the impaired healing phenotype. LC-MS analysis of alpha 1-ACT cleavage fragments identified a novel cleavage site within the reactive center loop and showed that neutrophil elastase was the predominant protease involved in unusual alpha 1-ACT cleavage and inactivation in nonhealing human wounds. These results reveal critical functions for locally acting alpha 1-ACT in the acute phase response following skin injury, provide mechanistic insight into its function during the repair response, and raise novel perspectives for its potential therapeutic value in inflammation-mediated tissue damage.	[Hoffmann, Daniel C.; Textoris, Christine; Krieg, Thomas; Eming, Sabine A.] Univ Cologne, Dept Dermatol, D-50931 Cologne, Germany; [Oehme, Felix] Bayer HealthCare, Biotech Dev, D-42117 Wuppertal, Germany; [Klaassen, Tobias; Roemer, Axel] A&M Lab GmbH, D-50126 Bergheim, Germany; [Goppelt, Andreas] Baxter Innovat GmbH, A-1020 Vienna, Austria; [Fugmann, Burkhard] Bayer Innovat GmbH, D-40225 Dusseldorf, Germany; [Davidson, Jeffrey M.] Vet Affairs Tennessee Valley Healthcare Syst, Res Serv, Nashville, TN 37212 USA; [Davidson, Jeffrey M.] Vanderbilt Univ, Sch Med, Nashville, TN 37240 USA; [Werner, Sabine] Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland; [Krieg, Thomas; Eming, Sabine A.] Univ Cologne, Ctr Mol Med Cologne, D-50674 Cologne, Germany	University of Cologne; Bayer AG; Bayer Healthcare Pharmaceuticals; Baxter International Inc; Baxter Innovations GmbH; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Cologne	Eming, SA (corresponding author), Univ Cologne, Dept Dermatol, Joseph Stelzmann Str 9, D-50931 Cologne, Germany.	sabine.eming@uni-koeln.de	Davidson, Jeff/AAI-7288-2021	Werner, Sabine/0000-0001-7397-8710	Deutsche Forschungsgemeinschaft [SFB829]; Bayer Innovation GmbH; European Union [NMP-LA-2008-214402]; Bundesministerium fur Wirtschaft und Technologie [KF2429603SB0]; NATIONAL INSTITUTE ON AGING [R01AG006528] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bayer Innovation GmbH; European Union(European Commission); Bundesministerium fur Wirtschaft und Technologie(Federal Ministry for Economic Affairs and Energy (BMWi)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Deutsche Forschungsgemeinschaft Grant SFB829 (to S. A. E. and T. K.), Bayer Innovation GmbH(to B. F.), the European Union Project Angioscaff Grant NMP-LA-2008-214402 (to S. A. E.), and the Bundesministerium fur Wirtschaft und Technologie Grant KF2429603SB0 (to S. A. E.).	ABBINK JJ, 1993, ARTHRITIS RHEUM, V36, P168, DOI 10.1002/art.1780360206; ARONSEN KF, 1972, SCAND J CLIN LAB INV, V29, P127, DOI 10.3109/00365517209102760; Ashcroft GS, 2000, NAT MED, V6, P1147, DOI 10.1038/80489; BAUMANN H, 1994, IMMUNOL TODAY, V15, P74, DOI 10.1016/0167-5699(94)90137-6; Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Buchstein N, 2009, AM J PATHOL, V174, P2116, DOI 10.2353/ajpath.2009.080597; BURNETT D, 1984, AM REV RESPIR DIS, V129, P473; CAPODICI C, 1989, INFLAMMATION, V13, P137, DOI 10.1007/BF00924785; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Chen P, 2009, J CELL BIOCHEM, V108, P1233, DOI 10.1002/jcb.22363; Chertov O, 1997, J EXP MED, V186, P739, DOI 10.1084/jem.186.5.739; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CICHY J, 1995, J CLIN INVEST, V95, P2729, DOI 10.1172/JCI117975; DESROCHERS PE, 1991, J CLIN INVEST, V87, P2258, DOI 10.1172/JCI115262; Egelund R, 1998, BIOCHEMISTRY-US, V37, P6375, DOI 10.1021/bi973043+; Eming SA, 2007, J INVEST DERMATOL, V127, P514, DOI 10.1038/sj.jid.5700701; Eming SA, 2010, J PROTEOME RES, V9, P4758, DOI 10.1021/pr100456d; FABER JP, 1993, J HEPATOL, V18, P313, DOI 10.1016/S0168-8278(05)80275-2; Forsyth S, 2003, GENOMICS, V81, P336, DOI 10.1016/S0888-7543(02)00041-1; Gettins PGW, 2002, CHEM REV, V102, P4751, DOI 10.1021/cr010170+; Gooptu B, 2009, ANNU REV BIOCHEM, V78, P147, DOI 10.1146/annurev.biochem.78.082107.133320; Goova MT, 2001, AM J PATHOL, V159, P513, DOI 10.1016/S0002-9440(10)61723-3; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Han YP, 2008, J INVEST DERMATOL, V128, P2334, DOI 10.1038/jid.2008.77; HAZUDA DJ, 1990, J BIOL CHEM, V265, P6318; Herrick S, 1997, LAB INVEST, V77, P281; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Huntington JA, 2000, NATURE, V407, P923, DOI 10.1038/35038119; Huttunen M, 2005, BRIT J DERMATOL, V152, P1149, DOI 10.1111/j.1365-2133.2005.06428.x; Kapui Z, 2003, J PHARMACOL EXP THER, V305, P451, DOI 10.1124/jpet.102.044263; KILPATRICK L, 1991, J IMMUNOL, V146, P2388; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOMAS DA, 1995, J BIOL CHEM, V270, P23437, DOI 10.1074/jbc.270.40.23437; MALEMUD CJ, 1975, ARTHRITIS RHEUM-US, V18, P361, DOI 10.1002/art.1780180413; MAST AE, 1991, J BIOL CHEM, V266, P15810; MCRAE B, 1980, BIOCHEMISTRY-US, V19, P3973, DOI 10.1021/bi00558a013; Nathan C, 2010, CELL, V140, P871, DOI 10.1016/j.cell.2010.02.029; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Porcellini E, 2008, CURR PHARM DESIGN, V14, P2659, DOI 10.2174/138161208786264151; POTEMPA J, 1991, J BIOL CHEM, V266, P21482; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; REILLY CF, 1980, BIOCHIM BIOPHYS ACTA, V621, P147, DOI 10.1016/0005-2795(80)90070-7; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; RUBIN H, 1994, BIOCHEMISTRY-US, V33, P7627, DOI 10.1021/bi00190a016; Sambrano GR, 2000, J BIOL CHEM, V275, P6819, DOI 10.1074/jbc.275.10.6819; Shrikumar A, 1998, J BIOL CHEM, V273, P17459, DOI 10.1074/jbc.273.28.17459; Stavridi ES, 1996, BIOCHEMISTRY-US, V35, P10608, DOI 10.1021/bi9605806; STEIN RL, 1987, BIOCHEMISTRY-US, V26, P1301, DOI 10.1021/bi00379a015; Sun RH, 2004, J IMMUNOL, V173, P428, DOI 10.4049/jimmunol.173.1.428; TAKADA S, 1986, CANCER RES, V46, P3688; Thorey IS, 2001, J BIOL CHEM, V276, P35818, DOI 10.1074/jbc.M104871200; vanBergen BH, 1996, ARCH DERMATOL RES, V288, P458, DOI 10.1007/s004030050083; VARTIO T, 1981, J BIOL CHEM, V256, P471; WEISS SJ, 1986, J IMMUNOL, V136, P636; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wingens M, 1998, J INVEST DERMATOL, V111, P996, DOI 10.1046/j.1523-1747.1998.00425.x; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	59	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 19	2011	286	33					28889	28901		10.1074/jbc.M111.249979	http://dx.doi.org/10.1074/jbc.M111.249979			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	806TY	21693707	Green Published, hybrid			2022-12-25	WOS:000293837000026
J	Li, X; Yeung, DF; Fiegen, AM; Sodroski, J				Li, Xing; Yeung, Darwin F.; Fiegen, Ann M.; Sodroski, Joseph			Determinants of the Higher Order Association of the Restriction Factor TRIM5 beta and Other Tripartite Motif (TRIM) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; B-BOX 2; RETROVIRAL RESTRICTION; TRIM5-ALPHA PROTEIN; RHESUS TRIM5-ALPHA; B30.2(SPRY) DOMAIN; MONKEY TRIM5-ALPHA; CYTOPLASMIC BODIES; HIV-1 INFECTION; CAPSID BINDING	Many tripartite motif (TRIM) proteins self-associate, forming dimers and higher order complexes. For example, dimers of TRIM5 alpha, a host factor that restricts retrovirus infection, assemble into higher order arrays on the surface of the viral capsid, resulting in an increase in avidity. Here we show that the higher order association of different TRIM proteins exhibits a wide range of efficiencies. Homologous association (self-association) was more efficient than the heterologous association of different TRIM proteins, indicating that specificity determinants of higher order self-association exist. To investigate the structural determinants of higher order self-association, we studied TRIM mutants and chimeras. These studies revealed the following: 1) the RING domain contributes to the efficiency of higher order self-association, which enhances the binding of TRIM5 alpha to the human immunodeficiency virus (HIV-1) capsid; 2) the RING and B-box 2 domains work together as a homologous unit to promote higher order association of dimers; 3) dimerization is probably required for efficient higher order self-association; 4) the Linker 2 region contributes to higher order self-association, independently of effects of Linker 2 changes on TRIM dimerization; and 5) for efficiently self-associating TRIM proteins, the B30.2(SPRY) domain is not required for higher order self-association. These results support a model in which both ends of the core TRIM dimer (RING-B-box 2 at one end and Linker 2 at the other) contribute to the formation of higher order arrays.	[Li, Xing; Yeung, Darwin F.; Fiegen, Ann M.; Sodroski, Joseph] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Canc Immunol & AIDS, Boston, MA 02215 USA; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Sodroski, J (corresponding author), Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Canc Immunol & AIDS, 450 Brookline Ave,CLS 1010, Boston, MA 02215 USA.	joseph_sodroski@dfci.harvard.edu		Durbin, Ann/0000-0002-7348-5243	National Institutes of Health [AI063987, AI076094]; Center for AIDS Research [AI06354]; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063987, R21AI076094] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for AIDS Research; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI063987 and AI076094 and Center for AIDS Research Award AI06354. This work was also supported by the International AIDS Vaccine Initiative and the late William F. McCarty-Cooper.	Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Campbell EM, 2008, J CELL BIOL, V180, P549, DOI 10.1083/jcb.200706154; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2011, P NATL ACAD SCI USA, V108, P534, DOI 10.1073/pnas.1013426108; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Hennig J, 2005, J BIOL CHEM, V280, P33250, DOI 10.1074/jbc.M503066200; Hennig J, 2008, J MOL BIOL, V377, P431, DOI 10.1016/j.jmb.2008.01.005; Javanbakht H, 2005, J BIOL CHEM, V280, P26933, DOI 10.1074/jbc.M502145200; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Kar AK, 2008, J VIROL, V82, P11669, DOI 10.1128/JVI.01559-08; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Langelier CR, 2008, J VIROL, V82, P11682, DOI 10.1128/JVI.01562-08; Li X, 2007, VIROLOGY, V366, P234, DOI 10.1016/j.virol.2007.04.022; Li X, 2007, VIROLOGY, V360, P419, DOI 10.1016/j.virol.2006.10.035; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Li Y, 2006, J VIROL, V80, P6738, DOI 10.1128/JVI.00270-06; Maillard PV, 2007, PLOS PATHOG, V3, P2052, DOI 10.1371/journal.ppat.0030200; Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304; Mische CC, 2005, J VIROL, V79, P14446, DOI 10.1128/JVI.79.22.14446-14450.2005; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Ottosson L, 2006, MOL IMMUNOL, V43, P588, DOI 10.1016/j.molimm.2005.04.013; Perez-Caballero D, 2005, J VIROL, V79, P15567, DOI 10.1128/JVI.79.24.15567-15572.2005; Perez-Caballero D, 2005, J VIROL, V79, P8969, DOI 10.1128/JVI.79.14.8969-8978.2005; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rold CJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000074; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Sastri J, 2010, VIROLOGY, V405, P259, DOI 10.1016/j.virol.2010.06.015; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Sebastian S, 2009, J VIROL, V83, P3365, DOI 10.1128/JVI.00432-08; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Song B, 2005, VIROLOGY, V343, P201, DOI 10.1016/j.virol.2005.08.019; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2005, J VIROL, V79, P3139, DOI 10.1128/JVI.79.5.3139-3145.2005; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Yap MW, 2007, VIROLOGY, V365, P302, DOI 10.1016/j.virol.2007.04.005; Yap MW, 2005, CURR BIOL, V15, P73, DOI 10.1016/j.cub.2004.12.042; Yap MW, 2004, P NATL ACAD SCI USA, V101, P10786, DOI 10.1073/pnas.0402876101; YEE JK, 1994, METHOD CELL BIOL, V43, P99	46	45	50	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					27959	27970		10.1074/jbc.M111.260406	http://dx.doi.org/10.1074/jbc.M111.260406			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21680743	hybrid, Green Published			2022-12-25	WOS:000293557800014
J	Xu, M; Joo, HJ; Paik, YK				Xu, Mo; Joo, Hyoe-Jin; Paik, Young-Ki			Novel Functions of Lipid-binding Protein 5 in Caenorhabditis elegans Fat Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; GENE-EXPRESSION; LIVER; IDENTIFICATION; NEMATODES; INSIGHTS; OBESITY; NHR-49; DAUER; ACIDS	The lipid-binding protein (LBP) family is conserved from Caenorhabditis elegans to mammals and essential for fatty acid homeostasis. RNAi-mediated knockdown of nine C. elegans lbp family members revealed that lbp-5 regulates fat accumulation. C. elegans LBP-5 bound directly to various fatty acids with varying affinities. lbp-5 expression in nhr-49(nr2041) worms was much lower than in N2 worms. Nhr-49 transcriptional activity also decreased with lbp-5 deletion, suggesting that they may work together as functional partners in fat metabolism. In support of this notion, LBP-5 translocated into nuclei, where it appeared to influence C. elegans NHR-49 target genes involved in energy metabolism. Interestingly, LBP-5 is required for stearic acid-induced transcription of NHR-49 target genes. Thus, this knowledge could help identify therapeutic targets to treat obesity and diseases associated with nematode-host interactions.	[Xu, Mo; Joo, Hyoe-Jin; Paik, Young-Ki] Yonsei Univ, Dept Biochem & Biomed Sci, Coll Life Sci & Biotechnol, World Class Univ Program,Yonsei Proteome Res Ctr, Seoul 120749, South Korea	Yonsei University	Paik, YK (corresponding author), 134 Shinchon Dong, Seoul 120749, South Korea.	paikyk@yonsei.ac.kr			Ministry of Education, Science and Technology [R31-2008-000-10086-0]; Ministry of Health and Welfare, Republic of Korea [A030003]	Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the World Class University program through the National Research Foundation of Korea funded by Ministry of Education, Science and Technology Grant R31-2008-000-10086-0 and Korean Health 21 R&D Project, Ministry of Health and Welfare, Republic of Korea Grant A030003 (to Y.-K. P.).	Bradley JE, 2001, TRENDS PARASITOL, V17, P471, DOI 10.1016/S1471-4922(01)02036-0; BRENNER S, 1974, GENETICS, V77, P71; Brooks KK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007545; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Costet P, 1998, J BIOL CHEM, V273, P29577, DOI 10.1074/jbc.273.45.29577; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Di Pietro SM, 1999, EUR J BIOCHEM, V259, P127, DOI 10.1046/j.1432-1327.1999.00015.x; Esteves A, 2006, COMP BIOCHEM PHYS C, V142, P262, DOI 10.1016/j.cbpc.2005.11.006; FIRE A, 1986, EMBO J, V5, P2673, DOI 10.1002/j.1460-2075.1986.tb04550.x; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; GLATZ JFC, 1995, PROSTAG LEUKOTR ESS, V52, P121, DOI 10.1016/0952-3278(95)90010-1; Gomez TA, 2007, DEV BIOL, V303, P493, DOI 10.1016/j.ydbio.2006.11.023; Haunerland NH, 2004, PROG LIPID RES, V43, P328, DOI 10.1016/j.plipres.2004.05.001; JANSSEN D, 1995, BIOCHEM J, V311, P49, DOI 10.1042/bj3110049; Jeong PY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004162; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Kennedy Malcolm W., 2001, P309, DOI 10.1079/9780851994239.0309; Kennedy MW, 2000, BBA-PROTEIN STRUCT M, V1476, P149, DOI 10.1016/S0167-4838(99)00249-6; MAATMAN RGHJ, 1994, BBA-LIPID LIPID MET, V1214, P1, DOI 10.1016/0005-2760(94)90002-7; Michalik L, 2008, PPAR RES, V2008, DOI 10.1155/2008/134059; Morck C, 2009, P NATL ACAD SCI USA, V106, P18285, DOI 10.1073/pnas.0907117106; Oh WS, 2009, PLOS ONE, V4, pA22, DOI 10.1371/journal.pone.0007593; Plenefisch J, 2000, MOL BIOCHEM PARASIT, V105, P223, DOI 10.1016/S0166-6851(99)00179-6; Porter MY, 2005, J NEUROSCI RES, V79, P836, DOI 10.1002/jnr.20403; RIDDLE DL, 1997, GENETIC ENV REGULATI, V26, P739; ROSS AC, 1993, FASEB J, V7, P317, DOI 10.1096/fasebj.7.2.8440409; Samulin J, 2008, COMP BIOCHEM PHYS B, V151, P147, DOI 10.1016/j.cbpb.2008.06.010; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stewart JM, 2000, CELL MOL LIFE SCI, V57, P1345, DOI 10.1007/PL00000620; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Storch J, 2008, ANNU REV NUTR, V28, P73, DOI 10.1146/annurev.nutr.27.061406.093710; Storch J, 2009, J LIPID RES, V50, pS126, DOI 10.1194/jlr.R800084-JLR200; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Van Gilst MR, 2005, P NATL ACAD SCI USA, V102, P13496, DOI 10.1073/pnas.0506234102; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; Wang YX, 2003, CELL, V113, P159, DOI 10.1016/S0092-8674(03)00269-1; Watts JL, 2009, TRENDS ENDOCRIN MET, V20, P58, DOI 10.1016/j.tem.2008.11.002; Wolfrum C, 2001, P NATL ACAD SCI USA, V98, P2323, DOI 10.1073/pnas.051619898; Zendzian-Piotrowska M, 1994, Postepy Hig Med Dosw, V48, P753; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y	40	15	18	3	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 12	2011	286	32					28111	28118		10.1074/jbc.M111.227165	http://dx.doi.org/10.1074/jbc.M111.227165			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	803CJ	21697096	Green Published, hybrid			2022-12-25	WOS:000293557800029
J	Burg, JS; Espenshade, PJ				Burg, John S.; Espenshade, Peter J.			Glucose Controls Phosphoregulation of Hydroxymethylglutaryl Coenzyme A Reductase through the Protein Phosphatase 2A-related Phosphatase Protein, Ppe1, and Insig in Fission Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HMG-COA REDUCTASE; SCHIZOSACCHAROMYCES-POMBE; CHOLESTEROL-SYNTHESIS; CELLULAR-ENERGY; CBS DOMAINS; KINASE; SENSOR; PHOSPHORYLATION; STEROLS; PATHWAY	HMG-CoA reductase (HMGR) catalyzes a rate-limiting step in sterol biosynthesis and is a key control point in the feedback inhibition that regulates this pathway. Through the action of the membrane protein Insig, HMGR synthesis and degradation are regulated to maintain sterol homeostasis. The fission yeast Schizosaccharomyces pombe encodes homologs of HMGR and Insig called hmg1(+) and ins1(+), respectively. In contrast to the mammalian system, Ins1 regulates Hmg1 by a nondegradative mechanism involving phosphorylation of the Hmg1 active site. Here, we investigate the role of the Ins1-Hmg1 system in coupling glucose sensing to regulation of sterol biosynthesis. We show that Ins1-dependent Hmg1 phosphorylation is strongly induced in response to glucose withdrawal and that HMGR activity is correspondingly reduced. We also find that inability to activate Hmg1 phosphorylation under nutrient limiting conditions results in overaccumulation of sterol pathway intermediates. Furthermore, we show that regulation of Hmg1 phosphorylation requires the protein phosphatase 2A-related phosphatase Ppe1 and its regulator Sds23. These results describe a mechanism by which cells tune the rate of sterol synthesis to match nutrient availability.	[Burg, John S.; Espenshade, Peter J.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Espenshade, PJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St,Physiol 107B, Baltimore, MD 21205 USA.	peter.espenshade@jhmi.edu			National Institutes of Health [HL-077588]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant HL-077588.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bimbo A, 2005, EUKARYOT CELL, V4, P799, DOI 10.1128/EC.4.4.799-813.2005; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; BURKE JD, 1994, MOL GEN GENET, V242, P169, DOI 10.1007/BF00391010; Engelking LJ, 2005, J CLIN INVEST, V115, P2489, DOI 10.1172/JCI25614; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Friesen JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-248; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Hanyu Y, 2009, GENES CELLS, V14, P539, DOI 10.1111/j.1365-2443.2009.01290.x; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hughes AL, 2007, J BIOL CHEM, V282, P24388, DOI 10.1074/jbc.M701326200; Hughes AL, 2005, CELL, V120, P831, DOI 10.1016/j.cell.2005.01.012; Ignoul S, 2005, AM J PHYSIOL-CELL PH, V289, pC1369, DOI 10.1152/ajpcell.00282.2005; INGEBRITSEN TS, 1983, EUR J BIOCHEM, V132, P275, DOI 10.1111/j.1432-1033.1983.tb07359.x; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Matsuzawa T, 2011, J BIOSCI BIOENG, V111, P158, DOI 10.1016/j.jbiosc.2010.10.007; MITCHISON JM, 1969, J CELL SCI, V5, P373; MORENO S, 1985, ARCH MICROBIOL, V142, P370, DOI 10.1007/BF00491906; OMKUMAR RV, 1994, J BIOL CHEM, V269, P6810; Pluskal T, 2011, FEBS J, V278, P1299, DOI 10.1111/j.1742-4658.2011.08050.x; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; SHIMANUKI M, 1993, MOL BIOL CELL, V4, P303, DOI 10.1091/mbc.4.3.303; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	29	6	6	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 5	2011	286	31					27139	27146		10.1074/jbc.M111.233452	http://dx.doi.org/10.1074/jbc.M111.233452			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	799EZ	21680738	Green Published, hybrid			2022-12-25	WOS:000293268700009
J	Hogl, S; Kuhn, PH; Colombo, A; Lichtenthaler, SF				Hogl, Sebastian; Kuhn, Peer-Hendrik; Colombo, Alessio; Lichtenthaler, Stefan F.			Determination of the Proteolytic Cleavage Sites of the Amyloid Precursor-Like Protein 2 by the Proteases ADAM10, BACE1 and gamma-Secretase	PLOS ONE			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; CHONDROITIN SULFATE GLYCOSAMINOGLYCAN; BETA-SECRETASE; ALPHA-SECRETASE; ALZHEIMERS-DISEASE; FAMILY-MEMBERS; TRANSMEMBRANE DOMAIN; HIPPOCAMPAL-NEURONS; DEFICIENT MICE; CELL-ADHESION	Regulated intramembrane proteolysis of the amyloid precursor protein (APP) by the protease activities alpha-, beta-and gamma-secretase controls the generation of the neurotoxic amyloid beta peptide. APLP2, the amyloid precursor-like protein 2, is a homolog of APP, which shows functional overlap with APP, but lacks an amyloid beta domain. Compared to APP, less is known about the proteolytic processing of APLP2, in particular in neurons, and the cleavage sites have not yet been determined. APLP2 is cleaved by the beta-secretase BACE1 and additionally by an alpha-secretase activity. The two metalloproteases ADAM10 and ADAM17 have been suggested as candidate APLP2 alpha-secretases in cell lines. Here, we used RNA interference and found that ADAM10, but not ADAM17, is required for the constitutive alpha-secretase cleavage of APLP2 in HEK293 and SH-SY5Y cells. Likewise, in primary murine neurons knock-down of ADAM10 suppressed APLP2 alpha-secretase cleavage. Using mass spectrometry we determined the proteolytic cleavage sites in the APLP2 sequence. ADAM10 was found to cleave APLP2 after arginine 670, whereas BACE1 cleaves after leucine 659. Both cleavage sites are located in close proximity to the membrane. c-secretase cleavage was found to occur at different peptide bonds between alanine 694 and valine 700, which is close to the N-terminus of the predicted APLP2 transmembrane domain. Determination of the APLP2 cleavage sites enables functional studies of the different APLP2 ectodomain fragments and the production of cleavage-site specific antibodies for APLP2, which may be used for biomarker development.	[Hogl, Sebastian; Kuhn, Peer-Hendrik; Colombo, Alessio; Lichtenthaler, Stefan F.] German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Hogl, Sebastian; Kuhn, Peer-Hendrik; Colombo, Alessio; Lichtenthaler, Stefan F.] Ludwig Maximilians Univ Munchen, Adolf Butenandt Inst, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich	Hogl, S (corresponding author), German Ctr Neurodegenerat Dis DZNE, Munich, Germany.	stefan.lichtenthaler@med.uni-muenchen.de	Lichtenthaler, Stefan F/B-6587-2016	Lichtenthaler, Stefan F/0000-0003-2211-2575; Kuhn, Peer-Hendrik/0000-0001-7891-5102	Deutsche Forschungsgemeinschaft [SFB596, B12]; BMBF; DAAD; Boehringer Ingelheim Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF(Federal Ministry of Education & Research (BMBF)); DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	We thank the following institutions for financial support: the Deutsche Forschungsgemeinschaft for SFB596 project B12, the competence network degenerative dementias (BMBF) and the PPP program (DAAD) (all to SFL) and the Boehringer Ingelheim Foundation to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Capell A, 2000, J BIOL CHEM, V275, P30849, DOI 10.1074/jbc.M003202200; Cong R, 2011, AM J PHYSIOL-CELL PH, V300, pC1366, DOI 10.1152/ajpcell.00451.2010; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Eggert S, 2004, J BIOL CHEM, V279, P18146, DOI 10.1074/jbc.M311601200; Endres K, 2005, FEBS J, V272, P5808, DOI 10.1111/j.1742-4658.2005.04976.x; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; Frigerio CS, 2010, FEBS J, V277, P1503, DOI 10.1111/j.1742-4658.2010.07579.x; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200; Grziwa B, 2003, J BIOL CHEM, V278, P6803, DOI 10.1074/jbc.M210047200; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Haass C, 2004, EMBO J, V23, P483, DOI 10.1038/sj.emboj.7600061; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jacobsen KT, 2010, J BIOL CHEM, V285, P10223, DOI 10.1074/jbc.M109.038224; Jacobsen KT, 2009, CELL MOL LIFE SCI, V66, P2299, DOI 10.1007/s00018-009-0020-8; Koike H, 1999, BIOCHEM J, V343, P371, DOI 10.1042/0264-6021:3430371; Kuhn PH, 2007, J BIOL CHEM, V282, P11982, DOI 10.1074/jbc.M700356200; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Li HM, 2010, P NATL ACAD SCI USA, V107, P17362, DOI 10.1073/pnas.1012568107; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lichtenthaler SF, 2002, P NATL ACAD SCI USA, V99, P1365, DOI 10.1073/pnas.032395699; Lichtenthaler SF, 2007, EMBO REP, V8, P537, DOI 10.1038/sj.embor.7400978; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Ludwig A, 2005, COMB CHEM HIGH T SCR, V8, P161, DOI 10.2174/1386207053258488; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; MULLER U, 1994, CELL, V79, P755, DOI 10.1016/0092-8674(94)90066-3; Neumann S, 2006, J BIOL CHEM, V281, P7583, DOI 10.1074/jbc.M508340200; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Nyborg AC, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-3; Okochi M, 2002, EMBO J, V21, P5408, DOI 10.1093/emboj/cdf541; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Pastorino L, 2004, MOL CELL NEUROSCI, V25, P642, DOI 10.1016/j.mcn.2003.12.013; Reiss K, 2005, EMBO J, V24, P742, DOI 10.1038/sj.emboj.7600548; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Rossner S, 2006, PROG NEUROBIOL, V79, P95, DOI 10.1016/j.pneurobio.2006.06.001; SANDBRINK R, 1994, J BIOL CHEM, V269, P14227; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Schobel S, 2008, J BIOL CHEM, V283, P14257, DOI 10.1074/jbc.M801531200; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Simons M, 1996, J NEUROSCI, V16, P899; Slack BE, 2001, BIOCHEM J, V357, P787, DOI 10.1042/0264-6021:3570787; SLUNT HH, 1994, J BIOL CHEM, V269, P2637; Stachel SJ, 2004, J MED CHEM, V47, P6447, DOI 10.1021/jm049379g; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; THINAKARAN G, 1994, J BIOL CHEM, V269, P22099; THINAKARAN G, 1995, J BIOL CHEM, V270, P16522, DOI 10.1074/jbc.270.28.16522; Ullrich S, 2010, J BIOL CHEM, V285, P20664, DOI 10.1074/jbc.M109.055608; Von Koch CS, 1997, NEUROBIOL AGING, V18, P661, DOI 10.1016/S0197-4580(97)00151-6; Wang R, 1996, J BIOL CHEM, V271, P31894, DOI 10.1074/jbc.271.50.31894; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yanagida K, 2009, EMBO MOL MED, V1, P223, DOI 10.1002/emmm.200900026; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	65	38	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21337	10.1371/journal.pone.0021337	http://dx.doi.org/10.1371/journal.pone.0021337			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695060	gold, Green Submitted, Green Published			2022-12-25	WOS:000291737600060
J	Prat, S; Pean, SC; Crepin, L; Drucker, DG; Puaud, SJ; Valladas, H; Laznickova-Galetova, M; van der Plicht, J; Yanevich, A				Prat, Sandrine; Pean, Stephane C.; Crepin, Laurent; Drucker, Dorothee G.; Puaud, Simon J.; Valladas, Helene; Laznickova-Galetova, Martina; van der Plicht, Johannes; Yanevich, Alexander			The Oldest Anatomically Modern Humans from Far Southeast Europe: Direct Dating, Culture and Behavior	PLOS ONE			English	Article							PESTERA CU OASE; ISOTOPIC EVIDENCE; BONE-COLLAGEN; HUMAN REMAINS; MIDDLE; CAVE; AURIGNACIAN; EXTINCTION; MORPHOLOGY; DISPERSAL	Background: Anatomically Modern Humans (AMHs) are known to have spread across Europe during the period coinciding with the Middle to Upper Paleolithic transition. Whereas their dispersal into Western Europe is relatively well established, evidence of an early settlement of Eastern Europe by modern humans are comparatively scarce. Methodology/Principal Finding: Based on a multidisciplinary approach for the study of human and faunal remains, we describe here the oldest AMH remains from the extreme southeast Europe, in conjunction with their associated cultural and paleoecological background. We applied taxonomy, paleoecology, and taphonomy combined with geomorphology, stratigraphy, archeology and radiocarbon dating. More than 160 human bone remains have been discovered. They originate from a well documented Upper Paleolithic archeological layer (Gravettian cultural tradition) from the site of Buran-Kaya III located in Crimea (Ukraine). The combination of non-metric dental traits and the morphology of the occipital bones allow us to attribute the human remains to Anatomically Modern Humans. A set of human and faunal remains from this layer has been radiocarbon dated by Accelerator Mass Spectrometry. The direct-dating results of human bone establish a secure presence of AMHs at 31,900+240/-220 BP in this region. They are the oldest direct evidence of the presence of AMHs in a well documented archeological context. Based on taphonomical observations (cut marks and distribution of skeletal elements), they represent the oldest Upper Paleolithic modern humans from Eastern Europe, showing post-mortem treatment of the dead as well. Conclusion/Significance: These findings are essential for the debate on the spread of modern humans in Europe during the Upper Paleolithic, as well as their cultural behaviors.	[Prat, Sandrine] CNRS, Lab Dynam Evolut Humaine, UPR 2147, Paris, France; [Pean, Stephane C.; Crepin, Laurent; Puaud, Simon J.] MNHN CNRS, Dept Prehist, UMR 7194, Paris, France; [Drucker, Dorothee G.] Univ Tubingen, Dept Geosci, Tubingen, Germany; [Valladas, Helene] CEA CNRS UVSQ, Lab Sci Climat & Environm, IPSL, Gif Sur Yvette, France; [Laznickova-Galetova, Martina] Moravian Museum, Anthropos Inst, GACR P405 10 1710, Brno, Czech Republic; [van der Plicht, Johannes] Univ Groningen, Ctr Isotope Res, Groningen, Netherlands; [van der Plicht, Johannes] Leiden Univ, Fac Archaeol, Leiden, Netherlands; [Yanevich, Alexander] Natl Ukrainian Acad Sci, Inst Archaeol, Kiev, Ukraine	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Eberhard Karls University of Tubingen; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Moravian Museum; University of Groningen; Leiden University; Leiden University - Excl LUMC; National Academy of Sciences Ukraine; Institute of Archaeology, National Academy of Sciences of Ukraine	Prat, S (corresponding author), CNRS, Lab Dynam Evolut Humaine, UPR 2147, Paris, France.	sandrine.prat@evolhum.cnrs.fr	van der Plicht, Johannes/B-9994-2013; Galetova, Martina/AAH-5244-2020; Drucker, Dorothée G./E-8900-2011	Drucker, Dorothée G./0000-0003-0854-4371; Yanevich, Olexandr/0000-0002-8088-6950	ANR, French National Research Agency (Agence Nationale de la Recherche) [ANR-05-JCJC-0240-01]; Museum National d'Histoire Naturelle (Paris); CNRS-UPR [2147]	ANR, French National Research Agency (Agence Nationale de la Recherche)(French National Research Agency (ANR)); Museum National d'Histoire Naturelle (Paris); CNRS-UPR	The analyses were supported by the ANR "Mammouths" Research Program No. ANR-05-JCJC-0240-01 of the French National Research Agency (Agence Nationale de la Recherche). The ATM Program "Relations Homme-Nature" of the Museum National d'Histoire Naturelle (Paris) and the CNRS-UPR 2147 funded the 2009 and 2010 field seasons. The funders had no role in study design, data collection and analysis, decision to publish, or preparation to the manuscript.	Alexandrescu E, 2010, ANTHROPOLOGIE, V114, P341, DOI 10.1016/j.anthro.2010.05.004; AMBROSE SH, 1990, J ARCHAEOL SCI, V17, P431, DOI 10.1016/0305-4403(90)90007-R; Anikovich MV, 2007, SCIENCE, V315, P223, DOI 10.1126/science.1133376; Bailey S, 2006, PERIOD BIOL, V108, P253; Bailey Shara E., 2002, Anatomical Record, V269, P148, DOI 10.1002/ar.10116; Bailey SE, 2009, J HUM EVOL, V57, P11, DOI 10.1016/j.jhevol.2009.02.003; Balzeau A, 2010, J HUM EVOL, V58, P1, DOI 10.1016/j.jhevol.2009.05.016; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Bar-Yosef O, 2002, ANNU REV ANTHROPOL, V31, P363, DOI 10.1146/annurev.anthro.31.040402.085416; Bastir M, 2010, J HUM EVOL, V58, P68, DOI 10.1016/j.jhevol.2009.08.006; Bocherens H, 2003, INT J OSTEOARCHAEOL, V13, P46, DOI 10.1002/oa.662; Bocherens H, 2009, P NATL ACAD SCI USA, V106, pE117, DOI 10.1073/pnas.0909392106; Bonch-Osmolovsky G.A., 1934, T 2 MEZH K ASS POIZ, P114; Boulestin B., 1999, BAR INT SER, V776, P276; Bruzek J, 2002, AM J PHYS ANTHROPOL, V117, P157, DOI 10.1002/ajpa.10012; CAILLEUX A, 1992, CODE COULEURS SOLS; CHABAI VP, 2004, MIDDLE PALEOLITHIC E, V104, P419; Churchill SE, 2000, YEARB PHYS ANTHROPOL, V43, P61; Conard NJ, 2003, J HUM EVOL, V44, P331, DOI 10.1016/S0047-2484(02)00202-6; Dean D, 1998, J HUM EVOL, V34, P485, DOI 10.1006/jhev.1998.0214; Demidenko YE, 2008, QUARTAR, V55, P99; DEMIDENKO YE, 1998, PREHISTOIRE ANATOLIE, V85, P367; DEMIDENKO YE, 2004, MIDDLE PALEOLITHIC E, V104, P113; DENIRO MJ, 1985, NATURE, V317, P806, DOI 10.1038/317806a0; Drucker D, 2004, INT J OSTEOARCHAEOL, V14, P162, DOI 10.1002/oa.753; Duday H., 2009, LECT ARCHAEOTHANATOL, DOI 10.2307/j.ctt1cd0pkv; FERRING CR, 1998, MIDDLE PALEOLITHIC W, V1, P17; GAVRIS GG, 2004, MIDDLE PALEOLITHIC E, V104, P79; GERASIMENKO N, 2004, MIDDLE PALEOLITHIC E, V104, P19; Gerasimenko N, 2007, QUATERN INT, V164-65, P207, DOI 10.1016/j.quaint.2006.12.018; GIRIA EY, 2004, MIDDLE PALEOLITHIC E, V104, P151; Griggo C., 1995, SIGNIFICATION PALEOE, P222; Haesaerts P., 1996, ARCHAEOL AUSTRIACA, V80, P25; Harvati K, 2007, J HUM EVOL, V53, P732, DOI 10.1016/j.jhevol.2007.09.009; Harvati Katerina, 2007, P1717, DOI 10.1007/978-3-540-33761-4_56; Henry-Gambier Dominique, 2008, Bulletins et Memoires de la Societe d'Anthropologie de Paris, V20, P79; Hoffecker J. F., 2002, DESOLATE LANDSCAPE I; Hoffecker JF, 2009, P NATL ACAD SCI USA, V106, P16040, DOI 10.1073/pnas.0903446106; Jacobi RM, 2008, J HUM EVOL, V55, P898, DOI 10.1016/j.jhevol.2008.08.007; Janevic AA, 1998, PREHISTOIRE EUROPEEN, V13, P133; Joris O, 2008, J HUM EVOL, V55, P782, DOI 10.1016/j.jhevol.2008.04.002; KOLOSOV Y, 1998, ZAPISKI NAUKOVOGO TO, V235, P38; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; KURBJUHN M, 2004, MIDDLE PALEOLITHIC E, V104, P249; LAROULANDIE V, 2004, MIDDLE PALEOLITHIC E, V104, P83; Le Mort F, 1981, DEGRADATIONS ARTIFIC; LEBON M, 2010, P LETHNOLOGIE, V2, P149; LONGIN R, 1971, NATURE, V230, P241, DOI 10.1038/230241a0; Lyman RL., 1994, VERTEBRATE TAPHONOMY, DOI [DOI 10.1017/CBO9781139878302, 10.1017/CBO9781139878302]; MARKOVA AK, 2004, MIDDLE PALEOLITHIC E, V104, P35; Marks AE, 2006, INTERD CONTRIB ARCH, P121, DOI 10.1007/0-387-24661-4_7; Mellars P, 2006, NATURE, V439, P931, DOI 10.1038/nature04521; MONIGAL K, 2004, MIDDLE PALEOLITHIC E, V104, P57; Monigal K., 2004, MIDDLE PALEOLITHIC E, V104, P3; Munsell AH., 2000, MUNSELL SOIL COLOR C; Neary DG, 1999, FOREST ECOL MANAG, V122, P51, DOI 10.1016/S0378-1127(99)00032-8; NELSON DE, 1991, SCIENCE, V251, P552, DOI 10.1126/science.1990430; Nicod Jean, 1997, QUATERNAIRE, V8, P71; Nuzhnyi D., 2009, QUARTAR, V56, P159; Otte M, 2004, DONLIN VESTONICE STU, V11, P8; Patou-Mathis M., 1994, OUTILLAGE PEU ELABOR; Patou-Mathis M., 2004, MIDDLE PALEOLITHIC E, V104, P95; Pettitt PB, 1998, PREHISTOIRE ANATOLIE, V85, P329; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Richards MP, 2008, P NATL ACAD SCI USA, V105, P600, DOI 10.1073/pnas.0711063105; Richards MP, 2009, P NATL ACAD SCI USA, V106, P16034, DOI 10.1073/pnas.0903821106; Richards MP, 2001, P NATL ACAD SCI USA, V98, P6528, DOI 10.1073/pnas.111155298; Richter J, 2004, MIDDLE PALEOLITHIC E, P233; Rozzi FVR, 2009, J ANTHROPOL SCI, V87, P153; Scott G.R., 1997, ANTHR MODERN HUMAN T, DOI 10.1017/CBO9781316529843; Sinitsyn AA, 2006, QUATERN INT, V152, P164, DOI 10.1016/j.quaint.2005.12.007; Smith FH, 2005, QUATERN INT, V137, P7, DOI 10.1016/j.quaint.2004.11.016; SMITH FH, 1991, AUX ORIGINES HOMO SA, P251; Soficaru A, 2007, CURR ANTHROPOL, V48, P611, DOI 10.1086/519915; Soficaru A, 2006, P NATL ACAD SCI USA, V103, P17196, DOI 10.1073/pnas.0608443103; Stodder A.L.W., 2008, BIOL ANTHR HUMAN SKE, P71, DOI [DOI 10.1002/9780470245842.CH3, 10.1002/9780470245842.ch3]; Synitsyn AA, 1997, RADIOUGLERODNAJA KHR, V52, P21; Tisnerat-Laborde N, 2003, RADIOCARBON, V45, P409, DOI 10.1017/S003382220003277X; Trinkaus E, 2003, P NATL ACAD SCI USA, V100, P11231, DOI 10.1073/pnas.2035108100; Trinkaus E., 2009, MAT CERCETARI ARHEOL, VV, P5; Trinkaus E, 2008, AM J PHYS ANTHROPOL, V137, P106, DOI 10.1002/ajpa.20833; Trinkaus E, 2008, ANTHROPOL SCI, V116, P231, DOI 10.1537/ase.071221; TURNER CG, 1991, ADVANCES IN DENTAL ANTHROPOLOGY, P13; Uthmeier T., 2004, ETUDES RECHERCHES AR, V104, P193; Valde-Nowak P, 2003, OBLAZOWA CAVE; VILLA P, 1986, SCIENCE, V233, P431, DOI 10.1126/science.233.4762.431; VLEK E, 1975, B MEM SOC ANTHRO PAR, V13, P257; White T.D., 1992, PREHISTORIC CANNIBAL; Wild EM, 2005, NATURE, V435, P332, DOI 10.1038/nature03585; Yanevich A, 2009, TOP ISSUES E EUROPEA, V20, P187; Yanevich A, 2000, ARCHEOLOGIA, V2, P11; Zilhao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008880	93	47	49	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e20834	10.1371/journal.pone.0020834	http://dx.doi.org/10.1371/journal.pone.0020834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	778VR	21698105	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600019
J	Watson, DS; Feng, XZ; Askew, DS; Jambunathan, K; Kodukula, K; Galande, AK				Watson, Douglas S.; Feng, Xizhi; Askew, David S.; Jambunathan, Kalyani; Kodukula, Krishna; Galande, Amit K.			Substrate Specifity Profiling of the Aspergillus fumigatus Proteolytic Secretome Reveals Consensus Motifs with Predominance of Ile/Leu and Phe/Tyr	PLOS ONE			English	Article							INVASIVE PULMONARY ASPERGILLOSIS; EXTRACELLULAR ALKALINE PROTEASE; SERINE-PROTEASE; PEPTIDE LIBRARY; ANIMAL-MODELS; VIRULENCE; GENE; PURIFICATION; ENZYME; GROWTH	Background: The filamentous fungus Aspergillus fumigatus (AF) can cause devastating infections in immunocompromised individuals. Early diagnosis improves patient outcomes but remains challenging because of the limitations of current methods. To augment the clinician's toolkit for rapid diagnosis of AF infections, we are investigating AF secreted proteases as novel diagnostic targets. The AF genome encodes up to 100 secreted proteases, but fewer than 15 of these enzymes have been characterized thus far. Given the large number of proteases in the genome, studies focused on individual enzymes may overlook potential diagnostic biomarkers. Methodology and Principal Findings: As an alternative, we employed a combinatorial library of internally quenched fluorogenic probes (IQFPs) to profile the global proteolytic secretome of an AF clinical isolate in vitro. Comparative protease activity profiling revealed 212 substrate sequences that were cleaved by AF secreted proteases but not by normal human serum. A central finding was that isoleucine, leucine, phenylalanine, and tyrosine predominated at each of the three variable positions of the library (44.1%, 59.1%, and 57.0%, respectively) among substrate sequences cleaved by AF secreted proteases. In contrast, fewer than 10% of the residues at each position of cleaved sequences were cationic or anionic. Consensus substrate motifs were cleaved by thermostable serine proteases that retained activity up to 50 degrees C. Precise proteolytic cleavage sites were reliably determined by a simple, rapid mass spectrometry-based method, revealing predominantly non-prime side specificity. A comparison of the secreted protease activities of three AF clinical isolates revealed consistent protease substrate specificity fingerprints. However, secreted proteases of A. flavus, A. nidulans, and A. terreus strains exhibited striking differences in their proteolytic signatures. Conclusions: This report provides proof-of-principle for the use of protease substrate specificity profiling to define the proteolytic secretome of Aspergillus fumigatus. Expansion of this technique to protease secretion during infection could lead to development of novel approaches to fungal diagnosis.	[Watson, Douglas S.; Jambunathan, Kalyani; Kodukula, Krishna; Galande, Amit K.] SRI Int, Ctr Adv Drug Res, Biosci Div, Harrisonburg, VA USA; [Feng, Xizhi; Askew, David S.] Univ Cincinnati, Coll Med, Dept Pathol & Lab Med, Cincinnati, OH 45267 USA	SRI International; University System of Ohio; University of Cincinnati	Watson, DS (corresponding author), SRI Int, Ctr Adv Drug Res, Biosci Div, Harrisonburg, VA USA.	amit.galande@sri.com		Askew, David/0000-0002-6477-2515	Commonwealth of Virginia; National Institute of Allergy and Infectious Diseases [R21AI085402]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI085402] Funding Source: NIH RePORTER	Commonwealth of Virginia; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	CADRE was established through funding support from the Commonwealth of Virginia to SRI International. In addition, this work was supported by grant R21AI085402 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adav SS, 2010, J PROTEOME RES, V9, P3932, DOI 10.1021/pr100148j; Alexander B D, 2002, Transpl Infect Dis, V4 Suppl 3, P32, DOI 10.1034/j.1399-3062.4.s3.5.x; Askew DS, 2008, CURR OPIN MICROBIOL, V11, P331, DOI 10.1016/j.mib.2008.05.009; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; BEHNSEN J, 2010, INFECT IMMUN; Bergmann A, 2009, INFECT IMMUN, V77, P4041, DOI 10.1128/IAI.00425-09; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; Bhabhra R, 2004, INFECT IMMUN, V72, P4731, DOI 10.1128/IAI.72.8.4731-4740.2004; Caillot D, 2001, CLIN MICROBIOL INFEC, V7, P54, DOI 10.1111/j.1469-0691.2001.tb00010.x; Caillot D, 1997, J CLIN ONCOL, V15, P139, DOI 10.1200/JCO.1997.15.1.139; Chang YC, 2004, FUNGAL GENET BIOL, V41, P888, DOI 10.1016/j.fgb.2004.06.004; Charles P, 2008, J BASIC MICROB, V48, P347, DOI 10.1002/jobm.200800043; Chen P, 2008, ANAL CHEM, V80, P1474, DOI 10.1021/ac7018798; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; dEnfert C, 1996, CURR GENET, V30, P76, DOI 10.1007/s002940050103; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Galande AK, 2006, J MED CHEM, V49, P4715, DOI 10.1021/jm051001a; Gifford AHT, 2002, INFECT IMMUN, V70, P19, DOI 10.1128/IAI.70.1.19-26.2002; Gill PK, 2006, BIORESOURCE TECHNOL, V97, P355, DOI 10.1016/j.biortech.2005.02.038; Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697; Hemelaar J, 2004, J PROTEOME RES, V3, P268, DOI 10.1021/pr0341080; Hope WW, 2005, LANCET INFECT DIS, V5, P609, DOI 10.1016/S1473-3099(05)70238-3; Iadarola P, 1998, EXP LUNG RES, V24, P233, DOI 10.3109/01902149809041532; Ibrahim-Granet O, 2008, CELL MICROBIOL, V10, P134, DOI 10.1111/j.1462-5822.2007.01025.x; JATONOGAY K, 1994, MOL MICROBIOL, V14, P917, DOI 10.1111/j.1365-2958.1994.tb01327.x; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; KOLATTUKUDY PE, 1993, INFECT IMMUN, V61, P2357, DOI 10.1128/IAI.61.6.2357-2368.1993; Kunert J, 2000, MYCOSES, V43, P339, DOI 10.1046/j.1439-0507.2000.00586.x; LARCHER G, 1992, FEBS LETT, V308, P65, DOI 10.1016/0014-5793(92)81052-N; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Machida M, 2005, NATURE, V438, P1157, DOI 10.1038/nature04300; MARKARYAN A, 1994, INFECT IMMUN, V62, P2149, DOI 10.1128/IAI.62.6.2149-2157.1994; MATTHEWS DJ, 1993, SCIENCE, V260, P1113, DOI 10.1126/science.8493554; McDonagh A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000154; McNeil MM, 2001, CLIN INFECT DIS, V33, P641, DOI 10.1086/322606; MONOD M, 1991, J MED MICROBIOL, V35, P23, DOI 10.1099/00222615-35-1-23; MONOD M, 1993, FEMS MICROBIOL LETT, V106, P39, DOI 10.1111/j.1574-6968.1993.tb05932.x; Monod M, 2002, INT J MED MICROBIOL, V292, P405, DOI 10.1078/1438-4221-00223; Monod M, 2008, MYCOPATHOLOGIA, V166, P285, DOI 10.1007/s11046-008-9105-4; Mylonakis E, 1998, CHEST, V114, P251, DOI 10.1378/chest.114.1.251; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Pain A, 2004, FUNGAL GENET BIOL, V41, P443, DOI 10.1016/j.fgb.2003.12.003; Patterson TF, 2005, MED MYCOL, V43, pS115, DOI 10.1080/13693780400029429; Rambach G, 2010, MOL IMMUNOL, V47, P1438, DOI 10.1016/j.molimm.2010.02.010; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; REICHARD U, 1994, J MED VET MYCOL, V32, P427; Reichard U, 2006, APPL ENVIRON MICROB, V72, P1739, DOI 10.1128/AEM.72.3.1739-1748.2006; Reichard U, 2008, MYCOSES, V51, P30, DOI 10.1111/j.1439-0507.2008.01584.x; Rhodes JC, 2001, MED MYCOL, V39, P253, DOI 10.1080/mmy.39.3.253.260; Richie DL, 2007, MOL MICROBIOL, V63, P591, DOI 10.1111/j.1365-2958.2006.05534.x; Richie DL, 2011, VIRULENCE, V2, P12, DOI 10.4161/viru.2.1.13345; Richie DL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000258; Robson GD, 2005, MED MYCOL, V43, pS41, DOI 10.1080/13693780400024305; Schaal R, 2007, J MICROBIOL METH, V71, P93, DOI 10.1016/j.mimet.2007.05.010; Schaller M, 2005, MYCOSES, V48, P365, DOI 10.1111/j.1439-0507.2005.01165.x; Schwienbacher M, 2005, MED MYCOL, V43, P623, DOI 10.1080/13693780500089216; Segal BH, 2009, NEW ENGL J MED, V360, P1870, DOI 10.1056/NEJMra0808853; Sharon H, 2009, INFECT IMMUN, V77, P4051, DOI 10.1128/IAI.00426-09; Simon GM, 2010, J BIOL CHEM, V285, P11051, DOI 10.1074/jbc.R109.097600; Sriranganadane D, 2011, MICROBIOL-SGM, V157, P1541, DOI 10.1099/mic.0.048603-0; Sriranganadane D, 2010, J PROTEOME RES, V9, P3511, DOI 10.1021/pr901202z; Steinbach WJ, 2004, ANTIMICROB AGENTS CH, V48, P3217, DOI 10.1128/AAC.48.9.3217-3225.2004; TANG CM, 1993, INFECT IMMUN, V61, P1650, DOI 10.1128/IAI.61.5.1650-1656.1993; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Teutschbein J, 2010, J PROTEOME RES, V9, P3427, DOI 10.1021/pr9010684; Thomas DA, 2006, PROTEOMICS, V6, P2112, DOI 10.1002/pmic.200500153; Tsang A, 2009, FUNGAL GENET BIOL, V46, pS153, DOI 10.1016/j.fgb.2008.07.014; Tung CH, 2004, BIOPOLYMERS, V76, P391, DOI 10.1002/bip.20139; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Wang Y, 2007, CURR MICROBIOL, V55, P65, DOI 10.1007/s00284-006-0613-5; WATSON DS, 2011, BIO TECHNIQ IN PRESS, V50; Willger S, 2009, MED MYCOL, V47, pS72, DOI 10.1080/13693780802455313	78	7	9	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2011	6	6							e21001	10.1371/journal.pone.0021001	http://dx.doi.org/10.1371/journal.pone.0021001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778VR	21695046	Green Published, gold, Green Submitted			2022-12-25	WOS:000291737600036
J	Remans, R; Flynn, DFB; DeClerck, F; Diru, W; Fanzo, J; Gaynor, K; Lambrecht, I; Mudiope, J; Mutuo, PK; Nkhoma, P; Siriri, D; Sullivan, C; Palm, CA				Remans, Roseline; Flynn, Dan F. B.; DeClerck, Fabrice; Diru, Willy; Fanzo, Jessica; Gaynor, Kaitlyn; Lambrecht, Isabel; Mudiope, Joseph; Mutuo, Patrick K.; Nkhoma, Phelire; Siriri, David; Sullivan, Clare; Palm, Cheryl A.			Assessing Nutritional Diversity of Cropping Systems in African Villages	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; DIETARY DIVERSITY; GENETIC DIVERSITY; FOOD-CONSUMPTION; INDICATORS; RISK; AGRICULTURE; REDUNDANCY; SECURITY; CHILDREN	Background: In Sub-Saharan Africa, 40% of children under five years in age are chronically undernourished. As new investments and attention galvanize action on African agriculture to reduce hunger, there is an urgent need for metrics that monitor agricultural progress beyond calories produced per capita and address nutritional diversity essential for human health. In this study we demonstrate how an ecological tool, functional diversity (FD), has potential to address this need and provide new insights on nutritional diversity of cropping systems in rural Africa. Methods and Findings: Data on edible plant species diversity, food security and diet diversity were collected for 170 farms in three rural settings in Sub-Saharan Africa. Nutritional FD metrics were calculated based on farm species composition and species nutritional composition. Iron and vitamin A deficiency were determined from blood samples of 90 adult women. Nutritional FD metrics summarized the diversity of nutrients provided by the farm and showed variability between farms and villages. Regression of nutritional FD against species richness and expected FD enabled identification of key species that add nutrient diversity to the system and assessed the degree of redundancy for nutrient traits. Nutritional FD analysis demonstrated that depending on the original composition of species on farm or village, adding or removing individual species can have radically different outcomes for nutritional diversity. While correlations between nutritional FD, food and nutrition indicators were not significant at household level, associations between these variables were observed at village level. Conclusion: This study provides novel metrics to address nutritional diversity in farming systems and examples of how these metrics can help guide agricultural interventions towards adequate nutrient diversity. New hypotheses on the link between agro-diversity, food security and human nutrition are generated and strategies for future research are suggested calling for integration of agriculture, ecology, nutrition, and socio-economics.	[Remans, Roseline; DeClerck, Fabrice; Gaynor, Kaitlyn; Mutuo, Patrick K.; Siriri, David; Sullivan, Clare; Palm, Cheryl A.] Columbia Univ, Earth Inst, New York, NY 10027 USA; [Remans, Roseline] Katholieke Univ Leuven, Leuven Sustainable Earth Res Ctr, Leuven, Belgium; [Flynn, Dan F. B.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [DeClerck, Fabrice] CATIE, Div Res & Dev, Turrialba, Costa Rica; [Diru, Willy] World Agroforestry Ctr, Kisumu, Kenya; [Fanzo, Jessica] Biovers Int, Rome, Italy; [Lambrecht, Isabel] Katholieke Univ Leuven, Dept Earth & Environm Sci, Leuven, Belgium; [Mudiope, Joseph; Siriri, David] United Nations Dev Program, Mbarara, Uganda; [Mutuo, Patrick K.] Millennium Dev Goals Ctr E & So Afr, Nairobi, Kenya; [Nkhoma, Phelire] United Nations Dev Program, Zomba, Malawi	Columbia University; KU Leuven; University of Zurich; CATIE - Centro Agronomico Tropical de Investigacion y Ensenanza; CGIAR; World Agroforestry (ICRAF); Alliance; Bioversity International; KU Leuven	Remans, R (corresponding author), Columbia Univ, Earth Inst, New York, NY 10027 USA.	rremans@ei.columbia.edu	DeClerck, Fabrice A.J./C-3642-2012; Fanzo, Jessica/HCH-3533-2022; Flynn, Dan/AAT-7028-2020; Flynn, Dan/A-4200-2008	Flynn, Dan/0000-0002-2978-5257; Flynn, Dan/0000-0002-2978-5257; Lambrecht, Isabel/0000-0003-1709-6611; Gaynor, Kaitlyn/0000-0002-5747-0543; Fanzo, Jessica/0000-0002-6760-1359	European Community; Earth Institute at Columbia University	European Community(European Commission); Earth Institute at Columbia University	R. Remans is supported by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme. The work was further supported by an Earth Clinic Grant of the Earth Institute at Columbia University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, INT ASSESSMENT AGR K; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; BATES TE, 1971, SOIL SCI, V112, P116, DOI 10.1097/00010694-197108000-00005; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Bilinsky P., 2007, MONTHS ADEQUATE HOUS; Blair MW, 2010, THEOR APPL GENET, V121, P237, DOI 10.1007/s00122-010-1305-x; BROCK JF, 1955, LANCET, V2, P355; Chewya J., 1999, BIODIVERSITY TRADITI; Coates J., 2007, FOOD NUTR TECHNICAL, DOI 10.1007/s13398-014-0173-7.2; Davey MW, 2009, J AGR FOOD CHEM, V57, P1742, DOI 10.1021/jf803137d; Deckelbaum RJ, 2006, FOOD NUTR BULL, V27, P335, DOI 10.1177/156482650602700408; DeClerck F, 2006, FRONT ECOL ENVIRON, V4, P533, DOI 10.1890/1540-9295(2006)4[533:TROETA]2.0.CO;2; DELRIO CMR, 2005, FRONT ECOL ENVIRON, V3, P463; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Drescher LS, 2007, J NUTR, V137, P647, DOI 10.1093/jn/137.3.647; Eyzaguirre, 2007, AFR J FOOD AGR NUTR, V7; FAO (Food and Agriculture Organization of the United Nations), 2010, STAT FOOD INS WORLD; *FAO FOOD NUTR TEC, 2008, GUID MEAS HOUS IND D; Flynn DFB, 2009, ECOL LETT, V12, P22, DOI 10.1111/j.1461-0248.2008.01255.x; Frison EA, 2006, FOOD NUTR BULL, V27, P167, DOI 10.1177/156482650602700208; Graham RD, 2007, ADV AGRON, V92, P1, DOI 10.1016/S0065-2113(04)92001-9; Graham Robin D., 2008, P41; Hatloy A, 1998, EUR J CLIN NUTR, V52, P891, DOI 10.1038/sj.ejcn.1600662; *INT FOOD POL RES, 1998, COMM VEG POL FISH PR, V2; *INT FOOD POL RES, 1998, COMM VEG POL FISH PR, V1; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; KANT AK, 1993, AM J CLIN NUTR, V57, P434, DOI 10.1093/ajcn/57.3.434; Kennedy G, 2005, J FOOD COMPOS ANAL, V18, P255, DOI 10.1016/j.jfca.2004.10.002; Kennedy G, 2003, FOOD CHEM, V80, P589, DOI 10.1016/S0308-8146(02)00507-1; Kennedy G, 2010, PUBLIC HEALTH NUTR, V13, P2010, DOI 10.1017/S136898001000145X; Laliberte E, 2010, ECOLOGY, V91, P299, DOI 10.1890/08-2244.1; LAMBRECHT I, 2009, THESIS KATHOLIEKE U; Latham M., 2010, WORLD NUTR, V1; Levi F, 1998, INT J CANCER, V77, P705, DOI 10.1002/(SICI)1097-0215(19980831)77:5&lt;705::AID-IJC8&gt;3.0.CO;2-Z; Maundu P., 2005, USEFUL TREES SHRUBS; Maundu P.M., 1999, TRADITIONAL FOOD PLA; MCLAREN DS, 1966, LANCET, V2, P485; MCLAREN DS, 1974, LANCET, V2, P93; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mouchet MA, 2010, FUNCT ECOL, V24, P867, DOI 10.1111/j.1365-2435.2010.01695.x; Moursi MM, 2008, J NUTR, V138, P2448, DOI 10.3945/jn.108.093971; National Academy of Sciences, 2009, DIET REF INT REC INT; National Research Council, 1996, LOST CROPS AFR, VI; National Research Council, 2008, LOST CROPS AFR, VIII; National Research Council, 2006, LOST CROPS AFR, VII; Negin J, 2009, FOOD SECUR, V1, P351, DOI 10.1007/s12571-009-0025-z; Niles D, 2008, GEOJOURNAL, V73, P1, DOI 10.1007/s10708-008-9174-4; Nziguheba G, 2010, ADV AGRON, V109, P75, DOI 10.1016/S0065-2113(10)09003-6; Petchey O.L., 2009, BIODIVERSITY ECOSYST, P49; Petchey OL, 2002, ECOL LETT, V5, P402, DOI 10.1046/j.1461-0248.2002.00339.x; Petchey OL, 2007, J ANIM ECOL, V76, P977, DOI 10.1111/j.1365-2656.2007.01271.x; Peters CJ, 2009, RENEW AGR FOOD SYST, V24, P1, DOI 10.1017/S1742170508002433; REMANS R, 2011, ECOLOGY POV IN PRESS; Rose D, 2008, FOOD NUTR BULL, V29, P113, DOI 10.1177/156482650802900205; Rose D, 2009, J FOOD COMPOS ANAL, V22, P525, DOI 10.1016/j.jfca.2008.10.002; Sachs J, 2010, NATURE, V466, P558, DOI 10.1038/466558a; Sanchez P, 2007, P NATL ACAD SCI USA, V104, P16775, DOI 10.1073/pnas.0700423104; SHIMBO S, 1994, ECOL FOOD NUTR, V32, P197, DOI 10.1080/03670244.1994.9991400; Slattery ML, 1997, CANCER CAUSE CONTROL, V8, P872, DOI 10.1023/A:1018416412906; Steyn NP, 2006, PUBLIC HEALTH NUTR, V9, P644, DOI 10.1079/PHN2005912; The Millennium Villages Project, 2010, HARV DEV RUR AFR MIL; *UN FAO, 1988, HUM VIT MIN REQ; *UN FAO, 2010, GLOB FOR FOOD SEC NU; UN Millennium Project, 2005, INV DEV PRACT PLAN A; United Nations Children's Fund, 2009, TRACK PROGR CHILD MA; Waijers PMCM, 2007, BRIT J NUTR, V97, P219, DOI 10.1017/S0007114507250421; Welch RM, 1999, FIELD CROP RES, V60, P1, DOI 10.1016/S0378-4290(98)00129-4; WHO, 2003, OB OV; *WHO, 2007, JOINT STAT WHO WORLD; World Bank, 2007, AGR NUTR PATHW SYN O, DOI 10.1596/28183; [No title captured]	71	105	106	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2011	6	6							e21235	10.1371/journal.pone.0021235	http://dx.doi.org/10.1371/journal.pone.0021235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778UW	21698127	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000291734100071
J	Akkina, R; Berges, BK; Palmer, BE; Remling, L; Neff, CP; Kuruvilla, J; Connick, E; Folkvord, J; Gagliardi, K; Kassu, A; Akkina, SR				Akkina, Ramesh; Berges, Bradford K.; Palmer, Brent E.; Remling, Leila; Neff, C. Preston; Kuruvilla, Jes; Connick, Elizabeth; Folkvord, Joy; Gagliardi, Kathy; Kassu, Afework; Akkina, Sarah R.			Humanized Rag1(-/-)gamma c(-/-) Mice Support Multilineage Hematopoiesis and Are Susceptible to HIV-1 Infection via Systemic and Vaginal Routes	PLOS ONE			English	Article							HUMAN IMMUNE-SYSTEM; T-CELL DEPLETION; MOUSE MODEL; HU MOUSE; TRANSMISSION; THERAPY; ENGRAFTMENT; INHIBITORS; DEFICIENT; RESPONSES	Several new immunodeficient mouse models for human cell engraftment have recently been introduced that include the Rag2(-/-)gamma c(-/-), NOD/SCID, NOD/SCID gamma c(-/-) and NOD/SCID beta 2m(-/-) strains. Transplantation of these mice with CD34(+) human hematopoietic stem cells leads to prolonged engraftment, multilineage hematopoiesis and the capacity to generate human immune responses against a variety of antigens. However, the various mouse strains used and different methods of engrafting human cells are beginning to illustrate strain specific variations in engraftment levels, duration and longevity of mouse life span. In these proof-of-concept studies we evaluated the Balb/c-Rag1(-/-)gamma c(-/-) strain for engraftment by human fetal liver derived CD34+ hematopoietic cells using the same protocol found to be effective for Balb/c-Rag2(-/-)gamma c(-/-) mice. We demonstrate that these mice can be efficiently engrafted and show multilineage human hematopoiesis with human cells populating different lymphoid organs. Generation of human cells continues beyond a year and production of human immunoglobulins is noted. Infection with HIV-1 leads to chronic viremia with a resultant CD4 T cell loss. To mimic the predominant sexual viral transmission, we challenged humanized Rag1(-/-)gamma c(-/-) mice with HIV-1 via vaginal route which also resulted in chronic viremia and helper T cell loss. Thus these mice can be further exploited for studying human pathogens that infect the human hematopoietic system in an in vivo setting.	[Akkina, Ramesh; Berges, Bradford K.; Remling, Leila; Neff, C. Preston; Kuruvilla, Jes; Gagliardi, Kathy; Akkina, Sarah R.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Palmer, Brent E.; Connick, Elizabeth; Folkvord, Joy; Kassu, Afework] Univ Colorado Denver, Dept Med, Aurora, CO USA	Colorado State University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Akkina, R (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	akkina@colostate.edu		Akkina, Sarah/0000-0002-0166-3901	NIH [R21 HL094257, RO1 AI057066, RO1 AI073255]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL094257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057066, R01AI073255] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R21 HL094257, RO1 AI057066 and RO1 AI073255. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2007, CLIN VACCINE IMMUNOL, V14, P391, DOI 10.1128/CVI.00403-06; Baenziger S, 2006, P NATL ACAD SCI USA, V103, P15951, DOI 10.1073/pnas.0604493103; Banerjee P, 2010, BLOOD, V115, P2640, DOI 10.1182/blood-2009-10-246959; Berges BK, 2008, VIROLOGY, V373, P342, DOI 10.1016/j.virol.2007.11.020; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Berges BK, 2010, VIROLOGY, V397, P100, DOI 10.1016/j.virol.2009.10.034; Brainard DM, 2009, J VIROL, V83, P7305, DOI 10.1128/JVI.02207-08; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Choudhary SK, 2009, J VIROL, V83, P8254, DOI 10.1128/JVI.00580-09; Denton PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008829; Denton PW, 2008, PLOS MED, V5, P79, DOI 10.1371/journal.pmed.0050016; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Holt N, 2010, NAT BIOTECHNOL, V28, P839, DOI 10.1038/nbt.1663; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Joseph A, 2010, J VIROL, V84, P6645, DOI 10.1128/JVI.02339-09; Kollet O, 2000, BLOOD, V95, P3102, DOI 10.1182/blood.V95.10.3102.010k14_3102_3105; Kumar P, 2008, CELL, V134, P577, DOI 10.1016/j.cell.2008.06.034; Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005; Kwant-Mitchell A, 2009, J VIROL, V83, P10664, DOI 10.1128/JVI.02584-08; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Lowry P A, 1996, Biol Blood Marrow Transplant, V2, P15; Marodon G, 2009, EUR J IMMUNOL, V39, P2136, DOI 10.1002/eji.200939480; Mazurier F, 1999, J INTERF CYTOK RES, V19, P533, DOI 10.1089/107999099313983; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Mosier DE, 2000, VIROLOGY, V271, P215, DOI 10.1006/viro.2000.0336; MOSIER DE, 1988, NATURE, V335, P256, DOI 10.1038/335256a0; Neff CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015257; Neff CP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001581; Sango K, 2010, AIDS RES HUM RETROV, V26, P735, DOI 10.1089/aid.2009.0136; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sun ZF, 2007, J EXP MED, V204, P705, DOI 10.1084/jem.20062411; TASSARA C, 1995, HUM MOL GENET, V4, P1693, DOI 10.1093/hmg/4.9.1693; ter Brake O, 2009, GENE THER, V16, P148, DOI 10.1038/gt.2008.124; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Van Duyne R, 2008, VIROLOGY, V376, P308, DOI 10.1016/j.virol.2008.02.036; Van Duyne R, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-76; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Zhang L, 2006, BLOOD, V108, p297B	45	48	48	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20169	10.1371/journal.pone.0020169	http://dx.doi.org/10.1371/journal.pone.0020169			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695116	Green Published, Green Submitted, gold			2022-12-25	WOS:000291682300004
J	Marr, N; Shah, NR; Lee, R; Kim, EJ; Fernandez, RC				Marr, Nico; Shah, Nita R.; Lee, Rose; Kim, Emma J.; Fernandez, Rachel C.			Bordetella pertussis Autotransporter Vag8 Binds Human C1 Esterase Inhibitor and Confers Serum Resistance	PLOS ONE			English	Article							FILAMENTOUS HEMAGGLUTININ; COMPLEMENT EVASION; ESCHERICHIA-COLI; PROTEIN; BRONCHISEPTICA; BRKA; PARAPERTUSSIS; SECRETION; VIR; MECHANISMS	Bordetella pertussis employs numerous strategies to evade the immune system, including the ability to resist killing via complement. Previously we have shown that B. pertussis binds a complement regulatory protein, C1 esterase inhibitor (C1inh) to its surface in a Bvg-regulated manner (i.e. during its virulence phase), but the B. pertussis factor was not identified. Here we set out to identify the B. pertussis C1inh-binding factor. Using a serum overlay assay, we found that this factor migrates at approximately 100 kDa on an SDS-PAGE gel. To identify this factor, we isolated proteins of approximately 100 kDa from wild type strain BP338 and from BP347, an isogenic Bvg mutant that does not bind C1inh. Using mass spectrometry and bioinformatics, we identified the autotransporter protein Vag8 as the putative C1inh binding protein. To prove that Vag8 binds C1inh, vag8 was disrupted in two different B. pertussis strains, namely BP338 and 18-323, and the mutants were tested for their ability to bind C1inh in a surface-binding assay. Neither mutant strain was capable of binding C1inh, whereas a complemented strain successfully bound C1inh. In addition, the passenger domain of Vag8 was expressed and purified as a histidine-tagged fusion protein and tested for C1inh-binding in an ELISA assay. Whereas the purified Vag8 passenger bound C1inh, the passenger domain of BrkA (a related autotransporter protein) failed to do so. Finally, serum assays were conducted to compare wild type and vag8 mutants. We determined that vag8 mutants from both strains were more susceptible to killing compared to their isogenic wild type counterparts. In conclusion, we have discovered a novel role for the previously uncharacterized protein Vag8 in the immune evasion of B. pertussis. Vag8 binds C1inh to the surface of the bacterium and confers serum resistance.	[Marr, Nico; Shah, Nita R.; Lee, Rose; Kim, Emma J.; Fernandez, Rachel C.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Marr, N (corresponding author), Univ British Columbia, Dept Pediat, Child & Family Res Inst, Vancouver, BC V6T 1W5, Canada.	rachelf@mail.ubc.ca	Marr, Nico/T-7741-2019	Marr, Nico/0000-0002-1927-7072	Canadian Institutes of Health Research [DOP-53723]; Natural Sciences and Engineering Research Council of Canada [194599]; Canada Foundation for Innovation; Michael Smith Foundation; Centre for Blood Research at UBC	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation(Michael Smith Foundation for Health Research); Centre for Blood Research at UBC	This work was funded in part by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/) grant # DOP-53723, and the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/) grant # 194599. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; We thank Theresa Yong for assistance with the preparation of B. pertussis membrane enrichments, Elizabeth Gagnon for the Vag8 and BrkA protein preparations used for the ELISA assays, and the UBC Proteomics Core Facility for assistance with the mass spectrometry data analysis. The CD spectrometer was provided through grants from the Canada Foundation for Innovation, the Michael Smith Foundation to the Laboratory of Molecular Biophysics and the Centre for Blood Research at UBC.	Barnes MG, 2002, INFECT IMMUN, V70, P403, DOI 10.1128/IAI.70.1.403-406.2002; Barnes MG, 2001, INFECT IMMUN, V69, P3067, DOI 10.1128/IAI.69.5.3067-3072.2001; Berggard K, 1997, INFECT IMMUN, V65, P3638; Berggard K, 2001, EUR J IMMUNOL, V31, P2771, DOI 10.1002/1521-4141(200109)31:9<2771::AID-IMMU2771>3.0.CO;2-0; BYRD DW, 1991, J MED MICROBIOL, V34, P159, DOI 10.1099/00222615-34-3-159; Carbonetti NH, 2007, CURR OPIN PHARMACOL, V7, P272, DOI 10.1016/j.coph.2006.12.004; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cummings CA, 2006, J BACTERIOL, V188, P1775, DOI 10.1128/JB.188.5.1775-1785.2006; FERNANDEZ RC, 1994, INFECT IMMUN, V62, P4727, DOI 10.1128/IAI.62.11.4727-4738.1994; Fernandez RC, 1998, FEMS MICROBIOL LETT, V163, P57, DOI 10.1111/j.1574-6968.1998.tb13026.x; Finn TM, 1998, INFECT IMMUN, V66, P3985, DOI 10.1128/IAI.66.8.3985-3989.1998; FINN TM, 1991, INFECT IMMUN, V59, P3273, DOI 10.1128/IAI.59.9.3273-3279.1991; Fuchslocher B, 2003, INFECT IMMUN, V71, P3043, DOI 10.1128/IAI.71.6.3043-3052.2003; Gauthier A, 2003, J BACTERIOL, V185, P6747, DOI 10.1128/JB.185.23.6747-6755.2003; Greiff L, 2003, CLIN PHYSIOL FUNCT I, V23, P301, DOI 10.1046/j.1475-0961.2003.00519.x; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; Hewitt M, 2010, LUNG, V188, pS73, DOI 10.1007/s00408-009-9196-9; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; Lathem WW, 2004, J EXP MED, V199, P1077, DOI 10.1084/jem.20030255; LEININGER E, 1991, P NATL ACAD SCI USA, V88, P345, DOI 10.1073/pnas.88.2.345; MARR N, 2007, THESIS U WUERZBURG G; Marr N, 2007, J INFECT DIS, V195, P585, DOI 10.1086/510913; Mills KHG, 2001, MICROBES INFECT, V3, P655, DOI 10.1016/S1286-4579(01)01421-6; Morgan BP., 1999, COMPLEMENT REGULATOR; Oliver DC, 2003, MOL MICROBIOL, V47, P1367, DOI 10.1046/j.1365-2958.2003.03377.x; Oliver DC, 2001, VACCINE, V20, P235, DOI 10.1016/S0264-410X(01)00269-9; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; PERSSON CGA, 1991, CLIN EXP ALLERGY, V21, P17, DOI 10.1111/j.1365-2222.1991.tb00799.x; Pillai L, 2006, INFECT IMMUN, V74, P3742, DOI 10.1128/IAI.00402-06; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Sebaihia M, 2006, J BACTERIOL, V188, P6002, DOI 10.1128/JB.01927-05; Serruto D, 2010, NAT REV MICROBIOL, V8, P393, DOI 10.1038/nrmicro2366; Shannon JL, 1999, J BACTERIOL, V181, P5838, DOI 10.1128/JB.181.18.5838-5842.1999; STIBITZ S, 1988, J BACTERIOL, V170, P2904, DOI 10.1128/jb.170.7.2904-2913.1988; TOMLINSON S, 1993, CURR OPIN IMMUNOL, V5, P83, DOI 10.1016/0952-7915(93)90085-7; UHL AM, 1995, 2 COMPONENT SIGNAL T, P333; Weingart CL, 1999, INFECT IMMUN, V67, P4264, DOI 10.1128/IAI.67.8.4264-4267.1999; WEISS AA, 1993, P NATL ACAD SCI USA, V90, P2970, DOI 10.1073/pnas.90.7.2970; WEISS AA, 1989, INFECT IMMUN, V57, P2674, DOI 10.1128/IAI.57.9.2674-2682.1989; WEISS AA, 1983, INFECT IMMUN, V42, P33, DOI 10.1128/IAI.42.1.33-41.1983	42	53	54	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20585	10.1371/journal.pone.0020585	http://dx.doi.org/10.1371/journal.pone.0020585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695123	Green Published, gold, Green Submitted			2022-12-25	WOS:000291682300007
J	Wolff, GA; Billett, DSM; Bett, BJ; Holtvoeth, J; FitzGeorge-Balfour, T; Fisher, EH; Cross, I; Shannon, R; Salter, I; Boorman, B; King, NJ; Jamieson, A; Chaillan, F				Wolff, George A.; Billett, David S. M.; Bett, Brian J.; Holtvoeth, Jens; FitzGeorge-Balfour, Tania; Fisher, Elizabeth H.; Cross, Ian; Shannon, Roger; Salter, Ian; Boorman, Ben; King, Nicola J.; Jamieson, Alan; Chaillan, Frederic			The Effects of Natural Iron Fertilisation on Deep-Sea Ecology: The Crozet Plateau, Southern Indian Ocean	PLOS ONE			English	Article							NORTHEAST ATLANTIC-OCEAN; NE ATLANTIC; WATER; PACIFIC; BLOOM; SEQUESTRATION; ENRICHMENT; CLIMATE	The addition of iron to high-nutrient low-chlorophyll (HNLC) oceanic waters stimulates phytoplankton, leading to greater primary production. Large-scale artificial ocean iron fertilization (OIF) has been proposed as a means of mitigating anthropogenic atmospheric CO2, but its impacts on ocean ecosystems below the photic zone are unknown. Natural OIF, through the addition of iron leached from volcanic islands, has been shown to enhance primary productivity and carbon export and so can be used to study the effects of OIF on life in the ocean. We compared two closely-located deep-sea sites (similar to 400 km apart and both at similar to 4200 m water depth) to the East (naturally iron fertilized; +Fe) and South (HNLC) of the Crozet Islands in the southern Indian Ocean. Our results suggest that long-term geo-engineering of surface oceanic waters via artificial OIF would lead to significant changes in deep-sea ecosystems. We found that the +Fe area had greater supplies of organic matter inputs to the seafloor, including polyunsaturated fatty acid and carotenoid nutrients. The +Fe site also had greater densities and biomasses of large deep-sea animals with lower levels of evenness in community structuring. The species composition was also very different, with the +Fe site showing similarities to eutrophic sites in other ocean basins. Moreover, major differences occurred in the taxa at the +Fe and HNLC sites revealing the crucial role that surface oceanic conditions play in changing and structuring deep-sea benthic communities.	[Wolff, George A.; Holtvoeth, Jens; Fisher, Elizabeth H.; Chaillan, Frederic] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England; [Billett, David S. M.; Bett, Brian J.; FitzGeorge-Balfour, Tania; Cross, Ian; Shannon, Roger; Salter, Ian; Boorman, Ben] Univ Southampton, Natl Oceanog Ctr, Southampton, Hants, England; [King, Nicola J.; Jamieson, Alan] Univ Aberdeen, Oceanlab, Newburgh, Scotland	University of Liverpool; NERC National Oceanography Centre; University of Southampton; University of Aberdeen	Wolff, GA (corresponding author), Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England.	wolff@liv.ac.uk; dsmb@noc.soton.ac.uk	Wolff, George/B-7982-2018; Hanifi, Mohammad/J-4344-2019; Salter, Ian/AAI-1015-2021; Fisher, Elizabeth/B-8802-2011	Wolff, George/0000-0002-9380-1039; Fisher, Elizabeth/0000-0002-6124-3618; Jamieson, Alan/0000-0001-9835-2909; Holtvoeth, Jens/0000-0002-9259-4728; Shannon, Roger/0000-0003-4009-0760; Salter, Ian/0000-0002-4513-0314	United Kingdom's Natural Environment Research Council [NER/A/S/2003/00573]; NERC [noc010009] Funding Source: UKRI; Natural Environment Research Council [noc010009, NER/A/S/2003/00573] Funding Source: researchfish	United Kingdom's Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The work was financially supported by the United Kingdom's Natural Environment Research Council (NER/A/S/2003/00573). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARLOW RG, 1993, DEEP-SEA RES PT II, V40, P459, DOI 10.1016/0967-0645(93)90027-K; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; Bett BJ, 2001, CONT SHELF RES, V21, P917, DOI 10.1016/S0278-4343(00)00119-9; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; BILLETT DSM, 1982, DEEP-SEA RES, V29, P799, DOI 10.1016/0198-0149(82)90047-4; Billett DSM, 2001, PROG OCEANOGR, V50, P325, DOI 10.1016/S0079-6611(01)00060-X; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Buesseler KO, 2008, SCIENCE, V319, P162, DOI 10.1126/science.1154305; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Conte MH, 1998, DEEP-SEA RES PT I, V45, P1819, DOI 10.1016/S0967-0637(98)00046-6; Cross IA, 2009, ZOOTAXA, P484, DOI 10.11646/zootaxa.2096.1.30; Gage J. D., 1991, DEEP SEA BIOL NATURA; George SB, 2001, AQUACULTURE, V199, P353, DOI 10.1016/S0044-8486(01)00578-6; Gussow K, 2010, MAR POLICY, V34, P911, DOI 10.1016/j.marpol.2010.01.015; Hansen B., 1975, Galathea Report, V13, P1; Heller A, 2008, CHEMSUSCHEM, V1, P651, DOI 10.1002/cssc.200800096; Hughes JA, 2007, DEEP-SEA RES PT II, V54, P2275, DOI 10.1016/j.dsr2.2007.06.006; Jamieson AJ, 2005, SEA TECHNOL, V46, P52; Jeffrey S.W., 1997, PHYTOPLANKTON PIGMEN; Jeffreys RM, 2009, DEEP-SEA RES PT II, V56, P358, DOI 10.1016/j.dsr2.2008.06.012; Kiriakoulakis K, 2004, DEEP-SEA RES PT I, V51, P1937, DOI 10.1016/j.dsr.2004.07.010; Kiriakoulakis K, 2001, PROG OCEANOGR, V50, P65, DOI 10.1016/S0079-6611(01)00048-9; Laglera LM, 2009, LIMNOL OCEANOGR, V54, P610, DOI 10.4319/lo.2009.54.2.0610; Lal R, 2008, ENERG ENVIRON SCI, V1, P86, DOI 10.1039/b809492f; Marsh R, 2007, DEEP-SEA RES PT II, V54, P2260, DOI 10.1016/j.dsr2.2007.06.004; Mawji E, 2008, ENVIRON SCI TECHNOL, V42, P8675, DOI 10.1021/es801884r; McLaughlin G, 2001, J SHELLFISH RES, V20, P377; Merrett N. R., 1981, PROG OCEANOGR, V9, P185, DOI DOI 10.1016/0079-6611(80)90002-6; Pollard R, 2007, DEEP-SEA RES PT II, V54, P1905, DOI 10.1016/j.dsr2.2007.07.023; Pollard RT, 2009, NATURE, V457, P577, DOI 10.1038/nature07716; Poulton AJ, 2007, DEEP-SEA RES PT II, V54, P2085, DOI 10.1016/j.dsr2.2007.06.005; Rex MA, 2006, MAR ECOL PROG SER, V317, P1, DOI 10.3354/meps317001; Ruhl HA, 2004, SCIENCE, V305, P513, DOI 10.1126/science.1099759; Ruhl HA, 2008, ECOLOGY, V89, P991, DOI 10.1890/06-2025.1; SALTER I, GLOBAL BIOG IN PRESS; Smetacek V, 2008, PHILOS T R SOC A, V366, P3947, DOI 10.1098/rsta.2008.0144; Smith KL, 2009, P NATL ACAD SCI USA, V106, P19211, DOI 10.1073/pnas.0908322106; Smith KL, 2008, LIMNOL OCEANOGR, V53, P2655, DOI 10.4319/lo.2008.53.6.2655; Sumida PYG, 2001, ACTA ZOOL-STOCKHOLM, V82, P11, DOI 10.1046/j.1463-6395.2001.00058.x; THIEL H, 1990, BIOL OCEANOGR, V6, P203; Turner SM, 1996, NATURE, V383, P513, DOI 10.1038/383513a0; Tyler P, 2009, OCEANOGRAPHY, V22, P46, DOI 10.5670/oceanog.2009.05; Venables HJ, 2007, DEEP-SEA RES PT II, V54, P1949, DOI 10.1016/j.dsr2.2007.06.014; Wakeham SG, 1997, DEEP-SEA RES PT II, V44, P2131, DOI 10.1016/S0967-0645(97)00035-0; WOLFF GA, 2006, BENTHIC CROZET SURFA	46	39	40	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2011	6	6							e20697	10.1371/journal.pone.0020697	http://dx.doi.org/10.1371/journal.pone.0020697			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	778EB	21695118	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000291682300009
J	Filippi-Chiela, EC; Villodre, ES; Zamin, LL; Lenz, G				Filippi-Chiela, Eduardo C.; Villodre, Emilly Schlee; Zamin, Lauren L.; Lenz, Guido			Autophagy Interplay with Apoptosis and Cell Cycle Regulation in the Growth Inhibiting Effect of Resveratrol in Glioma Cells	PLOS ONE			English	Article							S-PHASE ARREST; MITOCHONDRIAL PERMEABILITY TRANSITION; CANCER STEM-CELLS; MALIGNANT GLIOMA; INDUCED CYTOTOXICITY; SPECIAL EMPHASIS; DOWN-REGULATION; KAPPA-B; DEATH; PROTEIN	Prognosis of patients with glioblastoma (GBM) remains very poor, thus making the development of new drugs urgent. Resveratrol (Rsv) is a natural compound that has several beneficial effects such as neuroprotection and cytotoxicity for several GBM cell lines. Here we evaluated the mechanism of action of Rsv on human GBM cell lines, focusing on the role of autophagy and its crosstalk with apoptosis and cell cycle control. We further evaluated the role of autophagy and the effect of Rsv on GBM Cancer Stem Cells (gCSCs), involved in GBM resistance and recurrence. Glioma cells treated with Rsv was tested for autophagy, apoptosis, necrosis, cell cycle and phosphorylation or expression levels of key players of these processes. Rsv induced the formation of autophagosomes in three human GBM cell lines, accompanied by an upregulation of autophagy proteins Atg5, beclin-1 and LC3-II. Inhibition of Rsv-induced autophagy triggered apoptosis, with an increase in Bax and cleavage of caspase-3. While inhibition of apoptosis or autophagy alone did not revert Rsv-induced toxicity, inhibition of both processes blocked this toxicity. Rsv also induced a S-G2/M phase arrest, accompanied by an increase on levels of pCdc2(Y15), cyclin A, E and B, and pRb (S807/811) and a decrease of cyclin D1. Interestingly, this arrest was dependent on the induction of autophagy, since inhibition of Rsv-induced autophagy abolishes cell cycle arrest and returns the phosphorylation of Cdc2(Y15) and Rb(S807/811), and levels of cyclin A, and B to control levels. Finally, inhibition of autophagy or treatment with Rsv decreased the sphere formation and the percentage of CD133 and OCT4-positive cells, markers of gCSCs. In conclusion, the crosstalk among autophagy, cell cycle and apoptosis, together with the biology of gCSCs, has to be considered in tailoring pharmacological interventions aimed to reduce glioma growth using compounds with multiple targets such as Rsv.	[Filippi-Chiela, Eduardo C.; Villodre, Emilly Schlee; Lenz, Guido] Univ Fed Rio Grande UFRGS, Dept Biophys, Porto Alegre, RS, Brazil; [Zamin, Lauren L.] Univ Fed Fronteira UFFS, Cerro Largo, RS, Brazil; [Lenz, Guido] Univ Fed Rio Grande UFRGS, Ctr Biotechnol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal da Fronteira Sul; Universidade Federal do Rio Grande do Sul	Filippi-Chiela, EC (corresponding author), Univ Fed Rio Grande UFRGS, Dept Biophys, Porto Alegre, RS, Brazil.	lenz@ufrgs.br	Lenz, Guido/A-7618-2008; Villodre, Emilly Schlee/AAF-5786-2021; Filippi-Chiela, Eduardo/F-1959-2014	Filippi-Chiela, Eduardo/0000-0001-8192-3779	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) [473190/2004, 476491/2008-8]; Pronex-Fapergs/CNPq [10/0044-3]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Pronex-Fapergs/CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS))	This work was supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico), grant numbers 473190/2004, 476491/2008-8 and Pronex-Fapergs/CNPq number 10/0044-3. All authors of this work are or were recipients of CNPq fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alva AS, 2004, CELL DEATH DIFFER, V11, P1046, DOI 10.1038/sj.cdd.4401445; Aoki T, 2007, EXPERT OPIN PHARMACO, V8, P3133, DOI 10.1517/14656566.8.18.3133; Asensi M, 2002, FREE RADICAL BIO MED, V33, P387, DOI 10.1016/S0891-5849(02)00911-5; Baehrecke EH, 2005, NAT REV MOL CELL BIO, V6, P505, DOI 10.1038/nrm1666; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Bhardwaj A, 2007, BLOOD, V109, P2293, DOI 10.1182/blood-2006-02-003988; Boocock DJ, 2007, CANCER EPIDEM BIOMAR, V16, P1246, DOI 10.1158/1055-9965.EPI-07-0022; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741; Castino R, 2011, J AGR FOOD CHEM; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Collins K, 1997, P NATL ACAD SCI USA, V94, P2776, DOI 10.1073/pnas.94.7.2776; Crighton D, 2007, AUTOPHAGY, V3, P72, DOI 10.4161/auto.3438; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Eshleman JS, 2002, CANCER RES, V62, P7291; Estrov Z, 2003, BLOOD, V102, P987, DOI 10.1182/blood-2002-11-3550; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fu J, 2009, CHINESE MED J-PEKING, V122, P1255, DOI 10.3760/cma.j.issn.0366-6999.2009.11.004; Fuggetta MP, 2004, MELANOMA RES, V14, P189, DOI 10.1097/01.cmr.0000130007.54508.b2; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Geng Y, 2010, NEUROONCOL IN PRESS; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Gu J, 2009, NEUROTHERAPEUTICS, V6, P427, DOI 10.1016/j.nurt.2009.05.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harikumar KB, 2008, CELL CYCLE, V7, P1020, DOI 10.4161/cc.7.8.5740; HOFFMANN I, 1994, J CELL SCI, P75; Huang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-304; Ito H, 2005, INT J ONCOL, V26, P1401; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jiang H, 2005, MOL CANCER THER, V4, P554, DOI 10.1158/1535-7163.MCT-04-0056; Jiang H, 2009, METHOD ENZYMOL, V453, P273, DOI 10.1016/S0076-6879(08)04013-5; Jin SK, 2005, AUTOPHAGY, V1, P171, DOI 10.4161/auto.1.3.2051; Joe AK, 2002, CLIN CANCER RES, V8, P893; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2003, CANCER RES, V63, P2103; Kanzawa T, 2005, ONCOGENE, V24, P980, DOI 10.1038/sj.onc.1208095; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; KONDO S, 1995, CANCER RES, V55, P6166; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; Lefranc F, 2008, NEOPLASIA, V10, P198, DOI 10.1593/neo.07928; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Lefranc Florence, 2006, Neurosurg Focus, V20, pE7, DOI 10.3171/foc.2006.20.4.4; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Lenz G, 2010, MED HYPOTHESES, V75, P660, DOI 10.1016/j.mehy.2010.08.012; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Li J, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-215; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Lu KH, 2009, CHILD NERV SYST, V25, P543, DOI 10.1007/s00381-009-0826-6; Maher EA, 2001, GENE DEV, V15, P1311, DOI 10.1101/gad.891601; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Mason WP, 2005, NAT CLIN PRACT NEURO, V1, P88, DOI 10.1038/ncpneuro0045; Miracco C, 2007, INT J ONCOL, V30, P429; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; Pandey PR, 2010, BREAST CANC RES TREA; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; PETERSON GL, 1983, METHOD ENZYMOL, V91, P95; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Pozo-Guisado E, 2005, INT J CANCER, V115, P74, DOI 10.1002/ijc.20856; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ricci-Vitiani L, 2010, NATURE; ROSENBERG AR, 1995, ONCOGENE, V10, P1501; Sale S, 2004, BRIT J CANCER, V90, P736, DOI 10.1038/sj.bjc.6601568; Scifo C, 2004, ONCOL RES, V14, P415, DOI 10.3727/0965040041791437; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Sexton E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-45; Shakibaei M, 2009, MOL NUTR FOOD RES, V53, P115, DOI 10.1002/mnfr.200800148; Shankar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016530; Shintani T, 1999, EMBO J, V18, P5234, DOI 10.1093/emboj/18.19.5234; Singh SK, 2003, CANCER RES, V63, P5821; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tane S, 2009, CELL CYCLE, V8, P3900, DOI 10.4161/cc.8.23.10071; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang R, 2010, NATURE; Wang R, 2010, NATURE, V468, P829, DOI 10.1038/nature09624; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Whyte L, 2007, CANCER RES, V67, P12007, DOI 10.1158/0008-5472.CAN-07-2464; Wirawan E, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.16; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zamin LL, 2006, NEUROBIOL DIS, V24, P170, DOI 10.1016/j.nbd.2006.06.002; Zamin LL, 2009, CANCER SCI, V100, P1655, DOI 10.1111/j.1349-7006.2009.01215.x; Ziegler DS, 2008, J CLIN ONCOL, V26, P493, DOI 10.1200/JCO.2007.13.9717	98	130	135	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20849	10.1371/journal.pone.0020849	http://dx.doi.org/10.1371/journal.pone.0020849			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695150	Green Submitted, Green Published, gold			2022-12-25	WOS:000291663300025
J	Wiszniak, SE; Dredge, BK; Jensen, KB				Wiszniak, Sophie E.; Dredge, B. Kate; Jensen, Kirk B.			HuB (elavl2) mRNA Is Restricted to the Germ Cells by Post-Transcriptional Mechanisms including Stabilisation of the Message by DAZL	PLOS ONE			English	Article							BINDING PROTEINS; DEAD-END; ZEBRAFISH MIR-430; GENE-EXPRESSION; IN-VIVO; TRANSLATION; FAMILY; CLEARANCE; COMPONENT; HUMANS	The ability of germ cells to carry out a gene regulatory program distinct from the surrounding somatic tissue, and their capacity to specify an entire new organism has made them a focus of many studies that seek to understand how specific regulatory mechanisms, particularly post-transcriptional mechanisms, contribute to cell fate. In zebrafish, germ cells are specified through the inheritance of cytoplasmic determinants, termed the germ plasm, which contains a number of maternal mRNAs and proteins. Investigation of several of these messages has revealed that the restricted localisation of these mRNAs to the germ plasm and subsequent germ cells is due to cis-acting sequence elements present in their 3'UTRs. Here we show that a member of the Hu family of RNA-binding proteins, HuB, is maternally provided in the zebrafish embryo and exhibits germ cell specific expression during embryogenesis. Restriction of HuB mRNA to the germ cells is dependent on a number of sequence elements in its 3'UTR, which act to degrade the mRNA in the soma and stabilise it in the germ cells. In addition, we show that the germ cell specific RNA-binding protein DAZL is able to promote HuB mRNA stability and translation in germ cells, and further demonstrate that these activities require a 30 nucleotide element in the 3'UTR. Our study suggests that DAZL specifically binds the HuB 3'UTR and protects the message from degradation and/or enhances HuB translation, leading to the germ cell specific expression of HuB protein.	[Wiszniak, Sophie E.; Dredge, B. Kate; Jensen, Kirk B.] Univ Adelaide, Discipline Biochem, Sch Mol & Biomed Sci, Adelaide, SA, Australia	University of Adelaide	Wiszniak, SE (corresponding author), Univ Adelaide, Discipline Biochem, Sch Mol & Biomed Sci, Adelaide, SA, Australia.	kirk.jensen@adelaide.edu.au	Wiszniak, Sophie/ABC-5734-2020; Jensen, Kirk/AAL-5883-2020; Jensen, Kirk/B-4756-2008	Jensen, Kirk/0000-0002-2084-1734; Jensen, Kirk/0000-0002-2084-1734; Dredge, Kate/0000-0002-6103-5165; Wiszniak, Sophie/0000-0001-8666-9300	Centre for the Molecular Genetics of Development (CMGD), an Australian Research Council (ARC) Special Research Centre; ARC [DP0559550]; National Health and Medical Research Council (NHMRC) [565424]	Centre for the Molecular Genetics of Development (CMGD), an Australian Research Council (ARC) Special Research Centre; ARC(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Funding for this work was provided by: the Centre for the Molecular Genetics of Development (CMGD), an Australian Research Council (ARC) Special Research Centre; the ARC Discovery grant DP0559550; and by the National Health and Medical Research Council (NHMRC) Project Grant 565424. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Antic D, 1997, AM J HUM GENET, V61, P273, DOI 10.1086/514866; Atasoy U, 1998, J CELL SCI, V111, P3145; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; GOOD PJ, 1995, P NATL ACAD SCI USA, V92, P4557, DOI 10.1073/pnas.92.10.4557; Hashimoto Y, 2004, DEV BIOL, V268, P152, DOI 10.1016/j.ydbio.2003.12.013; Jeongsil KH, 1999, MOL CELL BIOL, V19, P2505; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; KIM YJ, 1993, J NEUROSCI, V13, P1045; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koebernick K, 2010, P NATL ACAD SCI USA, V107, P16148, DOI 10.1073/pnas.1004401107; Koprunner M, 2001, GENE DEV, V15, P2877; Ma WJ, 1996, J BIOL CHEM, V271, P8144, DOI 10.1074/jbc.271.14.8144; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Mickoleit M, 2011, DEV DYNAM, V240, P695, DOI 10.1002/dvdy.22571; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Park HC, 2000, NEUROSCI LETT, V279, P81, DOI 10.1016/S0304-3940(99)00940-4; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; Samson ML, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-392; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Slanchev K, 2008, MECH DEV; Soares AR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-195; Takeda Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007513; Thatcher EJ, 2007, DEV DYNAM, V236, P2172, DOI 10.1002/dvdy.21211; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Venables JP, 2001, NUCLEIC ACIDS RES, V29, P2479, DOI 10.1093/nar/29.12.2479; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; YAO KM, 1993, J NEUROBIOL, V24, P723, DOI 10.1002/neu.480240604	33	17	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20773	10.1371/journal.pone.0020773	http://dx.doi.org/10.1371/journal.pone.0020773			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	21695151	Green Published, Green Submitted, gold			2022-12-25	WOS:000291663300021
J	Mota, J; Rico-Hesse, R				Mota, Javier; Rico-Hesse, Rebeca			Dengue Virus Tropism in Humanized Mice Recapitulates Human Dengue Fever	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; PRINCIPAL TARGET-CELLS; HUMAN-BONE-MARROW; HEMORRHAGIC-FEVER; B-CELLS; IMMUNE-RESPONSES; T-CELLS; INFECTION; DISEASE; PATHOGENESIS	Animal models of dengue virus disease have been very difficult to develop because of the virus' specificity for infection and replication in certain human cells. We developed a model of dengue fever in immunodeficient mice transplanted with human stem cells from umbilical cord blood. These mice show measurable signs of dengue disease as in humans (fever, viremia, erythema and thrombocytopenia), and after infection with the most virulent strain of dengue serotype 2, humanized mice showed infection in human cells in bone marrow, spleen and blood. Cytokines and chemokines were secreted by these human cells into the mouse bloodstream. We demonstrated that the pathology of dengue virus infection in these mice follows that reported in human patients, making this the first valid and relevant model for studying dengue fever pathogenesis in humans.	[Mota, Javier; Rico-Hesse, Rebeca] SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX USA	Texas Biomedical Research Institute	Rico-Hesse, R (corresponding author), SW Fdn Biomed Res, Dept Virol & Immunol, San Antonio, TX USA.	rricoh@sfbr.org	Rico-Hesse, Rebeca/C-5294-2011; Rico-Hesse, Rebecca/AAW-9501-2021	Rico-Hesse, Rebeca/0000-0001-6216-1000; 	National Institutes of Health (NIH) [R01AI50123]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050123] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by National Institutes of Health (NIH) grant R01AI50123 to RRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong PM, 2001, VECTOR-BORNE ZOONOT, V1, P159, DOI 10.1089/153036601316977769; Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416; Bente DA, 2005, J VIROL, V79, P13797, DOI 10.1128/JVI.79.21.13797-13799.2005; Bente Dennis A, 2006, Drug Discov Today Dis Models, V3, P97, DOI 10.1016/j.ddmod.2006.03.014; BIERMAN HR, 1965, ANN INTERN MED, V62, P867, DOI 10.7326/0003-4819-62-5-867; Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07; BOONPUCKNAVIG S, 1976, AM J PATHOL, V85, P37; Brehm MA, 2010, CLIN IMMUNOL, V135, P84, DOI 10.1016/j.clim.2009.12.008; Cassetti MC, 2010, VACCINE, V28, P4229, DOI 10.1016/j.vaccine.2010.04.045; Chaturvedi UC, 2000, FEMS IMMUNOL MED MIC, V28, P183, DOI 10.1111/j.1574-695X.2000.tb01474.x; Cologna R, 2003, J VIROL, V77, P3929, DOI 10.1128/JVI.77.7.3929-3938.2003; Durbin AP, 2008, VIROLOGY, V376, P429, DOI 10.1016/j.virol.2008.03.028; Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G; Guzman M G, 1999, Int J Infect Dis, V3, P130, DOI 10.1016/S1201-9712(99)90033-4; HALL WC, 1991, AM J TROP MED HYG, V45, P408, DOI 10.4269/ajtmh.1991.45.408; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3; Huerre MR, 2001, VIRCHOWS ARCH, V438, P107; Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251; Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043; King Alan D., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P718; Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051; KURANE I, 1990, ARCH VIROL, V110, P91, DOI 10.1007/BF01310705; KURANE I, 1994, ARCH VIROL, P59; KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457; Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005; LARUSSA VF, 1995, BAILLIERE CLIN HAEM, V8, P249, DOI 10.1016/S0950-3536(05)80240-9; Lee YR, 2006, J GEN VIROL, V87, P3623, DOI 10.1099/vir.0.82093-0; Lin S F, 1989, Gaoxiong Yi Xue Ke Xue Za Zhi, V5, P12; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; Mentor NA, 1997, ACTA VIROL, V41, P175; Miagostovich MP, 1997, CLIN NEUROPATHOL, V16, P204; Mota J, 2009, J VIROL, V83, P8638, DOI 10.1128/JVI.00581-09; NAKAO S, 1989, BLOOD, V74, P1235; NISALAK A, 1970, YALE J BIOL MED, V42, P293; Priyadarshini D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008709; Ravetch JV, 2001, ANNU REV IMMUNOL, V19, P275, DOI 10.1146/annurev.immunol.19.1.275; Rico-Hesse R, 2003, ADV VIRUS RES, V59, P315, DOI 10.1016/S0065-3527(03)59009-1; Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7; Rothwell SW, 1996, AM J TROP MED HYG, V54, P503, DOI 10.4269/ajtmh.1996.54.503; Schmidt MR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003192; Seet RCS, 2009, INT J INFECT DIS, V13, pE248, DOI 10.1016/j.ijid.2008.11.028; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Srikiatkhachorn A, 2007, J VIROL, V81, P1592, DOI 10.1128/JVI.01642-06; Valero N, 2008, ARCH VIROL, V153, P199, DOI 10.1007/s00705-007-1080-4; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; *WHO, 2009, DENG FACTSH; Yauch LE, 2008, ANTIVIR RES, V80, P87, DOI 10.1016/j.antiviral.2008.06.010	50	62	65	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20762	10.1371/journal.pone.0020762	http://dx.doi.org/10.1371/journal.pone.0020762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695193	gold, Green Published, Green Submitted			2022-12-25	WOS:000291612600021
J	Waiboci, LW; Lebo, E; Williamson, JM; Mwiti, W; Kikwai, GK; Njuguna, H; Olack, B; Breiman, RF; Njenga, MK; Katz, MA				Waiboci, Lilian W.; Lebo, Emmaculate; Williamson, John M.; Mwiti, William; Kikwai, Gilbert K.; Njuguna, Henry; Olack, Beatrice; Breiman, Robert F.; Njenga, M. Kariuki; Katz, Mark A.			Viral Shedding in Patients Infected with Pandemic Influenza A (H1N1) Virus in Kenya, 2009	PLOS ONE			English	Article							TRANSMISSION; LOAD	Background: Understanding shedding patterns of 2009 pandemic influenza A (H1N1) (pH1N1) can inform recommendations about infection control measures. We evaluated the duration of pH1N1 virus shedding in patients in Nairobi, Kenya. Methods: Nasopharyngeal (NP) and oropharyngeal (OP) specimens were collected from consenting laboratory-confirmed pH1N1 cases every 2 days during October 14-November 25, 2009, and tested at the Centers for Diseases Control and Prevention-Kenya by real time reverse transcriptase polymerase chain reaction (rRT-PCR). A subset of rRT-PCR-positive samples was cultured. Results: Of 285 NP/OP specimens from patients with acute respiratory illness, 140 (49%) tested positive for pH1N1 by rRT-PCR; 106 (76%) patients consented and were enrolled. The median age was 6 years (Range: 4 months-41 years); only two patients, both asthmatic, received oseltamivir. The median duration of pH1N1 detection after illness onset was 8 days (95% CI: 7-10 days) for rRT-PCR and 3 days (Range: 0-13 days) for viral isolation. Viable pH1N1 virus was isolated from 132/162 (81%) of rRT-PCR-positive specimens, which included 118/125 (94%) rRT-PCR-positive specimens collected on day 0-7 after symptoms onset. Viral RNA was detectable in 18 (17%) and virus isolated in 7/18 (39%) of specimens collected from patients after all their symptoms had resolved. Conclusions: In this cohort, pH1N1 was detected by rRT-PCR for a median of 8 days. There was a strong correlation between rRT-PCR results and virus isolation in the first week of illness. In some patients, pH1N1 virus was detectable after all their symptoms had resolved.	[Waiboci, Lilian W.; Mwiti, William; Kikwai, Gilbert K.; Njuguna, Henry; Olack, Beatrice] US Ctr Dis Control & Prevent Kenya, Kenya Med Res Inst, Nairobi, Kenya; [Katz, Mark A.] Natl Ctr Immunizat & Resp Dis NCIRD, Influenza Div, Ctr Dis Control & Prevent, Atlanta, GA USA	Kenya Medical Research Institute; Centers for Disease Control & Prevention - USA	Waiboci, LW (corresponding author), US Ctr Dis Control & Prevent Kenya, Kenya Med Res Inst, Nairobi, Kenya.	lwaiboci@ke.cdc.gov		Muriira, William/0000-0001-5330-9798; Kikwai, Gilbert/0000-0002-2307-2280	US Centers for Disease Control and Prevention	US Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The research was funded by the US Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Bell D, 2006, EMERG INFECT DIS, V12, P81; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; *CDCP, 2009, REC AM TIM PERS INFL; *CTR DIS PREV CONT, 2009, INT GUID SPEC COLL P; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; De Serres G, 2010, EMERG INFECT DIS, V16, P783, DOI 10.3201/eid1605.091894; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; FEIKIN D, 2010, INT J EPIDEMIOL, V39, P1; Feiterna-Sperling C, 2010, CLIN INFECT DIS, V51, pE90, DOI 10.1086/657121; Lee CS, 2010, CLIN MICROBIOL INFEC, V16, P389, DOI 10.1111/j.1469-0691.2010.03117.x; Lee N, 2009, J INFECT DIS, V200, P492, DOI 10.1086/600383; Li IW, 2010, CHEST, V137, P759, DOI 10.1378/chest.09-3072; Ling LM, 2010, CLIN INFECT DIS, V50, P963, DOI 10.1086/651083; *NASCOP KEN, 2009, 2007 KEN AIDS IND SU, P15; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Suess T, 2010, AM J EPIDEMIOL, V171, P1157, DOI 10.1093/aje/kwq071; Tabu C., 2009, Morbidity and Mortality Weekly Report, V58, P1143; To KKW, 2010, J MED VIROL, V82, P1, DOI 10.1002/jmv.21664; *UNAIDS, 2009, UNAIDS WHO 2009 AIDS, P21; van Elden LJR, 2002, CLIN INFECT DIS, V34, P177, DOI 10.1086/338238; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P361; *WHO, 2003, ANT THER COV SUBS AF; *WHO, 2009, INF PREV CONTR HLTH; World Health Organization, 2009, CDC PROT REALT RTPCR	26	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20320	10.1371/journal.pone.0020320	http://dx.doi.org/10.1371/journal.pone.0020320			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	21695203	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612600008
J	Ballabio, E; Regan, R; Garimberti, E; Harbott, J; Bradtke, J; Teigler-Schlegel, A; Biondi, A; Cazzaniga, G; Giudici, G; Wainscoat, JS; Boultwood, J; Bridger, JM; Knight, SJL; Tosi, S				Ballabio, Erica; Regan, Regina; Garimberti, Elisa; Harbott, Jochen; Bradtke, Jutta; Teigler-Schlegel, Andrea; Biondi, Andrea; Cazzaniga, Giovanni; Giudici, Giovanni; Wainscoat, James S.; Boultwood, Jacqueline; Bridger, Joanna M.; Knight, Samantha J. L.; Tosi, Sabrina			Genomic Imbalances Are Confined to Non-Proliferating Cells in Paediatric Patients with Acute Myeloid Leukaemia and a Normal or Incomplete Karyotype	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; COPY NUMBER ALTERATIONS; NORMAL CYTOGENETICS; YOUNGER ADULTS; ONCOLOGY-GROUP; MUTATIONS; AML; ABNORMALITIES; ABERRATIONS; CANCER	Leukaemia is often associated with genetic alterations such as translocations, amplifications and deletions, and recurrent chromosome abnormalities are used as markers of diagnostic and prognostic relevance. However, a proportion of acute myeloid leukaemia (AML) cases have an apparently normal karyotype despite comprehensive cytogenetic analysis. Based on conventional cytogenetic analysis of banded chromosomes, we selected a series of 23 paediatric patients with acute myeloid leukaemia and performed whole genome array comparative genome hybridization (aCGH) using DNA samples derived from the same patients. Imbalances involving large chromosomal regions or entire chromosomes were detected by aCGH in seven of the patients studied. Results were validated by fluorescence in situ hybridization (FISH) to both interphase nuclei and metaphase chromosomes using appropriate bacterial artificial chromosome (BAC) probes. The majority of these copy number alterations (CNAs) were confirmed by FISH and found to localize to the interphase rather than metaphase nuclei. Furthermore, the proliferative states of the cells analyzed by FISH were tested by immunofluorescence using an antibody against the proliferation marker pKi67. Interestingly, these experiments showed that, in the vast majority of cases, the changes appeared to be confined to interphase nuclei in a non-proliferative status.	[Ballabio, Erica; Garimberti, Elisa; Bridger, Joanna M.; Tosi, Sabrina] Brunel Univ, Ctr Cell & Chromosome Biol, London, England; [Ballabio, Erica; Garimberti, Elisa; Bridger, Joanna M.; Tosi, Sabrina] Brunel Univ, Brunel Inst Canc Genet & Pharmacogen, Div Biosci, London, England; [Ballabio, Erica; Wainscoat, James S.; Boultwood, Jacqueline] John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, LRF Mol Haematol Unit, Oxford OX3 9DU, England; [Regan, Regina; Knight, Samantha J. L.] NIHR Biomed Res Ctr, Oxford, England; [Regan, Regina; Knight, Samantha J. L.] Wellcome Trust Ctr Human Genet, Oxford, England; [Harbott, Jochen; Bradtke, Jutta; Teigler-Schlegel, Andrea] Univ Giessen, Dept Paediat Haematol & Oncol, Oncogenet Lab, Giessen, Germany; [Biondi, Andrea; Cazzaniga, Giovanni; Giudici, Giovanni] Clin Pediat Univ Milano Bicocca, Ctr Ric Tettamanti, Monza, Italy	Brunel University; Brunel University; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Justus Liebig University Giessen; University of Milano-Bicocca	Ballabio, E (corresponding author), Brunel Univ, Ctr Cell & Chromosome Biol, London, England.	sabrina.tosi@brunel.ac.uk	Biondi, Andrea/AAX-1865-2020; Biondi, Andrea/K-9997-2016; Tosi, Sabrina/AAA-7199-2022; Cazzaniga, Giovanni/K-6338-2016	Biondi, Andrea/0000-0002-6757-6173; Tosi, Sabrina/0000-0002-0036-0191; Knight, Samantha/0000-0002-6047-3462; Cazzaniga, Giovanni/0000-0003-2955-4528; Bridger, Joanna/0000-0003-3999-042X; Boultwood, Jacqueline/0000-0002-4330-2928	Leukaemia Research UK [0253]; Department of Health's NIHR Biomedical Research Centre; Wellcome Trust [075491]	Leukaemia Research UK; Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from Leukaemia Research UK (grant no. 0253). SJLK and RR were supported by the NIHR Biomedical Research Centre, Oxford, with funding from the Department of Health's NIHR Biomedical Research Centres funding scheme. The work was also supported by core facilities funded by a Wellcome Trust core award grant (grant no. 075491). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armengol G, 2010, LEUKEMIA LYMPHOMA, V51, P114, DOI 10.3109/10428190903350397; Baldus CD, 2007, BRIT J HAEMATOL, V137, P387, DOI 10.1111/j.1365-2141.2007.06566.x; Bridger JM, 1998, CHROMOSOME RES, V6, P13, DOI 10.1023/A:1009210206855; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cazzaniga G, 2005, BLOOD, V106, P1419, DOI 10.1182/blood-2005-03-0899; CZEPULKOWSKI B, 2001, ANAL CHROMOSOMES, P19; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Frohling S, 2004, J CLIN ONCOL, V22, P624, DOI 10.1200/JCO.2004.06.060; Frohling S, 2002, BLOOD, V100, P4372, DOI 10.1182/blood-2002-05-1440; Gauvreau K, 2006, CIRCULATION, V114, P1545, DOI 10.1161/CIRCULATIONAHA.105.586487; Gilliland D Gary, 2004, Hematology Am Soc Hematol Educ Program, P80; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Kallioniemi A, 2008, CURR OPIN BIOTECH, V19, P36, DOI 10.1016/j.copbio.2007.11.004; Karst C, 2005, INT J ONCOL, V27, P355; Kearney Lyndal, 2002, Methods Mol Med, V68, P7; Kill IR, 1996, J CELL SCI, V109, P1253; Mrozek K, 2001, BEST PRACT RES CL HA, V14, P19, DOI 10.1053/beha.2000.0114; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Paulsson K, 2006, LEUKEMIA, V20, P840, DOI 10.1038/sj.leu.2404145; PRINCE TS, 2005, NUCLEIC ACIDS RES, V33, P3455; Raimondi SC, 1999, BLOOD, V94, P3707; Rucker FG, 2006, J CLIN ONCOL, V24, P3887, DOI 10.1200/JCO.2005.04.5450; Shaffer LG, 2009, INT SYST HUM CYT NOM; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Thiede C, 2006, BLOOD, V107, P4011, DOI 10.1182/blood-2005-08-3167; TOSI S, 1994, CANCER GENET CYTOGEN, V73, P103, DOI 10.1016/0165-4608(94)90193-7; Tyybakinoja A, 2007, LEUKEMIA, V21, P571, DOI 10.1038/sj.leu.2404543; Veltman JA, 2002, AM J HUM GENET, V70, P1269, DOI 10.1086/340426; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wiktor AE, 2006, GENET MED, V8, P16, DOI 10.1097/01.gim.0000195645.00446.61; Wolff DJ, 2007, J MOL DIAGN, V9, P134, DOI 10.2353/jmoldx.2007.060128	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20607	10.1371/journal.pone.0020607	http://dx.doi.org/10.1371/journal.pone.0020607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694761	gold, Green Published			2022-12-25	WOS:000291612900017
J	Shi, L; Zhao, SQ; Tang, ZY; Fang, JY				Shi, Lei; Zhao, Shuqing; Tang, Zhiyao; Fang, Jingyun			The Changes in China's Forests: An Analysis Using the Forest Identity	PLOS ONE			English	Article							ENVIRONMENTAL KUZNETS CURVE; ABOVEGROUND BIOMASS; TROPICAL FORESTS; CARBON STORAGE; DEFORESTATION; VEGETATION; ECOSYSTEMS; TRENDS; GROWTH; TIMBER	Changes in forest carbon stocks are a determinant of the regional carbon budget. In the past several decades, China has experienced a pronounced increase in forest area and density. However, few comprehensive analyses have been conducted. In this study, we employed the Forest Identity concept to evaluate the changing status of China's forests over the past three decades, using national forest inventory data of five periods (1977-1981, 1984-1988, 1989-1993, 1994-1998, and 1999-2003). The results showed that forest area and growing stock density increased by 0.51% and 0.44% annually over the past three decades, while the conversion ratio of forest biomass to growing stock declined by 0.10% annually. These developments resulted in a net annual increase of 0.85% in forest carbon sequestration, which is equivalent to a net biomass carbon uptake of 43.8 Tg per year (1 Tg = 10(12) g). This increase can be attributed to the national reforestation/afforestation programs, environmentally enhanced forest growth and economic development as indicated by the average gross domestic product.	[Shi, Lei] Peking Univ, Coll Urban & Environm Sci, Beijing 100871, Peoples R China; Peking Univ, Key Lab Earth Surface Proc, Minist Educ, Beijing 100871, Peoples R China	Peking University; Peking University	Shi, L (corresponding author), Peking Univ, Coll Urban & Environm Sci, Beijing 100871, Peoples R China.	jyfang@urban.pku.edu.cn	Tang, Zhiyao/B-8795-2008; Shi, Lei/F-2820-2011		National Natural Science Foundation of China [31021001, 30721140306]; National Basic Research Program of China on Global Change [2010CB50600]; Chinese Academy of Sciences [XDA05050503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China on Global Change(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	The work was supported by the National Natural Science Foundation of China (#31021001 and #30721140306), the National Basic Research Program of China on Global Change (#2010CB50600) and 'Strategic Priority Research Program - Climate Change: Carbon Budget and Related Issues' of the Chinese Academy of Sciences (#XDA05050503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akindele SO, 2006, FOREST ECOL MANAG, V226, P41, DOI 10.1016/j.foreco.2006.01.022; ALLEN JC, 1985, ANN ASSOC AM GEOGR, V75, P163, DOI 10.1111/j.1467-8306.1985.tb00079.x; Birdsey R, 1992, CARBON STORAGE ACCUM, DOI DOI 10.2737/WO-GTR-59; Boyd DS, 2002, APPL GEOGR, V22, P375, DOI 10.1016/S0143-6228(02)00048-6; BROWN S, 1984, SCIENCE, V223, P1290, DOI 10.1126/science.223.4642.1290; BROWN S, 1992, INTERCIENCIA, V17, P8; Brown S, 1995, ENVIRON MONIT ASSESS, V38, P157, DOI 10.1007/BF00546760; Brown S, 1997, 134 FAO; Brown SL, 1999, FOREST ECOL MANAG, V123, P81, DOI 10.1016/S0378-1127(99)00017-1; Burgi M, 1999, LANDSCAPE ECOL, V14, P567, DOI 10.1023/A:1008168209725; Carle J, 2002, FOREST PROD J, V52, P12; *CHIN MIN FOR, 2009, CHIN FOR RES 2004 20; Culas RJ, 2007, ECOL ECON, V61, P429, DOI 10.1016/j.ecolecon.2006.03.014; Culmsee H, 2010, J BIOGEOGR, V37, P960, DOI 10.1111/j.1365-2699.2009.02269.x; de Koning F, 2005, AMBIO, V34, P224; Ehrhardt-Martinez K, 2002, SOC SCI QUART, V83, P226, DOI 10.1111/1540-6237.00080; Fang JY, 2007, SCI CHINA SER D, V50, P1341, DOI 10.1007/s11430-007-0049-1; Fang JY, 2010, SCI CHINA LIFE SCI, V53, P753, DOI 10.1007/s11427-010-4032-2; Fang JY, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002253; Fang JY, 2004, SCI CHINA SER C, V47, P229, DOI 10.1360/03yc0068; Fang JY, 2003, FRONT ECOL ENVIRON, V1, P293; Fang JY, 2001, SCIENCE, V292, P2320, DOI 10.1126/science.1058629; Fang JY, 2001, ECOL RES, V16, P587, DOI 10.1046/j.1440-1703.2001.00419.x; FAO, 2006, 147 FAO; FAO, 2001, GLOBAL FOREST RESOUR; FAO, 2010, 163 FAO; Goodale CL, 2002, ECOL APPL, V12, P891, DOI 10.2307/3060997; Guo ZD, 2010, FOREST ECOL MANAG, V259, P1225, DOI 10.1016/j.foreco.2009.09.047; Handa IT, 2006, GLOBAL CHANGE BIOL, V12, P2417, DOI 10.1111/j.1365-2486.2006.01258.x; Hertel D, 2009, FOREST ECOL MANAG, V258, P1904, DOI 10.1016/j.foreco.2009.07.019; Houghton RA, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/4/045032; Kauppi PE, 2006, P NATL ACAD SCI USA, V103, P17574, DOI 10.1073/pnas.0608343103; Mather AS, 1999, GEOGRAPHY, V84, P55; MATTHEWS G, 1993, 4 FOR COMM TECHN; Mayer AL, 2005, SCIENCE, V308, P359, DOI 10.1126/science.1109476; MORTENSEN LM, 1995, ENVIRON POLLUT, V87, P337, DOI 10.1016/0269-7491(94)P4165-K; Pancer-Koteja E, 2009, PLANT ECOL, V205, P139, DOI 10.1007/s11258-009-9604-5; Piao SL, 2009, NATURE, V458, P1009, DOI 10.1038/nature07944; Piao SL, 2006, GLOBAL CHANGE BIOL, V12, P672, DOI 10.1111/j.1365-2486.2006.01123.x; Schroeder P, 1997, FOREST SCI, V43, P424; Stern DI, 1996, WORLD DEV, V24, P1151, DOI 10.1016/0305-750X(96)00032-0; Teobaldelli M, 2009, FOREST ECOL MANAG, V257, P1004, DOI 10.1016/j.foreco.2008.11.002; Waggoner PE, 2008, INT FOREST REV, V10, P689, DOI 10.1505/ifor.10.4.689; Wang GY, 2007, SCIENCE, V318, P1556, DOI 10.1126/science.1147247; Wang SQ, 2002, SCI CHINA SER C, V45, P40; Watson RT, 2000, LAND USE LAND USE CH	46	25	31	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20778	10.1371/journal.pone.0020778	http://dx.doi.org/10.1371/journal.pone.0020778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21695254	Green Published, Green Submitted, gold			2022-12-25	WOS:000291612900025
J	Combreau, O; Riou, S; Judas, J; Lawrence, M; Launay, F				Combreau, Olivier; Riou, Samuel; Judas, Jacky; Lawrence, Mark; Launay, Frederic			Migratory Pathways and Connectivity in Asian Houbara Bustards: Evidence from 15 Years of Satellite Tracking	PLOS ONE			English	Article							CHLAMYDOTIS-UNDULATA-MACQUEENII; SEASONAL INTERACTIONS; BIRD MIGRATION; CONSERVATION; POPULATION; DESERT; ROUTES; RANGE	Information on migratory pathways and connectivity is essential to understanding population dynamics and structure of migrant species. Our manuscript uses a unique dataset, the fruit of 103 individual Asian houbara bustards captured on their breeding grounds in Central Asia over 15 years and equipped with satellite transmitters, to provide a better understanding of migratory pathways and connectivity; such information is critical to the implementation of biologically sound conservation measures in migrant species. At the scale of the distribution range we find substantial migratory connectivity, with a clear separation of migration pathways and wintering areas between western and eastern migrants. Within eastern migrants, we also describe a pattern of segregation on the wintering grounds. But at the local level connectivity is weak: birds breeding within the limits of our study areas were often found several hundreds of kilometres apart during winter. Although houbara wintering in Arabia are known to originate from Central Asia, out of all the birds captured and tracked here not one wintered on the Arabian Peninsula. This is very likely the result of decades of unregulated off-take and severe habitat degradation in this area. At a time when conservation measures are being implemented to safeguard the long-term future of this species, this study provides critical data on the spatial structuring of populations.	[Combreau, Olivier] Int Fund Houbara Conservat, Abu Dhabi, U Arab Emirates; [Riou, Samuel; Judas, Jacky; Lawrence, Mark] Natl Avian Res Ctr, Abu Dhabi, U Arab Emirates; [Launay, Frederic] Mohamed Bin Zayed Species Conservat Fund, Abu Dhabi, U Arab Emirates		Combreau, O (corresponding author), Int Fund Houbara Conservat, Abu Dhabi, U Arab Emirates.	olivier.combreau@gmail.com	Judas, Jacky/AAA-7557-2021		International Fund for Houbara ConserUAEvation (IFHC) located in Abu Dhabi, UAE	International Fund for Houbara ConserUAEvation (IFHC) located in Abu Dhabi, UAE	The study is funded by the authors' organization, the International Fund for Houbara Conservation (IFHC) located in Abu Dhabi, UAE. The IFHC is a new Abu Dhabi governmental body that has emerged from the Environment Agency - Abu Dhabi (www.ead.ae) with the mission to supervise all Abu Dhabi Houbara Bustard projects. The National Avian Research Center that used to belong to the Environment Agency - Abu Dhabi is now operating under IFHC. No specific website exists to date since IFHC is new but details may be found at www.ead.ae. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; ALERSTAM T, 1979, ORNIS SCAND, V10, P76, DOI 10.2307/3676347; Ashmole M.J., 1962, IBIS, V104, P522, DOI [10.1111/j.1474-919X.1962.tb08684.x, DOI 10.1111/J.1474-919X.1962.TB08684.X]; Bairlein F, 2001, ARDEA, V89, P7; Berthold P, 2001, AUK, V2nd; Berthold P, 1996, CONTROL BIRD MIGRATI; Beyer HL., HAWTHS ANAL TOOLS AR; BIEBACH H, 1983, J ORNITHOL, V124, P251, DOI 10.1007/BF01640609; Boulet Marylene, 2006, Ornithological Monographs, V61, P29, DOI 10.1642/0078-6594(2006)61[29:IAOGSI]2.0.CO;2; Boulet Marylene, 2006, P1; Chernetsov N, 2004, J EXP BIOL, V207, P937, DOI 10.1242/jeb.00853; Collar N, 1996, HDB BIRDS WORLD HOAT, V3, P240; COLLAR NJ, 1980, BRIT BIRDS, V73, P198; Combreau O, 1999, CONDOR, V101, P159, DOI 10.2307/1370458; Combreau O, 2001, ANIM CONSERV, V4, P133, DOI 10.1017/S1367943001001160; COMBREAU O, 2006, ECOLOGY CONSERVATION; Cramp S., 1980, BIRDS W PALEARCTIC; Crawley MJ., 2007, R BOOK; Esler D, 2000, CONSERV BIOL, V14, P366, DOI 10.1046/j.1523-1739.2000.98147.x; Getz WM, 2004, ECOGRAPHY, V27, P489, DOI 10.1111/j.0906-7590.2004.03835.x; Goriup Paul D., 1997, Bird Conservation International, V7, P373; Gschweng M, 2008, P ROY SOC B-BIOL SCI, V275, P2887, DOI 10.1098/rspb.2008.0575; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Judas J, 2006, IBIS, V148, P343, DOI 10.1111/j.1474-919X.2006.00546.x; Kelly JF, 2005, CONDOR, V107, P197, DOI 10.1650/7805; Launay F, 1999, BIRD CONSERV INT, V9, P155, DOI 10.1017/S0959270900002276; Launay F, 1999, WILDLIFE SOC B, V27, P603; Launay F, 1997, J ARID ENVIRON, V35, P111, DOI 10.1006/jare.1995.0136; Mansoori J., 2006, IRANIAN J ORNITHOLOG, V1, P17; Marra P.P., 2006, MAINTAINING CONNECTI; Martin TG, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000751; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Norris DR, 2007, CONDOR, V109, P535; Norris D. Ryan, 2006, Ornithological Monographs, V61, P14; OATHEM M, 1996, DESERT ECOLOGY ABU D; Osborne Patrick E., 1996, P86; Osborne PE, 1997, IBIS, V139, P192, DOI 10.1111/j.1474-919X.1997.tb04527.x; Pitra C, 2004, CONSERV GENET, V5, P205, DOI 10.1023/B:COGE.0000030004.51398.28; *R FDN STAT COMP, R R LANG ENV STAT CO; RIOU S, BIRD CONSER IN PRESS; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Ruokonen M, 2004, CONSERV GENET, V5, P501, DOI 10.1023/B:COGE.0000041019.27119.b4; Satchell J.E., 1978, Journal of Arid Environments, V1, P201; Seddon PJ, 1996, BIOL CONSERV, V75, P139, DOI 10.1016/0006-3207(95)00062-3; Szep T, 2009, J ORNITHOL, V150, P621, DOI 10.1007/s10336-009-0382-6; Thorup K, 2007, P NATL ACAD SCI USA, V104, P18115, DOI 10.1073/pnas.0704734104; Tourenq C, 2005, BIOL CONSERV, V121, P1, DOI 10.1016/j.biocon.2004.03.031; Tourenq C, 2004, BIRD CONSERV INT, V14, P1, DOI 10.1017/S0959270904000012; Webster Michael S., 2005, P199; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1	50	33	34	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20570	10.1371/journal.pone.0020570	http://dx.doi.org/10.1371/journal.pone.0020570			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21687684	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500029
J	Joergensen, A; Broedbaek, K; Weimann, A; Semba, RD; Ferrucci, L; Joergensen, MB; Poulsen, HE				Joergensen, Anders; Broedbaek, Kasper; Weimann, Allan; Semba, Richard D.; Ferrucci, Luigi; Joergensen, Martin B.; Poulsen, Henrik E.			Association between Urinary Excretion of Cortisol and Markers of Oxidatively Damaged DNA and RNA in Humans	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; CHRONIC STRESS; REPAIR; RISK; MORTALITY; DEMENTIA; DISEASE; PROTEIN	Chronic psychological stress is associated with accelerated aging, but the underlying biological mechanisms are not known. Prolonged elevations of the stress hormone cortisol is suspected to play a critical role. Through its actions, cortisol may potentially induce oxidatively generated damage to cellular constituents such as DNA and RNA, a phenomenon which has been implicated in aging processes. We investigated the relationship between 24 h excretion of urinary cortisol and markers of oxidatively generated DNA and RNA damage, 8-oxo-7,8-dihydro-2'-deoxyguanosine and 8-oxo-7,8-dihydroguanosine, in a sample of 220 elderly men and women (age 65 - 83 years). We found a robust association between the excretion of cortisol and the oxidation markers (R-2 = 0.15, P < 0.001 for both markers). Individuals in the highest quartile of cortisol excretion had a 57% and 61% higher median excretion of the DNA and RNA oxidation marker, respectively, than individuals in the lowest quartile. The finding adds support to the hypothesis that cortisol-induced damage to DNA/RNA is an explanatory factor in the complex relation between stress, aging and disease.	[Joergensen, Anders; Joergensen, Martin B.] Ctr Psychiat, Copenhagen, Denmark; [Broedbaek, Kasper; Weimann, Allan; Poulsen, Henrik E.] Rigshosp, Lab Clin Pharmacol Q7642, DK-2100 Copenhagen, Denmark; [Broedbaek, Kasper; Weimann, Allan; Poulsen, Henrik E.] Bispebjerg Hosp, Dept Clin Pharmacol, DK-2400 Copenhagen, Denmark; [Semba, Richard D.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Ferrucci, Luigi] NIA, Longitudinal Studies Sect, Clin Res Branch, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Poulsen, Henrik E.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; Bispebjerg Hospital; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Copenhagen	Joergensen, A (corresponding author), Ctr Psychiat, Copenhagen, Denmark.	anders.01.joergensen@regionh.dk	Brødbæk, Kasper/G-5115-2012; Jorgensen, Martin Balslev MBJ/K-5758-2012; Jorgensen, Anders/H-6325-2018	Jorgensen, Martin Balslev MBJ/0000-0002-1321-8901; Jorgensen, Anders/0000-0001-6012-6965; Poulsen, Henrik Enghusen/0000-0003-4242-9924	Psychiatric Center Copenhagen; Research Committee at Copenhagen University Hospital, Rigshospitalet, National Institute on Aging [R01 AG027012, R01 AG029148, R01 HL094507]; Italian Ministry of Health [ICS110.1/RF97.71]; NIA [263 MD 9164, 263 MD 821336, N.1-AG-1-1, N.1-AG-1-2111, N01-AG-5-0002]; Intramural Research Program, National Institute on Aging, National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094507] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [N01AG012111, R01AG029148, R01AG027012] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [R01MD009164] Funding Source: NIH RePORTER	Psychiatric Center Copenhagen; Research Committee at Copenhagen University Hospital, Rigshospitalet, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Italian Ministry of Health(Ministry of Health, Italy); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural Research Program, National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by funding from Psychiatric Center Copenhagen, the Research Committee at Copenhagen University Hospital, Rigshospitalet, National Institute on Aging Grants R01 AG027012, R01 AG029148, R01 HL094507, the Italian Ministry of Health (ICS110.1/RF97.71), NIA contracts 263 MD 9164, 263 MD 821336, N.1-AG-1-1, N.1-AG-1-2111, and N01-AG-5-0002, and the Intramural Research Program, National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BROEDBAEK K, 2011, FREE RADIC RES; Brotman DJ, 2007, LANCET, V370, P1089, DOI 10.1016/S0140-6736(07)61305-1; Caro P, 2007, BIOGERONTOLOGY, V8, P1, DOI 10.1007/s10522-006-9026-x; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Deng XS, 1998, FREE RADICAL RES, V28, P323, DOI 10.3109/10715769809069284; Du J, 2009, P NATL ACAD SCI USA, V106, P3543, DOI 10.1073/pnas.0812671106; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Evans MD, 2010, MUTAGENESIS, V25, P433, DOI 10.1093/mutage/geq031; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Flint MS, 2007, PSYCHONEUROENDOCRINO, V32, P470, DOI 10.1016/j.psyneuen.2007.02.013; Forlenza MJ, 2006, PSYCHOSOM MED, V68, P1, DOI 10.1097/01.psy.0000195780.37277.2a; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Irie M, 2005, CANCER SCI, V96, P600, DOI 10.1111/j.1349-7006.2005.00083.x; Kananen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010826; Kao HT, 2008, MOL PSYCHIATR, V13, P118, DOI 10.1038/sj.mp.4002105; Kessing LV, 2004, J NEUROL NEUROSUR PS, V75, P1662, DOI 10.1136/jnnp.2003.031773; Liu JK, 1996, FASEB J, V10, P1532, DOI 10.1096/fasebj.10.13.8940299; Loft S, 2006, CARCINOGENESIS, V27, P1245, DOI 10.1093/carcin/bgi313; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lovell MA, 2001, ARCH NEUROL-CHICAGO, V58, P392, DOI 10.1001/archneur.58.3.392; Maynard S, 2009, CARCINOGENESIS, V30, P2, DOI 10.1093/carcin/bgn250; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Murakami K, 2008, NUTRITION, V24, P16, DOI 10.1016/j.nut.2007.09.001; Mykletun A, 2009, BRIT J PSYCHIAT, V195, P118, DOI 10.1192/bjp.bp.108.054866; Otte C, 2005, PSYCHONEUROENDOCRINO, V30, P80, DOI 10.1016/j.psyneuen.2004.06.002; Poulsen HE, 2005, EXP TOXICOL PATHOL, V57, P161, DOI 10.1016/j.etp.2005.05.015; Prieme H, 1998, CARCINOGENESIS, V19, P347, DOI 10.1093/carcin/19.2.347; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Richter T, 2007, EXP GERONTOL, V42, P1039, DOI 10.1016/j.exger.2007.08.005; Saczynski JS, 2010, NEUROLOGY, V75, P35, DOI 10.1212/WNL.0b013e3181e62138; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Sfar S, 2009, EXP GERONTOL, V44, P812, DOI 10.1016/j.exger.2009.10.008; Shan X, 2007, FASEB J, V21, P2753, DOI 10.1096/fj.07-8200com; Simon NM, 2006, BIOL PSYCHIAT, V60, P432, DOI 10.1016/j.biopsych.2006.02.004; Song L, 2009, NEUROCHEM RES, V34, P739, DOI 10.1007/s11064-008-9838-y; Tanaka M, 2007, P NATL ACAD SCI USA, V104, P66, DOI 10.1073/pnas.0609737104; Vita AJ, 1998, NEW ENGL J MED, V338, P1035, DOI 10.1056/NEJM199804093381506; Vogelzangs N, 2007, PSYCHONEUROENDOCRINO, V32, P151, DOI 10.1016/j.psyneuen.2006.11.009; Vogelzangs N, 2010, J CLIN ENDOCR METAB, V95, P4959, DOI 10.1210/jc.2010-0192; Wang ZL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000951; Weimann A, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e7; Wulsin LR, 2005, PSYCHOSOM MED, V67, P697, DOI 10.1097/01.psy.0000181274.56785.28; Zafir A, 2009, STRESS, V12, P167, DOI 10.1080/10253890802234168	48	53	53	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20795	10.1371/journal.pone.0020795	http://dx.doi.org/10.1371/journal.pone.0020795			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	21687734	Green Submitted, Green Published, gold			2022-12-25	WOS:000291607000022
J	Hume, JCC; Hamilton, H; Lee, KL; Lehmann, T				Hume, Jen C. C.; Hamilton, Howard, III; Lee, Kevin L.; Lehmann, Tovi			Susceptibility of Anopheles stephensi to Plasmodium gallinaceum: A Trait of the Mosquito, the Parasite, and the Environment	PLOS ONE			English	Article							COEVOLUTIONARY INTERACTIONS; CULICOIDES-VARIIPENNIS; MALARIA TRANSMISSION; WUCHERERIA-BANCROFTI; VECTOR COMPETENCE; LOCAL ADAPTATION; HOST; GAMBIAE; INFECTION; EPIDEMIOLOGY	Background: Vector susceptibility to Plasmodium infection is treated primarily as a vector trait, although it is a composite trait expressing the joint occurrence of the parasite and the vector with genetic contributions of both. A comprehensive approach to assess the specific contribution of genetic and environmental variation on "vector susceptibility" is lacking. Here we developed and implemented a simple scheme to assess the specific contributions of the vector, the parasite, and the environment to "vector susceptibility." To the best of our knowledge this is the first study that employs such an approach. Methodology/Principal Findings: We conducted selection experiments on the vector (while holding the parasite "constant") and on the parasite (while holding the vector "constant") to estimate the genetic contributions of the mosquito and the parasite to the susceptibility of Anopheles stephensi to Plasmodium gallinaceum. We separately estimated the realized heritability of (i) susceptibility to parasite infection by the mosquito vector and (ii) parasite compatibility (transmissibility) with the vector while controlling the other. The heritabilities of vector and the parasite were higher for the prevalence, i. e., fraction of infected mosquitoes, than the corresponding heritabilities of parasite load, i. e., the number of oocysts per mosquito. Conclusions: The vector's genetics (heritability) comprised 67% of "vector susceptibility" measured by the prevalence of mosquitoes infected with P. gallinaceum oocysts, whereas the specific contribution of parasite genetics (heritability) to this trait was only 5%. Our parasite source might possess minimal genetic diversity, which could explain its low heritability (and the high value of the vector). Notably, the environment contributed 28%. These estimates are relevant only to the particular system under study, but this experimental design could be useful for other parasite-host systems. The prospects and limitations of the genetic manipulation of vector populations to render the vector resistant to the parasite are better considered on the basis of this framework.	[Hume, Jen C. C.; Hamilton, Howard, III; Lee, Kevin L.; Lehmann, Tovi] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hume, JCC (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	tlehmann@niaid.nih.gov	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875; Lehmann, Tovi/0000-0002-8142-3915	NIH, NIAID; Direct For Biological Sciences [1153218] Funding Source: National Science Foundation	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the Intramural Research Program in NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Boakye DA, 2004, ANN TROP MED PARASIT, V98, P501, DOI 10.1179/000349804225003514; Brumpt E, 1936, CR HEBD ACAD SCI, V203, P750; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; Collins FH, 2000, B WORLD HEALTH ORGAN, V78, P1412; COLLINS RC, 1995, AM J TROP MED HYG, V52, P213, DOI 10.4269/ajtmh.1995.52.213; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; DIMOPOULOS G, 2007, J VIS EXP; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; FALCONER DS, 1996, INTRO QANTITATIVE GE; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; FONTENILLE D, 1992, J MED ENTOMOL, V29, P197, DOI 10.1093/jmedent/29.2.197; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gubler DJ, 2009, REV SCI TECH OIE, V28, P583, DOI 10.20506/rst.28.2.1904; Hogg JC, 1996, MED VET ENTOMOL, V10, P385, DOI 10.1111/j.1365-2915.1996.tb00761.x; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; HUFF CLAY G., 1929, ANN TROP MED & PARASIT [LIVERPOOL], V23, P427; Hume JCC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-139; HUNT RH, 1990, ANN TROP MED PARASIT, V84, P381, DOI 10.1080/00034983.1990.11812483; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; JAMES AA, 2007, J VIS EXP; JONES JS, 1987, NATURE, V325, P298, DOI 10.1038/325298a0; Koella JC, 1998, PARASITOLOGY, V116, pS47, DOI 10.1017/S0031182000084936; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lambrechts L, 2006, P ROY SOC B-BIOL SCI, V273, P1501, DOI 10.1098/rspb.2006.3483; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Laurence B. R., 1967, Journal of Helminthology, V41, P365, DOI 10.1017/S0022149X00021908; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Lemasson JJ, 1997, J MED ENTOMOL, V34, P396, DOI 10.1093/jmedent/34.4.396; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Ljungstr?m I., 2004, METHODS MALARIA RES; LYNCH M, 2008, EVOLUTION SELECTION, V2; Nace D, 2004, J AM MOSQUITO CONTR, V20, P272; NILES WJ, 1965, NATURE, V205, P411, DOI 10.1038/205411a0; Poulin R, 2007, EVOLUTIONARY ECOLOGY; Price P W, 1980, Monogr Popul Biol, V15, P1; RAMSDALE C D, 1975, Parassitologia (Rome), V17, P39; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; *SAS I INC, 2002, SAS WIND VERS 9 0; Shahabuddin M, 1995, EXP PARASITOL, V81, P386, DOI 10.1006/expr.1995.1129; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; TABACHNICK WJ, 1991, AM J TROP MED HYG, V45, P666, DOI 10.4269/ajtmh.1991.45.666; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Garamszegi LZ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-110	52	86	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20156	10.1371/journal.pone.0020156	http://dx.doi.org/10.1371/journal.pone.0020156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	22022570	Green Published, gold, Green Submitted			2022-12-25	WOS:000291612900006
J	Hamilton, CA; Formanowicz, DR; Bond, JE				Hamilton, Chris A.; Formanowicz, Daniel R.; Bond, Jason E.			Species Delimitation and Phylogeography of Aphonopelma hentzi (Araneae, Mygalomorphae, Theraphosidae): Cryptic Diversity in North American Tarantulas	PLOS ONE			English	Article							MULTIPLE PLEISTOCENE REFUGIA; GENETIC DIFFERENTIATION; CONSERVATION GENETICS; POPULATION HISTORY; STATISTICAL TESTS; TRAPDOOR SPIDERS; COMPUTER-PROGRAM; TIGER SALAMANDER; DNA BARCODES; SPECIATION	Background: The primary objective of this study is to reconstruct the phylogeny of the hentzi species group and sister species in the North American tarantula genus, Aphonopelma, using a set of mitochondrial DNA markers that include the animal "barcoding gene". An mtDNA genealogy is used to consider questions regarding species boundary delimitation and to evaluate timing of divergence to infer historical biogeographic events that played a role in shaping the present-day diversity and distribution. We aimed to identify potential refugial locations, directionality of range expansion, and test whether A. hentzi post-glacial expansion fit a predicted time frame. Methods and Findings: A Bayesian phylogenetic approach was used to analyze a 2051 base pair (bp) mtDNA data matrix comprising aligned fragments of the gene regions CO1 (1165 bp) and ND1-16S (886 bp). Multiple species delimitation techniques (DNA tree-based methods, a "barcode gap" using percent of pairwise sequence divergence (uncorrected p-distances), and the GMYC method) consistently recognized a number of divergent and genealogically exclusive groups. Conclusions: The use of numerous species delimitation methods, in concert, provide an effective approach to dissecting species boundaries in this spider group; as well they seem to provide strong evidence for a number of nominal, previously undiscovered, and cryptic species. Our data also indicate that Pleistocene habitat fragmentation and subsequent range expansion events may have shaped contemporary phylogeographic patterns of Aphonopelma diversity in the southwestern United States, particularly for the A. hentzi species group. These findings indicate that future species delimitation approaches need to be analyzed in context of a number of factors, such as the sampling distribution, loci used, biogeographic history, breadth of morphological variation, ecological factors, and behavioral data, to make truly integrative decisions about what constitutes an evolutionary lineage recognized as a "species".	[Hamilton, Chris A.; Bond, Jason E.] Auburn Univ, Auburn Univ Museum Nat Hist, Auburn, AL 36849 USA; [Hamilton, Chris A.; Bond, Jason E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Formanowicz, Daniel R.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Texas System; University of Texas Arlington	Hamilton, CA (corresponding author), Auburn Univ, Auburn Univ Museum Nat Hist, Auburn, AL 36849 USA.	chamilton@auburn.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875; Lehmann, Tovi/0000-0002-8142-3915	American Arachnological Society (AAS); NSF REVSYS [DEB0841610]; Direct For Biological Sciences [1153218] Funding Source: National Science Foundation	American Arachnological Society (AAS); NSF REVSYS(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the American Arachnological Society (AAS) (2009) Vincent Roth Fund for Systematic Research (http://www.americanarachnology.org) to C. Hamilton; NSF REVSYS #DEB0841610 "Systematics and taxonomy of the tarantula spider genus Aphonopelma (Araneae, Mygalomorphae, Theraphosidae)" (http://www.nsf.gov) to J. Bond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Amato ML, 2008, MOL ECOL, V17, P570, DOI 10.1111/j.1365-294X.2007.03580.x; Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2; Astrin JJ, 2006, ZOOL SCR, V35, P441, DOI 10.1111/j.1463-6409.2006.00239.x; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Avise John C., 1994, pi; Ayoub NA, 2004, MOL ECOL, V13, P3453, DOI 10.1111/j.1365-294X.2004.02335.x; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; Baerg WJ, 1958, TARANTULA; Bailey AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012744; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2006, ANIM CONSERV, V9, P145, DOI 10.1111/j.1469-1795.2006.00024.x; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; Bond JE, 2004, INVERTEBR SYST, V18, P361, DOI 10.1071/IS04008; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Boulton AM, 1998, BIOL J LINN SOC, V64, P69, DOI 10.1111/j.1095-8312.1998.tb01534.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Chamberlin R. V., 1939, Bulletin of the University of Utah Biological Series, V5, P1; Chamberlin R. V., 1940, Bulletin of the University of Utah Biological Series, V5, P1; Church SA, 2003, EVOLUTION, V57, P372; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; Costa FG, 2002, J ARACHNOL, V30, P571, DOI 10.1636/0161-8202(2002)030[0571:RBOUTA]2.0.CO;2; COYNE JA, 1994, EVOLUTION, V48, P19, DOI 10.1111/j.1558-5646.1994.tb01290.x; Croucher PJP, 2004, BIOL J LINN SOC, V81, P79, DOI 10.1111/j.1095-8312.2004.00280.x; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; Drummond AJ, 2010, BEAST V1 5 4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELIAS SA, 1992, SOUTHWEST NAT, V37, P101, DOI 10.2307/3671658; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ezard T. H. G., 2009, SPLITS SPECIES LIMIT; Foelix RF, 1996, BIOL SPIDERS; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gantenbein BI, 2003, J ARACHNOL, V31, P412, DOI 10.1636/H01-23; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Girard C, 1854, EXPLORATION RED RIVE, P262; Goloboff P.A., 1993, American Museum Novitates, P1; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Hamilton CA, 2009, THESIS U TEXAS ARLIN; Hamilton DE, 2008, THESIS TEXAS TU; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2009, MOL PHYLOGENET EVOL, V53, P300, DOI 10.1016/j.ympev.2009.06.001; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hull JM, 2010, MOL PHYLOGENET EVOL, V56, P212, DOI 10.1016/j.ympev.2010.02.027; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Janowski-Bell ME, 2001, THESIS U MISSOURI CO; Jennings CE, 2007, ENCY QUATERNARY SCI, P1044; Knowles LL, 2008, EVOLUTION, V62, P2713, DOI 10.1111/j.1558-5646.2008.00481.x; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kozak KH, 2006, MOL ECOL, V15, P191, DOI 10.1111/j.1365-294X.2005.02757.x; Lane N, 2009, NATURE, V462, P272, DOI 10.1038/462272a; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Longhorn SJ, 2007, J ARACHNOL, V35, P278, DOI 10.1636/S05-62.1; Maddison WP, 2010, MESQUITE MODULAR SYS; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Masta SE, 2000, EVOLUTION, V54, P1699; McGaughran A, 2008, MOL PHYLOGENET EVOL, V46, P606, DOI 10.1016/j.ympev.2007.10.003; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murray EA, 2006, THESIS KANSAS STATE; Musgrove M, 2001, GEOL SOC AM BULL, V113, P1532, DOI 10.1130/0016-7606(2001)113<1532:GOLPTH>2.0.CO;2; Okello JBA, 2005, HEREDITY, V95, P206, DOI 10.1038/sj.hdy.6800711; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Papadopoulou A, 2009, MOL ECOL, V18, P2503, DOI 10.1111/j.1365-294X.2009.04207.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pedersen AA, 2001, MOL ECOL, V10, P1133, DOI 10.1046/j.1365-294X.2001.01266.x; Perez-Miles Fernando, 1996, Mygalomorph, V1, P33; Petersen SD, 2007, CONSERV GENET, V8, P497, DOI 10.1007/s10592-006-9173-2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prentice TR, 1997, J ARACHNOL, V25, P137; Prentice TR, 2005, SPIDERS N AM IDENTIF, P54; Punzo F., 1989, Bulletin of the British Arachnological Society, V8, P72; Punzo F., 1991, Bulletin of the British Arachnological Society, V8, P277; Punzo F, 2007, J HYMENOPT RES, V16, P297; Punzo Fred, 1999, Bulletin of the British Arachnological Society, V11, P121; Rambaut A, 2010, TRACER V1 6 1; Rambaut A., 2002, TREEEDIT PHYLOGENETI; Ramirez MG, 2004, BIOL J LINN SOC, V82, P27, DOI 10.1111/j.1095-8312.2004.00312.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Raven R.J., 1990, Bulletin of Zoological Nomenclature, V47, P126; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Rebernig CA, 2010, MOL ECOL, V19, P3421, DOI 10.1111/j.1365-294X.2010.04754.x; Reichling SB, 2000, SW NATURALIST, V44, P518; Riddle BR, 2006, J ARID ENVIRON, V66, P435, DOI 10.1016/j.jaridenv.2006.01.014; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Roy M, 2004, EARTH PLANET SC LETT, V227, P281, DOI 10.1016/j.epsl.2004.09.001; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Seberg O, 2003, TRENDS ECOL EVOL, V18, P63, DOI 10.1016/S0169-5347(02)00059-9; Smith A. M., 1994, TARANTULA SPIDERS TA; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; TEMPLETON AR, 1995, GENETICS, V140, P767; Turgeon J, 2002, MOL ECOL, V11, P1989, DOI 10.1046/j.1365-294X.2002.01580.x; VANDEVENDER TR, 1979, SCIENCE, V204, P701, DOI 10.1126/science.204.4394.701; Velasco JD, 2009, BIOL PHILOS, V24, P473, DOI 10.1007/s10539-009-9151-4; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Warriner W., 2008, Journal of the Arkansas Academy of Science, V62, P107; WELLS PV, 1966, SCIENCE, V153, P970, DOI 10.1126/science.153.3739.970; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x	133	86	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26207	10.1371/journal.pone.0026207	http://dx.doi.org/10.1371/journal.pone.0026207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022570	gold, Green Submitted, Green Published			2022-12-25	WOS:000295976000087
J	Yu, X; Zheng, J				Yu, Xiang; Zheng, Jie			Polymorphic Structures of Alzheimer's beta-Amyloid Globulomers	PLOS ONE			English	Article							EXPERIMENTAL CONSTRAINTS; SOLUBLE OLIGOMERS; ION CHANNELS; PROTEIN; FIBRIL; PEPTIDE; SHEET; DISEASE; BETA(2)-MICROGLOBULIN; ORGANIZATION	Background: Misfolding and self-assembly of Amyloid-beta (A beta) peptides into amyloid fibrils is pathologically linked to the development of Alzheimer's disease. Polymorphic A beta structures derived from monomers to intermediate oligomers, protofilaments, and mature fibrils have been often observed in solution. Some aggregates are on-pathway species to amyloid fibrils, while the others are off-pathway species that do not evolve into amyloid fibrils. Both on-pathway and off-pathway species could be biologically relevant species. But, the lack of atomic-level structural information for these A beta species leads to the difficulty in the understanding of their biological roles in amyloid toxicity and amyloid formation. Methods and Findings: Here, we model a series of molecular structures of A beta globulomers assembled by monomer and dimer building blocks using our peptide-packing program and explicit-solvent molecular dynamics (MD) simulations. Structural and energetic analysis shows that although A beta globulomers could adopt different energetically favorable but structurally heterogeneous conformations in a rugged energy landscape, they are still preferentially organized by dynamic dimeric subunits with a hydrophobic core formed by the C-terminal residues independence of initial peptide packing and organization. Such structural organizations offer high structural stability by maximizing peptide-peptide association and optimizing peptide-water solvation. Moreover, curved surface, compact size, and less populated beta-structure in A beta globulomers make them difficult to convert into other high-order A beta aggregates and fibrils with dominant beta-structure, suggesting that they are likely to be off-pathway species to amyloid fibrils. These A beta globulomers are compatible with experimental data in overall size, subunit organization, and molecular weight from AFM images and H/D amide exchange NMR. Conclusions: Our computationally modeled A beta globulomers provide useful insights into structure, dynamics, and polymorphic nature of A beta globulomers which are completely different from A beta fibrils, suggesting that these globulomers are likely off-pathway species and explaining the independence of the aggregation kinetics between A beta globulomers and fibrils.	[Yu, Xiang; Zheng, Jie] Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA	University System of Ohio; University of Akron	Yu, X (corresponding author), Univ Akron, Dept Chem & Biomol Engn, Akron, OH 44325 USA.	zhengj@uakron.edu	Yu, Xiang/A-9765-2012; Zheng, Jie/B-5057-2013	Yu, Xiang/0000-0002-0486-1110; Zheng, Jie/0000-0003-1547-3612	National Science Foundation [CBET-0952624]; 3M Non-Tenured Faculty Award	National Science Foundation(National Science Foundation (NSF)); 3M Non-Tenured Faculty Award(3M)	This work is supported by a National Science Foundation CAREER Award (CBET-0952624) and a 3M Non-Tenured Faculty Award. This study utilized the high-performance Biowulf PC cluster at the Ohio Supercomputer Center and our ATOM Biowulf cluster at the University of Akron. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed M, 2010, NAT STRUCT MOL BIOL, V17, P561, DOI 10.1038/nsmb.1799; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bellesia G, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3216103; Blackley HKL, 1999, EXP NEUROL, V158, P437, DOI 10.1006/exnr.1999.7114; CATRIONA AM, 1999, ANN NEUROL, V46, P860; Cerf E, 2009, BIOCHEM J, V421, P415, DOI 10.1042/BJ20090379; Chaudhary N, 2008, BIOPOLYMERS, V90, P783, DOI 10.1002/bip.21087; Cheon M, 2007, PLOS COMPUT BIOL, V3, P1727, DOI 10.1371/journal.pcbi.0030173; DICARLO M, 2009, EURO BIOPHYS J; DOMINIC M, 2007, J NEUROCHEM, V101, P1172; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Goda R, 2008, BIOMED CHROMATOGR, V22, P1279, DOI 10.1002/bmc.1058; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Huang THJ, 2000, J MOL BIOL, V297, P73, DOI 10.1006/jmbi.2000.3559; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hung LW, 2008, J NEUROSCI, V28, P11950, DOI 10.1523/JNEUROSCI.3916-08.2008; Hwang W, 2004, P NATL ACAD SCI USA, V101, P12916, DOI 10.1073/pnas.0402634101; Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321; Jang H, 2007, BIOPHYS J, V93, P1938, DOI 10.1529/biophysj.107.110148; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200; Kim S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3447894; Kirkitadze MD, 2002, J NEUROSCI RES, V69, P567, DOI 10.1002/jnr.10328; Krone MG, 2008, J AM CHEM SOC, V130, P11066, DOI 10.1021/ja8017303; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lee YH, 2009, J BIOL CHEM, V284, P2169, DOI 10.1074/jbc.M806939200; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Ma BY, 2010, J BIOL CHEM, V285, P37102, DOI 10.1074/jbc.M110.133488; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Meredith SC, 2005, ANN NY ACAD SCI, V1066, P181, DOI 10.1196/annals.1363.030; Miller Y, 2011, J AM CHEM SOC, V133, P2742, DOI 10.1021/ja1100273; Miller Y, 2010, P NATL ACAD SCI USA, V107, P14128, DOI 10.1073/pnas.1004704107; Miller Y, 2010, CHEM REV, V110, P4820, DOI 10.1021/cr900377t; Mukherjee S, 2009, J PHYS CHEM B, V113, P531, DOI 10.1021/jp809817s; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Petkova AT, 2006, BIOCHEMISTRY-US, V45, P498, DOI 10.1021/bi051952q; Quist A, 2005, P NATL ACAD SCI USA, V102, P10427, DOI 10.1073/pnas.0502066102; Ravault S, 2005, PROTEIN SCI, V14, P1181, DOI 10.1110/ps.041291405; Reddy G, 2010, P NATL ACAD SCI USA, V107, P21459, DOI 10.1073/pnas.1008616107; Reddy G, 2009, J PHYS CHEM B, V113, P1162, DOI 10.1021/jp808914c; Rezaei-Ghaleh N, 2009, BIOPOLYMERS, V91, P28, DOI 10.1002/bip.21079; Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4; Roher AE, 1996, J BIOL CHEM, V271, P20631, DOI 10.1074/jbc.271.34.20631; Sato T, 2006, BIOCHEMISTRY-US, V45, P5503, DOI 10.1021/bi052485f; Schmechel A, 2003, J BIOL CHEM, V278, P35317, DOI 10.1074/jbc.M303547200; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Viola KL, 2008, J NUTR HEALTH AGING, V12, p51S, DOI 10.1007/BF02982587; Wray S, 2009, J NEUROSCI, V29, P9665, DOI 10.1523/JNEUROSCI.2234-09.2009; Yu LP, 2009, BIOCHEMISTRY-US, V48, P1870, DOI 10.1021/bi802046n; Yu XA, 2010, BIOPHYS J, V99, P666, DOI 10.1016/j.bpj.2010.05.006; Zhang A, 2009, BIOPHYS J, V96, P1091, DOI 10.1016/j.bpj.2008.10.022; Zheng J, 2008, J PHYS CHEM B, V112, P6856, DOI 10.1021/jp711335b; Zheng J, 2008, FRONT BIOSCI-LANDMRK, V13, P3919, DOI 10.2741/2980; Zheng J, 2008, BIOCHEMISTRY-US, V47, P2497, DOI 10.1021/bi7019194; Zheng J, 2007, BIOPHYS J, V93, P3046, DOI 10.1529/biophysj.107.110700; Zheng J, 2010, J PHYS CHEM B, V114, P463, DOI 10.1021/jp907608s; Zhu M, 2004, J BIOL CHEM, V279, P24452, DOI 10.1074/jbc.M400004200	62	87	88	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2011	6	6							e20575	10.1371/journal.pone.0020575	http://dx.doi.org/10.1371/journal.pone.0020575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777HR	22174866	Green Submitted, gold, Green Published			2022-12-25	WOS:000291607000013
J	Zhang, PF; Dong, GH; Sun, BJ; Zhang, LW; Chen, X; Ma, NN; Yu, F; Guo, HM; Huang, H; Lee, YL; Tang, NJ; Chen, J				Zhang, Pengfei; Dong, Guanghui; Sun, Baijun; Zhang, Liwen; Chen, Xi; Ma, Nannan; Yu, Fei; Guo, Huimin; Huang, Hui; Lee, Yungling Leo; Tang, Naijun; Chen, Jie			Long-Term Exposure to Ambient Air Pollution and Mortality Due to Cardiovascular Disease and Cerebrovascular Disease in Shenyang, China	PLOS ONE			English	Article							PARTICULATE MATTER; HEALTH; WOMEN; ASSOCIATIONS; VARIABILITY; ADMISSIONS; DEPOSITION; COMPONENTS; PARTICLES; EDUCATION	Background: The relationship between ambient air pollution exposure and mortality of cardiovascular and cerebrovascular diseases in human is controversial, and there is little information about how exposures to ambient air pollution contribution to the mortality of cardiovascular and cerebrovascular diseases among Chinese. The aim of the present study was to examine whether exposure to ambient-air pollution increases the risk for cardiovascular and cerebrovascular disease. Methodology/Principal Findings: We conducted a retrospective cohort study among humans to examine the association between compound-air pollutants [particulate matter <10 mu m in aerodynamic diameter (PM10), sulfur dioxide (SO2) and nitrogen dioxide (NO2)] and mortality in Shenyang, China, using 12 years of data (1998-2009). Also, stratified analysis by sex, age, education, and income was conducted for cardiovascular and cerebrovascular mortality. The results showed that an increase of 10 mu g/m(3) in a year average concentration of PM10 corresponds to 55% increase in the risk of a death cardiovascular disease (hazard ratio [HR], 1.55; 95% confidence interval [CI], 1.51 to 1.60) and 49% increase in cerebrovascular disease (HR, 1.49; 95% CI, 1.45 to 1.53), respectively. The corresponding figures of adjusted HR (95% CI) for a 10 mu g/m(3) increase in NO2 was 2.46 (2.31 to 2.63) for cardiovascular mortality and 2.44 (2.27 to 2.62) for cerebrovascular mortality, respectively. The effects of air pollution were more evident in female that in male, and nonsmokers and residents with BMI < 18.5 were more vulnerable to outdoor air pollution. Conclusion/Significance: Long-term exposure to ambient air pollution is associated with the death of cardiovascular and cerebrovascular diseases among Chinese populations.	[Zhang, Pengfei; Dong, Guanghui; Ma, Nannan; Yu, Fei; Guo, Huimin; Huang, Hui] China Med Univ, Sch Publ Hlth, Dept Biostat, Shenyang, Peoples R China; [Dong, Guanghui; Chen, Jie] China Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Shenyang, Peoples R China; [Sun, Baijun] Shenyang Ctr Dis Control & Prevent, Shenyang, Peoples R China; [Zhang, Liwen; Chen, Xi; Tang, Naijun] Tianjin Med Univ, Dept Occupat Hlth, Coll Publ Hlth, Tianjin, Peoples R China; [Lee, Yungling Leo] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Coll Publ Hlth, Taipei 10764, Taiwan	China Medical University; China Medical University; Tianjin Medical University; National Taiwan University	Zhang, PF (corresponding author), China Med Univ, Sch Publ Hlth, Dept Biostat, Shenyang, Peoples R China.	chenjie@mail.cmu.edu.cn	Lee, Yungling/S-7011-2018; Dong, Guanghui/AAN-4630-2020	Lee, Yungling/0000-0002-2234-9479; Zhang, Liwen/0000-0002-5077-9732; Dong, Guang-Hui/0000-0002-2578-3369	Welfare Profession of China Environmental Protection Foundation [200709048]	Welfare Profession of China Environmental Protection Foundation	The funding for this study is supported by grants from the Special Scientific Research Fund of Welfare Profession of China Environmental Protection Foundation (200709048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becklake MR, 1999, THORAX, V54, P1119, DOI 10.1136/thx.54.12.1119; Bell ML, 2009, AM J RESP CRIT CARE, V179, P1115, DOI 10.1164/rccm.200808-1240OC; Brauer Michael, 2010, Proc Am Thorac Soc, V7, P111, DOI 10.1513/pats.200908-093RM; Cakmak S, 2006, J OCCUP ENVIRON MED, V48, P89, DOI 10.1097/01.jom.0000184878.11956.4b; Chan CC, 2006, EUR HEART J, V27, P1238, DOI 10.1093/eurheartj/ehi835; DOCKERY DW, 1992, ENVIRON RES, V59, P362, DOI 10.1016/S0013-9351(05)80042-8; Filleul L, 2005, OCCUP ENVIRON MED, V62, P453, DOI 10.1136/oem.2004.014746; Finkelstein MM, 2005, J EPIDEMIOL COMMUN H, V59, P481, DOI 10.1136/jech.2004.026203; Frampton MW, 2006, ENVIRON HEALTH PERSP, V114, P51, DOI 10.1289/ehp.7962; Franklin M, 2008, EPIDEMIOLOGY, V19, P680, DOI 10.1097/EDE.0b013e3181812bb7; Hong YC, 2002, ENVIRON HEALTH PERSP, V110, P187, DOI 10.1289/ehp.02110187; Jerrett M, 2004, J EPIDEMIOL COMMUN H, V58, P31, DOI 10.1136/jech.58.1.31; Jousilahti P, 1996, LANCET, V348, P567, DOI 10.1016/S0140-6736(96)02374-4; Kan HD, 2008, ENVIRON HEALTH PERSP, V116, P1183, DOI 10.1289/ehp.10851; Kim CS, 1998, J APPL PHYSIOL, V84, P1834, DOI 10.1152/jappl.1998.84.6.1834; Kim E, 2005, ENVIRON SCI TECHNOL, V39, P4172, DOI 10.1021/es049824x; Kim SB, 2008, J AIR WASTE MANAGE, V58, P965, DOI 10.3155/1047-3289.58.7.965; Kohlhaufl M, 1999, AM J RESP CRIT CARE, V159, P902, DOI 10.1164/ajrccm.159.3.9805036; Kunzli N, 2005, ENVIRON HEALTH PERSP, V113, P201, DOI 10.1289/ehp.7523; Lipfert FW, 2006, INHAL TOXICOL, V18, P645, DOI 10.1080/08958370600742946; Lippmann M, 2006, ENVIRON HEALTH PERSP, V114, P1662, DOI 10.1289/ehp.9150; Lippmann M, 2009, CRIT REV TOXICOL, V39, P865, DOI 10.3109/10408440903300080; Maheswaran R, 2005, STROKE, V36, P239, DOI 10.1161/01.STR.0000151363.71221.12; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Moolgavkar SH, 1996, EPIDEMIOLOGY, V7, P420, DOI 10.1097/00001648-199607000-00014; Nafstad P, 2004, ENVIRON HEALTH PERSP, V112, P610, DOI 10.1289/ehp.6684; O'Neill MS, 2003, ENVIRON HEALTH PERSP, V111, P1861, DOI 10.1289/ehp.6334; Pererz L, 2009, ENVIRON SCI TECHNOL, V43, P4707, DOI 10.1021/es8031488; POLGAR G, 1979, AM REV RESPIR DIS, V120, P625; Pope CA, 2004, CIRCULATION, V109, P71, DOI 10.1161/01.CIR.0000108927.80044.7F; Ren DY, 2004, INT J COAL GEOL, V57, P187, DOI 10.1016/j.coal.2003.10.001; Romieu I, 2005, AM J RESP CRIT CARE, V172, P1534, DOI 10.1164/rccm.200503-372OC; Sun QH, 2010, CIRCULATION, V121, P2755, DOI 10.1161/CIRCULATIONAHA.109.893461; Sunyer J, 2000, AM J EPIDEMIOL, V151, P50, DOI 10.1093/oxfordjournals.aje.a010121; Toren K, 2007, OCCUP ENVIRON MED, V64, P515, DOI 10.1136/oem.2006.029488; Townend JN, 2005, THORAX, V60, P441, DOI 10.1136/thx.2004.037903; Wong TW, 2002, OCCUP ENVIRON MED, V59, P30, DOI 10.1136/oem.59.1.30; Xu ZY, 2000, ARCH ENVIRON HEALTH, V55, P115, DOI 10.1080/00039890009603397; YUNGINGER JW, 1992, AM REV RESPIR DIS, V146, P888, DOI 10.1164/ajrccm/146.4.888; Zhang JJ, 2007, ENVIRON HEALTH PERSP, V115, P848, DOI 10.1289/ehp.9479; ZHAO DW, 1986, JAPCA J AIR WASTE MA, V36, P371, DOI 10.1080/00022470.1986.10466074	41	125	132	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2011	6	6							e20827	10.1371/journal.pone.0020827	http://dx.doi.org/10.1371/journal.pone.0020827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JU	22164211	Green Submitted, gold, Green Published			2022-12-25	WOS:000291612600030
J	Kumar, A; Gao, H; Xu, J; Reuben, J; Yu, DH; Mehta, K				Kumar, Anupam; Gao, Hui; Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil			Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; DRUG-RESISTANT; GLAND CELLS; BREAST; PROLIFERATION; MECHANISMS	Cancer stem cells (CSCs) or tumor initiating cells (TICs) make up only a small fraction of total tumor cell population, but recent evidence suggests that they are responsible for tumor initiation and the maintenance of tumor growth. Whether CSCs/TICs originate from normal stem cells or result from the dedifferentiation of terminally differentiated cells remains unknown. Here we provide evidence that sustained expression of the proinflammatory protein tissue transglutaminase (TG2) confers stem cell like properties in non-transformed and transformed mammary epithelial cells. Sustained expression of TG2 was associated with increase in CD44(high)/CD24(low/-) subpopulation, increased ability of cells to form mammospheres, and acquisition of self-renewal ability. Mammospheres derived from TG2-transfected mammary epithelial cells (MCF10A) differentiated into complex secondary structures when grown in Matrigel cultures. Cells in these secondary structures differentiated into Muc1-positive (luminal marker) and integrin alpha 6-positive (basal marker) cells in response to prolactin treatment. Highly aggressive MDA-231 and drug-resistant MCF-7/RT breast cancer cells, which express high basal levels of TG2, shared many traits with TG2-transfected MCF10A stem cells but unlike MCF10A-derived stem cells they failed to form the secondary structures and to differentiate into Muc1-positive luminal cells when grown in Matrigel culture. Downregulation of TG2 attenuated stem cell properties in both non-transformed and transformed mammary epithelial cells. Taken together, these results suggested a new function for TG2 and revealed a novel mechanism responsible for promoting the stem cell characteristics in adult mammary epithelial cells.	[Kumar, Anupam; Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Gao, Hui; Reuben, James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Xu, Jia; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kumar, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kmehta@mdanderson.org	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Susan G. Komen for the Cure Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from Susan G. Komen for the Cure Foundation (http://ww5.komen.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gamucci T, 2007, BRIT J CANCER, V97, P1040, DOI 10.1038/sj.bjc.6603982; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Lacerda L, 2010, DRUG RESIST UPDATE, V13, P99, DOI 10.1016/j.drup.2010.08.001; Lawson JC, 2009, BREAST CANCER RES TR, V118, P241, DOI 10.1007/s10549-009-0524-9; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; LU S, 1995, J BIOL CHEM, V270, P9748, DOI 10.1074/jbc.270.17.9748; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; SUTO N, 1993, J BIOL CHEM, V268, P7469; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716	31	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20701	10.1371/journal.pone.0020701	http://dx.doi.org/10.1371/journal.pone.0020701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21526230	Green Published, gold, Green Submitted			2022-12-25	WOS:000291611500037
J	Kumar, A; Bullard, RL; Patel, P; Paslay, LC; Singh, D; Bienkiewicz, EA; Morgan, SE; Rangachari, V				Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Paslay, Lea C.; Singh, Dipti; Bienkiewicz, Ewa A.; Morgan, Sarah E.; Rangachari, Vijayaraghavan			Non-Esterified Fatty Acids Generate Distinct Low-Molecular Weight Amyloid-beta (A beta 42) Oligomers along Pathway Different from Fibril Formation	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; ALPHA-SYNUCLEIN; IN-VITRO; CONTAINING MEMBRANES; APOLIPOPROTEIN-E; ENDOGENOUS SEED; LIPID-MEMBRANES; TRANSGENIC MICE	Amyloid-beta (A beta) peptide aggregation is known to play a central role in the etiology of Alzheimer's disease (AD). Among various aggregates, low-molecular weight soluble oligomers of A beta are increasingly believed to be the primary neurotoxic agents responsible for memory impairment. Anionic interfaces are known to influence the A beta aggregation process significantly. Here, we report the effects of interfaces formed by medium-chain (C9-C12), saturated non-esterified fatty acids (NEFAs) on A beta 42 aggregation. NEFAs uniquely affected A beta 42 aggregation rates that depended on both the ratio of A beta:NEFA as well the critical micelle concentration (CMC) of the NEFAs. More importantly, irrespective of the kind of NEFA used, we observed that two distinct oligomers, 12-18 mers and 4-5 mers were formed via different pathway of aggregation under specific experimental conditions: (i) 12-18 mers were generated near the CMC in which NEFAs augment the rate of A beta 42 aggregation towards fibril formation, and, (ii) 4-5 mers were formed above the CMC, where NEFAs inhibit fibril formation. The data indicated that both 12-18 mers and 4-5 mers are formed along an alternate pathway called 'off-pathway' that did not result in fibril formation and yet have subtle structural and morphological differences that distinguish their bulk molecular behavior. These observations, (i) reflect the possible mechanism of A beta aggregation in physiological lipid-rich environments, and (ii) reiterate the fact that all oligomeric forms of A beta need not be obligatory intermediates of the fibril formation pathway.	[Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Paslay, Lea C.; Singh, Dipti; Morgan, Sarah E.] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA; [Bienkiewicz, Ewa A.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	University of Southern Mississippi; University of Southern Mississippi; State University System of Florida; Florida State University	Kumar, A (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Alzheimer's Association [NIRG-09-132721]; American Heart Association [0535185N]; National Science Foundation [DMR-0213883]; National Center for Research Resources, National Institutes of Health [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by NIRG grant from Alzheimer's Association (NIRG-09-132721) (www.Alz.org) and an American Heart Association SDG award (0535185N) for VR (www.AHA.org). Partial support by the MRSEC program of the National Science Foundation (DMR-0213883) as well as Mississippi INBRE funded by the National Center for Research Resources, National Institutes of Health (award# P20RR016476) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Carpentier YA, 2006, PROSTAG LEUKOTR ESS, V75, P145, DOI 10.1016/j.plefa.2006.05.004; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fletcher TG, 1997, PROTEIN SCI, V6, P666; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Hagihara Y, 2002, BIOCHEMISTRY-US, V41, P1020, DOI 10.1021/bi015693q; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; LUZZATI V, 1966, ANN NY ACAD SCI, V137, P409, DOI 10.1111/j.1749-6632.1966.tb50172.x; Ma Z, 2002, MOL MED, V8, P863, DOI 10.1007/BF03402092; Mandal PK, 2004, NEUROCHEM RES, V29, P2273, DOI 10.1007/s11064-004-7036-0; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MAYES PA, 2000, LANGE MED BOOKS, P268; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MICHAEL R, 2005, BIOCHEMISTRY-US, V44, P165; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Perczel A., 1996, CIRCULAR DICHROISM C, P285; Pillot T, 1996, J BIOL CHEM, V271, P28757, DOI 10.1074/jbc.271.46.28757; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; REISSHUSSON F, 1966, J COLLOID INTERF SCI, V21, P534, DOI 10.1016/0095-8522(66)90051-1; Ross BP, 2004, MOL PHARMACEUT, V1, P233, DOI 10.1021/mp049964d; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Schlame M, 1996, J LIPID RES, V37, P2608; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; SOLFRIZZI V, 2009, AGEING RES REV; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Waiter MF, 1997, BIOCHEM BIOPH RES CO, V233, P760, DOI 10.1006/bbrc.1997.6547; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Wood SJ, 1996, J BIOL CHEM, V271, P4086; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Yamamoto N, 2004, FEBS LETT, V569, P135, DOI 10.1016/j.febslet.2004.05.037; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	71	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18759	10.1371/journal.pone.0018759	http://dx.doi.org/10.1371/journal.pone.0018759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526230	Green Published, gold, Green Submitted			2022-12-25	WOS:000289671100019
J	Zhang, LJ; Xi, J; Xu, GQ; Shu, H; Wang, XY; Li, P				Zhang, Linjun; Xi, Jie; Xu, Guoqing; Shu, Hua; Wang, Xiaoyi; Li, Ping			Cortical Dynamics of Acoustic and Phonological Processing in Speech Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TOP-DOWN INFLUENCES; HIERARCHICAL ORGANIZATION; INTELLIGIBLE SPEECH; MECHANISMS; PITCH; NEUROANATOMY; INFORMATION; MODULATION; NETWORKS	In speech perception, a functional hierarchy has been proposed by recent functional neuroimaging studies: Core auditory areas on the dorsal plane of superior temporal gyrus (STG) are sensitive to basic acoustic characteristics, whereas downstream regions, specifically the left superior temporal sulcus (STS) and middle temporal gyrus (MTG) ventral to Heschl's gyrus (HG) are responsive to abstract phonological features. What is unclear so far is the relationship between the dorsal and ventral processes, especially with regard to whether low-level acoustic processing is modulated by high-level phonological processing. To address the issue, we assessed sensitivity of core auditory and downstream regions to acoustic and phonological variations by using within-and across-category lexical tonal continua with equal physical intervals. We found that relative to within-category variation, across-category variation elicited stronger activation in the left middle MTG (mMTG), apparently reflecting the abstract phonological representations. At the same time, activation in the core auditory region decreased, resulting from the top-down influences of phonological processing. These results support a hierarchical organization of the ventral acoustic-phonological processing stream, which originates in the right HG/STG and projects to the left mMTG. Furthermore, our study provides direct evidence that low-level acoustic analysis is modulated by high-level phonological representations, revealing the cortical dynamics of acoustic and phonological processing in speech perception. Our findings confirm the existence of reciprocal progression projections in the auditory pathways and the roles of both feed-forward and feedback mechanisms in speech perception.	[Zhang, Linjun; Xi, Jie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Linjun] Beijing Language & Culture Univ, Coll Chinese Studies, Beijing, Peoples R China; [Xi, Jie] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Xu, Guoqing] Dalian Med Univ, Dept Psychol, Dalian, Peoples R China; [Wang, Xiaoyi] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Li, Ping] Penn State Univ, Ctr Language Sci, University Pk, PA 16802 USA	Beijing Normal University; Beijing Language & Culture University; Chinese Academy of Sciences; Institute of Psychology, CAS; Dalian Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, LJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn; pul8@psu.edu	; Speicher, Andreas/B-3134-2014	Lin, Jinxing/0000-0001-9338-1356; Speicher, Andreas/0000-0001-6608-3994; Li, Ping/0000-0002-3314-943X	Program for Changjiang Scholars and Innovative Research Team in University [IRT0710]; Natural Science Foundation of China [30870758]; Natural Science Foundation of Beijing [7092051]; Fund for Foreign Scholars in University Research and Teaching Programs [B07008]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Fund for Foreign Scholars in University Research and Teaching Programs	The research was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0710, http://www.cksp.edu.cn/index.php), by grants from the Natural Science Foundation of China (30870758, http://www.nsfc.gov.cn/Portal0/default124.htm), by grants from the Natural Science Foundation of Beijing (7092051, http://www.bjnsf.org/) to HS, and the Fund for Foreign Scholars in University Research and Teaching Programs (B07008, http://www.bjnsf.org/) to PL and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Joanisse MF, 2007, CEREB CORTEX, V17, P2084, DOI 10.1093/cercor/bhl124; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Liebenthal E, 2010, CEREB CORTEX, V20, P2958, DOI 10.1093/cercor/bhq045; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Schofield TM, 2009, P NATL ACAD SCI USA, V106, P11765, DOI 10.1073/pnas.0811402106; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Tervaniemi M, 2006, J NEUROSCI, V26, P8647, DOI 10.1523/JNEUROSCI.0995-06.2006; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922	36	344	349	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20963	10.1371/journal.pone.0020963	http://dx.doi.org/10.1371/journal.pone.0020963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	22022536	gold, Green Published, Green Submitted			2022-12-25	WOS:000291663300033
